Citrus Sinensis ID: 010513
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 508 | 2.2.26 [Sep-21-2011] | |||||||
| Q3EDL4 | 472 | Probable serine/threonine | no | no | 0.834 | 0.898 | 0.633 | 1e-169 | |
| Q6NKZ9 | 437 | Probable receptor-like se | no | no | 0.811 | 0.942 | 0.558 | 1e-140 | |
| Q9SJG2 | 494 | Probable receptor-like pr | no | no | 0.852 | 0.876 | 0.534 | 1e-137 | |
| Q8LEB6 | 484 | Probable receptor-like pr | no | no | 0.864 | 0.907 | 0.537 | 1e-135 | |
| Q9LRP3 | 467 | Probable receptor-like pr | no | no | 0.834 | 0.907 | 0.512 | 1e-129 | |
| Q9ZUE0 | 720 | Proline-rich receptor-lik | no | no | 0.641 | 0.452 | 0.452 | 6e-78 | |
| Q9CAL8 | 710 | Proline-rich receptor-lik | no | no | 0.671 | 0.480 | 0.434 | 4e-76 | |
| Q9FFW5 | 681 | Proline-rich receptor-lik | no | no | 0.606 | 0.452 | 0.454 | 3e-74 | |
| Q9C660 | 762 | Proline-rich receptor-lik | no | no | 0.590 | 0.393 | 0.450 | 5e-74 | |
| Q9LV48 | 652 | Proline-rich receptor-lik | no | no | 0.557 | 0.434 | 0.457 | 2e-73 |
| >sp|Q3EDL4|Y1154_ARATH Probable serine/threonine-protein kinase At1g01540 OS=Arabidopsis thaliana GN=At1g01540 PE=1 SV=2 | Back alignment and function desciption |
|---|
Score = 597 bits (1538), Expect = e-169, Method: Compositional matrix adjust.
Identities = 303/478 (63%), Positives = 358/478 (74%), Gaps = 54/478 (11%)
Query: 1 MSHY--SFLNDQLSKRTSIFGLRLWVVLGICVGAGIVLVLFLISLWFTSKRNSNNSKRQL 58
MS Y +FLN +LSK TSIFGLRLWVV+GI +G+ IV+ LFL+SL TS+R + +
Sbjct: 1 MSVYDAAFLNTELSKPTSIFGLRLWVVIGILLGSLIVIALFLLSLCLTSRRKNRKPRADF 60
Query: 59 NAAKSSSLCSNYNSSSGNPTIPNISKEIQEIRIDPDSNSNSNCKPHSAPNPDPLPEPEPI 118
+A ++ P ISKEI+EI P
Sbjct: 61 ASAAIAT--------------PPISKEIKEI--------------------------VPA 80
Query: 119 LVEDSPASGRNRIHIEIGK-DHRIAYPER-AAGSHHGSGDQTVAAAIT------PEVSHL 170
+ PA I ++IGK +HR+ + +R ++G G+ + A+ + PEVSHL
Sbjct: 81 QNQSVPAE----IQVDIGKIEHRVVFSDRVSSGESRGTASASETASYSGSGNCGPEVSHL 136
Query: 171 GWGHWYTLRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFK 230
GWG WYTLRELE +TNG +ENVIGEGGYGIVY G+L D T VAVKNLLNNRGQAEKEFK
Sbjct: 137 GWGRWYTLRELEAATNGLCEENVIGEGGYGIVYRGILTDGTKVAVKNLLNNRGQAEKEFK 196
Query: 231 VEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMN 290
VEVE IGRVRHKNLVRLLGYC EGA+RMLVY+++DNGNLEQW+HGDVG SPLTW+IRMN
Sbjct: 197 VEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYDFVDNGNLEQWIHGDVGDVSPLTWDIRMN 256
Query: 291 IILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRV 350
IILG AKGL YLHEGLEPKVVHRDIKSSNILLD+QWN K+SDFGLAKLLG+E SYVTTRV
Sbjct: 257 IILGMAKGLAYLHEGLEPKVVHRDIKSSNILLDRQWNAKVSDFGLAKLLGSESSYVTTRV 316
Query: 351 MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVT 410
MGTFGYVAPEYA TGMLNE+SD+YSFGILIME+I+GRNPVDYSRP GE NLV+WLK+MV
Sbjct: 317 MGTFGYVAPEYACTGMLNEKSDIYSFGILIMEIITGRNPVDYSRPQGETNLVDWLKSMVG 376
Query: 411 NRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEEFPFRD 468
NR +E V+DP++ E P S+ALKR LLVALRCVDP+A+KRPKMGH+IHMLEAE+ +RD
Sbjct: 377 NRRSEEVVDPKIPEPPSSKALKRVLLVALRCVDPDANKRPKMGHIIHMLEAEDLLYRD 434
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q6NKZ9|Y4345_ARATH Probable receptor-like serine/threonine-protein kinase At4g34500 OS=Arabidopsis thaliana GN=At4g34500 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 499 bits (1284), Expect = e-140, Method: Compositional matrix adjust.
Identities = 256/458 (55%), Positives = 320/458 (69%), Gaps = 46/458 (10%)
Query: 12 SKRTSIFGLRLWVVLGICVGAGIVLVLFLISLWFTSKRNSNNSKRQLNAAKSSSLCSNYN 71
+ + S+FGL L++V+ IC + ++L + ++ N + R++ SS
Sbjct: 13 TTKPSVFGLNLYLVIAIC---SVFILLISLLIFLFVCLNRVSRARRMRVKHSSG------ 63
Query: 72 SSSGNPTIPNISKEIQEIRIDPDSNSNSNCKPHSAPNPDPLPEPEPILVEDSPASGRNRI 131
+IP +SKEI EI+ + I +DS N +
Sbjct: 64 ------SIPLVSKEISEIKT----------------------VGKFINSDDSKGKIGNEV 95
Query: 132 HIEIGKDHRIAYPERAAGSHHGSGDQTVAAAITPEVSHLGWGHWYTLRELEVSTNGFADE 191
+ + + A S SGD + A +GWG WY+L++LE++T GF+D+
Sbjct: 96 VVVVSATSKEATSGFDTLSVASSGDVGTSEA-------MGWGKWYSLKDLEIATRGFSDD 148
Query: 192 NVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYC 251
N+IGEGGYG+VY D + AVKNLLNN+GQAEKEFKVEVEAIG+VRHKNLV L+GYC
Sbjct: 149 NMIGEGGYGVVYRADFSDGSVAAVKNLLNNKGQAEKEFKVEVEAIGKVRHKNLVGLMGYC 208
Query: 252 AEGAH--RMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK 309
A+ A RMLVYEYIDNGNLEQWLHGDVGP SPLTW+IRM I +GTAKGL YLHEGLEPK
Sbjct: 209 ADSAQSQRMLVYEYIDNGNLEQWLHGDVGPVSPLTWDIRMKIAIGTAKGLAYLHEGLEPK 268
Query: 310 VVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNE 369
VVHRD+KSSNILLDK+WN K+SDFGLAKLLG+E SYVTTRVMGTFGYV+PEYASTGMLNE
Sbjct: 269 VVHRDVKSSNILLDKKWNAKVSDFGLAKLLGSETSYVTTRVMGTFGYVSPEYASTGMLNE 328
Query: 370 RSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSR 429
SDVYSFG+L+ME+I+GR+PVDYSRPPGE+NLV+W K MV +R E V+DP+++ P R
Sbjct: 329 CSDVYSFGVLLMEIITGRSPVDYSRPPGEMNLVDWFKGMVASRRGEEVIDPKIKTSPPPR 388
Query: 430 ALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEEFPFR 467
ALKRALLV LRC+D ++ KRPKMG +IHMLEAE+FPFR
Sbjct: 389 ALKRALLVCLRCIDLDSSKRPKMGQIIHMLEAEDFPFR 426
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SJG2|Y2296_ARATH Probable receptor-like protein kinase At2g42960 OS=Arabidopsis thaliana GN=At2g42960 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 489 bits (1258), Expect = e-137, Method: Compositional matrix adjust.
Identities = 264/494 (53%), Positives = 329/494 (66%), Gaps = 61/494 (12%)
Query: 1 MSHYSFLNDQLSKRTSIFGLR---LWVVLGICVGAGIVLVLFLISLWFTSKRNSNNSKRQ 57
M S LN ++SK+ S FGL+ LWV + + VG IV++L ++SLW T +R S S +
Sbjct: 1 MPPESSLNAEMSKKISFFGLKGLKLWVWVCLVVGVFIVMILCILSLWITFRRKSRRSSSK 60
Query: 58 LNAAKSSSLCSNYNSSSGNPTIPNISKEIQEIRIDPDSNSNSNCKPHSAPNPDPLPEPEP 117
+N IP++SK+I R+D N P PE
Sbjct: 61 FP----------FNQ------IPHVSKDI---RVDRAGFQN--------------PHPES 87
Query: 118 ILVEDSPASGRNRIHIEIGKDHR-----------IAYPERAAGSHHG-------SGDQTV 159
+ +E + S + +G+ + + ERA SH G +G Q
Sbjct: 88 LYIEMNDKSTGKTMMSHLGRTKSSDNDTLSQCSSVNHHERACSSHSGEEGGFGSAGRQYG 147
Query: 160 AAAIT-------PEVSHLGWGHWYTLRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTN 212
+T PE+SHLGWGHW+TLR+LE++TN FA NV+GEGGYG+VY G L + T
Sbjct: 148 GGPVTASPLVGLPEISHLGWGHWFTLRDLELATNRFAPVNVLGEGGYGVVYRGKLVNGTE 207
Query: 213 VAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQW 272
VAVK LLNN GQAEKEF+VEVEAIG VRHKNLVRLLGYC EG HRMLVYEY+++GNLEQW
Sbjct: 208 VAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEYVNSGNLEQW 267
Query: 273 LHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSD 332
LHG + H LTWE RM II GTA+ L YLHE +EPKVVHRDIK+SNIL+D ++N KLSD
Sbjct: 268 LHGAMRQHGNLTWEARMKIITGTAQALAYLHEAIEPKVVHRDIKASNILIDDEFNAKLSD 327
Query: 333 FGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDY 392
FGLAKLL + S++TTRVMGTFGYVAPEYA+TG+LNE+SD+YSFG+L++E I+GR+PVDY
Sbjct: 328 FGLAKLLDSGESHITTRVMGTFGYVAPEYANTGLLNEKSDIYSFGVLLLEAITGRDPVDY 387
Query: 393 SRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKM 452
RP EVNLVEWLK MV R AE V+DPRL+ +P ALKRALLV+LRCVDP A KRP+M
Sbjct: 388 GRPANEVNLVEWLKMMVGTRRAEEVVDPRLEPRPSKSALKRALLVSLRCVDPEAEKRPRM 447
Query: 453 GHVIHMLEAEEFPF 466
V MLE++E PF
Sbjct: 448 SQVARMLESDEHPF 461
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8LEB6|Y5185_ARATH Probable receptor-like protein kinase At5g18500 OS=Arabidopsis thaliana GN=At5g18500 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 482 bits (1241), Expect = e-135, Method: Compositional matrix adjust.
Identities = 250/465 (53%), Positives = 320/465 (68%), Gaps = 26/465 (5%)
Query: 5 SFLNDQLSKRTSIFGLRLWVVLGICVGAGIVLVLFLISLWFTSKRNSNNSKRQLNAAKSS 64
S LND LS+ + GL LW ++ I + A I +V+ ISLW T +R ++ S L
Sbjct: 3 SGLNDTLSRNYN--GLELWEIIVIVLSA-IFVVVLAISLWLTFRRKTSRSSSNLIPVSRQ 59
Query: 65 SLCSNYNSSSGNPTIPNISKEIQEIRIDPDSNSNSNCKPHSAPNPDPLPEPEPILVEDSP 124
P++ +EI+EIR+D S+SN S EPE + +S
Sbjct: 60 -------------IPPSVPEEIKEIRVDEVSSSNGGNGYPSISEKFGDKEPEKGIKAESE 106
Query: 125 ASGRNRIHIEIGKDHRIAYPERAAGSHHGSGDQTVAAAIT---PEVSHLGWGHWYTLREL 181
+R + E+ GS S + A + PE SHLGWGHW+TLR+L
Sbjct: 107 NGDSSR-------SGSFNHLEKKDGSSVSSANPLTAPSPLSGLPEFSHLGWGHWFTLRDL 159
Query: 182 EVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRH 241
+++TN F+ +N+IG+GGYG+VY G L + T VAVK LLNN GQA+K+F+VEVEAIG VRH
Sbjct: 160 QMATNQFSRDNIIGDGGYGVVYRGNLVNGTPVAVKKLLNNLGQADKDFRVEVEAIGHVRH 219
Query: 242 KNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTY 301
KNLVRLLGYC EG RMLVYEY++NGNLEQWL GD H LTWE R+ I++GTAK L Y
Sbjct: 220 KNLVRLLGYCMEGTQRMLVYEYVNNGNLEQWLRGDNQNHEYLTWEARVKILIGTAKALAY 279
Query: 302 LHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEY 361
LHE +EPKVVHRDIKSSNIL+D ++N K+SDFGLAKLLGA++S++TTRVMGTFGYVAPEY
Sbjct: 280 LHEAIEPKVVHRDIKSSNILIDDKFNSKISDFGLAKLLGADKSFITTRVMGTFGYVAPEY 339
Query: 362 ASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPR 421
A++G+LNE+SDVYSFG++++E I+GR PVDY+RPP EV+LVEWLK MV R +E V+DP
Sbjct: 340 ANSGLLNEKSDVYSFGVVLLEAITGRYPVDYARPPPEVHLVEWLKMMVQQRRSEEVVDPN 399
Query: 422 LQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEEFPF 466
L+ KP + ALKR LL ALRCVDP + KRP+M V MLE+EE+P
Sbjct: 400 LETKPSTSALKRTLLTALRCVDPMSEKRPRMSQVARMLESEEYPI 444
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LRP3|Y3174_ARATH Probable receptor-like protein kinase At3g17420 OS=Arabidopsis thaliana GN=At3g17420 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 463 bits (1191), Expect = e-129, Method: Compositional matrix adjust.
Identities = 239/466 (51%), Positives = 314/466 (67%), Gaps = 42/466 (9%)
Query: 5 SFLNDQLSKRTSIFGLRLWVVLGICVGAGIVLVLFLISLWFTSKRNSNNSKRQLNAAKSS 64
S L L+KR + L LW ++ I + A +++L L S+W + ++ S S S
Sbjct: 3 SQLKRTLTKRYGV--LELWEIIVIALFAAFIVILVL-SVWLSFRKKSKRSNATTLPVTQS 59
Query: 65 SLCSNYNSSSGNPTIPNISKEIQEIRIDPDSNSNSNCKPHSAPNPDPLPEPEPILVEDSP 124
P ++EI+EI +D S++N+ + + VED
Sbjct: 60 ---------------PRFTEEIKEISVDHGSSNNNGTSYQTL---------DEKFVED-- 93
Query: 125 ASGRNRIHIEIGKDHRIAYPERA-AGSHHGSGDQTVAAAI----TPEVSHLGWGHWYTLR 179
IE G + ++ GSH + A PEVSH+GWGHW+TLR
Sbjct: 94 --------IENGDKFSGSLEKKPLVGSHLPPSTPSTTAPSPLLGLPEVSHIGWGHWFTLR 145
Query: 180 ELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV 239
+L+++TN F+ E++IG+GGYG+VYHG L + T VAVK LLNN GQA+K+F+VEVEAIG V
Sbjct: 146 DLQLATNHFSKESIIGDGGYGVVYHGTLTNKTPVAVKKLLNNPGQADKDFRVEVEAIGHV 205
Query: 240 RHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGL 299
RHKNLVRLLGYC EG HRMLVYEY++NGNLEQWLHGD+ LTWE R+ +++GTAK L
Sbjct: 206 RHKNLVRLLGYCVEGTHRMLVYEYMNNGNLEQWLHGDMIHKGHLTWEARIKVLVGTAKAL 265
Query: 300 TYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAP 359
YLHE +EPKVVHRDIKSSNIL+D ++ KLSDFGLAKLLGA+ +YV+TRVMGTFGYVAP
Sbjct: 266 AYLHEAIEPKVVHRDIKSSNILMDDNFDAKLSDFGLAKLLGADSNYVSTRVMGTFGYVAP 325
Query: 360 EYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLD 419
EYA++G+LNE+SDVYS+G++++E I+GR PVDY+RP EV++VEWLK MV + E V+D
Sbjct: 326 EYANSGLLNEKSDVYSYGVVLLEAITGRYPVDYARPKEEVHMVEWLKLMVQQKQFEEVVD 385
Query: 420 PRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEEFP 465
L+ KP + LKRALL ALRCVDP+A KRPKM V MLE++E+P
Sbjct: 386 KELEIKPTTSELKRALLTALRCVDPDADKRPKMSQVARMLESDEYP 431
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZUE0|PEK12_ARATH Proline-rich receptor-like protein kinase PERK12 OS=Arabidopsis thaliana GN=PERK12 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 291 bits (746), Expect = 6e-78, Method: Compositional matrix adjust.
Identities = 152/336 (45%), Positives = 218/336 (64%), Gaps = 10/336 (2%)
Query: 164 TPEVSHLGWGHW-YTLRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNR 222
TP+ + LG G ++ EL T GFA +N++GEGG+G VY G L+D VAVK L
Sbjct: 346 TPDSAILGSGQTHFSYEELAEITQGFARKNILGEGGFGCVYKGTLQDGKVVAVKQLKAGS 405
Query: 223 GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSP 282
GQ ++EFK EVE I RV H++LV L+GYC HR+L+YEY+ N LE LHG P
Sbjct: 406 GQGDREFKAEVEIISRVHHRHLVSLVGYCISDQHRLLIYEYVSNQTLEHHLHGKGLPV-- 463
Query: 283 LTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE 342
L W R+ I +G+AKGL YLHE PK++HRDIKS+NILLD ++ +++DFGLA+L
Sbjct: 464 LEWSKRVRIAIGSAKGLAYLHEDCHPKIIHRDIKSANILLDDEYEAQVADFGLARLNDTT 523
Query: 343 RSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLV 402
+++V+TRVMGTFGY+APEYAS+G L +RSDV+SFG++++E+++GR PVD ++P GE +LV
Sbjct: 524 QTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELVTGRKPVDQTQPLGEESLV 583
Query: 403 EW-----LKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIH 457
EW LK + T +E ++D RL+++ + R + A CV + KRP+M V+
Sbjct: 584 EWARPLLLKAIETGDLSE-LIDTRLEKRYVEHEVFRMIETAAACVRHSGPKRPRMVQVVR 642
Query: 458 MLEAEEFPFRDVSFGRVIGILFFLKALLYSTLVMQL 493
L+ + D+S G IG + Y+ +M+
Sbjct: 643 ALDCDG-DSGDISNGIKIGQSTTYDSGQYNEDIMKF 677
|
Regulates the auxin-related MAX (More Axillary Growth) pathway during the shoot branching. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9CAL8|PEK13_ARATH Proline-rich receptor-like protein kinase PERK13 OS=Arabidopsis thaliana GN=PERK13 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 285 bits (730), Expect = 4e-76, Method: Compositional matrix adjust.
Identities = 152/350 (43%), Positives = 218/350 (62%), Gaps = 9/350 (2%)
Query: 149 GSHHGSGDQTVAAAITPEVSHLGWGHW-YTLRELEVSTNGFADENVIGEGGYGIVYHGVL 207
GS G G T + + P+ + +G G +T EL T GF+ N++GEGG+G VY G L
Sbjct: 314 GSQRGGGGYTRSGS-APDSAVMGSGQTHFTYEELTDITEGFSKHNILGEGGFGCVYKGKL 372
Query: 208 EDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNG 267
D VAVK L GQ ++EFK EVE I RV H++LV L+GYC + R+L+YEY+ N
Sbjct: 373 NDGKLVAVKQLKVGSGQGDREFKAEVEIISRVHHRHLVSLVGYCIADSERLLIYEYVPNQ 432
Query: 268 NLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWN 327
LE LHG P L W R+ I +G+AKGL YLHE PK++HRDIKS+NILLD ++
Sbjct: 433 TLEHHLHGKGRP--VLEWARRVRIAIGSAKGLAYLHEDCHPKIIHRDIKSANILLDDEFE 490
Query: 328 PKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGR 387
+++DFGLAKL + +++V+TRVMGTFGY+APEYA +G L +RSDV+SFG++++E+I+GR
Sbjct: 491 AQVADFGLAKLNDSTQTHVSTRVMGTFGYLAPEYAQSGKLTDRSDVFSFGVVLLELITGR 550
Query: 388 NPVDYSRPPGEVNLVEWLKTMVTNRNAEG----VLDPRLQEKPCSRALKRALLVALRCVD 443
PVD +P GE +LVEW + ++ G ++D RL++ + R + A CV
Sbjct: 551 KPVDQYQPLGEESLVEWARPLLHKAIETGDFSELVDRRLEKHYVENEVFRMIETAAACVR 610
Query: 444 PNAHKRPKMGHVIHMLEAEEFPFRDVSFGRVIGILFFLKALLYSTLVMQL 493
+ KRP+M V+ L++E D+S G +G + Y+ M+
Sbjct: 611 HSGPKRPRMVQVVRALDSEG-DMGDISNGNKVGQSSAYDSGQYNNDTMKF 659
|
Regulates negatively root hairs elongation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FFW5|PERK8_ARATH Proline-rich receptor-like protein kinase PERK8 OS=Arabidopsis thaliana GN=PERK8 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 280 bits (715), Expect = 3e-74, Method: Compositional matrix adjust.
Identities = 146/321 (45%), Positives = 209/321 (65%), Gaps = 13/321 (4%)
Query: 150 SHHGSGDQTVAAAITPEVSHLGWGHWYTLRELEVSTNGFADENVIGEGGYGIVYHGVLED 209
SH GS D A++ + VS+ W++ EL T+GF+++N++GEGG+G VY GVL D
Sbjct: 304 SHSGS-DYMYASSDSGMVSN--QRSWFSYDELSQVTSGFSEKNLLGEGGFGCVYKGVLSD 360
Query: 210 NTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNL 269
VAVK L Q E+EFK EVE I RV H++LV L+GYC HR+LVY+Y+ N L
Sbjct: 361 GREVAVKQLKIGGSQGEREFKAEVEIISRVHHRHLVTLVGYCISEQHRLLVYDYVPNNTL 420
Query: 270 EQWLHGDVGPHSP-LTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNP 328
LH P P +TWE R+ + G A+G+ YLHE P+++HRDIKSSNILLD +
Sbjct: 421 HYHLH---APGRPVMTWETRVRVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDNSFEA 477
Query: 329 KLSDFGLAKLLGA--ERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISG 386
++DFGLAK+ ++V+TRVMGTFGY+APEYA++G L+E++DVYS+G++++E+I+G
Sbjct: 478 LVADFGLAKIAQELDLNTHVSTRVMGTFGYMAPEYATSGKLSEKADVYSYGVILLELITG 537
Query: 387 RNPVDYSRPPGEVNLVEWLKTM----VTNRNAEGVLDPRLQEKPCSRALKRALLVALRCV 442
R PVD S+P G+ +LVEW + + + N + ++DPRL + + R + A CV
Sbjct: 538 RKPVDTSQPLGDESLVEWARPLLGQAIENEEFDELVDPRLGKNFIPGEMFRMVEAAAACV 597
Query: 443 DPNAHKRPKMGHVIHMLEAEE 463
+A KRPKM V+ L+ E
Sbjct: 598 RHSAAKRPKMSQVVRALDTLE 618
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9C660|PEK10_ARATH Proline-rich receptor-like protein kinase PERK10 OS=Arabidopsis thaliana GN=PERK10 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 278 bits (712), Expect = 5e-74, Method: Compositional matrix adjust.
Identities = 142/315 (45%), Positives = 204/315 (64%), Gaps = 15/315 (4%)
Query: 171 GWGH---WYTLRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEK 227
G+G ++ EL ++TNGF+DEN++GEGG+G VY GVL D VAVK L GQ ++
Sbjct: 410 GFGQSRELFSYEELVIATNGFSDENLLGEGGFGRVYKGVLPDERVVAVKQLKIGGGQGDR 469
Query: 228 EFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEI 287
EFK EV+ I RV H+NL+ ++GYC R+L+Y+Y+ N NL LH P L W
Sbjct: 470 EFKAEVDTISRVHHRNLLSMVGYCISENRRLLIYDYVPNNNLYFHLHAAGTPG--LDWAT 527
Query: 288 RMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVT 347
R+ I G A+GL YLHE P+++HRDIKSSNILL+ ++ +SDFGLAKL +++T
Sbjct: 528 RVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLENNFHALVSDFGLAKLALDCNTHIT 587
Query: 348 TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKT 407
TRVMGTFGY+APEYAS+G L E+SDV+SFG++++E+I+GR PVD S+P G+ +LVEW +
Sbjct: 588 TRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARP 647
Query: 408 MVTNRNA----EGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE--A 461
+++N + DP+L + R + A C+ +A KRP+M ++ + A
Sbjct: 648 LLSNATETEEFTALADPKLGRNYVGVEMFRMIEAAAACIRHSATKRPRMSQIVRAFDSLA 707
Query: 462 EEFPFRDVSFGRVIG 476
EE D++ G +G
Sbjct: 708 EE----DLTNGMRLG 718
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LV48|PERK1_ARATH Proline-rich receptor-like protein kinase PERK1 OS=Arabidopsis thaliana GN=PERK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 277 bits (708), Expect = 2e-73, Method: Compositional matrix adjust.
Identities = 133/291 (45%), Positives = 197/291 (67%), Gaps = 8/291 (2%)
Query: 176 YTLRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEA 235
+T EL +TNGF++ N++G+GG+G V+ G+L VAVK L GQ E+EF+ EVE
Sbjct: 268 FTYEELSRATNGFSEANLLGQGGFGYVHKGILPSGKEVAVKQLKAGSGQGEREFQAEVEI 327
Query: 236 IGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGT 295
I RV H++LV L+GYC G R+LVYE++ N NLE LHG P + W R+ I LG+
Sbjct: 328 ISRVHHRHLVSLIGYCMAGVQRLLVYEFVPNNNLEFHLHGKGRP--TMEWSTRLKIALGS 385
Query: 296 AKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFG 355
AKGL+YLHE PK++HRDIK+SNIL+D ++ K++DFGLAK+ ++V+TRVMGTFG
Sbjct: 386 AKGLSYLHEDCNPKIIHRDIKASNILIDFKFEAKVADFGLAKIASDTNTHVSTRVMGTFG 445
Query: 356 YVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNA- 414
Y+APEYA++G L E+SDV+SFG++++E+I+GR PVD + + +LV+W + ++ NR +
Sbjct: 446 YLAPEYAASGKLTEKSDVFSFGVVLLELITGRRPVDANNVYVDDSLVDWARPLL-NRASE 504
Query: 415 ----EGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461
EG+ D ++ + + R + A CV +A +RP+M ++ LE
Sbjct: 505 EGDFEGLADSKMGNEYDREEMARMVACAAACVRHSARRRPRMSQIVRALEG 555
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 508 | ||||||
| 255538254 | 528 | Serine/threonine-protein kinase PBS1, pu | 0.905 | 0.871 | 0.800 | 0.0 | |
| 449482676 | 521 | PREDICTED: probable serine/threonine-pro | 0.885 | 0.863 | 0.810 | 0.0 | |
| 225458659 | 519 | PREDICTED: probable serine/threonine-pro | 0.889 | 0.870 | 0.793 | 0.0 | |
| 224137574 | 469 | predicted protein [Populus trichocarpa] | 0.862 | 0.933 | 0.772 | 0.0 | |
| 359480850 | 516 | PREDICTED: probable serine/threonine-pro | 0.872 | 0.858 | 0.758 | 0.0 | |
| 356496904 | 503 | PREDICTED: probable serine/threonine-pro | 0.866 | 0.874 | 0.726 | 0.0 | |
| 449450231 | 842 | PREDICTED: uncharacterized protein LOC10 | 0.850 | 0.513 | 0.787 | 0.0 | |
| 307135852 | 842 | serine/threonine-protein kinase [Cucumis | 0.854 | 0.515 | 0.783 | 0.0 | |
| 255565232 | 509 | BRASSINOSTEROID INSENSITIVE 1-associated | 0.874 | 0.872 | 0.720 | 0.0 | |
| 449448310 | 505 | PREDICTED: probable serine/threonine-pro | 0.866 | 0.871 | 0.730 | 0.0 |
| >gi|255538254|ref|XP_002510192.1| Serine/threonine-protein kinase PBS1, putative [Ricinus communis] gi|223550893|gb|EEF52379.1| Serine/threonine-protein kinase PBS1, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 772 bits (1994), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 389/486 (80%), Positives = 417/486 (85%), Gaps = 26/486 (5%)
Query: 1 MSHYSFLNDQLSKRTSIFGLRLWVVLGICVGAGIVLVLFLISLWFTSKRNSNNSKRQLNA 60
MS+YSFLNDQLSKRTSIFGLRLWVVLGICVGA IVLVLF+IS+WFTS+R+ N ++
Sbjct: 1 MSNYSFLNDQLSKRTSIFGLRLWVVLGICVGAAIVLVLFIISVWFTSRRSKTNKNSTSHS 60
Query: 61 AKSSSLCSNYNSSSGNPTIPNISKEIQEIRIDPDSNSNSNCKPHSAPNPDPLPEPEPILV 120
K S N N + NPTIPN+SKEIQEIR+DP+ N A +PDP+PE EP+L+
Sbjct: 61 TKFRSYLYNNNHNH-NPTIPNVSKEIQEIRLDPNPNPK-------ALSPDPVPESEPVLL 112
Query: 121 ED--SPASGRNRIHIEIGKDHRIAYPERAAGSHHGSG---------DQTVAAAITPEVSH 169
E+ SP GRNRIHIEIGKDHRI+YPERA GS +GSG DQ A + PEVSH
Sbjct: 113 EEENSPVGGRNRIHIEIGKDHRISYPERAGGSGNGSGETRSSPRSGDQAGGAIVVPEVSH 172
Query: 170 LGWGHWYTLRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNR------- 222
LGWGHWYTLRELEVSTN FADENVIGEGGYGIVY G+L+DNTNVAVK L
Sbjct: 173 LGWGHWYTLRELEVSTNCFADENVIGEGGYGIVYRGILDDNTNVAVKICLTTACTFWWCM 232
Query: 223 GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSP 282
GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY+DNGNLEQWLHGDVGP SP
Sbjct: 233 GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVDNGNLEQWLHGDVGPCSP 292
Query: 283 LTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE 342
LTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLD+QWN K+SDFGLAKLLG+E
Sbjct: 293 LTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDRQWNAKVSDFGLAKLLGSE 352
Query: 343 RSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLV 402
RSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGIL+ME+ISGRNPVDYSRPPGEVNLV
Sbjct: 353 RSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILLMEIISGRNPVDYSRPPGEVNLV 412
Query: 403 EWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462
EWLKTMVTNRNAEGVLDPRL EKP SRALKRALLVALRCVDPNA KRPKMGHVIHMLEA+
Sbjct: 413 EWLKTMVTNRNAEGVLDPRLPEKPSSRALKRALLVALRCVDPNAQKRPKMGHVIHMLEAD 472
Query: 463 EFPFRD 468
EFPFRD
Sbjct: 473 EFPFRD 478
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449482676|ref|XP_004156368.1| PREDICTED: probable serine/threonine-protein kinase At1g01540-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 764 bits (1974), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 388/479 (81%), Positives = 414/479 (86%), Gaps = 29/479 (6%)
Query: 1 MSHYSFLNDQLSKRTSIFGLRLWVVLGICVGAGIVLVLFLISLWFTSKRNSNNSKRQLNA 60
MS+Y+FLNDQLSKRTSIFGLRLWVVLGICVGA IV+VLFLISLWFTS+RNS
Sbjct: 1 MSNYAFLNDQLSKRTSIFGLRLWVVLGICVGAAIVIVLFLISLWFTSRRNS--------- 51
Query: 61 AKSSSLCSNYNSSSGNPTIPNISKEIQEIRIDPDSNS-NSNCKPHSAPNPDPLPEPEPIL 119
SN + S NP IPN+SKEIQEIRID N+ +S+ K A NP+PLPE EP+
Sbjct: 52 -------SNKSKPSLNPIIPNVSKEIQEIRIDHSRNTTHSDPKVQLASNPEPLPEAEPLA 104
Query: 120 V-----EDSPASGRNRIHIEIGKDHRIAYPERAAGSHHG-----SGDQTVAAAITPEVSH 169
E SP SGR+RIHIEIGKDHRI+YPER GS HG SGDQ A PEVSH
Sbjct: 105 TLLQTEEGSPPSGRHRIHIEIGKDHRISYPERGGGSSHGSGEARSGDQ--APMTVPEVSH 162
Query: 170 LGWGHWYTLRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEF 229
LGWGHWYTLRELE STN FADENVIGEGGYGIVY GVLEDNT VA+KNLLNNRGQAEKEF
Sbjct: 163 LGWGHWYTLRELEYSTNSFADENVIGEGGYGIVYRGVLEDNTVVAIKNLLNNRGQAEKEF 222
Query: 230 KVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRM 289
KVEVEAIGRVRHKNLVRLLGYCAEGAHR+LVYEYIDNGNLEQWLHG+VGP SPLTW+IRM
Sbjct: 223 KVEVEAIGRVRHKNLVRLLGYCAEGAHRILVYEYIDNGNLEQWLHGEVGPCSPLTWDIRM 282
Query: 290 NIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTR 349
NII+GTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPK+SDFGLAKLLG+ERSYVTTR
Sbjct: 283 NIIVGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKVSDFGLAKLLGSERSYVTTR 342
Query: 350 VMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMV 409
VMGTFGYVAPEYASTGMLNE+SDVYSFGILIME+ISGRNPVDYSRP GEVNLVEWLKTMV
Sbjct: 343 VMGTFGYVAPEYASTGMLNEKSDVYSFGILIMEIISGRNPVDYSRPSGEVNLVEWLKTMV 402
Query: 410 TNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEEFPFRD 468
+NRNAEGVLDP+L EKP +RALKRALLVALRCVDPN KRPKMGHVIHMLEA+EFPFRD
Sbjct: 403 SNRNAEGVLDPKLPEKPSTRALKRALLVALRCVDPNVQKRPKMGHVIHMLEADEFPFRD 461
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225458659|ref|XP_002282863.1| PREDICTED: probable serine/threonine-protein kinase At1g01540-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 756 bits (1952), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 389/490 (79%), Positives = 412/490 (84%), Gaps = 38/490 (7%)
Query: 1 MSHYSFLNDQLSKRTSIFGLRLWVVLGICVGAGIVLVLFLISLWFTSKRNSNNSKRQLNA 60
M +FLND+LSK TSIFGLRLWVV+GICVGAGIVLVLFLISLWFTS+RNS
Sbjct: 1 MPEGAFLNDELSKHTSIFGLRLWVVVGICVGAGIVLVLFLISLWFTSRRNS--------- 51
Query: 61 AKSSSLCSNYNSSSGNPTIPNISKEIQEIRIDPD---SNSNSNCKPHSAPNPDPLPEPEP 117
AKSS PTIPN+SKEIQEIRID +N N + K H PN +PLPE +P
Sbjct: 52 AKSSH----------KPTIPNVSKEIQEIRIDHSRNPANPNPDPKTHHPPNANPLPESDP 101
Query: 118 ILV--------EDSPASGRNRIHIEIGKDHRIAYPERAAGSHHG-----SGDQTVAAAIT 164
E+SP G RIHIEIGKDHRI+YPER GS HG SGDQ A
Sbjct: 102 FAGAERLLQPGEESPV-GLQRIHIEIGKDHRISYPERGGGSSHGSGEARSGDQVTIA--V 158
Query: 165 PEVSHLGWGHWYTLRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQ 224
PEVSHLGWGHWYTLRELE+STNGFADENVIGEGGYGIVY GVLEDNT VAVKNLLNNRGQ
Sbjct: 159 PEVSHLGWGHWYTLRELELSTNGFADENVIGEGGYGIVYRGVLEDNTQVAVKNLLNNRGQ 218
Query: 225 AEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLT 284
AEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY+DNGNLEQWLHGDVGPHSPLT
Sbjct: 219 AEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVDNGNLEQWLHGDVGPHSPLT 278
Query: 285 WEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS 344
W+IRMNII+GTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPK+SDFGLAKLLG+ERS
Sbjct: 279 WDIRMNIIIGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKVSDFGLAKLLGSERS 338
Query: 345 YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEW 404
YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGIL+ME+ISGRNPVDYSRPPGEVNLVEW
Sbjct: 339 YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILLMEIISGRNPVDYSRPPGEVNLVEW 398
Query: 405 LKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEEF 464
LK MVTNRNAEGVLDP++ EKP SRALKRALLVALRCVDPNA KRPKMGHVIHMLEA++F
Sbjct: 399 LKAMVTNRNAEGVLDPKIPEKPSSRALKRALLVALRCVDPNAQKRPKMGHVIHMLEADDF 458
Query: 465 PFRDVSFGRV 474
PFRD R
Sbjct: 459 PFRDFQDRRA 468
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224137574|ref|XP_002327160.1| predicted protein [Populus trichocarpa] gi|222835475|gb|EEE73910.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 712 bits (1837), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 370/479 (77%), Positives = 395/479 (82%), Gaps = 41/479 (8%)
Query: 1 MSHYSFLNDQLSKRTSIFGLRLWVVLGICVGAGIVLVLFLISLWFTSKRNSNNSKRQLNA 60
MS+Y FLND+LSK+TSIFGLRLWVVLGICVGA IVL+LFLISLW TSKRN ++K
Sbjct: 1 MSNY-FLNDELSKKTSIFGLRLWVVLGICVGAAIVLLLFLISLWLTSKRNKTSNKANKPM 59
Query: 61 AKSSSLCSNYNSS-SGNPTIPNISKEIQEIRIDPDSNSNSNCKPHSAPNPDPLPEPEPIL 119
A +S+ + + SS + NPTIPNISKEIQEIR
Sbjct: 60 ATTSTATTKFVSSLNNNPTIPNISKEIQEIRTT--------------------------- 92
Query: 120 VEDSPASGRNRIHIEIGKDHRIAYPERAAGSHHGSG---------DQTVAAAITPEVSHL 170
SP G NRIHIEIGKDHRI+YPER G GSG DQ A PEVSHL
Sbjct: 93 ---SPVGGGNRIHIEIGKDHRISYPERVGGLGSGSGETRSGPRSGDQAGAVIAVPEVSHL 149
Query: 171 GWGHWYTLRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFK 230
GWGHWYTLRELE STN FADENVIGEGGYGIVY G+LEDNTNVAVKNLLNNRGQAEKEFK
Sbjct: 150 GWGHWYTLRELEESTNYFADENVIGEGGYGIVYRGLLEDNTNVAVKNLLNNRGQAEKEFK 209
Query: 231 VEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMN 290
VEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE+++NGNLEQWLHGDVGP SPLTWEIR+N
Sbjct: 210 VEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEFVENGNLEQWLHGDVGPCSPLTWEIRIN 269
Query: 291 IILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRV 350
II+GTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWN K+SDFGLAKLLG+E SYVTTRV
Sbjct: 270 IIIGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNSKVSDFGLAKLLGSESSYVTTRV 329
Query: 351 MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVT 410
MGTFGYVAPEYASTGMLNERSDVYSFGIL+ME+ISGRNPVDYSRP GEVNLVEWLKTMVT
Sbjct: 330 MGTFGYVAPEYASTGMLNERSDVYSFGILLMEIISGRNPVDYSRPAGEVNLVEWLKTMVT 389
Query: 411 NRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEEFPFRDV 469
RNAEGVLDPRL +KP RALKRALLVALRCVDPNA KRPKMGHV+HMLEA+EFPFRDV
Sbjct: 390 IRNAEGVLDPRLPKKPSPRALKRALLVALRCVDPNAQKRPKMGHVVHMLEADEFPFRDV 448
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359480850|ref|XP_002282732.2| PREDICTED: probable serine/threonine-protein kinase At1g01540-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 689 bits (1778), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 361/476 (75%), Positives = 392/476 (82%), Gaps = 33/476 (6%)
Query: 5 SFLNDQLSKRTSIFGLRLWVVLGICVGAGIVLVLFLISLWFTSKRNSNNSKRQLNAAKSS 64
+ +NDQLSK TSIFGLRLWVVLG+CVGA VL+LFLISLW TSKRN+++ R
Sbjct: 7 TLMNDQLSKPTSIFGLRLWVVLGVCVGAAFVLLLFLISLWLTSKRNNSSKIR-------- 58
Query: 65 SLCSNYNSSSGNPTIPNISKEIQEIRIDPDSNSNSNCKPHSAPNPDPLP--EPEPILV-- 120
S PTIP +SKEIQEIRID S P P D L E + +L+
Sbjct: 59 --------PSQKPTIPAVSKEIQEIRIDHGHRSQIQADPF--PESDQLAGIEGQALLLPP 108
Query: 121 -EDSPASGRNRIHIEIGKDHRIAYPERAAGSHHGSGDQTVAAAITPEVSHLGWGHWYTLR 179
E+SP G +RIHIE+GKDHRI+YPER + +Q A+ + PEVSHLGWGHWYTLR
Sbjct: 109 GEESPG-GVHRIHIELGKDHRISYPERVVSGEARAVEQ--ASIVAPEVSHLGWGHWYTLR 165
Query: 180 ELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNR-------GQAEKEFKVE 232
ELE STN FAD++VIGEGGYGIVYHGVLEDNT VAVKNLLNNR GQAEKEFKVE
Sbjct: 166 ELEASTNAFADDHVIGEGGYGIVYHGVLEDNTQVAVKNLLNNRCFLATTMGQAEKEFKVE 225
Query: 233 VEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNII 292
VEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY++NGNLEQWLHGDVGP SPLTWEIRMNII
Sbjct: 226 VEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPRSPLTWEIRMNII 285
Query: 293 LGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMG 352
LGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPK+SDFGLAKLLG+E SYVTTRVMG
Sbjct: 286 LGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKVSDFGLAKLLGSEHSYVTTRVMG 345
Query: 353 TFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNR 412
TFGYVAPEYASTGMLNERSDVYSFGILIME+ISGRNPVDYSRPP EVNLV+WLK MVT+R
Sbjct: 346 TFGYVAPEYASTGMLNERSDVYSFGILIMEIISGRNPVDYSRPPEEVNLVDWLKRMVTSR 405
Query: 413 NAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEEFPFRD 468
N EGVLDP++ EKP SRALKRALLVALRCVDPN+ KRPKMGHVIHMLEAEE PFRD
Sbjct: 406 NPEGVLDPKIPEKPTSRALKRALLVALRCVDPNSQKRPKMGHVIHMLEAEESPFRD 461
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356496904|ref|XP_003517305.1| PREDICTED: probable serine/threonine-protein kinase At1g01540-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 689 bits (1778), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 343/472 (72%), Positives = 381/472 (80%), Gaps = 32/472 (6%)
Query: 2 SHYSFLNDQLSKRTSIFGLRLWVVLGICVGAGIVLVLFLISLWFTSKRNSNNSKRQLNAA 61
S + +NDQLS TSIFGLRLWVVLG+CVGA IVL+LFLIS+W KR+ N
Sbjct: 6 SAAAAMNDQLSNPTSIFGLRLWVVLGVCVGAAIVLILFLISVWLAFKRSKTNPV------ 59
Query: 62 KSSSLCSNYNSSSGNPTIPNISKEIQEIRIDPDSNSNSNCKPHSAPNPDPLPEPEPI--L 119
+IP++SKEIQEIR+D N N +P PL EP+P+
Sbjct: 60 ----------------SIPDVSKEIQEIRLDHAPNLNPTLQPEP-----PLSEPDPVPPT 98
Query: 120 VEDSPASGRNRIHIEIGKDHRIAYPERA---AGSHHGSGDQTVAAAITPEVSHLGWGHWY 176
E++ G +RI EIGK+HRI+YPER + S+ S + + PEVSHLGWGHWY
Sbjct: 99 EEETTPLGYHRIQFEIGKNHRISYPERPLVRSSSNDPSSCEVQVPTVIPEVSHLGWGHWY 158
Query: 177 TLRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAI 236
TLRELE STN FA ENVIGEGGYGIVYHG+L DNTNVA+KNLLNNRGQAEKEFKVEVEAI
Sbjct: 159 TLRELEDSTNAFAPENVIGEGGYGIVYHGILNDNTNVAIKNLLNNRGQAEKEFKVEVEAI 218
Query: 237 GRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTA 296
GRVRHKNLVRLLGYCAEGAHRMLVYEY+DNGNLEQWLHGDVGP SPLTWEIRMNIILGTA
Sbjct: 219 GRVRHKNLVRLLGYCAEGAHRMLVYEYVDNGNLEQWLHGDVGPCSPLTWEIRMNIILGTA 278
Query: 297 KGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGY 356
KGLTYLHEGLEPKVVHRDIKSSNILL KQWN K+SDFGLAKLLG++ SY+TTRVMGTFGY
Sbjct: 279 KGLTYLHEGLEPKVVHRDIKSSNILLSKQWNAKVSDFGLAKLLGSDNSYITTRVMGTFGY 338
Query: 357 VAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEG 416
VAPEYASTGMLNERSDVYSFGILIME+I+GRNPVDYSRPP EVNLV+WLK MV+NRN EG
Sbjct: 339 VAPEYASTGMLNERSDVYSFGILIMELITGRNPVDYSRPPEEVNLVDWLKKMVSNRNPEG 398
Query: 417 VLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEEFPFRD 468
VLDP+L EKP SRALKRALLVALRC DPNA KRPKMGHVIHMLEAE+ P+++
Sbjct: 399 VLDPKLPEKPTSRALKRALLVALRCTDPNAQKRPKMGHVIHMLEAEDSPYKE 450
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449450231|ref|XP_004142867.1| PREDICTED: uncharacterized protein LOC101203008 [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 683 bits (1763), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 352/447 (78%), Positives = 376/447 (84%), Gaps = 15/447 (3%)
Query: 58 LNAAKSSSLCSNYNSSSGNPTIPNISKEIQEIRIDPDSNS-NSNCKPHSAPNPDPLPEPE 116
+N S SN + S NP IPN+SKEIQEIRID N+ +S+ K A NP+PLPE E
Sbjct: 363 INQLLSRRNSSNKSKPSLNPIIPNVSKEIQEIRIDHSRNTTHSDPKVQLASNPEPLPEAE 422
Query: 117 PILV-----EDSPASGRNRIHIEIGKDHRIAYPERAAGSHHG-----SGDQTVAAAITPE 166
P+ E SP SGR+RIHIEIGKDHRI+YPER GS HG SGDQ A PE
Sbjct: 423 PLATLLQTEEGSPPSGRHRIHIEIGKDHRISYPERGGGSSHGSGEARSGDQ--APMTVPE 480
Query: 167 VSHLGWGHWYTLRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAE 226
VSHLGWGHWYTLRELE STN FADENVIGEGGYGIVY GVLEDNT VA+KNLLNNRGQAE
Sbjct: 481 VSHLGWGHWYTLRELEYSTNSFADENVIGEGGYGIVYRGVLEDNTVVAIKNLLNNRGQAE 540
Query: 227 KEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWE 286
KEFKVEVEAIGRVRHKNLVRLLGYCAEGAHR+LVYEYIDNGNLEQWLHG+VGP SPLTW+
Sbjct: 541 KEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRILVYEYIDNGNLEQWLHGEVGPCSPLTWD 600
Query: 287 IRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYV 346
IRMNII+GTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPK+SDFGLAKLLG+ERSYV
Sbjct: 601 IRMNIIVGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKVSDFGLAKLLGSERSYV 660
Query: 347 TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLK 406
TTRVMGTFGYVAPEYASTGMLNE+SDVYSFGILIME+ISGRNPVDYSRP GEVNLVEWLK
Sbjct: 661 TTRVMGTFGYVAPEYASTGMLNEKSDVYSFGILIMEIISGRNPVDYSRPSGEVNLVEWLK 720
Query: 407 TMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEEFPF 466
TMV+NRNAEGVLDP+L EKP +RALKRALLVALRCVDPN KRPKMGHVIHMLEA+EFPF
Sbjct: 721 TMVSNRNAEGVLDPKLPEKPSTRALKRALLVALRCVDPNVQKRPKMGHVIHMLEADEFPF 780
Query: 467 R-DVSFGRVIGILFFLKALLYSTLVMQ 492
R D GR G LK L LV +
Sbjct: 781 RDDRRVGREPG-RSLLKEKLMERLVSE 806
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|307135852|gb|ADN33721.1| serine/threonine-protein kinase [Cucumis melo subsp. melo] | Back alignment and taxonomy information |
|---|
Score = 683 bits (1763), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 354/452 (78%), Positives = 381/452 (84%), Gaps = 18/452 (3%)
Query: 53 NSKRQLNAAKSSSLCSNYNSSSGNPTIPNISKEIQEIRIDPDSNS-NSNCKPHSAPNPDP 111
N+ QL + ++SS N + S NP IPN+SKEIQEIRID N+ +S+ K A NP+P
Sbjct: 361 NNINQLLSGRNSS---NKSKPSLNPIIPNVSKEIQEIRIDHSRNTTHSDPKVQLASNPEP 417
Query: 112 LPEPEPILV-----EDSPASGRNRIHIEIGKDHRIAYPERAAGSHHG-----SGDQTVAA 161
LPE EP+ E SP SGR+RIHIEIGKDHRI+YPER GS HG SGDQ A
Sbjct: 418 LPEAEPLATLLETEEGSPPSGRHRIHIEIGKDHRISYPERGGGSSHGSGEARSGDQ--AP 475
Query: 162 AITPEVSHLGWGHWYTLRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNN 221
PEVSHLGWGHWYTLRELE STN FADENVIGEGGYGIVY GVLEDNT VA+KNLLNN
Sbjct: 476 MTVPEVSHLGWGHWYTLRELEYSTNSFADENVIGEGGYGIVYRGVLEDNTVVAIKNLLNN 535
Query: 222 RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHS 281
RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHR+LVYEYIDNGNLEQWLHG+VGP S
Sbjct: 536 RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRILVYEYIDNGNLEQWLHGEVGPCS 595
Query: 282 PLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA 341
PLTW+IRMNII+GTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPK+SDFGLAKLLG+
Sbjct: 596 PLTWDIRMNIIVGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKVSDFGLAKLLGS 655
Query: 342 ERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNL 401
ERSYVTTRVMGTFGYVAPEYASTGMLNE+SDVYSFGILIME+ISGRNPVDYSRP GEVNL
Sbjct: 656 ERSYVTTRVMGTFGYVAPEYASTGMLNEKSDVYSFGILIMEIISGRNPVDYSRPSGEVNL 715
Query: 402 VEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461
VEWLKTMV+NRNAEGVLDP+L EKP +RALKRALLVALRCVDPN KRPKMGHVIHMLEA
Sbjct: 716 VEWLKTMVSNRNAEGVLDPKLPEKPSTRALKRALLVALRCVDPNVQKRPKMGHVIHMLEA 775
Query: 462 EEFPFR-DVSFGRVIGILFFLKALLYSTLVMQ 492
+EFPFR D GR G LK L LV +
Sbjct: 776 DEFPFRDDRRVGREPG-RSLLKEKLMERLVSE 806
|
Source: Cucumis melo subsp. melo Species: Cucumis melo Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255565232|ref|XP_002523608.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] gi|223537170|gb|EEF38803.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 682 bits (1760), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 340/472 (72%), Positives = 382/472 (80%), Gaps = 28/472 (5%)
Query: 6 FLNDQLSKRTSIFGLRLWVVLGICVGAGIVLVLFLISLWFTSKRNSNNSKRQLNAAKSSS 65
+NDQLSK TS+FGLR+WVVLG+CVGA VLVLFLI++W SKR+ ++K
Sbjct: 8 LMNDQLSKPTSVFGLRVWVVLGVCVGAAFVLVLFLITVWLASKRSKKDNK---------- 57
Query: 66 LCSNYNSSSGNPTIPNISKEIQEIRIDPDSNSNSNCKPHSAPNPDPLP--EPEPILV--- 120
+ P IP +SKEIQEIR++P + + + H P+P+ E + +L+
Sbjct: 58 --------NSKPKIPVVSKEIQEIRVEPVKPNRAQIQTHPFPDPEIAAGNERQALLLMPP 109
Query: 121 -EDSPAS---GRNRIHIEIGKDHRIAYPERAAGSHHGSGDQTVAAAITPEVSHLGWGHWY 176
E+SP G I IEIGK H I+YP + + G GDQ +A + P+VSHLGWGHWY
Sbjct: 110 EEESPMGYHHGTGNIQIEIGKGHLISYPVSSGEAPRGGGDQ-LAMVVGPDVSHLGWGHWY 168
Query: 177 TLRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAI 236
TLRELE STNGFADENVIG+GGYGIVY+GVL DNT VAVKNLLNNRGQAEKEFKVEVEAI
Sbjct: 169 TLRELEASTNGFADENVIGQGGYGIVYYGVLVDNTQVAVKNLLNNRGQAEKEFKVEVEAI 228
Query: 237 GRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTA 296
GRVRHKNLVRLLGYCAEG+HRMLVYEY++NGNLEQWLHGDVG SPLTWEIRMNIILGTA
Sbjct: 229 GRVRHKNLVRLLGYCAEGSHRMLVYEYVNNGNLEQWLHGDVGSCSPLTWEIRMNIILGTA 288
Query: 297 KGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGY 356
KGLTYLHEGLEPKVVHRDIKSSNILLDK WN K+SDFGLAKLL E SY+TTRVMGTFGY
Sbjct: 289 KGLTYLHEGLEPKVVHRDIKSSNILLDKLWNAKVSDFGLAKLLYPESSYITTRVMGTFGY 348
Query: 357 VAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEG 416
VAPEYASTGM+NERSDV+ FGILIME+ISGRNPVDYSRPP EVNLVEWLK MVTNRN EG
Sbjct: 349 VAPEYASTGMVNERSDVFGFGILIMEIISGRNPVDYSRPPDEVNLVEWLKRMVTNRNPEG 408
Query: 417 VLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEEFPFRD 468
VLDP+L E+P SRALKR LLVALRCVDPNA KRPKMGHV+HMLEA+EFPFRD
Sbjct: 409 VLDPKLPERPSSRALKRVLLVALRCVDPNAQKRPKMGHVVHMLEADEFPFRD 460
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449448310|ref|XP_004141909.1| PREDICTED: probable serine/threonine-protein kinase At1g01540-like [Cucumis sativus] gi|449485438|ref|XP_004157168.1| PREDICTED: probable serine/threonine-protein kinase At1g01540-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 680 bits (1755), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 350/479 (73%), Positives = 383/479 (79%), Gaps = 39/479 (8%)
Query: 7 LNDQLSKRTSIFGLRLWVVLGICVGAGIVLVLFLISLWFTSKRNSNNSKRQLNAAKSSSL 66
+ DQLSK+TSIFGLRLWVVLG+CVGA VL LFLISLW SKR S++++
Sbjct: 9 MADQLSKQTSIFGLRLWVVLGVCVGAAFVLFLFLISLWIASKR----SRKKI-------- 56
Query: 67 CSNYNSSSGNPTIPNISKEIQEIRID-PDSNSNSNCKP-HSAPNPDPLPEPEPI------ 118
S PTIP +SKEIQEIRID P + + KP S DPLPEPEPI
Sbjct: 57 -------SNRPTIPIVSKEIQEIRIDHPLPQNQEHNKPSRSHFQVDPLPEPEPIPGIERQ 109
Query: 119 --LVEDSPASGRNRIHIEIGKDHRIAYPER--------AAGSHHGSGDQTVAAAITPEVS 168
L NRIHI+IGKDHRI+YPER +G GDQ + PEVS
Sbjct: 110 ALLSLPQEEERVNRIHIDIGKDHRISYPERLGRSSSSQGSGEGRCGGDQL--PMVVPEVS 167
Query: 169 HLGWGHWYTLRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKE 228
HLGWGHWYTLRELE STNGF+ +NVIGEGGYGIVYHG+LED T VAVKNLLNNRGQAEKE
Sbjct: 168 HLGWGHWYTLRELEASTNGFSPDNVIGEGGYGIVYHGILEDGTQVAVKNLLNNRGQAEKE 227
Query: 229 FKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIR 288
FKVEVEAIGRVRHK+LVRLLGYCAEGAHRMLVYEYI+NGNLEQWLHGDVG SPLTWEIR
Sbjct: 228 FKVEVEAIGRVRHKSLVRLLGYCAEGAHRMLVYEYINNGNLEQWLHGDVGSFSPLTWEIR 287
Query: 289 MNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTT 348
MNIILGTAKGL YLHEGLEPKVVHRDIKSSNILLDKQWN K+SDFGLAKLL ++ SY+TT
Sbjct: 288 MNIILGTAKGLAYLHEGLEPKVVHRDIKSSNILLDKQWNSKVSDFGLAKLLCSDNSYITT 347
Query: 349 RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTM 408
RVMGTFGYVAPEYASTGMLNERSDVYSFGIL+ME+ISGRNPVDYSRPP EVNL++WLK M
Sbjct: 348 RVMGTFGYVAPEYASTGMLNERSDVYSFGILVMEIISGRNPVDYSRPPDEVNLIDWLKRM 407
Query: 409 VTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEEFPFR 467
V+NRN EGVLDP+L EKP +RALKRALLVALRCVDPNA KRPKMGH+IHMLEAE+ F+
Sbjct: 408 VSNRNPEGVLDPKLAEKPTTRALKRALLVALRCVDPNAQKRPKMGHIIHMLEAEDANFK 466
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 508 | ||||||
| TAIR|locus:2132353 | 492 | AT4G02630 [Arabidopsis thalian | 0.732 | 0.756 | 0.736 | 4.8e-170 | |
| TAIR|locus:2025396 | 472 | AT1G01540 [Arabidopsis thalian | 0.665 | 0.716 | 0.716 | 5.8e-150 | |
| TAIR|locus:2045620 | 494 | AT2G42960 [Arabidopsis thalian | 0.629 | 0.647 | 0.654 | 1.9e-125 | |
| TAIR|locus:2139559 | 437 | AT4G34500 [Arabidopsis thalian | 0.618 | 0.718 | 0.686 | 3.9e-125 | |
| TAIR|locus:2146203 | 484 | AT5G18500 [Arabidopsis thalian | 0.740 | 0.776 | 0.566 | 6.5e-123 | |
| TAIR|locus:2077730 | 512 | AT3G59110 [Arabidopsis thalian | 0.917 | 0.910 | 0.514 | 2.2e-121 | |
| TAIR|locus:2027559 | 492 | AT1G56720 [Arabidopsis thalian | 0.866 | 0.894 | 0.518 | 9.5e-121 | |
| TAIR|locus:2012325 | 466 | AT1G09440 [Arabidopsis thalian | 0.844 | 0.920 | 0.504 | 5.6e-116 | |
| TAIR|locus:2093591 | 467 | GPK1 "glyoxysomal protein kina | 0.592 | 0.644 | 0.647 | 1.6e-115 | |
| TAIR|locus:2159873 | 681 | PERK8 "proline-rich extensin-l | 0.606 | 0.452 | 0.448 | 8.5e-75 |
| TAIR|locus:2132353 AT4G02630 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1476 (524.6 bits), Expect = 4.8e-170, Sum P(2) = 4.8e-170
Identities = 291/395 (73%), Positives = 318/395 (80%)
Query: 79 IPNISKEIQEIRIDPDSNSNSNCKPHSAXXXXXXXXXXXILVEDSPASGRNRIHIEIGKD 138
+P +SKEIQEIR P + +PH ED N+IHIEIGKD
Sbjct: 67 VPVVSKEIQEIR--PPIQPDPTPEPHQNQQR-----------EDD-----NKIHIEIGKD 108
Query: 139 HRIAYPERA----AGSHHGSGDQTVAAAITPEVSHLGWGHWYTLRELEVSTNGFADENVI 194
HRIAYPER +GS GSGDQ + PEVSHLGWGHWYTLRELEVSTNGFADENVI
Sbjct: 109 HRIAYPERGGWTGSGSGSGSGDQGLLMLSGPEVSHLGWGHWYTLRELEVSTNGFADENVI 168
Query: 195 GEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEG 254
G+GGYGIVY GVLED + VA+KNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYC EG
Sbjct: 169 GQGGYGIVYRGVLEDKSMVAIKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCVEG 228
Query: 255 AHRMLVYEYIDNGNLEQWLHGD-VGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHR 313
AHRMLVYEY+DNGNLEQW+HG +G SPLTWEIRMNI+LGTAKGL YLHEGLEPKVVHR
Sbjct: 229 AHRMLVYEYVDNGNLEQWIHGGGLGFKSPLTWEIRMNIVLGTAKGLMYLHEGLEPKVVHR 288
Query: 314 DIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDV 373
DIKSSNILLDKQWN K+SDFGLAKLLG+E SYVTTRVMGTFGYVAPEYASTGMLNERSDV
Sbjct: 289 DIKSSNILLDKQWNSKVSDFGLAKLLGSEMSYVTTRVMGTFGYVAPEYASTGMLNERSDV 348
Query: 374 YSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSXXXXX 433
YSFG+L+ME+ISGR+PVDYSR PGEVNLVEWLK +VTNR+AEGVLDPR+ +KP
Sbjct: 349 YSFGVLVMEIISGRSPVDYSRAPGEVNLVEWLKRLVTNRDAEGVLDPRMVDKPSLRSLKR 408
Query: 434 XXXXXXXCVDPNAHKRPKMGHVIHMLEAEEFPFRD 468
CVDPNA KRPKMGH+IHMLEAE+ +D
Sbjct: 409 TLLVALRCVDPNAQKRPKMGHIIHMLEAEDLVSKD 443
|
|
| TAIR|locus:2025396 AT1G01540 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1329 (472.9 bits), Expect = 5.8e-150, Sum P(2) = 5.8e-150
Identities = 248/346 (71%), Positives = 287/346 (82%)
Query: 131 IHIEIGK-DHRIAYPER-AAGSHHGSGDQTVAAAIT------PEVSHLGWGHWYTLRELE 182
I ++IGK +HR+ + +R ++G G+ + A+ + PEVSHLGWG WYTLRELE
Sbjct: 89 IQVDIGKIEHRVVFSDRVSSGESRGTASASETASYSGSGNCGPEVSHLGWGRWYTLRELE 148
Query: 183 VSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHK 242
+TNG +ENVIGEGGYGIVY G+L D T VAVKNLLNNRGQAEKEFKVEVE IGRVRHK
Sbjct: 149 AATNGLCEENVIGEGGYGIVYRGILTDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHK 208
Query: 243 NLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYL 302
NLVRLLGYC EGA+RMLVY+++DNGNLEQW+HGDVG SPLTW+IRMNIILG AKGL YL
Sbjct: 209 NLVRLLGYCVEGAYRMLVYDFVDNGNLEQWIHGDVGDVSPLTWDIRMNIILGMAKGLAYL 268
Query: 303 HEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYA 362
HEGLEPKVVHRDIKSSNILLD+QWN K+SDFGLAKLLG+E SYVTTRVMGTFGYVAPEYA
Sbjct: 269 HEGLEPKVVHRDIKSSNILLDRQWNAKVSDFGLAKLLGSESSYVTTRVMGTFGYVAPEYA 328
Query: 363 STGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRL 422
TGMLNE+SD+YSFGILIME+I+GRNPVDYSRP GE NLV+WLK+MV NR +E V+DP++
Sbjct: 329 CTGMLNEKSDIYSFGILIMEIITGRNPVDYSRPQGETNLVDWLKSMVGNRRSEEVVDPKI 388
Query: 423 QEKPCSXXXXXXXXXXXXCVDPNAHKRPKMGHVIHMLEAEEFPFRD 468
E P S CVDP+A+KRPKMGH+IHMLEAE+ +RD
Sbjct: 389 PEPPSSKALKRVLLVALRCVDPDANKRPKMGHIIHMLEAEDLLYRD 434
|
|
| TAIR|locus:2045620 AT2G42960 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1142 (407.1 bits), Expect = 1.9e-125, Sum P(2) = 1.9e-125
Identities = 210/321 (65%), Positives = 251/321 (78%)
Query: 147 AAGSHHGSGDQTVAAAI-TPEVSHLGWGHWYTLRELEVSTNGFADENVIGEGGYGIVYHG 205
+AG +G G T + + PE+SHLGWGHW+TLR+LE++TN FA NV+GEGGYG+VY G
Sbjct: 141 SAGRQYGGGPVTASPLVGLPEISHLGWGHWFTLRDLELATNRFAPVNVLGEGGYGVVYRG 200
Query: 206 VLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYID 265
L + T VAVK LLNN GQAEKEF+VEVEAIG VRHKNLVRLLGYC EG HRMLVYEY++
Sbjct: 201 KLVNGTEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEYVN 260
Query: 266 NGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQ 325
+GNLEQWLHG + H LTWE RM II GTA+ L YLHE +EPKVVHRDIK+SNIL+D +
Sbjct: 261 SGNLEQWLHGAMRQHGNLTWEARMKIITGTAQALAYLHEAIEPKVVHRDIKASNILIDDE 320
Query: 326 WNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS 385
+N KLSDFGLAKLL + S++TTRVMGTFGYVAPEYA+TG+LNE+SD+YSFG+L++E I+
Sbjct: 321 FNAKLSDFGLAKLLDSGESHITTRVMGTFGYVAPEYANTGLLNEKSDIYSFGVLLLEAIT 380
Query: 386 GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSXXXXXXXXXXXXCVDPN 445
GR+PVDY RP EVNLVEWLK MV R AE V+DPRL+ +P CVDP
Sbjct: 381 GRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPRLEPRPSKSALKRALLVSLRCVDPE 440
Query: 446 AHKRPKMGHVIHMLEAEEFPF 466
A KRP+M V MLE++E PF
Sbjct: 441 AEKRPRMSQVARMLESDEHPF 461
|
|
| TAIR|locus:2139559 AT4G34500 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1185 (422.2 bits), Expect = 3.9e-125, Sum P(2) = 3.9e-125
Identities = 219/319 (68%), Positives = 262/319 (82%)
Query: 154 SGDQTVAAAITPEVSH---LGWGHWYTLRELEVSTNGFADENVIGEGGYGIVYHGVLEDN 210
SG T++ A + +V +GWG WY+L++LE++T GF+D+N+IGEGGYG+VY D
Sbjct: 108 SGFDTLSVASSGDVGTSEAMGWGKWYSLKDLEIATRGFSDDNMIGEGGYGVVYRADFSDG 167
Query: 211 TNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAH--RMLVYEYIDNGN 268
+ AVKNLLNN+GQAEKEFKVEVEAIG+VRHKNLV L+GYCA+ A RMLVYEYIDNGN
Sbjct: 168 SVAAVKNLLNNKGQAEKEFKVEVEAIGKVRHKNLVGLMGYCADSAQSQRMLVYEYIDNGN 227
Query: 269 LEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNP 328
LEQWLHGDVGP SPLTW+IRM I +GTAKGL YLHEGLEPKVVHRD+KSSNILLDK+WN
Sbjct: 228 LEQWLHGDVGPVSPLTWDIRMKIAIGTAKGLAYLHEGLEPKVVHRDVKSSNILLDKKWNA 287
Query: 329 KLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRN 388
K+SDFGLAKLLG+E SYVTTRVMGTFGYV+PEYASTGMLNE SDVYSFG+L+ME+I+GR+
Sbjct: 288 KVSDFGLAKLLGSETSYVTTRVMGTFGYVSPEYASTGMLNECSDVYSFGVLLMEIITGRS 347
Query: 389 PVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSXXXXXXXXXXXXCVDPNAHK 448
PVDYSRPPGE+NLV+W K MV +R E V+DP+++ P C+D ++ K
Sbjct: 348 PVDYSRPPGEMNLVDWFKGMVASRRGEEVIDPKIKTSPPPRALKRALLVCLRCIDLDSSK 407
Query: 449 RPKMGHVIHMLEAEEFPFR 467
RPKMG +IHMLEAE+FPFR
Sbjct: 408 RPKMGQIIHMLEAEDFPFR 426
|
|
| TAIR|locus:2146203 AT5G18500 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1126 (401.4 bits), Expect = 6.5e-123, Sum P(2) = 6.5e-123
Identities = 222/392 (56%), Positives = 278/392 (70%)
Query: 80 PNISKEIQEIRIDPDSNSNS-NCKPHSAXXXXXXXXXXXILVE----DSPASGR-NRIHI 133
P++ +EI+EIR+D S+SN N P + I E DS SG N +
Sbjct: 62 PSVPEEIKEIRVDEVSSSNGGNGYPSISEKFGDKEPEKGIKAESENGDSSRSGSFNHLEK 121
Query: 134 EIGKDHRIAYPERAAGSHHGSGDQTVAAAITPEVSHLGWGHWYTLRELEVSTNGFADENV 193
+ G A P A G PE SHLGWGHW+TLR+L+++TN F+ +N+
Sbjct: 122 KDGSSVSSANPLTAPSPLSG----------LPEFSHLGWGHWFTLRDLQMATNQFSRDNI 171
Query: 194 IGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE 253
IG+GGYG+VY G L + T VAVK LLNN GQA+K+F+VEVEAIG VRHKNLVRLLGYC E
Sbjct: 172 IGDGGYGVVYRGNLVNGTPVAVKKLLNNLGQADKDFRVEVEAIGHVRHKNLVRLLGYCME 231
Query: 254 GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHR 313
G RMLVYEY++NGNLEQWL GD H LTWE R+ I++GTAK L YLHE +EPKVVHR
Sbjct: 232 GTQRMLVYEYVNNGNLEQWLRGDNQNHEYLTWEARVKILIGTAKALAYLHEAIEPKVVHR 291
Query: 314 DIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDV 373
DIKSSNIL+D ++N K+SDFGLAKLLGA++S++TTRVMGTFGYVAPEYA++G+LNE+SDV
Sbjct: 292 DIKSSNILIDDKFNSKISDFGLAKLLGADKSFITTRVMGTFGYVAPEYANSGLLNEKSDV 351
Query: 374 YSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSXXXXX 433
YSFG++++E I+GR PVDY+RPP EV+LVEWLK MV R +E V+DP L+ KP +
Sbjct: 352 YSFGVVLLEAITGRYPVDYARPPPEVHLVEWLKMMVQQRRSEEVVDPNLETKPSTSALKR 411
Query: 434 XXXXXXXCVDPNAHKRPKMGHVIHMLEAEEFP 465
CVDP + KRP+M V MLE+EE+P
Sbjct: 412 TLLTALRCVDPMSEKRPRMSQVARMLESEEYP 443
|
|
| TAIR|locus:2077730 AT3G59110 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1194 (425.4 bits), Expect = 2.2e-121, P = 2.2e-121
Identities = 243/472 (51%), Positives = 304/472 (64%)
Query: 1 MSHYSFLNDQLSKRTSIFGLR---LWVVLGICVGAGIVLVLFLISLWFTSKRNSNNSKRQ 57
MS S L+ +SK+ S GL+ LWV++ + VG +VLV ++SLW +R S S +
Sbjct: 1 MSSESSLSADMSKKVSFLGLKGMKLWVLICLVVGTFVVLVFCILSLWIAFRRKSRRSSHK 60
Query: 58 LNAAKXXXXXXXXXXXXXXPTIPNISKEIQEIRIDPDSNSNSNCKPHSAXXXXXXXXXXX 117
L N ++ + D S+ NS K S
Sbjct: 61 LLPFSQIPRVAKDIRVDDRVGFQNHNENLSITNADKSSDRNSG-KMMSYLGRTKSSDNDS 119
Query: 118 ILVEDSPASGRNRIHIEIGKDHRIAYPERAAGSHHGSGDQTVAAAI-TPEVSHLGWGHWY 176
I S G+D R G G T + + PE+SHLGWGHW+
Sbjct: 120 ISQCSSVHHHERACSSHSGEDGSFGAAWRQNSLSQG-GLVTASPLVGLPEISHLGWGHWF 178
Query: 177 TLRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAI 236
TLR+L+++TN FA ENVIGEGGYG+VY G L + +VAVK LLNN GQAEKEF+VEVEAI
Sbjct: 179 TLRDLQLATNRFAAENVIGEGGYGVVYKGRLINGNDVAVKKLLNNLGQAEKEFRVEVEAI 238
Query: 237 GRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTA 296
G VRHKNLVRLLGYC EG +RMLVYEY+++GNLEQWLHG +G S LTWE RM I++GTA
Sbjct: 239 GHVRHKNLVRLLGYCIEGVNRMLVYEYVNSGNLEQWLHGAMGKQSTLTWEARMKILVGTA 298
Query: 297 KGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGY 356
+ L YLHE +EPKVVHRDIK+SNIL+D +N KLSDFGLAKLL + S++TTRVMGTFGY
Sbjct: 299 QALAYLHEAIEPKVVHRDIKASNILIDDDFNAKLSDFGLAKLLDSGESHITTRVMGTFGY 358
Query: 357 VAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEG 416
VAPEYA+TG+LNE+SD+YSFG+L++E I+GR+PVDY RP EVNLVEWLK MV R AE
Sbjct: 359 VAPEYANTGLLNEKSDIYSFGVLLLETITGRDPVDYERPANEVNLVEWLKMMVGTRRAEE 418
Query: 417 VLDPRLQEKPCSXXXXXXXXXXXXCVDPNAHKRPKMGHVIHMLEAEEFPFRD 468
V+D R++ P + CVDP A KRPKM V+ MLE++E PFR+
Sbjct: 419 VVDSRIEPPPATRALKRALLVALRCVDPEAQKRPKMSQVVRMLESDEHPFRE 470
|
|
| TAIR|locus:2027559 AT1G56720 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1188 (423.3 bits), Expect = 9.5e-121, P = 9.5e-121
Identities = 244/471 (51%), Positives = 319/471 (67%)
Query: 7 LNDQLSKRTSIFGLRLWVVLGICVGAGIVLVLFLISLWFTSKRNSNNSKRQLNAAKXXXX 66
L QLS+ + +FGL++W V+GI V I+ +L ++S TSK+ S SK L +
Sbjct: 5 LKSQLSRESHVFGLKVWEVIGIAVALLIIAILSVLSCCLTSKKKSRRSKTGLPVIQ---- 60
Query: 67 XXXXXXXXXXPTIPNISKEIQEIRIDPDSNSNSNCKPHSAXXXXXXXX----XXXILV-- 120
T P +SKEI+E+R++ S SN P ++V
Sbjct: 61 -----------TPPVVSKEIREVRVE--HVSASNFAPGEGILLTIQDKNNKDSEKVMVHL 107
Query: 121 ---EDSPASGRNRI--HIEIGKDHRIAYPERAAGSH-HGSGDQTVAAAITPEVSHLGWGH 174
+ +SGR+ H+EI H + E +A S + + + + PE SHLGWGH
Sbjct: 108 DMRKKRSSSGRSGSFHHLEIIDKHSDSAEEVSASSSLYNIATPSPLSGL-PE-SHLGWGH 165
Query: 175 WYTLRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVE 234
W+TLR+LE +TN F+ ENVIGEGGYG+VY G L + T VAVK +LN GQAEKEF+VEV+
Sbjct: 166 WFTLRDLETATNRFSKENVIGEGGYGVVYRGELMNGTPVAVKKILNQLGQAEKEFRVEVD 225
Query: 235 AIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILG 294
AIG VRHKNLVRLLGYC EG HR+LVYEY++NGNLEQWLHG + H LTWE RM +++G
Sbjct: 226 AIGHVRHKNLVRLLGYCIEGTHRILVYEYVNNGNLEQWLHGAMRQHGYLTWEARMKVLIG 285
Query: 295 TAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTF 354
T+K L YLHE +EPKVVHRDIKSSNIL++ ++N K+SDFGLAKLLGA +S+VTTRVMGTF
Sbjct: 286 TSKALAYLHEAIEPKVVHRDIKSSNILINDEFNAKVSDFGLAKLLGAGKSHVTTRVMGTF 345
Query: 355 GYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNA 414
GYVAPEYA++G+LNE+SDVYSFG++++E I+GR+PVDY RP EVNLV+WLK MV R +
Sbjct: 346 GYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRDPVDYGRPAHEVNLVDWLKMMVGTRRS 405
Query: 415 EGVLDPRLQEKPCSXXXXXXXXXXXXCVDPNAHKRPKMGHVIHMLEAEEFP 465
E V+DP ++ KP + CVDP++ KRPKM V+ MLE+EE+P
Sbjct: 406 EEVVDPNIEVKPPTRSLKRALLTALRCVDPDSDKRPKMSQVVRMLESEEYP 456
|
|
| TAIR|locus:2012325 AT1G09440 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1143 (407.4 bits), Expect = 5.6e-116, P = 5.6e-116
Identities = 227/450 (50%), Positives = 303/450 (67%)
Query: 19 GLRLWVVLGICVGAGIVLVLFLISLWFTSKRNSNNSKRQLNAAKXXXXXXXXXXXXXXPT 78
GL++W + I + I++VL ++S K+ S SK P
Sbjct: 3 GLKIWQAIFITIALIIIVVLSVLSFCLIWKKKSRRSK-----------------TLSLPI 45
Query: 79 I--PNISKEIQEIRIDPDSNSNSNCKPHSAXXXXXXXXXXXILVEDSPASGRNRIHIEIG 136
I P +SKEI+E+RI+ +++SN P + +E + +G + G
Sbjct: 46 IQTPVVSKEIKEVRIEHVVSTSSNFDPQDENNNESDKFLLNLEMEKNRENGLSSSRSGSG 105
Query: 137 KDHRIAYPERAAGSHHGSGDQTVAAAI-TPEVSHLGWGHWYTLRELEVSTNGFADENVIG 195
K+ + R+ S + + + PE SHLGWGHW+TLR+LE++TN F+ ENVIG
Sbjct: 106 KEGYLCVANRSTSSLYEMATPSPSPLSGLPE-SHLGWGHWFTLRDLEIATNRFSKENVIG 164
Query: 196 EGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGA 255
EGGYG+VY G L + + VAVK +LN+ GQAEKEF+VEV+AIG VRHKNLVRLLGYC EG
Sbjct: 165 EGGYGVVYRGELVNGSLVAVKKILNHLGQAEKEFRVEVDAIGHVRHKNLVRLLGYCIEGT 224
Query: 256 HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDI 315
+R+LVYEY++NGNLE+WLHG + H LTWE RM ++ GT+K L YLHE +EPKVVHRDI
Sbjct: 225 NRILVYEYMNNGNLEEWLHGAMKHHGYLTWEARMKVLTGTSKALAYLHEAIEPKVVHRDI 284
Query: 316 KSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYS 375
KSSNIL+D ++N K+SDFGLAKLLG +S+VTTRVMGTFGYVAPEYA+TG+LNE+SDVYS
Sbjct: 285 KSSNILIDDRFNAKISDFGLAKLLGDGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYS 344
Query: 376 FGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSXXXXXXX 435
FG+L++E I+GR+PVDY+RP EVNLVEWLK MV ++ E V+DP + +P +
Sbjct: 345 FGVLVLEAITGRDPVDYARPANEVNLVEWLKMMVGSKRLEEVIDPNIAVRPATRALKRVL 404
Query: 436 XXXXXCVDPNAHKRPKMGHVIHMLEAEEFP 465
C+DP++ KRPKM V+ MLE+EE+P
Sbjct: 405 LTALRCIDPDSEKRPKMSQVVRMLESEEYP 434
|
|
| TAIR|locus:2093591 GPK1 "glyoxysomal protein kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1089 (388.4 bits), Expect = 1.6e-115, Sum P(2) = 1.6e-115
Identities = 195/301 (64%), Positives = 245/301 (81%)
Query: 165 PEVSHLGWGHWYTLRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQ 224
PEVSH+GWGHW+TLR+L+++TN F+ E++IG+GGYG+VYHG L + T VAVK LLNN GQ
Sbjct: 131 PEVSHIGWGHWFTLRDLQLATNHFSKESIIGDGGYGVVYHGTLTNKTPVAVKKLLNNPGQ 190
Query: 225 AEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLT 284
A+K+F+VEVEAIG VRHKNLVRLLGYC EG HRMLVYEY++NGNLEQWLHGD+ LT
Sbjct: 191 ADKDFRVEVEAIGHVRHKNLVRLLGYCVEGTHRMLVYEYMNNGNLEQWLHGDMIHKGHLT 250
Query: 285 WEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS 344
WE R+ +++GTAK L YLHE +EPKVVHRDIKSSNIL+D ++ KLSDFGLAKLLGA+ +
Sbjct: 251 WEARIKVLVGTAKALAYLHEAIEPKVVHRDIKSSNILMDDNFDAKLSDFGLAKLLGADSN 310
Query: 345 YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEW 404
YV+TRVMGTFGYVAPEYA++G+LNE+SDVYS+G++++E I+GR PVDY+RP EV++VEW
Sbjct: 311 YVSTRVMGTFGYVAPEYANSGLLNEKSDVYSYGVVLLEAITGRYPVDYARPKEEVHMVEW 370
Query: 405 LKTMVTNRNAEGVLDPRLQEKPCSXXXXXXXXXXXXCVDPNAHKRPKMGHVIHMLEAEEF 464
LK MV + E V+D L+ KP + CVDP+A KRPKM V MLE++E+
Sbjct: 371 LKLMVQQKQFEEVVDKELEIKPTTSELKRALLTALRCVDPDADKRPKMSQVARMLESDEY 430
Query: 465 P 465
P
Sbjct: 431 P 431
|
|
| TAIR|locus:2159873 PERK8 "proline-rich extensin-like receptor kinase 8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 711 (255.3 bits), Expect = 8.5e-75, Sum P(2) = 8.5e-75
Identities = 144/321 (44%), Positives = 205/321 (63%)
Query: 150 SHHGSGDQTVAAAITPEVSHLGWGHWYTLRELEVSTNGFADENVIGEGGYGIVYHGVLED 209
SH GS D A++ + VS+ W++ EL T+GF+++N++GEGG+G VY GVL D
Sbjct: 304 SHSGS-DYMYASSDSGMVSNQR--SWFSYDELSQVTSGFSEKNLLGEGGFGCVYKGVLSD 360
Query: 210 NTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNL 269
VAVK L Q E+EFK EVE I RV H++LV L+GYC HR+LVY+Y+ N L
Sbjct: 361 GREVAVKQLKIGGSQGEREFKAEVEIISRVHHRHLVTLVGYCISEQHRLLVYDYVPNNTL 420
Query: 270 EQWLHGDVGPHSP-LTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNP 328
LH P P +TWE R+ + G A+G+ YLHE P+++HRDIKSSNILLD +
Sbjct: 421 HYHLHA---PGRPVMTWETRVRVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDNSFEA 477
Query: 329 KLSDFGLAKLLGAE--RSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISG 386
++DFGLAK+ ++V+TRVMGTFGY+APEYA++G L+E++DVYS+G++++E+I+G
Sbjct: 478 LVADFGLAKIAQELDLNTHVSTRVMGTFGYMAPEYATSGKLSEKADVYSYGVILLELITG 537
Query: 387 RNPVDYSRPPGEVNLVEWLKTM----VTNRNAEGVLDPRLQEKPCSXXXXXXXXXXXXCV 442
R PVD S+P G+ +LVEW + + + N + ++DPRL + CV
Sbjct: 538 RKPVDTSQPLGDESLVEWARPLLGQAIENEEFDELVDPRLGKNFIPGEMFRMVEAAAACV 597
Query: 443 DPNAHKRPKMGHVIHMLEAEE 463
+A KRPKM V+ L+ E
Sbjct: 598 RHSAAKRPKMSQVVRALDTLE 618
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | GSVIVG00014847001 | SubName- Full=Chromosome chr18 scaffold_1, whole genome shotgun sequence; (480 aa) | |||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 508 | |||
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 9e-49 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 5e-48 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 8e-48 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-45 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-44 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 5e-43 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-42 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-31 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 3e-31 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-30 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 4e-30 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 4e-30 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-29 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 4e-29 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-28 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-28 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 6e-28 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 3e-27 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 9e-27 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-26 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 7e-26 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-25 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 5e-25 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 6e-25 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-24 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-24 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 5e-24 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-23 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-23 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 5e-23 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 5e-23 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-22 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 4e-22 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 9e-22 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-21 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 1e-21 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-21 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-21 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-21 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-21 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-21 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 3e-21 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 4e-21 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 4e-21 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 4e-21 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 4e-21 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 4e-21 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 8e-21 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-20 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 3e-20 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 3e-20 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 3e-20 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 3e-20 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 4e-20 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 5e-20 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 6e-20 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 7e-20 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-19 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 3e-19 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 3e-19 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 4e-19 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 4e-19 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 5e-19 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 5e-19 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 5e-19 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 6e-19 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 6e-19 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 6e-19 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 8e-19 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 8e-19 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-18 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-18 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-18 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-18 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-18 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 3e-18 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 3e-18 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 3e-18 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 4e-18 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 4e-18 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 5e-18 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 6e-18 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 6e-18 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 7e-18 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 9e-18 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-17 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-17 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-17 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-17 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-17 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-17 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 3e-17 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 4e-17 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 5e-17 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 5e-17 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 7e-17 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 8e-17 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 8e-17 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 9e-17 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-16 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-16 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-16 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-16 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-16 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-16 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-16 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-16 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 3e-16 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 6e-16 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 6e-16 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 7e-16 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 7e-16 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 7e-16 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 7e-16 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 8e-16 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-15 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-15 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-15 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-15 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-15 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 3e-15 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 3e-15 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 3e-15 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 3e-15 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 4e-15 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 5e-15 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 5e-15 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 6e-15 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 6e-15 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 7e-15 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 7e-15 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 8e-15 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-14 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 1e-14 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-14 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-14 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-14 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-14 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-14 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-14 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 5e-14 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 7e-14 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 7e-14 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 9e-14 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 9e-14 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-13 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-13 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-13 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-13 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-13 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-13 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-13 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-13 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 3e-13 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 4e-13 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 4e-13 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 4e-13 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 4e-13 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 5e-13 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 6e-13 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 6e-13 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 8e-13 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-12 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 1e-12 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-12 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-12 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-12 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-12 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-12 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-12 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-12 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 3e-12 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 3e-12 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 3e-12 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 3e-12 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 4e-12 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 4e-12 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 4e-12 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 5e-12 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 6e-12 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 6e-12 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 6e-12 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 6e-12 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 7e-12 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-11 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-11 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-11 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-11 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-11 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-11 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-11 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-11 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 3e-11 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 3e-11 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 4e-11 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 4e-11 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 7e-11 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 7e-11 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-10 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-10 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-10 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-10 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-10 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-10 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-10 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 5e-10 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 5e-10 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 5e-10 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 5e-10 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 6e-10 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 6e-10 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 7e-10 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 7e-10 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 7e-10 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 7e-10 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 8e-10 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 8e-10 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 9e-10 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-09 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-09 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-09 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 1e-09 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-09 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-09 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-09 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-09 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-09 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 3e-09 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 3e-09 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 3e-09 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 3e-09 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 4e-09 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 4e-09 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 4e-09 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 4e-09 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 5e-09 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 5e-09 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 6e-09 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 7e-09 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 9e-09 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-08 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-08 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-08 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-08 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-08 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-08 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-08 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-08 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-08 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 2e-08 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 3e-08 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 3e-08 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 3e-08 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 3e-08 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 3e-08 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 3e-08 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-08 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 5e-08 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 5e-08 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 5e-08 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 8e-08 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 9e-08 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 9e-08 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-07 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-07 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-07 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-07 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-07 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-07 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 2e-07 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-07 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 3e-07 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-07 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 3e-07 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 4e-07 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 4e-07 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 4e-07 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 6e-07 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 6e-07 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 6e-07 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 8e-07 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 9e-07 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 9e-07 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-06 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 1e-06 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-06 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 4e-06 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 4e-06 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 6e-06 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 1e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 1e-05 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-05 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 3e-05 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 3e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-04 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 1e-04 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 1e-04 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 2e-04 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-04 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 3e-04 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 0.001 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 0.001 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 168 bits (427), Expect = 9e-49
Identities = 76/277 (27%), Positives = 124/277 (44%), Gaps = 31/277 (11%)
Query: 191 ENVIGEGGYGIVYHGVLEDN-----TNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNL 244
+GEG +G VY G L+ VAVK L + Q +EF E + ++ H N+
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63
Query: 245 VRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 304
V+LLG C E +V EY++ G+L +L L+ ++ L A+G+ YL
Sbjct: 64 VKLLGVCTEEEPLYIVMEYMEGGDLLSYLR---KNRPKLSLSDLLSFALQIARGMEYLES 120
Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAST 364
+HRD+ + N L+ + K+SDFGL++ L + Y ++APE
Sbjct: 121 K---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKE 177
Query: 365 GMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRL- 422
G +SDV+SFG+L+ E+ + G +P ++ E + + N RL
Sbjct: 178 GKFTSKSDVWSFGVLLWEIFTLG------EQPYPGMSNEE-VLEYLKNGY-------RLP 223
Query: 423 QEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHML 459
Q C L + L+C + RP ++ +L
Sbjct: 224 QPPNCPPELYD---LMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 164 bits (418), Expect = 5e-48
Identities = 67/193 (34%), Positives = 106/193 (54%), Gaps = 11/193 (5%)
Query: 194 IGEGGYGIVYHGV-LEDNTNVAVKNL-LNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYC 251
+GEGG+G VY + VA+K + + +E E+E + ++ H N+V+L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 252 AEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVV 311
+ H LV EY + G+L+ L L+ + + I+L +GL YLH ++
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLK---ENEGKLSEDEILRILLQILEGLEYLHSN---GII 114
Query: 312 HRDIKSSNILLDK-QWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGM-LNE 369
HRD+K NILLD KL+DFGL+KLL +++S + T V GT Y+APE +E
Sbjct: 115 HRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIV-GTPAYMAPEVLLGKGYYSE 173
Query: 370 RSDVYSFGILIME 382
+SD++S G+++ E
Sbjct: 174 KSDIWSLGVILYE 186
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 165 bits (421), Expect = 8e-48
Identities = 79/278 (28%), Positives = 126/278 (45%), Gaps = 32/278 (11%)
Query: 191 ENVIGEGGYGIVYHGVLEDN-----TNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNL 244
+GEG +G VY G L+ VAVK L + Q +EF E + ++ H N+
Sbjct: 4 GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNI 63
Query: 245 VRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 304
V+LLG C E M+V EY+ G+L +L L+ ++ L A+G+ YL
Sbjct: 64 VKLLGVCTEEEPLMIVMEYMPGGDLLDYLR--KNRPKELSLSDLLSFALQIARGMEYLES 121
Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAST 364
+HRD+ + N L+ + K+SDFGL++ L + Y ++APE
Sbjct: 122 K---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKE 178
Query: 365 GMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVN--LVEWLKTMVTNRNAEGVLDPR 421
G +SDV+SFG+L+ E+ + G P PG N ++E+LK R
Sbjct: 179 GKFTSKSDVWSFGVLLWEIFTLGEEP-----YPGMSNAEVLEYLKKG--YR--------L 223
Query: 422 LQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHML 459
+ C L + + L+C + RP ++ +L
Sbjct: 224 PKPPNCPPELYK---LMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 160 bits (406), Expect = 1e-45
Identities = 83/289 (28%), Positives = 127/289 (43%), Gaps = 47/289 (16%)
Query: 192 NVIGEGGYGIVYHGVLEDNTN----VAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNLVR 246
+GEG +G VY G L+ VAVK L + + K+F E + ++ H N+VR
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 247 LLGYCAEGAHRMLVYEYIDNGNLEQWL-----HGDVGPHSPLTWEIRMNIILGTAKGLTY 301
LLG C E LV EY++ G+L +L S L+ + ++ + AKG+ Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 302 LHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTT-------RVMGTF 354
L K VHRD+ + N L+ + K+SDFGL++ + + Y R M
Sbjct: 121 LA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWM--- 174
Query: 355 GYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRN 413
APE G+ +SDV+SFG+L+ E+ + G P Y ++ E + +
Sbjct: 175 ---APESLKDGIFTSKSDVWSFGVLLWEIFTLGATP--Y----PGLSNEE-VLEYLRKGY 224
Query: 414 AEGVLDPRLQEKP--CSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 460
RL KP C L + L C + RP ++ LE
Sbjct: 225 -------RL-PKPEYCPDELYE---LMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 156 bits (397), Expect = 2e-44
Identities = 70/207 (33%), Positives = 105/207 (50%), Gaps = 24/207 (11%)
Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKV---EVEAIGRVRHKNLVRLL 248
+G G +G VY VAVK +L R + K+ + E+ + R+ H N+VRL+
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVK-ILKKRSEKSKKDQTARREIRILRRLSHPNIVRLI 64
Query: 249 GYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEP 308
+ H LV EY + G+L +L PL+ + I L +GL YLH
Sbjct: 65 DAFEDKDHLYLVMEYCEGGDLFDYLS----RGGPLSEDEAKKIALQILRGLEYLHSN--- 117
Query: 309 KVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPE------YA 362
++HRD+K NILLD+ K++DFGLAK L S +TT V GT Y+APE
Sbjct: 118 GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFV-GTPWYMAPEVLLGGNGY 176
Query: 363 STGMLNERSDVYSFGILIMEVISGRNP 389
+ DV+S G+++ E+++G+ P
Sbjct: 177 GP-----KVDVWSLGVILYELLTGKPP 198
|
Length = 260 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 153 bits (388), Expect = 5e-43
Identities = 83/279 (29%), Positives = 126/279 (45%), Gaps = 38/279 (13%)
Query: 193 VIGEGGYGIVYHGVL-----EDNTNVAVKNLLNNRGQAEK-EFKVEVEAIGRVRHKNLVR 246
+GEG +G VY G L T VAVK L + E+ EF E + ++ H N+VR
Sbjct: 6 KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65
Query: 247 LLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGL 306
LLG C +G +V EY+ G+L +L LT + + + L AKG+ YL
Sbjct: 66 LLGVCTQGEPLYIVTEYMPGGDLLDFLR---KHGEKLTLKDLLQMALQIAKGMEYLESK- 121
Query: 307 EPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFG---YVAPEYAS 363
VHRD+ + N L+ + K+SDFGL++ + + Y G ++APE
Sbjct: 122 --NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRG--GGKLPIKWMAPESLK 177
Query: 364 TGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRL 422
G +SDV+SFG+L+ E+ + G P Y E ++E L+ RL
Sbjct: 178 DGKFTSKSDVWSFGVLLWEIFTLGEQP--YPGMSNE-EVLELLED-----------GYRL 223
Query: 423 QEKP--CSRALKRALLVALRCVDPNAHKRPKMGHVIHML 459
+P C L + L+C + RP ++ L
Sbjct: 224 -PRPENCPDELYE---LMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 151 bits (383), Expect = 2e-42
Identities = 72/266 (27%), Positives = 117/266 (43%), Gaps = 26/266 (9%)
Query: 188 FADENVIGEGGYGIVYHGV-LEDNTNVAVKNL-LNNRGQAEKEFKVEVEAIGRVRHKNLV 245
+ +GEG +G VY + VA+K + + + E++ + +++H N+V
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 246 RLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLT-WEIRMNIILGTAKGLTYLHE 304
RL + LV EY + G+L L L+ E R + L YLH
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLLK----KRGRLSEDEAR-FYLRQILSALEYLHS 115
Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAST 364
+VHRD+K NILLD+ + KL+DFGLA+ L TT V GT Y+APE
Sbjct: 116 ---KGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKL-TTFV-GTPEYMAPEVLLG 170
Query: 365 GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQE 424
+ D++S G+++ E+++G+ P PG+ L+E K + + E
Sbjct: 171 KGYGKAVDIWSLGVILYELLTGKPPF-----PGDDQLLELFKKIGKPK-----PPFPPPE 220
Query: 425 KPCSRALKRALLVALRCVDPNAHKRP 450
S K + + + + KR
Sbjct: 221 WDISPEAKDLI---RKLLVKDPEKRL 243
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 2e-31
Identities = 70/206 (33%), Positives = 101/206 (49%), Gaps = 18/206 (8%)
Query: 194 IGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE 253
IG+G +G V G VAVK L ++ A+ F E + +RH NLV+LLG +
Sbjct: 14 IGKGEFGDVMLGDYRGQK-VAVKCLKDDSTAAQA-FLAEASVMTTLRHPNLVQLLGVVLQ 71
Query: 254 GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHR 313
G +V EY+ G+L +L G +T ++ L +G+ YL E VHR
Sbjct: 72 GNPLYIVTEYMAKGSLVDYLRSR-GRAV-ITLAQQLGFALDVCEGMEYLE---EKNFVHR 126
Query: 314 DIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTF--GYVAPEYASTGMLNERS 371
D+ + N+L+ + K+SDFGLAK + G + APE + +S
Sbjct: 127 DLAARNVLVSEDLVAKVSDFGLAK---EASQGQDS---GKLPVKWTAPEALREKKFSTKS 180
Query: 372 DVYSFGILIMEVIS-GRNPVDYSRPP 396
DV+SFGIL+ E+ S GR P Y R P
Sbjct: 181 DVWSFGILLWEIYSFGRVP--YPRIP 204
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 3e-31
Identities = 78/262 (29%), Positives = 129/262 (49%), Gaps = 27/262 (10%)
Query: 192 NVIGEGGYGIVYHGV-LEDNTNVAVK--NLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLL 248
++IG G +G+VY G+ LE VA+K +L + +A K E++ + ++H N+V+ +
Sbjct: 6 DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYI 65
Query: 249 GYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEP 308
G ++ EY +NG+L Q + P + + +GL YLHE
Sbjct: 66 GSIETSDSLYIILEYAENGSLRQIIK----KFGPFPESLVAVYVYQVLQGLAYLHE---Q 118
Query: 309 KVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLN 368
V+HRDIK++NIL K KL+DFG+A L + V+GT ++APE +
Sbjct: 119 GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS-VVGTPYWMAPEVIEMSGAS 177
Query: 369 ERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCS 428
SD++S G ++E+++G NP P ++N + L +V + P L E S
Sbjct: 178 TASDIWSLGCTVIELLTG-NP-----PYYDLNPMAALFRIVQDD------HPPLPEG-IS 224
Query: 429 RALKRALLVALRCVDPNAHKRP 450
LK L ++C + + RP
Sbjct: 225 PELKDFL---MQCFQKDPNLRP 243
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 121 bits (303), Expect = 3e-30
Identities = 78/279 (27%), Positives = 125/279 (44%), Gaps = 23/279 (8%)
Query: 187 GFADENVIGEGGYGIVYHGVLEDNTNVAVKNL---LNNRGQAEKEFKVEVEAIGRVRH-K 242
+ +GEG +G VY D VA+K L L ++ + + F E++ + + H
Sbjct: 1 SYRILRKLGEGSFGEVYLA--RDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 243 NLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYL 302
N+V+L + + LV EY+D G+LE L +G PL+ + I+ L YL
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLK-KIGRKGPLSESEALFILAQILSALEYL 117
Query: 303 HEGLEPKVVHRDIKSSNILLDKQ-WNPKLSDFGLAKLLGAERS-----YVTTRVMGTFGY 356
H ++HRDIK NILLD+ KL DFGLAKLL S + + +GT GY
Sbjct: 118 HSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGY 174
Query: 357 VAPEYA---STGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRN 413
+APE S + SD++S GI + E+++G P + + LK ++
Sbjct: 175 MAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPP--FEGEKNSSATSQTLK-IILELP 231
Query: 414 AEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKM 452
+ P P + + L+ + + + R
Sbjct: 232 TPSLASPLSPSNPELISKAASDLL-KKLLAKDPKNRLSS 269
|
Length = 384 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 4e-30
Identities = 63/206 (30%), Positives = 101/206 (49%), Gaps = 17/206 (8%)
Query: 192 NVIGEGGYGIVYHGVLEDNTN-VAVK--NLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLL 248
++G G +G VY + +D +AVK L + + + + E+ + ++H N+VR
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 249 GYCAEGAHRML-VY-EYIDNGNLEQWLHGDVGPHSPLTWEIR--MNIILGTAKGLTYLHE 304
G + L ++ EY+ G+L L P+ IR IL +GL YLH
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPV---IRKYTRQIL---EGLAYLHS 119
Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVM-GTFGYVAPEYAS 363
+VHRDIK +NIL+D KL+DFG AK LG + T + GT ++APE
Sbjct: 120 N---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIR 176
Query: 364 TGMLNERSDVYSFGILIMEVISGRNP 389
+D++S G ++E+ +G+ P
Sbjct: 177 GEEYGRAADIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 4e-30
Identities = 66/201 (32%), Positives = 117/201 (58%), Gaps = 12/201 (5%)
Query: 188 FADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRL 247
F E +G G +G V+ G+ ++ VA+K L ++ +++F+ EV+A+ R+RHK+L+ L
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67
Query: 248 LGYCAEGAHRMLVYEYIDNGNLEQWL---HGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 304
C+ G ++ E ++ G+L +L G V P + L +++ A+G+ YL
Sbjct: 68 FAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASL-----IDMACQVAEGMAYLE- 121
Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAST 364
E +HRD+ + NIL+ + K++DFGLA+L+ E Y+++ + + APE AS
Sbjct: 122 --EQNSIHRDLAARNILVGEDLVCKVADFGLARLI-KEDVYLSSDKKIPYKWTAPEAASH 178
Query: 365 GMLNERSDVYSFGILIMEVIS 385
G + +SDV+SFGIL+ E+ +
Sbjct: 179 GTFSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 1e-29
Identities = 67/211 (31%), Positives = 112/211 (53%), Gaps = 17/211 (8%)
Query: 188 FADENVIGEGGYGIVYHGVLEDNTNV-AVKNL-LNNRGQAEKEFKV-EVEAIGRVRHKNL 244
F N IG+G +G+V+ V + + V A+K + L+ + E+E + E + ++ +
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 245 VRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLT----WEIRMNIILGTAKGLT 300
+R + +V EY +NG+L + L G PL W + I+LG L
Sbjct: 62 IRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRG--RPLPEDQVWRFFIQILLG----LA 115
Query: 301 YLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPE 360
+LH K++HRDIKS N+ LD N K+ D G+AKLL ++ T ++GT Y++PE
Sbjct: 116 HLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT-IVGTPYYLSPE 171
Query: 361 YASTGMLNERSDVYSFGILIMEVISGRNPVD 391
NE+SDV++ G+++ E +G++P D
Sbjct: 172 LCEDKPYNEKSDVWALGVVLYECCTGKHPFD 202
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 4e-29
Identities = 81/288 (28%), Positives = 142/288 (49%), Gaps = 32/288 (11%)
Query: 182 EVSTNGFADENVIGEGGYGIVYHGVLE----DNTNVAVKNLLNNRGQAEKE---FKVEVE 234
E+ + + VIG G +G V+ G+L+ VA+K L G EK+ F E
Sbjct: 1 EIHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTL--KPGYTEKQRQDFLSEAS 58
Query: 235 AIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILG 294
+G+ H N++RL G + M++ EY++NG L+++L G S + ++ G
Sbjct: 59 IMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQL---VGMLRG 115
Query: 295 TAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL--GAERSYVTTRVMG 352
A G+ YL + VHRD+ + NIL++ K+SDFGL+++L E +Y T+
Sbjct: 116 IAAGMKYLS---DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKI 172
Query: 353 TFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNR 412
+ APE + SDV+SFGI++ EV+S RP +++ E +K +
Sbjct: 173 PIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFG-----ERPYWDMSNHEVMKAI---- 223
Query: 413 NAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 460
+G P + C A+ + + L+C + +RP+ ++++L+
Sbjct: 224 -NDGFRLPAPMD--CPSAVYQLM---LQCWQQDRARRPRFVDIVNLLD 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 83/273 (30%), Positives = 121/273 (44%), Gaps = 41/273 (15%)
Query: 188 FADENVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVR 246
+ + IGEG G VY VA+K + R Q ++ E+ + +H N+V
Sbjct: 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKM-RLRKQNKELIINEILIMKDCKHPNIVD 79
Query: 247 LLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTW-EIRMN------IILGTAKGL 299
G +V EY+D G+L D+ +T +RMN + +GL
Sbjct: 80 YYDSYLVGDELWVVMEYMDGGSLT-----DI-----ITQNFVRMNEPQIAYVCREVLQGL 129
Query: 300 TYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAP 359
YLH V+HRDIKS NILL K + KL+DFG A L E+S + V GT ++AP
Sbjct: 130 EYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVV-GTPYWMAP 185
Query: 360 EYASTGMLNERSDVYSFGILIMEVISGRNPVDYSR-PPGEVNLVEWLKTMVTNRNAEGVL 418
E + D++S GI+ +E+ G P Y R PP + L + T G+
Sbjct: 186 EVIKRKDYGPKVDIWSLGIMCIEMAEGEPP--YLREPP-----LRALFLITTK----GI- 233
Query: 419 DPRLQEKPC-SRALKRALLVALRCVDPNAHKRP 450
P L+ S K L +C+ + KRP
Sbjct: 234 -PPLKNPEKWSPEFKDFL---NKCLVKDPEKRP 262
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 2e-28
Identities = 75/223 (33%), Positives = 111/223 (49%), Gaps = 18/223 (8%)
Query: 182 EVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKE-FKVEVEAIGRVR 240
E+ E +G G +G V+ G T VAVK L G E F E + + ++R
Sbjct: 2 EIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTL--KPGTMSPEAFLQEAQIMKKLR 59
Query: 241 HKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLT 300
H LV+L C+E +V EY+ G+L +L G L + M + A+G+
Sbjct: 60 HDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQI--AEGMA 117
Query: 301 YLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTF--GYVA 358
YL +HRD+ + NIL+ + K++DFGLA+L+ + Y T R F + A
Sbjct: 118 YLE---SRNYIHRDLAARNILVGENLVCKIADFGLARLI-EDDEY-TAREGAKFPIKWTA 172
Query: 359 PEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVN 400
PE A+ G +SDV+SFGIL+ E+++ GR P Y PG N
Sbjct: 173 PEAANYGRFTIKSDVWSFGILLTEIVTYGRVP--Y---PGMTN 210
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 111 bits (281), Expect = 6e-28
Identities = 58/209 (27%), Positives = 99/209 (47%), Gaps = 9/209 (4%)
Query: 188 FADENVIGEGGYGIVYHG-VLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVR 246
F IG+GG+G VY VA+K + + +++ E++ + + +H N+V+
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 247 LLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGL 306
G + +V E+ G+L+ L LT + KGL YLH
Sbjct: 62 YYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQT---LTESQIAYVCKELLKGLEYLHSN- 117
Query: 307 EPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGM 366
++HRDIK++NILL KL DFGL+ L ++ ++GT ++APE +
Sbjct: 118 --GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--RNTMVGTPYWMAPEVINGKP 173
Query: 367 LNERSDVYSFGILIMEVISGRNPVDYSRP 395
+ ++D++S GI +E+ G+ P P
Sbjct: 174 YDYKADIWSLGITAIELAEGKPPYSELPP 202
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 109 bits (276), Expect = 3e-27
Identities = 61/213 (28%), Positives = 100/213 (46%), Gaps = 23/213 (10%)
Query: 188 FADENVIGEGGYGIVY---HGVLEDNTNVAVKNL-LNNRGQAEKEFKV-EVEAIGRVRHK 242
+ IG+G +G VY D +K + L+N + E+E + EV+ + ++ H
Sbjct: 2 YEIIKQIGKGSFGKVYLVRR--KSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHP 59
Query: 243 NLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYL 302
N+++ E +V EY D G+L Q + P E ++ + L YL
Sbjct: 60 NIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYL 119
Query: 303 HEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPE-- 360
H K++HRDIK NI L KL DFG++K+L + T V GT Y++PE
Sbjct: 120 HS---RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV-GTPYYLSPELC 175
Query: 361 ----YASTGMLNERSDVYSFGILIMEVISGRNP 389
Y N +SD++S G ++ E+ + ++P
Sbjct: 176 QNKPY------NYKSDIWSLGCVLYELCTLKHP 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 9e-27
Identities = 65/270 (24%), Positives = 118/270 (43%), Gaps = 41/270 (15%)
Query: 193 VIGEGGYGIVYHGVL-EDNTNVAVKNL-LNNRGQAEKEFKVEVEAIGRVRHKNLVRLLG- 249
V+G+G G+VY A+K + ++ + K+ E++ + +V+ G
Sbjct: 8 VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGA 67
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSP-----LTWEIRMNIILGTAKGLTYLHE 304
+ EG +V EY+D G+L L VG + +I KGL YLH
Sbjct: 68 FYKEGEIS-IVLEYMDGGSLAD-LLKKVGKIPEPVLAYIARQI--------LKGLDYLHT 117
Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL----GAERSYVTTRVMGTFGYVAPE 360
++HRDIK SN+L++ + K++DFG++K+L ++V GT Y++PE
Sbjct: 118 KR--HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-----GTVTYMSPE 170
Query: 361 YASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDP 420
+ +D++S G+ ++E G+ P P L++ + + P
Sbjct: 171 RIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQ----AICDGPP-----P 221
Query: 421 RLQEKPCSRALKRALLVALRCVDPNAHKRP 450
L + S + ++ C+ + KRP
Sbjct: 222 SLPAEEFSPEFRD--FIS-ACLQKDPKKRP 248
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 1e-26
Identities = 70/213 (32%), Positives = 110/213 (51%), Gaps = 27/213 (12%)
Query: 191 ENVIGEGGYGIVYHGVL----EDNTNVAVKNLLNNRGQAEKE---FKVEVEAIGRVRHKN 243
E VIG G +G V G L + +VA+K L G ++K+ F E +G+ H N
Sbjct: 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTL--KAGSSDKQRLDFLTEASIMGQFDHPN 66
Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 303
++RL G + M++ EY++NG+L+++L + G T + ++ G A G+ YL
Sbjct: 67 IIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGK---FTVGQLVGMLRGIASGMKYLS 123
Query: 304 EGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFG------YV 357
E VHRD+ + NIL++ K+SDFGL++ L + TT+ G +
Sbjct: 124 E---MNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTK-----GGKIPIRWT 175
Query: 358 APEYASTGMLNERSDVYSFGILIMEVIS-GRNP 389
APE + SDV+SFGI++ EV+S G P
Sbjct: 176 APEAIAYRKFTSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 7e-26
Identities = 62/207 (29%), Positives = 109/207 (52%), Gaps = 9/207 (4%)
Query: 194 IGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE 253
IG G +G+V+ G + VA+K + +E++F E + + ++ H LV+L G C E
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIREG-AMSEEDFIEEAQVMMKLSHPKLVQLYGVCTE 70
Query: 254 GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHR 313
+ LV+E++++G L +L G S E + + L +G+ YL V+HR
Sbjct: 71 RSPICLVFEFMEHGCLSDYLRAQRGKFSQ---ETLLGMCLDVCEGMAYLESS---NVIHR 124
Query: 314 DIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDV 373
D+ + N L+ + K+SDFG+ + + ++ +T + +PE S + +SDV
Sbjct: 125 DLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDV 184
Query: 374 YSFGILIMEVIS-GRNPVDYSRPPGEV 399
+SFG+L+ EV S G+ P + +R EV
Sbjct: 185 WSFGVLMWEVFSEGKTPYE-NRSNSEV 210
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 3e-25
Identities = 76/276 (27%), Positives = 132/276 (47%), Gaps = 23/276 (8%)
Query: 190 DENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLG 249
+ENVI G G Y G N ++ ++ E+ +G+++H N+V+L+G
Sbjct: 694 EENVISRGKKGASYKGKSIKN---GMQFVVKEINDVNSIPSSEIADMGKLQHPNIVKLIG 750
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK 309
C L++EYI+ NL + L L+WE R I +G AK L +LH P
Sbjct: 751 LCRSEKGAYLIHEYIEGKNLSEVLRN-------LSWERRRKIAIGIAKALRFLHCRCSPA 803
Query: 310 VVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNE 369
VV ++ I++D + P L L LL + T+ + YVAPE T + E
Sbjct: 804 VVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD-----TKCFISSAYVAPETRETKDITE 857
Query: 370 RSDVYSFGILIMEVISGRNPVDYSRPPGEVN--LVEWLKTMVTNRNAEGVLDPRLQEKPC 427
+SD+Y FG++++E+++G++P D V+ +VEW + ++ + + +DP ++
Sbjct: 858 KSDIYGFGLILIELLTGKSPAD---AEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVS 914
Query: 428 S--RALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461
+ + +AL C + RP V+ LE+
Sbjct: 915 VNQNEIVEVMNLALHCTATDPTARPCANDVLKTLES 950
|
Length = 968 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 5e-25
Identities = 63/210 (30%), Positives = 106/210 (50%), Gaps = 21/210 (10%)
Query: 193 VIGEGGYGIVYHGV-LEDNTN----VAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNLVR 246
V+G G +G VY GV + + VA+K L +A KE E + V H ++VR
Sbjct: 14 VLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVR 73
Query: 247 LLGYCAEGAHRMLVYEYIDNGNLEQWLH---GDVGPHSPLTWEIRMNIILGTAKGLTYLH 303
LLG C L+ + + G L ++ ++G L W +++ AKG++YL
Sbjct: 74 LLGICLSSQV-QLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQI------AKGMSYLE 126
Query: 304 EGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA-ERSYVTTRVMGTFGYVAPEYA 362
E ++VHRD+ + N+L+ + K++DFGLAKLL E+ Y ++A E
Sbjct: 127 E---KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESI 183
Query: 363 STGMLNERSDVYSFGILIMEVIS-GRNPVD 391
+ +SDV+S+G+ + E+++ G P +
Sbjct: 184 LHRIYTHKSDVWSYGVTVWELMTFGAKPYE 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 6e-25
Identities = 70/210 (33%), Positives = 100/210 (47%), Gaps = 22/210 (10%)
Query: 192 NVIGEGGYGIVYHGV-LEDNTNVAVK--NLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLL 248
N IG G +G VY V L+ +AVK + +N + KE E++ + ++H NLV+
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 249 GYCAEGAHRMLVY---EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG 305
G E HR VY EY G LE+ L G + L +GL YLH
Sbjct: 66 G--VE-VHREKVYIFMEYCSGGTLEELLEH--GRILDEHVIRVYTLQL--LEGLAYLHSH 118
Query: 306 LEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRV---MGTFGYVAPEYA 362
+VHRDIK +NI LD KL DFG A L + + V GT Y+APE
Sbjct: 119 ---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVI 175
Query: 363 STGMLNER---SDVYSFGILIMEVISGRNP 389
+ G +D++S G +++E+ +G+ P
Sbjct: 176 TGGKGKGHGRAADIWSLGCVVLEMATGKRP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 71/227 (31%), Positives = 110/227 (48%), Gaps = 38/227 (16%)
Query: 192 NVIGEGGYGIVY---HGVLEDNTN--VAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNLV 245
+GEG +G V + L DNT VAVK+L ++ Q +F+ E+E + + H+N+V
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 246 RLLGYCAEGAHR---MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGT------- 295
+ G E L+ EY+ +G+L +L H I L
Sbjct: 70 KYKG-VCEKPGGRSLRLIMEYLPSGSLRDYLQR----HRD-------QINLKRLLLFSSQ 117
Query: 296 -AKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMG-- 352
KG+ YL + +HRD+ + NIL++ + K+SDFGLAK+L ++ Y + G
Sbjct: 118 ICKGMDYLGS---QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGES 174
Query: 353 -TFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGE 398
F Y APE T + SDV+SFG+ + E+ + +P S PP E
Sbjct: 175 PIFWY-APECLRTSKFSSASDVWSFGVTLYELFTYGDP-SQS-PPAE 218
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 1e-24
Identities = 62/201 (30%), Positives = 94/201 (46%), Gaps = 19/201 (9%)
Query: 194 IGEGGYGIVYHGVLEDNTN----VAVKNLLNNRGQA-EKEFKVEVEAIGRVRHKNLVRLL 248
+G G +G V GV + VAVK L A +KEF E + ++ H +VRL+
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 249 GYCAEGAHRMLVYEYIDNGNLEQWL--HGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGL 306
G C +G MLV E G L ++L ++ A G+ YL
Sbjct: 63 GVC-KGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKEL------AHQVAMGMAYLES-- 113
Query: 307 EPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTF--GYVAPEYAST 364
VHRD+ + N+LL + K+SDFG+++ LGA Y G + + APE +
Sbjct: 114 -KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINY 172
Query: 365 GMLNERSDVYSFGILIMEVIS 385
G + +SDV+S+G+ + E S
Sbjct: 173 GKFSSKSDVWSYGVTLWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 5e-24
Identities = 63/199 (31%), Positives = 102/199 (51%), Gaps = 11/199 (5%)
Query: 194 IGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE 253
+G G +G V+ G+ + T VAVK L + +F E + + ++RH L++L C
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPK-DFLAEAQIMKKLRHPKLIQLYAVCTL 72
Query: 254 GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHR 313
+V E + G+L ++L G G L I M + A G+ YL +HR
Sbjct: 73 EEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQV--ASGMAYLE---AQNYIHR 127
Query: 314 DIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTF--GYVAPEYASTGMLNERS 371
D+ + N+L+ + K++DFGLA+++ E Y R F + APE A + +S
Sbjct: 128 DLAARNVLVGENNICKVADFGLARVIK-EDIY-EAREGAKFPIKWTAPEAALYNRFSIKS 185
Query: 372 DVYSFGILIMEVIS-GRNP 389
DV+SFGIL+ E+++ GR P
Sbjct: 186 DVWSFGILLTEIVTYGRMP 204
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 99 bits (249), Expect = 1e-23
Identities = 77/278 (27%), Positives = 124/278 (44%), Gaps = 29/278 (10%)
Query: 180 ELEVSTNGFADENVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGR 238
E E + + V+G+G YGIVY L +A+K + + + E+
Sbjct: 2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSY 61
Query: 239 VRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGP--HSPLTWEIRMNIILGTA 296
++H+N+V+ LG +E + E + G+L L GP + T IL
Sbjct: 62 LKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQIL--- 118
Query: 297 KGLTYLHEGLEPKVVHRDIKSSNILLDKQWNP-KLSDFGLAKLLGAERSYVTTRVMGTFG 355
+GL YLH+ ++VHRDIK N+L++ K+SDFG +K L A + T GT
Sbjct: 119 EGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL-AGINPCTETFTGTLQ 174
Query: 356 YVAPEYASTGM--LNERSDVYSFGILIMEVISGRNP-VDYSRPPGEVNLVEWLKTMVTNR 412
Y+APE G +D++S G I+E+ +G+ P ++ P + V K
Sbjct: 175 YMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKI----- 229
Query: 413 NAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRP 450
P + E + A + + LRC +P+ KR
Sbjct: 230 ------HPEIPESLSAEA--KNFI--LRCFEPDPDKRA 257
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 2e-23
Identities = 70/229 (30%), Positives = 115/229 (50%), Gaps = 31/229 (13%)
Query: 180 ELEVSTNGFADENVIGEGGYGIVYHGVL------EDNTNVAVKNLL-NNRGQAEKEFKVE 232
E+ +S F +E +GEG +G VY G L T+VA+K L N + ++EF+ E
Sbjct: 1 EIPLSAVRFLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQE 58
Query: 233 VEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWL-----HGDVGP-------H 280
E + ++H N+V LLG C + +++EY+ +G+L ++L H DVG
Sbjct: 59 AELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVK 118
Query: 281 SPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG 340
S L ++I + A G+ YL VHRD+ + N L+ + K+SDFGL++ +
Sbjct: 119 SSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVKISDFGLSRDIY 175
Query: 341 AERSYVTTRVMGT----FGYVAPEYASTGMLNERSDVYSFGILIMEVIS 385
+ Y RV ++ PE G SD++SFG+++ E+ S
Sbjct: 176 SADYY---RVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 98.4 bits (246), Expect = 5e-23
Identities = 64/232 (27%), Positives = 101/232 (43%), Gaps = 43/232 (18%)
Query: 188 FADENVIGEGGYGIVYHGVL-EDNTNVAVKNL---LNNRGQAEKEFKVEVEAIGRV-RHK 242
F +IGEG + V E N A+K L + + K K+E E + R+ H
Sbjct: 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHP 62
Query: 243 NLVRLLGYCAEGAHRM-LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTY 301
+++L Y + + V EY NG L Q++ + L + L Y
Sbjct: 63 GIIKLY-YTFQDEENLYFVLEYAPNGELLQYIR----KYGSLDEKCTRFYAAEILLALEY 117
Query: 302 LHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVM---------- 351
LH ++HRD+K NILLDK + K++DFG AK+L S + +
Sbjct: 118 LHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEK 174
Query: 352 ---------GTFGYVAPEYASTGMLNE-----RSDVYSFGILIMEVISGRNP 389
GT YV+PE +LNE SD+++ G +I ++++G+ P
Sbjct: 175 NRRRFASFVGTAEYVSPE-----LLNEKPAGKSSDLWALGCIIYQMLTGKPP 221
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 5e-23
Identities = 82/287 (28%), Positives = 127/287 (44%), Gaps = 38/287 (13%)
Query: 192 NVIGEGGYGIVYHGVL----EDNT--NVAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNL 244
+G G +G VY G+ D VAVK L + Q E +F +E + + H+N+
Sbjct: 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71
Query: 245 VRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPH----SPLTWEIRMNIILGTAKGLT 300
VRL+G E R ++ E + G+L+ +L + P S LT + + AKG
Sbjct: 72 VRLIGVSFERLPRFILLELMAGGDLKSFLR-ENRPRPERPSSLTMKDLLFCARDVAKGCK 130
Query: 301 YLHEGLEPKVVHRDIKSSNILLDKQWNP----KLSDFGLAK-LLGAERSYVTTRVMGTFG 355
YL E +HRDI + N LL + P K++DFG+A+ + A R M
Sbjct: 131 YLEEN---HFIHRDIAARNCLLTCK-GPGRVAKIADFGMARDIYRASYYRKGGRAMLPIK 186
Query: 356 YVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNA 414
++ PE G+ ++DV+SFG+L+ E+ S G P PG N + + VT
Sbjct: 187 WMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPY-----PGRTN--QEVMEFVT---G 236
Query: 415 EGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461
G LDP K C + R + C RP ++ ++
Sbjct: 237 GGRLDP---PKGCPGPVYR---IMTDCWQHTPEDRPNFATILERIQY 277
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 97.1 bits (242), Expect = 2e-22
Identities = 64/216 (29%), Positives = 103/216 (47%), Gaps = 22/216 (10%)
Query: 193 VIGEGGYGIVYHGVL------EDNTNVAVKNLLN-NRGQAEKEFKVEVEAIGRVRHKNLV 245
+GEG +G V+ G D VAVK L A K+F+ E E + +H+N+V
Sbjct: 12 ELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIV 71
Query: 246 RLLGYCAEGAHRMLVYEYIDNGNLEQWL--HG--------DVGPHSPLTWEIRMNIILGT 295
+ G C EG ++V+EY+++G+L ++L HG P LT + I +
Sbjct: 72 KFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQI 131
Query: 296 AKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSY-VTTRVMGTF 354
A G+ YL VHRD+ + N L+ K+ DFG+++ + Y V M
Sbjct: 132 ASGMVYLA---SQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPI 188
Query: 355 GYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNP 389
++ PE SDV+SFG+++ E+ + G+ P
Sbjct: 189 RWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 95.7 bits (238), Expect = 4e-22
Identities = 83/283 (29%), Positives = 131/283 (46%), Gaps = 38/283 (13%)
Query: 191 ENVIGEGGYGIVYHGVLE----DNTNVAVKNLLNNRGQAEK---EFKVEVEAIGRVRHKN 243
E VIG G +G V G L+ VA+K L G EK +F E +G+ H N
Sbjct: 9 EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTL--KSGYTEKQRRDFLSEASIMGQFDHPN 66
Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 303
++ L G + M++ E+++NG L+ +L + G + + + ++ G A G+ YL
Sbjct: 67 IIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQL---VGMLRGIAAGMKYLS 123
Query: 304 EGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVT-TRVMG---TFGYVAP 359
E VHRD+ + NIL++ K+SDFGL++ L + S T T +G + AP
Sbjct: 124 ---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAP 180
Query: 360 EYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVL 418
E + SDV+S+GI++ EV+S G P +N +E
Sbjct: 181 EAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQ-------------- 226
Query: 419 DPRLQEKP-CSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 460
D RL C AL + + L C + + RPK G ++ L+
Sbjct: 227 DYRLPPPMDCPTALHQLM---LDCWQKDRNARPKFGQIVSTLD 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 9e-22
Identities = 65/199 (32%), Positives = 99/199 (49%), Gaps = 16/199 (8%)
Query: 194 IGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKE-FKVEVEAIGRVRHKNLVRLLGYCA 252
IG+G +G VY GVL+ NT VAVK + K F E E + + H N+V+L+G C
Sbjct: 3 IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCV 62
Query: 253 EGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK-VV 311
+ +V E + G+L +L + LT + + + L A G+ Y LE K +
Sbjct: 63 QKQPIYIVMELVPGGSLLTFLR---KKKNRLTVKKLLQMSLDAAAGMEY----LESKNCI 115
Query: 312 HRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGT----FGYVAPEYASTGML 367
HRD+ + N L+ + K+SDFG+++ E + T G + APE + G
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSR---EEEGGIYTVSDGLKQIPIKWTAPEALNYGRY 172
Query: 368 NERSDVYSFGILIMEVISG 386
SDV+S+GIL+ E S
Sbjct: 173 TSESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 94.3 bits (235), Expect = 1e-21
Identities = 61/204 (29%), Positives = 95/204 (46%), Gaps = 22/204 (10%)
Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYC 251
+GEG YG VY + E VA+K + + +E E+ + + +V+ G
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVVPVE--EDLQEIIKEISILKQCDSPYIVKYYGSY 67
Query: 252 AEGAHRMLVYEYIDNG------NLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG 305
+ +V EY G + LT E I+ T KGL YLH
Sbjct: 68 FKNTDLWIVMEYCGAGSVSDIMKITN---------KTLTEEEIAAILYQTLKGLEYLHSN 118
Query: 306 LEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTG 365
K +HRDIK+ NILL+++ KL+DFG++ L + T V+GT ++APE
Sbjct: 119 ---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT-VIGTPFWMAPEVIQEI 174
Query: 366 MLNERSDVYSFGILIMEVISGRNP 389
N ++D++S GI +E+ G+ P
Sbjct: 175 GYNNKADIWSLGITAIEMAEGKPP 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 1e-21
Identities = 70/222 (31%), Positives = 112/222 (50%), Gaps = 14/222 (6%)
Query: 194 IGEGGYGIVYHGVLE---DNTNVAVKNLLNNRGQAEK-EFKVEVEAIGRVRHKNLVRLLG 249
+G G +G V GV + +VA+K L N ++ + E E E + ++ + +VR++G
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK 309
C E MLV E G L ++L G +T + ++ + G+ YL
Sbjct: 63 VC-EAEALMLVMEMASGGPLNKFL---SGKKDEITVSNVVELMHQVSMGMKYLEG---KN 115
Query: 310 VVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTF--GYVAPEYASTGML 367
VHRD+ + N+LL Q K+SDFGL+K LGA+ SY R G + + APE +
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKF 175
Query: 368 NERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTM 408
+ RSDV+S+GI + E S G+ P + P ++ +E K +
Sbjct: 176 SSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRL 217
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 93.9 bits (234), Expect = 2e-21
Identities = 67/212 (31%), Positives = 100/212 (47%), Gaps = 22/212 (10%)
Query: 192 NVIGEGGYGIVYHGV-LEDNTNVAVKNL-LNNRGQAEKEFKV-EVEAIGRVRHKNLVRLL 248
IG+G +G V D + K + N + EK+ V EV + ++H N+VR
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVR-- 63
Query: 249 GYCAEGAHRM---------LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGL 299
Y R+ +V EY + G+L Q + + E I+ L
Sbjct: 64 -YY----DRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLAL 118
Query: 300 TYLHEGLEPK--VVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYV 357
H +P V+HRD+K +NI LD N KL DFGLAK+LG + S+ T V GT Y+
Sbjct: 119 YECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV-GTPYYM 177
Query: 358 APEYASTGMLNERSDVYSFGILIMEVISGRNP 389
+PE + +E+SD++S G LI E+ + P
Sbjct: 178 SPEQLNHMSYDEKSDIWSLGCLIYELCALSPP 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 93.9 bits (234), Expect = 2e-21
Identities = 63/209 (30%), Positives = 99/209 (47%), Gaps = 24/209 (11%)
Query: 192 NVIGEGGYGIVYHGVLEDNTN--VAVKNLLNNRGQAEKEFK---VEVEAIGRVRHKNLVR 246
+G G G+V VL T +AVK + E K E++ + + +V
Sbjct: 7 GELGAGNSGVVSK-VLHRPTGKIMAVKTIR--LEINEAIQKQILRELDILHKCNSPYIVG 63
Query: 247 LLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVG--PHSPLTWEIRMNIILGTAKGLTYLHE 304
G + EY+D G+L++ L G P L I + KGLTYLHE
Sbjct: 64 FYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILG-----KIAVAVLKGLTYLHE 118
Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL--GAERSYVTTRVMGTFGYVAPEYA 362
K++HRD+K SNIL++ + KL DFG++ L +++V GT Y+APE
Sbjct: 119 KH--KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFV-----GTSSYMAPERI 171
Query: 363 STGMLNERSDVYSFGILIMEVISGRNPVD 391
+ +SD++S G+ ++E+ +GR P
Sbjct: 172 QGNDYSVKSDIWSLGLSLIELATGRFPYP 200
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.9 bits (234), Expect = 2e-21
Identities = 56/207 (27%), Positives = 100/207 (48%), Gaps = 19/207 (9%)
Query: 194 IGEGGYGIVYHGVL------EDNTNVAVKNLLNNRGQAEK-EFKVEVEAIGRVRHKNLVR 246
+G+G +G+VY G+ E T VA+K + N E+ EF E + ++VR
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 247 LLGYCAEGAHRMLVYEYIDNGNLEQWLHG------DVGPHSPLTWEIRMNIILGTAKGLT 300
LLG + G ++V E + G+L+ +L + P T + + + A G+
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 301 YLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYV--TTRVMGTFGYVA 358
YL K VHRD+ + N ++ + K+ DFG+ + + E Y + + ++A
Sbjct: 134 YLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDI-YETDYYRKGGKGLLPVRWMA 189
Query: 359 PEYASTGMLNERSDVYSFGILIMEVIS 385
PE G+ +SDV+SFG+++ E+ +
Sbjct: 190 PESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 2e-21
Identities = 59/203 (29%), Positives = 99/203 (48%), Gaps = 16/203 (7%)
Query: 194 IGEGGYGIVYHGV-LEDNTNVAVK--NLLNNRGQAE---KEFKVEVEAIGRVRHKNLVRL 247
+G G +G VY G+ L+D AVK +L ++ + K+ + E+ + +++H N+V+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 248 LGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLE 307
LG E + + E + G+L + L G + GL YLH+
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAK-LLKKYGS---FPEPVIRLYTRQILLGLEYLHDR-- 121
Query: 308 PKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEY-ASTGM 366
VHRDIK +NIL+D KL+DFG+AK + G+ ++APE A G
Sbjct: 122 -NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSF--AKSFKGSPYWMAPEVIAQQGG 178
Query: 367 LNERSDVYSFGILIMEVISGRNP 389
+D++S G ++E+ +G+ P
Sbjct: 179 YGLAADIWSLGCTVLEMATGKPP 201
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 93.4 bits (232), Expect = 2e-21
Identities = 83/280 (29%), Positives = 136/280 (48%), Gaps = 34/280 (12%)
Query: 191 ENVIGEGGYGIVYHGVLE----DNTNVAVKNLLNNRGQAEKE---FKVEVEAIGRVRHKN 243
E VIG G +G V G L+ VA+K L G EK+ F E +G+ H N
Sbjct: 9 EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTL--KAGYTEKQRRDFLSEASIMGQFDHPN 66
Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 303
++ L G + M+V EY++NG+L+ +L G + + + ++ G A G+ YL
Sbjct: 67 IIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQL---VGMLRGIASGMKYLS 123
Query: 304 EGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL--GAERSYVTTRVMGTFGYVAPEY 361
+ VHRD+ + NIL++ K+SDFGL+++L E +Y T + APE
Sbjct: 124 ---DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEA 180
Query: 362 ASTGMLNERSDVYSFGILIMEVISGRNPVDY-SRPPGEVNLVEWLKTMVTNRNAEGVLDP 420
+ SDV+S+GI++ EV+S Y RP E++ + +K + EG P
Sbjct: 181 IAYRKFTSASDVWSYGIVMWEVMS------YGERPYWEMSNQDVIKAI-----EEGYRLP 229
Query: 421 RLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 460
+ C AL + + L C + ++RPK ++ +L+
Sbjct: 230 APMD--CPAALHQLM---LDCWQKDRNERPKFEQIVSILD 264
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 3e-21
Identities = 71/210 (33%), Positives = 111/210 (52%), Gaps = 17/210 (8%)
Query: 194 IGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE 253
+G+G +G V+ G T VA+K L E F E + + ++RH+ LV+L +E
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVSE 72
Query: 254 GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHR 313
+V EY+ G+L +L G++G + L + M + A G+ Y+ VHR
Sbjct: 73 EP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQI--ASGMAYVER---MNYVHR 126
Query: 314 DIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTF--GYVAPEYASTGMLNERS 371
D++++NIL+ + K++DFGLA+L+ E + T R F + APE A G +S
Sbjct: 127 DLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 184
Query: 372 DVYSFGILIMEVIS-GRNPVDYSRPPGEVN 400
DV+SFGIL+ E+ + GR P PG VN
Sbjct: 185 DVWSFGILLTELTTKGRVPY-----PGMVN 209
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 92.3 bits (229), Expect = 4e-21
Identities = 69/202 (34%), Positives = 105/202 (51%), Gaps = 22/202 (10%)
Query: 193 VIGEGGYGIVYHGVLEDNTNVAVKNL-LNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYC 251
+IGEG +G V G VAVKN+ + QA F E + ++ HKNLVRLLG
Sbjct: 13 IIGEGEFGAVLQGEYT-GQKVAVKNIKCDVTAQA---FLEETAVMTKLHHKNLVRLLGVI 68
Query: 252 A-EGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKV 310
G + +V E + GNL +L + ++ + L A+G+ YL K+
Sbjct: 69 LHNGLY--IVMELMSKGNLVNFLRTRGRALVSVIQLLQFS--LDVAEGMEYLES---KKL 121
Query: 311 VHRDIKSSNILLDKQWNPKLSDFGLAKL--LGAERSYVTTRVMGTFGYVAPEYASTGMLN 368
VHRD+ + NIL+ + K+SDFGLA++ +G + S + + + APE +
Sbjct: 122 VHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK------WTAPEALKHKKFS 175
Query: 369 ERSDVYSFGILIMEVIS-GRNP 389
+SDV+S+G+L+ EV S GR P
Sbjct: 176 SKSDVWSYGVLLWEVFSYGRAP 197
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 4e-21
Identities = 73/270 (27%), Positives = 119/270 (44%), Gaps = 29/270 (10%)
Query: 193 VIGEGGYGIVYHGVL------EDNTNVAVKNLLNNRGQ-AEKEFKVEVEAIGRVRHKNLV 245
+G G +G V+ T V VK L + + + EF+ E++ ++ HKN+V
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71
Query: 246 RLLGYCAEGAHRMLVYEYIDNGNLEQWL-----HGDVGPHSPLTWEIRMNIILGTAKGLT 300
RLLG C E ++ EY D G+L+Q+L + PL+ + ++ + A G+
Sbjct: 72 RLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMD 131
Query: 301 YLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPE 360
+L + VHRD+ + N L+ Q K+S L+K + Y + ++APE
Sbjct: 132 HLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPE 188
Query: 361 YASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDP 420
+ +SDV+SFG+L+ EV + GE+ V NR G L+
Sbjct: 189 AVQEDDFSTKSDVWSFGVLMWEVFT----------QGELPFYGLSDEEVLNRLQAGKLEL 238
Query: 421 RLQEKPCSRALKRALLVALRCVDPNAHKRP 450
+ E C L + + RC N RP
Sbjct: 239 PVPEG-CPSRLYKLM---TRCWAVNPKDRP 264
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 92.6 bits (230), Expect = 4e-21
Identities = 66/211 (31%), Positives = 110/211 (52%), Gaps = 19/211 (9%)
Query: 194 IGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKE-FKVEVEAIGRVRHKNLVRLLGYCA 252
+G G +G V+ G +T VA+K+L +G E F E + +++H LVRL
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSL--KQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT 71
Query: 253 EGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVH 312
+ ++ EY++NG+L +L G + I M + A+G+ ++ +H
Sbjct: 72 QEP-IYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQI--AEGMAFIER---KNYIH 125
Query: 313 RDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTF--GYVAPEYASTGMLNER 370
RD++++NIL+ + K++DFGLA+L+ E + T R F + APE + G +
Sbjct: 126 RDLRAANILVSETLCCKIADFGLARLI--EDNEYTAREGAKFPIKWTAPEAINYGTFTIK 183
Query: 371 SDVYSFGILIMEVIS-GRNPVDYSRPPGEVN 400
SDV+SFGIL+ E+++ GR P PG N
Sbjct: 184 SDVWSFGILLTEIVTYGRIPY-----PGMTN 209
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 4e-21
Identities = 70/278 (25%), Positives = 119/278 (42%), Gaps = 31/278 (11%)
Query: 186 NGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAE--KEFKVEVEAIGRVRHKN 243
+ + +GEG G V L++ + + + K+ E+E +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60
Query: 244 LVRLLGYCAEGAHRML--VYEYIDNGNLEQWLHGDVGPHSPLTWE-IRMNIILGTAKGLT 300
+V+ G + + + EY + G+L+ ++ V E + I KGL+
Sbjct: 61 IVKYYGAFLDESSSSIGIAMEYCEGGSLDS-IYKKVKKRGGRIGEKVLGKIAESVLKGLS 119
Query: 301 YLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPE 360
YLH K++HRDIK SNILL ++ KL DFG++ L S T GT Y+APE
Sbjct: 120 YLHS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELV--NSLAGTFT-GTSFYMAPE 173
Query: 361 YASTGMLNERSDVYSFGILIMEVISGRNPV--DYSRPPGEVNLVEWLKTMVTNRNAEGVL 418
+ SDV+S G+ ++EV R P + P G + L+ ++ M
Sbjct: 174 RIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPN-------- 225
Query: 419 DPRLQEKP-----CSRALKRALLVALRCVDPNAHKRPK 451
P L+++P S K + +C++ + +RP
Sbjct: 226 -PELKDEPGNGIKWSEEFKDFI---KQCLEKDPTRRPT 259
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.8 bits (231), Expect = 4e-21
Identities = 52/200 (26%), Positives = 91/200 (45%), Gaps = 16/200 (8%)
Query: 194 IGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKV----EVEAIGRVRHKNLVRLL 248
IGEG YG+VY VA+K + + E++ + + H N+++LL
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIK--LRFESEGIPKTALREIKLLKELNHPNIIKLL 64
Query: 249 GYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEP 308
LV+E++D +L + + L + + + +GL + H
Sbjct: 65 DVFRHKGDLYLVFEFMDT-DLYKLIKDR---QRGLPESLIKSYLYQLLQGLAFCHSH--- 117
Query: 309 KVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAST-GML 367
++HRD+K N+L++ + KL+DFGLA+ G+ T V+ T Y APE
Sbjct: 118 GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVV-TRWYRAPELLLGDKGY 176
Query: 368 NERSDVYSFGILIMEVISGR 387
+ D++S G + E++S R
Sbjct: 177 STPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 91.9 bits (228), Expect = 8e-21
Identities = 64/209 (30%), Positives = 103/209 (49%), Gaps = 18/209 (8%)
Query: 192 NVIGEGGYGIVYHGVLEDNTNVAVKNLL---NNRGQAEKEFKV---EVEAIGRVRHKNLV 245
V+G+G YG VY G+ +AVK + +N AEKE++ EV+ + ++H N+V
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 246 RLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG 305
+ LG C + + E++ G++ L+ GP + IL G+ YLH
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSILN-RFGPLPEPVFCKYTKQIL---DGVAYLHNN 121
Query: 306 LEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG-----AERSYVTTRVMGTFGYVAPE 360
VVHRDIK +N++L KL DFG A+ L S + + GT ++APE
Sbjct: 122 ---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPE 178
Query: 361 YASTGMLNERSDVYSFGILIMEVISGRNP 389
+ +SD++S G + E+ +G+ P
Sbjct: 179 VINESGYGRKSDIWSIGCTVFEMATGKPP 207
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 90.5 bits (225), Expect = 2e-20
Identities = 70/284 (24%), Positives = 112/284 (39%), Gaps = 49/284 (17%)
Query: 194 IGEGGYGIV----YHGVLEDNTNVAVKNLLNNRGQ-AEKEFKVEVEAIGRVRHKNLVRLL 248
+G+G +G+V + VAVK L +++ +F E + + H+NL+RL
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62
Query: 249 GYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLT--WEIRMNIILGTAKGLTYLHEGL 306
G M+V E G+L L D H ++ + + I A G+ YL
Sbjct: 63 GVVLTHP-LMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQI----ANGMRYLES-- 115
Query: 307 EPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTT----RVMGTFGYVAPEYA 362
+ +HRD+ + NILL K+ DFGL + L + +V F + APE
Sbjct: 116 -KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV--PFAWCAPESL 172
Query: 363 STGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVL---D 419
T + SDV+ FG+ + E+ + Y P W + +L D
Sbjct: 173 RTRTFSHASDVWMFGVTLWEMFT------YGEEP-------WA-----GLSGSQILKKID 214
Query: 420 PRLQ--EKP--CSRALKRALLVALRCVDPNAHKRPKMGHVIHML 459
+ E+P C + V L+C N RP + L
Sbjct: 215 KEGERLERPEACP---QDIYNVMLQCWAHNPADRPTFAALREFL 255
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 3e-20
Identities = 60/199 (30%), Positives = 98/199 (49%), Gaps = 9/199 (4%)
Query: 194 IGEGGYGIVYH-GVLEDNTNVAVKNL-LNNRGQAEKEFKV-EVEAIGRVRHKNLVRLLGY 250
+G+G YG VY L DN A+K + L + Q E+E V E+ + V H N++
Sbjct: 8 LGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEA 67
Query: 251 CAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKV 310
+G +V EY G+L + + + + I + +GL LHE K+
Sbjct: 68 FLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KI 124
Query: 311 VHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNER 370
+HRD+KS+NILL K+ D G++K+L + + +GT Y+APE + +
Sbjct: 125 LHRDLKSANILLVANDLVKIGDLGISKVL---KKNMAKTQIGTPHYMAPEVWKGRPYSYK 181
Query: 371 SDVYSFGILIMEVISGRNP 389
SD++S G L+ E+ + P
Sbjct: 182 SDIWSLGCLLYEMATFAPP 200
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 90.9 bits (226), Expect = 3e-20
Identities = 67/223 (30%), Positives = 95/223 (42%), Gaps = 44/223 (19%)
Query: 190 DENVIGEGGYGIVY---HGVLEDNTNVAVKNL-LNNRGQAEKEFKVEVEAIGRVRH-KNL 244
D IG G +G V H T +AVK + + +K ++++ + R +
Sbjct: 8 DLGEIGRGAFGTVNKMLHK--PSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYI 65
Query: 245 VRLLG---------YCAE------GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRM 289
V+ G C E VYE + + + EI
Sbjct: 66 VKFYGALFREGDCWICMELMDISLDKFYKYVYE-VLKSVIPE--------------EILG 110
Query: 290 NIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTR 349
I + T K L YL E L K++HRD+K SNILLD+ N KL DFG++ L S TR
Sbjct: 111 KIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQL--VDSIAKTR 166
Query: 350 VMGTFGYVAPEYASTGMLNE---RSDVYSFGILIMEVISGRNP 389
G Y+APE + RSDV+S GI + EV +G+ P
Sbjct: 167 DAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFP 209
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 3e-20
Identities = 63/215 (29%), Positives = 108/215 (50%), Gaps = 22/215 (10%)
Query: 194 IGEGGYGIVY----HGVL--EDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRL 247
+GEG +G V+ H +L +D VAVK L A ++F+ E E + ++H+++VR
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 248 LGYCAEGAHRMLVYEYIDNGNLEQWLH-----------GDVGPHSPLTWEIRMNIILGTA 296
G C EG ++V+EY+ +G+L ++L G+ LT + I A
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 297 KGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSY-VTTRVMGTFG 355
G+ YL L VHRD+ + N L+ + K+ DFG+++ + + Y V R M
Sbjct: 133 SGMVYL-ASLH--FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 189
Query: 356 YVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNP 389
++ PE SD++SFG+++ E+ + G+ P
Sbjct: 190 WMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 3e-20
Identities = 66/207 (31%), Positives = 107/207 (51%), Gaps = 27/207 (13%)
Query: 194 IGEGGYGIV---YHGVLEDNTN--VAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLL 248
+G+G +G V + L+DNT VAVK L ++ + ++F+ E+E + ++H N+V+
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71
Query: 249 GYCAEGAHR--MLVYEYIDNGNLEQWL--HGDVGPHSPL---TWEIRMNIILGTAKGLTY 301
G C R LV EY+ G+L +L H + H L +I KG+ Y
Sbjct: 72 GVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQI--------CKGMEY 123
Query: 302 LHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMG---TFGYVA 358
L + VHRD+ + NIL++ + K+ DFGL K+L ++ Y R G F Y A
Sbjct: 124 LGS---KRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWY-A 179
Query: 359 PEYASTGMLNERSDVYSFGILIMEVIS 385
PE + + SDV+SFG+++ E+ +
Sbjct: 180 PESLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.9 bits (224), Expect = 4e-20
Identities = 61/205 (29%), Positives = 102/205 (49%), Gaps = 26/205 (12%)
Query: 194 IGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKV----EVEAIGRVRHKNLVRLL 248
+GEG YG+VY + VA+K + + E+ E+ + ++H N+V+LL
Sbjct: 7 LGEGTYGVVYKARDKKTGEIVALKKIRLD--NEEEGIPSTALREISLLKELKHPNIVKLL 64
Query: 249 GYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEP 308
LV+EY D +L+++L I+ +I+ +GL Y H
Sbjct: 65 DVIHTERKLYLVFEYCDM-DLKKYLD-KRPGPLSPN-LIK-SIMYQLLRGLAYCHSH--- 117
Query: 309 KVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG-AERSYVTTRVMGTFGYVAPEYASTGML 367
+++HRD+K NIL+++ KL+DFGLA+ G R+Y T V+ T Y APE +L
Sbjct: 118 RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTY-THEVV-TLWYRAPEI----LL 171
Query: 368 NERS-----DVYSFGILIMEVISGR 387
+ D++S G + E+I+G+
Sbjct: 172 GSKHYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 5e-20
Identities = 60/212 (28%), Positives = 104/212 (49%), Gaps = 22/212 (10%)
Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKE---------FKVEVEAIGRVRHK 242
+IG G +G VY G+ +AVK + A + E+ + ++H+
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 243 NLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYL 302
N+V+ LG + H + EY+ G++ L+ L +R N + KGL YL
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETL---VR-NFVRQILKGLNYL 122
Query: 303 HEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTR-----VMGTFGYV 357
H ++HRDIK +NIL+D + K+SDFG++K L A T + G+ ++
Sbjct: 123 HN---RGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWM 179
Query: 358 APEYASTGMLNERSDVYSFGILIMEVISGRNP 389
APE ++D++S G L++E+++G++P
Sbjct: 180 APEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 89.3 bits (222), Expect = 6e-20
Identities = 80/267 (29%), Positives = 130/267 (48%), Gaps = 25/267 (9%)
Query: 192 NVIGEGGYGIVYHGV-LEDNTNVAVKNL-LNNRGQAEKEFKVEVEAIGRVRHKNLVRLLG 249
VIG G +VY + L +N VA+K + L + E + EV+A+ + H N+V+
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYT 66
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE-GLEP 308
G LV Y+ G+L + P L I ++ KGL YLH G
Sbjct: 67 SFVVGDELWLVMPYLSGGSLLDIMKSSY-PRGGLDEAIIATVLKEVLKGLEYLHSNGQ-- 123
Query: 309 KVVHRDIKSSNILLDKQWNPKLSDFGLAKLL---GAERSYVTTRVMGTFGYVAPEYASTG 365
+HRDIK+ NILL + + K++DFG++ L G V +GT ++APE
Sbjct: 124 --IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQV 181
Query: 366 M-LNERSDVYSFGILIMEVISGRNPVDYSR-PPGEVNLVEWLKTMVTNRNAEGVLDPRLQ 423
+ ++D++SFGI +E+ +G P YS+ PP +V M+T +N L+
Sbjct: 182 HGYDFKADIWSFGITAIELATGAAP--YSKYPPMKV-------LMLTLQNDPPSLETGAD 232
Query: 424 EKPCSRALKRALLVALRCVDPNAHKRP 450
K S++ ++ +++L C+ + KRP
Sbjct: 233 YKKYSKSFRK--MISL-CLQKDPSKRP 256
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.5 bits (223), Expect = 7e-20
Identities = 67/215 (31%), Positives = 100/215 (46%), Gaps = 39/215 (18%)
Query: 194 IGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKE-FKV----EVEAIGRVRHKNLVRL 247
IGEG YG VY + VA+K + R + EKE F + E++ + ++RH N+VRL
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKI---RMENEKEGFPITAIREIKLLQKLRHPNIVRL 63
Query: 248 LGYCAEGAHR--MLVYEYID---NGNLEQWLHGDVGPHSPLTW-EIR--MNIILGTAKGL 299
+V+EY+D G L+ P T +I+ M +L +GL
Sbjct: 64 KEIVTSKGKGSIYMVFEYMDHDLTGLLDS-------PEVKFTESQIKCYMKQLL---EGL 113
Query: 300 TYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAP 359
YLH ++HRDIK SNIL++ KL+DFGLA+ S T + T Y P
Sbjct: 114 QYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPP 170
Query: 360 EYASTGMLNERS-----DVYSFGILIMEVISGRNP 389
E +L D++S G ++ E+ G+
Sbjct: 171 EL----LLGATRYGPEVDMWSVGCILAELFLGKPI 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 2e-19
Identities = 58/206 (28%), Positives = 101/206 (49%), Gaps = 22/206 (10%)
Query: 194 IGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE 253
+G G +G+V+ G +VA+K ++ +E +F E + + ++ H NLV+L G C +
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIK-MIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70
Query: 254 GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTA----KGLTYLHEGLEPK 309
+V EY+ NG L +L G ++ +L + + YL
Sbjct: 71 QRPIFIVTEYMANGCLLNYLRERKG-------KLGTEWLLDMCSDVCEAMEYLESN---G 120
Query: 310 VVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGT---FGYVAPEYASTGM 366
+HRD+ + N L+ + K+SDFGLA+ + + Y ++ GT + PE
Sbjct: 121 FIHRDLAARNCLVGEDNVVKVSDFGLARYV-LDDQYTSS--QGTKFPVKWAPPEVFDYSR 177
Query: 367 LNERSDVYSFGILIMEVIS-GRNPVD 391
+ +SDV+SFG+L+ EV S G+ P +
Sbjct: 178 FSSKSDVWSFGVLMWEVFSEGKMPYE 203
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 3e-19
Identities = 81/299 (27%), Positives = 129/299 (43%), Gaps = 52/299 (17%)
Query: 193 VIGEGGYGIVYHGV------LEDNTNVAVKNLLNNRGQAE-KEFKVEVEAIGRVRHKNLV 245
+GEG +G V T VAVK L N +E ++ E + +V H +++
Sbjct: 7 TLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVI 66
Query: 246 RLLGYCAEGAHRMLVYEYIDNGNLEQWLHGD--VGP------------------HSPLTW 285
+L G C++ +L+ EY G+L +L VGP LT
Sbjct: 67 KLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTM 126
Query: 286 EIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSY 345
++ ++G+ YL E K+VHRD+ + N+L+ + K+SDFGL++ + E SY
Sbjct: 127 GDLISFAWQISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSY 183
Query: 346 VT-TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVE 403
V ++ ++A E + +SDV+SFG+L+ E+++ G NP Y E L
Sbjct: 184 VKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP--YPGIAPE-RLFN 240
Query: 404 WLKTMVTNRNAEGVLDPRLQEKP--CSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 460
LKT E+P CS + + L C KRP + LE
Sbjct: 241 LLKT------------GYRMERPENCSEEMYN---LMLTCWKQEPDKRPTFADISKELE 284
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 3e-19
Identities = 65/236 (27%), Positives = 103/236 (43%), Gaps = 41/236 (17%)
Query: 182 EVSTNGFADENVIGEGGYGIVYH----GVL--EDNTNVAVKNLLNNRG-QAEKEFKVEVE 234
E N IG+G +G V+ G+L E T VAVK L + +F+ E
Sbjct: 1 EYPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAA 60
Query: 235 AIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWL------------HGDV----- 277
+ H N+V+LLG CA G L++EY+ G+L ++L H
Sbjct: 61 LMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKC 120
Query: 278 -GPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLA 336
PL+ ++ I A G+ YL E K VHRD+ + N L+ + K++DFGL+
Sbjct: 121 GLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLS 177
Query: 337 KLL-------GAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS 385
+ + +E + R M PE SDV+++G+++ E+ S
Sbjct: 178 RNIYSADYYKASENDAIPIRWM------PPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.4 bits (217), Expect = 4e-19
Identities = 59/207 (28%), Positives = 92/207 (44%), Gaps = 27/207 (13%)
Query: 193 VIGEGGYGIVYHG-VLEDNTNVAVKNLLNNRGQAE-KEFKV-EVEAIGRVRHKNLVRLLG 249
V+GEG YG+V VA+K + + K+ + EV+ + ++RH+N+V L
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLH---GDVGPHSPLTWEIRMNIILGTAKGLTYLHEGL 306
LV+EY++ L + L G + P +R I + + Y H
Sbjct: 68 AFRRKGRLYLVFEYVER-TLLELLEASPGGLPPD-----AVRS-YIWQLLQAIAYCHSH- 119
Query: 307 EPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER-----SYVTTRVMGTFGYVAPE- 360
++HRDIK NIL+ + KL DFG A+ L A YV TR Y APE
Sbjct: 120 --NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATR-----WYRAPEL 172
Query: 361 YASTGMLNERSDVYSFGILIMEVISGR 387
+ DV++ G ++ E++ G
Sbjct: 173 LVGDTNYGKPVDVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 87.3 bits (216), Expect = 4e-19
Identities = 66/222 (29%), Positives = 112/222 (50%), Gaps = 21/222 (9%)
Query: 193 VIGEGGYGIVYHGVL--EDNT---NVAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNLVR 246
++G G +G V+ G+ E ++ VA+K + + G Q +E + A+G + H +VR
Sbjct: 14 LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVR 73
Query: 247 LLGYCAEGAHRMLVYEYIDNGNLEQWLH---GDVGPHSPLTWEIRMNIILGTAKGLTYLH 303
LLG C GA LV + G+L + + P L W +++ AKG+ YL
Sbjct: 74 LLGICP-GASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQI------AKGMYYLE 126
Query: 304 EGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA-ERSYVTTRVMGTFGYVAPEYA 362
E ++VHR++ + NILL +++DFG+A LL ++ Y + ++A E
Sbjct: 127 E---HRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESI 183
Query: 363 STGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVE 403
G +SDV+S+G+ + E++S G P RP +L+E
Sbjct: 184 LFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLE 225
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.6 bits (215), Expect = 5e-19
Identities = 63/202 (31%), Positives = 96/202 (47%), Gaps = 11/202 (5%)
Query: 192 NVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGY 250
IG G YG VY + VA+K + G + + E+ + RH N+V G
Sbjct: 9 QRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGS 68
Query: 251 CAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKV 310
+V EY G+L+ GP S L +I + T KGL YLHE
Sbjct: 69 YLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSEL--QIAY-VCRETLKGLAYLHE---TGK 122
Query: 311 VHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYA---STGML 367
+HRDIK +NILL + + KL+DFG++ L A + + + GT ++APE A G
Sbjct: 123 IHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFI-GTPYWMAPEVAAVERKGGY 181
Query: 368 NERSDVYSFGILIMEVISGRNP 389
+ + D+++ GI +E+ + P
Sbjct: 182 DGKCDIWALGITAIELAELQPP 203
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 5e-19
Identities = 65/204 (31%), Positives = 101/204 (49%), Gaps = 18/204 (8%)
Query: 193 VIGEGGYG---IVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLG 249
V+GEG +G +V H V D + L A ++ + E + +++H N+V
Sbjct: 7 VVGEGSFGRALLVQH-VNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKE 65
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSP----LTWEIRMNIILGTAKGLTYLHEG 305
H +V EY D G+L Q + G P L W ++M + G+ ++HE
Sbjct: 66 SFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCL------GVQHIHE- 118
Query: 306 LEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTG 365
+V+HRDIKS NI L + KL DFG A+LL + +Y T V GT YV PE
Sbjct: 119 --KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV-GTPYYVPPEIWENM 175
Query: 366 MLNERSDVYSFGILIMEVISGRNP 389
N +SD++S G ++ E+ + ++P
Sbjct: 176 PYNNKSDIWSLGCILYELCTLKHP 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 5e-19
Identities = 80/294 (27%), Positives = 131/294 (44%), Gaps = 49/294 (16%)
Query: 192 NVIGEGGYGIVYHGVLED-------NTNVAVKNLLNNRG---QAEKEFKVEVEAIGRVRH 241
N +G G +G VY G D VAVK L +G Q +KEF E + H
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTL--RKGATDQEKKEFLKEAHLMSNFNH 58
Query: 242 KNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHG---DVGPHSPLTWEIRMNIILGTAKG 298
N+V+LLG C + ++ E ++ G+L +L + LT + ++I L AKG
Sbjct: 59 PNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKG 118
Query: 299 LTYLHEGLEPKVVHRDIKSSNILL-DKQWNP----KLSDFGLAKLLGAERSYVTTRVMG- 352
YL + +HRD+ + N L+ +K ++ K+ DFGLA+ + Y R G
Sbjct: 119 CVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYY---RKEGE 172
Query: 353 ---TFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTM 408
++APE G +SDV+SFG+L+ E+++ G+ P P N +
Sbjct: 173 GLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPY-----PALNNQ-----EV 222
Query: 409 VTNRNAEGVLDPRLQEKP-CSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461
+ + A G RLQ+ C + + + C + +RP + +L+
Sbjct: 223 LQHVTAGG----RLQKPENCPDKIYQLM---TNCWAQDPSERPTFDRIQEILQN 269
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.6 bits (215), Expect = 6e-19
Identities = 68/210 (32%), Positives = 96/210 (45%), Gaps = 18/210 (8%)
Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV-RHKNLVRLLG- 249
VIGEG YG VY + VA+K +++ E+E K E + + H N+ G
Sbjct: 13 VIGEGTYGKVYKARHKKTGQLVAIK-IMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGA 71
Query: 250 YCAEGAHRM-----LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 304
+ + LV E G++ + G L E I+ T +GL YLHE
Sbjct: 72 FIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHE 131
Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPE---- 360
KV+HRDIK NILL K KL DFG++ L + T + GT ++APE
Sbjct: 132 N---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFI-GTPYWMAPEVIAC 187
Query: 361 -YASTGMLNERSDVYSFGILIMEVISGRNP 389
+ RSDV+S GI +E+ G+ P
Sbjct: 188 DEQPDASYDARSDVWSLGITAIELADGKPP 217
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 6e-19
Identities = 57/212 (26%), Positives = 106/212 (50%), Gaps = 11/212 (5%)
Query: 193 VIGEGGYGI-VYHGVLEDNTNVAVKNLLNNRGQAEKEFKV---EVEAIGRVRHKNLVRLL 248
V+G+G +G + ED++ V K + N +EKE + E+ + ++H N++
Sbjct: 7 VLGKGAFGEATLYRRTEDDSLVVWKEV-NLTRLSEKERRDALNEIVILSLLQHPNIIAYY 65
Query: 249 GYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEP 308
+ + ++ EY + G L + G E+ + + ++Y+H+
Sbjct: 66 NHFMDDNTLLIEMEYANGGTLYDKIVRQKGQL--FEEEMVLWYLFQIVSAVSYIHKA--- 120
Query: 309 KVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLN 368
++HRDIK+ NI L K KL DFG++K+LG+E S T V+GT Y++PE N
Sbjct: 121 GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET-VVGTPYYMSPELCQGVKYN 179
Query: 369 ERSDVYSFGILIMEVISGRNPVDYSRPPGEVN 400
+SD+++ G ++ E+++ + D + P V
Sbjct: 180 FKSDIWALGCVLYELLTLKRTFDATNPLNLVV 211
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 6e-19
Identities = 69/211 (32%), Positives = 104/211 (49%), Gaps = 12/211 (5%)
Query: 182 EVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRH 241
E+ +G G +G V+ G NT VAVK L E F E + + ++RH
Sbjct: 2 EIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPES-FLEEAQIMKKLRH 60
Query: 242 KNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTY 301
LV+L +E +V EY+ G+L +L G L + M + A G+ Y
Sbjct: 61 DKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQV--AAGMAY 117
Query: 302 LHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTF--GYVAP 359
+ +HRD++S+NIL+ K++DFGLA+L+ E + T R F + AP
Sbjct: 118 IER---MNYIHRDLRSANILVGDGLVCKIADFGLARLI--EDNEYTARQGAKFPIKWTAP 172
Query: 360 EYASTGMLNERSDVYSFGILIMEVIS-GRNP 389
E A G +SDV+SFGIL+ E+++ GR P
Sbjct: 173 EAALYGRFTIKSDVWSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 86.7 bits (214), Expect = 8e-19
Identities = 60/213 (28%), Positives = 105/213 (49%), Gaps = 20/213 (9%)
Query: 194 IGEGGYGIVYHGVL------EDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRL 247
+GEG +G V+ +D VAVK L + A K+F E E + ++H+++V+
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 248 LGYCAEGAHRMLVYEYIDNGNLEQWL--HG-------DVGPHSPLTWEIRMNIILGTAKG 298
G C EG ++V+EY+ +G+L ++L HG + + LT ++I A G
Sbjct: 73 YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132
Query: 299 LTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSY-VTTRVMGTFGYV 357
+ YL VHRD+ + N L+ + K+ DFG+++ + + Y V M ++
Sbjct: 133 MVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 189
Query: 358 APEYASTGMLNERSDVYSFGILIMEVIS-GRNP 389
PE SDV+S G+++ E+ + G+ P
Sbjct: 190 PPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 8e-19
Identities = 65/270 (24%), Positives = 124/270 (45%), Gaps = 30/270 (11%)
Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVKNLL---NNRGQAEK---EFKVEVEAIGRVRHKNLV 245
+G G + Y ++ T +AVK + N + E+ + E+ + R+ H +++
Sbjct: 7 QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66
Query: 246 RLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG 305
R+LG E +H L E++ G++ L G + +N +GL+YLHE
Sbjct: 67 RMLGATCEDSHFNLFVEWMAGGSVSHLLS-KYGAFKE---AVIINYTEQLLRGLSYLHEN 122
Query: 306 LEPKVVHRDIKSSNILLDKQWNP-KLSDFGLAKLLGAERS---YVTTRVMGTFGYVAPEY 361
+++HRD+K +N+L+D +++DFG A L A+ + +++GT ++APE
Sbjct: 123 ---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEV 179
Query: 362 ASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPR 421
DV+S G +I+E+ + + P + + + L+ + + T + L P
Sbjct: 180 LRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPG 239
Query: 422 LQEKPCSRALKRALLVALRCVDPNAHKRPK 451
L++ V LRC++ RP
Sbjct: 240 LRD------------VTLRCLELQPEDRPP 257
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 1e-18
Identities = 79/271 (29%), Positives = 127/271 (46%), Gaps = 30/271 (11%)
Query: 194 IGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE 253
+G+G +G V+ G T VA+K L E F E + + ++RH LV L +E
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEA-FLQEAQIMKKLRHDKLVPLYAVVSE 72
Query: 254 GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHR 313
+V E++ G+L +L G + L + M + A G+ Y+ +HR
Sbjct: 73 EP-IYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQI--ADGMAYIER---MNYIHR 126
Query: 314 DIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTF--GYVAPEYASTGMLNERS 371
D++++NIL+ K++DFGLA+L+ E + T R F + APE A G +S
Sbjct: 127 DLRAANILVGDNLVCKIADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 184
Query: 372 DVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRA 430
DV+SFGIL+ E+++ GR P PG VN E L+ + R PC +
Sbjct: 185 DVWSFGILLTELVTKGRVPY-----PGMVNR-EVLEQV-----------ERGYRMPCPQG 227
Query: 431 LKRALLVALR-CVDPNAHKRPKMGHVIHMLE 460
+L ++ C + +RP ++ LE
Sbjct: 228 CPESLHELMKLCWKKDPDERPTFEYIQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 1e-18
Identities = 65/226 (28%), Positives = 114/226 (50%), Gaps = 25/226 (11%)
Query: 180 ELEVSTNGFADENVIGEGGYGIVYHGVL-----EDNTNVAVKNLLN-NRGQAEKEFKVEV 233
EL +S F +E +GE +G +Y G L + VA+K L + N Q EF+ E
Sbjct: 1 ELPLSAVRFMEE--LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEA 58
Query: 234 EAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWL-----HGDVGPHSPLTWEIR 288
+ + H N+V LLG + +++EY++ G+L ++L H DVG S ++
Sbjct: 59 SLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVK 118
Query: 289 --------MNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG 340
++I + A G+ YL VH+D+ + NIL+ +Q + K+SD GL++ +
Sbjct: 119 SSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIY 175
Query: 341 AERSY-VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS 385
+ Y V + + ++ PE G + SD++SFG+++ E+ S
Sbjct: 176 SADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 2e-18
Identities = 52/194 (26%), Positives = 95/194 (48%), Gaps = 7/194 (3%)
Query: 191 ENVIGEGGYGIVYHGVLED-NTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLG 249
++ +G G YG VY GV + + VAVK L + +EF E + ++H NLV+LLG
Sbjct: 11 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLG 69
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK 309
C ++ E++ GNL +L + + + + + + YL +
Sbjct: 70 VCTREPPFYIITEFMTYGNLLDYLREC--NRQEVNAVVLLYMATQISSAMEYLEKK---N 124
Query: 310 VVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNE 369
+HRD+ + N L+ + K++DFGL++L+ + + APE + +
Sbjct: 125 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 184
Query: 370 RSDVYSFGILIMEV 383
+SDV++FG+L+ E+
Sbjct: 185 KSDVWAFGVLLWEI 198
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 85.5 bits (212), Expect = 2e-18
Identities = 60/215 (27%), Positives = 102/215 (47%), Gaps = 28/215 (13%)
Query: 194 IGEGGYGIVYHGVL------EDNTNVAVKNLLNNRGQAEKEFK---VEVEAIGRV-RHKN 243
+GEG +G V + + VAVK L ++ EK+ E+E + + +HKN
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKN 77
Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLH------------GDVGPHSPLTWEIRMNI 291
++ LLG C + +V EY +GNL +L P LT + ++
Sbjct: 78 IINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSF 137
Query: 292 ILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSY-VTTRV 350
A+G+ +L K +HRD+ + N+L+ + K++DFGLA+ + Y TT
Sbjct: 138 AYQVARGMEFLA---SKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNG 194
Query: 351 MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS 385
++APE + +SDV+SFG+L+ E+ +
Sbjct: 195 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 2e-18
Identities = 69/210 (32%), Positives = 109/210 (51%), Gaps = 21/210 (10%)
Query: 193 VIGEGGYGIVYHGVL--EDNT---NVAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNLVR 246
V+G G +G VY G+ E T VA+K L G +A EF E + + H +LVR
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73
Query: 247 LLGYCAEGAHRMLVYEYIDNGNLEQWLH---GDVGPHSPLTWEIRMNIILGTAKGLTYLH 303
LLG C + LV + + +G L ++H ++G L W +++ AKG+ YL
Sbjct: 74 LLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQI------AKGMMYLE 126
Query: 304 EGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL-GAERSYVTTRVMGTFGYVAPEYA 362
E ++VHRD+ + N+L+ + K++DFGLA+LL G E+ Y ++A E
Sbjct: 127 E---RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECI 183
Query: 363 STGMLNERSDVYSFGILIMEVIS-GRNPVD 391
+SDV+S+G+ I E+++ G P D
Sbjct: 184 HYRKFTHQSDVWSYGVTIWELMTFGGKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 3e-18
Identities = 66/209 (31%), Positives = 97/209 (46%), Gaps = 21/209 (10%)
Query: 194 IGEGGYGIVYHG-VLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGR-VRHKNLVRLLGYC 251
IGEG GIV VAVK + + R Q +E I R +H N+V +
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKM-DLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSY 85
Query: 252 AEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVV 311
G +V E+++ G L D+ H+ + E + L K L++LH V+
Sbjct: 86 LVGDELWVVMEFLEGGALT-----DIVTHTRMNEEQIATVCLAVLKALSFLHA---QGVI 137
Query: 312 HRDIKSSNILLDKQWNPKLSDFGLAKLLGAE----RSYVTTRVMGTFGYVAPEYASTGML 367
HRDIKS +ILL KLSDFG + E +S V GT ++APE S
Sbjct: 138 HRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLV-----GTPYWMAPEVISRLPY 192
Query: 368 NERSDVYSFGILIMEVISGRNPVDYSRPP 396
D++S GI+++E++ G P ++ PP
Sbjct: 193 GTEVDIWSLGIMVIEMVDGEPPY-FNEPP 220
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 3e-18
Identities = 63/210 (30%), Positives = 106/210 (50%), Gaps = 16/210 (7%)
Query: 194 IGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE 253
+G G +G V+ G ++T VAVK L + F E + ++H LVRL +
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQA-FLEEANLMKTLQHDKLVRLYAVVTK 72
Query: 254 GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHR 313
++ EY+ G+L +L D G L I + + A+G+ Y+ +HR
Sbjct: 73 EEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQI--AEGMAYIER---KNYIHR 127
Query: 314 DIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTF--GYVAPEYASTGMLNERS 371
D++++N+L+ + K++DFGLA+++ E + T R F + APE + G +S
Sbjct: 128 DLRAANVLVSESLMCKIADFGLARVI--EDNEYTAREGAKFPIKWTAPEAINFGSFTIKS 185
Query: 372 DVYSFGILIMEVIS-GRNPVDYSRPPGEVN 400
DV+SFGIL+ E+++ G+ P PG N
Sbjct: 186 DVWSFGILLYEIVTYGKIPY-----PGMSN 210
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 3e-18
Identities = 82/271 (30%), Positives = 133/271 (49%), Gaps = 36/271 (13%)
Query: 192 NVIGEGGYGIVYHGVLEDN----TNVAVKNL--LNNRGQAEKEFKVEVEAIGRVRHKNLV 245
VIG+G +G VYHG L D+ + AVK+L + + + E+ F E + H N++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQ-FLKEGIIMKDFSHPNVL 59
Query: 246 RLLGYC--AEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 303
LLG C +EG+ ++V Y+ +G+L ++ + H+P T + + L AKG+ YL
Sbjct: 60 SLLGICLPSEGS-PLVVLPYMKHGDLRNFIRSE--THNP-TVKDLIGFGLQVAKGMEYL- 114
Query: 304 EGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGT---FGYVAPE 360
K VHRD+ + N +LD+ + K++DFGLA+ + + Y G ++A E
Sbjct: 115 --ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALE 172
Query: 361 YASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDP 420
T +SDV+SFG+L+ E+++ P P +V+ + +T +G
Sbjct: 173 SLQTQKFTTKSDVWSFGVLLWELMTRGAP-----PYPDVDSFD-----ITVYLLQG---R 219
Query: 421 RL-QEKPCSRALKRALLVALRCVDPNAHKRP 450
RL Q + C L V L C P RP
Sbjct: 220 RLLQPEYCPDPLYE---VMLSCWHPKPEMRP 247
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 4e-18
Identities = 65/197 (32%), Positives = 100/197 (50%), Gaps = 13/197 (6%)
Query: 194 IGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEK-EFKVEVEAIGRVRHKNLVRLLGYC 251
IG G +G V+ G L DNT VAVK+ K +F E + + H N+VRL+G C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 252 AEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK-V 310
+ +V E + G+ +L + GP + I+M + A G+ YL E K
Sbjct: 63 TQKQPIYIVMELVQGGDFLTFLRTE-GPRLKVKELIQM--VENAAAGMEYL----ESKHC 115
Query: 311 VHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTF--GYVAPEYASTGMLN 368
+HRD+ + N L+ ++ K+SDFG+++ + Y +T M + APE + G +
Sbjct: 116 IHRDLAARNCLVTEKNVLKISDFGMSRE-EEDGVYASTGGMKQIPVKWTAPEALNYGRYS 174
Query: 369 ERSDVYSFGILIMEVIS 385
SDV+SFGIL+ E S
Sbjct: 175 SESDVWSFGILLWEAFS 191
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 84.3 bits (209), Expect = 4e-18
Identities = 52/172 (30%), Positives = 88/172 (51%), Gaps = 14/172 (8%)
Query: 194 IGEGGYGIVYH-GVLEDNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGY 250
IGEG +GIV+ E VA+K + R G + E++A+ +H +V+LL
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 251 CAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIR--MNIILGTAKGLTYLHEGLEP 308
G+ +LV EY+ + L + L + P +++ M ++L KG+ Y+H
Sbjct: 68 FPHGSGFVLVMEYMPSD-LSEVLRDEERPLPEA--QVKSYMRMLL---KGVAYMHAN--- 118
Query: 309 KVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPE 360
++HRD+K +N+L+ K++DFGLA+L E + + + T Y APE
Sbjct: 119 GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPE 170
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 5e-18
Identities = 67/208 (32%), Positives = 103/208 (49%), Gaps = 24/208 (11%)
Query: 194 IGEGGYGIVYHGVLE---DNTNVAVKNLLN--NRGQAEKEFKVEVEAIGRVRHKNLVRLL 248
+G G +G V G+ + VAVK L N N + E E + ++ + +VR++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 249 GYCAEGAHRMLVYEYIDNGNLEQWL----HGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 304
G C E MLV E + G L ++L H + L ++ M G+ YL E
Sbjct: 63 GIC-EAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSM--------GMKYLEE 113
Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTF--GYVAPEYA 362
VHRD+ + N+LL Q K+SDFGL+K LGA+ +Y + G + + APE
Sbjct: 114 T---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECM 170
Query: 363 STGMLNERSDVYSFGILIMEVIS-GRNP 389
+ + +SDV+SFG+L+ E S G+ P
Sbjct: 171 NYYKFSSKSDVWSFGVLMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.4 bits (207), Expect = 6e-18
Identities = 61/206 (29%), Positives = 101/206 (49%), Gaps = 15/206 (7%)
Query: 188 FADENVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKV---EVEAIGRVRHKN 243
F IG+G +G VY + N VA+K + + +AE E + E++ + + R
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVI--DLEEAEDEIEDIQQEIQFLSQCRSPY 60
Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 303
+ + G +G+ ++ EY G+ D+ L I+ GL YLH
Sbjct: 61 ITKYYGSFLKGSKLWIIMEYCGGGSCL-----DLLKPGKLDETYIAFILREVLLGLEYLH 115
Query: 304 EGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAS 363
E +HRDIK++NILL ++ + KL+DFG++ L + S T V GT ++APE
Sbjct: 116 EE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV-GTPFWMAPEVIK 171
Query: 364 TGMLNERSDVYSFGILIMEVISGRNP 389
+E++D++S GI +E+ G P
Sbjct: 172 QSGYDEKADIWSLGITAIELAKGEPP 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 6e-18
Identities = 74/273 (27%), Positives = 129/273 (47%), Gaps = 28/273 (10%)
Query: 191 ENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGY 250
E +G G +G V+ +T VAVK + E F E + ++H LV+L
Sbjct: 11 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA-FLAEANVMKTLQHDKLVKLHAV 69
Query: 251 CAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKV 310
+ ++ E++ G+L +L D G PL I + + A+G+ ++ +
Sbjct: 70 VTKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQI--AEGMAFIEQ---RNY 123
Query: 311 VHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTF--GYVAPEYASTGMLN 368
+HRD++++NIL+ K++DFGLA+++ E + T R F + APE + G
Sbjct: 124 IHRDLRAANILVSASLVCKIADFGLARVI--EDNEYTAREGAKFPIKWTAPEAINFGSFT 181
Query: 369 ERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPC 427
+SDV+SFGIL+ME+++ GR P PG N E ++ + G PR + P
Sbjct: 182 IKSDVWSFGILLMEIVTYGRIPY-----PGMSN-PEVIRAL-----ERGYRMPRPENCP- 229
Query: 428 SRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 460
+ + +RC +RP ++ +L+
Sbjct: 230 ----EELYNIMMRCWKNRPEERPTFEYIQSVLD 258
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.5 bits (207), Expect = 7e-18
Identities = 65/208 (31%), Positives = 105/208 (50%), Gaps = 31/208 (14%)
Query: 194 IGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKV------EVEAIGRVRHKNLVR 246
IGEG YG+VY VA+K + R + E E V E+ + + H N+VR
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKI---RLETEDE-GVPSTAIREISLLKELNHPNIVR 62
Query: 247 LLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGL 306
LL LV+E++D +L++++ D P + L + + + +G+ Y H
Sbjct: 63 LLDVVHSENKLYLVFEFLDL-DLKKYM--DSSPLTGLDPPLIKSYLYQLLQGIAYCHSH- 118
Query: 307 EPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE-RSYVTTRVMGTFGYVAPE----- 360
+V+HRD+K N+L+D++ KL+DFGLA+ G R+Y T V+ T Y APE
Sbjct: 119 --RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTY-THEVV-TLWYRAPEILLGS 174
Query: 361 -YASTGMLNERSDVYSFGILIMEVISGR 387
ST + D++S G + E+++ R
Sbjct: 175 RQYSTPV-----DIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 9e-18
Identities = 67/208 (32%), Positives = 98/208 (47%), Gaps = 16/208 (7%)
Query: 191 ENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGY 250
IG+G +G V G VAVK + N+ + F E + ++RH NLV+LLG
Sbjct: 11 LQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGV 67
Query: 251 CAEGAHRM-LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK 309
E + +V EY+ G+L +L S L + + L + + YL
Sbjct: 68 IVEEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEAN---N 122
Query: 310 VVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNE 369
VHRD+ + N+L+ + K+SDFGL K + + V T APE +
Sbjct: 123 FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREKKFST 178
Query: 370 RSDVYSFGILIMEVIS-GRNPVDYSRPP 396
+SDV+SFGIL+ E+ S GR P Y R P
Sbjct: 179 KSDVWSFGILLWEIYSFGRVP--YPRIP 204
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 1e-17
Identities = 56/202 (27%), Positives = 104/202 (51%), Gaps = 14/202 (6%)
Query: 194 IGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE 253
+G G +G+V +G +VA+K ++ +E EF E + + ++ H+ LV+L G C +
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIK-MIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTK 70
Query: 254 GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHR 313
+V EY+ NG L +L ++ + + +G+ YL + +HR
Sbjct: 71 QRPIYIVTEYMSNGCLLNYLRE--HGKRFQPSQL-LEMCKDVCEGMAYLE---SKQFIHR 124
Query: 314 DIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGT---FGYVAPEYASTGMLNER 370
D+ + N L+D Q K+SDFGL++ + + Y ++ +G+ + PE + +
Sbjct: 125 DLAARNCLVDDQGCVKVSDFGLSRYV-LDDEYTSS--VGSKFPVRWSPPEVLLYSKFSSK 181
Query: 371 SDVYSFGILIMEVIS-GRNPVD 391
SDV++FG+L+ EV S G+ P +
Sbjct: 182 SDVWAFGVLMWEVYSLGKMPYE 203
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 1e-17
Identities = 64/268 (23%), Positives = 125/268 (46%), Gaps = 27/268 (10%)
Query: 193 VIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKE---FKVEVEAIGRVRHKNLVRLLG 249
V+G G +GIV+ + + + + + + E + E + + + H N++
Sbjct: 7 VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYE 66
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK 309
E M+V EY G L +++ +S L + ++ + L ++H L
Sbjct: 67 NFLEDKALMIVMEYAPGGTLAEYIQKRC--NSLLDEDTILHFFVQILLALHHVHTKL--- 121
Query: 310 VVHRDIKSSNILLDKQWNP-KLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLN 368
++HRD+K+ NILLDK K+ DFG++K+L ++ T V+GT Y++PE N
Sbjct: 122 ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT--VVGTPCYISPELCEGKPYN 179
Query: 369 ERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCS 428
++SD+++ G ++ E+ S + + + P V LK M + R
Sbjct: 180 QKSDIWALGCVLYELASLKRAFEAANLPALV-----LKIM---SGTFAPISDRYSPD--- 228
Query: 429 RALKRALLVALRCVDPNAHKRPKMGHVI 456
R L++++ +DP+ KRP++ ++
Sbjct: 229 ---LRQLILSMLNLDPS--KRPQLSQIM 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 1e-17
Identities = 65/204 (31%), Positives = 107/204 (52%), Gaps = 23/204 (11%)
Query: 194 IGEGGYGIVYHGV-LEDNTNVAVK--NLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGY 250
+GEG Y VY G VA+K +L G + E+ + ++H+N+VRL
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIR-EISLMKELKHENIVRLHDV 66
Query: 251 CAEGAHRMLVYEYIDNGNLEQWL--HGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEP 308
MLV+EY+D +L++++ HG G P T + +L KG+ + HE
Sbjct: 67 IHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLL---KGIAFCHEN--- 119
Query: 309 KVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLN 368
+V+HRD+K N+L++K+ KL+DFGLA+ G + + V+ T Y AP+ +L
Sbjct: 120 RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV-TLWYRAPDV----LLG 174
Query: 369 ERS-----DVYSFGILIMEVISGR 387
R+ D++S G ++ E+I+GR
Sbjct: 175 SRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 2e-17
Identities = 61/207 (29%), Positives = 105/207 (50%), Gaps = 18/207 (8%)
Query: 193 VIGEGGYGIVYHGVLE-DNTNVAVKNL-LNNRGQAEKEF-KVEVEAIGRVRHKNLVRLLG 249
IGEG +G +Y + D+ + +K + L EKE K EV + +++H N+V
Sbjct: 7 KIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFA 66
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVG----PHSPLTWEIRMNIILGTAKGLTYLHEG 305
E +V EY D G+L + ++ G L+W +++++ GL ++H+
Sbjct: 67 SFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISL------GLKHIHD- 119
Query: 306 LEPKVVHRDIKSSNILLDKQWN-PKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAST 364
K++HRDIKS NI L K KL DFG+A+ L T +GT Y++PE
Sbjct: 120 --RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYT-CVGTPYYLSPEICQN 176
Query: 365 GMLNERSDVYSFGILIMEVISGRNPVD 391
N ++D++S G ++ E+ + ++P +
Sbjct: 177 RPYNNKTDIWSLGCVLYELCTLKHPFE 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 2e-17
Identities = 75/253 (29%), Positives = 117/253 (46%), Gaps = 22/253 (8%)
Query: 194 IGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKV-EVEAIGRVRHKNLVRLLGYCA 252
IGEG GIV ++ + + ++ R Q +E EV + +H+N+V +
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 253 EGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVH 312
G +V E+++ G L D+ H+ + E + L K L+ LH V+H
Sbjct: 88 VGDELWVVMEFLEGGALT-----DIVTHTRMNEEQIAAVCLAVLKALSVLHA---QGVIH 139
Query: 313 RDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTR--VMGTFGYVAPEYASTGMLNER 370
RDIKS +ILL KLSDFG + E V R ++GT ++APE S
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFGFCAQVSKE---VPRRKSLVGTPYWMAPELISRLPYGPE 196
Query: 371 SDVYSFGILIMEVISGRNPVDYSRPPGEV------NLVEWLKTM-VTNRNAEGVLDPRLQ 423
D++S GI+++E++ G P ++ PP + NL LK + + + +G LD L
Sbjct: 197 VDIWSLGIMVIEMVDGEPPY-FNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLV 255
Query: 424 EKPCSRALKRALL 436
P RA LL
Sbjct: 256 RDPAQRATAAELL 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 2e-17
Identities = 74/255 (29%), Positives = 116/255 (45%), Gaps = 26/255 (10%)
Query: 194 IGEGGYGIVYHGVLEDN-TNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCA 252
IGEG GIV + VAVK + + Q + EV + H+N+V +
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89
Query: 253 EGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVH 312
G +V E+++ G L D+ H+ + E + L + L+YLH V+H
Sbjct: 90 VGDELWVVMEFLEGGALT-----DIVTHTRMNEEQIATVCLSVLRALSYLHN---QGVIH 141
Query: 313 RDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTR--VMGTFGYVAPEYASTGMLNER 370
RDIKS +ILL KLSDFG + E V R ++GT ++APE S
Sbjct: 142 RDIKSDSILLTSDGRIKLSDFGFCAQVSKE---VPKRKSLVGTPYWMAPEVISRLPYGTE 198
Query: 371 SDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRA 430
D++S GI+++E+I G P ++ PP L+ M R L PR+++ +
Sbjct: 199 VDIWSLGIMVIEMIDGEPPY-FNEPP--------LQAM---RRIRDNLPPRVKDSHKVSS 246
Query: 431 LKRALLVALRCVDPN 445
+ R L + +P+
Sbjct: 247 VLRGFLDLMLVREPS 261
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 3e-17
Identities = 62/203 (30%), Positives = 101/203 (49%), Gaps = 15/203 (7%)
Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVKNL-LNNRGQAEKEFKVEVEAIGRVRH---KNLVRL 247
+IG G YG VY G + VA+K + L+ + + EV + ++R N+ +
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67
Query: 248 LGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLE 307
G +G ++ EY + G++ + P+ + II L Y+H+
Sbjct: 68 YGSYLKGPRLWIIMEYAEGGSVRTLMKA-----GPIAEKYISVIIREVLVALKYIHKV-- 120
Query: 308 PKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTG-M 366
V+HRDIK++NIL+ N KL DFG+A LL S +T V GT ++APE + G
Sbjct: 121 -GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV-GTPYWMAPEVITEGKY 178
Query: 367 LNERSDVYSFGILIMEVISGRNP 389
+ ++D++S GI I E+ +G P
Sbjct: 179 YDTKADIWSLGITIYEMATGNPP 201
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.5 bits (202), Expect = 4e-17
Identities = 61/218 (27%), Positives = 92/218 (42%), Gaps = 51/218 (23%)
Query: 192 NVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIG-------------- 237
IGEG YG VY ++L R A K+ +V + G
Sbjct: 5 AEIGEGAYGTVYKA----------RDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQ 54
Query: 238 --RVRHKNLVRLLGYCA-----EGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMN 290
H N+VRLL C LV+E++D +L +L P L E +
Sbjct: 55 LESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYL--SKCPKPGLPPETIKD 111
Query: 291 IILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRV 350
++ +G+ +LH ++VHRD+K NIL+ K++DFGLA++ E + T V
Sbjct: 112 LMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMAL--TSV 166
Query: 351 MGTFGYVAPE------YASTGMLNERSDVYSFGILIME 382
+ T Y APE YA+ D++S G + E
Sbjct: 167 VVTLWYRAPEVLLQSSYATP------VDMWSVGCIFAE 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 5e-17
Identities = 56/204 (27%), Positives = 99/204 (48%), Gaps = 15/204 (7%)
Query: 194 IGEGGYGIVYHGV-LEDNTNVAVK--NLLNNRGQAEKE---FKVEVEAIGRVRHKNLVRL 247
+G+G +G VY ++ +AVK + + +KE + E++ + ++H+ +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 248 LGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLE 307
G + + EY+ G+++ L + LT + +G+ YLH
Sbjct: 70 YGCLRDDETLSIFMEYMPGGSVKDQLKA----YGALTETVTRKYTRQILEGVEYLHSN-- 123
Query: 308 PKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVT--TRVMGTFGYVAPEYASTG 365
+VHRDIK +NIL D N KL DFG +K L S T V GT +++PE S
Sbjct: 124 -MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGE 182
Query: 366 MLNERSDVYSFGILIMEVISGRNP 389
++DV+S G ++E+++ + P
Sbjct: 183 GYGRKADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 5e-17
Identities = 68/229 (29%), Positives = 113/229 (49%), Gaps = 31/229 (13%)
Query: 180 ELEVSTNGFADENVIGEGGYGIVYHGVL------EDNTNVAVKNLLNN-RGQAEKEFKVE 232
E+ +ST F +E +GE +G VY G L E VA+K L + G +EFK E
Sbjct: 1 EINLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHE 58
Query: 233 VEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWL-----HGDVGP-------H 280
R++H N+V LLG + +++ Y + +L ++L H DVG
Sbjct: 59 AMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVK 118
Query: 281 SPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG 340
S L ++I+ A G+ +L VVH+D+ + N+L+ + N K+SD GL + +
Sbjct: 119 STLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGLFREVY 175
Query: 341 AERSYVTTRVMGT----FGYVAPEYASTGMLNERSDVYSFGILIMEVIS 385
A Y ++MG +++PE G + SD++S+G+++ EV S
Sbjct: 176 AADYY---KLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 7e-17
Identities = 56/199 (28%), Positives = 92/199 (46%), Gaps = 28/199 (14%)
Query: 291 IILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRV 350
I + K L YLH L V+HRD+K SN+L+++ KL DFG++ L S T
Sbjct: 108 IAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYL--VDSVAKTID 163
Query: 351 MGTFGYVAPEYASTGM----LNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLK 406
G Y+APE + + + +SDV+S GI ++E+ +GR P D + P + LK
Sbjct: 164 AGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP-----FQQLK 218
Query: 407 TMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEEFPF 466
+V + P+L + S + V +C+ N +RP E + PF
Sbjct: 219 QVVEEPS------PQLPAEKFSPEFQD--FVN-KCLKKNYKERPN------YPELLQHPF 263
Query: 467 RDVSFGRVIGILFFLKALL 485
++ + + F+ +L
Sbjct: 264 FELHLSKNTDVASFVSLIL 282
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 8e-17
Identities = 45/132 (34%), Positives = 72/132 (54%), Gaps = 9/132 (6%)
Query: 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNIL 321
E++D G+L+ P+ EI I + +GLTYL+ +++HRDIK SNIL
Sbjct: 83 EFMDCGSLD----RIYKKGGPIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNIL 136
Query: 322 LDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIM 381
++ + KL DFG++ G + + +GT Y++PE G +SDV+S GI I+
Sbjct: 137 VNSRGQIKLCDFGVS---GELINSIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISII 193
Query: 382 EVISGRNPVDYS 393
E+ G+ P +S
Sbjct: 194 ELALGKFPFAFS 205
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 8e-17
Identities = 61/216 (28%), Positives = 105/216 (48%), Gaps = 23/216 (10%)
Query: 194 IGEGGYGIVYHG------VLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRL 247
+GEG +G V+ +D VAVK L + A K+F+ E E + ++H+++V+
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 248 LGYCAEGAHRMLVYEYIDNGNLEQWL--HG-------DVGP---HSPLTWEIRMNIILGT 295
G C +G ++V+EY+ +G+L ++L HG D P L ++I
Sbjct: 73 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132
Query: 296 AKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSY-VTTRVMGTF 354
A G+ YL VHRD+ + N L+ K+ DFG+++ + + Y V M
Sbjct: 133 ASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 189
Query: 355 GYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNP 389
++ PE SDV+SFG+++ E+ + G+ P
Sbjct: 190 RWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 9e-17
Identities = 62/214 (28%), Positives = 108/214 (50%), Gaps = 26/214 (12%)
Query: 191 ENVIGEGGYGIVYHGVLEDN---TNVAVKNLLNNRGQAE-KEFKVEVEAIGRV-RHKNLV 245
E+VIGEG +G V +++ + N A+K L + + ++F E+E + ++ H N++
Sbjct: 7 EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66
Query: 246 RLLGYCAEGAHRMLVYEYIDNGNLEQWLHG------------DVGPHSPLTWEIRMNIIL 293
LLG C + + EY GNL +L + G S LT + +
Sbjct: 67 NLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFAS 126
Query: 294 GTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGT 353
A G+ YL E + +HRD+ + N+L+ + K++DFGL++ E YV + MG
Sbjct: 127 DVATGMQYLSE---KQFIHRDLAARNVLVGENLASKIADFGLSR---GEEVYV-KKTMGR 179
Query: 354 FG--YVAPEYASTGMLNERSDVYSFGILIMEVIS 385
++A E + + +SDV+SFG+L+ E++S
Sbjct: 180 LPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 1e-16
Identities = 61/198 (30%), Positives = 98/198 (49%), Gaps = 12/198 (6%)
Query: 194 IGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKV-EVEAIGRVRHKNLVRLLGYC 251
IG+G G VY + + VA+K + N + Q +KE + E+ + +H N+V L
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQM-NLQQQPKKELIINEILVMRENKHPNIVNYLDSY 85
Query: 252 AEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVV 311
G +V EY+ G+L DV + + + + L +LH +V+
Sbjct: 86 LVGDELWVVMEYLAGGSLT-----DVVTETCMDEGQIAAVCRECLQALEFLHSN---QVI 137
Query: 312 HRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERS 371
HRDIKS NILL + KL+DFG + E+S +T V GT ++APE + +
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKV 196
Query: 372 DVYSFGILIMEVISGRNP 389
D++S GI+ +E++ G P
Sbjct: 197 DIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 1e-16
Identities = 62/220 (28%), Positives = 110/220 (50%), Gaps = 27/220 (12%)
Query: 194 IGEGGYGIVYH----GVLEDN----TNVAVKNLLNNRGQAE-KEFKVEVEAIGRV-RHKN 243
+GEG +G V G+ +D VAVK L ++ + + + E+E + + +HKN
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHG----------DVG--PHSPLTWEIRMNI 291
++ LLG C + ++ EY GNL ++L D+ P +T++ ++
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142
Query: 292 ILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSY-VTTRV 350
A+G+ YL K +HRD+ + N+L+ + K++DFGLA+ + Y TT
Sbjct: 143 TYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNG 199
Query: 351 MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNP 389
++APE + +SDV+SFG+L+ E+ + G +P
Sbjct: 200 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 239
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 1e-16
Identities = 73/273 (26%), Positives = 118/273 (43%), Gaps = 28/273 (10%)
Query: 193 VIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEK-EFKVEVEAIGRVRHKNLVRLLGYC 251
++G+G +G V+ G L+D T VAVK + Q K +F E + + H N+V+L+G C
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 252 AEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVV 311
+ +V E + G+ +L L + + L A G+ YL +
Sbjct: 62 TQRQPIYIVMELVPGGDFLSFLRKK---KDELKTKQLVKFALDAAAGMAYLES---KNCI 115
Query: 312 HRDIKSSNILLDKQWNPKLSDFGLAKLL--GAERSYVTTRVMGTFGYVAPEYASTGMLNE 369
HRD+ + N L+ + K+SDFG+++ G S ++ + APE + G +
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI--PIKWTAPEALNYGRYSS 173
Query: 370 RSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCS 428
SDV+S+GIL+ E S G P PG +TN+ A ++ +
Sbjct: 174 ESDVWSYGILLWETFSLGVCPY-----PG-----------MTNQQAREQVEKGYRMSCPQ 217
Query: 429 RALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461
+ V RC D RPK + L A
Sbjct: 218 KCPDDVYKVMQRCWDYKPENRPKFSELQKELAA 250
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.7 bits (195), Expect = 2e-16
Identities = 63/222 (28%), Positives = 95/222 (42%), Gaps = 37/222 (16%)
Query: 194 IGEGGYGIVYHGVLEDNTN------VAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRL 247
+G+G +G V V + +T V K + R + E E + R+ H +V+L
Sbjct: 1 LGKGSFGKVL-LVRKKDTGKLYAMKVLKKKKIIKRKEVEH-TLTERNILSRINHPFIVKL 58
Query: 248 LGYCA--EGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAK-------- 297
+ A LV EY G L + H A+
Sbjct: 59 --HYAFQTEEKLYLVLEYAPGGEL--FSH----------LSKEGRFSEERARFYAAEIVL 104
Query: 298 GLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYV 357
L YLH +++RD+K NILLD + KL+DFGLAK L +E S T GT Y+
Sbjct: 105 ALEYLHS---LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC-GTPEYL 160
Query: 358 APEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEV 399
APE + D +S G+L+ E+++G+ P Y+ E+
Sbjct: 161 APEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPF-YAEDRKEI 201
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 2e-16
Identities = 76/281 (27%), Positives = 127/281 (45%), Gaps = 25/281 (8%)
Query: 193 VIGEGGYG--IVY-HGVLEDNTN--VAVKNLLNNRGQAEKE-FKVEVEAIGRVRHKNLVR 246
V+GEG +G +Y + D T VAVK L GQ +K E+ + + H+N+V+
Sbjct: 11 VLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVK 70
Query: 247 LLGYCAEGAHR--MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 304
G C+E + L+ EY+ G+L +L P L + +G+ YLH
Sbjct: 71 YKGCCSEQGGKGLQLIMEYVPLGSLRDYL-----PKHKLNLAQLLLFAQQICEGMAYLHS 125
Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMG---TFGYVAPEY 361
+HRD+ + N+LLD K+ DFGLAK + Y R G F Y A E
Sbjct: 126 ---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-AVEC 181
Query: 362 ASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGE-VNLVEWLKTMVTNRNAEGVLDP 420
+ SDV+SFG+ + E+++ + PP + ++ + +T +L+
Sbjct: 182 LKENKFSYASDVWSFGVTLYELLTHCDS--KQSPPKKFEEMIGPKQGQMTVVRLIELLE- 238
Query: 421 RLQEKPCSRALKRALLVALR-CVDPNAHKRPKMGHVIHMLE 460
R PC + + + + ++ C + A RP +I +L+
Sbjct: 239 RGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILK 279
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 2e-16
Identities = 69/225 (30%), Positives = 113/225 (50%), Gaps = 26/225 (11%)
Query: 178 LRELEVSTNGFADENVIGEGGYGIVYHGV-LEDNTN----VAVKNLLN-NRGQAEKEFKV 231
L+E E F V+G G +G VY G+ + + VA+K L +A KE
Sbjct: 4 LKETE-----FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD 58
Query: 232 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWL--HGD-VGPHSPLTWEIR 288
E + V + ++ RLLG C + L+ + + G L ++ H D +G L W ++
Sbjct: 59 EAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ 117
Query: 289 MNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA-ERSYVT 347
+ AKG+ YL E ++VHRD+ + N+L+ + K++DFGLAKLLGA E+ Y
Sbjct: 118 I------AKGMNYLEE---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHA 168
Query: 348 TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVD 391
++A E + +SDV+S+G+ + E+++ G P D
Sbjct: 169 EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 2e-16
Identities = 52/197 (26%), Positives = 99/197 (50%), Gaps = 8/197 (4%)
Query: 194 IGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE 253
+G G +G+V+ G VA+K + N +E++F E + + ++ H LV+L G C +
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAI-NEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQ 70
Query: 254 GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHR 313
+V E+++NG L +L G S ++ +++ +G+ YL +HR
Sbjct: 71 QKPLYIVTEFMENGCLLNYLRQRQGKLSK---DMLLSMCQDVCEGMEYLERN---SFIHR 124
Query: 314 DIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDV 373
D+ + N L+ K+SDFG+ + + + ++ + PE + + +SDV
Sbjct: 125 DLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDV 184
Query: 374 YSFGILIMEVIS-GRNP 389
+SFG+L+ EV + G+ P
Sbjct: 185 WSFGVLMWEVFTEGKMP 201
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 3e-16
Identities = 56/204 (27%), Positives = 99/204 (48%), Gaps = 17/204 (8%)
Query: 194 IGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKE-FKVEVEAIGRVRHKNLVRLL-GYC 251
+G+G +G VY ++ A ++ + E E F VE++ + +H N+V L Y
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 252 AEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTW-EIRMNIILGTAKGLTYLHEGLEPKV 310
E +L+ E+ D G L+ + + LT +IR + + L +LH KV
Sbjct: 73 YENKLWILI-EFCDGGALDSIM---LELERGLTEPQIRY-VCRQMLEALNFLHSH---KV 124
Query: 311 VHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGML--- 367
+HRD+K+ NILL + KL+DFG++ + T + GT ++APE +
Sbjct: 125 IHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI-GTPYWMAPEVVACETFKDN 183
Query: 368 --NERSDVYSFGILIMEVISGRNP 389
+ ++D++S GI ++E+ P
Sbjct: 184 PYDYKADIWSLGITLIELAQMEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 78.6 bits (193), Expect = 3e-16
Identities = 62/206 (30%), Positives = 99/206 (48%), Gaps = 15/206 (7%)
Query: 188 FADENVIGEGGYGIVYHGVLEDNTN---VAVKNLLNNRGQAEKE-FKVEVEAIGRVRHKN 243
F IG+G +G V+ G+ DN VA+K + + E E + E+ + +
Sbjct: 6 FTKLERIGKGSFGEVFKGI--DNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 303
+ + G +G ++ EY+ G+ L GP + IL KGL YLH
Sbjct: 64 VTKYYGSYLKGTKLWIIMEYLGGGSALDLLRA--GPFDEFQIATMLKEIL---KGLDYLH 118
Query: 304 EGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAS 363
K +HRDIK++N+LL +Q + KL+DFG+A L + T V GT ++APE
Sbjct: 119 S---EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIQ 174
Query: 364 TGMLNERSDVYSFGILIMEVISGRNP 389
+ ++D++S GI +E+ G P
Sbjct: 175 QSAYDSKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 6e-16
Identities = 80/305 (26%), Positives = 126/305 (41%), Gaps = 41/305 (13%)
Query: 102 KPHSAPNPDPLPEPEPILVEDSPASGRNRIHIEI---GKDHRIAYPERAAGSHHGSGDQT 158
KP P PLP + + R R + + +D +A P S +
Sbjct: 2 KPIQPPPGVPLPSTAR---HTTKSRPRRRPDLTLPLPQRDPSLAVPLPLPPPSSSSSSSS 58
Query: 159 VAAAITPEVSHLGWGHWYTLRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTN--VAVK 216
++A S +L ELE N IG G G VY V+ T A+K
Sbjct: 59 SSSASGSAPSAA-----KSLSELERV-------NRIGSGAGGTVYK-VIHRPTGRLYALK 105
Query: 217 NLLNNRGQA-EKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHG 275
+ N ++ E+E + V H N+V+ ++ E++D G+LE
Sbjct: 106 VIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIA 165
Query: 276 DVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGL 335
D + + +I G+ YLH +VHRDIK SN+L++ N K++DFG+
Sbjct: 166 DEQFLADVARQI--------LSGIAYLHR---RHIVHRDIKPSNLLINSAKNVKIADFGV 214
Query: 336 AKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNE------RSDVYSFGILIMEVISGRNP 389
+++L + V GT Y++PE +T LN D++S G+ I+E GR P
Sbjct: 215 SRILAQTMDPCNSSV-GTIAYMSPERINTD-LNHGAYDGYAGDIWSLGVSILEFYLGRFP 272
Query: 390 VDYSR 394
R
Sbjct: 273 FGVGR 277
|
Length = 353 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 6e-16
Identities = 57/214 (26%), Positives = 110/214 (51%), Gaps = 26/214 (12%)
Query: 191 ENVIGEGGYGIVYHGVLEDN---TNVAVKNLLNNRGQAE-KEFKVEVEAIGRV-RHKNLV 245
++VIGEG +G V ++ + + A+K + + + ++F E+E + ++ H N++
Sbjct: 12 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 71
Query: 246 RLLGYCAEGAHRMLVYEYIDNGNLEQWLHG----DVGPH--------SPLTWEIRMNIIL 293
LLG C + L EY +GNL +L + P S L+ + ++
Sbjct: 72 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 131
Query: 294 GTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGT 353
A+G+ YL + + +HRD+ + NIL+ + + K++DFGL++ + YV + MG
Sbjct: 132 DVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYV-KKTMGR 184
Query: 354 FG--YVAPEYASTGMLNERSDVYSFGILIMEVIS 385
++A E + + SDV+S+G+L+ E++S
Sbjct: 185 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 7e-16
Identities = 60/205 (29%), Positives = 99/205 (48%), Gaps = 13/205 (6%)
Query: 188 FADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEF---KVEVEAIGRVRHKNL 244
F IG+G +G VY G+ ++ T V + + +AE E + E+ + + +
Sbjct: 6 FTKLERIGKGSFGEVYKGI-DNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYI 64
Query: 245 VRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 304
R G +G ++ EY+ G+ D+ PL I+ KGL YLH
Sbjct: 65 TRYYGSYLKGTKLWIIMEYLGGGSAL-----DLLKPGPLEETYIATILREILKGLDYLHS 119
Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAST 364
+ +HRDIK++N+LL +Q + KL+DFG+A L + T V GT ++APE
Sbjct: 120 ---ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQ 175
Query: 365 GMLNERSDVYSFGILIMEVISGRNP 389
+ ++D++S GI +E+ G P
Sbjct: 176 SAYDFKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 7e-16
Identities = 58/203 (28%), Positives = 89/203 (43%), Gaps = 13/203 (6%)
Query: 193 VIGEGGYGIVYHGVL----EDNTNVAVKNLLNNRGQAEKE-FKVEVEAIGRVRHKNLVRL 247
IGEG +G VY GV + VAVK N + +E F E + + H ++V+L
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 248 LGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLE 307
+G E +V E G L +L + L + + L YL
Sbjct: 73 IGVITENP-VWIVMELAPLGELRSYLQVN---KYSLDLASLILYSYQLSTALAYLES--- 125
Query: 308 PKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGML 367
+ VHRDI + N+L+ KL DFGL++ L E Y ++ ++APE +
Sbjct: 126 KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRF 185
Query: 368 NERSDVYSFGILIMEVIS-GRNP 389
SDV+ FG+ + E++ G P
Sbjct: 186 TSASDVWMFGVCMWEILMLGVKP 208
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 7e-16
Identities = 60/205 (29%), Positives = 93/205 (45%), Gaps = 12/205 (5%)
Query: 191 ENVIGEGGYGIVYHGVLE----DNTNVAVKNLLNNRGQAEKE-FKVEVEAIGRVRHKNLV 245
E ++G G +G + G L+ VA+ L ++ F E +G+ H N+V
Sbjct: 10 ERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIV 69
Query: 246 RLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG 305
RL G G M+V EY+ NG L+ +L G L M ++ G A G+ YL E
Sbjct: 70 RLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQ---LVAGQLMGMLPGLASGMKYLSE- 125
Query: 306 LEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTG 365
VH+ + + +L++ K+S F + +E Y T + APE
Sbjct: 126 --MGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYH 183
Query: 366 MLNERSDVYSFGILIMEVIS-GRNP 389
+ SDV+SFGI++ EV+S G P
Sbjct: 184 HFSSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 7e-16
Identities = 56/213 (26%), Positives = 107/213 (50%), Gaps = 26/213 (12%)
Query: 192 NVIGEGGYGIVYHGVLEDN---TNVAVKNLLNNRGQAE-KEFKVEVEAIGRV-RHKNLVR 246
+VIGEG +G V ++ + + A+K + + + ++F E+E + ++ H N++
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 247 LLGYCAEGAHRMLVYEYIDNGNLEQWLHG------------DVGPHSPLTWEIRMNIILG 294
LLG C + L EY +GNL +L S L+ + ++
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 295 TAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTF 354
A+G+ YL + + +HRD+ + NIL+ + + K++DFGL++ + YV + MG
Sbjct: 121 VARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYV-KKTMGRL 173
Query: 355 G--YVAPEYASTGMLNERSDVYSFGILIMEVIS 385
++A E + + SDV+S+G+L+ E++S
Sbjct: 174 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 8e-16
Identities = 51/211 (24%), Positives = 97/211 (45%), Gaps = 21/211 (9%)
Query: 193 VIGEGGYGIVYHGVLEDNTNV-AVKNLLNNRGQAEKE----------FKVEVEAIGRVRH 241
+IG+G YG VY + + AVK + A + + E+E + + H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 242 KNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTY 301
N+V+ LG+ + + EY+ G++ L + ++ +GL Y
Sbjct: 68 LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRT----YGRFEEQLVRFFTEQVLEGLAY 123
Query: 302 LHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL-GAERSYVTTRVMGTFGYVAPE 360
LH ++HRD+K+ N+L+D K+SDFG++K + + G+ ++APE
Sbjct: 124 LHS---KGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPE 180
Query: 361 YASTGM--LNERSDVYSFGILIMEVISGRNP 389
+ + + D++S G +++E+ +GR P
Sbjct: 181 VIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 1e-15
Identities = 60/214 (28%), Positives = 102/214 (47%), Gaps = 43/214 (20%)
Query: 194 IGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIG-------------RVR 240
IGEG YG+VY +N L A K+ +++ E G +
Sbjct: 8 IGEGTYGVVYKA----------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 57
Query: 241 HKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLT 300
H N+V+LL LV+E++ + +L++++ D P S + + + + +GL
Sbjct: 58 HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM--DASPLSGIPLPLIKSYLFQLLQGLA 114
Query: 301 YLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE-RSYVTTRVMGTFGYVAP 359
+ H +V+HRD+K N+L++ + KL+DFGLA+ G R+Y T + T Y AP
Sbjct: 115 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTLWYRAP 169
Query: 360 E------YASTGMLNERSDVYSFGILIMEVISGR 387
E Y ST + D++S G + E+++ R
Sbjct: 170 EILLGCKYYSTAV-----DIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 1e-15
Identities = 56/201 (27%), Positives = 100/201 (49%), Gaps = 21/201 (10%)
Query: 194 IGEGGYG---IVYHGVLEDNTNVAVK--NLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLL 248
IGEG +G +V ED +K N+ + +E + EV + ++H N+V+
Sbjct: 8 IGEGSFGKAILVKSK--EDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQ 65
Query: 249 GYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSP----LTWEIRMNIILGTAKGLTYLHE 304
E + +V +Y + G+L + ++ G P L W +++ + L ++H+
Sbjct: 66 ESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICL------ALKHVHD 119
Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAST 364
K++HRDIKS NI L K KL DFG+A++L + T +GT Y++PE
Sbjct: 120 ---RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELART-CIGTPYYLSPEICEN 175
Query: 365 GMLNERSDVYSFGILIMEVIS 385
N +SD+++ G ++ E+ +
Sbjct: 176 RPYNNKSDIWALGCVLYEMCT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 2e-15
Identities = 76/279 (27%), Positives = 125/279 (44%), Gaps = 32/279 (11%)
Query: 194 IGEGGYGIVYHGVLEDNT-------NVAVKNLLNNRGQAEKEFKV-----EVEAIG-RVR 240
+G G +G VY ++N + V N + + E++ + EV I ++R
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 241 HKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLT 300
H N+VR E +V + I+ L + + T E NI + L
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALR 127
Query: 301 YLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPE 360
YLH+ E ++VHRD+ +NI+L + ++DFGLAK E S +T+ V+GT Y PE
Sbjct: 128 YLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPE-SKLTS-VVGTILYSCPE 183
Query: 361 YASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDP 420
E++DV++FG ++ ++ + P YS N++ +V E V +P
Sbjct: 184 IVKNEPYGEKADVWAFGCILYQMCT-LQPPFYS-----TNMLSLATKIV-----EAVYEP 232
Query: 421 RLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHML 459
L E S + V C+ P+A RP + V M+
Sbjct: 233 -LPEGMYSEDVT---DVITSCLTPDAEARPDIIQVSAMI 267
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 2e-15
Identities = 67/276 (24%), Positives = 122/276 (44%), Gaps = 23/276 (8%)
Query: 185 TNGFADENVIGEGGYGIVYHGV-LEDNTNVAVKNL----LNNRGQAEKEFKVEVEAIGRV 239
F E IG+G + +VY + L D VA+K + + + + K E++ + ++
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLK-EIDLLKQL 59
Query: 240 RHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGL 299
H N+++ L E +V E D G+L + + + + L
Sbjct: 60 DHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSAL 119
Query: 300 TYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAP 359
++H +++HRDIK +N+ + KL D GL + ++ + + V GT Y++P
Sbjct: 120 EHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSP 175
Query: 360 EYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLD 419
E N +SD++S G L+ E+ + ++P ++NL K E
Sbjct: 176 ERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD----KMNLYSLCK------KIEKCDY 225
Query: 420 PRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHV 455
P L S L+ LV+ RC++P+ KRP + +V
Sbjct: 226 PPLPADHYSEELRD--LVS-RCINPDPEKRPDISYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 76.7 bits (188), Expect = 2e-15
Identities = 73/258 (28%), Positives = 118/258 (45%), Gaps = 26/258 (10%)
Query: 194 IGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKV-EVEAIGRVRHKNLVRLLGYC 251
IG+G G VY + + VA++ + N + Q +KE + E+ + ++ N+V L
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQM-NLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 252 AEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVV 311
G +V EY+ G+L DV + + + + L +LH +V+
Sbjct: 87 LVGDELWVVMEYLAGGSLT-----DVVTETCMDEGQIAAVCRECLQALEFLHSN---QVI 138
Query: 312 HRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERS 371
HRDIKS NILL + KL+DFG + E+S + ++GT ++APE + +
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-RSTMVGTPYWMAPEVVTRKAYGPKV 197
Query: 372 DVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRAL 431
D++S GI+ +E+I G P P + L + TN P LQ A+
Sbjct: 198 DIWSLGIMAIEMIEGEPPYLNENP------LRALYLIATNGT------PELQNPEKLSAI 245
Query: 432 KRALLVALRCVDPNAHKR 449
R L RC+D + KR
Sbjct: 246 FRDFLN--RCLDMDVEKR 261
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 76.2 bits (188), Expect = 3e-15
Identities = 54/182 (29%), Positives = 92/182 (50%), Gaps = 12/182 (6%)
Query: 213 VAVKNLLNNRGQ-AEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQ 271
VAVK L + A ++F EV+ + R+ N+ RLLG C ++ EY++NG+L Q
Sbjct: 49 VAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQ 108
Query: 272 WLHGDVGPHS-------PLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDK 324
+L V S L++ + + A G+ YL VHRD+ + N L+ K
Sbjct: 109 FLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRDLATRNCLVGK 165
Query: 325 QWNPKLSDFGLAKLLGAERSY-VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEV 383
+ K++DFG+++ L + Y V R ++A E G +SDV++FG+ + E+
Sbjct: 166 NYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEI 225
Query: 384 IS 385
++
Sbjct: 226 LT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 3e-15
Identities = 58/198 (29%), Positives = 99/198 (50%), Gaps = 12/198 (6%)
Query: 194 IGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKV-EVEAIGRVRHKNLVRLLGYC 251
IG+G G V+ + + VA+K + N + Q +KE + E+ + +++ N+V L
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQI-NLQKQPKKELIINEILVMKELKNPNIVNFLDSF 85
Query: 252 AEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVV 311
G +V EY+ G+L DV + + + + L +LH +V+
Sbjct: 86 LVGDELFVVMEYLAGGSLT-----DVVTETCMDEAQIAAVCRECLQALEFLHAN---QVI 137
Query: 312 HRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERS 371
HRDIKS N+LL + KL+DFG + E+S +T V GT ++APE + +
Sbjct: 138 HRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKV 196
Query: 372 DVYSFGILIMEVISGRNP 389
D++S GI+ +E++ G P
Sbjct: 197 DIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 3e-15
Identities = 75/297 (25%), Positives = 134/297 (45%), Gaps = 41/297 (13%)
Query: 194 IGEGGYGIVYHGVLED------NTNVAVKNLLNNRGQAEK-EFKVEVEAIGRVRHKNLVR 246
+G+G +G+VY G D T VAVK + + E+ EF E + ++VR
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 247 LLGYCAEGAHRMLVYEYIDNGNLEQWLH-----GDVGPHSPL-TWEIRMNIILGTAKGLT 300
LLG ++G ++V E + +G+L+ +L + P P T + + + A G+
Sbjct: 74 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133
Query: 301 YLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTF--GYVA 358
YL+ K VHRD+ + N ++ + K+ DFG+ + + E Y G ++A
Sbjct: 134 YLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDI-YETDYYRKGGKGLLPVRWMA 189
Query: 359 PEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNA-EGV 417
PE G+ SD++SFG+++ E+ S L E ++N + V
Sbjct: 190 PESLKDGVFTTSSDMWSFGVVLWEITS---------------LAEQPYQGLSNEQVLKFV 234
Query: 418 LDPRLQEKP--CSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEEFP-FRDVSF 471
+D ++P C + + + C N RP ++++L+ + P F +VSF
Sbjct: 235 MDGGYLDQPDNCPERVTDLMRM---CWQFNPKMRPTFLEIVNLLKDDLHPSFPEVSF 288
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 3e-15
Identities = 64/209 (30%), Positives = 104/209 (49%), Gaps = 19/209 (9%)
Query: 193 VIGEGGYGIVY----HGVLEDNT--NVAVKNLLNNRGQAEKE-FKVEVEAIGRV-RHKNL 244
+G G +G V +G+ + + VAVK L +E+E E++ + + H+N+
Sbjct: 42 TLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENI 101
Query: 245 VRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 304
V LLG C G +++ EY G+L +L S LT E ++ AKG+ +L
Sbjct: 102 VNLLGACTIGGPILVITEYCCYGDLLNFLRRK--RESFLTLEDLLSFSYQVAKGMAFLAS 159
Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYV---TTRVMGTFGYVAPEY 361
+HRD+ + N+LL K+ DFGLA+ + + +YV R+ ++APE
Sbjct: 160 ---KNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARL--PVKWMAPES 214
Query: 362 ASTGMLNERSDVYSFGILIMEVIS-GRNP 389
+ SDV+S+GIL+ E+ S G NP
Sbjct: 215 IFNCVYTFESDVWSYGILLWEIFSLGSNP 243
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 4e-15
Identities = 61/210 (29%), Positives = 97/210 (46%), Gaps = 31/210 (14%)
Query: 193 VIGEGGYGIVY---HGVLEDNTNVAVKNLLNNRGQAE--KEFKVEVEAIGRVRHKNLVRL 247
++GEG YG+V H E VA+K L + K E+ + ++RH+NLV L
Sbjct: 8 LVGEGSYGMVMKCKHK--ETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNL 65
Query: 248 LGYCAEGAHRMLVYEYIDN---GNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 304
+ LV+E++D+ +LE++ +G L + +G+ + H
Sbjct: 66 IEVFRRKKRLYLVFEFVDHTVLDDLEKYPNG-------LDESRVRKYLFQILRGIEFCHS 118
Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE----RSYVTTRVMGTFGYVAPE 360
++HRDIK NIL+ + KL DFG A+ L A YV TR Y APE
Sbjct: 119 H---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATR-----WYRAPE 170
Query: 361 YASTGMLNERS-DVYSFGILIMEVISGRNP 389
R+ D+++ G L+ E+++G P
Sbjct: 171 LLVGDTKYGRAVDIWAVGCLVTEMLTG-EP 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 5e-15
Identities = 60/198 (30%), Positives = 98/198 (49%), Gaps = 12/198 (6%)
Query: 194 IGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKV-EVEAIGRVRHKNLVRLLGYC 251
IG+G G VY + + VA+K + N + Q +KE + E+ + ++ N+V L
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQM-NLQQQPKKELIINEILVMRENKNPNIVNYLDSY 85
Query: 252 AEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVV 311
G +V EY+ G+L DV + + + + L +LH +V+
Sbjct: 86 LVGDELWVVMEYLAGGSLT-----DVVTETCMDEGQIAAVCRECLQALDFLHSN---QVI 137
Query: 312 HRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERS 371
HRDIKS NILL + KL+DFG + E+S +T V GT ++APE + +
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKV 196
Query: 372 DVYSFGILIMEVISGRNP 389
D++S GI+ +E++ G P
Sbjct: 197 DIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 5e-15
Identities = 60/215 (27%), Positives = 89/215 (41%), Gaps = 29/215 (13%)
Query: 192 NVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEF-KVEVEAIGRVRHKNLVRLLGY 250
VIG+G +G V +++ K + A K K + G VR N++
Sbjct: 6 RVIGKGAFGKVC--IVQKRDT---KKMF-----AMKYMNKQKCVEKGSVR--NVLNERRI 53
Query: 251 CAEGAHRMLV---YEYIDNGNL----EQWLHGDVGPH----SPLTWEIRMNIILGTAKGL 299
E H LV Y + D N+ + L GD+ H + E I L
Sbjct: 54 LQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLAL 113
Query: 300 TYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAP 359
YLH ++HRDIK NILLD+Q + ++DF +A + +TT GT GY+AP
Sbjct: 114 EYLHS---KGIIHRDIKPDNILLDEQGHVHITDFNIATKV--TPDTLTTSTSGTPGYMAP 168
Query: 360 EYASTGMLNERSDVYSFGILIMEVISGRNPVDYSR 394
E + D +S G+ E + G+ P
Sbjct: 169 EVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHS 203
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 6e-15
Identities = 64/220 (29%), Positives = 109/220 (49%), Gaps = 27/220 (12%)
Query: 194 IGEGGYGIVYH----GVLEDNTN----VAVKNLLNNRGQAE-KEFKVEVEAIGRV-RHKN 243
+GEG +G V G+ +D N VAVK L ++ + + E+E + + +HKN
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHG------DVG------PHSPLTWEIRMNI 291
++ LLG C + ++ EY GNL ++L D P LT++ ++
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 292 ILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSY-VTTRV 350
A+G+ YL K +HRD+ + N+L+ + K++DFGLA+ + Y TT
Sbjct: 140 AYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196
Query: 351 MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNP 389
++APE + +SDV+SFG+L+ E+ + G +P
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSP 236
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 6e-15
Identities = 58/203 (28%), Positives = 103/203 (50%), Gaps = 18/203 (8%)
Query: 194 IGEGGYGIV---YHGVLEDNTN--VAVKNLL-NNRGQAEKEFKVEVEAIGRVRHKNLVRL 247
+GEG +G V + DNT VAVK+L + G + K E+E + + H+N+V+
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71
Query: 248 LGYCAEGAHR--MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG 305
G C E L+ E++ +G+L+++L + + + + ++ + KG+ YL
Sbjct: 72 KGICTEDGGNGIKLIMEFLPSGSLKEYLPRNK---NKINLKQQLKYAVQICKGMDYLGS- 127
Query: 306 LEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTT---RVMGTFGYVAPEYA 362
+ VHRD+ + N+L++ + K+ DFGL K + ++ Y T F Y APE
Sbjct: 128 --RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWY-APECL 184
Query: 363 STGMLNERSDVYSFGILIMEVIS 385
SDV+SFG+ + E+++
Sbjct: 185 IQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 7e-15
Identities = 59/214 (27%), Positives = 94/214 (43%), Gaps = 46/214 (21%)
Query: 194 IGEGGYGIVYHGVLEDNTN-VAVKNLLNNRGQAEKEFKV------EVEAIGRVRHKNLVR 246
IGEG YG+V+ + VA+K + ++E + + E+ + +++H NLV
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFV----ESEDDPVIKKIALREIRMLKQLKHPNLVN 64
Query: 247 LLGYCAEGAHRMLVYEYIDN---GNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 303
L+ LV+EY D+ LE+ G + + II T + + + H
Sbjct: 65 LIEVFRRKRKLHLVFEYCDHTVLNELEKNPRG-------VPEHLIKKIIWQTLQAVNFCH 117
Query: 304 EGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL----GAERSYVTTRVMGTFGYVAP 359
+ +HRD+K NIL+ KQ KL DFG A++L YV TR Y AP
Sbjct: 118 KH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATR-----WYRAP 169
Query: 360 E-------YASTGMLNERSDVYSFGILIMEVISG 386
E Y DV++ G + E+++G
Sbjct: 170 ELLVGDTQYGPP------VDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 7e-15
Identities = 66/209 (31%), Positives = 105/209 (50%), Gaps = 28/209 (13%)
Query: 192 NVIGEGGYGIVYHGVLEDNTN---VAVKNLLNNRGQAEKE-FKV----EVEAIGRVRHKN 243
N IGEG YGIVY D T+ VA+K + R E++ + E+ + +RH N
Sbjct: 13 NRIGEGTYGIVYRA--RDTTSGEIVALKKV---RMDNERDGIPISSLREITLLLNLRHPN 67
Query: 244 LVRLLGYCAEGAHR---MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLT 300
+V L G H LV EY + +L L P S +++ ++L +GL
Sbjct: 68 IVELK-EVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFS--ESQVKC-LMLQLLRGLQ 122
Query: 301 YLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPE 360
YLHE ++HRD+K SN+LL + K++DFGLA+ G +T +V+ T Y APE
Sbjct: 123 YLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV-TLWYRAPE 178
Query: 361 YASTGMLNERS--DVYSFGILIMEVISGR 387
G + D+++ G ++ E+++ +
Sbjct: 179 LL-LGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 8e-15
Identities = 68/211 (32%), Positives = 102/211 (48%), Gaps = 23/211 (10%)
Query: 188 FADENVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFK---VEVEAIGRVRHKN 243
F D IG G +G VY + N VA+K + + Q+ ++++ EV + ++RH N
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76
Query: 244 LVRLLGYCAEGAHRM-LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRM-NIILGTAKGLTY 301
+ G C H LV EY G+ L +V H E+ + I G +GL Y
Sbjct: 77 TIEYKG-CYLREHTAWLVMEYC-LGSASDIL--EV--HKKPLQEVEIAAICHGALQGLAY 130
Query: 302 LHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEY 361
LH + +HRDIK+ NILL + KL+DFG A L+ S+V GT ++APE
Sbjct: 131 LH---SHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV-----GTPYWMAPEV 182
Query: 362 ---ASTGMLNERSDVYSFGILIMEVISGRNP 389
G + + DV+S GI +E+ + P
Sbjct: 183 ILAMDEGQYDGKVDVWSLGITCIELAERKPP 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 74.5 bits (184), Expect = 1e-14
Identities = 62/212 (29%), Positives = 108/212 (50%), Gaps = 34/212 (16%)
Query: 194 IGEGGYGIVYHGV-LEDNTNVAVKNL-LNNRGQAE--------KEFKVEVEAIGRVRHKN 243
+GEG Y +VY E VA+K + L R +A+ +E K+ E ++H N
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQE----LKHPN 63
Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 303
++ LL ++ LV+E+++ +LE+ + +P +I+ + +L T +GL YLH
Sbjct: 64 IIGLLDVFGHKSNINLVFEFME-TDLEKVIKDKSIVLTPA--DIK-SYMLMTLRGLEYLH 119
Query: 304 EGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPE--- 360
++HRD+K +N+L+ KL+DFGLA+ G+ +T +V+ T Y APE
Sbjct: 120 SNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV-TRWYRAPELLF 175
Query: 361 ---YASTGMLNERSDVYSFGILIMEVISGRNP 389
+ G+ D++S G + E++ R P
Sbjct: 176 GARHYGVGV-----DMWSVGCIFAELLL-RVP 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 1e-14
Identities = 64/210 (30%), Positives = 103/210 (49%), Gaps = 21/210 (10%)
Query: 193 VIGEGGYGIVYHGV-LEDNTN----VAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNLVR 246
V+G G +G VY G+ + D N VA+K L N +A KE E + V + R
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73
Query: 247 LLGYCAEGAHRMLVYEYIDNGNLEQWLH---GDVGPHSPLTWEIRMNIILGTAKGLTYLH 303
LLG C + LV + + G L ++ +G L W +++ AKG++YL
Sbjct: 74 LLGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQI------AKGMSYLE 126
Query: 304 EGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA-ERSYVTTRVMGTFGYVAPEYA 362
E ++VHRD+ + N+L+ + K++DFGLA+LL E Y ++A E
Sbjct: 127 E---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESI 183
Query: 363 STGMLNERSDVYSFGILIMEVIS-GRNPVD 391
+SDV+S+G+ + E+++ G P D
Sbjct: 184 LHRRFTHQSDVWSYGVTVWELMTFGAKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 74.5 bits (184), Expect = 1e-14
Identities = 58/233 (24%), Positives = 95/233 (40%), Gaps = 67/233 (28%)
Query: 190 DENVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEA---------IGRV 239
IG G YG+V V VA+K + N F ++A + +
Sbjct: 4 LLKPIGSGAYGVVCSAVDKRTGRKVAIKKISN-------VFDDLIDAKRILREIKLLRHL 56
Query: 240 RHKNLVRLLG-------------YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWE 286
RH+N++ LL Y +V E ++ +L + + PLT +
Sbjct: 57 RHENIIGLLDILRPPSPEDFNDVY--------IVTELMET-DLHKVIKS----PQPLTDD 103
Query: 287 IRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS-- 344
+ +GL YLH V+HRD+K SNIL++ + K+ DFGLA+ + +
Sbjct: 104 HIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEK 160
Query: 345 -----YVTTRVMGTFGYVAPEYASTGMLNERS-----DVYSFGILIMEVISGR 387
YV TR Y APE +L+ D++S G + E+++ +
Sbjct: 161 GFLTEYVVTRW-----YRAPEL----LLSSSRYTKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 2e-14
Identities = 53/205 (25%), Positives = 100/205 (48%), Gaps = 19/205 (9%)
Query: 194 IGEGGYGIVYHGVL------EDNTNVAVKNLLNNRGQAEK-EFKVEVEAIGRVRHKNLVR 246
+G+G +G+VY G+ E T VA+K + E+ EF E + ++VR
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 247 LLGYCAEGAHRMLVYEYIDNGNLEQWLHG------DVGPHSPLTWEIRMNIILGTAKGLT 300
LLG ++G +++ E + G+L+ +L + +P + + + + A G+
Sbjct: 74 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMA 133
Query: 301 YLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFG--YVA 358
YL+ K VHRD+ + N ++ + + K+ DFG+ + + E Y G +++
Sbjct: 134 YLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDI-YETDYYRKGGKGLLPVRWMS 189
Query: 359 PEYASTGMLNERSDVYSFGILIMEV 383
PE G+ SDV+SFG+++ E+
Sbjct: 190 PESLKDGVFTTYSDVWSFGVVLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 2e-14
Identities = 58/219 (26%), Positives = 104/219 (47%), Gaps = 32/219 (14%)
Query: 194 IGEGGYGIVY----HGVLE----------DNTN-VAVKNLLNN-RGQAEKEFKVEVEAIG 237
+GEG +G V+ G+ E VAVK L + A +F E++ +
Sbjct: 13 LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMS 72
Query: 238 RVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWL----------HGDVGPHSPLTWEI 287
R+++ N++RLLG C ++ EY++NG+L Q+L H + P + +
Sbjct: 73 RLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLL 132
Query: 288 RMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSY-V 346
M + + A G+ YL VHRD+ + N L+ + K++DFG+++ L + Y +
Sbjct: 133 YMAVQI--ASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRI 187
Query: 347 TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS 385
R + ++A E G SDV++FG+ + E+ +
Sbjct: 188 QGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 2e-14
Identities = 54/190 (28%), Positives = 96/190 (50%), Gaps = 20/190 (10%)
Query: 213 VAVKNLLNNRGQ-AEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQ 271
VAVK L + + A +F EV+ + R++ N++RLLG C + ++ EY++NG+L Q
Sbjct: 49 VAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQ 108
Query: 272 WL------------HGDVGPHSPL---TWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIK 316
+L + V P L ++ +++ L A G+ YL VHRD+
Sbjct: 109 FLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS---SLNFVHRDLA 165
Query: 317 SSNILLDKQWNPKLSDFGLAKLLGAERSY-VTTRVMGTFGYVAPEYASTGMLNERSDVYS 375
+ N L+ + K++DFG+++ L A Y + R + ++A E G SDV++
Sbjct: 166 TRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWA 225
Query: 376 FGILIMEVIS 385
FG+ + E++
Sbjct: 226 FGVTLWEILM 235
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 2e-14
Identities = 56/215 (26%), Positives = 107/215 (49%), Gaps = 23/215 (10%)
Query: 193 VIGEGGYGIVYHGVL--EDNT--NVAVKNL-LNNRGQAE-KEFKVEVEAIGRVRHKNLVR 246
++GEG +G V G L +D + VAVK + L+ +E +EF E + H N+++
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 247 LLGYCAEGAHR------MLVYEYIDNGNLEQWLH----GDVGPHSPLTWEIRMNIILGTA 296
L+G C E + M++ ++ +G+L +L G + PL + + ++ A
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPL--QTLLKFMVDIA 123
Query: 297 KGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGT-FG 355
G+ YL +HRD+ + N +L + ++DFGL+K + + Y R+
Sbjct: 124 LGMEYLSN---RNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK 180
Query: 356 YVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNP 389
++A E + + +SDV++FG+ + E+ + G+ P
Sbjct: 181 WIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.0 bits (180), Expect = 2e-14
Identities = 62/228 (27%), Positives = 105/228 (46%), Gaps = 58/228 (25%)
Query: 194 IGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKV--------EVEAIGRV-RHKN 243
+G+G +G VY E VA+K + +K+F EV+++ ++ H N
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKM-------KKKFYSWEECMNLREVKSLRKLNEHPN 59
Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 303
+V+L E V+EY++ GNL Q + G P + + +II +GL ++H
Sbjct: 60 IVKLKEVFRENDELYFVFEYME-GNLYQLMKDRKG--KPFSESVIRSIIYQILQGLAHIH 116
Query: 304 E-GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS------YVTTRVMGTFGY 356
+ G HRD+K N+L+ K++DFGLA+ + RS YV+TR Y
Sbjct: 117 KHGF----FHRDLKPENLLVSGPEVVKIADFGLAREI---RSRPPYTDYVSTR-----WY 164
Query: 357 VAPE-------YASTGMLNERSDVYSFGILIMEVIS------GRNPVD 391
APE Y+S D+++ G ++ E+ + G + +D
Sbjct: 165 RAPEILLRSTSYSSP------VDIWALGCIMAELYTLRPLFPGSSEID 206
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 5e-14
Identities = 60/211 (28%), Positives = 100/211 (47%), Gaps = 21/211 (9%)
Query: 188 FADENVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFK---VEVEAIGRVRHKN 243
F+D IG G +G VY + ++ VA+K + + Q+ ++++ EV + ++RH N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIIL-GTAKGLTYL 302
++ G LV EY G+ L H E+ + + G +GL YL
Sbjct: 77 TIQYRGCYLREHTAWLVMEYC-LGSASDLLE----VHKKPLQEVEIAAVTHGALQGLAYL 131
Query: 303 HEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEY- 361
H ++HRD+K+ NILL + KL DFG A ++ +V GT ++APE
Sbjct: 132 HSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV-----GTPYWMAPEVI 183
Query: 362 --ASTGMLNERSDVYSFGILIMEVISGRNPV 390
G + + DV+S GI +E+ + P+
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKPPL 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 7e-14
Identities = 63/208 (30%), Positives = 98/208 (47%), Gaps = 30/208 (14%)
Query: 194 IGEGGYGIVYHGVLED---NTNVAVKNLLNNRGQAEKE-----FKVEVEAIGRVRHKNLV 245
IGEG YG+VY D N +A+K + R + E E E+ + ++H N+V
Sbjct: 10 IGEGTYGVVYKA--RDRVTNETIALKKI---RLEQEDEGVPSTAIREISLLKEMQHGNIV 64
Query: 246 RLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG 305
RL LV+EY+D L+ H D P + + +G+ Y H
Sbjct: 65 RLQDVVHSEKRLYLVFEYLD---LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH 121
Query: 306 LEPKVVHRDIKSSNILLDKQWNP-KLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAST 364
+V+HRD+K N+L+D++ N KL+DFGLA+ G T V+ T Y APE
Sbjct: 122 ---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV-TLWYRAPEI--- 174
Query: 365 GMLNERS-----DVYSFGILIMEVISGR 387
+L R D++S G + E+++ +
Sbjct: 175 -LLGSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 7e-14
Identities = 62/202 (30%), Positives = 96/202 (47%), Gaps = 20/202 (9%)
Query: 194 IGEGGYGIVYHGVLEDN-TNVAVKNLLNNRGQAEKEFKV-EVEAIGRVRHKNLVRLLGYC 251
IGEG GIV + + VAVK +++ R Q +E EV + +H+N+V +
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVK-MMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87
Query: 252 AEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVV 311
G ++ E++ G L D+ + L E + + L YLH V+
Sbjct: 88 LVGEELWVLMEFLQGGALT-----DIVSQTRLNEEQIATVCESVLQALCYLHS---QGVI 139
Query: 312 HRDIKSSNILLDKQWNPKLSDFG----LAKLLGAERSYVTTRVMGTFGYVAPEYASTGML 367
HRDIKS +ILL KLSDFG ++K + +S V GT ++APE S
Sbjct: 140 HRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-----GTPYWMAPEVISRTPY 194
Query: 368 NERSDVYSFGILIMEVISGRNP 389
D++S GI+++E++ G P
Sbjct: 195 GTEVDIWSLGIMVIEMVDGEPP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 9e-14
Identities = 61/220 (27%), Positives = 109/220 (49%), Gaps = 27/220 (12%)
Query: 194 IGEGGYGIVYH----GVLEDNTN----VAVKNLLNNRGQAE-KEFKVEVEAIGRV-RHKN 243
+GEG +G V G+ ++ N VAVK L ++ + + + E+E + + +HKN
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHG------------DVGPHSPLTWEIRMNI 291
++ LLG C + ++ EY GNL ++L P L+++ ++
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145
Query: 292 ILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSY-VTTRV 350
A+G+ YL K +HRD+ + N+L+ + K++DFGLA+ + Y TT
Sbjct: 146 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 202
Query: 351 MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNP 389
++APE + +SDV+SFG+L+ E+ + G +P
Sbjct: 203 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 242
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 9e-14
Identities = 59/215 (27%), Positives = 106/215 (49%), Gaps = 26/215 (12%)
Query: 194 IGEGGYGIVY----HGVLEDN----TNVAVKNLLNNRGQAE-KEFKVEVEAIGRV-RHKN 243
+GEG +G V +G+ + VAVK L +N + + E+E + + +HKN
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHG----------DVG--PHSPLTWEIRMNI 291
++ LLG C + ++ EY GNL ++L D+ P L+++ ++
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139
Query: 292 ILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSY-VTTRV 350
A+G+ YL + +HRD+ + N+L+ + K++DFGLA+ + Y T+
Sbjct: 140 AYQVARGMEYLE---SRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNG 196
Query: 351 MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS 385
++APE + +SDV+SFGIL+ E+ +
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 1e-13
Identities = 61/208 (29%), Positives = 102/208 (49%), Gaps = 15/208 (7%)
Query: 194 IGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV-RHKNLVRLLG--Y 250
IG+G YG VY + + ++A +L+ ++E + E + + H N+V+ G Y
Sbjct: 30 IGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFY 89
Query: 251 CAE---GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLE 307
A+ G LV E + G++ + + G + L + I+ G GL +LH
Sbjct: 90 KADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN-- 147
Query: 308 PKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGM- 366
+++HRD+K +NILL + KL DFG++ L + R T V GT ++APE +
Sbjct: 148 -RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GTPFWMAPEVIACEQQ 205
Query: 367 ----LNERSDVYSFGILIMEVISGRNPV 390
+ R DV+S GI +E+ G P+
Sbjct: 206 YDYSYDARCDVWSLGITAIELGDGDPPL 233
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 1e-13
Identities = 62/202 (30%), Positives = 97/202 (48%), Gaps = 14/202 (6%)
Query: 194 IGEGGYGIVYHGV-LEDNTNVAVKNL-LNNRGQAEKEFKV-EVEAIGRVRHKNLVRLLGY 250
IGEG YG V+ E + VA+K + L++ + + E+ + ++HKN+VRL
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67
Query: 251 CAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKV 310
LV+EY D +L+++ G P + M +L KGL + H V
Sbjct: 68 LHSDKKLTLVFEYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLL---KGLAFCHS---HNV 120
Query: 311 VHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE-RSYVTTRVMGTFGYVAPEYASTGMLNE 369
+HRD+K N+L++K KL+DFGLA+ G R Y V T Y P+ L
Sbjct: 121 LHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV--TLWYRPPDVLFGAKLYS 178
Query: 370 RS-DVYSFGILIMEVISGRNPV 390
S D++S G + E+ + P+
Sbjct: 179 TSIDMWSAGCIFAELANAGRPL 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 2e-13
Identities = 54/218 (24%), Positives = 103/218 (47%), Gaps = 29/218 (13%)
Query: 194 IGEGGYGIVY-------------HGVLEDNTN----VAVKNLLNNRGQ-AEKEFKVEVEA 235
+GEG +G V+ L+ + N VAVK L + + A +F E++
Sbjct: 13 LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKI 72
Query: 236 IGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIR------- 288
+ R++ N++RLL C ++ EY++NG+L Q+L + ++
Sbjct: 73 MSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTL 132
Query: 289 MNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSY-VT 347
+ + A G+ YL VHRD+ + N L+ K + K++DFG+++ L + Y +
Sbjct: 133 IFMATQIASGMKYLS---SLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQ 189
Query: 348 TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS 385
R + +++ E G SDV++FG+ + E+++
Sbjct: 190 GRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 71.5 bits (176), Expect = 2e-13
Identities = 66/234 (28%), Positives = 103/234 (44%), Gaps = 78/234 (33%)
Query: 194 IGEGGYGIVYHGVLEDNTN--VAVKNLLN---NRGQAEKEFKVEVEAIGRVR-HKNLVRL 247
+G+G YGIV+ + + T VA+K + + N A++ F+ E+ + + H N+V+L
Sbjct: 15 LGKGAYGIVWKAI-DRRTKEVVALKKIFDAFRNATDAQRTFR-EIMFLQELGDHPNIVKL 72
Query: 248 LGYCAEGAHRM-------LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNI--------- 291
L + LV+EY++ + L IR NI
Sbjct: 73 LN-----VIKAENDKDIYLVFEYME---------------TDLHAVIRANILEDVHKRYI 112
Query: 292 ---ILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS---- 344
+L K L Y+H G V+HRD+K SNILL+ KL+DFGLA+ L
Sbjct: 113 MYQLL---KALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPEN 166
Query: 345 -----YVTTRVMGTFGYVAPE------YASTGMLNERSDVYSFGILIMEVISGR 387
YV TR Y APE + G+ D++S G ++ E++ G+
Sbjct: 167 PVLTDYVATR-----WYRAPEILLGSTRYTKGV-----DMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 70.4 bits (173), Expect = 2e-13
Identities = 60/215 (27%), Positives = 101/215 (46%), Gaps = 34/215 (15%)
Query: 194 IGEGGYGIVYHGVLEDNTN--VAVKNL----LNNRGQAEKEFKVEVEAIGRVRHKNLVRL 247
I +G YG V+ + +T A+K + + + Q + + E + + + + +V+L
Sbjct: 1 ISKGAYGRVFL-AKKKSTGDIYAIKVIKKADMIRKNQVD-QVLTERDILSQAQSPYVVKL 58
Query: 248 LGYCAEGAHRM-LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGL 306
Y +G + LV EY+ G+L L +VG L ++ I L YLH
Sbjct: 59 Y-YSFQGKKNLYLVMEYLPGGDLASLLE-NVGS---LDEDVARIYIAEIVLALEYLHSN- 112
Query: 307 EPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYV--------TTRVMGTFGYVA 358
++HRD+K NIL+D + KL+DFGL+K +G R + R++GT Y+A
Sbjct: 113 --GIIHRDLKPDNILIDSNGHLKLTDFGLSK-VGLVRRQINLNDDEKEDKRIVGTPDYIA 169
Query: 359 PEYASTGMLNE----RSDVYSFGILIMEVISGRNP 389
PE +L + D +S G ++ E + G P
Sbjct: 170 PEV----ILGQGHSKTVDWWSLGCILYEFLVGIPP 200
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 2e-13
Identities = 71/262 (27%), Positives = 108/262 (41%), Gaps = 34/262 (12%)
Query: 194 IGEGGYGIVYHGVLEDNTN--VAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLL 248
+G+GG+G V T A K L R + E+ E + + +V + L
Sbjct: 1 LGKGGFGEVC-ACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKV-SSRFIVSL 58
Query: 249 GYCAEG-AHRMLVYEYIDNGNLEQWL--HGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG 305
Y E LV ++ G+L+ + G+ G II G L +LH+
Sbjct: 59 AYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICG----LEHLHQ- 113
Query: 306 LEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTG 365
++V+RD+K N+LLD N ++SD GLA L + GT GY+APE
Sbjct: 114 --RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK--IKGRAGTPGYMAPEVLQGE 169
Query: 366 MLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEK 425
+ + D ++ G + E+I+GR+P R E E LK E +K
Sbjct: 170 VYDFSVDWFALGCTLYEMIAGRSPF---RQRKEKVEKEELKRRTLEMAVE------YPDK 220
Query: 426 --PCSRALKRALLVALRCVDPN 445
P ++ L ALL DP
Sbjct: 221 FSPEAKDLCEALL----QKDPE 238
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 2e-13
Identities = 48/128 (37%), Positives = 69/128 (53%), Gaps = 14/128 (10%)
Query: 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNIL 321
E++D G+L+ ++ + H + I + KGLTYL L K++HRD+K SN+L
Sbjct: 79 EFMDGGSLD--VYRKIPEH------VLGRIAVAVVKGLTYLW-SL--KILHRDVKPSNML 127
Query: 322 LDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIM 381
++ + KL DFG++ L S T V GT Y+APE S SDV+S GI M
Sbjct: 128 VNTRGQVKLCDFGVSTQL--VNSIAKTYV-GTNAYMAPERISGEQYGIHSDVWSLGISFM 184
Query: 382 EVISGRNP 389
E+ GR P
Sbjct: 185 ELALGRFP 192
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 70.9 bits (173), Expect = 2e-13
Identities = 64/211 (30%), Positives = 99/211 (46%), Gaps = 21/211 (9%)
Query: 188 FADENVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFK---VEVEAIGRVRHKN 243
F D IG G +G VY + N VA+K + + Q+ ++++ EV+ + R++H N
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIIL-GTAKGLTYL 302
+ G LV EY G+ L H E+ + I G +GL YL
Sbjct: 87 SIEYKGCYLREHTAWLVMEYC-LGSASDLLE----VHKKPLQEVEIAAITHGALQGLAYL 141
Query: 303 HEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEY- 361
H ++HRDIK+ NILL + KL+DFG A + S+V GT ++APE
Sbjct: 142 HSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFV-----GTPYWMAPEVI 193
Query: 362 --ASTGMLNERSDVYSFGILIMEVISGRNPV 390
G + + DV+S GI +E+ + P+
Sbjct: 194 LAMDEGQYDGKVDVWSLGITCIELAERKPPL 224
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 3e-13
Identities = 64/212 (30%), Positives = 102/212 (48%), Gaps = 31/212 (14%)
Query: 194 IGEGGYGIVYHGV-LEDNTNVAVK---NLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLG 249
IG G YGIV E N VA+K N +NR A++ + E++ + + H+N++ +
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLR-EIKLLRHLDHENVIAIKD 71
Query: 250 YCAEGAHRM------LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 303
HR +VYE +D LH + L+ + + +GL Y+H
Sbjct: 72 -IMPPPHREAFNDVYIVYELMDTD-----LHQIIRSSQTLSDDHCQYFLYQLLRGLKYIH 125
Query: 304 EGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAS 363
V+HRD+K SN+LL+ + K+ DFGLA+ + ++T V+ T Y APE
Sbjct: 126 SA---NVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVV-TRWYRAPEL-- 179
Query: 364 TGMLNERS-----DVYSFGILIMEVISGRNPV 390
+LN DV+S G + E++ GR P+
Sbjct: 180 --LLNCSEYTTAIDVWSVGCIFAELL-GRKPL 208
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 4e-13
Identities = 44/107 (41%), Positives = 57/107 (53%), Gaps = 13/107 (12%)
Query: 292 ILG-----TAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYV 346
ILG K L YL E + V+HRD+K SNILLD N KL DFG++ L S
Sbjct: 115 ILGKMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRL--VDSKA 170
Query: 347 TTRVMGTFGYVAPEYASTGMLNE----RSDVYSFGILIMEVISGRNP 389
TR G Y+APE N R+DV+S GI ++E+ +G+ P
Sbjct: 171 KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFP 217
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 4e-13
Identities = 55/214 (25%), Positives = 104/214 (48%), Gaps = 24/214 (11%)
Query: 194 IGEGGYGIVYHGVLEDNTN---VAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKNLVRL 247
+GEG +G V G L + + VAVK + + R + E +F E + H N++RL
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEME-DFLSEAVCMKEFDHPNVMRL 65
Query: 248 LGYCAEGAHR------MLVYEYIDNGNLEQWLH----GDVGPHSPLTWEIRMNIILGTAK 297
+G C + +++ ++ +G+L +L GD + P ++ + + A
Sbjct: 66 IGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPT--QMLVKFMTDIAS 123
Query: 298 GLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGT-FGY 356
G+ YL +HRD+ + N +L++ N ++DFGL+K + Y R+ +
Sbjct: 124 GMEYLSS---KSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKW 180
Query: 357 VAPEYASTGMLNERSDVYSFGILIMEVIS-GRNP 389
+A E + + +SDV+SFG+ + E+ + G+ P
Sbjct: 181 IAIESLADRVYTTKSDVWSFGVTMWEIATRGQTP 214
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 4e-13
Identities = 56/207 (27%), Positives = 101/207 (48%), Gaps = 17/207 (8%)
Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKV-----EVEAIGRVRHKNLVR 246
++G+G +G VY ++ +A K + + E +V E++ + ++H+ +V+
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68
Query: 247 LLGYCAEGAHRMLV--YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 304
G + A + L EY+ G+++ L + LT + +G++YLH
Sbjct: 69 YYGCLRDRAEKTLTIFMEYMPGGSVKDQLKA----YGALTESVTRKYTRQILEGMSYLHS 124
Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVT--TRVMGTFGYVAPEYA 362
+ +VHRDIK +NIL D N KL DFG +K L T V GT +++PE
Sbjct: 125 NM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVI 181
Query: 363 STGMLNERSDVYSFGILIMEVISGRNP 389
S ++DV+S G ++E+++ + P
Sbjct: 182 SGEGYGRKADVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 4e-13
Identities = 64/207 (30%), Positives = 100/207 (48%), Gaps = 25/207 (12%)
Query: 194 IGEGGYGIVYHGVLEDNTN--VAVKNLLNNRGQ---AEKEFKVEVEAIGRVRHKNLVRLL 248
+G+GG+G V V NT A K L R + EK +E E + +V +V L
Sbjct: 1 LGKGGFGEVC-AVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLA 59
Query: 249 GYCAEGAHRMLVYEYIDNGNLEQWLH--GDVGPHSPLTWEIRMN-IILGTAK---GLTYL 302
H LV ++ G+L+ ++ G+ G + M +I +A+ G+ +L
Sbjct: 60 YAFESKTHLCLVMSLMNGGDLKYHIYNVGERG--------LEMERVIHYSAQITCGILHL 111
Query: 303 HEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYA 362
H +V+RD+K N+LLD Q N +LSD GLA L ++ T+ GT GY+APE
Sbjct: 112 HS---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT--ITQRAGTNGYMAPEIL 166
Query: 363 STGMLNERSDVYSFGILIMEVISGRNP 389
+ D ++ G I E+++GR P
Sbjct: 167 KEEPYSYPVDWFAMGCSIYEMVAGRTP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 69.0 bits (168), Expect = 5e-13
Identities = 54/199 (27%), Positives = 93/199 (46%), Gaps = 13/199 (6%)
Query: 194 IGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEF---KVEVEAIGRVRHKNLVRLLGY 250
IG+G +G V+ G+ ++ T V + + +AE E + E+ + + + + G
Sbjct: 12 IGKGSFGEVFKGI-DNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 70
Query: 251 CAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKV 310
+ ++ EY+ G+ L PL I+ KGL YLH K
Sbjct: 71 YLKDTKLWIIMEYLGGGSALDLLEP-----GPLDETQIATILREILKGLDYLHS---EKK 122
Query: 311 VHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNER 370
+HRDIK++N+LL + KL+DFG+A L + +GT ++APE + +
Sbjct: 123 IHRDIKAANVLLSEHGEVKLADFGVAGQL-TDTQIKRNTFVGTPFWMAPEVIKQSAYDSK 181
Query: 371 SDVYSFGILIMEVISGRNP 389
+D++S GI +E+ G P
Sbjct: 182 ADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 6e-13
Identities = 67/275 (24%), Positives = 123/275 (44%), Gaps = 21/275 (7%)
Query: 188 FADENVIGEGGYGIVYHGV-LEDNTNVAVKNLL---NNRGQAEKEFKVEVEAIGRVRHKN 243
F E IG G + VY L D VA+K + +A ++ E++ + ++ H N
Sbjct: 4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPN 63
Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 303
+++ L E +V E D G+L Q + + + + ++H
Sbjct: 64 VIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH 123
Query: 304 EGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAS 363
+V+HRDIK +N+ + KL D GL + ++ + + V GT Y++PE
Sbjct: 124 S---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERIH 179
Query: 364 TGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQ 423
N +SD++S G L+ E+ + ++P Y ++NL + + E P L
Sbjct: 180 ENGYNFKSDIWSLGCLLYEMAALQSPF-YG---DKMNLFSLCQKI------EQCDYPPLP 229
Query: 424 EKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458
+ S L+ LV++ C+ P+ +RP +G+V +
Sbjct: 230 TEHYSEKLRE--LVSM-CIYPDPDQRPDIGYVHQI 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 6e-13
Identities = 67/277 (24%), Positives = 124/277 (44%), Gaps = 25/277 (9%)
Query: 188 FADENVIGEGGYGIVYHGV-LEDNTNVAVK-----NLLNNRGQAEKEFKVEVEAIGRVRH 241
F E IG G + VY L D VA+K +L++ +A + E++ + ++ H
Sbjct: 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMD--AKARADCIKEIDLLKQLNH 61
Query: 242 KNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTY 301
N+++ E +V E D G+L + + + + + L +
Sbjct: 62 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEH 121
Query: 302 LHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEY 361
+H +V+HRDIK +N+ + KL D GL + + ++ ++GT Y++PE
Sbjct: 122 MHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFF-SSKTTAAHSLVGTPYYMSPER 177
Query: 362 ASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPR 421
N +SD++S G L+ E+ + ++P Y ++NL K + E P
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEMAALQSPF-YG---DKMNLYSLCKKI------EQCDYPP 227
Query: 422 LQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458
L S L++ LV + C++P+ KRP + +V +
Sbjct: 228 LPSDHYSEELRQ--LVNM-CINPDPEKRPDITYVYDV 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 8e-13
Identities = 71/232 (30%), Positives = 110/232 (47%), Gaps = 45/232 (19%)
Query: 182 EVSTNGFADENVIGEGGYGIVYHGVLED-NTNVAVKNLLNNRGQAEKE-FKV----EVEA 235
+ + F IGEG YG VY +D VA+K + R EKE F + E++
Sbjct: 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKV---RLDNEKEGFPITAIREIKI 59
Query: 236 IGRVRHKNLVRL----------LGYCAEGAHRMLVYEYIDN---GNLEQWLHGDVGPHSP 282
+ ++ H+N+V L L + + LV+EY+D+ G LE L
Sbjct: 60 LRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGL-------VH 112
Query: 283 LTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE 342
+ + + + +GL Y H+ +HRDIK SNILL+ + KL+DFGLA+L +E
Sbjct: 113 FSEDHIKSFMKQLLEGLNYCHK---KNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSE 169
Query: 343 --RSYVTTRVMGTFGYVAPEYASTGMLNERS-----DVYSFGILIMEVISGR 387
R Y T +V+ T Y PE +L E DV+S G ++ E+ + +
Sbjct: 170 ESRPY-TNKVI-TLWYRPPEL----LLGEERYGPAIDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 68.0 bits (167), Expect = 1e-12
Identities = 58/203 (28%), Positives = 87/203 (42%), Gaps = 19/203 (9%)
Query: 194 IGEGGYGIVYHGVLEDNTNVAV------KNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRL 247
+G GG+G V V + N K + GQ ++ E E + H +V+L
Sbjct: 1 LGVGGFGRVEL-VKVKSKNRTFALKCVKKRHIVETGQ-QEHIFSEKEILEECNHPFIVKL 58
Query: 248 LGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLE 307
+ + ++ EY G L L D G + R I YLH
Sbjct: 59 YRTFKDKKYIYMLMEYCLGGELWTILR-DRGLFD--EYTARF-YIACVVLAFEYLHN--- 111
Query: 308 PKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG-AERSYVTTRVMGTFGYVAPEYASTGM 366
+++RD+K N+LLD KL DFG AK L ++++ GT YVAPE
Sbjct: 112 RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT---FCGTPEYVAPEIILNKG 168
Query: 367 LNERSDVYSFGILIMEVISGRNP 389
+ D +S GIL+ E+++GR P
Sbjct: 169 YDFSVDYWSLGILLYELLTGRPP 191
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 1e-12
Identities = 52/156 (33%), Positives = 72/156 (46%), Gaps = 9/156 (5%)
Query: 234 EAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIIL 293
E RH LV L H V EY G+L +H DV P ++L
Sbjct: 54 ETANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFS-EPRAVFYAACVVL 112
Query: 294 GTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGT 353
G L YLHE K+V+RD+K N+LLD + K++DFGL K G T+ GT
Sbjct: 113 G----LQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCK-EGMGFGDRTSTFCGT 164
Query: 354 FGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNP 389
++APE + D + G+LI E++ G +P
Sbjct: 165 PEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESP 200
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 1e-12
Identities = 72/270 (26%), Positives = 119/270 (44%), Gaps = 33/270 (12%)
Query: 193 VIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV-RHKNLVRLLG-Y 250
++G G YG VY G +A +++ G E+E K E+ + + H+N+ G +
Sbjct: 13 LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAF 72
Query: 251 CAEGAHRM-----LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG 305
+ M LV E+ G++ + G + L E I +GL++LH+
Sbjct: 73 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG--NTLKEEWIAYICREILRGLSHLHQH 130
Query: 306 LEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAST- 364
KV+HRDIK N+LL + KL DFG++ L T +GT ++APE +
Sbjct: 131 ---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT-FIGTPYWMAPEVIACD 186
Query: 365 ----GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDP 420
+ +SD++S GI +E+ G P+ P + L+ RN P
Sbjct: 187 ENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIP--------RNPA----P 234
Query: 421 RLQEKPCSRALKRALLVALRCVDPNAHKRP 450
RL+ K S+ + + C+ N +RP
Sbjct: 235 RLKSKKWSKKFQSFI---ESCLVKNHSQRP 261
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 1e-12
Identities = 50/160 (31%), Positives = 80/160 (50%), Gaps = 12/160 (7%)
Query: 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNIL 321
E++D G+L+Q L + +I + + KGLTYL E + K++HRD+K SNIL
Sbjct: 83 EHMDGGSLDQVLK----KAGRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNIL 136
Query: 322 LDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIM 381
++ + KL DFG++ G + +GT Y++PE + +SD++S G+ ++
Sbjct: 137 VNSRGEIKLCDFGVS---GQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLV 193
Query: 382 EVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPR 421
E+ GR P+ PP L V AE PR
Sbjct: 194 EMAIGRYPIP---PPDAKELELMFGCPVEGDPAESETSPR 230
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 2e-12
Identities = 65/213 (30%), Positives = 107/213 (50%), Gaps = 22/213 (10%)
Query: 194 IGEGGYGIVYHGVLEDNTNV--AVKNLLNNRGQAE-KEFKVEVEAIGRVRHKNLVRLLG- 249
+G+G YG VY VL T V A+K + +++ + +E++ + + +V G
Sbjct: 9 LGKGNYGSVYK-VLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGA 67
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK 309
+ EGA M + EY+D G+L++ L+ + ++ I KGL +L E E
Sbjct: 68 FFIEGAVYMCM-EYMDAGSLDK-LYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHN 123
Query: 310 VVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNE 369
++HRD+K +N+L++ KL DFG++ L S T + G Y+APE +G N+
Sbjct: 124 IIHRDVKPTNVLVNGNGQVKLCDFGVSGNL--VASLAKTNI-GCQSYMAPERIKSGGPNQ 180
Query: 370 R------SDVYSFGILIMEVISGRNPVDYSRPP 396
SDV+S G+ I+E+ GR Y PP
Sbjct: 181 NPTYTVQSDVWSLGLSILEMALGR----YPYPP 209
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 2e-12
Identities = 61/214 (28%), Positives = 92/214 (42%), Gaps = 38/214 (17%)
Query: 213 VAVKNLLNNRGQAEKE---FKVEVEAIGRVRHKNLVRLL--GYCAEGAHRMLVYEYIDNG 267
VA+K L + + E + F+ E R+ H N+V LL G G V+EY+
Sbjct: 6 VAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPG-LLFAVFEYVPGR 64
Query: 268 NLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILL---DK 324
L + L D G M +L L H +VHRD+K NI++
Sbjct: 65 TLREVLAAD-GALPAGETGRLMLQVL---DALACAHNQ---GIVHRDLKPQNIMVSQTGV 117
Query: 325 QWNPKLSDFGLAKLL-GAE-----RSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGI 378
+ + K+ DFG+ LL G TT V+GT Y APE + SD+Y++G+
Sbjct: 118 RPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGL 177
Query: 379 LIMEVISGR----------------NPVDYSRPP 396
+ +E ++G+ +PVD S PP
Sbjct: 178 IFLECLTGQRVVQGASVAEILYQQLSPVDVSLPP 211
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 2e-12
Identities = 52/224 (23%), Positives = 111/224 (49%), Gaps = 29/224 (12%)
Query: 181 LEVSTNGFADENVIGEGGYGIVYHGVLEDNTN-----VAVKNLLNNRGQAEKEFKV-EVE 234
+ +S + +++ EG +G +++G+L D V VK + ++ + + + E
Sbjct: 1 IAISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESC 60
Query: 235 AIGRVRHKNLVRLLGYCAE-GAHRMLVYEYIDNGNLEQWL----HGDVGPHSPLTWEIRM 289
+ + H+N++ +L C E G ++Y Y++ GNL+ +L G+ L+ + +
Sbjct: 61 LLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLV 120
Query: 290 NIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK--------LLGA 341
++ + A G++YLH+ V+H+DI + N ++D++ K++D L++ LG
Sbjct: 121 HMAIQIACGMSYLHK---RGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLG- 176
Query: 342 ERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS 385
+ + M A E + SDV+SFG+L+ E+++
Sbjct: 177 DNENRPVKWM------ALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 2e-12
Identities = 55/213 (25%), Positives = 98/213 (46%), Gaps = 40/213 (18%)
Query: 194 IGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIG-------------RVR 240
IGEG YG+VY G +N + A K+ ++E E G ++
Sbjct: 8 IGEGTYGVVYKG----------RNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQ 57
Query: 241 HKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLT 300
H N+V L + + L++E++ +L+++L + + E+ + + +G+
Sbjct: 58 HPNIVCLQDVLMQESRLYLIFEFLSM-DLKKYLD-SLPKGQYMDAELVKSYLYQILQGIL 115
Query: 301 YLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPE 360
+ H +V+HRD+K N+L+D + KL+DFGLA+ G T V+ T Y APE
Sbjct: 116 FCHS---RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVV-TLWYRAPE 171
Query: 361 YA------STGMLNERSDVYSFGILIMEVISGR 387
ST + D++S G + E+ + +
Sbjct: 172 VLLGSPRYSTPV-----DIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 67.3 bits (165), Expect = 2e-12
Identities = 64/228 (28%), Positives = 104/228 (45%), Gaps = 53/228 (23%)
Query: 194 IGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKE-FKV----EVEAIGRVRHKNLVRL 247
+GEG +G VY ++ VA+K +L EK+ F + E++ + +++H N+V L
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALKKILM---HNEKDGFPITALREIKILKKLKHPNVVPL 72
Query: 248 LG----YCAEGAHRM----LVYEYID---NGNLEQWLHGDVGPHSPLTWEIRMNIILGTA 296
+ + + +V Y+D +G LE P LT +L
Sbjct: 73 IDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLEN-------PSVKLTESQIKCYMLQLL 125
Query: 297 KGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL------------GAERS 344
+G+ YLHE ++HRDIK++NIL+D Q K++DFGLA+ G R
Sbjct: 126 EGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRK 182
Query: 345 YVTTRVMGTFGYVAPEYASTGMLNERS-----DVYSFGILIMEVISGR 387
Y T ++ T Y PE +L ER D++ G + E+ + R
Sbjct: 183 Y--TNLVVTRWYRPPEL----LLGERRYTTAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 3e-12
Identities = 64/213 (30%), Positives = 95/213 (44%), Gaps = 29/213 (13%)
Query: 194 IGEGGYGIVYHGVLEDNTN--VAVKNLLNNRGQAEKEFKVEVEAIGRV---------RHK 242
IGEG YG V+ N VA+K + R Q +E + + I V H
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRV---RVQTGEE-GMPLSTIREVAVLRHLETFEHP 64
Query: 243 NLVRLLGYCA-----EGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAK 297
N+VRL C LV+E++D +L +L D P + E +++ +
Sbjct: 65 NVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYL--DKVPEPGVPTETIKDMMFQLLR 121
Query: 298 GLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYV 357
GL +LH +VVHRD+K NIL+ KL+DFGLA++ + T V+ T Y
Sbjct: 122 GLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ--MALTSVVVTLWYR 176
Query: 358 APEYASTGMLNERSDVYSFGILIMEVISGRNPV 390
APE D++S G + E+ R P+
Sbjct: 177 APEVLLQSSYATPVDLWSVGCIFAEMFR-RKPL 208
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 3e-12
Identities = 66/235 (28%), Positives = 109/235 (46%), Gaps = 47/235 (20%)
Query: 182 EVSTNGFADENVIGEGGYGIVYHGVLEDNTN-VAVKNLLNNRGQAEKE-FKV----EVEA 235
EVS + IG+G +G V+ + VA+K +L EKE F + E++
Sbjct: 10 EVSK--YEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMEN---EKEGFPITALREIKI 64
Query: 236 IGRVRHKNLVRLLGYC---AEGAHR-----MLVYEYIDN---GNLEQWLHGDVGPHSPLT 284
+ ++H+N+V L+ C A +R LV+E+ ++ G L + T
Sbjct: 65 LQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSN-------KNVKFT 117
Query: 285 WEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL----G 340
++ GL Y+H K++HRD+K++NIL+ K KL+DFGLA+
Sbjct: 118 LSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARAFSLSKN 174
Query: 341 AERSYVTTRVMGTFGYVAPEYASTGMLNERS-----DVYSFGILIMEVISGRNPV 390
++ + T RV+ T Y PE +L ER D++ G IM + R+P+
Sbjct: 175 SKPNRYTNRVV-TLWYRPPEL----LLGERDYGPPIDMWGAGC-IMAEMWTRSPI 223
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 3e-12
Identities = 59/208 (28%), Positives = 96/208 (46%), Gaps = 15/208 (7%)
Query: 194 IGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVR-HKNLVRLLGY-- 250
IG+G YG V+ + + N + A +L+ ++E + E + + H N+V+ G
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYY 85
Query: 251 ---CAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLE 307
G LV E + G++ + G + + I I+ GL +LH
Sbjct: 86 KKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN-- 143
Query: 308 PKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAST--- 364
K +HRD+K +NILL + KL DFG++ L + R T V GT ++APE +
Sbjct: 144 -KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GTPFWMAPEVIACEQQ 201
Query: 365 --GMLNERSDVYSFGILIMEVISGRNPV 390
+ R DV+S GI +E+ G P+
Sbjct: 202 LDSTYDARCDVWSLGITAIELGDGDPPL 229
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 3e-12
Identities = 61/208 (29%), Positives = 93/208 (44%), Gaps = 20/208 (9%)
Query: 194 IGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKV--EVEAIGRVR---HKNLVRL 247
IG G YG VY VA+K++ + EV + R+ H N+VRL
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 248 LGYCA-----EGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYL 302
+ CA LV+E++D +L +L P P E +++ +GL +L
Sbjct: 68 MDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPA--ETIKDLMRQFLRGLDFL 124
Query: 303 HEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYA 362
H +VHRD+K NIL+ KL+DFGLA++ + + T V+ T Y APE
Sbjct: 125 HAN---CIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMAL--TPVVVTLWYRAPEVL 179
Query: 363 STGMLNERSDVYSFGILIMEVISGRNPV 390
D++S G + E+ R P+
Sbjct: 180 LQSTYATPVDMWSVGCIFAEMFR-RKPL 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 4e-12
Identities = 58/210 (27%), Positives = 103/210 (49%), Gaps = 22/210 (10%)
Query: 185 TNGFADENVIGEGGYGIVYHGV-LEDNTNVAVKNLLN---NRGQAEKEFKVEVEAIGRVR 240
TN + D +G G +G+V NVA+K ++ A++ ++ E++ + +R
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYR-ELKLLKHLR 67
Query: 241 HKNLVRLLG-YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGL 299
H+N++ L + + V E + +L + L P + + IL +GL
Sbjct: 68 HENIISLSDIFISPLEDIYFVTELLGT-DLHRLL--TSRPLEKQFIQYFLYQIL---RGL 121
Query: 300 TYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS-YVTTRVMGTFGYVA 358
Y+H VVHRD+K SNIL+++ + K+ DFGLA++ + + YV+TR Y A
Sbjct: 122 KYVHSA---GVVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTRY-----YRA 173
Query: 359 PEYASTGM-LNERSDVYSFGILIMEVISGR 387
PE T + D++S G + E++ G+
Sbjct: 174 PEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 4e-12
Identities = 33/96 (34%), Positives = 57/96 (59%), Gaps = 8/96 (8%)
Query: 298 GLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK--LLGAERSYVTTRVMGTFG 355
GL +LHE +++RD+K N+LLD + + K++DFG+ K +LG T+ GT
Sbjct: 108 GLQFLHE---RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT---TSTFCGTPD 161
Query: 356 YVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVD 391
Y+APE S D ++ G+L+ E+++G++P +
Sbjct: 162 YIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFE 197
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 4e-12
Identities = 55/209 (26%), Positives = 96/209 (45%), Gaps = 20/209 (9%)
Query: 193 VIGEGGYGIVY----HGVLEDNTNVAVKNL----LNNRGQAEKEFKVEVEAIGRVRHKNL 244
V+G G YG V+ G + A+K L + + + + + E + + VR
Sbjct: 7 VLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPF 66
Query: 245 VRLLGYCAEGAHRM-LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILG-TAKGLTYL 302
+ L Y + ++ L+ +Y++ G L L+ E + + + L +L
Sbjct: 67 LVTLHYAFQTDTKLHLILDYVNGGELFTHLY-----QREHFTESEVRVYIAEIVLALDHL 121
Query: 303 HEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYA 362
H+ +++RDIK NILLD + + L+DFGL+K AE GT Y+APE
Sbjct: 122 HQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVI 178
Query: 363 STGML--NERSDVYSFGILIMEVISGRNP 389
G ++ D +S G+L E+++G +P
Sbjct: 179 RGGSGGHDKAVDWWSLGVLTFELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 5e-12
Identities = 63/219 (28%), Positives = 106/219 (48%), Gaps = 33/219 (15%)
Query: 189 ADENVIGEGGYGIVYHGVLEDNTN--VAVK---NLLNNRGQAEKEFKVEVEAIGRVRHKN 243
EN IG G YG+V + + + VA+K + + A++ + E++ + +H N
Sbjct: 9 PIEN-IGSGAYGVVCSAI-DTRSGKKVAIKKIPHAFDVPTLAKRTLR-ELKILRHFKHDN 65
Query: 244 LVRLLG-YCAEGAHRMLVYEYID--NGNLEQWLHGDVGPHSPLTWE-IR--MNIILGTAK 297
++ + GA VY +D +L +H D PLT E IR + +L +
Sbjct: 66 IIAIRDILRPPGADFKDVYVVMDLMESDLHHIIHSD----QPLTEEHIRYFLYQLL---R 118
Query: 298 GLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG---AERSYVTTRVMGTF 354
GL Y+H V+HRD+K SN+L+++ ++ DFG+A+ L E Y T + T
Sbjct: 119 GLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATR 175
Query: 355 GYVAPEYASTGMLNERS---DVYSFGILIMEVISGRNPV 390
Y APE + L E + D++S G + E++ GR +
Sbjct: 176 WYRAPELLLS--LPEYTTAIDMWSVGCIFAEML-GRRQL 211
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 6e-12
Identities = 64/250 (25%), Positives = 110/250 (44%), Gaps = 45/250 (18%)
Query: 193 VIGEGGYG---IVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLL- 248
V+G+G YG +V H + NL N + K + E + + +++H N+V
Sbjct: 7 VVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRE 66
Query: 249 GYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSP----LTWEIRMNIILGTAKGLTYLHE 304
+ E +V + + G+L L G P + W +++ A L YLHE
Sbjct: 67 SWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQI------AMALQYLHE 120
Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAST 364
++HRD+K+ N+ L + K+ D G+A++L + +T ++GT Y++PE S
Sbjct: 121 ---KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAST-LIGTPYYMSPELFSN 176
Query: 365 GMLNERSDVYSFGI-------------------LIMEVISGR---NPVDYSRPPGEVNLV 402
N +SDV++ G L+ +I G+ P DYS L
Sbjct: 177 KPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSP-----ELG 231
Query: 403 EWLKTMVTNR 412
E + TM++ R
Sbjct: 232 ELIATMLSKR 241
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 6e-12
Identities = 63/211 (29%), Positives = 97/211 (45%), Gaps = 21/211 (9%)
Query: 188 FADENVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFK---VEVEAIGRVRHKN 243
F + IG G +G VY N VAVK + + Q ++++ EV+ + +++H N
Sbjct: 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82
Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIIL-GTAKGLTYL 302
+ G + LV EY G+ L H E+ + I G +GL YL
Sbjct: 83 TIEYKGCYLKEHTAWLVMEYC-LGSASDLLE----VHKKPLQEVEIAAITHGALQGLAYL 137
Query: 303 HEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEY- 361
H ++HRDIK+ NILL + KL+DFG A S+V GT ++APE
Sbjct: 138 HSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV-----GTPYWMAPEVI 189
Query: 362 --ASTGMLNERSDVYSFGILIMEVISGRNPV 390
G + + DV+S GI +E+ + P+
Sbjct: 190 LAMDEGQYDGKVDVWSLGITCIELAERKPPL 220
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 6e-12
Identities = 57/211 (27%), Positives = 100/211 (47%), Gaps = 25/211 (11%)
Query: 193 VIGEGGYGIVYHGVLEDN-TNVAVKNLLNNRGQAEKEFKV-----EVEAIGRVRHKNLVR 246
++G+G +G VY D +AVK + + E +V E++ + + H+ +V+
Sbjct: 9 LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68
Query: 247 LLGYCAEGAHRML--VYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 304
G + R L E++ G+++ L + LT + +G++YLH
Sbjct: 69 YYGCLRDPMERTLSIFMEHMPGGSIKDQLKS----YGALTENVTRKYTRQILEGVSYLHS 124
Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL------GAERSYVTTRVMGTFGYVA 358
+ +VHRDIK +NIL D N KL DFG +K L G VT GT +++
Sbjct: 125 NM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVT----GTPYWMS 177
Query: 359 PEYASTGMLNERSDVYSFGILIMEVISGRNP 389
PE S ++D++S G ++E+++ + P
Sbjct: 178 PEVISGEGYGRKADIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 6e-12
Identities = 54/200 (27%), Positives = 103/200 (51%), Gaps = 21/200 (10%)
Query: 194 IGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKE-FKVEVEAIGRVRHKNLVRLLGYCA 252
+G+G +G VY ++ +A +++ + + E E + VE++ + H N+V+LL
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 253 EGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILG-TAKGLTYLHEGLEPKVV 311
+ ++ E+ G ++ + + PLT E ++ ++ T + L YLHE K++
Sbjct: 73 YENNLWILIEFCAGGAVDAVM---LELERPLT-EPQIRVVCKQTLEALNYLHEN---KII 125
Query: 312 HRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTR---VMGTFGYVAPEYASTGMLN 368
HRD+K+ NIL + KL+DFG++ A+ + R +GT ++APE
Sbjct: 126 HRDLKAGNILFTLDGDIKLADFGVS----AKNTRTIQRRDSFIGTPYWMAPEVVMCETSK 181
Query: 369 ER-----SDVYSFGILIMEV 383
+R +DV+S GI ++E+
Sbjct: 182 DRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 65.6 bits (161), Expect = 7e-12
Identities = 50/158 (31%), Positives = 75/158 (47%), Gaps = 11/158 (6%)
Query: 232 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNI 291
E + +RH LV L G + ++ LV EY+ G L L P+ +
Sbjct: 51 EKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQV 110
Query: 292 ILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVM 351
+L L YLH +V+RD+K N+LLD K++DFG AK + R+Y
Sbjct: 111 VLA----LEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRV-KGRTYTLC--- 159
Query: 352 GTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNP 389
GT Y+APE + + D ++ GILI E+++G P
Sbjct: 160 GTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 1e-11
Identities = 55/209 (26%), Positives = 99/209 (47%), Gaps = 21/209 (10%)
Query: 193 VIGEGGYGIVYHGVLEDN-TNVAVKNLLNNRGQAEKEFKV-----EVEAIGRVRHKNLVR 246
++G G +G VY D +AVK + + E +V E++ + +RH +V+
Sbjct: 9 LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68
Query: 247 LLGYCAEGAHRML--VYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 304
G + + L EY+ G+++ L + LT + +G++YLH
Sbjct: 69 YYGCLRDPEEKKLSIFVEYMPGGSIKDQLKA----YGALTENVTRRYTRQILQGVSYLHS 124
Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVT----TRVMGTFGYVAPE 360
+ +VHRDIK +NIL D N KL DFG +K + + ++ V GT +++PE
Sbjct: 125 NM---IVHRDIKGANILRDSAGNVKLGDFGASKRI--QTICMSGTGIKSVTGTPYWMSPE 179
Query: 361 YASTGMLNERSDVYSFGILIMEVISGRNP 389
S ++DV+S ++E+++ + P
Sbjct: 180 VISGEGYGRKADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 1e-11
Identities = 55/202 (27%), Positives = 104/202 (51%), Gaps = 25/202 (12%)
Query: 194 IGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKE-FKVEVEAIGRVRHKNLVRLLG-YC 251
+G+G +G VY ++ +A ++ + + E E + VE+E + H +V+LLG +
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 252 AEGAHRMLVYEYIDNGNLEQ-WLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKV 310
+G +++ E+ G ++ L D G P +I++ I + L YLH K+
Sbjct: 80 WDGKLWIMI-EFCPGGAVDAIMLELDRGLTEP---QIQV-ICRQMLEALQYLHS---MKI 131
Query: 311 VHRDIKSSNILLDKQWNPKLSDFGLA----KLLGAERSYVTTRVMGTFGYVAPEYASTGM 366
+HRD+K+ N+LL + KL+DFG++ K L S++ GT ++APE
Sbjct: 132 IHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI-----GTPYWMAPEVVMCET 186
Query: 367 LNE-----RSDVYSFGILIMEV 383
+ + ++D++S GI ++E+
Sbjct: 187 MKDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 1e-11
Identities = 47/163 (28%), Positives = 84/163 (51%), Gaps = 16/163 (9%)
Query: 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNIL 321
E++D G+L+Q L + EI + + +GL YL E + +++HRD+K SNIL
Sbjct: 83 EHMDGGSLDQVLK----EAKRIPEEILGKVSIAVLRGLAYLRE--KHQIMHRDVKPSNIL 136
Query: 322 LDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIM 381
++ + KL DFG++ G + +GT Y++PE + +SD++S G+ ++
Sbjct: 137 VNSRGEIKLCDFGVS---GQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLV 193
Query: 382 EVISGRNPVDYSRPPGEVNLVEWL--KTMVTNRNAEG-VLDPR 421
E+ GR P+ PP + +E + + +V E + PR
Sbjct: 194 ELAIGRYPI----PPPDAKELEAIFGRPVVDGEEGEPHSISPR 232
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 1e-11
Identities = 51/161 (31%), Positives = 79/161 (49%), Gaps = 17/161 (10%)
Query: 299 LTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVM-GTFGYV 357
L +H ++HRDIKS+NILL KL DFG +K+ A S R GT YV
Sbjct: 153 LLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYV 212
Query: 358 APEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGV 417
APE ++++D++S G+L+ E+++ + P D GE N+ E V ++ G
Sbjct: 213 APEIWRRKPYSKKADMFSLGVLLYELLTLKRPFD-----GE-NMEE-----VMHKTLAGR 261
Query: 418 LDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458
DP P + ++ AL DP +RP +++M
Sbjct: 262 YDPL---PPSISPEMQEIVTALLSSDP--KRRPSSSKLLNM 297
|
Length = 496 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 1e-11
Identities = 48/142 (33%), Positives = 75/142 (52%), Gaps = 16/142 (11%)
Query: 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNIL 321
E++D G+L+Q L G + I I + +GLTYL E + K++HRD+K SNIL
Sbjct: 79 EHMDGGSLDQVLK-KAGR---IPENILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNIL 132
Query: 322 LDKQWNPKLSDFGLAKLL--GAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGIL 379
++ + KL DFG++ L S+V TR Y++PE +SD++S G+
Sbjct: 133 VNSRGEIKLCDFGVSGQLIDSMANSFVGTR-----SYMSPERLQGTHYTVQSDIWSLGLS 187
Query: 380 IMEVISGRNPVDYSRPPGEVNL 401
++E+ GR P+ PP L
Sbjct: 188 LVEMAIGRYPIP---PPDAKEL 206
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 62/205 (30%), Positives = 100/205 (48%), Gaps = 27/205 (13%)
Query: 194 IGEGGYGIV---YHGVLEDNTNVAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKNLVRL 247
IG G GIV + VL NVAVK L N+ A++ ++ E+ + V HKN++ L
Sbjct: 29 IGSGAQGIVCAAFDTVL--GINVAVKKLSRPFQNQTHAKRAYR-ELVLLKCVNHKNIISL 85
Query: 248 LGY------CAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTY 301
L E LV E +D NL Q +H ++ H +++ ++ G+ +
Sbjct: 86 LNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIHMELD-HERMSY-----LLYQMLCGIKH 138
Query: 302 LHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEY 361
LH ++HRD+K SNI++ K+ DFGLA+ A +++ T + T Y APE
Sbjct: 139 LHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLART--ACTNFMMTPYVVTRYYRAPEV 193
Query: 362 ASTGMLNERSDVYSFGILIMEVISG 386
E D++S G ++ E++ G
Sbjct: 194 ILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 2e-11
Identities = 69/212 (32%), Positives = 97/212 (45%), Gaps = 37/212 (17%)
Query: 193 VIGEGGYGIV---YHGVLEDNTNVAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKNLVR 246
IG G GIV Y V NVA+K L N A++ ++ E+ + V HKN++
Sbjct: 23 PIGSGAQGIVCAAYDTVT--GQNVAIKKLSRPFQNVTHAKRAYR-ELVLMKLVNHKNIIG 79
Query: 247 LLGY------CAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIIL-GTAKGL 299
LL E LV E +D NL Q + D+ H RM+ +L G+
Sbjct: 80 LLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIQMDLD-HE------RMSYLLYQMLCGI 131
Query: 300 TYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS---YVTTRVMGTFGY 356
+LH ++HRD+K SNI++ K+ DFGLA+ G YV TR Y
Sbjct: 132 KHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY-----Y 183
Query: 357 VAPEYASTGM-LNERSDVYSFGILIMEVISGR 387
APE GM E D++S G ++ E+I G
Sbjct: 184 RAPEVI-LGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 2e-11
Identities = 61/205 (29%), Positives = 94/205 (45%), Gaps = 20/205 (9%)
Query: 194 IGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCA 252
+G G YG VY L AVK + G + E+ + +H N+V G
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76
Query: 253 EGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVH 312
+ EY G+L+ H GP S L + T +GL YLH + +H
Sbjct: 77 SREKLWICMEYCGGGSLQDIYHV-TGPLSELQIAY---VCRETLQGLAYLHSKGK---MH 129
Query: 313 RDIKSSNILLDKQWNPKLSDFGLAKLLGA----ERSYVTTRVMGTFGYVAPEYAS---TG 365
RDIK +NILL + KL+DFG+A + A +S++ GT ++APE A+ G
Sbjct: 130 RDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFI-----GTPYWMAPEVAAVEKNG 184
Query: 366 MLNERSDVYSFGILIMEVISGRNPV 390
N+ D+++ GI +E+ + P+
Sbjct: 185 GYNQLCDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 3e-11
Identities = 58/170 (34%), Positives = 87/170 (51%), Gaps = 15/170 (8%)
Query: 222 RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRML--VYEYIDNGNLEQWLHGDVGP 279
R + E+ E + V H ++RL + E R L + EY+ G L +L + G
Sbjct: 41 RLKQEQHVHNEKRVLKEVSHPFIIRL--FWTEHDQRFLYMLMEYVPGGELFSYLR-NSGR 97
Query: 280 HSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL 339
S T + I+ L YLH E +V+RD+K NILLDK+ + KL+DFG AK L
Sbjct: 98 FSNSTGLFYASEIVC---ALEYLH-SKE--IVYRDLKPENILLDKEGHIKLTDFGFAKKL 151
Query: 340 GAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNP 389
+R++ + GT Y+APE + N+ D ++ GILI E++ G P
Sbjct: 152 -RDRTWT---LCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 3e-11
Identities = 58/214 (27%), Positives = 95/214 (44%), Gaps = 26/214 (12%)
Query: 193 VIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV-RHKNLVRLLGYC 251
V+G G YG VY G +A +++ E+E K+E+ + + H+N+ G
Sbjct: 23 VVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAF 82
Query: 252 AEGA------HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG 305
+ + LV E+ G++ + G W I +GL +LH
Sbjct: 83 IKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDW--IAYICREILRGLAHLHAH 140
Query: 306 LEPKVVHRDIKSSNILLDKQWNPKLSDFG----LAKLLGAERSYVTTRVMGTFGYVAPEY 361
KV+HRDIK N+LL + KL DFG L + +G +++ GT ++APE
Sbjct: 141 ---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-----GTPYWMAPEV 192
Query: 362 AST-----GMLNERSDVYSFGILIMEVISGRNPV 390
+ + RSD++S GI +E+ G P+
Sbjct: 193 IACDENPDATYDYRSDIWSLGITAIEMAEGAPPL 226
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 4e-11
Identities = 36/94 (38%), Positives = 54/94 (57%), Gaps = 8/94 (8%)
Query: 298 GLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK--LLGAERSYVTTRVMGTFG 355
GL +LH +V+RD+K NILLD + K++DFG+ K +LG + T GT
Sbjct: 108 GLQFLHS---KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK---TCTFCGTPD 161
Query: 356 YVAPEYASTGMLNERSDVYSFGILIMEVISGRNP 389
Y+APE N D +SFG+L+ E++ G++P
Sbjct: 162 YIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 4e-11
Identities = 42/137 (30%), Positives = 66/137 (48%), Gaps = 12/137 (8%)
Query: 259 LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSS 318
LV EY++ G+ L +G P W + I G+ LH+ ++HRDIK
Sbjct: 74 LVMEYLNGGDCAS-LIKTLGG-LPEDW-AK-QYIAEVVLGVEDLHQR---GIIHRDIKPE 126
Query: 319 NILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGI 378
N+L+D+ + KL+DFGL++ + +GT Y+APE ++ SD +S G
Sbjct: 127 NLLIDQTGHLKLTDFGLSRN-----GLENKKFVGTPDYLAPETILGVGDDKMSDWWSLGC 181
Query: 379 LIMEVISGRNPVDYSRP 395
+I E + G P P
Sbjct: 182 VIFEFLFGYPPFHAETP 198
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 63.6 bits (154), Expect = 7e-11
Identities = 66/227 (29%), Positives = 110/227 (48%), Gaps = 32/227 (14%)
Query: 194 IGEGGYGIV---YHGVLEDNTNVAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKNLVRL 247
IG G GIV Y VL+ NVA+K L N+ A++ ++ E+ + V HKN++ L
Sbjct: 25 IGSGAQGIVCAAYDAVLD--RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISL 81
Query: 248 LGY------CAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTY 301
L E LV E +D NL Q + ++ H +++ ++ G+ +
Sbjct: 82 LNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIQMELD-HERMSY-----LLYQMLCGIKH 134
Query: 302 LHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEY 361
LH ++HRD+K SNI++ K+ DFGLA+ G S++ T + T Y APE
Sbjct: 135 LHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYVVTRYYRAPEV 189
Query: 362 ASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTM 408
E D++S G ++ E++ R+ + + PG + +W K +
Sbjct: 190 ILGMGYKENVDIWSVGCIMGEMV--RHKILF---PGRDYIDQWNKVI 231
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 7e-11
Identities = 55/178 (30%), Positives = 86/178 (48%), Gaps = 20/178 (11%)
Query: 298 GLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYV 357
GL LH+ ++V+RD+K NILLD + ++SD GLA + E + RV GT GY+
Sbjct: 114 GLEDLHQ---ERIVYRDLKPENILLDDHGHIRISDLGLAVHV-PEGQTIKGRV-GTVGYM 168
Query: 358 APEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGV 417
APE D ++ G L+ E+I+G++P + + VE L V +E
Sbjct: 169 APEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSE-- 226
Query: 418 LDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEEFP-FRDVSFGRV 474
+ P +R+L + LL C DP + G E +E P F+ ++F R+
Sbjct: 227 -----KFSPDARSLCKMLL----CKDPKERLGCQGGGA---REVKEHPLFKQINFKRL 272
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 1e-10
Identities = 65/228 (28%), Positives = 107/228 (46%), Gaps = 13/228 (5%)
Query: 194 IGEGGYGIVYHG--VLEDNTNVAVKNL-LNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGY 250
+GEG Y V+ G L +N VA+K + L + A EV + ++H N+V L
Sbjct: 14 LGEGTYATVFKGRSKLTENL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 251 CAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKV 310
LV+EY+D +L+Q++ S +I + IL +GL Y H KV
Sbjct: 73 VHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQIL---RGLAYCHR---RKV 125
Query: 311 VHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPE-YASTGMLNE 369
+HRD+K N+L++++ KL+DFGLA+ + V+ T Y P+ + +
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGSSEYST 184
Query: 370 RSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGV 417
+ D++ G + E+ SGR S E++L+ L T G+
Sbjct: 185 QIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGI 232
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 1e-10
Identities = 33/92 (35%), Positives = 53/92 (57%), Gaps = 4/92 (4%)
Query: 298 GLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYV 357
GL +LH+ +++RD+K N+LLDK + K++DFG+ K + GT Y+
Sbjct: 108 GLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCK-ENMNGEGKASTFCGTPDYI 163
Query: 358 APEYASTGMLNERSDVYSFGILIMEVISGRNP 389
APE NE D +SFG+L+ E++ G++P
Sbjct: 164 APEILKGQKYNESVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 1e-10
Identities = 30/89 (33%), Positives = 52/89 (58%), Gaps = 7/89 (7%)
Query: 301 YLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPE 360
YLH +++RD+K N+LLD + + K++DFG AK + +R++ + GT Y+APE
Sbjct: 133 YLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKV-PDRTFT---LCGTPEYLAPE 185
Query: 361 YASTGMLNERSDVYSFGILIMEVISGRNP 389
+ + D ++ G+L+ E I+G P
Sbjct: 186 VIQSKGHGKAVDWWTMGVLLYEFIAGYPP 214
|
Length = 329 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.3 bits (152), Expect = 2e-10
Identities = 59/225 (26%), Positives = 96/225 (42%), Gaps = 49/225 (21%)
Query: 188 FADENVIGEGGYGIVYHGV-LEDNTNVAVK-------NLLNNRGQAEKEFKVEVEAIGRV 239
+ + + IGEG YG+V VA+K R +E K+ + R
Sbjct: 7 YQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQR--TLREIKI----LRRF 60
Query: 240 RHKNLVRLLG-YCAEGAHRM----LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILG 294
+H+N++ +L +V E +E L+ + L+ + +
Sbjct: 61 KHENIIGILDIIRPPSFESFNDVYIVQEL-----METDLY-KLIKTQHLSNDHIQYFLYQ 114
Query: 295 TAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER-------SYVT 347
+GL Y+H V+HRD+K SN+LL+ + K+ DFGLA++ E YV
Sbjct: 115 ILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVA 171
Query: 348 TRVMGTFGYVAPEYASTGMLNERS-----DVYSFGILIMEVISGR 387
TR Y APE MLN + D++S G ++ E++S R
Sbjct: 172 TR-----WYRAPEI----MLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 2e-10
Identities = 51/203 (25%), Positives = 88/203 (43%), Gaps = 16/203 (7%)
Query: 194 IGEGGYGIVYHG---VLEDNTNVAVKNLLNNRGQAEK-EFKVEVEAIGRVRHKNLVRLLG 249
IG G +G V G V VK L + E+ F EV+ + H N+++ LG
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTW-EIRMNIILGTAKGLTYLHEGLEP 308
C E +LV E+ G+L+ +L + G + + ++ + A GL +LH+
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA--- 119
Query: 309 KVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGT-FGYVAPEYAS---- 363
+H D+ N L + K+ D+GLA E Y+T ++APE
Sbjct: 120 DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQ 179
Query: 364 ---TGMLNERSDVYSFGILIMEV 383
++S+++S G+ + E+
Sbjct: 180 DLLPKDQTKKSNIWSLGVTMWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 2e-10
Identities = 62/206 (30%), Positives = 100/206 (48%), Gaps = 27/206 (13%)
Query: 194 IGEGGYGIV---YHGVLEDNTNVAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKNLVRL 247
IG G GIV Y +LE NVA+K L N+ A++ ++ E+ + V HKN++ L
Sbjct: 32 IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGL 88
Query: 248 LGY------CAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTY 301
L E +V E +D NL Q + ++ H +++ ++ G+ +
Sbjct: 89 LNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQMELD-HERMSY-----LLYQMLCGIKH 141
Query: 302 LHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEY 361
LH ++HRD+K SNI++ K+ DFGLA+ G S++ T + T Y APE
Sbjct: 142 LHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYVVTRYYRAPEV 196
Query: 362 ASTGMLNERSDVYSFGILIMEVISGR 387
E D++S G ++ E+I G
Sbjct: 197 ILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 2e-10
Identities = 58/206 (28%), Positives = 93/206 (45%), Gaps = 22/206 (10%)
Query: 194 IGEGGYGIVYHGVLEDN---TNVAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNLVRLLG 249
IG G +G V G + V VK L + Q + +F E + ++H NL++ LG
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLH----GDVGPHSPLTWEIRMNIILGTAKGLTYLHEG 305
C E +LV E+ G+L+ +L ++ P T + RM + A GL +LH+
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQ-RMACEI--ALGLLHLHKN 119
Query: 306 LEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTT-RVMGTFGYVAPEYAST 364
+H D+ N LL K+ D+GL+ E YVT ++ ++APE
Sbjct: 120 ---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDE 176
Query: 365 GMLN-------ERSDVYSFGILIMEV 383
N + S+V+S G+ I E+
Sbjct: 177 VHGNLLVVDQTKESNVWSLGVTIWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 5e-10
Identities = 57/203 (28%), Positives = 97/203 (47%), Gaps = 14/203 (6%)
Query: 194 IGEGGYGIVYHGVLEDNTNV-AVKNLLNNRGQAEKEFK---VEVEAIGRVRHKNLVRLLG 249
+G+GG+G V + + A K L R + K ++ VE + +V + +V L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAK---GLTYLHEGL 306
LV ++ G+L ++ +V +P E R TA+ GL +LH+
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIY-NVDEENPGFPEPRA--CFYTAQIISGLEHLHQR- 116
Query: 307 EPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGM 366
++++RD+K N+LLD N ++SD GLA L +S T GT G++APE
Sbjct: 117 --RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-TKGYAGTPGFMAPELLQGEE 173
Query: 367 LNERSDVYSFGILIMEVISGRNP 389
+ D ++ G+ + E+I+ R P
Sbjct: 174 YDFSVDYFALGVTLYEMIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 5e-10
Identities = 59/203 (29%), Positives = 100/203 (49%), Gaps = 23/203 (11%)
Query: 194 IGEGGYGIVYHGVLEDNTN-VAVKNL-LNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYC 251
+GEG Y V+ G + N VA+K + L + A EV + ++H N+V L
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72
Query: 252 AEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVV 311
LV+EY+D+ +L+Q+L S +I M +L +GL+Y H+ K++
Sbjct: 73 HTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLL---RGLSYCHK---RKIL 125
Query: 312 HRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAP-------EYAST 364
HRD+K N+L++++ KL+DFGLA+ + V+ T Y P EY++
Sbjct: 126 HRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGSTEYSTP 184
Query: 365 GMLNERSDVYSFGILIMEVISGR 387
D++ G ++ E+ +GR
Sbjct: 185 ------IDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 5e-10
Identities = 58/204 (28%), Positives = 94/204 (46%), Gaps = 18/204 (8%)
Query: 194 IGEGGYGIVYHGVLEDNTNV----AVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLG 249
IG G YG VY N N A+K + G+ + E+ + +H N+V G
Sbjct: 17 IGSGTYGDVYKA---RNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFG 73
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK 309
+ E+ G+L+ H GP S + T +GL YLH +
Sbjct: 74 SYLRRDKLWICMEFCGGGSLQDIYHV-TGPLSESQIAY---VSRETLQGLYYLHSKGK-- 127
Query: 310 VVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAST---GM 366
+HRDIK +NILL + KL+DFG++ + A + + +GT ++APE A+ G
Sbjct: 128 -MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKS-FIGTPYWMAPEVAAVERKGG 185
Query: 367 LNERSDVYSFGILIMEVISGRNPV 390
N+ D+++ GI +E+ + P+
Sbjct: 186 YNQLCDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 5e-10
Identities = 74/281 (26%), Positives = 118/281 (41%), Gaps = 36/281 (12%)
Query: 193 VIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEA-----IGRVRHKNLVR 246
VIG+G +G V + D + AVK +L + +K+ + + A + ++H LV
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVK-VLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60
Query: 247 LLGYCAEGAHRM-LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG 305
L Y + A ++ V +Y++ G L L + P + A + YLH
Sbjct: 61 L-HYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEV----ASAIGYLHS- 114
Query: 306 LEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTG 365
+++RD+K NILLD Q + L+DFGL K G E T+ GT Y+APE
Sbjct: 115 --LNIIYRDLKPENILLDSQGHVVLTDFGLCK-EGVEPEETTSTFCGTPEYLAPEVLRKE 171
Query: 366 MLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEK 425
+ D + G ++ E++ G P YSR ++ + +L LQ
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYGLPPF-YSRDVSQM--------------YDNILHKPLQLP 216
Query: 426 PCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEEFPF 466
LLV L D +R ++G LE + F
Sbjct: 217 GGKTVAACDLLVGLLHKD----QRRRLGAKADFLEIKNHVF 253
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 6e-10
Identities = 62/199 (31%), Positives = 100/199 (50%), Gaps = 15/199 (7%)
Query: 194 IGEGGYGIVYHG--VLEDNTNVAVKNL-LNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGY 250
+GEG Y VY G L DN VA+K + L + A EV + ++H N+V L
Sbjct: 14 LGEGTYATVYKGRSKLTDNL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 251 CAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKV 310
LV+EY+D +L+Q+L D G +S +++ + +GL Y H KV
Sbjct: 73 IHTEKSLTLVFEYLDK-DLKQYLD-DCG-NSINMHNVKL-FLFQLLRGLNYCHR---RKV 125
Query: 311 VHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPE--YASTGMLN 368
+HRD+K N+L++++ KL+DFGLA+ + V+ T Y P+ ST +
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV-TLWYRPPDILLGSTDY-S 183
Query: 369 ERSDVYSFGILIMEVISGR 387
+ D++ G + E+ +GR
Sbjct: 184 TQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 6e-10
Identities = 33/94 (35%), Positives = 53/94 (56%), Gaps = 4/94 (4%)
Query: 298 GLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYV 357
L YLHE +++RD+K N+LLD + + KL+D+G+ K G T+ GT Y+
Sbjct: 108 ALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGDTTSTFCGTPNYI 163
Query: 358 APEYASTGMLNERSDVYSFGILIMEVISGRNPVD 391
APE D ++ G+L+ E+++GR+P D
Sbjct: 164 APEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 7e-10
Identities = 33/85 (38%), Positives = 48/85 (56%), Gaps = 6/85 (7%)
Query: 311 VHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAST------ 364
VHRDIK N+L+D+ + KL+DFG A L A + + +GT Y+APE +T
Sbjct: 124 VHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGK 183
Query: 365 GMLNERSDVYSFGILIMEVISGRNP 389
G D +S G++ E+I GR+P
Sbjct: 184 GTYGVECDWWSLGVIAYEMIYGRSP 208
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 7e-10
Identities = 70/216 (32%), Positives = 98/216 (45%), Gaps = 22/216 (10%)
Query: 193 VIGEGGYGIVY---HGVLEDNTNVAVKNLLNNRGQAEKEFK-VEVEA---IGRVRHKNLV 245
VIG+G +G V H D AVK L +KE K + E + V+H LV
Sbjct: 2 VIGKGSFGKVLLAKHK--ADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLV 59
Query: 246 RLLGYCAEGAHRM-LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILG-TAKGLTYLH 303
L Y + A ++ V +Y++ G L + H P E R A L YLH
Sbjct: 60 GL-HYSFQTADKLYFVLDYVNGGEL--FFHLQRERSFP---EPRARFYAAEIASALGYLH 113
Query: 304 EGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAS 363
+++RD+K NILLD Q + L+DFGL K G E S T+ GT Y+APE
Sbjct: 114 S---LNIIYRDLKPENILLDSQGHVVLTDFGLCK-EGIEHSKTTSTFCGTPEYLAPEVLR 169
Query: 364 TGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEV 399
+ D + G ++ E++ G P YSR E+
Sbjct: 170 KQPYDRTVDWWCLGAVLYEMLYGLPPF-YSRDTAEM 204
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 59.9 bits (146), Expect = 7e-10
Identities = 61/222 (27%), Positives = 112/222 (50%), Gaps = 40/222 (18%)
Query: 192 NVIGEGGYGIVYHGVLEDNTN--VAVKNLLNNRGQAEKE-FKV----EVEAIGRVRHKNL 244
N I EG YG+VY + T VA+K L + EKE F + E+ + +++H N+
Sbjct: 11 NRIEEGTYGVVYRA-RDKKTGEIVALKKLKMEK---EKEGFPITSLREINILLKLQHPNI 66
Query: 245 VRL----LGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLT 300
V + +G + +V EY+++ +L+ + + L E++ ++L G+
Sbjct: 67 VTVKEVVVG--SNLDKIYMVMEYVEH-DLKSLM--ETMKQPFLQSEVK-CLMLQLLSGVA 120
Query: 301 YLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPE 360
+LH+ ++HRD+K+SN+LL+ + K+ DFGLA+ G+ T V+ T Y APE
Sbjct: 121 HLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVV-TLWYRAPE 176
Query: 361 YASTGMLNERS-----DVYSFGILIMEVIS------GRNPVD 391
+L + D++S G + E+++ G++ +D
Sbjct: 177 L----LLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEID 214
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 7e-10
Identities = 57/207 (27%), Positives = 95/207 (45%), Gaps = 14/207 (6%)
Query: 186 NGFADENVIGEGGYGIVY---HGVLEDNTNVAVKNLLNNRGQAE-KEFKV-EVEAIGRVR 240
N F V+GEG YG+V H E VA+K ++ E KE + E++ + ++
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHK--ETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLK 58
Query: 241 HKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLT 300
+N+V L LV+EY++ LE + P+ ++R + I K +
Sbjct: 59 QENIVELKEAFRRRGKLYLVFEYVEKNMLELL---EEMPNGVPPEKVR-SYIYQLIKAIH 114
Query: 301 YLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPE 360
+ H+ +VHRDIK N+L+ KL DFG A+ L + T + T Y +PE
Sbjct: 115 WCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPE 171
Query: 361 YASTGMLNERSDVYSFGILIMEVISGR 387
+ D++S G ++ E+ G+
Sbjct: 172 LLLGAPYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 8e-10
Identities = 53/284 (18%), Positives = 117/284 (41%), Gaps = 49/284 (17%)
Query: 193 VIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKV-------EVEAIGRVRHKNLV 245
+I E +Y G+ +N V ++ + K KV E++ + R+ N++
Sbjct: 27 LIKENDQNSIYKGIF-NNKEVIIRTF----KKFHKGHKVLIDITENEIKNLRRIDSNNIL 81
Query: 246 RLLGY----CAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTY 301
++ G+ + L+ EY G L + L + L+++ ++++ + KGL
Sbjct: 82 KIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKE----KDLSFKTKLDMAIDCCKGLYN 137
Query: 302 LHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGY----- 356
L++ ++++ S + L+ + + K+ GL K+L + + M F Y
Sbjct: 138 LYK--YTNKPYKNLTSVSFLVTENYKLKIICHGLEKIL-SSPPFKNVNFMVYFSYKMLND 194
Query: 357 VAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEG 416
+ EY + D+YS G+++ E+ +G+ P + + ++ N+N
Sbjct: 195 IFSEY------TIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYD-------LIINKNNSL 241
Query: 417 VLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 460
L C +K + C ++ KRP + +++ L
Sbjct: 242 KLPLD-----CPLEIKC---IVEACTSHDSIKRPNIKEILYNLS 277
|
Length = 283 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 8e-10
Identities = 34/99 (34%), Positives = 58/99 (58%), Gaps = 10/99 (10%)
Query: 296 AKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSY--VTTRVM-G 352
A GL +LH +++RD+K N++LD + + K++DFG+ K E + TTR G
Sbjct: 111 AIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCK----ENIFGGKTTRTFCG 163
Query: 353 TFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVD 391
T Y+APE + + D ++FG+L+ E+++G+ P D
Sbjct: 164 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 9e-10
Identities = 58/218 (26%), Positives = 95/218 (43%), Gaps = 13/218 (5%)
Query: 193 VIGEGGYGIVYHGVLEDNTNV----AVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLL 248
VIG G Y V L+ N + VK L + + + E + + L
Sbjct: 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGL 61
Query: 249 GYCAEGAHRM-LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLE 307
C + R+ LV EY++ G+L H + L E L +LHE
Sbjct: 62 HSCFQTTSRLFLVIEYVNGGDL--MFH--MQRQRKLPEEHARFYAAEICIALNFLHE--- 114
Query: 308 PKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGML 367
+++RD+K N+LLD + KL+D+G+ K G T+ GT Y+APE
Sbjct: 115 RGIIYRDLKLDNVLLDADGHIKLTDYGMCK-EGLGPGDTTSTFCGTPNYIAPEILRGEEY 173
Query: 368 NERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWL 405
D ++ G+L+ E+++GR+P D ++N ++L
Sbjct: 174 GFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYL 211
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 1e-09
Identities = 60/227 (26%), Positives = 96/227 (42%), Gaps = 30/227 (13%)
Query: 194 IGEGGYGIVYHGVLEDNTN-VAVKNL-------LNNRGQAEKEFKVEVEAIGRVRHKNLV 245
+G+GGYG V+ +D VA+K + LN E + + + LV
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTT----KSEWLV 64
Query: 246 RLLGYCAEGAHRMLVYEYIDNGNLEQWLH--GDVGPHSPLTWEIRMNIILGTAKGLTYLH 303
+LL + + L EY+ G+ L+ G + + M + L Y
Sbjct: 65 KLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGY-- 122
Query: 304 EGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAS 363
+HRD+K N L+D + KL+DFGL+K +Y + V+G+ Y+APE
Sbjct: 123 -------IHRDLKPENFLIDASGHIKLTDFGLSK---GIVTYANS-VVGSPDYMAPEVLR 171
Query: 364 TGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEV--NLVEWLKTM 408
+ D +S G ++ E + G P S P E NL W +T+
Sbjct: 172 GKGYDFTVDYWSLGCMLYEFLCGFPPFSGST-PNETWENLKYWKETL 217
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 1e-09
Identities = 33/99 (33%), Positives = 58/99 (58%), Gaps = 10/99 (10%)
Query: 296 AKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSY--VTTRVM-G 352
+ GL +LH +++RD+K N++LD + + K++DFG+ K E VTTR G
Sbjct: 111 SVGLFFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCK----EHMVDGVTTRTFCG 163
Query: 353 TFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVD 391
T Y+APE + + D +++G+L+ E+++G+ P D
Sbjct: 164 TPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 1e-09
Identities = 44/153 (28%), Positives = 79/153 (51%), Gaps = 25/153 (16%)
Query: 248 LGYCAEGAHRM-LVYEYIDNGNLEQWLHGDVG----PHSPL-TWEIRMNIILGTAKGLTY 301
L C + R+ V EY++ G+L + VG PH+ EI + + +KG
Sbjct: 66 LHSCFQTMDRLYFVMEYVNGGDLMYQIQ-QVGRFKEPHAVFYAAEIAIGLFFLHSKG--- 121
Query: 302 LHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSY--VTTRVM-GTFGYVA 358
+++RD+K N++LD + + K++DFG+ K E + VTT+ GT Y+A
Sbjct: 122 --------IIYRDLKLDNVMLDSEGHIKIADFGMCK----ENMWDGVTTKTFCGTPDYIA 169
Query: 359 PEYASTGMLNERSDVYSFGILIMEVISGRNPVD 391
PE + + D ++FG+L+ E+++G+ P +
Sbjct: 170 PEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 1e-09
Identities = 55/212 (25%), Positives = 97/212 (45%), Gaps = 31/212 (14%)
Query: 194 IGEGGYGIVYHGVLEDNTN-------VAVKNLLNNRGQAEKEFKVEVEAIG---RVRHKN 243
+G+G + +Y GVL ++ V +L G ++ E ++ HK+
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 303
LV+L G C + M V EY+ G L+ +LH + + L W ++++ A L YL
Sbjct: 63 LVKLYGVCVRDENIM-VEEYVKFGPLDVFLHRE-KNNVSLHW--KLDVAKQLASALHYLE 118
Query: 304 EGLEPKVVHRDIKSSNILL-----DKQWNP--KLSDFGLAKLLGAERSYVTTRVMGTFGY 356
+ K+VH ++ NIL+ ++ + P KLSD G+ + + R R+ +
Sbjct: 119 DK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLS-REERVERI----PW 170
Query: 357 VAPEYASTGMLNERS--DVYSFGILIMEVISG 386
+APE G + D +SFG ++E+ S
Sbjct: 171 IAPECIRNGQASLTIAADKWSFGTTLLEICSN 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 1e-09
Identities = 60/225 (26%), Positives = 104/225 (46%), Gaps = 43/225 (19%)
Query: 192 NVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGY 250
N+IG G +G+VY + ++ + VA+K +L + +E + + + H N++ L Y
Sbjct: 72 NIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLI----MKNLNHINIIFLKDY 127
Query: 251 CAEGAHRM--------LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNII----LGTAKG 298
+ +V E+I Q +H + ++ + + ++ +
Sbjct: 128 YYTECFKKNEKNIFLNVVMEFI-----PQTVHKYMKHYARNNHALPLFLVKLYSYQLCRA 182
Query: 299 LTYLHEGLEPKVVHRDIKSSNILLDKQWNP-KLSDFGLAK-LLGAER--SYVTTRVMGTF 354
L Y+H + HRD+K N+L+D + KL DFG AK LL +R SY+ +R
Sbjct: 183 LAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRF---- 235
Query: 355 GYVAPEYASTGMLNERS--DVYSFGILIMEVI------SGRNPVD 391
Y APE G N + D++S G +I E+I SG++ VD
Sbjct: 236 -YRAPELM-LGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVD 278
|
Length = 440 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 2e-09
Identities = 39/96 (40%), Positives = 53/96 (55%), Gaps = 13/96 (13%)
Query: 298 GLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYV 357
GL LH ++V+RD+K NILLD + ++SD GLA + E + RV GT GY+
Sbjct: 114 GLEDLHR---ERIVYRDLKPENILLDDYGHIRISDLGLAVEI-PEGETIRGRV-GTVGYM 168
Query: 358 APEYASTGMLNER----SDVYSFGILIMEVISGRNP 389
APE NER D + G LI E+I G++P
Sbjct: 169 APEVVK----NERYTFSPDWWGLGCLIYEMIEGKSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 2e-09
Identities = 32/93 (34%), Positives = 53/93 (56%), Gaps = 4/93 (4%)
Query: 299 LTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVA 358
L +LHE +++RD+K N+LLD + + KL+D+G+ K G T+ GT Y+A
Sbjct: 109 LNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCK-EGIRPGDTTSTFCGTPNYIA 164
Query: 359 PEYASTGMLNERSDVYSFGILIMEVISGRNPVD 391
PE D ++ G+L+ E+++GR+P D
Sbjct: 165 PEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 2e-09
Identities = 32/93 (34%), Positives = 55/93 (59%), Gaps = 7/93 (7%)
Query: 298 GLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYV 357
GL ++H VV+RD+K +NILLD+ + ++SD GLA ++ + + +GT GY+
Sbjct: 109 GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---VGTHGYM 162
Query: 358 APEYASTGMLNERS-DVYSFGILIMEVISGRNP 389
APE G + S D +S G ++ +++ G +P
Sbjct: 163 APEVLQKGTAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 2e-09
Identities = 32/93 (34%), Positives = 56/93 (60%), Gaps = 7/93 (7%)
Query: 298 GLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYV 357
GL ++H VV+RD+K +NILLD+ + ++SD GLA ++ + + +GT GY+
Sbjct: 109 GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---VGTHGYM 162
Query: 358 APEYASTGMLNERS-DVYSFGILIMEVISGRNP 389
APE G+ + S D +S G ++ +++ G +P
Sbjct: 163 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 3e-09
Identities = 63/216 (29%), Positives = 93/216 (43%), Gaps = 38/216 (17%)
Query: 193 VIGEGGYGIVYHGVLEDNTN----VAVKNL------LNNRGQAEKEFKVEVEAIGRVRHK 242
V+G+GGYG V+ + A+K L N + A K E + V+H
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHT--KAERNILEAVKHP 60
Query: 243 NLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIIL-GTAK---- 297
+V L+ G L+ EY+ G L L R I + TA
Sbjct: 61 FIVDLIYAFQTGGKLYLILEYLSGGELFMHLE-------------REGIFMEDTACFYLS 107
Query: 298 ----GLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGT 353
L +LH+ +++RD+K NILLD Q + KL+DFGL K E + VT GT
Sbjct: 108 EISLALEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT-VTHTFCGT 163
Query: 354 FGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNP 389
Y+APE + D +S G L+ ++++G P
Sbjct: 164 IEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPP 199
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 3e-09
Identities = 62/210 (29%), Positives = 96/210 (45%), Gaps = 23/210 (10%)
Query: 193 VIGEGGYGIVY--HGVLEDNTN------VAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNL 244
V+G G YG V+ V +T V K L + + + + E + VR
Sbjct: 7 VLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPF 66
Query: 245 VRLLGYCAEGAHRM-LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRM---NIILGTAKGLT 300
+ L Y + ++ L+ +Y+ G + L+ E+R IIL L
Sbjct: 67 LVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSED---EVRFYSGEIILA----LE 119
Query: 301 YLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPE 360
+LH+ +V+RDIK NILLD + + L+DFGL+K +E T GT Y+APE
Sbjct: 120 HLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPE 176
Query: 361 YA-STGMLNERSDVYSFGILIMEVISGRNP 389
G + D +S GILI E+++G +P
Sbjct: 177 IIRGKGGHGKAVDWWSLGILIFELLTGASP 206
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 3e-09
Identities = 35/96 (36%), Positives = 59/96 (61%), Gaps = 8/96 (8%)
Query: 296 AKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK--LLGAERSYVTTRVMGT 353
A L +LH L +++RD+K NILLD++ + KL+DFGL+K + +++Y GT
Sbjct: 108 ALALDHLH-SL--GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAY---SFCGT 161
Query: 354 FGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNP 389
Y+APE + + +D +SFG+L+ E+++G P
Sbjct: 162 VEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLP 197
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 3e-09
Identities = 56/209 (26%), Positives = 94/209 (44%), Gaps = 29/209 (13%)
Query: 194 IGEGGYGIVYHGVLEDNTNVA---VKNLLNNRGQAEK-EFKVEVEAIGRVRHKNLVRLLG 249
IG G +G V + +T VA VK L N E+ EF + + ++H N+++ LG
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 250 YCAEGAHRMLVYEYIDNGNL------EQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 303
C E +LV+EY + G+L EQW + S L RM + A G+T++H
Sbjct: 63 QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRN----SQLLLLQRMACEI--AAGVTHMH 116
Query: 304 EGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTT--RVMGTFGYVAPEY 361
+ +H D+ N L K+ D+G+ E Y+ T ++APE
Sbjct: 117 ---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKE-DYIETEDDKCVPLRWLAPEL 172
Query: 362 AST---GML----NERSDVYSFGILIMEV 383
G++ + S+V++ G+ + E+
Sbjct: 173 VGEFHGGLITAEQTKPSNVWALGVTLWEL 201
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 4e-09
Identities = 54/206 (26%), Positives = 98/206 (47%), Gaps = 28/206 (13%)
Query: 194 IGEGGYGIVYHGV-LEDNTNVAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKNLVRLLG 249
+G G YG V + VA+K L + A++ ++ E+ + ++H+N++ LL
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYR-ELTLLKHMQHENVIGLLD 81
Query: 250 Y--CAEGAHRM----LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 303
A LV Y+ +L++ + PL+ + ++ GL Y+H
Sbjct: 82 VFTSAVSGDEFQDFYLVMPYMQT-DLQKIMG------HPLSEDKVQYLVYQMLCGLKYIH 134
Query: 304 EGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS-YVTTRVMGTFGYVAPEYA 362
++HRD+K N+ +++ K+ DFGLA+ AE + YV TR Y APE
Sbjct: 135 SA---GIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR-----WYRAPEVI 186
Query: 363 STGM-LNERSDVYSFGILIMEVISGR 387
M N+ D++S G ++ E+++G+
Sbjct: 187 LNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 4e-09
Identities = 36/92 (39%), Positives = 49/92 (53%), Gaps = 5/92 (5%)
Query: 298 GLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYV 357
GL LH V+RD+K NILLD + ++SD GLA + E + RV GT GY+
Sbjct: 114 GLEDLHR---ENTVYRDLKPENILLDDYGHIRISDLGLAVKI-PEGESIRGRV-GTVGYM 168
Query: 358 APEYASTGMLNERSDVYSFGILIMEVISGRNP 389
APE + D + G LI E+I G++P
Sbjct: 169 APEVLNNQRYTLSPDYWGLGCLIYEMIEGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 4e-09
Identities = 33/96 (34%), Positives = 49/96 (51%), Gaps = 5/96 (5%)
Query: 299 LTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVA 358
L YLH VV+RD+K N++LDK + K++DFGL K G GT Y+A
Sbjct: 108 LGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPEYLA 163
Query: 359 PEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSR 394
PE D + G+++ E++ GR P Y++
Sbjct: 164 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF-YNQ 198
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 4e-09
Identities = 38/139 (27%), Positives = 65/139 (46%), Gaps = 17/139 (12%)
Query: 299 LTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVA 358
L +LH+ +++RD+K N+LLD + + KL+DFG+ K G T+ GT Y+A
Sbjct: 109 LMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCK-EGIFNGKTTSTFCGTPDYIA 164
Query: 359 PEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPP--------GEVNLVEWLKTMVT 410
PE + D ++ G+L+ E++ G P + EV WL
Sbjct: 165 PEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWL----- 219
Query: 411 NRNAEGVLDPRLQEKPCSR 429
+++A +L + + P R
Sbjct: 220 SQDAVDILKAFMTKNPTMR 238
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 5e-09
Identities = 36/92 (39%), Positives = 51/92 (55%), Gaps = 5/92 (5%)
Query: 298 GLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYV 357
GL L ++V+RD+K NILLD + + ++SD GLA + E V RV GT GY+
Sbjct: 114 GLEDLQR---ERIVYRDLKPENILLDDRGHIRISDLGLAVQI-PEGETVRGRV-GTVGYM 168
Query: 358 APEYASTGMLNERSDVYSFGILIMEVISGRNP 389
APE + D + G LI E+I G++P
Sbjct: 169 APEVINNEKYTFSPDWWGLGCLIYEMIQGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 57.3 bits (139), Expect = 5e-09
Identities = 34/97 (35%), Positives = 53/97 (54%), Gaps = 18/97 (18%)
Query: 297 KGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS-YVTTRVMGTFG 355
+GL Y+H ++HRD+K SNI +++ K+ DFGLA+ E + YV TR
Sbjct: 129 RGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYVATR-----W 180
Query: 356 YVAPEYASTGMLNERS-----DVYSFGILIMEVISGR 387
Y APE MLN D++S G ++ E+++G+
Sbjct: 181 YRAPEI----MLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 6e-09
Identities = 39/104 (37%), Positives = 53/104 (50%), Gaps = 5/104 (4%)
Query: 296 AKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFG 355
A L YLH +V+RD+K NILLD Q + L+DFGL K G +S TT GT
Sbjct: 106 ASALGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCK-EGIAQSDTTTTFCGTPE 161
Query: 356 YVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEV 399
Y+APE + D + G ++ E++ G P Y R E+
Sbjct: 162 YLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPF-YCRDVAEM 204
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 7e-09
Identities = 33/92 (35%), Positives = 49/92 (53%), Gaps = 4/92 (4%)
Query: 298 GLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYV 357
L YLH G K+V+RD+K N++LDK + K++DFGL K G + GT Y+
Sbjct: 107 ALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCK-EGITDAATMKTFCGTPEYL 162
Query: 358 APEYASTGMLNERSDVYSFGILIMEVISGRNP 389
APE D + G+++ E++ GR P
Sbjct: 163 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.5 bits (137), Expect = 9e-09
Identities = 56/204 (27%), Positives = 87/204 (42%), Gaps = 49/204 (24%)
Query: 187 GFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVE------------ 234
+ E IG G YG VY KN + + A K+FK + E
Sbjct: 1 KYEIEGCIGRGTYGRVYKAKR--------KNGKDGKEYAIKKFKGDKEQYTGISQSACRE 52
Query: 235 -AIGR-VRHKNLVRLLGYCAEGAHRM--LVYEYI--DNGNLEQWLHGDVGPHSP------ 282
A+ R ++H+N+V L+ E A + L+++Y D + ++ P
Sbjct: 53 IALLRELKHENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKS 112
Query: 283 LTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILL----DKQWNPKLSDFGLAKL 338
L W+I +N G+ YLH V+HRD+K +NIL+ ++ K+ D GLA+L
Sbjct: 113 LLWQI-LN-------GVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARL 161
Query: 339 LGA--ERSYVTTRVMGTFGYVAPE 360
A + V+ T Y APE
Sbjct: 162 FNAPLKPLADLDPVVVTIWYRAPE 185
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 1e-08
Identities = 39/113 (34%), Positives = 62/113 (54%), Gaps = 9/113 (7%)
Query: 281 SPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG 340
SPLT E + A+G+ +L K +HRD+ + NILL + K+ DFGLA+ +
Sbjct: 169 SPLTMEDLICYSFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIY 225
Query: 341 AERSYV---TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNP 389
+ YV + R+ ++APE + +SDV+SFG+L+ E+ S G +P
Sbjct: 226 KDPDYVRKGSARL--PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASP 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 1e-08
Identities = 33/91 (36%), Positives = 50/91 (54%), Gaps = 4/91 (4%)
Query: 299 LTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVA 358
L +LH V++RD+K NILLD + + KL+DFG+ K G TT GT Y+A
Sbjct: 109 LMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCK-EGILNGVTTTTFCGTPDYIA 164
Query: 359 PEYASTGMLNERSDVYSFGILIMEVISGRNP 389
PE D ++ G+L+ E+++G+ P
Sbjct: 165 PEILQELEYGPSVDWWALGVLMYEMMAGQPP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 1e-08
Identities = 65/221 (29%), Positives = 100/221 (45%), Gaps = 43/221 (19%)
Query: 194 IGEGGYGIV----YHGVLEDNTNVAVK---NLLNNRGQAEKEFKVEVEAIGRVR-HKNLV 245
+G+G YGIV + VA+K N+ + + A++ + E++ + R HKN+
Sbjct: 8 LGQGAYGIVCSARNAET-SEEETVAIKKITNVFSKKILAKRALR-ELKLLRHFRGHKNIT 65
Query: 246 RL--LGYCAEGAHRML-VYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYL 302
L + G L +YE + +L Q + PLT + I GL Y+
Sbjct: 66 CLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQ----PLTDAHFQSFIYQILCGLKYI 121
Query: 303 HEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLA--------KLLGAERSYVTTRVMGTF 354
H V+HRD+K N+L++ K+ DFGLA + G YV TR
Sbjct: 122 HSA---NVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATR----- 173
Query: 355 GYVAPEYASTGMLNERS-----DVYSFGILIMEVISGRNPV 390
Y APE ML+ +S DV+S G ++ E++ GR PV
Sbjct: 174 WYRAPEI----MLSFQSYTKAIDVWSVGCILAELL-GRKPV 209
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 1e-08
Identities = 37/155 (23%), Positives = 74/155 (47%), Gaps = 9/155 (5%)
Query: 231 VEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMN 290
+E + V H +++R+ GA +V + + +L +L P L + +
Sbjct: 106 IEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY-SSDLYTYLTKRSRP---LPIDQALI 161
Query: 291 IILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRV 350
I +GL YLH +++HRD+K+ NI ++ + D G A+ +++ +
Sbjct: 162 IEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLG--L 216
Query: 351 MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS 385
GT APE + N ++D++S GI++ E+++
Sbjct: 217 AGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLA 251
|
Length = 357 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 2e-08
Identities = 31/94 (32%), Positives = 54/94 (57%), Gaps = 8/94 (8%)
Query: 298 GLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK--LLGAERSYVTTRVMGTFG 355
GL +LH +++RD+K N++LD+ + K++DFG+ K + G R+ + GT
Sbjct: 108 GLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRA---STFCGTPD 161
Query: 356 YVAPEYASTGMLNERSDVYSFGILIMEVISGRNP 389
Y+APE D +SFG+L+ E++ G++P
Sbjct: 162 YIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 2e-08
Identities = 60/247 (24%), Positives = 94/247 (38%), Gaps = 75/247 (30%)
Query: 193 VIGEGGYGIVYHGVLEDNTNVAV-------KNLLNNRGQ-----AEKEFKVEVEAIGRVR 240
VIG G +G V+ ++ D V K+ + R Q AE++ + A
Sbjct: 8 VIGRGAFGEVW--LVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILAD--ADSPW- 62
Query: 241 HKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIIL-GTAK-- 297
+V+L + H LV EY+ G+L + IR ++ TA+
Sbjct: 63 ---IVKLYYSFQDEEHLYLVMEYMPGGDL-------------MNLLIRKDVFPEETARFY 106
Query: 298 ------GLTYLHE-GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL--GAERSYVTT 348
L +H+ G +HRDIK NIL+D + KL+DFGL K + +R Y
Sbjct: 107 IAELVLALDSVHKLGF----IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLN 162
Query: 349 R--------------------------VMGTFGYVAPEYASTGMLNERSDVYSFGILIME 382
+GT Y+APE D +S G+++ E
Sbjct: 163 DSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYE 222
Query: 383 VISGRNP 389
++ G P
Sbjct: 223 MLYGFPP 229
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 75/248 (30%), Positives = 111/248 (44%), Gaps = 22/248 (8%)
Query: 193 VIGEGGYGIVYHGVLE-DNTNVAVKNLLNN---RGQAEKEFKVEVEAIGR-VRHKNLVRL 247
VIG+G +G V + + AVK L + + EK E + + V+H LV L
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61
Query: 248 LGYCAEGAHRM-LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGL 306
+ + A ++ V +YI+ G L L + P I A L YLH
Sbjct: 62 -HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEI----ASALGYLHS-- 114
Query: 307 EPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGM 366
+V+RD+K NILLD Q + L+DFGL K E + T+ GT Y+APE
Sbjct: 115 -LNIVYRDLKPENILLDSQGHIVLTDFGLCK-ENIEHNGTTSTFCGTPEYLAPEVLHKQP 172
Query: 367 LNERSDVYSFGILIMEVISGRNPVDYSRPPGE-----VNLVEWLKTMVTNRNAEGVLDPR 421
+ D + G ++ E++ G P YSR E +N LK +TN +A +L+
Sbjct: 173 YDRTVDWWCLGAVLYEMLYGLPPF-YSRNTAEMYDNILNKPLQLKPNITN-SARHLLEGL 230
Query: 422 LQEKPCSR 429
LQ+ R
Sbjct: 231 LQKDRTKR 238
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 2e-08
Identities = 47/157 (29%), Positives = 75/157 (47%), Gaps = 29/157 (18%)
Query: 193 VIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVE------AIGRV------R 240
+GEG Y VY G ++ L + A KE ++E E AI +
Sbjct: 12 KLGEGSYATVYKG----------RSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLK 61
Query: 241 HKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLT 300
H N+V L LV+EY+D +L+Q++ G S + + +L +GL
Sbjct: 62 HANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLL---RGLA 117
Query: 301 YLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK 337
Y H+ +V+HRD+K N+L+ ++ KL+DFGLA+
Sbjct: 118 YCHQ---RRVLHRDLKPQNLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 2e-08
Identities = 38/113 (33%), Positives = 61/113 (53%), Gaps = 9/113 (7%)
Query: 281 SPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG 340
PLT E ++ A+G+ +L K +HRD+ + NILL + K+ DFGLA+ +
Sbjct: 168 EPLTLEDLISYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIY 224
Query: 341 AERSYV---TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNP 389
+ YV R+ ++APE + +SDV+SFG+L+ E+ S G +P
Sbjct: 225 KDPDYVRKGDARL--PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASP 275
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 2e-08
Identities = 53/213 (24%), Positives = 96/213 (45%), Gaps = 30/213 (14%)
Query: 194 IGEGGYGIVYHGVLED--------NTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLV 245
+G+G + ++ G+ + T V +K L + + F + ++ HK+LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 246 RLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG 305
G C G ++V EY+ G+L+ +L + ++W+ L AK L +
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKN-KNLINISWK------LEVAKQLAWALHF 115
Query: 306 LEPK-VVHRDIKSSNILL-----DKQWNP---KLSDFGLAKLLGAERSYVTTRVMGTFGY 356
LE K + H ++ + N+LL K NP KLSD G++ + + + R+ +
Sbjct: 116 LEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLP-KEILLERI----PW 170
Query: 357 VAPEYASTGM-LNERSDVYSFGILIMEVISGRN 388
V PE L+ +D +SFG + E+ SG +
Sbjct: 171 VPPECIENPQNLSLAADKWSFGTTLWEIFSGGD 203
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 3e-08
Identities = 54/210 (25%), Positives = 92/210 (43%), Gaps = 22/210 (10%)
Query: 191 ENVIGEGGYGIVYHGV-LEDNTNVAVK---NLLNNRGQAEKEFKVEVEAIGRVRHKNLVR 246
+ VIG+G YG+V + VA+K ++ + A + + E++ + +RH ++V
Sbjct: 5 QEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILR-EIKLLRLLRHPDIVE 63
Query: 247 LLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGL 306
+ + R Y+ +E LH + + LT E + + L Y+H
Sbjct: 64 IKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTA- 122
Query: 307 EPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE-------RSYVTTRVMGTFGYVAP 359
V HRD+K NIL + K+ DFGLA++ + YV TR Y AP
Sbjct: 123 --NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR-----WYRAP 175
Query: 360 EYAST--GMLNERSDVYSFGILIMEVISGR 387
E + D++S G + EV++G+
Sbjct: 176 ELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 3e-08
Identities = 33/91 (36%), Positives = 48/91 (52%), Gaps = 4/91 (4%)
Query: 299 LTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVA 358
L LH+ V++RD+K NILLD Q + L DFGL K L + T GT Y+A
Sbjct: 106 LENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCK-LNMKDDDKTNTFCGTPEYLA 161
Query: 359 PEYASTGMLNERSDVYSFGILIMEVISGRNP 389
PE + D ++ G+L+ E+++G P
Sbjct: 162 PELLLGHGYTKAVDWWTLGVLLYEMLTGLPP 192
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 3e-08
Identities = 33/92 (35%), Positives = 48/92 (52%), Gaps = 3/92 (3%)
Query: 298 GLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYV 357
L YLH E VV+RD+K N++LDK + K++DFGL K G + GT Y+
Sbjct: 107 ALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKTFCGTPEYL 163
Query: 358 APEYASTGMLNERSDVYSFGILIMEVISGRNP 389
APE D + G+++ E++ GR P
Sbjct: 164 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 3e-08
Identities = 52/209 (24%), Positives = 99/209 (47%), Gaps = 21/209 (10%)
Query: 188 FADENVIGEGGYGIVYHGV-LEDNTNVAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKN 243
+ D +G G YG V + VA+K L + A++ ++ E+ + ++H+N
Sbjct: 17 YRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYR-ELRLLKHMKHEN 75
Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGP---HSPLTWEIRMNIILGTAKGLT 300
++ LL + + D + ++ D+G H L+ + ++ KGL
Sbjct: 76 VIGLLDVFTPDLS---LDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLKGLK 132
Query: 301 YLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS-YVTTRVMGTFGYVAP 359
Y+H ++HRD+K N+ +++ K+ DFGLA+ +E + YV TR Y AP
Sbjct: 133 YIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTR-----WYRAP 184
Query: 360 EYASTGM-LNERSDVYSFGILIMEVISGR 387
E M + D++S G ++ E+++G+
Sbjct: 185 EVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 3e-08
Identities = 63/254 (24%), Positives = 111/254 (43%), Gaps = 40/254 (15%)
Query: 194 IGEGGYGIVYHGVL--EDNTNVAVKNLLNNRGQAEKEFK---VEVEAIGRVRHKNLVRLL 248
+G G +G V ED VA+K ++ +K+ E + + + H V L
Sbjct: 38 LGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLY 97
Query: 249 GYCAEGAHRMLVYEYIDNGNLEQWLH------GDVGPHSPLTWEIRMNIILGTAKGLTYL 302
G + ++ LV E++ G +L DVG + ++ +I + L
Sbjct: 98 GSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVG----CFYAAQIVLIFEYLQSLN-- 151
Query: 303 HEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYA 362
+V+RD+K N+LLDK K++DFG AK++ R+Y + GT Y+APE
Sbjct: 152 -------IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT-RTYT---LCGTPEYIAPEIL 200
Query: 363 STGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLD-PR 421
+ +D ++ GI I E++ G P Y+ P ++ + EG++ P+
Sbjct: 201 LNVGHGKAADWWTLGIFIYEILVGCPPF-YANEP----------LLIYQKILEGIIYFPK 249
Query: 422 LQEKPCSRALKRAL 435
+ C +K+ L
Sbjct: 250 FLDNNCKHLMKKLL 263
|
Length = 340 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 3e-08
Identities = 48/172 (27%), Positives = 85/172 (49%), Gaps = 21/172 (12%)
Query: 236 IGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGT 295
+ +V H +L + G C G+ ++V E++++G L+ L + G P+ W+I + L +
Sbjct: 70 MSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKG-RVPVAWKITVAQQLAS 128
Query: 296 AKGLTYLHEGLEPKVVHRDIKSSNILLDKQW-----NP--KLSDFGLAKLLGAERSYVTT 348
A L+YL + +VH ++ + NILL + +P KLSD G++ R
Sbjct: 129 A--LSYLE---DKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVS-FTALSREERVE 182
Query: 349 RVMGTFGYVAPE-YASTGMLNERSDVYSFGILIMEV-ISGRNPVDYSRPPGE 398
R+ ++APE L+ +D +SFG ++E+ G P+ R P E
Sbjct: 183 RI----PWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLK-ERTPSE 229
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 3e-08
Identities = 53/231 (22%), Positives = 96/231 (41%), Gaps = 49/231 (21%)
Query: 192 NVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAE------------------KEFKVE 232
+GEG YG V VA+K + + +E K+
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74
Query: 233 VEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNII 292
E ++H+N++ L+ EG LV + + +L++ + + LT I+
Sbjct: 75 NE----IKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRKI----RLTESQVKCIL 125
Query: 293 LGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG------------ 340
L GL LH+ +HRD+ +NI ++ + K++DFGLA+ G
Sbjct: 126 LQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDE 182
Query: 341 --AERSYVTTRVMGTFGYVAPE--YASTGMLNERSDVYSFGILIMEVISGR 387
R +T++V+ T Y APE + + D++S G + E+++G+
Sbjct: 183 TMQRREEMTSKVV-TLWYRAPELLMGAE-KYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 5e-08
Identities = 34/99 (34%), Positives = 55/99 (55%), Gaps = 10/99 (10%)
Query: 291 IILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS-YVTTR 349
+I +GL Y+H ++HRD+K SN+ +++ K+ DFGLA+ E + YV TR
Sbjct: 125 LIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR 181
Query: 350 VMGTFGYVAPEYASTGM-LNERSDVYSFGILIMEVISGR 387
Y APE M N+ D++S G ++ E+++GR
Sbjct: 182 -----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 5e-08
Identities = 50/196 (25%), Positives = 92/196 (46%), Gaps = 11/196 (5%)
Query: 194 IGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEA--IGRVRHKNLVRLLGYC 251
+GEG Y VY G + N + ++ + + F EA + ++H N+V L
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDII 72
Query: 252 AEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVV 311
LV+EY+ + +L Q++ G P ++ + +L +GL+Y+H+ ++
Sbjct: 73 HTKETLTLVFEYV-HTDLCQYMDKHPGGLHPENVKLFLFQLL---RGLSYIHQRY---IL 125
Query: 312 HRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPE-YASTGMLNER 370
HRD+K N+L+ KL+DFGLA+ + V+ T Y P+ + +
Sbjct: 126 HRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVV-TLWYRPPDVLLGSTEYSTC 184
Query: 371 SDVYSFGILIMEVISG 386
D++ G + +E+I G
Sbjct: 185 LDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 55.5 bits (133), Expect = 5e-08
Identities = 58/224 (25%), Positives = 99/224 (44%), Gaps = 30/224 (13%)
Query: 194 IGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKE---FKVEVEAIGRVRHKNLVRLLGY 250
IG G +G V+ + ++ RG E+E +EV + ++HKN+VR +
Sbjct: 21 IGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDR 80
Query: 251 CAEGAHRML--VYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLE- 307
A++ L + E+ D G+L + + + ++I L Y H +
Sbjct: 81 FLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDG 140
Query: 308 ---PKVVHRDIKSSNILLDK----------QWN-------PKLSDFGLAKLLGAERSYVT 347
+V+HRD+K NI L Q N K+ DFGL+K +G E +
Sbjct: 141 PNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIES--MA 198
Query: 348 TRVMGTFGYVAPEYA--STGMLNERSDVYSFGILIMEVISGRNP 389
+GT Y +PE T +++SD+++ G +I E+ SG+ P
Sbjct: 199 HSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTP 242
|
Length = 1021 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 8e-08
Identities = 53/209 (25%), Positives = 93/209 (44%), Gaps = 20/209 (9%)
Query: 193 VIGEGGYGIVY--HGVLEDNT------NVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNL 244
V+G G YG V+ V ++ V K + + + + + E + + +R
Sbjct: 7 VLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 66
Query: 245 VRLLGYCAEGAHRM-LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILG-TAKGLTYL 302
+ L Y + ++ L+ +YI+ G L L E + I G L +L
Sbjct: 67 LVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFK-----EQEVQIYSGEIVLALEHL 121
Query: 303 HEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYA 362
H+ +++RDIK NILLD + L+DFGL+K + GT Y+AP+
Sbjct: 122 HK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIV 178
Query: 363 STGML--NERSDVYSFGILIMEVISGRNP 389
G ++ D +S G+L+ E+++G +P
Sbjct: 179 RGGDGGHDKAVDWWSMGVLMYELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 9e-08
Identities = 38/112 (33%), Positives = 59/112 (52%), Gaps = 9/112 (8%)
Query: 282 PLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA 341
LT E + AKG+ +L K +HRD+ + NILL + K+ DFGLA+ +
Sbjct: 175 VLTLEDLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYK 231
Query: 342 ERSYV---TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNP 389
+ YV R+ ++APE + +SDV+SFG+L+ E+ S G +P
Sbjct: 232 DPDYVRKGDARL--PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 281
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 9e-08
Identities = 59/215 (27%), Positives = 97/215 (45%), Gaps = 37/215 (17%)
Query: 194 IGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKE-----FKVEVEAIGRVRHKN-LVRL 247
IGEG YG VY D + L R + ++E E+ + + +VRL
Sbjct: 9 IGEGTYGKVYKA--RDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRL 66
Query: 248 LGYCAEGAHR-------MLVYEYIDNGNLEQWLHGDV-GPHSPLTWEIRMNIILGTAKGL 299
L E LV+EY+D+ +L++++ + GP PL + + + KG+
Sbjct: 67 L--DVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGV 123
Query: 300 TYLHEGLEPKVVHRDIKSSNILLDKQWNP-KLSDFGLAKLLGAE-RSYVTTRVMGTFGYV 357
+ H+ V+HRD+K N+L+DKQ K++D GL + +SY T + T Y
Sbjct: 124 AHCHK---HGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSY--THEIVTLWYR 178
Query: 358 APE------YASTGMLNERSDVYSFGILIMEVISG 386
APE + ST + D++S G + E+
Sbjct: 179 APEVLLGSTHYSTPV-----DIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 1e-07
Identities = 52/220 (23%), Positives = 101/220 (45%), Gaps = 30/220 (13%)
Query: 188 FADENVIGEGGYGIVYHGVLED-NTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVR 246
+ D +G G G+V+ V D + VAVK ++ Q+ K E++ I R+ H N+V+
Sbjct: 7 YMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVK 66
Query: 247 LLGYCAEGAHRM--------------LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNII 292
+ + +V EY++ +L L PL+ E +
Sbjct: 67 VYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMET-DLANVLE-----QGPLSEEHARLFM 120
Query: 293 LGTAKGLTYLHEGLEPKVVHRDIKSSNILLD-KQWNPKLSDFGLAKLLGAERS---YVTT 348
+GL Y+H V+HRD+K +N+ ++ + K+ DFGLA+++ S Y++
Sbjct: 121 YQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSE 177
Query: 349 RVMGTFGYVAPEYA-STGMLNERSDVYSFGILIMEVISGR 387
++ + Y +P S + D+++ G + E+++G+
Sbjct: 178 GLVTKW-YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 1e-07
Identities = 27/83 (32%), Positives = 41/83 (49%), Gaps = 4/83 (4%)
Query: 311 VHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEY----ASTGM 366
+HRD+K N+LLDK + KL+DFG + A +GT Y++PE G
Sbjct: 164 IHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGY 223
Query: 367 LNERSDVYSFGILIMEVISGRNP 389
D +S G+ + E++ G P
Sbjct: 224 YGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 1e-07
Identities = 65/288 (22%), Positives = 122/288 (42%), Gaps = 41/288 (14%)
Query: 193 VIGEGGYGIVYHGVL--EDNT--NVAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKNLV 245
++G+G +G V L ED + VAVK L + + E EF E + H N++
Sbjct: 6 MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIE-EFLREAACMKEFDHPNVI 64
Query: 246 RLLGYCAEGAHR------MLVYEYIDNGNLEQWLHGDVGPHSPLTW--EIRMNIILGTAK 297
+L+G + M++ ++ +G+L +L P T + + ++ A
Sbjct: 65 KLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIAS 124
Query: 298 GLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMG-TFGY 356
G+ YL +HRD+ + N +L++ ++DFGL+K + + Y +
Sbjct: 125 GMEYLSS---KNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKW 181
Query: 357 VAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVN--LVEWLKTMVTNRN 413
+A E + + SDV++FG+ + E+++ G+ P G N + +L
Sbjct: 182 LALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPY-----AGVENSEIYNYL-------- 228
Query: 414 AEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461
+ RL++ P L+ + +C P RP H+ LE
Sbjct: 229 ---IKGNRLKQPP--DCLEDVYELMCQCWSPEPKCRPSFQHLRDQLEL 271
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 57/221 (25%), Positives = 101/221 (45%), Gaps = 18/221 (8%)
Query: 194 IGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEA--IGRVRHKNLVRLLGYC 251
+GEG Y VY G+ N + +++ + + F EA + ++H N+V L
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDII 72
Query: 252 AEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVV 311
V+EY+ +L Q++ G P + M +L +GL Y+H ++
Sbjct: 73 HTKETLTFVFEYMHT-DLAQYMIQHPGGLHPYNVRLFMFQLL---RGLAYIHG---QHIL 125
Query: 312 HRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERS 371
HRD+K N+L+ KL+DFGLA+ ++ V+ T Y P+ G + S
Sbjct: 126 HRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV-TLWYRPPD-VLLGATDYSS 183
Query: 372 --DVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVT 410
D++ G + +E++ G+ P PG ++ E L+ + T
Sbjct: 184 ALDIWGAGCIFIEMLQGQ-PAF----PGVSDVFEQLEKIWT 219
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 56/231 (24%), Positives = 103/231 (44%), Gaps = 23/231 (9%)
Query: 218 LLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDV 277
+LN+ QA + E+ + H +V+ +L+ EY G+L + + +
Sbjct: 102 MLNDERQAAYA-RSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRL 160
Query: 278 GPHSPLT-WEIRM---NIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDF 333
H P +E+ + I+L L E K++HRD+KS+NI L KL DF
Sbjct: 161 KEHLPFQEYEVGLLFYQIVLA-------LDEVHSRKMMHRDLKSANIFLMPTGIIKLGDF 213
Query: 334 GLAKLLGAERSY-VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDY 392
G +K S V + GT Y+APE ++++D++S G+++ E+++ P
Sbjct: 214 GFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPF-- 271
Query: 393 SRPPGEVNLVEWLK-------TMVTNRNAEGVLDPRLQEKPCSRALKRALL 436
+ P + +++ + + + +LDP L + P R + LL
Sbjct: 272 -KGPSQREIMQQVLYGKYDPFPCPVSSGMKALLDPLLSKNPALRPTTQQLL 321
|
Length = 478 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 33/91 (36%), Positives = 46/91 (50%), Gaps = 4/91 (4%)
Query: 299 LTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVA 358
L YLH VV+RDIK N++LDK + K++DFGL K G GT Y+A
Sbjct: 108 LEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPEYLA 163
Query: 359 PEYASTGMLNERSDVYSFGILIMEVISGRNP 389
PE D + G+++ E++ GR P
Sbjct: 164 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 53.2 bits (127), Expect = 2e-07
Identities = 41/179 (22%), Positives = 80/179 (44%), Gaps = 19/179 (10%)
Query: 215 VKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRL--------LGYCAEGAHRMLVYEYIDN 266
+ + +A + + E+ A+GR+ H+N++++ Y + +Y ++ +
Sbjct: 196 IAKRVKAGSRAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYD 255
Query: 267 GNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQW 326
W PL + R I+ + Y+H+ K++HRDIK NI L+
Sbjct: 256 EAF-DW------KDRPLLKQTR-AIMKQLLCAVEYIHD---KKLIHRDIKLENIFLNCDG 304
Query: 327 NPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS 385
L DFG A ER +GT +PE + E +D++S G+++++++S
Sbjct: 305 KIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 2e-07
Identities = 48/172 (27%), Positives = 82/172 (47%), Gaps = 26/172 (15%)
Query: 296 AKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGT-- 353
AKG+++L +HRD+ + NILL K+ DFGLA+ + + +YV V G
Sbjct: 224 AKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYV---VKGNAR 277
Query: 354 --FGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVT 410
++APE + SDV+S+GIL+ E+ S G +P Y P + + +K
Sbjct: 278 LPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSP--YPGMPVDSKFYKMIK---- 331
Query: 411 NRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462
EG R+ C+ + ++ + C D + KRP ++ ++E +
Sbjct: 332 ----EGY---RMLSPECAPSEMYDIMKS--CWDADPLKRPTFKQIVQLIEQQ 374
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 3e-07
Identities = 53/221 (23%), Positives = 92/221 (41%), Gaps = 18/221 (8%)
Query: 178 LRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKE----FKVEV 233
+R+L++ + VIG G +G V + + V LL+ ++ F E
Sbjct: 35 IRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEER 94
Query: 234 EAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHG-DVGPHSPLTWEIRMNII 292
+ + +V+L + + +V EY+ G+L + DV P W
Sbjct: 95 DIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDV----PEKWAK----- 145
Query: 293 LGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMG 352
TA+ + L ++HRD+K N+LLDK + KL+DFG + +G
Sbjct: 146 FYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVG 205
Query: 353 TFGYVAPEYAST----GMLNERSDVYSFGILIMEVISGRNP 389
T Y++PE + G D +S G+ + E++ G P
Sbjct: 206 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 3e-07
Identities = 32/93 (34%), Positives = 50/93 (53%), Gaps = 6/93 (6%)
Query: 297 KGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGY 356
+GL YLH ++HRDIK N+L++ K+ DFGLA++ + S T+ + T Y
Sbjct: 114 RGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYY 170
Query: 357 VAPEYASTGMLNERS--DVYSFGILIMEVISGR 387
APE G + S D++S G + E++ R
Sbjct: 171 RAPEIL-MGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 3e-07
Identities = 58/218 (26%), Positives = 94/218 (43%), Gaps = 31/218 (14%)
Query: 193 VIGEGGYGIVY---HGVLEDNTNVAVKNL----LNNRGQAEKEFKVEVEAIGRVRHKNLV 245
+I G YG VY H E A+K + L R Q ++ F VE + + + +V
Sbjct: 8 LISNGAYGAVYLVRHK--ETRQRFAMKKINKQNLILRNQIQQVF-VERDILTFAENPFVV 64
Query: 246 RLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG 305
+ H +V EY++ G+ L ++G L ++ T L YLH
Sbjct: 65 SMFCSFETKRHLCMVMEYVEGGDCATLLK-NIGA---LPVDMARMYFAETVLALEYLHN- 119
Query: 306 LEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK--------------LLGAERSYVTTRVM 351
+VHRD+K N+L+ + KL+DFGL+K + R ++ +V
Sbjct: 120 --YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVC 177
Query: 352 GTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNP 389
GT Y+APE + D ++ GI++ E + G P
Sbjct: 178 GTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVP 215
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 4e-07
Identities = 28/86 (32%), Positives = 49/86 (56%), Gaps = 5/86 (5%)
Query: 298 GLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYV 357
G+ Y+H+ +++HRD+K+ NI L K+ DFG+++LL TT GT Y+
Sbjct: 118 GVHYMHQ---RRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATT-FTGTPYYM 172
Query: 358 APEYASTGMLNERSDVYSFGILIMEV 383
+PE + +SD++S G ++ E+
Sbjct: 173 SPEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 4e-07
Identities = 52/216 (24%), Positives = 92/216 (42%), Gaps = 42/216 (19%)
Query: 194 IGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIG---------------- 237
+G G +Y G+L + ++ EKE KV ++ +
Sbjct: 3 LGRGTRTQIYAGILNYKDDDE-----DDGYSYEKEIKVILKVLDPSHRDISLAFFETASM 57
Query: 238 --RVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGT 295
+V HK++V L G C ++V E+++ G L+ ++H LT + +
Sbjct: 58 MRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRK---SDVLTTPWKFKVAKQL 114
Query: 296 AKGLTYLHEGLEPKVVHRDIKSSNILL-----DKQWNP--KLSDFGLAKLLGAERSYVTT 348
A L+YL + +VH ++ + NILL D + P KLSD G+ + R
Sbjct: 115 ASALSYLE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIP-ITVLSRQECVE 170
Query: 349 RVMGTFGYVAPE-YASTGMLNERSDVYSFGILIMEV 383
R+ ++APE + L+ +D +SFG + E+
Sbjct: 171 RI----PWIAPECVEDSKNLSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 4e-07
Identities = 61/262 (23%), Positives = 101/262 (38%), Gaps = 48/262 (18%)
Query: 188 FADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKE----FKVEVEAIGRVRHKN 243
F VIG G +G V +D +V +L EKE + E + +
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLW 62
Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 303
+V++ + + L+ E++ G++ L LT E I T + +H
Sbjct: 63 VVKMFYSFQDKLNLYLIMEFLPGGDMMTLLM----KKDTLTEEETQFYIAETVLAIDSIH 118
Query: 304 EGLEPKVVHRDIKSSNILLDKQWNPKLSDFGL---------------------------- 335
+ +HRDIK N+LLD + + KLSDFGL
Sbjct: 119 Q---LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQN 175
Query: 336 ------AKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNP 389
A+ R + +GT Y+APE N+ D +S G+++ E++ G P
Sbjct: 176 MNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235
Query: 390 VDYSRPPGEV--NLVEWLKTMV 409
S P E ++ W +T++
Sbjct: 236 F-CSETPQETYKKVMNWKETLI 256
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 6e-07
Identities = 29/84 (34%), Positives = 44/84 (52%), Gaps = 5/84 (5%)
Query: 311 VHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEY-----ASTG 365
VHRDIK N+LLDK + +L+DFG L A+ + + +GT Y++PE G
Sbjct: 124 VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKG 183
Query: 366 MLNERSDVYSFGILIMEVISGRNP 389
D +S G+ + E++ G P
Sbjct: 184 RYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 6e-07
Identities = 34/96 (35%), Positives = 51/96 (53%), Gaps = 13/96 (13%)
Query: 299 LTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVA 358
L +LH+ +V+RD+K NILLD + L DFGL+K + T GT Y+A
Sbjct: 109 LEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSK-ANLTDNKTTNTFCGTTEYLA 164
Query: 359 PEYASTGMLNERS-----DVYSFGILIMEVISGRNP 389
PE +L+E+ D +S G+L+ E+ G +P
Sbjct: 165 PEV----LLDEKGYTKHVDFWSLGVLVFEMCCGWSP 196
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 6e-07
Identities = 54/221 (24%), Positives = 90/221 (40%), Gaps = 18/221 (8%)
Query: 178 LRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKE----FKVEV 233
+R+L + + VIG G +G V + V LL+ ++ F E
Sbjct: 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEER 94
Query: 234 EAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHG-DVGPHSPLTWEIRMNII 292
+ + +V+L + + +V EY+ G+L + DV P W
Sbjct: 95 DIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDV----PEKWAR----- 145
Query: 293 LGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMG 352
TA+ + L +HRD+K N+LLDK + KL+DFG + E +G
Sbjct: 146 FYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVG 205
Query: 353 TFGYVAPEYAST----GMLNERSDVYSFGILIMEVISGRNP 389
T Y++PE + G D +S G+ + E++ G P
Sbjct: 206 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 8e-07
Identities = 33/99 (33%), Positives = 55/99 (55%), Gaps = 11/99 (11%)
Query: 296 AKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGT-- 353
A+G+ +L +HRD+ + N+LL K+ DFGLA+ + + +YV V G
Sbjct: 222 AQGMDFLAS---KNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYV---VKGNAR 275
Query: 354 --FGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNP 389
++APE + +SDV+S+GIL+ E+ S G++P
Sbjct: 276 LPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSP 314
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 9e-07
Identities = 31/93 (33%), Positives = 52/93 (55%), Gaps = 10/93 (10%)
Query: 297 KGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS-YVTTRVMGTFG 355
+GL Y+H ++HRD+K SN+ +++ ++ DFGLA+ E + YV TR
Sbjct: 129 RGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATR-----W 180
Query: 356 YVAPEYASTGM-LNERSDVYSFGILIMEVISGR 387
Y APE M N+ D++S G ++ E++ G+
Sbjct: 181 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 9e-07
Identities = 32/93 (34%), Positives = 52/93 (55%), Gaps = 8/93 (8%)
Query: 296 AKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTF- 354
A+G+ +L VHRD+ + N+LL + K+ DFGLA+ + + +YV+ TF
Sbjct: 247 ARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKG--STFL 301
Query: 355 --GYVAPEYASTGMLNERSDVYSFGILIMEVIS 385
++APE + SDV+S+GIL+ E+ S
Sbjct: 302 PVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.0 bits (120), Expect = 1e-06
Identities = 63/237 (26%), Positives = 92/237 (38%), Gaps = 53/237 (22%)
Query: 193 VIGEGGYGIVYHGVLEDNTNV--AVKNLLNNRGQAEKEFKV-----EVEAIGRVRHKNLV 245
++G+G G V+ V T A+K L + K KV E E + + H L
Sbjct: 8 LLGKGDVGRVFL-VRLKGTGKLFALKVLDKK--EMIKRNKVKRVLTEQEILATLDHPFLP 64
Query: 246 RLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWE-IRM---NIILGTAKGLTY 301
L + LV +Y G L + L P L+ E R ++L L Y
Sbjct: 65 TLYASFQTETYLCLVMDYCPGGELFRLL--QRQPGKCLSEEVARFYAAEVLLA----LEY 118
Query: 302 LH-EGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG-------------------- 340
LH G +V+RD+K NILL + + LSDF L+K
Sbjct: 119 LHLLG----IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVN 174
Query: 341 --------AERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNP 389
E S+ + +GT Y+APE S D ++ GIL+ E++ G P
Sbjct: 175 SIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTP 231
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 62/263 (23%), Positives = 104/263 (39%), Gaps = 50/263 (19%)
Query: 188 FADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKE----FKVEVEAIGRVRHKN 243
F VIG G +G V +D ++ +L EKE + E + +
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAW 62
Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 303
+V++ + + L+ E++ G++ L L+ E I T + +H
Sbjct: 63 VVKMFYSFQDKRNLYLIMEFLPGGDMMTLLM----KKDTLSEEATQFYIAETVLAIDAIH 118
Query: 304 EGLEPKVVHRDIKSSNILLDKQWNPKLSDFGL---------------------------- 335
+ +HRDIK N+LLD + + KLSDFGL
Sbjct: 119 Q---LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQN 175
Query: 336 ------AKLLGAERSYVTTRVMGTFGYVAPE-YASTGMLNERSDVYSFGILIMEVISGRN 388
A+ R + +GT Y+APE + TG N+ D +S G+++ E++ G
Sbjct: 176 MNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGY-NKLCDWWSLGVIMYEMLIGYP 234
Query: 389 PVDYSRPPGEV--NLVEWLKTMV 409
P S P E ++ W +T+V
Sbjct: 235 PF-CSETPQETYRKVMNWKETLV 256
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 49.6 bits (119), Expect = 1e-06
Identities = 57/210 (27%), Positives = 98/210 (46%), Gaps = 22/210 (10%)
Query: 194 IGEGGYGIVYHG-VLEDNTNVAVKNLLNNRGQAEKEFKV-EVEAIGRVR-HKNLVRLLG- 249
IGEG + V + A+K + + E+ + E++A+ R+ H N++RL+
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEV 66
Query: 250 -YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEP 308
+ + LV+E +D NL + + G P + M +L K L ++H
Sbjct: 67 LFDRKTGRLALVFELMD-MNLYELIKGRKRPLPEKRVKSYMYQLL---KSLDHMHRN--- 119
Query: 309 KVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPE-YASTGML 367
+ HRDIK NIL+ K KL+DFG + + ++ Y T + T Y APE + G
Sbjct: 120 GIFHRDIKPENILI-KDDILKLADFGSCRGIYSKPPY--TEYISTRWYRAPECLLTDGYY 176
Query: 368 NERSDVYSFGILIMEVIS------GRNPVD 391
+ D+++ G + E++S G N +D
Sbjct: 177 GPKMDIWAVGCVFFEILSLFPLFPGTNELD 206
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 4e-06
Identities = 44/193 (22%), Positives = 75/193 (38%), Gaps = 34/193 (17%)
Query: 208 EDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLV------- 260
E V VK K E++ + + H+ ++ L+ + +V
Sbjct: 117 EQRKKVIVK-----AVTGGKTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKCD 171
Query: 261 -YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSN 319
+ Y+D PL E + I + L YLH ++HRD+K+ N
Sbjct: 172 LFTYVDR-------------SGPLPLEQAITIQRRLLEALAYLHG---RGIIHRDVKTEN 215
Query: 320 ILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYV---APEYASTGMLNERSDVYSF 376
I LD+ N L DFG A L A T + G G + +PE + ++D++S
Sbjct: 216 IFLDEPENAVLGDFGAACKLDA--HPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSA 273
Query: 377 GILIMEVISGRNP 389
G+++ E+
Sbjct: 274 GLVLFEMSVKNVT 286
|
Length = 392 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 4e-06
Identities = 27/84 (32%), Positives = 43/84 (51%), Gaps = 5/84 (5%)
Query: 311 VHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAST-----G 365
VHRDIK NIL+D + +L+DFG L + + ++ +GT Y++PE G
Sbjct: 124 VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKG 183
Query: 366 MLNERSDVYSFGILIMEVISGRNP 389
D +S G+ + E++ G P
Sbjct: 184 KYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 6e-06
Identities = 26/84 (30%), Positives = 43/84 (51%), Gaps = 5/84 (5%)
Query: 311 VHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAST-----G 365
VHRDIK N+LLD + +L+DFG + + + ++ +GT Y++PE G
Sbjct: 124 VHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMG 183
Query: 366 MLNERSDVYSFGILIMEVISGRNP 389
D +S G+ + E++ G P
Sbjct: 184 KYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 1e-05
Identities = 38/115 (33%), Positives = 57/115 (49%), Gaps = 25/115 (21%)
Query: 290 NIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTR 349
NI+ G +GL YLH+ +HR+IK+S+IL+ LS GL+ L R+ +
Sbjct: 105 NILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLS--GLSHLYSLVRNGQKAK 159
Query: 350 VMGTFGYVAPEYASTGML---------------NERSDVYSFGILIMEVISGRNP 389
V+ F P++ ST +L N +SD+YS GI E+ +GR P
Sbjct: 160 VVYDF----PQF-STSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 1e-05
Identities = 30/93 (32%), Positives = 51/93 (54%), Gaps = 8/93 (8%)
Query: 296 AKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTF- 354
A G+ +L VHRD+ + N+L+ + K+ DFGLA+ + + +Y++ TF
Sbjct: 249 ANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKG--STFL 303
Query: 355 --GYVAPEYASTGMLNERSDVYSFGILIMEVIS 385
++APE + SDV+SFGIL+ E+ +
Sbjct: 304 PLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 2e-05
Identities = 40/141 (28%), Positives = 61/141 (43%), Gaps = 46/141 (32%)
Query: 311 VHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTT---------------------- 348
+HRDIK N+LLD + + KLSDFGL G ++S+ T
Sbjct: 123 IHRDIKPDNLLLDAKGHIKLSDFGLCT--GLKKSHRTEFYRILSHALPSNFLDFISKPMS 180
Query: 349 ------------RVM-----GTFGYVAPE-YASTGMLNERSDVYSFGILIMEVISGRNPV 390
R + GT Y+APE + TG N+ D +S G+++ E++ G P
Sbjct: 181 SKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGY-NKECDWWSLGVIMYEMLVGYPPF 239
Query: 391 DYSRPPGEV--NLVEWLKTMV 409
S P E ++ W +T+
Sbjct: 240 -CSDNPQETYRKIINWKETLQ 259
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 3e-05
Identities = 28/95 (29%), Positives = 47/95 (49%), Gaps = 9/95 (9%)
Query: 297 KGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL---LGAERSYVTTRVMGT 353
+ + YLHE +++HRDIK+ NI ++ + L DFG A + A + Y GT
Sbjct: 193 RAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWA---GT 246
Query: 354 FGYVAPEYASTGMLNERSDVYSFGILIMEVISGRN 388
APE + D++S GI++ E+ + +
Sbjct: 247 IATNAPELLARDPYGPAVDIWSAGIVLFEMATCHD 281
|
Length = 391 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 3e-05
Identities = 29/105 (27%), Positives = 49/105 (46%), Gaps = 19/105 (18%)
Query: 310 VVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER---------------SYVTT--RVMG 352
V+HRD+K NILL + D+G A E S +T +++G
Sbjct: 134 VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVG 193
Query: 353 TFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPG 397
T Y+APE +E +D+Y+ G+++ ++++ P Y R G
Sbjct: 194 TPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP--YRRKKG 236
|
Length = 932 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 1e-04
Identities = 27/80 (33%), Positives = 44/80 (55%), Gaps = 7/80 (8%)
Query: 259 LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSS 318
LV EY+ G+++ LH + E+ + I A L YLH ++HRD+K
Sbjct: 81 LVMEYLIGGDVKSLLH----IYGYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPD 133
Query: 319 NILLDKQWNPKLSDFGLAKL 338
N+L+ + + KL+DFGL+K+
Sbjct: 134 NMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 43.7 bits (104), Expect = 1e-04
Identities = 32/106 (30%), Positives = 51/106 (48%), Gaps = 11/106 (10%)
Query: 290 NIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLD-KQWNPKLSDFGLAKLLGAERSYVTT 348
II + L LH+ ++H DIK N+L D + L D+GL K++G Y
Sbjct: 113 KIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCY--- 166
Query: 349 RVMGTFGYVAPEYASTGMLNERS-DVYSFGILIMEVISGRNPVDYS 393
GT Y +PE G + S D ++ G+L E+++G++P
Sbjct: 167 --DGTLDYFSPEKIK-GHNYDVSFDWWAVGVLTYELLTGKHPFKED 209
|
Length = 267 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 1e-04
Identities = 51/196 (26%), Positives = 78/196 (39%), Gaps = 30/196 (15%)
Query: 243 NLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSP----LTWEIRMNIILGTAKG 298
N+V L Y LV ++ + G L W H + P W M + L
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKL--WSHISKFLNIPEECVKRWAAEMVVALDA--- 100
Query: 299 LTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVA 358
LH +V RD+ +NILLD + + +L+ F + E S V Y A
Sbjct: 101 ---LHR---EGIVCRDLNPNNILLDDRGHIQLTYFS--RWSEVEDSCDGEAVENM--YCA 150
Query: 359 PEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPG-----EVNLVEWLKTMVTNRN 413
PE E D +S G ++ E+++G+ V+ P G +N+ EW+ +
Sbjct: 151 PEVGGISEETEACDWWSLGAILFELLTGKTLVE-CHPSGINTHTTLNIPEWV-----SEE 204
Query: 414 AEGVLDPRLQEKPCSR 429
A +L LQ P R
Sbjct: 205 ARSLLQQLLQFNPTER 220
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 2e-04
Identities = 36/142 (25%), Positives = 55/142 (38%), Gaps = 45/142 (31%)
Query: 311 VHRDIKSSNILLDKQWNPKLSDFGL----------------------------------- 335
+HRDIK NIL+D+ + KL+DFGL
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDR 182
Query: 336 AKLLGAERSYVT--TRVM-----GTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRN 388
+L ER R + GT Y+APE + D +S G+++ E++ G+
Sbjct: 183 CRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQP 242
Query: 389 PVDYSRPPGEVNL--VEWLKTM 408
P + P E L + W T+
Sbjct: 243 PF-LADTPAETQLKVINWETTL 263
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 43.1 bits (102), Expect = 2e-04
Identities = 47/195 (24%), Positives = 84/195 (43%), Gaps = 25/195 (12%)
Query: 210 NTNVAVKNLLNNRGQAEKEFKV---EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDN 266
NT VAVK + N ++++ K+ E+ +++H N++ + + +V +
Sbjct: 25 NTLVAVKKI-NLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAY 83
Query: 267 GNLEQWL--HGDVG-PHSPLTWEIRMNIILGTAKGLTYLH-EGLEPKVVHRDIKSSNILL 322
G+ E L H G P + I+ L Y+H +G +HR +K+S+ILL
Sbjct: 84 GSCEDLLKTHFPEGLPELAIA-----FILKDVLNALDYIHSKGF----IHRSVKASHILL 134
Query: 323 DKQWNPKLSDFGLAKLL--GAERSYV----TTRVMGTFGYVAPEYASTGML--NERSDVY 374
LS + + +R V + +++PE + NE+SD+Y
Sbjct: 135 SGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIY 194
Query: 375 SFGILIMEVISGRNP 389
S GI E+ +G P
Sbjct: 195 SVGITACELANGHVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 3e-04
Identities = 16/26 (61%), Positives = 21/26 (80%)
Query: 311 VHRDIKSSNILLDKQWNPKLSDFGLA 336
+HRDIK NIL+D+ + KLSDFGL+
Sbjct: 123 IHRDIKPDNILIDRGGHIKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.001
Identities = 27/84 (32%), Positives = 43/84 (51%), Gaps = 6/84 (7%)
Query: 301 YLH-EGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL-GAERSYVTTRVMGTFGYVA 358
Y+H EG ++HRDIK+ N+L++ + L DFG A G+ + + GT A
Sbjct: 275 YIHGEG----IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNA 330
Query: 359 PEYASTGMLNERSDVYSFGILIME 382
PE + D++S G++I E
Sbjct: 331 PEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.001
Identities = 51/235 (21%), Positives = 96/235 (40%), Gaps = 26/235 (11%)
Query: 173 GHWYTL--RELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFK 230
GH+Y + +++VST F +++GEG +G V ++ N + ++ K
Sbjct: 114 GHFYVVLGEDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAK 173
Query: 231 VEVEAIGRVRHKN------LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLT 284
+E++ + +VR + L+++ Y M + L W+ H P +
Sbjct: 174 IEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCIVMPKYGPCLLDWIM----KHGPFS 229
Query: 285 WEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLD-----------KQWNPKLSDF 333
II T L Y H E ++H D+K NIL++ + P
Sbjct: 230 HRHLAQIIFQTGVALDYFHT--ELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRV 287
Query: 334 GLAKLLG-AERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGR 387
+ L G + + T ++ T Y +PE +D++S G +I E+ +G+
Sbjct: 288 RICDLGGCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGK 342
|
Length = 467 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 508 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.98 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.98 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.97 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.97 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.96 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.96 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.95 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.95 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.94 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.93 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.92 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.91 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.9 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.9 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.9 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.89 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.88 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.86 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.86 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.86 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.84 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.84 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.84 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.83 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.82 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.79 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.78 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.78 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.77 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.75 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.75 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.75 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.68 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.67 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.67 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.66 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.56 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.49 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.49 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.42 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.38 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.38 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.3 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.28 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.21 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.2 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.2 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.19 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.05 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.02 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.01 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.96 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.85 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.72 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.72 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.68 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.55 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.5 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.47 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.39 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.39 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.36 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.23 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.22 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.15 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.08 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.06 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.93 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.91 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.88 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.87 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.85 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.78 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.63 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.56 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.47 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.42 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.39 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.34 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.29 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.21 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.11 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.07 | |
| PLN02236 | 344 | choline kinase | 97.06 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 97.05 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.7 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.62 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.53 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.36 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.35 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 96.3 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.27 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 96.26 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.08 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 95.79 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 95.63 | |
| PF13908 | 179 | Shisa: Wnt and FGF inhibitory regulator | 95.55 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.5 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 95.38 | |
| PF01102 | 122 | Glycophorin_A: Glycophorin A; InterPro: IPR001195 | 95.09 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 95.02 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 95.0 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-54 Score=435.15 Aligned_cols=290 Identities=55% Similarity=0.940 Sum_probs=256.8
Q ss_pred CCcccchhhHhhcCCCCcccceEcccCcEEEEEEEECCCcEEEEEEeecCCchhHHHHHHHHHHHHccCCCCeeeEeeee
Q 010513 172 WGHWYTLRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYC 251 (508)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~ 251 (508)
....|++.++..++++|...+.||+|+||.||+|...+++.||||++.....+...+|..|++++.+++|||+|+++|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 45668999999999999999999999999999999998899999987665443155699999999999999999999999
Q ss_pred ecCC-eeEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEE
Q 010513 252 AEGA-HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKL 330 (508)
Q Consensus 252 ~~~~-~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL 330 (508)
.+.+ +.+||||||++|+|.++|+..... +++|..+++|+.++|+||+|||+.+.+.|||||||++|||+|+++++||
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKl 218 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKL 218 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEc
Confidence 9988 599999999999999999887432 8999999999999999999999998889999999999999999999999
Q ss_pred eeeccceecCCCCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhc
Q 010513 331 SDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVT 410 (508)
Q Consensus 331 ~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~ 410 (508)
+|||+|+..........+...||.+|+|||++..+..++|+|||||||+|.||+||+.|.+...+..+.++.+|.+..+.
T Consensus 219 sDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~ 298 (361)
T KOG1187|consen 219 SDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLE 298 (361)
T ss_pred cCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHH
Confidence 99999976543111111111799999999999999999999999999999999999999998777777789999999999
Q ss_pred ccccccCCCccCC-CCchH-HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 010513 411 NRNAEGVLDPRLQ-EKPCS-RALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEE 463 (508)
Q Consensus 411 ~~~~~~~~~~~l~-~~~~~-~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~~~ 463 (508)
++...+++|+.+. ..... ..+.++..++.+|++.+|++||+|.+|+++|+...
T Consensus 299 ~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~ 353 (361)
T KOG1187|consen 299 EGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL 353 (361)
T ss_pred CcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence 9999999999987 44333 68888999999999999999999999999995443
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-50 Score=388.23 Aligned_cols=254 Identities=23% Similarity=0.385 Sum_probs=209.3
Q ss_pred cCCCCcccceEcccCcEEEEEEEE-CCCcEEEEEEeecCCch-------hHHHHHHHHHHHHccCCCCeeeEeeeeecCC
Q 010513 184 STNGFADENVIGEGGYGIVYHGVL-EDNTNVAVKNLLNNRGQ-------AEKEFKVEVEAIGRVRHKNLVRLLGYCAEGA 255 (508)
Q Consensus 184 ~~~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-------~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~ 255 (508)
..+.|.+.+.||+|+||.|-+|.. +++++||||++.+.... ....+.+|+++|++|+|||||+++++|+..+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 456789999999999999999995 47999999999654221 2234678999999999999999999999999
Q ss_pred eeEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCC---CCeEEee
Q 010513 256 HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQ---WNPKLSD 332 (508)
Q Consensus 256 ~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~---~~~kL~D 332 (508)
..||||||++||+|.+++-.+ +.+.+..-+.++.|++.|+.|||++ ||+||||||+|||+..+ ..+||+|
T Consensus 250 s~YmVlE~v~GGeLfd~vv~n----k~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItD 322 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVAN----KYLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITD 322 (475)
T ss_pred ceEEEEEEecCccHHHHHHhc----cccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEecc
Confidence 999999999999999999775 5788888899999999999999999 99999999999999665 6799999
Q ss_pred eccceecCCCCcceecceecCCCCCChhhhhcCC---CCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhh
Q 010513 333 FGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGM---LNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMV 409 (508)
Q Consensus 333 FG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~ 409 (508)
||+|+..+ ....+.++||||.|.|||++.++. +..+.|+||+||+||-+++|.+||....... . +++++
T Consensus 323 FGlAK~~g--~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~--s----l~eQI 394 (475)
T KOG0615|consen 323 FGLAKVSG--EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP--S----LKEQI 394 (475)
T ss_pred cchhhccc--cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc--c----HHHHH
Confidence 99999875 445577799999999999997764 3347899999999999999999997654332 1 12233
Q ss_pred cccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 410 TNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 410 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
..++.. +......+...+.+++|.+||..||++||++.|++++
T Consensus 395 ~~G~y~------f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 395 LKGRYA------FGPLQWDRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred hcCccc------ccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 322211 1122245566777889999999999999999999875
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-49 Score=380.91 Aligned_cols=253 Identities=27% Similarity=0.453 Sum_probs=210.5
Q ss_pred CCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecC-CchhHHHHHHHHHHHHccCCCCeeeEeeeeecCC-eeEEEEE
Q 010513 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGA-HRMLVYE 262 (508)
Q Consensus 186 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-~~~lV~e 262 (508)
++.+..+.||+|..|+||++.++ +++-+|+|.+... .....+++.+|+++++..+|||||.+||.|..+. .+.++||
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mE 158 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICME 158 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehh
Confidence 45666889999999999999987 5777899999443 4455678999999999999999999999999988 5999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCC
Q 010513 263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE-GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA 341 (508)
Q Consensus 263 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 341 (508)
||++|+|++++... +.+++....+++.++++||.|||+ . +||||||||+|||++..|++||||||.+..+-.
T Consensus 159 YMDgGSLd~~~k~~----g~i~E~~L~~ia~~VL~GL~YLh~~~---~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvn 231 (364)
T KOG0581|consen 159 YMDGGSLDDILKRV----GRIPEPVLGKIARAVLRGLSYLHEER---KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVN 231 (364)
T ss_pred hcCCCCHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhhcc---CeeeccCCHHHeeeccCCCEEeccccccHHhhh
Confidence 99999999999765 679999999999999999999996 5 999999999999999999999999999987633
Q ss_pred CCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCCcc
Q 010513 342 ERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPR 421 (508)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 421 (508)
. ...+++||..|||||.+.+..|+.++||||||++++|+.+|+.||....+ ......+.+.....+ ..|.
T Consensus 232 S---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~-~~~~~~~Ll~~Iv~~------ppP~ 301 (364)
T KOG0581|consen 232 S---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNP-PYLDIFELLCAIVDE------PPPR 301 (364)
T ss_pred h---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCC-CCCCHHHHHHHHhcC------CCCC
Confidence 3 55678999999999999999999999999999999999999999976521 122333333333321 1244
Q ss_pred CCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 422 LQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 422 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
+....++.+.+. ++..||++||.+||++.|++++
T Consensus 302 lP~~~fS~ef~~---FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 302 LPEGEFSPEFRS---FVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred CCcccCCHHHHH---HHHHHhcCCcccCCCHHHHhcC
Confidence 444434445554 6669999999999999999875
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-49 Score=398.81 Aligned_cols=248 Identities=25% Similarity=0.418 Sum_probs=210.4
Q ss_pred CCCcccceEcccCcEEEEEEEE-CCCcEEEEEEeecC---CchhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEE
Q 010513 186 NGFADENVIGEGGYGIVYHGVL-EDNTNVAVKNLLNN---RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY 261 (508)
Q Consensus 186 ~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 261 (508)
.+|...+.||+|||+.||.+++ ..|..||+|++.+. .....+.+.+||++.++|+|||||+|+++|++.+++|||+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5799999999999999999997 78999999999653 3445677889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCC
Q 010513 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA 341 (508)
Q Consensus 262 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 341 (508)
|+|..++|..+++++ .++++.+++.++.||+.||.|||++ +|+|||||..|+|++++.++||+|||+|..+..
T Consensus 98 ELC~~~sL~el~Krr----k~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~ 170 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRR----KPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEY 170 (592)
T ss_pred EecCCccHHHHHHhc----CCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecC
Confidence 999999999999854 7899999999999999999999999 999999999999999999999999999998854
Q ss_pred CCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCCcc
Q 010513 342 ERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPR 421 (508)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 421 (508)
+.. ...+.||||.|.|||++....++..+||||+||+||.|+.|++||+.. ++.+.......+. ..-|.
T Consensus 171 ~~E-rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk------~vkety~~Ik~~~----Y~~P~ 239 (592)
T KOG0575|consen 171 DGE-RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETK------TVKETYNKIKLNE----YSMPS 239 (592)
T ss_pred ccc-ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccc------hHHHHHHHHHhcC----ccccc
Confidence 433 344589999999999999999999999999999999999999999632 2333332222211 11111
Q ss_pred CCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 422 LQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 422 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
....+..+||.++|++||.+||++++|+.+
T Consensus 240 -------~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 240 -------HLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred -------ccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 222344457789999999999999999964
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-49 Score=379.57 Aligned_cols=199 Identities=27% Similarity=0.518 Sum_probs=180.8
Q ss_pred CCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecC--CchhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEE
Q 010513 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE 262 (508)
Q Consensus 186 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e 262 (508)
.+|...+.||+|+||+||+|+++ ++..||||.+.+. .....+-+..|+++|+.++|||||.++++++.++.+|+|||
T Consensus 10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVME 89 (429)
T KOG0595|consen 10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVME 89 (429)
T ss_pred ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEE
Confidence 47888899999999999999965 5889999999766 44555677889999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCC------CCeEEeeeccc
Q 010513 263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQ------WNPKLSDFGLA 336 (508)
Q Consensus 263 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~------~~~kL~DFG~a 336 (508)
||+||||.+|++.+ +.+++..++.++.|+|.||++||++ +||||||||.||||+.. -.+||+|||+|
T Consensus 90 yC~gGDLs~yi~~~----~~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA 162 (429)
T KOG0595|consen 90 YCNGGDLSDYIRRR----GRLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGFA 162 (429)
T ss_pred eCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence 99999999999886 5899999999999999999999999 99999999999999764 45899999999
Q ss_pred eecCCCCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCC
Q 010513 337 KLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS 393 (508)
Q Consensus 337 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~ 393 (508)
+.+.. .....+.||+|.|||||+++.+.|+.|+|+||+|++||+|++|+.||+..
T Consensus 163 R~L~~--~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~ 217 (429)
T KOG0595|consen 163 RFLQP--GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAE 217 (429)
T ss_pred hhCCc--hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCcccc
Confidence 98753 34456689999999999999999999999999999999999999999743
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-48 Score=390.26 Aligned_cols=260 Identities=32% Similarity=0.576 Sum_probs=212.5
Q ss_pred hcCCCCcccceEcccCcEEEEEEEECCCcEEEEEEeecCCch--hHHHHHHHHHHHHccCCCCeeeEeeeeecCC-eeEE
Q 010513 183 VSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQ--AEKEFKVEVEAIGRVRHKNLVRLLGYCAEGA-HRML 259 (508)
Q Consensus 183 ~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-~~~l 259 (508)
+....+.+.+.||+|+||+||+|.+.....||||++...... ..+.|.+|+.+|.+++|||||+|+|++.+.. ..++
T Consensus 38 i~~~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~i 117 (362)
T KOG0192|consen 38 IDPDELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCI 117 (362)
T ss_pred cChHHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEE
Confidence 344455667779999999999999985544999999764322 2568999999999999999999999999887 7899
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-eeeccCCCCCEEEcCCC-CeEEeeeccce
Q 010513 260 VYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK-VVHRDIKSSNILLDKQW-NPKLSDFGLAK 337 (508)
Q Consensus 260 V~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~-iiHrDlkp~NIll~~~~-~~kL~DFG~a~ 337 (508)
||||+++|+|.+++++. ....+++..++.++.|||+|+.|||++ + ||||||||+|||++.++ ++||+|||+++
T Consensus 118 VtEy~~~GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr 192 (362)
T KOG0192|consen 118 VTEYMPGGSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSR 192 (362)
T ss_pred EEEeCCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccce
Confidence 99999999999999874 247899999999999999999999999 7 99999999999999998 99999999999
Q ss_pred ecCCCCcceecceecCCCCCChhhhh--cCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccc
Q 010513 338 LLGAERSYVTTRVMGTFGYVAPEYAS--TGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAE 415 (508)
Q Consensus 338 ~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (508)
...... ...+...||+.|||||++. ...|+.|+||||||++||||+||+.||....+ .+....+..+.
T Consensus 193 ~~~~~~-~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~------~~~~~~v~~~~--- 262 (362)
T KOG0192|consen 193 EKVISK-TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP------VQVASAVVVGG--- 262 (362)
T ss_pred eecccc-ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH------HHHHHHHHhcC---
Confidence 764332 3344478999999999999 56899999999999999999999999985543 22222333222
Q ss_pred cCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 010513 416 GVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEE 463 (508)
Q Consensus 416 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~~~ 463 (508)
..|.+... ++..+.. ++.+||+.||++||++.+++..|+...
T Consensus 263 --~Rp~~p~~-~~~~l~~---l~~~CW~~dp~~RP~f~ei~~~l~~~~ 304 (362)
T KOG0192|consen 263 --LRPPIPKE-CPPHLSS---LMERCWLVDPSRRPSFLEIVSRLESIM 304 (362)
T ss_pred --CCCCCCcc-CCHHHHH---HHHHhCCCCCCcCCCHHHHHHHHHHHH
Confidence 22222222 4444444 777999999999999999999999643
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-49 Score=364.12 Aligned_cols=260 Identities=23% Similarity=0.352 Sum_probs=209.7
Q ss_pred CCCcccceEcccCcEEEEEEEE-CCCcEEEEEEeecC--CchhHHHHHHHHHHHHccCCCCeeeEee-eeecCCe-eEEE
Q 010513 186 NGFADENVIGEGGYGIVYHGVL-EDNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLLG-YCAEGAH-RMLV 260 (508)
Q Consensus 186 ~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~-~~~~~~~-~~lV 260 (508)
.+|.++++||+|.||+||++.+ .+|..+|.|.+.-. .....+....|+.+|++|+|||||++++ .|.+++. +++|
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 4688999999999999999994 57899999988633 2334567888999999999999999999 4555555 7899
Q ss_pred EEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CeeeccCCCCCEEEcCCCCeEEeeeccceec
Q 010513 261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEP-KVVHRDIKSSNILLDKQWNPKLSDFGLAKLL 339 (508)
Q Consensus 261 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~-~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~ 339 (508)
||||++|||.+.++........+++..+|+++.|++.||.++|+++.+ -|+||||||.||+++.+|.+||+|||+++.+
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 999999999999987766678899999999999999999999985322 2999999999999999999999999999988
Q ss_pred CCCCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCC
Q 010513 340 GAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLD 419 (508)
Q Consensus 340 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 419 (508)
..... .....+|||+||+||.+....|+.+|||||+||++|||+.-+.||.+. ++.+..++ +..+..
T Consensus 179 ~s~~t-fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~------n~~~L~~K-I~qgd~----- 245 (375)
T KOG0591|consen 179 SSKTT-FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD------NLLSLCKK-IEQGDY----- 245 (375)
T ss_pred cchhH-HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc------cHHHHHHH-HHcCCC-----
Confidence 55443 345689999999999999999999999999999999999999999744 33333332 222211
Q ss_pred ccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 010513 420 PRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461 (508)
Q Consensus 420 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~ 461 (508)
+.+..+. ...++..|+..|++.||+.||+...+++.+..
T Consensus 246 ~~~p~~~---YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 246 PPLPDEH---YSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred CCCcHHH---hhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 1122122 33445557779999999999996666655554
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-48 Score=384.81 Aligned_cols=263 Identities=27% Similarity=0.455 Sum_probs=220.0
Q ss_pred hhhHhhcCCCCcccceEcccCcEEEEEEEECCCcEEEEEEeecCCchhHHHHHHHHHHHHccCCCCeeeEeeeeecCCee
Q 010513 178 LRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHR 257 (508)
Q Consensus 178 ~~~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 257 (508)
...+++..+.+..++.||+|.||+||.|.++...+||+|.++.. ....+.|.+|+++|++|+|+|||+++++|..+..+
T Consensus 198 ~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~pi 276 (468)
T KOG0197|consen 198 RDPWEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPI 276 (468)
T ss_pred cCCeeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCce
Confidence 34446677778889999999999999999998889999998765 45567888999999999999999999999998899
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccce
Q 010513 258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK 337 (508)
Q Consensus 258 ~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~ 337 (508)
|||||||+.|+|.++|+... +..+...+.+.++.|||+|++||+++ ++|||||...||||+++..+||+|||+|+
T Consensus 277 yIVtE~m~~GsLl~yLr~~~--~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr 351 (468)
T KOG0197|consen 277 YIVTEYMPKGSLLDYLRTRE--GGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLAR 351 (468)
T ss_pred EEEEEecccCcHHHHhhhcC--CCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEccccccc
Confidence 99999999999999998732 46788999999999999999999999 99999999999999999999999999999
Q ss_pred ecCCCCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHhhccccccc
Q 010513 338 LLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEG 416 (508)
Q Consensus 338 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 416 (508)
...++.........-...|.|||.++.+.++.|||||||||+||||+| |+.||..... .+.+.......+.
T Consensus 352 ~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn------~ev~~~le~GyRl-- 423 (468)
T KOG0197|consen 352 LIGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSN------EEVLELLERGYRL-- 423 (468)
T ss_pred ccCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCH------HHHHHHHhccCcC--
Confidence 665444444444445668999999999999999999999999999999 9999975433 2222222222211
Q ss_pred CCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010513 417 VLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (508)
Q Consensus 417 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~~ 462 (508)
-.++.|+..+.+ ++..||+.+|++|||++.+...|+..
T Consensus 424 -----p~P~~CP~~vY~---lM~~CW~~~P~~RPtF~~L~~~l~~~ 461 (468)
T KOG0197|consen 424 -----PRPEGCPDEVYE---LMKSCWHEDPEDRPTFETLREVLEDF 461 (468)
T ss_pred -----CCCCCCCHHHHH---HHHHHhhCCcccCCCHHHHHHHHHHh
Confidence 123446666666 88899999999999999999888764
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-47 Score=365.89 Aligned_cols=243 Identities=25% Similarity=0.347 Sum_probs=201.4
Q ss_pred cCCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCc---hhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEE
Q 010513 184 STNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG---QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRML 259 (508)
Q Consensus 184 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 259 (508)
..++|++.++||+|+||+||+++.+ +++-+|+|.+.+... ...+....|..+|..++||+||+++..|++...+|+
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl 102 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL 102 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence 3468999999999999999999965 577899999876532 335667889999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceec
Q 010513 260 VYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL 339 (508)
Q Consensus 260 V~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~ 339 (508)
|+||+.||+|...|++. +.+++..+.-++..|+.||.|||++ +||||||||+|||+|.+|+++|+|||+++..
T Consensus 103 Vld~~~GGeLf~hL~~e----g~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~ 175 (357)
T KOG0598|consen 103 VLDYLNGGELFYHLQRE----GRFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKED 175 (357)
T ss_pred EEeccCCccHHHHHHhc----CCcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhc
Confidence 99999999999999876 6899999999999999999999999 9999999999999999999999999999864
Q ss_pred CCCCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCC
Q 010513 340 GAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLD 419 (508)
Q Consensus 340 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 419 (508)
. .....+.++|||+.|||||++.+..|+..+|+||||+++|||++|..||...+ ..++.......+ ..
T Consensus 176 ~-~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~------~~~~~~~I~~~k---~~-- 243 (357)
T KOG0598|consen 176 L-KDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAED------VKKMYDKILKGK---LP-- 243 (357)
T ss_pred c-cCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCcc------HHHHHHHHhcCc---CC--
Confidence 3 33344556899999999999999999999999999999999999999997543 222222222221 00
Q ss_pred ccCCCCchHHHHHHHHHHHHHccCCCCCCCC
Q 010513 420 PRLQEKPCSRALKRALLVALRCVDPNAHKRP 450 (508)
Q Consensus 420 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP 450 (508)
......+ .+..+++.+.|..||++|-
T Consensus 244 --~~p~~ls---~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 244 --LPPGYLS---EEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred --CCCccCC---HHHHHHHHHHhccCHHHhc
Confidence 0111122 3344477799999999996
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=350.01 Aligned_cols=265 Identities=23% Similarity=0.345 Sum_probs=210.9
Q ss_pred CCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCc--hhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEE
Q 010513 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG--QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE 262 (508)
Q Consensus 186 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e 262 (508)
+.|+...++|+|+||+||+|+.+ +|+-||||++..... ...+-..+|+++|++++|+|+|.++++|.....+++|+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 46888999999999999999976 588899999976543 334567789999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCC
Q 010513 263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE 342 (508)
Q Consensus 263 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 342 (508)
||+. ++.+-|... ...++...+.+++.|+++|+.|+|++ ++|||||||+||||+.+|.+||||||+|+.+..
T Consensus 82 ~~dh-TvL~eLe~~---p~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~- 153 (396)
T KOG0593|consen 82 YCDH-TVLHELERY---PNGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSA- 153 (396)
T ss_pred ecch-HHHHHHHhc---cCCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcC-
Confidence 9998 666666665 35688999999999999999999999 999999999999999999999999999998865
Q ss_pred CcceecceecCCCCCChhhhhc-CCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHH--------HHhhc-cc
Q 010513 343 RSYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWL--------KTMVT-NR 412 (508)
Q Consensus 343 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~--------~~~~~-~~ 412 (508)
.....+..+.|.+|.|||.+-+ ..|+...|||++||++.||++|.+-|.+..+.....++... ..... +.
T Consensus 154 pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~ 233 (396)
T KOG0593|consen 154 PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNP 233 (396)
T ss_pred CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCC
Confidence 3344566789999999998877 68999999999999999999999999765443222111110 11111 22
Q ss_pred ccccCCCccCCC-----CchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 413 NAEGVLDPRLQE-----KPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 413 ~~~~~~~~~l~~-----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
.+.++.-|..+. ...+....-+++++..||+.||++|++-++++++
T Consensus 234 ~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 234 FFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred ceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 233332222221 1123344567889999999999999999998864
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-45 Score=364.71 Aligned_cols=253 Identities=24% Similarity=0.358 Sum_probs=210.8
Q ss_pred hcCCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecC---CchhHHHHHHHHHHHHcc-CCCCeeeEeeeeecCCee
Q 010513 183 VSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN---RGQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEGAHR 257 (508)
Q Consensus 183 ~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~ 257 (508)
...++|.+++.||+|+|++|++|+.+ +++.||||++.+. +....+.+..|-+.|.+| .||.|++|+..|+++..+
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL 149 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL 149 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence 45578999999999999999999955 6889999988654 333445677899999999 899999999999999999
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccce
Q 010513 258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK 337 (508)
Q Consensus 258 ~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~ 337 (508)
|+|+||+++|+|.++|++. +.+++..++.++.+|+.||+|||++ |||||||||+|||+|+++++||+|||.|+
T Consensus 150 YFvLe~A~nGdll~~i~K~----Gsfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK 222 (604)
T KOG0592|consen 150 YFVLEYAPNGDLLDLIKKY----GSFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAK 222 (604)
T ss_pred EEEEEecCCCcHHHHHHHh----CcchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeeccccc
Confidence 9999999999999999987 7899999999999999999999999 99999999999999999999999999999
Q ss_pred ecCCCCcc------------eecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHH
Q 010513 338 LLGAERSY------------VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWL 405 (508)
Q Consensus 338 ~~~~~~~~------------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~ 405 (508)
.+...... ....++||..|.+||++..+..+..+|+|+|||+||+|+.|.+||...+ +...++
T Consensus 223 ~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~N---eyliFq-- 297 (604)
T KOG0592|consen 223 ILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAAN---EYLIFQ-- 297 (604)
T ss_pred cCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCcccc---HHHHHH--
Confidence 88542211 1145899999999999999999999999999999999999999997553 222222
Q ss_pred HHhhcccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 010513 406 KTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHML 459 (508)
Q Consensus 406 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 459 (508)
+.+. ++-.+... .+ ....+|+.+.|..||.+|++..+|.++-
T Consensus 298 -kI~~-------l~y~fp~~-fp---~~a~dLv~KLLv~dp~~Rlt~~qIk~Hp 339 (604)
T KOG0592|consen 298 -KIQA-------LDYEFPEG-FP---EDARDLIKKLLVRDPSDRLTSQQIKAHP 339 (604)
T ss_pred -HHHH-------hcccCCCC-CC---HHHHHHHHHHHccCccccccHHHHhhCc
Confidence 2221 11222222 22 3344577799999999999999998763
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=352.67 Aligned_cols=264 Identities=23% Similarity=0.330 Sum_probs=210.1
Q ss_pred hcCCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecC-CchhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEE
Q 010513 183 VSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLV 260 (508)
Q Consensus 183 ~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 260 (508)
...+.|++.++||.|..++||+|++. .+..||||++.-. .....+.+++|+..|+.++||||++++..|..+..+|+|
T Consensus 23 ~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvV 102 (516)
T KOG0582|consen 23 LNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVV 102 (516)
T ss_pred CCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEe
Confidence 44568999999999999999999954 6889999999543 333468899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecC
Q 010513 261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG 340 (508)
Q Consensus 261 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 340 (508)
|.||.+|++.++++... ...+++..+..|++++++||.|||++ |.||||||+.||||+.+|.+||+|||.+..+.
T Consensus 103 mpfMa~GS~ldIik~~~--~~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~ 177 (516)
T KOG0582|consen 103 MPFMAGGSLLDIIKTYY--PDGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLF 177 (516)
T ss_pred ehhhcCCcHHHHHHHHc--cccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeec
Confidence 99999999999998875 34599999999999999999999999 99999999999999999999999999876654
Q ss_pred CCCcce--e-cceecCCCCCChhhhhc--CCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccc
Q 010513 341 AERSYV--T-TRVMGTFGYVAPEYAST--GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAE 415 (508)
Q Consensus 341 ~~~~~~--~-~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (508)
...... . ..++||++|||||++.. ..|+.|+|||||||+..||.+|+.||....+. +.+...+.+...
T Consensus 178 ~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPm------kvLl~tLqn~pp- 250 (516)
T KOG0582|consen 178 DSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPM------KVLLLTLQNDPP- 250 (516)
T ss_pred ccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChH------HHHHHHhcCCCC-
Confidence 333221 1 45689999999999543 46999999999999999999999999754432 222222222110
Q ss_pred cCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 416 GVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 416 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
...-..+..+......+.+..++..||++||++|||+++++++
T Consensus 251 ~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 251 TLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred CcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 0001111112122233456668889999999999999999865
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=367.16 Aligned_cols=262 Identities=24% Similarity=0.296 Sum_probs=211.6
Q ss_pred cchhhHhhcCCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCc---hhHHHHHHHHHHHHccCCCCeeeEeeee
Q 010513 176 YTLRELEVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG---QAEKEFKVEVEAIGRVRHKNLVRLLGYC 251 (508)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~ 251 (508)
..++...+..++|+++++||+|+||.||+|+.+ +|..+|+|++.+... ...+.++.|..+|....+|+||+++..|
T Consensus 131 lR~~R~r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsF 210 (550)
T KOG0605|consen 131 LRLRRTRLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSF 210 (550)
T ss_pred HHhccccCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEe
Confidence 345556778899999999999999999999965 588899999977633 3456788899999999999999999999
Q ss_pred ecCCeeEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEe
Q 010513 252 AEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLS 331 (508)
Q Consensus 252 ~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~ 331 (508)
++..++||||||++|||+..+|... +.|++..+..++.+++.|++.+|+. |+|||||||+|+|||..|++||+
T Consensus 211 QD~~~LYLiMEylPGGD~mTLL~~~----~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLS 283 (550)
T KOG0605|consen 211 QDKEYLYLIMEYLPGGDMMTLLMRK----DTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLS 283 (550)
T ss_pred cCCCeeEEEEEecCCccHHHHHHhc----CcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeec
Confidence 9999999999999999999999876 6899999999999999999999999 99999999999999999999999
Q ss_pred eeccceecCC-----------------------CCc----ce-------------------ecceecCCCCCChhhhhcC
Q 010513 332 DFGLAKLLGA-----------------------ERS----YV-------------------TTRVMGTFGYVAPEYASTG 365 (508)
Q Consensus 332 DFG~a~~~~~-----------------------~~~----~~-------------------~~~~~gt~~y~aPE~~~~~ 365 (508)
|||++.-+.. +.. .. ....+|||.|+|||++.+.
T Consensus 284 DFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~k 363 (550)
T KOG0605|consen 284 DFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGK 363 (550)
T ss_pred cccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcC
Confidence 9999853211 000 00 0124799999999999999
Q ss_pred CCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCCccCCCCchHHHHHHHHHHHHHccCCC
Q 010513 366 MLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPN 445 (508)
Q Consensus 366 ~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~d 445 (508)
.|+..+|+||||||+|||+.|.+||...++.....-+...+..+.. | ....+. .+..++|.+|+. |
T Consensus 364 gY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~f--------P--~~~~~s---~eA~DLI~rll~-d 429 (550)
T KOG0605|consen 364 GYGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKF--------P--EEVDLS---DEAKDLITRLLC-D 429 (550)
T ss_pred CCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccC--------C--CcCccc---HHHHHHHHHHhc-C
Confidence 9999999999999999999999999877665443322222222211 0 111122 455568889998 9
Q ss_pred CCCCCC---HHHHHHH
Q 010513 446 AHKRPK---MGHVIHM 458 (508)
Q Consensus 446 P~~RPs---~~evl~~ 458 (508)
|++|-- +.||.++
T Consensus 430 ~~~RLG~~G~~EIK~H 445 (550)
T KOG0605|consen 430 PENRLGSKGAEEIKKH 445 (550)
T ss_pred HHHhcCcccHHHHhcC
Confidence 999965 6666653
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=363.48 Aligned_cols=272 Identities=26% Similarity=0.428 Sum_probs=220.9
Q ss_pred cchhhHhhcCCCCcccceEcccCcEEEEEEEECCCcEEEEEEeecC--CchhHHHHHHHHHHHHccCCCCeeeEeeeeec
Q 010513 176 YTLRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE 253 (508)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 253 (508)
...+++++..+.+.+...||+|.||+||+|.|. ..||||.+... ..+..+.|+.|+..+++-+|.||+-|.|+|..
T Consensus 382 ~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~ 459 (678)
T KOG0193|consen 382 DSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMN 459 (678)
T ss_pred ccccccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcC
Confidence 345888999999999999999999999999986 35999998654 44567899999999999999999999999998
Q ss_pred CCeeEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeee
Q 010513 254 GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDF 333 (508)
Q Consensus 254 ~~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DF 333 (508)
... .+|+.+|+|-+|+.+++.. ...+.....+.|++|+++|+.|||.+ +|||||||..||++.+++.|||+||
T Consensus 460 p~~-AIiTqwCeGsSLY~hlHv~---etkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDF 532 (678)
T KOG0193|consen 460 PPL-AIITQWCEGSSLYTHLHVQ---ETKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDF 532 (678)
T ss_pred Cce-eeeehhccCchhhhhccch---hhhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecc
Confidence 777 8999999999999999876 46799999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCC-CcceecceecCCCCCChhhhhcC---CCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhh
Q 010513 334 GLAKLLGAE-RSYVTTRVMGTFGYVAPEYASTG---MLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMV 409 (508)
Q Consensus 334 G~a~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~ 409 (508)
|++.....- .........|...|||||+++.+ +|++++||||||||+|||+||..||...... . . .+
T Consensus 533 GLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~d--q----I---if 603 (678)
T KOG0193|consen 533 GLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRD--Q----I---IF 603 (678)
T ss_pred cceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChh--h----e---EE
Confidence 999753211 11112233577899999999754 5899999999999999999999999732221 1 1 12
Q ss_pred cccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCCCCCC
Q 010513 410 TNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEEFPFRD 468 (508)
Q Consensus 410 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~~~~~~~~ 468 (508)
..++.....|.......+++++++ |+..||..++++||.+.+|+..|+..--.++.
T Consensus 604 mVGrG~l~pd~s~~~s~~pk~mk~---Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~pk 659 (678)
T KOG0193|consen 604 MVGRGYLMPDLSKIRSNCPKAMKR---LLSDCWKFDREERPLFPQLLSKLEELLPSLPK 659 (678)
T ss_pred EecccccCccchhhhccCHHHHHH---HHHHHHhcCcccCccHHHHHHHHHHhhhcccc
Confidence 223333334444444557777777 55599999999999999999999876644433
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=360.53 Aligned_cols=269 Identities=27% Similarity=0.450 Sum_probs=219.4
Q ss_pred HhhcCCCCcccceEcccCcEEEEEEEECCCcEEEEEEeecCCchh-HHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEE
Q 010513 181 LEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQA-EKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRML 259 (508)
Q Consensus 181 ~~~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 259 (508)
.+++.....+.++||+|-||+|.+|....+..||||+++...... ..+|..|+++|.+++||||++++|+|..++.+++
T Consensus 533 ~EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicm 612 (807)
T KOG1094|consen 533 VEFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCM 612 (807)
T ss_pred hhcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHH
Confidence 367788899999999999999999999888999999998765544 4899999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceec
Q 010513 260 VYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL 339 (508)
Q Consensus 260 V~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~ 339 (508)
|+|||++|+|.+++.....+. +.......|+.||+.|++||.+. +++||||.+.|+|+|+++++||+|||+++.+
T Consensus 613 I~EYmEnGDLnqFl~aheapt--~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~l 687 (807)
T KOG1094|consen 613 ITEYMENGDLNQFLSAHELPT--AETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNL 687 (807)
T ss_pred HHHHHhcCcHHHHHHhccCcc--cccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCccccccc
Confidence 999999999999998875433 45556677999999999999998 9999999999999999999999999999976
Q ss_pred CCCCccee-cceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHh--CCCCCCCCCCCCcchHHHHHHHhhccccccc
Q 010513 340 GAERSYVT-TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS--GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEG 416 (508)
Q Consensus 340 ~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt--g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 416 (508)
-....+.. ...+-...|||+|.+..++++.++|+|+||+++||+++ ...||..... ...++....+........
T Consensus 688 ysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~---e~vven~~~~~~~~~~~~ 764 (807)
T KOG1094|consen 688 YSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTD---EQVVENAGEFFRDQGRQV 764 (807)
T ss_pred ccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhH---HHHHHhhhhhcCCCCcce
Confidence 55555443 44566789999999999999999999999999999877 7789865432 233333333333221111
Q ss_pred CCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 010513 417 VLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEE 463 (508)
Q Consensus 417 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~~~ 463 (508)
.+ .+...|+..+. +++++||..|-++||+++++...|++..
T Consensus 765 ~l---~~P~~cp~~ly---elml~Cw~~es~~RPsFe~lh~~lq~~~ 805 (807)
T KOG1094|consen 765 VL---SRPPACPQGLY---ELMLRCWRRESEQRPSFEQLHLFLQEDA 805 (807)
T ss_pred ec---cCCCcCcHHHH---HHHHHHhchhhhcCCCHHHHHHHHHHhc
Confidence 11 12233555444 5888999999999999999999987653
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-45 Score=369.09 Aligned_cols=251 Identities=27% Similarity=0.432 Sum_probs=214.1
Q ss_pred cCCCCcccceEcccCcEEEEEEEE-CCCcEEEEEEeecCCchhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEE
Q 010513 184 STNGFADENVIGEGGYGIVYHGVL-EDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE 262 (508)
Q Consensus 184 ~~~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e 262 (508)
+...|....+||+|+.|.||.|.. .+++.||||++........+-+.+|+.+|+..+|+|||++++.|...+.+|.|||
T Consensus 271 P~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVME 350 (550)
T KOG0578|consen 271 PRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVME 350 (550)
T ss_pred hhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEe
Confidence 455788899999999999999994 4688899999987777777888999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCC
Q 010513 263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE 342 (508)
Q Consensus 263 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 342 (508)
|++||+|.|.+... .+++.++..|++++++||+|||.+ +|+|||||.+|||++.+|.+||+|||++..+...
T Consensus 351 ym~ggsLTDvVt~~-----~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~ 422 (550)
T KOG0578|consen 351 YMEGGSLTDVVTKT-----RMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEE 422 (550)
T ss_pred ecCCCchhhhhhcc-----cccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeeccccc
Confidence 99999999998765 599999999999999999999999 9999999999999999999999999999887555
Q ss_pred CcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCCccC
Q 010513 343 RSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRL 422 (508)
Q Consensus 343 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 422 (508)
.. .....+|||+|||||++....|+++.||||||++++||+-|.+||-..++ ...++....++. |.+
T Consensus 423 ~~-KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~P------lrAlyLIa~ng~------P~l 489 (550)
T KOG0578|consen 423 QS-KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENP------LRALYLIATNGT------PKL 489 (550)
T ss_pred cC-ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCCh------HHHHHHHhhcCC------CCc
Confidence 44 45567899999999999999999999999999999999999999975443 333333333332 222
Q ss_pred CC-CchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 423 QE-KPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 423 ~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
+. +..+..+++ ++.+||+.|+++|+++.|+|++
T Consensus 490 k~~~klS~~~kd---FL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 490 KNPEKLSPELKD---FLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred CCccccCHHHHH---HHHHHhhcchhcCCCHHHHhcC
Confidence 21 223344555 5559999999999999999976
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-45 Score=360.41 Aligned_cols=268 Identities=24% Similarity=0.306 Sum_probs=211.7
Q ss_pred cCCCCcccceEcccCcEEEEEEEE-CCCcEEEEEEeecCC--chhHHHHHHHHHHHHccCCCCeeeEeeeeecC--CeeE
Q 010513 184 STNGFADENVIGEGGYGIVYHGVL-EDNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEG--AHRM 258 (508)
Q Consensus 184 ~~~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--~~~~ 258 (508)
..+.|+.+++||+|.||.||+|++ .+|+.||+|++.... ........+||.+|++|.||||+++.+...+. ..+|
T Consensus 115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siY 194 (560)
T KOG0600|consen 115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIY 194 (560)
T ss_pred chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEE
Confidence 345789999999999999999995 578899999997654 34456678899999999999999999998876 6899
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeecccee
Q 010513 259 LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL 338 (508)
Q Consensus 259 lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~ 338 (508)
||+|||+. ||..++... .-.+++.+++.++.|+++||+|||++ +|+|||||.+|||||++|.+||+|||+|++
T Consensus 195 lVFeYMdh-DL~GLl~~p---~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~ 267 (560)
T KOG0600|consen 195 LVFEYMDH-DLSGLLSSP---GVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARF 267 (560)
T ss_pred EEEecccc-hhhhhhcCC---CcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceee
Confidence 99999998 999998764 46799999999999999999999999 999999999999999999999999999999
Q ss_pred cCCCCcceecceecCCCCCChhhhhcC-CCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHH-----Hhhccc
Q 010513 339 LGAERSYVTTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLK-----TMVTNR 412 (508)
Q Consensus 339 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~-----~~~~~~ 412 (508)
+........+..+-|.+|.|||++.+. .|+.+.|+||.||||.||++|++.|.+.+.....+.+-.+- ..|...
T Consensus 268 y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~ 347 (560)
T KOG0600|consen 268 YTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVS 347 (560)
T ss_pred ccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccc
Confidence 887777777888899999999988764 69999999999999999999999998765433222111110 011100
Q ss_pred ccc--cCCCccCCCCch-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 413 NAE--GVLDPRLQEKPC-----SRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 413 ~~~--~~~~~~l~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
... ..+.+.-.-... .......++|+..+|..||.+|.|+.++|+.
T Consensus 348 kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 348 KLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred cCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 000 111111110001 1112346668889999999999999998753
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-46 Score=364.94 Aligned_cols=266 Identities=22% Similarity=0.287 Sum_probs=209.9
Q ss_pred cCCCCcccceEcccCcEEEEEEEE-CCCcEEEEEEeecCCchh-HHHHHHHHHHHHccC-CCCeeeEeeeeecCC-eeEE
Q 010513 184 STNGFADENVIGEGGYGIVYHGVL-EDNTNVAVKNLLNNRGQA-EKEFKVEVEAIGRVR-HKNLVRLLGYCAEGA-HRML 259 (508)
Q Consensus 184 ~~~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~-~~~l 259 (508)
..++|...++||.|.||.||+|+. .+|..||||++++.-... +..-.+|++.|+++. |||||++.+++.+.+ .+|+
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 346899999999999999999994 468889999987653332 233457999999998 999999999999888 8999
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceec
Q 010513 260 VYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL 339 (508)
Q Consensus 260 V~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~ 339 (508)
|||||+. +|+++++++ ...+++..++.|+.||++||+|+|.+ |+.|||+||+|||+..+..+||+|||+|+.+
T Consensus 88 VfE~Md~-NLYqLmK~R---~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev 160 (538)
T KOG0661|consen 88 VFEFMDC-NLYQLMKDR---NRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREV 160 (538)
T ss_pred eHHhhhh-hHHHHHhhc---CCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEeccccccccc
Confidence 9999987 999999887 57899999999999999999999999 9999999999999998889999999999987
Q ss_pred CCCCcceecceecCCCCCChhhh-hcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhccc------
Q 010513 340 GAERSYVTTRVMGTFGYVAPEYA-STGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNR------ 412 (508)
Q Consensus 340 ~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~------ 412 (508)
..... .+..+.|.+|.|||++ +.+.|+.+.|+|++||+++|+.+-+.-|.+.........+..+.......
T Consensus 161 ~SkpP--YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~ 238 (538)
T KOG0661|consen 161 RSKPP--YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGY 238 (538)
T ss_pred ccCCC--cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHH
Confidence 54443 4667899999999965 66789999999999999999999999997665322111111000000000
Q ss_pred ---ccccCCCccCCC----CchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 413 ---NAEGVLDPRLQE----KPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 413 ---~~~~~~~~~l~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
....+.-|.... ...+....++++++.+|++.||++||||.|.+++
T Consensus 239 ~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 239 NLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 000111111111 1123356778889999999999999999999976
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-44 Score=363.79 Aligned_cols=251 Identities=25% Similarity=0.386 Sum_probs=205.2
Q ss_pred hcCCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecC----Cc-hhHHHHHHHHHHHHccC-CCCeeeEeeeeecCC
Q 010513 183 VSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN----RG-QAEKEFKVEVEAIGRVR-HKNLVRLLGYCAEGA 255 (508)
Q Consensus 183 ~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~ 255 (508)
...+.|.+.+.||+|+||+|++|... ++..||+|.+.+. .. ...+.+.+|+.+++.++ ||||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 45568999999999999999999854 6899999966443 11 23456778999999998 999999999999999
Q ss_pred eeEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCC-CCeEEeeec
Q 010513 256 HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQ-WNPKLSDFG 334 (508)
Q Consensus 256 ~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~-~~~kL~DFG 334 (508)
.+|+||||+.||+|.+++... +.+.+..+..+++|++.|++|||++ +|+||||||+|||++.+ +++||+|||
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~~----g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG 166 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVNK----GRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFG 166 (370)
T ss_pred eEEEEEEecCCccHHHHHHHc----CCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEeccc
Confidence 999999999999999999874 6789999999999999999999999 99999999999999999 999999999
Q ss_pred cceecCCCCcceecceecCCCCCChhhhhcCC-CC-CCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhccc
Q 010513 335 LAKLLGAERSYVTTRVMGTFGYVAPEYASTGM-LN-ERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNR 412 (508)
Q Consensus 335 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 412 (508)
++.... .........|||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||++... ....+. ...+
T Consensus 167 ~s~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~------~~l~~k-i~~~ 238 (370)
T KOG0583|consen 167 LSAISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNV------PNLYRK-IRKG 238 (370)
T ss_pred cccccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccH------HHHHHH-HhcC
Confidence 999764 3334456689999999999999877 76 689999999999999999999986322 111122 1111
Q ss_pred ccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 010513 413 NAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIH 457 (508)
Q Consensus 413 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 457 (508)
. +.-|.. .. ..++..++.+|+..||.+|+++.++++
T Consensus 239 ~---~~~p~~----~~--S~~~~~Li~~mL~~~P~~R~t~~~i~~ 274 (370)
T KOG0583|consen 239 E---FKIPSY----LL--SPEARSLIEKMLVPDPSTRITLLEILE 274 (370)
T ss_pred C---ccCCCC----cC--CHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence 1 101111 10 334455778999999999999999984
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=336.35 Aligned_cols=200 Identities=27% Similarity=0.401 Sum_probs=182.4
Q ss_pred CCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCc---hhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEE
Q 010513 185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG---QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLV 260 (508)
Q Consensus 185 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 260 (508)
.++|++.+.||.|+||.|.+++.+ +|..+|+|.+.+... ...+...+|..+|+.+.||+++++++.|.+.+.+|||
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv 122 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV 122 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence 457899999999999999999976 577899999876543 3345677899999999999999999999999999999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecC
Q 010513 261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG 340 (508)
Q Consensus 261 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 340 (508)
|||++||.|+.++++. +.+++..++.++.||+.||+|||+. +|++|||||+|||+|.+|.+||+|||+|+.+.
T Consensus 123 meyv~GGElFS~Lrk~----~rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~ 195 (355)
T KOG0616|consen 123 MEYVPGGELFSYLRKS----GRFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVS 195 (355)
T ss_pred EeccCCccHHHHHHhc----CCCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEec
Confidence 9999999999999876 6899999999999999999999999 99999999999999999999999999999764
Q ss_pred CCCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCC
Q 010513 341 AERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRP 395 (508)
Q Consensus 341 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~ 395 (508)
.. +-+.||||.|+|||++..+.|+.++|+|+|||++|||+.|..||...++
T Consensus 196 ~r----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~ 246 (355)
T KOG0616|consen 196 GR----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP 246 (355)
T ss_pred Cc----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh
Confidence 33 4568999999999999999999999999999999999999999986654
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-45 Score=361.88 Aligned_cols=247 Identities=29% Similarity=0.425 Sum_probs=210.3
Q ss_pred CCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCc--hhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEE
Q 010513 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG--QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE 262 (508)
Q Consensus 186 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e 262 (508)
++|.+.+.||+|.||.||+|+.+ +.+.||+|.+.+... ...+.+.+|+++++.++|||||.++++|+...++++|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 57889999999999999999966 567789999866533 345678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCC
Q 010513 263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE 342 (508)
Q Consensus 263 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 342 (508)
|+.| +|+.+|... +.++++.+..++.+++.||.|||++ +|+|||+||.|||+++.+.+|+||||+|+.+..
T Consensus 82 ~a~g-~L~~il~~d----~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~- 152 (808)
T KOG0597|consen 82 YAVG-DLFTILEQD----GKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMST- 152 (808)
T ss_pred hhhh-hHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhccc-
Confidence 9987 999999875 6899999999999999999999999 999999999999999999999999999998754
Q ss_pred CcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCCccC
Q 010513 343 RSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRL 422 (508)
Q Consensus 343 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 422 (508)
+....+...|||.|||||+..++.|+..+|+||+||++||+++|++||.. ....+..+.... ||
T Consensus 153 ~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a------~si~~Lv~~I~~--------d~-- 216 (808)
T KOG0597|consen 153 NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYA------RSITQLVKSILK--------DP-- 216 (808)
T ss_pred CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchH------HHHHHHHHHHhc--------CC--
Confidence 44556778999999999999999999999999999999999999999952 222333332222 11
Q ss_pred CCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 423 QEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 423 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
..+.+.....+.+++...|.+||.+|.+..+++.+
T Consensus 217 -v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 217 -VKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred -CCCcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 11233455566678889999999999999998764
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-44 Score=350.37 Aligned_cols=253 Identities=27% Similarity=0.420 Sum_probs=201.2
Q ss_pred CCcccceEcccCcEEEEEEEECC-CcEEEEEEeecCCchhHHHHHHHHHHHHccCCCCeeeEeeeeecCC--eeEEEEEe
Q 010513 187 GFADENVIGEGGYGIVYHGVLED-NTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGA--HRMLVYEY 263 (508)
Q Consensus 187 ~~~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~--~~~lV~e~ 263 (508)
++...+.||+|+||.||++...+ |...|||.+........+.+.+|+.+|.+++|||||+++|...... .++++|||
T Consensus 18 ~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy 97 (313)
T KOG0198|consen 18 NWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEY 97 (313)
T ss_pred hhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeec
Confidence 56778899999999999999764 8889999986654444677899999999999999999999854444 68899999
Q ss_pred cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcC-CCCeEEeeeccceecCC-
Q 010513 264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDK-QWNPKLSDFGLAKLLGA- 341 (508)
Q Consensus 264 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~-~~~~kL~DFG~a~~~~~- 341 (508)
+.+|+|.+++.+.. +.+++..+..+..|+++||+|||++ +|+||||||+|||++. ++.+||+|||++.....
T Consensus 98 ~~~GsL~~~~~~~g---~~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~ 171 (313)
T KOG0198|consen 98 APGGSLSDLIKRYG---GKLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLESK 171 (313)
T ss_pred cCCCcHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCccccccccc
Confidence 99999999998873 3799999999999999999999999 9999999999999999 79999999999987653
Q ss_pred -CCcceecceecCCCCCChhhhhcCC-CCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCC
Q 010513 342 -ERSYVTTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLD 419 (508)
Q Consensus 342 -~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 419 (508)
..........||+.|||||++..+. ...++|||||||++.||+||+.||... ....+++....... ..
T Consensus 172 ~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-----~~~~~~~~~ig~~~-----~~ 241 (313)
T KOG0198|consen 172 GTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-----FEEAEALLLIGRED-----SL 241 (313)
T ss_pred cccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-----cchHHHHHHHhccC-----CC
Confidence 2222334578999999999998643 335999999999999999999999743 11122222222211 11
Q ss_pred ccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 010513 420 PRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHML 459 (508)
Q Consensus 420 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 459 (508)
|.+... .+. +..+++.+|+..||++||||.++|++.
T Consensus 242 P~ip~~-ls~---~a~~Fl~~C~~~~p~~Rpta~eLL~hp 277 (313)
T KOG0198|consen 242 PEIPDS-LSD---EAKDFLRKCFKRDPEKRPTAEELLEHP 277 (313)
T ss_pred CCCCcc-cCH---HHHHHHHHHhhcCcccCcCHHHHhhCh
Confidence 222221 333 344477799999999999999999874
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=378.43 Aligned_cols=263 Identities=29% Similarity=0.499 Sum_probs=219.4
Q ss_pred HhhcCCCCcccceEcccCcEEEEEEEEC------CCcEEEEEEeecCCch-hHHHHHHHHHHHHccCCCCeeeEeeeeec
Q 010513 181 LEVSTNGFADENVIGEGGYGIVYHGVLE------DNTNVAVKNLLNNRGQ-AEKEFKVEVEAIGRVRHKNLVRLLGYCAE 253 (508)
Q Consensus 181 ~~~~~~~~~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 253 (508)
.++.+.+....+.||+|+||+||+|+.. +..-||||.+++.... ...+|++|+++++.++|||||+|+|+|.+
T Consensus 481 ~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~ 560 (774)
T KOG1026|consen 481 LEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCRE 560 (774)
T ss_pred eEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEcc
Confidence 4566677788899999999999999843 3456999999877665 67899999999999999999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHhccCCC------C----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEc
Q 010513 254 GAHRMLVYEYIDNGNLEQWLHGDVG------P----HSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLD 323 (508)
Q Consensus 254 ~~~~~lV~e~~~~g~L~~~l~~~~~------~----~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~ 323 (508)
++..+||+|||..|||.+||..... . ..+++..+.+.|+.|||.|++||-++ .+|||||-..|+||.
T Consensus 561 ~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVg 637 (774)
T KOG1026|consen 561 GDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVG 637 (774)
T ss_pred CCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceec
Confidence 9999999999999999999964321 1 23488999999999999999999999 999999999999999
Q ss_pred CCCCeEEeeeccceecCCCCcceec-ceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHh-CCCCCCCCCCCCcchH
Q 010513 324 KQWNPKLSDFGLAKLLGAERSYVTT-RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNL 401 (508)
Q Consensus 324 ~~~~~kL~DFG~a~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~ 401 (508)
++..|||+|||+++..-..+.+... ...-...|||||.|..++++++||||||||+|||+++ |+.||.+....+.
T Consensus 638 e~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EV--- 714 (774)
T KOG1026|consen 638 ENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEV--- 714 (774)
T ss_pred cceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHH---
Confidence 9999999999999987665555543 3345678999999999999999999999999999999 9999976654322
Q ss_pred HHHHHHhhcccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010513 402 VEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (508)
Q Consensus 402 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~~ 462 (508)
-+.+..++... ..+.|+..+.+ |++.||+.+|++||+++||-..|++-
T Consensus 715 ----Ie~i~~g~lL~------~Pe~CP~~vY~---LM~~CW~~~P~~RPsF~eI~~~L~~~ 762 (774)
T KOG1026|consen 715 ----IECIRAGQLLS------CPENCPTEVYS---LMLECWNENPKRRPSFKEIHSRLQAW 762 (774)
T ss_pred ----HHHHHcCCccc------CCCCCCHHHHH---HHHHHhhcCcccCCCHHHHHHHHHHH
Confidence 22333333211 23446666666 88899999999999999999998864
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-44 Score=326.75 Aligned_cols=272 Identities=22% Similarity=0.338 Sum_probs=212.2
Q ss_pred CCCcccceEcccCcEEEEEEEE-CCCcEEEEEEeecCCc--hhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEE
Q 010513 186 NGFADENVIGEGGYGIVYHGVL-EDNTNVAVKNLLNNRG--QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE 262 (508)
Q Consensus 186 ~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e 262 (508)
.+|..+++||+|.||.||+|++ ++|+.||||+++.... .......+|++.|+.++|+||+.++++|-..+.+-+|+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 4688899999999999999995 4799999999965432 223456789999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCC
Q 010513 263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE 342 (508)
Q Consensus 263 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 342 (508)
|++. ||+..+++. ...++...+..++.++++||+|||++ .|+||||||+|+|++.+|.+||+|||+++.++..
T Consensus 82 fm~t-dLe~vIkd~---~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p 154 (318)
T KOG0659|consen 82 FMPT-DLEVVIKDK---NIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSP 154 (318)
T ss_pred eccc-cHHHHhccc---ccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCC
Confidence 9998 999999887 46789999999999999999999999 8999999999999999999999999999998765
Q ss_pred CcceecceecCCCCCChhhhhc-CCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHh--hcccc------
Q 010513 343 RSYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTM--VTNRN------ 413 (508)
Q Consensus 343 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~--~~~~~------ 413 (508)
...... .+-|.+|.|||.+.+ ..|+...|+||.||++.||+-|.+-|.+..+.+. +...++.. .....
T Consensus 155 ~~~~~~-~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQ--L~~If~~LGTP~~~~WP~~~~ 231 (318)
T KOG0659|consen 155 NRIQTH-QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQ--LSKIFRALGTPTPDQWPEMTS 231 (318)
T ss_pred Cccccc-ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHH--HHHHHHHcCCCCcccCccccc
Confidence 444333 377999999998766 5699999999999999999999877765443211 11111100 00000
Q ss_pred ------cccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCCCCCC
Q 010513 414 ------AEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEEFPFRD 468 (508)
Q Consensus 414 ------~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~~~~~~~~ 468 (508)
....-.+.+ ....+.+..+.++++.+++..||.+|.++.|++++===...|.+.
T Consensus 232 lpdY~~~~~~P~~~~-~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~pt 291 (318)
T KOG0659|consen 232 LPDYVKIQQFPKPPL-NNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLPLPT 291 (318)
T ss_pred cccHHHHhcCCCCcc-ccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCCCCC
Confidence 010111111 113444566778899999999999999999999774333344443
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-44 Score=359.90 Aligned_cols=263 Identities=27% Similarity=0.426 Sum_probs=204.4
Q ss_pred hhcCCCCcccceEcccCcEEEEEEEEC------CCcEEEEEEeecCCc-hhHHHHHHHHHHHHcc-CCCCeeeEeeeeec
Q 010513 182 EVSTNGFADENVIGEGGYGIVYHGVLE------DNTNVAVKNLLNNRG-QAEKEFKVEVEAIGRV-RHKNLVRLLGYCAE 253 (508)
Q Consensus 182 ~~~~~~~~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~ 253 (508)
+++.++|++.+.||+|+||.||+|.+. ++..||+|++..... ...+.+..|++++..+ +||||+++++++..
T Consensus 3 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 82 (338)
T cd05102 3 EFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTK 82 (338)
T ss_pred ccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecC
Confidence 567789999999999999999999742 245799999865432 3345788899999999 89999999998876
Q ss_pred CC-eeEEEEEecCCCCHHHHhccCCCC-----------------------------------------------------
Q 010513 254 GA-HRMLVYEYIDNGNLEQWLHGDVGP----------------------------------------------------- 279 (508)
Q Consensus 254 ~~-~~~lV~e~~~~g~L~~~l~~~~~~----------------------------------------------------- 279 (508)
.+ ..++||||+++|+|.+++......
T Consensus 83 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (338)
T cd05102 83 PNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQE 162 (338)
T ss_pred CCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchh
Confidence 44 578999999999999998753210
Q ss_pred -----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCCCcce-ecceecC
Q 010513 280 -----HSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYV-TTRVMGT 353 (508)
Q Consensus 280 -----~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~-~~~~~gt 353 (508)
...+++..+..++.|+++||+|||++ +|+||||||+|||++.++.+||+|||+++......... .....++
T Consensus 163 ~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~ 239 (338)
T cd05102 163 TDDLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239 (338)
T ss_pred ccccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCC
Confidence 13578889999999999999999998 99999999999999999999999999998653332222 2233467
Q ss_pred CCCCChhhhhcCCCCCCCCeeehHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHhhcccccccCCCccCCCCchHHHHH
Q 010513 354 FGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALK 432 (508)
Q Consensus 354 ~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 432 (508)
+.|+|||++.+..++.++|||||||++|||++ |..||....... .. ......... ... ....+ .
T Consensus 240 ~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~--~~----~~~~~~~~~-----~~~-~~~~~---~ 304 (338)
T cd05102 240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE--EF----CQRLKDGTR-----MRA-PENAT---P 304 (338)
T ss_pred ccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH--HH----HHHHhcCCC-----CCC-CCCCC---H
Confidence 78999999999999999999999999999997 999997543211 11 111111110 011 11122 3
Q ss_pred HHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010513 433 RALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (508)
Q Consensus 433 ~l~~li~~cl~~dP~~RPs~~evl~~Le~~ 462 (508)
.+.+++.+||+.||++||++.++++.|+..
T Consensus 305 ~l~~li~~cl~~dp~~RPs~~el~~~l~~~ 334 (338)
T cd05102 305 EIYRIMLACWQGDPKERPTFSALVEILGDL 334 (338)
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 455588899999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=358.55 Aligned_cols=253 Identities=26% Similarity=0.484 Sum_probs=208.7
Q ss_pred hhHhhcCCCCcccceEcccCcEEEEEEEECCCcEEEEEEeecCCchhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeE
Q 010513 179 RELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM 258 (508)
Q Consensus 179 ~~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 258 (508)
+.|+++.+...-++.||.|+.|.||+|+.+ +..||||++..-+ ..+|+-|++|+||||+.|.|+|.....+|
T Consensus 117 e~WeiPFe~IsELeWlGSGaQGAVF~Grl~-netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyC 188 (904)
T KOG4721|consen 117 ELWEIPFEEISELEWLGSGAQGAVFLGRLH-NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYC 188 (904)
T ss_pred hhccCCHHHhhhhhhhccCcccceeeeecc-CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeE
Confidence 346788888888899999999999999987 6789999885432 23788899999999999999999999999
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeecccee
Q 010513 259 LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL 338 (508)
Q Consensus 259 lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~ 338 (508)
||||||..|-|...|+.. .+++......+..+||.|+.|||.+ +|||||||.-||||..+..+||+|||-++.
T Consensus 189 IiMEfCa~GqL~~VLka~----~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e 261 (904)
T KOG4721|consen 189 IIMEFCAQGQLYEVLKAG----RPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKE 261 (904)
T ss_pred EeeeccccccHHHHHhcc----CccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHh
Confidence 999999999999999876 5788888899999999999999999 999999999999999999999999999987
Q ss_pred cCCCCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCC
Q 010513 339 LGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVL 418 (508)
Q Consensus 339 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 418 (508)
.... ...-.++||..|||||++++...++|+||||||||||||+||..||.+-+... +++..- .. .+
T Consensus 262 ~~~~--STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA------IIwGVG-sN----sL 328 (904)
T KOG4721|consen 262 LSDK--STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA------IIWGVG-SN----SL 328 (904)
T ss_pred hhhh--hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe------eEEecc-CC----cc
Confidence 6443 23345899999999999999999999999999999999999999997543221 111110 00 00
Q ss_pred CccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 010513 419 DPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEE 463 (508)
Q Consensus 419 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~~~ 463 (508)
. ......|++.++ .|+++||+..|..||++.+++.+|+-..
T Consensus 329 ~-LpvPstcP~Gfk---lL~Kqcw~sKpRNRPSFrqil~HldIa~ 369 (904)
T KOG4721|consen 329 H-LPVPSTCPDGFK---LLLKQCWNSKPRNRPSFRQILLHLDIAS 369 (904)
T ss_pred c-ccCcccCchHHH---HHHHHHHhcCCCCCccHHHHHHHHhhcC
Confidence 0 011223555444 4777999999999999999999997554
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=357.74 Aligned_cols=247 Identities=25% Similarity=0.365 Sum_probs=205.6
Q ss_pred CCcccceEcccCcEEEEEEEE-CCCcEEEEEEeecCC---chhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEE
Q 010513 187 GFADENVIGEGGYGIVYHGVL-EDNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE 262 (508)
Q Consensus 187 ~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e 262 (508)
-|+.++.||.|+-|.|-+|++ .+|+.+|||.+.+.. ......+.+|+-+|+-+.|||++++|+++++..++|+|.|
T Consensus 13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlE 92 (786)
T KOG0588|consen 13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLE 92 (786)
T ss_pred ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEE
Confidence 367789999999999999995 479999999996552 2234567889999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCC
Q 010513 263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE 342 (508)
Q Consensus 263 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 342 (508)
|+++|.|++++-.. +++++.++.+++.||+.|+.|+|.. +|+||||||+|+|+|..+++||+|||+|.+-.
T Consensus 93 yv~gGELFdylv~k----G~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~-- 163 (786)
T KOG0588|consen 93 YVPGGELFDYLVRK----GPLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEV-- 163 (786)
T ss_pred ecCCchhHHHHHhh----CCCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeeccc--
Confidence 99999999999776 7899999999999999999999998 99999999999999999999999999998642
Q ss_pred CcceecceecCCCCCChhhhhcCCCC-CCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCCcc
Q 010513 343 RSYVTTRVMGTFGYVAPEYASTGMLN-ERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPR 421 (508)
Q Consensus 343 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 421 (508)
......+.||+|.|.|||++.+..|+ .++||||+||+||.|+||+.||++ .|+...+.+... +.++ -|
T Consensus 164 ~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD------dNir~LLlKV~~-G~f~---MP- 232 (786)
T KOG0588|consen 164 PGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD------DNIRVLLLKVQR-GVFE---MP- 232 (786)
T ss_pred CCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC------ccHHHHHHHHHc-Cccc---CC-
Confidence 33344567999999999999998875 689999999999999999999983 344443333322 2111 01
Q ss_pred CCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 010513 422 LQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHML 459 (508)
Q Consensus 422 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 459 (508)
...+.+.++ |+.+|++.||++|.|++||+++-
T Consensus 233 ---s~Is~eaQd---LLr~ml~VDp~~RiT~~eI~kHP 264 (786)
T KOG0588|consen 233 ---SNISSEAQD---LLRRMLDVDPSTRITTEEILKHP 264 (786)
T ss_pred ---CcCCHHHHH---HHHHHhccCccccccHHHHhhCc
Confidence 223334444 77799999999999999999873
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-44 Score=348.38 Aligned_cols=250 Identities=26% Similarity=0.394 Sum_probs=212.2
Q ss_pred CCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecC-CchhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEE
Q 010513 185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE 262 (508)
Q Consensus 185 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e 262 (508)
...|+..+.||+|.||.||+|.+. .++.||+|.+.-. .....+++.+|+.++.+++++||.++|+.|..+..++++||
T Consensus 12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMe 91 (467)
T KOG0201|consen 12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIME 91 (467)
T ss_pred ccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHH
Confidence 346777899999999999999965 5778999998543 44556789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCC
Q 010513 263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE 342 (508)
Q Consensus 263 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 342 (508)
||.||++.+.++.. ..+.+.....++++++.|+.|||.+ +.+|||||+.|||+..+|.+||+|||.+-.+...
T Consensus 92 y~~gGsv~~lL~~~----~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~ 164 (467)
T KOG0201|consen 92 YCGGGSVLDLLKSG----NILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNT 164 (467)
T ss_pred HhcCcchhhhhccC----CCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeech
Confidence 99999999999764 4558888888999999999999999 9999999999999999999999999999877554
Q ss_pred CcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCCccC
Q 010513 343 RSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRL 422 (508)
Q Consensus 343 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 422 (508)
.... .+++|||.|||||++....|+.|+||||||++.+||.+|.+|+....|..... .+..-..|.+
T Consensus 165 ~~rr-~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlf------------lIpk~~PP~L 231 (467)
T KOG0201|consen 165 VKRR-KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLF------------LIPKSAPPRL 231 (467)
T ss_pred hhcc-ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEE------------eccCCCCCcc
Confidence 4433 67899999999999998899999999999999999999999998666532211 1123334555
Q ss_pred CCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 423 QEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 423 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
+. .+...+++ ++..||++||+.||+|.+++++
T Consensus 232 ~~-~~S~~~kE---FV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 232 DG-DFSPPFKE---FVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred cc-ccCHHHHH---HHHHHhhcCcccCcCHHHHhhh
Confidence 55 45666666 5669999999999999999976
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-42 Score=342.19 Aligned_cols=266 Identities=24% Similarity=0.440 Sum_probs=204.1
Q ss_pred cCCCCcccceEcccCcEEEEEEEECC-----------------CcEEEEEEeecCC-chhHHHHHHHHHHHHccCCCCee
Q 010513 184 STNGFADENVIGEGGYGIVYHGVLED-----------------NTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLV 245 (508)
Q Consensus 184 ~~~~~~~~~~LG~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv 245 (508)
..++|.+.++||+|+||.||+|.+++ +..||+|.+.... .....++.+|++++.+++||||+
T Consensus 3 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv 82 (304)
T cd05096 3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNII 82 (304)
T ss_pred chhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCee
Confidence 45689999999999999999998542 2368999886543 33456788999999999999999
Q ss_pred eEeeeeecCCeeEEEEEecCCCCHHHHhccCC---------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 010513 246 RLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDV---------------GPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKV 310 (508)
Q Consensus 246 ~l~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~---------------~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i 310 (508)
++++++.+.+..++||||+++|+|.+++.... .....+++...+.++.|++.||.|||+. +|
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i 159 (304)
T cd05096 83 RLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NF 159 (304)
T ss_pred EEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Cc
Confidence 99999999999999999999999999986531 1123578889999999999999999999 99
Q ss_pred eeccCCCCCEEEcCCCCeEEeeeccceecCCCCcc-eecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHh--CC
Q 010513 311 VHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSY-VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS--GR 387 (508)
Q Consensus 311 iHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt--g~ 387 (508)
+||||||+|||++.++.+||+|||+++........ ......++..|+|||++.++.++.++|||||||++|||++ +.
T Consensus 160 vH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~ 239 (304)
T cd05096 160 VHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKE 239 (304)
T ss_pred cccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCC
Confidence 99999999999999999999999999865433222 2233456789999999988899999999999999999987 56
Q ss_pred CCCCCCCCCCcchHHHHHHHhhcccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 010513 388 NPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461 (508)
Q Consensus 388 ~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~ 461 (508)
.||..... ................... . .....++. .+.+++.+||+.||++||++.+|.+.|++
T Consensus 240 ~p~~~~~~---~~~~~~~~~~~~~~~~~~~--~-~~~~~~~~---~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 240 QPYGELTD---EQVIENAGEFFRDQGRQVY--L-FRPPPCPQ---GLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCCCcCCH---HHHHHHHHHHhhhcccccc--c-cCCCCCCH---HHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 67764332 1222222222211110000 0 01122333 44558889999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=338.39 Aligned_cols=248 Identities=21% Similarity=0.357 Sum_probs=208.7
Q ss_pred CCCCcccceEcccCcEEEEEEEE-CCCcEEEEEEeecCCch---hHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEE
Q 010513 185 TNGFADENVIGEGGYGIVYHGVL-EDNTNVAVKNLLNNRGQ---AEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLV 260 (508)
Q Consensus 185 ~~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 260 (508)
..+|++.+.||+|.||.|-+|.. ..|+.||||.+.+.... +.-.+++|+++|..|+||||+.+|++|++.+.+.+|
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 35899999999999999999994 67999999999776443 344678999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecC
Q 010513 261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG 340 (508)
Q Consensus 261 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 340 (508)
|||..+|.|+||+... +.+++.++..+++||..|+.|+|.+ +++|||||.+|||+|.++++||+|||++.++.
T Consensus 132 MEYaS~GeLYDYiSer----~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly~ 204 (668)
T KOG0611|consen 132 MEYASGGELYDYISER----GSLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLYA 204 (668)
T ss_pred EEecCCccHHHHHHHh----ccccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhhc
Confidence 9999999999999876 6899999999999999999999999 99999999999999999999999999998874
Q ss_pred CCCcceecceecCCCCCChhhhhcCCC-CCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCC
Q 010513 341 AERSYVTTRVMGTFGYVAPEYASTGML-NERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLD 419 (508)
Q Consensus 341 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 419 (508)
.. ....++||+|-|.+||++++..| ++..|-|||||+||.|+.|..||++.+. ..+-+++..+.. ..
T Consensus 205 ~~--kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh-------k~lvrQIs~GaY---rE 272 (668)
T KOG0611|consen 205 DK--KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH-------KRLVRQISRGAY---RE 272 (668)
T ss_pred cc--cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH-------HHHHHHhhcccc---cC
Confidence 43 34567899999999999999887 4689999999999999999999986532 112222332211 12
Q ss_pred ccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 010513 420 PRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHML 459 (508)
Q Consensus 420 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 459 (508)
|.- +... .-||.+||-.||++|.|+.+|..+.
T Consensus 273 P~~-----PSdA---~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 273 PET-----PSDA---SGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred CCC-----CchH---HHHHHHHHhcCcccchhHHHHhhhh
Confidence 211 1122 2277799999999999999998875
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=365.70 Aligned_cols=260 Identities=24% Similarity=0.348 Sum_probs=216.2
Q ss_pred hHhhcCCCCcccceEcccCcEEEEEEEECCC-cEEEEEEeecCCchhHHHHHHHHHHHHccC-CCCeeeEee-eeec---
Q 010513 180 ELEVSTNGFADENVIGEGGYGIVYHGVLEDN-TNVAVKNLLNNRGQAEKEFKVEVEAIGRVR-HKNLVRLLG-YCAE--- 253 (508)
Q Consensus 180 ~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~-~~~~--- 253 (508)
-+.+...++++++.|.+|||+.||+|.+..+ .+||+|++.-......+.+++|+++|+.|+ |+|||.+++ ....
T Consensus 31 ~~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~ 110 (738)
T KOG1989|consen 31 TFTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSS 110 (738)
T ss_pred EEEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccC
Confidence 3467778899999999999999999998765 999999998888888899999999999996 999999999 3321
Q ss_pred ---CCeeEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEE
Q 010513 254 ---GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKL 330 (508)
Q Consensus 254 ---~~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL 330 (508)
.-+++|.||||+||.|-|++..+.. ..|++.++++|+.++++|+++||.. ++.|||||||-+||||+.+|+.||
T Consensus 111 ~~~~~EvllLmEyC~gg~Lvd~mn~Rlq--~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KL 187 (738)
T KOG1989|consen 111 NNGVWEVLLLMEYCKGGSLVDFMNTRLQ--TRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKL 187 (738)
T ss_pred CCceeEEEeehhhccCCcHHHHHHHHHh--ccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEe
Confidence 1357899999999999999987643 4499999999999999999999985 888999999999999999999999
Q ss_pred eeeccceecCCCCccee--------cceecCCCCCChhhh---hcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcc
Q 010513 331 SDFGLAKLLGAERSYVT--------TRVMGTFGYVAPEYA---STGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEV 399 (508)
Q Consensus 331 ~DFG~a~~~~~~~~~~~--------~~~~gt~~y~aPE~~---~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~ 399 (508)
||||.+.-......... -...-|+.|.|||++ .+...++|+|||+|||+||-|+....||+.....
T Consensus 188 CDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l--- 264 (738)
T KOG1989|consen 188 CDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL--- 264 (738)
T ss_pred CcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce---
Confidence 99999874322110000 012358999999977 4678999999999999999999999999755332
Q ss_pred hHHHHHHHhhcccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 010513 400 NLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461 (508)
Q Consensus 400 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~ 461 (508)
.+++..+...+.+....++.+||..||+.||++||++-++++.+-.
T Consensus 265 ----------------aIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~ 310 (738)
T KOG1989|consen 265 ----------------AILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFE 310 (738)
T ss_pred ----------------eEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHH
Confidence 3445555555566777788889999999999999999999887654
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-43 Score=356.16 Aligned_cols=246 Identities=25% Similarity=0.353 Sum_probs=202.4
Q ss_pred HhhcCCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCC---chhHHHHHHHHHHHHcc-CCCCeeeEeeeeecCC
Q 010513 181 LEVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEGA 255 (508)
Q Consensus 181 ~~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~ 255 (508)
..+..++|.+.++||+|.||+|+++..+ +++.+|||.+++.. .+..+....|.+++... +||.+++++.+|+..+
T Consensus 363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~ 442 (694)
T KOG0694|consen 363 GPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKE 442 (694)
T ss_pred CcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCC
Confidence 3566789999999999999999999976 57789999998763 34556777788888777 5999999999999999
Q ss_pred eeEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeecc
Q 010513 256 HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGL 335 (508)
Q Consensus 256 ~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~ 335 (508)
++|+||||+.||++..+.+. ..+++..+.-++..++.||.|||++ +|||||||.+|||+|.+|++||+|||+
T Consensus 443 ~l~fvmey~~Ggdm~~~~~~-----~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGl 514 (694)
T KOG0694|consen 443 HLFFVMEYVAGGDLMHHIHT-----DVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGL 514 (694)
T ss_pred eEEEEEEecCCCcEEEEEec-----ccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEeccccc
Confidence 99999999999995555443 4799999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccc
Q 010513 336 AKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAE 415 (508)
Q Consensus 336 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (508)
++..- .....+.++||||.|||||++.+..|+.++|+|||||+||||+.|+.||.+.+.. .+.+.+. ..
T Consensus 515 cKe~m-~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEe---e~FdsI~---~d---- 583 (694)
T KOG0694|consen 515 CKEGM-GQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEE---EVFDSIV---ND---- 583 (694)
T ss_pred ccccC-CCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHH---HHHHHHh---cC----
Confidence 98642 2334567799999999999999999999999999999999999999999865432 2222111 10
Q ss_pred cCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCH
Q 010513 416 GVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKM 452 (508)
Q Consensus 416 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 452 (508)
++.. +.-..++.+.++.++|..+|++|.-+
T Consensus 584 ---~~~y----P~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 584 ---EVRY----PRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred ---CCCC----CCcccHHHHHHHHHHhccCcccccCC
Confidence 1111 11123455568889999999999865
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=345.87 Aligned_cols=248 Identities=24% Similarity=0.384 Sum_probs=193.2
Q ss_pred CCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCc-hhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEEe
Q 010513 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY 263 (508)
Q Consensus 186 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~ 263 (508)
++|+..+.||+|+||+||+|.+. +++.||+|.+..... .....+.+|+++++.++|+||+++++++.+++..++||||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 153 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF 153 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence 45677899999999999999965 688999999865433 3346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCCC
Q 010513 264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER 343 (508)
Q Consensus 264 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 343 (508)
+++|+|.+. ....+..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+++......
T Consensus 154 ~~~~~L~~~--------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~ 222 (353)
T PLN00034 154 MDGGSLEGT--------HIADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM 222 (353)
T ss_pred CCCCccccc--------ccCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceeccccc
Confidence 999998653 2356777889999999999999999 99999999999999999999999999998764322
Q ss_pred cceecceecCCCCCChhhhhc-----CCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCC
Q 010513 344 SYVTTRVMGTFGYVAPEYAST-----GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVL 418 (508)
Q Consensus 344 ~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 418 (508)
.......||..|+|||++.. ...+.++|||||||++|||++|+.||........ ...........
T Consensus 223 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~---~~~~~~~~~~~------ 292 (353)
T PLN00034 223 -DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDW---ASLMCAICMSQ------ 292 (353)
T ss_pred -ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccH---HHHHHHHhccC------
Confidence 12234579999999998743 3345689999999999999999999974332211 11111111000
Q ss_pred CccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 419 DPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 419 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
.+.. ......++.+++.+||+.||++||++.|++++
T Consensus 293 ~~~~----~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 293 PPEA----PATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred CCCC----CCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0111 11122345558889999999999999999976
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-42 Score=337.66 Aligned_cols=266 Identities=22% Similarity=0.279 Sum_probs=202.5
Q ss_pred CCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCC--chhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEE
Q 010513 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE 262 (508)
Q Consensus 186 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e 262 (508)
++|++.+.||+|+||+||+|+++ ++..||+|++.... ....+.+.+|+++++.++||||+++++++.++...++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 47899999999999999999976 57789999886542 2334567889999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCC
Q 010513 263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE 342 (508)
Q Consensus 263 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 342 (508)
|++++.+..+... ...+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||++......
T Consensus 81 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 153 (287)
T cd07848 81 YVEKNMLELLEEM----PNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEG 153 (287)
T ss_pred cCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCccccccc
Confidence 9998776655432 24689999999999999999999998 9999999999999999999999999999876443
Q ss_pred CcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHH---------HHHHhhcccc
Q 010513 343 RSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVE---------WLKTMVTNRN 413 (508)
Q Consensus 343 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~---------~~~~~~~~~~ 413 (508)
.........||+.|+|||++.+..++.++|+|||||++|||++|+.||............. ..+.......
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07848 154 SNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPR 233 (287)
T ss_pred ccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccch
Confidence 3333344578999999999998899999999999999999999999997543211110000 0000001100
Q ss_pred cccCCCccCCCC------chHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 414 AEGVLDPRLQEK------PCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 414 ~~~~~~~~l~~~------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
......+..... ........+.+++.+||+.||++||++++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 234 FHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred hcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000000111000 001123456778889999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-42 Score=337.37 Aligned_cols=252 Identities=24% Similarity=0.302 Sum_probs=199.8
Q ss_pred CCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCC---chhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEE
Q 010513 187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE 262 (508)
Q Consensus 187 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e 262 (508)
.|+..+.||+|+||+||+|... +++.||+|.+.... ......+.+|+++++.++|+||+++++++.+++..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 3678899999999999999964 68899999886542 2223457789999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCC
Q 010513 263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE 342 (508)
Q Consensus 263 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 342 (508)
|+++|+|.+++.... ...+++..++.++.|++.||+|||++ +|+||||||+|||+++++.+||+|||++......
T Consensus 81 ~~~~g~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (285)
T cd05631 81 IMNGGDLKFHIYNMG--NPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG 155 (285)
T ss_pred ecCCCcHHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC
Confidence 999999998886432 24689999999999999999999999 9999999999999999999999999999875332
Q ss_pred CcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCCccC
Q 010513 343 RSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRL 422 (508)
Q Consensus 343 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 422 (508)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||......... +.+........ ...
T Consensus 156 ~--~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~---~~~~~~~~~~~------~~~ 224 (285)
T cd05631 156 E--TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKR---EEVDRRVKEDQ------EEY 224 (285)
T ss_pred C--eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhH---HHHHHHhhccc------ccC
Confidence 2 223457999999999999999999999999999999999999999755432111 11111111100 001
Q ss_pred CCCchHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 010513 423 QEKPCSRALKRALLVALRCVDPNAHKRPK-----MGHVIHM 458 (508)
Q Consensus 423 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~ 458 (508)
... .+ ..+.+++.+||+.||++||+ +++++++
T Consensus 225 ~~~-~s---~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 225 SEK-FS---EDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred Ccc-CC---HHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 111 22 34455788999999999997 7888864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=343.91 Aligned_cols=253 Identities=23% Similarity=0.315 Sum_probs=203.3
Q ss_pred CCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCC---chhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEE
Q 010513 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY 261 (508)
Q Consensus 186 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 261 (508)
++|++.+.||+|+||.||+|++. +++.||+|++.... ......+..|++++..++||||+++++++.+++..|+||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 36899999999999999999976 57889999986542 233456788999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCC
Q 010513 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA 341 (508)
Q Consensus 262 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 341 (508)
||+++|+|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~ 153 (333)
T cd05600 81 EYVPGGDFRTLLNNL----GVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT 153 (333)
T ss_pred eCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc
Confidence 999999999999764 4689999999999999999999999 999999999999999999999999999986533
Q ss_pred CCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCCcc
Q 010513 342 ERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPR 421 (508)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 421 (508)
......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ....+... .. ....+.
T Consensus 154 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~---~~~~i~~~---~~--~~~~~~ 221 (333)
T cd05600 154 ----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNE---TWENLKYW---KE--TLQRPV 221 (333)
T ss_pred ----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHH---HHHHHHhc---cc--cccCCC
Confidence 2344679999999999999999999999999999999999999997543211 11111110 00 000111
Q ss_pred CCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 422 LQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 422 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
.. +.......++.+++.+||+.+|++||++.+++++
T Consensus 222 ~~-~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 222 YD-DPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred CC-ccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 11 0011123345557789999999999999999976
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=335.02 Aligned_cols=245 Identities=19% Similarity=0.383 Sum_probs=196.8
Q ss_pred ceEcccCcEEEEEEEECCCcEEEEEEeecCCchh---HHHHHHHHHHHHccCCCCeeeEeeeeec----CCeeEEEEEec
Q 010513 192 NVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQA---EKEFKVEVEAIGRVRHKNLVRLLGYCAE----GAHRMLVYEYI 264 (508)
Q Consensus 192 ~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~----~~~~~lV~e~~ 264 (508)
..||+|++|.||+|.++ |+.||||.+....... .+.+.+|+.+|++++||||+++++++.+ ....++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIFN-NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEEC-CEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 67999999999999984 8899999986543322 4678899999999999999999999876 34678999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCCCc
Q 010513 265 DNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS 344 (508)
Q Consensus 265 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~ 344 (508)
++|+|.+++... ..+++.....++.|++.||.|||+.. +++||||||+|||+++++.+||+|||+++......
T Consensus 105 ~~g~L~~~l~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~- 177 (283)
T PHA02988 105 TRGYLREVLDKE----KDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP- 177 (283)
T ss_pred CCCcHHHHHhhC----CCCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhhcccc-
Confidence 999999999765 46889999999999999999999732 78899999999999999999999999998653321
Q ss_pred ceecceecCCCCCChhhhhc--CCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCCccC
Q 010513 345 YVTTRVMGTFGYVAPEYAST--GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRL 422 (508)
Q Consensus 345 ~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 422 (508)
....|+..|+|||++.+ ..++.++|||||||++|||++|+.||..... .+.......... .+.+
T Consensus 178 ---~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~------~~~~~~i~~~~~-----~~~~ 243 (283)
T PHA02988 178 ---FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT------KEIYDLIINKNN-----SLKL 243 (283)
T ss_pred ---ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCH------HHHHHHHHhcCC-----CCCC
Confidence 23468899999999976 6899999999999999999999999974431 122222211111 1111
Q ss_pred CCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010513 423 QEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (508)
Q Consensus 423 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~~ 462 (508)
.. .++..+. +++.+||+.||++||++.++++.|+..
T Consensus 244 ~~-~~~~~l~---~li~~cl~~dp~~Rps~~ell~~l~~~ 279 (283)
T PHA02988 244 PL-DCPLEIK---CIVEACTSHDSIKRPNIKEILYNLSLY 279 (283)
T ss_pred CC-cCcHHHH---HHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 11 2344444 477799999999999999999999764
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-42 Score=344.91 Aligned_cols=246 Identities=20% Similarity=0.303 Sum_probs=200.7
Q ss_pred CCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCC---chhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEE
Q 010513 185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLV 260 (508)
Q Consensus 185 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 260 (508)
.++|++.+.||+|+||.||+|+++ +++.||+|.+.... ....+.+.+|+++++.++||||+++++++.+++..|+|
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 96 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL 96 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence 357899999999999999999976 57889999986542 23345688899999999999999999999999999999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecC
Q 010513 261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG 340 (508)
Q Consensus 261 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 340 (508)
|||+++|+|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++....
T Consensus 97 ~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 169 (329)
T PTZ00263 97 LEFVVGGELFTHLRKA----GRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVP 169 (329)
T ss_pred EcCCCCChHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcC
Confidence 9999999999999764 4688999999999999999999999 99999999999999999999999999998653
Q ss_pred CCCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCCc
Q 010513 341 AERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDP 420 (508)
Q Consensus 341 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 420 (508)
... ...+||+.|+|||++.+..++.++|||||||++|||++|+.||....+ .+....... ...
T Consensus 170 ~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~------~~~~~~i~~-~~~------ 232 (329)
T PTZ00263 170 DRT----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP------FRIYEKILA-GRL------ 232 (329)
T ss_pred CCc----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH------HHHHHHHhc-CCc------
Confidence 322 235799999999999999999999999999999999999999964321 121222111 110
Q ss_pred cCCCCchHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 010513 421 RLQEKPCSRALKRALLVALRCVDPNAHKRPK-----MGHVIHM 458 (508)
Q Consensus 421 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~ 458 (508)
.+. ...+. ++.+++.+||+.||++||+ +.+++++
T Consensus 233 ~~p-~~~~~---~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 233 KFP-NWFDG---RARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred CCC-CCCCH---HHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 011 11222 3445788999999999997 6777755
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-42 Score=344.04 Aligned_cols=242 Identities=22% Similarity=0.273 Sum_probs=195.3
Q ss_pred ceEcccCcEEEEEEEEC-CCcEEEEEEeecCC---chhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEEecCCC
Q 010513 192 NVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNG 267 (508)
Q Consensus 192 ~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~g 267 (508)
+.||+|+||.||+|+.+ +++.||+|.+.... ......+..|+++++.++||||+++++++.+++..|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999965 68889999986542 233456778999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCCCccee
Q 010513 268 NLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVT 347 (508)
Q Consensus 268 ~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~ 347 (508)
+|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++..... ....
T Consensus 81 ~L~~~l~~~----~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~-~~~~ 152 (323)
T cd05571 81 ELFFHLSRE----RVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISD-GATM 152 (323)
T ss_pred cHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccC-CCcc
Confidence 999998764 5789999999999999999999999 9999999999999999999999999998753222 2223
Q ss_pred cceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCCccCCCCch
Q 010513 348 TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPC 427 (508)
Q Consensus 348 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 427 (508)
...+||+.|+|||++.+..++.++|||||||++|||++|+.||...+. .......... . ..+... .
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~------~~~~~~~~~~-~------~~~p~~-~ 218 (323)
T cd05571 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH------EKLFELILME-E------IRFPRT-L 218 (323)
T ss_pred cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCH------HHHHHHHHcC-C------CCCCCC-C
Confidence 446799999999999999999999999999999999999999964321 1111111111 0 111111 2
Q ss_pred HHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 010513 428 SRALKRALLVALRCVDPNAHKRP-----KMGHVIHM 458 (508)
Q Consensus 428 ~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 458 (508)
+ .++.+++.+||+.||++|| ++.+++++
T Consensus 219 ~---~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 219 S---PEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred C---HHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 2 3445577899999999999 78888754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=336.61 Aligned_cols=257 Identities=26% Similarity=0.426 Sum_probs=203.5
Q ss_pred hcCCCCcccceEcccCcEEEEEEEEC----CCcEEEEEEeecCCc-hhHHHHHHHHHHHHccCCCCeeeEeeeeecCCee
Q 010513 183 VSTNGFADENVIGEGGYGIVYHGVLE----DNTNVAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHR 257 (508)
Q Consensus 183 ~~~~~~~~~~~LG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 257 (508)
+..++|++.+.||+|+||.||+|.++ .+..||+|.+..... .....+.+|+..++.++||||+++++++..++..
T Consensus 2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 81 (266)
T cd05064 2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTM 81 (266)
T ss_pred CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCc
Confidence 34567999999999999999999853 356789998865532 3345788999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccce
Q 010513 258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK 337 (508)
Q Consensus 258 ~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~ 337 (508)
++||||+++|+|.+++... ...+++..++.++.|++.||+|||++ +++||||||+|||++.++.++++|||.+.
T Consensus 82 ~lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~ 155 (266)
T cd05064 82 MIVTEYMSNGALDSFLRKH---EGQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQ 155 (266)
T ss_pred EEEEEeCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCcccc
Confidence 9999999999999999764 24689999999999999999999999 99999999999999999999999999876
Q ss_pred ecCCCCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHhhccccccc
Q 010513 338 LLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEG 416 (508)
Q Consensus 338 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 416 (508)
..............++..|+|||.+.+..++.++|||||||++||+++ |..||...... +.+... ....
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~------~~~~~~-~~~~--- 225 (266)
T cd05064 156 EDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ------DVIKAV-EDGF--- 225 (266)
T ss_pred cccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH------HHHHHH-HCCC---
Confidence 542222222222345678999999999999999999999999999875 99999654321 112211 1110
Q ss_pred CCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 010513 417 VLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461 (508)
Q Consensus 417 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~ 461 (508)
.... ...++.. +.+++.+||+.+|++||++.++++.|+.
T Consensus 226 --~~~~-~~~~~~~---~~~li~~c~~~~p~~RP~~~~i~~~l~~ 264 (266)
T cd05064 226 --RLPA-PRNCPNL---LHQLMLDCWQKERGERPRFSQIHSILSK 264 (266)
T ss_pred --CCCC-CCCCCHH---HHHHHHHHcCCCchhCCCHHHHHHHHHh
Confidence 0011 1123333 4457789999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-42 Score=340.30 Aligned_cols=245 Identities=24% Similarity=0.320 Sum_probs=200.3
Q ss_pred CCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCC---chhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEE
Q 010513 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY 261 (508)
Q Consensus 186 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 261 (508)
++|++.+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+++++.++||||+++++++.++...++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 46889999999999999999976 68889999986432 233456888999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCC
Q 010513 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA 341 (508)
Q Consensus 262 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 341 (508)
||+++|+|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~ 153 (291)
T cd05612 81 EYVPGGELFSYLRNS----GRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD 153 (291)
T ss_pred eCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccC
Confidence 999999999999765 4689999999999999999999999 999999999999999999999999999986533
Q ss_pred CCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCCcc
Q 010513 342 ERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPR 421 (508)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 421 (508)
. ....+||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+......... ..
T Consensus 154 ~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~------~~~~~~i~~~~-------~~ 216 (291)
T cd05612 154 R----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNP------FGIYEKILAGK-------LE 216 (291)
T ss_pred C----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhCC-------cC
Confidence 2 2235799999999999999999999999999999999999999974321 12222222111 01
Q ss_pred CCCCchHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 010513 422 LQEKPCSRALKRALLVALRCVDPNAHKRPK-----MGHVIHM 458 (508)
Q Consensus 422 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~ 458 (508)
+... .+. .+.+++.+||+.||++||+ +.+++++
T Consensus 217 ~~~~-~~~---~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 217 FPRH-LDL---YAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred CCcc-CCH---HHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 1111 122 3445888999999999995 8888765
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-42 Score=333.83 Aligned_cols=258 Identities=24% Similarity=0.445 Sum_probs=208.5
Q ss_pred hhcCCCCcccceEcccCcEEEEEEEECCCcEEEEEEeecCCchhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEE
Q 010513 182 EVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY 261 (508)
Q Consensus 182 ~~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 261 (508)
++..++|++.++||+|+||.||+|...++..||+|.+.... ...+.+..|+.+++.++|+||+++++++.+.+..+++|
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 80 (261)
T cd05072 2 EIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIIT 80 (261)
T ss_pred cCchHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEE
Confidence 35567899999999999999999998888889999876433 33567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCC
Q 010513 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA 341 (508)
Q Consensus 262 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 341 (508)
||+++|+|.+++.... ...+++..++.++.|++.||+|||+. +++||||||+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 155 (261)
T cd05072 81 EYMAKGSLLDFLKSDE--GGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIED 155 (261)
T ss_pred ecCCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCC
Confidence 9999999999997642 35688899999999999999999998 999999999999999999999999999987644
Q ss_pred CCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHhhcccccccCCCc
Q 010513 342 ERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDP 420 (508)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 420 (508)
..........++..|+|||++.+..++.++|||||||++|+|++ |+.||...... .....+ .... ..+
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~---~~~~~~---~~~~-----~~~ 224 (261)
T cd05072 156 NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS---DVMSAL---QRGY-----RMP 224 (261)
T ss_pred CceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH---HHHHHH---HcCC-----CCC
Confidence 33222233446678999999998899999999999999999998 99999643211 111111 1110 011
Q ss_pred cCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 010513 421 RLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461 (508)
Q Consensus 421 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~ 461 (508)
.. ...+ .++.+++.+||+.+|++||+++++.+.|++
T Consensus 225 ~~--~~~~---~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 225 RM--ENCP---DELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred CC--CCCC---HHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 11 1122 345558889999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=342.22 Aligned_cols=202 Identities=25% Similarity=0.389 Sum_probs=177.2
Q ss_pred hcCCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCC-chhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEE
Q 010513 183 VSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLV 260 (508)
Q Consensus 183 ~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 260 (508)
+..++|++.+.||+|+||.||++.+. ++..+|+|.+.... ....+.+.+|+++++.++||||+++++++.+++..++|
T Consensus 2 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 81 (331)
T cd06649 2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 81 (331)
T ss_pred CCcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 34578999999999999999999976 57788999886542 33456788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecC
Q 010513 261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG 340 (508)
Q Consensus 261 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 340 (508)
|||+++|+|.+++... ..+++..+..++.|++.||.|||+.. +|+||||||+|||++.++.+||+|||++....
T Consensus 82 ~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 155 (331)
T cd06649 82 MEHMDGGSLDQVLKEA----KRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 155 (331)
T ss_pred eecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccc
Confidence 9999999999999764 46889999999999999999999852 69999999999999999999999999997653
Q ss_pred CCCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCC
Q 010513 341 AERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS 393 (508)
Q Consensus 341 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~ 393 (508)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 156 ~~---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~ 205 (331)
T cd06649 156 DS---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPP 205 (331)
T ss_pred cc---ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 22 223457999999999999999999999999999999999999999643
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-42 Score=351.60 Aligned_cols=262 Identities=26% Similarity=0.433 Sum_probs=205.2
Q ss_pred hhcCCCCcccceEcccCcEEEEEEEE------CCCcEEEEEEeecCC-chhHHHHHHHHHHHHcc-CCCCeeeEeeeeec
Q 010513 182 EVSTNGFADENVIGEGGYGIVYHGVL------EDNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAE 253 (508)
Q Consensus 182 ~~~~~~~~~~~~LG~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~ 253 (508)
++..++|++.+.||+|+||.||+|.+ .++..||+|++.... ....+.+.+|++++..+ +||||+++++++.+
T Consensus 31 ~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~ 110 (375)
T cd05104 31 EFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTV 110 (375)
T ss_pred ccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeecc
Confidence 45667899999999999999999973 235579999886443 23445788899999999 89999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHhccCCC-------------------------------------------------------
Q 010513 254 GAHRMLVYEYIDNGNLEQWLHGDVG------------------------------------------------------- 278 (508)
Q Consensus 254 ~~~~~lV~e~~~~g~L~~~l~~~~~------------------------------------------------------- 278 (508)
+...++||||+++|+|.+++.....
T Consensus 111 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (375)
T cd05104 111 GGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVR 190 (375)
T ss_pred CCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccc
Confidence 9999999999999999999865321
Q ss_pred ----------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCC
Q 010513 279 ----------------PHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE 342 (508)
Q Consensus 279 ----------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 342 (508)
....+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 267 (375)
T cd05104 191 SGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRND 267 (375)
T ss_pred cceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCc
Confidence 012578889999999999999999998 9999999999999999999999999999876443
Q ss_pred Ccce-ecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHhhcccccccCCCc
Q 010513 343 RSYV-TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDP 420 (508)
Q Consensus 343 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 420 (508)
.... .....++..|+|||++.+..++.++|||||||++|||++ |..||...... ......+ .... ....+
T Consensus 268 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~--~~~~~~~----~~~~--~~~~~ 339 (375)
T cd05104 268 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD--SKFYKMI----KEGY--RMLSP 339 (375)
T ss_pred ccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch--HHHHHHH----HhCc--cCCCC
Confidence 3222 122345668999999999999999999999999999998 89998654321 1122221 1111 00011
Q ss_pred cCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 010513 421 RLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461 (508)
Q Consensus 421 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~ 461 (508)
...+ .++.+++.+||+.||++||++.+++++|+.
T Consensus 340 ----~~~~---~~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 340 ----ECAP---SEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred ----CCCC---HHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 1122 345558889999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=314.38 Aligned_cols=250 Identities=26% Similarity=0.378 Sum_probs=208.4
Q ss_pred cCCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCC---chhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEE
Q 010513 184 STNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRML 259 (508)
Q Consensus 184 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 259 (508)
..++|++++.||+|.||.||+|+.+ ++--||+|++.+.. .+...++++|+++-+.|+||||+++|++|.+....|+
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL 99 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL 99 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence 4568999999999999999999965 56678999987653 3345688999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceec
Q 010513 260 VYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL 339 (508)
Q Consensus 260 V~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~ 339 (508)
++||...|+|...|+... ...+++.....++.|+|.||.|+|.+ +||||||||+|+|++.++.+|++|||.+..-
T Consensus 100 ilEya~~gel~k~L~~~~--~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~ 174 (281)
T KOG0580|consen 100 ILEYAPRGELYKDLQEGR--MKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHA 174 (281)
T ss_pred EEEecCCchHHHHHHhcc--cccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeec
Confidence 999999999999998543 46789999999999999999999999 9999999999999999999999999999753
Q ss_pred CCCCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCC
Q 010513 340 GAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLD 419 (508)
Q Consensus 340 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 419 (508)
. .......|||..|.+||..++..++...|+|++|++.||++.|..||.... .......+.+. +..+
T Consensus 175 p---~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~---~~etYkrI~k~-------~~~~ 241 (281)
T KOG0580|consen 175 P---SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS---HSETYKRIRKV-------DLKF 241 (281)
T ss_pred C---CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh---hHHHHHHHHHc-------cccC
Confidence 2 444566899999999999999999999999999999999999999997443 11122211111 1222
Q ss_pred ccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 420 PRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 420 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
| +.....+.++|.+|+.++|.+|.+..|++.+
T Consensus 242 p-------~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 242 P-------STISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred C-------cccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 2 2222344458889999999999999999865
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=328.60 Aligned_cols=252 Identities=23% Similarity=0.436 Sum_probs=202.9
Q ss_pred CCCcccceEcccCcEEEEEEEECCCcEEEEEEeecCCchhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEEecC
Q 010513 186 NGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYID 265 (508)
Q Consensus 186 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~ 265 (508)
++|++.+.||+|+||.||++.++++..+|+|.+.... ...+.+..|+++++.++||||+++++++.+....++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 4688899999999999999998888889999875432 334678889999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCCCcc
Q 010513 266 NGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSY 345 (508)
Q Consensus 266 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~ 345 (508)
+|+|.++++... ..+++..++.++.|++.||+|||++ +++||||||+||++++++.+||+|||.++........
T Consensus 83 ~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~ 156 (256)
T cd05114 83 NGCLLNYLRQRQ---GKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT 156 (256)
T ss_pred CCcHHHHHHhCc---cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCcee
Confidence 999999997642 4688999999999999999999999 9999999999999999999999999998865333222
Q ss_pred eecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHhhcccccccCCCccCCC
Q 010513 346 VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQE 424 (508)
Q Consensus 346 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 424 (508)
......++..|+|||.+.+..++.++|+||||+++|||++ |+.||..... ..... ...... ....+.
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~---~~~~~---~i~~~~---~~~~~~--- 224 (256)
T cd05114 157 SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN---YEVVE---MISRGF---RLYRPK--- 224 (256)
T ss_pred ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH---HHHHH---HHHCCC---CCCCCC---
Confidence 2222345668999999988889999999999999999999 9999964432 11222 111111 111111
Q ss_pred CchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 010513 425 KPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 460 (508)
Q Consensus 425 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le 460 (508)
..+ ..+.+++.+||+.||++||++.++++.|.
T Consensus 225 -~~~---~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 225 -LAS---MTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred -CCC---HHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 122 34556888999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=335.93 Aligned_cols=266 Identities=23% Similarity=0.339 Sum_probs=201.1
Q ss_pred CCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCC-chhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEE
Q 010513 185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE 262 (508)
Q Consensus 185 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e 262 (508)
.++|++.+.||+|+||+||+|..+ ++..||+|.+.... ......+.+|+++++.++||||+++++++.++...++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE 83 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence 357999999999999999999965 67889999886443 2234567789999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCC
Q 010513 263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE 342 (508)
Q Consensus 263 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 342 (508)
|+++ +|.+++... ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 84 ~~~~-~l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~ 156 (288)
T cd07871 84 YLDS-DLKQYLDNC---GNLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVP 156 (288)
T ss_pred CCCc-CHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCC
Confidence 9985 999988654 24578999999999999999999999 9999999999999999999999999999865332
Q ss_pred CcceecceecCCCCCChhhhhc-CCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHH---------HHhhccc
Q 010513 343 RSYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWL---------KTMVTNR 412 (508)
Q Consensus 343 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~---------~~~~~~~ 412 (508)
.. ......|++.|+|||++.+ ..++.++|||||||++|||++|+.||............... .......
T Consensus 157 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd07871 157 TK-TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNE 235 (288)
T ss_pred Cc-cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccch
Confidence 22 2234578999999998865 56899999999999999999999999754322111110000 0000000
Q ss_pred ccccCCCccCCCCch----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 413 NAEGVLDPRLQEKPC----SRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 413 ~~~~~~~~~l~~~~~----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
.......+....... +....++.+++.+||+.||.+|||++|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 236 EFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred hhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 111111111111110 1112355678889999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=341.51 Aligned_cols=252 Identities=25% Similarity=0.288 Sum_probs=199.3
Q ss_pred CCcccceEcccCcEEEEEEEEC----CCcEEEEEEeecCC----chhHHHHHHHHHHHHcc-CCCCeeeEeeeeecCCee
Q 010513 187 GFADENVIGEGGYGIVYHGVLE----DNTNVAVKNLLNNR----GQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEGAHR 257 (508)
Q Consensus 187 ~~~~~~~LG~G~~g~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~ 257 (508)
+|++.+.||+|+||+||+++.. +++.||+|.+.+.. ....+.+..|+++++.+ +||||+++++++.+++..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 4788999999999999999852 57889999986432 22345677899999999 599999999999999999
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccce
Q 010513 258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK 337 (508)
Q Consensus 258 ~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~ 337 (508)
++||||+++|+|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 81 ~lv~e~~~~g~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~ 153 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQR----DNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSK 153 (332)
T ss_pred EEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCc
Confidence 9999999999999998764 4689999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCcceecceecCCCCCChhhhhcC-CCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhccccccc
Q 010513 338 LLGAERSYVTTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEG 416 (508)
Q Consensus 338 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 416 (508)
.............+||+.|+|||++.+. .++.++|||||||++|||++|+.||.......... ........
T Consensus 154 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~--~~~~~~~~------ 225 (332)
T cd05614 154 EFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQS--EVSRRILK------ 225 (332)
T ss_pred cccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHH--HHHHHHhc------
Confidence 6544333334456799999999998765 47889999999999999999999997543322211 11111111
Q ss_pred CCCccCCCCchHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 010513 417 VLDPRLQEKPCSRALKRALLVALRCVDPNAHKRP-----KMGHVIHM 458 (508)
Q Consensus 417 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 458 (508)
.++.+... .+.. +.+++.+||+.||++|| ++++++++
T Consensus 226 -~~~~~~~~-~~~~---~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 226 -CDPPFPSF-IGPE---AQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred -CCCCCCCC-CCHH---HHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 11111111 2233 44577799999999999 67787764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-42 Score=336.95 Aligned_cols=291 Identities=22% Similarity=0.346 Sum_probs=235.9
Q ss_pred CCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCchh--HHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEEe
Q 010513 187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQA--EKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY 263 (508)
Q Consensus 187 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~ 263 (508)
-|.+++.||+|.|.+|-+|++- +|.+||||++.+...+. ...+.+|++.|+-++|||||++|++......+|||+|.
T Consensus 19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLEL 98 (864)
T KOG4717|consen 19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILEL 98 (864)
T ss_pred eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEe
Confidence 5788899999999999999954 79999999997665443 34677899999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEE-cCCCCeEEeeeccceecCCC
Q 010513 264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILL-DKQWNPKLSDFGLAKLLGAE 342 (508)
Q Consensus 264 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll-~~~~~~kL~DFG~a~~~~~~ 342 (508)
-++|+|++||.+. ...+.++.+.+++.||+.|+.|+|+. .+|||||||+|+.+ .+-|-+||+|||++-.+...
T Consensus 99 GD~GDl~DyImKH---e~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG 172 (864)
T KOG4717|consen 99 GDGGDLFDYIMKH---EEGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG 172 (864)
T ss_pred cCCchHHHHHHhh---hccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCCCc
Confidence 9999999999776 36799999999999999999999998 99999999999877 66788999999999876444
Q ss_pred CcceecceecCCCCCChhhhhcCCCCC-CCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCCcc
Q 010513 343 RSYVTTRVMGTFGYVAPEYASTGMLNE-RSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPR 421 (508)
Q Consensus 343 ~~~~~~~~~gt~~y~aPE~~~~~~~~~-~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 421 (508)
. ..+..||+..|-|||++.+..|+. +.|||||||+||.|++|+.||+..++.+... .++|.+
T Consensus 173 ~--kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLT---------------mImDCK 235 (864)
T KOG4717|consen 173 K--KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLT---------------MIMDCK 235 (864)
T ss_pred c--hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhh---------------hhhccc
Confidence 3 346679999999999999988864 6799999999999999999998665443221 233443
Q ss_pred CCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhcCCCCCCCC------------CCCcc-----ch------
Q 010513 422 LQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIH--MLEAEEFPFRDV------------SFGRV-----IG------ 476 (508)
Q Consensus 422 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~Le~~~~~~~~~------------~~~~~-----~~------ 476 (508)
... +.-...+|.+||..||..||++|.+.++|.. .|++.+-++... -...| .+
T Consensus 236 Ytv--PshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~~~sT~iPLvsr~~L~ee~Ha~IIq~Mv~G~IAs~e 313 (864)
T KOG4717|consen 236 YTV--PSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDRGLSTAIPLVSRHHLPEEAHATIIQQMVAGAIASEE 313 (864)
T ss_pred ccC--chhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCCCCccccCceeehhhCChHHHHHHHHHHhcccccCHH
Confidence 332 4556778888999999999999999999975 455554333221 00011 11
Q ss_pred -hhhhHHHhhcchhhhhhhhhhhhhhh
Q 010513 477 -ILFFLKALLYSTLVMQLYLLKNFLLH 502 (508)
Q Consensus 477 -~~~~~~~~~~~~~~~~~~~~~~~~~~ 502 (508)
++.++..--|+.++|++|+|++++|.
T Consensus 314 ~Il~aLe~n~YNhiTATYfLLAEr~Lr 340 (864)
T KOG4717|consen 314 DILRALENNEYNHITATYFLLAERVLR 340 (864)
T ss_pred HHHHHHhccccchhhhHHHHHHHHHHH
Confidence 33355566799999999999999885
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=343.30 Aligned_cols=252 Identities=25% Similarity=0.370 Sum_probs=209.3
Q ss_pred CCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCC--chhHHHHHHHHHHHHccCCCCeeeEeeeeecCCe-eEEE
Q 010513 185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAH-RMLV 260 (508)
Q Consensus 185 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~-~~lV 260 (508)
.+.|..++++|+|+||.+++++.+ +++.+++|++.-.. ....+....|+.++++++|||||.+.+.|.+++. .++|
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 357889999999999999999965 67889999985443 2333467789999999999999999999998888 8999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecC
Q 010513 261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG 340 (508)
Q Consensus 261 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 340 (508)
|+||+||+|.+.+.+.. ...++++.+..++.|++.|+.|||++ .|+|||||+.|||++.++.+||+|||+|+.++
T Consensus 83 m~Y~eGg~l~~~i~~~k--~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~ 157 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQK--GVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILN 157 (426)
T ss_pred EeecCCCCHHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcC
Confidence 99999999999998764 46799999999999999999999998 99999999999999999999999999999886
Q ss_pred CCCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCCc
Q 010513 341 AERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDP 420 (508)
Q Consensus 341 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 420 (508)
.... .....+||+.||.||++.+.+|+.|+|||||||++|||++-+.+|...+.. ....+... ....|
T Consensus 158 ~~~~-~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~------~Li~ki~~-----~~~~P 225 (426)
T KOG0589|consen 158 PEDS-LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMS------ELILKINR-----GLYSP 225 (426)
T ss_pred Cchh-hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchH------HHHHHHhh-----ccCCC
Confidence 6542 345578999999999999999999999999999999999999999755432 11111111 11122
Q ss_pred cCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 421 RLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 421 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
.......++..++..|++.+|+.||++.++|.+
T Consensus 226 -----lp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 226 -----LPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred -----CCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 122233444557779999999999999999876
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=331.02 Aligned_cols=258 Identities=27% Similarity=0.453 Sum_probs=207.7
Q ss_pred hhcCCCCcccceEcccCcEEEEEEEECCCcEEEEEEeecCCchhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEE
Q 010513 182 EVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY 261 (508)
Q Consensus 182 ~~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 261 (508)
++..++|++.+.||+|+||.||+|.+.+++.||+|.+.... ...+.+.+|++++++++||||+++++++...+..++||
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 80 (261)
T cd05068 2 EIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVT 80 (261)
T ss_pred ccchhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeee
Confidence 45677899999999999999999998778889999886543 34567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCC
Q 010513 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA 341 (508)
Q Consensus 262 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 341 (508)
||+++++|.+++.... ...+++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 155 (261)
T cd05068 81 ELMKYGSLLEYLQGGA--GRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKE 155 (261)
T ss_pred ecccCCcHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccC
Confidence 9999999999997652 34689999999999999999999999 999999999999999999999999999987653
Q ss_pred CCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHhhcccccccCCCc
Q 010513 342 ERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDP 420 (508)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 420 (508)
..........++..|+|||++.+..++.++|+||||+++|||++ |+.||..... .+.......... . +
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~------~~~~~~~~~~~~----~-~ 224 (261)
T cd05068 156 DIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN------AEVLQQVDQGYR----M-P 224 (261)
T ss_pred CcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCH------HHHHHHHHcCCC----C-C
Confidence 22221222223457999999998899999999999999999999 9999964321 111111111100 0 0
Q ss_pred cCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 010513 421 RLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461 (508)
Q Consensus 421 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~ 461 (508)
. .... ...+.+++.+|++.+|++||++.++++.||+
T Consensus 225 -~-~~~~---~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 225 -C-PPGC---PKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred -C-CCcC---CHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 0 1112 2345568889999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-42 Score=323.05 Aligned_cols=265 Identities=22% Similarity=0.306 Sum_probs=205.4
Q ss_pred CCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCchh--HHHHHHHHHHHHccCCCCeeeEeeeeecC--CeeEEE
Q 010513 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQA--EKEFKVEVEAIGRVRHKNLVRLLGYCAEG--AHRMLV 260 (508)
Q Consensus 186 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~hpniv~l~~~~~~~--~~~~lV 260 (508)
+.|+..+.|++|+||.||+|+++ ++.-||+|+++...... .-.-.+||.+|.+.+|||||.+-.+.... +.+|||
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 46888999999999999999976 57789999997654221 12346799999999999999999988754 479999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecC
Q 010513 261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG 340 (508)
Q Consensus 261 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 340 (508)
||||+. ||..++... ..++...+++.++.|+++|++|||.+ .|+|||||++|+|+++.|.+||+|||+|+.++
T Consensus 156 Me~~Eh-DLksl~d~m---~q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg 228 (419)
T KOG0663|consen 156 MEYVEH-DLKSLMETM---KQPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREYG 228 (419)
T ss_pred HHHHHh-hHHHHHHhc---cCCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhhc
Confidence 999998 999999877 36899999999999999999999999 89999999999999999999999999999986
Q ss_pred CCCcceecceecCCCCCChhhhhc-CCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCC
Q 010513 341 AERSYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLD 419 (508)
Q Consensus 341 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 419 (508)
... ...+..+-|.+|.|||++.+ ..|+++.|+||+||++.||+++++-|.+.......+.+-.+.....+..+.++..
T Consensus 229 sp~-k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~ 307 (419)
T KOG0663|consen 229 SPL-KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSE 307 (419)
T ss_pred CCc-ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccc
Confidence 553 34566778999999998766 4699999999999999999999999976654322222111111111222222111
Q ss_pred cc------CCCCchH---------HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 420 PR------LQEKPCS---------RALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 420 ~~------l~~~~~~---------~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
.. +...+.. ......++++..+|..||++|-|+.+.|++
T Consensus 308 lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 308 LPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred cchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 11 1111111 122455667789999999999999999876
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=344.18 Aligned_cols=248 Identities=22% Similarity=0.301 Sum_probs=201.4
Q ss_pred hcCCCCcccceEcccCcEEEEEEEECC--CcEEEEEEeecCC---chhHHHHHHHHHHHHccCCCCeeeEeeeeecCCee
Q 010513 183 VSTNGFADENVIGEGGYGIVYHGVLED--NTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHR 257 (508)
Q Consensus 183 ~~~~~~~~~~~LG~G~~g~Vy~~~~~~--~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 257 (508)
+..++|.+.+.||+|+||.||+|.++. +..||+|.+.... ....+.+..|+++++.++||||+++++++.++...
T Consensus 27 ~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~ 106 (340)
T PTZ00426 27 MKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYL 106 (340)
T ss_pred CChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEE
Confidence 445689999999999999999998653 3579999886432 23345678899999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccce
Q 010513 258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK 337 (508)
Q Consensus 258 ~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~ 337 (508)
|+||||+++|+|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++.
T Consensus 107 ~lv~Ey~~~g~L~~~i~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~ 179 (340)
T PTZ00426 107 YLVLEFVIGGEFFTFLRRN----KRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAK 179 (340)
T ss_pred EEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCe
Confidence 9999999999999999765 4689999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccC
Q 010513 338 LLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGV 417 (508)
Q Consensus 338 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 417 (508)
..... ....+||+.|+|||++.+..++.++|||||||++|||++|+.||....+. ........ ...
T Consensus 180 ~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~------~~~~~i~~-~~~--- 245 (340)
T PTZ00426 180 VVDTR----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL------LIYQKILE-GII--- 245 (340)
T ss_pred ecCCC----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH------HHHHHHhc-CCC---
Confidence 75322 23457999999999999988999999999999999999999999754321 11111111 110
Q ss_pred CCccCCCCchHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 010513 418 LDPRLQEKPCSRALKRALLVALRCVDPNAHKRP-----KMGHVIHM 458 (508)
Q Consensus 418 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 458 (508)
.+. ...+. .+.+++.+|++.||++|+ ++++++++
T Consensus 246 ---~~p-~~~~~---~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 246 ---YFP-KFLDN---NCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred ---CCC-CCCCH---HHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 011 11222 344577799999999995 89988875
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=345.16 Aligned_cols=252 Identities=25% Similarity=0.333 Sum_probs=199.3
Q ss_pred CCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCC---chhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEE
Q 010513 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY 261 (508)
Q Consensus 186 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 261 (508)
++|++.+.||+|+||+||+|+.. +++.||||++.... ......+.+|++++..++||||+++++++.+++..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47899999999999999999975 58889999986532 233456788999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCC
Q 010513 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA 341 (508)
Q Consensus 262 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 341 (508)
||+++|+|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++..+..
T Consensus 81 E~~~~g~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 153 (364)
T cd05599 81 EYLPGGDMMTLLMKK----DTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKK 153 (364)
T ss_pred CCCCCcHHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceeccc
Confidence 999999999999764 4689999999999999999999999 999999999999999999999999999876432
Q ss_pred CCcc-------------------------------------eecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHH
Q 010513 342 ERSY-------------------------------------VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVI 384 (508)
Q Consensus 342 ~~~~-------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ell 384 (508)
.... .....+||+.|+|||++.+..++.++|||||||++|||+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~ 233 (364)
T cd05599 154 SHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEML 233 (364)
T ss_pred cccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhh
Confidence 1100 011246999999999999999999999999999999999
Q ss_pred hCCCCCCCCCCCCcchHHHHHHHhhcccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCC---HHHHHHH
Q 010513 385 SGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPK---MGHVIHM 458 (508)
Q Consensus 385 tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~evl~~ 458 (508)
+|+.||....+ .+.......... ....+. ....+.. +.+++.+|+. +|.+|++ +.+++++
T Consensus 234 ~G~~Pf~~~~~------~~~~~~i~~~~~--~~~~~~--~~~~s~~---~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 234 VGYPPFCSDNP------QETYRKIINWKE--TLQFPD--EVPLSPE---AKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred cCCCCCCCCCH------HHHHHHHHcCCC--ccCCCC--CCCCCHH---HHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 99999975432 122222211110 000010 0112333 3446678886 9999998 8888774
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=345.66 Aligned_cols=258 Identities=21% Similarity=0.275 Sum_probs=204.0
Q ss_pred hHhhcCCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCC---chhHHHHHHHHHHHHccCCCCeeeEeeeeecCC
Q 010513 180 ELEVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGA 255 (508)
Q Consensus 180 ~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~ 255 (508)
..+...++|++.+.||+|+||.||+|+.. +++.||+|.+.+.. ......+..|+.+++.++||||+++++++.+++
T Consensus 37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~ 116 (370)
T cd05596 37 KLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDK 116 (370)
T ss_pred cCCCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence 34556678999999999999999999975 57889999986432 223345778999999999999999999999999
Q ss_pred eeEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeecc
Q 010513 256 HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGL 335 (508)
Q Consensus 256 ~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~ 335 (508)
..|+||||+++|+|.+++... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 117 ~~~lv~Ey~~gg~L~~~l~~~-----~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~ 188 (370)
T cd05596 117 YLYMVMEYMPGGDLVNLMSNY-----DIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGT 188 (370)
T ss_pred EEEEEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccc
Confidence 999999999999999998653 578889999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCcceecceecCCCCCChhhhhcC----CCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcc
Q 010513 336 AKLLGAERSYVTTRVMGTFGYVAPEYASTG----MLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTN 411 (508)
Q Consensus 336 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~ 411 (508)
+..............+||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ..........
T Consensus 189 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~------~~~~~~i~~~ 262 (370)
T cd05596 189 CMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL------VGTYSKIMDH 262 (370)
T ss_pred eeeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH------HHHHHHHHcC
Confidence 987644333333456799999999998653 478899999999999999999999975432 1222222221
Q ss_pred cccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHH
Q 010513 412 RNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHK--RPKMGHVIHM 458 (508)
Q Consensus 412 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~ 458 (508)
... . .+.. .......+.+++.+||+.+|++ ||++.+++++
T Consensus 263 ~~~--~---~~~~--~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 263 KNS--L---TFPD--DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred CCc--C---CCCC--cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 110 0 0111 1112234445777999999988 9999999876
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=337.54 Aligned_cols=240 Identities=23% Similarity=0.278 Sum_probs=192.7
Q ss_pred EcccCcEEEEEEEEC-CCcEEEEEEeecC---CchhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEEecCCCCH
Q 010513 194 IGEGGYGIVYHGVLE-DNTNVAVKNLLNN---RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNL 269 (508)
Q Consensus 194 LG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~g~L 269 (508)
||+|+||.||+|... ++..||+|.+... .......+..|++++++++||||+++++++.+++..|+||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999976 5778999998643 223345677899999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCCCcceecc
Q 010513 270 EQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTR 349 (508)
Q Consensus 270 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~ 349 (508)
.+++... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++..... ......
T Consensus 81 ~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~-~~~~~~ 152 (312)
T cd05585 81 FHHLQRE----GRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKD-DDKTNT 152 (312)
T ss_pred HHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccC-CCcccc
Confidence 9999764 4689999999999999999999999 9999999999999999999999999999854222 222344
Q ss_pred eecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCCccCCCCchHH
Q 010513 350 VMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSR 429 (508)
Q Consensus 350 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 429 (508)
.+||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+......... ..+. ...+.
T Consensus 153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~------~~~~~~~~~~~~-------~~~~-~~~~~ 218 (312)
T cd05585 153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDEN------VNEMYRKILQEP-------LRFP-DGFDR 218 (312)
T ss_pred ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCC------HHHHHHHHHcCC-------CCCC-CcCCH
Confidence 679999999999999999999999999999999999999997432 222222222110 0111 11223
Q ss_pred HHHHHHHHHHHccCCCCCCCCC---HHHHHHH
Q 010513 430 ALKRALLVALRCVDPNAHKRPK---MGHVIHM 458 (508)
Q Consensus 430 ~~~~l~~li~~cl~~dP~~RPs---~~evl~~ 458 (508)
.+.+++.+||+.||++||+ +.+++++
T Consensus 219 ---~~~~li~~~L~~dp~~R~~~~~~~e~l~h 247 (312)
T cd05585 219 ---DAKDLLIGLLSRDPTRRLGYNGAQEIKNH 247 (312)
T ss_pred ---HHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence 3445777999999999985 5565543
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-42 Score=350.23 Aligned_cols=262 Identities=24% Similarity=0.410 Sum_probs=204.4
Q ss_pred hhcCCCCcccceEcccCcEEEEEEEEC------CCcEEEEEEeecCC-chhHHHHHHHHHHHHcc-CCCCeeeEeeeeec
Q 010513 182 EVSTNGFADENVIGEGGYGIVYHGVLE------DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAE 253 (508)
Q Consensus 182 ~~~~~~~~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~ 253 (508)
..+.++|++.+.||+|+||.||+|++. ++..||+|.+.... ....+.+.+|+++++.+ +|+||++++++|.+
T Consensus 34 ~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~ 113 (374)
T cd05106 34 EFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTH 113 (374)
T ss_pred cccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecC
Confidence 456678999999999999999999842 23479999986543 33345688899999999 89999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHhccCCC-------------------------------------------------------
Q 010513 254 GAHRMLVYEYIDNGNLEQWLHGDVG------------------------------------------------------- 278 (508)
Q Consensus 254 ~~~~~lV~e~~~~g~L~~~l~~~~~------------------------------------------------------- 278 (508)
....++||||+++|+|.+++.....
T Consensus 114 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (374)
T cd05106 114 GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQ 193 (374)
T ss_pred CCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccc
Confidence 9999999999999999999854310
Q ss_pred -----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCCCcce-
Q 010513 279 -----------PHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYV- 346 (508)
Q Consensus 279 -----------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~- 346 (508)
...++++..++.++.|+++||+|||++ +|+||||||+|||+++++.+||+|||+++.........
T Consensus 194 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~ 270 (374)
T cd05106 194 SSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVV 270 (374)
T ss_pred cccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceee
Confidence 123578889999999999999999998 99999999999999999999999999998654332221
Q ss_pred ecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHhhcccccccCCCccCCCC
Q 010513 347 TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEK 425 (508)
Q Consensus 347 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 425 (508)
.....++..|+|||++.+..++.++|||||||++|||++ |+.||....... . ......... .+.. ..
T Consensus 271 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~--~----~~~~~~~~~-----~~~~-~~ 338 (374)
T cd05106 271 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS--K----FYKMVKRGY-----QMSR-PD 338 (374)
T ss_pred ccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH--H----HHHHHHccc-----CccC-CC
Confidence 122335668999999998999999999999999999997 999997543211 1 111111110 1111 11
Q ss_pred chHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 010513 426 PCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461 (508)
Q Consensus 426 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~ 461 (508)
..+ .++.+++.+||+.||++||++.+++++|++
T Consensus 339 ~~~---~~l~~li~~cl~~dp~~RPs~~~l~~~l~~ 371 (374)
T cd05106 339 FAP---PEIYSIMKMCWNLEPTERPTFSQISQLIQR 371 (374)
T ss_pred CCC---HHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 122 345558889999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=356.22 Aligned_cols=252 Identities=21% Similarity=0.323 Sum_probs=204.0
Q ss_pred CCcccceEcccCcEEEEEEEEC-C-CcEEEEEEeecCCchhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEEec
Q 010513 187 GFADENVIGEGGYGIVYHGVLE-D-NTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYI 264 (508)
Q Consensus 187 ~~~~~~~LG~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~ 264 (508)
.|.+.+.||+|+||.||+|... + +..||+|.+..........+..|+++++.++||||+++++++..++..|+||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 4889999999999999999854 3 5678888776555555567888999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCCCc
Q 010513 265 DNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS 344 (508)
Q Consensus 265 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~ 344 (508)
++|+|.+++........++++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.+.....
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 99999998865433346789999999999999999999998 999999999999999999999999999987644322
Q ss_pred -ceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCCccCC
Q 010513 345 -YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQ 423 (508)
Q Consensus 345 -~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 423 (508)
......+||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+.+....... .++ ..
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~------~~~~~~~~~~~-----~~~-~~ 292 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ------REIMQQVLYGK-----YDP-FP 292 (478)
T ss_pred cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhCC-----CCC-CC
Confidence 123446799999999999999999999999999999999999999964321 22222222111 111 01
Q ss_pred CCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 010513 424 EKPCSRALKRALLVALRCVDPNAHKRPKMGHVIH 457 (508)
Q Consensus 424 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 457 (508)
...+ .++.+++.+||+.||++||++.++++
T Consensus 293 -~~~s---~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 293 -CPVS---SGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred -ccCC---HHHHHHHHHHhccChhhCcCHHHHHh
Confidence 1122 34555788999999999999999875
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=342.89 Aligned_cols=252 Identities=24% Similarity=0.315 Sum_probs=203.5
Q ss_pred CCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCC---chhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEE
Q 010513 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY 261 (508)
Q Consensus 186 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 261 (508)
++|.+.+.||+|+||+||+|... +++.||+|++.... ......+..|++++..++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47899999999999999999976 68899999986532 234567888999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCC
Q 010513 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA 341 (508)
Q Consensus 262 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 341 (508)
||+++|+|.+++... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 153 (350)
T cd05573 81 EYMPGGDLMNLLIRK----DVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNK 153 (350)
T ss_pred cCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCcc
Confidence 999999999999765 5789999999999999999999998 999999999999999999999999999986644
Q ss_pred CC----------------------------cceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCC
Q 010513 342 ER----------------------------SYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS 393 (508)
Q Consensus 342 ~~----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~ 393 (508)
.. ........||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~ 233 (350)
T cd05573 154 AKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSD 233 (350)
T ss_pred cCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCC
Confidence 32 11223457999999999999999999999999999999999999999754
Q ss_pred CCCCcchHHHHHHHhhcccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCC-HHHHHHH
Q 010513 394 RPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPK-MGHVIHM 458 (508)
Q Consensus 394 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~~ 458 (508)
.. .+.......... ....+... ..+ .++.+++.+|+. ||++||+ +.+++++
T Consensus 234 ~~------~~~~~~i~~~~~--~~~~p~~~--~~~---~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 234 TL------QETYNKIINWKE--SLRFPPDP--PVS---PEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred CH------HHHHHHHhccCC--cccCCCCC--CCC---HHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 31 111122211000 00011100 022 344457779997 9999999 9999986
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=338.92 Aligned_cols=242 Identities=23% Similarity=0.296 Sum_probs=195.5
Q ss_pred ceEcccCcEEEEEEEEC-CCcEEEEEEeecCC---chhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEEecCCC
Q 010513 192 NVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNG 267 (508)
Q Consensus 192 ~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~g 267 (508)
+.||+|+||.||++... +++.||+|++.+.. ......+.+|+++++.++||||+++++++.+.+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999965 58899999986542 233456788999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCCCccee
Q 010513 268 NLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVT 347 (508)
Q Consensus 268 ~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~ 347 (508)
+|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++..... ....
T Consensus 81 ~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~-~~~~ 152 (328)
T cd05593 81 ELFFHLSRE----RVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD-AATM 152 (328)
T ss_pred CHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCc-cccc
Confidence 999998654 4689999999999999999999999 9999999999999999999999999998753222 2223
Q ss_pred cceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCCccCCCCch
Q 010513 348 TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPC 427 (508)
Q Consensus 348 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 427 (508)
...+||+.|+|||++.+..++.++|||||||++|||++|+.||...+. .+........ +..+... .
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~------~~~~~~~~~~-------~~~~p~~-~ 218 (328)
T cd05593 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH------EKLFELILME-------DIKFPRT-L 218 (328)
T ss_pred ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCH------HHHHHHhccC-------CccCCCC-C
Confidence 346799999999999999999999999999999999999999964322 1111111111 0111111 2
Q ss_pred HHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 010513 428 SRALKRALLVALRCVDPNAHKRP-----KMGHVIHM 458 (508)
Q Consensus 428 ~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 458 (508)
+ .++.+++.+||+.||++|| ++.+++++
T Consensus 219 ~---~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 219 S---ADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred C---HHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 2 2345577799999999997 89998865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-41 Score=342.46 Aligned_cols=259 Identities=20% Similarity=0.292 Sum_probs=202.7
Q ss_pred hhhHhhcCCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecC---CchhHHHHHHHHHHHHccCCCCeeeEeeeeec
Q 010513 178 LRELEVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN---RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE 253 (508)
Q Consensus 178 ~~~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 253 (508)
++.+....++|++.+.||+|+||.||+|... +++.+|+|.+.+. .......+.+|+.+++.++||||+++++++.+
T Consensus 35 ~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (370)
T cd05621 35 IRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQD 114 (370)
T ss_pred HHhcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEc
Confidence 3445666789999999999999999999976 5778999988642 22234567789999999999999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeee
Q 010513 254 GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDF 333 (508)
Q Consensus 254 ~~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DF 333 (508)
+...|+||||+++|+|.+++... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+||
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~l~~~-----~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DF 186 (370)
T cd05621 115 DKYLYMVMEYMPGGDLVNLMSNY-----DVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADF 186 (370)
T ss_pred CCEEEEEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEec
Confidence 99999999999999999999653 578899999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCcceecceecCCCCCChhhhhcC----CCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhh
Q 010513 334 GLAKLLGAERSYVTTRVMGTFGYVAPEYASTG----MLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMV 409 (508)
Q Consensus 334 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~ 409 (508)
|++..............+||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ........
T Consensus 187 G~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~------~~~~~~i~ 260 (370)
T cd05621 187 GTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL------VGTYSKIM 260 (370)
T ss_pred ccceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH------HHHHHHHH
Confidence 99987644333333456799999999998754 378899999999999999999999974422 12222222
Q ss_pred cccccccCCCccCCCC-chHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHH
Q 010513 410 TNRNAEGVLDPRLQEK-PCSRALKRALLVALRCVDPNAHK--RPKMGHVIHM 458 (508)
Q Consensus 410 ~~~~~~~~~~~~l~~~-~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~ 458 (508)
..... ..+... ..+.. +.+++.+|+..++.+ |+++.+++++
T Consensus 261 ~~~~~-----~~~p~~~~~s~~---~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 261 DHKNS-----LNFPEDVEISKH---AKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred hCCcc-----cCCCCcccCCHH---HHHHHHHHccCchhccCCCCHHHHhcC
Confidence 11110 011111 12233 344666888755543 8899999887
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-42 Score=326.68 Aligned_cols=266 Identities=24% Similarity=0.372 Sum_probs=205.6
Q ss_pred CCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeec--CCchhHHHHHHHHHHHHccCCCCeeeEeeeeec-----CCe
Q 010513 185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLN--NRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE-----GAH 256 (508)
Q Consensus 185 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-----~~~ 256 (508)
...|...+.||+|+||.|+.|.++ +|..||||++.+ ......++..+|+++|+.++|+||+.+++++.- -+.
T Consensus 21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D 100 (359)
T KOG0660|consen 21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND 100 (359)
T ss_pred cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence 345666889999999999999965 689999999974 344556778889999999999999999998864 357
Q ss_pred eEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccc
Q 010513 257 RMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLA 336 (508)
Q Consensus 257 ~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a 336 (508)
+|+|+|+|+. +|.+.++.. ..++...+..+++|+++||.|+|+. +|+||||||+|++++.+..+||+|||+|
T Consensus 101 vYiV~elMet-DL~~iik~~----~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGLA 172 (359)
T KOG0660|consen 101 VYLVFELMET-DLHQIIKSQ----QDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGLA 172 (359)
T ss_pred eEEehhHHhh-HHHHHHHcC----ccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccccce
Confidence 8999999976 999999876 4599999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCC-CcceecceecCCCCCChhhh-hcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHH--------
Q 010513 337 KLLGAE-RSYVTTRVMGTFGYVAPEYA-STGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLK-------- 406 (508)
Q Consensus 337 ~~~~~~-~~~~~~~~~gt~~y~aPE~~-~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~-------- 406 (508)
+..... ....++..+-|.+|.|||++ ....|+.+.||||.||++.||++|+.-|.+.+.....++...+.
T Consensus 173 R~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l 252 (359)
T KOG0660|consen 173 RYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDL 252 (359)
T ss_pred eeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHH
Confidence 987432 23345667889999999976 45679999999999999999999999998765432222111110
Q ss_pred HhhcccccccCC--CccCCCCc----hHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 407 TMVTNRNAEGVL--DPRLQEKP----CSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 407 ~~~~~~~~~~~~--~~~l~~~~----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
....+......+ -|.....+ .+......++++.+||..||.+|+|++|.|++
T Consensus 253 ~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 253 QKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred HHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 000100000000 01111111 12233456778889999999999999999875
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-42 Score=332.00 Aligned_cols=257 Identities=28% Similarity=0.502 Sum_probs=210.3
Q ss_pred hcCCCCcccceEcccCcEEEEEEEECCCcEEEEEEeecCCchhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEE
Q 010513 183 VSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE 262 (508)
Q Consensus 183 ~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e 262 (508)
.+..+|++.++||+|+||.||+|.+.++..+++|.+..........+..|+.+++.++||||+++++++.+....++|||
T Consensus 3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 82 (261)
T cd05148 3 RPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE 82 (261)
T ss_pred CcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence 34567999999999999999999988888999999877666566788999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCC
Q 010513 263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE 342 (508)
Q Consensus 263 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 342 (508)
|+++|+|.+++.... ...+++..++.++.|++.||.|||++ +++||||||+||++++++.+||+|||.+......
T Consensus 83 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~ 157 (261)
T cd05148 83 LMEKGSLLAFLRSPE--GQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKED 157 (261)
T ss_pred ecccCCHHHHHhcCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCCc
Confidence 999999999997653 35689999999999999999999998 9999999999999999999999999999866432
Q ss_pred CcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHhhcccccccCCCcc
Q 010513 343 RSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPR 421 (508)
Q Consensus 343 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 421 (508)
. .......++..|+|||.+.+..++.++|+||||+++|+|++ |+.||..... .+.+........ +.
T Consensus 158 ~-~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~------~~~~~~~~~~~~------~~ 224 (261)
T cd05148 158 V-YLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN------HEVYDQITAGYR------MP 224 (261)
T ss_pred c-ccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCH------HHHHHHHHhCCc------CC
Confidence 2 22223346678999999988899999999999999999998 8999965431 111111111100 00
Q ss_pred CCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 010513 422 LQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461 (508)
Q Consensus 422 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~ 461 (508)
. ...++ ..+.+++.+||+.||++||++.++++.|++
T Consensus 225 ~-~~~~~---~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 225 C-PAKCP---QEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred C-CCCCC---HHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 1 11122 344558889999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=345.84 Aligned_cols=252 Identities=21% Similarity=0.295 Sum_probs=196.0
Q ss_pred CCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCC---chhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEE
Q 010513 187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE 262 (508)
Q Consensus 187 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e 262 (508)
.|+.++.||+|+||+||+|+.. +++.||+|++.... ......+..|+++++.++||||+++++++.+++..|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5888999999999999999965 57889999986532 2334578889999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCC
Q 010513 263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE 342 (508)
Q Consensus 263 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 342 (508)
|+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++..+...
T Consensus 82 ~~~gg~L~~~l~~~----~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~ 154 (381)
T cd05626 82 YIPGGDMMSLLIRM----EVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWT 154 (381)
T ss_pred cCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCcccccc
Confidence 99999999999764 4688999999999999999999998 9999999999999999999999999997643110
Q ss_pred Cc----------------------------------------------ceecceecCCCCCChhhhhcCCCCCCCCeeeh
Q 010513 343 RS----------------------------------------------YVTTRVMGTFGYVAPEYASTGMLNERSDVYSF 376 (508)
Q Consensus 343 ~~----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSl 376 (508)
.. ......+||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (381)
T cd05626 155 HNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSV 234 (381)
T ss_pred cccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeeh
Confidence 00 00123579999999999998899999999999
Q ss_pred HHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCCccCCCCchHHHHHHHHHHHHH--ccCCCCCCCCCHHH
Q 010513 377 GILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALR--CVDPNAHKRPKMGH 454 (508)
Q Consensus 377 Gvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~--cl~~dP~~RPs~~e 454 (508)
||++|||++|+.||....+. +........... ....+ ....+.. +.+++.+ |+..++..||++.+
T Consensus 235 G~il~elltG~~Pf~~~~~~------~~~~~i~~~~~~-~~~~~---~~~~s~~---~~dli~~ll~~~~~~~~R~~~~~ 301 (381)
T cd05626 235 GVILFEMLVGQPPFLAPTPT------ETQLKVINWENT-LHIPP---QVKLSPE---AVDLITKLCCSAEERLGRNGADD 301 (381)
T ss_pred hhHHHHHHhCCCCCcCCCHH------HHHHHHHccccc-cCCCC---CCCCCHH---HHHHHHHHccCcccccCCCCHHH
Confidence 99999999999999754321 111111110000 00000 0012233 3345555 56667777999999
Q ss_pred HHHH
Q 010513 455 VIHM 458 (508)
Q Consensus 455 vl~~ 458 (508)
++++
T Consensus 302 ~l~h 305 (381)
T cd05626 302 IKAH 305 (381)
T ss_pred HhcC
Confidence 9976
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-42 Score=334.52 Aligned_cols=255 Identities=24% Similarity=0.333 Sum_probs=200.6
Q ss_pred hhcCCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCc--------------hhHHHHHHHHHHHHccCCCCeee
Q 010513 182 EVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG--------------QAEKEFKVEVEAIGRVRHKNLVR 246 (508)
Q Consensus 182 ~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------------~~~~~~~~E~~~l~~l~hpniv~ 246 (508)
....++|++++.||+|.||.|-+|+.. +++.||||++.+... ...+.+++||.+|++++|||||+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~ 172 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK 172 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence 456689999999999999999999965 688999999843211 12357889999999999999999
Q ss_pred EeeeeecC--CeeEEEEEecCCCCHHHHhccCCCCCCC-CCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEc
Q 010513 247 LLGYCAEG--AHRMLVYEYIDNGNLEQWLHGDVGPHSP-LTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLD 323 (508)
Q Consensus 247 l~~~~~~~--~~~~lV~e~~~~g~L~~~l~~~~~~~~~-l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~ 323 (508)
++++..+. +.+|||+|||..|.+...= ...+ +++.++++++++++.||+|||.+ +||||||||+|+||+
T Consensus 173 LiEvLDDP~s~~~YlVley~s~G~v~w~p-----~d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~ 244 (576)
T KOG0585|consen 173 LIEVLDDPESDKLYLVLEYCSKGEVKWCP-----PDKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLS 244 (576)
T ss_pred EEEeecCcccCceEEEEEeccCCccccCC-----CCcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEc
Confidence 99999764 5789999999988876532 2234 99999999999999999999999 999999999999999
Q ss_pred CCCCeEEeeeccceecCCC----CcceecceecCCCCCChhhhhcCC----CCCCCCeeehHHHHHHHHhCCCCCCCCCC
Q 010513 324 KQWNPKLSDFGLAKLLGAE----RSYVTTRVMGTFGYVAPEYASTGM----LNERSDVYSFGILIMEVISGRNPVDYSRP 395 (508)
Q Consensus 324 ~~~~~kL~DFG~a~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDvwSlGvvl~elltg~~Pf~~~~~ 395 (508)
++|++||+|||.+...... ........+|||.|+|||...++. .+.+.||||+||+||.|+.|+.||-...
T Consensus 245 ~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~- 323 (576)
T KOG0585|consen 245 SDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDF- 323 (576)
T ss_pred CCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccch-
Confidence 9999999999999876222 112233468999999999887632 3567899999999999999999996332
Q ss_pred CCcchHHHHHHHhhcccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 010513 396 PGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHML 459 (508)
Q Consensus 396 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 459 (508)
..+...+.. ...+.....++...++.+|++++|++||++|.+..+|..+.
T Consensus 324 -----~~~l~~KIv---------n~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp 373 (576)
T KOG0585|consen 324 -----ELELFDKIV---------NDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHP 373 (576)
T ss_pred -----HHHHHHHHh---------cCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence 222222222 22222222333445566688899999999999999998774
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=341.40 Aligned_cols=253 Identities=21% Similarity=0.263 Sum_probs=202.4
Q ss_pred CCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCC---chhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEE
Q 010513 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY 261 (508)
Q Consensus 186 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 261 (508)
++|.+.+.||+|+||+||+|... +++.||+|.+.... ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 46899999999999999999965 68889999987542 234456888999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCC
Q 010513 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA 341 (508)
Q Consensus 262 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 341 (508)
||+++|+|.+++... ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~ 154 (330)
T cd05601 81 EYQPGGDLLSLLNRY---EDQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTA 154 (330)
T ss_pred CCCCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCC
Confidence 999999999999765 25789999999999999999999999 999999999999999999999999999987654
Q ss_pred CCcceecceecCCCCCChhhhh------cCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccc
Q 010513 342 ERSYVTTRVMGTFGYVAPEYAS------TGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAE 415 (508)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (508)
..........||+.|+|||++. ...++.++|||||||++|||++|+.||..... ..............
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~------~~~~~~i~~~~~~~ 228 (330)
T cd05601 155 NKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTS------AKTYNNIMNFQRFL 228 (330)
T ss_pred CCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCH------HHHHHHHHcCCCcc
Confidence 4443334457999999999986 45678999999999999999999999974432 12222222211100
Q ss_pred cCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 416 GVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 416 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
. +.. .+.....+.+++.+|++ +|++||++.+++++
T Consensus 229 ~-----~~~--~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 229 K-----FPE--DPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred C-----CCC--CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 0 111 11122334457779997 99999999998864
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-41 Score=338.18 Aligned_cols=202 Identities=26% Similarity=0.407 Sum_probs=176.3
Q ss_pred hcCCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCC-chhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEE
Q 010513 183 VSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLV 260 (508)
Q Consensus 183 ~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 260 (508)
+..++|++.++||+|+||.||+|.+. ++..+|+|.+.... ......+.+|+++++.++||||++++++|.+++..++|
T Consensus 2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 81 (333)
T cd06650 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 81 (333)
T ss_pred cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEE
Confidence 34578999999999999999999976 57788888876542 33446788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecC
Q 010513 261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG 340 (508)
Q Consensus 261 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 340 (508)
|||+++|+|.+++... ..+++..+..++.|++.||.|||+.. +++||||||+|||++.++.+||+|||++....
T Consensus 82 ~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~ 155 (333)
T cd06650 82 MEHMDGGSLDQVLKKA----GRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 155 (333)
T ss_pred EecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhh
Confidence 9999999999999764 46889999999999999999999742 69999999999999999999999999987553
Q ss_pred CCCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCC
Q 010513 341 AERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS 393 (508)
Q Consensus 341 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~ 393 (508)
.. ......|+..|+|||++.+..++.++|+|||||++|||++|+.||...
T Consensus 156 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 205 (333)
T cd06650 156 DS---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP 205 (333)
T ss_pred hh---ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 22 223357899999999999889999999999999999999999999754
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=345.24 Aligned_cols=262 Identities=18% Similarity=0.247 Sum_probs=198.9
Q ss_pred hcCCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCchhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEE
Q 010513 183 VSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY 261 (508)
Q Consensus 183 ~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 261 (508)
+..++|++.+.||+|+||.||+|.+. +++.||+|... ...+.+|++++++++||||++++++|......++||
T Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~ 162 (391)
T PHA03212 89 IEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLIL 162 (391)
T ss_pred cccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEE
Confidence 44568999999999999999999965 57889999643 234678999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCC
Q 010513 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA 341 (508)
Q Consensus 262 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 341 (508)
|++. ++|..++... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 163 e~~~-~~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~ 234 (391)
T PHA03212 163 PRYK-TDLYCYLAAK----RNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVD 234 (391)
T ss_pred ecCC-CCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCccccccc
Confidence 9996 5899888654 4688999999999999999999999 999999999999999999999999999975433
Q ss_pred CCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCC-cchHHHHHHHhhccc-c------
Q 010513 342 ERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPG-EVNLVEWLKTMVTNR-N------ 413 (508)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~-~~~~~~~~~~~~~~~-~------ 413 (508)
..........||+.|+|||++.+..++.++|||||||++|||++|+.||....... .......+....... .
T Consensus 235 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~ 314 (391)
T PHA03212 235 INANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFP 314 (391)
T ss_pred ccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcC
Confidence 22223344679999999999999999999999999999999999998875432111 000000010000000 0
Q ss_pred ---------------cccCCCccCCCC--chHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 414 ---------------AEGVLDPRLQEK--PCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 414 ---------------~~~~~~~~l~~~--~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
......+..... .......++.+++.+||+.||++|||+.|++++
T Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h 376 (391)
T PHA03212 315 IDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF 376 (391)
T ss_pred cchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 000000000000 011223466778899999999999999999854
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-41 Score=333.52 Aligned_cols=264 Identities=21% Similarity=0.295 Sum_probs=198.9
Q ss_pred CCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCc-hhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEE
Q 010513 185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE 262 (508)
Q Consensus 185 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e 262 (508)
.++|++.+.||+|+||+||+|... +++.||+|++..... .....+.+|+++++.++||||+++++++.++...++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 368999999999999999999976 688899999864432 233456789999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCC
Q 010513 263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE 342 (508)
Q Consensus 263 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 342 (508)
|+. ++|.+++... ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++......
T Consensus 84 ~~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 156 (303)
T cd07869 84 YVH-TDLCQYMDKH---PGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVP 156 (303)
T ss_pred CCC-cCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccCC
Confidence 996 5888888654 35688999999999999999999999 9999999999999999999999999999764322
Q ss_pred CcceecceecCCCCCChhhhhc-CCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccc---cc---
Q 010513 343 RSYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRN---AE--- 415 (508)
Q Consensus 343 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~---~~--- 415 (508)
. .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....+.. ...+.+........ ..
T Consensus 157 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 233 (303)
T cd07869 157 S-HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQ--DQLERIFLVLGTPNEDTWPGVH 233 (303)
T ss_pred C-ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHH--HHHHHHHHHhCCCChhhccchh
Confidence 2 22234578999999998865 458889999999999999999999997543211 11111111110000 00
Q ss_pred --cCCCcc-C---CCCchHH------HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 416 --GVLDPR-L---QEKPCSR------ALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 416 --~~~~~~-l---~~~~~~~------~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
...++. + ....... ....+.+++.+||+.||++|||+.|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h 288 (303)
T cd07869 234 SLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH 288 (303)
T ss_pred hccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence 000000 0 0000000 11345568889999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=338.68 Aligned_cols=242 Identities=24% Similarity=0.278 Sum_probs=194.4
Q ss_pred ceEcccCcEEEEEEEEC-CCcEEEEEEeecCC---chhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEEecCCC
Q 010513 192 NVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNG 267 (508)
Q Consensus 192 ~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~g 267 (508)
+.||+|+||.||++... +|+.||+|.+.... ......+..|+++++.++||||+++++++...+..|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999965 68899999986542 233456678999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCCCccee
Q 010513 268 NLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVT 347 (508)
Q Consensus 268 ~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~ 347 (508)
+|.+++... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++...... ....
T Consensus 81 ~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~-~~~~ 152 (323)
T cd05595 81 ELFFHLSRE----RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD-GATM 152 (323)
T ss_pred cHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCC-CCcc
Confidence 999988764 4689999999999999999999999 9999999999999999999999999998753221 1222
Q ss_pred cceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCCccCCCCch
Q 010513 348 TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPC 427 (508)
Q Consensus 348 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 427 (508)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...+. ........... ..+.. ..
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~------~~~~~~~~~~~-------~~~p~-~~ 218 (323)
T cd05595 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH------ERLFELILMEE-------IRFPR-TL 218 (323)
T ss_pred ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCH------HHHHHHHhcCC-------CCCCC-CC
Confidence 345799999999999999999999999999999999999999964322 11111111111 01111 12
Q ss_pred HHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 010513 428 SRALKRALLVALRCVDPNAHKRP-----KMGHVIHM 458 (508)
Q Consensus 428 ~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 458 (508)
+. ++.+++.+||+.||++|| ++.+++++
T Consensus 219 ~~---~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 219 SP---EAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred CH---HHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 33 344577799999999998 78888764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=345.31 Aligned_cols=266 Identities=29% Similarity=0.451 Sum_probs=213.8
Q ss_pred hhhHhhcCCCCcccceEcccCcEEEEEEEECC--C--cE-EEEEEeec---CCchhHHHHHHHHHHHHccCCCCeeeEee
Q 010513 178 LRELEVSTNGFADENVIGEGGYGIVYHGVLED--N--TN-VAVKNLLN---NRGQAEKEFKVEVEAIGRVRHKNLVRLLG 249 (508)
Q Consensus 178 ~~~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~~--~--~~-vavK~~~~---~~~~~~~~~~~E~~~l~~l~hpniv~l~~ 249 (508)
-..|++..++..+.++||+|+||.||+|.++. + .. ||+|.... .......+|..|.++|++++|||||+|||
T Consensus 149 r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yG 228 (474)
T KOG0194|consen 149 RQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYG 228 (474)
T ss_pred ccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEE
Confidence 45567888888999999999999999999653 2 23 89998874 23566788999999999999999999999
Q ss_pred eeecCCeeEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeE
Q 010513 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPK 329 (508)
Q Consensus 250 ~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~k 329 (508)
++.....+|+|||+|.||+|.++|++.. ..++..+...++.+.|.||+|||++ ++|||||-..|+|++.++.+|
T Consensus 229 Va~~~~Pl~ivmEl~~gGsL~~~L~k~~---~~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vK 302 (474)
T KOG0194|consen 229 VAVLEEPLMLVMELCNGGSLDDYLKKNK---KSLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVK 302 (474)
T ss_pred EEcCCCccEEEEEecCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEE
Confidence 9999999999999999999999999873 4699999999999999999999999 999999999999999999999
Q ss_pred EeeeccceecCCCCcceecc-e-ecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHh-CCCCCCCCCCCCcchHHHHHH
Q 010513 330 LSDFGLAKLLGAERSYVTTR-V-MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLK 406 (508)
Q Consensus 330 L~DFG~a~~~~~~~~~~~~~-~-~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~ 406 (508)
|+|||+++.-. .+.... . .-...|+|||.+..+.|++++|||||||++||+++ |..||.+... .+...
T Consensus 303 ISDFGLs~~~~---~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~------~~v~~ 373 (474)
T KOG0194|consen 303 ISDFGLSRAGS---QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKN------YEVKA 373 (474)
T ss_pred eCccccccCCc---ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCH------HHHHH
Confidence 99999988532 222222 2 23568999999999999999999999999999999 8889975432 22222
Q ss_pred HhhcccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCCCCC
Q 010513 407 TMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEEFPFR 467 (508)
Q Consensus 407 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~~~~~~~ 467 (508)
+...++.... .....+..+.. ++.+||..||++||+|.++.+.|+...-...
T Consensus 374 kI~~~~~r~~------~~~~~p~~~~~---~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~ 425 (474)
T KOG0194|consen 374 KIVKNGYRMP------IPSKTPKELAK---VMKQCWKKDPEDRPTMSTIKKKLEALEKKKE 425 (474)
T ss_pred HHHhcCccCC------CCCCCHHHHHH---HHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence 2212211110 11123444444 6679999999999999999999997654443
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=327.66 Aligned_cols=252 Identities=24% Similarity=0.410 Sum_probs=202.9
Q ss_pred CCCcccceEcccCcEEEEEEEECCCcEEEEEEeecCCchhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEEecC
Q 010513 186 NGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYID 265 (508)
Q Consensus 186 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~ 265 (508)
++|++.+.||+|+||+||+|.+.++..+|+|.+.... ...+.+.+|+.+++.++||||+++++++.+....++||||+.
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 4688899999999999999998777779999886443 334678899999999999999999999998888999999999
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCCCcc
Q 010513 266 NGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSY 345 (508)
Q Consensus 266 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~ 345 (508)
+|+|.+++.... ..+++..++.++.|++.||+|||+. +++|+||||+||+++.++.+||+|||.++........
T Consensus 83 ~~~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~ 156 (256)
T cd05113 83 NGCLLNYLREHG---KRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT 156 (256)
T ss_pred CCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCcee
Confidence 999999997642 3689999999999999999999999 9999999999999999999999999999866443222
Q ss_pred eecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHhhcccccccCCCccCCC
Q 010513 346 VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQE 424 (508)
Q Consensus 346 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 424 (508)
......++..|+|||.+.+..++.++|+|||||++|||++ |..||...... ...+ ....... +.. .
T Consensus 157 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~---~~~~---~~~~~~~------~~~-~ 223 (256)
T cd05113 157 SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS---ETVE---KVSQGLR------LYR-P 223 (256)
T ss_pred ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH---HHHH---HHhcCCC------CCC-C
Confidence 2222345678999999988889999999999999999999 99999643321 1111 1111110 000 1
Q ss_pred CchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 010513 425 KPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 460 (508)
Q Consensus 425 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le 460 (508)
... ...+.+++.+||+.||++||++.++++.|+
T Consensus 224 ~~~---~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 224 HLA---SEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCC---CHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 112 234555888999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=308.70 Aligned_cols=267 Identities=23% Similarity=0.307 Sum_probs=214.4
Q ss_pred hhcCCCCcccceEcccCcEEEEEEE-ECCCcEEEEEEeecCCchhHHHHHHHHHHHHccCCCCeeeEeeeeecCC-----
Q 010513 182 EVSTNGFADENVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGA----- 255 (508)
Q Consensus 182 ~~~~~~~~~~~~LG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~----- 255 (508)
.+..++|++.+.||+|||+-||+++ ..++.-||+|++.....+..+...+|++..++++|||+++++++...+.
T Consensus 17 ~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~ 96 (302)
T KOG2345|consen 17 IINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKH 96 (302)
T ss_pred EEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCce
Confidence 3566799999999999999999999 5567889999999888888889999999999999999999999875443
Q ss_pred eeEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeecc
Q 010513 256 HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGL 335 (508)
Q Consensus 256 ~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~ 335 (508)
..|++++|...|+|.+.+......+..+++.+.+.|+.++++||++||+. .+.++||||||.|||+.+.+.++|.|||.
T Consensus 97 ~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS 175 (302)
T KOG2345|consen 97 EAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGS 175 (302)
T ss_pred eEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccC
Confidence 48999999999999999987766667899999999999999999999997 44599999999999999999999999999
Q ss_pred ceecCCCCcce--------ecceecCCCCCChhhhh---cCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHH
Q 010513 336 AKLLGAERSYV--------TTRVMGTFGYVAPEYAS---TGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEW 404 (508)
Q Consensus 336 a~~~~~~~~~~--------~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~ 404 (508)
+.......... ...-..|..|.|||.+. +...++++|||||||+||+|+.|..||+..-..+.-
T Consensus 176 ~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgS----- 250 (302)
T KOG2345|consen 176 ATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGS----- 250 (302)
T ss_pred ccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCe-----
Confidence 87653211111 01123588999999885 445788999999999999999999999744221110
Q ss_pred HHHhhcccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010513 405 LKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (508)
Q Consensus 405 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~~ 462 (508)
-...+..+.+.....++....+.+++..|++.||.+||++.+++..++..
T Consensus 251 --------laLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 251 --------LALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred --------EEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 01122233333222333555666788899999999999999999988653
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-41 Score=336.74 Aligned_cols=249 Identities=23% Similarity=0.320 Sum_probs=196.4
Q ss_pred ceEcccCcEEEEEEEEC-CCcEEEEEEeecCC---chhHHHHHHHHHHHHcc-CCCCeeeEeeeeecCCeeEEEEEecCC
Q 010513 192 NVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYIDN 266 (508)
Q Consensus 192 ~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lV~e~~~~ 266 (508)
++||+|+||.||+|.+. +++.||+|.+.+.. ....+.+..|..++..+ +||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999975 57889999987542 23345678899999888 799999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCCCcce
Q 010513 267 GNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYV 346 (508)
Q Consensus 267 g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~ 346 (508)
|+|.+++... ..+++..++.++.|++.||+|||++ +++||||||+|||++.++.+||+|||+++..... ...
T Consensus 81 g~L~~~~~~~----~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-~~~ 152 (329)
T cd05588 81 GDLMFHMQRQ----RKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP-GDT 152 (329)
T ss_pred CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccC-CCc
Confidence 9999988654 5799999999999999999999999 9999999999999999999999999998743211 222
Q ss_pred ecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCC--cchHHHHHHHhhcccccccCCCccCCC
Q 010513 347 TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPG--EVNLVEWLKTMVTNRNAEGVLDPRLQE 424 (508)
Q Consensus 347 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~l~~ 424 (508)
....+||+.|+|||++.+..++.++|+|||||++|||++|+.||+...... .....+++.+....... .+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~------~~p~ 226 (329)
T cd05588 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI------RIPR 226 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC------CCCC
Confidence 334679999999999999999999999999999999999999997543221 12222333332222111 1111
Q ss_pred CchHHHHHHHHHHHHHccCCCCCCCCC------HHHHHHH
Q 010513 425 KPCSRALKRALLVALRCVDPNAHKRPK------MGHVIHM 458 (508)
Q Consensus 425 ~~~~~~~~~l~~li~~cl~~dP~~RPs------~~evl~~ 458 (508)
..+. ++.+++.+||+.||++||+ +.+++++
T Consensus 227 -~~~~---~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 227 -SLSV---KASSVLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred -CCCH---HHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 1222 3445778999999999997 6677643
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=379.53 Aligned_cols=259 Identities=29% Similarity=0.558 Sum_probs=210.1
Q ss_pred CCcccceEcccCcEEEEEEEE-CCCcEEEEEEeecCCchhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEEecC
Q 010513 187 GFADENVIGEGGYGIVYHGVL-EDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYID 265 (508)
Q Consensus 187 ~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~ 265 (508)
.|...+.||+|+||.||+|+. .++..||+|++....... ..|++.+++++|||||+++++|.++...|+||||++
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~----~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~ 766 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIP----SSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIE 766 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcccc----HHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCC
Confidence 466678999999999999997 468899999886443222 236888999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCCCcc
Q 010513 266 NGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSY 345 (508)
Q Consensus 266 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~ 345 (508)
+|+|.++++ .+++..+..++.|+++|++|||..++++|+||||||+||+++.++..++. ||........
T Consensus 767 ~g~L~~~l~-------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~--- 835 (968)
T PLN00113 767 GKNLSEVLR-------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD--- 835 (968)
T ss_pred CCcHHHHHh-------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC---
Confidence 999999995 37899999999999999999996656699999999999999999888875 6655432211
Q ss_pred eecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCCccCCCC
Q 010513 346 VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEK 425 (508)
Q Consensus 346 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 425 (508)
....||+.|+|||++.+..++.++|||||||++|||+||+.||+... .......+|.+...........+|+.+...
T Consensus 836 --~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (968)
T PLN00113 836 --TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEF-GVHGSIVEWARYCYSDCHLDMWIDPSIRGD 912 (968)
T ss_pred --CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCccc-CCCCcHHHHHHHhcCccchhheeCccccCC
Confidence 22368899999999999999999999999999999999999996433 233456666665544444455566655432
Q ss_pred --chHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 010513 426 --PCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEE 463 (508)
Q Consensus 426 --~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~~~ 463 (508)
...+...++.+++.+||+.||++||+|.|+++.|++..
T Consensus 913 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~ 952 (968)
T PLN00113 913 VSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESAS 952 (968)
T ss_pred CCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhh
Confidence 23456677888999999999999999999999998764
|
|
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-41 Score=326.19 Aligned_cols=257 Identities=28% Similarity=0.442 Sum_probs=205.0
Q ss_pred hhcCCCCcccceEcccCcEEEEEEEECCCcEEEEEEeecCCchhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEE
Q 010513 182 EVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY 261 (508)
Q Consensus 182 ~~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 261 (508)
++..++|++.+.||+|+||.||+|..+++..+|+|.+..... ..+.+.+|+.++++++|+|++++++++.+ ...+++|
T Consensus 2 ~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~ 79 (260)
T cd05070 2 EIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVT 79 (260)
T ss_pred CCchHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEE
Confidence 345668999999999999999999988888899998865433 34678899999999999999999998854 5688999
Q ss_pred EecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCC
Q 010513 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA 341 (508)
Q Consensus 262 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 341 (508)
||+++++|.+++.... ...+++..++.++.|++.||+|||++ +++||||||+||++++++.++|+|||++..+..
T Consensus 80 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05070 80 EYMSKGSLLDFLKDGE--GRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIED 154 (260)
T ss_pred EecCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccC
Confidence 9999999999997642 34689999999999999999999999 999999999999999999999999999987644
Q ss_pred CCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHhhcccccccCCCc
Q 010513 342 ERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDP 420 (508)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 420 (508)
..........++..|+|||.+.+..++.++|+||||+++|||++ |..||..... .+......... .+
T Consensus 155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~------~~~~~~~~~~~------~~ 222 (260)
T cd05070 155 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN------REVLEQVERGY------RM 222 (260)
T ss_pred cccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH------HHHHHHHHcCC------CC
Confidence 33222222345668999999988899999999999999999999 8999964321 12222211110 00
Q ss_pred cCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 010513 421 RLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461 (508)
Q Consensus 421 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~ 461 (508)
... ...+ ..+.+++.+|+++||++||++.++++.|++
T Consensus 223 ~~~-~~~~---~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 223 PCP-QDCP---ISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCC-CcCC---HHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 111 1122 345558889999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-41 Score=335.67 Aligned_cols=242 Identities=26% Similarity=0.346 Sum_probs=194.1
Q ss_pred ceEcccCcEEEEEEEE----CCCcEEEEEEeecCC----chhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEEe
Q 010513 192 NVIGEGGYGIVYHGVL----EDNTNVAVKNLLNNR----GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY 263 (508)
Q Consensus 192 ~~LG~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~ 263 (508)
+.||+|+||.||+++. .+++.||+|.+.... ......+..|+++++.++||||+++++++.+++..|+||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 6799999999999985 257789999986532 22334577899999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCCC
Q 010513 264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER 343 (508)
Q Consensus 264 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 343 (508)
+++|+|.+++... ..+.+..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~L~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 154 (323)
T cd05584 82 LSGGELFMHLERE----GIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG 154 (323)
T ss_pred CCCchHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC
Confidence 9999999999765 4688899999999999999999999 99999999999999999999999999987543222
Q ss_pred cceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCCccCC
Q 010513 344 SYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQ 423 (508)
Q Consensus 344 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 423 (508)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+......... . .+.
T Consensus 155 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~------~~~~~~~~~~~---~----~~~ 220 (323)
T cd05584 155 -TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENR------KKTIDKILKGK---L----NLP 220 (323)
T ss_pred -CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCH------HHHHHHHHcCC---C----CCC
Confidence 223345799999999999988899999999999999999999999974332 12222222111 0 111
Q ss_pred CCchHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 010513 424 EKPCSRALKRALLVALRCVDPNAHKRP-----KMGHVIHM 458 (508)
Q Consensus 424 ~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 458 (508)
. ..+ .++.+++.+||+.||++|| ++.+++++
T Consensus 221 ~-~~~---~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 221 P-YLT---PEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred C-CCC---HHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 1 122 2345588899999999999 78887764
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=341.96 Aligned_cols=263 Identities=23% Similarity=0.346 Sum_probs=195.6
Q ss_pred CCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecC--CchhHHHHHHHHHHHHccCCCCeeeEeeeeecC-----CeeE
Q 010513 187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEG-----AHRM 258 (508)
Q Consensus 187 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-----~~~~ 258 (508)
+|++.+.||+|+||.||+|... ++..||+|++... .......+.+|+++++.++||||+++++++... ...|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 5888999999999999999965 6889999988643 223345678899999999999999999988543 3579
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeecccee
Q 010513 259 LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL 338 (508)
Q Consensus 259 lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~ 338 (508)
+||||+. ++|.+++... ..+++..+..++.|+++||+|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 81 lv~e~~~-~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~ 152 (338)
T cd07859 81 VVFELME-SDLHQVIKAN----DDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARV 152 (338)
T ss_pred EEEecCC-CCHHHHHHhc----ccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCccccc
Confidence 9999996 5999998754 4689999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCc--ceecceecCCCCCChhhhhc--CCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHH---------HH
Q 010513 339 LGAERS--YVTTRVMGTFGYVAPEYAST--GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVE---------WL 405 (508)
Q Consensus 339 ~~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~---------~~ 405 (508)
...... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||............. ..
T Consensus 153 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 232 (338)
T cd07859 153 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETI 232 (338)
T ss_pred cccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 432221 11234579999999999876 678999999999999999999999997543211100000 00
Q ss_pred HHhhcccccc---cCCCccCCCCc---hHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 406 KTMVTNRNAE---GVLDPRLQEKP---CSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 406 ~~~~~~~~~~---~~~~~~l~~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
.. +...... ..+........ .+.....+.+++.+||+.||++||++++++++
T Consensus 233 ~~-i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 233 SR-VRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HH-hhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 00 0000000 00000000000 01112345668889999999999999999975
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=331.63 Aligned_cols=258 Identities=28% Similarity=0.505 Sum_probs=205.0
Q ss_pred CCCCcccceEcccCcEEEEEEEECC-C-----cEEEEEEeecCC-chhHHHHHHHHHHHHccCCCCeeeEeeeeecCCee
Q 010513 185 TNGFADENVIGEGGYGIVYHGVLED-N-----TNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHR 257 (508)
Q Consensus 185 ~~~~~~~~~LG~G~~g~Vy~~~~~~-~-----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 257 (508)
.++|++.+.||+|+||.||+|.... + ..||+|.+.... ......+.+|+++++.++||||+++++++.+....
T Consensus 4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T cd05048 4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPT 83 (283)
T ss_pred hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCce
Confidence 4578899999999999999998643 2 468999886443 23446788999999999999999999999998999
Q ss_pred EEEEEecCCCCHHHHhccCCCC------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCC
Q 010513 258 MLVYEYIDNGNLEQWLHGDVGP------------HSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQ 325 (508)
Q Consensus 258 ~lV~e~~~~g~L~~~l~~~~~~------------~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~ 325 (508)
+++|||+++|+|.+++...... ...+++..++.++.|++.||+|||++ +++||||||+||+++++
T Consensus 84 ~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~ 160 (283)
T cd05048 84 CMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEG 160 (283)
T ss_pred EEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCC
Confidence 9999999999999999754211 14688899999999999999999999 99999999999999999
Q ss_pred CCeEEeeeccceecCCCCc-ceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHh-CCCCCCCCCCCCcchHHH
Q 010513 326 WNPKLSDFGLAKLLGAERS-YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVE 403 (508)
Q Consensus 326 ~~~kL~DFG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~ 403 (508)
+.+||+|||+++....... .......+++.|+|||.+.+..++.++|||||||++|||++ |..||...... ...
T Consensus 161 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~---~~~- 236 (283)
T cd05048 161 LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ---EVI- 236 (283)
T ss_pred CcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH---HHH-
Confidence 9999999999986533222 22233467889999999988899999999999999999998 99999754321 111
Q ss_pred HHHHhhcccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 010513 404 WLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461 (508)
Q Consensus 404 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~ 461 (508)
..+..+.... . ...++ .++.+++.+||+.||++||++.+|+++|++
T Consensus 237 ---~~i~~~~~~~-----~-~~~~~---~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 237 ---EMIRSRQLLP-----C-PEDCP---ARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred ---HHHHcCCcCC-----C-cccCC---HHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 1122211110 1 11233 445558889999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=340.33 Aligned_cols=261 Identities=20% Similarity=0.259 Sum_probs=196.6
Q ss_pred CCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCchhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEEe
Q 010513 185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY 263 (508)
Q Consensus 185 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~ 263 (508)
..+|.+.+.||+|+||.||+|.+. .++.||+|... ...+.+|++++++++|+|||++++++..+...++|||+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 457999999999999999999976 47789999532 22356799999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCCC
Q 010513 264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER 343 (508)
Q Consensus 264 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 343 (508)
+. ++|.+++... ...+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 242 ~~-~~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~ 314 (461)
T PHA03211 242 YR-SDLYTYLGAR---LRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSW 314 (461)
T ss_pred cC-CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceeccccc
Confidence 95 6999988654 24799999999999999999999999 99999999999999999999999999998764332
Q ss_pred cc-eecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCC-CCCCc----chHHHHHHHhhcc-ccccc
Q 010513 344 SY-VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS-RPPGE----VNLVEWLKTMVTN-RNAEG 416 (508)
Q Consensus 344 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~-~~~~~----~~~~~~~~~~~~~-~~~~~ 416 (508)
.. ......||+.|+|||++.+..++.++|||||||+||||++|..|+-.. ..... ..+...+...... .....
T Consensus 315 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~ 394 (461)
T PHA03211 315 STPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQ 394 (461)
T ss_pred ccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCC
Confidence 21 223457999999999999999999999999999999999988665332 11111 1111211111000 00000
Q ss_pred ----------------CCCccCCCCchH---HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 417 ----------------VLDPRLQEKPCS---RALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 417 ----------------~~~~~l~~~~~~---~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
...+........ .....+.+++.+||+.||++||++.|++++
T Consensus 395 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 395 HAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred CcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 000000000001 111245668889999999999999999976
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=327.15 Aligned_cols=256 Identities=27% Similarity=0.418 Sum_probs=204.8
Q ss_pred hcCCCCcccceEcccCcEEEEEEEECCCcEEEEEEeecCCchhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEE
Q 010513 183 VSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE 262 (508)
Q Consensus 183 ~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e 262 (508)
+..++|++.++||+|+||.||+|.+.++..||+|++.... ...+.+.+|+++++.++||||+++++++.+ ...++|||
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e 80 (262)
T cd05071 3 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 80 (262)
T ss_pred CChHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEE
Confidence 4567899999999999999999998777789999886533 234678889999999999999999998754 56789999
Q ss_pred ecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCC
Q 010513 263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE 342 (508)
Q Consensus 263 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 342 (508)
|+++|+|.+++.... ...+++..+..++.|+++||+|||+. +++||||||+||++++++.++|+|||.+......
T Consensus 81 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~ 155 (262)
T cd05071 81 YMSKGSLLDFLKGEM--GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDN 155 (262)
T ss_pred cCCCCcHHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeecccc
Confidence 999999999997642 24578999999999999999999998 9999999999999999999999999999876543
Q ss_pred CcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHhhcccccccCCCcc
Q 010513 343 RSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPR 421 (508)
Q Consensus 343 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 421 (508)
.........++..|+|||++.+..++.++|+|||||++|||+| |..||...... +......... ...
T Consensus 156 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~------~~~~~~~~~~------~~~ 223 (262)
T cd05071 156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR------EVLDQVERGY------RMP 223 (262)
T ss_pred ccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH------HHHHHHhcCC------CCC
Confidence 3322223456778999999988899999999999999999999 88898644221 1111111110 000
Q ss_pred CCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 010513 422 LQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461 (508)
Q Consensus 422 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~ 461 (508)
. .......+.+++.+|++.||++||++.+++++|+.
T Consensus 224 ~----~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~ 259 (262)
T cd05071 224 C----PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 259 (262)
T ss_pred C----ccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHH
Confidence 1 11223445668889999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=327.65 Aligned_cols=257 Identities=23% Similarity=0.418 Sum_probs=205.4
Q ss_pred hcCCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCchhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEE
Q 010513 183 VSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY 261 (508)
Q Consensus 183 ~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 261 (508)
+...+|.+.+.||+|+||.||+|.++ .++.||+|.+... ....+++.+|+++++.++||||+++++++..+...+++|
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (263)
T cd05052 3 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 81 (263)
T ss_pred CchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEE
Confidence 44557888999999999999999965 4778999987644 334567888999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCC
Q 010513 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA 341 (508)
Q Consensus 262 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 341 (508)
||+++++|.+++.... ...+++..++.++.|+++||+|||++ +++||||||+||++++++.+||+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~ 156 (263)
T cd05052 82 EFMTYGNLLDYLRECN--RQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTG 156 (263)
T ss_pred EeCCCCcHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCcccccccc
Confidence 9999999999997642 34689999999999999999999998 999999999999999999999999999987644
Q ss_pred CCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHhhcccccccCCCc
Q 010513 342 ERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDP 420 (508)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 420 (508)
..........++..|+|||.+.+..++.++|||||||++|||++ |..||..... .+..... ... ..+
T Consensus 157 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~------~~~~~~~-~~~-----~~~ 224 (263)
T cd05052 157 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL------SQVYELL-EKG-----YRM 224 (263)
T ss_pred ceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH------HHHHHHH-HCC-----CCC
Confidence 32222222334668999999999999999999999999999998 9999864321 1111111 111 011
Q ss_pred cCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 010513 421 RLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461 (508)
Q Consensus 421 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~ 461 (508)
... ...+. .+.+++.+||+.||++||++.+++++|++
T Consensus 225 ~~~-~~~~~---~~~~li~~cl~~~p~~Rp~~~~l~~~l~~ 261 (263)
T cd05052 225 ERP-EGCPP---KVYELMRACWQWNPSDRPSFAEIHQAFET 261 (263)
T ss_pred CCC-CCCCH---HHHHHHHHHccCCcccCCCHHHHHHHHHh
Confidence 111 11333 34457789999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-41 Score=325.99 Aligned_cols=257 Identities=25% Similarity=0.451 Sum_probs=206.8
Q ss_pred hhcCCCCcccceEcccCcEEEEEEEECCCcEEEEEEeecCCchhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEE
Q 010513 182 EVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY 261 (508)
Q Consensus 182 ~~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 261 (508)
++..++|++.++||+|+||.||+|..++++.||+|.+..... ....+.+|+.+++.++|+||+++++++.. +..+++|
T Consensus 2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~ 79 (260)
T cd05067 2 EVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVTQ-EPIYIIT 79 (260)
T ss_pred ccchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEcc-CCcEEEE
Confidence 456778999999999999999999988889999998865443 34678889999999999999999998754 5689999
Q ss_pred EecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCC
Q 010513 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA 341 (508)
Q Consensus 262 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 341 (508)
||+.+++|.+++.... ...+++..++.++.|++.||+|||+. +++||||||+||+++.++.++|+|||++.....
T Consensus 80 e~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05067 80 EYMENGSLVDFLKTPE--GIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIED 154 (260)
T ss_pred EcCCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCC
Confidence 9999999999986642 35689999999999999999999998 999999999999999999999999999987643
Q ss_pred CCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHhhcccccccCCCc
Q 010513 342 ERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDP 420 (508)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 420 (508)
..........++..|+|||++.+..++.++|+||||+++|||++ |+.||...... ...+ .+ .... ..
T Consensus 155 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~~---~~-~~~~-----~~ 222 (260)
T cd05067 155 NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP---EVIQ---NL-ERGY-----RM 222 (260)
T ss_pred CCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH---HHHH---HH-HcCC-----CC
Confidence 32222233456778999999998899999999999999999999 99999744321 1111 11 1110 00
Q ss_pred cCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 010513 421 RLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461 (508)
Q Consensus 421 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~ 461 (508)
... ...+ .++.+++.+||+.+|++||+++++++.|+.
T Consensus 223 ~~~-~~~~---~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 223 PRP-DNCP---EELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CCC-CCCC---HHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 011 1122 345568889999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-41 Score=331.03 Aligned_cols=262 Identities=24% Similarity=0.334 Sum_probs=193.9
Q ss_pred CCCcccceEcccCcEEEEEEEEC--CCcEEEEEEeecCCc--hhHHHHHHHHHHHHcc---CCCCeeeEeeeee-----c
Q 010513 186 NGFADENVIGEGGYGIVYHGVLE--DNTNVAVKNLLNNRG--QAEKEFKVEVEAIGRV---RHKNLVRLLGYCA-----E 253 (508)
Q Consensus 186 ~~~~~~~~LG~G~~g~Vy~~~~~--~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~hpniv~l~~~~~-----~ 253 (508)
++|++.+.||+|+||+||+|+.. +++.||+|.+..... .....+.+|+.+++.+ +||||+++++++. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 37899999999999999999863 467799998864322 2233455677776665 6999999999885 3
Q ss_pred CCeeEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeee
Q 010513 254 GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDF 333 (508)
Q Consensus 254 ~~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DF 333 (508)
....++||||++ ++|.+++.... ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Df 154 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADF 154 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEccc
Confidence 456889999997 59999987542 34589999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcc--
Q 010513 334 GLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTN-- 411 (508)
Q Consensus 334 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~-- 411 (508)
|+++..... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||....... ....+......
T Consensus 155 g~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~---~~~~i~~~~~~~~ 229 (290)
T cd07862 155 GLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD---QLGKILDVIGLPG 229 (290)
T ss_pred cceEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHH---HHHHHHHHhCCCC
Confidence 999865433 22344578999999999998899999999999999999999999997543211 11111111100
Q ss_pred -ccc-------ccCCCccCCCC---chHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 412 -RNA-------EGVLDPRLQEK---PCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 412 -~~~-------~~~~~~~l~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
... ...+.+..... ..+.....+.+++.+||+.||++||++.+++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h 287 (290)
T cd07862 230 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 287 (290)
T ss_pred hhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 000 00000000000 001112344568889999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-41 Score=337.82 Aligned_cols=252 Identities=23% Similarity=0.320 Sum_probs=211.6
Q ss_pred cCCCCcccceEcccCcEEEEEEEECC-CcEEEEEEeecCCch---hHHHHHHHHHHHHccC-CCCeeeEeeeeecCCeeE
Q 010513 184 STNGFADENVIGEGGYGIVYHGVLED-NTNVAVKNLLNNRGQ---AEKEFKVEVEAIGRVR-HKNLVRLLGYCAEGAHRM 258 (508)
Q Consensus 184 ~~~~~~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~ 258 (508)
....|++.+.||+|.||.||++..+. |+.+|+|.+.+.... ..+.+.+|+.+|+++. |||||.++++|++...++
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 34578889999999999999999764 999999999766443 3468899999999998 999999999999999999
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcC----CCCeEEeeec
Q 010513 259 LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDK----QWNPKLSDFG 334 (508)
Q Consensus 259 lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~----~~~~kL~DFG 334 (508)
+|||+|.||.|++.+... .+++..+..++.|++.|+.|||+. +|+||||||+|+|+.. ++.+|++|||
T Consensus 113 lvmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFG 184 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFG 184 (382)
T ss_pred EEEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCC
Confidence 999999999999999765 299999999999999999999998 9999999999999943 3579999999
Q ss_pred cceecCCCCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhccccc
Q 010513 335 LAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNA 414 (508)
Q Consensus 335 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 414 (508)
++..... .......+||+.|+|||++....|+..+||||+|+++|.|++|..||.......... .+....
T Consensus 185 la~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~-------~i~~~~- 254 (382)
T KOG0032|consen 185 LAKFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL-------AILRGD- 254 (382)
T ss_pred CceEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH-------HHHcCC-
Confidence 9998755 455667899999999999999999999999999999999999999998654322211 111111
Q ss_pred ccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 415 EGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 415 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
..+..++.+.....+.+++.+|+..||.+|+++.+++++
T Consensus 255 -----~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 255 -----FDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred -----CCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 123333344444555558889999999999999999996
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=338.96 Aligned_cols=201 Identities=26% Similarity=0.350 Sum_probs=175.5
Q ss_pred CCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCC---chhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEE
Q 010513 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY 261 (508)
Q Consensus 186 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 261 (508)
++|++.+.||+|+||+||+|... +++.||+|++.+.. ......+..|+.++..++||||+++++++.+....|+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47899999999999999999965 57889999986532 223456788999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCC
Q 010513 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA 341 (508)
Q Consensus 262 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 341 (508)
||+++|+|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.+..
T Consensus 81 E~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~ 153 (363)
T cd05628 81 EFLPGGDMMTLLMKK----DTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKK 153 (363)
T ss_pred cCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCcccccc
Confidence 999999999999764 5789999999999999999999999 999999999999999999999999999875432
Q ss_pred CCc----------------------------------ceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCC
Q 010513 342 ERS----------------------------------YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGR 387 (508)
Q Consensus 342 ~~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~ 387 (508)
... ......+||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~ 233 (363)
T cd05628 154 AHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (363)
T ss_pred cccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCC
Confidence 110 0012357999999999999999999999999999999999999
Q ss_pred CCCCCC
Q 010513 388 NPVDYS 393 (508)
Q Consensus 388 ~Pf~~~ 393 (508)
.||...
T Consensus 234 ~Pf~~~ 239 (363)
T cd05628 234 PPFCSE 239 (363)
T ss_pred CCCCCC
Confidence 999754
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=334.94 Aligned_cols=249 Identities=24% Similarity=0.340 Sum_probs=194.7
Q ss_pred ceEcccCcEEEEEEEEC-CCcEEEEEEeecC---CchhHHHHHHHHHHHHcc-CCCCeeeEeeeeecCCeeEEEEEecCC
Q 010513 192 NVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN---RGQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYIDN 266 (508)
Q Consensus 192 ~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lV~e~~~~ 266 (508)
+.||+|+||+||+|... +++.||+|.+.+. .....+.+..|+.++.++ +||||+++++++.+++..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999975 5778999998754 223345677888888777 899999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCCCcce
Q 010513 267 GNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYV 346 (508)
Q Consensus 267 g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~ 346 (508)
|+|.+++... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~~----~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~-~~ 152 (329)
T cd05618 81 GDLMFHMQRQ----RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-DT 152 (329)
T ss_pred CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC-Cc
Confidence 9999988654 4689999999999999999999999 99999999999999999999999999987532221 22
Q ss_pred ecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCC--cchHHHHHHHhhcccccccCCCccCCC
Q 010513 347 TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPG--EVNLVEWLKTMVTNRNAEGVLDPRLQE 424 (508)
Q Consensus 347 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~l~~ 424 (508)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....... ......++......... .+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~------~~p~ 226 (329)
T cd05618 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI------RIPR 226 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC------CCCC
Confidence 334679999999999999999999999999999999999999996432211 12222333332222111 1111
Q ss_pred CchHHHHHHHHHHHHHccCCCCCCCCC------HHHHHHH
Q 010513 425 KPCSRALKRALLVALRCVDPNAHKRPK------MGHVIHM 458 (508)
Q Consensus 425 ~~~~~~~~~l~~li~~cl~~dP~~RPs------~~evl~~ 458 (508)
..+ ..+.+++.+||+.||++||+ +.+++++
T Consensus 227 -~~~---~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 227 -SLS---VKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred -CCC---HHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 122 23445788999999999998 4566543
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=330.79 Aligned_cols=257 Identities=26% Similarity=0.493 Sum_probs=204.9
Q ss_pred CCCCcccceEcccCcEEEEEEEECC------CcEEEEEEeecCCch-hHHHHHHHHHHHHccCCCCeeeEeeeeecCCee
Q 010513 185 TNGFADENVIGEGGYGIVYHGVLED------NTNVAVKNLLNNRGQ-AEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHR 257 (508)
Q Consensus 185 ~~~~~~~~~LG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 257 (508)
.++|.+.+.||+|+||.||+|.+.+ +..||+|.+...... ..+.+.+|+++++.++|+||+++++++......
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 4578889999999999999998643 467999998765443 457899999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhccCC----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCC
Q 010513 258 MLVYEYIDNGNLEQWLHGDV----------GPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWN 327 (508)
Q Consensus 258 ~lV~e~~~~g~L~~~l~~~~----------~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~ 327 (508)
++||||+++|+|.+++.... .....+++..+..++.|++.|+.|||++ +++||||||+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCe
Confidence 99999999999999997542 1234578999999999999999999999 9999999999999999999
Q ss_pred eEEeeeccceecCCCCcc-eecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHh-CCCCCCCCCCCCcchHHHHH
Q 010513 328 PKLSDFGLAKLLGAERSY-VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWL 405 (508)
Q Consensus 328 ~kL~DFG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~ 405 (508)
+||+|||++......... ......+++.|+|||++.+..++.++|||||||++|||++ |..||...... ...+..
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~---~~~~~~ 237 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE---EVIECI 237 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH---HHHHHH
Confidence 999999999865332221 1223356788999999999999999999999999999998 99999644321 111111
Q ss_pred HHhhcccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 010513 406 KTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 460 (508)
Q Consensus 406 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le 460 (508)
. .... .. .....+. .+.+++.+||+.||++||++.|+++.|+
T Consensus 238 ---~-~~~~----~~--~~~~~~~---~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 238 ---T-QGRL----LQ--RPRTCPS---EVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred ---H-cCCc----CC--CCCCCCH---HHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 1 1111 00 0111233 3445888999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=326.23 Aligned_cols=252 Identities=24% Similarity=0.410 Sum_probs=201.4
Q ss_pred CCCcccceEcccCcEEEEEEEECCCcEEEEEEeecCCchhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEEecC
Q 010513 186 NGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYID 265 (508)
Q Consensus 186 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~ 265 (508)
.+|++.+.||+|+||.||+|.++++..+|+|.+.+.. .....+.+|+++++.++||||+++++++.+.+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA 82 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence 3688899999999999999998877789999875433 234567889999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCCCcc
Q 010513 266 NGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSY 345 (508)
Q Consensus 266 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~ 345 (508)
+++|.+++.... ..+++..++.++.|++.||+|||++ +++||||||+||+++.++.+||+|||+++........
T Consensus 83 ~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~ 156 (256)
T cd05059 83 NGCLLNYLRERK---GKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT 156 (256)
T ss_pred CCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceeccccccc
Confidence 999999997652 4689999999999999999999999 9999999999999999999999999999865432222
Q ss_pred eecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHhhcccccccCCCccCCC
Q 010513 346 VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQE 424 (508)
Q Consensus 346 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 424 (508)
......++..|+|||.+.+..++.++|+||||+++|||++ |+.||...++. +....... . ......
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~------~~~~~~~~-~-----~~~~~~- 223 (256)
T cd05059 157 SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS------EVVESVSA-G-----YRLYRP- 223 (256)
T ss_pred ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH------HHHHHHHc-C-----CcCCCC-
Confidence 2222234457999999998999999999999999999999 89999754321 11111111 1 011111
Q ss_pred CchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 010513 425 KPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 460 (508)
Q Consensus 425 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le 460 (508)
...+. ++.+++.+||+.+|++||++.+++++|.
T Consensus 224 ~~~~~---~~~~li~~cl~~~p~~Rpt~~~~l~~l~ 256 (256)
T cd05059 224 KLAPT---EVYTIMYSCWHEKPEDRPAFKKLLSQLT 256 (256)
T ss_pred CCCCH---HHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence 11233 4555888999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-41 Score=363.30 Aligned_cols=262 Identities=29% Similarity=0.505 Sum_probs=215.0
Q ss_pred hcCCCCcccceEcccCcEEEEEEEECC--Cc----EEEEEEeecC-CchhHHHHHHHHHHHHccCCCCeeeEeeeeecCC
Q 010513 183 VSTNGFADENVIGEGGYGIVYHGVLED--NT----NVAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGA 255 (508)
Q Consensus 183 ~~~~~~~~~~~LG~G~~g~Vy~~~~~~--~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~ 255 (508)
++....+..+.||+|+||.||.|...+ +. .||+|.+.+. ..+...+|.+|..+|++++|||||+++|++.+..
T Consensus 689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~ 768 (1025)
T KOG1095|consen 689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSG 768 (1025)
T ss_pred CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCC
Confidence 456677888999999999999999653 33 4899998765 4456678999999999999999999999999999
Q ss_pred eeEEEEEecCCCCHHHHhccCCC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEee
Q 010513 256 HRMLVYEYIDNGNLEQWLHGDVG---PHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSD 332 (508)
Q Consensus 256 ~~~lV~e~~~~g~L~~~l~~~~~---~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~D 332 (508)
..++++|||++|||..||++.+. ....++..+.+.++.|+|+|+.||+++ ++|||||...|+||+....+||+|
T Consensus 769 ~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaD 845 (1025)
T KOG1095|consen 769 PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIAD 845 (1025)
T ss_pred CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcc
Confidence 99999999999999999987532 245689999999999999999999999 999999999999999999999999
Q ss_pred eccceecCCCCcceecce-ecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHhhc
Q 010513 333 FGLAKLLGAERSYVTTRV-MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVT 410 (508)
Q Consensus 333 FG~a~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~ 410 (508)
||+|+.+.....+..... .-...|||||.+..+.++.|+|||||||+|||++| |..||...++ .+.+.....
T Consensus 846 FGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n------~~v~~~~~~ 919 (1025)
T KOG1095|consen 846 FGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSN------FEVLLDVLE 919 (1025)
T ss_pred cchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcch------HHHHHHHHh
Confidence 999996655444444333 33458999999999999999999999999999999 9999974432 222222233
Q ss_pred ccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 010513 411 NRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEE 463 (508)
Q Consensus 411 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~~~ 463 (508)
.++ ++ +...|++.+. ++|.+||+.+|++||++..+++.+++..
T Consensus 920 ggR----L~---~P~~CP~~ly---~lM~~CW~~~pe~RP~F~~i~~q~~~i~ 962 (1025)
T KOG1095|consen 920 GGR----LD---PPSYCPEKLY---QLMLQCWKHDPEDRPSFRTIVEQDPAIS 962 (1025)
T ss_pred CCc----cC---CCCCCChHHH---HHHHHHccCChhhCccHHHHHhhhhhhh
Confidence 321 12 2344666655 4888999999999999999999888653
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-41 Score=344.33 Aligned_cols=200 Identities=24% Similarity=0.337 Sum_probs=173.2
Q ss_pred CCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCC---chhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEE
Q 010513 187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE 262 (508)
Q Consensus 187 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e 262 (508)
.|+..+.||+|+||+||+|+.. +++.||+|.+.+.. ......+.+|+++++.++||||+++++.+.+++..|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5889999999999999999965 57889999986532 2334568889999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCC
Q 010513 263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE 342 (508)
Q Consensus 263 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 342 (508)
|+++|+|.+++.+. ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++..+...
T Consensus 82 ~~~gg~L~~~l~~~----~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~ 154 (382)
T cd05625 82 YIPGGDMMSLLIRM----GIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (382)
T ss_pred CCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCcccccc
Confidence 99999999999764 4688999999999999999999999 9999999999999999999999999997532100
Q ss_pred C----------------------------------------------cceecceecCCCCCChhhhhcCCCCCCCCeeeh
Q 010513 343 R----------------------------------------------SYVTTRVMGTFGYVAPEYASTGMLNERSDVYSF 376 (508)
Q Consensus 343 ~----------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSl 376 (508)
. .......+||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (382)
T cd05625 155 HDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV 234 (382)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEec
Confidence 0 000123479999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCC
Q 010513 377 GILIMEVISGRNPVDYS 393 (508)
Q Consensus 377 Gvvl~elltg~~Pf~~~ 393 (508)
||++|||++|+.||...
T Consensus 235 Gvil~elltG~~Pf~~~ 251 (382)
T cd05625 235 GVILYEMLVGQPPFLAQ 251 (382)
T ss_pred hHHHHHHHhCCCCCCCC
Confidence 99999999999999754
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=345.96 Aligned_cols=264 Identities=25% Similarity=0.404 Sum_probs=206.6
Q ss_pred hHhhcCCCCcccceEcccCcEEEEEEEECC------CcEEEEEEeecCCc-hhHHHHHHHHHHHHccC-CCCeeeEeeee
Q 010513 180 ELEVSTNGFADENVIGEGGYGIVYHGVLED------NTNVAVKNLLNNRG-QAEKEFKVEVEAIGRVR-HKNLVRLLGYC 251 (508)
Q Consensus 180 ~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-hpniv~l~~~~ 251 (508)
.+++..++|++.+.||+|+||.||+|.+.. +..||||++..... ...+.+.+|+++++++. ||||+++++++
T Consensus 31 ~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~ 110 (400)
T cd05105 31 RWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGAC 110 (400)
T ss_pred ceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEE
Confidence 346677899999999999999999998531 24699999865433 33467889999999996 99999999999
Q ss_pred ecCCeeEEEEEecCCCCHHHHhccCCC-----------------------------------------------------
Q 010513 252 AEGAHRMLVYEYIDNGNLEQWLHGDVG----------------------------------------------------- 278 (508)
Q Consensus 252 ~~~~~~~lV~e~~~~g~L~~~l~~~~~----------------------------------------------------- 278 (508)
.+....|+|||||++|+|.+++.....
T Consensus 111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (400)
T cd05105 111 TKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVP 190 (400)
T ss_pred ccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccch
Confidence 999999999999999999999865311
Q ss_pred ---------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCC
Q 010513 279 ---------------------------------------PHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSN 319 (508)
Q Consensus 279 ---------------------------------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~N 319 (508)
....+++..+..++.|+++||+|||++ +++||||||+|
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~N 267 (400)
T cd05105 191 MLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARN 267 (400)
T ss_pred hhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHh
Confidence 013478888999999999999999998 99999999999
Q ss_pred EEEcCCCCeEEeeeccceecCCCCcc-eecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHh-CCCCCCCCCCCC
Q 010513 320 ILLDKQWNPKLSDFGLAKLLGAERSY-VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPG 397 (508)
Q Consensus 320 Ill~~~~~~kL~DFG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~Pf~~~~~~~ 397 (508)
||++.++.+||+|||+++........ ......+++.|+|||.+.+..++.++|||||||++|||++ |..||.......
T Consensus 268 ill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~ 347 (400)
T cd05105 268 VLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS 347 (400)
T ss_pred EEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH
Confidence 99999999999999999866433222 1223456788999999998999999999999999999997 999996432211
Q ss_pred cchHHHHHHHhhcccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 010513 398 EVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461 (508)
Q Consensus 398 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~ 461 (508)
. ......... .+.. .... ..++.+++.+||+.||++||++.++.++|+.
T Consensus 348 --~----~~~~~~~~~-----~~~~-~~~~---~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~ 396 (400)
T cd05105 348 --T----FYNKIKSGY-----RMAK-PDHA---TQEVYDIMVKCWNSEPEKRPSFLHLSDIVES 396 (400)
T ss_pred --H----HHHHHhcCC-----CCCC-CccC---CHHHHHHHHHHCccCHhHCcCHHHHHHHHHH
Confidence 1 111111110 0111 1112 2345568889999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=345.74 Aligned_cols=252 Identities=23% Similarity=0.296 Sum_probs=196.1
Q ss_pred CCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCC---chhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEE
Q 010513 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY 261 (508)
Q Consensus 186 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 261 (508)
++|++.+.||+|+||.||+|+.. +++.||+|.+.+.. ......+.+|+++++.++||||+++++.+.+++..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 36899999999999999999965 58889999885432 223456788999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCC
Q 010513 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA 341 (508)
Q Consensus 262 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 341 (508)
||+++|+|.+++.+. ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++..+..
T Consensus 81 E~~~~g~L~~~i~~~----~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~ 153 (376)
T cd05598 81 DYIPGGDMMSLLIRL----GIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 153 (376)
T ss_pred eCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCccccc
Confidence 999999999999764 4688999999999999999999999 999999999999999999999999999753210
Q ss_pred C------------------------------------------CcceecceecCCCCCChhhhhcCCCCCCCCeeehHHH
Q 010513 342 E------------------------------------------RSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGIL 379 (508)
Q Consensus 342 ~------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvv 379 (508)
. ........+||+.|+|||++.+..++.++|||||||+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi 233 (376)
T cd05598 154 THDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 233 (376)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccce
Confidence 0 0001123579999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCC---CHHHHH
Q 010513 380 IMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRP---KMGHVI 456 (508)
Q Consensus 380 l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP---s~~evl 456 (508)
+|||++|+.||....+. +.......... ....+. ....+.. +.+++.+|+ .+|++|+ ++.+++
T Consensus 234 lyell~G~~Pf~~~~~~------~~~~~i~~~~~--~~~~~~--~~~~s~~---~~~li~~l~-~~p~~R~~~~t~~ell 299 (376)
T cd05598 234 LYEMLVGQPPFLADTPA------ETQLKVINWET--TLHIPS--QAKLSRE---ASDLILRLC-CGAEDRLGKNGADEIK 299 (376)
T ss_pred eeehhhCCCCCCCCCHH------HHHHHHhccCc--cccCCC--CCCCCHH---HHHHHHHHh-cCHhhcCCCCCHHHHh
Confidence 99999999999754321 11111111100 000010 0112233 334555765 5999999 889988
Q ss_pred HH
Q 010513 457 HM 458 (508)
Q Consensus 457 ~~ 458 (508)
++
T Consensus 300 ~h 301 (376)
T cd05598 300 AH 301 (376)
T ss_pred CC
Confidence 66
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=338.92 Aligned_cols=261 Identities=21% Similarity=0.286 Sum_probs=204.2
Q ss_pred hhhHhhcCCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCC---chhHHHHHHHHHHHHccCCCCeeeEeeeeec
Q 010513 178 LRELEVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE 253 (508)
Q Consensus 178 ~~~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 253 (508)
++++++..++|++.+.||+|+||.||+|..+ +++.||+|.+.+.. ......+.+|+.+++.++||||+++++++.+
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 5566777889999999999999999999976 57789999885422 2234457789999999999999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeee
Q 010513 254 GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDF 333 (508)
Q Consensus 254 ~~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DF 333 (508)
+...|+||||+++|+|.+++... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+||
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~Df 186 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSNY-----DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADF 186 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeC
Confidence 99999999999999999998653 478899999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCcceecceecCCCCCChhhhhcC----CCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhh
Q 010513 334 GLAKLLGAERSYVTTRVMGTFGYVAPEYASTG----MLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMV 409 (508)
Q Consensus 334 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~ 409 (508)
|++..............+||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ........
T Consensus 187 G~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~------~~~~~~i~ 260 (371)
T cd05622 187 GTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL------VGTYSKIM 260 (371)
T ss_pred CceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH------HHHHHHHH
Confidence 99987654433334456799999999998754 378999999999999999999999974322 22222222
Q ss_pred cccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHHH
Q 010513 410 TNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHK--RPKMGHVIHML 459 (508)
Q Consensus 410 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~L 459 (508)
.........+ ....+.. +.+++.+|+..++.+ ||++.+++++.
T Consensus 261 ~~~~~~~~~~----~~~~s~~---~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 261 NHKNSLTFPD----DNDISKE---AKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred cCCCcccCCC----cCCCCHH---HHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 2111101100 1112333 444777999844433 78999998864
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-41 Score=336.60 Aligned_cols=242 Identities=22% Similarity=0.269 Sum_probs=194.1
Q ss_pred ceEcccCcEEEEEEEEC-CCcEEEEEEeecCC---chhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEEecCCC
Q 010513 192 NVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNG 267 (508)
Q Consensus 192 ~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~g 267 (508)
+.||+|+||.||++... ++..||+|.+.... ......+..|++++..++||||+++++++.+.+..|+||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999965 68899999986542 233456678999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCCCcce
Q 010513 268 NLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE-GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYV 346 (508)
Q Consensus 268 ~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~ 346 (508)
+|.+++... ..+++..+..++.|++.||+|||+ + +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~ 152 (325)
T cd05594 81 ELFFHLSRE----RVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG-AT 152 (325)
T ss_pred cHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCC-cc
Confidence 999988654 468999999999999999999997 6 89999999999999999999999999987542222 22
Q ss_pred ecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCCccCCCCc
Q 010513 347 TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKP 426 (508)
Q Consensus 347 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 426 (508)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+........ . ..+...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~------~~~~~~i~~~-~------~~~p~~- 218 (325)
T cd05594 153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH------EKLFELILME-E------IRFPRT- 218 (325)
T ss_pred cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCH------HHHHHHHhcC-C------CCCCCC-
Confidence 3345799999999999999999999999999999999999999964321 1111111111 0 011111
Q ss_pred hHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 010513 427 CSRALKRALLVALRCVDPNAHKRP-----KMGHVIHM 458 (508)
Q Consensus 427 ~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 458 (508)
.+. ++.+++.+||+.||++|+ ++.+++++
T Consensus 219 ~~~---~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 219 LSP---EAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred CCH---HHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 222 344577799999999996 89998865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=333.97 Aligned_cols=245 Identities=27% Similarity=0.351 Sum_probs=193.1
Q ss_pred CcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCC---chhHHHHHHHHHHH---HccCCCCeeeEeeeeecCCeeEEE
Q 010513 188 FADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAI---GRVRHKNLVRLLGYCAEGAHRMLV 260 (508)
Q Consensus 188 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~hpniv~l~~~~~~~~~~~lV 260 (508)
|++.+.||+|+||.||+|.+. +++.||+|.+.+.. ....+.+..|++++ +.++||||+++++++.+.+..|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 677899999999999999965 58899999986542 22334566666554 567899999999999999999999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecC
Q 010513 261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG 340 (508)
Q Consensus 261 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 340 (508)
|||+++|+|..++.. ..+++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||+++...
T Consensus 81 ~E~~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~ 152 (324)
T cd05589 81 MEYAAGGDLMMHIHT-----DVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGM 152 (324)
T ss_pred EcCCCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCC
Confidence 999999999998864 3689999999999999999999999 99999999999999999999999999987532
Q ss_pred CCCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCCc
Q 010513 341 AERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDP 420 (508)
Q Consensus 341 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 420 (508)
... ......+|++.|+|||.+.+..++.++|||||||++|||++|+.||..... .+......... +
T Consensus 153 ~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~------~~~~~~i~~~~-------~ 218 (324)
T cd05589 153 GFG-DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDE------EEVFDSIVNDE-------V 218 (324)
T ss_pred CCC-CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhCC-------C
Confidence 221 223446799999999999999999999999999999999999999974422 11122211111 0
Q ss_pred cCCCCchHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 010513 421 RLQEKPCSRALKRALLVALRCVDPNAHKRP-----KMGHVIHM 458 (508)
Q Consensus 421 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 458 (508)
.... ..+ ..+.+++.+||+.||++|| ++.+++++
T Consensus 219 ~~p~-~~~---~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 219 RYPR-FLS---REAISIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred CCCC-CCC---HHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 1111 122 3345578899999999999 56666654
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=332.86 Aligned_cols=242 Identities=24% Similarity=0.324 Sum_probs=193.7
Q ss_pred ceEcccCcEEEEEEEEC-CCcEEEEEEeecCC---chhHHHHHHHHHHHHcc-CCCCeeeEeeeeecCCeeEEEEEecCC
Q 010513 192 NVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYIDN 266 (508)
Q Consensus 192 ~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lV~e~~~~ 266 (508)
++||+|+||.||+|+.. +++.||+|.+.... ....+.+..|.+++..+ +||||+++++++.+++..|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999976 47789999986542 23345567788888866 899999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCCCcce
Q 010513 267 GNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYV 346 (508)
Q Consensus 267 g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~ 346 (508)
|+|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++....... ..
T Consensus 81 ~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~-~~ 152 (321)
T cd05591 81 GDLMFQIQRS----RKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG-VT 152 (321)
T ss_pred CcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCC-cc
Confidence 9999998764 4688999999999999999999999 99999999999999999999999999987542222 22
Q ss_pred ecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCCccCCCCc
Q 010513 347 TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKP 426 (508)
Q Consensus 347 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 426 (508)
....+||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+......... ...+ ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~------~~~~~~i~~~~----~~~p----~~ 218 (321)
T cd05591 153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNE------DDLFESILHDD----VLYP----VW 218 (321)
T ss_pred ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCH------HHHHHHHHcCC----CCCC----CC
Confidence 3446799999999999999999999999999999999999999974432 12222222111 0011 11
Q ss_pred hHHHHHHHHHHHHHccCCCCCCCC-------CHHHHHHH
Q 010513 427 CSRALKRALLVALRCVDPNAHKRP-------KMGHVIHM 458 (508)
Q Consensus 427 ~~~~~~~l~~li~~cl~~dP~~RP-------s~~evl~~ 458 (508)
.+ .++.+++.+||+.||++|| ++.+++++
T Consensus 219 ~~---~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 219 LS---KEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred CC---HHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 22 3445578899999999999 78888755
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=339.13 Aligned_cols=252 Identities=23% Similarity=0.291 Sum_probs=196.2
Q ss_pred CCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCC---chhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEE
Q 010513 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY 261 (508)
Q Consensus 186 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 261 (508)
++|++.+.||+|+||+||+|... +++.||+|++.+.. ....+.+.+|+++++.++||||+++++++.+....|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 47889999999999999999965 68889999986532 233456888999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCC
Q 010513 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA 341 (508)
Q Consensus 262 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 341 (508)
||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.+..
T Consensus 81 E~~~gg~L~~~l~~~----~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~ 153 (377)
T cd05629 81 EFLPGGDLMTMLIKY----DTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHK 153 (377)
T ss_pred eCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeeccccccccc
Confidence 999999999999764 4688999999999999999999999 999999999999999999999999999864321
Q ss_pred CCcc----------------------------------------------eecceecCCCCCChhhhhcCCCCCCCCeee
Q 010513 342 ERSY----------------------------------------------VTTRVMGTFGYVAPEYASTGMLNERSDVYS 375 (508)
Q Consensus 342 ~~~~----------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS 375 (508)
.... .....+||+.|+|||++.+..++.++||||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS 233 (377)
T cd05629 154 QHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWS 233 (377)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEe
Confidence 0000 001246999999999999999999999999
Q ss_pred hHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCC---CCH
Q 010513 376 FGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKR---PKM 452 (508)
Q Consensus 376 lGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~R---Ps~ 452 (508)
|||++|||++|+.||..... .+.............. +.. ...+. ++.+++.+|+. +|.+| +++
T Consensus 234 lGvil~elltG~~Pf~~~~~------~~~~~~i~~~~~~~~~--p~~--~~~s~---~~~dli~~lL~-~~~~r~~r~~~ 299 (377)
T cd05629 234 LGAIMFECLIGWPPFCSENS------HETYRKIINWRETLYF--PDD--IHLSV---EAEDLIRRLIT-NAENRLGRGGA 299 (377)
T ss_pred cchhhhhhhcCCCCCCCCCH------HHHHHHHHccCCccCC--CCC--CCCCH---HHHHHHHHHhc-CHhhcCCCCCH
Confidence 99999999999999975432 1111222111100000 100 01223 34447778987 66665 599
Q ss_pred HHHHHH
Q 010513 453 GHVIHM 458 (508)
Q Consensus 453 ~evl~~ 458 (508)
.+++++
T Consensus 300 ~~~l~h 305 (377)
T cd05629 300 HEIKSH 305 (377)
T ss_pred HHHhcC
Confidence 998876
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=335.27 Aligned_cols=241 Identities=22% Similarity=0.298 Sum_probs=192.6
Q ss_pred CCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCC---chhHHHHHHHHHHHHccCCC-CeeeEeeeeecCCeeEEEE
Q 010513 187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHK-NLVRLLGYCAEGAHRMLVY 261 (508)
Q Consensus 187 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hp-niv~l~~~~~~~~~~~lV~ 261 (508)
+|++.+.||+|+||.||+|... +++.||+|.+.+.. ....+.+..|.+++..+.|+ +|+++++++.+.+..|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4788999999999999999976 46789999986532 23345677899999999764 6888999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCC
Q 010513 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA 341 (508)
Q Consensus 262 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 341 (508)
||+++|+|.+++... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 E~~~~g~L~~~~~~~----~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05587 81 EYVNGGDLMYHIQQV----GKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIF 153 (324)
T ss_pred cCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCC
Confidence 999999999998764 4688999999999999999999999 999999999999999999999999999875322
Q ss_pred CCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCCcc
Q 010513 342 ERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPR 421 (508)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 421 (508)
.. ......+||+.|+|||++.+..++.++|||||||++|||+||+.||..... .+......... ..
T Consensus 154 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~------~~~~~~i~~~~-------~~ 219 (324)
T cd05587 154 GG-KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE------DELFQSIMEHN-------VS 219 (324)
T ss_pred CC-CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH------HHHHHHHHcCC-------CC
Confidence 11 223346799999999999999999999999999999999999999974431 11112111110 11
Q ss_pred CCCCchHHHHHHHHHHHHHccCCCCCCCCCH
Q 010513 422 LQEKPCSRALKRALLVALRCVDPNAHKRPKM 452 (508)
Q Consensus 422 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 452 (508)
+... . ..++.+++.+||+.||++|++.
T Consensus 220 ~~~~-~---~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 220 YPKS-L---SKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred CCCC-C---CHHHHHHHHHHhhcCHHHcCCC
Confidence 1111 2 2345558889999999999976
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=351.41 Aligned_cols=257 Identities=24% Similarity=0.330 Sum_probs=205.0
Q ss_pred hcCCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCC--chhHHHHHHHHHHHHccCCCCeeeEeeeeecCC----
Q 010513 183 VSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGA---- 255 (508)
Q Consensus 183 ~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~---- 255 (508)
...++|.+.+.||+|+||+||+|+.. +++.||||.+.... ......+.+|+..+..++|+||+++++.+....
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~ 108 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP 108 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence 34568999999999999999999854 68899999986542 334456788999999999999999988775432
Q ss_pred ----eeEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEe
Q 010513 256 ----HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLS 331 (508)
Q Consensus 256 ----~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~ 331 (508)
.+++||||+++|+|.+++.........+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+
T Consensus 109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL~ 185 (496)
T PTZ00283 109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKLG 185 (496)
T ss_pred ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEEE
Confidence 36799999999999999976544456799999999999999999999999 99999999999999999999999
Q ss_pred eeccceecCCCC-cceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhc
Q 010513 332 DFGLAKLLGAER-SYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVT 410 (508)
Q Consensus 332 DFG~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~ 410 (508)
|||+++.+.... .......+||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+.+.....
T Consensus 186 DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~------~~~~~~~~~~ 259 (496)
T PTZ00283 186 DFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN------MEEVMHKTLA 259 (496)
T ss_pred ecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC------HHHHHHHHhc
Confidence 999998764322 222344679999999999999999999999999999999999999996432 2222222222
Q ss_pred ccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 411 NRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 411 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
.. .++ +. ...+ .++.+++.+||+.||++||++.+++++
T Consensus 260 ~~-----~~~-~~-~~~~---~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 260 GR-----YDP-LP-PSIS---PEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred CC-----CCC-CC-CCCC---HHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 11 111 11 1122 344557889999999999999999875
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-41 Score=319.99 Aligned_cols=265 Identities=22% Similarity=0.318 Sum_probs=203.8
Q ss_pred CCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCc--hhHHHHHHHHHHHHccCCCC-eeeEeeeeecCC------
Q 010513 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG--QAEKEFKVEVEAIGRVRHKN-LVRLLGYCAEGA------ 255 (508)
Q Consensus 186 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpn-iv~l~~~~~~~~------ 255 (508)
..|...++||+|+||+||+|+.+ +|+.||+|++.-... .......+|+.+++.++|+| ||++++++...+
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 45777888999999999999954 688999999965433 23455678999999999999 999999998877
Q ss_pred eeEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeecc
Q 010513 256 HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGL 335 (508)
Q Consensus 256 ~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~ 335 (508)
..++|+||++. +|..++.........++...++.++.||+.||+|||++ +|+||||||.||||+++|.+||+|||+
T Consensus 91 ~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 91 KLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred eEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccch
Confidence 78999999987 99999987643224567789999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCcceecceecCCCCCChhhhhcC-CCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhc---c
Q 010513 336 AKLLGAERSYVTTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVT---N 411 (508)
Q Consensus 336 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~---~ 411 (508)
|+.+..... ..+..++|.+|.|||++.+. .|+...||||+||+++||++++.-|.+.... ..+.... +.+. +
T Consensus 167 Ara~~ip~~-~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~--~ql~~If-~~lGtP~e 242 (323)
T KOG0594|consen 167 ARAFSIPMR-TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEI--DQLFRIF-RLLGTPNE 242 (323)
T ss_pred HHHhcCCcc-cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHH--HHHHHHH-HHcCCCCc
Confidence 997643322 23456789999999998776 7999999999999999999999999766431 1111111 1111 1
Q ss_pred cccccCC---C--ccCCCC----c-hHHHH---HHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 412 RNAEGVL---D--PRLQEK----P-CSRAL---KRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 412 ~~~~~~~---~--~~l~~~----~-~~~~~---~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
..+.++. + +.+... . ..... .+..+++.+|++.+|.+|.+++.++++
T Consensus 243 ~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 243 KDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred cCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 1111110 1 011111 0 11111 356778889999999999999999987
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=326.38 Aligned_cols=248 Identities=22% Similarity=0.265 Sum_probs=194.9
Q ss_pred EcccCcEEEEEEEEC-CCcEEEEEEeecCCc---hhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEEecCCCCH
Q 010513 194 IGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG---QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNL 269 (508)
Q Consensus 194 LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~g~L 269 (508)
||+|+||+||++.+. +++.||+|++..... ...+.+..|+++++.++|+||+++.+++..+...++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999965 678899999865432 2235667899999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCCCcceecc
Q 010513 270 EQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTR 349 (508)
Q Consensus 270 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~ 349 (508)
.+++.........+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++........ ....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~ 156 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTKG 156 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-cccc
Confidence 988865433346789999999999999999999999 999999999999999999999999999986543322 2334
Q ss_pred eecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCCccCCCCchHH
Q 010513 350 VMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSR 429 (508)
Q Consensus 350 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 429 (508)
..||+.|+|||++.+..++.++|+|||||++|||++|+.||........ .......... .... ....
T Consensus 157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~---------~~~~--~~~~ 223 (280)
T cd05608 157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE--NKELKQRILN---------DSVT--YPDK 223 (280)
T ss_pred cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchh--HHHHHHhhcc---------cCCC--Cccc
Confidence 5789999999999999999999999999999999999999975432111 1111111110 0000 0111
Q ss_pred HHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 010513 430 ALKRALLVALRCVDPNAHKRP-----KMGHVIHM 458 (508)
Q Consensus 430 ~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 458 (508)
....+.+++.+||+.||++|| ++++++++
T Consensus 224 ~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 224 FSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred CCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 223445577899999999999 67777764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=333.24 Aligned_cols=236 Identities=22% Similarity=0.325 Sum_probs=189.5
Q ss_pred ceEcccCcEEEEEEEEC-CCcEEEEEEeecCC---chhHHHHHHHHHHHHcc-CCCCeeeEeeeeecCCeeEEEEEecCC
Q 010513 192 NVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYIDN 266 (508)
Q Consensus 192 ~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lV~e~~~~ 266 (508)
+.||+|+||+||+|+.+ +++.||+|.+.+.. ....+.+..|.+++..+ +||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999976 57889999986532 23345566788888776 799999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCCCcce
Q 010513 267 GNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYV 346 (508)
Q Consensus 267 g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~ 346 (508)
|+|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++..... ...
T Consensus 81 g~L~~~i~~~----~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~-~~~ 152 (320)
T cd05590 81 GDLMFHIQKS----RRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN-GKT 152 (320)
T ss_pred chHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC-CCc
Confidence 9999998765 4689999999999999999999999 9999999999999999999999999998754222 222
Q ss_pred ecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCCccCCCCc
Q 010513 347 TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKP 426 (508)
Q Consensus 347 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 426 (508)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+........ . ...+ ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~------~~~~~~i~~~-~---~~~~----~~ 218 (320)
T cd05590 153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE------DDLFEAILND-E---VVYP----TW 218 (320)
T ss_pred ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH------HHHHHHHhcC-C---CCCC----CC
Confidence 3446799999999999999999999999999999999999999974432 1222222211 1 0011 11
Q ss_pred hHHHHHHHHHHHHHccCCCCCCCCCH
Q 010513 427 CSRALKRALLVALRCVDPNAHKRPKM 452 (508)
Q Consensus 427 ~~~~~~~l~~li~~cl~~dP~~RPs~ 452 (508)
.+ .++.+++.+||+.||++||++
T Consensus 219 ~~---~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 219 LS---QDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred CC---HHHHHHHHHHcccCHHHCCCC
Confidence 22 334557789999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=324.32 Aligned_cols=255 Identities=29% Similarity=0.489 Sum_probs=203.7
Q ss_pred CCCCcccceEcccCcEEEEEEEECC----CcEEEEEEeecCC-chhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEE
Q 010513 185 TNGFADENVIGEGGYGIVYHGVLED----NTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRML 259 (508)
Q Consensus 185 ~~~~~~~~~LG~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 259 (508)
.++|++.+.||+|+||+||+|.+.. ...||+|.+.... ......+..|+.+++.++||||+++++++.+....++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 4578999999999999999999752 3468999886543 3344678889999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceec
Q 010513 260 VYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL 339 (508)
Q Consensus 260 V~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~ 339 (508)
||||+++++|.+++... ...+++..++.++.|++.||+|||++ +|+||||||+||++++++.++|+|||++...
T Consensus 83 v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~ 156 (266)
T cd05033 83 ITEYMENGSLDKFLREN---DGKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRL 156 (266)
T ss_pred EEEcCCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhcc
Confidence 99999999999999765 24789999999999999999999998 9999999999999999999999999999977
Q ss_pred CCCCc-ceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHhhcccccccC
Q 010513 340 GAERS-YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGV 417 (508)
Q Consensus 340 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 417 (508)
..... .......++..|+|||.+.+..++.++||||||+++|||++ |..||...... ...+.. ....
T Consensus 157 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~---~~~~~~---~~~~----- 225 (266)
T cd05033 157 EDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ---DVIKAV---EDGY----- 225 (266)
T ss_pred cccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH---HHHHHH---HcCC-----
Confidence 52222 22222345678999999998899999999999999999998 99999643211 111111 1110
Q ss_pred CCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 010513 418 LDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461 (508)
Q Consensus 418 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~ 461 (508)
..+. ....+ ..+.+++.+||+.+|++||++.+++++|++
T Consensus 226 ~~~~--~~~~~---~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~ 264 (266)
T cd05033 226 RLPP--PMDCP---SALYQLMLDCWQKDRNERPTFSQIVSTLDK 264 (266)
T ss_pred CCCC--CCCCC---HHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 0010 11122 345568889999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-40 Score=330.35 Aligned_cols=255 Identities=23% Similarity=0.291 Sum_probs=197.4
Q ss_pred CCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecC---CchhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEE
Q 010513 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN---RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY 261 (508)
Q Consensus 186 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 261 (508)
++|++.+.||+|+||+||+++.. +++.||+|.+.+. .....+.+.+|+.++..++|+||+++++++.+++..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47899999999999999999965 5888999998642 2223456888999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCC
Q 010513 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA 341 (508)
Q Consensus 262 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 341 (508)
||+++|+|.+++.+. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 154 (331)
T cd05597 81 DYYVGGDLLTLLSKF---EDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA 154 (331)
T ss_pred ecCCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCC
Confidence 999999999999754 35689999999999999999999999 999999999999999999999999999986644
Q ss_pred CCcceecceecCCCCCChhhhhc-----CCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhccccccc
Q 010513 342 ERSYVTTRVMGTFGYVAPEYAST-----GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEG 416 (508)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 416 (508)
.........+||+.|+|||++.. ..++.++|||||||++|||++|+.||.... ..+.............
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~------~~~~~~~i~~~~~~~~ 228 (331)
T cd05597 155 DGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAES------LVETYGKIMNHKEHFQ 228 (331)
T ss_pred CCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCC------HHHHHHHHHcCCCccc
Confidence 43333334579999999999863 457889999999999999999999996432 2222222222111101
Q ss_pred CCCccCCCCchHHHHHHHHHHHHHccCC--CCCCCCCHHHHHHH
Q 010513 417 VLDPRLQEKPCSRALKRALLVALRCVDP--NAHKRPKMGHVIHM 458 (508)
Q Consensus 417 ~~~~~l~~~~~~~~~~~l~~li~~cl~~--dP~~RPs~~evl~~ 458 (508)
+.+. ....+...++ ++.+|+.. ++..||++.+++++
T Consensus 229 -~~~~--~~~~~~~~~~---li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 229 -FPPD--VTDVSEEAKD---LIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred -CCCc--cCCCCHHHHH---HHHHHccCcccccCCCCHHHHhcC
Confidence 1111 0113334444 55576654 33448899998877
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=325.01 Aligned_cols=261 Identities=23% Similarity=0.433 Sum_probs=203.4
Q ss_pred hhcCCCCcccceEcccCcEEEEEEEEC------CCcEEEEEEeecCC-chhHHHHHHHHHHHHccCCCCeeeEeeeeecC
Q 010513 182 EVSTNGFADENVIGEGGYGIVYHGVLE------DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEG 254 (508)
Q Consensus 182 ~~~~~~~~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~ 254 (508)
++..++|++.+.||+|+||.||+|.+. .+..||+|++.... .....++.+|+.+++.++||||+++++++.++
T Consensus 2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~ 81 (277)
T cd05062 2 EVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 81 (277)
T ss_pred cccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 456678999999999999999999853 24579999875432 23345688899999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHhccCCCC------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCe
Q 010513 255 AHRMLVYEYIDNGNLEQWLHGDVGP------HSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNP 328 (508)
Q Consensus 255 ~~~~lV~e~~~~g~L~~~l~~~~~~------~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~ 328 (508)
...++||||+++|+|.+++...... ...+++..+..++.|+++||+|||+. +++||||||+||++++++.+
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~ 158 (277)
T cd05062 82 QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTV 158 (277)
T ss_pred CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCE
Confidence 9999999999999999998653211 23467888999999999999999998 99999999999999999999
Q ss_pred EEeeeccceecCCCCcce-ecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHh-CCCCCCCCCCCCcchHHHHHH
Q 010513 329 KLSDFGLAKLLGAERSYV-TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLK 406 (508)
Q Consensus 329 kL~DFG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~ 406 (508)
+|+|||++.......... .....+++.|+|||++.++.++.++|||||||++|||++ |..||..... .+...
T Consensus 159 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~------~~~~~ 232 (277)
T cd05062 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN------EQVLR 232 (277)
T ss_pred EECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH------HHHHH
Confidence 999999987653322221 112345778999999999999999999999999999999 7889864322 11111
Q ss_pred HhhcccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 010513 407 TMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461 (508)
Q Consensus 407 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~ 461 (508)
... ..... ... ..++. .+.+++.+||+.||++||++.+++++|+.
T Consensus 233 ~~~-~~~~~-----~~~-~~~~~---~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 233 FVM-EGGLL-----DKP-DNCPD---MLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred HHH-cCCcC-----CCC-CCCCH---HHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 111 11110 011 11233 34558889999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=332.07 Aligned_cols=243 Identities=24% Similarity=0.331 Sum_probs=193.5
Q ss_pred ceEcccCcEEEEEEEEC-CCcEEEEEEeecCC---chhHHHHHHHHHHHHcc-CCCCeeeEeeeeecCCeeEEEEEecCC
Q 010513 192 NVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYIDN 266 (508)
Q Consensus 192 ~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lV~e~~~~ 266 (508)
+.||+|+||+||+|... +++.||+|.+.+.. ....+.+..|+.++.++ +||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999965 57789999987542 23345677899999888 699999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCCCcce
Q 010513 267 GNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYV 346 (508)
Q Consensus 267 g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~ 346 (508)
|+|.+++... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++..... ...
T Consensus 81 ~~L~~~~~~~----~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~-~~~ 152 (327)
T cd05617 81 GDLMFHMQRQ----RKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP-GDT 152 (327)
T ss_pred CcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCC-CCc
Confidence 9999988654 4689999999999999999999999 9999999999999999999999999998753222 122
Q ss_pred ecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCCccCCCCc
Q 010513 347 TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKP 426 (508)
Q Consensus 347 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 426 (508)
....+||+.|+|||++.+..++.++|||||||++|||++|+.||.........+..+.+.+....... .+.. .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~------~~p~-~ 225 (327)
T cd05617 153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPI------RIPR-F 225 (327)
T ss_pred eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCC------CCCC-C
Confidence 34467999999999999999999999999999999999999999754433333333333333322111 1111 1
Q ss_pred hHHHHHHHHHHHHHccCCCCCCCCCH
Q 010513 427 CSRALKRALLVALRCVDPNAHKRPKM 452 (508)
Q Consensus 427 ~~~~~~~l~~li~~cl~~dP~~RPs~ 452 (508)
.+. .+.+++.+||+.||++|+++
T Consensus 226 ~~~---~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 226 LSV---KASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred CCH---HHHHHHHHHhccCHHHcCCC
Confidence 222 34457779999999999985
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=321.12 Aligned_cols=260 Identities=23% Similarity=0.369 Sum_probs=207.3
Q ss_pred CCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecC---CchhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEE
Q 010513 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN---RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY 261 (508)
Q Consensus 186 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 261 (508)
++|++.+.||+|+||.||+|+.. +++.||+|.+... .......+..|+++++.++||||+++++++.+.+..++||
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 47899999999999999999965 6889999987542 2333456888999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCC
Q 010513 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA 341 (508)
Q Consensus 262 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 341 (508)
||+++|+|.+++.........+++..++.++.|++.||+|||++ +++||||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 99999999998864333345688999999999999999999998 999999999999999999999999999987643
Q ss_pred CCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCCcc
Q 010513 342 ERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPR 421 (508)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 421 (508)
... ......|++.|+|||.+.+..++.++|+||||+++|||++|+.||..... +..+..... .... .+.
T Consensus 159 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~----~~~~~~~~~-~~~~-----~~~ 227 (267)
T cd08228 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLFSLCQKI-EQCD-----YPP 227 (267)
T ss_pred hhH-HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccc----cHHHHHHHH-hcCC-----CCC
Confidence 221 22335688999999999888899999999999999999999999864322 112222211 1111 111
Q ss_pred CCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010513 422 LQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (508)
Q Consensus 422 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~~ 462 (508)
.. .......+.+++.+||+.+|++||++.++++.|++.
T Consensus 228 ~~---~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 228 LP---TEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred CC---hhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 11 112223455588899999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=343.36 Aligned_cols=267 Identities=22% Similarity=0.293 Sum_probs=194.4
Q ss_pred hhHhhcCCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCchhHHHHHHHHHHHHccCC------CCeeeEeeee
Q 010513 179 RELEVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRH------KNLVRLLGYC 251 (508)
Q Consensus 179 ~~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h------pniv~l~~~~ 251 (508)
++++...++|++.+.||+|+||+||+|.+. .++.||||++.... .....+..|+++++.++| .++++++++|
T Consensus 122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~ 200 (467)
T PTZ00284 122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF 200 (467)
T ss_pred CccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence 344566789999999999999999999965 57789999985432 223445667777777654 4588999988
Q ss_pred ecC-CeeEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeeccCCCCCEEEcCCC---
Q 010513 252 AEG-AHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE-GLEPKVVHRDIKSSNILLDKQW--- 326 (508)
Q Consensus 252 ~~~-~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~~iiHrDlkp~NIll~~~~--- 326 (508)
..+ .+.|+|||++ +++|.+++.+. ..+++..+..++.|++.||+|||+ . +|+||||||+|||++.++
T Consensus 201 ~~~~~~~~iv~~~~-g~~l~~~l~~~----~~l~~~~~~~i~~qi~~aL~yLH~~~---gIiHrDlKP~NILl~~~~~~~ 272 (467)
T PTZ00284 201 QNETGHMCIVMPKY-GPCLLDWIMKH----GPFSHRHLAQIIFQTGVALDYFHTEL---HLMHTDLKPENILMETSDTVV 272 (467)
T ss_pred EcCCceEEEEEecc-CCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEecCCccc
Confidence 765 4788999988 66899988764 478999999999999999999997 5 899999999999998765
Q ss_pred -------------CeEEeeeccceecCCCCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCC
Q 010513 327 -------------NPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS 393 (508)
Q Consensus 327 -------------~~kL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~ 393 (508)
.+||+|||.+.... ......+||+.|+|||++.+..|+.++|||||||++|||++|+.||+..
T Consensus 273 ~~~~~~~~~~~~~~vkl~DfG~~~~~~----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~ 348 (467)
T PTZ00284 273 DPVTNRALPPDPCRVRICDLGGCCDER----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTH 348 (467)
T ss_pred ccccccccCCCCceEEECCCCccccCc----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 49999999886422 2234468999999999999999999999999999999999999999765
Q ss_pred CCCCcchHHHHHHH----hhcc----cc------cccCCCccCCCC---------chH--HHHHHHHHHHHHccCCCCCC
Q 010513 394 RPPGEVNLVEWLKT----MVTN----RN------AEGVLDPRLQEK---------PCS--RALKRALLVALRCVDPNAHK 448 (508)
Q Consensus 394 ~~~~~~~~~~~~~~----~~~~----~~------~~~~~~~~l~~~---------~~~--~~~~~l~~li~~cl~~dP~~ 448 (508)
.............. .+.. .. ....+.+..... ... .....+.+|+.+||+.||++
T Consensus 349 ~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~ 428 (467)
T PTZ00284 349 DNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQK 428 (467)
T ss_pred ChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhh
Confidence 43211111110000 0000 00 000001100000 000 01234567899999999999
Q ss_pred CCCHHHHHHH
Q 010513 449 RPKMGHVIHM 458 (508)
Q Consensus 449 RPs~~evl~~ 458 (508)
||++.|++++
T Consensus 429 R~ta~e~L~H 438 (467)
T PTZ00284 429 RLNARQMTTH 438 (467)
T ss_pred CCCHHHHhcC
Confidence 9999999973
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=329.24 Aligned_cols=261 Identities=25% Similarity=0.461 Sum_probs=207.1
Q ss_pred cCCCCcccceEcccCcEEEEEEEEC------CCcEEEEEEeecCCchhHHHHHHHHHHHHccCCCCeeeEeeeeecCCee
Q 010513 184 STNGFADENVIGEGGYGIVYHGVLE------DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHR 257 (508)
Q Consensus 184 ~~~~~~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 257 (508)
..++|.+.+.||+|+||.||++... ++..+|+|.+........+.+..|++++++++||||+++++++...+..
T Consensus 3 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (288)
T cd05093 3 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL 82 (288)
T ss_pred chHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 3467899999999999999999852 2345889988766555667899999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhccCC---------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCe
Q 010513 258 MLVYEYIDNGNLEQWLHGDV---------GPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNP 328 (508)
Q Consensus 258 ~lV~e~~~~g~L~~~l~~~~---------~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~ 328 (508)
++||||+++++|.+++.... .....+++..++.++.|++.||+|||++ +++||||||+||++++++.+
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~ 159 (288)
T cd05093 83 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLV 159 (288)
T ss_pred EEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcE
Confidence 99999999999999986542 1123589999999999999999999998 99999999999999999999
Q ss_pred EEeeeccceecCCCCcc-eecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHh-CCCCCCCCCCCCcchHHHHHH
Q 010513 329 KLSDFGLAKLLGAERSY-VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLK 406 (508)
Q Consensus 329 kL~DFG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~ 406 (508)
||+|||+++........ ......++..|+|||++.+..++.++|+|||||++|||++ |..||...... +...
T Consensus 160 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~------~~~~ 233 (288)
T cd05093 160 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN------EVIE 233 (288)
T ss_pred EeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH------HHHH
Confidence 99999999865332221 1223345778999999998999999999999999999998 99998644321 1111
Q ss_pred HhhcccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 010513 407 TMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEE 463 (508)
Q Consensus 407 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~~~ 463 (508)
... ..... ... ...+. .+.+++.+||+.||.+||++.++++.|++..
T Consensus 234 ~i~-~~~~~-----~~~-~~~~~---~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~ 280 (288)
T cd05093 234 CIT-QGRVL-----QRP-RTCPK---EVYDLMLGCWQREPHMRLNIKEIHSLLQNLA 280 (288)
T ss_pred HHH-cCCcC-----CCC-CCCCH---HHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence 111 11110 011 11223 3556888999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=322.72 Aligned_cols=256 Identities=25% Similarity=0.347 Sum_probs=203.0
Q ss_pred cCCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCchhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEE
Q 010513 184 STNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE 262 (508)
Q Consensus 184 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e 262 (508)
..++|++.+.||+|+||.||+|... +++.||+|++..........+.+|+.+++.++||||+++++++..+...++|||
T Consensus 7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e 86 (267)
T cd06646 7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICME 86 (267)
T ss_pred chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEe
Confidence 3457999999999999999999964 678899999876555556678889999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCC
Q 010513 263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE 342 (508)
Q Consensus 263 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 342 (508)
|+++++|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 87 ~~~~~~L~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd06646 87 YCGGGSLQDIYHVT----GPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITAT 159 (267)
T ss_pred CCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeeccc
Confidence 99999999998754 4689999999999999999999998 9999999999999999999999999999865322
Q ss_pred CcceecceecCCCCCChhhhh---cCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCC
Q 010513 343 RSYVTTRVMGTFGYVAPEYAS---TGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLD 419 (508)
Q Consensus 343 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 419 (508)
. .......|++.|+|||.+. ...++.++|+|||||++|||++|+.||....+.... .. +... ....
T Consensus 160 ~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~------~~-~~~~---~~~~ 228 (267)
T cd06646 160 I-AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL------FL-MSKS---NFQP 228 (267)
T ss_pred c-cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhh------ee-eecC---CCCC
Confidence 1 1123356889999999874 345788999999999999999999999644322110 00 0000 1111
Q ss_pred ccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 010513 420 PRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHML 459 (508)
Q Consensus 420 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 459 (508)
+.... .......+.+++.+||+.||++||++++++++|
T Consensus 229 ~~~~~--~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 229 PKLKD--KTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred CCCcc--ccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 11111 112234555688899999999999999999764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=322.98 Aligned_cols=260 Identities=25% Similarity=0.359 Sum_probs=199.9
Q ss_pred CCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCchhHHHHHHHHHHHHccCCCCeeeEeeeeecCC-----eeEEE
Q 010513 187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGA-----HRMLV 260 (508)
Q Consensus 187 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-----~~~lV 260 (508)
.|+..+++|.|+||.||+|... ++..||||++.....- -.+|+++|+.+.|||||++.-+|.... ...+|
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 5677899999999999999965 4688999999765432 234899999999999999998886432 23489
Q ss_pred EEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCC-CCeEEeeeccceec
Q 010513 261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQ-WNPKLSDFGLAKLL 339 (508)
Q Consensus 261 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~-~~~kL~DFG~a~~~ 339 (508)
||||+. +|.+.++.....+..++...++-+..||.+||.|||+. +|+||||||.|+|+|.+ |.+||||||.|+.+
T Consensus 101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 999998 99999986554556788888999999999999999998 99999999999999976 88999999999987
Q ss_pred CCCCcceecceecCCCCCChhhhhc-CCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHh-------h--
Q 010513 340 GAERSYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTM-------V-- 409 (508)
Q Consensus 340 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~-------~-- 409 (508)
...... .....|..|.|||.+.+ ..|+.+.||||.|||+.||+-|+.-|.+... ...+.+.++-. +
T Consensus 177 ~~~epn--iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~--~dQL~eIik~lG~Pt~e~I~~ 252 (364)
T KOG0658|consen 177 VKGEPN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSS--VDQLVEIIKVLGTPTREDIKS 252 (364)
T ss_pred ccCCCc--eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCH--HHHHHHHHHHhCCCCHHHHhh
Confidence 544433 23456889999998866 5699999999999999999999999986432 22333333211 0
Q ss_pred cccccccCCCccCCCCc-----hHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 410 TNRNAEGVLDPRLQEKP-----CSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 410 ~~~~~~~~~~~~l~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
.+........|.+...+ ......+.++++.++|..+|.+|.++.|++.+
T Consensus 253 mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 253 MNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred cCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 01111122223333222 22344567778899999999999999998865
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=331.40 Aligned_cols=241 Identities=22% Similarity=0.311 Sum_probs=192.4
Q ss_pred CCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCC---chhHHHHHHHHHHHHcc-CCCCeeeEeeeeecCCeeEEEE
Q 010513 187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVY 261 (508)
Q Consensus 187 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lV~ 261 (508)
+|.+.+.||+|+||.||+|+.. ++..||+|.+.+.. ....+.+..|..++..+ +|++|+++++++.+.+..|+||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4788999999999999999976 46789999986542 22334566678888777 5899999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCC
Q 010513 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA 341 (508)
Q Consensus 262 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 341 (508)
||+++|+|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 81 E~~~~g~L~~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~ 153 (323)
T cd05616 81 EYVNGGDLMYQIQQV----GRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW 153 (323)
T ss_pred cCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCC
Confidence 999999999998764 4689999999999999999999999 999999999999999999999999999975422
Q ss_pred CCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCCcc
Q 010513 342 ERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPR 421 (508)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 421 (508)
. .......+||+.|+|||++.+..++.++|||||||++|||+||+.||..... .+........ . ..
T Consensus 154 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~------~~~~~~i~~~-~------~~ 219 (323)
T cd05616 154 D-GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE------DELFQSIMEH-N------VA 219 (323)
T ss_pred C-CCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCH------HHHHHHHHhC-C------CC
Confidence 2 1223346799999999999999999999999999999999999999974432 1112221111 1 01
Q ss_pred CCCCchHHHHHHHHHHHHHccCCCCCCCCCH
Q 010513 422 LQEKPCSRALKRALLVALRCVDPNAHKRPKM 452 (508)
Q Consensus 422 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 452 (508)
+.. ....++.+++.+|++.||++|++.
T Consensus 220 ~p~----~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 220 YPK----SMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred CCC----cCCHHHHHHHHHHcccCHHhcCCC
Confidence 111 122345558889999999999984
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=329.11 Aligned_cols=261 Identities=25% Similarity=0.451 Sum_probs=207.9
Q ss_pred CCCCcccceEcccCcEEEEEEEEC------CCcEEEEEEeecCCchhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeE
Q 010513 185 TNGFADENVIGEGGYGIVYHGVLE------DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM 258 (508)
Q Consensus 185 ~~~~~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 258 (508)
..+|.+.+.||+|+||.||+|.+. ++..+++|.+........+.+.+|+++++.++||||+++++++.++...+
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (291)
T cd05094 4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLI 83 (291)
T ss_pred hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceE
Confidence 456888999999999999999843 24558889887666666678999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCC
Q 010513 259 LVYEYIDNGNLEQWLHGDVG------------PHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQW 326 (508)
Q Consensus 259 lV~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~ 326 (508)
+||||+++++|.+++..... ....+++..++.++.|++.||+|||++ +++||||||+||+++.++
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~ 160 (291)
T cd05094 84 MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANL 160 (291)
T ss_pred EEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCC
Confidence 99999999999999965421 224589999999999999999999999 999999999999999999
Q ss_pred CeEEeeeccceecCCCCcc-eecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHh-CCCCCCCCCCCCcchHHHH
Q 010513 327 NPKLSDFGLAKLLGAERSY-VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEW 404 (508)
Q Consensus 327 ~~kL~DFG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~ 404 (508)
.++|+|||++......... ......++..|+|||.+.+..++.++|||||||++|||+| |+.||...... +.
T Consensus 161 ~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~------~~ 234 (291)
T cd05094 161 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT------EV 234 (291)
T ss_pred cEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH------HH
Confidence 9999999999865433221 1233456788999999999999999999999999999999 99998654321 11
Q ss_pred HHHhhcccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCC
Q 010513 405 LKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEEF 464 (508)
Q Consensus 405 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~~~~ 464 (508)
... ........ . ....+ ..+.+++.+||+.||++||++.+++++|++...
T Consensus 235 ~~~-~~~~~~~~-----~-~~~~~---~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 235 IEC-ITQGRVLE-----R-PRVCP---KEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred HHH-HhCCCCCC-----C-CccCC---HHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 111 11111110 0 11122 345568889999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=328.12 Aligned_cols=262 Identities=26% Similarity=0.419 Sum_probs=206.4
Q ss_pred HhhcCCCCcccceEcccCcEEEEEEEECC------CcEEEEEEeecCC-chhHHHHHHHHHHHHcc-CCCCeeeEeeeee
Q 010513 181 LEVSTNGFADENVIGEGGYGIVYHGVLED------NTNVAVKNLLNNR-GQAEKEFKVEVEAIGRV-RHKNLVRLLGYCA 252 (508)
Q Consensus 181 ~~~~~~~~~~~~~LG~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~ 252 (508)
+++..++|++.+.||+|+||.||++...+ ...+|+|.+.... ......+.+|++++..+ +|+||+++++++.
T Consensus 7 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 86 (293)
T cd05053 7 WELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT 86 (293)
T ss_pred cccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc
Confidence 35667789999999999999999998642 3568999886542 23345688899999999 8999999999999
Q ss_pred cCCeeEEEEEecCCCCHHHHhccCC------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCE
Q 010513 253 EGAHRMLVYEYIDNGNLEQWLHGDV------------GPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNI 320 (508)
Q Consensus 253 ~~~~~~lV~e~~~~g~L~~~l~~~~------------~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NI 320 (508)
.+...+++|||+++|+|.+++.... .....+++..++.++.|++.||+|||++ +|+||||||+||
T Consensus 87 ~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Ni 163 (293)
T cd05053 87 QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNV 163 (293)
T ss_pred CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeE
Confidence 9999999999999999999996532 2345789999999999999999999998 999999999999
Q ss_pred EEcCCCCeEEeeeccceecCCCCcce-ecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHh-CCCCCCCCCCCCc
Q 010513 321 LLDKQWNPKLSDFGLAKLLGAERSYV-TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGE 398 (508)
Q Consensus 321 ll~~~~~~kL~DFG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~Pf~~~~~~~~ 398 (508)
++++++.+||+|||+++.+....... .....++..|+|||++.+..++.++|||||||++|||++ |..||.....
T Consensus 164 l~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--- 240 (293)
T cd05053 164 LVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV--- 240 (293)
T ss_pred EEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCH---
Confidence 99999999999999998764432221 122345678999999988999999999999999999998 9999864321
Q ss_pred chHHHHHHHhhcccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 010513 399 VNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461 (508)
Q Consensus 399 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~ 461 (508)
.+..... ..... +.. ......++.+++.+||+.||++||++.++++.|++
T Consensus 241 ---~~~~~~~-~~~~~-----~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~ 290 (293)
T cd05053 241 ---EELFKLL-KEGYR-----MEK----PQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDR 290 (293)
T ss_pred ---HHHHHHH-HcCCc-----CCC----CCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHH
Confidence 1111111 11110 000 11122345568889999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=311.98 Aligned_cols=252 Identities=22% Similarity=0.340 Sum_probs=203.6
Q ss_pred CCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCc--------hhHHHHHHHHHHHHcc-CCCCeeeEeeeeecC
Q 010513 185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG--------QAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEG 254 (508)
Q Consensus 185 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~ 254 (508)
.+.|.-.++||+|..++|-++.++ +|+++|+|++..... .-.++-..|+.+|+++ .||+|+.+.++|+.+
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~ 95 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD 95 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence 456777889999999999999865 688999998843211 1224556799999999 799999999999999
Q ss_pred CeeEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeec
Q 010513 255 AHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFG 334 (508)
Q Consensus 255 ~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG 334 (508)
...++|+|.|+.|.|+|+|... -.+++.....|+.|+.+|++|||.. +|+||||||+|||+|++.++||+|||
T Consensus 96 sF~FlVFdl~prGELFDyLts~----VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDFG 168 (411)
T KOG0599|consen 96 AFVFLVFDLMPRGELFDYLTSK----VTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDFG 168 (411)
T ss_pred chhhhhhhhcccchHHHHhhhh----eeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEeccc
Confidence 9999999999999999999876 5799999999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCcceecceecCCCCCChhhhh------cCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHh
Q 010513 335 LAKLLGAERSYVTTRVMGTFGYVAPEYAS------TGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTM 408 (508)
Q Consensus 335 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~ 408 (508)
+++.+... ......||||+|+|||.+. ...|+...|+|++||+||.|+.|..||-.... -.+.++
T Consensus 169 Fa~~l~~G--ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQ-------mlMLR~ 239 (411)
T KOG0599|consen 169 FACQLEPG--EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQ-------MLMLRM 239 (411)
T ss_pred eeeccCCc--hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHH-------HHHHHH
Confidence 99976443 3456789999999999884 34578889999999999999999999952211 112223
Q ss_pred hcccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 409 VTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 409 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
+..+.. .+..+...+......+++.+||+.||++|.|++|+|++
T Consensus 240 ImeGky------qF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 240 IMEGKY------QFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred HHhccc------ccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 333322 12222233444445558889999999999999998864
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-41 Score=323.61 Aligned_cols=265 Identities=23% Similarity=0.271 Sum_probs=213.0
Q ss_pred hhcCCCCcccceEcccCcEEEEEEEECC-CcEEEEEEeecCCc---hhHHHHHHHHHHHHccCCCCeeeEeeeeecCCee
Q 010513 182 EVSTNGFADENVIGEGGYGIVYHGVLED-NTNVAVKNLLNNRG---QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHR 257 (508)
Q Consensus 182 ~~~~~~~~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 257 (508)
.+..++|+.++.||.|.-|+||+++.++ +..+|+|++.+... ........|-++|+.++||.++.+|..|+.+...
T Consensus 73 ~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~ 152 (459)
T KOG0610|consen 73 SLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYS 152 (459)
T ss_pred ccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeecccee
Confidence 4555678899999999999999999774 57899999976533 3344667799999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccce
Q 010513 258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK 337 (508)
Q Consensus 258 ~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~ 337 (508)
|+|||||+||+|..+++++ +...+++..++.++..++-||+|||-. |||+|||||+||||.++|++-|+||.++.
T Consensus 153 cl~meyCpGGdL~~LrqkQ--p~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~ 227 (459)
T KOG0610|consen 153 CLVMEYCPGGDLHSLRQKQ--PGKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSL 227 (459)
T ss_pred EEEEecCCCccHHHHHhhC--CCCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccc
Confidence 9999999999999999876 467899999999999999999999999 99999999999999999999999999874
Q ss_pred ecCC---------------------------------C-C---------------------cceecceecCCCCCChhhh
Q 010513 338 LLGA---------------------------------E-R---------------------SYVTTRVMGTFGYVAPEYA 362 (508)
Q Consensus 338 ~~~~---------------------------------~-~---------------------~~~~~~~~gt~~y~aPE~~ 362 (508)
.... . . ......++||-.|+|||++
T Consensus 228 ~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI 307 (459)
T KOG0610|consen 228 RCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVI 307 (459)
T ss_pred cCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceee
Confidence 3210 0 0 0112236899999999999
Q ss_pred hcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCCccCCCCchHHHHHHHHHHHHHcc
Q 010513 363 STGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCV 442 (508)
Q Consensus 363 ~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl 442 (508)
.+...+.++|||+|||+||||+.|..||.+.+... .+ ...+.. +..+.. .+.....+.+||.+.|
T Consensus 308 ~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~--Tl----~NIv~~-------~l~Fp~--~~~vs~~akDLIr~LL 372 (459)
T KOG0610|consen 308 RGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKE--TL----RNIVGQ-------PLKFPE--EPEVSSAAKDLIRKLL 372 (459)
T ss_pred ecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchh--hH----HHHhcC-------CCcCCC--CCcchhHHHHHHHHHh
Confidence 99999999999999999999999999998664321 11 111111 122222 2234455666888999
Q ss_pred CCCCCCCCC----HHHHHHH--HhcCCCCC
Q 010513 443 DPNAHKRPK----MGHVIHM--LEAEEFPF 466 (508)
Q Consensus 443 ~~dP~~RPs----~~evl~~--Le~~~~~~ 466 (508)
.+||++|.. +.||.++ +++.++.+
T Consensus 373 vKdP~kRlg~~rGA~eIK~HpFF~gVnWaL 402 (459)
T KOG0610|consen 373 VKDPSKRLGSKRGAAEIKRHPFFEGVNWAL 402 (459)
T ss_pred ccChhhhhccccchHHhhcCccccCCChhh
Confidence 999999998 8888764 55655555
|
|
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=322.17 Aligned_cols=258 Identities=28% Similarity=0.477 Sum_probs=208.5
Q ss_pred hhcCCCCcccceEcccCcEEEEEEEECCCcEEEEEEeecCCchhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEE
Q 010513 182 EVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY 261 (508)
Q Consensus 182 ~~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 261 (508)
++..++|++.+.||+|+||.||+|..+++..+|+|.+.... ...+++.+|+++++.++|+||+++++++.++...++||
T Consensus 2 ~~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (261)
T cd05034 2 EIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVT 80 (261)
T ss_pred ccchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEE
Confidence 45678999999999999999999998888889999886543 34567889999999999999999999999988999999
Q ss_pred EecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCC
Q 010513 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA 341 (508)
Q Consensus 262 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 341 (508)
||+++++|.+++.... ...+++..+..++.|++.|+.|||++ +++|+||||+||+++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~i~~~~--~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~ 155 (261)
T cd05034 81 EYMSKGSLLDFLKSGE--GKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIED 155 (261)
T ss_pred eccCCCCHHHHHhccc--cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccc
Confidence 9999999999997652 34689999999999999999999999 999999999999999999999999999987643
Q ss_pred CCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHhhcccccccCCCc
Q 010513 342 ERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDP 420 (508)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 420 (508)
..........++..|+|||.+.+..++.++|+||||+++|||++ |+.||..... ...+........ .
T Consensus 156 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~------~~~~~~~~~~~~------~ 223 (261)
T cd05034 156 DEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN------REVLEQVERGYR------M 223 (261)
T ss_pred hhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHHHcCCC------C
Confidence 22222222335678999999998899999999999999999999 9999964321 111222111100 0
Q ss_pred cCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 010513 421 RLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461 (508)
Q Consensus 421 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~ 461 (508)
... ...+ .++.+++.+|++.+|++||+++++++.|+.
T Consensus 224 ~~~-~~~~---~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 224 PRP-PNCP---EELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CCC-CCCC---HHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 001 1122 345558889999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=321.86 Aligned_cols=256 Identities=25% Similarity=0.402 Sum_probs=203.0
Q ss_pred hcCCCCcccceEcccCcEEEEEEEECCCcEEEEEEeecCCchhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEE
Q 010513 183 VSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE 262 (508)
Q Consensus 183 ~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e 262 (508)
+..++|.+.+.||+|+||.||+|.+.++..+|+|.+.... ...+.+.+|+++++.++|||++++++++.. +..++|||
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e 80 (260)
T cd05069 3 IPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTE 80 (260)
T ss_pred CChHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEE
Confidence 3446789999999999999999998877789999875433 334678889999999999999999998854 56789999
Q ss_pred ecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCC
Q 010513 263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE 342 (508)
Q Consensus 263 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 342 (508)
|+.+|+|.+++.... ...+++..++.++.|++.||+|||+. +++||||||+||++++++.++|+|||++......
T Consensus 81 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05069 81 FMGKGSLLDFLKEGD--GKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDN 155 (260)
T ss_pred cCCCCCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCC
Confidence 999999999997642 34588999999999999999999998 9999999999999999999999999999876433
Q ss_pred CcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHhhcccccccCCCcc
Q 010513 343 RSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPR 421 (508)
Q Consensus 343 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 421 (508)
.........++..|+|||.+.+..++.++|+||||+++|||++ |+.||....+. +.... ..... .+.
T Consensus 156 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~------~~~~~-~~~~~-----~~~ 223 (260)
T cd05069 156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR------EVLEQ-VERGY-----RMP 223 (260)
T ss_pred cccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH------HHHHH-HHcCC-----CCC
Confidence 2222223346678999999988899999999999999999999 99999743321 11111 11110 001
Q ss_pred CCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 010513 422 LQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461 (508)
Q Consensus 422 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~ 461 (508)
.. ......+.+++.+||+.||++||++.++++.|++
T Consensus 224 ~~----~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 224 CP----QGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CC----cccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 11 1122345558889999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-41 Score=344.24 Aligned_cols=258 Identities=29% Similarity=0.513 Sum_probs=212.5
Q ss_pred hhcCCCCcccceEcccCcEEEEEEEECC----CcEEEEEEeecCCc-hhHHHHHHHHHHHHccCCCCeeeEeeeeecCCe
Q 010513 182 EVSTNGFADENVIGEGGYGIVYHGVLED----NTNVAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAH 256 (508)
Q Consensus 182 ~~~~~~~~~~~~LG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 256 (508)
++......++++||.|.||+||+|+++- ...||||.++.... ....+|..|..+|.++.||||+++-|+......
T Consensus 625 EId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~P 704 (996)
T KOG0196|consen 625 EIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKP 704 (996)
T ss_pred hcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCce
Confidence 4555667889999999999999999763 23589999977644 445689999999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccc
Q 010513 257 RMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLA 336 (508)
Q Consensus 257 ~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a 336 (508)
.++|.|||++|+|+.||+.+. +.+++.+...++++||.|+.||-+. ++|||||...|||++.+...|++|||++
T Consensus 705 vMIiTEyMENGsLDsFLR~~D---GqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLS 778 (996)
T KOG0196|consen 705 VMIITEYMENGSLDSFLRQND---GQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLS 778 (996)
T ss_pred eEEEhhhhhCCcHHHHHhhcC---CceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccce
Confidence 999999999999999998884 6799999999999999999999998 9999999999999999999999999999
Q ss_pred eecCCCCcceecceec--CCCCCChhhhhcCCCCCCCCeeehHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHhhcccc
Q 010513 337 KLLGAERSYVTTRVMG--TFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRN 413 (508)
Q Consensus 337 ~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 413 (508)
+.+.++.....+..-| ...|.|||.+...+++.+||||||||+|||.++ |..||-+...... ++......+
T Consensus 779 Rvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdV------IkaIe~gyR 852 (996)
T KOG0196|consen 779 RVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDV------IKAIEQGYR 852 (996)
T ss_pred eecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHH------HHHHHhccC
Confidence 9885544333333323 458999999999999999999999999999988 9999975543322 222222211
Q ss_pred cccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 010513 414 AEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461 (508)
Q Consensus 414 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~ 461 (508)
+. | ...|+..+. +|++.||++|-.+||++.+|+.+|..
T Consensus 853 LP----p---PmDCP~aL~---qLMldCWqkdR~~RP~F~qiV~~lDk 890 (996)
T KOG0196|consen 853 LP----P---PMDCPAALY---QLMLDCWQKDRNRRPKFAQIVSTLDK 890 (996)
T ss_pred CC----C---CCCCcHHHH---HHHHHHHHHHhhcCCCHHHHHHHHHH
Confidence 11 1 112555544 58999999999999999999999975
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=336.76 Aligned_cols=262 Identities=27% Similarity=0.431 Sum_probs=203.9
Q ss_pred hhcCCCCcccceEcccCcEEEEEEEEC------CCcEEEEEEeecCCc-hhHHHHHHHHHHHHcc-CCCCeeeEeeeeec
Q 010513 182 EVSTNGFADENVIGEGGYGIVYHGVLE------DNTNVAVKNLLNNRG-QAEKEFKVEVEAIGRV-RHKNLVRLLGYCAE 253 (508)
Q Consensus 182 ~~~~~~~~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~ 253 (508)
.++.++|++.+.||+|+||.||+|... +++.||+|++..... ...+.+..|++++.++ +|+||+++++++..
T Consensus 3 ~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~ 82 (337)
T cd05054 3 EFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTK 82 (337)
T ss_pred ccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEec
Confidence 566778999999999999999999742 246799998865432 3345677899999999 89999999998864
Q ss_pred -CCeeEEEEEecCCCCHHHHhccCCCC-----------------------------------------------------
Q 010513 254 -GAHRMLVYEYIDNGNLEQWLHGDVGP----------------------------------------------------- 279 (508)
Q Consensus 254 -~~~~~lV~e~~~~g~L~~~l~~~~~~----------------------------------------------------- 279 (508)
+...+++|||+++|+|.+++......
T Consensus 83 ~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (337)
T cd05054 83 PGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEG 162 (337)
T ss_pred CCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhh
Confidence 45678999999999999998643210
Q ss_pred ----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCCCcce-ecceecCC
Q 010513 280 ----HSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYV-TTRVMGTF 354 (508)
Q Consensus 280 ----~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~-~~~~~gt~ 354 (508)
...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.++|+|||+++.+....... .....++.
T Consensus 163 ~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~ 239 (337)
T cd05054 163 DELYKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 239 (337)
T ss_pred hHHhhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCc
Confidence 13688999999999999999999998 99999999999999999999999999998764332222 22345677
Q ss_pred CCCChhhhhcCCCCCCCCeeehHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHhhcccccccCCCccCCCCchHHHHHH
Q 010513 355 GYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKR 433 (508)
Q Consensus 355 ~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 433 (508)
.|+|||++.+..++.++|||||||++|||++ |..||....... .+.......... .. .. ....+
T Consensus 240 ~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~------~~~~~~~~~~~~-----~~-~~---~~~~~ 304 (337)
T cd05054 240 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE------EFCRRLKEGTRM-----RA-PE---YATPE 304 (337)
T ss_pred cccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH------HHHHHHhccCCC-----CC-Cc---cCCHH
Confidence 8999999999999999999999999999998 999997533211 111222211110 00 11 12234
Q ss_pred HHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 010513 434 ALLVALRCVDPNAHKRPKMGHVIHMLEA 461 (508)
Q Consensus 434 l~~li~~cl~~dP~~RPs~~evl~~Le~ 461 (508)
+.+++.+||+.+|++||++.+++++|+.
T Consensus 305 ~~~l~~~cl~~~p~~RPs~~ell~~l~~ 332 (337)
T cd05054 305 IYSIMLDCWHNNPEDRPTFSELVEILGD 332 (337)
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 5668889999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=339.61 Aligned_cols=261 Identities=23% Similarity=0.320 Sum_probs=199.1
Q ss_pred CCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecC--CchhHHHHHHHHHHHHccCCCCeeeEeeeeecCC-----eeE
Q 010513 187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGA-----HRM 258 (508)
Q Consensus 187 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-----~~~ 258 (508)
+|++.+.||+|+||+||+|... +++.||+|++... .....+.+.+|+++++.++||||+++++++.... ..|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4788999999999999999964 6889999988543 2234467888999999999999999999998776 789
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeecccee
Q 010513 259 LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL 338 (508)
Q Consensus 259 lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~ 338 (508)
+||||+.+ +|.+++... ..+++..++.++.|++.||+|||++ +++||||||+|||++.++.+||+|||+++.
T Consensus 81 lv~e~~~~-~l~~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~ 152 (372)
T cd07853 81 VVTELMQS-DLHKIIVSP----QPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARV 152 (372)
T ss_pred EEeecccc-CHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceee
Confidence 99999974 888887654 4789999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCcceecceecCCCCCChhhhhcC-CCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHH-------------
Q 010513 339 LGAERSYVTTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEW------------- 404 (508)
Q Consensus 339 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~------------- 404 (508)
.............+++.|+|||++.+. .++.++|||||||++|||++|+.||....+.........
T Consensus 153 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 232 (372)
T cd07853 153 EEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSA 232 (372)
T ss_pred cccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHh
Confidence 644333333445689999999998764 578999999999999999999999976543211110000
Q ss_pred ---HHHhhcccccccCCCccCCC--CchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 405 ---LKTMVTNRNAEGVLDPRLQE--KPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 405 ---~~~~~~~~~~~~~~~~~l~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
......... ...+.... ........++.+++.+||+.||++||++.+++++
T Consensus 233 ~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 233 CEGARAHILRGP---HKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred hHHHHHHHHhCC---CCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 000000000 00000000 0001113455668889999999999999999975
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=329.03 Aligned_cols=241 Identities=25% Similarity=0.366 Sum_probs=189.6
Q ss_pred ceEcccCcEEEEEEEEC-CCcEEEEEEeecCC---chhHHHHHHHHHHHHcc-CCCCeeeEeeeeecCCeeEEEEEecCC
Q 010513 192 NVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYIDN 266 (508)
Q Consensus 192 ~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lV~e~~~~ 266 (508)
+.||+|+||+||+|.+. +++.||+|.+.... ....+.+..|..++..+ +||||+++++++..+...|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999975 57789999986542 22334455566777654 899999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCCCcce
Q 010513 267 GNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYV 346 (508)
Q Consensus 267 g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~ 346 (508)
|+|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~~~~~----~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~ 152 (316)
T cd05592 81 GDLMFHIQSS----GRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GK 152 (316)
T ss_pred CcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Cc
Confidence 9999998764 4689999999999999999999998 99999999999999999999999999998643222 22
Q ss_pred ecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCCccCCCCc
Q 010513 347 TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKP 426 (508)
Q Consensus 347 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 426 (508)
....+||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+........ .+.+.. .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~------~~~~~~i~~~-------~~~~~~-~ 218 (316)
T cd05592 153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE------DELFDSILND-------RPHFPR-W 218 (316)
T ss_pred cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH------HHHHHHHHcC-------CCCCCC-C
Confidence 3446799999999999999999999999999999999999999975432 1112221111 111111 1
Q ss_pred hHHHHHHHHHHHHHccCCCCCCCCCHH-HHHH
Q 010513 427 CSRALKRALLVALRCVDPNAHKRPKMG-HVIH 457 (508)
Q Consensus 427 ~~~~~~~l~~li~~cl~~dP~~RPs~~-evl~ 457 (508)
.+. ++.+++.+||+.||++||++. ++++
T Consensus 219 ~~~---~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 219 ISK---EAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred CCH---HHHHHHHHHccCCHHHcCCChHHHHc
Confidence 223 344577799999999999875 5544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-40 Score=323.51 Aligned_cols=252 Identities=23% Similarity=0.281 Sum_probs=199.6
Q ss_pred CCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCc---hhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEE
Q 010513 187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG---QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE 262 (508)
Q Consensus 187 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e 262 (508)
.|++.+.||+|+||+||++... +++.||+|++..... .....+.+|+++++.++||||+++++++.+++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4788899999999999999965 688899999865322 223456789999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCC
Q 010513 263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE 342 (508)
Q Consensus 263 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 342 (508)
|+++|+|.+++.... ...+++..+..++.|++.||.|||++ +++||||||+||++++++.++|+|||++......
T Consensus 81 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05605 81 LMNGGDLKFHIYNMG--NPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG 155 (285)
T ss_pred ccCCCcHHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCC
Confidence 999999999886532 24689999999999999999999999 9999999999999999999999999999875332
Q ss_pred CcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCCccC
Q 010513 343 RSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRL 422 (508)
Q Consensus 343 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 422 (508)
.. .....|++.|+|||++.+..++.++|||||||++|||++|+.||....... ..+.+........ ...
T Consensus 156 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~---~~~~~~~~~~~~~------~~~ 224 (285)
T cd05605 156 ET--IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV---KREEVERRVKEDQ------EEY 224 (285)
T ss_pred Cc--cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhh---HHHHHHHHhhhcc------ccc
Confidence 21 233478999999999998899999999999999999999999997543211 1111111111100 011
Q ss_pred CCCchHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 010513 423 QEKPCSRALKRALLVALRCVDPNAHKRP-----KMGHVIHM 458 (508)
Q Consensus 423 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 458 (508)
.......+.+++.+||+.||++|| ++++++++
T Consensus 225 ----~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 225 ----SEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred ----CcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 111223445588899999999999 88888765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=332.57 Aligned_cols=257 Identities=26% Similarity=0.461 Sum_probs=202.0
Q ss_pred cCCCCcccceEcccCcEEEEEEEEC-CCc----EEEEEEeecCC-chhHHHHHHHHHHHHccCCCCeeeEeeeeecCCee
Q 010513 184 STNGFADENVIGEGGYGIVYHGVLE-DNT----NVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHR 257 (508)
Q Consensus 184 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 257 (508)
...+|+..+.||+|+||.||+|.+. ++. .||+|.+.... ....+++..|+.+++.++||||+++++++... ..
T Consensus 5 ~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~ 83 (316)
T cd05108 5 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV 83 (316)
T ss_pred chhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cc
Confidence 3457999999999999999999864 333 38999886543 34456788999999999999999999999874 56
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccce
Q 010513 258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK 337 (508)
Q Consensus 258 ~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~ 337 (508)
++++||+++|+|.+++... ...+++...+.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 84 ~~v~e~~~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~ 157 (316)
T cd05108 84 QLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAK 157 (316)
T ss_pred eeeeecCCCCCHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEccccccc
Confidence 7999999999999999765 24688899999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCcce-ecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHhhcccccc
Q 010513 338 LLGAERSYV-TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAE 415 (508)
Q Consensus 338 ~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (508)
......... .....++..|+|||.+.+..++.++|||||||++|||++ |+.||+.... .+. .........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~------~~~-~~~~~~~~~- 229 (316)
T cd05108 158 LLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA------SEI-SSILEKGER- 229 (316)
T ss_pred cccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH------HHH-HHHHhCCCC-
Confidence 765433222 222344678999999999999999999999999999998 9999964321 111 111111110
Q ss_pred cCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 010513 416 GVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEE 463 (508)
Q Consensus 416 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~~~ 463 (508)
... ...++ .++.+++.+||+.||++||++.+++..|....
T Consensus 230 -~~~----~~~~~---~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~ 269 (316)
T cd05108 230 -LPQ----PPICT---IDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 269 (316)
T ss_pred -CCC----CCCCC---HHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 000 11122 24455888999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=323.91 Aligned_cols=266 Identities=24% Similarity=0.370 Sum_probs=198.2
Q ss_pred CcccceEcccCcEEEEEEEE-----CCCcEEEEEEeecCCc-hhHHHHHHHHHHHHccCCCCeeeEeeeeecC--CeeEE
Q 010513 188 FADENVIGEGGYGIVYHGVL-----EDNTNVAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEG--AHRML 259 (508)
Q Consensus 188 ~~~~~~LG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--~~~~l 259 (508)
|.+.+.||+|+||+||++.+ .++..||+|.+..... .....+.+|+++++.++||||+++++++... ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 38889999999999988763 3567899998865432 3456788899999999999999999988653 45789
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceec
Q 010513 260 VYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL 339 (508)
Q Consensus 260 V~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~ 339 (508)
||||+++|+|.+++... .+++..++.++.|++.||+|||++ +++||||||+|||++.++.+||+|||+++..
T Consensus 86 v~e~~~~~~l~~~~~~~-----~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 157 (283)
T cd05080 86 IMEYVPLGSLRDYLPKH-----KLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 157 (283)
T ss_pred EecCCCCCCHHHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeeccccccc
Confidence 99999999999999653 589999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCcce--ecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccC
Q 010513 340 GAERSYV--TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGV 417 (508)
Q Consensus 340 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 417 (508)
....... .....++..|+|||.+.+..++.++||||||+++|||+||..||......-. ..................
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 236 (283)
T cd05080 158 PEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFE-EMIGPKQGQMTVVRLIEL 236 (283)
T ss_pred CCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhh-hhhcccccccchhhhhhh
Confidence 4322211 1223456679999999888899999999999999999999999864432100 000000000000000000
Q ss_pred CCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010513 418 LDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (508)
Q Consensus 418 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~~ 462 (508)
++..............+.+++.+||+.||++||++++++++|++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~ 281 (283)
T cd05080 237 LERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281 (283)
T ss_pred hhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence 111110000111223455588899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=319.76 Aligned_cols=257 Identities=25% Similarity=0.447 Sum_probs=206.2
Q ss_pred hhcCCCCcccceEcccCcEEEEEEEECCCcEEEEEEeecCCchhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEE
Q 010513 182 EVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY 261 (508)
Q Consensus 182 ~~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 261 (508)
++..++|.+.+.||+|+||.||+|.+.++..+|+|.+.... ...+.+.+|+++++.++|+||+++++++.+ ...+++|
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~ 79 (260)
T cd05073 2 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIIT 79 (260)
T ss_pred cccccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEE
Confidence 45677899999999999999999998778889999876432 345678889999999999999999999887 7789999
Q ss_pred EecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCC
Q 010513 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA 341 (508)
Q Consensus 262 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 341 (508)
||+++|+|.+++.... ...+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||.+.....
T Consensus 80 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 154 (260)
T cd05073 80 EFMAKGSLLDFLKSDE--GSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIED 154 (260)
T ss_pred EeCCCCcHHHHHHhCC--ccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccC
Confidence 9999999999997642 34678889999999999999999998 999999999999999999999999999986643
Q ss_pred CCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHhhcccccccCCCc
Q 010513 342 ERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDP 420 (508)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 420 (508)
..........++..|+|||++..+.++.++|+|||||++|++++ |+.||...... ...... ..... .+
T Consensus 155 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~---~~~~~~----~~~~~----~~ 223 (260)
T cd05073 155 NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP---EVIRAL----ERGYR----MP 223 (260)
T ss_pred CCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH---HHHHHH----hCCCC----CC
Confidence 32222223345678999999998899999999999999999999 99999643221 111111 11100 01
Q ss_pred cCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 010513 421 RLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461 (508)
Q Consensus 421 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~ 461 (508)
. .......+.+++.+|++.+|++||++.++++.|+.
T Consensus 224 ~-----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 224 R-----PENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred C-----cccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 0 11222345568889999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=318.22 Aligned_cols=248 Identities=26% Similarity=0.430 Sum_probs=197.8
Q ss_pred ceEcccCcEEEEEEEECCCcEEEEEEeecCCc-hhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEEecCCCCHH
Q 010513 192 NVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLE 270 (508)
Q Consensus 192 ~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~g~L~ 270 (508)
++||+|+||.||+|...+++.+|+|.+..... .....+.+|+++++.++||||+++++++......++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 36899999999999988888999998865543 33456888999999999999999999999999999999999999999
Q ss_pred HHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCCCcceecce
Q 010513 271 QWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRV 350 (508)
Q Consensus 271 ~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~ 350 (508)
+++... ...+++..++.++.|++.||.|||++ +++||||||+||+++.++.+||+|||++..............
T Consensus 81 ~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 154 (250)
T cd05085 81 SFLRKK---KDELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLK 154 (250)
T ss_pred HHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccccCCCC
Confidence 998754 24678999999999999999999998 999999999999999999999999999976433222222223
Q ss_pred ecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHhhcccccccCCCccCCCCchHH
Q 010513 351 MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSR 429 (508)
Q Consensus 351 ~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 429 (508)
.++..|+|||++.+..++.++||||||+++|++++ |..||...... ... ... .... ..... ...
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~---~~~---~~~-~~~~-----~~~~~-~~~-- 219 (250)
T cd05085 155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ---QAR---EQV-EKGY-----RMSCP-QKC-- 219 (250)
T ss_pred CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH---HHH---HHH-HcCC-----CCCCC-CCC--
Confidence 44667999999998899999999999999999998 99999644221 111 111 1110 00111 112
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 010513 430 ALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461 (508)
Q Consensus 430 ~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~ 461 (508)
..++.+++.+||+.+|++||++.++++.|.+
T Consensus 220 -~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 250 (250)
T cd05085 220 -PDDVYKVMQRCWDYKPENRPKFSELQKELAA 250 (250)
T ss_pred -CHHHHHHHHHHcccCcccCCCHHHHHHHhcC
Confidence 2345568889999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=315.51 Aligned_cols=260 Identities=23% Similarity=0.392 Sum_probs=208.5
Q ss_pred CCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecC---CchhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEE
Q 010513 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN---RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY 261 (508)
Q Consensus 186 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 261 (508)
++|++.+.||+|+||.||+|... +++.||+|.+... .....+.+.+|++++++++|+|++++++++.+.+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57999999999999999999976 7889999988532 2233567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCC
Q 010513 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA 341 (508)
Q Consensus 262 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 341 (508)
||+++|+|.+++.........+++..++.++.+++.||.|||+. +++||||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 99999999999875433345689999999999999999999998 999999999999999999999999999886543
Q ss_pred CCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCCcc
Q 010513 342 ERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPR 421 (508)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 421 (508)
... ......|++.|+|||.+.+..++.++|+|||||++|+|++|+.||.... .+..+...... .+. .. .
T Consensus 159 ~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~----~~~~~~~~~~~-~~~----~~-~ 227 (267)
T cd08224 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK----MNLYSLCKKIE-KCD----YP-P 227 (267)
T ss_pred CCc-ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC----ccHHHHHhhhh-cCC----CC-C
Confidence 222 1233568899999999988889999999999999999999999996432 11222211111 111 11 1
Q ss_pred CCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010513 422 LQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (508)
Q Consensus 422 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~~ 462 (508)
.. .......+.+++.+||+.+|++||++.+|+++|+..
T Consensus 228 ~~---~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 228 LP---ADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred CC---hhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 11 112233455688899999999999999999999753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=328.75 Aligned_cols=255 Identities=20% Similarity=0.259 Sum_probs=198.2
Q ss_pred CCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCC---chhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEE
Q 010513 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY 261 (508)
Q Consensus 186 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 261 (508)
++|++.+.||+|+||+||+++.. +++.||+|.+.+.. ......+..|+.++..++|+||+++++++.+++..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47899999999999999999976 57789999886432 223445788999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCC
Q 010513 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA 341 (508)
Q Consensus 262 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 341 (508)
||+++|+|.+++... ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 Ey~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 154 (331)
T cd05624 81 DYYVGGDLLTLLSKF---EDRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQ 154 (331)
T ss_pred eCCCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccC
Confidence 999999999999764 24689999999999999999999998 999999999999999999999999999987654
Q ss_pred CCcceecceecCCCCCChhhhhc-----CCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhccccccc
Q 010513 342 ERSYVTTRVMGTFGYVAPEYAST-----GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEG 416 (508)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 416 (508)
.........+||+.|+|||++.+ +.++.++|||||||++|||++|+.||..... .+........... .
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~------~~~~~~i~~~~~~-~ 227 (331)
T cd05624 155 DGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESL------VETYGKIMNHEER-F 227 (331)
T ss_pred CCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCH------HHHHHHHHcCCCc-c
Confidence 43333344679999999999875 5688899999999999999999999964321 2222222221100 0
Q ss_pred CCCccCCCCchHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHH
Q 010513 417 VLDPRLQEKPCSRALKRALLVALRCVDPNAHK--RPKMGHVIHM 458 (508)
Q Consensus 417 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~ 458 (508)
.+.+.. .....++.+++.+|+..++++ |+++.+++++
T Consensus 228 ~~p~~~-----~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 228 QFPSHI-----TDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred cCCCcc-----ccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 011111 112234455777888866544 4678888765
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=326.08 Aligned_cols=263 Identities=24% Similarity=0.397 Sum_probs=201.3
Q ss_pred CCCCcccceEcccCcEEEEEEEEC-----CCcEEEEEEeecCCchhHHHHHHHHHHHHccCCCCeeeEeeeeec--CCee
Q 010513 185 TNGFADENVIGEGGYGIVYHGVLE-----DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE--GAHR 257 (508)
Q Consensus 185 ~~~~~~~~~LG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~--~~~~ 257 (508)
..+|++.+.||+|+||.||+|..+ ++..||+|++........+.+..|+++++.++||||+++++++.. ....
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 82 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 82 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCce
Confidence 357889999999999999999843 477899999877666666788999999999999999999998753 3467
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccce
Q 010513 258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK 337 (508)
Q Consensus 258 ~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~ 337 (508)
++||||+++|+|.+++... ...+++..++.++.|++.||+|||++ +++||||||+||+++.++.+||+|||++.
T Consensus 83 ~lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~ 156 (284)
T cd05081 83 RLVMEYLPYGSLRDYLQKH---RERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTK 156 (284)
T ss_pred EEEEEecCCCCHHHHHHhc---CcCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCcccc
Confidence 8999999999999999764 24689999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCccee--cceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCC------c---chHHHHHH
Q 010513 338 LLGAERSYVT--TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPG------E---VNLVEWLK 406 (508)
Q Consensus 338 ~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~------~---~~~~~~~~ 406 (508)
.......... ....++..|+|||.+.+..++.++|+|||||++|||++|..|+......- . ......+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd05081 157 VLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLI 236 (284)
T ss_pred cccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHH
Confidence 7644332211 11223446999999998899999999999999999999887764321100 0 00011111
Q ss_pred HhhcccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010513 407 TMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (508)
Q Consensus 407 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~~ 462 (508)
....... ... .....+ .++.+++.+||+.+|++|||+.++++.|++.
T Consensus 237 ~~~~~~~-----~~~-~~~~~~---~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 237 ELLKNNG-----RLP-APPGCP---AEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHHhcCC-----cCC-CCCCCC---HHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 1111100 000 011122 3455588899999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-42 Score=310.51 Aligned_cols=253 Identities=22% Similarity=0.306 Sum_probs=202.8
Q ss_pred cCCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeec--CCchhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEE
Q 010513 184 STNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLN--NRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLV 260 (508)
Q Consensus 184 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 260 (508)
..+.|++-++||+|.|+.||++... +|+++|+|.+.- -.....+++.+|+.+-+.|+|||||++.+.+.+....|||
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 4467888899999999999999854 688999997732 2344678899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEc---CCCCeEEeeeccce
Q 010513 261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLD---KQWNPKLSDFGLAK 337 (508)
Q Consensus 261 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~---~~~~~kL~DFG~a~ 337 (508)
+|+|+|++|..-+-.+ ...++..+-.+++||++||.|+|.+ +|||||+||+|+++- ...-+||+|||+|.
T Consensus 89 Fe~m~G~dl~~eIV~R----~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi 161 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVAR----EFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAI 161 (355)
T ss_pred EecccchHHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEE
Confidence 9999999997655433 3578888999999999999999999 999999999999993 33459999999999
Q ss_pred ecCCCCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccC
Q 010513 338 LLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGV 417 (508)
Q Consensus 338 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 417 (508)
.++ .......++|||.|||||++...+|+..+|||+.||+||-|+.|+.||.+.+. ..+.+.++ .+..
T Consensus 162 ~l~--~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~---~rlye~I~----~g~y--- 229 (355)
T KOG0033|consen 162 EVN--DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ---HRLYEQIK----AGAY--- 229 (355)
T ss_pred EeC--CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccH---HHHHHHHh----cccc---
Confidence 886 34445668899999999999999999999999999999999999999975332 12222221 1111
Q ss_pred CCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 418 LDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 418 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
.+.....+....+..+|+.+||..||.+|.|+.|.|++
T Consensus 230 ---d~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~H 267 (355)
T KOG0033|consen 230 ---DYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKH 267 (355)
T ss_pred ---CCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCC
Confidence 11111222233344457779999999999999998864
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=330.89 Aligned_cols=237 Identities=27% Similarity=0.317 Sum_probs=187.4
Q ss_pred ceEcccCcEEEEEEEEC-CCcEEEEEEeecCCc---hhHHHHHHHHH-HHHccCCCCeeeEeeeeecCCeeEEEEEecCC
Q 010513 192 NVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG---QAEKEFKVEVE-AIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDN 266 (508)
Q Consensus 192 ~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~-~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~ 266 (508)
+.||+|+||+||+|... +++.||+|.+..... .....+..|.. +++.++||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999975 688899999865321 22234444544 56789999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCCCcce
Q 010513 267 GNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYV 346 (508)
Q Consensus 267 g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~ 346 (508)
|+|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++..... ...
T Consensus 81 g~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~-~~~ 152 (323)
T cd05575 81 GELFFHLQRE----RSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH-SKT 152 (323)
T ss_pred CCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccC-CCc
Confidence 9999998764 4689999999999999999999999 9999999999999999999999999998753222 222
Q ss_pred ecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCCccCCCCc
Q 010513 347 TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKP 426 (508)
Q Consensus 347 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 426 (508)
....+||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+......... ..+...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~------~~~~~~~i~~~~-------~~~~~~- 218 (323)
T cd05575 153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRD------TAEMYDNILNKP-------LRLKPN- 218 (323)
T ss_pred cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCC------HHHHHHHHHcCC-------CCCCCC-
Confidence 344679999999999999999999999999999999999999996432 122222222110 011111
Q ss_pred hHHHHHHHHHHHHHccCCCCCCCCCHH
Q 010513 427 CSRALKRALLVALRCVDPNAHKRPKMG 453 (508)
Q Consensus 427 ~~~~~~~l~~li~~cl~~dP~~RPs~~ 453 (508)
.+ ..+.+++.+||+.||++||++.
T Consensus 219 ~~---~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 219 IS---VSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred CC---HHHHHHHHHHhhcCHHhCCCCC
Confidence 22 3345577899999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=328.29 Aligned_cols=255 Identities=22% Similarity=0.291 Sum_probs=196.9
Q ss_pred CCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecC---CchhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEE
Q 010513 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN---RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY 261 (508)
Q Consensus 186 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 261 (508)
++|++.++||+|+||+||+++.+ +++.+|+|.+.+. .......+..|+.++..++|+||+++++++.+....|+||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 47899999999999999999976 4677999988542 1223345788999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCC
Q 010513 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA 341 (508)
Q Consensus 262 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 341 (508)
||+++|+|.+++.+. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 ey~~~g~L~~~l~~~---~~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~ 154 (332)
T cd05623 81 DYYVGGDLLTLLSKF---EDRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLME 154 (332)
T ss_pred eccCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheeccc
Confidence 999999999999764 24689999999999999999999998 999999999999999999999999999976543
Q ss_pred CCcceecceecCCCCCChhhhh-----cCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhccccccc
Q 010513 342 ERSYVTTRVMGTFGYVAPEYAS-----TGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEG 416 (508)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 416 (508)
.........+||+.|+|||++. ...++.++|||||||++|||++|+.||.... ..+.............
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~------~~~~~~~i~~~~~~~~ 228 (332)
T cd05623 155 DGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAES------LVETYGKIMNHKERFQ 228 (332)
T ss_pred CCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCC------HHHHHHHHhCCCcccc
Confidence 3333334467999999999986 3468899999999999999999999996432 2222222222111000
Q ss_pred CCCccCCCCchHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHH
Q 010513 417 VLDPRLQEKPCSRALKRALLVALRCVDPNAHK--RPKMGHVIHM 458 (508)
Q Consensus 417 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~ 458 (508)
. +.. ....+.. +.+++.+|+..++++ |+++.+++++
T Consensus 229 -~-p~~-~~~~s~~---~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 229 -F-PAQ-VTDVSED---AKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred -C-CCc-cccCCHH---HHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 0 100 0112333 444666777554444 7899999877
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=329.51 Aligned_cols=240 Identities=21% Similarity=0.319 Sum_probs=190.1
Q ss_pred ceEcccCcEEEEEEEEC-CCcEEEEEEeecCC---chhHHHHHHHHHHHHcc-CCCCeeeEeeeeecCCeeEEEEEecCC
Q 010513 192 NVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYIDN 266 (508)
Q Consensus 192 ~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lV~e~~~~ 266 (508)
+.||+|+||.||+|+++ ++..||+|.+.... ......+..|..++... +||||+++++++.+.+..|+||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999976 57889999986542 22344566677777754 899999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCCCcce
Q 010513 267 GNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYV 346 (508)
Q Consensus 267 g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~ 346 (508)
|+|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++..... ...
T Consensus 81 g~L~~~i~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~ 152 (316)
T cd05620 81 GDLMFHIQDK----GRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG-DNR 152 (316)
T ss_pred CcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccC-CCc
Confidence 9999998764 4688999999999999999999999 9999999999999999999999999998743211 222
Q ss_pred ecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCCccCCCCc
Q 010513 347 TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKP 426 (508)
Q Consensus 347 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 426 (508)
....+||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+..... ... .+.+.. .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~------~~~~~~~-~~~------~~~~~~-~ 218 (316)
T cd05620 153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE------DELFESI-RVD------TPHYPR-W 218 (316)
T ss_pred eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH------HHHHHHH-HhC------CCCCCC-C
Confidence 3446799999999999999999999999999999999999999964421 1111111 111 111111 1
Q ss_pred hHHHHHHHHHHHHHccCCCCCCCCCHH-HHH
Q 010513 427 CSRALKRALLVALRCVDPNAHKRPKMG-HVI 456 (508)
Q Consensus 427 ~~~~~~~l~~li~~cl~~dP~~RPs~~-evl 456 (508)
.+. ++.+++.+||+.||++||++. +++
T Consensus 219 ~~~---~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 219 ITK---ESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred CCH---HHHHHHHHHccCCHHHcCCChHHHH
Confidence 223 344577799999999999984 565
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-40 Score=318.63 Aligned_cols=259 Identities=23% Similarity=0.357 Sum_probs=206.8
Q ss_pred CCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCC---chhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEE
Q 010513 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY 261 (508)
Q Consensus 186 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 261 (508)
++|++.+.||+|+||.||+|... ++..+|||.+.... .....++.+|+++++.++||||+++++++.+++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 46888999999999999999964 78899999875432 233457888999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCC
Q 010513 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA 341 (508)
Q Consensus 262 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 341 (508)
||+++++|.+++.........+++..++.++.|++.||.|||++ +++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 99999999999875433345789999999999999999999999 999999999999999999999999999886543
Q ss_pred CCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCCcc
Q 010513 342 ERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPR 421 (508)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 421 (508)
... ......|+..|+|||.+.+..++.++|+||||+++|+|++|..||...... ..+..+... ....+.
T Consensus 159 ~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~------~~~~~~ 227 (267)
T cd08229 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLCKKIE------QCDYPP 227 (267)
T ss_pred CCc-ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch----HHHHhhhhh------cCCCCC
Confidence 322 223356899999999998888999999999999999999999999643221 111111111 111111
Q ss_pred CCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 010513 422 LQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461 (508)
Q Consensus 422 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~ 461 (508)
......+. .+.+++.+||+.||++||++.+|++.++.
T Consensus 228 ~~~~~~~~---~~~~li~~~l~~~p~~Rpt~~~i~~~~~~ 264 (267)
T cd08229 228 LPSDHYSE---ELRQLVNMCINPDPEKRPDITYVYDVAKR 264 (267)
T ss_pred CCcccccH---HHHHHHHHhcCCCcccCCCHHHHHHHHhh
Confidence 22222333 44557789999999999999999998865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=324.81 Aligned_cols=259 Identities=26% Similarity=0.448 Sum_probs=202.6
Q ss_pred cCCCCcccceEcccCcEEEEEEEE-----CCCcEEEEEEeecCC-chhHHHHHHHHHHHHccCCCCeeeEeeeeecCCee
Q 010513 184 STNGFADENVIGEGGYGIVYHGVL-----EDNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHR 257 (508)
Q Consensus 184 ~~~~~~~~~~LG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 257 (508)
..++|++.+.||+|+||+||+|.. .++..+++|.+.... .+....+.+|+++++.++||||+++++++..+...
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 82 (283)
T cd05090 3 PLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPV 82 (283)
T ss_pred ChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCce
Confidence 345788999999999999999984 245679999986533 33446788999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhccCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcC
Q 010513 258 MLVYEYIDNGNLEQWLHGDVG-------------PHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDK 324 (508)
Q Consensus 258 ~lV~e~~~~g~L~~~l~~~~~-------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~ 324 (508)
|+||||+++|+|.+++..... ....+++.....++.|++.||+|||++ +++||||||+|||++.
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~ 159 (283)
T cd05090 83 CMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGE 159 (283)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcC
Confidence 999999999999999853311 123578899999999999999999999 9999999999999999
Q ss_pred CCCeEEeeeccceecCCCCc-ceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHh-CCCCCCCCCCCCcchHH
Q 010513 325 QWNPKLSDFGLAKLLGAERS-YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLV 402 (508)
Q Consensus 325 ~~~~kL~DFG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~ 402 (508)
++.+||+|||+++....... .......++..|+|||++.+..++.++|+|||||++|||++ |..||....+ ....
T Consensus 160 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~---~~~~ 236 (283)
T cd05090 160 QLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN---QEVI 236 (283)
T ss_pred CCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH---HHHH
Confidence 99999999999986533221 12233446778999999988889999999999999999998 9999964321 1111
Q ss_pred HHHHHhhcccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 010513 403 EWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461 (508)
Q Consensus 403 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~ 461 (508)
......... + .. ..++. ++.+++.+||+.||++||++.+++++|.+
T Consensus 237 ----~~~~~~~~~----~-~~-~~~~~---~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 237 ----EMVRKRQLL----P-CS-EDCPP---RMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred ----HHHHcCCcC----C-CC-CCCCH---HHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 111111110 0 11 11233 34457779999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=331.37 Aligned_cols=238 Identities=25% Similarity=0.315 Sum_probs=191.0
Q ss_pred ceEcccCcEEEEEEEE----CCCcEEEEEEeecCCc--hhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEEecC
Q 010513 192 NVIGEGGYGIVYHGVL----EDNTNVAVKNLLNNRG--QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYID 265 (508)
Q Consensus 192 ~~LG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~ 265 (508)
+.||+|+||.||+++. .+++.||+|.+..... .....+..|++++++++||||+++++++.++...|+||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999985 3578899999865432 233456779999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCCCcc
Q 010513 266 NGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSY 345 (508)
Q Consensus 266 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~ 345 (508)
+|+|.+++.+. ..+++..+..++.|+++||+|||++ +|+||||||+|||++.++.+||+|||++....... .
T Consensus 82 ~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-~ 153 (318)
T cd05582 82 GGDLFTRLSKE----VMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE-K 153 (318)
T ss_pred CCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC-C
Confidence 99999999664 4689999999999999999999999 99999999999999999999999999998653321 2
Q ss_pred eecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCCccCCCC
Q 010513 346 VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEK 425 (508)
Q Consensus 346 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 425 (508)
......||+.|+|||.+.+..++.++|||||||++|||++|+.||..... .+......... . .+..
T Consensus 154 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~------~~~~~~i~~~~-~------~~p~- 219 (318)
T cd05582 154 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDR------KETMTMILKAK-L------GMPQ- 219 (318)
T ss_pred ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCH------HHHHHHHHcCC-C------CCCC-
Confidence 23346799999999999988899999999999999999999999974321 12222221111 0 0111
Q ss_pred chHHHHHHHHHHHHHccCCCCCCCCCHHH
Q 010513 426 PCSRALKRALLVALRCVDPNAHKRPKMGH 454 (508)
Q Consensus 426 ~~~~~~~~l~~li~~cl~~dP~~RPs~~e 454 (508)
..+. .+.+++.+||+.||++||++.+
T Consensus 220 ~~~~---~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 220 FLSP---EAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCH---HHHHHHHHHhhcCHhHcCCCCC
Confidence 1222 3445778999999999999554
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-40 Score=328.58 Aligned_cols=242 Identities=24% Similarity=0.336 Sum_probs=193.8
Q ss_pred ceEcccCcEEEEEEEEC-CCcEEEEEEeecCC---chhHHHHHHHHHHHHcc-CCCCeeeEeeeeecCCeeEEEEEecCC
Q 010513 192 NVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYIDN 266 (508)
Q Consensus 192 ~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lV~e~~~~ 266 (508)
+.||+|+||+||+|.+. +++.||+|.+.+.. ......+..|.+++..+ +||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999976 47789999987542 23345667788888888 799999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCCCcce
Q 010513 267 GNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYV 346 (508)
Q Consensus 267 g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~ 346 (508)
|+|.+++... ..+++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||+++..... ...
T Consensus 81 ~~L~~~~~~~----~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~-~~~ 152 (318)
T cd05570 81 GDLMFHIQRS----GRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILG-GVT 152 (318)
T ss_pred CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcC-CCc
Confidence 9999998764 4689999999999999999999999 9999999999999999999999999998753222 222
Q ss_pred ecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCCccCCCCc
Q 010513 347 TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKP 426 (508)
Q Consensus 347 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 426 (508)
....+||+.|+|||++.+..++.++|+|||||++|+|++|+.||..... .+........ . ..+. ..
T Consensus 153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~------~~~~~~i~~~-~------~~~~-~~ 218 (318)
T cd05570 153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDE------DELFQSILED-E------VRYP-RW 218 (318)
T ss_pred ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCH------HHHHHHHHcC-C------CCCC-Cc
Confidence 3345799999999999999999999999999999999999999964321 1111111111 0 0111 11
Q ss_pred hHHHHHHHHHHHHHccCCCCCCCCCH-----HHHHHH
Q 010513 427 CSRALKRALLVALRCVDPNAHKRPKM-----GHVIHM 458 (508)
Q Consensus 427 ~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~~ 458 (508)
.+ ..+.+++.+||+.||++||++ .+++++
T Consensus 219 ~~---~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 219 LS---KEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred CC---HHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 22 344558889999999999999 887754
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-40 Score=329.75 Aligned_cols=241 Identities=26% Similarity=0.294 Sum_probs=187.5
Q ss_pred ceEcccCcEEEEEEEEC-CCcEEEEEEeecCCc---hhHHHHHHHH-HHHHccCCCCeeeEeeeeecCCeeEEEEEecCC
Q 010513 192 NVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG---QAEKEFKVEV-EAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDN 266 (508)
Q Consensus 192 ~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~-~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~ 266 (508)
+.||+|+||+||+|++. +++.||+|.+..... .....+..|. .+++.++||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999976 567899999865321 2223333343 456788999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCCCcce
Q 010513 267 GNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYV 346 (508)
Q Consensus 267 g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~ 346 (508)
|+|.+++... ..+.+..+..++.|+++||+|||++ +|+||||||+|||++.++.+||+|||+++..... ...
T Consensus 81 ~~L~~~~~~~----~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~-~~~ 152 (325)
T cd05602 81 GELFYHLQRE----RCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH-NGT 152 (325)
T ss_pred CcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccC-CCC
Confidence 9999999764 4678889999999999999999999 9999999999999999999999999999754222 222
Q ss_pred ecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCCccCCCCc
Q 010513 347 TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKP 426 (508)
Q Consensus 347 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 426 (508)
....+||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+......... ....+ .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~~~i~~~~---~~~~~-----~ 218 (325)
T cd05602 153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT------AEMYDNILNKP---LQLKP-----N 218 (325)
T ss_pred cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCH------HHHHHHHHhCC---cCCCC-----C
Confidence 3446799999999999999999999999999999999999999964322 12222221110 00111 1
Q ss_pred hHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 010513 427 CSRALKRALLVALRCVDPNAHKRPKMGHVIH 457 (508)
Q Consensus 427 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 457 (508)
.+. .+.+++.+||+.||.+||++.+.+.
T Consensus 219 ~~~---~~~~li~~~l~~~p~~R~~~~~~~~ 246 (325)
T cd05602 219 ITN---SARHLLEGLLQKDRTKRLGAKDDFM 246 (325)
T ss_pred CCH---HHHHHHHHHcccCHHHCCCCCCCHH
Confidence 223 3444777999999999999875443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=346.54 Aligned_cols=263 Identities=22% Similarity=0.302 Sum_probs=194.3
Q ss_pred hcCCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCchhHHHHHHHHHHHHccCCCCeeeEeeeeecC-------
Q 010513 183 VSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEG------- 254 (508)
Q Consensus 183 ~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~------- 254 (508)
....+|++.+.||+|+||.||+|... ++..||||++.... ....+|+.+++.++||||+++++++...
T Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~ 138 (440)
T PTZ00036 63 SPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEK 138 (440)
T ss_pred CcCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCC
Confidence 34568999999999999999999975 57889999886543 2234699999999999999999886432
Q ss_pred -CeeEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCC-CeEEee
Q 010513 255 -AHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQW-NPKLSD 332 (508)
Q Consensus 255 -~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~-~~kL~D 332 (508)
..+++||||+++ +|.+++.........+++..++.++.|++.||+|||++ +|+||||||+|||++.++ .+||+|
T Consensus 139 ~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~D 214 (440)
T PTZ00036 139 NIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCD 214 (440)
T ss_pred ceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeec
Confidence 246689999986 78887764333346799999999999999999999999 999999999999998665 699999
Q ss_pred eccceecCCCCcceecceecCCCCCChhhhhc-CCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcc
Q 010513 333 FGLAKLLGAERSYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTN 411 (508)
Q Consensus 333 FG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~ 411 (508)
||+++.+..... .....||+.|+|||++.+ ..|+.++|||||||++|||++|+.||....... .+....+ ....
T Consensus 215 FGla~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~--~~~~i~~-~~~~ 289 (440)
T PTZ00036 215 FGSAKNLLAGQR--SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVD--QLVRIIQ-VLGT 289 (440)
T ss_pred cccchhccCCCC--cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHH-HhCC
Confidence 999986543222 223578999999998865 468999999999999999999999997543221 1111111 0000
Q ss_pred ----------cccccCCCccCCCC-----chHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 412 ----------RNAEGVLDPRLQEK-----PCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 412 ----------~~~~~~~~~~l~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
.......-+..... .......++.+++.+||+.||.+||++.|++++
T Consensus 290 p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 290 PTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred CCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 00000000111100 001122456778889999999999999998854
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=329.38 Aligned_cols=241 Identities=24% Similarity=0.343 Sum_probs=190.3
Q ss_pred ceEcccCcEEEEEEEEC-CCcEEEEEEeecCC---chhHHHHHHHHHHHHcc-CCCCeeeEeeeeecCCeeEEEEEecCC
Q 010513 192 NVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYIDN 266 (508)
Q Consensus 192 ~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lV~e~~~~ 266 (508)
+.||+|+||+||+|.+. +++.||+|.+.... ......+..|..++... +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999976 47789999986542 22334556677777764 899999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCCCcce
Q 010513 267 GNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYV 346 (508)
Q Consensus 267 g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~ 346 (508)
|+|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++...... ...
T Consensus 81 g~L~~~l~~~----~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~ 152 (316)
T cd05619 81 GDLMFHIQSC----HKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLG-DAK 152 (316)
T ss_pred CcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCC-CCc
Confidence 9999999754 4688999999999999999999999 9999999999999999999999999998753222 122
Q ss_pred ecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCCccCCCCc
Q 010513 347 TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKP 426 (508)
Q Consensus 347 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 426 (508)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+........ .+.+.. .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~------~~~~~~i~~~-------~~~~~~-~ 218 (316)
T cd05619 153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE------EELFQSIRMD-------NPCYPR-W 218 (316)
T ss_pred eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhC-------CCCCCc-c
Confidence 3346799999999999999999999999999999999999999974321 1111111111 111111 1
Q ss_pred hHHHHHHHHHHHHHccCCCCCCCCCHH-HHHH
Q 010513 427 CSRALKRALLVALRCVDPNAHKRPKMG-HVIH 457 (508)
Q Consensus 427 ~~~~~~~l~~li~~cl~~dP~~RPs~~-evl~ 457 (508)
.+. ++.+++.+||+.||++||++. ++++
T Consensus 219 ~~~---~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 219 LTR---EAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred CCH---HHHHHHHHHhccCHhhcCCChHHHHc
Confidence 222 344577899999999999997 6654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=319.96 Aligned_cols=261 Identities=25% Similarity=0.451 Sum_probs=206.2
Q ss_pred hhcCCCCcccceEcccCcEEEEEEEECC------CcEEEEEEeecCC-chhHHHHHHHHHHHHccCCCCeeeEeeeeecC
Q 010513 182 EVSTNGFADENVIGEGGYGIVYHGVLED------NTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEG 254 (508)
Q Consensus 182 ~~~~~~~~~~~~LG~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~ 254 (508)
++..++|++.+.||+|+||.||+|.... +..||+|.+.... ......+.+|+.+++.++||||+++++++...
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 81 (277)
T cd05032 2 ELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTG 81 (277)
T ss_pred ccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCC
Confidence 4566789999999999999999998642 3679999886443 23445788899999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHhccCCC------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCe
Q 010513 255 AHRMLVYEYIDNGNLEQWLHGDVG------PHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNP 328 (508)
Q Consensus 255 ~~~~lV~e~~~~g~L~~~l~~~~~------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~ 328 (508)
...++||||+++|+|.+++..... ....+++..++.++.|++.||.|||+. +++||||||+||+++.++.+
T Consensus 82 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~ 158 (277)
T cd05032 82 QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTV 158 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCE
Confidence 999999999999999999965432 123578899999999999999999998 99999999999999999999
Q ss_pred EEeeeccceecCCCCcc-eecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHh-CCCCCCCCCCCCcchHHHHHH
Q 010513 329 KLSDFGLAKLLGAERSY-VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLK 406 (508)
Q Consensus 329 kL~DFG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~ 406 (508)
||+|||+++........ ......++..|+|||.+.++.++.++|||||||++|||++ |..||..... .+..+
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~------~~~~~ 232 (277)
T cd05032 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN------EEVLK 232 (277)
T ss_pred EECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCH------HHHHH
Confidence 99999999865433221 1233456789999999988889999999999999999998 9999964322 11111
Q ss_pred HhhcccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 010513 407 TMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461 (508)
Q Consensus 407 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~ 461 (508)
... .... +... ..++ .++.+++.+||+.+|++||++.++++.|++
T Consensus 233 ~~~-~~~~-----~~~~-~~~~---~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 233 FVI-DGGH-----LDLP-ENCP---DKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred HHh-cCCC-----CCCC-CCCC---HHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 111 1110 1111 1123 345568889999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=321.39 Aligned_cols=266 Identities=24% Similarity=0.423 Sum_probs=202.7
Q ss_pred cCCCCcccceEcccCcEEEEEEEEC-----------------CCcEEEEEEeecCC-chhHHHHHHHHHHHHccCCCCee
Q 010513 184 STNGFADENVIGEGGYGIVYHGVLE-----------------DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLV 245 (508)
Q Consensus 184 ~~~~~~~~~~LG~G~~g~Vy~~~~~-----------------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv 245 (508)
+.++|++.+.||+|+||.||++.+. +...+|+|.+.... ......+.+|+++++.++|+||+
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 82 (296)
T cd05095 3 PRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNII 82 (296)
T ss_pred ChhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcc
Confidence 4568999999999999999998643 23358999886543 33456788999999999999999
Q ss_pred eEeeeeecCCeeEEEEEecCCCCHHHHhccCCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCC
Q 010513 246 RLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGP-------HSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSS 318 (508)
Q Consensus 246 ~l~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~-------~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~ 318 (508)
++++++.++...++||||+++|+|.+++...... ...+++..++.++.|++.||+|||+. +++||||||+
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~ 159 (296)
T cd05095 83 RLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATR 159 (296)
T ss_pred eEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChh
Confidence 9999999999999999999999999998764211 23477889999999999999999999 9999999999
Q ss_pred CEEEcCCCCeEEeeeccceecCCCCcce-ecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHh--CCCCCCCCCC
Q 010513 319 NILLDKQWNPKLSDFGLAKLLGAERSYV-TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS--GRNPVDYSRP 395 (508)
Q Consensus 319 NIll~~~~~~kL~DFG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt--g~~Pf~~~~~ 395 (508)
|||++.++.++|+|||++..+....... .....+++.|+|||...++.++.++|+|||||++|||++ |..||.....
T Consensus 160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~ 239 (296)
T cd05095 160 NCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSD 239 (296)
T ss_pred eEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccCh
Confidence 9999999999999999998653332211 222344678999999888899999999999999999998 7788864332
Q ss_pred CCcchHHHHHHHhhcccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 010513 396 PGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461 (508)
Q Consensus 396 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~ 461 (508)
.. ............. .....+. ...++ ..+.+++.+||+.||++||++.+|++.|+.
T Consensus 240 ~~---~~~~~~~~~~~~~-~~~~~~~--~~~~~---~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 240 EQ---VIENTGEFFRDQG-RQVYLPK--PALCP---DSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred HH---HHHHHHHHHhhcc-ccccCCC--CCCCC---HHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 11 1111111111110 0111111 11133 345558889999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=336.78 Aligned_cols=252 Identities=24% Similarity=0.339 Sum_probs=196.1
Q ss_pred CCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCC---chhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEE
Q 010513 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY 261 (508)
Q Consensus 186 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 261 (508)
++|++.+.||+|+||+||+|..+ +++.||+|.+.... ......+..|++++..++||||+++++++.+.+..|+||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46889999999999999999975 58889999986432 233456788999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCC
Q 010513 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA 341 (508)
Q Consensus 262 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 341 (508)
||+++|+|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 E~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~ 153 (360)
T cd05627 81 EFLPGGDMMTLLMKK----DTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKK 153 (360)
T ss_pred eCCCCccHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCccccc
Confidence 999999999999764 4689999999999999999999999 999999999999999999999999999875422
Q ss_pred CCc----------------------------------ceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCC
Q 010513 342 ERS----------------------------------YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGR 387 (508)
Q Consensus 342 ~~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~ 387 (508)
... ......+||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~ 233 (360)
T cd05627 154 AHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (360)
T ss_pred ccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCC
Confidence 110 0012357999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCcchHHHHHHHhhcccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCC---HHHHHHH
Q 010513 388 NPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPK---MGHVIHM 458 (508)
Q Consensus 388 ~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~evl~~ 458 (508)
.||....+. ........... .....+. ...+...+ +++.+|+ .||++|++ +.+++++
T Consensus 234 ~Pf~~~~~~------~~~~~i~~~~~-~~~~p~~---~~~s~~~~---~li~~l~-~~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 234 PPFCSETPQ------ETYRKVMNWKE-TLVFPPE---VPISEKAK---DLILRFC-TDSENRIGSNGVEEIKSH 293 (360)
T ss_pred CCCCCCCHH------HHHHHHHcCCC-ceecCCC---CCCCHHHH---HHHHHhc-cChhhcCCCCCHHHHhcC
Confidence 999754321 11222211110 0001111 11233333 4666766 49999985 5666654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=330.37 Aligned_cols=241 Identities=27% Similarity=0.324 Sum_probs=189.0
Q ss_pred ceEcccCcEEEEEEEEC-CCcEEEEEEeecCC---chhHHHHHHHHH-HHHccCCCCeeeEeeeeecCCeeEEEEEecCC
Q 010513 192 NVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVE-AIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDN 266 (508)
Q Consensus 192 ~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~ 266 (508)
+.||+|+||+||+|... +++.||+|.+.+.. ......+..|.. +++.++||||+++++++..++..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999965 68899999986542 222344455554 56778999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCCCcce
Q 010513 267 GNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYV 346 (508)
Q Consensus 267 g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~ 346 (508)
|+|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++..... ...
T Consensus 81 ~~L~~~l~~~----~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~-~~~ 152 (325)
T cd05604 81 GELFFHLQRE----RSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ-SDT 152 (325)
T ss_pred CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCC-CCC
Confidence 9999988654 5789999999999999999999999 9999999999999999999999999998753222 222
Q ss_pred ecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCCccCCCCc
Q 010513 347 TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKP 426 (508)
Q Consensus 347 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 426 (508)
....+||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+......... ..+.+ .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~------~~~~~~~~~~~---~~~~~----~- 218 (325)
T cd05604 153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDV------AEMYDNILHKP---LVLRP----G- 218 (325)
T ss_pred cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCH------HHHHHHHHcCC---ccCCC----C-
Confidence 3446799999999999999999999999999999999999999974421 12222222110 11111 1
Q ss_pred hHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 010513 427 CSRALKRALLVALRCVDPNAHKRPKMGHVIH 457 (508)
Q Consensus 427 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 457 (508)
.+ ..+.+++.+|++.||++||++.+.++
T Consensus 219 ~~---~~~~~ll~~ll~~~p~~R~~~~~~~~ 246 (325)
T cd05604 219 AS---LTAWSILEELLEKDRQRRLGAKEDFL 246 (325)
T ss_pred CC---HHHHHHHHHHhccCHHhcCCCCCCHH
Confidence 22 33445788999999999998864333
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=322.70 Aligned_cols=265 Identities=25% Similarity=0.426 Sum_probs=201.4
Q ss_pred cCCCCcccceEcccCcEEEEEEEECC---------------CcEEEEEEeecCC-chhHHHHHHHHHHHHccCCCCeeeE
Q 010513 184 STNGFADENVIGEGGYGIVYHGVLED---------------NTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRL 247 (508)
Q Consensus 184 ~~~~~~~~~~LG~G~~g~Vy~~~~~~---------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l 247 (508)
+.++|++.+.||+|+||.||+|+..+ ...||+|.+.... ......+.+|++++++++|+|++++
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~ 82 (295)
T cd05097 3 PRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRL 82 (295)
T ss_pred chHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeE
Confidence 45689999999999999999998642 1248999886543 3344578899999999999999999
Q ss_pred eeeeecCCeeEEEEEecCCCCHHHHhccCCC--------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCC
Q 010513 248 LGYCAEGAHRMLVYEYIDNGNLEQWLHGDVG--------PHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSN 319 (508)
Q Consensus 248 ~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~--------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~N 319 (508)
++++...+..++||||+++++|.+++..... ....+++..++.++.|++.||+|||++ +++||||||+|
T Consensus 83 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~N 159 (295)
T cd05097 83 LGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRN 159 (295)
T ss_pred EEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhh
Confidence 9999999999999999999999999864311 112468889999999999999999999 99999999999
Q ss_pred EEEcCCCCeEEeeeccceecCCCCcce-ecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHh--CCCCCCCCCCC
Q 010513 320 ILLDKQWNPKLSDFGLAKLLGAERSYV-TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS--GRNPVDYSRPP 396 (508)
Q Consensus 320 Ill~~~~~~kL~DFG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt--g~~Pf~~~~~~ 396 (508)
|++++++.+||+|||++.......... .....++..|+|||.+.++.++.++|+|||||++|+|++ |..||.....
T Consensus 160 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~- 238 (295)
T cd05097 160 CLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD- 238 (295)
T ss_pred EEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh-
Confidence 999999999999999998653322211 222345678999999988899999999999999999998 6677764332
Q ss_pred CcchHHHHHHHhhcccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 010513 397 GEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 460 (508)
Q Consensus 397 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le 460 (508)
................ ..... .....+ ..+.+++.+||+.||++||++.+|++.|+
T Consensus 239 --~~~~~~~~~~~~~~~~-~~~~~--~~~~~~---~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 239 --EQVIENTGEFFRNQGR-QIYLS--QTPLCP---SPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred --HHHHHHHHHhhhhccc-cccCC--CCCCCC---HHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 1122211111111100 00000 011122 34556888999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=323.11 Aligned_cols=256 Identities=26% Similarity=0.452 Sum_probs=200.0
Q ss_pred CCCCcccceEcccCcEEEEEEEEC-CCc----EEEEEEeecCCc-hhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeE
Q 010513 185 TNGFADENVIGEGGYGIVYHGVLE-DNT----NVAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM 258 (508)
Q Consensus 185 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 258 (508)
.++|++.+.||+|+||+||+|.+. ++. .+++|.+..... ....++..|+..++++.||||+++++++.. ...+
T Consensus 6 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~ 84 (279)
T cd05111 6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQ 84 (279)
T ss_pred HhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccE
Confidence 357888999999999999999974 344 367777654332 234567788889999999999999998864 5578
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeecccee
Q 010513 259 LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL 338 (508)
Q Consensus 259 lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~ 338 (508)
+++||+++|+|.+++... ...+++..++.++.|++.||+|||++ +++||||||+||+++.++.+||+|||+++.
T Consensus 85 ~i~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~ 158 (279)
T cd05111 85 LVTQLSPLGSLLDHVRQH---RDSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADL 158 (279)
T ss_pred EEEEeCCCCcHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCcccee
Confidence 999999999999999765 35689999999999999999999998 999999999999999999999999999986
Q ss_pred cCCCCc-ceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHhhccccccc
Q 010513 339 LGAERS-YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEG 416 (508)
Q Consensus 339 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 416 (508)
...... .......++..|+|||.+.++.++.++|||||||++|||++ |+.||....+. ...+. ...+. .
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~---~~~~~----~~~~~--~ 229 (279)
T cd05111 159 LYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH---EVPDL----LEKGE--R 229 (279)
T ss_pred ccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHH----HHCCC--c
Confidence 643222 22233457778999999998999999999999999999998 99999754321 11111 11111 1
Q ss_pred CCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 010513 417 VLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEE 463 (508)
Q Consensus 417 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~~~ 463 (508)
...+ ..++. .+.+++.+||+.||++||++.|+++.|+...
T Consensus 230 ~~~~----~~~~~---~~~~li~~c~~~~p~~Rps~~el~~~l~~~~ 269 (279)
T cd05111 230 LAQP----QICTI---DVYMVMVKCWMIDENVRPTFKELANEFTRMA 269 (279)
T ss_pred CCCC----CCCCH---HHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 1111 11222 3455788999999999999999999998744
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=321.47 Aligned_cols=249 Identities=31% Similarity=0.572 Sum_probs=192.6
Q ss_pred ccceEcccCcEEEEEEEEC-----CCcEEEEEEeecCCc-hhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEEe
Q 010513 190 DENVIGEGGYGIVYHGVLE-----DNTNVAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY 263 (508)
Q Consensus 190 ~~~~LG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~ 263 (508)
+.+.||.|.||.||+|.+. .+..|+||.+..... ...+.+.+|++.+++++||||++++|++.+.+..++||||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 4678999999999999976 256799999955433 3468899999999999999999999999988889999999
Q ss_pred cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCCC
Q 010513 264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER 343 (508)
Q Consensus 264 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 343 (508)
+++|+|.++|.... ...+++..++.++.|+++||.|||++ +++|+||+++||+++.++.+||+|||++.......
T Consensus 83 ~~~g~L~~~L~~~~--~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~ 157 (259)
T PF07714_consen 83 CPGGSLDDYLKSKN--KEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS 157 (259)
T ss_dssp -TTEBHHHHHHHTC--TTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSS
T ss_pred cccccccccccccc--cccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence 99999999998762 35789999999999999999999999 99999999999999999999999999998763222
Q ss_pred c-ceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHhhcccccccCCCcc
Q 010513 344 S-YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPR 421 (508)
Q Consensus 344 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 421 (508)
. .......+...|+|||.+....++.++||||||+++|||++ |+.||... +..+.......... ..
T Consensus 158 ~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~------~~~~~~~~~~~~~~------~~ 225 (259)
T PF07714_consen 158 KYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY------DNEEIIEKLKQGQR------LP 225 (259)
T ss_dssp SEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS------CHHHHHHHHHTTEE------TT
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccc------cccccccccccccc------ce
Confidence 2 22233456778999999999999999999999999999999 78998643 22222222211111 00
Q ss_pred CCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 010513 422 LQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHML 459 (508)
Q Consensus 422 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 459 (508)
....++..+. +++.+||+.||++||++.++++.|
T Consensus 226 -~~~~~~~~~~---~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 226 -IPDNCPKDIY---SLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp -SBTTSBHHHH---HHHHHHT-SSGGGS--HHHHHHHH
T ss_pred -eccchhHHHH---HHHHHHcCCChhhCcCHHHHHhcC
Confidence 1112344444 477899999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=317.25 Aligned_cols=251 Identities=26% Similarity=0.386 Sum_probs=200.7
Q ss_pred CCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCc-----hhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEE
Q 010513 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG-----QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRML 259 (508)
Q Consensus 186 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 259 (508)
+.|.+.+.||+|++|.||+|... ++..+|+|.+..... ...+.+.+|++++++++||||+++++++.++...++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 46888999999999999999964 588999998854321 123568889999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceec
Q 010513 260 VYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL 339 (508)
Q Consensus 260 V~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~ 339 (508)
||||+++++|.+++... ..+++..+..++.|++.||.|||+. +++||||||+||++++++.++|+|||+++..
T Consensus 82 v~e~~~~~~l~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~ 154 (263)
T cd06625 82 FMEYMPGGSVKDQLKAY----GALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRL 154 (263)
T ss_pred EEEECCCCcHHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceec
Confidence 99999999999998764 4688999999999999999999999 9999999999999999999999999999865
Q ss_pred CCCCccee--cceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccC
Q 010513 340 GAERSYVT--TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGV 417 (508)
Q Consensus 340 ~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 417 (508)
........ ....|+..|+|||.+.+..++.++||||||+++|||++|+.||..... ...........
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~------~~~~~~~~~~~----- 223 (263)
T cd06625 155 QTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEA------MAAIFKIATQP----- 223 (263)
T ss_pred cccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccch------HHHHHHHhccC-----
Confidence 43222111 234678899999999998899999999999999999999999964321 11111111111
Q ss_pred CCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 418 LDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 418 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
..+.+.. ..+. .+.+++.+||+.+|++||++.+++++
T Consensus 224 ~~~~~~~-~~~~---~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 224 TNPQLPS-HVSP---DARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred CCCCCCc-cCCH---HHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 0111111 1233 34457779999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=317.98 Aligned_cols=247 Identities=27% Similarity=0.433 Sum_probs=194.6
Q ss_pred ceEcccCcEEEEEEEEC-CCcEEEEEEeecCC-chhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEEecCCCCH
Q 010513 192 NVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNL 269 (508)
Q Consensus 192 ~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~g~L 269 (508)
+.||+|+||.||+|.+. +++.+|+|.+.... .+....+.+|+++++.++||||+++++++......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 36899999999999965 68889999876543 34456788999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCCCccee-c
Q 010513 270 EQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVT-T 348 (508)
Q Consensus 270 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~-~ 348 (508)
.+++... ...+++..++.++.|++.||+|||++ +++||||||+||+++.++.+||+|||++........... .
T Consensus 81 ~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 154 (252)
T cd05084 81 LTFLRTE---GPRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGG 154 (252)
T ss_pred HHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccCC
Confidence 9999754 24688999999999999999999999 999999999999999999999999999876432211111 1
Q ss_pred ceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHhhcccccccCCCccCCCCch
Q 010513 349 RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPC 427 (508)
Q Consensus 349 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 427 (508)
...++..|+|||.+.++.++.++|+|||||++|||++ |..||...... . ........ ..... ....
T Consensus 155 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~------~-~~~~~~~~-----~~~~~-~~~~ 221 (252)
T cd05084 155 MKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ------Q-TREAIEQG-----VRLPC-PELC 221 (252)
T ss_pred CCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH------H-HHHHHHcC-----CCCCC-cccC
Confidence 1123456999999999899999999999999999998 88998643211 1 11111111 00011 1112
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 010513 428 SRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 460 (508)
Q Consensus 428 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le 460 (508)
+. .+.+++.+||+.||++||++.+++++|+
T Consensus 222 ~~---~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 222 PD---AVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred CH---HHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 33 4555888999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=331.85 Aligned_cols=262 Identities=19% Similarity=0.247 Sum_probs=199.2
Q ss_pred cCCCCcccceEcccCcEEEEEEEEC---CCcEEEEEEeecCCchhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEE
Q 010513 184 STNGFADENVIGEGGYGIVYHGVLE---DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLV 260 (508)
Q Consensus 184 ~~~~~~~~~~LG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 260 (508)
...+|.+.+.||+|+||.||+|... .+..||+|.+... ....+|+++++.++||||+++++++......++|
T Consensus 90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv 164 (392)
T PHA03207 90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMV 164 (392)
T ss_pred ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEE
Confidence 4458999999999999999999854 3567899987543 2345799999999999999999999999999999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecC
Q 010513 261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG 340 (508)
Q Consensus 261 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 340 (508)
||++. ++|.+++... ..+++..++.++.|++.||.|||++ +|+||||||+|||++.++.++|+|||+++...
T Consensus 165 ~e~~~-~~l~~~l~~~----~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~~ 236 (392)
T PHA03207 165 MPKYK-CDLFTYVDRS----GPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLD 236 (392)
T ss_pred ehhcC-CCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccccccC
Confidence 99996 5899988433 5789999999999999999999999 99999999999999999999999999998664
Q ss_pred CCCcc-eecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccc------
Q 010513 341 AERSY-VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRN------ 413 (508)
Q Consensus 341 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~------ 413 (508)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..............+........
T Consensus 237 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~ 316 (392)
T PHA03207 237 AHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQN 316 (392)
T ss_pred cccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCc
Confidence 43222 22345799999999999999999999999999999999999999976544322111111111110000
Q ss_pred -----------cccCCCccCCCCc-h--HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 414 -----------AEGVLDPRLQEKP-C--SRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 414 -----------~~~~~~~~l~~~~-~--~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
......+...... . .....++.+++.+||..||++||++.+++.+
T Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 317 GSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred cchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0000000000000 0 0012345567889999999999999999977
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=311.25 Aligned_cols=250 Identities=26% Similarity=0.431 Sum_probs=203.2
Q ss_pred CCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecC--CchhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEEe
Q 010513 187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY 263 (508)
Q Consensus 187 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~ 263 (508)
+|++.+.||+|+||.||+|..+ +++.|++|.+... .....+.+..|+++++.++||||+++++++.+.+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4778899999999999999975 5888999988543 334456788899999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCCC
Q 010513 264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER 343 (508)
Q Consensus 264 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 343 (508)
+++++|.+++.... ...+++..++.++.|++.||.|||+. +++||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~--~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~ 155 (256)
T cd08529 81 AENGDLHKLLKMQR--GRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT 155 (256)
T ss_pred CCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCcc
Confidence 99999999997642 35789999999999999999999998 99999999999999999999999999998764432
Q ss_pred cceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCCccCC
Q 010513 344 SYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQ 423 (508)
Q Consensus 344 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 423 (508)
. ......|++.|+|||+..+..++.++|+|||||++|+|++|+.||..... .+....... . ... .+.
T Consensus 156 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~-~----~~~-~~~ 222 (256)
T cd08529 156 N-FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ------GALILKIIR-G----VFP-PVS 222 (256)
T ss_pred c-hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHc-C----CCC-CCc
Confidence 2 22345688999999999999999999999999999999999999964431 111111111 1 111 111
Q ss_pred CCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 424 EKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 424 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
. .....+.+++.+||+.+|++||++.+++++
T Consensus 223 ~----~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 223 Q----MYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred c----ccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 1 222345558889999999999999999865
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=318.67 Aligned_cols=266 Identities=25% Similarity=0.419 Sum_probs=205.4
Q ss_pred cCCCCcccceEcccCcEEEEEEEECC-----------------CcEEEEEEeecCC-chhHHHHHHHHHHHHccCCCCee
Q 010513 184 STNGFADENVIGEGGYGIVYHGVLED-----------------NTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLV 245 (508)
Q Consensus 184 ~~~~~~~~~~LG~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv 245 (508)
...+|++.+.||+|+||.||+|...+ +..||+|.+.... ....+.+.+|+++++.++||||+
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~ 82 (296)
T cd05051 3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIA 82 (296)
T ss_pred chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEe
Confidence 45689999999999999999998542 2357899886553 33456788999999999999999
Q ss_pred eEeeeeecCCeeEEEEEecCCCCHHHHhccCCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCC
Q 010513 246 RLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVG-------PHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSS 318 (508)
Q Consensus 246 ~l~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~-------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~ 318 (508)
++++++..+...+++|||+++++|.+++..... ....+++..++.++.|++.||+|||++ +++||||||+
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~ 159 (296)
T cd05051 83 RLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATR 159 (296)
T ss_pred EEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchh
Confidence 999999999999999999999999999976531 123689999999999999999999998 9999999999
Q ss_pred CEEEcCCCCeEEeeeccceecCCCCcc-eecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHh--CCCCCCCCCC
Q 010513 319 NILLDKQWNPKLSDFGLAKLLGAERSY-VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS--GRNPVDYSRP 395 (508)
Q Consensus 319 NIll~~~~~~kL~DFG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt--g~~Pf~~~~~ 395 (508)
||+++.++.++|+|||+++........ ......+++.|+|||.+.+..++.++|||||||++|||++ |..||.....
T Consensus 160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~ 239 (296)
T cd05051 160 NCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD 239 (296)
T ss_pred ceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh
Confidence 999999999999999999865433222 2233456788999999988899999999999999999998 6778754321
Q ss_pred CCcchHHHHHHHhhcccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 010513 396 PGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461 (508)
Q Consensus 396 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~ 461 (508)
..................... .......++.+++.+||+.||++||++.++++.|+.
T Consensus 240 ---~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 240 ---QQVIENAGHFFRDDGRQIYLP------RPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred ---HHHHHHHHhccccccccccCC------CccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 122222222111111000000 011122456668889999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-40 Score=328.08 Aligned_cols=265 Identities=23% Similarity=0.356 Sum_probs=198.9
Q ss_pred CCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCc-hhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEEe
Q 010513 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY 263 (508)
Q Consensus 186 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~ 263 (508)
++|.+.+.||+|+||+||+|+.+ +++.||+|.+..... .....+.+|+++++.++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 57899999999999999999975 577899998864432 2334677899999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCCC
Q 010513 264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER 343 (508)
Q Consensus 264 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 343 (508)
+++ +|.+++... ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++.......
T Consensus 86 ~~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 158 (309)
T cd07872 86 LDK-DLKQYMDDC---GNIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPT 158 (309)
T ss_pred CCC-CHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCCc
Confidence 986 898888654 34588999999999999999999998 99999999999999999999999999998653322
Q ss_pred cceecceecCCCCCChhhhhc-CCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHH---------Hhhcccc
Q 010513 344 SYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLK---------TMVTNRN 413 (508)
Q Consensus 344 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~---------~~~~~~~ 413 (508)
. ......+|+.|+|||.+.+ ..++.++|||||||++|||+||+.||................ .......
T Consensus 159 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (309)
T cd07872 159 K-TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDE 237 (309)
T ss_pred c-ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhh
Confidence 2 2233468999999998865 468899999999999999999999997554322111111000 0000000
Q ss_pred cccCCCccCCCCc----hHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 414 AEGVLDPRLQEKP----CSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 414 ~~~~~~~~l~~~~----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
....-.+...... .+....++.+++.+||+.||++|||+.|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 286 (309)
T cd07872 238 FKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH 286 (309)
T ss_pred hhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence 0000001110000 01122345568889999999999999999874
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-40 Score=325.33 Aligned_cols=259 Identities=24% Similarity=0.416 Sum_probs=200.1
Q ss_pred hcCCCCcccceEcccCcEEEEEEEEC-CCc--EEEEEEeecCC-chhHHHHHHHHHHHHcc-CCCCeeeEeeeeecCCee
Q 010513 183 VSTNGFADENVIGEGGYGIVYHGVLE-DNT--NVAVKNLLNNR-GQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEGAHR 257 (508)
Q Consensus 183 ~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~ 257 (508)
+..++|++.+.||+|+||.||+|.++ ++. .+++|.+.... ......+.+|++++.++ +||||+++++++.+++..
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~ 83 (303)
T cd05088 4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL 83 (303)
T ss_pred cchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCc
Confidence 34568899999999999999999965 344 35777765432 33456788899999999 899999999999999999
Q ss_pred EEEEEecCCCCHHHHhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCC
Q 010513 258 MLVYEYIDNGNLEQWLHGDVG------------PHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQ 325 (508)
Q Consensus 258 ~lV~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~ 325 (508)
|+||||+++|+|.++++.... ....+++..++.++.|++.||+|||++ +++||||||+|||++.+
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~ 160 (303)
T cd05088 84 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGEN 160 (303)
T ss_pred eEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCC
Confidence 999999999999999975421 123688999999999999999999998 99999999999999999
Q ss_pred CCeEEeeeccceecCCCCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHh-CCCCCCCCCCCCcchHHHH
Q 010513 326 WNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEW 404 (508)
Q Consensus 326 ~~~kL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~ 404 (508)
+.+||+|||++..... ........++..|+|||.+.+..++.++|||||||++|||+| |..||...... +.
T Consensus 161 ~~~kl~dfg~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~------~~ 232 (303)
T cd05088 161 YVAKIADFGLSRGQEV--YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA------EL 232 (303)
T ss_pred CcEEeCccccCcccch--hhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH------HH
Confidence 9999999999864211 111111234567999999988889999999999999999998 99999643321 11
Q ss_pred HHHhhcccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010513 405 LKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (508)
Q Consensus 405 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~~ 462 (508)
...... . ....... ..+ ..+.+++.+||+.+|++||++.+++++|+..
T Consensus 233 ~~~~~~-~-----~~~~~~~-~~~---~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~ 280 (303)
T cd05088 233 YEKLPQ-G-----YRLEKPL-NCD---DEVYDLMRQCWREKPYERPSFAQILVSLNRM 280 (303)
T ss_pred HHHHhc-C-----CcCCCCC-CCC---HHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 111111 1 0000111 122 2345588899999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=319.24 Aligned_cols=249 Identities=24% Similarity=0.301 Sum_probs=194.3
Q ss_pred EcccCcEEEEEEEEC-CCcEEEEEEeecCCc---hhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEEecCCCCH
Q 010513 194 IGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG---QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNL 269 (508)
Q Consensus 194 LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~g~L 269 (508)
||+|+||+||++..+ +|+.||+|.+..... .....+..|+++++.++||||+++++++.++...++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999999965 588999999854321 2234456699999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCCCcceecc
Q 010513 270 EQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTR 349 (508)
Q Consensus 270 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~ 349 (508)
.+++.... ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++....... ....
T Consensus 81 ~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~ 153 (277)
T cd05607 81 KYHIYNVG--ERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQ 153 (277)
T ss_pred HHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eeec
Confidence 99886542 24588999999999999999999998 99999999999999999999999999998764322 2234
Q ss_pred eecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCCccCCCCchHH
Q 010513 350 VMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSR 429 (508)
Q Consensus 350 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 429 (508)
..|+..|+|||++.+..++.++|+|||||++|||++|+.||...... ....+........ ... ......+.
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~--~~~~~~~~~~~~~-----~~~--~~~~~~~~ 224 (277)
T cd05607 154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEK--VAKEELKRRTLED-----EVK--FEHQNFTE 224 (277)
T ss_pred cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcch--hhHHHHHHHhhcc-----ccc--cccccCCH
Confidence 57899999999999888999999999999999999999999754321 1111222221111 010 11111233
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 010513 430 ALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461 (508)
Q Consensus 430 ~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~ 461 (508)
++.+++.+||+.||++||++.|+++.+..
T Consensus 225 ---~~~~li~~~L~~~P~~R~~~~~~~~~~~~ 253 (277)
T cd05607 225 ---ESKDICRLFLAKKPEDRLGSREKNDDPRK 253 (277)
T ss_pred ---HHHHHHHHHhccCHhhCCCCccchhhhhc
Confidence 34558889999999999999877655443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=326.19 Aligned_cols=241 Identities=22% Similarity=0.317 Sum_probs=192.2
Q ss_pred CCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCC---chhHHHHHHHHHHHHccC-CCCeeeEeeeeecCCeeEEEE
Q 010513 187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVR-HKNLVRLLGYCAEGAHRMLVY 261 (508)
Q Consensus 187 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~lV~ 261 (508)
+|++.+.||+|+||+||+|... +++.||+|++.+.. ....+.+..|.+++..+. |++|+++++++.+.+..|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4778899999999999999965 58889999986532 233456777888888885 577888999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCC
Q 010513 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA 341 (508)
Q Consensus 262 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 341 (508)
||+++|+|.+++... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 81 Ey~~~g~L~~~i~~~----~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~ 153 (323)
T cd05615 81 EYVNGGDLMYHIQQV----GKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV 153 (323)
T ss_pred cCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCC
Confidence 999999999998764 4689999999999999999999999 999999999999999999999999999875422
Q ss_pred CCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCCcc
Q 010513 342 ERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPR 421 (508)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 421 (508)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ........... . .
T Consensus 154 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~------~~~~~~i~~~~-~------~ 219 (323)
T cd05615 154 DG-VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE------DELFQSIMEHN-V------S 219 (323)
T ss_pred CC-ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH------HHHHHHHHhCC-C------C
Confidence 21 223345799999999999999999999999999999999999999975432 11122222111 0 1
Q ss_pred CCCCchHHHHHHHHHHHHHccCCCCCCCCCH
Q 010513 422 LQEKPCSRALKRALLVALRCVDPNAHKRPKM 452 (508)
Q Consensus 422 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 452 (508)
... ..+ .++.+++.+||+.||++|++.
T Consensus 220 ~p~-~~~---~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 220 YPK-SLS---KEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred CCc-cCC---HHHHHHHHHHcccCHhhCCCC
Confidence 111 122 344558889999999999984
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=320.50 Aligned_cols=258 Identities=25% Similarity=0.400 Sum_probs=201.9
Q ss_pred CCCCcccceEcccCcEEEEEEEECC------CcEEEEEEeecCCch-hHHHHHHHHHHHHccCCCCeeeEeeeeecCCee
Q 010513 185 TNGFADENVIGEGGYGIVYHGVLED------NTNVAVKNLLNNRGQ-AEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHR 257 (508)
Q Consensus 185 ~~~~~~~~~LG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 257 (508)
..+|.+.+.||+|+||.||+|.+.+ +..||+|.+...... ..+.+..|+.++..++||||+++++++.+....
T Consensus 4 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~ 83 (283)
T cd05091 4 LSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPL 83 (283)
T ss_pred HHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCce
Confidence 3467889999999999999998642 467999998654332 345688899999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhccCC------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCC
Q 010513 258 MLVYEYIDNGNLEQWLHGDV------------GPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQ 325 (508)
Q Consensus 258 ~lV~e~~~~g~L~~~l~~~~------------~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~ 325 (508)
++++||+.+++|.+++.... .....+++..++.++.|++.||+|||++ +++||||||+||+++++
T Consensus 84 ~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~ 160 (283)
T cd05091 84 SMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDK 160 (283)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCC
Confidence 99999999999999985321 1123578888999999999999999998 99999999999999999
Q ss_pred CCeEEeeeccceecCCCCcc-eecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHh-CCCCCCCCCCCCcchHHH
Q 010513 326 WNPKLSDFGLAKLLGAERSY-VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVE 403 (508)
Q Consensus 326 ~~~kL~DFG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~ 403 (508)
+.+||+|||+++........ ......+++.|+|||.+.++.++.++|||||||++|||++ |..||..... .+
T Consensus 161 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~------~~ 234 (283)
T cd05091 161 LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN------QD 234 (283)
T ss_pred CceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH------HH
Confidence 99999999998865432221 1233456789999999988899999999999999999998 8888864321 12
Q ss_pred HHHHhhcccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 010513 404 WLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461 (508)
Q Consensus 404 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~ 461 (508)
..... ...... .. ...++.. +.+++.+||+.+|++||++.+|++.|+.
T Consensus 235 ~~~~i-~~~~~~-----~~-~~~~~~~---~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 235 VIEMI-RNRQVL-----PC-PDDCPAW---VYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHHHH-HcCCcC-----CC-CCCCCHH---HHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 22221 111110 01 1123444 4457889999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-40 Score=321.77 Aligned_cols=259 Identities=27% Similarity=0.463 Sum_probs=201.1
Q ss_pred hcCCCCcccceEcccCcEEEEEEEECC------CcEEEEEEeecCC-chhHHHHHHHHHHHHccCCCCeeeEeeeeecCC
Q 010513 183 VSTNGFADENVIGEGGYGIVYHGVLED------NTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGA 255 (508)
Q Consensus 183 ~~~~~~~~~~~LG~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~ 255 (508)
+.+++|.+.+.||+|+||.||+|.+.+ +..||+|.+.... ......+..|+.+++.++|+||+++++++.+..
T Consensus 3 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (277)
T cd05036 3 VPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERL 82 (277)
T ss_pred CCHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence 345679999999999999999999753 4568888775443 333456888999999999999999999999888
Q ss_pred eeEEEEEecCCCCHHHHhccCCC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCC---CeE
Q 010513 256 HRMLVYEYIDNGNLEQWLHGDVG---PHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQW---NPK 329 (508)
Q Consensus 256 ~~~lV~e~~~~g~L~~~l~~~~~---~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~---~~k 329 (508)
..++||||+++++|.+++..... ....+++..++.++.|++.||+|||++ +++||||||+||+++.++ .+|
T Consensus 83 ~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~k 159 (277)
T cd05036 83 PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAK 159 (277)
T ss_pred CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceE
Confidence 99999999999999999976421 123589999999999999999999999 999999999999998755 589
Q ss_pred EeeeccceecCCCCcce-ecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHH
Q 010513 330 LSDFGLAKLLGAERSYV-TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKT 407 (508)
Q Consensus 330 L~DFG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~ 407 (508)
|+|||+++......... .....++..|+|||++.+..++.++|||||||++|||++ |+.||...... .. ...
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~---~~---~~~ 233 (277)
T cd05036 160 IADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ---EV---MEF 233 (277)
T ss_pred eccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HH---HHH
Confidence 99999998763322111 112233567999999999999999999999999999997 99999754321 11 111
Q ss_pred hhcccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 010513 408 MVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 460 (508)
Q Consensus 408 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le 460 (508)
....... ... ...+ ..+.+++.+||+.+|++||++.+++++|+
T Consensus 234 ~~~~~~~------~~~-~~~~---~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 234 VTGGGRL------DPP-KGCP---GPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred HHcCCcC------CCC-CCCC---HHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 1111110 011 1122 34555888999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=328.81 Aligned_cols=193 Identities=23% Similarity=0.352 Sum_probs=165.3
Q ss_pred hcCCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCchhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEE
Q 010513 183 VSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY 261 (508)
Q Consensus 183 ~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 261 (508)
....+|++.+.||+|+||.||+|... ++..||+|..... ....|+.++++++||||+++++++.+....++||
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 136 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL 136 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence 34457999999999999999999976 4677888864332 2345899999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCC
Q 010513 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA 341 (508)
Q Consensus 262 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 341 (508)
||+. ++|.+++... ...+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 137 e~~~-~~l~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 209 (357)
T PHA03209 137 PHYS-SDLYTYLTKR---SRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVV 209 (357)
T ss_pred EccC-CcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCcccccccc
Confidence 9996 5899988654 35789999999999999999999999 999999999999999999999999999975322
Q ss_pred CCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCC
Q 010513 342 ERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPV 390 (508)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf 390 (508)
. .......||+.|+|||++.+..++.++|||||||++|||+++..|+
T Consensus 210 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 210 A--PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred C--cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 2 1223457999999999999999999999999999999999865544
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=330.47 Aligned_cols=198 Identities=29% Similarity=0.367 Sum_probs=169.4
Q ss_pred CCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecC--CchhHHHHHHHHHHHHccCCCCeeeEeeeeecCC------
Q 010513 185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGA------ 255 (508)
Q Consensus 185 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~------ 255 (508)
.++|++.+.||+|+||.||+|.+. ++..||+|++... .......+.+|+.+++.++||||+++++++....
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 99 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ 99 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence 468999999999999999999965 5889999998643 2334566788999999999999999999986443
Q ss_pred eeEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeecc
Q 010513 256 HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGL 335 (508)
Q Consensus 256 ~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~ 335 (508)
..|+||||+++ +|.+.+.. .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 100 ~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg~ 169 (359)
T cd07876 100 DVYLVMELMDA-NLCQVIHM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 169 (359)
T ss_pred eeEEEEeCCCc-CHHHHHhc------cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCCC
Confidence 47899999976 67776642 478889999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCC
Q 010513 336 AKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSR 394 (508)
Q Consensus 336 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~ 394 (508)
++..... .......||+.|+|||.+.+..++.++|||||||++|+|++|+.||...+
T Consensus 170 a~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~ 226 (359)
T cd07876 170 ARTACTN--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTD 226 (359)
T ss_pred ccccccC--ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence 9754322 22334578999999999999999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=317.30 Aligned_cols=250 Identities=24% Similarity=0.390 Sum_probs=198.4
Q ss_pred CCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecC-CchhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEEe
Q 010513 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY 263 (508)
Q Consensus 186 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~ 263 (508)
++|++.+.||+|+||.||+|.+. +++.||+|.+... .......+..|++++++++||||+++++++...+..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 36788899999999999999964 6788999988654 334456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCCC
Q 010513 264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER 343 (508)
Q Consensus 264 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 343 (508)
+++++|..+ ..+++..+..++.|++.||.|||+. +|+|+||||+|||++.++.++|+|||++......
T Consensus 81 ~~~~~l~~~--------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~- 148 (279)
T cd06619 81 MDGGSLDVY--------RKIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS- 148 (279)
T ss_pred CCCCChHHh--------hcCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceecccc-
Confidence 999999754 2467888999999999999999999 9999999999999999999999999999865322
Q ss_pred cceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcc-hHHHHHHHhhcccccccCCCccC
Q 010513 344 SYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEV-NLVEWLKTMVTNRNAEGVLDPRL 422 (508)
Q Consensus 344 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l 422 (508)
......||..|+|||++.+..++.++|+|||||++|+|++|+.||......... ......... .... .+.+
T Consensus 149 --~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~-----~~~~ 220 (279)
T cd06619 149 --IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCI-VDED-----PPVL 220 (279)
T ss_pred --cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHH-hccC-----CCCC
Confidence 223457899999999999889999999999999999999999999754322111 111111111 1110 1111
Q ss_pred CCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 423 QEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 423 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
.. .....++.+++.+||+.||++||++.+++++
T Consensus 221 ~~---~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 221 PV---GQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred CC---CcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 11 1122345568889999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=322.60 Aligned_cols=258 Identities=25% Similarity=0.455 Sum_probs=204.1
Q ss_pred CCCCcccceEcccCcEEEEEEEEC------CCcEEEEEEeecCCchhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeE
Q 010513 185 TNGFADENVIGEGGYGIVYHGVLE------DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM 258 (508)
Q Consensus 185 ~~~~~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 258 (508)
..+|...++||+|+||.||++... ++..+|+|.+..........+.+|+++++.++|+||+++++++.+....+
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLL 83 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceE
Confidence 457888999999999999999742 35578899887666666778999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhccCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCC
Q 010513 259 LVYEYIDNGNLEQWLHGDVG-----------PHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWN 327 (508)
Q Consensus 259 lV~e~~~~g~L~~~l~~~~~-----------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~ 327 (508)
++|||+++|+|.+++..... ....+++..++.++.|++.|++|||+. +++||||||+|||+++++.
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~~ 160 (280)
T cd05092 84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGLV 160 (280)
T ss_pred EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCCC
Confidence 99999999999999875421 113588999999999999999999998 9999999999999999999
Q ss_pred eEEeeeccceecCCCCcce-ecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHh-CCCCCCCCCCCCcchHHHHH
Q 010513 328 PKLSDFGLAKLLGAERSYV-TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWL 405 (508)
Q Consensus 328 ~kL~DFG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~ 405 (508)
+||+|||++.......... .....+++.|+|||.+.+..++.++|||||||++|||++ |..||...... +..
T Consensus 161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~------~~~ 234 (280)
T cd05092 161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNT------EAI 234 (280)
T ss_pred EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHH------HHH
Confidence 9999999998654322211 222345778999999999999999999999999999998 99998643221 111
Q ss_pred HHhhcccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 010513 406 KTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461 (508)
Q Consensus 406 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~ 461 (508)
........ .. ....++.. +.+++.+||+.||++||++.++++.|++
T Consensus 235 ~~~~~~~~------~~-~~~~~~~~---~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 235 ECITQGRE------LE-RPRTCPPE---VYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred HHHHcCcc------CC-CCCCCCHH---HHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 11111110 00 11123333 4457789999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=327.55 Aligned_cols=261 Identities=26% Similarity=0.439 Sum_probs=203.6
Q ss_pred hhcCCCCcccceEcccCcEEEEEEEEC--------CCcEEEEEEeecCC-chhHHHHHHHHHHHHcc-CCCCeeeEeeee
Q 010513 182 EVSTNGFADENVIGEGGYGIVYHGVLE--------DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRV-RHKNLVRLLGYC 251 (508)
Q Consensus 182 ~~~~~~~~~~~~LG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~l~~~~ 251 (508)
++..++|.+.+.||+|+||.||+|.+. +...+|+|.+.... .....++..|+++++.+ +||||+++++++
T Consensus 14 ~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (307)
T cd05098 14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC 93 (307)
T ss_pred eeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence 555678999999999999999999853 12468999886542 33456688899999999 799999999999
Q ss_pred ecCCeeEEEEEecCCCCHHHHhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCC
Q 010513 252 AEGAHRMLVYEYIDNGNLEQWLHGDVG------------PHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSN 319 (508)
Q Consensus 252 ~~~~~~~lV~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~N 319 (508)
.+....|+||||+++|+|.+++..... ....+++..++.++.|++.||+|||+. +++||||||+|
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~N 170 (307)
T cd05098 94 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARN 170 (307)
T ss_pred ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHh
Confidence 999999999999999999999976422 123588999999999999999999998 99999999999
Q ss_pred EEEcCCCCeEEeeeccceecCCCCcce-ecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHh-CCCCCCCCCCCC
Q 010513 320 ILLDKQWNPKLSDFGLAKLLGAERSYV-TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPG 397 (508)
Q Consensus 320 Ill~~~~~~kL~DFG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~Pf~~~~~~~ 397 (508)
|+++.++.+||+|||.+.......... .....+++.|+|||.+.+..++.++|+|||||++|||++ |..||....
T Consensus 171 ill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~--- 247 (307)
T cd05098 171 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP--- 247 (307)
T ss_pred eEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCC---
Confidence 999999999999999987653322111 112234568999999998899999999999999999998 888985332
Q ss_pred cchHHHHHHHhhcccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 010513 398 EVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461 (508)
Q Consensus 398 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~ 461 (508)
..+... ....... ... ......++.+++.+||+.+|++||++.++++.|+.
T Consensus 248 ---~~~~~~-~~~~~~~-----~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~ 298 (307)
T cd05098 248 ---VEELFK-LLKEGHR-----MDK----PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 298 (307)
T ss_pred ---HHHHHH-HHHcCCC-----CCC----CCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHH
Confidence 111111 1111110 001 11122345558889999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=314.32 Aligned_cols=255 Identities=23% Similarity=0.427 Sum_probs=198.8
Q ss_pred CcccceEcccCcEEEEEEEECC----CcEEEEEEeecCC--chhHHHHHHHHHHHHccCCCCeeeEeeeeecCCe-----
Q 010513 188 FADENVIGEGGYGIVYHGVLED----NTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAH----- 256 (508)
Q Consensus 188 ~~~~~~LG~G~~g~Vy~~~~~~----~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~----- 256 (508)
|.+.+.||+|+||.||+|.... +..||+|.+.... ......+..|++.++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 5678899999999999998642 3679999886542 2334678899999999999999999998866554
Q ss_pred -eEEEEEecCCCCHHHHhccCCC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeee
Q 010513 257 -RMLVYEYIDNGNLEQWLHGDVG--PHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDF 333 (508)
Q Consensus 257 -~~lV~e~~~~g~L~~~l~~~~~--~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DF 333 (508)
.+++|||+++|+|.+++..... ....+++..++.++.|++.||+|||++ +++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCc
Confidence 7899999999999999855321 234689999999999999999999998 9999999999999999999999999
Q ss_pred ccceecCCCCccee-cceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHhhcc
Q 010513 334 GLAKLLGAERSYVT-TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTN 411 (508)
Q Consensus 334 G~a~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~ 411 (508)
|+++.......... ....++..|+|||.+.+..++.++|||||||++|||++ |..||...... ...+.+ ...
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~---~~~~~~---~~~ 231 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH---EIYDYL---RHG 231 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHH---HcC
Confidence 99987644332221 12335678999999988899999999999999999999 89999643321 122211 111
Q ss_pred cccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 010513 412 RNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461 (508)
Q Consensus 412 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~ 461 (508)
.. +... ..+ ..++.+++.+||+.||++||++.++++.|++
T Consensus 232 ~~------~~~~-~~~---~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~ 271 (273)
T cd05035 232 NR------LKQP-EDC---LDELYDLMYSCWRADPKDRPTFTKLREVLEN 271 (273)
T ss_pred CC------CCCC-cCC---CHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 10 1111 112 2345568889999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=320.99 Aligned_cols=250 Identities=26% Similarity=0.385 Sum_probs=203.1
Q ss_pred CCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCchhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEEec
Q 010513 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYI 264 (508)
Q Consensus 186 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~ 264 (508)
.+|++.+.||+|+||.||+|... +++.|++|.+........+.+..|+.+++.+.||||+++++.+..+...++||||+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 48999999999999999999964 68899999987665555677889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCCCc
Q 010513 265 DNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS 344 (508)
Q Consensus 265 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~ 344 (508)
++++|.+++... .+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++........
T Consensus 100 ~~~~L~~~~~~~-----~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~ 171 (296)
T cd06654 100 AGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (296)
T ss_pred CCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhcccccc
Confidence 999999998643 578999999999999999999999 999999999999999999999999999876533221
Q ss_pred ceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCCccCCC
Q 010513 345 YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQE 424 (508)
Q Consensus 345 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 424 (508)
......|++.|+|||.+.+..++.++|+|||||++|+|++|+.||....+. ........... +.+..
T Consensus 172 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~------~~~~~~~~~~~------~~~~~ 238 (296)
T cd06654 172 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL------RALYLIATNGT------PELQN 238 (296)
T ss_pred -ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHH------HhHHHHhcCCC------CCCCC
Confidence 123346899999999999888999999999999999999999999654321 11111111110 01100
Q ss_pred CchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 425 KPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 425 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
.......+.+++.+||+.||++||++.+++++
T Consensus 239 --~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 239 --PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred --ccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 11122345558889999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=322.44 Aligned_cols=258 Identities=23% Similarity=0.354 Sum_probs=200.3
Q ss_pred CCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecC-CchhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEEe
Q 010513 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY 263 (508)
Q Consensus 186 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~ 263 (508)
++|++.+.||+|+||.||++.+. ++..+|+|.+... .......+.+|++++++++||||+++++++.+++..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 46899999999999999999965 5677888887544 223345688899999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCCC
Q 010513 264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER 343 (508)
Q Consensus 264 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 343 (508)
+++++|.+++... ..+++..+..++.|+++||.|||++. +++||||||+|||++.++.+||+|||++......
T Consensus 81 ~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~- 153 (308)
T cd06615 81 MDGGSLDQVLKKA----GRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 153 (308)
T ss_pred cCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCccccccc-
Confidence 9999999999764 56899999999999999999999732 8999999999999999999999999998754322
Q ss_pred cceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccc--------
Q 010513 344 SYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAE-------- 415 (508)
Q Consensus 344 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~-------- 415 (508)
......|+..|+|||.+.+..++.++|+|||||++|+|++|+.||...+... ...............
T Consensus 154 --~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 228 (308)
T cd06615 154 --MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKE---LEAMFGRPVSEGEAKESHRPVSG 228 (308)
T ss_pred --ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhh---HHHhhcCccccccccCCcccccC
Confidence 1234578999999999988889999999999999999999999996443211 111110000000000
Q ss_pred -------------------cCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 416 -------------------GVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 416 -------------------~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
....+.+.... ...++.+++.+||+.||++||++.+++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 229 HPPDSPRPMAIFELLDYIVNEPPPKLPSGA---FSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred CCCCccchhhHHHHHHHHhcCCCccCcCcc---cCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00011111111 22345668889999999999999999976
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=319.44 Aligned_cols=265 Identities=26% Similarity=0.445 Sum_probs=205.2
Q ss_pred hhcCCCCcccceEcccCcEEEEEEEECC------CcEEEEEEeecCC-chhHHHHHHHHHHHHccCCCCeeeEeeeeecC
Q 010513 182 EVSTNGFADENVIGEGGYGIVYHGVLED------NTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEG 254 (508)
Q Consensus 182 ~~~~~~~~~~~~LG~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~ 254 (508)
++..++|++.+.||+|+||.||+|..++ +..||+|.+.... ......+.+|+.+++.++||||+++++++.+.
T Consensus 2 ~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 81 (288)
T cd05061 2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKG 81 (288)
T ss_pred cccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 4567789999999999999999997542 4478999875443 22334678899999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHhccCCC------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCe
Q 010513 255 AHRMLVYEYIDNGNLEQWLHGDVG------PHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNP 328 (508)
Q Consensus 255 ~~~~lV~e~~~~g~L~~~l~~~~~------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~ 328 (508)
...++||||+++|+|.+++..... ....++...+..++.|++.||.|||++ +++||||||+||+++.++.+
T Consensus 82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~ 158 (288)
T cd05061 82 QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTV 158 (288)
T ss_pred CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcE
Confidence 999999999999999999965321 124457788899999999999999999 99999999999999999999
Q ss_pred EEeeeccceecCCCCcce-ecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHh-CCCCCCCCCCCCcchHHHHHH
Q 010513 329 KLSDFGLAKLLGAERSYV-TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLK 406 (508)
Q Consensus 329 kL~DFG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~ 406 (508)
+|+|||+++......... .....++..|+|||.+.++.++.++|+|||||++|||++ |..||..... .+...
T Consensus 159 ~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~------~~~~~ 232 (288)
T cd05061 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN------EQVLK 232 (288)
T ss_pred EECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCH------HHHHH
Confidence 999999998653322211 122345678999999998899999999999999999999 7889864321 12222
Q ss_pred HhhcccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCCC
Q 010513 407 TMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEEFP 465 (508)
Q Consensus 407 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~~~~~ 465 (508)
........ ... ..++ ..+.+++.+||+.||++||++.++++.|++.-.+
T Consensus 233 ~~~~~~~~------~~~-~~~~---~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~ 281 (288)
T cd05061 233 FVMDGGYL------DQP-DNCP---ERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHP 281 (288)
T ss_pred HHHcCCCC------CCC-CCCC---HHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCC
Confidence 21111110 011 1122 3455588899999999999999999999876544
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=316.08 Aligned_cols=253 Identities=26% Similarity=0.500 Sum_probs=202.8
Q ss_pred CCCCcccceEcccCcEEEEEEEECCCcEEEEEEeecCCchhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEEec
Q 010513 185 TNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYI 264 (508)
Q Consensus 185 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~ 264 (508)
..+|++.+.||+|+||.||+|.+.++..+|+|.+.... .....+..|+++++.++|||++++++++......++||||+
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFM 81 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcC
Confidence 34788899999999999999998778889999876443 23457888999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCCCc
Q 010513 265 DNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS 344 (508)
Q Consensus 265 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~ 344 (508)
++++|.+++... ...+++..++.++.|++.|++|||+. +++||||||+||+++.++.+||+|||++........
T Consensus 82 ~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 155 (256)
T cd05112 82 EHGCLSDYLRAQ---RGKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY 155 (256)
T ss_pred CCCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCcc
Confidence 999999998765 24688999999999999999999998 999999999999999999999999999986543322
Q ss_pred ceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHhhcccccccCCCccCC
Q 010513 345 YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQ 423 (508)
Q Consensus 345 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 423 (508)
.......++..|+|||.+.++.++.++|+||||+++|||++ |+.||..... .+......... ....+.
T Consensus 156 ~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~------~~~~~~~~~~~---~~~~~~-- 224 (256)
T cd05112 156 TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN------SEVVETINAGF---RLYKPR-- 224 (256)
T ss_pred cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH------HHHHHHHhCCC---CCCCCC--
Confidence 21222335678999999998899999999999999999998 9999964321 11122111110 111111
Q ss_pred CCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 010513 424 EKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 460 (508)
Q Consensus 424 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le 460 (508)
..+ .++.+++.+||+.+|++||++.+++++|.
T Consensus 225 --~~~---~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 225 --LAS---QSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred --CCC---HHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 122 34556888999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=322.37 Aligned_cols=257 Identities=28% Similarity=0.451 Sum_probs=201.3
Q ss_pred CCcccceEcccCcEEEEEEEEC------CCcEEEEEEeecCCc-hhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEE
Q 010513 187 GFADENVIGEGGYGIVYHGVLE------DNTNVAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRML 259 (508)
Q Consensus 187 ~~~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 259 (508)
+|++.+.||+|+||.||+|... ....+++|.+..... .....+..|+.+++.++||||+++++.+..+...++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4778899999999999999853 224688888765433 344678889999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhccCCC--------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCC
Q 010513 260 VYEYIDNGNLEQWLHGDVG--------------------PHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSN 319 (508)
Q Consensus 260 V~e~~~~g~L~~~l~~~~~--------------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~N 319 (508)
+|||+.+|+|.+++..... ....+++..++.++.|++.||+|||+. +++||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhhhhhhe
Confidence 9999999999999864311 123588999999999999999999998 99999999999
Q ss_pred EEEcCCCCeEEeeeccceecCCCCcce-ecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHh-CCCCCCCCCCCC
Q 010513 320 ILLDKQWNPKLSDFGLAKLLGAERSYV-TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPG 397 (508)
Q Consensus 320 Ill~~~~~~kL~DFG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~Pf~~~~~~~ 397 (508)
||+++++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..||....+.
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~- 236 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE- 236 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH-
Confidence 999999999999999998654333221 222345678999999988889999999999999999999 99999643321
Q ss_pred cchHHHHHHHhhcccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010513 398 EVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (508)
Q Consensus 398 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~~ 462 (508)
.+.+. ..... ..... ...+ .++.+++.+||+.||++||++.++++.|++.
T Consensus 237 --~~~~~----~~~~~-----~~~~~-~~~~---~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~ 286 (290)
T cd05045 237 --RLFNL----LKTGY-----RMERP-ENCS---EEMYNLMLTCWKQEPDKRPTFADISKELEKM 286 (290)
T ss_pred --HHHHH----HhCCC-----CCCCC-CCCC---HHHHHHHHHHccCCcccCCCHHHHHHHHHHH
Confidence 11111 11110 01111 1122 3455688899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=325.85 Aligned_cols=237 Identities=23% Similarity=0.288 Sum_probs=186.0
Q ss_pred ceEcccCcEEEEEEEEC-CCcEEEEEEeecCCc---hhHHHHHHHH-HHHHccCCCCeeeEeeeeecCCeeEEEEEecCC
Q 010513 192 NVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG---QAEKEFKVEV-EAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDN 266 (508)
Q Consensus 192 ~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~-~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~ 266 (508)
+.||+|+||.||+|+.. +++.||+|.+.+... .....+..|. .+++.++||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999975 578899999865321 2233444454 467889999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCCCcce
Q 010513 267 GNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYV 346 (508)
Q Consensus 267 g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~ 346 (508)
|+|.+++... ..+++..+..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++..... ...
T Consensus 81 ~~L~~~l~~~----~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~-~~~ 152 (321)
T cd05603 81 GELFFHLQRE----RCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP-EET 152 (321)
T ss_pred CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCC-CCc
Confidence 9999988654 4688999999999999999999998 9999999999999999999999999998753222 222
Q ss_pred ecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCCccCCCCc
Q 010513 347 TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKP 426 (508)
Q Consensus 347 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 426 (508)
....+||+.|+|||++.+..++.++|||||||++|||++|+.||...+ ..+........ . ..+.. .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~------~~~~~~~i~~~-~------~~~~~-~ 218 (321)
T cd05603 153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD------VSQMYDNILHK-P------LQLPG-G 218 (321)
T ss_pred cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC------HHHHHHHHhcC-C------CCCCC-C
Confidence 344679999999999999899999999999999999999999996432 11222222111 0 01111 1
Q ss_pred hHHHHHHHHHHHHHccCCCCCCCCCHH
Q 010513 427 CSRALKRALLVALRCVDPNAHKRPKMG 453 (508)
Q Consensus 427 ~~~~~~~l~~li~~cl~~dP~~RPs~~ 453 (508)
.+ ..+.+++.+||+.||++||++.
T Consensus 219 ~~---~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 219 KT---VAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CC---HHHHHHHHHHccCCHhhcCCCC
Confidence 22 2345578899999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=317.88 Aligned_cols=256 Identities=28% Similarity=0.499 Sum_probs=202.7
Q ss_pred cCCCCcccceEcccCcEEEEEEEEC-CCc---EEEEEEeecCC-chhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeE
Q 010513 184 STNGFADENVIGEGGYGIVYHGVLE-DNT---NVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM 258 (508)
Q Consensus 184 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~---~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 258 (508)
..++|+..+.||+|+||.||+|... ++. .+|+|.+.... ....+.+..|+++++.++||||+++++++.+.+..+
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (268)
T cd05063 3 HPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAM 82 (268)
T ss_pred ChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcE
Confidence 4557888999999999999999965 232 68999886542 334567889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeecccee
Q 010513 259 LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL 338 (508)
Q Consensus 259 lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~ 338 (508)
+||||+++++|.+++... ...+++..++.++.|++.|++|||+. +++||||||+||+++.++.+||+|||++..
T Consensus 83 lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~ 156 (268)
T cd05063 83 IITEYMENGALDKYLRDH---DGEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRV 156 (268)
T ss_pred EEEEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCcccee
Confidence 999999999999999764 35689999999999999999999998 999999999999999999999999999986
Q ss_pred cCCCCcceec--ceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHhhcccccc
Q 010513 339 LGAERSYVTT--RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAE 415 (508)
Q Consensus 339 ~~~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (508)
.......... ....+..|+|||++.+..++.++|||||||++|||++ |+.||..... .+...... ...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~------~~~~~~i~-~~~-- 227 (268)
T cd05063 157 LEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN------HEVMKAIN-DGF-- 227 (268)
T ss_pred cccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH------HHHHHHHh-cCC--
Confidence 6432222111 1223457999999998899999999999999999998 9999964321 12222221 110
Q ss_pred cCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 010513 416 GVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461 (508)
Q Consensus 416 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~ 461 (508)
..+. ....+ .++.+++.+||+.+|++||++.++++.|++
T Consensus 228 --~~~~--~~~~~---~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~ 266 (268)
T cd05063 228 --RLPA--PMDCP---SAVYQLMLQCWQQDRARRPRFVDIVNLLDK 266 (268)
T ss_pred --CCCC--CCCCC---HHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 0111 11122 345568889999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=323.67 Aligned_cols=257 Identities=25% Similarity=0.408 Sum_probs=199.2
Q ss_pred CCCcccceEcccCcEEEEEEEECC-Cc--EEEEEEeecC-CchhHHHHHHHHHHHHcc-CCCCeeeEeeeeecCCeeEEE
Q 010513 186 NGFADENVIGEGGYGIVYHGVLED-NT--NVAVKNLLNN-RGQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLV 260 (508)
Q Consensus 186 ~~~~~~~~LG~G~~g~Vy~~~~~~-~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lV 260 (508)
++|++.+.||+|+||.||+|..++ +. .+++|.+... .....+.+..|++++.++ +||||+++++++.+....++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 578999999999999999999753 33 4688877643 233456788899999999 799999999999999999999
Q ss_pred EEecCCCCHHHHhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCe
Q 010513 261 YEYIDNGNLEQWLHGDVG------------PHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNP 328 (508)
Q Consensus 261 ~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~ 328 (508)
|||+++|+|.+++..... ....+++..++.++.|++.||+|||++ +++||||||+|||++.++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeE
Confidence 999999999999965321 123588999999999999999999998 99999999999999999999
Q ss_pred EEeeeccceecCCCCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHH
Q 010513 329 KLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKT 407 (508)
Q Consensus 329 kL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~ 407 (508)
||+|||++..... .........+..|+|||++.+..++.++|||||||++|||++ |..||...... +....
T Consensus 159 kl~dfg~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~------~~~~~ 230 (297)
T cd05089 159 KIADFGLSRGEEV--YVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA------ELYEK 230 (297)
T ss_pred EECCcCCCccccc--eeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH------HHHHH
Confidence 9999999864221 111111223457999999988899999999999999999998 99999644321 11111
Q ss_pred hhcccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 010513 408 MVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEE 463 (508)
Q Consensus 408 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~~~ 463 (508)
.... ..+... ...+. .+.+++.+||+.||.+||++.++++.|++..
T Consensus 231 ~~~~------~~~~~~-~~~~~---~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~ 276 (297)
T cd05089 231 LPQG------YRMEKP-RNCDD---EVYELMRQCWRDRPYERPPFAQISVQLSRML 276 (297)
T ss_pred HhcC------CCCCCC-CCCCH---HHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 1111 011111 11233 3455888999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=316.44 Aligned_cols=246 Identities=28% Similarity=0.454 Sum_probs=194.5
Q ss_pred eEcccCcEEEEEEEEC---CCcEEEEEEeecCC--chhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEEecCCC
Q 010513 193 VIGEGGYGIVYHGVLE---DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNG 267 (508)
Q Consensus 193 ~LG~G~~g~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~g 267 (508)
+||+|+||.||+|.++ ++..+|+|++.... ....+++..|+.+++.++||||+++++++.+ ...++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence 5899999999999753 56789999875443 2345678899999999999999999998864 5678999999999
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCCCccee
Q 010513 268 NLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVT 347 (508)
Q Consensus 268 ~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~ 347 (508)
+|.+++... ..+++..+..++.|++.||+|||++ +++||||||.||+++.++.+||+|||++...........
T Consensus 81 ~L~~~l~~~----~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 153 (257)
T cd05116 81 PLNKFLQKN----KHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK 153 (257)
T ss_pred cHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeee
Confidence 999999754 4689999999999999999999999 999999999999999999999999999987644333221
Q ss_pred --cceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHhhcccccccCCCccCCC
Q 010513 348 --TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQE 424 (508)
Q Consensus 348 --~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 424 (508)
....++..|+|||.+....++.++|+|||||++|||++ |+.||..... .+.... ...... +...
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~------~~~~~~-i~~~~~-----~~~~- 220 (257)
T cd05116 154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG------NEVTQM-IESGER-----MECP- 220 (257)
T ss_pred ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH------HHHHHH-HHCCCC-----CCCC-
Confidence 22234578999999988889999999999999999998 9999974322 111111 111111 1111
Q ss_pred CchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010513 425 KPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (508)
Q Consensus 425 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~~ 462 (508)
...+. ++.+++.+||+.||++||++.+|.+.|++.
T Consensus 221 ~~~~~---~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 221 QRCPP---EMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred CCCCH---HHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 11333 344588899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=319.41 Aligned_cols=255 Identities=22% Similarity=0.327 Sum_probs=202.2
Q ss_pred hhcCCCCcccceEcccCcEEEEEEEECCCcEEEEEEeec--CCchhHHHHHHHHHHHHcc-CCCCeeeEeeeeecCCeeE
Q 010513 182 EVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLN--NRGQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRM 258 (508)
Q Consensus 182 ~~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~ 258 (508)
.+....|+++++||+||.+.||++...+.+.||+|++.. ...+...-|..|+++|.+| .|.+||++++|-..++.+|
T Consensus 357 ~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lY 436 (677)
T KOG0596|consen 357 KVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLY 436 (677)
T ss_pred EECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEE
Confidence 455667999999999999999999988888899887743 3445567899999999999 5899999999999999999
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeecccee
Q 010513 259 LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL 338 (508)
Q Consensus 259 lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~ 338 (508)
|||||-+. ||..+|++.. .......++.+..|++.|+.++|++ ||||.||||.|+|+-+ |.+||+|||+|..
T Consensus 437 mvmE~Gd~-DL~kiL~k~~---~~~~~~~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlVk-G~LKLIDFGIA~a 508 (677)
T KOG0596|consen 437 MVMECGDI-DLNKILKKKK---SIDPDWFLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLVK-GRLKLIDFGIANA 508 (677)
T ss_pred EEeecccc-cHHHHHHhcc---CCCchHHHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEEe-eeEEeeeechhcc
Confidence 99998766 9999998873 3344347889999999999999999 9999999999998865 4899999999998
Q ss_pred cCCCCcc-eecceecCCCCCChhhhhcCC-----------CCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHH
Q 010513 339 LGAERSY-VTTRVMGTFGYVAPEYASTGM-----------LNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLK 406 (508)
Q Consensus 339 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~-----------~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~ 406 (508)
+..+... .....+||+.||+||.+.... .+.++|||||||+||+|+.|+.||..- .+....+
T Consensus 509 I~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~-----~n~~aKl- 582 (677)
T KOG0596|consen 509 IQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQI-----INQIAKL- 582 (677)
T ss_pred cCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHH-----HHHHHHH-
Confidence 7654433 345579999999999885322 457899999999999999999999621 1111111
Q ss_pred HhhcccccccCCCccCCCCchH-HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 407 TMVTNRNAEGVLDPRLQEKPCS-RALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 407 ~~~~~~~~~~~~~~~l~~~~~~-~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
..+.+|....++.. ....+++++++.||+.||.+||++.++|++
T Consensus 583 --------~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 583 --------HAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred --------HhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 13344432222111 111227889999999999999999999976
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=318.28 Aligned_cols=253 Identities=28% Similarity=0.453 Sum_probs=200.7
Q ss_pred CcccceEcccCcEEEEEEEECC-CcEEEEEEeecCCchhHH--HHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEEec
Q 010513 188 FADENVIGEGGYGIVYHGVLED-NTNVAVKNLLNNRGQAEK--EFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYI 264 (508)
Q Consensus 188 ~~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~--~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~ 264 (508)
|++.+.||+|+||+||++.... ++.||+|.+......... ....|+.++++++||||+++++++.+....++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 6788999999999999999875 567999999776544332 3456999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCCCc
Q 010513 265 DNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS 344 (508)
Q Consensus 265 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~ 344 (508)
++++|.+++... ..+++..++.++.|+++||++||++ +++|+||||+||+++.++.++|+|||.+... ....
T Consensus 81 ~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~-~~~~ 152 (260)
T PF00069_consen 81 PGGSLQDYLQKN----KPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKL-SENN 152 (260)
T ss_dssp TTEBHHHHHHHH----SSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEES-TSTT
T ss_pred cccccccccccc----ccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccc-cccc
Confidence 999999999833 5789999999999999999999999 9999999999999999999999999999864 2222
Q ss_pred ceecceecCCCCCChhhhh-cCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCCccCC
Q 010513 345 YVTTRVMGTFGYVAPEYAS-TGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQ 423 (508)
Q Consensus 345 ~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 423 (508)
.......++..|+|||++. +..++.++|+||||+++|+|++|..||..... .+............. .....
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~---~~~~~~~~~~~~~~~-----~~~~~ 224 (260)
T PF00069_consen 153 ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNS---DDQLEIIEKILKRPL-----PSSSQ 224 (260)
T ss_dssp SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSH---HHHHHHHHHHHHTHH-----HHHTT
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccc---hhhhhhhhhcccccc-----ccccc
Confidence 3344567899999999998 78899999999999999999999999975411 111111111111000 00000
Q ss_pred CCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 424 EKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 424 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
. .......+.+++.+||+.||++||++.+++++
T Consensus 225 ~--~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 225 Q--SREKSEELRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp S--HTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred c--cchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 00011566668889999999999999999864
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=324.76 Aligned_cols=260 Identities=26% Similarity=0.415 Sum_probs=204.8
Q ss_pred hhcCCCCcccceEcccCcEEEEEEEEC------CCcEEEEEEeecCC-chhHHHHHHHHHHHHcc-CCCCeeeEeeeeec
Q 010513 182 EVSTNGFADENVIGEGGYGIVYHGVLE------DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAE 253 (508)
Q Consensus 182 ~~~~~~~~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~ 253 (508)
.+..++|.+.+.||+|+||.||+|... .+..||+|.+.... ....+.+.+|+++++++ +||||+++++++..
T Consensus 31 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 110 (302)
T cd05055 31 EFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTI 110 (302)
T ss_pred cccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEec
Confidence 345567999999999999999999742 24468999886543 33446788999999999 79999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeee
Q 010513 254 GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDF 333 (508)
Q Consensus 254 ~~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DF 333 (508)
.+..++||||+.+|+|.++++... ...+++..++.++.|++.||+|||++ +++|+||||+|||++.++.++|+||
T Consensus 111 ~~~~~lv~e~~~~~~L~~~i~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~df 185 (302)
T cd05055 111 GGPILVITEYCCYGDLLNFLRRKR--ESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDF 185 (302)
T ss_pred CCceEEEEEcCCCCcHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCC
Confidence 999999999999999999997642 23489999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCcc-eecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHhhcc
Q 010513 334 GLAKLLGAERSY-VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTN 411 (508)
Q Consensus 334 G~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~ 411 (508)
|+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |..||....... ........
T Consensus 186 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~------~~~~~~~~ 259 (302)
T cd05055 186 GLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS------KFYKLIKE 259 (302)
T ss_pred cccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH------HHHHHHHc
Confidence 999865433221 1222346778999999999999999999999999999998 999986443211 11111111
Q ss_pred cccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 010513 412 RNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461 (508)
Q Consensus 412 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~ 461 (508)
.. .+. .....+ .++.+++.+||+.+|++||++.++++.|++
T Consensus 260 ~~-----~~~-~~~~~~---~~~~~li~~cl~~~p~~Rpt~~ell~~l~~ 300 (302)
T cd05055 260 GY-----RMA-QPEHAP---AEIYDIMKTCWDADPLKRPTFKQIVQLIGK 300 (302)
T ss_pred CC-----cCC-CCCCCC---HHHHHHHHHHcCCCchhCcCHHHHHHHHHh
Confidence 10 000 011122 345568889999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=317.98 Aligned_cols=252 Identities=23% Similarity=0.290 Sum_probs=198.5
Q ss_pred CCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCc---hhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEE
Q 010513 187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG---QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE 262 (508)
Q Consensus 187 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e 262 (508)
.|+..+.||+|+||.||+|.+. +++.||+|.+..... .....+..|+.+++.++|+||+++++.+.+.+..++|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 3677899999999999999965 578899998865422 223456789999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCC
Q 010513 263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE 342 (508)
Q Consensus 263 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 342 (508)
|+++++|.+++.... ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.++|+|||++......
T Consensus 81 ~~~g~~L~~~l~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05630 81 LMNGGDLKFHIYHMG--EAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 155 (285)
T ss_pred ecCCCcHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCC
Confidence 999999999986542 24589999999999999999999998 9999999999999999999999999998765332
Q ss_pred CcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCCccC
Q 010513 343 RSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRL 422 (508)
Q Consensus 343 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 422 (508)
.. .....|+..|+|||++.+..++.++|+|||||++|+|++|+.||.......... ......... ....
T Consensus 156 ~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~---~~~~~~~~~------~~~~ 224 (285)
T cd05630 156 QT--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKRE---EVERLVKEV------QEEY 224 (285)
T ss_pred cc--ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHH---HHHhhhhhh------hhhc
Confidence 22 223478999999999999999999999999999999999999997543221111 111111110 0011
Q ss_pred CCCchHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 010513 423 QEKPCSRALKRALLVALRCVDPNAHKRPK-----MGHVIHM 458 (508)
Q Consensus 423 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~ 458 (508)
.. ..+. .+.+++.+||+.||++||+ +.|++++
T Consensus 225 ~~-~~~~---~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h 261 (285)
T cd05630 225 SE-KFSP---DARSLCKMLLCKDPKERLGCQGGGAREVKEH 261 (285)
T ss_pred Cc-cCCH---HHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence 11 1222 3445778999999999999 8888864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=317.92 Aligned_cols=257 Identities=25% Similarity=0.406 Sum_probs=203.4
Q ss_pred hcCCCCcccceEcccCcEEEEEEEECC----CcEEEEEEeecCC-chhHHHHHHHHHHHHccCCCCeeeEeeeeecCCee
Q 010513 183 VSTNGFADENVIGEGGYGIVYHGVLED----NTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHR 257 (508)
Q Consensus 183 ~~~~~~~~~~~LG~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 257 (508)
+..++|.+.+.||+|+||.||+|.+.+ ...|++|...... ....+.+.+|+.+++.++||||+++++++.+ ...
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~ 81 (270)
T cd05056 3 IQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPV 81 (270)
T ss_pred echhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCc
Confidence 455678999999999999999998643 2468899876554 3455678999999999999999999999876 457
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccce
Q 010513 258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK 337 (508)
Q Consensus 258 ~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~ 337 (508)
++||||+++|+|.+++... ...+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++
T Consensus 82 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~ 155 (270)
T cd05056 82 WIVMELAPLGELRSYLQVN---KYSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSR 155 (270)
T ss_pred EEEEEcCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceee
Confidence 8999999999999999765 24689999999999999999999998 99999999999999999999999999998
Q ss_pred ecCCCCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHhhccccccc
Q 010513 338 LLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEG 416 (508)
Q Consensus 338 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 416 (508)
..........+...++..|+|||.+....++.++||||||+++|||++ |..||...... .....+ .... .
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~---~~~~~~----~~~~--~ 226 (270)
T cd05056 156 YLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN---DVIGRI----ENGE--R 226 (270)
T ss_pred ecccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH---HHHHHH----HcCC--c
Confidence 765443333333345568999999988889999999999999999996 99999654321 111111 1111 0
Q ss_pred CCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010513 417 VLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (508)
Q Consensus 417 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~~ 462 (508)
. .. ...++. .+.+++.+|+..+|++||++.++++.|++.
T Consensus 227 ~---~~-~~~~~~---~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~ 265 (270)
T cd05056 227 L---PM-PPNCPP---TLYSLMTKCWAYDPSKRPRFTELKAQLSDI 265 (270)
T ss_pred C---CC-CCCCCH---HHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 0 01 111233 445578899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=314.65 Aligned_cols=254 Identities=26% Similarity=0.362 Sum_probs=202.1
Q ss_pred cCCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCchhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEE
Q 010513 184 STNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE 262 (508)
Q Consensus 184 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e 262 (508)
..++|.+.+.||+|+||.||+|... +++.||+|.+..........+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 7 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e 86 (267)
T cd06645 7 PQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICME 86 (267)
T ss_pred cHHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEe
Confidence 3457889999999999999999965 588899998876655555678889999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCC
Q 010513 263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE 342 (508)
Q Consensus 263 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 342 (508)
|+++++|.+++... +.+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++......
T Consensus 87 ~~~~~~L~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd06645 87 FCGGGSLQDIYHVT----GPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITAT 159 (267)
T ss_pred ccCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCc
Confidence 99999999998754 4689999999999999999999999 9999999999999999999999999998765432
Q ss_pred CcceecceecCCCCCChhhhh---cCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCC
Q 010513 343 RSYVTTRVMGTFGYVAPEYAS---TGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLD 419 (508)
Q Consensus 343 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 419 (508)
........|++.|+|||++. ...++.++|+|||||++|+|++|..||....+... ........ ...
T Consensus 160 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~------~~~~~~~~----~~~ 228 (267)
T cd06645 160 -IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA------LFLMTKSN----FQP 228 (267)
T ss_pred -ccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh------HHhhhccC----CCC
Confidence 22223457899999999874 45688999999999999999999999864432111 11111111 111
Q ss_pred ccCCC-CchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 420 PRLQE-KPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 420 ~~l~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
+.... ...+. .+.+++.+||+.||++||++++++++
T Consensus 229 ~~~~~~~~~~~---~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 229 PKLKDKMKWSN---SFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred CcccccCCCCH---HHHHHHHHHccCCchhCcCHHHHhcC
Confidence 11111 01222 34558889999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-39 Score=310.18 Aligned_cols=250 Identities=24% Similarity=0.346 Sum_probs=201.5
Q ss_pred CCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecC-CchhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEEec
Q 010513 187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYI 264 (508)
Q Consensus 187 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~ 264 (508)
+|++.+.||+|+||.||++... ++..+|+|.+... .....+.+..|+.+++.++|+||+++++.+.++...|+||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4788999999999999999965 5888999988543 2334567888999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCCCc
Q 010513 265 DNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS 344 (508)
Q Consensus 265 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~ 344 (508)
++|+|.+++.... ...+++...+.++.|++.||.|||++ +++|+||||+||++++++.++|+|||.+........
T Consensus 81 ~~~~l~~~~~~~~--~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 155 (255)
T cd08219 81 DGGDLMQKIKLQR--GKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA 155 (255)
T ss_pred CCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeeccccc
Confidence 9999999986542 34578999999999999999999999 999999999999999999999999999986643322
Q ss_pred ceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCCccCCC
Q 010513 345 YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQE 424 (508)
Q Consensus 345 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 424 (508)
......|++.|+|||++.+..++.++|+||||+++|+|++|..||..... ........ .... .+ +.
T Consensus 156 -~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~------~~~~~~~~-~~~~----~~-~~- 221 (255)
T cd08219 156 -YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSW------KNLILKVC-QGSY----KP-LP- 221 (255)
T ss_pred -ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCH------HHHHHHHh-cCCC----CC-CC-
Confidence 22345689999999999988899999999999999999999999974321 11111111 1111 11 11
Q ss_pred CchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 425 KPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 425 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
......+.+++.+||+.||++||++.+++..
T Consensus 222 ---~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 222 ---SHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred ---cccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 1112345568889999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=336.05 Aligned_cols=264 Identities=23% Similarity=0.408 Sum_probs=205.2
Q ss_pred HhhcCCCCcccceEcccCcEEEEEEEEC------CCcEEEEEEeecCCc-hhHHHHHHHHHHHHccC-CCCeeeEeeeee
Q 010513 181 LEVSTNGFADENVIGEGGYGIVYHGVLE------DNTNVAVKNLLNNRG-QAEKEFKVEVEAIGRVR-HKNLVRLLGYCA 252 (508)
Q Consensus 181 ~~~~~~~~~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-hpniv~l~~~~~ 252 (508)
++++.++|.+.+.||+|+||.||+|++. .+..||+|++..... ...+.+..|++++..+. ||||+++++++.
T Consensus 32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~ 111 (401)
T cd05107 32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT 111 (401)
T ss_pred ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence 4566678889999999999999999863 245799999975432 33456888999999997 999999999999
Q ss_pred cCCeeEEEEEecCCCCHHHHhccCCC------------------------------------------------------
Q 010513 253 EGAHRMLVYEYIDNGNLEQWLHGDVG------------------------------------------------------ 278 (508)
Q Consensus 253 ~~~~~~lV~e~~~~g~L~~~l~~~~~------------------------------------------------------ 278 (508)
.....++||||+.+|+|.++++....
T Consensus 112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (401)
T cd05107 112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP 191 (401)
T ss_pred cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence 99999999999999999999965421
Q ss_pred ----------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCC
Q 010513 279 ----------------------------------------PHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSS 318 (508)
Q Consensus 279 ----------------------------------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~ 318 (508)
....+++.....++.|++.||+|||+. +++||||||+
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~ 268 (401)
T cd05107 192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAAR 268 (401)
T ss_pred hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcc
Confidence 112467778899999999999999998 9999999999
Q ss_pred CEEEcCCCCeEEeeeccceecCCCCcc-eecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHh-CCCCCCCCCCC
Q 010513 319 NILLDKQWNPKLSDFGLAKLLGAERSY-VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPP 396 (508)
Q Consensus 319 NIll~~~~~~kL~DFG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~Pf~~~~~~ 396 (508)
|||+++++.+||+|||+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |..||......
T Consensus 269 NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~ 348 (401)
T cd05107 269 NVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMN 348 (401)
T ss_pred eEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCch
Confidence 999999999999999999865332221 1223457889999999998889999999999999999998 89998643211
Q ss_pred CcchHHHHHHHhhcccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010513 397 GEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (508)
Q Consensus 397 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~~ 462 (508)
+.......... .+... ...+. ++.+++.+||+.+|++||++++|++.|+..
T Consensus 349 ------~~~~~~~~~~~-----~~~~p-~~~~~---~l~~li~~cl~~~P~~RPs~~ell~~L~~~ 399 (401)
T cd05107 349 ------EQFYNAIKRGY-----RMAKP-AHASD---EIYEIMQKCWEEKFEIRPDFSQLVHLVGDL 399 (401)
T ss_pred ------HHHHHHHHcCC-----CCCCC-CCCCH---HHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 11111111110 01111 11233 444577799999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=312.46 Aligned_cols=255 Identities=26% Similarity=0.366 Sum_probs=206.2
Q ss_pred CCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCchhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEEe
Q 010513 185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY 263 (508)
Q Consensus 185 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~ 263 (508)
.++|++.+.||+|+||.||+|... +++.+++|.+........+.+..|+++++.++||||+++++++.++...+++|||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 468999999999999999999975 5778999998776655677889999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCCC
Q 010513 264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER 343 (508)
Q Consensus 264 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 343 (508)
+++++|.+++... ...+++..++.++.|++.||.|||++ +++|+||||+||++++++.+||+|||++.......
T Consensus 82 ~~~~~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 155 (262)
T cd06613 82 CGGGSLQDIYQVT---RGPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI 155 (262)
T ss_pred CCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhhh
Confidence 9999999998764 25689999999999999999999998 99999999999999999999999999987653321
Q ss_pred cceecceecCCCCCChhhhhcC---CCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCCc
Q 010513 344 SYVTTRVMGTFGYVAPEYASTG---MLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDP 420 (508)
Q Consensus 344 ~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 420 (508)
.......++..|+|||.+.+. .++.++|+|||||++|||++|+.||....+.. ........ ....+
T Consensus 156 -~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~------~~~~~~~~----~~~~~ 224 (262)
T cd06613 156 -AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMR------ALFLISKS----NFPPP 224 (262)
T ss_pred -hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHhc----cCCCc
Confidence 122335688899999998776 78999999999999999999999997443211 11111110 00111
Q ss_pred cCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 421 RLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 421 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
.+. .......++.+++.+||+.||++||++.+++.+
T Consensus 225 ~~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 225 KLK--DKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred ccc--chhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 111 122334456678889999999999999999854
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=314.73 Aligned_cols=251 Identities=29% Similarity=0.455 Sum_probs=204.2
Q ss_pred cCCCCcccceEcccCcEEEEEEEECCCcEEEEEEeecCCchhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEEe
Q 010513 184 STNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY 263 (508)
Q Consensus 184 ~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~ 263 (508)
..++|++.+.||+|+||.||+|... ++.||+|.+..... ..+.+..|+.+++.++|+||+++++++.+....++||||
T Consensus 4 ~~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 81 (256)
T cd05039 4 NSKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEY 81 (256)
T ss_pred ChhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEe
Confidence 4568899999999999999999876 78899999876544 567788899999999999999999999988999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCCC
Q 010513 264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER 343 (508)
Q Consensus 264 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 343 (508)
+++++|.+++.... ...+++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||.++......
T Consensus 82 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~ 156 (256)
T cd05039 82 MAKGSLVDYLRSRG--RAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ 156 (256)
T ss_pred cCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEccccccccccccc
Confidence 99999999997652 23689999999999999999999999 99999999999999999999999999998653221
Q ss_pred cceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHhhcccccccCCCccC
Q 010513 344 SYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRL 422 (508)
Q Consensus 344 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 422 (508)
. ...++..|+|||.+.++.++.++|+||||+++|||++ |+.||..... ..+ ......... ...
T Consensus 157 ~----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~----~~~~~~~~~-----~~~ 220 (256)
T cd05039 157 D----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---KDV----VPHVEKGYR-----MEA 220 (256)
T ss_pred c----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH---HHH----HHHHhcCCC-----CCC
Confidence 1 2334668999999988889999999999999999997 9999964321 111 111111100 001
Q ss_pred CCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 010513 423 QEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461 (508)
Q Consensus 423 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~ 461 (508)
. ...+ ..+.+++.+||+.+|++||++.+++++|++
T Consensus 221 ~-~~~~---~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 221 P-EGCP---PEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred c-cCCC---HHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 1 1122 345558889999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=319.78 Aligned_cols=262 Identities=23% Similarity=0.374 Sum_probs=206.0
Q ss_pred hcCCCCcccceEcccCcEEEEEEEECC-----CcEEEEEEeecCC-chhHHHHHHHHHHHHccCCCCeeeEeeeeec-CC
Q 010513 183 VSTNGFADENVIGEGGYGIVYHGVLED-----NTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE-GA 255 (508)
Q Consensus 183 ~~~~~~~~~~~LG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~ 255 (508)
+..++|.+.+.||+|+||.||+|.+.+ +..|++|.+.... ....+.+.+|+.+++.++||||+++++++.. +.
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 82 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGE 82 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence 456789999999999999999999765 6778999876543 3445678889999999999999999998765 46
Q ss_pred eeEEEEEecCCCCHHHHhccCCCC----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEe
Q 010513 256 HRMLVYEYIDNGNLEQWLHGDVGP----HSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLS 331 (508)
Q Consensus 256 ~~~lV~e~~~~g~L~~~l~~~~~~----~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~ 331 (508)
..++++||+.+|+|.+++...... ...+++..++.++.|++.||+|||++ +++||||||+||++++++.+||+
T Consensus 83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~ 159 (280)
T cd05043 83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKIT 159 (280)
T ss_pred CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEEC
Confidence 788999999999999998664221 15689999999999999999999998 99999999999999999999999
Q ss_pred eeccceecCCCCcc-eecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHhh
Q 010513 332 DFGLAKLLGAERSY-VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMV 409 (508)
Q Consensus 332 DFG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~ 409 (508)
|||+++.+...... ......++..|+|||++.+..++.++|||||||++||+++ |+.||...++ .++... .
T Consensus 160 d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~------~~~~~~-~ 232 (280)
T cd05043 160 DNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP------FEMAAY-L 232 (280)
T ss_pred CCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH------HHHHHH-H
Confidence 99999865433221 1122345678999999988889999999999999999999 9999975432 121111 1
Q ss_pred cccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 010513 410 TNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEE 463 (508)
Q Consensus 410 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~~~ 463 (508)
.... ..... ..++. ++.+++.+||+.||++||++.++++.|+...
T Consensus 233 ~~~~-----~~~~~-~~~~~---~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~ 277 (280)
T cd05043 233 KDGY-----RLAQP-INCPD---ELFAVMACCWALDPEERPSFSQLVQCLTDFH 277 (280)
T ss_pred HcCC-----CCCCC-CcCCH---HHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 1110 01111 11233 4455888999999999999999999998643
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=313.67 Aligned_cols=255 Identities=24% Similarity=0.397 Sum_probs=195.6
Q ss_pred CcccceEcccCcEEEEEEEECCCc---EEEEEEeecC--CchhHHHHHHHHHHHHccCCCCeeeEeeeeecC------Ce
Q 010513 188 FADENVIGEGGYGIVYHGVLEDNT---NVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEG------AH 256 (508)
Q Consensus 188 ~~~~~~LG~G~~g~Vy~~~~~~~~---~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~------~~ 256 (508)
|.+.+.||+|+||.||+|.+.++. .+|+|.+... .....+.+..|+++++.++||||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 356788999999999999976432 5899987543 234456788899999999999999999987432 24
Q ss_pred eEEEEEecCCCCHHHHhccCC--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeec
Q 010513 257 RMLVYEYIDNGNLEQWLHGDV--GPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFG 334 (508)
Q Consensus 257 ~~lV~e~~~~g~L~~~l~~~~--~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG 334 (508)
.+++|||+++|+|.+++.... .....+++.....++.|++.||+|||++ +|+||||||+|||++.++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCC
Confidence 689999999999999874321 1234589999999999999999999998 99999999999999999999999999
Q ss_pred cceecCCCCccee-cceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHhhccc
Q 010513 335 LAKLLGAERSYVT-TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNR 412 (508)
Q Consensus 335 ~a~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~ 412 (508)
+++.+........ ....+++.|+|||.+.+..++.++|||||||++|||++ |+.||..... .+... .....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~------~~~~~-~~~~~ 230 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN------SEIYD-YLRQG 230 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH------HHHHH-HHHcC
Confidence 9987643322211 22345678999999999999999999999999999999 8899964321 11111 12211
Q ss_pred ccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 010513 413 NAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461 (508)
Q Consensus 413 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~ 461 (508)
... ... ...+. .+.+++.+||+.||++||++.++++.|+.
T Consensus 231 ~~~-----~~~-~~~~~---~~~~li~~~l~~~p~~Rps~~~l~~~l~~ 270 (272)
T cd05075 231 NRL-----KQP-PDCLD---GLYSLMSSCWLLNPKDRPSFETLRCELEK 270 (272)
T ss_pred CCC-----CCC-CCCCH---HHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 110 001 11223 34558889999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=318.90 Aligned_cols=257 Identities=25% Similarity=0.435 Sum_probs=201.7
Q ss_pred cCCCCcccceEcccCcEEEEEEEEC-CCc----EEEEEEeecCC-chhHHHHHHHHHHHHccCCCCeeeEeeeeecCCee
Q 010513 184 STNGFADENVIGEGGYGIVYHGVLE-DNT----NVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHR 257 (508)
Q Consensus 184 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 257 (508)
..++|++.+.||+|+||+||+|.+. ++. .||+|.+.... ......+.+|+.+++.++||||+++++++.. ...
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~ 83 (279)
T cd05109 5 KETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STV 83 (279)
T ss_pred chhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCc
Confidence 3457899999999999999999854 344 47999886543 3345678889999999999999999999976 457
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccce
Q 010513 258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK 337 (508)
Q Consensus 258 ~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~ 337 (508)
+++|||+++|+|.+++... ...+++..++.++.|++.||+|||++ +++||||||+|||+++++.+||+|||+++
T Consensus 84 ~l~~~~~~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~ 157 (279)
T cd05109 84 QLVTQLMPYGCLLDYVREN---KDRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLAR 157 (279)
T ss_pred EEEEEcCCCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCcee
Confidence 8999999999999999764 34689999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCcce-ecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHhhcccccc
Q 010513 338 LLGAERSYV-TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAE 415 (508)
Q Consensus 338 ~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (508)
......... .....+++.|+|||.+.+..++.++|||||||++|||++ |..||..... ..+...+ .....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~~~~~----~~~~~- 229 (279)
T cd05109 158 LLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA---REIPDLL----EKGER- 229 (279)
T ss_pred ecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHH----HCCCc-
Confidence 764332221 122345678999999988899999999999999999998 9999964322 1111111 11110
Q ss_pred cCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 010513 416 GVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEE 463 (508)
Q Consensus 416 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~~~ 463 (508)
.+ .. ..++ .++.+++.+||+.||++||++.++++.|+...
T Consensus 230 ---~~-~~-~~~~---~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~ 269 (279)
T cd05109 230 ---LP-QP-PICT---IDVYMIMVKCWMIDSECRPRFRELVDEFSRMA 269 (279)
T ss_pred ---CC-CC-ccCC---HHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 00 00 1122 34556888999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=317.11 Aligned_cols=254 Identities=28% Similarity=0.483 Sum_probs=201.3
Q ss_pred CCCcccceEcccCcEEEEEEEEC-C---CcEEEEEEeecCC-chhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEE
Q 010513 186 NGFADENVIGEGGYGIVYHGVLE-D---NTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLV 260 (508)
Q Consensus 186 ~~~~~~~~LG~G~~g~Vy~~~~~-~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 260 (508)
++|++.+.||+|+||.||+|.+. + +..+|+|.+.... ....+.+..|+.+++.++||||+++++++.+++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 47888999999999999999864 2 3368999886543 23356788899999999999999999999999999999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecC
Q 010513 261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG 340 (508)
Q Consensus 261 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 340 (508)
|||+++++|.+++... ...+++..++.++.|++.||+|||++ +++||||||+|||++.++.++|+|||++....
T Consensus 84 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd05066 84 TEYMENGSLDAFLRKH---DGQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 157 (267)
T ss_pred EEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCcccccc
Confidence 9999999999999765 24689999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCcceec--ceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHhhcccccccC
Q 010513 341 AERSYVTT--RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGV 417 (508)
Q Consensus 341 ~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 417 (508)
.......+ ...++..|+|||.+.+..++.++|+|||||++||+++ |..||...... ... ........
T Consensus 158 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~---~~~---~~~~~~~~---- 227 (267)
T cd05066 158 DDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ---DVI---KAIEEGYR---- 227 (267)
T ss_pred cccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH---HHH---HHHhCCCc----
Confidence 43322221 1233567999999998899999999999999999887 99999644321 111 11111100
Q ss_pred CCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 010513 418 LDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461 (508)
Q Consensus 418 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~ 461 (508)
.+ .. ...+ ..+.+++.+|++.+|++||++.++++.|++
T Consensus 228 -~~-~~-~~~~---~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 265 (267)
T cd05066 228 -LP-AP-MDCP---AALHQLMLDCWQKDRNERPKFEQIVSILDK 265 (267)
T ss_pred -CC-CC-CCCC---HHHHHHHHHHcccCchhCCCHHHHHHHHHh
Confidence 01 00 1122 334558889999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=321.08 Aligned_cols=261 Identities=26% Similarity=0.458 Sum_probs=204.9
Q ss_pred hhcCCCCcccceEcccCcEEEEEEEEC--------CCcEEEEEEeecCC-chhHHHHHHHHHHHHcc-CCCCeeeEeeee
Q 010513 182 EVSTNGFADENVIGEGGYGIVYHGVLE--------DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRV-RHKNLVRLLGYC 251 (508)
Q Consensus 182 ~~~~~~~~~~~~LG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~l~~~~ 251 (508)
++..++|.+.+.||+|+||.||+|.+. ++..||+|.+.... ......+.+|+.+++.+ +||||+++++++
T Consensus 11 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 90 (304)
T cd05101 11 EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 90 (304)
T ss_pred cccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEE
Confidence 456678999999999999999999742 23468999876543 34456788999999999 899999999999
Q ss_pred ecCCeeEEEEEecCCCCHHHHhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCC
Q 010513 252 AEGAHRMLVYEYIDNGNLEQWLHGDVG------------PHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSN 319 (508)
Q Consensus 252 ~~~~~~~lV~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~N 319 (508)
......++||||+++|+|.+++..... ....+++..++.++.|+++||.|||++ +++||||||+|
T Consensus 91 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~N 167 (304)
T cd05101 91 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARN 167 (304)
T ss_pred ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---Ceeecccccce
Confidence 999999999999999999999976422 124578889999999999999999999 99999999999
Q ss_pred EEEcCCCCeEEeeeccceecCCCCcce-ecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHh-CCCCCCCCCCCC
Q 010513 320 ILLDKQWNPKLSDFGLAKLLGAERSYV-TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPG 397 (508)
Q Consensus 320 Ill~~~~~~kL~DFG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~Pf~~~~~~~ 397 (508)
|+++.++.+||+|||+++......... .....+++.|+|||++.+..++.++||||||+++|||++ |..||....
T Consensus 168 ili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~--- 244 (304)
T cd05101 168 VLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP--- 244 (304)
T ss_pred EEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC---
Confidence 999999999999999998764433222 222345678999999988889999999999999999998 788885332
Q ss_pred cchHHHHHHHhhcccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 010513 398 EVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461 (508)
Q Consensus 398 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~ 461 (508)
..+.......... . . ....++.. +.+++.+||+.+|++||++.++++.|+.
T Consensus 245 ---~~~~~~~~~~~~~---~---~-~~~~~~~~---~~~li~~cl~~~p~~Rps~~e~l~~l~~ 295 (304)
T cd05101 245 ---VEELFKLLKEGHR---M---D-KPANCTNE---LYMMMRDCWHAIPSHRPTFKQLVEDLDR 295 (304)
T ss_pred ---HHHHHHHHHcCCc---C---C-CCCCCCHH---HHHHHHHHcccChhhCCCHHHHHHHHHH
Confidence 2222222211110 0 0 11123333 4457889999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=318.44 Aligned_cols=261 Identities=26% Similarity=0.362 Sum_probs=192.6
Q ss_pred CCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCc--hhHHHHHHHHHHHHcc---CCCCeeeEeeeeec-----CC
Q 010513 187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG--QAEKEFKVEVEAIGRV---RHKNLVRLLGYCAE-----GA 255 (508)
Q Consensus 187 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~hpniv~l~~~~~~-----~~ 255 (508)
+|++.+.||+|+||+||+|.+. +++.||+|.+..... .....+.+|+++++.+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 5888999999999999999976 578899998864322 1223455677766655 79999999998864 34
Q ss_pred eeEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeecc
Q 010513 256 HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGL 335 (508)
Q Consensus 256 ~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~ 335 (508)
..++||||+.+ +|.+++.... ...+++..+..++.|++.||.|||++ +++||||||+|||++.++.+||+|||+
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~ 154 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVP--PPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGL 154 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCc
Confidence 57899999985 8999887642 24589999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhc---cc
Q 010513 336 AKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVT---NR 412 (508)
Q Consensus 336 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~---~~ 412 (508)
+....... ......||..|+|||++.+..++.++|||||||++|||++|+.||....... .+.... .... ..
T Consensus 155 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~--~~~~~~-~~~~~~~~~ 229 (288)
T cd07863 155 ARIYSCQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD--QLGKIF-DLIGLPPED 229 (288)
T ss_pred cccccCcc--cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHH--HHHHHH-HHhCCCChh
Confidence 98654322 2234578999999999998899999999999999999999999996543211 111111 1000 00
Q ss_pred cc-------ccCCCccCCC---CchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 413 NA-------EGVLDPRLQE---KPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 413 ~~-------~~~~~~~l~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
.. .....+.... ...+.....+.+++.+||+.||++||++.+++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 230 DWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred hCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00 0000000000 0001122345668889999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=315.76 Aligned_cols=254 Identities=22% Similarity=0.318 Sum_probs=202.3
Q ss_pred cCCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCchhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEE
Q 010513 184 STNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE 262 (508)
Q Consensus 184 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e 262 (508)
..+.|++.+.||+|+||.||+|... ++..+++|.+........+.+..|+++++.++||||+++++++..+...++|||
T Consensus 10 ~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 89 (292)
T cd06644 10 PNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIE 89 (292)
T ss_pred cchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEe
Confidence 4467999999999999999999976 478899999877666667788899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCC
Q 010513 263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE 342 (508)
Q Consensus 263 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 342 (508)
|+++++|..++.+. ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++......
T Consensus 90 ~~~~~~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 163 (292)
T cd06644 90 FCPGGAVDAIMLEL---DRGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT 163 (292)
T ss_pred cCCCCcHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceecccc
Confidence 99999999887654 24689999999999999999999998 9999999999999999999999999998754222
Q ss_pred CcceecceecCCCCCChhhhh-----cCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccC
Q 010513 343 RSYVTTRVMGTFGYVAPEYAS-----TGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGV 417 (508)
Q Consensus 343 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 417 (508)
........+++.|+|||++. ...++.++|+|||||++|||++|..||....+ .+.........
T Consensus 164 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~------~~~~~~~~~~~----- 231 (292)
T cd06644 164 -LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP------MRVLLKIAKSE----- 231 (292)
T ss_pred -ccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH------HHHHHHHhcCC-----
Confidence 12223456889999999884 34578899999999999999999999964332 11111111110
Q ss_pred CCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 418 LDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 418 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
.+.... ......++.+++.+||+.||++||++.+++++
T Consensus 232 -~~~~~~--~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 232 -PPTLSQ--PSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred -CccCCC--CcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 111110 11122345568889999999999999999864
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=315.71 Aligned_cols=258 Identities=27% Similarity=0.461 Sum_probs=203.9
Q ss_pred CCCCcccceEcccCcEEEEEEEEC------CCcEEEEEEeecCCch-hHHHHHHHHHHHHccCCCCeeeEeeeeecCCee
Q 010513 185 TNGFADENVIGEGGYGIVYHGVLE------DNTNVAVKNLLNNRGQ-AEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHR 257 (508)
Q Consensus 185 ~~~~~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 257 (508)
.++|++.+.||+|+||.||+|+.+ +.+.+++|.+...... ..+.+..|++++++++|+||+++++++.+....
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 83 (275)
T cd05046 4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPH 83 (275)
T ss_pred hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcc
Confidence 457899999999999999999964 2356889987654443 456789999999999999999999999998999
Q ss_pred EEEEEecCCCCHHHHhccCCCC-----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEee
Q 010513 258 MLVYEYIDNGNLEQWLHGDVGP-----HSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSD 332 (508)
Q Consensus 258 ~lV~e~~~~g~L~~~l~~~~~~-----~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~D 332 (508)
++||||+++|+|.+++...... ...+++..++.++.|++.||+|||++ +++||||||+||+++.++.++++|
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~ 160 (275)
T cd05046 84 YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSL 160 (275)
T ss_pred eEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEcc
Confidence 9999999999999999765321 12689999999999999999999999 999999999999999999999999
Q ss_pred eccceecCCCCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHhhcc
Q 010513 333 FGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTN 411 (508)
Q Consensus 333 FG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~ 411 (508)
||++...............++..|+|||.+.+..++.++||||||+++|+|++ |..||...... .. +... ..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~---~~---~~~~-~~ 233 (275)
T cd05046 161 LSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE---EV---LNRL-QA 233 (275)
T ss_pred cccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH---HH---HHHH-Hc
Confidence 99987543333333334466788999999988889999999999999999999 88898643221 11 1111 11
Q ss_pred cccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 010513 412 RNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 460 (508)
Q Consensus 412 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le 460 (508)
...... .....+.. +.+++.+||+.||++||++.+++++|.
T Consensus 234 ~~~~~~-----~~~~~~~~---l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 234 GKLELP-----VPEGCPSR---LYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred CCcCCC-----CCCCCCHH---HHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 111000 11223333 445788999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=311.23 Aligned_cols=251 Identities=27% Similarity=0.409 Sum_probs=204.0
Q ss_pred CCCCcccceEcccCcEEEEEEEECC-CcEEEEEEeecCCchhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEEe
Q 010513 185 TNGFADENVIGEGGYGIVYHGVLED-NTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY 263 (508)
Q Consensus 185 ~~~~~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~ 263 (508)
.++|++.+.||+|+||.||+|...+ +..+++|.+..... .+.+.+|+++++.++||||+++++++.++...|+++||
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~ 79 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY 79 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence 4689999999999999999999764 78899998865432 67899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCCC
Q 010513 264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER 343 (508)
Q Consensus 264 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 343 (508)
+.+++|.+++... ...+++..++.++.|++.||.|||+. +++||||+|+||+++.++.++|+|||++.......
T Consensus 80 ~~~~~L~~~l~~~---~~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~ 153 (256)
T cd06612 80 CGAGSVSDIMKIT---NKTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM 153 (256)
T ss_pred CCCCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccCc
Confidence 9999999999654 35789999999999999999999999 99999999999999999999999999998764332
Q ss_pred cceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCCccCC
Q 010513 344 SYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQ 423 (508)
Q Consensus 344 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 423 (508)
. ......|+..|+|||++.+..++.++||||||+++|+|++|+.||....+.... .. ... ...+.+.
T Consensus 154 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~------~~-~~~-----~~~~~~~ 220 (256)
T cd06612 154 A-KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAI------FM-IPN-----KPPPTLS 220 (256)
T ss_pred c-ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhh------hh-hcc-----CCCCCCC
Confidence 1 223345889999999999999999999999999999999999999754322110 00 000 0011111
Q ss_pred CCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 424 EKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 424 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
. ......++.+++.+||+.||++||++.+++++
T Consensus 221 ~--~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 221 D--PEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred c--hhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence 1 11122345668889999999999999999864
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=313.78 Aligned_cols=247 Identities=29% Similarity=0.493 Sum_probs=193.4
Q ss_pred eEcccCcEEEEEEEEC---CCcEEEEEEeecCCc-hhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEEecCCCC
Q 010513 193 VIGEGGYGIVYHGVLE---DNTNVAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGN 268 (508)
Q Consensus 193 ~LG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~g~ 268 (508)
.||+|+||.||+|.+. ++..||+|.+..... ...+.+.+|+.++++++||||+++++++.. ...++||||+++|+
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence 3899999999999864 345689998865533 334678899999999999999999999864 57889999999999
Q ss_pred HHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCCCcceec
Q 010513 269 LEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTT 348 (508)
Q Consensus 269 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~ 348 (508)
|.+++... ...+++..++.++.|++.||+|||++ +++||||||+||+++.++.+||+|||++............
T Consensus 81 L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 154 (257)
T cd05115 81 LNKFLSGK---KDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA 154 (257)
T ss_pred HHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccceec
Confidence 99998754 35789999999999999999999998 9999999999999999999999999999865443332221
Q ss_pred c--eecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHhhcccccccCCCccCCCC
Q 010513 349 R--VMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEK 425 (508)
Q Consensus 349 ~--~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 425 (508)
. ..++..|+|||.+.+..++.++|||||||++|||++ |..||...... +.... ..... .+... .
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~------~~~~~-~~~~~-----~~~~~-~ 221 (257)
T cd05115 155 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP------EVMSF-IEQGK-----RLDCP-A 221 (257)
T ss_pred cCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH------HHHHH-HHCCC-----CCCCC-C
Confidence 1 233578999999988889999999999999999996 99999744321 11111 11111 01111 1
Q ss_pred chHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010513 426 PCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (508)
Q Consensus 426 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~~ 462 (508)
.++..+ .+++.+||+.||++||++.+|.+.|+..
T Consensus 222 ~~~~~l---~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 222 ECPPEM---YALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCHHH---HHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 233344 4477799999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=329.62 Aligned_cols=263 Identities=25% Similarity=0.302 Sum_probs=197.2
Q ss_pred cCCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecC--CchhHHHHHHHHHHHHccCCCCeeeEeeeeecC------
Q 010513 184 STNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEG------ 254 (508)
Q Consensus 184 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~------ 254 (508)
..++|++.+.||+|+||.||+|... .++.||+|++... .......+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 4568999999999999999999965 5788999998653 223445677899999999999999999988643
Q ss_pred CeeEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeec
Q 010513 255 AHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFG 334 (508)
Q Consensus 255 ~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG 334 (508)
...|+||||+++ +|.+.+.. .+++..+..++.|+++||+|||++ +|+||||||+|||++.++.+||+|||
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg 164 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 164 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCc
Confidence 357899999976 77777643 478889999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchH-H-----------
Q 010513 335 LAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNL-V----------- 402 (508)
Q Consensus 335 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~-~----------- 402 (508)
+++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||........... .
T Consensus 165 ~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 242 (355)
T cd07874 165 LARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 242 (355)
T ss_pred ccccCCCc--cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 99865322 223445789999999999999999999999999999999999999975432111000 0
Q ss_pred ----HHHHHhhccc-ccccCCCcc------CCC--CchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 403 ----EWLKTMVTNR-NAEGVLDPR------LQE--KPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 403 ----~~~~~~~~~~-~~~~~~~~~------l~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
.......... .......+. ... ........++.+++.+||+.||++|||+.|++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 0000010000 000000000 000 0001112345668889999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=323.90 Aligned_cols=263 Identities=25% Similarity=0.438 Sum_probs=204.2
Q ss_pred hhcCCCCcccceEcccCcEEEEEEEEC--------CCcEEEEEEeecCC-chhHHHHHHHHHHHHcc-CCCCeeeEeeee
Q 010513 182 EVSTNGFADENVIGEGGYGIVYHGVLE--------DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRV-RHKNLVRLLGYC 251 (508)
Q Consensus 182 ~~~~~~~~~~~~LG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~l~~~~ 251 (508)
++..++|.+.+.||+|+||.||+|... ....+|+|.+.... ......+..|+++++.+ +||||+++++++
T Consensus 8 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 87 (314)
T cd05099 8 EFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVC 87 (314)
T ss_pred cccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEE
Confidence 456678999999999999999999742 23468899876543 33456788899999999 699999999999
Q ss_pred ecCCeeEEEEEecCCCCHHHHhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCC
Q 010513 252 AEGAHRMLVYEYIDNGNLEQWLHGDVG------------PHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSN 319 (508)
Q Consensus 252 ~~~~~~~lV~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~N 319 (508)
.+....++||||+++|+|.+++..... ....+++..+..++.|++.||.|||++ +++||||||+|
T Consensus 88 ~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~N 164 (314)
T cd05099 88 TQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARN 164 (314)
T ss_pred ccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---Ceeecccccee
Confidence 998999999999999999999976421 124588999999999999999999998 99999999999
Q ss_pred EEEcCCCCeEEeeeccceecCCCCcce-ecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHh-CCCCCCCCCCCC
Q 010513 320 ILLDKQWNPKLSDFGLAKLLGAERSYV-TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPG 397 (508)
Q Consensus 320 Ill~~~~~~kL~DFG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~Pf~~~~~~~ 397 (508)
||++.++.+||+|||+++......... .....++..|+|||.+.+..++.++|||||||++|||++ |..||.....
T Consensus 165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~-- 242 (314)
T cd05099 165 VLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV-- 242 (314)
T ss_pred EEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCH--
Confidence 999999999999999998664322211 112234567999999999899999999999999999999 8999854321
Q ss_pred cchHHHHHHHhhcccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 010513 398 EVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEE 463 (508)
Q Consensus 398 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~~~ 463 (508)
.+.... ...... ... ...++. ++.+++.+||+.||++||++.++++.|++..
T Consensus 243 ----~~~~~~-~~~~~~-----~~~-~~~~~~---~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~ 294 (314)
T cd05099 243 ----EELFKL-LREGHR-----MDK-PSNCTH---ELYMLMRECWHAVPTQRPTFKQLVEALDKVL 294 (314)
T ss_pred ----HHHHHH-HHcCCC-----CCC-CCCCCH---HHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 111111 111110 001 111223 4445888999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=316.85 Aligned_cols=258 Identities=26% Similarity=0.390 Sum_probs=206.2
Q ss_pred cCCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCC-chhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEE
Q 010513 184 STNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY 261 (508)
Q Consensus 184 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 261 (508)
..++|++.+.||+|+||+||++... +++.||+|.+.... ....+.+.+|+++++.++||||+++++++......++||
T Consensus 3 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (284)
T cd06620 3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCM 82 (284)
T ss_pred cHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEE
Confidence 4467899999999999999999965 57889999876543 344577889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCC
Q 010513 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA 341 (508)
Q Consensus 262 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 341 (508)
||+++++|.+++... +.+++..+..++.+++.||.|||+.. +++||||||+||++++++.++|+|||++.....
T Consensus 83 e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~ 156 (284)
T cd06620 83 EFMDCGSLDRIYKKG----GPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELIN 156 (284)
T ss_pred ecCCCCCHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhh
Confidence 999999999998764 46899999999999999999999632 899999999999999999999999999875422
Q ss_pred CCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCc-----chHHHHHHHhhccccccc
Q 010513 342 ERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGE-----VNLVEWLKTMVTNRNAEG 416 (508)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~-----~~~~~~~~~~~~~~~~~~ 416 (508)
. ......|+..|+|||++.+..++.++|+|||||++|+|++|+.||.......+ ....+.........
T Consensus 157 ~---~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 229 (284)
T cd06620 157 S---IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP---- 229 (284)
T ss_pred h---ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc----
Confidence 1 12235789999999999888999999999999999999999999986543211 12223333322211
Q ss_pred CCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 010513 417 VLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHML 459 (508)
Q Consensus 417 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 459 (508)
.+.+.... ....+.+++.+||+.||++||++.|++++.
T Consensus 230 --~~~~~~~~---~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 230 --PPRLPSSD---FPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred --CCCCCchh---cCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 11111111 223455688899999999999999999863
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=313.62 Aligned_cols=250 Identities=23% Similarity=0.342 Sum_probs=198.1
Q ss_pred CcccceEcccCcEEEEEEEECC-CcEEEEEEeecCCchhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEEecCC
Q 010513 188 FADENVIGEGGYGIVYHGVLED-NTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDN 266 (508)
Q Consensus 188 ~~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~ 266 (508)
|++.+.||+|+||.||+|.... +..+++|.+........+.+.+|+++++.++||||+++++++..+...++||||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 6778899999999999999764 667788888665555667788899999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCCCcce
Q 010513 267 GNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYV 346 (508)
Q Consensus 267 g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~ 346 (508)
++|..++.+. ..++++..++.++.|+++||.|||+. +++||||||+||+++.++.+||+|||++....... ..
T Consensus 87 ~~l~~~~~~~---~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~-~~ 159 (282)
T cd06643 87 GAVDAVMLEL---ERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QR 159 (282)
T ss_pred CcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEccccccccccccc-cc
Confidence 9999988654 35789999999999999999999998 99999999999999999999999999987653221 12
Q ss_pred ecceecCCCCCChhhhh-----cCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCCcc
Q 010513 347 TTRVMGTFGYVAPEYAS-----TGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPR 421 (508)
Q Consensus 347 ~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 421 (508)
.....|++.|+|||++. +..++.++|+|||||++|||++|+.||....+ .+.......... ....
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~------~~~~~~~~~~~~-~~~~--- 229 (282)
T cd06643 160 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNP------MRVLLKIAKSEP-PTLA--- 229 (282)
T ss_pred cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCH------HHHHHHHhhcCC-CCCC---
Confidence 23356899999999873 44578899999999999999999999964321 111111111110 0000
Q ss_pred CCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 422 LQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 422 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
.....+ .++.+++.+||+.||++||++.+++++
T Consensus 230 -~~~~~~---~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 230 -QPSRWS---SEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred -CccccC---HHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111122 344557889999999999999998855
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-39 Score=316.17 Aligned_cols=252 Identities=25% Similarity=0.296 Sum_probs=197.5
Q ss_pred CCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCc---hhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEE
Q 010513 187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG---QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE 262 (508)
Q Consensus 187 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e 262 (508)
.|+..+.||+|+||+||+|.+. +++.+|+|.+..... .....+..|+++++.++|+||+++++.+..++..++|||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 3677889999999999999975 688899998865432 223456789999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCC
Q 010513 263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE 342 (508)
Q Consensus 263 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 342 (508)
|+++++|.+++.... ...+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+|||++......
T Consensus 81 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 155 (285)
T cd05632 81 IMNGGDLKFHIYNMG--NPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG 155 (285)
T ss_pred eccCccHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCC
Confidence 999999999886542 24699999999999999999999998 9999999999999999999999999999765332
Q ss_pred CcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCCccC
Q 010513 343 RSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRL 422 (508)
Q Consensus 343 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 422 (508)
.. .....|+..|+|||.+.+..++.++|+|||||++|||++|..||........ .+.+........ ...
T Consensus 156 ~~--~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~---~~~~~~~~~~~~------~~~ 224 (285)
T cd05632 156 ES--IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK---REEVDRRVLETE------EVY 224 (285)
T ss_pred Cc--ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHhhhccc------ccc
Confidence 21 2335789999999999989999999999999999999999999975432111 111111111110 011
Q ss_pred CCCchHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 010513 423 QEKPCSRALKRALLVALRCVDPNAHKRPK-----MGHVIHM 458 (508)
Q Consensus 423 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~ 458 (508)
... .+. .+.+++.+||+.||++||+ +.+++++
T Consensus 225 ~~~-~~~---~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 225 SAK-FSE---EAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred Ccc-CCH---HHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 111 222 3445778999999999999 6666654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=307.94 Aligned_cols=250 Identities=31% Similarity=0.508 Sum_probs=201.5
Q ss_pred ceEcccCcEEEEEEEECC----CcEEEEEEeecCCchh-HHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEEecCC
Q 010513 192 NVIGEGGYGIVYHGVLED----NTNVAVKNLLNNRGQA-EKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDN 266 (508)
Q Consensus 192 ~~LG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~ 266 (508)
+.||+|+||.||+|.... +..|++|.+....... .+.+..|++.+..++|+||+++++++.+....++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 469999999999999753 7789999986654433 67888999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCC-----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCC
Q 010513 267 GNLEQWLHGDVGP-----HSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA 341 (508)
Q Consensus 267 g~L~~~l~~~~~~-----~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 341 (508)
++|.+++...... ...+++..++.++.|++.||+|||++ +++||||||+||+++.++.+||+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999999775211 36799999999999999999999998 999999999999999999999999999987654
Q ss_pred CCc-ceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHhhcccccccCCC
Q 010513 342 ERS-YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLD 419 (508)
Q Consensus 342 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 419 (508)
... .......+++.|+|||.+....++.++|||||||++|||++ |..||..... .+....... .. .
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~------~~~~~~~~~-~~--~--- 225 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN------EEVLEYLRK-GY--R--- 225 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH------HHHHHHHHc-CC--C---
Confidence 332 12233467889999999988899999999999999999999 6999975521 111111111 10 0
Q ss_pred ccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 010513 420 PRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 460 (508)
Q Consensus 420 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le 460 (508)
... .... ..++.+++.+||+.||++||++.+++++|+
T Consensus 226 ~~~-~~~~---~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 226 LPK-PEYC---PDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred CCC-CccC---ChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 000 1112 345556888999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=310.43 Aligned_cols=248 Identities=27% Similarity=0.447 Sum_probs=197.8
Q ss_pred ceEcccCcEEEEEEEECCCcEEEEEEeecCCch-hHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEEecCCCCHH
Q 010513 192 NVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQ-AEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLE 270 (508)
Q Consensus 192 ~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~g~L~ 270 (508)
++||+|+||.||+|.+.+++.||+|.+...... ..+.+..|++++++++|+||+++++++.+....++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 469999999999999877899999988665443 4567899999999999999999999999999999999999999999
Q ss_pred HHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCCCccee-cc
Q 010513 271 QWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVT-TR 349 (508)
Q Consensus 271 ~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~-~~ 349 (508)
+++... ...+++...+.++.+++.||+|||++ +++||||||+||+++.++.+||+|||++........... ..
T Consensus 81 ~~l~~~---~~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 154 (251)
T cd05041 81 TFLRKK---KNRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGL 154 (251)
T ss_pred HHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceecccc
Confidence 999764 24678999999999999999999999 999999999999999999999999999986542221111 11
Q ss_pred eecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHhhcccccccCCCccCCCCchH
Q 010513 350 VMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCS 428 (508)
Q Consensus 350 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 428 (508)
..++..|+|||.+.++.++.++|+|||||++|||+| |..||...... ... ....... .. .. .+..
T Consensus 155 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~---~~~----~~~~~~~--~~---~~-~~~~- 220 (251)
T cd05041 155 KQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ---QTR----ERIESGY--RM---PA-PQLC- 220 (251)
T ss_pred CcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH---HHH----HHHhcCC--CC---CC-CccC-
Confidence 234567999999988899999999999999999999 88898654321 111 1111110 00 00 1112
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 010513 429 RALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461 (508)
Q Consensus 429 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~ 461 (508)
...+.+++.+||..+|++||++.|+++.|++
T Consensus 221 --~~~~~~li~~~l~~~p~~Rp~~~ell~~l~~ 251 (251)
T cd05041 221 --PEEIYRLMLQCWAYDPENRPSFSEIYNELQI 251 (251)
T ss_pred --CHHHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence 2345568889999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=322.23 Aligned_cols=198 Identities=22% Similarity=0.377 Sum_probs=162.0
Q ss_pred cceEcccCcEEEEEEEEC---CCcEEEEEEeecCCchhHHHHHHHHHHHHccCCCCeeeEeeeeec--CCeeEEEEEecC
Q 010513 191 ENVIGEGGYGIVYHGVLE---DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE--GAHRMLVYEYID 265 (508)
Q Consensus 191 ~~~LG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~--~~~~~lV~e~~~ 265 (508)
.++||+|+||+||+|+.. +++.||+|.+.... ....+.+|++++++++||||+++++++.. +...++||||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 468999999999999965 45789999886442 23456789999999999999999999854 456789999996
Q ss_pred CCCHHHHhccCCC-----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEE----cCCCCeEEeeeccc
Q 010513 266 NGNLEQWLHGDVG-----PHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILL----DKQWNPKLSDFGLA 336 (508)
Q Consensus 266 ~g~L~~~l~~~~~-----~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll----~~~~~~kL~DFG~a 336 (508)
+ +|.+++..... ....+++..++.++.|++.||+|||++ +|+||||||+|||+ +.++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 5 88888753211 123589999999999999999999999 99999999999999 45678999999999
Q ss_pred eecCCCCc--ceecceecCCCCCChhhhhc-CCCCCCCCeeehHHHHHHHHhCCCCCCCCC
Q 010513 337 KLLGAERS--YVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSR 394 (508)
Q Consensus 337 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~Pf~~~~ 394 (508)
+....... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 87643321 12234678999999998876 458999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-39 Score=316.34 Aligned_cols=260 Identities=26% Similarity=0.421 Sum_probs=203.7
Q ss_pred hcCCCCcccceEcccCcEEEEEEEEC------CCcEEEEEEeecCC-chhHHHHHHHHHHHHccCCCCeeeEeeeeecCC
Q 010513 183 VSTNGFADENVIGEGGYGIVYHGVLE------DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGA 255 (508)
Q Consensus 183 ~~~~~~~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~ 255 (508)
+..++|++.+.||+|+||.||+|... ++..||+|.+.... ......+.+|+.+++.++||||+++++++.++.
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~ 81 (288)
T cd05050 2 YPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGK 81 (288)
T ss_pred CChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCC
Confidence 34568999999999999999999863 46779999886543 334567889999999999999999999999999
Q ss_pred eeEEEEEecCCCCHHHHhccCCC------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCC
Q 010513 256 HRMLVYEYIDNGNLEQWLHGDVG------------------PHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKS 317 (508)
Q Consensus 256 ~~~lV~e~~~~g~L~~~l~~~~~------------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp 317 (508)
..++||||+++|+|.+++..... ....+++..++.++.|++.||+|||++ +++||||||
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p 158 (288)
T cd05050 82 PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLAT 158 (288)
T ss_pred ccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccH
Confidence 99999999999999999964311 123578889999999999999999998 999999999
Q ss_pred CCEEEcCCCCeEEeeeccceecCCCCcce-ecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHh-CCCCCCCCCC
Q 010513 318 SNILLDKQWNPKLSDFGLAKLLGAERSYV-TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRP 395 (508)
Q Consensus 318 ~NIll~~~~~~kL~DFG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~Pf~~~~~ 395 (508)
+||+++.++.++|+|||++.......... .....++..|+|||.+.+..++.++|||||||++|||++ |..||.....
T Consensus 159 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~ 238 (288)
T cd05050 159 RNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH 238 (288)
T ss_pred hheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 99999999999999999987653322211 122234667999999998999999999999999999998 8889863321
Q ss_pred CCcchHHHHHHHhhcccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 010513 396 PGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461 (508)
Q Consensus 396 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~ 461 (508)
.+..... ...... + . ....+ .++.+++.+||+.||++||++.|+++.|+.
T Consensus 239 ------~~~~~~~-~~~~~~----~-~-~~~~~---~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 239 ------EEVIYYV-RDGNVL----S-C-PDNCP---LELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred ------HHHHHHH-hcCCCC----C-C-CCCCC---HHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 1222221 111110 0 0 11122 345558889999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=334.29 Aligned_cols=254 Identities=22% Similarity=0.349 Sum_probs=207.8
Q ss_pred cCCCCcccceEcccCcEEEEEEEECCCcEE-EEEEeecCCchhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEE
Q 010513 184 STNGFADENVIGEGGYGIVYHGVLEDNTNV-AVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE 262 (508)
Q Consensus 184 ~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~v-avK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e 262 (508)
+.+.|.++..||.|+||.||+|..++...+ |.|.+.-...+..+++..||++|+.+.||+||++++.|..++.++|+.|
T Consensus 30 P~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliE 109 (1187)
T KOG0579|consen 30 PRDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIE 109 (1187)
T ss_pred HHHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEe
Confidence 344578889999999999999997754444 5677766677778899999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCC
Q 010513 263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE 342 (508)
Q Consensus 263 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 342 (508)
||.||-...++-.- ...+++.++..+++|++.||.|||++ +|||||||..|||++-+|.++|+|||.+.... .
T Consensus 110 FC~GGAVDaimlEL---~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~-~ 182 (1187)
T KOG0579|consen 110 FCGGGAVDAIMLEL---GRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNK-S 182 (1187)
T ss_pred ecCCchHhHHHHHh---ccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccch-h
Confidence 99999999887654 46899999999999999999999999 99999999999999999999999999886432 1
Q ss_pred CcceecceecCCCCCChhhhh-----cCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccC
Q 010513 343 RSYVTTRVMGTFGYVAPEYAS-----TGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGV 417 (508)
Q Consensus 343 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 417 (508)
.......+.|||+|||||++. ..+|+.++||||||++|.||..+.+|-. +.+....+.......
T Consensus 183 t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHh------elnpMRVllKiaKSe----- 251 (1187)
T KOG0579|consen 183 TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHH------ELNPMRVLLKIAKSE----- 251 (1187)
T ss_pred HHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCcc------ccchHHHHHHHhhcC-----
Confidence 222345578999999999864 4679999999999999999999999976 334444333322211
Q ss_pred CCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 418 LDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 418 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
.|.+-. ++.+...+.+++.+||.+||+.||++++++++
T Consensus 252 -PPTLlq--PS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 252 -PPTLLQ--PSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred -CCcccC--cchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 222221 34455566668889999999999999999976
|
|
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=327.99 Aligned_cols=263 Identities=25% Similarity=0.396 Sum_probs=201.8
Q ss_pred hhcCCCCcccceEcccCcEEEEEEEE------CCCcEEEEEEeecCCc-hhHHHHHHHHHHHHcc-CCCCeeeEeeeeec
Q 010513 182 EVSTNGFADENVIGEGGYGIVYHGVL------EDNTNVAVKNLLNNRG-QAEKEFKVEVEAIGRV-RHKNLVRLLGYCAE 253 (508)
Q Consensus 182 ~~~~~~~~~~~~LG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~ 253 (508)
+++.++|++.+.||+|+||+||+|.+ .+++.||||.+..... .....+..|+.++.++ +||||+++++++..
T Consensus 3 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 82 (343)
T cd05103 3 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK 82 (343)
T ss_pred ccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeec
Confidence 45677899999999999999999974 2467899999865432 3345688899999999 68999999998865
Q ss_pred C-CeeEEEEEecCCCCHHHHhccCCC------------------------------------------------------
Q 010513 254 G-AHRMLVYEYIDNGNLEQWLHGDVG------------------------------------------------------ 278 (508)
Q Consensus 254 ~-~~~~lV~e~~~~g~L~~~l~~~~~------------------------------------------------------ 278 (508)
. ...++||||+++|+|.+++.....
T Consensus 83 ~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (343)
T cd05103 83 PGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVE 162 (343)
T ss_pred CCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccch
Confidence 4 467899999999999999865321
Q ss_pred ---------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCCCcc-eec
Q 010513 279 ---------PHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSY-VTT 348 (508)
Q Consensus 279 ---------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~-~~~ 348 (508)
....+++..+..++.|+++||+|||++ +|+||||||+|||++.++.+||+|||++......... ...
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 239 (343)
T cd05103 163 EEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKG 239 (343)
T ss_pred hhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcC
Confidence 012467888899999999999999999 9999999999999999999999999999865332221 112
Q ss_pred ceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHhhcccccccCCCccCCCCch
Q 010513 349 RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPC 427 (508)
Q Consensus 349 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 427 (508)
...+++.|+|||.+.+..++.++||||||+++|||++ |..||....... .. .....+.... ..+ ...
T Consensus 240 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~----~~~~~~~~~~--~~~----~~~ 307 (343)
T cd05103 240 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--EF----CRRLKEGTRM--RAP----DYT 307 (343)
T ss_pred CCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH--HH----HHHHhccCCC--CCC----CCC
Confidence 2345678999999988899999999999999999997 999996543211 11 1111111100 001 111
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010513 428 SRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (508)
Q Consensus 428 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~~ 462 (508)
+ .++.+++.+||+.||++||++.+++++|+..
T Consensus 308 ~---~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~ 339 (343)
T cd05103 308 T---PEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 339 (343)
T ss_pred C---HHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 2 2456688899999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=309.23 Aligned_cols=249 Identities=29% Similarity=0.425 Sum_probs=198.3
Q ss_pred CCCCcccceEcccCcEEEEEEEECCCcEEEEEEeecCCchhHHHHHHHHHHHHccCCCCeeeEeeeee-cCCeeEEEEEe
Q 010513 185 TNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCA-EGAHRMLVYEY 263 (508)
Q Consensus 185 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~~~~~lV~e~ 263 (508)
..+|.+.+.||+|+||.||+|... +..+|+|.+.... ..+.+..|+.+++.++|+|++++++++. ++...++||||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~ 81 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 81 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEEC
Confidence 457889999999999999999876 7789999875443 3467889999999999999999999764 55678999999
Q ss_pred cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCCC
Q 010513 264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER 343 (508)
Q Consensus 264 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 343 (508)
+++++|.+++.... ...+++..++.++.|++.||+|||++ +++||||||+||++++++.+||+|||++.......
T Consensus 82 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~ 156 (256)
T cd05082 82 MAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 156 (256)
T ss_pred CCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceeccccC
Confidence 99999999997652 24588999999999999999999998 99999999999999999999999999988643221
Q ss_pred cceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHhhcccccccCCCccC
Q 010513 344 SYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRL 422 (508)
Q Consensus 344 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 422 (508)
....++..|+|||++.+..++.++|||||||++|||++ |+.||.... ..+..... .... .+..
T Consensus 157 ----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~------~~~~~~~~-~~~~-----~~~~ 220 (256)
T cd05082 157 ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP------LKDVVPRV-EKGY-----KMDA 220 (256)
T ss_pred ----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCC------HHHHHHHH-hcCC-----CCCC
Confidence 22344668999999998899999999999999999998 999986332 11211111 1110 0111
Q ss_pred CCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 010513 423 QEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461 (508)
Q Consensus 423 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~ 461 (508)
.+.++. .+.+++.+||+.||++||++.++++.|+.
T Consensus 221 -~~~~~~---~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 221 -PDGCPP---VVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred -CCCCCH---HHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 112333 44457889999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=321.58 Aligned_cols=263 Identities=22% Similarity=0.333 Sum_probs=198.6
Q ss_pred CCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCC-chhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEE
Q 010513 185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE 262 (508)
Q Consensus 185 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e 262 (508)
.++|++.+.||+|+||.||+|... +++.||+|.+.... ......+.+|+++++.++||||+++++++.++...++|||
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 84 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 84 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence 357999999999999999999975 57889999886432 2334467789999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCC
Q 010513 263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE 342 (508)
Q Consensus 263 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 342 (508)
|+++ +|.+++... ...+++..++.++.|+++||+|||+. +++||||||+||+++.++.+||+|||++......
T Consensus 85 ~~~~-~l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 157 (301)
T cd07873 85 YLDK-DLKQYLDDC---GNSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIP 157 (301)
T ss_pred cccc-CHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCC
Confidence 9974 999988765 34688999999999999999999998 9999999999999999999999999999764332
Q ss_pred CcceecceecCCCCCChhhhhc-CCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHh------------h
Q 010513 343 RSYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTM------------V 409 (508)
Q Consensus 343 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~------------~ 409 (508)
.. ......+++.|+|||.+.+ ..++.++|||||||++|||++|+.||...+... ........ .
T Consensus 158 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 233 (301)
T cd07873 158 TK-TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEE---QLHFIFRILGTPTEETWPGIL 233 (301)
T ss_pred CC-cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHcCCCChhhchhhh
Confidence 21 1223457899999998865 457889999999999999999999997543211 11111110 0
Q ss_pred cccccccCCCccCCCCc----hHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 410 TNRNAEGVLDPRLQEKP----CSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 410 ~~~~~~~~~~~~l~~~~----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
........-.+....+. .......+.+++.+||+.||++|||++|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h 286 (301)
T cd07873 234 SNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH 286 (301)
T ss_pred ccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 00000000001111100 01112345568889999999999999999974
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=312.04 Aligned_cols=254 Identities=29% Similarity=0.492 Sum_probs=199.8
Q ss_pred CCCcccceEcccCcEEEEEEEECC-C---cEEEEEEeecC-CchhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEE
Q 010513 186 NGFADENVIGEGGYGIVYHGVLED-N---TNVAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLV 260 (508)
Q Consensus 186 ~~~~~~~~LG~G~~g~Vy~~~~~~-~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 260 (508)
..|.+.+.||+|+||.||+|.+.. + ..||+|.+... .......|..|+.+++.++||||+++++++.++...++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 357889999999999999999653 3 35999988654 333456789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecC
Q 010513 261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG 340 (508)
Q Consensus 261 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 340 (508)
|||+++|+|.+++... .+.+++..++.++.|++.||+|||++ +++||||||+||+++.++.+||+|||++....
T Consensus 84 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~ 157 (269)
T cd05065 84 TEFMENGALDSFLRQN---DGQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 157 (269)
T ss_pred EecCCCCcHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCccccccc
Confidence 9999999999999765 34689999999999999999999998 99999999999999999999999999987654
Q ss_pred CCCcce--eccee--cCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHhhcccccc
Q 010513 341 AERSYV--TTRVM--GTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAE 415 (508)
Q Consensus 341 ~~~~~~--~~~~~--gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (508)
...... ..... .+..|+|||.+.+..++.++|||||||++|||++ |..||..... ....+++ ......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~---~~~~~~i---~~~~~~- 230 (269)
T cd05065 158 DDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN---QDVINAI---EQDYRL- 230 (269)
T ss_pred cCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCH---HHHHHHH---HcCCcC-
Confidence 322211 11111 2357999999999999999999999999999887 9999964321 1112211 111000
Q ss_pred cCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 010513 416 GVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461 (508)
Q Consensus 416 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~ 461 (508)
+ . ...++.. +.+++.+||+.+|++||++.++++.|++
T Consensus 231 ----~-~-~~~~~~~---~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 267 (269)
T cd05065 231 ----P-P-PMDCPTA---LHQLMLDCWQKDRNARPKFGQIVSTLDK 267 (269)
T ss_pred ----C-C-cccCCHH---HHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 0 0 1112333 4457889999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-39 Score=311.46 Aligned_cols=240 Identities=23% Similarity=0.393 Sum_probs=188.3
Q ss_pred ceEcccCcEEEEEEEECC-------------CcEEEEEEeecCCchhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeE
Q 010513 192 NVIGEGGYGIVYHGVLED-------------NTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM 258 (508)
Q Consensus 192 ~~LG~G~~g~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 258 (508)
+.||+|+||.||+|...+ ...+++|.+..........+.+|+.+++.++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 358999999999998532 2247888876555555567888999999999999999999999988999
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCC-------eEEe
Q 010513 259 LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWN-------PKLS 331 (508)
Q Consensus 259 lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~-------~kL~ 331 (508)
+||||+++|+|..++... ...+++..++.++.|+++||+|||++ +|+||||||+|||++.++. ++++
T Consensus 81 lv~e~~~~~~l~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l~ 154 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRK---SDVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLS 154 (262)
T ss_pred EEEecccCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEeC
Confidence 999999999999998754 35689999999999999999999999 9999999999999987664 8999
Q ss_pred eeccceecCCCCcceecceecCCCCCChhhhh-cCCCCCCCCeeehHHHHHHHH-hCCCCCCCCCCCCcchHHHHHHHhh
Q 010513 332 DFGLAKLLGAERSYVTTRVMGTFGYVAPEYAS-TGMLNERSDVYSFGILIMEVI-SGRNPVDYSRPPGEVNLVEWLKTMV 409 (508)
Q Consensus 332 DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwSlGvvl~ell-tg~~Pf~~~~~~~~~~~~~~~~~~~ 409 (508)
|||++...... ....|+..|+|||.+. +..++.++|||||||++|||+ +|..||....... . ....
T Consensus 155 d~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~------~-~~~~ 222 (262)
T cd05077 155 DPGIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE------K-ERFY 222 (262)
T ss_pred CCCCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH------H-HHHH
Confidence 99998754322 2245788999999886 467899999999999999998 5888886432211 0 1111
Q ss_pred cccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 010513 410 TNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 460 (508)
Q Consensus 410 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le 460 (508)
... . . . ..+.. .++.+++.+||+.||++||++.++++.++
T Consensus 223 ~~~-~-~-----~-~~~~~---~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 223 EGQ-C-M-----L-VTPSC---KELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred hcC-c-c-----C-CCCCh---HHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 110 0 0 0 01122 34556888999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-39 Score=326.86 Aligned_cols=208 Identities=24% Similarity=0.338 Sum_probs=177.2
Q ss_pred cchhhHhhcCCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCchhHHHHHHHHHHHHccC-C-----CCeeeEe
Q 010513 176 YTLRELEVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVR-H-----KNLVRLL 248 (508)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-----pniv~l~ 248 (508)
|.+..-+...-+|++.+.||+|+||.|-+|.+. +++.||||++++.. .-..+-..|+.+|..|+ | -|+|+++
T Consensus 176 Y~~v~~d~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~ 254 (586)
T KOG0667|consen 176 YQLVVNDHIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRML 254 (586)
T ss_pred eeEEecceeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEee
Confidence 444444444458999999999999999999965 68899999987654 33455566999999996 4 3899999
Q ss_pred eeeecCCeeEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCC--C
Q 010513 249 GYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQ--W 326 (508)
Q Consensus 249 ~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~--~ 326 (508)
++|...++.|||+|.+.. +|.++++.+. ...++...++.++.||+.||.+||+. +|||+||||+||||.+. .
T Consensus 255 d~F~fr~HlciVfELL~~-NLYellK~n~--f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~ 328 (586)
T KOG0667|consen 255 DYFYFRNHLCIVFELLST-NLYELLKNNK--FRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRS 328 (586)
T ss_pred eccccccceeeeehhhhh-hHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcC
Confidence 999999999999999976 9999998874 35699999999999999999999998 99999999999999643 4
Q ss_pred CeEEeeeccceecCCCCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCC
Q 010513 327 NPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSR 394 (508)
Q Consensus 327 ~~kL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~ 394 (508)
.+||+|||.++...... ....-+..|.|||++.+..|+.+.||||||||+.||++|.+-|.+.+
T Consensus 329 ~vKVIDFGSSc~~~q~v----ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~n 392 (586)
T KOG0667|consen 329 RIKVIDFGSSCFESQRV----YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDN 392 (586)
T ss_pred ceeEEecccccccCCcc----eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCC
Confidence 69999999999753322 14567889999999999999999999999999999999988887664
|
|
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=314.06 Aligned_cols=260 Identities=24% Similarity=0.440 Sum_probs=200.6
Q ss_pred CCCcccceEcccCcEEEEEEEE-----CCCcEEEEEEeecCC-chhHHHHHHHHHHHHccCCCCeeeEeeeeecC--Cee
Q 010513 186 NGFADENVIGEGGYGIVYHGVL-----EDNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEG--AHR 257 (508)
Q Consensus 186 ~~~~~~~~LG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--~~~ 257 (508)
.-|++.+.||+|+||.||+|.+ .++..||+|.+.... ......+.+|+++++.++||||+++++++.+. ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 3578899999999999999984 247789999986443 34456789999999999999999999998775 567
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccce
Q 010513 258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK 337 (508)
Q Consensus 258 ~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~ 337 (508)
++||||+++++|.+++.+. ...+++..+..++.|++.||+|||++ +++||||||+||+++.++.++|+|||+++
T Consensus 84 ~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRN---KNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTK 157 (284)
T ss_pred EEEEEccCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCcccc
Confidence 8999999999999999654 24689999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCcc--eecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCC---------CCcchHHHHHH
Q 010513 338 LLGAERSY--VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRP---------PGEVNLVEWLK 406 (508)
Q Consensus 338 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~---------~~~~~~~~~~~ 406 (508)
........ ......|+..|+|||++.+..++.++|||||||++|||++++.|+..... ...........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05079 158 AIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVR 237 (284)
T ss_pred ccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHH
Confidence 76433221 12234567789999999888899999999999999999998776532210 01111111111
Q ss_pred HhhcccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 010513 407 TMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461 (508)
Q Consensus 407 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~ 461 (508)
....... .+ . .... ...+.+++.+||+.||++||++.++++.|++
T Consensus 238 -~~~~~~~----~~-~-~~~~---~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~ 282 (284)
T cd05079 238 -VLEEGKR----LP-R-PPNC---PEEVYQLMRKCWEFQPSKRTTFQNLIEGFEA 282 (284)
T ss_pred -HHHcCcc----CC-C-CCCC---CHHHHHHHHHHccCCcccCcCHHHHHHHHHh
Confidence 1111110 00 0 1112 2345668889999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=311.81 Aligned_cols=247 Identities=27% Similarity=0.471 Sum_probs=195.6
Q ss_pred ceEcccCcEEEEEEEECC-C---cEEEEEEeecCCc-hhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEEecCC
Q 010513 192 NVIGEGGYGIVYHGVLED-N---TNVAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDN 266 (508)
Q Consensus 192 ~~LG~G~~g~Vy~~~~~~-~---~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~ 266 (508)
++||+|+||.||+|.+.. + ..+|+|.+..... ...+.+..|+++++.+.||||+++++++.. +..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEEEeCCC
Confidence 469999999999998542 2 5799998875543 345678899999999999999999998764 567999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCCCcce
Q 010513 267 GNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYV 346 (508)
Q Consensus 267 g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~ 346 (508)
|+|.+++... ..+++..++.++.|++.||+|||+. +++||||||+|||++.++.+||+|||+++.........
T Consensus 80 ~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~ 152 (257)
T cd05060 80 GPLLKYLKKR----REIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY 152 (257)
T ss_pred CcHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCccc
Confidence 9999999765 3689999999999999999999998 99999999999999999999999999998764433322
Q ss_pred ecc--eecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHhhcccccccCCCccCC
Q 010513 347 TTR--VMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQ 423 (508)
Q Consensus 347 ~~~--~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 423 (508)
... ..++..|+|||.+.+..++.++|||||||++|||++ |..||..... ......+. .... ...
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~---~~~~~~~~----~~~~------~~~ 219 (257)
T cd05060 153 RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG---AEVIAMLE----SGER------LPR 219 (257)
T ss_pred ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH---HHHHHHHH----cCCc------CCC
Confidence 211 223467999999998999999999999999999998 9999965432 11222211 1110 011
Q ss_pred CCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010513 424 EKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (508)
Q Consensus 424 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~~ 462 (508)
...++. .+.+++.+||+.||++||++.++++.|++.
T Consensus 220 ~~~~~~---~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 220 PEECPQ---EIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred CCCCCH---HHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 112333 344588899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=351.24 Aligned_cols=262 Identities=23% Similarity=0.369 Sum_probs=201.2
Q ss_pred hhhHhhcCCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecC--CchhHHHHHHHHHHHHccCCCCeeeEeeeeec-
Q 010513 178 LRELEVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE- 253 (508)
Q Consensus 178 ~~~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~- 253 (508)
+...+...++|++.+.||+|+||+||+|.+. ++..+|+|.+... .......+..|+.+++.++|||||+++++|.+
T Consensus 5 ~~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de 84 (1021)
T PTZ00266 5 YDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNK 84 (1021)
T ss_pred ccCCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEec
Confidence 3445566789999999999999999999976 4667888887543 22345678889999999999999999998854
Q ss_pred -CCeeEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC----CCCeeeccCCCCCEEEcC----
Q 010513 254 -GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGL----EPKVVHRDIKSSNILLDK---- 324 (508)
Q Consensus 254 -~~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~----~~~iiHrDlkp~NIll~~---- 324 (508)
...+|+||||+++|+|.++|.........+++..++.|+.||+.||+|||+.. ..+|+||||||+||||+.
T Consensus 85 ~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~ 164 (1021)
T PTZ00266 85 ANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRH 164 (1021)
T ss_pred CCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccc
Confidence 35689999999999999999764333467999999999999999999999851 025999999999999964
Q ss_pred -------------CCCeEEeeeccceecCCCCcceecceecCCCCCChhhhhc--CCCCCCCCeeehHHHHHHHHhCCCC
Q 010513 325 -------------QWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAST--GMLNERSDVYSFGILIMEVISGRNP 389 (508)
Q Consensus 325 -------------~~~~kL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlGvvl~elltg~~P 389 (508)
.+.+||+|||++..+.... ......||+.|+|||++.+ ..++.++|||||||+||||+||+.|
T Consensus 165 lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~P 242 (1021)
T PTZ00266 165 IGKITAQANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTP 242 (1021)
T ss_pred cccccccccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCC
Confidence 2348999999998654322 2234579999999999854 4588999999999999999999999
Q ss_pred CCCCCCCCcchHHHHHHHhhcccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 010513 390 VDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIH 457 (508)
Q Consensus 390 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 457 (508)
|..... ..+.+.. +... +.+.....+ .++.+++.+||+.+|++||++.++++
T Consensus 243 F~~~~~-----~~qli~~-lk~~-------p~lpi~~~S---~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 243 FHKANN-----FSQLISE-LKRG-------PDLPIKGKS---KELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred CCcCCc-----HHHHHHH-HhcC-------CCCCcCCCC---HHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 964321 1122211 1111 111111122 34555888999999999999999984
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-39 Score=317.98 Aligned_cols=250 Identities=25% Similarity=0.383 Sum_probs=203.2
Q ss_pred CCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCchhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEEec
Q 010513 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYI 264 (508)
Q Consensus 186 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~ 264 (508)
.+|++.+.||+|+||.||+|... +++.||+|.+........+.+..|+.+++.++|+||+++++++..+...++||||+
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 98 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence 57999999999999999999964 68899999987665555677888999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCCCc
Q 010513 265 DNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS 344 (508)
Q Consensus 265 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~ 344 (508)
++++|.+++.+. .+++..+..++.|++.||.|||+. +++||||||+|||++.++.++|+|||++........
T Consensus 99 ~~~~L~~~~~~~-----~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~ 170 (297)
T cd06656 99 AGGSLTDVVTET-----CMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (297)
T ss_pred CCCCHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccCCcc
Confidence 999999998643 578899999999999999999998 999999999999999999999999999986543322
Q ss_pred ceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCCccCCC
Q 010513 345 YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQE 424 (508)
Q Consensus 345 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 424 (508)
......|++.|+|||.+.+..++.++|+|||||++|+|++|+.||....+.... ....... .+...
T Consensus 171 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~------~~~~~~~------~~~~~- 236 (297)
T cd06656 171 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL------YLIATNG------TPELQ- 236 (297)
T ss_pred -CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhe------eeeccCC------CCCCC-
Confidence 223356889999999999888999999999999999999999999754332111 0000000 00000
Q ss_pred CchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 425 KPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 425 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
........+.+++.+||+.||++||++.+++++
T Consensus 237 -~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 237 -NPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred -CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 011122334457789999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-39 Score=349.33 Aligned_cols=260 Identities=21% Similarity=0.317 Sum_probs=200.6
Q ss_pred CCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCC---chhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEE
Q 010513 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY 261 (508)
Q Consensus 186 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 261 (508)
++|++.++||+|+||.||+|.+. +++.||+|++.... ....+.+.+|+++++.++||||+++++++.+++..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 57999999999999999999975 58899999986532 223457889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeec
Q 010513 262 EYIDNGNLEQWLHGDVG-------PHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFG 334 (508)
Q Consensus 262 e~~~~g~L~~~l~~~~~-------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG 334 (508)
||++||+|.+++..... .....++..++.++.|+++||+|||++ +|+||||||+|||++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecC
Confidence 99999999999864211 123456778899999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCc-----------------ceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCC
Q 010513 335 LAKLLGAERS-----------------YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPG 397 (508)
Q Consensus 335 ~a~~~~~~~~-----------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~ 397 (508)
+++....... ......+||+.|+|||.+.+..++.++|||||||++|||+||+.||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 9986621110 01123579999999999999999999999999999999999999996532110
Q ss_pred cchHHHHHHHhhcccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCC-CHHHHHHHHhcC
Q 010513 398 EVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRP-KMGHVIHMLEAE 462 (508)
Q Consensus 398 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~Le~~ 462 (508)
. . .... ..++.-. .+.......+.+++.+|++.||++|| +++++++.|+..
T Consensus 239 i---~--~~~~--------i~~P~~~-~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~ 290 (932)
T PRK13184 239 I---S--YRDV--------ILSPIEV-APYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPH 290 (932)
T ss_pred h---h--hhhh--------ccChhhc-cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 0 0 0000 0011000 00111123344588899999999996 577777777654
|
|
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=310.66 Aligned_cols=257 Identities=27% Similarity=0.456 Sum_probs=201.1
Q ss_pred HhhcCCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCchhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEE
Q 010513 181 LEVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRML 259 (508)
Q Consensus 181 ~~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 259 (508)
++..++.+.....||+|+||.||+|.+. ++..|++|.+........+.+.+|+++++.++|+||+++++++..++..++
T Consensus 3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 82 (268)
T cd06624 3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI 82 (268)
T ss_pred cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence 3456667777789999999999999965 577899998877666667789999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhccCCCCCCCC--CHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcC-CCCeEEeeeccc
Q 010513 260 VYEYIDNGNLEQWLHGDVGPHSPL--TWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDK-QWNPKLSDFGLA 336 (508)
Q Consensus 260 V~e~~~~g~L~~~l~~~~~~~~~l--~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~-~~~~kL~DFG~a 336 (508)
|+||+++++|.+++.... ..+ ++..+..++.|++.||+|||++ +|+||||||+||+++. ++.++|+|||++
T Consensus 83 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~ 156 (268)
T cd06624 83 FMEQVPGGSLSALLRSKW---GPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTS 156 (268)
T ss_pred EEecCCCCCHHHHHHHhc---ccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhh
Confidence 999999999999997642 334 7888899999999999999998 9999999999999976 678999999998
Q ss_pred eecCCCCcceecceecCCCCCChhhhhcCC--CCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhccccc
Q 010513 337 KLLGAERSYVTTRVMGTFGYVAPEYASTGM--LNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNA 414 (508)
Q Consensus 337 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 414 (508)
........ ......|++.|+|||++.+.. ++.++|+||||+++|+|++|+.||........ ..+ ..... +
T Consensus 157 ~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~---~~~-~~~~~-~-- 228 (268)
T cd06624 157 KRLAGINP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA---AMF-KVGMF-K-- 228 (268)
T ss_pred eecccCCC-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh---hHh-hhhhh-c--
Confidence 76543222 222345889999999986543 78899999999999999999999964322111 000 00000 0
Q ss_pred ccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 415 EGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 415 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
..+.+.. ....++.+++.+||+.+|++||++.+++++
T Consensus 229 ---~~~~~~~----~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 229 ---IHPEIPE----SLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred ---cCCCCCc----ccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 0111111 122334557889999999999999999865
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=309.15 Aligned_cols=251 Identities=27% Similarity=0.448 Sum_probs=199.2
Q ss_pred CCcccceEcccCcEEEEEEEECCCcEEEEEEeecCCc------hhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEE
Q 010513 187 GFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRG------QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLV 260 (508)
Q Consensus 187 ~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 260 (508)
+|++.+.||+|+||+||+|...+++.+|+|.+..... .....+.+|+++++.++|+||+++++++.+....++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 4778899999999999999988888999998854321 2234688899999999999999999999999999999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecC
Q 010513 261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG 340 (508)
Q Consensus 261 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 340 (508)
|||+++++|.+++.+. ..+++..++.++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++....
T Consensus 81 ~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 153 (265)
T cd06631 81 MEFVPGGSISSILNRF----GPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLA 153 (265)
T ss_pred EecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhh
Confidence 9999999999999764 4688999999999999999999998 99999999999999999999999999987653
Q ss_pred CCC-----cceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccc
Q 010513 341 AER-----SYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAE 415 (508)
Q Consensus 341 ~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (508)
... ........|+..|+|||++.+..++.++|+|||||++|+|++|+.||...+.. ... .......
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~-----~~~-~~~~~~~--- 224 (265)
T cd06631 154 WVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRL-----AAM-FYIGAHR--- 224 (265)
T ss_pred hccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChH-----HHH-HHhhhcc---
Confidence 211 11122346899999999999888999999999999999999999999643221 111 1111100
Q ss_pred cCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 416 GVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 416 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
...+.+.. ..+ .++.+++.+||+.+|++||++.+++++
T Consensus 225 -~~~~~~~~-~~~---~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 262 (265)
T cd06631 225 -GLMPRLPD-SFS---AAAIDFVTSCLTRDQHERPSALQLLRH 262 (265)
T ss_pred -CCCCCCCC-CCC---HHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 01111111 123 334557789999999999999999853
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=326.01 Aligned_cols=262 Identities=27% Similarity=0.321 Sum_probs=196.5
Q ss_pred CCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecC--CchhHHHHHHHHHHHHccCCCCeeeEeeeeecC------C
Q 010513 185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEG------A 255 (508)
Q Consensus 185 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~------~ 255 (508)
.++|.+.+.||+|+||.||+|... .++.||||++... .......+.+|+.+++.++||||+++++++... .
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 468999999999999999999965 5788999998653 233445677899999999999999999987543 3
Q ss_pred eeEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeecc
Q 010513 256 HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGL 335 (508)
Q Consensus 256 ~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~ 335 (508)
..|+||||+++ +|.+++.. .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 103 ~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~ 172 (364)
T cd07875 103 DVYIVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 172 (364)
T ss_pred eEEEEEeCCCC-CHHHHHHh------cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCCC
Confidence 57999999976 78877743 478889999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchH------------HH
Q 010513 336 AKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNL------------VE 403 (508)
Q Consensus 336 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~------------~~ 403 (508)
++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...+....... ..
T Consensus 173 a~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (364)
T cd07875 173 ARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMK 250 (364)
T ss_pred ccccCCC--CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 9865332 223345789999999999999999999999999999999999999975432111000 00
Q ss_pred HH----HHhhccccc-ccC----CCccC--C--CCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 404 WL----KTMVTNRNA-EGV----LDPRL--Q--EKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 404 ~~----~~~~~~~~~-~~~----~~~~l--~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
.+ .....++.. ... +.+.. . ..........+.+++.+||+.||++|||+.+++++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 251 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred hhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00 000001000 000 00000 0 00001112355668889999999999999999985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=311.76 Aligned_cols=249 Identities=25% Similarity=0.399 Sum_probs=202.7
Q ss_pred CCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCC-chhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEEe
Q 010513 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY 263 (508)
Q Consensus 186 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~ 263 (508)
++|++.+.||.|+||.||+|.+. +++.||+|.+.... ......+.+|+++++.++|+||+++++++.++...++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 46888999999999999999965 57889999886543 34456788899999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCCC
Q 010513 264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER 343 (508)
Q Consensus 264 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 343 (508)
+++++|.+++... .+++..++.++.|++.|+.|||++ +++||||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~L~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 152 (274)
T cd06609 81 CGGGSCLDLLKPG-----KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM 152 (274)
T ss_pred eCCCcHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeecccc
Confidence 9999999998753 789999999999999999999998 99999999999999999999999999998765432
Q ss_pred cceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCCccCC
Q 010513 344 SYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQ 423 (508)
Q Consensus 344 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 423 (508)
.......|++.|+|||.+.+..++.++|||||||++|+|+||+.||....+. +...... .. ..+.+.
T Consensus 153 -~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~------~~~~~~~-~~-----~~~~~~ 219 (274)
T cd06609 153 -SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPM------RVLFLIP-KN-----NPPSLE 219 (274)
T ss_pred -cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchH------HHHHHhh-hc-----CCCCCc
Confidence 2223456888999999999888999999999999999999999999754321 1111111 11 111111
Q ss_pred CCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 424 EKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 424 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
....+. .+.+++.+||..||++||++++++++
T Consensus 220 ~~~~~~---~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 220 GNKFSK---PFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred ccccCH---HHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 111222 34557789999999999999999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=306.00 Aligned_cols=250 Identities=21% Similarity=0.340 Sum_probs=200.1
Q ss_pred CCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCC--chhHHHHHHHHHHHHccCCCCeeeEeeeeec-CCeeEEEEE
Q 010513 187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE-GAHRMLVYE 262 (508)
Q Consensus 187 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~~lV~e 262 (508)
+|++.+.||+|++|.||++..+ +++.||+|++.... ....+.+..|+++++.++|+|++++++.+.. +...+++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4889999999999999999965 57789999986432 2345568889999999999999999998864 446789999
Q ss_pred ecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCC
Q 010513 263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE 342 (508)
Q Consensus 263 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 342 (508)
|+++++|.+++.... ...+++..++.++.|++.|++|||++ +++||||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~l~~~l~~~~--~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~ 155 (257)
T cd08223 81 FCEGGDLYHKLKEQK--GKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ 155 (257)
T ss_pred ccCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEeccc
Confidence 999999999997642 34689999999999999999999999 9999999999999999999999999999876432
Q ss_pred CcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCCccC
Q 010513 343 RSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRL 422 (508)
Q Consensus 343 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 422 (508)
.. ......|++.|+|||++.+..++.++|+|||||++|+|++|+.||...+ ........... . + +..
T Consensus 156 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~------~~~~~~~~~~~-~----~-~~~ 222 (257)
T cd08223 156 CD-MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD------MNSLVYRIIEG-K----L-PPM 222 (257)
T ss_pred CC-ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC------HHHHHHHHHhc-C----C-CCC
Confidence 22 2334568999999999999999999999999999999999999996432 11222222111 1 1 111
Q ss_pred CCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 423 QEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 423 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
.......+.+++.+|++.||++||++.+++++
T Consensus 223 ----~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 223 ----PKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred ----ccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 11223345568889999999999999999865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=312.81 Aligned_cols=253 Identities=23% Similarity=0.339 Sum_probs=203.1
Q ss_pred cCCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCchhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEE
Q 010513 184 STNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE 262 (508)
Q Consensus 184 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e 262 (508)
+.++|++.+.||+|+||.||+|... ++..+|+|.+........+.+..|++++++++||||+++++++.++...|+|||
T Consensus 3 ~~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (280)
T cd06611 3 PNDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIE 82 (280)
T ss_pred chhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEee
Confidence 3467999999999999999999975 578899999876665666788899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCC
Q 010513 263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE 342 (508)
Q Consensus 263 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 342 (508)
|+++++|.+++... ...+++..++.++.|++.||.|||++ +++|+||||+||+++.++.++|+|||++......
T Consensus 83 ~~~~~~L~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 156 (280)
T cd06611 83 FCDGGALDSIMLEL---ERGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKST 156 (280)
T ss_pred ccCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhccc
Confidence 99999999998764 24689999999999999999999999 9999999999999999999999999988764332
Q ss_pred CcceecceecCCCCCChhhhh-----cCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccC
Q 010513 343 RSYVTTRVMGTFGYVAPEYAS-----TGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGV 417 (508)
Q Consensus 343 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 417 (508)
. .......|++.|+|||.+. ...++.++|+|||||++|||++|+.||...... +.+...... .
T Consensus 157 ~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~-~---- 224 (280)
T cd06611 157 L-QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM------RVLLKILKS-E---- 224 (280)
T ss_pred c-cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH------HHHHHHhcC-C----
Confidence 2 1223456899999999875 345778999999999999999999999744221 111111111 0
Q ss_pred CCccCC-CCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 418 LDPRLQ-EKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 418 ~~~~l~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
.+.+. ....+. ++.+++.+||+.||++||++.+++++
T Consensus 225 -~~~~~~~~~~~~---~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 225 -PPTLDQPSKWSS---SFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred -CCCcCCcccCCH---HHHHHHHHHhccChhhCcCHHHHhcC
Confidence 11111 111223 34457789999999999999999875
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=308.44 Aligned_cols=248 Identities=26% Similarity=0.423 Sum_probs=198.6
Q ss_pred ceEcccCcEEEEEEEECC--Cc--EEEEEEeecCCc-hhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEEecCC
Q 010513 192 NVIGEGGYGIVYHGVLED--NT--NVAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDN 266 (508)
Q Consensus 192 ~~LG~G~~g~Vy~~~~~~--~~--~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~ 266 (508)
+.||+|+||.||+|.+.+ ++ .||+|.+..... ...+.+..|++++++++||||+++++++.+ ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999999653 22 589999877655 566789999999999999999999999988 888999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCCCcc-
Q 010513 267 GNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSY- 345 (508)
Q Consensus 267 g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~- 345 (508)
|+|.+++..... ..+++..++.++.|++.||+|||++ +++||||||+||+++.++.+||+|||++.........
T Consensus 80 ~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 154 (257)
T cd05040 80 GSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY 154 (257)
T ss_pred CcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccccccccce
Confidence 999999977532 5689999999999999999999999 9999999999999999999999999999876442221
Q ss_pred -eecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHhhcccccccCCCccCC
Q 010513 346 -VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQ 423 (508)
Q Consensus 346 -~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 423 (508)
......++..|+|||.+.+..++.++|||||||++|||++ |+.||...+. .+.......... ... .
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~------~~~~~~~~~~~~--~~~----~ 222 (257)
T cd05040 155 VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSG------SQILKKIDKEGE--RLE----R 222 (257)
T ss_pred ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHHHhcCC--cCC----C
Confidence 1122457789999999999999999999999999999999 9999964322 122221111110 000 1
Q ss_pred CCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 010513 424 EKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 460 (508)
Q Consensus 424 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le 460 (508)
.... ...+.+++.+||+.+|++||++.++++.|.
T Consensus 223 ~~~~---~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 223 PEAC---PQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred CccC---CHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 1112 234556888999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=314.98 Aligned_cols=251 Identities=24% Similarity=0.379 Sum_probs=203.5
Q ss_pred CCCCcccceEcccCcEEEEEEEE-CCCcEEEEEEeecCCchhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEEe
Q 010513 185 TNGFADENVIGEGGYGIVYHGVL-EDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY 263 (508)
Q Consensus 185 ~~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~ 263 (508)
..+|++.+.||.|+||.||+|.. .+++.|++|.+........+.+.+|+++++.++||||+++++++.++...++|+||
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 97 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEY 97 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEe
Confidence 35699999999999999999986 46889999998766555667888999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCCC
Q 010513 264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER 343 (508)
Q Consensus 264 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 343 (508)
+++++|.+++... .+++..+..++.|++.||+|||++ +++||||||+||+++.++.+||+|||++.......
T Consensus 98 ~~~~~L~~~~~~~-----~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~ 169 (296)
T cd06655 98 LAGGSLTDVVTET-----CMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ 169 (296)
T ss_pred cCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhccccc
Confidence 9999999998643 589999999999999999999999 99999999999999999999999999988654332
Q ss_pred cceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCCccCC
Q 010513 344 SYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQ 423 (508)
Q Consensus 344 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 423 (508)
. ......|++.|+|||.+.+..++.++|+|||||++|+|++|+.||....+. ........... .... .
T Consensus 170 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~------~~~~~~~~~~~-~~~~----~ 237 (296)
T cd06655 170 S-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL------RALYLIATNGT-PELQ----N 237 (296)
T ss_pred c-cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhcCC-cccC----C
Confidence 2 223346889999999999888999999999999999999999999754321 11111111110 0000 0
Q ss_pred CCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 424 EKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 424 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
....+. .+.+++.+||+.||++||++.+++++
T Consensus 238 ~~~~~~---~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 238 PEKLSP---IFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred cccCCH---HHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 111222 34457789999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=311.93 Aligned_cols=253 Identities=26% Similarity=0.395 Sum_probs=197.8
Q ss_pred cCCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCchhHHHHHHHHHHHHcc-CCCCeeeEeeeeecC------C
Q 010513 184 STNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEG------A 255 (508)
Q Consensus 184 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~------~ 255 (508)
+.+.|++.+.||+|+||.||+|... +++.||+|.+.... .....+..|+.++..+ +|+||+++++++... .
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 82 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence 4567899999999999999999965 57789999886543 3446788899999998 799999999998753 4
Q ss_pred eeEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeecc
Q 010513 256 HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGL 335 (508)
Q Consensus 256 ~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~ 335 (508)
..|+||||+.+|+|.+++.... ...+++..++.++.|++.||+|||++ +++||||||+||++++++.++|+|||+
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~--~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg~ 157 (272)
T cd06637 83 QLWLVMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGV 157 (272)
T ss_pred EEEEEEEcCCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCCC
Confidence 6789999999999999987642 34689999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCcceecceecCCCCCChhhhh-----cCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhc
Q 010513 336 AKLLGAERSYVTTRVMGTFGYVAPEYAS-----TGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVT 410 (508)
Q Consensus 336 a~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~ 410 (508)
+....... .......|++.|+|||++. +..++.++|+|||||++|||++|..||....+.. .. .....
T Consensus 158 ~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~-----~~-~~~~~ 230 (272)
T cd06637 158 SAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR-----AL-FLIPR 230 (272)
T ss_pred ceeccccc-ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHH-----HH-HHHhc
Confidence 98653322 1223457899999999885 3458889999999999999999999996433211 11 11111
Q ss_pred ccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 411 NRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 411 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
. ..+.......+. .+.+++.+||+.||.+||++.+++++
T Consensus 231 -~-----~~~~~~~~~~~~---~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 231 -N-----PAPRLKSKKWSK---KFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred -C-----CCCCCCCCCcCH---HHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 0 011111112233 34557889999999999999999864
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=311.74 Aligned_cols=247 Identities=24% Similarity=0.388 Sum_probs=201.5
Q ss_pred CCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCC-chhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEEec
Q 010513 187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYI 264 (508)
Q Consensus 187 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~ 264 (508)
.|+..+.||.|+||.||+|.+. ++..||+|.+.... ......+.+|+++++.+.||||+++++++.++...++||||+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence 5778899999999999999975 57889999886543 344567889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCCCc
Q 010513 265 DNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS 344 (508)
Q Consensus 265 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~ 344 (508)
++|+|.+++.. .++++.....++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++........
T Consensus 85 ~~~~L~~~i~~-----~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06640 85 GGGSALDLLRA-----GPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence 99999999864 3588899999999999999999998 999999999999999999999999999986643322
Q ss_pred ceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCCccCCC
Q 010513 345 YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQE 424 (508)
Q Consensus 345 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 424 (508)
......++..|+|||++.+..++.++|+|||||++|||++|..||....+... ...... ...+.
T Consensus 157 -~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~------~~~~~~------~~~~~--- 220 (277)
T cd06640 157 -KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRV------LFLIPK------NNPPT--- 220 (277)
T ss_pred -ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhH------hhhhhc------CCCCC---
Confidence 22334688899999999888899999999999999999999999975432111 111000 00111
Q ss_pred CchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 425 KPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 425 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
........+.+++.+||+.+|++||++.+++++
T Consensus 221 -~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 221 -LTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred -CchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 122334455668889999999999999999876
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=307.94 Aligned_cols=254 Identities=26% Similarity=0.368 Sum_probs=191.5
Q ss_pred ceEcccCcEEEEEEEECC---CcEEEEEEeecCCc-hhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEEecCCC
Q 010513 192 NVIGEGGYGIVYHGVLED---NTNVAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNG 267 (508)
Q Consensus 192 ~~LG~G~~g~Vy~~~~~~---~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~g 267 (508)
+.||+|+||.||+|.+.+ +..+|+|.+..... .....+.+|+.+++.++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 358999999999998643 45689998865433 33457888999999999999999999999988999999999999
Q ss_pred CHHHHhccCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCCCcce
Q 010513 268 NLEQWLHGDVG-PHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYV 346 (508)
Q Consensus 268 ~L~~~l~~~~~-~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~ 346 (508)
+|.+++..... .....++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||++..........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 99999975422 123567778889999999999999998 99999999999999999999999999997543322211
Q ss_pred -ecceecCCCCCChhhhhcC-------CCCCCCCeeehHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHhhcccccccC
Q 010513 347 -TTRVMGTFGYVAPEYASTG-------MLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGV 417 (508)
Q Consensus 347 -~~~~~gt~~y~aPE~~~~~-------~~~~~sDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 417 (508)
.....|+..|+|||++.+. .++.++|+||||+++|||++ |+.||....+.. .. ..... ......
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~---~~---~~~~~-~~~~~~ 230 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ---VL---TYTVR-EQQLKL 230 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHH---HH---HHHhh-cccCCC
Confidence 2234678889999988642 35789999999999999996 999996543221 11 11111 111122
Q ss_pred CCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 010513 418 LDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 460 (508)
Q Consensus 418 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le 460 (508)
.++.+.. ..+.. +.+++.+|+ .+|++||++++|++.|+
T Consensus 231 ~~~~~~~-~~~~~---~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 231 PKPRLKL-PLSDR---WYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCccCC-CCChH---HHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 2222221 12233 344777998 68999999999999885
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=321.00 Aligned_cols=264 Identities=26% Similarity=0.438 Sum_probs=205.6
Q ss_pred HhhcCCCCcccceEcccCcEEEEEEEECC--------CcEEEEEEeecCC-chhHHHHHHHHHHHHcc-CCCCeeeEeee
Q 010513 181 LEVSTNGFADENVIGEGGYGIVYHGVLED--------NTNVAVKNLLNNR-GQAEKEFKVEVEAIGRV-RHKNLVRLLGY 250 (508)
Q Consensus 181 ~~~~~~~~~~~~~LG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~l~~~ 250 (508)
+++...+|++.+.||+|+||.||+|.+.. ...||+|.+.... ....+++.+|+++++++ +||||++++++
T Consensus 7 ~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 86 (334)
T cd05100 7 WELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGA 86 (334)
T ss_pred cccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEE
Confidence 35556689999999999999999997421 2368999876443 23456788999999999 89999999999
Q ss_pred eecCCeeEEEEEecCCCCHHHHhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCC
Q 010513 251 CAEGAHRMLVYEYIDNGNLEQWLHGDVG------------PHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSS 318 (508)
Q Consensus 251 ~~~~~~~~lV~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~ 318 (508)
+.++...+++|||+++|+|.+++..... ....+++..++.++.|++.||+|||++ +++||||||+
T Consensus 87 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~ 163 (334)
T cd05100 87 CTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAAR 163 (334)
T ss_pred EccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---Ceeccccccc
Confidence 9999999999999999999999975421 234578899999999999999999998 9999999999
Q ss_pred CEEEcCCCCeEEeeeccceecCCCCcce-ecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHh-CCCCCCCCCCC
Q 010513 319 NILLDKQWNPKLSDFGLAKLLGAERSYV-TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPP 396 (508)
Q Consensus 319 NIll~~~~~~kL~DFG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~Pf~~~~~~ 396 (508)
|||++.++.+||+|||+++......... .....++..|+|||++.+..++.++|||||||++|||++ |..||....
T Consensus 164 Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~-- 241 (334)
T cd05100 164 NVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP-- 241 (334)
T ss_pred eEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCC--
Confidence 9999999999999999998664332221 122234567999999999999999999999999999998 889986432
Q ss_pred CcchHHHHHHHhhcccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 010513 397 GEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEE 463 (508)
Q Consensus 397 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~~~ 463 (508)
..+...... ..... ... ..++ .++.+++.+||+.+|++||++.++++.|+...
T Consensus 242 ----~~~~~~~~~-~~~~~-----~~~-~~~~---~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~ 294 (334)
T cd05100 242 ----VEELFKLLK-EGHRM-----DKP-ANCT---HELYMIMRECWHAVPSQRPTFKQLVEDLDRVL 294 (334)
T ss_pred ----HHHHHHHHH-cCCCC-----CCC-CCCC---HHHHHHHHHHcccChhhCcCHHHHHHHHHHHh
Confidence 222222221 11100 011 1122 34556888999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-39 Score=323.27 Aligned_cols=240 Identities=23% Similarity=0.268 Sum_probs=184.8
Q ss_pred EcccCcEEEEEEEEC-CCcEEEEEEeecCCc---hhHHHHHHHHHHHHcc---CCCCeeeEeeeeecCCeeEEEEEecCC
Q 010513 194 IGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG---QAEKEFKVEVEAIGRV---RHKNLVRLLGYCAEGAHRMLVYEYIDN 266 (508)
Q Consensus 194 LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l---~hpniv~l~~~~~~~~~~~lV~e~~~~ 266 (508)
||+|+||+||+|+.. +++.||+|.+.+... .....+..|..++... .||||+++++++.+.+..|+||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 699999999999975 588999999864322 1223344566666655 699999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCCCcce
Q 010513 267 GNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYV 346 (508)
Q Consensus 267 g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~ 346 (508)
|+|.+++... ..+++..++.++.|+++||+|||++ +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~l~~~----~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~-~~ 152 (330)
T cd05586 81 GELFWHLQKE----GRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDN-KT 152 (330)
T ss_pred ChHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC-CC
Confidence 9999998764 5689999999999999999999999 99999999999999999999999999987542222 22
Q ss_pred ecceecCCCCCChhhhhcC-CCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCCccCCCC
Q 010513 347 TTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEK 425 (508)
Q Consensus 347 ~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 425 (508)
....+||+.|+|||++.+. .++.++|||||||++|||++|+.||..... .+..+.... .. ..+...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~------~~~~~~i~~-~~------~~~~~~ 219 (330)
T cd05586 153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT------QQMYRNIAF-GK------VRFPKN 219 (330)
T ss_pred ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCH------HHHHHHHHc-CC------CCCCCc
Confidence 3346799999999998754 489999999999999999999999964321 122222111 11 111111
Q ss_pred chHHHHHHHHHHHHHccCCCCCCCCC----HHHHHH
Q 010513 426 PCSRALKRALLVALRCVDPNAHKRPK----MGHVIH 457 (508)
Q Consensus 426 ~~~~~~~~l~~li~~cl~~dP~~RPs----~~evl~ 457 (508)
..+.. +.+++.+||+.||++||+ +.++++
T Consensus 220 ~~~~~---~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 220 VLSDE---GRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred cCCHH---HHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 12333 344777999999999984 556554
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-39 Score=312.74 Aligned_cols=249 Identities=24% Similarity=0.430 Sum_probs=192.4
Q ss_pred ceEcccCcEEEEEEEECC-Cc--EEEEEEeecCC-chhHHHHHHHHHHHHcc-CCCCeeeEeeeeecCCeeEEEEEecCC
Q 010513 192 NVIGEGGYGIVYHGVLED-NT--NVAVKNLLNNR-GQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYIDN 266 (508)
Q Consensus 192 ~~LG~G~~g~Vy~~~~~~-~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lV~e~~~~ 266 (508)
+.||+|+||.||+|.+.+ +. .+++|.+.... ....+.+..|++++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 368999999999999754 33 46888776433 34456788999999999 899999999999999999999999999
Q ss_pred CCHHHHhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeec
Q 010513 267 GNLEQWLHGDVG------------PHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFG 334 (508)
Q Consensus 267 g~L~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG 334 (508)
|+|.+++..... ....+++..++.++.|++.||+|||+. +++||||||+||++++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCC
Confidence 999999975421 123578999999999999999999998 99999999999999999999999999
Q ss_pred cceecCCCCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHhhcccc
Q 010513 335 LAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRN 413 (508)
Q Consensus 335 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 413 (508)
++..... .........+..|+|||++....++.++|+|||||++|||++ |..||..... .+..........
T Consensus 158 l~~~~~~--~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~------~~~~~~~~~~~~ 229 (270)
T cd05047 158 LSRGQEV--YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC------AELYEKLPQGYR 229 (270)
T ss_pred Cccccch--hhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCH------HHHHHHHhCCCC
Confidence 9863211 111111233567999999988899999999999999999997 9999964321 111121111100
Q ss_pred cccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 010513 414 AEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461 (508)
Q Consensus 414 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~ 461 (508)
.... ...+ ..+.+++.+||+.||.+||++.++++.|+.
T Consensus 230 ------~~~~-~~~~---~~~~~li~~~l~~~p~~Rps~~~il~~l~~ 267 (270)
T cd05047 230 ------LEKP-LNCD---DEVYDLMRQCWREKPYERPSFAQILVSLNR 267 (270)
T ss_pred ------CCCC-CcCC---HHHHHHHHHHcccChhhCCCHHHHHHHHHH
Confidence 0011 1122 345568889999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=314.33 Aligned_cols=263 Identities=22% Similarity=0.314 Sum_probs=197.0
Q ss_pred CCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCC--chhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEEe
Q 010513 187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY 263 (508)
Q Consensus 187 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~ 263 (508)
+|++.+.||+|+||.||+|+.. ++..||+|++.... ....+.+.+|+.+++.++||||+++++++.++...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4788899999999999999975 68889999885432 22346778899999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCCC
Q 010513 264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER 343 (508)
Q Consensus 264 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 343 (508)
++ ++|.+++.... ....+++..++.++.|+++||+|||++ +++||||||+||+++.++.+||+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 155 (285)
T cd07861 81 LS-MDLKKYLDSLP-KGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV 155 (285)
T ss_pred CC-CCHHHHHhcCC-CCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence 97 58999886542 235689999999999999999999999 99999999999999999999999999998654322
Q ss_pred cceecceecCCCCCChhhhhcC-CCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcc--c--------
Q 010513 344 SYVTTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTN--R-------- 412 (508)
Q Consensus 344 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~--~-------- 412 (508)
. ......+++.|+|||.+.+. .++.++|+|||||++|+|+||+.||....... ............ .
T Consensus 156 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 232 (285)
T cd07861 156 R-VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEID--QLFRIFRILGTPTEDVWPGVTSL 232 (285)
T ss_pred c-cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHHHHhCCCChhhhhcchhh
Confidence 1 22234678899999988654 57889999999999999999999997543211 011100000000 0
Q ss_pred -----ccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 413 -----NAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 413 -----~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
.........+.. .......++.+++.+||+.||++||++.+++++
T Consensus 233 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 233 PDYKNTFPKWKKGSLRS-AVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred HHHHhhccccCcchhHH-hcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 000000000000 000112344568889999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=311.02 Aligned_cols=264 Identities=25% Similarity=0.385 Sum_probs=203.4
Q ss_pred chhhHhhcCCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCchhHHHHHHHHHHHHcc-CCCCeeeEeeeee--
Q 010513 177 TLRELEVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV-RHKNLVRLLGYCA-- 252 (508)
Q Consensus 177 ~~~~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~-- 252 (508)
.++.+....++|++.+.||+|+||.||+|... +++.+|+|.+.... .....+..|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 87 (286)
T cd06638 9 IFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKK 87 (286)
T ss_pred EeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeec
Confidence 34555667889999999999999999999965 57889999875432 2345678899999999 6999999999874
Q ss_pred ---cCCeeEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeE
Q 010513 253 ---EGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPK 329 (508)
Q Consensus 253 ---~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~k 329 (508)
.+...++||||+++++|.+++.........+++..+..++.|+++||.|||+. +++||||||+||+++.++.+|
T Consensus 88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~k 164 (286)
T cd06638 88 DVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVK 164 (286)
T ss_pred ccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCEE
Confidence 44578999999999999998865433345788999999999999999999998 999999999999999999999
Q ss_pred EeeeccceecCCCCcceecceecCCCCCChhhhhc-----CCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHH
Q 010513 330 LSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAST-----GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEW 404 (508)
Q Consensus 330 L~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~ 404 (508)
|+|||++....... .......|++.|+|||++.. ..++.++|||||||++|||++|+.||....+.. .
T Consensus 165 l~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~------~ 237 (286)
T cd06638 165 LVDFGVSAQLTSTR-LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR------A 237 (286)
T ss_pred EccCCceeecccCC-CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH------H
Confidence 99999998664322 22233468999999998753 457889999999999999999999997543211 1
Q ss_pred HHHhhcccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 010513 405 LKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHML 459 (508)
Q Consensus 405 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 459 (508)
+..... .......++ ...+ ..+.+++.+||+.||++||++.|+++++
T Consensus 238 ~~~~~~-~~~~~~~~~----~~~~---~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 238 LFKIPR-NPPPTLHQP----ELWS---NEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred Hhhccc-cCCCcccCC----CCcC---HHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 111110 000011111 1122 2455588899999999999999999763
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=308.35 Aligned_cols=249 Identities=25% Similarity=0.445 Sum_probs=198.3
Q ss_pred CCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCch---------hHHHHHHHHHHHHccCCCCeeeEeeeeecCCe
Q 010513 187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQ---------AEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAH 256 (508)
Q Consensus 187 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---------~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 256 (508)
+|.+...||+|+||.||+|... +++.+|+|.+...... ..+.+.+|++++++++||||+++++++.+...
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 4677889999999999999965 5788999988543221 22567889999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccc
Q 010513 257 RMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLA 336 (508)
Q Consensus 257 ~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a 336 (508)
.++||||+++++|.+++... ..+++..+..++.|++.||+|||++ +++||||||+||++++++.++|+|||++
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~ 153 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNY----GAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGIS 153 (267)
T ss_pred cEEEEEecCCCCHHHHHHhc----cCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCC
Confidence 99999999999999999764 4688999999999999999999998 9999999999999999999999999999
Q ss_pred eecCCCCcc-----eecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcc
Q 010513 337 KLLGAERSY-----VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTN 411 (508)
Q Consensus 337 ~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~ 411 (508)
+........ ......|+..|+|||.+.+..++.++|+|||||++|+|++|+.||..... .........
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~- 226 (267)
T cd06628 154 KKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQ------LQAIFKIGE- 226 (267)
T ss_pred cccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccH------HHHHHHHhc-
Confidence 876422111 11234588899999999988899999999999999999999999974321 111111111
Q ss_pred cccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 412 RNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 412 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
...+.+... .+ ..+.+++.+||+.||++||++.+++++
T Consensus 227 -----~~~~~~~~~-~~---~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 227 -----NASPEIPSN-IS---SEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred -----cCCCcCCcc-cC---HHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 111112111 22 344457779999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-39 Score=314.40 Aligned_cols=247 Identities=26% Similarity=0.423 Sum_probs=199.5
Q ss_pred CCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCC-chhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEEec
Q 010513 187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYI 264 (508)
Q Consensus 187 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~ 264 (508)
.|+..+.||+|+||.||+|.+. ++..||+|.+.... ....+.+..|+++++.++||||+++++++..+...++||||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 4677888999999999999865 57789999876443 344567889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCCCc
Q 010513 265 DNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS 344 (508)
Q Consensus 265 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~ 344 (508)
++++|.+++.. ..+++..++.++.|+++|+.|||++ +++|+||+|+||++++++.++|+|||++.......
T Consensus 85 ~~~~L~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~- 155 (277)
T cd06642 85 GGGSALDLLKP-----GPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ- 155 (277)
T ss_pred CCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcc-
Confidence 99999999854 3688999999999999999999998 99999999999999999999999999998654322
Q ss_pred ceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCCccCCC
Q 010513 345 YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQE 424 (508)
Q Consensus 345 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 424 (508)
.......|+..|+|||.+.+..++.++|+|||||++|||++|+.||....+.. .... .... ..+.+.
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~------~~~~-~~~~-----~~~~~~- 222 (277)
T cd06642 156 IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR------VLFL-IPKN-----SPPTLE- 222 (277)
T ss_pred hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh------HHhh-hhcC-----CCCCCC-
Confidence 12223468889999999999899999999999999999999999986432211 1111 1111 111111
Q ss_pred CchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 425 KPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 425 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
......+.+++.+||+.+|++||++.+++++
T Consensus 223 ---~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 223 ---GQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred ---cccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 1223345568889999999999999999986
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=304.72 Aligned_cols=251 Identities=23% Similarity=0.375 Sum_probs=203.5
Q ss_pred CCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecC--CchhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEEe
Q 010513 187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY 263 (508)
Q Consensus 187 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~ 263 (508)
+|+..+.||+|+||.||.++.. ++..+++|.+... .....+.+.+|++++++++|+||+++++++.+....+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 5888999999999999999954 5888999987543 234456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCCC
Q 010513 264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER 343 (508)
Q Consensus 264 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 343 (508)
+++|+|.+++.... ...+++..+..++.|++.||.|||+. +++||||||+||++++++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~ 155 (256)
T cd08221 81 ANGGTLYDKIVRQK--GQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY 155 (256)
T ss_pred cCCCcHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence 99999999997652 35689999999999999999999998 99999999999999999999999999998764433
Q ss_pred cceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCCccCC
Q 010513 344 SYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQ 423 (508)
Q Consensus 344 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 423 (508)
. ......|++.|+|||.+.+..++.++|+||||+++|||++|..||..... .+....... +.. .+.
T Consensus 156 ~-~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~------~~~~~~~~~-~~~----~~~-- 221 (256)
T cd08221 156 S-MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP------LNLVVKIVQ-GNY----TPV-- 221 (256)
T ss_pred c-cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHHc-CCC----CCC--
Confidence 2 23345689999999999888899999999999999999999999964322 122222221 111 110
Q ss_pred CCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 010513 424 EKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHML 459 (508)
Q Consensus 424 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 459 (508)
....+ .++.+++.+||+.+|++||++.++++++
T Consensus 222 ~~~~~---~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 222 VSVYS---SELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred ccccC---HHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 11122 3455578899999999999999999763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-39 Score=314.54 Aligned_cols=239 Identities=23% Similarity=0.399 Sum_probs=187.2
Q ss_pred eEcccCcEEEEEEEECC-------------------------CcEEEEEEeecCCchhHHHHHHHHHHHHccCCCCeeeE
Q 010513 193 VIGEGGYGIVYHGVLED-------------------------NTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRL 247 (508)
Q Consensus 193 ~LG~G~~g~Vy~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l 247 (508)
.||+|+||.||+|.... ...|++|.+..........+.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 59999999999997421 12478888765544555678889999999999999999
Q ss_pred eeeeecCCeeEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCC-
Q 010513 248 LGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQW- 326 (508)
Q Consensus 248 ~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~- 326 (508)
++++.+....++||||+++|+|.+++... ...+++..++.++.|+++||+|||++ +|+||||||+|||++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~~ 155 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKE---KGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGL 155 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEeccCc
Confidence 99999999999999999999999998754 35688999999999999999999998 999999999999997654
Q ss_pred ------CeEEeeeccceecCCCCcceecceecCCCCCChhhhhc-CCCCCCCCeeehHHHHHHHH-hCCCCCCCCCCCCc
Q 010513 327 ------NPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVI-SGRNPVDYSRPPGE 398 (508)
Q Consensus 327 ------~~kL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~ell-tg~~Pf~~~~~~~~ 398 (508)
.+|++|||++...... ....++..|+|||.+.+ ..++.++|||||||++|||+ +|+.||....+...
T Consensus 156 ~~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~ 230 (274)
T cd05076 156 AEGTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK 230 (274)
T ss_pred ccCccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH
Confidence 3799999988643221 22357888999998865 56899999999999999995 69999975433211
Q ss_pred chHHHHHHHhhcccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 010513 399 VNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 460 (508)
Q Consensus 399 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le 460 (508)
....... ..+... .. .++.+++.+||+.+|++||++.++++.|+
T Consensus 231 ---~~~~~~~-----------~~~~~~-~~---~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 231 ---ERFYEKK-----------HRLPEP-SC---KELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred ---HHHHHhc-----------cCCCCC-CC---hHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 1111110 001111 11 24556888999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=325.02 Aligned_cols=245 Identities=28% Similarity=0.404 Sum_probs=202.0
Q ss_pred CCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCc---hhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEE
Q 010513 187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG---QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE 262 (508)
Q Consensus 187 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e 262 (508)
.|...+.||.|+||.||-|++. +...||||+..-... +.-.++..|+..|++++|||++.+.|+|..+...|+|||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 5777899999999999999965 567789999854433 334578889999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCC
Q 010513 263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE 342 (508)
Q Consensus 263 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 342 (508)
||-| +-.|++.-. ..++-+.++..|+.+.+.||+|||+. +.||||||..|||+++.|.|||+|||.|......
T Consensus 107 YClG-SAsDlleVh---kKplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA 179 (948)
T KOG0577|consen 107 YCLG-SASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA 179 (948)
T ss_pred HHhc-cHHHHHHHH---hccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCch
Confidence 9965 777777544 36789999999999999999999999 9999999999999999999999999999865433
Q ss_pred CcceecceecCCCCCChhhhh---cCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCC
Q 010513 343 RSYVTTRVMGTFGYVAPEYAS---TGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLD 419 (508)
Q Consensus 343 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 419 (508)
..++|||+|||||++. .+.|+-++|||||||+..||.-.++|+-.. |....+.-.. ..-.
T Consensus 180 -----nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnM------NAMSALYHIA------QNes 242 (948)
T KOG0577|consen 180 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM------NAMSALYHIA------QNES 242 (948)
T ss_pred -----hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCc------hHHHHHHHHH------hcCC
Confidence 4468999999999874 578999999999999999999999997533 2222222222 2224
Q ss_pred ccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 420 PRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 420 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
|.++....+..... ++..||++-|++|||.++++++
T Consensus 243 PtLqs~eWS~~F~~---Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 243 PTLQSNEWSDYFRN---FVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred CCCCCchhHHHHHH---HHHHHHhhCcccCCcHHHHhhc
Confidence 56665555555555 5559999999999999999976
|
|
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=312.66 Aligned_cols=262 Identities=23% Similarity=0.353 Sum_probs=200.6
Q ss_pred CCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCC--chhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEE
Q 010513 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE 262 (508)
Q Consensus 186 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e 262 (508)
++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+++++.++|||++++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46889999999999999999976 58889999886543 2234567889999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCC
Q 010513 263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE 342 (508)
Q Consensus 263 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 342 (508)
|+++++|..++... ..+++..++.++.|++.||+|||+. +++||||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~l~~~~~~~----~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07847 81 YCDHTVLNELEKNP----RGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGP 153 (286)
T ss_pred ccCccHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCC
Confidence 99998888876543 4689999999999999999999998 9999999999999999999999999999876443
Q ss_pred CcceecceecCCCCCChhhhhc-CCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcc----------
Q 010513 343 RSYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTN---------- 411 (508)
Q Consensus 343 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~---------- 411 (508)
.. ......++..|+|||.+.+ ..++.++|+||||+++|||++|+.||........ ... .......
T Consensus 154 ~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~--~~~-~~~~~~~~~~~~~~~~~ 229 (286)
T cd07847 154 GD-DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQ--LYL-IRKTLGDLIPRHQQIFS 229 (286)
T ss_pred cc-cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHH--HHH-HHHHhCCCChHHhhhcc
Confidence 22 2223457889999998876 5588999999999999999999999975432211 111 1110000
Q ss_pred -cc-cccCCCccCCCCc-----hHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 412 -RN-AEGVLDPRLQEKP-----CSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 412 -~~-~~~~~~~~l~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
.. ......+...... .+.....+.+++.+||+.||++||++.+++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 230 TNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred cccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 00 0000001100000 01123456678899999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=325.61 Aligned_cols=261 Identities=27% Similarity=0.456 Sum_probs=216.6
Q ss_pred hhhHhhcCCCCcccceEcccCcEEEEEEEECC---Cc--EEEEEEeecC-CchhHHHHHHHHHHHHccCCCCeeeEeeee
Q 010513 178 LRELEVSTNGFADENVIGEGGYGIVYHGVLED---NT--NVAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNLVRLLGYC 251 (508)
Q Consensus 178 ~~~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~~---~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~ 251 (508)
.+.+++..+..+..++||+|-||.||+|.+.+ |. .||||..+.+ ..+..+.|..|.-+|++++||||++++|+|
T Consensus 381 ~rnyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~ 460 (974)
T KOG4257|consen 381 VRNYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVC 460 (974)
T ss_pred CCcceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeee
Confidence 34566777788889999999999999999643 33 4889988764 556678899999999999999999999999
Q ss_pred ecCCeeEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEe
Q 010513 252 AEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLS 331 (508)
Q Consensus 252 ~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~ 331 (508)
.+ ...++|||.++.|.|..||+.+ ...++......+++||+.||+|||+. .+|||||...|||+...--+||+
T Consensus 461 ~e-~P~WivmEL~~~GELr~yLq~n---k~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLa 533 (974)
T KOG4257|consen 461 VE-QPMWIVMELAPLGELREYLQQN---KDSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLA 533 (974)
T ss_pred ec-cceeEEEecccchhHHHHHHhc---cccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeec
Confidence 87 5689999999999999999887 46799999999999999999999999 99999999999999999999999
Q ss_pred eeccceecCCCCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHhhc
Q 010513 332 DFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVT 410 (508)
Q Consensus 332 DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~ 410 (508)
|||+++.+.+...+..+...-...|||||.++-..++.++|||.|||++||++. |..||.+-....... .+.
T Consensus 534 DFGLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~-------~iE 606 (974)
T KOG4257|consen 534 DFGLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIG-------HIE 606 (974)
T ss_pred ccchhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEE-------Eec
Confidence 999999998877777665566778999999999999999999999999999998 999998654432221 111
Q ss_pred ccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 010513 411 NRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461 (508)
Q Consensus 411 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~ 461 (508)
++. .. -..+.|+..+. .++.+||+.||.+||.+.++...|+.
T Consensus 607 nGe--Rl----P~P~nCPp~LY---slmskcWayeP~kRPrftei~~~lsd 648 (974)
T KOG4257|consen 607 NGE--RL----PCPPNCPPALY---SLMSKCWAYEPSKRPRFTEIKAILSD 648 (974)
T ss_pred CCC--CC----CCCCCCChHHH---HHHHHHhccCcccCCcHHHHHHHHHH
Confidence 111 00 11223555544 48889999999999999998887764
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=307.74 Aligned_cols=254 Identities=22% Similarity=0.348 Sum_probs=190.1
Q ss_pred ceEcccCcEEEEEEEECCCc---EEEEEEeecCC-chhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEEecCCC
Q 010513 192 NVIGEGGYGIVYHGVLEDNT---NVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNG 267 (508)
Q Consensus 192 ~~LG~G~~g~Vy~~~~~~~~---~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~g 267 (508)
+.||+|+||.||+|...++. .+++|.+.... ....+.+.+|+.+++.++||||+++++.+.+....++||||+++|
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 35999999999999854333 35666655433 234567889999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCCC-cce
Q 010513 268 NLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER-SYV 346 (508)
Q Consensus 268 ~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~-~~~ 346 (508)
+|.+++.+........++...+.++.|+++||+|||++ +++||||||+|||++.++.+||+|||++....... ...
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 99999976533345577788889999999999999998 99999999999999999999999999986432111 111
Q ss_pred ecceecCCCCCChhhhhc-------CCCCCCCCeeehHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHhhcccccccCC
Q 010513 347 TTRVMGTFGYVAPEYAST-------GMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVL 418 (508)
Q Consensus 347 ~~~~~gt~~y~aPE~~~~-------~~~~~~sDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 418 (508)
.....|+..|+|||++.. ..++.++|||||||++|||++ |..||....+ .+.+..... .......
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~------~~~~~~~~~-~~~~~~~ 230 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD------REVLNHVIK-DQQVKLF 230 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHHHh-hcccccC
Confidence 234568889999998743 245789999999999999997 5678854322 122222221 1222333
Q ss_pred CccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 010513 419 DPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 460 (508)
Q Consensus 419 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le 460 (508)
++.+... .... +.+++..|| .+|++||+++++++.|.
T Consensus 231 ~~~~~~~-~~~~---~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 231 KPQLELP-YSER---WYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCccCCC-CcHH---HHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 4444332 2233 344667899 68999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=308.98 Aligned_cols=249 Identities=25% Similarity=0.363 Sum_probs=209.0
Q ss_pred CCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCchhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEEecC
Q 010513 187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYID 265 (508)
Q Consensus 187 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~ 265 (508)
-|.+..+||+|+||.||+|.++ .|+.+|||++-- ..+.+++..|+.+|++.+.|++|++||.|.....+++|||||.
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV--~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG 111 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV--DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG 111 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc--cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence 4778899999999999999965 588899998743 3456788889999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCCCcc
Q 010513 266 NGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSY 345 (508)
Q Consensus 266 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~ 345 (508)
.|+..++++-+ +.++++.++..+++..++||+|||.. .-||||||..|||++.+|..||+|||.|-.+.+. -.
T Consensus 112 AGSiSDI~R~R---~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT-MA 184 (502)
T KOG0574|consen 112 AGSISDIMRAR---RKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT-MA 184 (502)
T ss_pred CCcHHHHHHHh---cCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhh-HH
Confidence 99999999876 57899999999999999999999998 8999999999999999999999999999765322 22
Q ss_pred eecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCCccCCCC
Q 010513 346 VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEK 425 (508)
Q Consensus 346 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 425 (508)
...++.|||.|||||++..-.|+.++||||||++..||..|++||.+-.+..-. . |+ .-...|.++.
T Consensus 185 KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAI------F-MI-----PT~PPPTF~K- 251 (502)
T KOG0574|consen 185 KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAI------F-MI-----PTKPPPTFKK- 251 (502)
T ss_pred hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccccee------E-ec-----cCCCCCCCCC-
Confidence 345578999999999999999999999999999999999999999754432111 0 00 0111223322
Q ss_pred chHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 426 PCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 426 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
......++.+++.+||-++|++|-++-+++++
T Consensus 252 -PE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 252 -PEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred -hHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 34456677779999999999999999998876
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=329.16 Aligned_cols=245 Identities=30% Similarity=0.472 Sum_probs=202.1
Q ss_pred eEcccCcEEEEEEEECC-CcEEEEEEeecCCchhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEEecCCCCHHH
Q 010513 193 VIGEGGYGIVYHGVLED-NTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQ 271 (508)
Q Consensus 193 ~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~g~L~~ 271 (508)
+||+|.||+||.|++.+ ...+|||.+........+-+.+|+.+-++|+|.|||+++|.+.++..+-+.||-++||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 69999999999999765 45689999977777777788999999999999999999999999998899999999999999
Q ss_pred HhccCCCCCCCC--CHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEc-CCCCeEEeeeccceecCCCCcceec
Q 010513 272 WLHGDVGPHSPL--TWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLD-KQWNPKLSDFGLAKLLGAERSYVTT 348 (508)
Q Consensus 272 ~l~~~~~~~~~l--~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~-~~~~~kL~DFG~a~~~~~~~~~~~~ 348 (508)
+|...= +++ ++...-.+..||++||.|||++ .|||||||-+|+|++ -.|.+||+|||-++.+..- ...+.
T Consensus 662 LLrskW---GPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi-nP~TE 734 (1226)
T KOG4279|consen 662 LLRSKW---GPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI-NPCTE 734 (1226)
T ss_pred HHHhcc---CCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccC-Ccccc
Confidence 998763 455 7788889999999999999999 999999999999995 5788999999999887443 44466
Q ss_pred ceecCCCCCChhhhhcC--CCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCCccCCCCc
Q 010513 349 RVMGTFGYVAPEYASTG--MLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKP 426 (508)
Q Consensus 349 ~~~gt~~y~aPE~~~~~--~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 426 (508)
++.||..|||||++..+ .|+.++|||||||++.||.||++||.....+.- .|..-+-. ...| +.
T Consensus 735 TFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA--------AMFkVGmy--KvHP----~i 800 (1226)
T KOG4279|consen 735 TFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA--------AMFKVGMY--KVHP----PI 800 (1226)
T ss_pred ccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH--------hhhhhcce--ecCC----CC
Confidence 68899999999999765 489999999999999999999999975543211 11111100 0111 22
Q ss_pred hHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 427 CSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 427 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
+.+...++..++++|+.+||.+||++.++++.
T Consensus 801 Peelsaeak~FilrcFepd~~~R~sA~~LL~D 832 (1226)
T KOG4279|consen 801 PEELSAEAKNFILRCFEPDPCDRPSAKDLLQD 832 (1226)
T ss_pred cHHHHHHHHHHHHHHcCCCcccCccHHHhccC
Confidence 33445667779999999999999999999863
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=309.69 Aligned_cols=255 Identities=27% Similarity=0.413 Sum_probs=200.6
Q ss_pred CCcccceEcccCcEEEEEEEECC--CcEEEEEEeecC----------CchhHHHHHHHHHHHHc-cCCCCeeeEeeeeec
Q 010513 187 GFADENVIGEGGYGIVYHGVLED--NTNVAVKNLLNN----------RGQAEKEFKVEVEAIGR-VRHKNLVRLLGYCAE 253 (508)
Q Consensus 187 ~~~~~~~LG~G~~g~Vy~~~~~~--~~~vavK~~~~~----------~~~~~~~~~~E~~~l~~-l~hpniv~l~~~~~~ 253 (508)
+|++.+.||+|+||.||+|.... ++.+|+|.+... ......++..|+.++.+ ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47888999999999999999764 677999987532 12233456778888865 799999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeeccCCCCCEEEcCCCCeEEee
Q 010513 254 GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE-GLEPKVVHRDIKSSNILLDKQWNPKLSD 332 (508)
Q Consensus 254 ~~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~~iiHrDlkp~NIll~~~~~~kL~D 332 (508)
++..+++|||+++++|.+++.........+++..++.++.|++.||.|||+ . +++|+||||+||+++.++.+||+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK---RIVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC---ceeecCCCHHHEEECCCCcEEEec
Confidence 999999999999999999885533334578999999999999999999996 5 899999999999999999999999
Q ss_pred eccceecCCCCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhccc
Q 010513 333 FGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNR 412 (508)
Q Consensus 333 FG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 412 (508)
||++....... ......|+..|+|||.+.+..++.++|+||||+++|||++|+.||..... ......... .
T Consensus 158 fg~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~------~~~~~~~~~-~ 228 (269)
T cd08528 158 FGLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNM------LSLATKIVE-A 228 (269)
T ss_pred ccceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCH------HHHHHHHhh-c
Confidence 99998764433 33445789999999999988899999999999999999999999964321 111111111 1
Q ss_pred ccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 010513 413 NAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461 (508)
Q Consensus 413 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~ 461 (508)
. ..+. .....+ ..+.+++.+||+.||++||++.|+..++++
T Consensus 229 ~----~~~~-~~~~~~---~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~ 269 (269)
T cd08528 229 V----YEPL-PEGMYS---EDVTDVITSCLTPDAEARPDIIQVSAMISD 269 (269)
T ss_pred c----CCcC-CcccCC---HHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence 1 1111 111122 344557789999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=304.40 Aligned_cols=251 Identities=29% Similarity=0.514 Sum_probs=200.4
Q ss_pred CcccceEcccCcEEEEEEEECC-----CcEEEEEEeecCCch-hHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEE
Q 010513 188 FADENVIGEGGYGIVYHGVLED-----NTNVAVKNLLNNRGQ-AEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY 261 (508)
Q Consensus 188 ~~~~~~LG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 261 (508)
+++.+.||+|+||.||+|.+.+ +..||+|.+...... ..+.+..|++.+..++|+||+++++++.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 4567899999999999999764 377999998655433 5678899999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCC
Q 010513 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA 341 (508)
Q Consensus 262 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 341 (508)
||+++++|.+++..... ..+++..++.++.|++.||+|||+. +++||||||+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 155 (258)
T smart00219 81 EYMEGGDLLDYLRKNRP--KELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYD 155 (258)
T ss_pred eccCCCCHHHHHHhhhh--ccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceeccc
Confidence 99999999999976521 1289999999999999999999999 999999999999999999999999999987654
Q ss_pred CCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHhhcccccccCCCc
Q 010513 342 ERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDP 420 (508)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 420 (508)
..........+++.|+|||.+.+..++.++|+||||+++|+|++ |+.||.... ..+.......... .
T Consensus 156 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~------~~~~~~~~~~~~~------~ 223 (258)
T smart00219 156 DDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMS------NEEVLEYLKKGYR------L 223 (258)
T ss_pred ccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC------HHHHHHHHhcCCC------C
Confidence 43332222347789999999988889999999999999999998 888886421 1111111111110 0
Q ss_pred cCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 010513 421 RLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHML 459 (508)
Q Consensus 421 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 459 (508)
... ... ..++.+++.+|++.||++||++.++++.|
T Consensus 224 ~~~-~~~---~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 224 PKP-ENC---PPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred CCC-CcC---CHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 011 112 33455588899999999999999999865
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=312.16 Aligned_cols=254 Identities=25% Similarity=0.435 Sum_probs=199.4
Q ss_pred CCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecC-CchhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEEe
Q 010513 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY 263 (508)
Q Consensus 186 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~ 263 (508)
++|++.+.||+|+||.||+|.+. ++..||+|.+... .......+.+|++++++++||||+++++++...+..++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 46888999999999999999976 6889999988654 233346788899999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCCC
Q 010513 264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER 343 (508)
Q Consensus 264 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 343 (508)
+++++|.+++.... ....+++..+..++.|++.||.|||++. +++||||||+||+++.++.+||+|||++..+...
T Consensus 81 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~- 156 (286)
T cd06622 81 MDAGSLDKLYAGGV-ATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS- 156 (286)
T ss_pred cCCCCHHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccCC-
Confidence 99999999987542 1347899999999999999999999632 8999999999999999999999999998765322
Q ss_pred cceecceecCCCCCChhhhhcC------CCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccC
Q 010513 344 SYVTTRVMGTFGYVAPEYASTG------MLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGV 417 (508)
Q Consensus 344 ~~~~~~~~gt~~y~aPE~~~~~------~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 417 (508)
......|++.|+|||.+.+. .++.++|+|||||++|+|++|+.||...... .....+...... .
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---~~~~~~~~~~~~-~---- 226 (286)
T cd06622 157 --LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYA---NIFAQLSAIVDG-D---- 226 (286)
T ss_pred --ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchh---hHHHHHHHHhhc-C----
Confidence 22334688899999988554 3578999999999999999999999644321 111111111111 0
Q ss_pred CCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 418 LDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 418 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
.+.+. +....++.+++.+||+.+|++||++.+++.+
T Consensus 227 -~~~~~----~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 227 -PPTLP----SGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred -CCCCC----cccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 11111 1123344558889999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=306.80 Aligned_cols=249 Identities=29% Similarity=0.465 Sum_probs=190.6
Q ss_pred ceEcccCcEEEEEEEECC----CcEEEEEEeecC-CchhHHHHHHHHHHHHccCCCCeeeEeeeee-cCCeeEEEEEecC
Q 010513 192 NVIGEGGYGIVYHGVLED----NTNVAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCA-EGAHRMLVYEYID 265 (508)
Q Consensus 192 ~~LG~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~~~~~lV~e~~~ 265 (508)
+.||+|+||.||+|.+.+ +..+|+|.+... .....+.+..|+.+++.++||||+++++++. .+...++||||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 468999999999998532 346899987543 2344567888999999999999999999775 4556789999999
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCCCcc
Q 010513 266 NGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSY 345 (508)
Q Consensus 266 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~ 345 (508)
+|+|.+++... ...+++.....++.|+++||+|||+. +++||||||+|||++.++.+||+|||+++........
T Consensus 81 ~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~ 154 (262)
T cd05058 81 HGDLRNFIRSE---THNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY 154 (262)
T ss_pred CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCcce
Confidence 99999999764 23467788889999999999999998 9999999999999999999999999999865332211
Q ss_pred e---ecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhC-CCCCCCCCCCCcchHHHHHHHhhcccccccCCCcc
Q 010513 346 V---TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISG-RNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPR 421 (508)
Q Consensus 346 ~---~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg-~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 421 (508)
. .....++..|+|||.+.+..++.++|||||||++|||++| ..||.... ..+.......... +.
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~------~~~~~~~~~~~~~------~~ 222 (262)
T cd05058 155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD------SFDITVYLLQGRR------LL 222 (262)
T ss_pred eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCC------HHHHHHHHhcCCC------CC
Confidence 1 1223467789999999888999999999999999999995 55664322 1122222211110 00
Q ss_pred CCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010513 422 LQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (508)
Q Consensus 422 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~~ 462 (508)
. ....+. .+.+++.+||+.+|++||++.++++.|++.
T Consensus 223 ~-~~~~~~---~~~~li~~cl~~~p~~Rp~~~~il~~l~~~ 259 (262)
T cd05058 223 Q-PEYCPD---PLYEVMLSCWHPKPEMRPTFSELVSRIEQI 259 (262)
T ss_pred C-CCcCCH---HHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 0 111223 455588899999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=322.14 Aligned_cols=258 Identities=22% Similarity=0.321 Sum_probs=193.8
Q ss_pred CCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCc--hhHHHHHHHHHHHHccCCCCeeeEeeeeecC------C
Q 010513 185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG--QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEG------A 255 (508)
Q Consensus 185 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~------~ 255 (508)
.++|++.+.||+|+||+||+|... +++.||+|++..... ...+.+.+|+++++.++||||+++++++... .
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07878 14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFN 93 (343)
T ss_pred hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccC
Confidence 468999999999999999999964 678899999865422 2345677899999999999999999988543 3
Q ss_pred eeEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeecc
Q 010513 256 HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGL 335 (508)
Q Consensus 256 ~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~ 335 (508)
..|++++++ +++|.+++.. ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 94 ~~~~~~~~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~ 164 (343)
T cd07878 94 EVYLVTNLM-GADLNNIVKC-----QKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGL 164 (343)
T ss_pred cEEEEeecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCCcc
Confidence 568999988 6799988754 3689999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCcceecceecCCCCCChhhhhc-CCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcc---
Q 010513 336 AKLLGAERSYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTN--- 411 (508)
Q Consensus 336 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~--- 411 (508)
++..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||....... ....+......
T Consensus 165 ~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~~~~~~~~~~~ 237 (343)
T cd07878 165 ARQADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYID---QLKRIMEVVGTPSP 237 (343)
T ss_pred ceecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH---HHHHHHHHhCCCCH
Confidence 9865332 234578999999999876 568999999999999999999999996543211 00000000000
Q ss_pred --------cccccCCC--ccCCCCch----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 412 --------RNAEGVLD--PRLQEKPC----SRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 412 --------~~~~~~~~--~~l~~~~~----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
......+. +....... ......+.+++.+||+.||++||++.+++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 238 EVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred HHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000000 00000000 0011235668889999999999999999965
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=308.90 Aligned_cols=268 Identities=27% Similarity=0.431 Sum_probs=200.8
Q ss_pred CcccceEcccCcEEEEEEEECCCcEEEEEEeecCCchhHHHHHHHHHHHHc--cCCCCeeeEeeeeecCC----eeEEEE
Q 010513 188 FADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGR--VRHKNLVRLLGYCAEGA----HRMLVY 261 (508)
Q Consensus 188 ~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~hpniv~l~~~~~~~~----~~~lV~ 261 (508)
....+.||+|.||.||+|.+. ++.||||++.. +..+.|..|-++.+. ++|+||++|++.-.... .++||+
T Consensus 212 l~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt 287 (534)
T KOG3653|consen 212 LQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVT 287 (534)
T ss_pred hhhHHHhhcCccceeehhhcc-CceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEe
Confidence 345678999999999999987 58899999843 445567777777665 48999999999876655 789999
Q ss_pred EecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc------CCCCeeeccCCCCCEEEcCCCCeEEeeecc
Q 010513 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG------LEPKVVHRDIKSSNILLDKQWNPKLSDFGL 335 (508)
Q Consensus 262 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~------~~~~iiHrDlkp~NIll~~~~~~kL~DFG~ 335 (508)
+|.+.|+|.+||+.+ .++|....+++..+++||+|||+. .+|.|+|||||+.||||..|++..|+|||+
T Consensus 288 ~fh~kGsL~dyL~~n-----tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGL 362 (534)
T KOG3653|consen 288 EFHPKGSLCDYLKAN-----TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGL 362 (534)
T ss_pred eeccCCcHHHHHHhc-----cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccce
Confidence 999999999999876 799999999999999999999965 378899999999999999999999999999
Q ss_pred ceecCCCCcc-eecceecCCCCCChhhhhcCC-CC-----CCCCeeehHHHHHHHHhCCCCCCCCCC----------CCc
Q 010513 336 AKLLGAERSY-VTTRVMGTFGYVAPEYASTGM-LN-----ERSDVYSFGILIMEVISGRNPVDYSRP----------PGE 398 (508)
Q Consensus 336 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~-~~-----~~sDvwSlGvvl~elltg~~Pf~~~~~----------~~~ 398 (508)
|..+...... .....+||..|||||++.+.. +. .+.||||+|.|||||++...-++.... .+.
T Consensus 363 Al~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~ 442 (534)
T KOG3653|consen 363 ALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGN 442 (534)
T ss_pred eEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcC
Confidence 9987643322 233478999999999997643 22 258999999999999996544321111 111
Q ss_pred chHHHHHHHhhcccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCCCCC
Q 010513 399 VNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEEFPFR 467 (508)
Q Consensus 399 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~~~~~~~ 467 (508)
.-.++.++..+...+....+............+.+ .+..||+.||+-|.|+.=+-+.+.+....-+
T Consensus 443 hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~e---t~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~ 508 (534)
T KOG3653|consen 443 HPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCE---TIEECWDHDAEARLTAGCVEERMAELMMLWE 508 (534)
T ss_pred CCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHH---HHHHHcCCchhhhhhhHHHHHHHHHHhccCC
Confidence 12233334333332222222333333334444444 6669999999999999888888877654443
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=317.34 Aligned_cols=199 Identities=20% Similarity=0.236 Sum_probs=166.1
Q ss_pred ccceEccc--CcEEEEEEEEC-CCcEEEEEEeecCC--chhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEEec
Q 010513 190 DENVIGEG--GYGIVYHGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYI 264 (508)
Q Consensus 190 ~~~~LG~G--~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~ 264 (508)
++++||+| +|++||++..+ +|+.||+|++.... ....+.+.+|+++++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 46789999 78999999865 68889999986542 334456788999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCCCc
Q 010513 265 DNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS 344 (508)
Q Consensus 265 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~ 344 (508)
++|+|.+++.... ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.++++||+..........
T Consensus 82 ~~~~l~~~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~ 156 (327)
T cd08227 82 AYGSAKDLICTHF--MDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ 156 (327)
T ss_pred CCCcHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence 9999999996542 23589999999999999999999998 999999999999999999999999986543321111
Q ss_pred c------eecceecCCCCCChhhhhc--CCCCCCCCeeehHHHHHHHHhCCCCCCCC
Q 010513 345 Y------VTTRVMGTFGYVAPEYAST--GMLNERSDVYSFGILIMEVISGRNPVDYS 393 (508)
Q Consensus 345 ~------~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlGvvl~elltg~~Pf~~~ 393 (508)
. ......++..|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 213 (327)
T cd08227 157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM 213 (327)
T ss_pred cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence 0 0112356778999999876 45899999999999999999999999743
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=308.33 Aligned_cols=262 Identities=25% Similarity=0.440 Sum_probs=203.8
Q ss_pred CCCcccceEcccCcEEEEEEEEC-----CCcEEEEEEeecCCch-hHHHHHHHHHHHHccCCCCeeeEeeeeec--CCee
Q 010513 186 NGFADENVIGEGGYGIVYHGVLE-----DNTNVAVKNLLNNRGQ-AEKEFKVEVEAIGRVRHKNLVRLLGYCAE--GAHR 257 (508)
Q Consensus 186 ~~~~~~~~LG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~--~~~~ 257 (508)
..|.+.+.||+|+||.||+|.+. ++..+|+|.+...... ..+.+..|+++++.++||||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 46788899999999999999854 3578999998765443 46789999999999999999999999877 5678
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccce
Q 010513 258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK 337 (508)
Q Consensus 258 ~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~ 337 (508)
++||||+++++|.+++... ...+++..++.++.|++.||+|||++ +++||||||+||+++.++.++|+|||++.
T Consensus 84 ~lv~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRH---RDQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAK 157 (284)
T ss_pred EEEEecCCCCCHHHHHHhC---ccccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEccccccc
Confidence 9999999999999999765 23689999999999999999999998 99999999999999999999999999998
Q ss_pred ecCCCCccee--cceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcc--------hHHHHHHH
Q 010513 338 LLGAERSYVT--TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEV--------NLVEWLKT 407 (508)
Q Consensus 338 ~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~--------~~~~~~~~ 407 (508)
.......... ....++..|+|||.+.+..++.++|+||||+++|||++|+.||......... .....+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05038 158 VLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLE 237 (284)
T ss_pred ccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHH
Confidence 7653322211 1223456799999998889999999999999999999999998643221100 11111111
Q ss_pred hhcccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010513 408 MVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (508)
Q Consensus 408 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~~ 462 (508)
....... . + ....++ .++.+++.+||+.+|++||++.+++++|++.
T Consensus 238 ~~~~~~~---~-~--~~~~~~---~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 238 LLKEGER---L-P--RPPSCP---DEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHcCCc---C-C--CCccCC---HHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 1111100 0 0 011122 3456688899999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=308.22 Aligned_cols=238 Identities=25% Similarity=0.444 Sum_probs=188.9
Q ss_pred ceEcccCcEEEEEEEECCCc-----------EEEEEEeecCCchhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEE
Q 010513 192 NVIGEGGYGIVYHGVLEDNT-----------NVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLV 260 (508)
Q Consensus 192 ~~LG~G~~g~Vy~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 260 (508)
+.||+|+||.||+|.+.+.. .+++|.+...... ...+.+|+.+++.++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 36899999999999976433 4677766544333 6788899999999999999999999988 778999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCC-------CeEEeee
Q 010513 261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQW-------NPKLSDF 333 (508)
Q Consensus 261 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~-------~~kL~DF 333 (508)
|||+++|+|.+++.... ..+++..++.++.|++.||+|||++ +++||||||+|||++.++ .+||+||
T Consensus 79 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Df 152 (259)
T cd05037 79 EEYVKFGPLDVFLHREK---NNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDP 152 (259)
T ss_pred EEcCCCCcHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCCC
Confidence 99999999999997752 3689999999999999999999998 999999999999999887 7999999
Q ss_pred ccceecCCCCcceecceecCCCCCChhhhhcC--CCCCCCCeeehHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHhhc
Q 010513 334 GLAKLLGAERSYVTTRVMGTFGYVAPEYASTG--MLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVT 410 (508)
Q Consensus 334 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~ 410 (508)
|++..... .....++..|+|||++.+. .++.++|+|||||++|||++ |..||........ ..+.. .
T Consensus 153 g~a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~---~~~~~---~ 221 (259)
T cd05037 153 GIPITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEK---ERFYQ---D 221 (259)
T ss_pred Cccccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhH---HHHHh---c
Confidence 99986533 2224567789999998876 78999999999999999999 5788865432111 11110 0
Q ss_pred ccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 010513 411 NRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 460 (508)
Q Consensus 411 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le 460 (508)
.. . . ..+.. ..+.+++.+||+.+|++||++.++++.|+
T Consensus 222 ~~---~-----~-~~~~~---~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 222 QH---R-----L-PMPDC---AELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred CC---C-----C-CCCCc---hHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 00 0 0 00011 45566888999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=316.54 Aligned_cols=196 Identities=22% Similarity=0.374 Sum_probs=160.6
Q ss_pred ceEcccCcEEEEEEEEC---CCcEEEEEEeecCCchhHHHHHHHHHHHHccCCCCeeeEeeeeec--CCeeEEEEEecCC
Q 010513 192 NVIGEGGYGIVYHGVLE---DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE--GAHRMLVYEYIDN 266 (508)
Q Consensus 192 ~~LG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~--~~~~~lV~e~~~~ 266 (508)
.+||+|+||+||+|+.. ++..||+|.+.... ....+.+|+++++.++||||+++++++.. +...++||||+.+
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH 84 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence 67999999999999965 34679999886543 23457789999999999999999998853 5577899999875
Q ss_pred CCHHHHhccCC-----CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEE----cCCCCeEEeeeccce
Q 010513 267 GNLEQWLHGDV-----GPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILL----DKQWNPKLSDFGLAK 337 (508)
Q Consensus 267 g~L~~~l~~~~-----~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll----~~~~~~kL~DFG~a~ 337 (508)
+|.+++.... .....+++..++.++.|++.||.|||++ +|+||||||+|||+ +.++.+||+|||+++
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 8888774321 1123588999999999999999999999 99999999999999 566789999999998
Q ss_pred ecCCCCc--ceecceecCCCCCChhhhhc-CCCCCCCCeeehHHHHHHHHhCCCCCCCC
Q 010513 338 LLGAERS--YVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYS 393 (508)
Q Consensus 338 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~Pf~~~ 393 (508)
....... .......||+.|+|||++.+ ..++.++|||||||++|||+||+.||...
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 7643322 12234578999999998876 45889999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=306.87 Aligned_cols=254 Identities=24% Similarity=0.383 Sum_probs=188.7
Q ss_pred ceEcccCcEEEEEEEECC---CcEEEEEEeecCC-chhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEEecCCC
Q 010513 192 NVIGEGGYGIVYHGVLED---NTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNG 267 (508)
Q Consensus 192 ~~LG~G~~g~Vy~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~g 267 (508)
+.||+|+||+||+|...+ ...+++|.+.... ......+.+|++.++.++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 358999999999997543 3467888765443 233456788999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCCCcce
Q 010513 268 NLEQWLHGDVGP-HSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYV 346 (508)
Q Consensus 268 ~L~~~l~~~~~~-~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~ 346 (508)
+|.+++...... ....++.....++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++..........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 999999765321 23356788899999999999999999 99999999999999999999999999987543222111
Q ss_pred -ecceecCCCCCChhhhhc-------CCCCCCCCeeehHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHhhcccccccC
Q 010513 347 -TTRVMGTFGYVAPEYAST-------GMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGV 417 (508)
Q Consensus 347 -~~~~~gt~~y~aPE~~~~-------~~~~~~sDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 417 (508)
.....++..|+|||++.. ..++.++|||||||++|||++ |..||....+ .+.+........ ...
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~------~~~~~~~~~~~~-~~~ 230 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSD------EQVLKQVVREQD-IKL 230 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCH------HHHHHHHhhccC-ccC
Confidence 122345678999998753 356789999999999999999 7888864322 111222222211 112
Q ss_pred CCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 010513 418 LDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 460 (508)
Q Consensus 418 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le 460 (508)
.++.+.. ..+... .+++..|| .||++||++++|++.|.
T Consensus 231 ~~~~~~~-~~~~~~---~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 231 PKPQLDL-KYSDRW---YEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCCcccc-cCCHHH---HHHHHHHh-cCcccccCHHHHHHHhc
Confidence 2222221 123333 34666888 59999999999999873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=307.81 Aligned_cols=262 Identities=24% Similarity=0.330 Sum_probs=202.2
Q ss_pred CCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCc-hhHHHHHHHHHHHHccCCCCeeeEeeeeecC--CeeEEEE
Q 010513 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEG--AHRMLVY 261 (508)
Q Consensus 186 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--~~~~lV~ 261 (508)
++|+..+.||.|++|.||+|.+. +++.+|+|.+..... .....+.+|+++++.++||||++++++|.+. ...++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 46888999999999999999975 578899998865432 4456788999999999999999999988653 4689999
Q ss_pred EecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCC
Q 010513 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA 341 (508)
Q Consensus 262 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 341 (508)
||+++++|.+++.........+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 99999999998765433346689999999999999999999998 999999999999999999999999999875432
Q ss_pred CCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCCcc
Q 010513 342 ERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPR 421 (508)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 421 (508)
.. .....++..|+|||.+.+..++.++|+|||||++|+|++|+.||....... ....+....... ...... ...
T Consensus 158 ~~---~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~-~~~~~~-~~~ 231 (287)
T cd06621 158 SL---AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPP-LGPIELLSYIVN-MPNPEL-KDE 231 (287)
T ss_pred cc---cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCC-CChHHHHHHHhc-CCchhh-ccC
Confidence 21 123467889999999999999999999999999999999999998653311 111222211111 111011 101
Q ss_pred CCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 422 LQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 422 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
... .......+.+++.+||+.||++||++.|++++
T Consensus 232 ~~~--~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 232 PGN--GIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred CCC--CCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 000 01123455668889999999999999999975
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=303.30 Aligned_cols=250 Identities=21% Similarity=0.376 Sum_probs=201.6
Q ss_pred CCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecC--CchhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEEe
Q 010513 187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY 263 (508)
Q Consensus 187 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~ 263 (508)
+|++.+.||+|+||.||++... +++.||+|.+... .....+++.+|+++++.++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 5888999999999999999965 6788999998643 233446788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCCC
Q 010513 264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER 343 (508)
Q Consensus 264 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 343 (508)
+.+++|.+++.... ...+++..++.++.|++.|+.|||++ +++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~ 155 (256)
T cd08218 81 CEGGDLYKKINAQR--GVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV 155 (256)
T ss_pred CCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcch
Confidence 99999999987542 23578999999999999999999998 99999999999999999999999999998764332
Q ss_pred cceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCCccCC
Q 010513 344 SYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQ 423 (508)
Q Consensus 344 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 423 (508)
. ......|++.|+|||++.+..++.++|+|||||++|+|++|+.||.... ..+.......... +..
T Consensus 156 ~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~------~~~~~~~~~~~~~------~~~- 221 (256)
T cd08218 156 E-LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGN------MKNLVLKIIRGSY------PPV- 221 (256)
T ss_pred h-hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCC------HHHHHHHHhcCCC------CCC-
Confidence 2 2233468899999999998899999999999999999999999996432 1222222221110 011
Q ss_pred CCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 424 EKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 424 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
......++.+++.+||+.+|++||++.+++++
T Consensus 222 ---~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 222 ---SSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred ---cccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 11122345558889999999999999999974
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=311.04 Aligned_cols=251 Identities=28% Similarity=0.500 Sum_probs=195.2
Q ss_pred ceEcccCcEEEEEEEECC-------CcEEEEEEeecCC-chhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEEe
Q 010513 192 NVIGEGGYGIVYHGVLED-------NTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY 263 (508)
Q Consensus 192 ~~LG~G~~g~Vy~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~ 263 (508)
+.||+|+||.||+|+..+ +..+|+|.+.... ......+.+|+++++.++||||+++++++......++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 368999999999998653 2468999875543 23456788899999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCC-----CeEEeeecc
Q 010513 264 IDNGNLEQWLHGDVG---PHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQW-----NPKLSDFGL 335 (508)
Q Consensus 264 ~~~g~L~~~l~~~~~---~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~-----~~kL~DFG~ 335 (508)
+++++|.+++..... ....+++..++.++.|++.||+|||+. +++|+||||+||+++.++ .++|+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 999999999965321 124578899999999999999999998 999999999999999877 899999999
Q ss_pred ceecCCCCcc-eecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHhhcccc
Q 010513 336 AKLLGAERSY-VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRN 413 (508)
Q Consensus 336 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 413 (508)
+......... ......++..|+|||++.++.++.++|||||||++|||++ |+.||..... .+..........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~------~~~~~~~~~~~~ 231 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN------QEVLQHVTAGGR 231 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH------HHHHHHHhcCCc
Confidence 9765332211 1122345778999999999999999999999999999998 9999964322 111111111110
Q ss_pred cccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 010513 414 AEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461 (508)
Q Consensus 414 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~ 461 (508)
. . .....+ ..+.+++.+||+.+|++||++.++++.|++
T Consensus 232 ~------~-~~~~~~---~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 232 L------Q-KPENCP---DKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred c------C-Ccccch---HHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 0 0 011122 345568889999999999999999999864
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=304.61 Aligned_cols=257 Identities=27% Similarity=0.422 Sum_probs=204.1
Q ss_pred CCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCC-chhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEEe
Q 010513 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY 263 (508)
Q Consensus 186 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~ 263 (508)
++|++.+.||.|+||+||+|... ++..+++|++.... ....+.+.+|++.++.++|+||+++++.+..++..++|||+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 47899999999999999999965 57789999886443 33557789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCCC
Q 010513 264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER 343 (508)
Q Consensus 264 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 343 (508)
+++++|.+++..... ...+++..++.++.|++.||+|||+. +++||||||+||++++++.++|+|||++..+....
T Consensus 81 ~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~ 156 (267)
T cd06610 81 LSGGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGG 156 (267)
T ss_pred cCCCcHHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence 999999999976421 24689999999999999999999998 99999999999999999999999999987664432
Q ss_pred cc---eecceecCCCCCChhhhhcC-CCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCC
Q 010513 344 SY---VTTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLD 419 (508)
Q Consensus 344 ~~---~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 419 (508)
.. ......|+..|+|||++... .++.++|+|||||++|+|++|+.||....+.. ......... .
T Consensus 157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~------~~~~~~~~~------~ 224 (267)
T cd06610 157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK------VLMLTLQND------P 224 (267)
T ss_pred cccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh------hHHHHhcCC------C
Confidence 22 12335689999999998777 78999999999999999999999997543321 111111110 1
Q ss_pred ccCCCCc-hHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 420 PRLQEKP-CSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 420 ~~l~~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
+.+.... .......+.+++.+||+.||++||++.+++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 225 PSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred CCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 1111110 11223445568889999999999999999864
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=307.09 Aligned_cols=254 Identities=23% Similarity=0.385 Sum_probs=198.0
Q ss_pred CCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCc----------hhHHHHHHHHHHHHccCCCCeeeEeeeeecCC
Q 010513 187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG----------QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGA 255 (508)
Q Consensus 187 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----------~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~ 255 (508)
+|...+.||+|+||.||+|... +++.+|+|.+..... ...+.+..|+++++.++|||++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4677899999999999999865 588899998753211 11346788999999999999999999999999
Q ss_pred eeEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeecc
Q 010513 256 HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGL 335 (508)
Q Consensus 256 ~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~ 335 (508)
..++||||+++++|.+++.+. ..+++..+..++.|++.||.|||++ +++||||||+||+++.++.++|+|||+
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~ 154 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY----GRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGI 154 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeeccc
Confidence 999999999999999999765 5789999999999999999999998 999999999999999999999999999
Q ss_pred ceecCCCCcc-eecceecCCCCCChhhhhcCC--CCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhccc
Q 010513 336 AKLLGAERSY-VTTRVMGTFGYVAPEYASTGM--LNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNR 412 (508)
Q Consensus 336 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 412 (508)
+......... ......|+..|+|||.+.... ++.++|+||||+++|||++|..||..... .+.........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~------~~~~~~~~~~~ 228 (272)
T cd06629 155 SKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA------IAAMFKLGNKR 228 (272)
T ss_pred cccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch------HHHHHHhhccc
Confidence 9765322111 123356889999999987654 88999999999999999999999963321 11111111111
Q ss_pred ccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 413 NAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 413 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
. .+.+...........+.+++.+||++||++||++.+++++
T Consensus 229 -~----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 229 -S----APPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred -c----CCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 1 1111111111223445557889999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=315.28 Aligned_cols=253 Identities=24% Similarity=0.282 Sum_probs=201.3
Q ss_pred CCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCch---hHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEE
Q 010513 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQ---AEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY 261 (508)
Q Consensus 186 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 261 (508)
++|+..+.||+|+||.||+|... +++.||+|.+...... ..+.+..|+++++.++||||+++++.+.++...|+||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 36888999999999999999976 4889999998755332 4456888999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCC
Q 010513 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA 341 (508)
Q Consensus 262 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 341 (508)
||+.+++|.+++.... ...+++..+..++.|+++||+|||+. +++||||||+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~~~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 155 (316)
T cd05574 81 DYCPGGELFRLLQRQP--GKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDV 155 (316)
T ss_pred EecCCCCHHHHHHhCC--CCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhcccc
Confidence 9999999999987542 35789999999999999999999998 999999999999999999999999999875432
Q ss_pred CCc----------------------------ceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCC
Q 010513 342 ERS----------------------------YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS 393 (508)
Q Consensus 342 ~~~----------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~ 393 (508)
... .......||..|+|||++.+..++.++||||||+++|+|++|+.||...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~ 235 (316)
T cd05574 156 EPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGS 235 (316)
T ss_pred cccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCC
Confidence 111 0112346889999999999888999999999999999999999999744
Q ss_pred CCCCcchHHHHHHHhhcccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCC----HHHHHHH
Q 010513 394 RPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPK----MGHVIHM 458 (508)
Q Consensus 394 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs----~~evl~~ 458 (508)
+.. ..+....... ..... .......+.+++.+||+.||++||+ +.+++++
T Consensus 236 ~~~------~~~~~~~~~~-------~~~~~--~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~ 289 (316)
T cd05574 236 NRD------ETFSNILKKE-------VTFPG--SPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH 289 (316)
T ss_pred chH------HHHHHHhcCC-------ccCCC--ccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence 321 1111111111 00111 1113345556888999999999999 7777663
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=308.02 Aligned_cols=253 Identities=23% Similarity=0.439 Sum_probs=200.1
Q ss_pred CCcccceEcccCcEEEEEEEE-CCCcEEEEEEeecCC------chhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEE
Q 010513 187 GFADENVIGEGGYGIVYHGVL-EDNTNVAVKNLLNNR------GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRML 259 (508)
Q Consensus 187 ~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 259 (508)
+|+..+.||+|+||.||+|.. .+++.||+|.+.... ....+.+..|+++++.++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477789999999999999996 468899999886432 1234678899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCC-CeEEeeecccee
Q 010513 260 VYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQW-NPKLSDFGLAKL 338 (508)
Q Consensus 260 V~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~-~~kL~DFG~a~~ 338 (508)
||||+++++|.+++.+. .++++..+..++.|++.||.|||++ +++|+||||+||+++.++ .+||+|||.+..
T Consensus 81 v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~ 153 (268)
T cd06630 81 FVEWMAGGSVSHLLSKY----GAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAAR 153 (268)
T ss_pred EEeccCCCcHHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEcccccccc
Confidence 99999999999999764 4688999999999999999999999 999999999999998776 599999999876
Q ss_pred cCCCCc---ceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccc
Q 010513 339 LGAERS---YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAE 415 (508)
Q Consensus 339 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (508)
...... .......|+..|+|||.+.+..++.++|+||||+++|+|++|..||........ ..........
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~---~~~~~~~~~~---- 226 (268)
T cd06630 154 LAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNH---LALIFKIASA---- 226 (268)
T ss_pred cccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcch---HHHHHHHhcc----
Confidence 643211 112234688999999999888899999999999999999999999964432211 1111111110
Q ss_pred cCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 416 GVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 416 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
...+ ........++.+++.+||+.+|++||++.+++++
T Consensus 227 -~~~~----~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 227 -TTAP----SIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred -CCCC----CCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence 0011 1112233455668889999999999999999854
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=304.99 Aligned_cols=248 Identities=25% Similarity=0.404 Sum_probs=199.6
Q ss_pred CCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCC-----chhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEE
Q 010513 187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR-----GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLV 260 (508)
Q Consensus 187 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 260 (508)
+|+..+.||+|+||+||+|... ++..|++|.+.... .+..+.+..|+++++.++|+||+++++++.++...+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4677889999999999999976 78899999885533 23456788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecC
Q 010513 261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG 340 (508)
Q Consensus 261 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 340 (508)
|||+++++|.+++... ..+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.+||+|||++....
T Consensus 81 ~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~ 153 (258)
T cd06632 81 LELVPGGSLAKLLKKY----GSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVV 153 (258)
T ss_pred EEecCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceecc
Confidence 9999999999999764 4688999999999999999999998 99999999999999999999999999988754
Q ss_pred CCCcceecceecCCCCCChhhhhcCC-CCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCC
Q 010513 341 AERSYVTTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLD 419 (508)
Q Consensus 341 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 419 (508)
... ......|+..|+|||.+.... ++.++|+|||||++|+|++|+.||....+ .+...........
T Consensus 154 ~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~------~~~~~~~~~~~~~----- 220 (258)
T cd06632 154 EFS--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG------VAAVFKIGRSKEL----- 220 (258)
T ss_pred ccc--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH------HHHHHHHHhcccC-----
Confidence 332 233456899999999987776 89999999999999999999999964431 1111111110100
Q ss_pred ccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 420 PRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 420 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
+.+. ...+ ..+.+++.+||+.+|++||++.+++++
T Consensus 221 ~~~~-~~~~---~~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 221 PPIP-DHLS---DEAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred CCcC-CCcC---HHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 1111 1122 334457889999999999999999864
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=312.45 Aligned_cols=240 Identities=23% Similarity=0.412 Sum_probs=188.1
Q ss_pred ceEcccCcEEEEEEEECC-C-------cEEEEEEeecCCchhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEEe
Q 010513 192 NVIGEGGYGIVYHGVLED-N-------TNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY 263 (508)
Q Consensus 192 ~~LG~G~~g~Vy~~~~~~-~-------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~ 263 (508)
+.||+|+||.||+|.... + ..+++|.+........+.+..|+.+++.++||||+++++++..+...++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 368999999999998642 2 24788877655545566788899999999999999999999998999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCC--------eEEeeecc
Q 010513 264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWN--------PKLSDFGL 335 (508)
Q Consensus 264 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~--------~kL~DFG~ 335 (508)
+++|+|.+++... ...+++..++.++.|++.||+|||++ +|+||||||+||+++.++. ++++|||+
T Consensus 81 ~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~ 154 (258)
T cd05078 81 VKFGSLDTYLKKN---KNLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGI 154 (258)
T ss_pred CCCCcHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEeccccc
Confidence 9999999999765 24689999999999999999999999 9999999999999987765 69999998
Q ss_pred ceecCCCCcceecceecCCCCCChhhhhc-CCCCCCCCeeehHHHHHHHHhCC-CCCCCCCCCCcchHHHHHHHhhcccc
Q 010513 336 AKLLGAERSYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGR-NPVDYSRPPGEVNLVEWLKTMVTNRN 413 (508)
Q Consensus 336 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~-~Pf~~~~~~~~~~~~~~~~~~~~~~~ 413 (508)
+..... .....++..|+|||++.+ ..++.++|||||||++|||++|. .||....+. .... .....
T Consensus 155 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~------~~~~-~~~~~- 221 (258)
T cd05078 155 SITVLP-----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQ------KKLQ-FYEDR- 221 (258)
T ss_pred ccccCC-----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHH------HHHH-HHHcc-
Confidence 875432 223467889999999876 45889999999999999999985 555432211 1111 11110
Q ss_pred cccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 010513 414 AEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 460 (508)
Q Consensus 414 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le 460 (508)
..+.. .. ..++.+++.+||+.||++||+++++++.|+
T Consensus 222 ------~~~~~-~~---~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 222 ------HQLPA-PK---WTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred ------ccCCC-CC---cHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 01111 11 134556888999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=302.54 Aligned_cols=253 Identities=24% Similarity=0.409 Sum_probs=206.6
Q ss_pred CCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCc-hhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEEe
Q 010513 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY 263 (508)
Q Consensus 186 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~ 263 (508)
++|++.+.||+|++|.||+|... +++.|++|++..... ...+.+..|++.+..++|+|++++++++......++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 36888999999999999999976 488999999866544 4567889999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCC
Q 010513 264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE-GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE 342 (508)
Q Consensus 264 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 342 (508)
+++++|.+++... ..+++...+.++.|+++|++|||+ . +++||||+|+||+++.++.++|+|||.+......
T Consensus 81 ~~~~~L~~~l~~~----~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~ 153 (264)
T cd06623 81 MDGGSLADLLKKV----GKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENT 153 (264)
T ss_pred cCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecccC
Confidence 9999999999764 578999999999999999999999 8 9999999999999999999999999999876433
Q ss_pred CcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCCccC
Q 010513 343 RSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRL 422 (508)
Q Consensus 343 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 422 (508)
... .....++..|+|||.+.+..++.++|+||||+++|+|++|+.||............. ..... ..+.+
T Consensus 154 ~~~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~---~~~~~------~~~~~ 223 (264)
T cd06623 154 LDQ-CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQ---AICDG------PPPSL 223 (264)
T ss_pred CCc-ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHH---HHhcC------CCCCC
Confidence 322 234568899999999999999999999999999999999999997654322222222 21111 11111
Q ss_pred CCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 423 QEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 423 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
.....+ ..+.+++.+||+.+|++||++.+++++
T Consensus 224 ~~~~~~---~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 224 PAEEFS---PEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred CcccCC---HHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 111122 345557779999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=325.16 Aligned_cols=262 Identities=23% Similarity=0.406 Sum_probs=217.8
Q ss_pred hhHhhcCCCCcccceEcccCcEEEEEEEECC-CcEEEEEEeecCCchhHHHHHHHHHHHHccCCCCeeeEeeeeecCCee
Q 010513 179 RELEVSTNGFADENVIGEGGYGIVYHGVLED-NTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHR 257 (508)
Q Consensus 179 ~~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 257 (508)
+.|++...+.....+||-|.||.||.|.|+. .-.||||.++.. ....++|..|..+|+.++|||+|+++|+|..+..+
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPF 338 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPF 338 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCe
Confidence 6778888899999999999999999999874 556899987654 45578899999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccce
Q 010513 258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK 337 (508)
Q Consensus 258 ~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~ 337 (508)
|||+|||..|+|.+||++.. ...++....+.++.||+.|++||..+ ++|||||...|+|+.++..+|++|||+++
T Consensus 339 YIiTEfM~yGNLLdYLRecn--r~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsR 413 (1157)
T KOG4278|consen 339 YIITEFMCYGNLLDYLRECN--RSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSR 413 (1157)
T ss_pred EEEEecccCccHHHHHHHhc--hhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhh
Confidence 99999999999999998763 45677888899999999999999998 99999999999999999999999999999
Q ss_pred ecCCCCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHhhccccccc
Q 010513 338 LLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEG 416 (508)
Q Consensus 338 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 416 (508)
++..+.............|.|||-+....++.|+|||+|||+|||+.| |..||.+-+- .+. ...+.++..
T Consensus 414 lMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidl------SqV-Y~LLEkgyR-- 484 (1157)
T KOG4278|consen 414 LMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDL------SQV-YGLLEKGYR-- 484 (1157)
T ss_pred hhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccH------HHH-HHHHhcccc--
Confidence 986554333333344668999999999999999999999999999999 9999964432 221 111111110
Q ss_pred CCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010513 417 VLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (508)
Q Consensus 417 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~~ 462 (508)
.-..+.|+....+ |+++||+..|.+||++.|+-+.+|..
T Consensus 485 ----M~~PeGCPpkVYe---LMraCW~WsPsDRPsFaeiHqafEtm 523 (1157)
T KOG4278|consen 485 ----MDGPEGCPPKVYE---LMRACWNWSPSDRPSFAEIHQAFETM 523 (1157)
T ss_pred ----ccCCCCCCHHHHH---HHHHHhcCCcccCccHHHHHHHHHHH
Confidence 1123457766666 78899999999999999999999853
|
|
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=308.85 Aligned_cols=260 Identities=27% Similarity=0.400 Sum_probs=201.5
Q ss_pred chhhHhhcCCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCchhHHHHHHHHHHHHcc-CCCCeeeEeeeeec-
Q 010513 177 TLRELEVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAE- 253 (508)
Q Consensus 177 ~~~~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~- 253 (508)
++.+...+.+.|++.+.||+|+||.||+|... +++.+|+|.+.... ....++..|+.+++++ +|+||+++++++..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 45555567789999999999999999999975 57889999875443 3345678899999998 79999999999853
Q ss_pred -----CCeeEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCe
Q 010513 254 -----GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNP 328 (508)
Q Consensus 254 -----~~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~ 328 (508)
....|++|||+++|+|.+++.... ...+++..++.++.|++.||+|||+. +++||||||+||++++++.+
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~~ 160 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTK--GNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEV 160 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCE
Confidence 457899999999999999987642 34588889999999999999999998 99999999999999999999
Q ss_pred EEeeeccceecCCCCcceecceecCCCCCChhhhh-----cCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHH
Q 010513 329 KLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAS-----TGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVE 403 (508)
Q Consensus 329 kL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~ 403 (508)
+|+|||++........ ......|++.|+|||.+. ...++.++|+|||||++|||++|..||....+....
T Consensus 161 ~l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~---- 235 (282)
T cd06636 161 KLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRAL---- 235 (282)
T ss_pred EEeeCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhh----
Confidence 9999999876532211 123356899999999875 346888999999999999999999999644321111
Q ss_pred HHHHhhcccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 404 WLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 404 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
.... ....+.......+ ..+.+++.+||+.||.+||++.|++++
T Consensus 236 --~~~~------~~~~~~~~~~~~~---~~~~~li~~cl~~~p~~Rp~~~ell~~ 279 (282)
T cd06636 236 --FLIP------RNPPPKLKSKKWS---KKFIDFIEGCLVKNYLSRPSTEQLLKH 279 (282)
T ss_pred --hhHh------hCCCCCCcccccC---HHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence 1000 0111111111223 345558889999999999999999854
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=313.22 Aligned_cols=262 Identities=24% Similarity=0.374 Sum_probs=199.4
Q ss_pred CCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCc--hhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEE
Q 010513 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG--QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE 262 (508)
Q Consensus 186 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e 262 (508)
++|++.+.||+|+||.||+|.++ +++.||+|.+..... ...+.+.+|+++++.++||||+++++++.++...++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 46889999999999999999976 578899998754322 234568889999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCC
Q 010513 263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE 342 (508)
Q Consensus 263 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 342 (508)
|+++++|.++.... ..+++..++.++.|+++||+|||+. +++||||+|+||++++++.++|+|||++......
T Consensus 81 ~~~~~~l~~~~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07846 81 FVDHTVLDDLEKYP----NGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 153 (286)
T ss_pred cCCccHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCC
Confidence 99999988876543 3589999999999999999999998 9999999999999999999999999999876443
Q ss_pred CcceecceecCCCCCChhhhhc-CCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhc-----------
Q 010513 343 RSYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVT----------- 410 (508)
Q Consensus 343 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~----------- 410 (508)
. .......++..|+|||++.+ ..++.++||||||+++|||++|+.||....... ..........
T Consensus 154 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 229 (286)
T cd07846 154 G-EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDID---QLYHIIKCLGNLIPRHQEIFQ 229 (286)
T ss_pred c-cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHH---HHHHHHHHhCCCchhhHHHhc
Confidence 3 22233568899999998865 457889999999999999999999996443211 0000000000
Q ss_pred cc-ccccCCCccCCCCc-----hHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 411 NR-NAEGVLDPRLQEKP-----CSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 411 ~~-~~~~~~~~~l~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
.. .......+...... .+.....+.+++.+||+.||++||++.+++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 230 KNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred cchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 00 00000111111000 11123456668889999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=312.43 Aligned_cols=263 Identities=24% Similarity=0.338 Sum_probs=201.8
Q ss_pred CCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecC--CchhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEE
Q 010513 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE 262 (508)
Q Consensus 186 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e 262 (508)
++|++.+.||+|+||.||+|.++ +++.||+|.+... .....+.+..|+++++.++|+||+++++++.+++..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36889999999999999999976 5788999987543 22334678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCC
Q 010513 263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE 342 (508)
Q Consensus 263 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 342 (508)
|++++.+..+.... ..+++..++.++.|++.||.|||++ +++||||+|+||++++++.+||+|||++......
T Consensus 81 ~~~~~~l~~~~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~ 153 (288)
T cd07833 81 YVERTLLELLEASP----GGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRAR 153 (288)
T ss_pred cCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCC
Confidence 99987776665443 4589999999999999999999999 9999999999999999999999999999876544
Q ss_pred CcceecceecCCCCCChhhhhcC-CCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhc-----------
Q 010513 343 RSYVTTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVT----------- 410 (508)
Q Consensus 343 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~----------- 410 (508)
.........++..|+|||++.+. .++.++|+||||+++|+|++|+.||...... ...........
T Consensus 154 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 230 (288)
T cd07833 154 PASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDI---DQLYLIQKCLGPLPPSHQELFS 230 (288)
T ss_pred ccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhCCCCHHHhhhcc
Confidence 43233446788999999999888 8899999999999999999999999754321 11111111000
Q ss_pred -ccccc--cCCCccCCC----CchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 411 -NRNAE--GVLDPRLQE----KPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 411 -~~~~~--~~~~~~l~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
+.... ...+..... ........++.+++.+||+.+|++||++++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 231 SNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred cCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 00000 000000000 0000114556778889999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=333.75 Aligned_cols=271 Identities=19% Similarity=0.289 Sum_probs=191.6
Q ss_pred hhcCCCCcccceEcccCcEEEEEEEECC--CcEEEEEE--------------e---ecCCchhHHHHHHHHHHHHccCCC
Q 010513 182 EVSTNGFADENVIGEGGYGIVYHGVLED--NTNVAVKN--------------L---LNNRGQAEKEFKVEVEAIGRVRHK 242 (508)
Q Consensus 182 ~~~~~~~~~~~~LG~G~~g~Vy~~~~~~--~~~vavK~--------------~---~~~~~~~~~~~~~E~~~l~~l~hp 242 (508)
....++|++.+.||+|+||+||+|..+. +...+.|. + ..........+.+|++++++++||
T Consensus 144 ~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hp 223 (501)
T PHA03210 144 DEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHE 223 (501)
T ss_pred hhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCC
Confidence 3445789999999999999999987542 11122221 1 111222345678899999999999
Q ss_pred CeeeEeeeeecCCeeEEEEEecCCCCHHHHhccCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEE
Q 010513 243 NLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVG-PHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNIL 321 (508)
Q Consensus 243 niv~l~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~-~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIl 321 (508)
||+++++++.+.+..|+|++++.+ +|.+++..... .........+..++.|++.||+|||++ +|+||||||+|||
T Consensus 224 nIv~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NIL 299 (501)
T PHA03210 224 NILKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIF 299 (501)
T ss_pred CcCcEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEE
Confidence 999999999999999999999965 78887754321 122344667788999999999999999 9999999999999
Q ss_pred EcCCCCeEEeeeccceecCCCCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCC-CCCCCCCCCcch
Q 010513 322 LDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRN-PVDYSRPPGEVN 400 (508)
Q Consensus 322 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~-Pf~~~~~~~~~~ 400 (508)
++.++.+||+|||+++.+............||..|+|||++.+..++.++|||||||++|||++|.. ||..........
T Consensus 300 l~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~ 379 (501)
T PHA03210 300 LNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQ 379 (501)
T ss_pred ECCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHH
Confidence 9999999999999998775544433445679999999999999999999999999999999999875 443322211111
Q ss_pred HHHHHHHhhcccccccCCCc-----------cC--CCCchHH------HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 401 LVEWLKTMVTNRNAEGVLDP-----------RL--QEKPCSR------ALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 401 ~~~~~~~~~~~~~~~~~~~~-----------~l--~~~~~~~------~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
+.+.+..... ....+.++ .+ .....+. ...++.+++.+||+.||++||++.|++++
T Consensus 380 ~~~~~~~~~~--~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 380 LLKIIDSLSV--CDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHHHHHhccc--ChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 2111110000 00000000 00 0000011 11234557889999999999999999875
|
|
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=307.32 Aligned_cols=252 Identities=26% Similarity=0.394 Sum_probs=202.0
Q ss_pred CCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecC--CchhHHHHHHHHHHHHccCCCCeeeEeeeeec--CCeeEEEE
Q 010513 187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE--GAHRMLVY 261 (508)
Q Consensus 187 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~--~~~~~lV~ 261 (508)
+|++.+.||.|+||.||++... +++.+|+|.+... .....+.+..|+++++.++||||+++++++.. +...+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 4788899999999999999864 6788999988643 23344578889999999999999999998753 45678999
Q ss_pred EecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHH-----hcCCCCeeeccCCCCCEEEcCCCCeEEeeeccc
Q 010513 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH-----EGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLA 336 (508)
Q Consensus 262 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH-----~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a 336 (508)
||+++++|.+++.........+++..++.++.|++.||+||| +. +++|+||||+||+++.++.+||+|||++
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~~kl~d~g~~ 157 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNNVKLGDFGLA 157 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCCEEEeccccc
Confidence 999999999999765444567999999999999999999999 66 9999999999999999999999999999
Q ss_pred eecCCCCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhccccccc
Q 010513 337 KLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEG 416 (508)
Q Consensus 337 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 416 (508)
......... .....|++.|+|||.+.+..++.++|+||||+++|+|++|+.||..... .+ +.+.......
T Consensus 158 ~~~~~~~~~-~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~-~~~~~~~~~~-- 227 (265)
T cd08217 158 KILGHDSSF-AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ------LQ-LASKIKEGKF-- 227 (265)
T ss_pred ccccCCccc-ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH------HH-HHHHHhcCCC--
Confidence 876543321 2335689999999999988899999999999999999999999975431 11 1112222111
Q ss_pred CCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 417 VLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 417 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
+.+. .....++.+++.+|++.+|++||++.+|+++
T Consensus 228 ---~~~~----~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 228 ---RRIP----YRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred ---CCCc----cccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 1111 1223455668889999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=315.16 Aligned_cols=248 Identities=26% Similarity=0.364 Sum_probs=199.1
Q ss_pred CCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCchhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEEecC
Q 010513 187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYID 265 (508)
Q Consensus 187 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~ 265 (508)
.|.....||+|+||.||++... ++..||+|.+........+.+.+|+..++.++|+||+++++.+..++..++||||++
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~ 102 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLE 102 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCC
Confidence 3444577999999999999965 588899999876655666778899999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCCCcc
Q 010513 266 NGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSY 345 (508)
Q Consensus 266 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~ 345 (508)
+++|.+++.. ..+++..++.++.|++.||+|||++ +++||||||+||++++++.++|+|||++........
T Consensus 103 ~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~- 173 (292)
T cd06658 103 GGALTDIVTH-----TRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP- 173 (292)
T ss_pred CCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc-
Confidence 9999998854 3588999999999999999999999 999999999999999999999999999876533222
Q ss_pred eecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCCccCCC-
Q 010513 346 VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQE- 424 (508)
Q Consensus 346 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~- 424 (508)
......|+..|+|||.+.+..++.++|+||||+++|||++|+.||....+. +.+..... ...+.+..
T Consensus 174 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~------~~~~~~~~------~~~~~~~~~ 241 (292)
T cd06658 174 KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL------QAMRRIRD------NLPPRVKDS 241 (292)
T ss_pred cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHh------cCCCccccc
Confidence 223457899999999998888999999999999999999999999744321 11111110 11111111
Q ss_pred CchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 425 KPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 425 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
...+.. +.+++.+||+.||++||++.+++++
T Consensus 242 ~~~~~~---~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 242 HKVSSV---LRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred cccCHH---HHHHHHHHccCChhHCcCHHHHhhC
Confidence 112233 4447779999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=311.42 Aligned_cols=262 Identities=22% Similarity=0.336 Sum_probs=196.2
Q ss_pred CCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCC--chhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEEe
Q 010513 187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY 263 (508)
Q Consensus 187 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~ 263 (508)
+|++.+.||+|+||.||+|.+. +|+.||+|.+.... ......+..|+++++.++||||+++++++.+....++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4788899999999999999975 58889999886432 22235677899999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCCC
Q 010513 264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER 343 (508)
Q Consensus 264 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 343 (508)
+++ +|.+++... ...+++..++.++.|+++||.|||++ +++||||||+||+++.++.+||+|||+++......
T Consensus 81 ~~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 153 (284)
T cd07839 81 CDQ-DLKKYFDSC---NGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV 153 (284)
T ss_pred CCC-CHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCC
Confidence 975 888887654 25689999999999999999999999 99999999999999999999999999998654322
Q ss_pred cceecceecCCCCCChhhhhcC-CCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccc------ccc
Q 010513 344 SYVTTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRN------AEG 416 (508)
Q Consensus 344 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~------~~~ 416 (508)
. ......+++.|+|||.+.+. .++.++|||||||++|||+||..||...... . ...+.+........ ...
T Consensus 154 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~-~-~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07839 154 R-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV-D-DQLKRIFRLLGTPTEESWPGVSK 230 (284)
T ss_pred C-CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCH-H-HHHHHHHHHhCCCChHHhHHhhh
Confidence 2 12334678899999988764 4789999999999999999999986433221 1 11111111100000 000
Q ss_pred CCC----ccCCCC-----chHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 417 VLD----PRLQEK-----PCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 417 ~~~----~~l~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
..+ +..... ..+....++.+++.+||+.||++|||+++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 231 LPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred cccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 000 000000 011123455668889999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=309.47 Aligned_cols=263 Identities=22% Similarity=0.335 Sum_probs=197.0
Q ss_pred CCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCc-hhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEEe
Q 010513 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY 263 (508)
Q Consensus 186 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~ 263 (508)
++|++.+.||+|+||.||+|..+ +++.||+|.+..... .....+.+|+++++.++|+||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 57899999999999999999976 678899999865432 2234567799999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCCC
Q 010513 264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER 343 (508)
Q Consensus 264 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 343 (508)
+.+ +|.+++... ...+++..++.++.|+++||.|||++ +++||||||+||+++.++.+||+|||+++......
T Consensus 85 ~~~-~L~~~~~~~---~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~ 157 (291)
T cd07844 85 LDT-DLKQYMDDC---GGGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPS 157 (291)
T ss_pred CCC-CHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCCC
Confidence 985 999998765 24688999999999999999999999 99999999999999999999999999987543221
Q ss_pred cceecceecCCCCCChhhhhc-CCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhccc----------
Q 010513 344 SYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNR---------- 412 (508)
Q Consensus 344 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~---------- 412 (508)
. ......++..|+|||++.+ ..++.++|||||||++|+|++|+.||.......+ ........+...
T Consensus 158 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 234 (291)
T cd07844 158 K-TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVED--QLHKIFRVLGTPTEETWPGVSS 234 (291)
T ss_pred c-cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH--HHHHHHHhcCCCChhhhhhhhh
Confidence 1 1122356889999998865 4588999999999999999999999965431110 011010000000
Q ss_pred --ccccCCCccCCCCc----hHH--HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 413 --NAEGVLDPRLQEKP----CSR--ALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 413 --~~~~~~~~~l~~~~----~~~--~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
.......+...... ... ....+.+++.+||+.||++||++.+++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~ 288 (291)
T cd07844 235 NPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH 288 (291)
T ss_pred ccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence 00000000000000 000 11456678899999999999999998853
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=311.54 Aligned_cols=262 Identities=23% Similarity=0.325 Sum_probs=201.4
Q ss_pred CCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCC--chhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEEe
Q 010513 187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY 263 (508)
Q Consensus 187 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~ 263 (508)
+|++.+.||+|+||.||+|.+. +++.||+|++.... ......+.+|+.+++.++||||+++++++.++...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4788999999999999999975 68899999986543 33456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCCC
Q 010513 264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER 343 (508)
Q Consensus 264 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 343 (508)
+ +++|.+++... ...+++..++.++.|+++||+|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~-~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 153 (286)
T cd07832 81 M-PSDLSEVLRDE---ERPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEE 153 (286)
T ss_pred c-CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCC
Confidence 9 99999998765 25689999999999999999999999 99999999999999999999999999998765443
Q ss_pred cceecceecCCCCCChhhhhcC-CCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhccc----------
Q 010513 344 SYVTTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNR---------- 412 (508)
Q Consensus 344 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~---------- 412 (508)
........|+..|+|||.+.+. .++.++|||||||++|||++|..||...... .............
T Consensus 154 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 230 (286)
T cd07832 154 PRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDI---EQLAIVFRTLGTPNEETWPGLTS 230 (286)
T ss_pred CCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHH---HHHHHHHHHcCCCChHHHhhccC
Confidence 2223345689999999988654 4689999999999999999998888643321 1111111100000
Q ss_pred --ccccCCCccCCCC----chHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 413 --NAEGVLDPRLQEK----PCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 413 --~~~~~~~~~l~~~----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
.......+..... ..+.....+.+++.+||+.||++||++++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 231 LPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred cchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0000000000000 001123566678889999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=307.33 Aligned_cols=248 Identities=30% Similarity=0.483 Sum_probs=197.1
Q ss_pred CCCcccceEcccCcEEEEEEEECCCcEEEEEEeecCCchhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEEecC
Q 010513 186 NGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYID 265 (508)
Q Consensus 186 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~ 265 (508)
++|++.+.||+|+||.||++.. ++..||+|.+.... ..+.+.+|+.+++.++|||++++++++..+ ..++||||+.
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 4688999999999999999975 47789999885432 345788899999999999999999998764 5789999999
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCCCcc
Q 010513 266 NGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSY 345 (508)
Q Consensus 266 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~ 345 (508)
+++|.+++.... ...+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||++......
T Consensus 82 ~~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~--- 153 (254)
T cd05083 82 KGNLVNFLRTRG--RALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG--- 153 (254)
T ss_pred CCCHHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceecccc---
Confidence 999999997652 34688999999999999999999998 9999999999999999999999999998764321
Q ss_pred eecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHhhcccccccCCCccCCC
Q 010513 346 VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQE 424 (508)
Q Consensus 346 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 424 (508)
......+..|+|||.+.+..++.++|+|||||++|||++ |+.||..... .+... ....+. ..++ .
T Consensus 154 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~------~~~~~-~~~~~~---~~~~---~ 219 (254)
T cd05083 154 -VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSL------KEVKE-CVEKGY---RMEP---P 219 (254)
T ss_pred -CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCH------HHHHH-HHhCCC---CCCC---C
Confidence 112234567999999988899999999999999999998 9999964432 11111 111111 0011 1
Q ss_pred CchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010513 425 KPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (508)
Q Consensus 425 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~~ 462 (508)
+..+ ..+.+++.+||+.+|++||+++++++.|+.+
T Consensus 220 ~~~~---~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 254 (254)
T cd05083 220 EGCP---ADVYVLMTSCWETEPKKRPSFHKLREKLEKE 254 (254)
T ss_pred CcCC---HHHHHHHHHHcCCChhhCcCHHHHHHHHccC
Confidence 1122 3445588899999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=308.09 Aligned_cols=263 Identities=27% Similarity=0.383 Sum_probs=202.9
Q ss_pred chhhHhhcCCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCchhHHHHHHHHHHHHcc-CCCCeeeEeeeeecC
Q 010513 177 TLRELEVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEG 254 (508)
Q Consensus 177 ~~~~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~ 254 (508)
.+..+..+.++|.+.+.||+|+||.||+|... +++.+|+|.+.... .....+..|+.+++++ +|||++++++++...
T Consensus 13 ~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~ 91 (291)
T cd06639 13 GLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKA 91 (291)
T ss_pred hcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEec
Confidence 34455557789999999999999999999975 57889999875432 2345677899999999 899999999998753
Q ss_pred -----CeeEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeE
Q 010513 255 -----AHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPK 329 (508)
Q Consensus 255 -----~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~k 329 (508)
...++||||+++|+|.++++........+++..++.++.|++.||+|||+. +++||||||+||+++.++.+|
T Consensus 92 ~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~~k 168 (291)
T cd06639 92 DKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVK 168 (291)
T ss_pred cccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEE
Confidence 357899999999999999865433346789999999999999999999998 999999999999999999999
Q ss_pred EeeeccceecCCCCcceecceecCCCCCChhhhhcC-----CCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHH
Q 010513 330 LSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTG-----MLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEW 404 (508)
Q Consensus 330 L~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~ 404 (508)
|+|||++........ ......|+..|+|||.+... .++.++|+|||||++|||++|+.||....+. +.
T Consensus 169 l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~------~~ 241 (291)
T cd06639 169 LVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV------KT 241 (291)
T ss_pred Eeecccchhcccccc-cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH------HH
Confidence 999999886543221 12234688999999988643 3688999999999999999999999643321 11
Q ss_pred HHHhhcccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 405 LKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 405 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
+...... ......+ .......+.+++.+||+.||++||++.+++++
T Consensus 242 ~~~~~~~-~~~~~~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 242 LFKIPRN-PPPTLLH-------PEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred HHHHhcC-CCCCCCc-------ccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 1111111 0001111 11122345668889999999999999999875
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=306.72 Aligned_cols=256 Identities=27% Similarity=0.469 Sum_probs=202.2
Q ss_pred cCCCCcccceEcccCcEEEEEEEECC-Cc----EEEEEEeecCCc-hhHHHHHHHHHHHHccCCCCeeeEeeeeecCCee
Q 010513 184 STNGFADENVIGEGGYGIVYHGVLED-NT----NVAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHR 257 (508)
Q Consensus 184 ~~~~~~~~~~LG~G~~g~Vy~~~~~~-~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 257 (508)
...+|++.+.||+|+||.||+|.+++ +. .+|+|.+..... .....+.+|+++++.++||||+++++++.. ...
T Consensus 5 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 83 (279)
T cd05057 5 KETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQV 83 (279)
T ss_pred CHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-Cce
Confidence 34578889999999999999999653 32 588888765543 345678889999999999999999999987 788
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccce
Q 010513 258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK 337 (508)
Q Consensus 258 ~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~ 337 (508)
++||||+++|+|.+++... ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++
T Consensus 84 ~~v~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~ 157 (279)
T cd05057 84 QLITQLMPLGCLLDYVRNH---KDNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAK 157 (279)
T ss_pred EEEEecCCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCcccc
Confidence 9999999999999999765 34689999999999999999999998 99999999999999999999999999998
Q ss_pred ecCCCCccee-cceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHhhcccccc
Q 010513 338 LLGAERSYVT-TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAE 415 (508)
Q Consensus 338 ~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (508)
.......... ....++..|+|||.+....++.++|+|||||++||+++ |+.||..... .+... ......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~------~~~~~-~~~~~~-- 228 (279)
T cd05057 158 LLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA------VEIPD-LLEKGE-- 228 (279)
T ss_pred cccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH------HHHHH-HHhCCC--
Confidence 7643322221 12234568999999988899999999999999999999 9999975432 11111 111111
Q ss_pred cCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010513 416 GVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (508)
Q Consensus 416 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~~ 462 (508)
....+ ..++ .++.+++.+||..||++||++.++++.|+..
T Consensus 229 ~~~~~----~~~~---~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~ 268 (279)
T cd05057 229 RLPQP----PICT---IDVYMVLVKCWMIDAESRPTFKELINEFSKM 268 (279)
T ss_pred CCCCC----CCCC---HHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 00011 1122 2455578899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=304.95 Aligned_cols=254 Identities=26% Similarity=0.402 Sum_probs=204.3
Q ss_pred CCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCC-chhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEEe
Q 010513 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY 263 (508)
Q Consensus 186 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~ 263 (508)
++|++.+.||+|+||.||+|..+ +++.+|+|.+.... ....+.+.+|+++++.++||||+++++.+..+...++++||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 36788899999999999999976 57889999886653 34456788899999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCC
Q 010513 264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE-GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE 342 (508)
Q Consensus 264 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 342 (508)
+++++|.+++.... ..+++.....++.|++.||+|||+ . +++||||||+||++++++.++|+|||.+......
T Consensus 81 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~ 154 (265)
T cd06605 81 MDGGSLDKILKEVQ---GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS 154 (265)
T ss_pred cCCCcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHH
Confidence 99999999997652 578999999999999999999999 7 9999999999999999999999999998765322
Q ss_pred CcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCCccC
Q 010513 343 RSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRL 422 (508)
Q Consensus 343 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 422 (508)
.. ....|+..|+|||.+.+..++.++|+||||+++|+|++|+.||....... ....+.+....... .+.+
T Consensus 155 ~~---~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~------~~~~ 224 (265)
T cd06605 155 LA---KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPP-DGIFELLQYIVNEP------PPRL 224 (265)
T ss_pred Hh---hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccc-ccHHHHHHHHhcCC------CCCC
Confidence 11 12678899999999999999999999999999999999999997543221 12222222222111 1111
Q ss_pred CCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 423 QEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 423 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
.... ....+.+++.+||..||++||++.+++++
T Consensus 225 ~~~~---~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 225 PSGK---FSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred Chhh---cCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 1111 23345568889999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-38 Score=305.22 Aligned_cols=256 Identities=31% Similarity=0.407 Sum_probs=200.5
Q ss_pred cCCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCchhHHHHHHHHHHHHcc-CCCCeeeEeeeeecCC------
Q 010513 184 STNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEGA------ 255 (508)
Q Consensus 184 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~------ 255 (508)
++++|++.+.||+|+||.||+|..+ +++.+++|.+..... ..+.+..|+++++++ .|+||+++++++.+..
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 4678999999999999999999975 577899998765443 346788999999999 7999999999997544
Q ss_pred eeEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeecc
Q 010513 256 HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGL 335 (508)
Q Consensus 256 ~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~ 335 (508)
..++||||+++++|.+++.........+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.+||+|||+
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCCcc
Confidence 48999999999999999876433346789999999999999999999998 999999999999999999999999999
Q ss_pred ceecCCCCcceecceecCCCCCChhhhhc-----CCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhc
Q 010513 336 AKLLGAERSYVTTRVMGTFGYVAPEYAST-----GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVT 410 (508)
Q Consensus 336 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~ 410 (508)
+....... .......|+..|+|||++.. ..++.++|||||||++|+|++|+.||....+. ........
T Consensus 160 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~ 232 (275)
T cd06608 160 SAQLDSTL-GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM------RALFKIPR 232 (275)
T ss_pred ceecccch-hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH------HHHHHhhc
Confidence 88653322 22233568999999998754 34678999999999999999999999643221 11111111
Q ss_pred ccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 411 NRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 411 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
. . .+.+.. ......++.+++.+||..||++||++.+++++
T Consensus 233 ~-~-----~~~~~~--~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 233 N-P-----PPTLKS--PENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred c-C-----CCCCCc--hhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 1 0 111111 11123345568889999999999999999864
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=309.61 Aligned_cols=256 Identities=23% Similarity=0.344 Sum_probs=200.7
Q ss_pred CCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCc---hhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEE
Q 010513 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG---QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY 261 (508)
Q Consensus 186 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 261 (508)
++|++.+.||+|+||.||++... +++.|++|.+..... ...+.+.+|+++++.++||||+++++.+..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 46889999999999999999976 477899998865432 23456778999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCC
Q 010513 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA 341 (508)
Q Consensus 262 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 341 (508)
||+++++|.+++... ..+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++....
T Consensus 81 e~~~g~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~ 153 (305)
T cd05609 81 EYVEGGDCATLLKNI----GALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLM 153 (305)
T ss_pred ecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCc
Confidence 999999999999664 4689999999999999999999998 999999999999999999999999999864211
Q ss_pred C--------------CcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHH
Q 010513 342 E--------------RSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKT 407 (508)
Q Consensus 342 ~--------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~ 407 (508)
. .........|+..|+|||.+.+..++.++|+|||||++|||++|..||....+ .+....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~------~~~~~~ 227 (305)
T cd05609 154 SLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP------EELFGQ 227 (305)
T ss_pred CccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHH
Confidence 0 00111224578899999999888899999999999999999999999964321 222222
Q ss_pred hhcccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010513 408 MVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (508)
Q Consensus 408 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~~ 462 (508)
..... ...+... ...+.. +.+++.+||+.||++||+..++.+.|+..
T Consensus 228 ~~~~~----~~~~~~~-~~~~~~---~~~li~~~l~~~P~~R~~~~~~~~ll~~~ 274 (305)
T cd05609 228 VISDD----IEWPEGD-EALPAD---AQDLISRLLRQNPLERLGTGGAFEVKQHR 274 (305)
T ss_pred HHhcc----cCCCCcc-ccCCHH---HHHHHHHHhccChhhccCccCHHHHHhCc
Confidence 22111 0111111 112333 44588899999999999977777777653
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=305.26 Aligned_cols=254 Identities=26% Similarity=0.403 Sum_probs=195.5
Q ss_pred CCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCC-chhHHHHHHHHHH-HHccCCCCeeeEeeeeecCCeeEEEEE
Q 010513 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR-GQAEKEFKVEVEA-IGRVRHKNLVRLLGYCAEGAHRMLVYE 262 (508)
Q Consensus 186 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~-l~~l~hpniv~l~~~~~~~~~~~lV~e 262 (508)
++|++.+.||+|+||.||+|.+. +|+.||+|.+.... ......+..|+.. ++.++||||+++++++..+...|++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 47889999999999999999976 58899999886543 2233445556664 566799999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCC
Q 010513 263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE 342 (508)
Q Consensus 263 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 342 (508)
|++ |+|.+++.........+++..++.++.|++.||+|||++. +++||||||+||+++.++.+||+|||++......
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 997 5898888664444467999999999999999999999753 7999999999999999999999999999865322
Q ss_pred CcceecceecCCCCCChhhhhc----CCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCC
Q 010513 343 RSYVTTRVMGTFGYVAPEYAST----GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVL 418 (508)
Q Consensus 343 ~~~~~~~~~gt~~y~aPE~~~~----~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 418 (508)
...+...|+..|+|||.+.+ ..++.++|+|||||++|+|++|+.||...... .+.+...... .
T Consensus 158 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-----~~~~~~~~~~------~ 224 (283)
T cd06617 158 --VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP-----FQQLKQVVEE------P 224 (283)
T ss_pred --cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC-----HHHHHHHHhc------C
Confidence 12233468899999998864 45688999999999999999999999643211 1112221111 1
Q ss_pred CccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 419 DPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 419 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
.+.+.....+ .++.+++.+||..+|++||++.+++++
T Consensus 225 ~~~~~~~~~~---~~l~~li~~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 225 SPQLPAEKFS---PEFQDFVNKCLKKNYKERPNYPELLQH 261 (283)
T ss_pred CCCCCccccC---HHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1112111122 345558889999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-38 Score=305.02 Aligned_cols=250 Identities=24% Similarity=0.377 Sum_probs=194.3
Q ss_pred CCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCC-----chhHHHHHHHHHHHHccCCCCeeeEeeeeec--CCee
Q 010513 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR-----GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE--GAHR 257 (508)
Q Consensus 186 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~--~~~~ 257 (508)
.+|+..+.||+|+||.||+|... ++..|++|.+.... ......+.+|+++++.++||||+++++++.+ +...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 46888999999999999999965 58899999875432 1234568889999999999999999999875 3567
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccce
Q 010513 258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK 337 (508)
Q Consensus 258 ~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~ 337 (508)
+++|||+++++|.+++... ..+++...+.++.|++.||+|||+. +++||||||+||+++.++.+||+|||++.
T Consensus 82 ~l~~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~ 154 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAY----GALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK 154 (266)
T ss_pred EEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCcc
Confidence 8999999999999999764 4588999999999999999999998 99999999999999999999999999987
Q ss_pred ecCCCC--cceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccc
Q 010513 338 LLGAER--SYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAE 415 (508)
Q Consensus 338 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (508)
...... ........++..|+|||.+.+..++.++|+|||||++|||++|+.||..... .+.........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~------~~~~~~~~~~~--- 225 (266)
T cd06651 155 RLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA------MAAIFKIATQP--- 225 (266)
T ss_pred ccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccch------HHHHHHHhcCC---
Confidence 653211 1112234588899999999988899999999999999999999999964321 11111111111
Q ss_pred cCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 416 GVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 416 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
..+.+.. ..+... .+++ +||..+|++||++++++++
T Consensus 226 --~~~~~~~-~~~~~~---~~li-~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 226 --TNPQLPS-HISEHA---RDFL-GCIFVEARHRPSAEELLRH 261 (266)
T ss_pred --CCCCCch-hcCHHH---HHHH-HHhcCChhhCcCHHHHhcC
Confidence 1122211 112222 3344 6888999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-38 Score=310.04 Aligned_cols=248 Identities=25% Similarity=0.354 Sum_probs=198.2
Q ss_pred CcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCchhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEEecCC
Q 010513 188 FADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDN 266 (508)
Q Consensus 188 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~ 266 (508)
|.....||+|+||.||+|... +++.||+|.+........+.+.+|+.+++.++||||+++++++..++..++||||+++
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~ 102 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG 102 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence 444567999999999999965 6889999998655545566788899999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCCCcce
Q 010513 267 GNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYV 346 (508)
Q Consensus 267 g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~ 346 (508)
++|.+++.. ..+++..++.++.|++.||+|||++ +++||||||+||+++.++.+||+|||++....... ..
T Consensus 103 ~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~-~~ 173 (297)
T cd06659 103 GALTDIVSQ-----TRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-PK 173 (297)
T ss_pred CCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhccccc-cc
Confidence 999998754 3588999999999999999999999 99999999999999999999999999987553322 22
Q ss_pred ecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCCccCCCCc
Q 010513 347 TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKP 426 (508)
Q Consensus 347 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 426 (508)
.....|+..|+|||++.+..++.++|+|||||++|||++|+.||....+. +.+..... .. .+....
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~------~~~~~~~~-~~-----~~~~~~-- 239 (297)
T cd06659 174 RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV------QAMKRLRD-SP-----PPKLKN-- 239 (297)
T ss_pred ccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHhc-cC-----CCCccc--
Confidence 23457899999999999888999999999999999999999999743321 11111111 00 000000
Q ss_pred hHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 427 CSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 427 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
.......+.+++.+||+.+|++||++.+++++
T Consensus 240 ~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 240 AHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred cCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 01112234457779999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=303.77 Aligned_cols=250 Identities=23% Similarity=0.332 Sum_probs=195.1
Q ss_pred CCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCC-----chhHHHHHHHHHHHHccCCCCeeeEeeeeecC--Cee
Q 010513 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR-----GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEG--AHR 257 (508)
Q Consensus 186 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--~~~ 257 (508)
++|++.+.||+|+||.||+|... ++..||+|.+.... ....+.+.+|+++++.++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 47889999999999999999965 58899999875321 22345788899999999999999999998763 467
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccce
Q 010513 258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK 337 (508)
Q Consensus 258 ~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~ 337 (508)
++||||+++++|.+++... ..+++.....++.|++.||+|||++ +++|+||||+||+++.++.++|+|||++.
T Consensus 82 ~~v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~ 154 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSY----GALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASK 154 (265)
T ss_pred EEEEEecCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCcccc
Confidence 8999999999999998754 4578899999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCc--ceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccc
Q 010513 338 LLGAERS--YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAE 415 (508)
Q Consensus 338 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (508)
....... .......|+..|+|||.+.+..++.++|+|||||++|||++|+.||...... ..........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~------~~~~~~~~~~--- 225 (265)
T cd06652 155 RLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM------AAIFKIATQP--- 225 (265)
T ss_pred ccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchH------HHHHHHhcCC---
Confidence 6532111 1122346889999999998888999999999999999999999999643211 1111111110
Q ss_pred cCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 416 GVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 416 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
..+.. .......+.+++.+|+ .+|++||++++++++
T Consensus 226 --~~~~~----~~~~~~~~~~~i~~~l-~~p~~Rp~~~~il~~ 261 (265)
T cd06652 226 --TNPVL----PPHVSDHCRDFLKRIF-VEAKLRPSADELLRH 261 (265)
T ss_pred --CCCCC----chhhCHHHHHHHHHHh-cChhhCCCHHHHhcC
Confidence 11111 1222334555777888 499999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=302.02 Aligned_cols=252 Identities=27% Similarity=0.421 Sum_probs=200.9
Q ss_pred CCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCch--hHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEEe
Q 010513 187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQ--AEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY 263 (508)
Q Consensus 187 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~ 263 (508)
+|.+.+.||+|+||.||+|... +++.|++|.+...... ..+.+..|+++++.++|+||+++++++.+.+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 5788899999999999999965 6888999998765443 567889999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCCC
Q 010513 264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER 343 (508)
Q Consensus 264 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 343 (508)
+++++|.+++... ..+++..++.++.|++.||.|||+. +++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~ 153 (264)
T cd06626 81 CSGGTLEELLEHG----RILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNT 153 (264)
T ss_pred CCCCcHHHHHhhc----CCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCC
Confidence 9999999999764 4578999999999999999999998 99999999999999999999999999998764433
Q ss_pred cceec---ceecCCCCCChhhhhcCC---CCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccC
Q 010513 344 SYVTT---RVMGTFGYVAPEYASTGM---LNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGV 417 (508)
Q Consensus 344 ~~~~~---~~~gt~~y~aPE~~~~~~---~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 417 (508)
..... ...++..|+|||++.+.. ++.++||||||+++|||++|+.||...... ...... ....
T Consensus 154 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~-----~~~~~~-~~~~----- 222 (264)
T cd06626 154 TTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE-----FQIMFH-VGAG----- 222 (264)
T ss_pred CcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch-----HHHHHH-HhcC-----
Confidence 22211 356788999999998766 889999999999999999999999644311 111111 1111
Q ss_pred CCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 418 LDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 418 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
..+.+.. .......+.+++.+||+.||++||++.+++.+
T Consensus 223 ~~~~~~~--~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~ 261 (264)
T cd06626 223 HKPPIPD--SLQLSPEGKDFLDRCLESDPKKRPTASELLQH 261 (264)
T ss_pred CCCCCCc--ccccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 1111111 11112334457789999999999999998753
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=315.02 Aligned_cols=256 Identities=27% Similarity=0.480 Sum_probs=199.2
Q ss_pred cCCCCcccceEcccCcEEEEEEEEC-CCc----EEEEEEeecCCc-hhHHHHHHHHHHHHccCCCCeeeEeeeeecCCee
Q 010513 184 STNGFADENVIGEGGYGIVYHGVLE-DNT----NVAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHR 257 (508)
Q Consensus 184 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 257 (508)
..++|+..+.||+|+||.||+|.+. ++. .+|+|.+..... ....++..|+.+++.++||||+++++++... ..
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~ 83 (303)
T cd05110 5 KETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TI 83 (303)
T ss_pred chhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cc
Confidence 3457888999999999999999864 343 468887765433 2334688899999999999999999998764 46
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccce
Q 010513 258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK 337 (508)
Q Consensus 258 ~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~ 337 (508)
++++||+++|+|.+++... ...+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++
T Consensus 84 ~~v~e~~~~g~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~ 157 (303)
T cd05110 84 QLVTQLMPHGCLLDYVHEH---KDNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLAR 157 (303)
T ss_pred eeeehhcCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEccccccc
Confidence 7999999999999998765 34688999999999999999999998 99999999999999999999999999998
Q ss_pred ecCCCCcc-eecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHhhcccccc
Q 010513 338 LLGAERSY-VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAE 415 (508)
Q Consensus 338 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (508)
........ ......++..|+|||.+.+..++.++|||||||++|||++ |..||..... ....+ .......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~---~~~~~----~~~~~~~- 229 (303)
T cd05110 158 LLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT---REIPD----LLEKGER- 229 (303)
T ss_pred cccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHH----HHHCCCC-
Confidence 76433222 1222345778999999998999999999999999999997 9999964321 11111 1111110
Q ss_pred cCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010513 416 GVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (508)
Q Consensus 416 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~~ 462 (508)
. + .. ..++ ..+.+++.+||..+|++||++.++++.|+..
T Consensus 230 -~--~-~~-~~~~---~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~ 268 (303)
T cd05110 230 -L--P-QP-PICT---IDVYMVMVKCWMIDADSRPKFKELAAEFSRM 268 (303)
T ss_pred -C--C-CC-CCCC---HHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 0 0 00 1122 2455588899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=312.79 Aligned_cols=267 Identities=19% Similarity=0.289 Sum_probs=199.0
Q ss_pred CCcccceEcccCcEEEEEEEECC---CcEEEEEEeecCC---chhHHHHHHHHHHHHccCCCCeeeEeeeeecC--CeeE
Q 010513 187 GFADENVIGEGGYGIVYHGVLED---NTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEG--AHRM 258 (508)
Q Consensus 187 ~~~~~~~LG~G~~g~Vy~~~~~~---~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--~~~~ 258 (508)
+|.+.+.||+|+||.||+|.... +..||+|.+.... ....+.+.+|+++++.++||||+++++++.+. ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 47888999999999999999753 7889999987633 33346677899999999999999999999988 7899
Q ss_pred EEEEecCCCCHHHHhccCCCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcC----CCCeEEeee
Q 010513 259 LVYEYIDNGNLEQWLHGDVGP-HSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDK----QWNPKLSDF 333 (508)
Q Consensus 259 lV~e~~~~g~L~~~l~~~~~~-~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~----~~~~kL~DF 333 (508)
+||||+++ +|.+++...... ...+++..++.++.|++.||+|||+. +++||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999976 787777543222 23789999999999999999999999 9999999999999999 899999999
Q ss_pred ccceecCCCCc--ceecceecCCCCCChhhhhcC-CCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcc-------hHHH
Q 010513 334 GLAKLLGAERS--YVTTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRNPVDYSRPPGEV-------NLVE 403 (508)
Q Consensus 334 G~a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~-------~~~~ 403 (508)
|++........ .......+++.|+|||++.+. .++.++|||||||++|+|++|+.||......... .+..
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99987643322 122335688999999987664 5889999999999999999999999765433200 0110
Q ss_pred HHHHhhccc------------cccc----CCCccCCCCchH-------HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 404 WLKTMVTNR------------NAEG----VLDPRLQEKPCS-------RALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 404 ~~~~~~~~~------------~~~~----~~~~~l~~~~~~-------~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
.+ ..+... .... ............ ....++.+++.+||+.||++||++.|++++
T Consensus 237 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 237 IF-EVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred HH-HHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 00 100000 0000 000001100001 122357778999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=308.01 Aligned_cols=245 Identities=25% Similarity=0.336 Sum_probs=199.2
Q ss_pred CCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCC---chhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEE
Q 010513 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY 261 (508)
Q Consensus 186 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 261 (508)
++|++.+.||+|+||.||++.+. +++.+|+|.+.... ....+.+.+|++++++++||||+++++++.++...++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 46889999999999999999975 57889999886542 233466888999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCC
Q 010513 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA 341 (508)
Q Consensus 262 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 341 (508)
||+++++|.+++... ..+++..+..++.|+++||.|||+. +++||||+|+||+++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~~~~~----~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 153 (290)
T cd05580 81 EYVPGGELFSHLRKS----GRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG 153 (290)
T ss_pred ecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCC
Confidence 999999999999765 5789999999999999999999998 999999999999999999999999999987643
Q ss_pred CCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCCcc
Q 010513 342 ERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPR 421 (508)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 421 (508)
. .....|++.|+|||.+.+..++.++|+||||+++|+|++|+.||..... .+....... .. ..
T Consensus 154 ~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~-~~------~~ 216 (290)
T cd05580 154 R----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP------IQIYEKILE-GK------VR 216 (290)
T ss_pred C----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHhc-CC------cc
Confidence 3 2345789999999999888899999999999999999999999964431 111111111 10 11
Q ss_pred CCCCchHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 010513 422 LQEKPCSRALKRALLVALRCVDPNAHKRP-----KMGHVIHM 458 (508)
Q Consensus 422 l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 458 (508)
+... .+ ..+.+++.+||+.||++|+ ++++++++
T Consensus 217 ~~~~-~~---~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~ 254 (290)
T cd05580 217 FPSF-FS---PDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH 254 (290)
T ss_pred CCcc-CC---HHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence 1111 22 3344577799999999999 67776643
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-39 Score=340.50 Aligned_cols=261 Identities=24% Similarity=0.296 Sum_probs=215.8
Q ss_pred chhhHhhcCCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecC---CchhHHHHHHHHHHHHccCCCCeeeEeeeee
Q 010513 177 TLRELEVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN---RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCA 252 (508)
Q Consensus 177 ~~~~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~ 252 (508)
.++++++..++|+++++||+|+||.|.+++.+ +++.||+|++.+. .......|..|..+|..-..+-|+.++..|+
T Consensus 66 ~v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQ 145 (1317)
T KOG0612|consen 66 KVKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQ 145 (1317)
T ss_pred HHHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhc
Confidence 36778899999999999999999999999976 5777899998663 3344567999999999999999999999999
Q ss_pred cCCeeEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEee
Q 010513 253 EGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSD 332 (508)
Q Consensus 253 ~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~D 332 (508)
++.++|+||||++||||..++.+. ..+++++++.++..++.||+-||+. |+|||||||+|||||..|++||+|
T Consensus 146 D~~~LYlVMdY~pGGDlltLlSk~----~~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLAD 218 (1317)
T KOG0612|consen 146 DERYLYLVMDYMPGGDLLTLLSKF----DRLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLAD 218 (1317)
T ss_pred CccceEEEEecccCchHHHHHhhc----CCChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeecc
Confidence 999999999999999999999876 3799999999999999999999999 999999999999999999999999
Q ss_pred eccceecCCCCcceecceecCCCCCChhhhhc-----CCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHH
Q 010513 333 FGLAKLLGAERSYVTTRVMGTFGYVAPEYAST-----GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKT 407 (508)
Q Consensus 333 FG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~ 407 (508)
||.+-.+..++.......+|||.|.+||++.. +.|++.+|+||+||++|||+.|..||. ...+++-..+
T Consensus 219 FGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFY------adslveTY~K 292 (1317)
T KOG0612|consen 219 FGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFY------ADSLVETYGK 292 (1317)
T ss_pred chhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcch------HHHHHHHHHH
Confidence 99999888777777778899999999999853 579999999999999999999999996 3344444444
Q ss_pred hhcccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCC---HHHHHHH
Q 010513 408 MVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPK---MGHVIHM 458 (508)
Q Consensus 408 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~evl~~ 458 (508)
.+...+.-.+.+. . ..+...+. ||.+.+ -+|+.|-. ++++-.+
T Consensus 293 Im~hk~~l~FP~~-~---~VSeeakd---LI~~ll-~~~e~RLgrngiedik~H 338 (1317)
T KOG0612|consen 293 IMNHKESLSFPDE-T---DVSEEAKD---LIEALL-CDREVRLGRNGIEDIKNH 338 (1317)
T ss_pred HhchhhhcCCCcc-c---ccCHHHHH---HHHHHh-cChhhhcccccHHHHHhC
Confidence 4443222222110 1 13334444 554554 57888877 8888765
|
|
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=308.75 Aligned_cols=251 Identities=25% Similarity=0.388 Sum_probs=202.6
Q ss_pred CCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCchhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEEe
Q 010513 185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY 263 (508)
Q Consensus 185 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~ 263 (508)
.++|.+.+.||+|+||.||+|... +++.||+|.+........+.+..|+.+++.++||||+++++++..++..|+|+||
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~ 97 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY 97 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence 358899999999999999999864 6788999998655545567788899999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCCC
Q 010513 264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER 343 (508)
Q Consensus 264 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 343 (508)
+++++|.+++.+. .+++..+..++.|++.||.|||++ +++||||||+||+++.++.++|+|||++.......
T Consensus 98 ~~~~~L~~~~~~~-----~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~ 169 (293)
T cd06647 98 LAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (293)
T ss_pred CCCCcHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceecccccc
Confidence 9999999998653 578899999999999999999999 99999999999999999999999999987654332
Q ss_pred cceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCCccCC
Q 010513 344 SYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQ 423 (508)
Q Consensus 344 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 423 (508)
. ......|++.|+|||.+.+..++.++|+||||+++|++++|+.||...++.... ....... .+.+.
T Consensus 170 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~------~~~~~~~------~~~~~ 236 (293)
T cd06647 170 S-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL------YLIATNG------TPELQ 236 (293)
T ss_pred c-ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhe------eehhcCC------CCCCC
Confidence 2 223346889999999998888999999999999999999999999754332111 0000000 01111
Q ss_pred CCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 424 EKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 424 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
. .......+.+++.+||+.+|++||++.+++++
T Consensus 237 ~--~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 237 N--PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred C--ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 11122345558889999999999999999976
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=307.13 Aligned_cols=261 Identities=23% Similarity=0.291 Sum_probs=199.1
Q ss_pred CCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCch-----hHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEE
Q 010513 187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQ-----AEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLV 260 (508)
Q Consensus 187 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 260 (508)
+|++.+.||+|+||.||+|... +++.||+|.+...... ....+..|+++++.++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4778899999999999999965 6889999998654322 334567899999999999999999999999999999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecC
Q 010513 261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG 340 (508)
Q Consensus 261 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 340 (508)
|||+ +|+|.+++.... ..+++..++.++.|+++||.|||++ +++||||||+||+++.++.++|+|||++....
T Consensus 81 ~e~~-~~~L~~~i~~~~---~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~ 153 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS---IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFG 153 (298)
T ss_pred Eccc-CCCHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeecc
Confidence 9999 889999997652 3689999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCcceecceecCCCCCChhhhhc-CCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhccc-------
Q 010513 341 AERSYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNR------- 412 (508)
Q Consensus 341 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~------- 412 (508)
.... ......+++.|+|||.+.+ ..++.++|+|||||++|||++|..||....+. .............
T Consensus 154 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 229 (298)
T cd07841 154 SPNR-KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDI---DQLGKIFEALGTPTEENWPG 229 (298)
T ss_pred CCCc-cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccH---HHHHHHHHHcCCCchhhhhh
Confidence 4322 1223356888999998854 46788999999999999999998887644321 1111111100000
Q ss_pred --ccccCCCccCCCC-----chHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 413 --NAEGVLDPRLQEK-----PCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 413 --~~~~~~~~~l~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
............. ........+.+++.+||+.||++||++.+++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 230 VTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred cccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 0000000000000 011223566778999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=302.76 Aligned_cols=247 Identities=23% Similarity=0.285 Sum_probs=200.9
Q ss_pred CCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCC---chhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEE
Q 010513 187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE 262 (508)
Q Consensus 187 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e 262 (508)
+|++.+.||.|+||.||+|.+. +++.||+|.+.+.. ....+.+.+|++++++++||||+++++++.++...++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4788999999999999999976 58889999986543 2345678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCC
Q 010513 263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE 342 (508)
Q Consensus 263 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 342 (508)
|+++++|.+++... ..+++..+..++.|+++||.|||++ +++|+||||+||++++++.++|+|||++......
T Consensus 81 ~~~~~~L~~~l~~~----~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 153 (258)
T cd05578 81 LLLGGDLRYHLSQK----VKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD 153 (258)
T ss_pred CCCCCCHHHHHHhc----CCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCC
Confidence 99999999999764 4788999999999999999999999 9999999999999999999999999998865433
Q ss_pred CcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCCccC
Q 010513 343 RSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRL 422 (508)
Q Consensus 343 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 422 (508)
. ......|+..|+|||.+.+..++.++|+||||+++|+|++|..||....... .+.+...... ... ..
T Consensus 154 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----~~~~~~~~~~--~~~----~~ 221 (258)
T cd05578 154 T--LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI----RDQIRAKQET--ADV----LY 221 (258)
T ss_pred c--cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccH----HHHHHHHhcc--ccc----cC
Confidence 2 2234568889999999988889999999999999999999999997654321 1111111111 001 11
Q ss_pred CCCchHHHHHHHHHHHHHccCCCCCCCCCH--HHHH
Q 010513 423 QEKPCSRALKRALLVALRCVDPNAHKRPKM--GHVI 456 (508)
Q Consensus 423 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~--~evl 456 (508)
.......+.+++.+||+.||.+||++ ++++
T Consensus 222 ----~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 222 ----PATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred ----cccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 11122455568889999999999999 6554
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=299.00 Aligned_cols=249 Identities=22% Similarity=0.396 Sum_probs=199.4
Q ss_pred CCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecC--CchhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEEe
Q 010513 187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY 263 (508)
Q Consensus 187 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~ 263 (508)
+|+..+.||+|+||.||+|... +++.+|+|.+... .......+..|+++++.++|||++++++.+..++..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 4788999999999999999965 5788999988654 233456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCC-CeEEeeeccceecCCC
Q 010513 264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQW-NPKLSDFGLAKLLGAE 342 (508)
Q Consensus 264 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~-~~kL~DFG~a~~~~~~ 342 (508)
+++++|.+++.... ...+++..++.++.|++.||+|||++ +++||||||+||+++.++ .+||+|||++......
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (256)
T cd08220 81 APGGTLAEYIQKRC--NSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK 155 (256)
T ss_pred CCCCCHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence 99999999997642 34589999999999999999999999 999999999999998654 5799999999876433
Q ss_pred CcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCCccC
Q 010513 343 RSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRL 422 (508)
Q Consensus 343 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 422 (508)
. ......|+..|+|||.+.+..++.++|+||||+++|+|++|+.||...+.. ......... .... +
T Consensus 156 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~------~~~~~~~~~-~~~~-----~ 221 (256)
T cd08220 156 S--KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP------ALVLKIMSG-TFAP-----I 221 (256)
T ss_pred c--cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH------HHHHHHHhc-CCCC-----C
Confidence 2 122356889999999999888999999999999999999999999654321 111111111 0000 1
Q ss_pred CCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 423 QEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 423 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
. +.. ...+.+++.+||+.||++||++.+++++
T Consensus 222 ~-~~~---~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 222 S-DRY---SPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred C-CCc---CHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 1 112 2344558889999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=301.59 Aligned_cols=264 Identities=26% Similarity=0.401 Sum_probs=203.3
Q ss_pred CCCcccceEcccCcEEEEEEEECCCcEEEEEEeecCCchhHHHHHHHHHHHHcc--CCCCeeeEeeeeecC----CeeEE
Q 010513 186 NGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV--RHKNLVRLLGYCAEG----AHRML 259 (508)
Q Consensus 186 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~hpniv~l~~~~~~~----~~~~l 259 (508)
.+..+.+.||+|.||+||+|.|. |..||||++... +++...+|.++.+.+ +|+||+.|++.-..+ .+++|
T Consensus 211 rqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~sr---dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwL 286 (513)
T KOG2052|consen 211 RQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSR---DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWL 286 (513)
T ss_pred heeEEEEEecCccccceeecccc-CCceEEEEeccc---chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEE
Confidence 46788999999999999999998 788999998533 344556688887765 999999999876433 36899
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-----CCCCeeeccCCCCCEEEcCCCCeEEeeec
Q 010513 260 VYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-----LEPKVVHRDIKSSNILLDKQWNPKLSDFG 334 (508)
Q Consensus 260 V~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~-----~~~~iiHrDlkp~NIll~~~~~~kL~DFG 334 (508)
|.+|.+.|+|+|||.+. .++.+..++++..+|.||++||-. .+|.|.|||||+.|||+.+++...|+|+|
T Consensus 287 vTdYHe~GSL~DyL~r~-----tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLG 361 (513)
T KOG2052|consen 287 VTDYHEHGSLYDYLNRN-----TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 361 (513)
T ss_pred eeecccCCcHHHHHhhc-----cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeece
Confidence 99999999999999875 799999999999999999999954 48999999999999999999999999999
Q ss_pred cceecCCCCcc---eecceecCCCCCChhhhhcCC----C-C-CCCCeeehHHHHHHHHhC----------CCCCCCCCC
Q 010513 335 LAKLLGAERSY---VTTRVMGTFGYVAPEYASTGM----L-N-ERSDVYSFGILIMEVISG----------RNPVDYSRP 395 (508)
Q Consensus 335 ~a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~----~-~-~~sDvwSlGvvl~elltg----------~~Pf~~~~~ 395 (508)
+|......... ..+..+||..|||||++.... + + ..+||||||.|+||+... +.||.+.-+
T Consensus 362 LAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp 441 (513)
T KOG2052|consen 362 LAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVP 441 (513)
T ss_pred eeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCC
Confidence 99876543222 234568999999999986532 1 1 258999999999999762 468865533
Q ss_pred CCcchHHHHHHHhhcccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 010513 396 PGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEE 463 (508)
Q Consensus 396 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~~~ 463 (508)
. +.+. +.+++.+=.++....+++... ..+.+..+.+++..||..+|.-|-|+--+.+.|....
T Consensus 442 ~-DPs~-eeMrkVVCv~~~RP~ipnrW~---s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~ 504 (513)
T KOG2052|consen 442 S-DPSF-EEMRKVVCVQKLRPNIPNRWK---SDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLS 504 (513)
T ss_pred C-CCCH-HHHhcceeecccCCCCCcccc---cCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHh
Confidence 2 2222 223333322333333333333 3456677777999999999999999998888886543
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=303.39 Aligned_cols=248 Identities=26% Similarity=0.446 Sum_probs=198.6
Q ss_pred CCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecC-CchhHHHHHHHHHHHHccC---CCCeeeEeeeeecCCeeEEEE
Q 010513 187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN-RGQAEKEFKVEVEAIGRVR---HKNLVRLLGYCAEGAHRMLVY 261 (508)
Q Consensus 187 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~---hpniv~l~~~~~~~~~~~lV~ 261 (508)
.|+..+.||+|+||.||+|.+. ++..||+|.+... ......++.+|+++++.++ |||++++++++.++...++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 4778899999999999999964 6888999988644 3344567888999999996 999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCC
Q 010513 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA 341 (508)
Q Consensus 262 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 341 (508)
||+++++|.+++... .+++..++.++.|++.||.|||+. +++||||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~-----~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06917 82 EYAEGGSVRTLMKAG-----PIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQ 153 (277)
T ss_pred ecCCCCcHHHHHHcc-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCC
Confidence 999999999998643 688999999999999999999998 999999999999999999999999999987654
Q ss_pred CCcceecceecCCCCCChhhhhcC-CCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCCc
Q 010513 342 ERSYVTTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDP 420 (508)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 420 (508)
.. .......|+..|+|||.+.++ .++.++|+|||||++|+|++|+.||........ .. .... ...+
T Consensus 154 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~------~~-~~~~-----~~~~ 220 (277)
T cd06917 154 NS-SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRA------MM-LIPK-----SKPP 220 (277)
T ss_pred Cc-cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhh------hh-cccc-----CCCC
Confidence 33 222335689999999988654 578899999999999999999999975432111 10 0000 1112
Q ss_pred cCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 421 RLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 421 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
.+..+.. ..++.+++.+||+.||++||++.+++++
T Consensus 221 ~~~~~~~---~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 221 RLEDNGY---SKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred CCCcccC---CHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 2222212 2345568889999999999999999864
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=304.41 Aligned_cols=247 Identities=26% Similarity=0.425 Sum_probs=198.7
Q ss_pred CCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCC-chhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEEec
Q 010513 187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYI 264 (508)
Q Consensus 187 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~ 264 (508)
-|+..+.||+|+||.||+|... ++..+|+|.+.... ......+.+|+++++.++||||+++++++.++...++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 4677889999999999999865 57889999875432 233467888999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCCCc
Q 010513 265 DNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS 344 (508)
Q Consensus 265 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~ 344 (508)
++++|.+++.. ..+++..+..++.|++.|+.|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 85 ~~~~l~~~i~~-----~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~- 155 (277)
T cd06641 85 GGGSALDLLEP-----GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ- 155 (277)
T ss_pred CCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccch-
Confidence 99999999864 3588999999999999999999998 99999999999999999999999999988654322
Q ss_pred ceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCCccCCC
Q 010513 345 YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQE 424 (508)
Q Consensus 345 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 424 (508)
.......|+..|+|||.+.+..++.++|+|||||++|+|++|..||..... ....... .... .+.+..
T Consensus 156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~------~~~~~~~-~~~~-----~~~~~~ 223 (277)
T cd06641 156 IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHP------MKVLFLI-PKNN-----PPTLEG 223 (277)
T ss_pred hhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccch------HHHHHHH-hcCC-----CCCCCc
Confidence 122334688899999999888899999999999999999999999964321 1111111 1110 111111
Q ss_pred CchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 425 KPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 425 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
..+ ..+.+++.+||+.+|++||++.+++++
T Consensus 224 -~~~---~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 224 -NYS---KPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred -ccC---HHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 122 334557889999999999999999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=288.60 Aligned_cols=254 Identities=26% Similarity=0.409 Sum_probs=196.6
Q ss_pred cCCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecC-CchhHHHHHHHHHHHHcc-CCCCeeeEeeeeecCCeeEEE
Q 010513 184 STNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN-RGQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLV 260 (508)
Q Consensus 184 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lV 260 (508)
..++.+++..||.|..|+||+++.+ +|.-.|||..... +.+..+.+...+.++..- .+|+||+.+|+|..+...++.
T Consensus 90 dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~Ic 169 (391)
T KOG0983|consen 90 DINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFIC 169 (391)
T ss_pred ChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHH
Confidence 3345666788999999999999976 4788899998655 344556777777777665 489999999999999999999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecC
Q 010513 261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG 340 (508)
Q Consensus 261 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 340 (508)
||.|.. -++.++++. ..++++..+-++...++.||.||.++. +|+|||+||+|||+|+.|++||||||++-.+-
T Consensus 170 MelMs~-C~ekLlkri---k~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlv 243 (391)
T KOG0983|consen 170 MELMST-CAEKLLKRI---KGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLV 243 (391)
T ss_pred HHHHHH-HHHHHHHHh---cCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceee
Confidence 999854 556666554 467999999999999999999998776 99999999999999999999999999997663
Q ss_pred CCCcceecceecCCCCCChhhhhc---CCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccC
Q 010513 341 AERSYVTTRVMGTFGYVAPEYAST---GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGV 417 (508)
Q Consensus 341 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 417 (508)
+ +...+...|.+.|||||.+.. ..|+-++||||||++++||.||+.||..-.. +. +.+-....+.
T Consensus 244 d--SkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~t--dF---e~ltkvln~e----- 311 (391)
T KOG0983|consen 244 D--SKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKT--DF---EVLTKVLNEE----- 311 (391)
T ss_pred c--ccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCc--cH---HHHHHHHhcC-----
Confidence 3 233445679999999998854 4689999999999999999999999975432 22 2222222211
Q ss_pred CCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 418 LDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 418 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
.|.+....- ....+.+++..||.+|+.+||...+++++
T Consensus 312 -PP~L~~~~g--FSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 312 -PPLLPGHMG--FSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred -CCCCCcccC--cCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 133332210 22334457779999999999999998865
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=293.75 Aligned_cols=250 Identities=27% Similarity=0.440 Sum_probs=204.1
Q ss_pred CCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCchhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEEecC
Q 010513 187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYID 265 (508)
Q Consensus 187 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~ 265 (508)
+|+..+.||+|++|.||++... ++..+++|++........+.+.+|++.++.++|+|++++++++......++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 4778899999999999999976 688899999876655566788999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCCCcc
Q 010513 266 NGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSY 345 (508)
Q Consensus 266 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~ 345 (508)
+++|.+++.... ..+++..+..++.|++.||.|||++ +++||||+|+||++++++.++|+|||.+........
T Consensus 81 ~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~- 153 (253)
T cd05122 81 GGSLKDLLKSTN---QTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA- 153 (253)
T ss_pred CCcHHHHHhhcC---CCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccccc-
Confidence 999999987652 5789999999999999999999998 999999999999999999999999999987654332
Q ss_pred eecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCCccCCCC
Q 010513 346 VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEK 425 (508)
Q Consensus 346 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 425 (508)
.....|+..|+|||.+.+..++.++|+||||+++|+|++|+.||..... .+....... ... +.+...
T Consensus 154 -~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~-~~~-----~~~~~~ 220 (253)
T cd05122 154 -RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPP------MKALFKIAT-NGP-----PGLRNP 220 (253)
T ss_pred -ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCch------HHHHHHHHh-cCC-----CCcCcc
Confidence 3445789999999999888899999999999999999999999964331 111111111 100 011110
Q ss_pred chHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 426 PCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 426 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
......+.+++.+||+.||++||++.+++++
T Consensus 221 --~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 221 --EKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred --cccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0012345558889999999999999999864
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=315.31 Aligned_cols=263 Identities=26% Similarity=0.299 Sum_probs=197.9
Q ss_pred cCCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecC--CchhHHHHHHHHHHHHccCCCCeeeEeeeeecC------
Q 010513 184 STNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEG------ 254 (508)
Q Consensus 184 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~------ 254 (508)
..++|+..+.||+|+||.||+|... +++.||+|.+.+. .......+.+|+++++.++||||++++++|...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 3468999999999999999999965 6889999988643 233445677899999999999999999988643
Q ss_pred CeeEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeec
Q 010513 255 AHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFG 334 (508)
Q Consensus 255 ~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG 334 (508)
...|+||||+.+ +|.+.+.. .+++..+..++.|++.||+|||++ +++||||||+||+++.++.+||+|||
T Consensus 94 ~~~~lv~e~~~~-~l~~~~~~------~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg 163 (353)
T cd07850 94 QDVYLVMELMDA-NLCQVIQM------DLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 163 (353)
T ss_pred CcEEEEEeccCC-CHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCc
Confidence 356899999965 88888753 278899999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcc------------hHH
Q 010513 335 LAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEV------------NLV 402 (508)
Q Consensus 335 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~------------~~~ 402 (508)
+++...... ......|++.|+|||.+.+..++.++|||||||++|+|++|+.||...+..... ...
T Consensus 164 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 241 (353)
T cd07850 164 LARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFM 241 (353)
T ss_pred cceeCCCCC--CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 998754322 223346889999999999999999999999999999999999999754321100 000
Q ss_pred HHH----HHhhcccc------cccCC----CccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 403 EWL----KTMVTNRN------AEGVL----DPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 403 ~~~----~~~~~~~~------~~~~~----~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
..+ ......+. ..... .+.............+.+++.+||+.||++||++.|++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 242 SRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred HHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000 00000000 00000 0000111111223455678889999999999999999965
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=305.65 Aligned_cols=261 Identities=20% Similarity=0.260 Sum_probs=195.3
Q ss_pred CCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCc-hhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEE
Q 010513 185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE 262 (508)
Q Consensus 185 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e 262 (508)
+++|.+.+.||+|+||.||+|... ++..||+|.+..... .....+.+|+++++.++|+||+++++++.++...|+|||
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 83 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE 83 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence 468999999999999999999865 588999999865432 223466789999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCC
Q 010513 263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE 342 (508)
Q Consensus 263 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 342 (508)
|+. ++|.+++... ...+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++.....
T Consensus 84 ~~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 156 (291)
T cd07870 84 YMH-TDLAQYMIQH---PGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIP 156 (291)
T ss_pred ccc-CCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence 996 6888877554 24578888899999999999999998 9999999999999999999999999998764322
Q ss_pred CcceecceecCCCCCChhhhhcC-CCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcc----------
Q 010513 343 RSYVTTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTN---------- 411 (508)
Q Consensus 343 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~---------- 411 (508)
.. ......+++.|+|||.+.+. .++.++|+|||||++|||++|+.||+..... .+.+...+..
T Consensus 157 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~-----~~~~~~~~~~~~~~~~~~~~ 230 (291)
T cd07870 157 SQ-TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDV-----FEQLEKIWTVLGVPTEDTWP 230 (291)
T ss_pred CC-CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhH-----HHHHHHHHHHcCCCChhhhh
Confidence 21 12334578999999988654 5788999999999999999999999754321 1111111100
Q ss_pred ------cccccCCCccCCCCc-----hHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 412 ------RNAEGVLDPRLQEKP-----CSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 412 ------~~~~~~~~~~l~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
............... .......+.+++.+|++.||++|||+.+++.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h 288 (291)
T cd07870 231 GVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH 288 (291)
T ss_pred hhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence 000000000000000 00012344557889999999999999998854
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=306.60 Aligned_cols=249 Identities=27% Similarity=0.377 Sum_probs=197.4
Q ss_pred hcCCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCC---chhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeE
Q 010513 183 VSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM 258 (508)
Q Consensus 183 ~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 258 (508)
.+...|.+.+.||+|+||+||+|... +++.||+|.+.... ....+.+.+|+++++.++||||+++++++.+.+..+
T Consensus 12 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~ 91 (307)
T cd06607 12 DPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAW 91 (307)
T ss_pred CcchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEE
Confidence 34457899999999999999999965 58889999885432 233457888999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeecccee
Q 010513 259 LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL 338 (508)
Q Consensus 259 lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~ 338 (508)
+||||+.+ +|.+++... ...+++..+..++.|++.||.|||+. +++||||+|+||++++++.++|+|||++..
T Consensus 92 lv~e~~~g-~l~~~~~~~---~~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~ 164 (307)
T cd06607 92 LVMEYCLG-SASDILEVH---KKPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASL 164 (307)
T ss_pred EEHHhhCC-CHHHHHHHc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCccee
Confidence 99999974 887777543 24689999999999999999999998 999999999999999999999999999876
Q ss_pred cCCCCcceecceecCCCCCChhhhh---cCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccc
Q 010513 339 LGAERSYVTTRVMGTFGYVAPEYAS---TGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAE 415 (508)
Q Consensus 339 ~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (508)
.... ....|++.|+|||++. ...++.++||||||+++|||++|+.||...... ..........
T Consensus 165 ~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~------~~~~~~~~~~--- 230 (307)
T cd06607 165 VSPA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYHIAQND--- 230 (307)
T ss_pred cCCC-----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHH------HHHHHHhcCC---
Confidence 5322 2346788999999874 456889999999999999999999999643211 1111111110
Q ss_pred cCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 416 GVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 416 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
.+.+... .....+.+++.+||+.||++||++.+++++
T Consensus 231 ---~~~~~~~---~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 231 ---SPTLSSN---DWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred ---CCCCCch---hhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 1111111 123345668889999999999999999875
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=306.04 Aligned_cols=262 Identities=17% Similarity=0.221 Sum_probs=186.3
Q ss_pred hhcCCCCcccceEcccCcEEEEEEEECCC----cEEEEEEeecCCchhH-----------HHHHHHHHHHHccCCCCeee
Q 010513 182 EVSTNGFADENVIGEGGYGIVYHGVLEDN----TNVAVKNLLNNRGQAE-----------KEFKVEVEAIGRVRHKNLVR 246 (508)
Q Consensus 182 ~~~~~~~~~~~~LG~G~~g~Vy~~~~~~~----~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~hpniv~ 246 (508)
++..++|.+.+.||+|+||+||+|.+.++ ..+|+|.......... .....+...+..+.|+|+++
T Consensus 8 ~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~ 87 (294)
T PHA02882 8 DITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPK 87 (294)
T ss_pred ccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCc
Confidence 34557899999999999999999997643 3456664322211110 11122344556778999999
Q ss_pred EeeeeecCC----eeEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEE
Q 010513 247 LLGYCAEGA----HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILL 322 (508)
Q Consensus 247 l~~~~~~~~----~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll 322 (508)
+++++.... ..+++++++.. ++.+.+... ...++..+..++.|+++||+|||++ +|+||||||+|||+
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill 159 (294)
T PHA02882 88 YYGCGSFKRCRMYYRFILLEKLVE-NTKEIFKRI----KCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMV 159 (294)
T ss_pred EEEeeeEecCCceEEEEEEehhcc-CHHHHHHhh----ccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEE
Confidence 999765543 34678887754 777766543 3457888899999999999999998 99999999999999
Q ss_pred cCCCCeEEeeeccceecCCCCc------ceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCC
Q 010513 323 DKQWNPKLSDFGLAKLLGAERS------YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPP 396 (508)
Q Consensus 323 ~~~~~~kL~DFG~a~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~ 396 (508)
+.++.++|+|||+++.+..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 160 ~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~ 239 (294)
T PHA02882 160 DGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHN 239 (294)
T ss_pred cCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccc
Confidence 9999999999999987643221 1112346999999999999999999999999999999999999999765322
Q ss_pred CcchHHHHHHHhhcccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 010513 397 GEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 460 (508)
Q Consensus 397 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le 460 (508)
.. .....+.... ..+..+......++ +.+.+++..|++.+|++||++.++++.|+
T Consensus 240 ~~--~~~~~~~~~~----~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 240 GN--LIHAAKCDFI----KRLHEGKIKIKNAN---KFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred hH--HHHHhHHHHH----HHhhhhhhccCCCC---HHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 21 1111110000 01111111222233 34455777999999999999999998763
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=302.49 Aligned_cols=249 Identities=27% Similarity=0.388 Sum_probs=199.5
Q ss_pred CCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCchhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEEecC
Q 010513 187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYID 265 (508)
Q Consensus 187 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~ 265 (508)
.|...+.||+|++|.||++... ++..+++|++........+.+.+|+.+++.++||||+++++++..++..++|+||++
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~ 99 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE 99 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence 3555689999999999999964 678899998865555556678889999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCCCcc
Q 010513 266 NGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSY 345 (508)
Q Consensus 266 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~ 345 (508)
+++|.+++.. ..+++..++.++.|++.||+|||++ +++||||+|+||+++.++.++|+|||++........
T Consensus 100 ~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~- 170 (285)
T cd06648 100 GGALTDIVTH-----TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP- 170 (285)
T ss_pred CCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCCc-
Confidence 9999999865 3588999999999999999999999 999999999999999999999999998875533222
Q ss_pred eecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCCccCCCC
Q 010513 346 VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEK 425 (508)
Q Consensus 346 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 425 (508)
......|++.|+|||.+.+..++.++|+|||||++|||++|+.||...++ .......... ..+.....
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~------~~~~~~~~~~------~~~~~~~~ 238 (285)
T cd06648 171 RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP------LQAMKRIRDN------LPPKLKNL 238 (285)
T ss_pred ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH------HHHHHHHHhc------CCCCCccc
Confidence 22335689999999999888899999999999999999999999964332 1212211111 01111111
Q ss_pred chHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 426 PCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 426 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
......+.+++.+||+.+|++||++.+++++
T Consensus 239 --~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 239 --HKVSPRLRSFLDRMLVRDPAQRATAAELLNH 269 (285)
T ss_pred --ccCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence 1122345568889999999999999999964
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=308.49 Aligned_cols=257 Identities=25% Similarity=0.314 Sum_probs=202.9
Q ss_pred ccchhhHhhcCCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCc---hhHHHHHHHHHHHHccCCCCeeeEeee
Q 010513 175 WYTLRELEVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG---QAEKEFKVEVEAIGRVRHKNLVRLLGY 250 (508)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~ 250 (508)
|-.++...+..+.|..-++||+||||.||-+..+ +|+.+|+|++.+.+. .......+|-.+|.+++.+.||.+-..
T Consensus 174 WK~lE~qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYA 253 (591)
T KOG0986|consen 174 WKWLELQPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYA 253 (591)
T ss_pred HHHHHhhhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeee
Confidence 3334445567788999999999999999999855 688899998854432 223456679999999999999999999
Q ss_pred eecCCeeEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEE
Q 010513 251 CAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKL 330 (508)
Q Consensus 251 ~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL 330 (508)
|+..+.+++||..|.||||.-.|.... ...+++..+..++.+|+.||++||+. +||+|||||+|||+|+.|+++|
T Consensus 254 feTkd~LClVLtlMNGGDLkfHiyn~g--~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRI 328 (591)
T KOG0986|consen 254 FETKDALCLVLTLMNGGDLKFHIYNHG--NPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRI 328 (591)
T ss_pred ecCCCceEEEEEeecCCceeEEeeccC--CCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEe
Confidence 999999999999999999988776553 25799999999999999999999999 9999999999999999999999
Q ss_pred eeeccceecCCCCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhc
Q 010513 331 SDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVT 410 (508)
Q Consensus 331 ~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~ 410 (508)
+|+|+|..+...... +..+||.+|||||+++++.|+...|+|||||+||||+.|+.||......... +.+.++..
T Consensus 329 SDLGLAvei~~g~~~--~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~---eEvdrr~~ 403 (591)
T KOG0986|consen 329 SDLGLAVEIPEGKPI--RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKR---EEVDRRTL 403 (591)
T ss_pred eccceEEecCCCCcc--ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhH---HHHHHHHh
Confidence 999999987554433 3458999999999999999999999999999999999999999644321111 11122211
Q ss_pred ccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCC
Q 010513 411 NRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPK 451 (508)
Q Consensus 411 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs 451 (508)
+. + .+.......++..++...|++||++|.-
T Consensus 404 ~~-------~---~ey~~kFS~eakslc~~LL~Kdp~~RLG 434 (591)
T KOG0986|consen 404 ED-------P---EEYSDKFSEEAKSLCEGLLTKDPEKRLG 434 (591)
T ss_pred cc-------h---hhcccccCHHHHHHHHHHHccCHHHhcc
Confidence 11 1 1112222333444666888999999953
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=300.08 Aligned_cols=256 Identities=22% Similarity=0.407 Sum_probs=196.8
Q ss_pred CcccceEcccCcEEEEEEEEC----CCcEEEEEEeecCC--chhHHHHHHHHHHHHccCCCCeeeEeeeeecCC------
Q 010513 188 FADENVIGEGGYGIVYHGVLE----DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGA------ 255 (508)
Q Consensus 188 ~~~~~~LG~G~~g~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~------ 255 (508)
|.+.+.||+|+||.||+|.+. ++..||+|.+.... ....+++.+|+++++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 567889999999999999853 35789999886542 334567888999999999999999999886532
Q ss_pred eeEEEEEecCCCCHHHHhccCC--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeee
Q 010513 256 HRMLVYEYIDNGNLEQWLHGDV--GPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDF 333 (508)
Q Consensus 256 ~~~lV~e~~~~g~L~~~l~~~~--~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DF 333 (508)
..++++||+.+|+|.+++.... .....+++...+.++.|++.||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcc
Confidence 2368899999999998875321 1123578899999999999999999998 9999999999999999999999999
Q ss_pred ccceecCCCCcce-ecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHhhcc
Q 010513 334 GLAKLLGAERSYV-TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTN 411 (508)
Q Consensus 334 G~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~ 411 (508)
|+++......... .....+++.|++||.+.+..++.++|||||||++|||++ |+.||..... .....+. ...
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~---~~~~~~~---~~~ 231 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN---SEIYNYL---IKG 231 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH---HHHHHHH---HcC
Confidence 9998654332211 222345678999999999999999999999999999999 8899864322 1111111 111
Q ss_pred cccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010513 412 RNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (508)
Q Consensus 412 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~~ 462 (508)
.. .... +.....+.+++.+||+.+|++||++.++++.|++.
T Consensus 232 ~~------~~~~----~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 232 NR------LKQP----PDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred Cc------CCCC----CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 10 0000 11223566688899999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-39 Score=299.32 Aligned_cols=244 Identities=25% Similarity=0.291 Sum_probs=198.4
Q ss_pred hhcCCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCchhH---HHHHHHHHHHHccCCCCeeeEeeeeecCCee
Q 010513 182 EVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAE---KEFKVEVEAIGRVRHKNLVRLLGYCAEGAHR 257 (508)
Q Consensus 182 ~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~---~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 257 (508)
.+-.++|...++||+|.||+|.+++.+ +++.+|+|++++...-.. ..-..|-++|+..+||.+..+...|+..+.+
T Consensus 164 kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drl 243 (516)
T KOG0690|consen 164 KVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRL 243 (516)
T ss_pred eeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceE
Confidence 345678999999999999999999965 688899999977644333 3345688999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccce
Q 010513 258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK 337 (508)
Q Consensus 258 ~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~ 337 (508)
|+||||..||.|+-.|.+. ..+++.....+...|+.||.|||++ +||+||||.+|+|+|++|++||+|||+++
T Consensus 244 CFVMeyanGGeLf~HLsre----r~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCK 316 (516)
T KOG0690|consen 244 CFVMEYANGGELFFHLSRE----RVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCK 316 (516)
T ss_pred EEEEEEccCceEeeehhhh----hcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccch
Confidence 9999999999999888765 5789999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccC
Q 010513 338 LLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGV 417 (508)
Q Consensus 338 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 417 (508)
.- ......+..+||||.|+|||++....|+.+.|+|.+||++|||++|+.||...+.. .+++.+.. .
T Consensus 317 E~-I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~---kLFeLIl~--e------- 383 (516)
T KOG0690|consen 317 EE-IKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHE---KLFELILM--E------- 383 (516)
T ss_pred hc-ccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchh---HHHHHHHh--h-------
Confidence 53 23344567799999999999999999999999999999999999999999644322 23332211 1
Q ss_pred CCccCCCCchHHHHHHHHHHHHHccCCCCCCCC
Q 010513 418 LDPRLQEKPCSRALKRALLVALRCVDPNAHKRP 450 (508)
Q Consensus 418 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP 450 (508)
|-.+... ...+.+ .|+...|.+||.+|.
T Consensus 384 -d~kFPr~-ls~eAk---tLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 384 -DLKFPRT-LSPEAK---TLLSGLLKKDPKKRL 411 (516)
T ss_pred -hccCCcc-CCHHHH---HHHHHHhhcChHhhc
Confidence 1112222 122223 355578899999994
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=300.30 Aligned_cols=253 Identities=27% Similarity=0.396 Sum_probs=203.7
Q ss_pred cCCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCchhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEE
Q 010513 184 STNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE 262 (508)
Q Consensus 184 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e 262 (508)
..+.|+..+.||+|+||.||+|.+. ++..+++|.+..... ..+.+..|++.++.++|+|++++++++......++|+|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 5567888999999999999999976 688899999876544 45678889999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCC
Q 010513 263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE 342 (508)
Q Consensus 263 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 342 (508)
|+++++|.+++.... ..+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++......
T Consensus 96 ~~~~~~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 169 (286)
T cd06614 96 YMDGGSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE 169 (286)
T ss_pred ccCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhccc
Confidence 999999999998752 4789999999999999999999998 9999999999999999999999999988755332
Q ss_pred CcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCCccC
Q 010513 343 RSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRL 422 (508)
Q Consensus 343 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 422 (508)
.. ......++..|+|||.+.+..++.++|+||||+++|+|++|+.||....+. ......... .. .+..
T Consensus 170 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~------~~~~~~~~~-~~----~~~~ 237 (286)
T cd06614 170 KS-KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL------RALFLITTK-GI----PPLK 237 (286)
T ss_pred hh-hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhc-CC----CCCc
Confidence 21 223345788999999998888999999999999999999999999643221 111111111 00 0000
Q ss_pred CCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 423 QEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 423 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
.....+ ..+.+++.+||+.+|.+||++.+++++
T Consensus 238 ~~~~~~---~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 238 NPEKWS---PEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred chhhCC---HHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 111122 344557889999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-38 Score=315.89 Aligned_cols=262 Identities=23% Similarity=0.329 Sum_probs=196.1
Q ss_pred CCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecC-CchhHHHHHHHHHHHHccCCCCeeeEeeeeecC-----Cee
Q 010513 185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEG-----AHR 257 (508)
Q Consensus 185 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-----~~~ 257 (508)
.++|++.+.||+|+||.||+|... +++.||+|.+... .......+..|+.+++.++||||+++++++... ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 368999999999999999999965 6889999988543 223445677899999999999999999987544 357
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccce
Q 010513 258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK 337 (508)
Q Consensus 258 ~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~ 337 (508)
|+|+||+.+ +|.+++.. ..+++..++.++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++.
T Consensus 84 ~lv~e~~~~-~l~~~~~~-----~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~ 154 (336)
T cd07849 84 YIVQELMET-DLYKLIKT-----QHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLAR 154 (336)
T ss_pred EEEehhccc-CHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECccccee
Confidence 899999975 88888754 3689999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCcc--eecceecCCCCCChhhhhc-CCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhccc--
Q 010513 338 LLGAERSY--VTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNR-- 412 (508)
Q Consensus 338 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~-- 412 (508)
........ ......|++.|+|||.+.+ ..++.++|||||||++|+|++|+.||...+... ....+.......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~---~~~~~~~~~~~~~~ 231 (336)
T cd07849 155 IADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLH---QLNLILGVLGTPSQ 231 (336)
T ss_pred eccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHcCCCCH
Confidence 65432221 1223568999999998654 568899999999999999999999996543111 011010000000
Q ss_pred -ccc-----------cCCCccCCCC---chHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 413 -NAE-----------GVLDPRLQEK---PCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 413 -~~~-----------~~~~~~l~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
... .......... ..+....++.+++.+||+.||++||++.+++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 232 EDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred HHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000 0000000000 011223456778999999999999999999987
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=305.49 Aligned_cols=262 Identities=21% Similarity=0.290 Sum_probs=197.3
Q ss_pred CCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCc--hhHHHHHHHHHHHHccCCCCeeeEeeeeecC--CeeEEE
Q 010513 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG--QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEG--AHRMLV 260 (508)
Q Consensus 186 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--~~~~lV 260 (508)
++|++.+.||+|+||.||+|.+. +++.+|+|.+..... .....+.+|++++++++||||+++++++... ...|+|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 47888999999999999999976 578899999865432 2234567899999999999999999998877 889999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecC
Q 010513 261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG 340 (508)
Q Consensus 261 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 340 (508)
|||+++ +|.+++... ...+++..++.++.|++.||+|||++ +++||||||+||+++.++.+||+|||++....
T Consensus 85 ~e~~~~-~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 157 (293)
T cd07843 85 MEYVEH-DLKSLMETM---KQPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYG 157 (293)
T ss_pred ehhcCc-CHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeecc
Confidence 999985 999998765 23689999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCcceecceecCCCCCChhhhhcC-CCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhc---------
Q 010513 341 AERSYVTTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVT--------- 410 (508)
Q Consensus 341 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~--------- 410 (508)
.... ......+++.|+|||.+.+. .++.++|+||||+++|||++|..||....... ....+.....
T Consensus 158 ~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~---~~~~~~~~~~~~~~~~~~~ 233 (293)
T cd07843 158 SPLK-PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEID---QLNKIFKLLGTPTEKIWPG 233 (293)
T ss_pred CCcc-ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhCCCchHHHHH
Confidence 4321 12334578899999988654 46889999999999999999999997543211 1111111000
Q ss_pred --c------cccccCCCccCCCCchHH-HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 411 --N------RNAEGVLDPRLQEKPCSR-ALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 411 --~------~~~~~~~~~~l~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
. ..........+....... ....+.+++.+||+.||++||++.|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 234 FSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred hhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 0 000000000011111100 13345568889999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=304.15 Aligned_cols=261 Identities=26% Similarity=0.331 Sum_probs=199.4
Q ss_pred CcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCC--chhHHHHHHHHHHHHccCCCCeeeEeeeeecC--CeeEEEEE
Q 010513 188 FADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEG--AHRMLVYE 262 (508)
Q Consensus 188 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--~~~~lV~e 262 (508)
|++.+.||+|+||.||+|... +++.+|+|.+.... ......+.+|+++++.++|+|++++++++.+. ...++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 567899999999999999976 47889999997653 33445688899999999999999999999887 78999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCC
Q 010513 263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE 342 (508)
Q Consensus 263 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 342 (508)
|+++ +|.+++... ...+++..++.++.|+++||+|||+. +++|+||||+||++++++.+||+|||++......
T Consensus 81 ~~~~-~l~~~~~~~---~~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~ 153 (287)
T cd07840 81 YMDH-DLTGLLDSP---EVKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKR 153 (287)
T ss_pred cccc-cHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence 9985 899988654 25789999999999999999999998 9999999999999999999999999999876544
Q ss_pred CcceecceecCCCCCChhhhhc-CCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcc---ccccc--
Q 010513 343 RSYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTN---RNAEG-- 416 (508)
Q Consensus 343 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~---~~~~~-- 416 (508)
.....+...++..|+|||.+.+ ..++.++||||||+++|||++|+.||....... ....+...... .....
T Consensus 154 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 230 (287)
T cd07840 154 NSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELE---QLEKIFELCGSPTDENWPGVS 230 (287)
T ss_pred CcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhCCCchhhccccc
Confidence 3322334467889999997654 457899999999999999999999997544321 11111111100 00000
Q ss_pred ------CCCccC--CC---CchHH-HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 417 ------VLDPRL--QE---KPCSR-ALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 417 ------~~~~~l--~~---~~~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
...+.. .. +.... ....+.+++.+||+.||++||++.+++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 231 KLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred cchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 000000 00 00001 14566778999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=297.28 Aligned_cols=250 Identities=23% Similarity=0.406 Sum_probs=199.5
Q ss_pred CCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCC--chhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEEe
Q 010513 187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY 263 (508)
Q Consensus 187 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~ 263 (508)
+|++.+.||+|+||.||+|..+ ++..+|+|.+.... ....+.+.+|+++++.++|+||+++++.+.+....++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4788899999999999999976 57889999885532 23445778899999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCC-eEEeeeccceecCCC
Q 010513 264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWN-PKLSDFGLAKLLGAE 342 (508)
Q Consensus 264 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~-~kL~DFG~a~~~~~~ 342 (508)
+++++|.+++.... ...+++..+..++.|+++||.|||+. +++|+||||+||++++++. +||+|||.+......
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (257)
T cd08225 81 CDGGDLMKRINRQR--GVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS 155 (257)
T ss_pred CCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence 99999999997642 24579999999999999999999998 9999999999999988864 699999999866433
Q ss_pred CcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCCccC
Q 010513 343 RSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRL 422 (508)
Q Consensus 343 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 422 (508)
.. ......|++.|+|||+..+..++.++|+||||+++|||++|+.||.... ..+........ .+.+.
T Consensus 156 ~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~------~~~~~~~~~~~-----~~~~~- 222 (257)
T cd08225 156 ME-LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN------LHQLVLKICQG-----YFAPI- 222 (257)
T ss_pred cc-cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc------HHHHHHHHhcc-----cCCCC-
Confidence 22 2223468999999999988889999999999999999999999996332 22222222111 11111
Q ss_pred CCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 423 QEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 423 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
.+.....+.+++.+||+.+|++||++.+++++
T Consensus 223 ----~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 223 ----SPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred ----CCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 11112345557889999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=305.38 Aligned_cols=265 Identities=22% Similarity=0.285 Sum_probs=195.3
Q ss_pred CCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCc--hhHHHHHHHHHHHHccC-CCCeeeEeeeeecCCe-----
Q 010513 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG--QAEKEFKVEVEAIGRVR-HKNLVRLLGYCAEGAH----- 256 (508)
Q Consensus 186 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~----- 256 (508)
++|++.+.||+|+||.||+|.+. +++.||+|.+..... .....+.+|+.+++.+. ||||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46889999999999999999975 588899998754322 23456788999999995 6999999999877665
Q ss_pred eEEEEEecCCCCHHHHhccCCCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcC-CCCeEEeeec
Q 010513 257 RMLVYEYIDNGNLEQWLHGDVGP-HSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDK-QWNPKLSDFG 334 (508)
Q Consensus 257 ~~lV~e~~~~g~L~~~l~~~~~~-~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~-~~~~kL~DFG 334 (508)
.|+||||+++ +|.+++...... ...+++..++.++.|+++||.|||++ +++||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeecc
Confidence 7999999986 899888654322 35689999999999999999999999 9999999999999998 8899999999
Q ss_pred cceecCCCCcceecceecCCCCCChhhhhc-CCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccc
Q 010513 335 LAKLLGAERSYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRN 413 (508)
Q Consensus 335 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 413 (508)
++........ ......+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||....+... ..... .......
T Consensus 157 ~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~--~~~~~-~~~~~~~ 232 (295)
T cd07837 157 LGRAFSIPVK-SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQ--LLHIF-KLLGTPT 232 (295)
T ss_pred cceecCCCcc-ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHH--HHHHH-HHhCCCC
Confidence 9886533211 1122357889999998765 4578999999999999999999999975432111 11100 0000000
Q ss_pred ---cccC---C----CccCCCC----chHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 414 ---AEGV---L----DPRLQEK----PCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 414 ---~~~~---~----~~~l~~~----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
.... . -+..... ..+....++.+++.+||+.||++||++.+++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 233 EQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred hhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 0000 0 0000000 001123456668889999999999999999864
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-38 Score=317.49 Aligned_cols=252 Identities=26% Similarity=0.425 Sum_probs=206.3
Q ss_pred cCCCCcccceEcccCcEEEEEEEECC--Cc--EEEEEEeecCCch-hHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeE
Q 010513 184 STNGFADENVIGEGGYGIVYHGVLED--NT--NVAVKNLLNNRGQ-AEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM 258 (508)
Q Consensus 184 ~~~~~~~~~~LG~G~~g~Vy~~~~~~--~~--~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 258 (508)
..++....++||+|.||+|++|.|+. |+ .||||.+...... ...+|.+|+..|.+|+|+|++++||+..+ ....
T Consensus 108 pee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~m 186 (1039)
T KOG0199|consen 108 PEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAM 186 (1039)
T ss_pred cHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhh
Confidence 34456678899999999999999863 43 5799999765443 67899999999999999999999999988 6788
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeecccee
Q 010513 259 LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL 338 (508)
Q Consensus 259 lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~ 338 (508)
||||.++.|+|.+.|++ .....+.......++.|||.|+.||.++ ++|||||-..|+|+-....+||+|||+.+.
T Consensus 187 MV~ELaplGSLldrLrk--a~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRa 261 (1039)
T KOG0199|consen 187 MVFELAPLGSLLDRLRK--AKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRA 261 (1039)
T ss_pred HHhhhcccchHHHHHhh--ccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceec
Confidence 99999999999999988 3357788999999999999999999999 999999999999998888999999999998
Q ss_pred cCCCCcce-ec-ceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHhhcccccc
Q 010513 339 LGAERSYV-TT-RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAE 415 (508)
Q Consensus 339 ~~~~~~~~-~~-~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (508)
++...... +. ...-.+.|+|||.++...++.++|||+|||+||||+| |..||-+- .-.+.++..-...++
T Consensus 262 Lg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~------~g~qIL~~iD~~erL- 334 (1039)
T KOG0199|consen 262 LGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGC------RGIQILKNIDAGERL- 334 (1039)
T ss_pred cCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCC------CHHHHHHhccccccC-
Confidence 86654433 22 2234568999999999999999999999999999999 89999643 334444433321111
Q ss_pred cCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 010513 416 GVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIH 457 (508)
Q Consensus 416 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 457 (508)
-+.++|++.+. ++++.||..+|++||++..|.+
T Consensus 335 ------pRPk~csedIY---~imk~cWah~paDRptFsair~ 367 (1039)
T KOG0199|consen 335 ------PRPKYCSEDIY---QIMKNCWAHNPADRPTFSAIRE 367 (1039)
T ss_pred ------CCCCCChHHHH---HHHHHhccCCccccccHHHHHH
Confidence 12344665555 4888999999999999999973
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=308.39 Aligned_cols=264 Identities=24% Similarity=0.323 Sum_probs=197.3
Q ss_pred cCCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCc--hhHHHHHHHHHHHHccCCCCeeeEeeeeecC--CeeE
Q 010513 184 STNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG--QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEG--AHRM 258 (508)
Q Consensus 184 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--~~~~ 258 (508)
..++|++.+.||+|+||.||+|.+. +++.||+|.+..... .....+.+|+.++++++|+||+++++++.+. +..+
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF 84 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence 3468999999999999999999975 588999998864322 2233456799999999999999999998765 4689
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeecccee
Q 010513 259 LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL 338 (508)
Q Consensus 259 lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~ 338 (508)
+||||+.+ +|.+++... ...+++..++.++.|+++||+|||+. +++||||||+||+++.++.+||+|||++..
T Consensus 85 lv~e~~~~-~l~~~l~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~ 157 (309)
T cd07845 85 LVMEYCEQ-DLASLLDNM---PTPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLART 157 (309)
T ss_pred EEEecCCC-CHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeee
Confidence 99999975 899888754 25689999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCcceecceecCCCCCChhhhhc-CCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhccc---cc
Q 010513 339 LGAERSYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNR---NA 414 (508)
Q Consensus 339 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~---~~ 414 (508)
...... ......+++.|+|||.+.+ ..++.++|+|||||++|||++|+.||....+.. ............ ..
T Consensus 158 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~---~~~~~~~~~~~~~~~~~ 233 (309)
T cd07845 158 YGLPAK-PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIE---QLDLIIQLLGTPNESIW 233 (309)
T ss_pred cCCccC-CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHhcCCCChhhc
Confidence 644321 1223346788999998865 568899999999999999999999997543221 111111111000 00
Q ss_pred c--------cCCC-ccCCCCch----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 415 E--------GVLD-PRLQEKPC----SRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 415 ~--------~~~~-~~l~~~~~----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
. .... +.-..... ......+.+++.+||+.||++||++.+++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 234 PGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred hhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0 0000 00000000 0123445668889999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=303.90 Aligned_cols=257 Identities=28% Similarity=0.390 Sum_probs=195.1
Q ss_pred CCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCC-chhHHHHHHHHHHHHccC-CCCeeeEeeeeecCCeeEEEEE
Q 010513 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVR-HKNLVRLLGYCAEGAHRMLVYE 262 (508)
Q Consensus 186 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~lV~e 262 (508)
++|+..+.||+|+||.||++... +++.+|+|.+.... ......+..|+.++.++. |+||+++++++..+...+++||
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e 83 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME 83 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence 35667789999999999999965 57889999886543 344567888999999996 9999999999999899999999
Q ss_pred ecCCCCHHHHhccC-CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCC
Q 010513 263 YIDNGNLEQWLHGD-VGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA 341 (508)
Q Consensus 263 ~~~~g~L~~~l~~~-~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 341 (508)
|+.. ++.++.... ......+++..+..++.|++.||+|||+.. +++||||||+||+++.++.+||+|||++.....
T Consensus 84 ~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 84 LMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred cccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 9875 665543211 011357899999999999999999999632 899999999999999999999999999976532
Q ss_pred CCcceecceecCCCCCChhhhhcC---CCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCC
Q 010513 342 ERSYVTTRVMGTFGYVAPEYASTG---MLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVL 418 (508)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 418 (508)
.. ......|++.|+|||++.+. .++.++|||||||++|||++|+.||.... ...+.+...... .
T Consensus 161 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-----~~~~~~~~~~~~------~ 227 (288)
T cd06616 161 SI--AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN-----SVFDQLTQVVKG------D 227 (288)
T ss_pred CC--ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc-----hHHHHHhhhcCC------C
Confidence 22 12334688999999998766 68999999999999999999999996432 122222222111 1
Q ss_pred CccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 419 DPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 419 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
.+.+..........++.+++.+||+.||++||++.+++++
T Consensus 228 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 228 PPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred CCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1122211111223345568889999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=304.12 Aligned_cols=262 Identities=22% Similarity=0.330 Sum_probs=196.3
Q ss_pred CCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCC--chhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEEe
Q 010513 187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY 263 (508)
Q Consensus 187 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~ 263 (508)
+|+..+.||+|+||.||+|... +++.||+|++.... ......+..|++++++++||||+++++++.++...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4788999999999999999975 58889999885432 22335788899999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCCC
Q 010513 264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER 343 (508)
Q Consensus 264 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 343 (508)
+. ++|.+++.... ...+++..++.++.|++.||+|||+. +++||||+|+||+++.++.+||+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~--~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~ 154 (284)
T cd07860 81 LH-QDLKKFMDASP--LSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 154 (284)
T ss_pred cc-cCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCc
Confidence 96 58999886542 35689999999999999999999998 99999999999999999999999999987654322
Q ss_pred cceecceecCCCCCChhhhhcCC-CCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhccc----------
Q 010513 344 SYVTTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNR---------- 412 (508)
Q Consensus 344 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~---------- 412 (508)
. ......+++.|+|||.+.+.. ++.++|+|||||++|||+||+.||...... ....+.....-...
T Consensus 155 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07860 155 R-TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI--DQLFRIFRTLGTPDEVVWPGVTSL 231 (284)
T ss_pred c-ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH--HHHHHHHHHhCCCChhhhhhhhHH
Confidence 1 122335788999999876544 688999999999999999999999644321 11111111000000
Q ss_pred -----ccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 413 -----NAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 413 -----~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
.........+. +..+....++.+++.+||+.||++||++++++++
T Consensus 232 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 232 PDYKPSFPKWARQDFS-KVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred HHHHhhcccccccCHH-HHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 00000000000 0001112345568889999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=317.74 Aligned_cols=246 Identities=23% Similarity=0.409 Sum_probs=196.7
Q ss_pred cccceEcccCcEEEEEEEEC-CCcEEEEE--Eeec--CCchhHHHHHHHHHHHHccCCCCeeeEeeeeecCCe--eEEEE
Q 010513 189 ADENVIGEGGYGIVYHGVLE-DNTNVAVK--NLLN--NRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAH--RMLVY 261 (508)
Q Consensus 189 ~~~~~LG~G~~g~Vy~~~~~-~~~~vavK--~~~~--~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~--~~lV~ 261 (508)
.+..+||+|+|-+||+|.+. +|.+||=- ++.+ ......+.|..|+.+|+.|+||||++||+++.+... +.+|+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 44578999999999999975 46666521 1221 233445789999999999999999999999987665 66899
Q ss_pred EecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcC-CCCeEEeeeccceecC
Q 010513 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDK-QWNPKLSDFGLAKLLG 340 (508)
Q Consensus 262 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~-~~~~kL~DFG~a~~~~ 340 (508)
|.+..|+|..|+++. ...+....+.|++||++||.|||++ .|+|||||||.+||+|+. .|.|||+|+|+|..+.
T Consensus 123 EL~TSGtLr~Y~kk~----~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r 197 (632)
T KOG0584|consen 123 ELFTSGTLREYRKKH----RRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLR 197 (632)
T ss_pred ecccCCcHHHHHHHh----ccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhh
Confidence 999999999999886 5788899999999999999999997 899999999999999975 5889999999999764
Q ss_pred CCCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCCc
Q 010513 341 AERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDP 420 (508)
Q Consensus 341 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 420 (508)
... ...+.|||.|||||+.. ..|++.+||||||+++.||+|+..||. +-.+..+..++...... ..
T Consensus 198 ~s~---aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYs-----EC~n~AQIYKKV~SGiK-----P~ 263 (632)
T KOG0584|consen 198 KSH---AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYS-----ECTNPAQIYKKVTSGIK-----PA 263 (632)
T ss_pred ccc---cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChh-----hhCCHHHHHHHHHcCCC-----HH
Confidence 322 23378999999999986 889999999999999999999999995 23355666666554321 11
Q ss_pred cCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 421 RLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 421 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
.+..- ...+.++ +|.+|+.. ..+||++.|+|+.
T Consensus 264 sl~kV-~dPevr~---fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 264 ALSKV-KDPEVRE---FIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred Hhhcc-CCHHHHH---HHHHHhcC-chhccCHHHHhhC
Confidence 12111 1233444 77799999 9999999999964
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=291.89 Aligned_cols=251 Identities=26% Similarity=0.403 Sum_probs=203.5
Q ss_pred CCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCc--hhHHHHHHHHHHHHccCCCCeeeEeeeeecC--CeeEEEE
Q 010513 187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG--QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEG--AHRMLVY 261 (508)
Q Consensus 187 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--~~~~lV~ 261 (508)
+|...+.||+|++|.||+|... +++.|++|.+..... ...+.+.+|++.+++++||||+++++.+.+. ...++|+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4777899999999999999976 688899998865542 4567889999999999999999999999988 8899999
Q ss_pred EecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCC
Q 010513 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA 341 (508)
Q Consensus 262 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 341 (508)
||+++++|.+++... ..+++..++.++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||.+.....
T Consensus 81 e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 153 (260)
T cd06606 81 EYVSGGSLSSLLKKF----GKLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGD 153 (260)
T ss_pred EecCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEeccc
Confidence 999999999999765 3789999999999999999999998 999999999999999999999999999987654
Q ss_pred CCcc-eecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCCc
Q 010513 342 ERSY-VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDP 420 (508)
Q Consensus 342 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 420 (508)
.... ......++..|+|||.+.+..++.++|+||||+++|+|++|+.||.... +............. .+
T Consensus 154 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~~~~-----~~ 223 (260)
T cd06606 154 IETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG-----NPMAALYKIGSSGE-----PP 223 (260)
T ss_pred ccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----chHHHHHhccccCC-----Cc
Confidence 4321 1233568899999999988889999999999999999999999997554 11111111111000 01
Q ss_pred cCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 421 RLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 421 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
.+. ......+.+++.+|++.||++||++.+++++
T Consensus 224 ~~~----~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 224 EIP----EHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred CCC----cccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 111 1113445557889999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=294.87 Aligned_cols=242 Identities=24% Similarity=0.307 Sum_probs=195.4
Q ss_pred EcccCcEEEEEEEEC-CCcEEEEEEeecCCc---hhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEEecCCCCH
Q 010513 194 IGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG---QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNL 269 (508)
Q Consensus 194 LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~g~L 269 (508)
||.|+||.||+|... +++.+|+|.+..... ...+.+..|+++++.++||||+++++++.++...++||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999976 488899999865432 3446788999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCCCcceecc
Q 010513 270 EQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTR 349 (508)
Q Consensus 270 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~ 349 (508)
.+++.+. ..+++..+..++.|++.||+|||++ +++|+||||+||+++.++.++|+|||++....... ....
T Consensus 81 ~~~l~~~----~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~ 151 (262)
T cd05572 81 WTILRDR----GLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWT 151 (262)
T ss_pred HHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--cccc
Confidence 9999765 3589999999999999999999998 99999999999999999999999999998764432 2233
Q ss_pred eecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCCccCCCCchHH
Q 010513 350 VMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSR 429 (508)
Q Consensus 350 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 429 (508)
..|++.|+|||.+.+..++.++|+||||+++|+|++|..||..... +..+.......... ....... .
T Consensus 152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~~~~~~-----~~~~~~~-~-- 219 (262)
T cd05572 152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDE----DPMEIYNDILKGNG-----KLEFPNY-I-- 219 (262)
T ss_pred ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCC----CHHHHHHHHhccCC-----CCCCCcc-c--
Confidence 4689999999999888899999999999999999999999975542 12222222221010 1111111 1
Q ss_pred HHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 010513 430 ALKRALLVALRCVDPNAHKRPK-----MGHVIH 457 (508)
Q Consensus 430 ~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 457 (508)
...+.+++.+||+.||++||+ ++|+++
T Consensus 220 -~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 220 -DKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred -CHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 334556888999999999999 777765
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=293.63 Aligned_cols=252 Identities=24% Similarity=0.389 Sum_probs=205.7
Q ss_pred CCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCc--hhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEEe
Q 010513 187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG--QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY 263 (508)
Q Consensus 187 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~ 263 (508)
+|.+.+.||+|+||.||++.+. ++..+++|++..... ...+.+..|+++++.++|||++++++.+..+...++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4788899999999999999975 588899999865433 4556788899999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCCC
Q 010513 264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER 343 (508)
Q Consensus 264 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 343 (508)
+++++|.+++.........+++..+..++.+++.||.|||++ +++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 999999999977533346799999999999999999999999 99999999999999999999999999998764433
Q ss_pred cceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCCccCC
Q 010513 344 SYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQ 423 (508)
Q Consensus 344 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 423 (508)
.......|++.|+|||...+..++.++|+||+|+++|+|++|+.||.... ..+....... ... . .+.
T Consensus 158 -~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~------~~~~~~~~~~-~~~----~-~~~ 224 (258)
T cd08215 158 -DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN------LLELALKILK-GQY----P-PIP 224 (258)
T ss_pred -ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc------HHHHHHHHhc-CCC----C-CCC
Confidence 23344578999999999988889999999999999999999999996443 1122222221 111 1 111
Q ss_pred CCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 424 EKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 424 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
. ..+ ..+.+++.+||+.+|++||++.+++++
T Consensus 225 ~-~~~---~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 225 S-QYS---SELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred C-CCC---HHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 1 122 344558889999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=295.24 Aligned_cols=250 Identities=24% Similarity=0.312 Sum_probs=203.6
Q ss_pred CCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCC--chhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEEe
Q 010513 187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY 263 (508)
Q Consensus 187 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~ 263 (508)
+|++.+.||+|+||.||++..+ ++..+++|.+.... ......+..|+++++.++|+||+++++++.+....++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4788999999999999999865 67889999886532 23345677899999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCCC
Q 010513 264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER 343 (508)
Q Consensus 264 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 343 (508)
+++++|.+++.+.......+++..++.++.|++.||+|||+. +++|+||+|+||++++++.+||+|||++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 999999999876433346789999999999999999999999 9999999999999999999999999999876443
Q ss_pred cceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCCccCC
Q 010513 344 SYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQ 423 (508)
Q Consensus 344 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 423 (508)
......|++.|+|||.+.+..++.++|+||||+++|||++|+.||..... .+ +...........
T Consensus 157 --~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~------~~-~~~~~~~~~~~~------- 220 (256)
T cd08530 157 --MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSM------QD-LRYKVQRGKYPP------- 220 (256)
T ss_pred --CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HH-HHHHHhcCCCCC-------
Confidence 22234688999999999988899999999999999999999999964432 11 111111111111
Q ss_pred CCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 424 EKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 424 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
.......++.+++.+|++.+|++||++.+++++
T Consensus 221 --~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 221 --IPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred --CchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 112334456668889999999999999999865
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=286.82 Aligned_cols=253 Identities=22% Similarity=0.286 Sum_probs=198.1
Q ss_pred CCCCccc-ceEcccCcEEEEEEEEC-CCcEEEEEEeecCCchhHHHHHHHHHHHHcc-CCCCeeeEeeeeec----CCee
Q 010513 185 TNGFADE-NVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAE----GAHR 257 (508)
Q Consensus 185 ~~~~~~~-~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~----~~~~ 257 (508)
+++|.+- ++||-|-.|.|..+..+ +++++|+|.+... ...++|+++--.. .|||||.++++|++ ...+
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcL 134 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCL 134 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceee
Confidence 3455443 67999999999999965 6888999988543 3445677765444 79999999999864 3567
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcC---CCCeEEeeec
Q 010513 258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDK---QWNPKLSDFG 334 (508)
Q Consensus 258 ~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~---~~~~kL~DFG 334 (508)
.+|||+|+||.|++.++++. ...+++.++..|+.||+.|+.|||+. +|.||||||+|+|... |..+||+|||
T Consensus 135 LiVmE~meGGeLfsriq~~g--~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtDfG 209 (400)
T KOG0604|consen 135 LIVMECMEGGELFSRIQDRG--DQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTDFG 209 (400)
T ss_pred EeeeecccchHHHHHHHHcc--cccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEecccc
Confidence 79999999999999998874 46799999999999999999999999 9999999999999954 4559999999
Q ss_pred cceecCCCCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhccccc
Q 010513 335 LAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNA 414 (508)
Q Consensus 335 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 414 (508)
+|+.... .....+.|-||+|.|||++....|+..+|+||+||++|-|++|.+||....- ..+..-++..++.+..
T Consensus 210 FAK~t~~--~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg---~aispgMk~rI~~gqy 284 (400)
T KOG0604|consen 210 FAKETQE--PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG---LAISPGMKRRIRTGQY 284 (400)
T ss_pred cccccCC--CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCC---ccCChhHHhHhhccCc
Confidence 9996533 3344556889999999999999999999999999999999999999975421 1111222222332221
Q ss_pred ccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 415 EGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 415 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
.+..+..+...+...++|+.+|..+|.+|-|+.+++.+
T Consensus 285 ------~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 285 ------EFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred ------cCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 22333345556666678889999999999999998864
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=306.34 Aligned_cols=266 Identities=23% Similarity=0.320 Sum_probs=194.6
Q ss_pred CCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCC--chhHHHHHHHHHHHHccCCCCeeeEeeeeecCC-------
Q 010513 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGA------- 255 (508)
Q Consensus 186 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~------- 255 (508)
++|++.+.||+|+||.||+|... +++.||+|.+.... ......+.+|++++++++||||+++++++....
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 91 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK 91 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence 47999999999999999999975 58889999886432 222345567999999999999999999987544
Q ss_pred -eeEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeec
Q 010513 256 -HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFG 334 (508)
Q Consensus 256 -~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG 334 (508)
..++||||+.+ +|.+++... ...+++..++.++.|+++||.|||++ +++|+||||+||+++.++.+||+|||
T Consensus 92 ~~~~lv~e~~~~-~l~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg 164 (310)
T cd07865 92 GSFYLVFEFCEH-DLAGLLSNK---NVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFG 164 (310)
T ss_pred ceEEEEEcCCCc-CHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcCC
Confidence 45899999975 888888654 24689999999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCcc---eecceecCCCCCChhhhhcC-CCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhc
Q 010513 335 LAKLLGAERSY---VTTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVT 410 (508)
Q Consensus 335 ~a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~ 410 (508)
++......... ......++..|+|||.+.+. .++.++|+||||+++|||++|+.||....+.........+.....
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (310)
T cd07865 165 LARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSIT 244 (310)
T ss_pred CcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 99866432221 12334678899999987654 478899999999999999999999975543221111111110000
Q ss_pred ccccccC-----CCc-cCCCCc---hHH------HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 411 NRNAEGV-----LDP-RLQEKP---CSR------ALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 411 ~~~~~~~-----~~~-~l~~~~---~~~------~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
....... .+. .+.... ... ....+.+++.+||+.||++||++++++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 245 PEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred hhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 0000000 000 000000 000 12345568889999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=300.39 Aligned_cols=242 Identities=22% Similarity=0.287 Sum_probs=185.4
Q ss_pred eEcccCcEEEEEEEEC-CCcEEEEEEeecCCc---hhHHHHHHHHHH---HHccCCCCeeeEeeeeecCCeeEEEEEecC
Q 010513 193 VIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG---QAEKEFKVEVEA---IGRVRHKNLVRLLGYCAEGAHRMLVYEYID 265 (508)
Q Consensus 193 ~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~---l~~l~hpniv~l~~~~~~~~~~~lV~e~~~ 265 (508)
.||+|+||.||++... +++.+|+|.+.+... .....+.+|..+ +....||||+.+++++..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999975 578899998865422 112233344433 334479999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCCCcc
Q 010513 266 NGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSY 345 (508)
Q Consensus 266 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~ 345 (508)
+|+|.+++... ..+++..+..++.|++.||+|||++ +++||||||+|||++.++.++|+|||++.......
T Consensus 81 ~~~L~~~i~~~----~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~-- 151 (279)
T cd05633 81 GGDLHYHLSQH----GVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-- 151 (279)
T ss_pred CCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccC--
Confidence 99999998754 4699999999999999999999999 99999999999999999999999999987553221
Q ss_pred eecceecCCCCCChhhhhc-CCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCCccCCC
Q 010513 346 VTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQE 424 (508)
Q Consensus 346 ~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 424 (508)
.....|+..|+|||.+.+ ..++.++|+|||||++|||++|+.||.......... +...... .+..+.
T Consensus 152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~----~~~~~~~------~~~~~~- 219 (279)
T cd05633 152 -PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE----IDRMTLT------VNVELP- 219 (279)
T ss_pred -ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHH----HHHHhhc------CCcCCc-
Confidence 223468999999998864 568999999999999999999999997543322111 1111110 011111
Q ss_pred CchHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 010513 425 KPCSRALKRALLVALRCVDPNAHKRP-----KMGHVIHM 458 (508)
Q Consensus 425 ~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 458 (508)
.....++.+++.+||+.||++|| ++++++++
T Consensus 220 ---~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 220 ---DSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred ---cccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 11223445577899999999999 59998876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=300.40 Aligned_cols=263 Identities=24% Similarity=0.371 Sum_probs=198.4
Q ss_pred CCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCc-hhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEEec
Q 010513 187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYI 264 (508)
Q Consensus 187 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~ 264 (508)
+|++.+.||+|++|.||+|... ++..||+|.+..... ...+.+.+|+++++.++||||+++++++.+.+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 4788999999999999999976 588899998865432 23456778999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCCCc
Q 010513 265 DNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS 344 (508)
Q Consensus 265 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~ 344 (508)
++ +|.+++.... ....+++..++.++.|++.||+|||+. +++||||||+||++++++.++|+|||++........
T Consensus 81 ~~-~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~ 155 (284)
T cd07836 81 DK-DLKKYMDTHG-VRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN 155 (284)
T ss_pred Cc-cHHHHHHhcC-CCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc
Confidence 85 8999886542 134689999999999999999999998 999999999999999999999999999976533221
Q ss_pred ceecceecCCCCCChhhhhc-CCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcc---cccc-----
Q 010513 345 YVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTN---RNAE----- 415 (508)
Q Consensus 345 ~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~---~~~~----- 415 (508)
......+++.|++||.+.+ ..++.++|+|||||++|+|++|+.||........ ..... ..... ....
T Consensus 156 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~--~~~~~-~~~~~~~~~~~~~~~~~ 231 (284)
T cd07836 156 -TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQ--LLKIF-RIMGTPTESTWPGISQL 231 (284)
T ss_pred -ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHH--HHHHH-HHhCCCChhhHHHHhcC
Confidence 1223457889999998765 4578899999999999999999999975543211 11111 00000 0000
Q ss_pred cCCCccCCC-------CchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 416 GVLDPRLQE-------KPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 416 ~~~~~~l~~-------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
......... ...+.....+.+++.+|++.||++||++.+++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 232 PEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred chhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 000000000 0011223455668889999999999999999854
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=304.74 Aligned_cols=267 Identities=25% Similarity=0.331 Sum_probs=199.2
Q ss_pred hhcCCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCC--chhHHHHHHHHHHHHccCCCCeeeEeeeeecCC---
Q 010513 182 EVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGA--- 255 (508)
Q Consensus 182 ~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~--- 255 (508)
+...++|++.+.||+|+||.||+|..+ +++.||+|.+.... ......+..|+++++.++||||+++++++.+..
T Consensus 3 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~ 82 (302)
T cd07864 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDAL 82 (302)
T ss_pred hhhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhh
Confidence 345678999999999999999999976 57889999986442 223356778999999999999999999987654
Q ss_pred -------eeEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCe
Q 010513 256 -------HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNP 328 (508)
Q Consensus 256 -------~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~ 328 (508)
..++|+||+++ ++.+.+... ...+++..++.++.|++.||+|||+. +|+||||||+||++++++.+
T Consensus 83 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~ 155 (302)
T cd07864 83 DFKKDKGAFYLVFEYMDH-DLMGLLESG---LVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQI 155 (302)
T ss_pred hccccCCcEEEEEcccCc-cHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcE
Confidence 78999999986 787777654 34789999999999999999999999 99999999999999999999
Q ss_pred EEeeeccceecCCCCcceecceecCCCCCChhhhhc-CCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHH
Q 010513 329 KLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKT 407 (508)
Q Consensus 329 kL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~ 407 (508)
||+|||++...............++..|+|||.+.+ ..++.++|||||||++|||++|+.||..... ......+..
T Consensus 156 kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~---~~~~~~~~~ 232 (302)
T cd07864 156 KLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQE---LAQLELISR 232 (302)
T ss_pred EeCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHH
Confidence 999999998764433222233456888999998865 4578899999999999999999999974432 111112222
Q ss_pred hhccccc---ccC--------CCccCC--C---CchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 408 MVTNRNA---EGV--------LDPRLQ--E---KPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 408 ~~~~~~~---~~~--------~~~~l~--~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
....... ..+ .++... . .........+.+++.+||+.||++||++.+++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 233 LCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred HhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1111000 000 000000 0 0000112345668889999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=303.47 Aligned_cols=247 Identities=26% Similarity=0.370 Sum_probs=197.1
Q ss_pred cccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCchhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEEecCCC
Q 010513 189 ADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNG 267 (508)
Q Consensus 189 ~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~g 267 (508)
....+||+|+||.||++..+ ++..||+|++..........+.+|+.+++.++|+||+++++++..++..++||||++++
T Consensus 23 ~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 102 (292)
T cd06657 23 DNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGG 102 (292)
T ss_pred hhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCC
Confidence 33467999999999999875 68889999886555555677889999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCCCccee
Q 010513 268 NLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVT 347 (508)
Q Consensus 268 ~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~ 347 (508)
+|.+++.. ..+++.....++.|++.||+|||++ +++||||||+||+++.++.++|+|||++........ ..
T Consensus 103 ~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-~~ 173 (292)
T cd06657 103 ALTDIVTH-----TRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RR 173 (292)
T ss_pred cHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceecccccc-cc
Confidence 99998754 3578999999999999999999999 999999999999999999999999999876543221 12
Q ss_pred cceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCCccCCCCch
Q 010513 348 TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPC 427 (508)
Q Consensus 348 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 427 (508)
....|++.|+|||.+.+..++.++|+||||+++|+|++|..||...... .....+... +.+.+.. .
T Consensus 174 ~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~---~~~~~~~~~---------~~~~~~~--~ 239 (292)
T cd06657 174 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL---KAMKMIRDN---------LPPKLKN--L 239 (292)
T ss_pred cccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhh---------CCcccCC--c
Confidence 3356899999999998888999999999999999999999999643221 111111111 1111111 0
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 428 SRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 428 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
......+.+++.+||+.||.+||++.+++++
T Consensus 240 ~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 240 HKVSPSLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred ccCCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 1112234457789999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=312.26 Aligned_cols=264 Identities=22% Similarity=0.317 Sum_probs=199.0
Q ss_pred CCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecC--CchhHHHHHHHHHHHHccCCCCeeeEeeeeecC-----Ce
Q 010513 185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEG-----AH 256 (508)
Q Consensus 185 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-----~~ 256 (508)
.++|.+.+.||+|+||+||+|... +++.||+|.+... .......+..|+.+++.++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 347999999999999999999965 6889999988653 223345677899999999999999999988654 34
Q ss_pred eEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccc
Q 010513 257 RMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLA 336 (508)
Q Consensus 257 ~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a 336 (508)
.|+||||+. ++|.+++... ..+++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||++
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~ 155 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSS----QTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLA 155 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCccc
Confidence 799999996 5899988654 5699999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCcceecceecCCCCCChhhhhc-CCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcc----
Q 010513 337 KLLGAERSYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTN---- 411 (508)
Q Consensus 337 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~---- 411 (508)
....... .......++..|+|||.+.. ..++.++|+|||||++|+|++|+.||....... ...........
T Consensus 156 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~ 231 (337)
T cd07858 156 RTTSEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVH---QLKLITELLGSPSEE 231 (337)
T ss_pred cccCCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHH---HHHHHHHHhCCCChH
Confidence 8664332 22234567889999998765 568999999999999999999999997543211 11111110000
Q ss_pred -------ccc-------ccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--Hhc
Q 010513 412 -------RNA-------EGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM--LEA 461 (508)
Q Consensus 412 -------~~~-------~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--Le~ 461 (508)
... ....++.+.. ..+....++.+++.+||+.||++||++.+++++ ++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~ 296 (337)
T cd07858 232 DLGFIRNEKARRYIRSLPYTPRQSFAR-LFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLAS 296 (337)
T ss_pred HhhhcCchhhhHHHHhcCcccccCHHH-HcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhh
Confidence 000 0000000000 011223456678889999999999999999987 544
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=300.74 Aligned_cols=258 Identities=22% Similarity=0.288 Sum_probs=193.2
Q ss_pred CcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCC-chhHHHHHHHHHHHHccC-CCCeeeEeeeeecC--CeeEEEEE
Q 010513 188 FADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVR-HKNLVRLLGYCAEG--AHRMLVYE 262 (508)
Q Consensus 188 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~--~~~~lV~e 262 (508)
|++.+.||+|+||.||+|... +++.||+|++.... .........|+..+.++. |+|++++++++.++ +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 567889999999999999965 58889999886542 222233456888898885 99999999999987 88999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCC
Q 010513 263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE 342 (508)
Q Consensus 263 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 342 (508)
|+++ +|.+++... ...+++..++.++.|++.||+|||+. +++||||||+||+++. +.+||+|||++......
T Consensus 81 ~~~~-~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~ 152 (282)
T cd07831 81 LMDM-NLYELIKGR---KRPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSK 152 (282)
T ss_pred cCCc-cHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccccC
Confidence 9975 888888654 24689999999999999999999999 9999999999999999 99999999999876433
Q ss_pred CcceecceecCCCCCChhhhhc-CCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhh-----------c
Q 010513 343 RSYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMV-----------T 410 (508)
Q Consensus 343 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~-----------~ 410 (508)
... ....++..|+|||.+.. +.++.++|+|||||++|||++|..||...+... ......... .
T Consensus 153 ~~~--~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 227 (282)
T cd07831 153 PPY--TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD---QIAKIHDVLGTPDAEVLKKFR 227 (282)
T ss_pred CCc--CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHH---HHHHHHHHcCCCCHHHHHhhc
Confidence 222 23467899999997644 567889999999999999999999997543211 111111110 0
Q ss_pred ccccccCCCccCCCCc----hHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 411 NRNAEGVLDPRLQEKP----CSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 411 ~~~~~~~~~~~l~~~~----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
.........+...... .......+.+++.+||+.||++||++.+++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 228 KSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred ccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 0000000011000000 11224566778889999999999999999864
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=312.20 Aligned_cols=265 Identities=22% Similarity=0.342 Sum_probs=197.5
Q ss_pred CCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCC--chhHHHHHHHHHHHHccCCCCeeeEeeeeec----CCeeE
Q 010513 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE----GAHRM 258 (508)
Q Consensus 186 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~----~~~~~ 258 (508)
++|++.+.||+|+||.||+|... ++..||+|++.... ....+.+..|+.+++.++||||+++++++.. ....+
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 58999999999999999999965 58899999886542 2334567789999999999999999998763 35689
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeecccee
Q 010513 259 LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL 338 (508)
Q Consensus 259 lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~ 338 (508)
+||||+. |+|.+++... ..+++..+..++.|++.||+|||++ +++||||||+||+++.++.+||+|||++..
T Consensus 85 lv~e~~~-~~l~~~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~ 156 (334)
T cd07855 85 VVMDLME-SDLHHIIHSD----QPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARG 156 (334)
T ss_pred EEEehhh-hhHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEeccccccee
Confidence 9999996 5999998654 4589999999999999999999998 999999999999999999999999999976
Q ss_pred cCCCCc---ceecceecCCCCCChhhhhc-CCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHH--------H
Q 010513 339 LGAERS---YVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWL--------K 406 (508)
Q Consensus 339 ~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~--------~ 406 (508)
...... .......|+..|+|||.+.+ ..++.++|||||||++|||++|+.||............... .
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~ 236 (334)
T cd07855 157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVL 236 (334)
T ss_pred ecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhh
Confidence 533221 11233578999999998865 46899999999999999999999999754322111100000 0
Q ss_pred Hhhccccccc---CCCccCCC---CchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 407 TMVTNRNAEG---VLDPRLQE---KPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 407 ~~~~~~~~~~---~~~~~l~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
.......... ........ ...+....++.+++.+||+.||++||++++++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 237 NRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred hhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 0000000000 00000000 0011224556678889999999999999998874
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=301.41 Aligned_cols=261 Identities=24% Similarity=0.345 Sum_probs=196.2
Q ss_pred CcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCC--chhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEEec
Q 010513 188 FADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYI 264 (508)
Q Consensus 188 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~ 264 (508)
|++.+.||.|++|.||+|.+. +|..||+|++.... ......+.+|+++++.++|||++++++++.++...+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 567899999999999999965 68899999886443 223356788999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCCCc
Q 010513 265 DNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS 344 (508)
Q Consensus 265 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~ 344 (508)
+ ++|.+++.... ...+++..++.++.|+++||+|||++ +++||||+|+||+++.++.++|+|||++........
T Consensus 81 ~-~~l~~~~~~~~--~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~ 154 (283)
T cd07835 81 D-LDLKKYMDSSP--LTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR 154 (283)
T ss_pred C-cCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc
Confidence 6 59999987652 24689999999999999999999998 999999999999999999999999999976533221
Q ss_pred ceecceecCCCCCChhhhhcC-CCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhccc-----------
Q 010513 345 YVTTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNR----------- 412 (508)
Q Consensus 345 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~----------- 412 (508)
. .....+++.|+|||++.+. .++.++|+||||+++|+|++|+.||....+.. .............
T Consensus 155 ~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd07835 155 T-YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEID--QLFRIFRTLGTPDEDVWPGVTSLP 231 (283)
T ss_pred c-cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCChHHhhhhhhch
Confidence 1 1223568899999987654 57889999999999999999999997543211 1111111000000
Q ss_pred c----cccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 413 N----AEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 413 ~----~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
. ......+.. ....+.....+.+++.+||+.||++||++.+++++
T Consensus 232 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 232 DYKPTFPKWARQDL-SKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hhhhhcccccccch-hhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0 000000000 00011122456668889999999999999999854
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=311.84 Aligned_cols=249 Identities=22% Similarity=0.313 Sum_probs=204.0
Q ss_pred cCCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCch--hHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEE
Q 010513 184 STNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQ--AEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLV 260 (508)
Q Consensus 184 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 260 (508)
....|.+.+.||+|.|++|.+|++. ++.+||||.+.+.... ....+.+|+++|..++|||||+++.+.+.+..+|+|
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV 133 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence 4457899999999999999999965 6899999998765332 334578899999999999999999999999999999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecC
Q 010513 261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG 340 (508)
Q Consensus 261 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 340 (508)
|||+.+|.+++++... +...+..+..++.|+..|++|||++ .|+|||||++||||+.+.++||+|||++..+.
T Consensus 134 ~eya~~ge~~~yl~~~----gr~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~ 206 (596)
T KOG0586|consen 134 MEYASGGELFDYLVKH----GRMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFD 206 (596)
T ss_pred EEeccCchhHHHHHhc----ccchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeec
Confidence 9999999999999876 5667788999999999999999999 99999999999999999999999999999885
Q ss_pred CCCcceecceecCCCCCChhhhhcCCC-CCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCC
Q 010513 341 AERSYVTTRVMGTFGYVAPEYASTGML-NERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLD 419 (508)
Q Consensus 341 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 419 (508)
. .......||++.|.|||++.+..| ++.+|+||+|++||.|+.|..||++..-.+-. . .++.
T Consensus 207 ~--~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr-----------~----rvl~ 269 (596)
T KOG0586|consen 207 Y--GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELR-----------P----RVLR 269 (596)
T ss_pred c--cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccccc-----------c----hhee
Confidence 3 334566899999999999998776 57899999999999999999999855321110 0 1111
Q ss_pred ccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 420 PRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 420 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
..++.. .-...++-+++.+++-++|.+|++++++.+.
T Consensus 270 gk~rIp--~~ms~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 270 GKYRIP--FYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred eeeccc--ceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence 111111 1112234447779999999999999998654
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=301.71 Aligned_cols=249 Identities=28% Similarity=0.402 Sum_probs=196.6
Q ss_pred CCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCC---chhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEE
Q 010513 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY 261 (508)
Q Consensus 186 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 261 (508)
+.|...+.||+|+||.||+|+.. ++..+|+|.+.... ......+..|+++++.++|||++++++++.++...++||
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 104 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM 104 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence 34788899999999999999965 57889999886432 233456888999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCC
Q 010513 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA 341 (508)
Q Consensus 262 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 341 (508)
||+.+ +|.+++... ..++++..+..++.|++.||.|||++ +++||||+|+||+++.++.++|+|||++.....
T Consensus 105 e~~~g-~l~~~~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~ 177 (317)
T cd06635 105 EYCLG-SASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASP 177 (317)
T ss_pred eCCCC-CHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCC
Confidence 99975 888877554 35689999999999999999999999 999999999999999999999999999875432
Q ss_pred CCcceecceecCCCCCChhhhh---cCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCC
Q 010513 342 ERSYVTTRVMGTFGYVAPEYAS---TGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVL 418 (508)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 418 (508)
. ....|++.|+|||.+. .+.++.++|+|||||++|||++|+.||..... ...........
T Consensus 178 ~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~------~~~~~~~~~~~------ 240 (317)
T cd06635 178 A-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSALYHIAQNE------ 240 (317)
T ss_pred c-----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccH------HHHHHHHHhcc------
Confidence 2 2346889999999873 45688999999999999999999999864321 11111111111
Q ss_pred CccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 010513 419 DPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461 (508)
Q Consensus 419 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~ 461 (508)
.+.......+ ..+.+++.+||+.+|++||++.++++++-.
T Consensus 241 ~~~~~~~~~~---~~l~~li~~~l~~~p~~Rpt~~~il~~~~~ 280 (317)
T cd06635 241 SPTLQSNEWS---DYFRNFVDSCLQKIPQDRPTSEELLKHMFV 280 (317)
T ss_pred CCCCCCcccc---HHHHHHHHHHccCCcccCcCHHHHHhChhh
Confidence 0111111122 334557889999999999999999987543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=302.00 Aligned_cols=263 Identities=22% Similarity=0.346 Sum_probs=195.1
Q ss_pred CCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCc--hhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEE
Q 010513 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG--QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE 262 (508)
Q Consensus 186 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e 262 (508)
++|++.+.||+|++|+||+|..+ +++.||+|.+..... ...+.+..|+++++.++||||+++++++.++...++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 57899999999999999999975 688899998854322 334567889999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcC-CCCeEEeeeccceecCC
Q 010513 263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDK-QWNPKLSDFGLAKLLGA 341 (508)
Q Consensus 263 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~-~~~~kL~DFG~a~~~~~ 341 (508)
|+++ +|.+++.... ...+++..+..++.|++.||+|||++ +++||||||+||+++. ++.+||+|||++.....
T Consensus 82 ~~~~-~l~~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~ 155 (294)
T PLN00009 82 YLDL-DLKKHMDSSP--DFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI 155 (294)
T ss_pred cccc-cHHHHHHhCC--CCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCC
Confidence 9964 8888876542 23467888899999999999999999 9999999999999985 45799999999976533
Q ss_pred CCcceecceecCCCCCChhhhhc-CCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhccc---ccccC
Q 010513 342 ERSYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNR---NAEGV 417 (508)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~---~~~~~ 417 (508)
... ..+...+++.|+|||.+.+ ..++.++|||||||++|+|+||+.||....+.+.. .. ........ .....
T Consensus 156 ~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~--~~-~~~~~~~~~~~~~~~~ 231 (294)
T PLN00009 156 PVR-TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDEL--FK-IFRILGTPNEETWPGV 231 (294)
T ss_pred Ccc-ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH--HH-HHHHhCCCChhhcccc
Confidence 221 1233467889999998866 45789999999999999999999999754322111 10 00000000 00000
Q ss_pred --------CCccCCCC----chHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 418 --------LDPRLQEK----PCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 418 --------~~~~l~~~----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
.-+..... ..+....++.+++.+|++.||++||++.+++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 232 TSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred ccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000000 011122345668889999999999999999864
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=297.91 Aligned_cols=244 Identities=25% Similarity=0.297 Sum_probs=190.7
Q ss_pred EcccCcEEEEEEEEC-CCcEEEEEEeecCC---chhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEEecCCCCH
Q 010513 194 IGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNL 269 (508)
Q Consensus 194 LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~g~L 269 (508)
||+|+||+||+|... +++.||+|.+.... ......+..|+++++.++||||+++++++...+..|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999865 58889999886432 22334567799999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCCCcceecc
Q 010513 270 EQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTR 349 (508)
Q Consensus 270 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~ 349 (508)
.+++.... ...+++..++.++.|++.||.|||+. +++||||+|+||++++++.++|+|||.+...... .....
T Consensus 81 ~~~l~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~--~~~~~ 153 (277)
T cd05577 81 KYHIYNVG--EPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG--KKIKG 153 (277)
T ss_pred HHHHHHcC--cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccC--Ccccc
Confidence 99997652 24689999999999999999999998 9999999999999999999999999998765332 12233
Q ss_pred eecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCCccCCCCchHH
Q 010513 350 VMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSR 429 (508)
Q Consensus 350 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 429 (508)
..++..|+|||.+.+..++.++|+|||||++|+|++|+.||......... +.+....... ...... ..+
T Consensus 154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---~~~~~~~~~~------~~~~~~-~~~- 222 (277)
T cd05577 154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEK---EELKRRTLEM------AVEYPD-KFS- 222 (277)
T ss_pred ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccH---HHHHhccccc------cccCCc-cCC-
Confidence 46788999999998888999999999999999999999999755432111 1111111100 001111 122
Q ss_pred HHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 010513 430 ALKRALLVALRCVDPNAHKRP-----KMGHVIH 457 (508)
Q Consensus 430 ~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 457 (508)
..+.+++.+||+.||++|| ++.++++
T Consensus 223 --~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 223 --PEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred --HHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 3344577899999999999 6666664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=289.51 Aligned_cols=248 Identities=28% Similarity=0.470 Sum_probs=201.8
Q ss_pred CCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCc--hhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEEe
Q 010513 187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG--QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY 263 (508)
Q Consensus 187 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~ 263 (508)
+|++.+.||+|++|.||+|... +++.|++|.+..... ...+.+.+|++++++++|||++++++++.+++..+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4788899999999999999865 578899999866543 4556789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCCC
Q 010513 264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER 343 (508)
Q Consensus 264 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 343 (508)
+++++|.+++... ..+++..+..++.|++.||.|||+. +++||||||+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~----~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 153 (254)
T cd06627 81 AENGSLRQIIKKF----GPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVS 153 (254)
T ss_pred CCCCcHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCc
Confidence 9999999998765 5789999999999999999999999 99999999999999999999999999998765433
Q ss_pred cceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCCccCC
Q 010513 344 SYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQ 423 (508)
Q Consensus 344 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 423 (508)
.. .....++..|+|||...+..++.++|+||||+++|+|++|+.||....+ ........... .+.+.
T Consensus 154 ~~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~------~~~~~~~~~~~------~~~~~ 220 (254)
T cd06627 154 KD-DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP------MAALFRIVQDD------HPPLP 220 (254)
T ss_pred cc-ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH------HHHHHHHhccC------CCCCC
Confidence 22 2335688999999999888889999999999999999999999964331 11111111110 01111
Q ss_pred CCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 424 EKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 424 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
. ..+. .+.+++.+||+.+|++||++.+++++
T Consensus 221 ~-~~~~---~~~~~i~~~l~~~p~~R~~~~~~l~~ 251 (254)
T cd06627 221 E-GISP---ELKDFLMQCFQKDPNLRPTAKQLLKH 251 (254)
T ss_pred C-CCCH---HHHHHHHHHHhCChhhCcCHHHHhcC
Confidence 1 1223 34457789999999999999999853
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=299.56 Aligned_cols=260 Identities=23% Similarity=0.317 Sum_probs=199.6
Q ss_pred CcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCc--hhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEEec
Q 010513 188 FADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG--QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYI 264 (508)
Q Consensus 188 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~ 264 (508)
|++.+.||+|++|.||+|... +++.+++|.+..... .....+..|+++++.++|+||+++++++.++...++||||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 567789999999999999965 688899998865432 24567788999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCCCc
Q 010513 265 DNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS 344 (508)
Q Consensus 265 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~ 344 (508)
++ +|.+++... ...+++..++.++.|+++||.|||++ +++|+||||+||+++.++.++|+|||.+.......
T Consensus 81 ~~-~l~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~- 152 (283)
T cd05118 81 DT-DLYKLIKDR---QRGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPV- 152 (283)
T ss_pred CC-CHHHHHHhh---cccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-
Confidence 76 898888764 25789999999999999999999999 99999999999999999999999999998765443
Q ss_pred ceecceecCCCCCChhhhhcC-CCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhccc---ccccCCC-
Q 010513 345 YVTTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNR---NAEGVLD- 419 (508)
Q Consensus 345 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~- 419 (508)
.......++..|+|||.+.+. .++.++|+||||+++|+|+||+.||........ ........... ......+
T Consensus 153 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 229 (283)
T cd05118 153 RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQ---LFKIFRTLGTPDPEVWPKFTSL 229 (283)
T ss_pred ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHcCCCchHhcccchhh
Confidence 122234678899999998776 789999999999999999999999965432111 10010000000 0000000
Q ss_pred --------ccCC----CCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 420 --------PRLQ----EKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 420 --------~~l~----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
+... ....+....++.+++.+||++||.+||++.+++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 230 ARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred hhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 0000 00112234567779999999999999999999864
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=295.18 Aligned_cols=244 Identities=22% Similarity=0.279 Sum_probs=187.5
Q ss_pred CCCCcccceE--cccCcEEEEEEEEC-CCcEEEEEEeecCCchhHHHHHHHHHHHHcc-CCCCeeeEeeeeecCCeeEEE
Q 010513 185 TNGFADENVI--GEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLV 260 (508)
Q Consensus 185 ~~~~~~~~~L--G~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lV 260 (508)
.+.|++.+.+ |+|+||.||++..+ ++..+|+|.+........ |+.....+ +||||+++++++...+..++|
T Consensus 13 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv 87 (267)
T PHA03390 13 LKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLKGHVLI 87 (267)
T ss_pred HHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCCeeEEE
Confidence 3466666666 99999999999965 577889998754322211 22222222 799999999999999999999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCC-CeEEeeeccceec
Q 010513 261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQW-NPKLSDFGLAKLL 339 (508)
Q Consensus 261 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~-~~kL~DFG~a~~~ 339 (508)
|||+++|+|.+++... ..+++..+..++.|+++||.|||+. +++||||||+||+++.++ .++|+|||++...
T Consensus 88 ~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~ 160 (267)
T PHA03390 88 MDYIKDGDLFDLLKKE----GKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKII 160 (267)
T ss_pred EEcCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecCccceec
Confidence 9999999999999765 3789999999999999999999999 999999999999999988 9999999998865
Q ss_pred CCCCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCC
Q 010513 340 GAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLD 419 (508)
Q Consensus 340 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 419 (508)
.... ...|+..|+|||++.+..++.++|+||||+++|||++|+.||..... .......+.... .. . .
T Consensus 161 ~~~~-----~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~-~~~~~~~~~~~~-~~----~--~ 227 (267)
T PHA03390 161 GTPS-----CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDED-EELDLESLLKRQ-QK----K--L 227 (267)
T ss_pred CCCc-----cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCc-chhhHHHHHHhh-cc----c--C
Confidence 4322 23688999999999998999999999999999999999999974432 222222222221 10 0 0
Q ss_pred ccCCCCchHHHHHHHHHHHHHccCCCCCCCCC-HHHHHHH
Q 010513 420 PRLQEKPCSRALKRALLVALRCVDPNAHKRPK-MGHVIHM 458 (508)
Q Consensus 420 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~~ 458 (508)
+. .......+.+++.+||+.||++||+ +++++++
T Consensus 228 ~~-----~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h 262 (267)
T PHA03390 228 PF-----IKNVSKNANDFVQSMLKYNINYRLTNYNEIIKH 262 (267)
T ss_pred Cc-----ccccCHHHHHHHHHHhccChhhCCchHHHHhcC
Confidence 00 1122234455777999999999996 6888853
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=298.35 Aligned_cols=252 Identities=23% Similarity=0.309 Sum_probs=196.0
Q ss_pred CCcccceEcccCcEEEEEEEE----CCCcEEEEEEeecCC----chhHHHHHHHHHHHHcc-CCCCeeeEeeeeecCCee
Q 010513 187 GFADENVIGEGGYGIVYHGVL----EDNTNVAVKNLLNNR----GQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEGAHR 257 (508)
Q Consensus 187 ~~~~~~~LG~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~ 257 (508)
+|++.+.||+|+||.||+|.. .+|..||+|.+.... ....+.+..|++++..+ +|+||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 477889999999999999986 367889999986532 22345678899999999 599999999999999999
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccce
Q 010513 258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK 337 (508)
Q Consensus 258 ~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~ 337 (508)
++||||+++++|.+++... ..+++..+..++.|+++||.|||+. +++||||||+|||++.++.+||+|||++.
T Consensus 81 ~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~ 153 (290)
T cd05613 81 HLILDYINGGELFTHLSQR----ERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSK 153 (290)
T ss_pred EEEEecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCccce
Confidence 9999999999999999764 4688999999999999999999998 99999999999999999999999999998
Q ss_pred ecCCCCcceecceecCCCCCChhhhhcC--CCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccc
Q 010513 338 LLGAERSYVTTRVMGTFGYVAPEYASTG--MLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAE 415 (508)
Q Consensus 338 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (508)
..............|+..|+|||.+.+. .++.++||||||+++|+|++|..||....... ...+.........
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~--~~~~~~~~~~~~~--- 228 (290)
T cd05613 154 EFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKN--SQAEISRRILKSE--- 228 (290)
T ss_pred ecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccc--cHHHHHHHhhccC---
Confidence 7644333333345689999999988653 47789999999999999999999997433221 1122222111110
Q ss_pred cCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 010513 416 GVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRP-----KMGHVIHM 458 (508)
Q Consensus 416 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 458 (508)
+... ...+. .+.+++.+||+.||++|| ++.+++.+
T Consensus 229 ----~~~~-~~~~~---~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 229 ----PPYP-QEMSA---LAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred ----CCCC-ccCCH---HHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 1111 11223 344577799999999997 66666543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=294.24 Aligned_cols=250 Identities=23% Similarity=0.344 Sum_probs=195.0
Q ss_pred CCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecC-----CchhHHHHHHHHHHHHccCCCCeeeEeeeeecC--Cee
Q 010513 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN-----RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEG--AHR 257 (508)
Q Consensus 186 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--~~~ 257 (508)
++|++.+.||+|+||.||+|... ++..||+|.+... .......+.+|+++++.++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 47889999999999999999965 5889999987432 223446788999999999999999999998764 457
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccce
Q 010513 258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK 337 (508)
Q Consensus 258 ~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~ 337 (508)
+++|||+++++|.+++... ..+++.....++.|++.||.|||++ +++|+||||+||+++.++.++|+|||+++
T Consensus 82 ~~v~e~~~~~~L~~~~~~~----~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~ 154 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAY----GALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK 154 (264)
T ss_pred EEEEEeCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcccccc
Confidence 8999999999999998754 4588999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCC--cceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccc
Q 010513 338 LLGAER--SYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAE 415 (508)
Q Consensus 338 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (508)
...... ........|+..|+|||.+.+..++.++|+|||||++|+|++|+.||...... ....+.....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~--- 225 (264)
T cd06653 155 RIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM------AAIFKIATQP--- 225 (264)
T ss_pred ccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH------HHHHHHHcCC---
Confidence 653211 11122356889999999998888999999999999999999999999643211 1111111100
Q ss_pred cCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 416 GVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 416 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
..+.+. +... ..+.+++.+||+ +|.+||++.+++.+
T Consensus 226 --~~~~~p-~~~~---~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 226 --TKPMLP-DGVS---DACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred --CCCCCC-cccC---HHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 111111 1122 334447779998 57999999988864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=297.58 Aligned_cols=256 Identities=25% Similarity=0.309 Sum_probs=200.2
Q ss_pred CCcccceEcccCcEEEEEEEEC----CCcEEEEEEeecCC----chhHHHHHHHHHHHHcc-CCCCeeeEeeeeecCCee
Q 010513 187 GFADENVIGEGGYGIVYHGVLE----DNTNVAVKNLLNNR----GQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEGAHR 257 (508)
Q Consensus 187 ~~~~~~~LG~G~~g~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~ 257 (508)
+|++.+.||+|+||.||++... ++..||+|.+.+.. ....+.+..|++++.++ +||||+++++.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4778899999999999999842 46789999886432 22345678899999999 599999999999999999
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccce
Q 010513 258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK 337 (508)
Q Consensus 258 ~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~ 337 (508)
++||||+.+|+|.+++... ..+++..+..++.|+++||.|||+. +++||||||+||+++.++.++|+|||+++
T Consensus 81 ~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~ 153 (288)
T cd05583 81 HLILDYVNGGELFTHLYQR----EHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSK 153 (288)
T ss_pred EEEEecCCCCcHHHHHhhc----CCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECcccc
Confidence 9999999999999998654 4688999999999999999999998 99999999999999999999999999988
Q ss_pred ecCCCCcceecceecCCCCCChhhhhcCC--CCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccc
Q 010513 338 LLGAERSYVTTRVMGTFGYVAPEYASTGM--LNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAE 415 (508)
Q Consensus 338 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (508)
..............|+..|+|||.+.+.. ++.++|+||||+++|||++|..||....... ...+..+.....
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--~~~~~~~~~~~~---- 227 (288)
T cd05583 154 EFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN--SQSEISRRILKS---- 227 (288)
T ss_pred ccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc--hHHHHHHHHHcc----
Confidence 75443333333456899999999987655 7889999999999999999999996432211 111212222111
Q ss_pred cCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010513 416 GVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (508)
Q Consensus 416 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~~ 462 (508)
.+.... ..+. .+.+++.+||+.||++||++.++.+.|+..
T Consensus 228 ---~~~~~~-~~~~---~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 228 ---KPPFPK-TMSA---EARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred ---CCCCCc-ccCH---HHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 011111 1222 344577899999999999998888877653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=308.71 Aligned_cols=261 Identities=23% Similarity=0.342 Sum_probs=200.4
Q ss_pred CCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCC--chhHHHHHHHHHHHHccCCCCeeeEeeeeecCC-----eeE
Q 010513 187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGA-----HRM 258 (508)
Q Consensus 187 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-----~~~ 258 (508)
+|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+++++.++||||+++++++.... ..|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 5788999999999999999975 48899999886543 344567888999999999999999999998775 789
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeecccee
Q 010513 259 LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL 338 (508)
Q Consensus 259 lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~ 338 (508)
+||||+.+ +|.+++... ..+++..++.++.|++.||+|||++ +++||||||+|||++.++.++|+|||++..
T Consensus 81 lv~e~~~~-~l~~~l~~~----~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~ 152 (330)
T cd07834 81 IVTELMET-DLHKVIKSP----QPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARG 152 (330)
T ss_pred EEecchhh-hHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEe
Confidence 99999985 899998764 4799999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCc--ceecceecCCCCCChhhhhcC-CCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhc-----
Q 010513 339 LGAERS--YVTTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVT----- 410 (508)
Q Consensus 339 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~----- 410 (508)
...... .......+++.|+|||.+.+. .++.++|+||||+++|+|++|+.||........ ...+.....
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~---~~~i~~~~~~~~~~ 229 (330)
T cd07834 153 VDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQ---LNLIVEVLGTPSEE 229 (330)
T ss_pred ecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHH---HHHHHHhcCCCChh
Confidence 654321 123345689999999999887 789999999999999999999999975542110 000000000
Q ss_pred ------ccccccCCC---ccCCC---CchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 411 ------NRNAEGVLD---PRLQE---KPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 411 ------~~~~~~~~~---~~l~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
.......+. ..... ...+.....+.+++.+||+.||++||++.+++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 289 (330)
T cd07834 230 DLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289 (330)
T ss_pred HhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 000000000 00000 0001123455668889999999999999999985
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=303.70 Aligned_cols=264 Identities=22% Similarity=0.303 Sum_probs=195.4
Q ss_pred CCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCc--hhHHHHHHHHHHHHccCCCCeeeEeeeeecCC------
Q 010513 185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG--QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGA------ 255 (508)
Q Consensus 185 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~------ 255 (508)
.++|++.+.||+|+||.||+|... +++.+|+|++..... .....+.+|+++++.++||||+++++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 468999999999999999999975 578899998864432 22345678999999999999999999875433
Q ss_pred --eeEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeee
Q 010513 256 --HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDF 333 (508)
Q Consensus 256 --~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DF 333 (508)
..++||||+.+ +|.+.+... ...+++..++.++.|+++||+|||++ +++||||||+||++++++.++|+||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~---~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~df 159 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENP---SVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADF 159 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcC
Confidence 46899999976 788777654 35799999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCcc----------eecceecCCCCCChhhhhc-CCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHH
Q 010513 334 GLAKLLGAERSY----------VTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLV 402 (508)
Q Consensus 334 G~a~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~ 402 (508)
|++......... ..+...|++.|+|||.+.+ ..++.++|||||||++|||++|+.||.........
T Consensus 160 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~--- 236 (311)
T cd07866 160 GLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQL--- 236 (311)
T ss_pred ccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHH---
Confidence 999865432211 1123467889999998765 45889999999999999999999999754332111
Q ss_pred HHHHHhhcc---------ccccc----CCCccCCCCc---hHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 403 EWLKTMVTN---------RNAEG----VLDPRLQEKP---CSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 403 ~~~~~~~~~---------~~~~~----~~~~~l~~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
+.+...... ..... .......... .......+.+++.+||+.||++||++.+++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 237 HLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred HHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence 111110000 00000 0000111100 01122456778889999999999999998854
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=292.70 Aligned_cols=245 Identities=24% Similarity=0.353 Sum_probs=195.1
Q ss_pred EcccCcEEEEEEEEC-CCcEEEEEEeecCCc---hhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEEecCCCCH
Q 010513 194 IGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG---QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNL 269 (508)
Q Consensus 194 LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~g~L 269 (508)
||+|+||.||++++. +++.+++|.+..... ...+.+.+|+++++.++||||+++++.+..+...|++|||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999987 488999998865433 3456788899999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCCCc-----
Q 010513 270 EQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS----- 344 (508)
Q Consensus 270 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~----- 344 (508)
.+++.+. ..+++..++.++.|+++||+|||+. +++||||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~l~~~----~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 153 (265)
T cd05579 81 ASLLENV----GSLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLND 153 (265)
T ss_pred HHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccc
Confidence 9999764 3789999999999999999999998 999999999999999999999999999875432211
Q ss_pred --ceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCCccC
Q 010513 345 --YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRL 422 (508)
Q Consensus 345 --~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 422 (508)
.......++..|+|||......++.++|+||||+++|+|++|..||....+ .+....... ... ..
T Consensus 154 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~------~~~~~~~~~-~~~----~~-- 220 (265)
T cd05579 154 DEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETP------EEIFQNILN-GKI----EW-- 220 (265)
T ss_pred ccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHhc-CCc----CC--
Confidence 122335688899999999888899999999999999999999999974432 121222111 100 00
Q ss_pred CCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 010513 423 QEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 460 (508)
Q Consensus 423 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le 460 (508)
. ..+ .....+.+++.+||+.+|++||++..+.+.|+
T Consensus 221 ~-~~~-~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 221 P-EDV-EVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred C-ccc-cCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 0 001 01344556888999999999999966666554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=299.67 Aligned_cols=262 Identities=18% Similarity=0.202 Sum_probs=192.4
Q ss_pred cccceEcccCcEEEEEEEECCCcEEEEEEeecC--CchhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEEecCC
Q 010513 189 ADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDN 266 (508)
Q Consensus 189 ~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~ 266 (508)
.+.+.+|.|+++.||++.. +++.||+|++... .....+.+..|+++++.++|+||+++++++.+.+..+++|||+++
T Consensus 5 ~i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~ 83 (314)
T cd08216 5 LIGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAY 83 (314)
T ss_pred hhhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCC
Confidence 3445555556655555554 5889999998654 344557899999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCCCc--
Q 010513 267 GNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS-- 344 (508)
Q Consensus 267 g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~-- 344 (508)
|+|.+++.... ...+++...+.++.|+++||+|||++ +|+||||||+||+++.++.+||+|||.+........
T Consensus 84 ~~l~~~l~~~~--~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~ 158 (314)
T cd08216 84 GSCEDLLKTHF--PEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQ 158 (314)
T ss_pred CCHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeeccccccc
Confidence 99999997642 24588999999999999999999999 999999999999999999999999998875532211
Q ss_pred ----ceecceecCCCCCChhhhhc--CCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhc--------
Q 010513 345 ----YVTTRVMGTFGYVAPEYAST--GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVT-------- 410 (508)
Q Consensus 345 ----~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~-------- 410 (508)
.......++..|+|||++.. ..++.++|+|||||++|||++|+.||....... ...+.......
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~ 236 (314)
T cd08216 159 RVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKVRGTVPCLLDKSTY 236 (314)
T ss_pred cccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhccCccccccCch
Confidence 11223457788999999866 358899999999999999999999997543211 11111100000
Q ss_pred ---cccccc----CCCccC----CCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 411 ---NRNAEG----VLDPRL----QEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 411 ---~~~~~~----~~~~~l----~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
...... ..++.. ..........++.+++.+||+.||++||++.+++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 237 PLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred hhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 000000 000000 001111223456778999999999999999999875
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=301.32 Aligned_cols=260 Identities=22% Similarity=0.279 Sum_probs=191.0
Q ss_pred ceEccc--CcEEEEEEEEC-CCcEEEEEEeecCC--chhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEEecCC
Q 010513 192 NVIGEG--GYGIVYHGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDN 266 (508)
Q Consensus 192 ~~LG~G--~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~ 266 (508)
..||+| +||+||++.+. +++.||+|.+.... ....+.+.+|+.+++.++||||++++++|..+...++||||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 456666 99999999975 68999999886432 23346788899999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCCCcce
Q 010513 267 GNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYV 346 (508)
Q Consensus 267 g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~ 346 (508)
|+|.+++.... ...+++..++.++.|++.||+|||++ +++||||||+|||++.++.++++||+.+..........
T Consensus 84 ~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~ 158 (328)
T cd08226 84 GSANSLLKTYF--PEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA 158 (328)
T ss_pred CCHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc
Confidence 99999987653 23588999999999999999999998 99999999999999999999999998654321111100
Q ss_pred ------ecceecCCCCCChhhhhcC--CCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHH-----------
Q 010513 347 ------TTRVMGTFGYVAPEYASTG--MLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKT----------- 407 (508)
Q Consensus 347 ------~~~~~gt~~y~aPE~~~~~--~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~----------- 407 (508)
.....++..|+|||++.+. .++.++|||||||++|||++|+.||....... .....+..
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 236 (328)
T cd08226 159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQ--MLLQKLKGPPYSPLDITTF 236 (328)
T ss_pred cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHH--HHHHHhcCCCCCCcccccc
Confidence 0112346679999998764 47899999999999999999999997543210 00000000
Q ss_pred -----hh----------------cccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 408 -----MV----------------TNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 408 -----~~----------------~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
.. .........+..+...........+.+++.+||+.||++|||+.+++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~ 308 (328)
T cd08226 237 PCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH 308 (328)
T ss_pred chhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 00 0000000111111111122234567779999999999999999999865
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=329.56 Aligned_cols=251 Identities=24% Similarity=0.374 Sum_probs=185.8
Q ss_pred CCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecC-CchhHHHHHHHHHHHHccCCCCeeeEeeeee-----------
Q 010513 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCA----------- 252 (508)
Q Consensus 186 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~----------- 252 (508)
++|+.++.||+||||.||+++.+ ||+.||||+|.-. .......+.+|+.++++|+|||||+++..+.
T Consensus 479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei 558 (1351)
T KOG1035|consen 479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEI 558 (1351)
T ss_pred hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccc
Confidence 47888999999999999999976 8999999999544 3334456888999999999999999885210
Q ss_pred ------------------------------------------------------cC------------------------
Q 010513 253 ------------------------------------------------------EG------------------------ 254 (508)
Q Consensus 253 ------------------------------------------------------~~------------------------ 254 (508)
++
T Consensus 559 ~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~ 638 (1351)
T KOG1035|consen 559 VASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEG 638 (1351)
T ss_pred cccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCC
Confidence 00
Q ss_pred ------------------------------CeeEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 010513 255 ------------------------------AHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 304 (508)
Q Consensus 255 ------------------------------~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~ 304 (508)
..+||-||||+...|.++++++. ..-....++.++++|++||.|+|+
T Consensus 639 ~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~---~~~~~d~~wrLFreIlEGLaYIH~ 715 (1351)
T KOG1035|consen 639 SVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNH---FNSQRDEAWRLFREILEGLAYIHD 715 (1351)
T ss_pred ccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcc---cchhhHHHHHHHHHHHHHHHHHHh
Confidence 12578999999977788877652 111577889999999999999999
Q ss_pred cCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecC-----------------CCCcceecceecCCCCCChhhhhcCC-
Q 010513 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG-----------------AERSYVTTRVMGTFGYVAPEYASTGM- 366 (508)
Q Consensus 305 ~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~-----------------~~~~~~~~~~~gt~~y~aPE~~~~~~- 366 (508)
+ |+|||||||.||++|.++.+||+|||+|.... .......+..+||.-|+|||++.+..
T Consensus 716 ~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~ 792 (1351)
T KOG1035|consen 716 Q---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSS 792 (1351)
T ss_pred C---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccc
Confidence 9 99999999999999999999999999998721 11122345678999999999997654
Q ss_pred --CCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCCccCCCCchHHHHHHHHHHHHHccCC
Q 010513 367 --LNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDP 444 (508)
Q Consensus 367 --~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~ 444 (508)
|+.|+|+||||||++||+. ||... .+....... .+.+..... +.+ .......-..+|.++++.
T Consensus 793 ~~Yn~KiDmYSLGIVlFEM~y---PF~Ts--MERa~iL~~----LR~g~iP~~--~~f----~~~~~~~e~slI~~Ll~h 857 (1351)
T KOG1035|consen 793 NKYNSKIDMYSLGIVLFEMLY---PFGTS--MERASILTN----LRKGSIPEP--ADF----FDPEHPEEASLIRWLLSH 857 (1351)
T ss_pred ccccchhhhHHHHHHHHHHhc---cCCch--HHHHHHHHh----cccCCCCCC--ccc----ccccchHHHHHHHHHhcC
Confidence 9999999999999999986 45311 111111111 112111111 111 111122223478899999
Q ss_pred CCCCCCCHHHHHH
Q 010513 445 NAHKRPKMGHVIH 457 (508)
Q Consensus 445 dP~~RPs~~evl~ 457 (508)
||.+||||.|+|+
T Consensus 858 dP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 858 DPSKRPTATELLN 870 (1351)
T ss_pred CCccCCCHHHHhh
Confidence 9999999999884
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=291.59 Aligned_cols=244 Identities=23% Similarity=0.278 Sum_probs=187.3
Q ss_pred ceEcccCcEEEEEEEEC-CCcEEEEEEeecCCc---hhHHHHHHHHHHH-HccCCCCeeeEeeeeecCCeeEEEEEecCC
Q 010513 192 NVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG---QAEKEFKVEVEAI-GRVRHKNLVRLLGYCAEGAHRMLVYEYIDN 266 (508)
Q Consensus 192 ~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l-~~l~hpniv~l~~~~~~~~~~~lV~e~~~~ 266 (508)
+.||+|+||.||+|... +++.||+|.+.+... .....+..|..++ ...+|+|++++++++..++..|+||||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 56899999999999965 578999998865432 1222344454444 445899999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCCCcce
Q 010513 267 GNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYV 346 (508)
Q Consensus 267 g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~ 346 (508)
++|.+++... ..+++..+..++.|++.||.|||+. +++||||+|+||+++.++.++|+|||++.....
T Consensus 82 ~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----- 149 (260)
T cd05611 82 GDCASLIKTL----GGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----- 149 (260)
T ss_pred CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc-----
Confidence 9999999764 4689999999999999999999998 999999999999999999999999999875432
Q ss_pred ecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCCccCCCCc
Q 010513 347 TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKP 426 (508)
Q Consensus 347 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 426 (508)
.....|++.|+|||.+.+..++.++||||||+++|||++|..||..... .+......... .. ..+..
T Consensus 150 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~-~~--~~~~~---- 216 (260)
T cd05611 150 NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP------DAVFDNILSRR-IN--WPEEV---- 216 (260)
T ss_pred cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHHhcc-cC--CCCcc----
Confidence 2234688999999999888899999999999999999999999964322 11111111111 00 00001
Q ss_pred hHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 010513 427 CSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 460 (508)
Q Consensus 427 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le 460 (508)
.......+.+++.+||+.||++||++.++.+.|.
T Consensus 217 ~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~ 250 (260)
T cd05611 217 KEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKS 250 (260)
T ss_pred cccCCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence 1112234555888999999999998766655544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=298.15 Aligned_cols=249 Identities=25% Similarity=0.360 Sum_probs=201.2
Q ss_pred CCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecC---CchhHHHHHHHHHHHHccC-CCCeeeEeeeeecCCeeEEE
Q 010513 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN---RGQAEKEFKVEVEAIGRVR-HKNLVRLLGYCAEGAHRMLV 260 (508)
Q Consensus 186 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~lV 260 (508)
++|.+.+.||+|+||.||+|... +++.||+|.+.+. .....+.+..|++++++++ ||||+++++++.+++..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 47889999999999999999975 6889999988653 2233467888999999998 99999999999999999999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecC
Q 010513 261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG 340 (508)
Q Consensus 261 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 340 (508)
|||+++++|.+++.+. ..+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++....
T Consensus 81 ~e~~~~~~L~~~l~~~----~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~ 153 (280)
T cd05581 81 LEYAPNGELLQYIRKY----GSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLD 153 (280)
T ss_pred EcCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccC
Confidence 9999999999999765 4799999999999999999999998 99999999999999999999999999998764
Q ss_pred CCCc-------------------ceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchH
Q 010513 341 AERS-------------------YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNL 401 (508)
Q Consensus 341 ~~~~-------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~ 401 (508)
.... .......|+..|+|||......++.++|+||||++++++++|+.||..... ..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~~- 229 (280)
T cd05581 154 PNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE---YL- 229 (280)
T ss_pred CccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH---HH-
Confidence 4322 122334678899999999888899999999999999999999999974431 11
Q ss_pred HHHHHHhhcccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCH----HHHHHH
Q 010513 402 VEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKM----GHVIHM 458 (508)
Q Consensus 402 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~----~evl~~ 458 (508)
......... . .+. ......+.+++.+||+.||++||++ .+++++
T Consensus 230 --~~~~~~~~~---~----~~~----~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~ 277 (280)
T cd05581 230 --TFQKILKLE---Y----SFP----PNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH 277 (280)
T ss_pred --HHHHHHhcC---C----CCC----CccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence 111111100 0 011 1113345568889999999999999 777653
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=297.59 Aligned_cols=255 Identities=26% Similarity=0.418 Sum_probs=196.0
Q ss_pred hhcCCCCcccceEcccCcEEEEEEEECC-CcEEEEEEeecCC-chhHHHHHHHHHHHHcc-CCCCeeeEeeeeecCCeeE
Q 010513 182 EVSTNGFADENVIGEGGYGIVYHGVLED-NTNVAVKNLLNNR-GQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRM 258 (508)
Q Consensus 182 ~~~~~~~~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~ 258 (508)
.+..++|++.+.||+|+||.||+|.+++ ++.||||.+.... ......+..|++++... .||||+++++++.++...|
T Consensus 11 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~ 90 (296)
T cd06618 11 PADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVF 90 (296)
T ss_pred cCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEE
Confidence 4456789999999999999999999875 8889999986543 23345566677777666 4999999999999999999
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeeccCCCCCEEEcCCCCeEEeeeccce
Q 010513 259 LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE-GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK 337 (508)
Q Consensus 259 lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~ 337 (508)
+||||+.+ +|.+++... ...+++..+..++.|++.||+|||+ . +++||||+|+||++++++.+||+|||++.
T Consensus 91 ~v~e~~~~-~l~~l~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~~---~i~H~dl~p~nill~~~~~~kL~dfg~~~ 163 (296)
T cd06618 91 ICMELMST-CLDKLLKRI---QGPIPEDILGKMTVAIVKALHYLKEKH---GVIHRDVKPSNILLDASGNVKLCDFGISG 163 (296)
T ss_pred EEeeccCc-CHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhhC---CEecCCCcHHHEEEcCCCCEEECccccch
Confidence 99999865 788877654 2478999999999999999999997 5 89999999999999999999999999987
Q ss_pred ecCCCCcceecceecCCCCCChhhhhcCC----CCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccc
Q 010513 338 LLGAERSYVTTRVMGTFGYVAPEYASTGM----LNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRN 413 (508)
Q Consensus 338 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 413 (508)
.+...... ....++..|+|||.+.+.. ++.++|+||||+++|+|++|+.||..... ..+.+........
T Consensus 164 ~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~~~~~~~~~~~~~ 236 (296)
T cd06618 164 RLVDSKAK--TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKT-----EFEVLTKILQEEP 236 (296)
T ss_pred hccCCCcc--cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchh-----HHHHHHHHhcCCC
Confidence 65332221 2335788999999987554 78899999999999999999999964221 1122222222110
Q ss_pred cccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 414 AEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 414 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
+..... .....++.+++.+||+.||++||++.+++++
T Consensus 237 ------~~~~~~--~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 237 ------PSLPPN--EGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred ------CCCCCC--CCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 111110 0112345558889999999999999999865
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=291.92 Aligned_cols=261 Identities=24% Similarity=0.333 Sum_probs=195.2
Q ss_pred CcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCc--hhHHHHHHHHHHHHcc---CCCCeeeEeeeeecCCe-----
Q 010513 188 FADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG--QAEKEFKVEVEAIGRV---RHKNLVRLLGYCAEGAH----- 256 (508)
Q Consensus 188 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~hpniv~l~~~~~~~~~----- 256 (508)
|++.+.||+|+||.||+|.++ +++.||+|.+..... .....+..|+.+++++ .|||++++++++.....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 567899999999999999986 488999999864322 2234566677777665 59999999999987766
Q ss_pred eEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccc
Q 010513 257 RMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLA 336 (508)
Q Consensus 257 ~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a 336 (508)
.+++|||+.+ +|.+++.... ...+++..++.++.|+++||.|||+. +++|+||+|+||+++.++.+||+|||++
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~--~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~ 154 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCP--KPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLA 154 (287)
T ss_pred eEEEehhccc-CHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCcc
Confidence 8999999975 8999887642 23689999999999999999999998 9999999999999999999999999999
Q ss_pred eecCCCCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhccccc--
Q 010513 337 KLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNA-- 414 (508)
Q Consensus 337 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~-- 414 (508)
........ .....++..|+|||++.+..++.++|+|||||++|||++|+.||....... ...............
T Consensus 155 ~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~ 230 (287)
T cd07838 155 RIYSFEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEAD--QLDKIFDVIGLPSEEEW 230 (287)
T ss_pred eeccCCcc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHH--HHHHHHHHcCCCChHhc
Confidence 87643322 223457889999999999899999999999999999999999997543211 111111110000000
Q ss_pred -------ccCCCccCC---CCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 415 -------EGVLDPRLQ---EKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 415 -------~~~~~~~l~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
......... ....+.....+.+++.+||+.||++||++.+++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 231 PRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred CCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 000000000 01112233566778999999999999999999854
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=293.68 Aligned_cols=242 Identities=21% Similarity=0.295 Sum_probs=186.1
Q ss_pred eEcccCcEEEEEEEEC-CCcEEEEEEeecCCch---hHHHHHHHH---HHHHccCCCCeeeEeeeeecCCeeEEEEEecC
Q 010513 193 VIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQ---AEKEFKVEV---EAIGRVRHKNLVRLLGYCAEGAHRMLVYEYID 265 (508)
Q Consensus 193 ~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~---~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~ 265 (508)
.||+|+||.||+|... +++.||+|.+.+.... ....+..|. +.++...||||+.+++++.+.+..++||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999965 5788999988654221 112233333 34455689999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCCCcc
Q 010513 266 NGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSY 345 (508)
Q Consensus 266 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~ 345 (508)
+|+|.+++... ..+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||++.......
T Consensus 81 g~~L~~~l~~~----~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~-- 151 (278)
T cd05606 81 GGDLHYHLSQH----GVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-- 151 (278)
T ss_pred CCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccC--
Confidence 99999988654 4699999999999999999999998 99999999999999999999999999987553222
Q ss_pred eecceecCCCCCChhhhhcC-CCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCCccCCC
Q 010513 346 VTTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQE 424 (508)
Q Consensus 346 ~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 424 (508)
.....|+..|+|||.+.++ .++.++|+||+||++|||++|+.||............ .... ..++.+..
T Consensus 152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~----~~~~------~~~~~~~~ 220 (278)
T cd05606 152 -PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID----RMTL------TMAVELPD 220 (278)
T ss_pred -CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHH----HHhh------ccCCCCCC
Confidence 2234789999999998754 6899999999999999999999999765332221111 1110 01111211
Q ss_pred CchHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 010513 425 KPCSRALKRALLVALRCVDPNAHKRP-----KMGHVIHM 458 (508)
Q Consensus 425 ~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 458 (508)
. . ..++.+++.+|++.+|++|| ++.+++++
T Consensus 221 ~-~---s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 221 S-F---SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred c-C---CHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 1 2 23455577799999999999 99999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=304.78 Aligned_cols=265 Identities=25% Similarity=0.358 Sum_probs=195.6
Q ss_pred CCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecC--CchhHHHHHHHHHHHHcc-CCCCeeeEeeeeecC--CeeE
Q 010513 185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEG--AHRM 258 (508)
Q Consensus 185 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~--~~~~ 258 (508)
.++|++.+.||+|+||.||+|.+. +++.+|+|++... .......+..|+.+++++ +||||+++++++... ...+
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 85 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY 85 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence 457899999999999999999976 5788999988543 223345677899999999 999999999998643 4679
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeecccee
Q 010513 259 LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL 338 (508)
Q Consensus 259 lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~ 338 (508)
+||||+++ +|.+++... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++..
T Consensus 86 lv~e~~~~-~L~~~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~~ 156 (337)
T cd07852 86 LVFEYMET-DLHAVIRAN-----ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARS 156 (337)
T ss_pred EEeccccc-CHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence 99999975 999988653 678889999999999999999998 999999999999999999999999999986
Q ss_pred cCCCCc----ceecceecCCCCCChhhhhc-CCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHH-----------
Q 010513 339 LGAERS----YVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLV----------- 402 (508)
Q Consensus 339 ~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~----------- 402 (508)
...... .......|++.|+|||.+.+ ..++.++|+||||+++|+|++|+.||....+.......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 236 (337)
T cd07852 157 LSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAED 236 (337)
T ss_pred cccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 643322 12234578999999997754 56788999999999999999999999654322110000
Q ss_pred -HHHHHhhcccccccCCCccCC--CCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 403 -EWLKTMVTNRNAEGVLDPRLQ--EKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 403 -~~~~~~~~~~~~~~~~~~~l~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
..+.................. ....+....++.+++.+||+.||++||++.+++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 237 IESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 000000000000000000000 00011123456668889999999999999999975
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=298.02 Aligned_cols=248 Identities=27% Similarity=0.403 Sum_probs=194.9
Q ss_pred CCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecC---CchhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEE
Q 010513 185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN---RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLV 260 (508)
Q Consensus 185 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 260 (508)
.+.|...+.||+|+||.||+|+.. ++..+|+|.+... .......+..|+++++.++|+|++++++++......++|
T Consensus 14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 93 (308)
T cd06634 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 93 (308)
T ss_pred HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEE
Confidence 345778899999999999999965 5778999988532 223345677899999999999999999999999999999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecC
Q 010513 261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG 340 (508)
Q Consensus 261 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 340 (508)
|||+. |+|.+++... ...+++..+..++.|++.|+.|||+. +++||||||+||+++.++.++|+|||++....
T Consensus 94 ~e~~~-~~l~~~~~~~---~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 166 (308)
T cd06634 94 MEYCL-GSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMA 166 (308)
T ss_pred EEccC-CCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeec
Confidence 99997 5888877544 24688999999999999999999998 99999999999999999999999999988653
Q ss_pred CCCcceecceecCCCCCChhhhh---cCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccC
Q 010513 341 AERSYVTTRVMGTFGYVAPEYAS---TGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGV 417 (508)
Q Consensus 341 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 417 (508)
.. ....|++.|+|||.+. ...++.++|||||||++|+|++|+.||..... .+........ .
T Consensus 167 ~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~------~~~~~~~~~~-~---- 230 (308)
T cd06634 167 PA-----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSALYHIAQN-E---- 230 (308)
T ss_pred Cc-----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccH------HHHHHHHhhc-C----
Confidence 32 2346889999999874 35688899999999999999999999864321 1111111111 0
Q ss_pred CCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 010513 418 LDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHML 459 (508)
Q Consensus 418 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 459 (508)
.+.......+ ..+.+++.+||+.+|++||++.+++++.
T Consensus 231 -~~~~~~~~~~---~~~~~li~~cl~~~P~~Rp~~~~ll~~~ 268 (308)
T cd06634 231 -SPALQSGHWS---EYFRNFVDSCLQKIPQDRPTSEVLLKHR 268 (308)
T ss_pred -CCCcCccccc---HHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence 1111122233 3344577899999999999999999773
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=303.64 Aligned_cols=262 Identities=23% Similarity=0.327 Sum_probs=194.0
Q ss_pred CCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCchhHHHHHHHHHHHHccCCCCeeeEeeeeecC----------
Q 010513 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEG---------- 254 (508)
Q Consensus 186 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~---------- 254 (508)
.+|.+.+.||.|+||.||+|... +++.||+|++........+.+.+|+++++.++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 58999999999999999999975 5889999998766656667788899999999999999999876543
Q ss_pred ----CeeEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcC-CCCeE
Q 010513 255 ----AHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDK-QWNPK 329 (508)
Q Consensus 255 ----~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~-~~~~k 329 (508)
...++||||+++ +|.+++.. ..+++..++.++.|+++||.|||+. +++||||||+||+++. ++.+|
T Consensus 85 ~~~~~~~~lv~e~~~~-~L~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~k 155 (342)
T cd07854 85 LTELNSVYIVQEYMET-DLANVLEQ-----GPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVLK 155 (342)
T ss_pred ccccceEEEEeecccc-cHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceEE
Confidence 357899999974 99988854 3588999999999999999999998 9999999999999974 55789
Q ss_pred EeeeccceecCCCCcc--eecceecCCCCCChhhhhc-CCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHH
Q 010513 330 LSDFGLAKLLGAERSY--VTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLK 406 (508)
Q Consensus 330 L~DFG~a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~ 406 (508)
|+|||++......... ......|+..|+|||.+.. ..++.++|||||||++|+|++|+.||....+..... ..+.
T Consensus 156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~--~~~~ 233 (342)
T cd07854 156 IGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQ--LILE 233 (342)
T ss_pred ECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH--HHHH
Confidence 9999999865332111 1123467889999997654 568889999999999999999999997543211110 0000
Q ss_pred Hhhccc---------cc-ccCC-CccCCCCch----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 407 TMVTNR---------NA-EGVL-DPRLQEKPC----SRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 407 ~~~~~~---------~~-~~~~-~~~l~~~~~----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
...... .. .... .......+. +....++.+++.+||+.||++||++.+++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 234 SVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred hcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 000000 00 0000 000000000 1122456678889999999999999999843
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=296.03 Aligned_cols=244 Identities=28% Similarity=0.412 Sum_probs=192.8
Q ss_pred CcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCc---hhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEEe
Q 010513 188 FADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG---QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY 263 (508)
Q Consensus 188 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~ 263 (508)
|...+.||+|+||+||+|+.. ++..|++|++..... .....+..|+++++.++|||++++++++.+....|+||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 666788999999999999965 578899998864322 3345678899999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCCC
Q 010513 264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER 343 (508)
Q Consensus 264 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 343 (508)
+. |+|.+++... ..++++..++.++.|++.||.|||++ +++||||||+||+++.++.+||+|||++.....
T Consensus 103 ~~-~~l~~~l~~~---~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~-- 173 (313)
T cd06633 103 CL-GSASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSP-- 173 (313)
T ss_pred CC-CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCC--
Confidence 96 4888887654 35689999999999999999999999 999999999999999999999999998864321
Q ss_pred cceecceecCCCCCChhhhh---cCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCCc
Q 010513 344 SYVTTRVMGTFGYVAPEYAS---TGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDP 420 (508)
Q Consensus 344 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 420 (508)
.....|+..|+|||++. ...++.++|+|||||++|||++|..||..... ........... .+
T Consensus 174 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~------~~~~~~~~~~~------~~ 238 (313)
T cd06633 174 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSALYHIAQND------SP 238 (313)
T ss_pred ---CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHHhcC------CC
Confidence 22356889999999874 45688899999999999999999999864422 11111111111 11
Q ss_pred cCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 421 RLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 421 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
.......+.. +.+++.+||+.+|++||++.+++++
T Consensus 239 ~~~~~~~~~~---l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 239 TLQSNEWTDS---FRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred CCCccccCHH---HHHHHHHHccCChhhCcCHHHHhcC
Confidence 1111112233 4457779999999999999999965
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=292.11 Aligned_cols=263 Identities=22% Similarity=0.306 Sum_probs=196.4
Q ss_pred CcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCc-hhHHHHHHHHHHHHccC-CCCeeeEeeeeecCCeeEEEEEec
Q 010513 188 FADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG-QAEKEFKVEVEAIGRVR-HKNLVRLLGYCAEGAHRMLVYEYI 264 (508)
Q Consensus 188 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~lV~e~~ 264 (508)
|++.+.||+|+||+||+|... +++.|++|++..... .......+|+..+++++ |||++++++++.++...++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 567899999999999999976 477899998865432 22234456899999998 999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCCCc
Q 010513 265 DNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS 344 (508)
Q Consensus 265 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~ 344 (508)
+|+|.+++.... ...+++..++.++.|++.+|.|||++ +++|+||+|+||+++.++.++|+|||++........
T Consensus 81 -~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (283)
T cd07830 81 -EGNLYQLMKDRK--GKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP 154 (283)
T ss_pred -CCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCCC
Confidence 779999887652 24689999999999999999999998 999999999999999999999999999987643322
Q ss_pred ceecceecCCCCCChhhhh-cCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHH----------HHHHHhhcccc
Q 010513 345 YVTTRVMGTFGYVAPEYAS-TGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLV----------EWLKTMVTNRN 413 (508)
Q Consensus 345 ~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~----------~~~~~~~~~~~ 413 (508)
.....|+..|+|||++. +..++.++|+||||+++|||++|+.||............ .|.........
T Consensus 155 --~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd07830 155 --YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASK 232 (283)
T ss_pred --cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcc
Confidence 22346888999999774 455889999999999999999999999655321111000 00000000000
Q ss_pred cccCCCccCCCC---chHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 414 AEGVLDPRLQEK---PCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 414 ~~~~~~~~l~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
....+....... ..+....++.+++.+||+.||++||++.|++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 233 LGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred ccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 100111000000 011113456778999999999999999999864
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=303.60 Aligned_cols=262 Identities=21% Similarity=0.268 Sum_probs=195.0
Q ss_pred CCCc-ccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCchh--------------HHHHHHHHHHHHccCCCCeeeEee
Q 010513 186 NGFA-DENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQA--------------EKEFKVEVEAIGRVRHKNLVRLLG 249 (508)
Q Consensus 186 ~~~~-~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~hpniv~l~~ 249 (508)
++|. +.+.||+|+||+||+|.+. +++.||+|++....... ...+.+|+++++.++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 3554 4577999999999999965 68899999886442221 124678999999999999999999
Q ss_pred eeecCCeeEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeE
Q 010513 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPK 329 (508)
Q Consensus 250 ~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~k 329 (508)
++..++..++||||+. |+|.+++... ..+++.....++.|++.||+|||+. +++||||||+||+++.++.++
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~----~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~k 159 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDRK----IRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICK 159 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEE
Confidence 9999999999999997 5999998654 4689999999999999999999998 999999999999999999999
Q ss_pred EeeeccceecCCCC-------------cceecceecCCCCCChhhhhcC-CCCCCCCeeehHHHHHHHHhCCCCCCCCCC
Q 010513 330 LSDFGLAKLLGAER-------------SYVTTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRNPVDYSRP 395 (508)
Q Consensus 330 L~DFG~a~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~Pf~~~~~ 395 (508)
|+|||++....... ........+++.|+|||.+.+. .++.++|+|||||++|||++|+.||...++
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~ 239 (335)
T PTZ00024 160 IADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENE 239 (335)
T ss_pred ECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 99999998664111 1111223568899999988764 468899999999999999999999975543
Q ss_pred CCcchHHHHHHHhhcccc---cccC--------CCccCCCCc---hHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 396 PGEVNLVEWLKTMVTNRN---AEGV--------LDPRLQEKP---CSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 396 ~~~~~~~~~~~~~~~~~~---~~~~--------~~~~l~~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
.. ....+........ .... ......... ......++.+++.+||+.||++||++.+++.+
T Consensus 240 ~~---~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~ 313 (335)
T PTZ00024 240 ID---QLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKH 313 (335)
T ss_pred HH---HHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence 21 1111111111000 0000 000000000 01123456678889999999999999999975
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=289.70 Aligned_cols=251 Identities=19% Similarity=0.308 Sum_probs=195.1
Q ss_pred CCcccceEcccCcEEEEEEEECC-CcEEEEEEeecC-----CchhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEE
Q 010513 187 GFADENVIGEGGYGIVYHGVLED-NTNVAVKNLLNN-----RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLV 260 (508)
Q Consensus 187 ~~~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 260 (508)
+|.+.+.||+|+||.||++.+.. +..+++|.+... .......+..|+.+++.++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 57889999999999999998653 344555554321 222334566799999999999999999999999999999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecC
Q 010513 261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG 340 (508)
Q Consensus 261 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 340 (508)
|||+++++|.+++.........+++..++.++.|+++||.|||+. +++|+||||+||+++. +.++|+|||++....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecC
Confidence 999999999999875433456799999999999999999999998 9999999999999975 569999999998764
Q ss_pred CCCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCCc
Q 010513 341 AERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDP 420 (508)
Q Consensus 341 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 420 (508)
... .......|++.|+|||.+.+..++.++|+||||+++|+|++|..||.... ........... ..+
T Consensus 157 ~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~------~~~~~~~~~~~------~~~ 223 (260)
T cd08222 157 GSC-DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN------FLSVVLRIVEG------PTP 223 (260)
T ss_pred CCc-ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc------HHHHHHHHHcC------CCC
Confidence 322 22233568889999999988889999999999999999999999996322 12222221111 111
Q ss_pred cCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 421 RLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 421 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
.+. .....++.+++.+||+.||++||++.+++++
T Consensus 224 ~~~----~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 224 SLP----ETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred CCc----chhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 111 1223355568889999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=284.13 Aligned_cols=254 Identities=22% Similarity=0.351 Sum_probs=200.9
Q ss_pred cceEcccCcEEEEEEE-ECCCcEEEEEEeecCCchhHHHHHHHHHHHHcc-CCCCeeeEeeeeecCCeeEEEEEecCCCC
Q 010513 191 ENVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYIDNGN 268 (508)
Q Consensus 191 ~~~LG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lV~e~~~~g~ 268 (508)
.+.||+|+|+.|--++ ..++.+||||++.+........+.+|++++.+. .|+||+.++++|+++..+|||||-|.||.
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGp 162 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGP 162 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCch
Confidence 3679999999999988 678999999999988888888999999999998 59999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCC---eEEeeeccceecCCCCcc
Q 010513 269 LEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWN---PKLSDFGLAKLLGAERSY 345 (508)
Q Consensus 269 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~---~kL~DFG~a~~~~~~~~~ 345 (508)
|.+.|+++ ..+++.++..+..+|+.||.|||.+ ||.||||||+|||..+... +|||||.+..-.......
T Consensus 163 lLshI~~~----~~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~ 235 (463)
T KOG0607|consen 163 LLSHIQKR----KHFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDC 235 (463)
T ss_pred HHHHHHHh----hhccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeeccccccccccCCCC
Confidence 99999876 5799999999999999999999999 9999999999999976554 899999887644322211
Q ss_pred ------eecceecCCCCCChhhhh-----cCCCCCCCCeeehHHHHHHHHhCCCCCCCCCC------CCcc--hHHHHHH
Q 010513 346 ------VTTRVMGTFGYVAPEYAS-----TGMLNERSDVYSFGILIMEVISGRNPVDYSRP------PGEV--NLVEWLK 406 (508)
Q Consensus 346 ------~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~------~~~~--~~~~~~~ 406 (508)
...+.+|+..|||||+.. ...|+.++|.||||++||-|++|..||.+... .++. ...+.+.
T Consensus 236 spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LF 315 (463)
T KOG0607|consen 236 SPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLF 315 (463)
T ss_pred CCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHH
Confidence 123357888999999763 34689999999999999999999999976521 1111 1112222
Q ss_pred HhhcccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 010513 407 TMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIH 457 (508)
Q Consensus 407 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 457 (508)
..+.++.. .+..........+..+++...+..|+.+|-++.++++
T Consensus 316 esIQEGkY------eFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 316 ESIQEGKY------EFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred HHHhccCC------cCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 22322221 1122223333445555777888899999999999887
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=309.59 Aligned_cols=202 Identities=28% Similarity=0.428 Sum_probs=173.0
Q ss_pred cccceEcccCcEEEEEEEE-CCCcEEEEEEeecCC-chhHHHHHHHHHHHHccCCCCeeeEeeeeecCC------eeEEE
Q 010513 189 ADENVIGEGGYGIVYHGVL-EDNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGA------HRMLV 260 (508)
Q Consensus 189 ~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~------~~~lV 260 (508)
...+.||+||||.||+|+. .+|..||||.+.+.. ....+...+|+++|++++|+|||+++++-++.. ...+|
T Consensus 16 ~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlv 95 (732)
T KOG4250|consen 16 EMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLV 95 (732)
T ss_pred eehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEE
Confidence 3456799999999999994 579999999986543 334566778999999999999999999876543 45799
Q ss_pred EEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEc--CCCC--eEEeeeccc
Q 010513 261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLD--KQWN--PKLSDFGLA 336 (508)
Q Consensus 261 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~--~~~~--~kL~DFG~a 336 (508)
||||.||+|...|.+-. ....+++.+.+.++..++.||.|||++ +|+||||||.||++- .+|+ .||+|||.|
T Consensus 96 mEyC~gGsL~~~L~~PE-N~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 96 MEYCSGGSLRKVLNSPE-NAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred EeecCCCcHHHHhcCcc-cccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 99999999999998753 356799999999999999999999999 999999999999993 3344 799999999
Q ss_pred eecCCCCcceecceecCCCCCChhhhhc-CCCCCCCCeeehHHHHHHHHhCCCCCCCCCCC
Q 010513 337 KLLGAERSYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSRPP 396 (508)
Q Consensus 337 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~ 396 (508)
+.+.+.. ..+.++||..|++||+... +.|+..+|.|||||++|+++||..||.....+
T Consensus 172 rel~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~p 230 (732)
T KOG4250|consen 172 RELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGP 230 (732)
T ss_pred ccCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCc
Confidence 9875544 5677899999999999984 88999999999999999999999999866544
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=291.40 Aligned_cols=259 Identities=24% Similarity=0.379 Sum_probs=198.7
Q ss_pred CcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCC--chhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEEec
Q 010513 188 FADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYI 264 (508)
Q Consensus 188 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~ 264 (508)
|+..+.||+|+||.||+|... +++.+|+|.+.... ....+.+..|+++++.++|+|++++++++.+....++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 566788999999999999976 48899999987653 333466778999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCCCc
Q 010513 265 DNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS 344 (508)
Q Consensus 265 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~ 344 (508)
++ +|.+++.... ..+++..++.++.|++.||.|||++ +++||||+|+||++++++.++|+|||++........
T Consensus 81 ~~-~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 153 (282)
T cd07829 81 DM-DLKKYLDKRP---GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR 153 (282)
T ss_pred Cc-CHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCcc
Confidence 85 9999997652 4689999999999999999999999 999999999999999999999999999987643322
Q ss_pred ceecceecCCCCCChhhhhcC-CCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhc-----------cc
Q 010513 345 YVTTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVT-----------NR 412 (508)
Q Consensus 345 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~-----------~~ 412 (508)
......++..|+|||.+.+. .++.++|+|||||++|||++|+.||........ ......... ..
T Consensus 154 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 229 (282)
T cd07829 154 -TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQ---LFKIFQILGTPTEESWPGVTKL 229 (282)
T ss_pred -ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH---HHHHHHHhCCCcHHHHHhhccc
Confidence 22234567889999998776 789999999999999999999999965432111 111111000 00
Q ss_pred c-cccCCCccCCC----CchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 413 N-AEGVLDPRLQE----KPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 413 ~-~~~~~~~~l~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
. ..... +.... ...+.....+.+++.+||+.||++||++.+++.+
T Consensus 230 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 230 PDYKPTF-PKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred ccccccc-cccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 0 00000 01100 0011123456778889999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=302.17 Aligned_cols=262 Identities=23% Similarity=0.350 Sum_probs=196.1
Q ss_pred hcCCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCC--chhHHHHHHHHHHHHccCCCCeeeEeeeeec-CCeeE
Q 010513 183 VSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE-GAHRM 258 (508)
Q Consensus 183 ~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~~ 258 (508)
..+++|++.+.||+|+||.||+|... ++..||+|++.... ....+.+..|+++++.++||||++++++|.. ....+
T Consensus 7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 86 (328)
T cd07856 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY 86 (328)
T ss_pred ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence 35678999999999999999999965 68899999885432 2334667789999999999999999999865 56788
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeecccee
Q 010513 259 LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL 338 (508)
Q Consensus 259 lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~ 338 (508)
++|||+. ++|.+++... .+++..+..++.|+++||.|||++ +++||||||+||+++.++.++|+|||++..
T Consensus 87 lv~e~~~-~~L~~~~~~~-----~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~~~ 157 (328)
T cd07856 87 FVTELLG-TDLHRLLTSR-----PLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLARI 157 (328)
T ss_pred EEeehhc-cCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCccccccc
Confidence 9999984 5999888643 578888899999999999999999 999999999999999999999999999875
Q ss_pred cCCCCcceecceecCCCCCChhhhhc-CCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchH---------HHHHHHh
Q 010513 339 LGAERSYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNL---------VEWLKTM 408 (508)
Q Consensus 339 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~---------~~~~~~~ 408 (508)
.... .....++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||........... .++....
T Consensus 158 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (328)
T cd07856 158 QDPQ----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTI 233 (328)
T ss_pred cCCC----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence 4321 123467889999998765 5689999999999999999999999965432111000 0000000
Q ss_pred hcccccccCCCc-cCC-CCch----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 409 VTNRNAEGVLDP-RLQ-EKPC----SRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 409 ~~~~~~~~~~~~-~l~-~~~~----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
..... ..+... ... ..+. +....++.+++.+||+.+|++||++.+++.+
T Consensus 234 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 234 CSENT-LRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred cchhh-HHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000 000000 000 0000 1122456668889999999999999999876
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=302.98 Aligned_cols=266 Identities=23% Similarity=0.285 Sum_probs=196.9
Q ss_pred hhhHhhcCCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCC--chhHHHHHHHHHHHHccCCCCeeeEeeeeecC
Q 010513 178 LRELEVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEG 254 (508)
Q Consensus 178 ~~~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~ 254 (508)
...+....++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++...
T Consensus 9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~ 88 (345)
T cd07877 9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 88 (345)
T ss_pred HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence 3445566789999999999999999999854 68889999886542 22345677899999999999999999988643
Q ss_pred ------CeeEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCe
Q 010513 255 ------AHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNP 328 (508)
Q Consensus 255 ------~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~ 328 (508)
...|++++++ +++|.+++... .+++..++.++.|+++||+|||+. +++||||||+||+++.++.+
T Consensus 89 ~~~~~~~~~~lv~~~~-~~~L~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~ 159 (345)
T cd07877 89 RSLEEFNDVYLVTHLM-GADLNNIVKCQ-----KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCEL 159 (345)
T ss_pred ccccccccEEEEehhc-ccCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCCE
Confidence 3467888887 67999888643 589999999999999999999999 99999999999999999999
Q ss_pred EEeeeccceecCCCCcceecceecCCCCCChhhhhc-CCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHH
Q 010513 329 KLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKT 407 (508)
Q Consensus 329 kL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~ 407 (508)
||+|||++...... .....|+..|+|||.+.+ ..++.++|||||||++|||++|+.||....... ........
T Consensus 160 kl~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~--~~~~~~~~ 233 (345)
T cd07877 160 KILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID--QLKLILRL 233 (345)
T ss_pred EEeccccccccccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHH
Confidence 99999998864322 233468899999998866 568899999999999999999999996443211 11110000
Q ss_pred hh----------ccccc---ccCCCccCCCCc---hHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 408 MV----------TNRNA---EGVLDPRLQEKP---CSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 408 ~~----------~~~~~---~~~~~~~l~~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
.. ..... ...++....... ......++.+++.+|++.||++||++.+++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 234 VGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred hCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 00 00000 000000000000 00112345678889999999999999998865
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=333.27 Aligned_cols=250 Identities=26% Similarity=0.352 Sum_probs=198.6
Q ss_pred CCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCC--chhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEEe
Q 010513 187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY 263 (508)
Q Consensus 187 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~ 263 (508)
++.....||.|.||.||-|... +|.-.|+|.+.-.. ....+.+.+|+.++..++|||+|+++|+-.+.+..+|.|||
T Consensus 1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEy 1315 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEY 1315 (1509)
T ss_pred eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHH
Confidence 5666788999999999999954 57778999875432 33346678899999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCCC
Q 010513 264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER 343 (508)
Q Consensus 264 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 343 (508)
|++|+|.+.+... ...++.....+..|++.|+.|||++ |||||||||.||+++.+|-+|++|||.|..+....
T Consensus 1316 C~~GsLa~ll~~g----ri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~ 1388 (1509)
T KOG4645|consen 1316 CEGGSLASLLEHG----RIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNA 1388 (1509)
T ss_pred hccCcHHHHHHhc----chhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEecCch
Confidence 9999999999764 4577777888899999999999999 99999999999999999999999999999875542
Q ss_pred cc---eecceecCCCCCChhhhhcC---CCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccC
Q 010513 344 SY---VTTRVMGTFGYVAPEYASTG---MLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGV 417 (508)
Q Consensus 344 ~~---~~~~~~gt~~y~aPE~~~~~---~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 417 (508)
.. .....+||+.|||||++.+. ....++||||||||..||+||+.||...+. -.+.+.. +..++
T Consensus 1389 ~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn-----e~aIMy~-V~~gh---- 1458 (1509)
T KOG4645|consen 1389 QTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN-----EWAIMYH-VAAGH---- 1458 (1509)
T ss_pred hcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc-----hhHHHhH-HhccC----
Confidence 11 12346899999999999754 356689999999999999999999974432 1121221 22121
Q ss_pred CCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 418 LDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 418 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
.|.+.. +...+-.+++.+||..||++|-++.|++++
T Consensus 1459 -~Pq~P~----~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1459 -KPQIPE----RLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred -CCCCch----hhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 222222 233444557779999999999998888765
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=310.60 Aligned_cols=253 Identities=27% Similarity=0.435 Sum_probs=204.3
Q ss_pred CcccceEcccCcEEEEEEEEC-CC----cEEEEEEeecC-CchhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEE
Q 010513 188 FADENVIGEGGYGIVYHGVLE-DN----TNVAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY 261 (508)
Q Consensus 188 ~~~~~~LG~G~~g~Vy~~~~~-~~----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 261 (508)
...+++||+|+||+||+|.|- .| -+||+|++... ..+...++.+|.-.|.+++|||++++++++.... ..||+
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt 776 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT 776 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence 344689999999999999853 33 35899988655 3455678999999999999999999999998765 77999
Q ss_pred EecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCC
Q 010513 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA 341 (508)
Q Consensus 262 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 341 (508)
+|++.|+|.++++.. +..+.-...+.|..|||+|+.|||++ .++||||-..|||+..-..+|+.|||+++.+..
T Consensus 777 q~mP~G~LlDyvr~h---r~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~ 850 (1177)
T KOG1025|consen 777 QLMPLGCLLDYVREH---RDNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAP 850 (1177)
T ss_pred HhcccchHHHHHHHh---hccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCc
Confidence 999999999999886 46788899999999999999999999 999999999999999999999999999998865
Q ss_pred CCcce-ecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHhhcccccccCCC
Q 010513 342 ERSYV-TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLD 419 (508)
Q Consensus 342 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 419 (508)
..... .....-.+.|||-|.+....|+.++|||||||++||++| |..||+.....+..++ +..+.
T Consensus 851 d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dl-------le~ge------ 917 (1177)
T KOG1025|consen 851 DEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDL-------LEKGE------ 917 (1177)
T ss_pred ccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHH-------Hhccc------
Confidence 44333 222334568999999999999999999999999999999 9999986543322222 22211
Q ss_pred ccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 010513 420 PRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEE 463 (508)
Q Consensus 420 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~~~ 463 (508)
++.. .+-...++..++.+||..|+..||+++++...+....
T Consensus 918 -RLsq--PpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~a 958 (1177)
T KOG1025|consen 918 -RLSQ--PPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMA 958 (1177)
T ss_pred -cCCC--CCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHh
Confidence 1111 2223344555888999999999999999988877544
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=281.12 Aligned_cols=251 Identities=23% Similarity=0.324 Sum_probs=204.5
Q ss_pred hhcCCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecC---CchhHHHHHHHHHHHHcc-CCCCeeeEeeeeecCCe
Q 010513 182 EVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN---RGQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEGAH 256 (508)
Q Consensus 182 ~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~ 256 (508)
.+..++|...++||+|+|.+|.+++++ +.+-+|+|++++. ..++.+.+..|-.+..+- +||.+|.++.+|+.+..
T Consensus 246 ~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesr 325 (593)
T KOG0695|consen 246 GLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESR 325 (593)
T ss_pred ccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccce
Confidence 456778999999999999999999965 5667899988654 345556777777777666 79999999999999999
Q ss_pred eEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccc
Q 010513 257 RMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLA 336 (508)
Q Consensus 257 ~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a 336 (508)
+++|.||++||+|.-.+++. ..++++.+..+...|+.||.|||+. |||+||||.+|+|+|.+|++||+|+|++
T Consensus 326 lffvieyv~ggdlmfhmqrq----rklpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmc 398 (593)
T KOG0695|consen 326 LFFVIEYVNGGDLMFHMQRQ----RKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMC 398 (593)
T ss_pred EEEEEEEecCcceeeehhhh----hcCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchh
Confidence 99999999999998777665 5799999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCC-CCCCcchHHHHHHHhhcccccc
Q 010513 337 KLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS-RPPGEVNLVEWLKTMVTNRNAE 415 (508)
Q Consensus 337 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~-~~~~~~~~~~~~~~~~~~~~~~ 415 (508)
+.- -.....+.++||||.|.|||++++..|+...|+|+||++++||+.|+.||+-- ....+.+..+++.+.+.++...
T Consensus 399 ke~-l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqir 477 (593)
T KOG0695|consen 399 KEG-LGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIR 477 (593)
T ss_pred hcC-CCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhccc
Confidence 853 23344566799999999999999999999999999999999999999999854 2333556777777666544221
Q ss_pred cCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCC
Q 010513 416 GVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRP 450 (508)
Q Consensus 416 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP 450 (508)
+...+ ..+.-.+++.-|++||.+|.
T Consensus 478 --iprsl--------svkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 478 --IPRSL--------SVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred --cccee--------ehhhHHHHHHhhcCCcHHhc
Confidence 01111 11222355677889999984
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=296.74 Aligned_cols=259 Identities=23% Similarity=0.359 Sum_probs=193.6
Q ss_pred cCCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCC--chhHHHHHHHHHHHHccCCCCeeeEeeeeecCC-----
Q 010513 184 STNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGA----- 255 (508)
Q Consensus 184 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~----- 255 (508)
..++|++.+.||+|+||.||+|... ++..||+|++.... ......+..|+++++.++||||+++++++..+.
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 4568999999999999999999854 68899999885432 223456788999999999999999999987553
Q ss_pred -eeEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeec
Q 010513 256 -HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFG 334 (508)
Q Consensus 256 -~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG 334 (508)
..++||||+ +++|.+++.. ..+++..++.++.|+++||+|||+. +|+||||||+||+++.++.++|+|||
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~dfg 163 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMKH-----EKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFG 163 (343)
T ss_pred ceEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecc
Confidence 458999999 6699988864 3689999999999999999999998 99999999999999999999999999
Q ss_pred cceecCCCCcceecceecCCCCCChhhhhc-CCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHH-------
Q 010513 335 LAKLLGAERSYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLK------- 406 (508)
Q Consensus 335 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~------- 406 (508)
++...... .....+++.|+|||.+.+ ..++.++|+|||||++|+|++|+.||....... ......+
T Consensus 164 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~ 237 (343)
T cd07880 164 LARQTDSE----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLD--QLMEIMKVTGTPSK 237 (343)
T ss_pred cccccccC----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHhcCCCCH
Confidence 99865322 223467899999998876 458889999999999999999999997543210 0000000
Q ss_pred ---HhhcccccccCCC--ccCCCC----chHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 010513 407 ---TMVTNRNAEGVLD--PRLQEK----PCSRALKRALLVALRCVDPNAHKRPKMGHVIH 457 (508)
Q Consensus 407 ---~~~~~~~~~~~~~--~~l~~~----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 457 (508)
............. +..... ........+.+++.+|++.||++||++.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 238 EFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred HHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0000000000000 000000 00111234567888999999999999999983
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=292.47 Aligned_cols=244 Identities=23% Similarity=0.294 Sum_probs=198.1
Q ss_pred hhcCCCCcccceEcccCcEEEEEEEECC-CcEEEEEEeecCCc---hhHHHHHHHHHHHHcc-CCCCeeeEeeeeecCCe
Q 010513 182 EVSTNGFADENVIGEGGYGIVYHGVLED-NTNVAVKNLLNNRG---QAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEGAH 256 (508)
Q Consensus 182 ~~~~~~~~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~ 256 (508)
.+...+|.++.+||+|+||.|.+|..+. ..-+|||++++... ++.+.-..|-++|+-. +-|.+++++.+|+.-+.
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR 424 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR 424 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence 4556789999999999999999999764 45589999876532 3334445577777766 57899999999999999
Q ss_pred eEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccc
Q 010513 257 RMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLA 336 (508)
Q Consensus 257 ~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a 336 (508)
+|+||||+.||+|.-.+++. +.+.+..+..++..||-||-|||++ +||+||||.+|||+|.+|++||+|||++
T Consensus 425 LyFVMEyvnGGDLMyhiQQ~----GkFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmc 497 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQQV----GKFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMC 497 (683)
T ss_pred eeeEEEEecCchhhhHHHHh----cccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeecccc
Confidence 99999999999999988775 6788888999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhccccccc
Q 010513 337 KLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEG 416 (508)
Q Consensus 337 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 416 (508)
+.- .-....+.++||||.|+|||++...+|+.++|+|||||+||||+.|+.||++.+. ..+++.+...-
T Consensus 498 KEn-i~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE---~elF~aI~ehn------- 566 (683)
T KOG0696|consen 498 KEN-IFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE---DELFQAIMEHN------- 566 (683)
T ss_pred ccc-ccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCH---HHHHHHHHHcc-------
Confidence 842 2233445678999999999999999999999999999999999999999987653 23333322211
Q ss_pred CCCccCCCCchHHHHHHHHHHHHHccCCCCCCCC
Q 010513 417 VLDPRLQEKPCSRALKRALLVALRCVDPNAHKRP 450 (508)
Q Consensus 417 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP 450 (508)
..++....++...++...+.+.|.+|.
T Consensus 567 -------vsyPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 567 -------VSYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred -------CcCcccccHHHHHHHHHHhhcCCcccc
Confidence 111223345566688888999999994
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=302.60 Aligned_cols=261 Identities=22% Similarity=0.361 Sum_probs=194.3
Q ss_pred CCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCC--chhHHHHHHHHHHHHccCCCCeeeEeeeeecC------C
Q 010513 185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEG------A 255 (508)
Q Consensus 185 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~------~ 255 (508)
.++|.+.+.||+|+||.||+|... +++.||+|++.... ......+.+|+++++.++||||+++++++... .
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 458999999999999999999965 68899999886532 22335678899999999999999999998654 3
Q ss_pred eeEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeecc
Q 010513 256 HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGL 335 (508)
Q Consensus 256 ~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~ 335 (508)
..++|+||+.. +|.+++. ..+++..+..++.|++.||+|||++ +++||||||+||+++.++.+||+|||+
T Consensus 94 ~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~ 163 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIMG------HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGL 163 (342)
T ss_pred eEEEEeccccc-CHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCC
Confidence 46899999975 7877652 3588999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCcceecceecCCCCCChhhhhc-CCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHh------
Q 010513 336 AKLLGAERSYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTM------ 408 (508)
Q Consensus 336 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~------ 408 (508)
++..... .....+++.|+|||.+.+ ..++.++|+|||||++|||++|+.||........ .......
T Consensus 164 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~---~~~~~~~~~~~~~ 236 (342)
T cd07879 164 ARHADAE----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ---LTQILKVTGVPGP 236 (342)
T ss_pred CcCCCCC----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHhcCCCCH
Confidence 8864322 223467889999998866 4688999999999999999999999975432111 1100000
Q ss_pred -----hcccccccCC--CccCCCCc----hHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--HhcC
Q 010513 409 -----VTNRNAEGVL--DPRLQEKP----CSRALKRALLVALRCVDPNAHKRPKMGHVIHM--LEAE 462 (508)
Q Consensus 409 -----~~~~~~~~~~--~~~l~~~~----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--Le~~ 462 (508)
.......... .+...... .+....++.+++.+||+.||++||++++++.+ ++..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~ 303 (342)
T cd07879 237 EFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF 303 (342)
T ss_pred HHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhc
Confidence 0000000000 00000000 01122346678889999999999999999965 5544
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=303.62 Aligned_cols=259 Identities=22% Similarity=0.320 Sum_probs=195.7
Q ss_pred cCCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCC--chhHHHHHHHHHHHHccCCCCeeeEeeeeecCCe----
Q 010513 184 STNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAH---- 256 (508)
Q Consensus 184 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~---- 256 (508)
..++|++.+.||+|+||.||+|... ++..||+|++.... ....+.+.+|+.+++.++||||+++++++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 3568999999999999999999976 57889999886432 2334567789999999999999999998876554
Q ss_pred --eEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeec
Q 010513 257 --RMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFG 334 (508)
Q Consensus 257 --~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG 334 (508)
.++|+||+ +++|.+++.. ..+++..++.++.|+++||+|||+. +++||||||+||+++.++.++|+|||
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg 163 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC-----QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFG 163 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEcccc
Confidence 89999999 5699999864 3689999999999999999999998 99999999999999999999999999
Q ss_pred cceecCCCCcceecceecCCCCCChhhhhc-CCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhc---
Q 010513 335 LAKLLGAERSYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVT--- 410 (508)
Q Consensus 335 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~--- 410 (508)
++...... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||........ ...+.....
T Consensus 164 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~---~~~i~~~~~~~~ 236 (343)
T cd07851 164 LARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQ---LKRIMNLVGTPD 236 (343)
T ss_pred cccccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHhcCCCC
Confidence 99865332 233467889999998865 3678899999999999999999999975432111 111100000
Q ss_pred --------ccccccC---CCccCCCCc---hHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 411 --------NRNAEGV---LDPRLQEKP---CSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 411 --------~~~~~~~---~~~~l~~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
....... +....+... ......++.+++.+||+.||++||++.+++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 237 EELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred HHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 0000000 000000000 01123466778889999999999999999864
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=300.93 Aligned_cols=220 Identities=23% Similarity=0.336 Sum_probs=186.1
Q ss_pred CcccchhhHhhcCCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCc---hhHHHHHHHHHHHHccCCCCeeeEe
Q 010513 173 GHWYTLRELEVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG---QAEKEFKVEVEAIGRVRHKNLVRLL 248 (508)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~ 248 (508)
.+|..++.-.....-|..++.||-|+||+|.+++.. +...||+|.+.+... .....++.|..+|+.-..+-||+||
T Consensus 616 SnYiRLkRaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLy 695 (1034)
T KOG0608|consen 616 SNYIRLKRAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLY 695 (1034)
T ss_pred hhHHHHHHhhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEE
Confidence 344555666667777999999999999999999854 455689998865422 2345678899999999999999999
Q ss_pred eeeecCCeeEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCe
Q 010513 249 GYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNP 328 (508)
Q Consensus 249 ~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~ 328 (508)
..|++.+++|+||||++||++..+|.+. +-+.+..+..++..++.|+++.|.. |+|||||||+|||||.+|++
T Consensus 696 ySFQDkdnLYFVMdYIPGGDmMSLLIrm----gIFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHI 768 (1034)
T KOG0608|consen 696 YSFQDKDNLYFVMDYIPGGDMMSLLIRM----GIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHI 768 (1034)
T ss_pred EEeccCCceEEEEeccCCccHHHHHHHh----ccCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCce
Confidence 9999999999999999999999999876 6789999999999999999999998 99999999999999999999
Q ss_pred EEeeeccceec---------CCCC-----------------c---------------ceecceecCCCCCChhhhhcCCC
Q 010513 329 KLSDFGLAKLL---------GAER-----------------S---------------YVTTRVMGTFGYVAPEYASTGML 367 (508)
Q Consensus 329 kL~DFG~a~~~---------~~~~-----------------~---------------~~~~~~~gt~~y~aPE~~~~~~~ 367 (508)
||+|||++.-+ .... . ......+||+.|+|||++....|
T Consensus 769 KLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~ 848 (1034)
T KOG0608|consen 769 KLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGY 848 (1034)
T ss_pred eeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCc
Confidence 99999998432 1000 0 00122579999999999999999
Q ss_pred CCCCCeeehHHHHHHHHhCCCCCCCCCCCCcc
Q 010513 368 NERSDVYSFGILIMEVISGRNPVDYSRPPGEV 399 (508)
Q Consensus 368 ~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~ 399 (508)
+..+|+||.||+||||+.|+.||....+.+..
T Consensus 849 ~q~cdwws~gvil~em~~g~~pf~~~tp~~tq 880 (1034)
T KOG0608|consen 849 TQLCDWWSVGVILYEMLVGQPPFLADTPGETQ 880 (1034)
T ss_pred cccchhhHhhHHHHHHhhCCCCccCCCCCcce
Confidence 99999999999999999999999988776544
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=315.76 Aligned_cols=265 Identities=28% Similarity=0.488 Sum_probs=212.5
Q ss_pred hHhhcCCCCcccceEcccCcEEEEEEEEC----C----CcEEEEEEeecCCc-hhHHHHHHHHHHHHcc-CCCCeeeEee
Q 010513 180 ELEVSTNGFADENVIGEGGYGIVYHGVLE----D----NTNVAVKNLLNNRG-QAEKEFKVEVEAIGRV-RHKNLVRLLG 249 (508)
Q Consensus 180 ~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~----~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpniv~l~~ 249 (508)
.+++..++..+.+.||+|.||.|++|... . ...||||.++.... ...+.+..|+++|+.+ +|+||+.++|
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG 369 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG 369 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence 46777777788889999999999999843 1 34689999876544 4557889999999999 6999999999
Q ss_pred eeecCCeeEEEEEecCCCCHHHHhccCC---CC-------C--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCC
Q 010513 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDV---GP-------H--SPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKS 317 (508)
Q Consensus 250 ~~~~~~~~~lV~e~~~~g~L~~~l~~~~---~~-------~--~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp 317 (508)
+|......++|+||+..|+|.++++... .. . ..++..+.+.++.|||.|++||++. +++||||-.
T Consensus 370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAa 446 (609)
T KOG0200|consen 370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAA 446 (609)
T ss_pred eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---Cccchhhhh
Confidence 9999899999999999999999998765 11 1 2389999999999999999999999 999999999
Q ss_pred CCEEEcCCCCeEEeeeccceecCCCCcceecceec--CCCCCChhhhhcCCCCCCCCeeehHHHHHHHHh-CCCCCCCCC
Q 010513 318 SNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMG--TFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSR 394 (508)
Q Consensus 318 ~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~Pf~~~~ 394 (508)
.|||++++..+||+|||+++.......+......| ...|||||.+....|+.++|||||||+||||+| |..||....
T Consensus 447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~ 526 (609)
T KOG0200|consen 447 RNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP 526 (609)
T ss_pred hhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC
Confidence 99999999999999999999765555554443333 335999999999999999999999999999999 999996422
Q ss_pred CCCcchHHHHHHHhhcccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010513 395 PPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (508)
Q Consensus 395 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~~ 462 (508)
. ...+.+++ ..+.. .-++..|..++ .++++.||+.+|++||++.++.+.++..
T Consensus 527 ~--~~~l~~~l----~~G~r------~~~P~~c~~ei---Y~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 527 P--TEELLEFL----KEGNR------MEQPEHCSDEI---YDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred c--HHHHHHHH----hcCCC------CCCCCCCCHHH---HHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 1 11222222 22211 11223344444 4589999999999999999999999883
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=284.45 Aligned_cols=260 Identities=28% Similarity=0.381 Sum_probs=198.1
Q ss_pred cCCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCc-hhHHHHHHHHHHHHcc-CCCCeeeEeeeeecCCeeEEE
Q 010513 184 STNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG-QAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLV 260 (508)
Q Consensus 184 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lV 260 (508)
..++.+.+..||.|+||+|++-.++ .|+..|||++..... ...+++..|.+...+- ++||||+|||.+..+...|+.
T Consensus 62 ~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiC 141 (361)
T KOG1006|consen 62 TSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWIC 141 (361)
T ss_pred ccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeee
Confidence 3445566778999999999999866 688899999976544 4456777787765544 799999999999988999999
Q ss_pred EEecCCCCHHHHhccC-CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceec
Q 010513 261 YEYIDNGNLEQWLHGD-VGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL 339 (508)
Q Consensus 261 ~e~~~~g~L~~~l~~~-~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~ 339 (508)
||.|+- +|..+.+.- .-....+++...-.|...++.||.||-... .|||||+||+|||+|..|.+||||||++-.+
T Consensus 142 MELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqL 218 (361)
T KOG1006|consen 142 MELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQL 218 (361)
T ss_pred HHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhH
Confidence 999976 776654321 112357899999999999999999998654 8999999999999999999999999998754
Q ss_pred CCCCcceecceecCCCCCChhhhhc--CCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccC
Q 010513 340 GAERSYVTTRVMGTFGYVAPEYAST--GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGV 417 (508)
Q Consensus 340 ~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 417 (508)
..+...+.-.|...|||||.+.. ..|+-+||+||||++|||+.||..||.... +.++.+.+.+... ...
T Consensus 219 --v~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~-----svfeql~~Vv~gd-pp~- 289 (361)
T KOG1006|consen 219 --VDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWD-----SVFEQLCQVVIGD-PPI- 289 (361)
T ss_pred --HHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHH-----HHHHHHHHHHcCC-CCe-
Confidence 23344455578899999998854 358999999999999999999999997543 2444444444322 111
Q ss_pred CCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 418 LDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 418 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
+.. ...+-.....+.+++--|+-+|-.+||+..+++++
T Consensus 290 l~~---~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 290 LLF---DKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred ecC---cccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 111 11122234455557779999999999999998864
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=317.41 Aligned_cols=146 Identities=28% Similarity=0.411 Sum_probs=131.5
Q ss_pred CCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCC---chhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEE
Q 010513 185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLV 260 (508)
Q Consensus 185 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 260 (508)
.++|.+.+.||+|+||+||+|.+. +++.||+|++.... ......+..|+.+++.++||||+++++++......|+|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 357999999999999999999976 68899999986532 22346788899999999999999999999999999999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccce
Q 010513 261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK 337 (508)
Q Consensus 261 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~ 337 (508)
|||+.+++|.+++... ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 83 mEy~~g~~L~~li~~~----~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHIY----GYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999999999764 4688999999999999999999998 99999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=296.66 Aligned_cols=244 Identities=25% Similarity=0.378 Sum_probs=200.3
Q ss_pred cceEcccCcEEEEEEEE-CCCcEEEEEEeecC--CchhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEEecCCC
Q 010513 191 ENVIGEGGYGIVYHGVL-EDNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNG 267 (508)
Q Consensus 191 ~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~g 267 (508)
.++||.|.||+||-|++ ++|+.||||.+.+- .......+++|+.+|+++.||.||.+-..|+..+..+.|||-+.|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G- 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG- 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc-
Confidence 57899999999999995 47999999999654 234457899999999999999999999999999999999999966
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCC---CCeEEeeeccceecCCCCc
Q 010513 268 NLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQ---WNPKLSDFGLAKLLGAERS 344 (508)
Q Consensus 268 ~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~---~~~kL~DFG~a~~~~~~~~ 344 (508)
++.+.+-... .+.+++.....++.||+.||.|||.+ +|+|+||||+|||+... .++||||||+|+.+++.
T Consensus 648 DMLEMILSsE--kgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk-- 720 (888)
T KOG4236|consen 648 DMLEMILSSE--KGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK-- 720 (888)
T ss_pred hHHHHHHHhh--cccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecchh--
Confidence 6666553332 57899999999999999999999999 99999999999999544 45999999999987543
Q ss_pred ceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCCccCCC
Q 010513 345 YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQE 424 (508)
Q Consensus 345 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 424 (508)
.....++|||.|+|||+++++.|+..-|+||.||++|.-++|..||....+ +.+ ++.+.. -....
T Consensus 721 sFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd-----Ind----QIQNAa------FMyPp 785 (888)
T KOG4236|consen 721 SFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDED-----IND----QIQNAA------FMYPP 785 (888)
T ss_pred hhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccc-----hhH----Hhhccc------cccCC
Confidence 334567999999999999999999999999999999999999999964322 111 222211 12344
Q ss_pred CchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 010513 425 KPCSRALKRALLVALRCVDPNAHKRPKMGHVIH 457 (508)
Q Consensus 425 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 457 (508)
.+..+.....+++|...|+..-++|-+...-+.
T Consensus 786 ~PW~eis~~AidlIn~LLqVkm~kRysvdk~ls 818 (888)
T KOG4236|consen 786 NPWSEISPEAIDLINNLLQVKMRKRYSVDKSLS 818 (888)
T ss_pred CchhhcCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence 556666777888999999999999999876554
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-35 Score=280.18 Aligned_cols=236 Identities=27% Similarity=0.322 Sum_probs=191.1
Q ss_pred EcccCcEEEEEEEEC-CCcEEEEEEeecCCc---hhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEEecCCCCH
Q 010513 194 IGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG---QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNL 269 (508)
Q Consensus 194 LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~g~L 269 (508)
||+|+||.||++... +++.+|+|.+..... .....+..|+++++.++||||+++++.+..+...++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999976 488899998865432 2456788899999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCCCcceecc
Q 010513 270 EQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTR 349 (508)
Q Consensus 270 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~ 349 (508)
.+++... ..+++.....++.|+++||.|||+. +++|+||+|+||+++.++.++|+|||++....... .....
T Consensus 81 ~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~ 152 (250)
T cd05123 81 FSHLSKE----GRFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNT 152 (250)
T ss_pred HHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccC
Confidence 9999765 3689999999999999999999998 99999999999999999999999999998764332 22334
Q ss_pred eecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCCccCCCCchHH
Q 010513 350 VMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSR 429 (508)
Q Consensus 350 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 429 (508)
..++..|+|||...+..++.++|+||||+++|+|++|+.||..... .+......... ..+... .
T Consensus 153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~------~~~~~~~~~~~-------~~~~~~-~-- 216 (250)
T cd05123 153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR------KEIYEKILKDP-------LRFPEF-L-- 216 (250)
T ss_pred CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHhcCC-------CCCCCC-C--
Confidence 5688899999999888889999999999999999999999964432 11111111100 011111 1
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHH
Q 010513 430 ALKRALLVALRCVDPNAHKRPKMGH 454 (508)
Q Consensus 430 ~~~~l~~li~~cl~~dP~~RPs~~e 454 (508)
...+.+++.+||..||++||++.+
T Consensus 217 -~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 217 -SPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred -CHHHHHHHHHHhcCCHhhCCCccc
Confidence 234555888999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=294.96 Aligned_cols=263 Identities=23% Similarity=0.292 Sum_probs=190.5
Q ss_pred CCcccceEcccCcEEEEEEEEC-C--CcEEEEEEeecC--CchhHHHHHHHHHHHHcc-CCCCeeeEeeeeec----CCe
Q 010513 187 GFADENVIGEGGYGIVYHGVLE-D--NTNVAVKNLLNN--RGQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAE----GAH 256 (508)
Q Consensus 187 ~~~~~~~LG~G~~g~Vy~~~~~-~--~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~----~~~ 256 (508)
+|++.+.||+|+||.||++... + +..||+|++... .....+.+..|+++++++ +||||+++++.+.. ...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4788899999999999999965 3 678999988643 222345677899999999 59999999987532 245
Q ss_pred eEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccc
Q 010513 257 RMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLA 336 (508)
Q Consensus 257 ~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a 336 (508)
.|+++||+. ++|.+++... ..+++..++.++.|++.||+|||++ +++||||||+|||++.++.+||+|||++
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a 152 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSG----QPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLA 152 (332)
T ss_pred EEEEEeccc-CCHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCc
Confidence 788999986 5999998654 5689999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCcc---eecceecCCCCCChhhhhc-CCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcch---------HHH
Q 010513 337 KLLGAERSY---VTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVN---------LVE 403 (508)
Q Consensus 337 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~---------~~~ 403 (508)
+........ ......||+.|+|||.+.+ ..++.++|+|||||++|+|++|+.||.......... ..+
T Consensus 153 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 232 (332)
T cd07857 153 RGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEE 232 (332)
T ss_pred eecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 865432211 1233578999999998765 468999999999999999999999997543210000 000
Q ss_pred HHHHhhccc------ccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 404 WLKTMVTNR------NAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 404 ~~~~~~~~~------~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
.+....... .....-...+. ...+.....+.+++.+|++.||++||++.+++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 233 TLSRIGSPKAQNYIRSLPNIPKKPFE-SIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred HHHhhhhhhHHHHHHhccccCCcchH-hhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000000000 00000000000 0000112345568889999999999999998754
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=279.57 Aligned_cols=267 Identities=24% Similarity=0.301 Sum_probs=207.8
Q ss_pred hhhHhhcCCCCcccceEcccCcEEEEEEEEC------CCcEEEEEEeecCCc-hhHHHHHHHHHHHHccCCCCeeeEeee
Q 010513 178 LRELEVSTNGFADENVIGEGGYGIVYHGVLE------DNTNVAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNLVRLLGY 250 (508)
Q Consensus 178 ~~~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~ 250 (508)
+.++.+..++++....+-+|.||.||.|.|. +.+.|.+|.+++... -....+..|--++..+.|||+..+.++
T Consensus 276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V 355 (563)
T KOG1024|consen 276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV 355 (563)
T ss_pred HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence 5677788889999999999999999999654 334567787766543 344667889999999999999999998
Q ss_pred eec-CCeeEEEEEecCCCCHHHHhccCC----CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCC
Q 010513 251 CAE-GAHRMLVYEYIDNGNLEQWLHGDV----GPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQ 325 (508)
Q Consensus 251 ~~~-~~~~~lV~e~~~~g~L~~~l~~~~----~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~ 325 (508)
+.+ ....+.++.++.-|+|..+|...+ .....++..+...++.|++.|++|||+. ++||.||...|.+||+.
T Consensus 356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd~ 432 (563)
T KOG1024|consen 356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDDQ 432 (563)
T ss_pred EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcceehhh
Confidence 765 456678899999999999997322 1234567777888999999999999999 99999999999999999
Q ss_pred CCeEEeeeccceecCCCCcceecc-eecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHh-CCCCCCCCCCCCcchHHH
Q 010513 326 WNPKLSDFGLAKLLGAERSYVTTR-VMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVE 403 (508)
Q Consensus 326 ~~~kL~DFG~a~~~~~~~~~~~~~-~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~ 403 (508)
.++||+|=.+++.+...+...... -.....||+||.+.+..|+.++|+||||++||||+| |+.||..-+| ++
T Consensus 433 LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDP------fE 506 (563)
T KOG1024|consen 433 LQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDP------FE 506 (563)
T ss_pred eeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCH------HH
Confidence 999999999998765444333222 233558999999999999999999999999999999 9999974443 33
Q ss_pred HHHHhhcccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 010513 404 WLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEE 463 (508)
Q Consensus 404 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~~~ 463 (508)
.........+. -++..|++++ +.++.-||..+|++||+.+|++.-|.+..
T Consensus 507 m~~ylkdGyRl-------aQP~NCPDeL---f~vMacCWallpeeRPsf~Qlv~cLseF~ 556 (563)
T KOG1024|consen 507 MEHYLKDGYRL-------AQPFNCPDEL---FTVMACCWALLPEERPSFSQLVICLSEFH 556 (563)
T ss_pred HHHHHhcccee-------cCCCCCcHHH---HHHHHHHHhcCcccCCCHHHHHHHHHHHH
Confidence 21111111111 1222355554 44888999999999999999999887644
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=304.49 Aligned_cols=261 Identities=27% Similarity=0.387 Sum_probs=212.8
Q ss_pred chhhHhhcCCCCcccceEcccCcEEEEEEEE-CCCcEEEEEEeecCCchhHHHHHHHHHHHHcc-CCCCeeeEeeeee--
Q 010513 177 TLRELEVSTNGFADENVIGEGGYGIVYHGVL-EDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV-RHKNLVRLLGYCA-- 252 (508)
Q Consensus 177 ~~~~~~~~~~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~-- 252 (508)
.+..+..+++.|++++.||.|.+|.||+++. ++++..|+|+.... .+..+++..|.++++.+ .|||++.++|+|.
T Consensus 10 ~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~-~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~ 88 (953)
T KOG0587|consen 10 DLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPT-EDEEEEIELEYNMLKKYSHHPNVATFYGAFIKK 88 (953)
T ss_pred chhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCC-ccccHHHHHHHHHHHhccCCCCcceEEEEEEEe
Confidence 4555566788899999999999999999995 46777888876443 34456778899999888 6999999999985
Q ss_pred ---cCCeeEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeE
Q 010513 253 ---EGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPK 329 (508)
Q Consensus 253 ---~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~k 329 (508)
.++++|||||||.+|+..|+++... ...+.|..+..|++.++.|+.+||.+ .++|||||-.|||++.++.+|
T Consensus 89 ~~~~~DqLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VK 163 (953)
T KOG0587|consen 89 DPGNGDQLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVK 163 (953)
T ss_pred cCCCCCeEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEE
Confidence 3568999999999999999998765 57899999999999999999999999 999999999999999999999
Q ss_pred EeeeccceecCCCCcceecceecCCCCCChhhhhcC-----CCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHH
Q 010513 330 LSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTG-----MLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEW 404 (508)
Q Consensus 330 L~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~ 404 (508)
|+|||++..+.... ....+..|||+|||||++.-. .|+..+|+||||++..||.-|.+|+.+..+. ..
T Consensus 164 LvDFGvSaQldsT~-grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPm------ra 236 (953)
T KOG0587|consen 164 LVDFGVSAQLDSTV-GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPM------RA 236 (953)
T ss_pred Eeeeeeeeeeeccc-ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchh------hh
Confidence 99999998764433 234457899999999998543 4777899999999999999999999765432 11
Q ss_pred HHHhhcccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 405 LKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 405 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
+.... ..-.|.+.. .....+++.++|..||.+|.++||++.+++++
T Consensus 237 LF~Ip------RNPPPkLkr--p~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 237 LFLIP------RNPPPKLKR--PKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred hccCC------CCCCccccc--hhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 11111 112233322 55678888999999999999999999998865
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=256.11 Aligned_cols=262 Identities=23% Similarity=0.329 Sum_probs=198.4
Q ss_pred CCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCC--chhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEEe
Q 010513 187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY 263 (508)
Q Consensus 187 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~ 263 (508)
.|.-.++||+|.||+||+|+.. ++.-||+|++.-.. ........+|+.+++.++|.|||+++++...++.+-+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 4566788999999999999954 57789999885432 22345677899999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCCC
Q 010513 264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER 343 (508)
Q Consensus 264 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 343 (508)
|+. +|..+...- .+.++...+..++.|+++||.|+|++ ++.|||+||.|.||+.+|++||+|||+++.++...
T Consensus 83 cdq-dlkkyfdsl---ng~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgipv 155 (292)
T KOG0662|consen 83 CDQ-DLKKYFDSL---NGDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV 155 (292)
T ss_pred hhH-HHHHHHHhc---CCcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCce
Confidence 976 999988765 57799999999999999999999999 99999999999999999999999999999886654
Q ss_pred cceecceecCCCCCChhhhhcC-CCCCCCCeeehHHHHHHHHh-CCCCCCCCCCCCcchHHHHHH--HhhcccccccC--
Q 010513 344 SYVTTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLK--TMVTNRNAEGV-- 417 (508)
Q Consensus 344 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~-- 417 (508)
.... .-+-|.+|.+|.++.+. -|+...|+||-||++.|+.. |++-|.+.+-. .++...++ .+..+.....+
T Consensus 156 rcys-aevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvd--dqlkrif~~lg~p~ed~wps~t~ 232 (292)
T KOG0662|consen 156 RCYS-AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD--DQLKRIFRLLGTPTEDQWPSMTK 232 (292)
T ss_pred Eeee-ceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHH--HHHHHHHHHhCCCccccCCcccc
Confidence 4333 34569999999988765 58999999999999999987 77667644322 12222222 22222222111
Q ss_pred -CC----ccCCCC-----chHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 418 -LD----PRLQEK-----PCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 418 -~~----~~l~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
.| |..... ..++....-.++..+.+.-+|..|.++++.+++
T Consensus 233 lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 233 LPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred CCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 11 111110 011222233456678888899999999998865
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=276.03 Aligned_cols=204 Identities=23% Similarity=0.354 Sum_probs=170.3
Q ss_pred CCCcccceEcccCcEEEEEEEEC-C----CcEEEEEEeecCCc--hhHHHHHHHHHHHHccCCCCeeeEeeeeec-CCee
Q 010513 186 NGFADENVIGEGGYGIVYHGVLE-D----NTNVAVKNLLNNRG--QAEKEFKVEVEAIGRVRHKNLVRLLGYCAE-GAHR 257 (508)
Q Consensus 186 ~~~~~~~~LG~G~~g~Vy~~~~~-~----~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~ 257 (508)
..|+....||+|.||.||+|..+ + ++.+|+|+++.... .......+|+.+++.++|||++.+..+|.. +..+
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 47889999999999999999633 2 33689999865422 223456679999999999999999999977 7889
Q ss_pred EEEEEecCCCCHHHHhccCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCC----CCeEEee
Q 010513 258 MLVYEYIDNGNLEQWLHGDVG-PHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQ----WNPKLSD 332 (508)
Q Consensus 258 ~lV~e~~~~g~L~~~l~~~~~-~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~----~~~kL~D 332 (508)
+|++||.+. ||..+++-... ....++...++.|+.||+.|+.|||++ =|+||||||.|||+..+ |.+||+|
T Consensus 104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEeec
Confidence 999999998 99999864332 235689999999999999999999999 69999999999999877 8999999
Q ss_pred eccceecCCCCcc--eecceecCCCCCChhhhhc-CCCCCCCCeeehHHHHHHHHhCCCCCCCC
Q 010513 333 FGLAKLLGAERSY--VTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYS 393 (508)
Q Consensus 333 FG~a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~Pf~~~ 393 (508)
||+++.+...-.. ....++-|.+|.|||++.+ ..|+.+.|||+.||++.||+|-.+-|.+.
T Consensus 180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~ 243 (438)
T KOG0666|consen 180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGR 243 (438)
T ss_pred ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccch
Confidence 9999988653322 3345678999999998776 46899999999999999999998888765
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=299.73 Aligned_cols=241 Identities=24% Similarity=0.306 Sum_probs=191.5
Q ss_pred cCCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCchhHHHHHHHHHHHHcc-CCCCeeeEeeeeecCCeeEEEE
Q 010513 184 STNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVY 261 (508)
Q Consensus 184 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lV~ 261 (508)
.++.|.+...+|.|+|+.|-.+... +++..++|++.+...+ ..+|+.++... +||||+++.+.+.++.+.|+||
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~----~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~ 395 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADD----NQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM 395 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccccc----cccccchhhhhcCCCcceeecceecCCceeeeee
Confidence 3567888889999999999999855 5788999999766332 23366555554 7999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEE-cCCCCeEEeeeccceecC
Q 010513 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILL-DKQWNPKLSDFGLAKLLG 340 (508)
Q Consensus 262 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll-~~~~~~kL~DFG~a~~~~ 340 (508)
|.+.|+-|.+.+.... ... ..+..|+.+|+.|+.|||++ |++||||||+|||+ +..++++|+|||.++...
T Consensus 396 e~l~g~ell~ri~~~~----~~~-~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~ 467 (612)
T KOG0603|consen 396 ELLDGGELLRRIRSKP----EFC-SEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELE 467 (612)
T ss_pred hhccccHHHHHHHhcc----hhH-HHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhCc
Confidence 9999999888876542 222 67778999999999999999 99999999999999 689999999999999764
Q ss_pred CCCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCCc
Q 010513 341 AERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDP 420 (508)
Q Consensus 341 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 420 (508)
.. ....+-|..|.|||++....|++++||||||++||+|++|+.||...... .+.. ..+.. +
T Consensus 468 ~~----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-----~ei~-~~i~~--------~ 529 (612)
T KOG0603|consen 468 RS----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-----IEIH-TRIQM--------P 529 (612)
T ss_pred hh----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch-----HHHH-HhhcC--------C
Confidence 44 22335688999999999999999999999999999999999999755433 1222 22221 1
Q ss_pred cCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 421 RLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 421 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
.+. +..+...++ |+.+||+.||.+||+|.++..+
T Consensus 530 ~~s-~~vS~~AKd---Ll~~LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 530 KFS-ECVSDEAKD---LLQQLLQVDPALRLGADEIGAH 563 (612)
T ss_pred ccc-cccCHHHHH---HHHHhccCChhhCcChhhhccC
Confidence 111 223444455 6669999999999999998754
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=279.95 Aligned_cols=272 Identities=19% Similarity=0.281 Sum_probs=209.3
Q ss_pred cchhhHhhcCCCCcccceEcccCcEEEEEEEECC-CcEEEEEEeecCCchhHHHHHHHHHHHHccC-C-C----CeeeEe
Q 010513 176 YTLRELEVSTNGFADENVIGEGGYGIVYHGVLED-NTNVAVKNLLNNRGQAEKEFKVEVEAIGRVR-H-K----NLVRLL 248 (508)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-p----niv~l~ 248 (508)
+-+...+...++|.+...+|+|+||.|-.+.+.. +..||+|+++.- ....+..+-|++++.++. + | -+|.+.
T Consensus 79 ~v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~ 157 (415)
T KOG0671|consen 79 YVYQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV-DKYREAALIEIEVLQKINESDPNGKFRCVQMR 157 (415)
T ss_pred EEEEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH-HHHhhHHHHHHHHHHHHHhcCCCCceEEEeee
Confidence 4566677789999999999999999999999654 678999987543 334456677999999993 2 3 388899
Q ss_pred eeeecCCeeEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcC----
Q 010513 249 GYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDK---- 324 (508)
Q Consensus 249 ~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~---- 324 (508)
+||.-.++.|+|+|.+ |-+++++|..+. ..+++...+..++.|++++++|||+. +++|.||||+|||+..
T Consensus 158 ~wFdyrghiCivfell-G~S~~dFlk~N~--y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~ 231 (415)
T KOG0671|consen 158 DWFDYRGHICIVFELL-GLSTFDFLKENN--YIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYF 231 (415)
T ss_pred hhhhccCceEEEEecc-ChhHHHHhccCC--ccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceE
Confidence 9999999999999998 449999998753 56789999999999999999999999 9999999999999921
Q ss_pred ----------------CCCeEEeeeccceecCCCCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCC
Q 010513 325 ----------------QWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRN 388 (508)
Q Consensus 325 ----------------~~~~kL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~ 388 (508)
+..++++|||.|..-.... ...+.|..|.|||++.+-.++.++||||+||+|+|+.||..
T Consensus 232 ~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~ 307 (415)
T KOG0671|consen 232 KTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGET 307 (415)
T ss_pred EEeccCCccceeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccce
Confidence 2358999999999754443 44678999999999999999999999999999999999999
Q ss_pred CCCCCCCCCcchHHHHHH-----Hhhccc-----ccccCCC---------------ccC----CCCchHHHHHHHHHHHH
Q 010513 389 PVDYSRPPGEVNLVEWLK-----TMVTNR-----NAEGVLD---------------PRL----QEKPCSRALKRALLVAL 439 (508)
Q Consensus 389 Pf~~~~~~~~~~~~~~~~-----~~~~~~-----~~~~~~~---------------~~l----~~~~~~~~~~~l~~li~ 439 (508)
-|....+.+...+.+.+. .|+... ...+.+| +-. .-...+.+-.++++|+.
T Consensus 308 LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~ 387 (415)
T KOG0671|consen 308 LFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLR 387 (415)
T ss_pred ecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHH
Confidence 998766433322222211 000000 0000111 000 00112345567999999
Q ss_pred HccCCCCCCCCCHHHHHHH
Q 010513 440 RCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 440 ~cl~~dP~~RPs~~evl~~ 458 (508)
+||..||.+|+|+.|++++
T Consensus 388 ~mL~fDP~~RiTl~EAL~H 406 (415)
T KOG0671|consen 388 RMLEFDPARRITLREALSH 406 (415)
T ss_pred HHHccCccccccHHHHhcC
Confidence 9999999999999999865
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=297.29 Aligned_cols=253 Identities=24% Similarity=0.277 Sum_probs=208.3
Q ss_pred hcCCCCcccceEcccCcEEEEEEEECCCc-EEEEEEeecC---CchhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeE
Q 010513 183 VSTNGFADENVIGEGGYGIVYHGVLEDNT-NVAVKNLLNN---RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM 258 (508)
Q Consensus 183 ~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~-~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 258 (508)
+...++..+..||-||||.|=++..+... .+|+|.+++. .....+.+..|-.+|...+.|.||++|..|.++...|
T Consensus 417 v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvY 496 (732)
T KOG0614|consen 417 VKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVY 496 (732)
T ss_pred cchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhh
Confidence 44556777888999999999999876433 3788877654 3344567788999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeecccee
Q 010513 259 LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL 338 (508)
Q Consensus 259 lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~ 338 (508)
|+||-|-||.|...|.++ +.++...+..++..+++|++|||++ +||+|||||+|+|+|.+|.+||.|||+|+.
T Consensus 497 mLmEaClGGElWTiLrdR----g~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKk 569 (732)
T KOG0614|consen 497 MLMEACLGGELWTILRDR----GSFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKK 569 (732)
T ss_pred hhHHhhcCchhhhhhhhc----CCcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHH
Confidence 999999999999999886 6788999999999999999999999 999999999999999999999999999998
Q ss_pred cCCCCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCC
Q 010513 339 LGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVL 418 (508)
Q Consensus 339 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 418 (508)
++.. ..+.++||||.|.|||++.++.++.++|.||||+++|||++|.+||...++....+++-....++
T Consensus 570 i~~g--~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i--------- 638 (732)
T KOG0614|consen 570 IGSG--RKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKI--------- 638 (732)
T ss_pred hccC--CceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhh---------
Confidence 7543 34566899999999999999999999999999999999999999998776644333322111111
Q ss_pred CccCCCCchHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHHH
Q 010513 419 DPRLQEKPCSRALKRALLVALRCVDPNAHKRPK-----MGHVIHML 459 (508)
Q Consensus 419 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~L 459 (508)
+.+....+...+++++.+..+|.+|.- +.+|.++-
T Consensus 639 ------~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~ 678 (732)
T KOG0614|consen 639 ------EFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHR 678 (732)
T ss_pred ------hcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhh
Confidence 112334455666888999999999975 67776653
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=277.53 Aligned_cols=219 Identities=20% Similarity=0.175 Sum_probs=173.8
Q ss_pred cCcEEEEEEEEC-CCcEEEEEEeecCCchhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEEecCCCCHHHHhcc
Q 010513 197 GGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHG 275 (508)
Q Consensus 197 G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~g~L~~~l~~ 275 (508)
|.||.||++++. +++.||+|.+.... .+..|...+....||||+++++++.+....++||||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 889999999975 67889999986543 233455555566799999999999999999999999999999999876
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCCCcceecceecCCC
Q 010513 276 DVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFG 355 (508)
Q Consensus 276 ~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~gt~~ 355 (508)
. ..+++..+..++.|+++||+|||+. +++||||||+||+++.++.++++|||.+...... .....++..
T Consensus 79 ~----~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~~ 147 (237)
T cd05576 79 F----LNIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVENM 147 (237)
T ss_pred h----cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCcCcc
Confidence 4 3589999999999999999999998 9999999999999999999999999987654322 122356778
Q ss_pred CCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCCccCCCCchHHHHHHHH
Q 010513 356 YVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRAL 435 (508)
Q Consensus 356 y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~ 435 (508)
|+|||.+.+..++.++|+||+|+++|||++|+.||........ ......+. ...+ ..+.
T Consensus 148 y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~-----------------~~~~~~~~-~~~~---~~~~ 206 (237)
T cd05576 148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGIN-----------------THTTLNIP-EWVS---EEAR 206 (237)
T ss_pred ccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcc-----------------cccccCCc-ccCC---HHHH
Confidence 9999999888899999999999999999999988753211100 00000011 1122 2344
Q ss_pred HHHHHccCCCCCCCCCH
Q 010513 436 LVALRCVDPNAHKRPKM 452 (508)
Q Consensus 436 ~li~~cl~~dP~~RPs~ 452 (508)
+++.+|++.||++||++
T Consensus 207 ~li~~~l~~dp~~R~~~ 223 (237)
T cd05576 207 SLLQQLLQFNPTERLGA 223 (237)
T ss_pred HHHHHHccCCHHHhcCC
Confidence 57779999999999996
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=258.20 Aligned_cols=225 Identities=26% Similarity=0.373 Sum_probs=183.5
Q ss_pred cchhhHhhcCCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecC-CchhHHHHHHHHHHHHcc-CCCCeeeEeeeee
Q 010513 176 YTLRELEVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN-RGQAEKEFKVEVEAIGRV-RHKNLVRLLGYCA 252 (508)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~ 252 (508)
...+.++++.++..-+..||+|+||.|-+-++. +|+-.|+|.+... ..+..+....|+.+..+. .+|.+|.|||...
T Consensus 36 I~~~~~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~ 115 (282)
T KOG0984|consen 36 IGDRNFEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALF 115 (282)
T ss_pred EecCccccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhh
Confidence 334456777788888899999999999888754 6888999998654 334456677788876555 7999999999999
Q ss_pred cCCeeEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEee
Q 010513 253 EGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSD 332 (508)
Q Consensus 253 ~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~D 332 (508)
.+...++.||.|+. +|..+..+-...+..+++...-+|+..+.+||.|||++. .+||||+||+||||+.+|++|+||
T Consensus 116 regdvwIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCD 192 (282)
T KOG0984|consen 116 REGDVWICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICD 192 (282)
T ss_pred ccccEEEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcc
Confidence 99999999999987 888876654445678999999999999999999999886 899999999999999999999999
Q ss_pred eccceecCCCCcceecceecCCCCCChhhhhc----CCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHh
Q 010513 333 FGLAKLLGAERSYVTTRVMGTFGYVAPEYAST----GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTM 408 (508)
Q Consensus 333 FG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~ 408 (508)
||.+-.+.+ +...+--.|...|||||.+.. ..|+-++||||||+++.||.+++.||+.... .++.+++.
T Consensus 193 FGIsG~L~d--SiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~t-----pF~qLkqv 265 (282)
T KOG0984|consen 193 FGISGYLVD--SIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGT-----PFQQLKQV 265 (282)
T ss_pred cccceeehh--hhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCC-----HHHHHHHH
Confidence 999987632 222333467889999998753 4689999999999999999999999975543 35555655
Q ss_pred hc
Q 010513 409 VT 410 (508)
Q Consensus 409 ~~ 410 (508)
+.
T Consensus 266 Ve 267 (282)
T KOG0984|consen 266 VE 267 (282)
T ss_pred hc
Confidence 54
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=304.49 Aligned_cols=262 Identities=19% Similarity=0.254 Sum_probs=173.3
Q ss_pred hcCCCCcccceEcccCcEEEEEEEEC-C----CcEEEEEEeecCCchhHHHHHHHHHHHHccCCCCeeeEeee------e
Q 010513 183 VSTNGFADENVIGEGGYGIVYHGVLE-D----NTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGY------C 251 (508)
Q Consensus 183 ~~~~~~~~~~~LG~G~~g~Vy~~~~~-~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~------~ 251 (508)
...++|.+.+.||+|+||.||+|++. + +..||+|++...... +....+ .+....+.++..++.. .
T Consensus 129 ~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~ 204 (566)
T PLN03225 129 FKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSS 204 (566)
T ss_pred CccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhccccc
Confidence 46789999999999999999999975 4 578999987543221 111111 1222223333333222 2
Q ss_pred ecCCeeEEEEEecCCCCHHHHhccCCCC----------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccC
Q 010513 252 AEGAHRMLVYEYIDNGNLEQWLHGDVGP----------------HSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDI 315 (508)
Q Consensus 252 ~~~~~~~lV~e~~~~g~L~~~l~~~~~~----------------~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDl 315 (508)
.++...++||||+.+++|.+++...... ........+..++.|++.||+|||++ +|+||||
T Consensus 205 ~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDL 281 (566)
T PLN03225 205 KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDV 281 (566)
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcC
Confidence 4566789999999999999998754210 01112344668999999999999998 9999999
Q ss_pred CCCCEEEcC-CCCeEEeeeccceecCCCCcceecceecCCCCCChhhhhcC----------------------CCCCCCC
Q 010513 316 KSSNILLDK-QWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTG----------------------MLNERSD 372 (508)
Q Consensus 316 kp~NIll~~-~~~~kL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~sD 372 (508)
||+|||++. ++.+||+|||+++.+............||+.|+|||.+... .++.++|
T Consensus 282 KP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 282 KPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred CHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 999999985 57899999999987655444555667899999999965322 2345679
Q ss_pred eeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccc----cccCCCccCCCC------chHHHHHHHHHHHHHcc
Q 010513 373 VYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRN----AEGVLDPRLQEK------PCSRALKRALLVALRCV 442 (508)
Q Consensus 373 vwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~l~~~------~~~~~~~~l~~li~~cl 442 (508)
||||||+||||+++..|++.. ............. ......+....+ ..........+++.+||
T Consensus 362 VwSlGviL~el~~~~~~~~~~-------~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL 434 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRSDSN-------LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMM 434 (566)
T ss_pred cHHHHHHHHHHHhCcCCCchH-------HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHc
Confidence 999999999999987765421 1111111100000 000011110000 00001122346888999
Q ss_pred CCCCCCCCCHHHHHHH
Q 010513 443 DPNAHKRPKMGHVIHM 458 (508)
Q Consensus 443 ~~dP~~RPs~~evl~~ 458 (508)
+.||++|||+.+++++
T Consensus 435 ~~dP~kR~ta~e~L~H 450 (566)
T PLN03225 435 RFKGRQRISAKAALAH 450 (566)
T ss_pred cCCcccCCCHHHHhCC
Confidence 9999999999999976
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=271.91 Aligned_cols=266 Identities=22% Similarity=0.356 Sum_probs=198.6
Q ss_pred CCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCC--chhHHHHHHHHHHHHccCCCCeeeEeeeeec--------C
Q 010513 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE--------G 254 (508)
Q Consensus 186 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~--------~ 254 (508)
+.|+-..+||+|.||+||+|+.+ +|++||+|++.... ..-.....+|+++|..++|+|++.+++.|.. .
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 46777889999999999999965 57788998775432 2223445679999999999999999998742 3
Q ss_pred CeeEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeec
Q 010513 255 AHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFG 334 (508)
Q Consensus 255 ~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG 334 (508)
..+|+||++|+. +|..+|... ...++..++.+++.++..||.|+|.. .|+|||+|+.|+||+.+|.+||+|||
T Consensus 97 ~t~ylVf~~ceh-DLaGlLsn~---~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFG 169 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLSNR---KVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFG 169 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhcCc---cccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeeccc
Confidence 458999999998 999999765 46789999999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCcc---eecceecCCCCCChhhhhc-CCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhc
Q 010513 335 LAKLLGAERSY---VTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVT 410 (508)
Q Consensus 335 ~a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~ 410 (508)
+++.+...... ..++.+-|.+|.+||.+.+ ..|+++.|||..||++.||.||.+-+..........++..+-....
T Consensus 170 lar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~t 249 (376)
T KOG0669|consen 170 LARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSIT 249 (376)
T ss_pred cccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCC
Confidence 99876433222 1344567999999997765 5699999999999999999999988876654333333332211111
Q ss_pred cccccc--------CC--CccCCC--CchHHHHH------HHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 411 NRNAEG--------VL--DPRLQE--KPCSRALK------RALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 411 ~~~~~~--------~~--~~~l~~--~~~~~~~~------~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
..-+.. .+ .|--+. ......++ +.++++.+++..||.+|+++.+++.+
T Consensus 250 kevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 250 KEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred cccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence 111000 00 110000 01112222 55668889999999999999999865
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=290.39 Aligned_cols=264 Identities=23% Similarity=0.366 Sum_probs=181.7
Q ss_pred hhcCCCCcccceEcccCcEEEEEEEE-----------------CCCcEEEEEEeecCCchhHHH--------------HH
Q 010513 182 EVSTNGFADENVIGEGGYGIVYHGVL-----------------EDNTNVAVKNLLNNRGQAEKE--------------FK 230 (508)
Q Consensus 182 ~~~~~~~~~~~~LG~G~~g~Vy~~~~-----------------~~~~~vavK~~~~~~~~~~~~--------------~~ 230 (508)
+...++|++.++||+|+||+||+|.+ .+++.||||++........++ ..
T Consensus 141 r~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~ 220 (507)
T PLN03224 141 RWSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGM 220 (507)
T ss_pred CccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhH
Confidence 34678999999999999999999964 234679999986543322222 33
Q ss_pred HHHHHHHccCCCCe-----eeEeeeeec--------CCeeEEEEEecCCCCHHHHhccCCC-------------------
Q 010513 231 VEVEAIGRVRHKNL-----VRLLGYCAE--------GAHRMLVYEYIDNGNLEQWLHGDVG------------------- 278 (508)
Q Consensus 231 ~E~~~l~~l~hpni-----v~l~~~~~~--------~~~~~lV~e~~~~g~L~~~l~~~~~------------------- 278 (508)
.|+.++.+++|.++ ++++++|.. ....++||||+++|+|.++++...+
T Consensus 221 vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~ 300 (507)
T PLN03224 221 VEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDN 300 (507)
T ss_pred HHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhh
Confidence 46777777776654 677777653 3467999999999999999875321
Q ss_pred -CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCCCcceecceecCCCCC
Q 010513 279 -PHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYV 357 (508)
Q Consensus 279 -~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~gt~~y~ 357 (508)
....+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++...............+|+.|+
T Consensus 301 ~~~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~ 377 (507)
T PLN03224 301 MPQDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYS 377 (507)
T ss_pred cccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCccee
Confidence 112356778899999999999999998 9999999999999999999999999999765433222222234588999
Q ss_pred ChhhhhcCC--------------------C--CCCCCeeehHHHHHHHHhCCC-CCCCCCCCC-c-----chHHHHHHHh
Q 010513 358 APEYASTGM--------------------L--NERSDVYSFGILIMEVISGRN-PVDYSRPPG-E-----VNLVEWLKTM 408 (508)
Q Consensus 358 aPE~~~~~~--------------------~--~~~sDvwSlGvvl~elltg~~-Pf~~~~~~~-~-----~~~~~~~~~~ 408 (508)
|||.+.... | ..+.|+||+||++|+|++|.. ||.....-. + .....| +.
T Consensus 378 aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~--r~ 455 (507)
T PLN03224 378 PPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRW--RM 455 (507)
T ss_pred ChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHH--Hh
Confidence 999875432 1 134799999999999999875 775321100 0 001111 11
Q ss_pred hcccccccCCCccCCCCchHHHHHHHHHHHHHccCCCC---CCCCCHHHHHHH
Q 010513 409 VTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNA---HKRPKMGHVIHM 458 (508)
Q Consensus 409 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP---~~RPs~~evl~~ 458 (508)
..... .+ +. ..+.......+++.+||..+| .+|+|++|++++
T Consensus 456 ~~~~~----~~--~~--~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 456 YKGQK----YD--FS--LLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred hcccC----CC--cc--cccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 11110 01 10 111122334457778888765 689999999975
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=276.88 Aligned_cols=278 Identities=22% Similarity=0.349 Sum_probs=202.1
Q ss_pred hcCCCCcccceEcccCcEEEEEEEE-CCCcEEEEEEeecCCc-------hhHHHHHHHHHHHHccCCCCeeeEeeeee-c
Q 010513 183 VSTNGFADENVIGEGGYGIVYHGVL-EDNTNVAVKNLLNNRG-------QAEKEFKVEVEAIGRVRHKNLVRLLGYCA-E 253 (508)
Q Consensus 183 ~~~~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~ 253 (508)
...++|-.+..||+|||+.||+|.+ ...+.||||+-.-+.. ...+...+|.++-+.|.||.||++|++|. +
T Consensus 460 tLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslD 539 (775)
T KOG1151|consen 460 TLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLD 539 (775)
T ss_pred chHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeec
Confidence 3456788999999999999999984 4577788986532221 12245667999999999999999999996 4
Q ss_pred CCeeEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEc---CCCCeEE
Q 010513 254 GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLD---KQWNPKL 330 (508)
Q Consensus 254 ~~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~---~~~~~kL 330 (508)
.+.+|-|+|||+|.+|.-||+.. ..+++.++..|+.||+.||.||.+. +++|||-||||.|||+- .-|.+||
T Consensus 540 tdsFCTVLEYceGNDLDFYLKQh----klmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKI 614 (775)
T KOG1151|consen 540 TDSFCTVLEYCEGNDLDFYLKQH----KLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKI 614 (775)
T ss_pred cccceeeeeecCCCchhHHHHhh----hhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEe
Confidence 56778999999999999999876 5789999999999999999999985 89999999999999993 4578999
Q ss_pred eeeccceecCCCCcc------eecceecCCCCCChhhhhc----CCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcch
Q 010513 331 SDFGLAKLLGAERSY------VTTRVMGTFGYVAPEYAST----GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVN 400 (508)
Q Consensus 331 ~DFG~a~~~~~~~~~------~~~~~~gt~~y~aPE~~~~----~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~ 400 (508)
+|||+++.+.++... .+....||.+|++||.+-- ...+.|+||||.||++|..+.|+.||.......
T Consensus 615 TDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQ--- 691 (775)
T KOG1151|consen 615 TDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQ--- 691 (775)
T ss_pred eecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHH---
Confidence 999999988654333 2345689999999996533 346789999999999999999999996442211
Q ss_pred HHHHHHHhhcccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCccchhhhh
Q 010513 401 LVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEEFPFRDVSFGRVIGILFF 480 (508)
Q Consensus 401 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~~~~~~~~~~~~~~~~~~~~ 480 (508)
+.+. ...+...-.-.+.. -+....+...+|.+||+.-.++|....++. .+.+-++-.++..+.+.+++
T Consensus 692 --dILq----eNTIlkAtEVqFP~--KPvVsseAkaFIRRCLaYRKeDR~DV~qLA----~dpyllPh~rrs~s~gs~~~ 759 (775)
T KOG1151|consen 692 --DILQ----ENTILKATEVQFPP--KPVVSSEAKAFIRRCLAYRKEDRIDVQQLA----CDPYLLPHIRRSVSTGSPAG 759 (775)
T ss_pred --HHHh----hhchhcceeccCCC--CCccCHHHHHHHHHHHHhhhhhhhhHHHHc----cCccccchhhhccccCCCcc
Confidence 1111 11100000111111 111222333477799999999998877654 33333343344444444443
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=260.82 Aligned_cols=238 Identities=26% Similarity=0.378 Sum_probs=192.1
Q ss_pred CcEEEEEEEEC-CCcEEEEEEeecCCchh-HHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEEecCCCCHHHHhcc
Q 010513 198 GYGIVYHGVLE-DNTNVAVKNLLNNRGQA-EKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHG 275 (508)
Q Consensus 198 ~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~g~L~~~l~~ 275 (508)
+||.||+|... ++..+++|.+....... .+.+..|++.+++++|+|++++++++......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999986 48899999987655444 67899999999999999999999999999999999999999999999876
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCCCcceecceecCCC
Q 010513 276 DVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFG 355 (508)
Q Consensus 276 ~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~gt~~ 355 (508)
. ..+++..++.++.+++.++.|||+. +++|+||+|+||++++++.++|+|||.+....... ......++..
T Consensus 81 ~----~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~ 151 (244)
T smart00220 81 R----GRLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPE 151 (244)
T ss_pred c----cCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcC
Confidence 5 2388999999999999999999998 99999999999999999999999999998764432 2334568889
Q ss_pred CCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCCccCCCCchHHHHHHHH
Q 010513 356 YVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRAL 435 (508)
Q Consensus 356 y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~ 435 (508)
|++||.+.+..++.++|+||||+++++|++|..||..... .....+.+ ..... .. .........++.
T Consensus 152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~--~~~~~~~~----~~~~~----~~---~~~~~~~~~~~~ 218 (244)
T smart00220 152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQ--LLELFKKI----GKPKP----PF---PPPEWKISPEAK 218 (244)
T ss_pred CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc--HHHHHHHH----hccCC----CC---ccccccCCHHHH
Confidence 9999999888899999999999999999999999965311 11111111 11100 00 000000223455
Q ss_pred HHHHHccCCCCCCCCCHHHHHH
Q 010513 436 LVALRCVDPNAHKRPKMGHVIH 457 (508)
Q Consensus 436 ~li~~cl~~dP~~RPs~~evl~ 457 (508)
+++.+|+..+|++||++.++++
T Consensus 219 ~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 219 DLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHccCCchhccCHHHHhh
Confidence 6888999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=269.06 Aligned_cols=149 Identities=23% Similarity=0.322 Sum_probs=126.5
Q ss_pred ccCCCCcccchhhHhhcC-CCCcccceEcccCcEEEEEEEECC-CcEEEEEEeecCCchhHHHHHHHHHHHHccC-----
Q 010513 168 SHLGWGHWYTLRELEVST-NGFADENVIGEGGYGIVYHGVLED-NTNVAVKNLLNNRGQAEKEFKVEVEAIGRVR----- 240 (508)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~-~~~~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~----- 240 (508)
.....|.|.+++.+++.. .+|.+.++||.|.|++||+|++.. .+.||+|+.+ ......+....||++|++++
T Consensus 59 ~dY~kGGYHpV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvK-SAqhYtEaAlDEIklL~~v~~~Dp~ 137 (590)
T KOG1290|consen 59 EDYRKGGYHPVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVK-SAQHYTEAALDEIKLLQQVREGDPN 137 (590)
T ss_pred hhhhcCCCceeeccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEe-hhhHHHHHHHHHHHHHHHHHhcCCC
Confidence 446678888888888887 899999999999999999999764 5667888764 44555667778999999983
Q ss_pred C---CCeeeEeeeee----cCCeeEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeec
Q 010513 241 H---KNLVRLLGYCA----EGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHR 313 (508)
Q Consensus 241 h---pniv~l~~~~~----~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHr 313 (508)
| ..||+|++.|. ++.++|||+|++ |.+|..+|.... ...++...+++|++|++.||.|||..| +|||.
T Consensus 138 ~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~--YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHT 212 (590)
T KOG1290|consen 138 DPGKKCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSN--YRGLPLSCVKEICRQVLTGLDYLHREC--GIIHT 212 (590)
T ss_pred CCCCceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhC--CCCCcHHHHHHHHHHHHHHHHHHHHhc--Ccccc
Confidence 3 36999999996 456899999999 559999987763 567899999999999999999999998 99999
Q ss_pred cCCCCCEEE
Q 010513 314 DIKSSNILL 322 (508)
Q Consensus 314 Dlkp~NIll 322 (508)
||||+|||+
T Consensus 213 DlKPENvLl 221 (590)
T KOG1290|consen 213 DLKPENVLL 221 (590)
T ss_pred CCCcceeee
Confidence 999999999
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.3e-34 Score=261.39 Aligned_cols=272 Identities=21% Similarity=0.298 Sum_probs=205.6
Q ss_pred CCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecC--CchhHHHHHHHHHHHHccCCCCeeeEeeeeecC-----CeeE
Q 010513 187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEG-----AHRM 258 (508)
Q Consensus 187 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-----~~~~ 258 (508)
+.+-.+-||.|+||+||.+.+. +|+.||+|++.+- +-...+.+-+|+++|..++|.|++..++..+-. .++|
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY 133 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY 133 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence 3445688999999999999864 7999999998553 334456788899999999999999998876533 2467
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeecccee
Q 010513 259 LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL 338 (508)
Q Consensus 259 lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~ 338 (508)
.++|.|.. +|..++-.- ..++.+.++-+++||++||.|||+. +|.||||||.|.|++.+..+||||||+++.
T Consensus 134 V~TELmQS-DLHKIIVSP----Q~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARv 205 (449)
T KOG0664|consen 134 VLTELMQS-DLHKIIVSP----QALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLART 205 (449)
T ss_pred HHHHHHHh-hhhheeccC----CCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccc
Confidence 88888866 888777543 5788899999999999999999999 999999999999999999999999999998
Q ss_pred cCCCCcceecceecCCCCCChhhhhcC-CCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHH---------Hh
Q 010513 339 LGAERSYVTTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLK---------TM 408 (508)
Q Consensus 339 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~---------~~ 408 (508)
...+....++.-+-|.+|.|||++.+. .|+.+.||||.||++.||+..+.-|....+.....++..+. ..
T Consensus 206 ee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~A 285 (449)
T KOG0664|consen 206 WDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYA 285 (449)
T ss_pred cchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHH
Confidence 776666667777789999999988775 69999999999999999999999998776654444433321 11
Q ss_pred hccccc----ccCCCccCCC----CchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCCCC
Q 010513 409 VTNRNA----EGVLDPRLQE----KPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEEFPF 466 (508)
Q Consensus 409 ~~~~~~----~~~~~~~l~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~~~~~~ 466 (508)
....+. .....|.++. ......-.+.+++..+++..||++|.+..+.+.++-.++-.+
T Consensus 286 CEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~R~ 351 (449)
T KOG0664|consen 286 CEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEGRL 351 (449)
T ss_pred hhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccccce
Confidence 111000 0111111111 001122334455677899999999999999988776544333
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.2e-33 Score=248.69 Aligned_cols=271 Identities=22% Similarity=0.359 Sum_probs=202.9
Q ss_pred CCCCcccchhhHhh---cCCCCcccceEcccCcEEEEEEE-ECCCcEEEEEEeecCCchhHHHHHHHHHHHHccC-CCCe
Q 010513 170 LGWGHWYTLRELEV---STNGFADENVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVR-HKNL 244 (508)
Q Consensus 170 ~~~~~~~~~~~~~~---~~~~~~~~~~LG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpni 244 (508)
.....++.++...+ ..++|++.+++|+|.|++||.|. ..++.+++||.++.- ..+.+.+|+++|..|. ||||
T Consensus 19 ~rp~eYWdYE~~~i~wg~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NI 95 (338)
T KOG0668|consen 19 ERPREYWDYESLVIDWGNQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNI 95 (338)
T ss_pred cCchhhcchhheeeeccccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCe
Confidence 33445555555443 34679999999999999999998 456788999988543 3567889999999996 9999
Q ss_pred eeEeeeeecCC--eeEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEE
Q 010513 245 VRLLGYCAEGA--HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILL 322 (508)
Q Consensus 245 v~l~~~~~~~~--~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll 322 (508)
++++++..+.. ...+|+||+++-+...+. ..++...+..++.+++.||.|+|+. ||+|||+||.|+||
T Consensus 96 i~L~DiV~Dp~SktpaLiFE~v~n~Dfk~ly-------~tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmI 165 (338)
T KOG0668|consen 96 IKLLDIVKDPESKTPSLIFEYVNNTDFKQLY-------PTLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMI 165 (338)
T ss_pred eehhhhhcCccccCchhHhhhhccccHHHHh-------hhhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeee
Confidence 99999998764 456999999998877765 4678889999999999999999999 99999999999999
Q ss_pred cCC-CCeEEeeeccceecCCCCcceecceecCCCCCChhhhhc-CCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcch
Q 010513 323 DKQ-WNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVN 400 (508)
Q Consensus 323 ~~~-~~~kL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~ 400 (508)
|.. -.++|+|+|+|.++.....+.. .+.+..|--||.+-. ..|+.+-|+|||||+|..|+..+.||-...... .+
T Consensus 166 dh~~rkLrlIDWGLAEFYHp~~eYnV--RVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~-DQ 242 (338)
T KOG0668|consen 166 DHELRKLRLIDWGLAEFYHPGKEYNV--RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY-DQ 242 (338)
T ss_pred chhhceeeeeecchHhhcCCCceeee--eeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCH-HH
Confidence 865 4599999999999877665543 366888999998754 568889999999999999999999986543321 12
Q ss_pred HHHHHH--------HhhcccccccCCCccCCC-------CchH---------HHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 010513 401 LVEWLK--------TMVTNRNAEGVLDPRLQE-------KPCS---------RALKRALLVALRCVDPNAHKRPKMGHVI 456 (508)
Q Consensus 401 ~~~~~~--------~~~~~~~~~~~~~~~l~~-------~~~~---------~~~~~l~~li~~cl~~dP~~RPs~~evl 456 (508)
++...+ ..+.... -.+||.+.. .... -...+.++++-+.|..|-++|+|++|..
T Consensus 243 LVkIakVLGt~el~~Yl~KY~--i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam 320 (338)
T KOG0668|consen 243 LVKIAKVLGTDELYAYLNKYQ--IDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAM 320 (338)
T ss_pred HHHHHHHhChHHHHHHHHHHc--cCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHh
Confidence 222111 1111111 112332211 0000 0124566777799999999999999977
Q ss_pred HH
Q 010513 457 HM 458 (508)
Q Consensus 457 ~~ 458 (508)
.+
T Consensus 321 ~H 322 (338)
T KOG0668|consen 321 AH 322 (338)
T ss_pred cC
Confidence 54
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-32 Score=286.48 Aligned_cols=248 Identities=27% Similarity=0.390 Sum_probs=188.5
Q ss_pred CCcccceEcccCcEE-EEEEEECCCcEEEEEEeecCCchhHHHHHHHHHHHHcc-CCCCeeeEeeeeecCCeeEEEEEec
Q 010513 187 GFADENVIGEGGYGI-VYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYI 264 (508)
Q Consensus 187 ~~~~~~~LG~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lV~e~~ 264 (508)
-|.-.+++|.|..|+ ||+|.+. ++.||||++... ..+...+|+..|+.- .|||||++++.-.++...|+..|.|
T Consensus 510 ~~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC 585 (903)
T KOG1027|consen 510 FFSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC 585 (903)
T ss_pred eeccHHHcccCCCCcEEEEEeeC-CceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh
Confidence 355567899999885 6999987 789999998543 234566799999888 7999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcC---C--CCeEEeeeccceec
Q 010513 265 DNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDK---Q--WNPKLSDFGLAKLL 339 (508)
Q Consensus 265 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~---~--~~~kL~DFG~a~~~ 339 (508)
.. +|.+++...............+.+..|+++||++||+. +||||||||.||||+. + ..++|+|||+++.+
T Consensus 586 ~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl 661 (903)
T KOG1027|consen 586 AC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL 661 (903)
T ss_pred hh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence 77 99999977411111122245677889999999999997 9999999999999965 3 45899999999998
Q ss_pred CCCCccee--cceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhC-CCCCCCCCCCCcchHHHHHHHhhccccccc
Q 010513 340 GAERSYVT--TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISG-RNPVDYSRPPGEVNLVEWLKTMVTNRNAEG 416 (508)
Q Consensus 340 ~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg-~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 416 (508)
....+... ....||-+|+|||.++...-+.++|||||||++|+.++| ..||.+.-.. +.|+ .....
T Consensus 662 ~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R-~~NI-------l~~~~--- 730 (903)
T KOG1027|consen 662 AGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLER-QANI-------LTGNY--- 730 (903)
T ss_pred CCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHh-hhhh-------hcCcc---
Confidence 76555443 346799999999999988888899999999999999994 9999744211 0010 01100
Q ss_pred CCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 417 VLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 417 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
.+. .+...... +..+||.+|+++||..||++.+|+.+
T Consensus 731 ~L~-~L~~~~d~----eA~dLI~~ml~~dP~~RPsa~~VL~H 767 (903)
T KOG1027|consen 731 TLV-HLEPLPDC----EAKDLISRMLNPDPQLRPSATDVLNH 767 (903)
T ss_pred cee-eeccCchH----HHHHHHHHhcCCCcccCCCHHHHhCC
Confidence 000 11111111 55568889999999999999999854
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.9e-33 Score=273.24 Aligned_cols=277 Identities=21% Similarity=0.209 Sum_probs=215.3
Q ss_pred CcccchhhHhhcCCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCchhHHHHHHHHHHHHccCC------CCee
Q 010513 173 GHWYTLRELEVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRH------KNLV 245 (508)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h------pniv 245 (508)
.+||.+.-+++.-.+|.+....|+|-|++|..|.+. .|..||||+|.++.... +.=..|+++|++|+. -|++
T Consensus 419 EGYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~-KtGl~EleiLkKL~~AD~Edk~Hcl 497 (752)
T KOG0670|consen 419 EGYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMH-KTGLKELEILKKLNDADPEDKFHCL 497 (752)
T ss_pred cceEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHh-hhhhHHHHHHHHhhccCchhhhHHH
Confidence 567888889999999999999999999999999965 47799999998775443 334559999999963 4899
Q ss_pred eEeeeeecCCeeEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCC
Q 010513 246 RLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQ 325 (508)
Q Consensus 246 ~l~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~ 325 (508)
+++..|...+++|||+|-+.. +|.+.|++.. ....|....+..++.|+..||..|-.. +|+|.||||.|||+++.
T Consensus 498 rl~r~F~hknHLClVFE~Lsl-NLRevLKKyG-~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~ 572 (752)
T KOG0670|consen 498 RLFRHFKHKNHLCLVFEPLSL-NLREVLKKYG-RNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNES 572 (752)
T ss_pred HHHHHhhhcceeEEEehhhhc-hHHHHHHHhC-cccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccC
Confidence 999999999999999998855 9999998863 345688889999999999999999987 99999999999999876
Q ss_pred C-CeEEeeeccceecCCCCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHH
Q 010513 326 W-NPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEW 404 (508)
Q Consensus 326 ~-~~kL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~ 404 (508)
. .+||||||.|...+... .+...-+..|.|||++.+-.|+...|+||.||+||||.||+..|.+........+...
T Consensus 573 k~iLKLCDfGSA~~~~ene---itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me 649 (752)
T KOG0670|consen 573 KNILKLCDFGSASFASENE---ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFME 649 (752)
T ss_pred cceeeeccCcccccccccc---ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHH
Confidence 4 48999999998764322 2223335579999999999999999999999999999999999987765433333332
Q ss_pred HH-----Hhhccccc-ccCCCccC-------------------------------------CCCchHHHHHHHHHHHHHc
Q 010513 405 LK-----TMVTNRNA-EGVLDPRL-------------------------------------QEKPCSRALKRALLVALRC 441 (508)
Q Consensus 405 ~~-----~~~~~~~~-~~~~~~~l-------------------------------------~~~~~~~~~~~l~~li~~c 441 (508)
++ .|+..+.+ ..-+|..+ ..+..+..+..+.+|+-+|
T Consensus 650 ~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkm 729 (752)
T KOG0670|consen 650 LKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKM 729 (752)
T ss_pred hcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHH
Confidence 22 12221110 01111111 0111334456677788899
Q ss_pred cCCCCCCCCCHHHHHHH
Q 010513 442 VDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 442 l~~dP~~RPs~~evl~~ 458 (508)
+..||++|.+..+.|++
T Consensus 730 l~LdP~KRit~nqAL~H 746 (752)
T KOG0670|consen 730 LILDPEKRITVNQALKH 746 (752)
T ss_pred hccChhhcCCHHHHhcC
Confidence 99999999999998875
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-32 Score=271.51 Aligned_cols=196 Identities=24% Similarity=0.400 Sum_probs=169.7
Q ss_pred CCCcccceEcccCcEEEEEEEECC-CcEEEEEEeecCCchhHH--------HHHHHHHHHHccC---CCCeeeEeeeeec
Q 010513 186 NGFADENVIGEGGYGIVYHGVLED-NTNVAVKNLLNNRGQAEK--------EFKVEVEAIGRVR---HKNLVRLLGYCAE 253 (508)
Q Consensus 186 ~~~~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~--------~~~~E~~~l~~l~---hpniv~l~~~~~~ 253 (508)
.+|+..+.+|+|+||.|++|.++. ...|+||.+.+.+.-... .+-.|+++|..++ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 468999999999999999999874 567899988765432111 2445999999997 9999999999999
Q ss_pred CCeeEEEEEec-CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEee
Q 010513 254 GAHRMLVYEYI-DNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSD 332 (508)
Q Consensus 254 ~~~~~lV~e~~-~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~D 332 (508)
++.+|++||.. ++-+|++++... ..+++.++..|+.|++.|+++||++ +|||||||-+|+.++.+|-+||+|
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~k----p~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~klid 713 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEFK----PRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLID 713 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhcc----CccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEee
Confidence 99999999976 456999999765 6799999999999999999999999 999999999999999999999999
Q ss_pred eccceecCCCCcceecceecCCCCCChhhhhcCCCC-CCCCeeehHHHHHHHHhCCCCCC
Q 010513 333 FGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLN-ERSDVYSFGILIMEVISGRNPVD 391 (508)
Q Consensus 333 FG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDvwSlGvvl~elltg~~Pf~ 391 (508)
||.+...... ....++||..|.|||++.+..|- ..-|||++|++||.++....||.
T Consensus 714 fgsaa~~ksg---pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 714 FGSAAYTKSG---PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred ccchhhhcCC---CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 9999875332 23457899999999999988764 45799999999999999999984
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-32 Score=275.85 Aligned_cols=255 Identities=26% Similarity=0.370 Sum_probs=208.9
Q ss_pred hcCCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCchhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEE
Q 010513 183 VSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY 261 (508)
Q Consensus 183 ~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 261 (508)
-+.++|+..+.+|.|.||.||+++++ .+...|+|.++-...+...-+.+|+-+++..+|||||.++|.+......++.|
T Consensus 12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicM 91 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICM 91 (829)
T ss_pred CCccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEE
Confidence 45678999999999999999999965 67888999998888888888889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCC
Q 010513 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA 341 (508)
Q Consensus 262 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 341 (508)
|||.+|+|.+..+.. +++++.++...++...+|++|||++ +=+|||||-.||++++.|.+|++|||.+-.+..
T Consensus 92 EycgggslQdiy~~T----gplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqita 164 (829)
T KOG0576|consen 92 EYCGGGSLQDIYHVT----GPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITA 164 (829)
T ss_pred EecCCCcccceeeec----ccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhh
Confidence 999999999988765 7899999999999999999999999 899999999999999999999999999876543
Q ss_pred CCcceecceecCCCCCChhhh---hcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCC
Q 010513 342 ERSYVTTRVMGTFGYVAPEYA---STGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVL 418 (508)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 418 (508)
. -.....+.||++|||||+. +.+.|+.++|||++|+...|+---+.|-- +....+.+..|-.. ..-
T Consensus 165 t-i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplf------dlhpmr~l~LmTkS----~~q 233 (829)
T KOG0576|consen 165 T-IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLF------DLHPMRALFLMTKS----GFQ 233 (829)
T ss_pred h-hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCccc------ccchHHHHHHhhcc----CCC
Confidence 2 2233457899999999965 46789999999999999999988887743 22333333333322 122
Q ss_pred CccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 010513 419 DPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIH 457 (508)
Q Consensus 419 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 457 (508)
.|.++. ..+...-+-++++.|+-++|++||++.-+|+
T Consensus 234 pp~lkD--k~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 234 PPTLKD--KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred CCcccC--CccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 233332 2234444555888999999999999976554
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=236.17 Aligned_cols=211 Identities=33% Similarity=0.583 Sum_probs=182.4
Q ss_pred EcccCcEEEEEEEECC-CcEEEEEEeecCCch-hHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEEecCCCCHHH
Q 010513 194 IGEGGYGIVYHGVLED-NTNVAVKNLLNNRGQ-AEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQ 271 (508)
Q Consensus 194 LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~g~L~~ 271 (508)
||+|++|.||++...+ ++.+++|.+...... ..+.+.+|++.++.++|++++++++++......+++|||+++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999764 888999998655432 35678899999999999999999999999899999999999999999
Q ss_pred HhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcC-CCCeEEeeeccceecCCCCcceecce
Q 010513 272 WLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDK-QWNPKLSDFGLAKLLGAERSYVTTRV 350 (508)
Q Consensus 272 ~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~-~~~~kL~DFG~a~~~~~~~~~~~~~~ 350 (508)
++.... ..+++..+..++.++++++.+||+. +++|+||+|.||+++. ++.++|+|||.+........ .....
T Consensus 81 ~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~ 153 (215)
T cd00180 81 LLKENE---GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTI 153 (215)
T ss_pred HHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcc
Confidence 987642 4689999999999999999999999 9999999999999999 89999999999987644321 22334
Q ss_pred ecCCCCCChhhhhcC-CCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCCccCCCCchHH
Q 010513 351 MGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSR 429 (508)
Q Consensus 351 ~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 429 (508)
.+...|++||..... .++.++|+|++|+++++|
T Consensus 154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------------------- 187 (215)
T cd00180 154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------------------- 187 (215)
T ss_pred cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------------
Confidence 578899999999877 888999999999999999
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 010513 430 ALKRALLVALRCVDPNAHKRPKMGHVIHML 459 (508)
Q Consensus 430 ~~~~l~~li~~cl~~dP~~RPs~~evl~~L 459 (508)
..+.+++.+|++.||++||++.++++.+
T Consensus 188 --~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 --PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred --HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 2344588899999999999999998753
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-29 Score=236.98 Aligned_cols=199 Identities=31% Similarity=0.476 Sum_probs=174.2
Q ss_pred CcccceEcccCcEEEEEEEECC-CcEEEEEEeecCCch-hHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEEecC
Q 010513 188 FADENVIGEGGYGIVYHGVLED-NTNVAVKNLLNNRGQ-AEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYID 265 (508)
Q Consensus 188 ~~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~ 265 (508)
|.+.+.||+|++|.||+|...+ ++.+++|.+...... ..+.+..|++.++.++|+|++++++++......++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 5667899999999999999765 888999998766544 66788899999999999999999999999899999999999
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCCCcc
Q 010513 266 NGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSY 345 (508)
Q Consensus 266 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~ 345 (508)
+++|.+++.... ..+++.....++.+++.++.+||+. +++|+||+|+||+++.++.++|+|||.+.........
T Consensus 81 ~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~ 154 (225)
T smart00221 81 GGDLFDYLRKKG---GKLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA 154 (225)
T ss_pred CCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc
Confidence 999999997652 1278999999999999999999998 9999999999999999999999999999876544311
Q ss_pred eecceecCCCCCChhhh-hcCCCCCCCCeeehHHHHHHHHhCCCCCCC
Q 010513 346 VTTRVMGTFGYVAPEYA-STGMLNERSDVYSFGILIMEVISGRNPVDY 392 (508)
Q Consensus 346 ~~~~~~gt~~y~aPE~~-~~~~~~~~sDvwSlGvvl~elltg~~Pf~~ 392 (508)
......++..|++||.. ....++.++|+|+||++++||++|+.||..
T Consensus 155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 23345788899999998 666788899999999999999999999964
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.8e-31 Score=246.54 Aligned_cols=255 Identities=26% Similarity=0.297 Sum_probs=193.8
Q ss_pred CCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecC--CchhHHHHHHHHHHHHccCCCCeeeEeeeeec------CCe
Q 010513 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE------GAH 256 (508)
Q Consensus 186 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~------~~~ 256 (508)
.+|...+.+|.|.- .|..+.+. .++.||+|+.... .....+...+|..++..++|+||++++.+|.- ...
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 36777888999988 66666543 5888999988544 23345667789999999999999999999853 346
Q ss_pred eEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccc
Q 010513 257 RMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLA 336 (508)
Q Consensus 257 ~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a 336 (508)
.|+|||+|.. +|.+.+.- .++-+...++..|++.|+.|||+. +|+||||||+||++..++.+||.|||++
T Consensus 96 ~y~v~e~m~~-nl~~vi~~------elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~a 165 (369)
T KOG0665|consen 96 VYLVMELMDA-NLCQVILM------ELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGLA 165 (369)
T ss_pred HHHHHHhhhh-HHHHHHHH------hcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchhh
Confidence 7999999976 99998863 467788899999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHH----------
Q 010513 337 KLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLK---------- 406 (508)
Q Consensus 337 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~---------- 406 (508)
+.- .....++..+.|..|.|||++-+..|.+.+||||+||++.||++|+.-|.+.+ .+.+|.+
T Consensus 166 r~e--~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d-----~idQ~~ki~~~lgtpd~ 238 (369)
T KOG0665|consen 166 RTE--DTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKD-----HIDQWNKIIEQLGTPDP 238 (369)
T ss_pred ccc--CcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCch-----HHHHHHHHHHHhcCCCH
Confidence 853 33356777889999999999988889999999999999999999999886432 2222221
Q ss_pred -----------Hhhccc------cc-ccCCCccCCCCc--hHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 407 -----------TMVTNR------NA-EGVLDPRLQEKP--CSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 407 -----------~~~~~~------~~-~~~~~~~l~~~~--~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
....+. .. +.+-|-.+.... ......-+.+++.+||-.||++|-++.++|++
T Consensus 239 ~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 239 SFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred HHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 111110 00 111111111111 11122234457789999999999999999976
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-29 Score=231.05 Aligned_cols=252 Identities=21% Similarity=0.361 Sum_probs=183.9
Q ss_pred CCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCchhHHHHHHHHHHHHcc-CCCCeeeEeee-eecCCeeEEEEE
Q 010513 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV-RHKNLVRLLGY-CAEGAHRMLVYE 262 (508)
Q Consensus 186 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~-~~~~~~~~lV~e 262 (508)
+.|.+.+.||+|.||.+-+++++ +++.+++|.+... ....++|.+|...--.| .|.||+.-|++ |+..+.+++++|
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE 102 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQE 102 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeec
Confidence 57999999999999999999977 4677888877544 34467888898877777 58999998875 566667779999
Q ss_pred ecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEE-c-CCCCeEEeeeccceecC
Q 010513 263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILL-D-KQWNPKLSDFGLAKLLG 340 (508)
Q Consensus 263 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll-~-~~~~~kL~DFG~a~~~~ 340 (508)
|++.|+|.+-+.. ..+.+....+++.|++.|+.|||++ ++||||||.+|||| + +.-++||||||+.+..+
T Consensus 103 ~aP~gdL~snv~~-----~GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g 174 (378)
T KOG1345|consen 103 FAPRGDLRSNVEA-----AGIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTRKVG 174 (378)
T ss_pred cCccchhhhhcCc-----ccccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeecccccccC
Confidence 9999999987754 3578888999999999999999999 99999999999999 2 33479999999998653
Q ss_pred CCCcceecceecCCCCCChhhhhcC-----CCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccc
Q 010513 341 AERSYVTTRVMGTFGYVAPEYASTG-----MLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAE 415 (508)
Q Consensus 341 ~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (508)
... ....-+..|.+||+.... ..++.+|+|.||+++|.++||..||. .....+....+|.+..-...
T Consensus 175 ~tV----~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQ-ka~~~d~~Y~~~~~w~~rk~--- 246 (378)
T KOG1345|consen 175 TTV----KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQ-KASIMDKPYWEWEQWLKRKN--- 246 (378)
T ss_pred cee----hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcch-hhhccCchHHHHHHHhcccC---
Confidence 322 223345679999976432 25678999999999999999999998 33333444444433221111
Q ss_pred cCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 010513 416 GVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHML 459 (508)
Q Consensus 416 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 459 (508)
..+...++ +.++. +.++..+-+.+++++|-..-++.++.
T Consensus 247 ~~~P~~F~--~fs~~---a~r~Fkk~lt~~~~drcki~~~kk~r 285 (378)
T KOG1345|consen 247 PALPKKFN--PFSEK---ALRLFKKSLTPRFKDRCKIWTAKKMR 285 (378)
T ss_pred ccCchhhc--ccCHH---HHHHHHHhcCCcccccchhHHHHHHH
Confidence 11111111 12222 33355588899999996665555443
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-28 Score=275.30 Aligned_cols=196 Identities=18% Similarity=0.252 Sum_probs=139.5
Q ss_pred ccCC-CCeeeEeeee-------ecCCeeEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC
Q 010513 238 RVRH-KNLVRLLGYC-------AEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK 309 (508)
Q Consensus 238 ~l~h-pniv~l~~~~-------~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ 309 (508)
.++| +||++++++| .+...+++++||++ ++|.++|... ...+++..++.++.||++||+|||++ +
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---g 100 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECED-VSLRQWLDNP---DRSVDAFECFHVFRQIVEIVNAAHSQ---G 100 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccCC-ccHHHHHhcc---cccccHHHHHHHHHHHHHHHHHHHhC---C
Confidence 4455 5888888887 23345678889874 5999999754 35699999999999999999999999 9
Q ss_pred eeeccCCCCCEEEcCCC-------------------CeEEeeeccceecCCCC---------------cceecceecCCC
Q 010513 310 VVHRDIKSSNILLDKQW-------------------NPKLSDFGLAKLLGAER---------------SYVTTRVMGTFG 355 (508)
Q Consensus 310 iiHrDlkp~NIll~~~~-------------------~~kL~DFG~a~~~~~~~---------------~~~~~~~~gt~~ 355 (508)
|+||||||+||||+..+ .+|++|||+++...... .......+||+.
T Consensus 101 IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 180 (793)
T PLN00181 101 IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSW 180 (793)
T ss_pred eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcc
Confidence 99999999999996544 45566666655321100 000112468999
Q ss_pred CCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCCccCCCCchHHHHHHHH
Q 010513 356 YVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRAL 435 (508)
Q Consensus 356 y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~ 435 (508)
|+|||++.+..|+.++|||||||+||||++|..|+.... .....+.. ..+.+.. .....+..
T Consensus 181 Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~-----~~~~~~~~--------~~~~~~~-----~~~~~~~~ 242 (793)
T PLN00181 181 YTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS-----RTMSSLRH--------RVLPPQI-----LLNWPKEA 242 (793)
T ss_pred eEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH-----HHHHHHHH--------hhcChhh-----hhcCHHHH
Confidence 999999999999999999999999999999988864211 11111110 0111111 11122344
Q ss_pred HHHHHccCCCCCCCCCHHHHHHH
Q 010513 436 LVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 436 ~li~~cl~~dP~~RPs~~evl~~ 458 (508)
.++.+||++||.+||++.|++++
T Consensus 243 ~~~~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 243 SFCLWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred HHHHHhCCCChhhCcChHHHhhc
Confidence 57789999999999999999875
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-27 Score=232.31 Aligned_cols=201 Identities=26% Similarity=0.399 Sum_probs=165.9
Q ss_pred hhcCCCCcccceEcccCcEEEEEEEEC----CCcEEEEEEeecCCchhHHHHHHHHHHHHcc-CCCCeeeEeeeeecCCe
Q 010513 182 EVSTNGFADENVIGEGGYGIVYHGVLE----DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEGAH 256 (508)
Q Consensus 182 ~~~~~~~~~~~~LG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~ 256 (508)
....+.|..+++||+|.|++||++.+. .+..||+|.+... .....+..|+++|..+ .+.||+++.+++..+++
T Consensus 32 p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t--s~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~ 109 (418)
T KOG1167|consen 32 PFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT--SSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQ 109 (418)
T ss_pred hhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccc--cCchHHHHHHHHHHHhccchhhhcchhhhccCCe
Confidence 334567899999999999999999843 3667999988543 3345688899999999 68999999999999999
Q ss_pred eEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcC-CCCeEEeeecc
Q 010513 257 RMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDK-QWNPKLSDFGL 335 (508)
Q Consensus 257 ~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~-~~~~kL~DFG~ 335 (508)
..+|+||++..+..+++. .++...+..+++.+..||.++|.+ |||||||||+|+|.+. .+.-.|+|||+
T Consensus 110 v~ivlp~~~H~~f~~l~~-------~l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDFgL 179 (418)
T KOG1167|consen 110 VAIVLPYFEHDRFRDLYR-------SLSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDFGL 179 (418)
T ss_pred eEEEecccCccCHHHHHh-------cCCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEechh
Confidence 999999999999888874 456888999999999999999999 9999999999999975 45689999999
Q ss_pred ceecCC---------------------------------CCcc----------eecceecCCCCCChhhhhc-CCCCCCC
Q 010513 336 AKLLGA---------------------------------ERSY----------VTTRVMGTFGYVAPEYAST-GMLNERS 371 (508)
Q Consensus 336 a~~~~~---------------------------------~~~~----------~~~~~~gt~~y~aPE~~~~-~~~~~~s 371 (508)
|..... ...+ ......||++|.|||++.. ..-++++
T Consensus 180 A~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qttai 259 (418)
T KOG1167|consen 180 AQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAI 259 (418)
T ss_pred HHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcc
Confidence 972110 0000 0112469999999998865 4578899
Q ss_pred CeeehHHHHHHHHhCCCCCCCCC
Q 010513 372 DVYSFGILIMEVISGRNPVDYSR 394 (508)
Q Consensus 372 DvwSlGvvl~elltg~~Pf~~~~ 394 (508)
||||.|+++.-+++++.||-...
T Consensus 260 Diws~GVI~Lslls~~~PFf~a~ 282 (418)
T KOG1167|consen 260 DIWSAGVILLSLLSRRYPFFKAK 282 (418)
T ss_pred ceeeccceeehhhccccccccCc
Confidence 99999999999999999997554
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.94 E-value=2e-26 Score=210.46 Aligned_cols=166 Identities=25% Similarity=0.238 Sum_probs=125.7
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCCCcce
Q 010513 267 GNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYV 346 (508)
Q Consensus 267 g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~ 346 (508)
|+|.+++... ...+++..++.++.|++.||+|||++ + ||+|||++.++.+|+ ||++.......
T Consensus 1 GsL~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~--- 63 (176)
T smart00750 1 VSLADILEVR---GRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ--- 63 (176)
T ss_pred CcHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc---
Confidence 6899999764 35699999999999999999999998 5 999999999999999 99998754322
Q ss_pred ecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCCccCCCCc
Q 010513 347 TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKP 426 (508)
Q Consensus 347 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 426 (508)
..||+.|+|||++.+..++.++|||||||++|||+||+.||....... .........+.. . ++.... .
T Consensus 64 ---~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~-~~~~~~~~~~~~-~------~~~~~~-~ 131 (176)
T smart00750 64 ---SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS-AILEILLNGMPA-D------DPRDRS-N 131 (176)
T ss_pred ---CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc-HHHHHHHHHhcc-C------Cccccc-c
Confidence 268999999999999999999999999999999999999996443211 111111111111 0 010000 0
Q ss_pred hHHHH--HHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 010513 427 CSRAL--KRALLVALRCVDPNAHKRPKMGHVIHMLEA 461 (508)
Q Consensus 427 ~~~~~--~~l~~li~~cl~~dP~~RPs~~evl~~Le~ 461 (508)
..... .++.+++.+||+.||++||++.++++++..
T Consensus 132 ~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~ 168 (176)
T smart00750 132 LESVSAARSFADFMRVCASRLPQRREAANHYLAHCRA 168 (176)
T ss_pred HHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHH
Confidence 11111 247778899999999999999999998754
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.1e-25 Score=223.98 Aligned_cols=164 Identities=20% Similarity=0.238 Sum_probs=128.7
Q ss_pred cCCCCcccceEcccCcEEEEEEEEC--CCcEEEEEEeecC-----CchhHHHHHHHHHHHHccCCCCeee-EeeeeecCC
Q 010513 184 STNGFADENVIGEGGYGIVYHGVLE--DNTNVAVKNLLNN-----RGQAEKEFKVEVEAIGRVRHKNLVR-LLGYCAEGA 255 (508)
Q Consensus 184 ~~~~~~~~~~LG~G~~g~Vy~~~~~--~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~hpniv~-l~~~~~~~~ 255 (508)
..++|.+.+.||+|+||+||+|.+. +++.+|||++... .....+.+.+|+++|++++|+|+++ ++++ .
T Consensus 16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----~ 91 (365)
T PRK09188 16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----G 91 (365)
T ss_pred ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----C
Confidence 4457999999999999999999865 4677899987533 1223456899999999999999985 4432 4
Q ss_pred eeEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccC-CCCCEEEcCCCCeEEeeec
Q 010513 256 HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDI-KSSNILLDKQWNPKLSDFG 334 (508)
Q Consensus 256 ~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDl-kp~NIll~~~~~~kL~DFG 334 (508)
..|+||||++|++|... ... . ...++.|+++||.|||++ +|+|||| ||+|||++.++.+||+|||
T Consensus 92 ~~~LVmE~~~G~~L~~~-~~~----~------~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDFG 157 (365)
T PRK09188 92 KDGLVRGWTEGVPLHLA-RPH----G------DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDFQ 157 (365)
T ss_pred CcEEEEEccCCCCHHHh-Ccc----c------hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEECc
Confidence 57999999999999732 111 1 145788999999999999 9999999 9999999999999999999
Q ss_pred cceecCCCCcc-------eecceecCCCCCChhhhhcC
Q 010513 335 LAKLLGAERSY-------VTTRVMGTFGYVAPEYASTG 365 (508)
Q Consensus 335 ~a~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~ 365 (508)
+++.+...... ..+..++++.|+|||.+...
T Consensus 158 lA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 158 LASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred cceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 99977543211 11456789999999988543
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.8e-25 Score=219.03 Aligned_cols=258 Identities=18% Similarity=0.242 Sum_probs=192.8
Q ss_pred CCcccceEcccCcEEEEEEEECCC--cEEEEEEeecCCchhHHHHHHHHHHHHccCC----CCeeeEeeee-ecCCeeEE
Q 010513 187 GFADENVIGEGGYGIVYHGVLEDN--TNVAVKNLLNNRGQAEKEFKVEVEAIGRVRH----KNLVRLLGYC-AEGAHRML 259 (508)
Q Consensus 187 ~~~~~~~LG~G~~g~Vy~~~~~~~--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h----pniv~l~~~~-~~~~~~~l 259 (508)
+|.+.+.||+|+||.||+|..... ..+|+|............+..|..++..+.. +++..+++.. ..+...|+
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 899999999999999999997653 4688887765433333367778888888863 6899999999 57778899
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCC-----CCeEEeeec
Q 010513 260 VYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQ-----WNPKLSDFG 334 (508)
Q Consensus 260 V~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~-----~~~kL~DFG 334 (508)
||+.+ |.+|.++..... ...++...+..++.|++.+|++||+. |++||||||+|+++... ..+.|.|||
T Consensus 99 VM~l~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDfG 172 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDFG 172 (322)
T ss_pred EEecc-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEecC
Confidence 99988 669999876553 47899999999999999999999999 99999999999999755 359999999
Q ss_pred cce--ecCCCCc-----c-e-ecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHH
Q 010513 335 LAK--LLGAERS-----Y-V-TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWL 405 (508)
Q Consensus 335 ~a~--~~~~~~~-----~-~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~ 405 (508)
+++ .+..... . . ...+.||..|+++....+...+.+.|+||++.++.|++.|..||......... ..+
T Consensus 173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~---~~~ 249 (322)
T KOG1164|consen 173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLK---SKF 249 (322)
T ss_pred CCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchH---HHH
Confidence 998 3211111 1 1 12356999999999999999999999999999999999999999655433221 111
Q ss_pred HHhhcccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010513 406 KTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (508)
Q Consensus 406 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~~ 462 (508)
......... .. .....+.....+. ..+-..+...+|....+...|+..
T Consensus 250 ~~~~~~~~~----~~--~~~~~~~~~~~~~---~~~~~~~~~~~Pdy~~~~~~l~~~ 297 (322)
T KOG1164|consen 250 EKDPRKLLT----DR--FGDLKPEEFAKIL---EYIDSLDYEDKPDYEKLAELLKDV 297 (322)
T ss_pred HHHhhhhcc----cc--ccCCChHHHHHHH---HHhhccCCcCCCCHHHHHHHHHHH
Confidence 111111110 00 1112334444433 344458999999999998887543
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.5e-23 Score=206.25 Aligned_cols=261 Identities=28% Similarity=0.397 Sum_probs=197.6
Q ss_pred CcccceEcccCcEEEEEEEECCCcEEEEEEeecCCch---hHHHHHHHHHHHHccCCC-CeeeEeeeeecCCeeEEEEEe
Q 010513 188 FADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQ---AEKEFKVEVEAIGRVRHK-NLVRLLGYCAEGAHRMLVYEY 263 (508)
Q Consensus 188 ~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hp-niv~l~~~~~~~~~~~lV~e~ 263 (508)
|.+.+.||.|+||.||++... ..+++|.+...... ....+.+|+.+++.+.|+ +++++.+.+......++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 677889999999999999987 77899988655333 367889999999999988 799999999887778999999
Q ss_pred cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCC-CeEEeeeccceecCCC
Q 010513 264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQW-NPKLSDFGLAKLLGAE 342 (508)
Q Consensus 264 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~-~~kL~DFG~a~~~~~~ 342 (508)
+.++++.+++...... ..+.......++.|++.++.|+|+. +++|||+||+||+++..+ .++++|||.++.....
T Consensus 80 ~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~ 155 (384)
T COG0515 80 VDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP 155 (384)
T ss_pred CCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence 9999999777654211 3689999999999999999999999 999999999999999988 6999999999866443
Q ss_pred Ccc-----eecceecCCCCCChhhhhc---CCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhccccc
Q 010513 343 RSY-----VTTRVMGTFGYVAPEYAST---GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNA 414 (508)
Q Consensus 343 ~~~-----~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 414 (508)
... ......||..|+|||.+.+ ..++...|+||+|++++++++|..||...... ...............
T Consensus 156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~---~~~~~~~~~~~~~~~ 232 (384)
T COG0515 156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS---SATSQTLKIILELPT 232 (384)
T ss_pred CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc---ccHHHHHHHHHhcCC
Confidence 322 2456789999999999987 57888999999999999999999997654331 001111111111110
Q ss_pred ccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 415 EGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 415 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
. .................+.+++.+|+..+|..|.+..+....
T Consensus 233 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 233 P-SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred c-ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 0 000011110001122344557779999999999998877654
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.1e-23 Score=197.36 Aligned_cols=203 Identities=21% Similarity=0.310 Sum_probs=170.8
Q ss_pred CCCcccceEcccCcEEEEEEE-ECCCcEEEEEEeecCCchhHHHHHHHHHHHHcc-CCCCeeeEeeeeecCCeeEEEEEe
Q 010513 186 NGFADENVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEY 263 (508)
Q Consensus 186 ~~~~~~~~LG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lV~e~ 263 (508)
-.|.+.++||+|.||+.+.|+ .-++..||||.- ......-+++.|.+..+.| ..++|...|.+..++.+..||||.
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfE--PrkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL 105 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFE--PRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL 105 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEec--cccCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence 378999999999999999999 446899999953 3334455677888888888 579999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCC-----CeEEeeecccee
Q 010513 264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQW-----NPKLSDFGLAKL 338 (508)
Q Consensus 264 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~-----~~kL~DFG~a~~ 338 (508)
+ |.+|+|++.-. ...++...+.-++.|++.-++|+|++ .+|+|||||+|+||...+ .+.++|||+|+.
T Consensus 106 L-GPSLEDLFD~C---gR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~ 178 (449)
T KOG1165|consen 106 L-GPSLEDLFDLC---GRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE 178 (449)
T ss_pred h-CcCHHHHHHHh---cCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence 8 66898887654 46799999999999999999999999 999999999999996433 489999999998
Q ss_pred cCCCCcc------eecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCC
Q 010513 339 LGAERSY------VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPG 397 (508)
Q Consensus 339 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~ 397 (508)
+.+.... ......||..||+=-...+.+-+.+.|+-|||-++++.+-|..||.+...+.
T Consensus 179 YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~t 243 (449)
T KOG1165|consen 179 YRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADT 243 (449)
T ss_pred hcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcc
Confidence 7543322 1234679999999888888889999999999999999999999999775443
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1e-24 Score=232.99 Aligned_cols=254 Identities=22% Similarity=0.268 Sum_probs=187.7
Q ss_pred cccceEcccCcEEEEEEEEC-CCcEEEEEEeecC--CchhH----HHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEE
Q 010513 189 ADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN--RGQAE----KEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY 261 (508)
Q Consensus 189 ~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~----~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 261 (508)
.....+|.|++|.|+..... ....++.|..... ..... ..+..|+.+-..+.|||++..+..+.+....+-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 45778999999988877643 3333444433210 11111 12556777788899999999888888777776679
Q ss_pred EecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCC
Q 010513 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA 341 (508)
Q Consensus 262 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 341 (508)
|||++ +|+.++... ..++...+..++.|++.|+.|+|+. |+.|||+|++|++++.+|.+||+|||.+..+.-
T Consensus 401 E~~~~-Dlf~~~~~~----~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~ 472 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSN----GKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRY 472 (601)
T ss_pred hcccH-HHHHHHhcc----cccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeecc
Confidence 99999 999999764 4688899999999999999999999 999999999999999999999999999987754
Q ss_pred CCc---ceecceecCCCCCChhhhhcCCCCCC-CCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccC
Q 010513 342 ERS---YVTTRVMGTFGYVAPEYASTGMLNER-SDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGV 417 (508)
Q Consensus 342 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~-sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 417 (508)
... ......+|+..|+|||++.+..|++. .||||.|++++.|++|+.||.......... ............
T Consensus 473 ~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~-----~~~~~~~~~~~~ 547 (601)
T KOG0590|consen 473 PWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF-----KTNNYSDQRNIF 547 (601)
T ss_pred CcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch-----hhhccccccccc
Confidence 333 44566899999999999999999885 699999999999999999998664432211 000000000000
Q ss_pred CCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 418 LDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 418 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
.. ..........+...++.++|+.||.+|-++++|++.
T Consensus 548 ~~---~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d 585 (601)
T KOG0590|consen 548 EG---PNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND 585 (601)
T ss_pred cC---hHHHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence 00 011122233445568889999999999999998853
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=8.4e-24 Score=191.86 Aligned_cols=260 Identities=19% Similarity=0.229 Sum_probs=193.3
Q ss_pred hcCCCCcccceEcccCcEEEEEEE-ECCCcEEEEEEeecCCchhHHHHHHHHHHHHccCC-CCeeeEeeeeecCCeeEEE
Q 010513 183 VSTNGFADENVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRH-KNLVRLLGYCAEGAHRMLV 260 (508)
Q Consensus 183 ~~~~~~~~~~~LG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~l~~~~~~~~~~~lV 260 (508)
+-.+.|.++++||.|+||.+|+|. ..+|.+||||.-..... ...+..|.++.+.|++ ..|..+..++.+..+..+|
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlV 89 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLV 89 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhccccccceee
Confidence 455689999999999999999999 56799999997544332 3456668888888865 6788888889999999999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcC---CCCeEEeeeccce
Q 010513 261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDK---QWNPKLSDFGLAK 337 (508)
Q Consensus 261 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~---~~~~kL~DFG~a~ 337 (508)
||.. |.+|++++.-. ...++..+++-++-|++.-++|+|.+ ++|||||||+|+|+.- ...+.|+|||+++
T Consensus 90 MdLL-GPsLEdLfnfC---~R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaK 162 (341)
T KOG1163|consen 90 MDLL-GPSLEDLFNFC---SRRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAK 162 (341)
T ss_pred eecc-CccHHHHHHHH---hhhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchh
Confidence 9998 66999988644 35689999999999999999999999 9999999999999953 3469999999998
Q ss_pred ecCCCCcc------eecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcc
Q 010513 338 LLGAERSY------VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTN 411 (508)
Q Consensus 338 ~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~ 411 (508)
.+.+.... ......||..|.+--..-+..-+...|+-|+|.+|.++.-|..||.+.......+..+.+.+.-..
T Consensus 163 ky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s 242 (341)
T KOG1163|consen 163 KYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMS 242 (341)
T ss_pred hhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcC
Confidence 77443221 123467999999987777777788899999999999999999999987665544443333222111
Q ss_pred cccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 010513 412 RNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 460 (508)
Q Consensus 412 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le 460 (508)
...+ ..|...+.++...+.-|-..--++-|+...+-+.+.
T Consensus 243 ~~ie---------~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFr 282 (341)
T KOG1163|consen 243 TPIE---------VLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFR 282 (341)
T ss_pred CCHH---------HHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHH
Confidence 1100 012222233333444666666677777666655544
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.2e-24 Score=200.33 Aligned_cols=250 Identities=20% Similarity=0.323 Sum_probs=186.2
Q ss_pred CCcccceEcccCcEEEEEEEECCCcEEEEEEee--cCCchhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEEec
Q 010513 187 GFADENVIGEGGYGIVYHGVLEDNTNVAVKNLL--NNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYI 264 (508)
Q Consensus 187 ~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~ 264 (508)
+..+.-+|.+...|+.|+|+|..+ .+++|++. ........+|..|.-.|+-+.||||+++++.|....+..++..||
T Consensus 191 ~lnl~tkl~e~hsgelwrgrwqgn-divakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~m 269 (448)
T KOG0195|consen 191 SLNLITKLAESHSGELWRGRWQGN-DIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYM 269 (448)
T ss_pred hhhhhhhhccCCCcccccccccCc-chhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeec
Confidence 344566799999999999999854 45666553 234445578999999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCCCc
Q 010513 265 DNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS 344 (508)
Q Consensus 265 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~ 344 (508)
+.|+|+..|++.. .-..+..++.+++.++++|++|||+. ++-|----|.+..+++|++.+.+|.- +-.++ +
T Consensus 270 p~gslynvlhe~t--~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarism-ad~kf-----s 340 (448)
T KOG0195|consen 270 PFGSLYNVLHEQT--SVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISM-ADTKF-----S 340 (448)
T ss_pred cchHHHHHHhcCc--cEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheec-cccee-----e
Confidence 9999999998763 34567788999999999999999986 55455557889999999998877641 11111 1
Q ss_pred ceecceecCCCCCChhhhhcCCCC---CCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCCcc
Q 010513 345 YVTTRVMGTFGYVAPEYASTGMLN---ERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPR 421 (508)
Q Consensus 345 ~~~~~~~gt~~y~aPE~~~~~~~~---~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 421 (508)
+......-.|.||+||.++.++-+ .++|+|||+++||||.|...||.+..+.+- ..+. . .+-+.+.
T Consensus 341 fqe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmec------gmki-a----leglrv~ 409 (448)
T KOG0195|consen 341 FQEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMEC------GMKI-A----LEGLRVH 409 (448)
T ss_pred eeccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhh------hhhh-h----hcccccc
Confidence 112223457899999999876644 468999999999999999999986554221 1111 1 1122222
Q ss_pred CCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 010513 422 LQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461 (508)
Q Consensus 422 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~ 461 (508)
+ ++.....+-+++.-|++.||.+||.+..|+-.||.
T Consensus 410 i----ppgis~hm~klm~icmnedpgkrpkfdmivpilek 445 (448)
T KOG0195|consen 410 I----PPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEK 445 (448)
T ss_pred C----CCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHH
Confidence 2 22233344447778999999999999999988874
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1e-24 Score=232.90 Aligned_cols=254 Identities=22% Similarity=0.215 Sum_probs=184.4
Q ss_pred CCcccceEcccCcEEEEEEEECCCcEEEEEEeecCC-chhHHHHHHHHHH--HHccCCCCeeeEeeeeecCCeeEEEEEe
Q 010513 187 GFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNR-GQAEKEFKVEVEA--IGRVRHKNLVRLLGYCAEGAHRMLVYEY 263 (508)
Q Consensus 187 ~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~--l~~l~hpniv~l~~~~~~~~~~~lV~e~ 263 (508)
.|...+.||++.|=+|.+|+++.|. |+||++.+.. .-..+.|.++++- ...++|||.+++.-+-......|||-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 5777899999999999999988776 9999987664 3334444443333 4455899999999998888888999999
Q ss_pred cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecC--C
Q 010513 264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG--A 341 (508)
Q Consensus 264 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~--~ 341 (508)
+.+ +|+|.+..+ .-+..-+.+.|+.|++.||..+|.. ||+|||||.+||||+.-+-+.|+||...+..- .
T Consensus 103 vkh-nLyDRlSTR----PFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPe 174 (1431)
T KOG1240|consen 103 VKH-NLYDRLSTR----PFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPE 174 (1431)
T ss_pred Hhh-hhhhhhccc----hHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCCC
Confidence 987 999999765 4577788899999999999999999 99999999999999999899999998776432 2
Q ss_pred CCcceec----ceecCCCCCChhhhhcC-----------CCCCCCCeeehHHHHHHHHh-CCCCCCCCCCCCcchHHHHH
Q 010513 342 ERSYVTT----RVMGTFGYVAPEYASTG-----------MLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWL 405 (508)
Q Consensus 342 ~~~~~~~----~~~gt~~y~aPE~~~~~-----------~~~~~sDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~ 405 (508)
++....+ +...-.+|.|||.+... ..+++.||||+||++.||++ |++||... +.+
T Consensus 175 DNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS---------QL~ 245 (1431)
T KOG1240|consen 175 DNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS---------QLL 245 (1431)
T ss_pred CCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH---------HHH
Confidence 2211111 11223479999976431 15678999999999999999 89999522 111
Q ss_pred HHhhcccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCCC
Q 010513 406 KTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEEFP 465 (508)
Q Consensus 406 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~~~~~ 465 (508)
.....+....+ .+-....+. .+.++++.|++.||.+|-++++.|+.-.+.-||
T Consensus 246 aYr~~~~~~~e----~~Le~Ied~---~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~~FP 298 (1431)
T KOG1240|consen 246 AYRSGNADDPE----QLLEKIEDV---SLRNLILSMIQRDPSKRLSAEDYLQKYRGLVFP 298 (1431)
T ss_pred hHhccCccCHH----HHHHhCcCc---cHHHHHHHHHccCchhccCHHHHHHhhhccccH
Confidence 11110000000 000000111 234488899999999999999999886665543
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=8e-23 Score=191.47 Aligned_cols=173 Identities=13% Similarity=0.149 Sum_probs=134.9
Q ss_pred hhcCCCCcccceEcccCcEEEEEEEECCCcEEEEEEeecCCchhHH---------HHHHHHHHHHccCCCCeeeEeeeee
Q 010513 182 EVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEK---------EFKVEVEAIGRVRHKNLVRLLGYCA 252 (508)
Q Consensus 182 ~~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~---------~~~~E~~~l~~l~hpniv~l~~~~~ 252 (508)
++..++|...+.||.|+||.||++.. ++..+|+|.+......... .+.+|+..+.++.|++|..+.+++.
T Consensus 27 ~~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~ 105 (232)
T PRK10359 27 DFLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYL 105 (232)
T ss_pred HHhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeee
Confidence 45678999999999999999999766 5778999998654332222 2678999999999999999998866
Q ss_pred cC--------CeeEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcC
Q 010513 253 EG--------AHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDK 324 (508)
Q Consensus 253 ~~--------~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~ 324 (508)
.. ...++||||++|.+|.++.. +++ ....+++.++..+|+. +++|||+||+||+++.
T Consensus 106 ~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~--------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~ 170 (232)
T PRK10359 106 LAERKTLRYAHTYIMLIEYIEGVELNDMPE--------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSK 170 (232)
T ss_pred ecccccccccCCeEEEEEEECCccHHHhhh--------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeC
Confidence 43 35789999999999988731 222 2455899999999999 9999999999999999
Q ss_pred CCCeEEeeeccceecCCCCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHH
Q 010513 325 QWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVI 384 (508)
Q Consensus 325 ~~~~kL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ell 384 (508)
++ ++|+|||........... ..+.....|+.++|+||||+++..+.
T Consensus 171 ~g-i~liDfg~~~~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 171 NG-LRIIDLSGKRCTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CC-EEEEECCCcccccchhhH-------------HHHHHHhHhcccccccceeEeehHHH
Confidence 88 999999988754211111 11344556778999999999986654
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.3e-22 Score=184.75 Aligned_cols=139 Identities=17% Similarity=0.170 Sum_probs=108.3
Q ss_pred cceEcccCcEEEEEEEECCCcEEEEEEeecCCch--h------------------------HHHHHHHHHHHHccCCCCe
Q 010513 191 ENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQ--A------------------------EKEFKVEVEAIGRVRHKNL 244 (508)
Q Consensus 191 ~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~------------------------~~~~~~E~~~l~~l~hpni 244 (508)
...||+|+||.||+|...+|+.||+|++...... . ......|++.+.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4679999999999999878999999998654211 0 1122349999999988776
Q ss_pred eeEeeeeecCCeeEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCeeeccCCCCCEEEc
Q 010513 245 VRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYL-HEGLEPKVVHRDIKSSNILLD 323 (508)
Q Consensus 245 v~l~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~L-H~~~~~~iiHrDlkp~NIll~ 323 (508)
.....+.. ...++||||++++++....... ..++...+..++.|++.+|.|+ |+. +|+||||||+|||++
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~----~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~ 152 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLKD----APLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH 152 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE
Confidence 44333222 2238999999998776543222 4688899999999999999999 688 999999999999998
Q ss_pred CCCCeEEeeeccceec
Q 010513 324 KQWNPKLSDFGLAKLL 339 (508)
Q Consensus 324 ~~~~~kL~DFG~a~~~ 339 (508)
++.++|+|||++...
T Consensus 153 -~~~v~LiDFG~a~~~ 167 (190)
T cd05147 153 -DGKLYIIDVSQSVEH 167 (190)
T ss_pred -CCcEEEEEccccccC
Confidence 478999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.2e-21 Score=177.80 Aligned_cols=140 Identities=21% Similarity=0.202 Sum_probs=111.2
Q ss_pred cceEcccCcEEEEEEEECCCcEEEEEEeecCCch--------------------------hHHHHHHHHHHHHccCCCCe
Q 010513 191 ENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQ--------------------------AEKEFKVEVEAIGRVRHKNL 244 (508)
Q Consensus 191 ~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------------------------~~~~~~~E~~~l~~l~hpni 244 (508)
...||+|+||.||+|...+|+.||||.+...... ....+..|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4679999999999999878999999998654211 01234578999999999987
Q ss_pred eeEeeeeecCCeeEEEEEecCCCCHHHH-hccCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeeccCCCCCEEE
Q 010513 245 VRLLGYCAEGAHRMLVYEYIDNGNLEQW-LHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE-GLEPKVVHRDIKSSNILL 322 (508)
Q Consensus 245 v~l~~~~~~~~~~~lV~e~~~~g~L~~~-l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~~iiHrDlkp~NIll 322 (508)
.....+... ..++||||++++++... +.. ..++......++.|++.++.++|+ . +|+||||||+|||+
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~-----~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll 151 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKD-----VPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILY 151 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhhh-----ccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEE
Confidence 554444333 24899999998855443 322 357788899999999999999999 8 99999999999999
Q ss_pred cCCCCeEEeeeccceecCC
Q 010513 323 DKQWNPKLSDFGLAKLLGA 341 (508)
Q Consensus 323 ~~~~~~kL~DFG~a~~~~~ 341 (508)
+ ++.++|+|||++.....
T Consensus 152 ~-~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 152 H-DGKPYIIDVSQAVELDH 169 (190)
T ss_pred E-CCCEEEEEcccceecCC
Confidence 9 78999999999987643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=4e-21 Score=176.34 Aligned_cols=188 Identities=17% Similarity=0.123 Sum_probs=140.5
Q ss_pred cccceEcccCcEEEEEEEECCCcEEEEEEeecCCch----hHHHHHHHHHHHHccC-CCCeeeEeeeeecCCeeEEEEEe
Q 010513 189 ADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQ----AEKEFKVEVEAIGRVR-HKNLVRLLGYCAEGAHRMLVYEY 263 (508)
Q Consensus 189 ~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~lV~e~ 263 (508)
.....|++|+||+||.+.. .+.+++.+.+...... ....+.+|+++|++|. |+++++++++ +..+++|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 3467899999999997766 5777777766544321 1125788999999995 5889999886 346899999
Q ss_pred cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccC-CCCCEEEcCCCCeEEeeeccceecCCC
Q 010513 264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDI-KSSNILLDKQWNPKLSDFGLAKLLGAE 342 (508)
Q Consensus 264 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDl-kp~NIll~~~~~~kL~DFG~a~~~~~~ 342 (508)
+.|.+|.+.+.. . ...++.|++++|+++|++ ||+|||| ||+|||++.++.++|+|||++......
T Consensus 80 I~G~~L~~~~~~-----~------~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~ 145 (218)
T PRK12274 80 LAGAAMYQRPPR-----G------DLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPR 145 (218)
T ss_pred ecCccHHhhhhh-----h------hHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCc
Confidence 999998754321 1 134677999999999999 9999999 799999999999999999999865433
Q ss_pred Ccc----e--------ecceecCCCCCChhhhhcC-CCC-CCCCeeehHHHHHHHHhCCCCCCCCCC
Q 010513 343 RSY----V--------TTRVMGTFGYVAPEYASTG-MLN-ERSDVYSFGILIMEVISGRNPVDYSRP 395 (508)
Q Consensus 343 ~~~----~--------~~~~~gt~~y~aPE~~~~~-~~~-~~sDvwSlGvvl~elltg~~Pf~~~~~ 395 (508)
... . ......++.|++|+...-- ..+ ...++++-|+-+|.++|++.|+-..+.
T Consensus 146 ~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~ 212 (218)
T PRK12274 146 ARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDNE 212 (218)
T ss_pred chHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccCC
Confidence 210 0 1112468889999854321 222 456999999999999999998754443
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.4e-22 Score=207.25 Aligned_cols=186 Identities=27% Similarity=0.317 Sum_probs=157.0
Q ss_pred eEcccCcEEEEEEEE----CCCcEEEEEEeecCCch--hHHHHHHHHHHHHccC-CCCeeeEeeeeecCCeeEEEEEecC
Q 010513 193 VIGEGGYGIVYHGVL----EDNTNVAVKNLLNNRGQ--AEKEFKVEVEAIGRVR-HKNLVRLLGYCAEGAHRMLVYEYID 265 (508)
Q Consensus 193 ~LG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~lV~e~~~ 265 (508)
.+|+|.||.|++++. +.+.-+|+|.+.+.... .......|..++...+ ||.+|++...++.+...+++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 379999999998762 34667888877554221 1114556888888886 9999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCCCcc
Q 010513 266 NGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSY 345 (508)
Q Consensus 266 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~ 345 (508)
+|+|...+... ..+++.....+...++-|++++|+. +++|||+|++||+++.+|++++.|||+++..-....
T Consensus 81 gg~lft~l~~~----~~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~- 152 (612)
T KOG0603|consen 81 GGDLFTRLSKE----VMFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI- 152 (612)
T ss_pred cchhhhccccC----CchHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhh-
Confidence 99999988765 4677888888888999999999999 999999999999999999999999999986532221
Q ss_pred eecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCC
Q 010513 346 VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDY 392 (508)
Q Consensus 346 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~ 392 (508)
.|||..|||||+++ .+..++|+||||++++||+||..||..
T Consensus 153 ----~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 153 ----ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred ----cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 28999999999998 567889999999999999999999974
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.7e-20 Score=204.58 Aligned_cols=253 Identities=19% Similarity=0.205 Sum_probs=187.4
Q ss_pred hhhHhhcCCCCcccceEcccCcEEEEEEEECCCcEEEEEEeecCCchhHHHHHHHHHHHHccC---CCCeeeEeeeeecC
Q 010513 178 LRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVR---HKNLVRLLGYCAEG 254 (508)
Q Consensus 178 ~~~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---hpniv~l~~~~~~~ 254 (508)
..+.++..+.|.+.+.||+|+||+||+|...+|+.||+|.-+..... +|.--.+++.+|+ -+.|..+...+...
T Consensus 690 ~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~ 766 (974)
T KOG1166|consen 690 NTEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMHISSAHVFQ 766 (974)
T ss_pred cceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHHHHHHHccC
Confidence 45567788899999999999999999999888999999987655433 3333344555555 34566666666667
Q ss_pred CeeEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcC-------CCC
Q 010513 255 AHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDK-------QWN 327 (508)
Q Consensus 255 ~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~-------~~~ 327 (508)
+.-++|+||.+.|+|.+++... ...++...+.+..|++..++.||.. +|||+||||+|.||.. ..-
T Consensus 767 ~~S~lv~ey~~~Gtlld~~N~~----~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~ 839 (974)
T KOG1166|consen 767 NASVLVSEYSPYGTLLDLINTN----KVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKG 839 (974)
T ss_pred CcceeeeeccccccHHHhhccC----CCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccc
Confidence 7788999999999999999844 6789999999999999999999999 9999999999999932 334
Q ss_pred eEEeeeccceecCCC-CcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHH
Q 010513 328 PKLSDFGLAKLLGAE-RSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLK 406 (508)
Q Consensus 328 ~kL~DFG~a~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~ 406 (508)
++|+|||.+..+.-- ........++|-.+--+|+..+..++.++|.|.|+-+++.|+.|+.- +
T Consensus 840 l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~----------------q 903 (974)
T KOG1166|consen 840 LYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM----------------E 903 (974)
T ss_pred eEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH----------------H
Confidence 899999998765332 22345567889999999999999999999999999999999999642 1
Q ss_pred HhhcccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010513 407 TMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (508)
Q Consensus 407 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~~ 462 (508)
..++... .++..++.-.-.....++++ .+|+.|-..=|...++...|++.
T Consensus 904 --~~~g~~~-~~~~~~~Ry~~~~~W~~~F~---~lLN~~~~~~p~l~~lr~~~~~~ 953 (974)
T KOG1166|consen 904 --VKNGSSW-MVKTNFPRYWKRDMWNKFFD---LLLNPDCDTLPNLQELRTELEEV 953 (974)
T ss_pred --hcCCcce-eccccchhhhhHHHHHHHHH---HHhCcCcccchhHHHHHHHHHHH
Confidence 1111111 11222222222233445444 45556655667777777776643
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.8e-20 Score=172.78 Aligned_cols=136 Identities=15% Similarity=0.250 Sum_probs=106.0
Q ss_pred cccceEcccCcEEEEEEEECCCcEEEEEEeecCCchhHHHHHHHHHHHHcc-----CCCCeeeEeeeeecCC---eeE-E
Q 010513 189 ADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV-----RHKNLVRLLGYCAEGA---HRM-L 259 (508)
Q Consensus 189 ~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~hpniv~l~~~~~~~~---~~~-l 259 (508)
.-.+.||+|+||.||. +......+||++........+.+.+|+++++.+ .||||++++|+++++. ..+ +
T Consensus 5 ~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~ 82 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV 82 (210)
T ss_pred CCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence 3457899999999996 433333479988665445567899999999999 5799999999998864 334 7
Q ss_pred EEEe--cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHH-HHHHhcCCCCeeeccCCCCCEEEcC----CCCeEEee
Q 010513 260 VYEY--IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGL-TYLHEGLEPKVVHRDIKSSNILLDK----QWNPKLSD 332 (508)
Q Consensus 260 V~e~--~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al-~~LH~~~~~~iiHrDlkp~NIll~~----~~~~kL~D 332 (508)
|+|| +.+|+|.+++.+. .+++. ..++.+++.++ +|||++ +|+||||||+|||++. ++.++|+|
T Consensus 83 I~e~~G~~~~tL~~~l~~~-----~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~LiD 152 (210)
T PRK10345 83 IADFDGKPSITLTEFAEQC-----RYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVCD 152 (210)
T ss_pred EecCCCCcchhHHHHHHcc-----cccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEEE
Confidence 8999 5579999999653 35544 35567777777 999999 9999999999999974 34799999
Q ss_pred eccc
Q 010513 333 FGLA 336 (508)
Q Consensus 333 FG~a 336 (508)
|+-+
T Consensus 153 g~G~ 156 (210)
T PRK10345 153 NIGE 156 (210)
T ss_pred CCCC
Confidence 4433
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.1e-20 Score=191.28 Aligned_cols=215 Identities=27% Similarity=0.500 Sum_probs=164.7
Q ss_pred HHccCCCCeeeEeeeeecCCeeEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCe-eecc
Q 010513 236 IGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKV-VHRD 314 (508)
Q Consensus 236 l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i-iHrD 314 (508)
|+.+.|.|+.+|+|.+.++...+.|.+||..|+|.|.+... ...+++.....+++++++||+|||+. .| .|+.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~---~~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~ 74 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE---DIKLDYFFILSFIRDISKGLAYLHNS---PIGYHGA 74 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc---ccCccHHHHHHHHHHHHHHHHHHhcC---cceeeee
Confidence 45789999999999999999999999999999999999774 46789999999999999999999976 44 9999
Q ss_pred CCCCCEEEcCCCCeEEeeeccceecCCCCc-ceecceecCCCCCChhhhhcCC-------CCCCCCeeehHHHHHHHHhC
Q 010513 315 IKSSNILLDKQWNPKLSDFGLAKLLGAERS-YVTTRVMGTFGYVAPEYASTGM-------LNERSDVYSFGILIMEVISG 386 (508)
Q Consensus 315 lkp~NIll~~~~~~kL~DFG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~-------~~~~sDvwSlGvvl~elltg 386 (508)
+++.|.++|..+.+||+|||+......... .......-..-|.|||.++... .+.+.|+||||++++|+++.
T Consensus 75 l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r 154 (484)
T KOG1023|consen 75 LKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFR 154 (484)
T ss_pred eccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhc
Confidence 999999999999999999999887642100 0111112345699999987642 45678999999999999999
Q ss_pred CCCCCCCCCCCcc-hHHHHHHHhhcccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 010513 387 RNPVDYSRPPGEV-NLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEE 463 (508)
Q Consensus 387 ~~Pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~~~ 463 (508)
+.||+......+. .+...++. .....+.|.+.... +...+++.++.+||..+|++||+++++-..++...
T Consensus 155 ~~~~~~~~~~~~~~eii~~~~~-----~~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~ 225 (484)
T KOG1023|consen 155 SGPFDLRNLVEDPDEIILRVKK-----GGSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTIN 225 (484)
T ss_pred cCccccccccCChHHHHHHHHh-----cCCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhc
Confidence 9999875443332 22222222 12233444443221 22235777888999999999999999998887654
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.5e-20 Score=181.46 Aligned_cols=234 Identities=23% Similarity=0.343 Sum_probs=146.1
Q ss_pred CCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCC---chhHHHHHHHHHHHHccCC----------CCeeeEeeee-
Q 010513 187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRH----------KNLVRLLGYC- 251 (508)
Q Consensus 187 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h----------pniv~l~~~~- 251 (508)
.+...+.||.|+++.||.+++. +++++|+|...... ....+.+++|.-....+.+ -.++-.++..
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 3456788999999999999987 48899999885443 2234556666544444322 1222222221
Q ss_pred --------ecC---C-----eeEEEEEecCCCCHHHHhc---cCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeee
Q 010513 252 --------AEG---A-----HRMLVYEYIDNGNLEQWLH---GDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVH 312 (508)
Q Consensus 252 --------~~~---~-----~~~lV~e~~~~g~L~~~l~---~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH 312 (508)
... . +.+++|+-+.+ ||.+++. ........+....++.+..|+++.+++||.. |++|
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~-dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVH 168 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQG-DLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVH 168 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE--SE-EHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEE
T ss_pred EcCCCcceecCCCCccceeehhhhccchhhh-cHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEe
Confidence 111 1 23678887754 8888753 2211122344556677889999999999999 9999
Q ss_pred ccCCCCCEEEcCCCCeEEeeeccceecCCCCcceecceecCCCCCChhhhhcC--------CCCCCCCeeehHHHHHHHH
Q 010513 313 RDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTG--------MLNERSDVYSFGILIMEVI 384 (508)
Q Consensus 313 rDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--------~~~~~sDvwSlGvvl~ell 384 (508)
+||||+|++++.+|.++|+||+.....+.... . ...+..|.+||..... .++.+.|.|+||+++|.|.
T Consensus 169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~---~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lW 244 (288)
T PF14531_consen 169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTRYR---C-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLW 244 (288)
T ss_dssp ST-SGGGEEE-TTS-EEE--GGGEEETTEEEE---G-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHH
T ss_pred cccceeeEEEcCCCCEEEcChHHHeecCceee---c-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHH
Confidence 99999999999999999999998875433211 1 2345789999976442 4678899999999999999
Q ss_pred hCCCCCCCCCCCCcchHHHHHHHhhcccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCC
Q 010513 385 SGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKR 449 (508)
Q Consensus 385 tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~R 449 (508)
+|..||+...+...... .+. .|......+..||..+|+.||++|
T Consensus 245 C~~lPf~~~~~~~~~~~-------------------~f~--~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 245 CGRLPFGLSSPEADPEW-------------------DFS--RCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HSS-STCCCGGGSTSGG-------------------GGT--TSS---HHHHHHHHHHT-SSGGGS
T ss_pred HccCCCCCCCccccccc-------------------cch--hcCCcCHHHHHHHHHHccCCcccC
Confidence 99999986543322111 111 133333334447779999999988
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=3.2e-20 Score=179.52 Aligned_cols=196 Identities=23% Similarity=0.314 Sum_probs=136.1
Q ss_pred CCCCeeeEeeeeec---------------------------CCeeEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHH
Q 010513 240 RHKNLVRLLGYCAE---------------------------GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNII 292 (508)
Q Consensus 240 ~hpniv~l~~~~~~---------------------------~~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~ 292 (508)
+|||||++.+.|.+ +..+|+||.-.+. +|.+++..+ ..+.....-++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~-----~~s~r~~~~~l 347 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTR-----HRSYRTGRVIL 347 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcC-----CCchHHHHHHH
Confidence 59999999987743 2357899998877 999999765 45666777788
Q ss_pred HHHHHHHHHHHhcCCCCeeeccCCCCCEEE--cCCC--CeEEeeeccceecCCCC---cce--ecceecCCCCCChhhhh
Q 010513 293 LGTAKGLTYLHEGLEPKVVHRDIKSSNILL--DKQW--NPKLSDFGLAKLLGAER---SYV--TTRVMGTFGYVAPEYAS 363 (508)
Q Consensus 293 ~qi~~al~~LH~~~~~~iiHrDlkp~NIll--~~~~--~~kL~DFG~a~~~~~~~---~~~--~~~~~gt~~y~aPE~~~ 363 (508)
.|+++|+.|||++ ||.|||+|++|||+ |+|+ .+.++|||++-.-.... .+. .-...|...-||||+..
T Consensus 348 aQlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~t 424 (598)
T KOG4158|consen 348 AQLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIAT 424 (598)
T ss_pred HHHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhh
Confidence 9999999999999 99999999999999 4443 37899999886432211 111 11235777899999886
Q ss_pred cCC------CCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCCccCCCCchHHHHHHHHHH
Q 010513 364 TGM------LNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLV 437 (508)
Q Consensus 364 ~~~------~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l 437 (508)
..+ --.|+|.|+.|.+.||+++...||.... +.. ...+...+.--|.+... ++...+ ++
T Consensus 425 a~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rG---em~--------L~~r~Yqe~qLPalp~~-vpp~~r---ql 489 (598)
T KOG4158|consen 425 AVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRG---EML--------LDTRTYQESQLPALPSR-VPPVAR---QL 489 (598)
T ss_pred cCCCCceeeccchhhhhhhhhhHHHHhccCCcccccc---hhe--------echhhhhhhhCCCCccc-CChHHH---HH
Confidence 432 2358999999999999999999997521 111 11111212222333222 333333 47
Q ss_pred HHHccCCCCCCCCCHHHHHHHH
Q 010513 438 ALRCVDPNAHKRPKMGHVIHML 459 (508)
Q Consensus 438 i~~cl~~dP~~RPs~~evl~~L 459 (508)
+...|+.||.+|++..-....|
T Consensus 490 V~~lL~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 490 VFDLLKRDPSKRVSPNIAANVL 511 (598)
T ss_pred HHHHhcCCccccCCccHHHhHH
Confidence 7789999999999865443333
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.79 E-value=5.3e-19 Score=168.97 Aligned_cols=141 Identities=19% Similarity=0.159 Sum_probs=110.7
Q ss_pred CCcccceEcccCcEEEEEEE--ECCCcEEEEEEeecCCch------------------------hHHHHHHHHHHHHccC
Q 010513 187 GFADENVIGEGGYGIVYHGV--LEDNTNVAVKNLLNNRGQ------------------------AEKEFKVEVEAIGRVR 240 (508)
Q Consensus 187 ~~~~~~~LG~G~~g~Vy~~~--~~~~~~vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l~ 240 (508)
.|.+.+.||+|+||.||+|. ..+|+.||+|.+...... ....+..|++.+.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 48899999999999999998 457999999988643210 1123567999999997
Q ss_pred CCC--eeeEeeeeecCCeeEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-eeeccCCC
Q 010513 241 HKN--LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK-VVHRDIKS 317 (508)
Q Consensus 241 hpn--iv~l~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~-iiHrDlkp 317 (508)
+.+ +.+++++ ...++||||+++++|..+.... ..+.......++.|++.++.+||++ + ++||||||
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp 177 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD----VEPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSE 177 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCccccccccc----CCcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCCh
Confidence 533 3344432 2348999999998887764332 3455666788999999999999999 9 99999999
Q ss_pred CCEEEcCCCCeEEeeeccceec
Q 010513 318 SNILLDKQWNPKLSDFGLAKLL 339 (508)
Q Consensus 318 ~NIll~~~~~~kL~DFG~a~~~ 339 (508)
+||+++ +++++|+|||.+...
T Consensus 178 ~NIli~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 178 YNILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred hhEEEE-CCCEEEEEChhhhcc
Confidence 999999 789999999998754
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.6e-18 Score=161.79 Aligned_cols=134 Identities=21% Similarity=0.341 Sum_probs=112.9
Q ss_pred ceEcccCcEEEEEEEECCCcEEEEEEeecCCch--------hHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEEe
Q 010513 192 NVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQ--------AEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY 263 (508)
Q Consensus 192 ~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~ 263 (508)
+.||+|++|.||+|.+ ++..+++|+....... ....+.+|++++..+.|+++.....++.+....++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999988 5778999976533211 123577899999999999988877777777888999999
Q ss_pred cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeecccee
Q 010513 264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL 338 (508)
Q Consensus 264 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~ 338 (508)
++|++|.+++... .. ....++.+++.+|.++|+. +++|||++|.|||++ ++.++|+|||.+..
T Consensus 81 ~~G~~L~~~~~~~-------~~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSN-------GM-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhc-------cH-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999998643 11 7788999999999999999 999999999999999 78899999998874
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.5e-19 Score=191.90 Aligned_cols=210 Identities=23% Similarity=0.336 Sum_probs=144.3
Q ss_pred CCCCcccceEcccCcEEEEEEEECC-CcEEEEEEeecCCchhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEEe
Q 010513 185 TNGFADENVIGEGGYGIVYHGVLED-NTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY 263 (508)
Q Consensus 185 ~~~~~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~ 263 (508)
.++|..++.|..|+||.||..+++. .+.+|+| +.+++.. +++ ++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~li----lRn---ilt~a~npfvv------------------ 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNLI----LRN---ILTFAGNPFVV------------------ 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhc-ccccchh----hhc---cccccCCccee------------------
Confidence 4578999999999999999999774 5668884 4332211 000 22222333333
Q ss_pred cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCC-
Q 010513 264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE- 342 (508)
Q Consensus 264 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~- 342 (508)
||-...++.. ++++... +.+++|||+. +|+|||+||+|.+|+.-|++|++|||+++.....
T Consensus 136 ---gDc~tllk~~----g~lPvdm--------vla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~ 197 (1205)
T KOG0606|consen 136 ---GDCATLLKNI----GPLPVDM--------VLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSL 197 (1205)
T ss_pred ---chhhhhcccC----CCCcchh--------hHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhhc
Confidence 4555555443 3444433 7789999998 9999999999999999999999999998743210
Q ss_pred -------------CcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhh
Q 010513 343 -------------RSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMV 409 (508)
Q Consensus 343 -------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~ 409 (508)
.......++|||.|.|||++....|+..+|||++|+++||.+-|..||....+.+ .+...+
T Consensus 198 atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpee------lfg~vi 271 (1205)
T KOG0606|consen 198 ATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE------LFGQVI 271 (1205)
T ss_pred cchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHH------HHhhhh
Confidence 1112234699999999999999999999999999999999999999998765432 222222
Q ss_pred cccc-cccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHH
Q 010513 410 TNRN-AEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMG 453 (508)
Q Consensus 410 ~~~~-~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 453 (508)
.... +.+- |. ..+.+.+ +++.+.|+.+|..|--..
T Consensus 272 sd~i~wpE~-de-----a~p~Ea~---dli~~LL~qnp~~Rlgt~ 307 (1205)
T KOG0606|consen 272 SDDIEWPEE-DE-----ALPPEAQ---DLIEQLLRQNPLCRLGTG 307 (1205)
T ss_pred hhhcccccc-Cc-----CCCHHHH---HHHHHHHHhChHhhcccc
Confidence 2211 1111 11 1223333 466688999999996443
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.77 E-value=2e-19 Score=180.96 Aligned_cols=173 Identities=21% Similarity=0.403 Sum_probs=129.4
Q ss_pred eeEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeecc
Q 010513 256 HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGL 335 (508)
Q Consensus 256 ~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~ 335 (508)
+.|+.|++|+..+|.+||.++. .....++.....++.|++.|++| + +.+|||+||.||+...+..+||+|||+
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~-~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl 402 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRR-TGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGL 402 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCC-cccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhh
Confidence 5789999999999999997542 24567788889999999999999 5 899999999999999999999999999
Q ss_pred ceecCCCC-----cceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHhh
Q 010513 336 AKLLGAER-----SYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMV 409 (508)
Q Consensus 336 a~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~ 409 (508)
........ ....+...||..||+||.+.+..|+.++||||||++|+|++. -..+|+. ...+-
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er------------~~t~~ 470 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFER------------IATLT 470 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHH------------HHhhh
Confidence 88664433 233456789999999999999999999999999999999998 3333321 01000
Q ss_pred cccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHH
Q 010513 410 TNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGH 454 (508)
Q Consensus 410 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e 454 (508)
......++|.+..+... -..++.+++.+.|.+||++.+
T Consensus 471 --d~r~g~ip~~~~~d~p~-----e~~ll~~lls~~p~~RP~~~~ 508 (516)
T KOG1033|consen 471 --DIRDGIIPPEFLQDYPE-----EYTLLQQLLSPSPEERPSAIE 508 (516)
T ss_pred --hhhcCCCChHHhhcCcH-----HHHHHHHhcCCCcccCchHHH
Confidence 01112333322222111 122667999999999994443
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.75 E-value=7.4e-18 Score=180.57 Aligned_cols=137 Identities=20% Similarity=0.325 Sum_probs=112.0
Q ss_pred CCCCcccceEcccCcEEEEEEEECCCcEEEEEEeecC--Cc------hhHHHHHHHHHHHHccCCCCeeeEeeeeecCCe
Q 010513 185 TNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNN--RG------QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAH 256 (508)
Q Consensus 185 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~------~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 256 (508)
...|...+.||+|+||+||+|.+.++. +++|+.... .. ...+.+.+|+++++.++|++++....++.+...
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~ 410 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE 410 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence 345567899999999999999876444 444433211 11 123567889999999999999988877777778
Q ss_pred eEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccc
Q 010513 257 RMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLA 336 (508)
Q Consensus 257 ~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a 336 (508)
.++||||+++++|.+++. ....++.+++++|.|||+. +++||||||+|||+ +++.++|+|||++
T Consensus 411 ~~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla 474 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLG 474 (535)
T ss_pred CEEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCccc
Confidence 899999999999999874 3467889999999999999 99999999999999 5779999999999
Q ss_pred ee
Q 010513 337 KL 338 (508)
Q Consensus 337 ~~ 338 (508)
+.
T Consensus 475 ~~ 476 (535)
T PRK09605 475 KY 476 (535)
T ss_pred cc
Confidence 85
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.75 E-value=9.9e-18 Score=156.32 Aligned_cols=137 Identities=20% Similarity=0.163 Sum_probs=108.4
Q ss_pred CCcccceEcccCcEEEEEEEECCCcEEEEEEeecCCch----------------------hHHHHHHHHHHHHccCCCC-
Q 010513 187 GFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQ----------------------AEKEFKVEVEAIGRVRHKN- 243 (508)
Q Consensus 187 ~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~E~~~l~~l~hpn- 243 (508)
.|.+.+.||+|+||.||+|...+|+.||||.+...... ....+..|+.++..+.|++
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 48888999999999999999888999999987543210 1123567888999888774
Q ss_pred -eeeEeeeeecCCeeEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEE
Q 010513 244 -LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILL 322 (508)
Q Consensus 244 -iv~l~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll 322 (508)
+...++. ...++||||+++++|.+.... .....++.+++.++.++|+. +++||||||+||++
T Consensus 96 ~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~----------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~p~Nill 158 (198)
T cd05144 96 PVPKPIDW----NRHAVVMEYIDGVELYRVRVL----------EDPEEVLDEILEEIVKAYKH---GIIHGDLSEFNILV 158 (198)
T ss_pred CCCceeec----CCceEEEEEeCCcchhhcccc----------ccHHHHHHHHHHHHHHHHHC---CCCcCCCCcccEEE
Confidence 4444432 345899999999998765321 23457888999999999998 99999999999999
Q ss_pred cCCCCeEEeeeccceecC
Q 010513 323 DKQWNPKLSDFGLAKLLG 340 (508)
Q Consensus 323 ~~~~~~kL~DFG~a~~~~ 340 (508)
++++.++|+|||++....
T Consensus 159 ~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 159 DDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred cCCCcEEEEECCccccCC
Confidence 999999999999997553
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.75 E-value=6.7e-18 Score=157.47 Aligned_cols=130 Identities=22% Similarity=0.363 Sum_probs=106.1
Q ss_pred eEcccCcEEEEEEEECCCcEEEEEEeecCCc--------hhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEEec
Q 010513 193 VIGEGGYGIVYHGVLEDNTNVAVKNLLNNRG--------QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYI 264 (508)
Q Consensus 193 ~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~ 264 (508)
.||+|+||.||+|.+. +..+++|....... ...+.+.+|++++..++|+++.....++.+....++||||+
T Consensus 1 ~ig~G~~~~vy~~~~~-~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFL-GLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeecC-CccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 3899999999999964 67899998654321 11255778999999999887665555555666779999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeecccee
Q 010513 265 DNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL 338 (508)
Q Consensus 265 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~ 338 (508)
+|++|.+++.... . .++.+++.+|.+||+. +++|||++|.||+++ ++.++++|||++..
T Consensus 80 ~g~~l~~~~~~~~----~-------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGN----D-------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcH----H-------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 9999999875431 1 7888999999999999 999999999999999 78999999998875
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.68 E-value=3.4e-16 Score=144.39 Aligned_cols=135 Identities=23% Similarity=0.228 Sum_probs=97.0
Q ss_pred cceEcccCcEEEEEEEECCCcEEEEEEeecCCchh--HHH----------------------HHHHHHHHHccCCCC--e
Q 010513 191 ENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQA--EKE----------------------FKVEVEAIGRVRHKN--L 244 (508)
Q Consensus 191 ~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--~~~----------------------~~~E~~~l~~l~hpn--i 244 (508)
.+.||+|+||+||+|...+++.||||.+....... ... ...|.+.+..+.+.+ +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 46799999999999998889999999886532211 111 134555555554332 3
Q ss_pred eeEeeeeecCCeeEEEEEecCCCCHHHH-hccCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeeccCCCCCEEE
Q 010513 245 VRLLGYCAEGAHRMLVYEYIDNGNLEQW-LHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE-GLEPKVVHRDIKSSNILL 322 (508)
Q Consensus 245 v~l~~~~~~~~~~~lV~e~~~~g~L~~~-l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~~iiHrDlkp~NIll 322 (508)
.+.+++ ...++||||++++++... +... .. ...+..++.+++.++.++|. . +++||||||+||++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~-----~~-~~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili 148 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDV-----RL-LEDPEELYDQILELMRKLYREA---GLVHGDLSEYNILV 148 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhh-----hh-cccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEE
Confidence 444433 235899999999654321 1111 01 15678899999999999998 7 99999999999999
Q ss_pred cCCCCeEEeeeccceec
Q 010513 323 DKQWNPKLSDFGLAKLL 339 (508)
Q Consensus 323 ~~~~~~kL~DFG~a~~~ 339 (508)
+ ++.++|+|||.+...
T Consensus 149 ~-~~~~~liDfg~a~~~ 164 (187)
T cd05119 149 D-DGKVYIIDVPQAVEI 164 (187)
T ss_pred E-CCcEEEEECcccccc
Confidence 9 889999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.67 E-value=4.9e-16 Score=137.08 Aligned_cols=135 Identities=19% Similarity=0.174 Sum_probs=113.3
Q ss_pred ccceEcccCcEEEEEEEECCCcEEEEEEeecCCchhHHHHHHHHHHHHccCC--CCeeeEeeeeecCCeeEEEEEecCCC
Q 010513 190 DENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRH--KNLVRLLGYCAEGAHRMLVYEYIDNG 267 (508)
Q Consensus 190 ~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--pniv~l~~~~~~~~~~~lV~e~~~~g 267 (508)
+.+.||+|.++.||++...+ ..+++|....... ...+..|+..+..++| .+++++++++...+..+++|||++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 35779999999999999864 7899998755433 5678889999999976 58999999988888899999999987
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeecccee
Q 010513 268 NLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL 338 (508)
Q Consensus 268 ~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~ 338 (508)
.+..+ +......++.+++++++++|.....+++|+|++|+||++++.+.++++|||.+..
T Consensus 79 ~~~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 66543 4566677889999999999986334799999999999999989999999998874
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.67 E-value=7.5e-18 Score=180.35 Aligned_cols=254 Identities=24% Similarity=0.336 Sum_probs=185.5
Q ss_pred CCCcccceEcccCcEEEEEEEECC--CcEEEEEEeecCC--chhHHHHHHHHHHHHccC-CCCeeeEeeeeecCCeeEEE
Q 010513 186 NGFADENVIGEGGYGIVYHGVLED--NTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVR-HKNLVRLLGYCAEGAHRMLV 260 (508)
Q Consensus 186 ~~~~~~~~LG~G~~g~Vy~~~~~~--~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~lV 260 (508)
..|.+.+.||+|.|+.|-...... ...+|+|.+.... ....+....|..+-..+. |+|++.+++...+....+++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 356677789999999998887543 3345666654432 222334445777767776 99999999999999999999
Q ss_pred EEecCCCCHHHHh-ccCCCCCCCCCHHHHHHHHHHHHHHHHHHH-hcCCCCeeeccCCCCCEEEcCCC-CeEEeeeccce
Q 010513 261 YEYIDNGNLEQWL-HGDVGPHSPLTWEIRMNIILGTAKGLTYLH-EGLEPKVVHRDIKSSNILLDKQW-NPKLSDFGLAK 337 (508)
Q Consensus 261 ~e~~~~g~L~~~l-~~~~~~~~~l~~~~~~~i~~qi~~al~~LH-~~~~~~iiHrDlkp~NIll~~~~-~~kL~DFG~a~ 337 (508)
++|.+++++.+.+ +.. ....+...+..++.|+..++.|+| .. ++.|||+||+|.+++..+ .++++|||+|.
T Consensus 100 ~~~s~g~~~f~~i~~~~---~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At 173 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISHPD---STGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLAT 173 (601)
T ss_pred cCcccccccccccccCC---ccCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhc
Confidence 9999999999988 433 124566677788999999999999 77 999999999999999999 99999999998
Q ss_pred ecCC--CCcceecceec-CCCCCChhhhhcC-CCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccc
Q 010513 338 LLGA--ERSYVTTRVMG-TFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRN 413 (508)
Q Consensus 338 ~~~~--~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 413 (508)
.+.. .........+| ++.|+|||...+. ...+..|+||.|+++.-+++|..|++........ ...|.. ..
T Consensus 174 ~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~-~~~~~~----~~- 247 (601)
T KOG0590|consen 174 AYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR-YSSWKS----NK- 247 (601)
T ss_pred cccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccc-ceeecc----cc-
Confidence 7755 33344455688 9999999988774 5677899999999999999999999866433211 111110 00
Q ss_pred cccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 010513 414 AEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIH 457 (508)
Q Consensus 414 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 457 (508)
......+.........++..+++..+|..|.+.+++..
T Consensus 248 ------~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 248 ------GRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred ------cccccCccccCChhhhhcccccccCCchhccccccccc
Confidence 00001111122223344666888899999998877653
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.66 E-value=1.2e-15 Score=146.11 Aligned_cols=135 Identities=21% Similarity=0.271 Sum_probs=104.9
Q ss_pred cceEc-ccCcEEEEEEEECCCcEEEEEEeecCC-------------chhHHHHHHHHHHHHccCCCCe--eeEeeeeecC
Q 010513 191 ENVIG-EGGYGIVYHGVLEDNTNVAVKNLLNNR-------------GQAEKEFKVEVEAIGRVRHKNL--VRLLGYCAEG 254 (508)
Q Consensus 191 ~~~LG-~G~~g~Vy~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~E~~~l~~l~hpni--v~l~~~~~~~ 254 (508)
...|| .||.|+||.+... +..+++|.+.... ......+.+|++++..+.|++| +..+++...+
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 35687 8999999998875 6789999874321 1223457789999999998875 6677664432
Q ss_pred Ce----eEEEEEecCC-CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeE
Q 010513 255 AH----RMLVYEYIDN-GNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPK 329 (508)
Q Consensus 255 ~~----~~lV~e~~~~-g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~k 329 (508)
.. .++|||+++| .+|.+++... .++.. .+.+++.+|.+||++ ||+||||||.|||++.++.++
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~-----~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~ 182 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEA-----PLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFW 182 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcC-----CCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEE
Confidence 22 2599999997 6999988542 34444 356899999999999 999999999999999988999
Q ss_pred Eeeecccee
Q 010513 330 LSDFGLAKL 338 (508)
Q Consensus 330 L~DFG~a~~ 338 (508)
|+|||.+..
T Consensus 183 LIDfg~~~~ 191 (239)
T PRK01723 183 LIDFDRGEL 191 (239)
T ss_pred EEECCCccc
Confidence 999998875
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.56 E-value=5.3e-15 Score=140.61 Aligned_cols=224 Identities=21% Similarity=0.308 Sum_probs=155.5
Q ss_pred HHHHHccCCCCeeeEeeeeecCC-----eeEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC
Q 010513 233 VEAIGRVRHKNLVRLLGYCAEGA-----HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLE 307 (508)
Q Consensus 233 ~~~l~~l~hpniv~l~~~~~~~~-----~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ 307 (508)
..-|-++.|.|||+++.|+.+.+ ...++.|||..|+|.++|++.......+......+++.||..||.|||+ +.
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~~ 196 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-CD 196 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-cC
Confidence 34455667999999999986543 4678999999999999998876666778889999999999999999998 59
Q ss_pred CCeeeccCCCCCEEEcCCCCeEEeeeccceecCCC----CcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHH
Q 010513 308 PKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE----RSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEV 383 (508)
Q Consensus 308 ~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~el 383 (508)
|.|+|+++..+-|++..+|-+|++- +.-...... .........+-++|.|||.=.....+.++|||+||....||
T Consensus 197 PpiihgnlTc~tifiq~ngLIkig~-~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlem 275 (458)
T KOG1266|consen 197 PPIIHGNLTCDTIFIQHNGLIKIGS-VAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEM 275 (458)
T ss_pred CccccCCcchhheeecCCceEEecc-cCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHH
Confidence 9999999999999999888888742 111111100 00111123467899999976666677889999999999999
Q ss_pred HhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 010513 384 ISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEE 463 (508)
Q Consensus 384 ltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~~~ 463 (508)
.-+..--...... ....+..... --.+...++.+ ++.+|++..|..||+|.+++.+
T Consensus 276 ailEiq~tnseS~--~~~ee~ia~~------i~~len~lqr~-----------~i~kcl~~eP~~rp~ar~llfH----- 331 (458)
T KOG1266|consen 276 AILEIQSTNSESK--VEVEENIANV------IIGLENGLQRG-----------SITKCLEGEPNGRPDARLLLFH----- 331 (458)
T ss_pred HHheeccCCCcce--eehhhhhhhh------eeeccCccccC-----------cCcccccCCCCCCcchhhhhcC-----
Confidence 8876532211110 0001111100 01111222222 6779999999999999887744
Q ss_pred CCCCCCCCCccchhhhhHHHhhcchhhh
Q 010513 464 FPFRDVSFGRVIGILFFLKALLYSTLVM 491 (508)
Q Consensus 464 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 491 (508)
..+.++++++.+..++++.
T Consensus 332 ---------pllfeVhslkll~ahclv~ 350 (458)
T KOG1266|consen 332 ---------PLLFEVHSLKLLMAHCLVL 350 (458)
T ss_pred ---------ceeeecchHHHHhhHheec
Confidence 3455567777777666664
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.49 E-value=1.3e-13 Score=141.80 Aligned_cols=250 Identities=21% Similarity=0.258 Sum_probs=182.9
Q ss_pred CCCCcccceEcc--cCcEEEEEEEE--C-CCcEEEEEEeecCCc--hhHHHHHHHHHHHHcc-CCCCeeeEeeeeecCCe
Q 010513 185 TNGFADENVIGE--GGYGIVYHGVL--E-DNTNVAVKNLLNNRG--QAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEGAH 256 (508)
Q Consensus 185 ~~~~~~~~~LG~--G~~g~Vy~~~~--~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~ 256 (508)
...|.+...+|. |.+|.||.+.. . ++..+|+|+-+.... .....=.+|+...+.+ .|+|.++.+..+++++.
T Consensus 113 ~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~ 192 (524)
T KOG0601|consen 113 DQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGI 192 (524)
T ss_pred hhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCc
Confidence 345677888999 99999999986 3 577889987433322 2223334466666666 59999999999999999
Q ss_pred eEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHH----HHHHHHhcCCCCeeeccCCCCCEEEcCC-CCeEEe
Q 010513 257 RMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAK----GLTYLHEGLEPKVVHRDIKSSNILLDKQ-WNPKLS 331 (508)
Q Consensus 257 ~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~----al~~LH~~~~~~iiHrDlkp~NIll~~~-~~~kL~ 331 (508)
.++-+|+|. .+|.++.+.. ..-++....+....+..+ ||.++|+. +++|-|+||.||++..+ ...+++
T Consensus 193 lfiqtE~~~-~sl~~~~~~~---~~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~ 265 (524)
T KOG0601|consen 193 LFIQTELCG-ESLQSYCHTP---CNFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLT 265 (524)
T ss_pred ceeeecccc-chhHHhhhcc---cccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecC
Confidence 999999996 5888887654 345778888888888888 99999999 99999999999999998 789999
Q ss_pred eeccceecCCCCcce----ecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHH
Q 010513 332 DFGLAKLLGAERSYV----TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKT 407 (508)
Q Consensus 332 DFG~a~~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~ 407 (508)
|||+...++...-.. ..+..|..-|++||.. .+.++..+|+|++|.++.+..++..+....... .| .
T Consensus 266 df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~------~W--~ 336 (524)
T KOG0601|consen 266 DFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGKNS------SW--S 336 (524)
T ss_pred CcceeEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCCCC------Cc--c
Confidence 999999886544111 1223677889999987 457788999999999999999987665322100 00 0
Q ss_pred hhcccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 408 MVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 408 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
..+ .-.++.+.+.....++...+..+++.+|..|++...+..+
T Consensus 337 ~~r--------~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l 379 (524)
T KOG0601|consen 337 QLR--------QGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTAL 379 (524)
T ss_pred ccc--------cccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhcc
Confidence 000 0112333343333444447789999999999998877644
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.49 E-value=1.3e-13 Score=143.32 Aligned_cols=141 Identities=23% Similarity=0.226 Sum_probs=98.4
Q ss_pred cceEcccCcEEEEEEEECCCcEEEEEEeecCCchhH------------------------------H----------HHH
Q 010513 191 ENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAE------------------------------K----------EFK 230 (508)
Q Consensus 191 ~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~------------------------------~----------~~~ 230 (508)
.+.||.|++|.||+|+.++|+.||||+......... + +|.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 367999999999999999999999999854321100 0 133
Q ss_pred HHHHHHHcc----CCCCeeeEeeeee-cCCeeEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHH-HHHHHHh
Q 010513 231 VEVEAIGRV----RHKNLVRLLGYCA-EGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAK-GLTYLHE 304 (508)
Q Consensus 231 ~E~~~l~~l----~hpniv~l~~~~~-~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~-al~~LH~ 304 (508)
.|.+.+.++ +|.+-+.+-.++. .....++||||++|++|.++..... .... ...++..++. .+..+|.
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~---~~~~---~~~ia~~~~~~~l~ql~~ 275 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDE---AGLD---RKALAENLARSFLNQVLR 275 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHh---cCCC---HHHHHHHHHHHHHHHHHh
Confidence 344444443 2333344434443 2445789999999999988764321 1122 2345555555 4678888
Q ss_pred cCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecC
Q 010513 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG 340 (508)
Q Consensus 305 ~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 340 (508)
. |++|+|+||.||+++++++++++|||++..+.
T Consensus 276 ~---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 276 D---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred C---CceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 8 99999999999999999999999999998764
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.42 E-value=2.1e-13 Score=143.59 Aligned_cols=145 Identities=16% Similarity=0.124 Sum_probs=95.6
Q ss_pred CCCcccceEcccCcEEEEEEEECC-CcEEEEEEeecCCch----------------------------------hHHH--
Q 010513 186 NGFADENVIGEGGYGIVYHGVLED-NTNVAVKNLLNNRGQ----------------------------------AEKE-- 228 (508)
Q Consensus 186 ~~~~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~----------------------------------~~~~-- 228 (508)
..|+. +.||+|++|.||+|+.++ |+.||||++...... ..+.
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 45665 789999999999999887 999999998644211 0111
Q ss_pred ----HHHHHHHHHcc----CCCCeeeEeeeeec-CCeeEEEEEecCCCCHHHH--hccCCCCCCCCCHHHHHHHHHHHHH
Q 010513 229 ----FKVEVEAIGRV----RHKNLVRLLGYCAE-GAHRMLVYEYIDNGNLEQW--LHGDVGPHSPLTWEIRMNIILGTAK 297 (508)
Q Consensus 229 ----~~~E~~~l~~l----~hpniv~l~~~~~~-~~~~~lV~e~~~~g~L~~~--l~~~~~~~~~l~~~~~~~i~~qi~~ 297 (508)
+.+|..-+.++ .+.+.+.+-.++++ ....+|||||++|+.+.++ +.........+....+..++.|+.
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif- 277 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF- 277 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH-
Confidence 22233333333 24444554445543 4567899999999999875 222210011233444444444443
Q ss_pred HHHHHHhcCCCCeeeccCCCCCEEEcCCC----CeEEeeeccceecCC
Q 010513 298 GLTYLHEGLEPKVVHRDIKSSNILLDKQW----NPKLSDFGLAKLLGA 341 (508)
Q Consensus 298 al~~LH~~~~~~iiHrDlkp~NIll~~~~----~~kL~DFG~a~~~~~ 341 (508)
.. |++|+|+||.||+++.++ +++++|||++..++.
T Consensus 278 ------~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 278 ------RD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred ------hC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 35 999999999999999888 899999999987644
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.38 E-value=1.4e-12 Score=118.03 Aligned_cols=131 Identities=21% Similarity=0.139 Sum_probs=95.0
Q ss_pred cceEcccCcEEEEEEEECCCcEEEEEEeecCCchhHHHHHHHHHHHHccCCCCee-eEeeeeecCCeeEEEEEecCCCCH
Q 010513 191 ENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLV-RLLGYCAEGAHRMLVYEYIDNGNL 269 (508)
Q Consensus 191 ~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv-~l~~~~~~~~~~~lV~e~~~~g~L 269 (508)
.+.|+.|.++.||++... +..|++|....... ....+..|++.++.+.+.+++ +++.+. ....++||||++|.++
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence 356899999999999876 77899998654432 223456788889888655544 444443 2345799999999877
Q ss_pred HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeeeccCCCCCEEEcCCCCeEEeeecccee
Q 010513 270 EQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGL--EPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL 338 (508)
Q Consensus 270 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~ 338 (508)
.+. . .....+..+++++|+.||+.. ...++|+|++|.||+++ ++.++++|||.+..
T Consensus 79 ~~~---~---------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 79 LTE---D---------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred ccc---c---------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 543 0 011235678999999999871 11259999999999999 66899999998763
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.38 E-value=6.9e-12 Score=130.33 Aligned_cols=166 Identities=20% Similarity=0.224 Sum_probs=128.3
Q ss_pred ECCCcEEEEEEeecCCchhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEEecCCCCHHHHhccCCCCCCCCCHH
Q 010513 207 LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWE 286 (508)
Q Consensus 207 ~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~ 286 (508)
..++.+|.|...............+-++-|+.++||||+++++.++.+...|+|+|-+. -|..++++. +..
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l-------~~~ 104 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL-------GKE 104 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh-------HHH
Confidence 34677888888776665445567778899999999999999999999999999999885 677777553 367
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCCCcceecceecCCCCCChhhhhcCC
Q 010513 287 IRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGM 366 (508)
Q Consensus 287 ~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 366 (508)
.....+.||+.||.|||+.+ +++|++|.-..|+++..|+.||++|-++........ ......---.|..|+.+....
T Consensus 105 ~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s~ 181 (690)
T KOG1243|consen 105 EVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPSE 181 (690)
T ss_pred HHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCccc
Confidence 77778899999999999766 999999999999999999999999988765432221 011111122466776553322
Q ss_pred CCCCCCeeehHHHHHHHHhC
Q 010513 367 LNERSDVYSFGILIMEVISG 386 (508)
Q Consensus 367 ~~~~sDvwSlGvvl~elltg 386 (508)
-..|.|-|||+++|++.|
T Consensus 182 --~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 182 --WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred --cchhhhhHHHHHHHHhCc
Confidence 246999999999999999
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.30 E-value=4.9e-11 Score=109.64 Aligned_cols=136 Identities=18% Similarity=0.183 Sum_probs=97.6
Q ss_pred cceEcccCcEEEEEEEECC-------CcEEEEEEeecCC----------------------chhHHHH----HHHHHHHH
Q 010513 191 ENVIGEGGYGIVYHGVLED-------NTNVAVKNLLNNR----------------------GQAEKEF----KVEVEAIG 237 (508)
Q Consensus 191 ~~~LG~G~~g~Vy~~~~~~-------~~~vavK~~~~~~----------------------~~~~~~~----~~E~~~l~ 237 (508)
...||.|--+.||.|...+ +..+|||..+-.. ....+.+ .+|.+.|.
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3569999999999998543 4789999763210 0112222 37999998
Q ss_pred ccCC--CCeeeEeeeeecCCeeEEEEEecCCCCHHH-HhccCCCCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCeeec
Q 010513 238 RVRH--KNLVRLLGYCAEGAHRMLVYEYIDNGNLEQ-WLHGDVGPHSPLTWEIRMNIILGTAKGLTYL-HEGLEPKVVHR 313 (508)
Q Consensus 238 ~l~h--pniv~l~~~~~~~~~~~lV~e~~~~g~L~~-~l~~~~~~~~~l~~~~~~~i~~qi~~al~~L-H~~~~~~iiHr 313 (508)
++.. -++...+++ ...++||||+.++.+.. .++. ..++......+..+++.+|..| |+. +++||
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd-----~~~~~~~~~~i~~~i~~~l~~l~H~~---glVHG 149 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD-----AKLNDEEMKNAYYQVLSMMKQLYKEC---NLVHA 149 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc-----cccCHHHHHHHHHHHHHHHHHHHHhC---CeecC
Confidence 8843 456666654 45689999998754422 2222 2344556677788999999999 887 99999
Q ss_pred cCCCCCEEEcCCCCeEEeeeccceec
Q 010513 314 DIKSSNILLDKQWNPKLSDFGLAKLL 339 (508)
Q Consensus 314 Dlkp~NIll~~~~~~kL~DFG~a~~~ 339 (508)
||++.|||+++ +.++|+|||.+...
T Consensus 150 DLs~~NIL~~~-~~v~iIDF~qav~~ 174 (197)
T cd05146 150 DLSEYNMLWHD-GKVWFIDVSQSVEP 174 (197)
T ss_pred CCCHHHEEEEC-CcEEEEECCCceeC
Confidence 99999999974 68999999988754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.28 E-value=3.7e-12 Score=131.13 Aligned_cols=250 Identities=20% Similarity=0.202 Sum_probs=175.4
Q ss_pred HhhcCCCCcccceEcccCcEEEEEEEEC--CCcEEEEEEeecCCchhHHHH--HHHHHHHHcc-CCCCeeeEeeeeecCC
Q 010513 181 LEVSTNGFADENVIGEGGYGIVYHGVLE--DNTNVAVKNLLNNRGQAEKEF--KVEVEAIGRV-RHKNLVRLLGYCAEGA 255 (508)
Q Consensus 181 ~~~~~~~~~~~~~LG~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~~--~~E~~~l~~l-~hpniv~l~~~~~~~~ 255 (508)
......+|..+..||.|.|+.|+....+ ++..|++|.+.+.......++ ..|+-+...+ .|.++++.+..+....
T Consensus 260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r 339 (524)
T KOG0601|consen 260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLR 339 (524)
T ss_pred ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccc
Confidence 4455668999999999999999998744 577899998877654443332 2355555555 5888999888887777
Q ss_pred eeEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCC-CCeEEeeec
Q 010513 256 HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQ-WNPKLSDFG 334 (508)
Q Consensus 256 ~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~-~~~kL~DFG 334 (508)
+.|+-.|||+++++...+.. ...+.+...+.+..|++.++.++|+. .++|+|+||+||++..+ +..+++|||
T Consensus 340 ~~~ip~e~~~~~s~~l~~~~----~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~ 412 (524)
T KOG0601|consen 340 QGYIPLEFCEGGSSSLRSVT----SQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFG 412 (524)
T ss_pred cccCchhhhcCcchhhhhHH----HHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhccccc
Confidence 88899999999988877622 24577788899999999999999998 99999999999999876 778999999
Q ss_pred cceecCCCCcceecceecCCCC-CChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccc
Q 010513 335 LAKLLGAERSYVTTRVMGTFGY-VAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRN 413 (508)
Q Consensus 335 ~a~~~~~~~~~~~~~~~gt~~y-~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 413 (508)
+...+.- .......++..| .+++......+..+.|++|||.-+.+.++|..--. . ..+|.. ..
T Consensus 413 ~~t~~~~---~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~-~-------~~~~~~--i~--- 476 (524)
T KOG0601|consen 413 CWTRLAF---SSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSE-S-------GVQSLT--IR--- 476 (524)
T ss_pred cccccce---ecccccccccccccchhhccccccccccccccccccccccccCcccCc-c-------ccccee--ee---
Confidence 8864211 111111233344 46666677788999999999999999999864211 1 011100 00
Q ss_pred cccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 010513 414 AEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 460 (508)
Q Consensus 414 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le 460 (508)
.-.-+.... ....+..+...+..+++..||.+.++..+.+
T Consensus 477 --~~~~p~~~~-----~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~ 516 (524)
T KOG0601|consen 477 --SGDTPNLPG-----LKLQLQVLLKVMINPDRKRRPSAVELSLHSE 516 (524)
T ss_pred --cccccCCCc-----hHHhhhhhhhhhcCCccccchhhhhhcccch
Confidence 000111111 1123333566788899999999988776543
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.21 E-value=1.3e-10 Score=109.84 Aligned_cols=142 Identities=19% Similarity=0.242 Sum_probs=108.9
Q ss_pred ceEcccCcEEEEEEEECCCcEEEEEEeecCCc-hhHHHHHHHHHHHHccCC--CCeeeEeeeeecCC---eeEEEEEecC
Q 010513 192 NVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRG-QAEKEFKVEVEAIGRVRH--KNLVRLLGYCAEGA---HRMLVYEYID 265 (508)
Q Consensus 192 ~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h--pniv~l~~~~~~~~---~~~lV~e~~~ 265 (508)
+.|+.|.++.||++...+|..+++|....... .....+..|.++++.+.+ .++.+++.+..... ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 56899999999999987668899998754332 134567889999999975 34567777766542 5689999999
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC---------------------------------------
Q 010513 266 NGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGL--------------------------------------- 306 (508)
Q Consensus 266 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--------------------------------------- 306 (508)
|.++.+.+.. ..++......++.+++++|..||+..
T Consensus 84 G~~l~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (223)
T cd05154 84 GRVLRDRLLR-----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME 158 (223)
T ss_pred CEecCCCCCC-----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence 9888765421 24677777888888888888888521
Q ss_pred --------------CCCeeeccCCCCCEEEcC--CCCeEEeeecccee
Q 010513 307 --------------EPKVVHRDIKSSNILLDK--QWNPKLSDFGLAKL 338 (508)
Q Consensus 307 --------------~~~iiHrDlkp~NIll~~--~~~~kL~DFG~a~~ 338 (508)
...++|+|+++.||+++. ++.+.|+||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 245799999999999998 56689999998764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.20 E-value=1.9e-10 Score=102.35 Aligned_cols=131 Identities=23% Similarity=0.373 Sum_probs=99.3
Q ss_pred ceEcccCcEEEEEEEECCCcEEEEEEeecCCc---h-----hHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEEe
Q 010513 192 NVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRG---Q-----AEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY 263 (508)
Q Consensus 192 ~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~---~-----~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~ 263 (508)
..+++|+-+.+|.+.+. |.++++|.-....- + ......+|..++.+++--.|..-+=++.+.....++|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 35789999999999876 44466665432211 1 123456799999988766655555556677778899999
Q ss_pred cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeecccee
Q 010513 264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL 338 (508)
Q Consensus 264 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~ 338 (508)
++|-.|.+.+... ...++..+-.-+.-||.. +|+|+||.++||++..++ +.++|||++..
T Consensus 81 I~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA-----------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc-----------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999999888654 144666777778899999 999999999999998874 99999999985
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.20 E-value=2.2e-10 Score=101.46 Aligned_cols=143 Identities=20% Similarity=0.288 Sum_probs=105.9
Q ss_pred ccceEcccCcEEEEEEEECCCcEEEEEEeecCC--c------hhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEE
Q 010513 190 DENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNR--G------QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY 261 (508)
Q Consensus 190 ~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~------~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 261 (508)
....+-+|+-+.|+++.+. |+...||.-.... . -......+|.+++.++.--.|.--.-++.+...-.++|
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 4678999999999999986 6666777542211 1 12345678999999887556555555666667778999
Q ss_pred EecCC-CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCC---CeEEeeeccce
Q 010513 262 EYIDN-GNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQW---NPKLSDFGLAK 337 (508)
Q Consensus 262 e~~~~-g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~---~~kL~DFG~a~ 337 (508)
||++| .++.+++..... ..........++..+-+.+.-||.+ +|||+||..+||++..++ .+.++|||++.
T Consensus 90 E~~~g~~~vk~~i~~~~~--~~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~ 164 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTME--DESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSS 164 (229)
T ss_pred EeccchhHHHHHHHHHcc--CcccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchh
Confidence 99987 588888876532 2222233377888999999999999 999999999999995544 35899999986
Q ss_pred e
Q 010513 338 L 338 (508)
Q Consensus 338 ~ 338 (508)
.
T Consensus 165 ~ 165 (229)
T KOG3087|consen 165 V 165 (229)
T ss_pred c
Confidence 4
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.19 E-value=3.2e-12 Score=138.04 Aligned_cols=209 Identities=23% Similarity=0.280 Sum_probs=155.9
Q ss_pred HhhcCCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecC---CchhHHHHHHHHHHHHccCCCCeeeEeeeeecCCe
Q 010513 181 LEVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN---RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAH 256 (508)
Q Consensus 181 ~~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 256 (508)
++...+.+.+.+-+.+|.++.++.+.-. .+.-.+.|..... .....+....+-.++-..++|-++.....+.-...
T Consensus 799 yrsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP 878 (1205)
T KOG0606|consen 799 YRSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSP 878 (1205)
T ss_pred ccCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCC
Confidence 3566778888999999999999988743 2333333332111 11122233334444444566777777766667778
Q ss_pred eEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccc
Q 010513 257 RMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLA 336 (508)
Q Consensus 257 ~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a 336 (508)
.+++++|..+++|...|+.. ++.+.+.+...+..+.++++|||.. .+.|||++|.|+++..++..+++|||..
T Consensus 879 ~~L~~~~~~~~~~~Skl~~~----~~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~ 951 (1205)
T KOG0606|consen 879 LPLVGHYLNGGDLPSKLHNS----GCLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTL 951 (1205)
T ss_pred cchhhHHhccCCchhhhhcC----CCcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCccccc
Confidence 89999999999999999875 4567777777888899999999987 7999999999999999999999999844
Q ss_pred eecCCC------------------------------CcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhC
Q 010513 337 KLLGAE------------------------------RSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISG 386 (508)
Q Consensus 337 ~~~~~~------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg 386 (508)
...+.. .........||+.|.+||...+......+|+|++|++++|.++|
T Consensus 952 ~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g 1031 (1205)
T KOG0606|consen 952 SKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTG 1031 (1205)
T ss_pred cccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcC
Confidence 322100 00112235789999999999999999999999999999999999
Q ss_pred CCCCCCCCCC
Q 010513 387 RNPVDYSRPP 396 (508)
Q Consensus 387 ~~Pf~~~~~~ 396 (508)
..||....+.
T Consensus 1032 ~pp~na~tpq 1041 (1205)
T KOG0606|consen 1032 IPPFNAETPQ 1041 (1205)
T ss_pred CCCCCCcchh
Confidence 9999866543
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.05 E-value=6.5e-09 Score=105.31 Aligned_cols=169 Identities=18% Similarity=0.277 Sum_probs=128.8
Q ss_pred cEEEEEEEE-CCCcEEEEEEeecCCchhHHHHHHHHHHHHccCCCCeeeEeeeee----cCCeeEEEEEecCC-CCHHHH
Q 010513 199 YGIVYHGVL-EDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCA----EGAHRMLVYEYIDN-GNLEQW 272 (508)
Q Consensus 199 ~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~----~~~~~~lV~e~~~~-g~L~~~ 272 (508)
..+.|++.. .||..|++|++...+.+.....-.-++.++++.|+|+|+|.++|. .+..+++||+|.++ ++|.++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 457789884 479999999994444333323334578899999999999999886 34578899999886 578776
Q ss_pred hccCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCC
Q 010513 273 LHGDV-----------GPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA 341 (508)
Q Consensus 273 l~~~~-----------~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 341 (508)
..... ......++...|.++.|++.||.++|+. |..-+-|.+.+|+++.+.+++|...|....+..
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 53321 1234578899999999999999999999 999999999999999999999998887776543
Q ss_pred CCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCC
Q 010513 342 ERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRN 388 (508)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~ 388 (508)
+. . |.+.. -.+-|.=.||.++..|.||..
T Consensus 446 d~-------------~--~~le~---~Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 446 DP-------------T--EPLES---QQQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred CC-------------C--cchhH---HhhhhHHHHHHHHHHHhhccc
Confidence 32 1 11111 124688899999999999964
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.02 E-value=1.9e-08 Score=99.63 Aligned_cols=264 Identities=14% Similarity=0.166 Sum_probs=158.4
Q ss_pred cccceEcccCcEEEEEEEECCCcEEEEEEeecCCchhHHHHHHHHHHHHcc-CCCCeeeEeee----e--ecC-CeeEEE
Q 010513 189 ADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV-RHKNLVRLLGY----C--AEG-AHRMLV 260 (508)
Q Consensus 189 ~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~----~--~~~-~~~~lV 260 (508)
...+.||+|+-+.+|-.-.- +.. +.|+..........+ .++.|... .||-+-.=+.| . -++ ....+.
T Consensus 14 ~~gr~LgqGgea~ly~l~e~-~d~-VAKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl 88 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEV-RDQ-VAKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL 88 (637)
T ss_pred CCCccccCCccceeeecchh-hch-hheeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence 34577999999999954322 223 447776654433332 23334444 56533221211 1 122 235688
Q ss_pred EEecCCCC-HHHHhc--cCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccce
Q 010513 261 YEYIDNGN-LEQWLH--GDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK 337 (508)
Q Consensus 261 ~e~~~~g~-L~~~l~--~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~ 337 (508)
|..+.+.. ...++. .++.......|....+.++.++.+.+.||+. |.+-+|+.++|+|+.+++.+.|.|=....
T Consensus 89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDsfq 165 (637)
T COG4248 89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDSFQ 165 (637)
T ss_pred cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEccccee
Confidence 88887642 222321 1223345688999999999999999999999 99999999999999999999999854433
Q ss_pred ecCCCCcceecceecCCCCCChhhhh-----cCCCCCCCCeeehHHHHHHHHhC-CCCCCCCCC------CCcchHHHHH
Q 010513 338 LLGAERSYVTTRVMGTFGYVAPEYAS-----TGMLNERSDVYSFGILIMEVISG-RNPVDYSRP------PGEVNLVEWL 405 (508)
Q Consensus 338 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvvl~elltg-~~Pf~~~~~------~~~~~~~~~~ 405 (508)
.-... ......+|...|++||.-+ +..-+...|.|.||+++++++.| +.||.+-.. +.+..+....
T Consensus 166 i~~ng--~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~ 243 (637)
T COG4248 166 INANG--TLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGR 243 (637)
T ss_pred eccCC--ceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcce
Confidence 32111 1222347899999999765 33456678999999999999986 999975421 1111111100
Q ss_pred HHhhcccccccCCCccCCC---CchHHHHHHHHHHHHHccCC--CCCCCCCHHHHHHHHhcCCCCCC
Q 010513 406 KTMVTNRNAEGVLDPRLQE---KPCSRALKRALLVALRCVDP--NAHKRPKMGHVIHMLEAEEFPFR 467 (508)
Q Consensus 406 ~~~~~~~~~~~~~~~~l~~---~~~~~~~~~l~~li~~cl~~--dP~~RPs~~evl~~Le~~~~~~~ 467 (508)
.. ......... .+.-.. ...+..+.. +..+|+.. ++.-||+++.++..|.+....+-
T Consensus 244 f~-ya~~~~~g~-~p~P~~~P~~~Lpp~vqA---lF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~ 305 (637)
T COG4248 244 FA-YASDQRRGL-KPPPRSIPLSMLPPDVQA---LFQQAFTESGVATPRPTAKAWVAALDALRQQLK 305 (637)
T ss_pred ee-echhccCCC-CCCCCCCChhhcCHHHHH---HHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhh
Confidence 00 000001111 111111 112233444 44477643 36789999999888876554443
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.01 E-value=3.5e-09 Score=96.98 Aligned_cols=125 Identities=27% Similarity=0.322 Sum_probs=81.4
Q ss_pred EEEEEEECCCcEEEEEEeecCCc--------------------------hhHHHHHHHHHHHHccCCC--CeeeEeeeee
Q 010513 201 IVYHGVLEDNTNVAVKNLLNNRG--------------------------QAEKEFKVEVEAIGRVRHK--NLVRLLGYCA 252 (508)
Q Consensus 201 ~Vy~~~~~~~~~vavK~~~~~~~--------------------------~~~~~~~~E~~~l~~l~hp--niv~l~~~~~ 252 (508)
.||.|...+|..+|+|....... .......+|.+.|.++..- ++.+.+++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 48999998899999997742110 0123466799999999765 456666442
Q ss_pred cCCeeEEEEEecC--CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHH-HHhcCCCCeeeccCCCCCEEEcCCCCeE
Q 010513 253 EGAHRMLVYEYID--NGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTY-LHEGLEPKVVHRDIKSSNILLDKQWNPK 329 (508)
Q Consensus 253 ~~~~~~lV~e~~~--~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~-LH~~~~~~iiHrDlkp~NIll~~~~~~k 329 (508)
..++||||++ |..+..+.... ++......++.+++..+.. +|+. |++|+||.+.|||++++ .+.
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~------~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~ 146 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVD------LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVY 146 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCG------GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEE
T ss_pred ---CCEEEEEecCCCccchhhHHhcc------ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEE
Confidence 3479999998 54444433221 1133445666777775555 4677 99999999999999988 999
Q ss_pred Eeeeccceec
Q 010513 330 LSDFGLAKLL 339 (508)
Q Consensus 330 L~DFG~a~~~ 339 (508)
++|||.+...
T Consensus 147 iIDf~qav~~ 156 (188)
T PF01163_consen 147 IIDFGQAVDS 156 (188)
T ss_dssp E--GTTEEET
T ss_pred EEecCcceec
Confidence 9999988754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.96 E-value=1.4e-08 Score=98.58 Aligned_cols=139 Identities=15% Similarity=0.090 Sum_probs=96.5
Q ss_pred EcccCcEEEEEEEECCCcEEEEEEeecCCch-----------hHHHHHHHHHHHHccCCCC--eeeEeeeeec-----CC
Q 010513 194 IGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQ-----------AEKEFKVEVEAIGRVRHKN--LVRLLGYCAE-----GA 255 (508)
Q Consensus 194 LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~hpn--iv~l~~~~~~-----~~ 255 (508)
+-+.....|+++... |+.|.||........ ....+.+|...+..+..-+ ....+++.+. ..
T Consensus 30 v~~~~~rrvvr~~~~-g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~ 108 (268)
T PRK15123 30 FRELEGRRTLRFELA-GKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATR 108 (268)
T ss_pred EecCCCceEEEEEEC-CEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccc
Confidence 333333446666664 678999976432211 1113677888888774333 2333444432 23
Q ss_pred eeEEEEEecCCC-CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcC-------CCC
Q 010513 256 HRMLVYEYIDNG-NLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDK-------QWN 327 (508)
Q Consensus 256 ~~~lV~e~~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~-------~~~ 327 (508)
..++|||++++. +|.+++.... ....+......++.+++..+.-||+. ||+|+|++++|||++. +..
T Consensus 109 ~s~LVte~l~~~~sL~~~~~~~~--~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~~~ 183 (268)
T PRK15123 109 TSFIITEDLAPTISLEDYCADWA--TNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREEDLK 183 (268)
T ss_pred eeEEEEeeCCCCccHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCCce
Confidence 568999999986 8999985421 13456677788999999999999999 9999999999999975 467
Q ss_pred eEEeeecccee
Q 010513 328 PKLSDFGLAKL 338 (508)
Q Consensus 328 ~kL~DFG~a~~ 338 (508)
+.|+||+.++.
T Consensus 184 ~~LIDl~r~~~ 194 (268)
T PRK15123 184 LSVIDLHRAQI 194 (268)
T ss_pred EEEEECCcccc
Confidence 99999998763
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.85 E-value=2.4e-08 Score=94.28 Aligned_cols=136 Identities=23% Similarity=0.196 Sum_probs=96.9
Q ss_pred CCcccceEcccCcEEEEEEEECCCcEEEEEEeecCCc----------------------hhHHHHHHHHHHHHccCCC--
Q 010513 187 GFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRG----------------------QAEKEFKVEVEAIGRVRHK-- 242 (508)
Q Consensus 187 ~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~----------------------~~~~~~~~E~~~l~~l~hp-- 242 (508)
-..+...||-|--+.||.|....|.++|||.=.-... .......+|.++|..|...
T Consensus 92 ve~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 92 VEAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HHhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 4567889999999999999999999999995321110 0122456799999998644
Q ss_pred CeeeEeeeeecCCeeEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEE
Q 010513 243 NLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILL 322 (508)
Q Consensus 243 niv~l~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll 322 (508)
.+.+.+++ +...+||||++|-.|... +++.+....++..|++-+.-+-.. ||||+|+.+-||++
T Consensus 172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~---------r~~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV 235 (304)
T COG0478 172 KVPKPIAW----NRHAVVMEYIEGVELYRL---------RLDVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILV 235 (304)
T ss_pred CCCCcccc----ccceeeeehcccceeecc---------cCcccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEE
Confidence 56666654 445799999998655432 112333444444555555544455 99999999999999
Q ss_pred cCCCCeEEeeecccee
Q 010513 323 DKQWNPKLSDFGLAKL 338 (508)
Q Consensus 323 ~~~~~~kL~DFG~a~~ 338 (508)
+++|.+.++||--+..
T Consensus 236 ~~dg~~~vIDwPQ~v~ 251 (304)
T COG0478 236 TEDGDIVVIDWPQAVP 251 (304)
T ss_pred ecCCCEEEEeCccccc
Confidence 9999999999976653
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.72 E-value=4.8e-09 Score=109.90 Aligned_cols=149 Identities=21% Similarity=0.328 Sum_probs=98.5
Q ss_pred HHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCCCcceec--------ceecCCCCCChhhhhcC
Q 010513 294 GTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTT--------RVMGTFGYVAPEYASTG 365 (508)
Q Consensus 294 qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~--------~~~gt~~y~aPE~~~~~ 365 (508)
+++.|+.|+|... ++||++|.|++|.++.++.+||+.|+++........+... -..-...|.|||++.+.
T Consensus 107 ~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~ 184 (700)
T KOG2137|consen 107 NVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT 184 (700)
T ss_pred cccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence 4558999999654 9999999999999999999999999988654332221111 01235579999999998
Q ss_pred CCCCCCCeeehHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHhhcccccccCCCccCCCCchHHHHHHHHHHHHHccCC
Q 010513 366 MLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDP 444 (508)
Q Consensus 366 ~~~~~sDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~ 444 (508)
..+.++|+||+||++|.+.. |+.-+.................. .........+.++.+ -+.+++..
T Consensus 185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~----------~~~~~s~~~p~el~~---~l~k~l~~ 251 (700)
T KOG2137|consen 185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNA----------GAFGYSNNLPSELRE---SLKKLLNG 251 (700)
T ss_pred cccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhccccc----------ccccccccCcHHHHH---HHHHHhcC
Confidence 88999999999999999994 55545433222111111100000 000001123344444 55588999
Q ss_pred CCCCCCCHHHHHH
Q 010513 445 NAHKRPKMGHVIH 457 (508)
Q Consensus 445 dP~~RPs~~evl~ 457 (508)
++..||++.++..
T Consensus 252 ~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 252 DSAVRPTLDLLLS 264 (700)
T ss_pred CcccCcchhhhhc
Confidence 9999998777654
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.72 E-value=1.5e-07 Score=88.23 Aligned_cols=105 Identities=22% Similarity=0.258 Sum_probs=80.7
Q ss_pred HHHHHHHHHHHccCCC--CeeeEeeeeecC----CeeEEEEEecCCC-CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHH
Q 010513 227 KEFKVEVEAIGRVRHK--NLVRLLGYCAEG----AHRMLVYEYIDNG-NLEQWLHGDVGPHSPLTWEIRMNIILGTAKGL 299 (508)
Q Consensus 227 ~~~~~E~~~l~~l~hp--niv~l~~~~~~~----~~~~lV~e~~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al 299 (508)
....+|...+..+..- ...+.+++.+.. ...++|+|++++. +|.+++.... ..+......++.++++.+
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~----~~~~~~~~~ll~~l~~~i 131 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE----QLDPSQRRELLRALARLI 131 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc----ccchhhHHHHHHHHHHHH
Confidence 3566677777776432 234445554432 2457999999884 8999987642 256667788999999999
Q ss_pred HHHHhcCCCCeeeccCCCCCEEEcCCC---CeEEeeecccee
Q 010513 300 TYLHEGLEPKVVHRDIKSSNILLDKQW---NPKLSDFGLAKL 338 (508)
Q Consensus 300 ~~LH~~~~~~iiHrDlkp~NIll~~~~---~~kL~DFG~a~~ 338 (508)
.-||++ ||+|+|+++.|||++.++ .+.++||+-++.
T Consensus 132 ~~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 132 AKLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 999999 999999999999998887 799999997775
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.68 E-value=3.5e-07 Score=84.52 Aligned_cols=137 Identities=15% Similarity=0.167 Sum_probs=101.7
Q ss_pred EcccCcEEEEEEEECCCcEEEEEEeecCC------chhHHHHHHHHHHHHccCCC--CeeeEeeeee---cC--CeeEEE
Q 010513 194 IGEGGYGIVYHGVLEDNTNVAVKNLLNNR------GQAEKEFKVEVEAIGRVRHK--NLVRLLGYCA---EG--AHRMLV 260 (508)
Q Consensus 194 LG~G~~g~Vy~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~hp--niv~l~~~~~---~~--~~~~lV 260 (508)
-|+||.+.|+..... |+.+-+|+-.+.. .-....|.+|+..+.++..- .+.+.. ++. .+ -..+||
T Consensus 26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 367999999998776 4468888764221 22456789999999988532 244444 332 11 235799
Q ss_pred EEecCC-CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCC--eEEeeeccce
Q 010513 261 YEYIDN-GNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWN--PKLSDFGLAK 337 (508)
Q Consensus 261 ~e~~~~-g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~--~kL~DFG~a~ 337 (508)
+|-+++ -+|.+++.... ..+.+......++.++++.+.-||+. |+.|+|+.+.||+++.++. ++++||.-++
T Consensus 104 Te~L~g~~~L~~~l~~~~--~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 104 TEDMAGFISIADWYAQHA--VSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EEeCCCCccHHHHHhcCC--cCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 997763 58999986542 24567777889999999999999999 9999999999999986667 9999997665
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.55 E-value=3.2e-07 Score=96.48 Aligned_cols=141 Identities=21% Similarity=0.196 Sum_probs=89.8
Q ss_pred ceEcccCcEEEEEEEECCCcEEEEEEeecCCchh------------------------------HH----------HHHH
Q 010513 192 NVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQA------------------------------EK----------EFKV 231 (508)
Q Consensus 192 ~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~------------------------------~~----------~~~~ 231 (508)
+-|+.++-|.||+|++++|+.||||+...+-... .+ ++.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 5699999999999999999999999875432110 01 1223
Q ss_pred HHHHHHcc----CCCCeeeEeeeeec-CCeeEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHH-HHHHHhc
Q 010513 232 EVEAIGRV----RHKNLVRLLGYCAE-GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKG-LTYLHEG 305 (508)
Q Consensus 232 E~~~l~~l----~hpniv~l~~~~~~-~~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~a-l~~LH~~ 305 (508)
|..-+.++ +...-+.+=.+|++ .+...|+|||++|-.+.+...-.. ...+.... +..++++ +..+-..
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~---~g~d~k~i---a~~~~~~f~~q~~~d 284 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS---AGIDRKEL---AELLVRAFLRQLLRD 284 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh---cCCCHHHH---HHHHHHHHHHHHHhc
Confidence 33333333 22223344444443 566789999999988888742221 12332222 2222211 1122223
Q ss_pred CCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCC
Q 010513 306 LEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA 341 (508)
Q Consensus 306 ~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 341 (508)
|++|.|.+|.||+++.+|++.+.|||+...++.
T Consensus 285 ---gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 285 ---GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred ---CccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 899999999999999999999999999876643
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.50 E-value=2e-06 Score=81.68 Aligned_cols=139 Identities=19% Similarity=0.178 Sum_probs=84.6
Q ss_pred ceEcccCcEEEEEEEECCCcEEEEEEeecCCchhHHHHHHHHHHHHccCCCC--eeeEeeeeecCCeeEEEEEecCCCC-
Q 010513 192 NVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKN--LVRLLGYCAEGAHRMLVYEYIDNGN- 268 (508)
Q Consensus 192 ~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn--iv~l~~~~~~~~~~~lV~e~~~~g~- 268 (508)
..||+|..+.||+. .+..+++|...... ......+|.++++.+..-+ +.+.+++..+.+...+|||+++|.+
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 46899999999984 25567788765432 3345688999998886433 4667777777777889999999863
Q ss_pred HHHH---------------------hccCCCCCCCCCHHHHHHHHHH----------HHH-HHHHHHhc-CCCCeeeccC
Q 010513 269 LEQW---------------------LHGDVGPHSPLTWEIRMNIILG----------TAK-GLTYLHEG-LEPKVVHRDI 315 (508)
Q Consensus 269 L~~~---------------------l~~~~~~~~~l~~~~~~~i~~q----------i~~-al~~LH~~-~~~~iiHrDl 315 (508)
+... ++.-......+.... ..+..+ +.+ ...+|... ..+.++|+|+
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~-~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~ 160 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYK-EKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDF 160 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHH-HHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCC
Confidence 1111 121100111111100 000000 000 12222211 1335789999
Q ss_pred CCCCEEEcCCCCeEEeeeccce
Q 010513 316 KSSNILLDKQWNPKLSDFGLAK 337 (508)
Q Consensus 316 kp~NIll~~~~~~kL~DFG~a~ 337 (508)
.|.||++++++ +.++||+.+.
T Consensus 161 ~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 161 QIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCCcEEEcCCC-cEEEechhcC
Confidence 99999999888 9999999776
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.47 E-value=3e-08 Score=102.92 Aligned_cols=189 Identities=18% Similarity=0.125 Sum_probs=138.2
Q ss_pred CCCCcccceEcccCcEEEEEEEECCCcEEEEEEeecCCchhHHHHHHHHHHHHccCCCC-eeeEeeeeecCCeeEEEEEe
Q 010513 185 TNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKN-LVRLLGYCAEGAHRMLVYEY 263 (508)
Q Consensus 185 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn-iv~l~~~~~~~~~~~lV~e~ 263 (508)
+.-+...+.+++|+++++++.+....+....+.+... ....-++++|.+++||| .+..++-++.+...++++++
T Consensus 241 ~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i 315 (829)
T KOG0576|consen 241 TKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRI 315 (829)
T ss_pred ccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhh
Confidence 3345556678999999999987543444445554332 44556899999999999 77778888888888999999
Q ss_pred cCCC-CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCC
Q 010513 264 IDNG-NLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE 342 (508)
Q Consensus 264 ~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 342 (508)
+.+| +-....... .-.+...+...+.+.-+++++++|+. .=+|+| ||+..+ +..+..||+....+...
T Consensus 316 ~s~~rs~~~~~~~s---e~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~ 384 (829)
T KOG0576|consen 316 CSTGRSSALEMTVS---EIALEQYQFAYPLRKETRPLAELHSS---YKVHRD----NILGSE-EEVKLLDFAVPPQLTRT 384 (829)
T ss_pred hcCCccccccCChh---hHhhhhhhhhhhhhhhcccccccccc---cccCcc----cccccc-cccccccccCCcccCcc
Confidence 9887 221111100 12234445566677778899999976 568998 777666 57899999998866433
Q ss_pred CcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCC
Q 010513 343 RSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVD 391 (508)
Q Consensus 343 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~ 391 (508)
. ..+...+|+.|+|||+.....+...-|.|++|+-..++--|-.|-.
T Consensus 385 ~--~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 385 M--KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred c--ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 2 4455689999999999999999999999999987777777776643
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.39 E-value=4.6e-06 Score=78.31 Aligned_cols=137 Identities=21% Similarity=0.221 Sum_probs=92.4
Q ss_pred cceEcccCcEEEEEEEECCCcEEEEEEeecCCchh------------------------HHHHHHHHHHHHccC--CCCe
Q 010513 191 ENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQA------------------------EKEFKVEVEAIGRVR--HKNL 244 (508)
Q Consensus 191 ~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~------------------------~~~~~~E~~~l~~l~--hpni 244 (508)
...|+.|--+.||+|...++..+|+|+.......- ......|+.-|.++. +-.+
T Consensus 53 ~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrv 132 (268)
T COG1718 53 VGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRV 132 (268)
T ss_pred EeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCC
Confidence 34688888899999998889999999885432110 112344666666663 3334
Q ss_pred eeEeeeeecCCeeEEEEEecCCC-CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEc
Q 010513 245 VRLLGYCAEGAHRMLVYEYIDNG-NLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLD 323 (508)
Q Consensus 245 v~l~~~~~~~~~~~lV~e~~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~ 323 (508)
.+-+++. +..|||||+... .-.-.|.+ -++...++..+..++++.+.-|-..+ ++||+||+.-|||+.
T Consensus 133 P~Pi~~~----~nVLvMEfIg~~g~pAP~LkD-----v~~e~~e~~~~~~~~v~~~~~l~~~a--~LVHgDLSEyNiL~~ 201 (268)
T COG1718 133 PEPIAFR----NNVLVMEFIGDDGLPAPRLKD-----VPLELEEAEGLYEDVVEYMRRLYKEA--GLVHGDLSEYNILVH 201 (268)
T ss_pred CCceeec----CCeEEEEeccCCCCCCCCccc-----CCcCchhHHHHHHHHHHHHHHHHHhc--CcccccchhhheEEE
Confidence 4444443 247999999653 11111111 12333357777888888888887632 999999999999999
Q ss_pred CCCCeEEeeeccceec
Q 010513 324 KQWNPKLSDFGLAKLL 339 (508)
Q Consensus 324 ~~~~~kL~DFG~a~~~ 339 (508)
++.+.++|||-|...
T Consensus 202 -~~~p~iID~~QaV~~ 216 (268)
T COG1718 202 -DGEPYIIDVSQAVTI 216 (268)
T ss_pred -CCeEEEEECcccccc
Confidence 779999999988754
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.39 E-value=5.7e-06 Score=76.84 Aligned_cols=139 Identities=14% Similarity=0.170 Sum_probs=91.7
Q ss_pred hhcCCCCcccceEcccCcEEEEEEEECCCcEEEEEEeecCCchhHHHH---------HHHHHHHHccC---CCCeeeEee
Q 010513 182 EVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEF---------KVEVEAIGRVR---HKNLVRLLG 249 (508)
Q Consensus 182 ~~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~---------~~E~~~l~~l~---hpniv~l~~ 249 (508)
.+..++|...+++-......|.+-..+ |+.+++|..........+.| .+++..+..++ -.....++-
T Consensus 27 ~i~~~~~~~~kv~k~~~r~~ValIei~-~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl 105 (229)
T PF06176_consen 27 KILDNNYKIIKVFKNTKRNYVALIEID-GKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYL 105 (229)
T ss_pred HHHhCCceEEEeecCCCccEEEEEEEC-CcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCcccccccee
Confidence 456678888888888887777776665 67899997755432222222 23333333332 223333332
Q ss_pred ee-----ecCCeeEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcC
Q 010513 250 YC-----AEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDK 324 (508)
Q Consensus 250 ~~-----~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~ 324 (508)
+. .-....+++|||++|..|.+.. .+++. +...+.+++.-||+. |+.|+|..|.|+++++
T Consensus 106 ~~ekk~~~~~~~~~ll~EYIeG~~l~d~~--------~i~e~----~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~~ 170 (229)
T PF06176_consen 106 AAEKKIFRYTSSYVLLMEYIEGVELNDIE--------DIDED----LAEKIVEAIKQLHKH---GFYHGDPHPGNFLVSN 170 (229)
T ss_pred eeeeeeccceeEEEEEEEEecCeecccch--------hcCHH----HHHHHHHHHHHHHHc---CCccCCCCcCcEEEEC
Confidence 22 2234556899999998776643 12222 334567789999999 9999999999999996
Q ss_pred CCCeEEeeeccce
Q 010513 325 QWNPKLSDFGLAK 337 (508)
Q Consensus 325 ~~~~kL~DFG~a~ 337 (508)
+ .++++||+..+
T Consensus 171 ~-~i~iID~~~k~ 182 (229)
T PF06176_consen 171 N-GIRIIDTQGKR 182 (229)
T ss_pred C-cEEEEECcccc
Confidence 6 49999998665
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.36 E-value=6.4e-06 Score=78.09 Aligned_cols=145 Identities=22% Similarity=0.242 Sum_probs=84.8
Q ss_pred cceEcccCcEEEEEEEECCCcEEEEEEeecCCchhHHHHHHHHHHHHccCCC--CeeeEeeeee---cCCeeEEEEEecC
Q 010513 191 ENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHK--NLVRLLGYCA---EGAHRMLVYEYID 265 (508)
Q Consensus 191 ~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp--niv~l~~~~~---~~~~~~lV~e~~~ 265 (508)
++.|+.|..+.||+....+ ..+++|..... .....+..|..+++.+... .+.+++.+.. .....+++|++++
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~ 78 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP 78 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence 4678999999999999886 68999986444 4566778888888888433 3456665432 2334689999999
Q ss_pred CCCHHH----------------Hh---ccCCCCCCCCCHHH---------HHHH------------HHHHHH-HHHHHHh
Q 010513 266 NGNLEQ----------------WL---HGDVGPHSPLTWEI---------RMNI------------ILGTAK-GLTYLHE 304 (508)
Q Consensus 266 ~g~L~~----------------~l---~~~~~~~~~l~~~~---------~~~i------------~~qi~~-al~~LH~ 304 (508)
|..+.. .+ +............. .... ...+.+ .++.+++
T Consensus 79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (239)
T PF01636_consen 79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA 158 (239)
T ss_dssp SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence 987777 11 11101111111110 0000 011222 3333332
Q ss_pred c----CCCCeeeccCCCCCEEEc-CCCCeEEeeecccee
Q 010513 305 G----LEPKVVHRDIKSSNILLD-KQWNPKLSDFGLAKL 338 (508)
Q Consensus 305 ~----~~~~iiHrDlkp~NIll~-~~~~~kL~DFG~a~~ 338 (508)
. ....++|+|+.+.|||++ .++.+.|+||+.+..
T Consensus 159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred hhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 1 234799999999999999 666667999987763
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.23 E-value=3e-05 Score=71.75 Aligned_cols=128 Identities=23% Similarity=0.318 Sum_probs=92.0
Q ss_pred cceEcccCcEEEEEEEECCCcEEEEEEeecCC----------------chhHHHHHHHHHHHHccC------CCCeeeEe
Q 010513 191 ENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNR----------------GQAEKEFKVEVEAIGRVR------HKNLVRLL 248 (508)
Q Consensus 191 ~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~E~~~l~~l~------hpniv~l~ 248 (508)
...||+|+.-.||. +.++...+||+..... ....++..+|+.....+. +.+|.+++
T Consensus 6 ~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 6 SDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred CcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 45699999999995 4445567888876554 122455666766666665 78899999
Q ss_pred eeeecCCeeEEEEEecCC------CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEE
Q 010513 249 GYCAEGAHRMLVYEYIDN------GNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILL 322 (508)
Q Consensus 249 ~~~~~~~~~~lV~e~~~~------g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll 322 (508)
|+.+++.-..+|+|.+.. -+|.+++... .++. .. ...+-+-.+||-++ .|+.+|++|.||++
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~-----~~~~-~~---~~~L~~f~~~l~~~---~Iv~~dl~~~NIv~ 151 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKEG-----GLTE-EL---RQALDEFKRYLLDH---HIVIRDLNPHNIVV 151 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHHcC-----CccH-HH---HHHHHHHHHHHHHc---CCeecCCCcccEEE
Confidence 999999888999998743 3788888543 3554 33 33344556777777 89999999999999
Q ss_pred cCC--C--CeEEee
Q 010513 323 DKQ--W--NPKLSD 332 (508)
Q Consensus 323 ~~~--~--~~kL~D 332 (508)
..+ + .+.|+|
T Consensus 152 ~~~~~~~~~lvlID 165 (199)
T PF10707_consen 152 QRRDSGEFRLVLID 165 (199)
T ss_pred EecCCCceEEEEEe
Confidence 533 2 477887
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.22 E-value=1.3e-05 Score=76.97 Aligned_cols=140 Identities=16% Similarity=0.144 Sum_probs=83.5
Q ss_pred EcccCc-EEEEEEEECCCcEEEEEEeecCCchhHHHHHHHHHHHHccC-CCCeeeEeeeeecCCeeEEEEEecCCCCHHH
Q 010513 194 IGEGGY-GIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVR-HKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQ 271 (508)
Q Consensus 194 LG~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~lV~e~~~~g~L~~ 271 (508)
|..|.+ ..||+.... +..+++|...... ...+.+|+++++.+. +--+.+++++...++..++|||+++|.+|.+
T Consensus 6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~ 81 (244)
T cd05150 6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAA 81 (244)
T ss_pred cCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhH
Confidence 445555 788988765 4677888764332 345667888888873 4446677777776667789999999877654
Q ss_pred Hh-------------------ccCCCCCCCCCHH--HHHHHHH--------------------HHHHHHHHHHhc----C
Q 010513 272 WL-------------------HGDVGPHSPLTWE--IRMNIIL--------------------GTAKGLTYLHEG----L 306 (508)
Q Consensus 272 ~l-------------------~~~~~~~~~l~~~--~~~~i~~--------------------qi~~al~~LH~~----~ 306 (508)
.. +.......++... ....... .+...+..|-.. .
T Consensus 82 ~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 161 (244)
T cd05150 82 LWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEE 161 (244)
T ss_pred hhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcC
Confidence 31 1110001111100 0000000 011112222111 1
Q ss_pred CCCeeeccCCCCCEEEcCCCCeEEeeeccce
Q 010513 307 EPKVVHRDIKSSNILLDKQWNPKLSDFGLAK 337 (508)
Q Consensus 307 ~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~ 337 (508)
.+.++|+|+.|.|||+++++.+.|+||+.+.
T Consensus 162 ~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 162 DLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred ceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 3468999999999999998778899998775
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.15 E-value=1.5e-05 Score=83.75 Aligned_cols=140 Identities=19% Similarity=0.223 Sum_probs=86.9
Q ss_pred cceEcccCcEEEEEEEECCCcEEEEEEeecCCchh-------------------------------HH------HHHHHH
Q 010513 191 ENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQA-------------------------------EK------EFKVEV 233 (508)
Q Consensus 191 ~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-------------------------------~~------~~~~E~ 233 (508)
.+.||.-+.|.||+|+.++|+.||||+-+..-... .+ +|..|.
T Consensus 166 ~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 166 EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 36799999999999999999999999875432110 00 112222
Q ss_pred H----HHHccCCCC---eeeEeeeeec-CCeeEEEEEecCCCCHHHH--hccCCCCCCCCCHHHHHHHHHHHHHHHHHHH
Q 010513 234 E----AIGRVRHKN---LVRLLGYCAE-GAHRMLVYEYIDNGNLEQW--LHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 303 (508)
Q Consensus 234 ~----~l~~l~hpn---iv~l~~~~~~-~~~~~lV~e~~~~g~L~~~--l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH 303 (508)
+ ..+.+.|-+ -|.+=.++++ .....|+||||+|..+.|. |.+. .++...+..-+.+...-.-
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~-----gi~~~~i~~~l~~~~~~qI--- 317 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKR-----GISPHDILNKLVEAYLEQI--- 317 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHc-----CCCHHHHHHHHHHHHHHHH---
Confidence 2 222334555 2223334443 3467899999999876654 3333 3444433332222211111
Q ss_pred hcCCCCeeeccCCCCCEEEcC----CCCeEEeeeccceecC
Q 010513 304 EGLEPKVVHRDIKSSNILLDK----QWNPKLSDFGLAKLLG 340 (508)
Q Consensus 304 ~~~~~~iiHrDlkp~NIll~~----~~~~kL~DFG~a~~~~ 340 (508)
...|++|+|-.|.||+++. ++.+.+-|||+.....
T Consensus 318 --f~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 318 --FKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred --HhcCCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 2228999999999999983 6779999999988653
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.08 E-value=2.4e-05 Score=69.59 Aligned_cols=130 Identities=18% Similarity=0.274 Sum_probs=88.9
Q ss_pred CcccceEcccCcEEEEEEEECCCcEEEEEEeecCCchhHHHHHHHHHHHHccCCCCeee-EeeeeecCCeeEEEEEecCC
Q 010513 188 FADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVR-LLGYCAEGAHRMLVYEYIDN 266 (508)
Q Consensus 188 ~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~-l~~~~~~~~~~~lV~e~~~~ 266 (508)
....+.|++|++|.||+|.+. |..+|+|+-..+ .....+..|.++|..+.--++-+ ++.+..+ ++.|||++|
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~d--s~r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~i~G 96 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGEWR-GGEVALKVRRRD--SPRRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEYIDG 96 (201)
T ss_pred hhhhhhhhcccccEEEEeecc-CceEEEEEecCC--cchhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhhhcC
Confidence 345678999999999999997 558899876443 33467888999998887665543 4444332 455999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCC-C-CEEEcCCCCeEEeeeccceec
Q 010513 267 GNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKS-S-NILLDKQWNPKLSDFGLAKLL 339 (508)
Q Consensus 267 g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp-~-NIll~~~~~~kL~DFG~a~~~ 339 (508)
-.|.++-... +. +-...++++---|... ||-|+.|.- . ||++.+ +.+.|+||..|...
T Consensus 97 ~~L~~~~~~~-------~r----k~l~~vlE~a~~LD~~---GI~H~El~~~~k~vlv~~-~~~~iIDFd~At~k 156 (201)
T COG2112 97 RPLGKLEIGG-------DR----KHLLRVLEKAYKLDRL---GIEHGELSRPWKNVLVND-RDVYIIDFDSATFK 156 (201)
T ss_pred cchhhhhhcc-------cH----HHHHHHHHHHHHHHHh---ccchhhhcCCceeEEecC-CcEEEEEccchhhc
Confidence 8887764321 12 2233455554444555 899999874 4 555544 48999999988743
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.06 E-value=5.5e-05 Score=85.53 Aligned_cols=148 Identities=13% Similarity=0.221 Sum_probs=91.3
Q ss_pred cceEcccCcEEEEEEEECCC---cEEEEEEeecCC-chhHHHHHHHHHHHHccC-CCCe--eeEeeeeecC---CeeEEE
Q 010513 191 ENVIGEGGYGIVYHGVLEDN---TNVAVKNLLNNR-GQAEKEFKVEVEAIGRVR-HKNL--VRLLGYCAEG---AHRMLV 260 (508)
Q Consensus 191 ~~~LG~G~~g~Vy~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-hpni--v~l~~~~~~~---~~~~lV 260 (508)
.+.++.|.+..+|+....++ ..+++|+..... ......+.+|+++++.+. |.++ .+++.++.+. ...|+|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 56789999999999887654 367777653322 123456888999999995 6664 7778877664 357899
Q ss_pred EEecCCCCHHH--------------------H---hccCCCC-------CCCCCH--HHHHHHH---------------H
Q 010513 261 YEYIDNGNLEQ--------------------W---LHGDVGP-------HSPLTW--EIRMNII---------------L 293 (508)
Q Consensus 261 ~e~~~~g~L~~--------------------~---l~~~~~~-------~~~l~~--~~~~~i~---------------~ 293 (508)
|||++|..+.+ . |+.-... ..+... .+...+. -
T Consensus 123 ME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~ 202 (822)
T PLN02876 123 MEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRNP 202 (822)
T ss_pred EEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCCh
Confidence 99998854321 1 2221000 011111 1111111 1
Q ss_pred HHHHHHHHHHhcCC--------CCeeeccCCCCCEEEcCC-CC-eEEeeecccee
Q 010513 294 GTAKGLTYLHEGLE--------PKVVHRDIKSSNILLDKQ-WN-PKLSDFGLAKL 338 (508)
Q Consensus 294 qi~~al~~LH~~~~--------~~iiHrDlkp~NIll~~~-~~-~kL~DFG~a~~ 338 (508)
.+.+.+++|..+.. +.+||+|+++.|||++.+ +. .-|.||.++..
T Consensus 203 ~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~ 257 (822)
T PLN02876 203 KMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTL 257 (822)
T ss_pred hHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeecccc
Confidence 12344667754321 359999999999999853 34 57899998864
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.93 E-value=8.5e-05 Score=71.02 Aligned_cols=73 Identities=14% Similarity=0.221 Sum_probs=44.7
Q ss_pred ceEcccCcE-EEEEEEECCCcEEEEEEeecCCchhHHHHHHHHHHHHccCCC---CeeeEeeeeecC---CeeEEEEEec
Q 010513 192 NVIGEGGYG-IVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHK---NLVRLLGYCAEG---AHRMLVYEYI 264 (508)
Q Consensus 192 ~~LG~G~~g-~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp---niv~l~~~~~~~---~~~~lV~e~~ 264 (508)
+.|+.||.. .||+. +..+++|.... ......+..|.+.+..+... -+.++++..... ...+++|+++
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~--~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSA--AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCc--cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 457777776 48875 33577775433 22345788899999887532 234444443322 2347899999
Q ss_pred CCCCHH
Q 010513 265 DNGNLE 270 (508)
Q Consensus 265 ~~g~L~ 270 (508)
+|.++.
T Consensus 77 ~G~~l~ 82 (235)
T cd05155 77 EGETAT 82 (235)
T ss_pred cCCCCC
Confidence 986653
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.91 E-value=6e-05 Score=69.33 Aligned_cols=103 Identities=22% Similarity=0.264 Sum_probs=80.3
Q ss_pred HHHHHHHccCC-CCeeeEeeeeecCCeeEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC
Q 010513 231 VEVEAIGRVRH-KNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK 309 (508)
Q Consensus 231 ~E~~~l~~l~h-pniv~l~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ 309 (508)
.|.-+++.+++ +++.+++|+|-. ++|.||...+++..... ........+|..+.+|+.++++.+++|+......
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~-~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYR-PLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCcccccccc-ccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 47788888876 699999999943 67999998776543200 0001134689999999999999999999754336
Q ss_pred eeeccCCCCCEEEcCCCCeEEeeecccee
Q 010513 310 VVHRDIKSSNILLDKQWNPKLSDFGLAKL 338 (508)
Q Consensus 310 iiHrDlkp~NIll~~~~~~kL~DFG~a~~ 338 (508)
+.-.|++++|+-+++++++|++|...+..
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcch
Confidence 88899999999999999999999886654
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.88 E-value=0.00021 Score=70.84 Aligned_cols=78 Identities=10% Similarity=0.050 Sum_probs=56.0
Q ss_pred cccceEcccCcEEEEEEEECCCcEEEEEEeecCCchhHHHHHHHHHHHHccCC---CCeeeEeeeeecC---CeeEEEEE
Q 010513 189 ADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRH---KNLVRLLGYCAEG---AHRMLVYE 262 (508)
Q Consensus 189 ~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h---pniv~l~~~~~~~---~~~~lV~e 262 (508)
.-.+.||.|..+.||.....++ ++++|.... ......+..|.+.|+.+.- -.+.++++++..+ +..++|||
T Consensus 17 ~~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE 93 (297)
T PRK10593 17 SRVECISEQPYAALWALYDSQG-NPMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLE 93 (297)
T ss_pred heeeecCCccceeEEEEEcCCC-CEEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEe
Confidence 3456799999999999876655 466676432 1133578889999988843 3577888777543 56799999
Q ss_pred ecCCCCH
Q 010513 263 YIDNGNL 269 (508)
Q Consensus 263 ~~~~g~L 269 (508)
+++++++
T Consensus 94 ~i~G~~~ 100 (297)
T PRK10593 94 RLRGVSV 100 (297)
T ss_pred ccCCEec
Confidence 9998754
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.87 E-value=0.00018 Score=66.16 Aligned_cols=125 Identities=26% Similarity=0.369 Sum_probs=88.8
Q ss_pred CCCcccceEcccCc-EEEEEEEECCCcEEEEEEeecC-----------Cc----------hhHHHHHHHHHHHHccC---
Q 010513 186 NGFADENVIGEGGY-GIVYHGVLEDNTNVAVKNLLNN-----------RG----------QAEKEFKVEVEAIGRVR--- 240 (508)
Q Consensus 186 ~~~~~~~~LG~G~~-g~Vy~~~~~~~~~vavK~~~~~-----------~~----------~~~~~~~~E~~~l~~l~--- 240 (508)
.+++.++.||.|.- |.||+++.. |..+|+|..... .. .....|..|.+...+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~-g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEID-GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEEC-CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 57888999999999 999999987 679999983210 00 11235677877777764
Q ss_pred CCCe--eeEeeeeecC------------------CeeEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHH
Q 010513 241 HKNL--VRLLGYCAEG------------------AHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLT 300 (508)
Q Consensus 241 hpni--v~l~~~~~~~------------------~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~ 300 (508)
+.++ |+++||..-. ....||.||++... .++.. -+.++.+-+.
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-------------~~~~~----~~~~~~~dl~ 178 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-------------PLQIR----DIPQMLRDLK 178 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-------------ccchh----HHHHHHHHHH
Confidence 4566 9999987322 11347888876522 22333 3446677788
Q ss_pred HHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccc
Q 010513 301 YLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLA 336 (508)
Q Consensus 301 ~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a 336 (508)
.+|.. +|+-+|+++.|.. .-||+|||.+
T Consensus 179 ~~~k~---gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 179 ILHKL---GIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHHC---CeeeccCcccccc-----CCEEEecccC
Confidence 99988 9999999999985 3489999864
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.85 E-value=0.00022 Score=67.99 Aligned_cols=74 Identities=15% Similarity=0.095 Sum_probs=47.5
Q ss_pred cceEcccCcEEEEEEEECC--CcEEEEEEeecCCchhHHHHHHHHHHHHccCCCC-eeeEeeeeecCCeeEEEEEecCCC
Q 010513 191 ENVIGEGGYGIVYHGVLED--NTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKN-LVRLLGYCAEGAHRMLVYEYIDNG 267 (508)
Q Consensus 191 ~~~LG~G~~g~Vy~~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn-iv~l~~~~~~~~~~~lV~e~~~~g 267 (508)
.+.|..|-...+|+....+ +..|++|........ .-...+|+.+++.+...+ ..++++.+.. .++|||++|.
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~~----~~l~e~i~G~ 77 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQN----GLIYEFIPGR 77 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeCC----cEEEEeeCCC
Confidence 3567778888999998664 567888866433221 123346888888884333 3444444332 4899999986
Q ss_pred CH
Q 010513 268 NL 269 (508)
Q Consensus 268 ~L 269 (508)
++
T Consensus 78 ~l 79 (235)
T cd05157 78 TL 79 (235)
T ss_pred cC
Confidence 65
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.78 E-value=0.00013 Score=70.64 Aligned_cols=139 Identities=14% Similarity=0.095 Sum_probs=77.6
Q ss_pred EcccCcEEEEEEEECCCcEEEEEEeecCCchhHHHHHHHHHHHHccCCCCe-eeEeeeeecCCeeEEEEEecCCCCHHH-
Q 010513 194 IGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNL-VRLLGYCAEGAHRMLVYEYIDNGNLEQ- 271 (508)
Q Consensus 194 LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpni-v~l~~~~~~~~~~~lV~e~~~~g~L~~- 271 (508)
+..|-...+|+... ++..+++|..........-...+|.++++.+...++ .+++.... -++||||++|..+..
T Consensus 4 ~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~~ 78 (256)
T TIGR02721 4 LSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITLD 78 (256)
T ss_pred CCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccccc
Confidence 45677889998874 466788886543322211134668888888854333 33343332 368999999865432
Q ss_pred -------------H---hccCCCCCCCCCHHH-HHHHHHHH---------HHHHHHHHhc-----CCCCeeeccCCCCCE
Q 010513 272 -------------W---LHGDVGPHSPLTWEI-RMNIILGT---------AKGLTYLHEG-----LEPKVVHRDIKSSNI 320 (508)
Q Consensus 272 -------------~---l~~~~~~~~~l~~~~-~~~i~~qi---------~~al~~LH~~-----~~~~iiHrDlkp~NI 320 (508)
. ++.......+++... ...+..++ ...+..+-.. ....++|+|+.|.||
T Consensus 79 ~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Ni 158 (256)
T TIGR02721 79 QFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNL 158 (256)
T ss_pred cccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcE
Confidence 1 222211112222211 11111111 1112222111 123589999999999
Q ss_pred EEcCCCCeEEeeecccee
Q 010513 321 LLDKQWNPKLSDFGLAKL 338 (508)
Q Consensus 321 ll~~~~~~kL~DFG~a~~ 338 (508)
++++++ +.|+||..+..
T Consensus 159 l~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 159 VVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEeCCC-CEEEeccccCc
Confidence 999876 78999988763
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.63 E-value=0.00011 Score=81.96 Aligned_cols=197 Identities=20% Similarity=0.253 Sum_probs=135.6
Q ss_pred HHHHHHHHHHccCCCCeeeEeeeeecCCeeE----EEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHH
Q 010513 228 EFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM----LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 303 (508)
Q Consensus 228 ~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~----lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH 303 (508)
....|.+.+.+..|+|++.++.|-.+....- ...+++..-++.+.+..- ..++....+.+..++.+|++|+|
T Consensus 228 ~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v----~~i~~~~~r~~~~~~~~GL~~~h 303 (1351)
T KOG1035|consen 228 TTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSV----GSIPLETLRILHQKLLEGLAYLH 303 (1351)
T ss_pred HHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhc----cccCHHHHHHHHHHHhhhHHHHH
Confidence 3445778888889999999999876554332 445788888888887654 57888999999999999999999
Q ss_pred hcCCCCeeeccCCCC---CEEEcCCCCeEEe--eeccceecCCCCcceecceecCCCCCChhhhhcCCCCCC--CCeeeh
Q 010513 304 EGLEPKVVHRDIKSS---NILLDKQWNPKLS--DFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNER--SDVYSF 376 (508)
Q Consensus 304 ~~~~~~iiHrDlkp~---NIll~~~~~~kL~--DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~--sDvwSl 376 (508)
+. ...|.-+..+ +--.+.++....+ ||+....+........ ..-+..|.++|......+..+ .|+|++
T Consensus 304 ~~---~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~--~~~~~~~~~~e~~~~~~~~~~r~~dL~~l 378 (1351)
T KOG1035|consen 304 SL---SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFS--DLLAEIRNADEDLKENTAKKSRLTDLWCL 378 (1351)
T ss_pred Hh---ccceeEEecccccccccCccceeecchhhhcccccCCCcccchh--hcCccccccccccccccchhhhhhHHHHH
Confidence 88 6666555554 4455666677777 9988876644333222 223455788887766655554 699999
Q ss_pred HHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 010513 377 GILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVI 456 (508)
Q Consensus 377 Gvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl 456 (508)
|.....+..|..+-....... .+++. .+.. .+.+...+|+.-++++|+++.+++
T Consensus 379 gll~~~~~~~~~i~~~~~~~~------------------~~l~~-----~~~~---~~~d~~~~~~~~~~~~Rl~~~~ll 432 (1351)
T KOG1035|consen 379 GLLLLQLSQGEDISEKSAVPV------------------SLLDV-----LSTS---ELLDALPKCLDEDSEERLSALELL 432 (1351)
T ss_pred HHHHhhhhhcCcccccccchh------------------hhhcc-----ccch---hhhhhhhhhcchhhhhccchhhhh
Confidence 999999998865532211100 01111 0111 334466689999999999999998
Q ss_pred HHH
Q 010513 457 HML 459 (508)
Q Consensus 457 ~~L 459 (508)
.+.
T Consensus 433 ~~~ 435 (1351)
T KOG1035|consen 433 THP 435 (1351)
T ss_pred hch
Confidence 764
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.56 E-value=0.00041 Score=68.65 Aligned_cols=143 Identities=16% Similarity=0.161 Sum_probs=84.3
Q ss_pred cceEcccCcEEEEEEEECCCcEEEEEEeecCCchhHHHHHHHHHHHHccCCCC--eeeEeee------eecCCeeEEEEE
Q 010513 191 ENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKN--LVRLLGY------CAEGAHRMLVYE 262 (508)
Q Consensus 191 ~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn--iv~l~~~------~~~~~~~~lV~e 262 (508)
.+.|..|....+|+....+ ..+++|.... .....+..|++++..+.+.+ +.+++.. ....+..++|++
T Consensus 19 i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 19 FEGISAGIENTNYFVTTDS-GRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred eecccCccccceEEEEeCC-CcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 5668888888999987654 4688887653 23455667888888774332 4444432 123345689999
Q ss_pred ecCCCCHHH--------------HhccCC---CC----CCCCCHHHHH----------HHHHHHHHHHHHHHh----cCC
Q 010513 263 YIDNGNLEQ--------------WLHGDV---GP----HSPLTWEIRM----------NIILGTAKGLTYLHE----GLE 307 (508)
Q Consensus 263 ~~~~g~L~~--------------~l~~~~---~~----~~~l~~~~~~----------~i~~qi~~al~~LH~----~~~ 307 (508)
|++|..+.. .++... .. .....+.... .....+..++.++.+ ...
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 999865421 011110 00 0111111110 011112334445443 123
Q ss_pred CCeeeccCCCCCEEEcCCCCeEEeeeccce
Q 010513 308 PKVVHRDIKSSNILLDKQWNPKLSDFGLAK 337 (508)
Q Consensus 308 ~~iiHrDlkp~NIll~~~~~~kL~DFG~a~ 337 (508)
.+++|+|+.|.||++++++.+.|+||+.+.
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 479999999999999998777899998776
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.47 E-value=0.0024 Score=65.52 Aligned_cols=75 Identities=19% Similarity=0.262 Sum_probs=53.0
Q ss_pred cceEcccCcEEEEEEEECCC-cEEEEEEeecC-----C--chhHHHHHHHHHHHHccC---CCCeeeEeeeeecCCeeEE
Q 010513 191 ENVIGEGGYGIVYHGVLEDN-TNVAVKNLLNN-----R--GQAEKEFKVEVEAIGRVR---HKNLVRLLGYCAEGAHRML 259 (508)
Q Consensus 191 ~~~LG~G~~g~Vy~~~~~~~-~~vavK~~~~~-----~--~~~~~~~~~E~~~l~~l~---hpniv~l~~~~~~~~~~~l 259 (508)
.+.||.|.+..||++...+| +.++||.-... . ....+....|.+.|..+. ..++.+++.+ +....++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence 35799999999999998876 48999975311 1 123456677888887762 2456677766 3355789
Q ss_pred EEEecCCC
Q 010513 260 VYEYIDNG 267 (508)
Q Consensus 260 V~e~~~~g 267 (508)
||||+++.
T Consensus 109 VME~L~~~ 116 (401)
T PRK09550 109 VMEDLSDH 116 (401)
T ss_pred EEecCCCc
Confidence 99999864
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.42 E-value=0.0011 Score=65.99 Aligned_cols=141 Identities=26% Similarity=0.294 Sum_probs=81.8
Q ss_pred ceEcccCcEEEEEEEECC-------CcEEEEEEeecCCchhHHHHHHHHHHHHccCCCC-eeeEeeeeecCCeeEEEEEe
Q 010513 192 NVIGEGGYGIVYHGVLED-------NTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKN-LVRLLGYCAEGAHRMLVYEY 263 (508)
Q Consensus 192 ~~LG~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn-iv~l~~~~~~~~~~~lV~e~ 263 (508)
+.|..|-...+|+....+ +..+++|...... ........|.+++..+...+ ..++++++.+ .+|+||
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~ 78 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEF 78 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhe
Confidence 456667777999988654 4778888865433 22234566888888774333 3345555542 368999
Q ss_pred cCCCCHHHH-----------------hccCCCCC-C----CCC--HHHHHH--------------------------HHH
Q 010513 264 IDNGNLEQW-----------------LHGDVGPH-S----PLT--WEIRMN--------------------------IIL 293 (508)
Q Consensus 264 ~~~g~L~~~-----------------l~~~~~~~-~----~l~--~~~~~~--------------------------i~~ 293 (508)
++|..+... ++...... . ..+ +..... +..
T Consensus 79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (302)
T cd05156 79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE 158 (302)
T ss_pred eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence 988665321 12211110 0 111 111100 111
Q ss_pred HHHHHHHHHHh------cCCCCeeeccCCCCCEEEcCC----CCeEEeeeccce
Q 010513 294 GTAKGLTYLHE------GLEPKVVHRDIKSSNILLDKQ----WNPKLSDFGLAK 337 (508)
Q Consensus 294 qi~~al~~LH~------~~~~~iiHrDlkp~NIll~~~----~~~kL~DFG~a~ 337 (508)
.+...+.++-. .....++|+|+.+.|||++++ +.++++||..+.
T Consensus 159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 22223334432 134578999999999999985 789999998775
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.39 E-value=0.0033 Score=62.62 Aligned_cols=147 Identities=16% Similarity=0.198 Sum_probs=83.6
Q ss_pred CcccceEcccCcEEEEEEEECCCcEEEEEEeecCCchhHHHHHHHHHHHHccCCCC--eeeEeeee------ecCCeeEE
Q 010513 188 FADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKN--LVRLLGYC------AEGAHRML 259 (508)
Q Consensus 188 ~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn--iv~l~~~~------~~~~~~~l 259 (508)
....+.++.|....+|+....++ .+++|...... ..+.+..|.+++..|...+ +.+++... ...+..++
T Consensus 24 ~~~i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~ 100 (307)
T TIGR00938 24 LLSLKGIAEGVENSNYLLTTDVG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPAC 100 (307)
T ss_pred ceeccccCCccccceEEEEeCCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEE
Confidence 33456678887789999876544 57788764422 1344556777777774322 34444321 22356789
Q ss_pred EEEecCCCCHH-----H---------HhccCCC---CCC-----CCCHHHHH------------HHHHHHHHHHHHHHh-
Q 010513 260 VYEYIDNGNLE-----Q---------WLHGDVG---PHS-----PLTWEIRM------------NIILGTAKGLTYLHE- 304 (508)
Q Consensus 260 V~e~~~~g~L~-----~---------~l~~~~~---~~~-----~l~~~~~~------------~i~~qi~~al~~LH~- 304 (508)
+++|++|..+. + .++.... ... .-.|.... .....+.+.++++..
T Consensus 101 l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~ 180 (307)
T TIGR00938 101 LVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKF 180 (307)
T ss_pred EEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhh
Confidence 99999885431 1 1221100 000 00111100 001123344555542
Q ss_pred ---cCCCCeeeccCCCCCEEEcCCCCeEEeeeccce
Q 010513 305 ---GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK 337 (508)
Q Consensus 305 ---~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~ 337 (508)
....+++|+|+.+.||++++++...|+||+.+.
T Consensus 181 ~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 181 WPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred hhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 224589999999999999988767899999775
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.34 E-value=2.3e-05 Score=88.93 Aligned_cols=160 Identities=13% Similarity=0.012 Sum_probs=119.3
Q ss_pred HHHHHHHHccCCCCeeeEeeeeec--CCeeEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-
Q 010513 230 KVEVEAIGRVRHKNLVRLLGYCAE--GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGL- 306 (508)
Q Consensus 230 ~~E~~~l~~l~hpniv~l~~~~~~--~~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~- 306 (508)
..|...++...|+++.....=... ...-+.+++|+.+|++++.+.+.......+....+.....+...+..-+|+..
T Consensus 1277 l~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tn 1356 (2724)
T KOG1826|consen 1277 LSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTN 1356 (2724)
T ss_pred hhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhccc
Confidence 345556677789998877655432 34568899999999999998776555555655555544444455555555442
Q ss_pred -CCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCCCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHh
Q 010513 307 -EPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS 385 (508)
Q Consensus 307 -~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt 385 (508)
..-.+|+++|+-|.+|..+-++|++++|+.+.... .....+...+++.|++|+..+.-.++.++|+|..|+.+|+...
T Consensus 1357 lg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp-~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~ 1435 (2724)
T KOG1826|consen 1357 LGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNP-VLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSD 1435 (2724)
T ss_pred CCccchhhhhhhhccceecCCcccccccccccccCc-hHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhc
Confidence 22368999999999999999999999999983322 2223344577889999999998899999999999999999988
Q ss_pred CCCCC
Q 010513 386 GRNPV 390 (508)
Q Consensus 386 g~~Pf 390 (508)
|..+|
T Consensus 1436 ~n~~f 1440 (2724)
T KOG1826|consen 1436 GNAYF 1440 (2724)
T ss_pred ccHHH
Confidence 88776
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.29 E-value=0.0037 Score=62.58 Aligned_cols=143 Identities=13% Similarity=0.154 Sum_probs=76.8
Q ss_pred cceEcccCcEEEEEEEECCCcEEEEEEeecCCchhHHHHHHHHHHHHccCCCC--eeeEee------eeecCCeeEEEEE
Q 010513 191 ENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKN--LVRLLG------YCAEGAHRMLVYE 262 (508)
Q Consensus 191 ~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn--iv~l~~------~~~~~~~~~lV~e 262 (508)
.+.|+.|....+|+....+| .+++|+.. . ...+.+..|.+++..|...+ +.+.+. +....+..+++++
T Consensus 27 ~~~l~~G~~n~~y~v~t~~g-~~vLK~~~-~--~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~ 102 (319)
T PRK05231 27 LKGIAEGIENSNFFLTTTQG-EYVLTLFE-R--LTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVT 102 (319)
T ss_pred cchhccccccceEEEEeCCC-cEEEEEec-c--CChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEE
Confidence 45577788789999887655 68888764 1 12334444556666553211 223332 1122456789999
Q ss_pred ecCCCCHH-----------HH---hccCCC-C--C----CCCCH-HHHHH------------HHHH-HHHHHHHHHh---
Q 010513 263 YIDNGNLE-----------QW---LHGDVG-P--H----SPLTW-EIRMN------------IILG-TAKGLTYLHE--- 304 (508)
Q Consensus 263 ~~~~g~L~-----------~~---l~~~~~-~--~----~~l~~-~~~~~------------i~~q-i~~al~~LH~--- 304 (508)
|++|..+. .. ++.... . . ..+.+ ..... .+.+ +...++.+.+
T Consensus 103 ~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 182 (319)
T PRK05231 103 FLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAW 182 (319)
T ss_pred ecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhcccc
Confidence 99986431 11 121100 0 0 01111 11110 1111 1112233321
Q ss_pred -cCCCCeeeccCCCCCEEEcCCCCeEEeeeccce
Q 010513 305 -GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK 337 (508)
Q Consensus 305 -~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~ 337 (508)
....++||+|+.+.||+++++...-++||+.+.
T Consensus 183 ~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 183 PALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred ccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 124489999999999999976556899999876
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.21 E-value=0.00035 Score=68.05 Aligned_cols=142 Identities=15% Similarity=0.080 Sum_probs=93.0
Q ss_pred hhHhhcCCCCcccceEcccCcEEEEEEEECCCcEEEEEEeecC---------Cc-------h------hHHHHHHHHHHH
Q 010513 179 RELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNN---------RG-------Q------AEKEFKVEVEAI 236 (508)
Q Consensus 179 ~~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~---------~~-------~------~~~~~~~E~~~l 236 (508)
+.+..-..-+.+.+.||=|--+.||.+.+.+|++.++|.-.-. .. . ..-...+|...|
T Consensus 85 ktL~~R~~v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafm 164 (465)
T KOG2268|consen 85 KTLSNRGSVESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFM 164 (465)
T ss_pred HHHHhcchhhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHH
Confidence 3333333357889999999999999999999999998842110 00 0 001234577788
Q ss_pred HccC-CCC-eeeEeeeeecCCeeEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecc
Q 010513 237 GRVR-HKN-LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRD 314 (508)
Q Consensus 237 ~~l~-hpn-iv~l~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrD 314 (508)
+.|. |.. +.+.+++ +..++|||++.+-.|.+.-+- .+... +...+..-+--|..+ |+||+|
T Consensus 165 kaL~e~gfpVPkpiD~----~RH~Vvmelv~g~Pl~~v~~v-------~d~~~---ly~~lm~~Iv~la~~---GlIHgD 227 (465)
T KOG2268|consen 165 KALYERGFPVPKPIDH----NRHCVVMELVDGYPLRQVRHV-------EDPPT---LYDDLMGLIVRLANH---GLIHGD 227 (465)
T ss_pred HHHHHcCCCCCCcccc----cceeeHHHhhcccceeeeeec-------CChHH---HHHHHHHHHHHHHHc---Cceecc
Confidence 7774 322 3334433 445789999998777654321 12222 222333335555566 999999
Q ss_pred CCCCCEEEcCCCCeEEeeeccce
Q 010513 315 IKSSNILLDKQWNPKLSDFGLAK 337 (508)
Q Consensus 315 lkp~NIll~~~~~~kL~DFG~a~ 337 (508)
..--||++++++.++++||--..
T Consensus 228 FNEFNimv~dd~~i~vIDFPQmv 250 (465)
T KOG2268|consen 228 FNEFNIMVKDDDKIVVIDFPQMV 250 (465)
T ss_pred cchheeEEecCCCEEEeechHhh
Confidence 99999999999999999997544
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.11 E-value=0.0042 Score=61.77 Aligned_cols=140 Identities=17% Similarity=0.200 Sum_probs=93.9
Q ss_pred cccceEcccCcEEEEEEEECCCcEEEEEEeecC------Cc--------------------hhHHHHHHHHHHHHccCCC
Q 010513 189 ADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNN------RG--------------------QAEKEFKVEVEAIGRVRHK 242 (508)
Q Consensus 189 ~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~------~~--------------------~~~~~~~~E~~~l~~l~hp 242 (508)
.+...|..|--+.||.|...+|..+|||+++-. +. ...-....|++-|.++...
T Consensus 147 ~inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a 226 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA 226 (520)
T ss_pred ecccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence 445679999999999999999999999977321 00 0111234566667776544
Q ss_pred CeeeEeeeeecCCeeEEEEEecCCCCH-HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEE
Q 010513 243 NLVRLLGYCAEGAHRMLVYEYIDNGNL-EQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNIL 321 (508)
Q Consensus 243 niv~l~~~~~~~~~~~lV~e~~~~g~L-~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIl 321 (508)
.|.-. .-..- ....|||+|+..... .-.|+ .-.++...+..+-.|++.-+.-|.+.| ++||.||.--|+|
T Consensus 227 GIP~P-ePIlL-k~hVLVM~FlGrdgw~aPkLK-----d~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~L 297 (520)
T KOG2270|consen 227 GIPCP-EPILL-KNHVLVMEFLGRDGWAAPKLK-----DASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLL 297 (520)
T ss_pred CCCCC-Cceee-ecceEeeeeccCCCCcCcccc-----cccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhhe
Confidence 42211 11111 123689999864211 11122 235666777788888888899998777 9999999999999
Q ss_pred EcCCCCeEEeeecccee
Q 010513 322 LDKQWNPKLSDFGLAKL 338 (508)
Q Consensus 322 l~~~~~~kL~DFG~a~~ 338 (508)
+.+. .+.++|-+-+..
T Consensus 298 yhdG-~lyiIDVSQSVE 313 (520)
T KOG2270|consen 298 YHDG-KLYIIDVSQSVE 313 (520)
T ss_pred EECC-EEEEEEcccccc
Confidence 8764 899999887654
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.07 E-value=0.0062 Score=59.70 Aligned_cols=31 Identities=32% Similarity=0.496 Sum_probs=26.0
Q ss_pred CCeeeccCCCCCEEEcCCCC-eEEeeecccee
Q 010513 308 PKVVHRDIKSSNILLDKQWN-PKLSDFGLAKL 338 (508)
Q Consensus 308 ~~iiHrDlkp~NIll~~~~~-~kL~DFG~a~~ 338 (508)
+.++|+|+++.|||+++++. .-|+||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 45899999999999997565 46999998874
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.06 E-value=0.007 Score=61.34 Aligned_cols=142 Identities=19% Similarity=0.186 Sum_probs=80.4
Q ss_pred cceEcccCcEEEEEEEECC-----CcEEEEEEeecCCchhHHHHHHHHHHHHccCCCC-eeeEeeeeecCCeeEEEEEec
Q 010513 191 ENVIGEGGYGIVYHGVLED-----NTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKN-LVRLLGYCAEGAHRMLVYEYI 264 (508)
Q Consensus 191 ~~~LG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn-iv~l~~~~~~~~~~~lV~e~~ 264 (508)
...|..|-.-.+|++...+ ++.|++|..........+ -..|..+++.+..-+ -.++++.+.++ .|.+|+
T Consensus 41 i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi 115 (344)
T PLN02236 41 VIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFD-RDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFI 115 (344)
T ss_pred EEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeec-hHHHHHHHHHHHHcCCCCceEEEECCc----eEEEee
Confidence 3455557888999987542 357888877554332222 256888888774333 33455666443 589999
Q ss_pred CCCCHHHH-----------------hccCCCCCC--CCCHHHHHHHHHH-----------------HHHHHHHHH----h
Q 010513 265 DNGNLEQW-----------------LHGDVGPHS--PLTWEIRMNIILG-----------------TAKGLTYLH----E 304 (508)
Q Consensus 265 ~~g~L~~~-----------------l~~~~~~~~--~l~~~~~~~i~~q-----------------i~~al~~LH----~ 304 (508)
++.+|... +|....+.. ...+....++..+ +...+..|. .
T Consensus 116 ~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~ 195 (344)
T PLN02236 116 HARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSG 195 (344)
T ss_pred CCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcc
Confidence 87665321 222211111 1112222222211 111122222 1
Q ss_pred -cCCCCeeeccCCCCCEEEcC-CCCeEEeeeccce
Q 010513 305 -GLEPKVVHRDIKSSNILLDK-QWNPKLSDFGLAK 337 (508)
Q Consensus 305 -~~~~~iiHrDlkp~NIll~~-~~~~kL~DFG~a~ 337 (508)
.....++|+|+++.|||+++ ++.+.++||..+.
T Consensus 196 ~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 196 DDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred cCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 11336899999999999986 4679999998776
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=97.05 E-value=0.0056 Score=60.18 Aligned_cols=76 Identities=14% Similarity=0.223 Sum_probs=47.3
Q ss_pred CcccceEcccCcEEEEEEEECCCcEEEEEEeecCCchhHHHHHHHHHHHHccC---CCCeeeEeeeeecCCeeEEEEEec
Q 010513 188 FADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVR---HKNLVRLLGYCAEGAHRMLVYEYI 264 (508)
Q Consensus 188 ~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---hpniv~l~~~~~~~~~~~lV~e~~ 264 (508)
.+-.+.++-|....+|+.. .+++.+.||.-. ......|..|.+-|+.|. --.+.+++++....+..+|||||+
T Consensus 19 i~~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l 94 (288)
T PF03881_consen 19 ITSIEPVSGGDINEAYRLD-TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFL 94 (288)
T ss_dssp --EEEEE--SSSSEEEEEE-TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE--
T ss_pred eeeeEecCCCChhheEEEE-CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEee
Confidence 3445678989999999877 567789999765 233355777877777773 445778888887777779999999
Q ss_pred CCC
Q 010513 265 DNG 267 (508)
Q Consensus 265 ~~g 267 (508)
+.+
T Consensus 95 ~~~ 97 (288)
T PF03881_consen 95 EMG 97 (288)
T ss_dssp ---
T ss_pred cCC
Confidence 876
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.70 E-value=0.021 Score=56.69 Aligned_cols=138 Identities=20% Similarity=0.253 Sum_probs=79.8
Q ss_pred cceEcccCcEEEEEEEECCCcEEEEEEee--cCCchhHHHHHHHHHHHHccCC--CCeeeEeeeeecCC--eeEEEEEec
Q 010513 191 ENVIGEGGYGIVYHGVLEDNTNVAVKNLL--NNRGQAEKEFKVEVEAIGRVRH--KNLVRLLGYCAEGA--HRMLVYEYI 264 (508)
Q Consensus 191 ~~~LG~G~~g~Vy~~~~~~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~h--pniv~l~~~~~~~~--~~~lV~e~~ 264 (508)
.+.+..|-.-.+|..... ++++++. .- ...........+|+++++.+.- --+...+++|.++. ..+.||+|+
T Consensus 30 v~~~~~G~sn~t~~~~~~-~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~v 107 (321)
T COG3173 30 VEEISGGWSNDTFRLGDT-GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWV 107 (321)
T ss_pred eeeccCCcccceEEEecC-CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEe
Confidence 344433433344444443 6677777 22 1222334556678888887743 23445566776665 668999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHH-HHHHH---------------------------------------------
Q 010513 265 DNGNLEQWLHGDVGPHSPLTWEIRMNIIL-GTAKG--------------------------------------------- 298 (508)
Q Consensus 265 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~-qi~~a--------------------------------------------- 298 (508)
+|..+.+.+... ... ..++. .+++.
T Consensus 108 eGe~~~~~~~~~-----~~~----~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p 178 (321)
T COG3173 108 EGEVVWSALPPE-----SLG----RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIP 178 (321)
T ss_pred cceeccCcCCcc-----cch----HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCc
Confidence 984222211100 000 01111 23333
Q ss_pred -----HHHHHhcC-----CCCeeeccCCCCCEEEcCCCCeEEeeeccceec
Q 010513 299 -----LTYLHEGL-----EPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL 339 (508)
Q Consensus 299 -----l~~LH~~~-----~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~ 339 (508)
..||+++. .+.++|+|+.+.|++++.++-+=+.||+++..-
T Consensus 179 ~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 179 LADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred hHHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence 33443332 346899999999999999888999999999853
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.62 E-value=0.02 Score=57.00 Aligned_cols=29 Identities=28% Similarity=0.343 Sum_probs=25.6
Q ss_pred CCeeeccCCCCCEEEcCCCCeEEeeeccce
Q 010513 308 PKVVHRDIKSSNILLDKQWNPKLSDFGLAK 337 (508)
Q Consensus 308 ~~iiHrDlkp~NIll~~~~~~kL~DFG~a~ 337 (508)
.+++|+|+.+.||+++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 47999999999999988 678999998665
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.53 E-value=0.034 Score=55.40 Aligned_cols=32 Identities=22% Similarity=0.321 Sum_probs=28.4
Q ss_pred CCCeeeccCCCCCEEEcCCCCeEEeeecccee
Q 010513 307 EPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL 338 (508)
Q Consensus 307 ~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~ 338 (508)
..+++|+|+.+.|+|+++++.+.++||..+..
T Consensus 195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 34799999999999999999999999987763
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.36 E-value=0.039 Score=55.63 Aligned_cols=72 Identities=18% Similarity=0.297 Sum_probs=46.5
Q ss_pred eEcccCcEEEEEEEECCC-cEEEEEEeec-------CCchhHHHHHHHHHHHHccC--CCC-eeeEeeeeecCCeeEEEE
Q 010513 193 VIGEGGYGIVYHGVLEDN-TNVAVKNLLN-------NRGQAEKEFKVEVEAIGRVR--HKN-LVRLLGYCAEGAHRMLVY 261 (508)
Q Consensus 193 ~LG~G~~g~Vy~~~~~~~-~~vavK~~~~-------~~~~~~~~~~~E~~~l~~l~--hpn-iv~l~~~~~~~~~~~lV~ 261 (508)
.||.|....||++...+| +.|+||.-.. .-.-..+....|.+.|+... .|. +.+++.+ ++....+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 579999999999997654 5799996532 11223445556777776653 353 4444433 445567999
Q ss_pred EecCC
Q 010513 262 EYIDN 266 (508)
Q Consensus 262 e~~~~ 266 (508)
|+++.
T Consensus 80 EdL~~ 84 (370)
T TIGR01767 80 EDLSH 84 (370)
T ss_pred hhCcc
Confidence 99854
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.35 E-value=0.04 Score=55.53 Aligned_cols=141 Identities=21% Similarity=0.298 Sum_probs=76.9
Q ss_pred ceEcccCcEEEEEEEECC----CcEEEEEEeecCCchhHHHHHHHHHHHHccCCCCe-eeEeeeeecCCeeEEEEEecCC
Q 010513 192 NVIGEGGYGIVYHGVLED----NTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNL-VRLLGYCAEGAHRMLVYEYIDN 266 (508)
Q Consensus 192 ~~LG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpni-v~l~~~~~~~~~~~lV~e~~~~ 266 (508)
+.|..|=.-.+|+....+ +..|++|........ .-.-.+|..+++.+..-++ .++++++..+ +|.+|+++
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~-~IdR~~E~~il~~l~~~gl~P~~l~~~~~G----~i~~fi~g 94 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDY-VIDRERELQAIKYLSAAGFGAKLLGVFGNG----MIQSFINA 94 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCe-EechHHHHHHHHHHHhcCCCCceeEEeCCc----EeehhhcC
Confidence 445447777889887543 237888877554332 1223457888888754443 3556555332 58899877
Q ss_pred CCHHH-----------------HhccCCCCCC--CCCHHHHHHHHHHH----------------------HHHHHHHHh-
Q 010513 267 GNLEQ-----------------WLHGDVGPHS--PLTWEIRMNIILGT----------------------AKGLTYLHE- 304 (508)
Q Consensus 267 g~L~~-----------------~l~~~~~~~~--~l~~~~~~~i~~qi----------------------~~al~~LH~- 304 (508)
..|.. .+|....+.. +-.+.....+..++ .+-+..+.+
T Consensus 95 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~ 174 (330)
T PLN02421 95 RTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEI 174 (330)
T ss_pred CCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHH
Confidence 65421 1222211111 11122222222111 111222211
Q ss_pred ----cCCCCeeeccCCCCCEEEcC-CCCeEEeeeccce
Q 010513 305 ----GLEPKVVHRDIKSSNILLDK-QWNPKLSDFGLAK 337 (508)
Q Consensus 305 ----~~~~~iiHrDlkp~NIll~~-~~~~kL~DFG~a~ 337 (508)
....-.+|+|+.+.|||+++ ++.++++||..|.
T Consensus 175 ~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag 212 (330)
T PLN02421 175 TDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGS 212 (330)
T ss_pred hccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccC
Confidence 11224799999999999975 5689999998775
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.30 E-value=0.045 Score=54.85 Aligned_cols=142 Identities=21% Similarity=0.306 Sum_probs=82.2
Q ss_pred ceEcccCcEEEEEEEECCCcEEEEEEeecCCchhHHHHHHHHHHHHccCCCC------eeeEee----eeecCCeeEEEE
Q 010513 192 NVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKN------LVRLLG----YCAEGAHRMLVY 261 (508)
Q Consensus 192 ~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn------iv~l~~----~~~~~~~~~lV~ 261 (508)
..|.+ .-..||+....+|.. ++|..... ....++..|.+.|..|.-.+ +..+-| ....+...+-++
T Consensus 32 ~~l~s-~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf 107 (331)
T COG2334 32 RGLNS-EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALF 107 (331)
T ss_pred ccccc-ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEE
Confidence 34554 456789988876665 77766544 45667777888888873211 222222 222223667899
Q ss_pred EecCCCCHHH------------H---hc----cCC----CCCCCCCHHH-------------HHHHHHHHHHHHHHHHhc
Q 010513 262 EYIDNGNLEQ------------W---LH----GDV----GPHSPLTWEI-------------RMNIILGTAKGLTYLHEG 305 (508)
Q Consensus 262 e~~~~g~L~~------------~---l~----~~~----~~~~~l~~~~-------------~~~i~~qi~~al~~LH~~ 305 (508)
+|++|..+.. + |+ +.. .......|.. ......++...++.+.+.
T Consensus 108 ~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~ 187 (331)
T COG2334 108 EYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLAR 187 (331)
T ss_pred EecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhh
Confidence 9999877762 0 11 110 1111223320 011222333444444432
Q ss_pred C----CCC---eeeccCCCCCEEEcCCCC-eEEeeeccce
Q 010513 306 L----EPK---VVHRDIKSSNILLDKQWN-PKLSDFGLAK 337 (508)
Q Consensus 306 ~----~~~---iiHrDlkp~NIll~~~~~-~kL~DFG~a~ 337 (508)
. ... +||+|+.|.||+++.+.. .-++||+-+.
T Consensus 188 ~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 188 LPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred chhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 2 223 899999999999999885 8899999776
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.27 E-value=0.071 Score=54.74 Aligned_cols=73 Identities=14% Similarity=0.229 Sum_probs=49.2
Q ss_pred cceEcccCcEEEEEEEECCCcEEEEEEeecC----Cc---hhHHHHHHHHHHHHccC---CCCeeeEeeeeecCCeeEEE
Q 010513 191 ENVIGEGGYGIVYHGVLEDNTNVAVKNLLNN----RG---QAEKEFKVEVEAIGRVR---HKNLVRLLGYCAEGAHRMLV 260 (508)
Q Consensus 191 ~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~----~~---~~~~~~~~E~~~l~~l~---hpniv~l~~~~~~~~~~~lV 260 (508)
.+.||.|....||+.... +..++||.-... .. .....-..|.+.|+.+. ..++.+++.++.+ ..+++
T Consensus 37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded--~~vlv 113 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT--MALIG 113 (418)
T ss_pred EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC--CCEEE
Confidence 567899999999998875 456889876411 11 12333344566666553 2477888888774 45789
Q ss_pred EEecCC
Q 010513 261 YEYIDN 266 (508)
Q Consensus 261 ~e~~~~ 266 (508)
||++++
T Consensus 114 ME~L~~ 119 (418)
T PLN02756 114 MRYLEP 119 (418)
T ss_pred EeecCC
Confidence 999976
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=96.26 E-value=0.023 Score=52.75 Aligned_cols=117 Identities=18% Similarity=0.129 Sum_probs=75.1
Q ss_pred cCcEEEEEEEECCCcEEEEEEeecCCch-hHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEEecCCCCHHHHhcc
Q 010513 197 GGYGIVYHGVLEDNTNVAVKNLLNNRGQ-AEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHG 275 (508)
Q Consensus 197 G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~g~L~~~l~~ 275 (508)
|+.++.-.+..+-| ...+|++....-. ...-|..+.++++++. .|+++..= +.-.+.++.|+|....
T Consensus 73 ~gNsTl~~~kt~iG-~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~------- 140 (308)
T PF07387_consen 73 NGNSTLLIGKTKIG-PLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIK------- 140 (308)
T ss_pred CCceEEEEeccccc-hhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCcc-------
Confidence 45555555554433 4566766443333 3445677888888774 46776622 3334458999985411
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccc
Q 010513 276 DVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLA 336 (508)
Q Consensus 276 ~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a 336 (508)
-.. ..++..=+.+|.-.|+. ..+.+|||..|+|||-|..|.+||.|-+.-
T Consensus 141 ------i~~----~N~i~agi~~L~~fH~~-~~~~lHGD~np~NiM~D~~G~lKlVDP~~L 190 (308)
T PF07387_consen 141 ------INF----SNFITAGIKDLMDFHSE-NQHCLHGDCNPDNIMCDKFGYLKLVDPVCL 190 (308)
T ss_pred ------cch----hHHHHHhHHHHHHhhcc-CCCeecCCCChhheeecCCCCEEecChhhh
Confidence 111 12222225678888954 558999999999999999999999997643
|
The function of this family is unknown. |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.08 E-value=0.029 Score=52.52 Aligned_cols=30 Identities=37% Similarity=0.527 Sum_probs=21.4
Q ss_pred CeeeccCCCCCEEE-cCCCCeEEeeecccee
Q 010513 309 KVVHRDIKSSNILL-DKQWNPKLSDFGLAKL 338 (508)
Q Consensus 309 ~iiHrDlkp~NIll-~~~~~~kL~DFG~a~~ 338 (508)
.++|+|+.+.|||+ +.++.++++||..+..
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 58999999999999 8889999999988764
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.79 E-value=0.22 Score=49.97 Aligned_cols=71 Identities=15% Similarity=0.072 Sum_probs=43.3
Q ss_pred cCcEEEEEEEECCCcEEEEEEeecCCchhHHHHHHHHHHHHccCCCC--eeeEe---e--eeecCCeeEEEEEecCCCC
Q 010513 197 GGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKN--LVRLL---G--YCAEGAHRMLVYEYIDNGN 268 (508)
Q Consensus 197 G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn--iv~l~---~--~~~~~~~~~lV~e~~~~g~ 268 (508)
+.-..||+....++..+++|..... .....++..|.+.+..|.... ++... | ....++..+.++++++|..
T Consensus 36 s~eN~vy~v~~~~~~~~vlKv~r~~-~~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~ 113 (325)
T PRK11768 36 SYENRVYQFGDEDGRRVVAKFYRPE-RWSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRA 113 (325)
T ss_pred cccceEEEEecCCCCEEEEEEcCcc-cCCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCC
Confidence 3446789998877888888876432 234556677888777763211 22211 1 1222456778999998753
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.63 E-value=0.12 Score=59.91 Aligned_cols=143 Identities=18% Similarity=0.271 Sum_probs=79.0
Q ss_pred ceEcccCcEEEEEEEECCCcEEEEEEeecCCchhHHHHHHHHHHHHcc-------CCCCeeeEee-----eeec-CC--e
Q 010513 192 NVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV-------RHKNLVRLLG-----YCAE-GA--H 256 (508)
Q Consensus 192 ~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-------~hpniv~l~~-----~~~~-~~--~ 256 (508)
+.|+ |..-.+|+....++..+++|+..... .......|.+.|..| .-|.+++-.+ .... +. .
T Consensus 31 ~~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~--~~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~ 107 (1013)
T PRK06148 31 TPLD-GERDLNFRLTTDDGADYILKIVNPSE--PRVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPR 107 (1013)
T ss_pred eecC-CcCCceEEEEeCCCCeEEEEEcCCcc--chhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceE
Confidence 4564 45678898887778889999875442 233444455666555 2334443221 1111 12 4
Q ss_pred eEEEEEecCCCCHHHH-----------------hc----cCCC--CCCCCCHHH-----------------HHHHHHHHH
Q 010513 257 RMLVYEYIDNGNLEQW-----------------LH----GDVG--PHSPLTWEI-----------------RMNIILGTA 296 (508)
Q Consensus 257 ~~lV~e~~~~g~L~~~-----------------l~----~~~~--~~~~l~~~~-----------------~~~i~~qi~ 296 (508)
.+-+++|++|..+.+. ++ +... ....+.|.. ...++.++.
T Consensus 108 ~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~~ 187 (1013)
T PRK06148 108 LLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERFL 187 (1013)
T ss_pred EEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHHH
Confidence 5678999998766541 11 1100 011122211 122222332
Q ss_pred HHHH-----HHHhcCCCCeeeccCCCCCEEEcCCC--CeE-Eeeecccee
Q 010513 297 KGLT-----YLHEGLEPKVVHRDIKSSNILLDKQW--NPK-LSDFGLAKL 338 (508)
Q Consensus 297 ~al~-----~LH~~~~~~iiHrDlkp~NIll~~~~--~~k-L~DFG~a~~ 338 (508)
+... .+. ....++||+|+.+.|||++.++ ++. |+|||.+..
T Consensus 188 ~~~~~~v~p~l~-~Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 188 ARFERNVAPRLA-ALPAQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred HHHHHHHHHHHh-cCCcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 2222 121 2244799999999999998875 565 999998763
|
|
| >PF13908 Shisa: Wnt and FGF inhibitory regulator | Back alignment and domain information |
|---|
Probab=95.55 E-value=0.037 Score=50.43 Aligned_cols=28 Identities=14% Similarity=0.185 Sum_probs=21.3
Q ss_pred ccchhhHHHHHHHHHHHHHHHHHHHHhh
Q 010513 17 IFGLRLWVVLGICVGAGIVLVLFLISLW 44 (508)
Q Consensus 17 ~~g~~~~~ii~I~~g~~~~~~l~~~~~~ 44 (508)
..++..++++||++||++|+++++++++
T Consensus 73 ~~~~~~~iivgvi~~Vi~Iv~~Iv~~~C 100 (179)
T PF13908_consen 73 PIYFITGIIVGVICGVIAIVVLIVCFCC 100 (179)
T ss_pred cccceeeeeeehhhHHHHHHHhHhhhee
Confidence 4577888999999998877766665553
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.50 E-value=0.18 Score=51.75 Aligned_cols=75 Identities=13% Similarity=0.236 Sum_probs=44.0
Q ss_pred cceEcccCcEEEEEEEECCC--cE-----EEEEEeecCCchhHHHHHHHHHHHHccCCCC-eeeEeeeeecCCeeEEEEE
Q 010513 191 ENVIGEGGYGIVYHGVLEDN--TN-----VAVKNLLNNRGQAEKEFKVEVEAIGRVRHKN-LVRLLGYCAEGAHRMLVYE 262 (508)
Q Consensus 191 ~~~LG~G~~g~Vy~~~~~~~--~~-----vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn-iv~l~~~~~~~~~~~lV~e 262 (508)
.+.|..|-...+|++...++ .. |.++..... ....-+-.+|+++++.+...+ -.++++.+.+ ++|.|
T Consensus 55 i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~-~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~l~e 129 (383)
T PTZ00384 55 IKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTY-NSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----FTIQE 129 (383)
T ss_pred EEEeCCcccceEEEEEecCCCCCccccceEEEEeccCC-CceEeccHHHHHHHHHHHhCCCCCeEEEecCC----EEEEE
Confidence 34555588899999975433 22 333332111 111112345888888885444 4456666643 59999
Q ss_pred ecCCCCHH
Q 010513 263 YIDNGNLE 270 (508)
Q Consensus 263 ~~~~g~L~ 270 (508)
|++|-+|.
T Consensus 130 fIeGr~l~ 137 (383)
T PTZ00384 130 WVEGNTMG 137 (383)
T ss_pred EeccccCC
Confidence 99987653
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.38 E-value=0.049 Score=54.33 Aligned_cols=73 Identities=22% Similarity=0.261 Sum_probs=56.3
Q ss_pred CeeEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeec
Q 010513 255 AHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFG 334 (508)
Q Consensus 255 ~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG 334 (508)
...|++|++- |+++.- + ....+.++..++.+.+..++-+..+. ..-|||+.-.||||+ +|++-|+||-
T Consensus 299 ~y~yl~~kdh-gt~is~-i-------k~~~~~e~lsff~s~~sil~~lekkf--~fehrnlt~~niLId-~GnvtLIDfk 366 (488)
T COG5072 299 LYLYLHFKDH-GTPISI-I-------KADRSEEELSFFWSCISILDILEKKF--PFEHRNLTLDNILID-EGNVTLIDFK 366 (488)
T ss_pred eEEEEEEecC-Cceeee-e-------ecccHHHHHHHHHHHHHHHhhhhhcC--Ccccccccccceeee-cCceEEEEee
Confidence 3456777764 333322 2 23467888999999888888887654 899999999999999 9999999999
Q ss_pred cceec
Q 010513 335 LAKLL 339 (508)
Q Consensus 335 ~a~~~ 339 (508)
+++.-
T Consensus 367 lsRl~ 371 (488)
T COG5072 367 LSRLS 371 (488)
T ss_pred eeecc
Confidence 99953
|
|
| >PF01102 Glycophorin_A: Glycophorin A; InterPro: IPR001195 Proteins in this group are responsible for the molecular basis of the blood group antigens, surface markers on the outside of the red blood cell membrane | Back alignment and domain information |
|---|
Probab=95.09 E-value=0.016 Score=48.64 Aligned_cols=32 Identities=22% Similarity=0.320 Sum_probs=16.5
Q ss_pred chhhHHHHHHHHHHHHHHH--HHHHHhhhhhccc
Q 010513 19 GLRLWVVLGICVGAGIVLV--LFLISLWFTSKRN 50 (508)
Q Consensus 19 g~~~~~ii~I~~g~~~~~~--l~~~~~~~~~rr~ 50 (508)
+|.-..|+||++||++-++ ++++.||++|+||
T Consensus 60 ~fs~~~i~~Ii~gv~aGvIg~Illi~y~irR~~K 93 (122)
T PF01102_consen 60 RFSEPAIIGIIFGVMAGVIGIILLISYCIRRLRK 93 (122)
T ss_dssp SSS-TCHHHHHHHHHHHHHHHHHHHHHHHHHHS-
T ss_pred CccccceeehhHHHHHHHHHHHHHHHHHHHHHhc
Confidence 5666677777777664332 2234455544444
|
Most of these markers are proteins, but some are carbohydrates attached to lipids or proteins [Reid M.E., Lomas-Francis C. The Blood Group Antigen FactsBook Academic Press, London / San Diego, (1997)]. Glycophorin A (PAS-2) and glycophorin B (PAS-3) belong to the MNS blood group system and are associated with antigens that include M/N, S/s, U, He, Mi(a), M(c), Vw, Mur, M(g), Vr, M(e), Mt(a), St(a), Ri(a), Cl(a), Ny(a), Hut, Hil, M(v), Far, Mit, Dantu, Hop, Nob, En(a), ENKT, amongst others. Glycophorin A is the major sialoglycoprotein of the erythrocyte membrane []. Structurally, glycophorin A consists of an N-terminal extracellular domain, heavily glycosylated on serine and threonine residues, followed by a transmembrane region and a C-terminal cytoplasmic domain. Other glycophorins in this entry such as Glycophorin B and Glycophorin E represent minor sialoglycoproteins in the erythrocyte membrane.; GO: 0016021 integral to membrane; PDB: 2KPF_B 1AFO_B 2KPE_A. |
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=95.02 E-value=0.35 Score=45.48 Aligned_cols=75 Identities=17% Similarity=0.250 Sum_probs=48.6
Q ss_pred ceEcccCcEEEEEEEECCCcEEEEEEeecCCchhHHHHHHHHHHHHcc---CCCCeeeEeeeeecCCeeEEEEEecCCCC
Q 010513 192 NVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV---RHKNLVRLLGYCAEGAHRMLVYEYIDNGN 268 (508)
Q Consensus 192 ~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l---~hpniv~l~~~~~~~~~~~lV~e~~~~g~ 268 (508)
+.+.-|.--..|...+ +...+.||.= .......|..|+.-|..+ +.-++.+++.+..+..+.|+||||++.|.
T Consensus 22 ~~v~gG~inea~~v~d-g~~~~FvK~n---~~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~ 97 (286)
T COG3001 22 EEVSGGDINEAWRLRD-GTDPFFVKCN---QREQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGP 97 (286)
T ss_pred cccCCccccceeEeec-CCcceEEEec---chhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCC
Confidence 3444444444454443 3556788853 223345677776666655 44567888888888899999999998865
Q ss_pred HH
Q 010513 269 LE 270 (508)
Q Consensus 269 L~ 270 (508)
+.
T Consensus 98 ~d 99 (286)
T COG3001 98 LD 99 (286)
T ss_pred CC
Confidence 54
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.00 E-value=0.037 Score=57.51 Aligned_cols=49 Identities=18% Similarity=0.257 Sum_probs=38.0
Q ss_pred HHHHHHHHHHHccCCCCeeeEeeeeecCC-eeEEEEEecCCCCHHHHhccC
Q 010513 227 KEFKVEVEAIGRVRHKNLVRLLGYCAEGA-HRMLVYEYIDNGNLEQWLHGD 276 (508)
Q Consensus 227 ~~~~~E~~~l~~l~hpniv~l~~~~~~~~-~~~lV~e~~~~g~L~~~l~~~ 276 (508)
..+.-...+++.+.|+|...++++-.... ...+|||++.. +|++++..+
T Consensus 27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~~~-Sled~~~~~ 76 (725)
T KOG1093|consen 27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHYTM-SLEDILKTG 76 (725)
T ss_pred HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhhcc-chHHHHHhc
Confidence 34555678899999999999998876543 35689999865 999998765
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 508 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 3e-63 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 8e-62 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 9e-51 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-50 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-40 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-40 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 8e-40 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 4e-38 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-26 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 5e-26 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-21 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-21 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-21 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-21 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-21 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-21 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 5e-21 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 5e-21 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-20 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-20 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-20 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 4e-20 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 5e-20 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 5e-20 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 5e-20 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 5e-20 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 6e-20 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 6e-20 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 6e-20 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 7e-20 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 7e-20 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 8e-20 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 8e-20 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 8e-20 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 8e-20 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 8e-20 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 9e-20 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 9e-20 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-19 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-19 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-19 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-19 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-19 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-19 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-19 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-19 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-19 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-19 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-19 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 3e-19 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 3e-19 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-19 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 3e-19 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-19 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 3e-19 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 4e-19 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 4e-19 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 5e-19 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-18 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-18 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-18 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-18 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-18 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-18 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-18 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-18 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-18 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-18 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-18 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-18 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 3e-18 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 3e-18 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 3e-18 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 3e-18 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 3e-18 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 3e-18 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 3e-18 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 3e-18 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 3e-18 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 3e-18 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 4e-18 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 5e-18 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-18 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 6e-18 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 7e-18 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 7e-18 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 9e-18 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-17 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-17 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-17 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-17 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-17 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-17 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-17 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-17 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-17 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-17 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-17 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-17 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-17 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-17 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-17 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-17 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-17 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-17 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-17 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 3e-17 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 4e-17 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-17 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 5e-17 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 5e-17 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 6e-17 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 6e-17 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 6e-17 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 6e-17 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 6e-17 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 7e-17 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 7e-17 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 7e-17 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 7e-17 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 8e-17 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-17 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-17 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 9e-17 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-16 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-16 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-16 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-16 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-16 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-16 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-16 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-16 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-16 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-16 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-16 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 1e-16 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-16 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-16 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-16 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-16 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-16 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-16 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-16 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-16 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-16 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-16 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-16 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-16 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-16 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-16 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-16 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-16 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-16 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-16 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-16 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-16 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-16 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-16 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-16 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-16 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 3e-16 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-16 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 3e-16 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 3e-16 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 3e-16 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-16 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-16 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 3e-16 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-16 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 3e-16 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-16 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 3e-16 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-16 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 3e-16 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 3e-16 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 3e-16 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 3e-16 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 4e-16 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 4e-16 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-16 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-16 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 4e-16 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 5e-16 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 5e-16 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 5e-16 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 5e-16 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 6e-16 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 6e-16 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 6e-16 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 6e-16 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 6e-16 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 6e-16 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 6e-16 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 6e-16 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 6e-16 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 6e-16 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 6e-16 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 6e-16 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 6e-16 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 7e-16 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 7e-16 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 7e-16 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 7e-16 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 7e-16 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 7e-16 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 7e-16 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 7e-16 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 7e-16 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 7e-16 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 8e-16 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 8e-16 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 8e-16 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 9e-16 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 9e-16 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 9e-16 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 9e-16 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 9e-16 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 9e-16 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-15 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-15 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-15 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-15 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-15 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-15 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-15 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-15 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-15 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-15 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-15 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 3e-15 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 3e-15 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-15 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-15 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 3e-15 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 3e-15 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-15 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-15 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 4e-15 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 4e-15 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 4e-15 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 4e-15 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 4e-15 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 4e-15 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-15 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 4e-15 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 4e-15 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 4e-15 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 5e-15 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-15 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 5e-15 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-15 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 5e-15 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 5e-15 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 5e-15 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 5e-15 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 5e-15 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 5e-15 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 6e-15 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 6e-15 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 6e-15 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 6e-15 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 6e-15 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 6e-15 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 6e-15 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 6e-15 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 7e-15 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 7e-15 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 8e-15 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 8e-15 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 8e-15 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 8e-15 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 9e-15 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 9e-15 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 9e-15 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 9e-15 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 9e-15 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-14 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-14 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-14 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-14 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 1e-14 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-14 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 1e-14 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-14 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 1e-14 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 1e-14 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-14 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-14 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-14 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 1e-14 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-14 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-14 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-14 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-14 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-14 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-14 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-14 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-14 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-14 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-14 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 2e-14 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-14 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-14 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-14 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-14 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-14 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-14 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-14 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-14 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-14 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-14 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-14 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-14 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-14 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-14 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-14 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-14 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 2e-14 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-14 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 3e-14 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 3e-14 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 3e-14 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 3e-14 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-14 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 3e-14 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 3e-14 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-14 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 3e-14 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 3e-14 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 3e-14 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-14 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-14 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 3e-14 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 3e-14 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 4e-14 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 4e-14 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 5e-14 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 5e-14 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 5e-14 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 5e-14 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 5e-14 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 6e-14 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 6e-14 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-14 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 7e-14 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 9e-14 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 9e-14 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 9e-14 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 9e-14 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-13 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-13 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-13 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 1e-13 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-13 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-13 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-13 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-13 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-13 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 1e-13 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-13 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-13 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-13 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-13 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-13 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-13 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-13 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-13 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-13 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-13 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-13 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 4e-13 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 4e-13 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 5e-13 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-13 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-13 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 5e-13 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 5e-13 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 5e-13 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 5e-13 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 6e-13 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 6e-13 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 6e-13 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 6e-13 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 6e-13 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 6e-13 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 7e-13 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 7e-13 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 7e-13 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 7e-13 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 8e-13 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 8e-13 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 8e-13 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 8e-13 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 9e-13 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 9e-13 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-13 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-12 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-12 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-12 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-12 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-12 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-12 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-12 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-12 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-12 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-12 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-12 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-12 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-12 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-12 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-12 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-12 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-12 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-12 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-12 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-12 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-12 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 3e-12 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-12 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-12 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 4e-12 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 4e-12 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-12 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-12 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 5e-12 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-12 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 5e-12 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-12 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 6e-12 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 6e-12 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 6e-12 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 6e-12 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 6e-12 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 7e-12 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 7e-12 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 7e-12 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 7e-12 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 8e-12 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 8e-12 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 8e-12 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 8e-12 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 9e-12 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 9e-12 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 9e-12 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-11 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-11 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-11 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-11 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-11 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-11 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-11 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-11 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-11 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-11 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-11 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-11 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-11 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-11 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-11 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-11 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-11 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-11 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-11 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-11 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-11 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-11 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-11 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-11 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-11 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-11 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-11 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-11 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-11 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-11 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-11 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-11 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-11 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-11 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-11 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-11 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-11 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-11 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-11 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-11 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-11 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-11 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-11 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-11 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-11 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-11 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-11 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-11 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-11 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-11 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-11 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-11 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-11 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-11 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-11 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-11 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-11 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-11 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-11 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 3e-11 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-11 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-11 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 3e-11 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 3e-11 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 3e-11 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-11 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 3e-11 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 3e-11 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 3e-11 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 3e-11 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-11 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-11 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-11 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-11 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-11 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 3e-11 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 3e-11 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 4e-11 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-11 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 4e-11 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 4e-11 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 4e-11 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 4e-11 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-11 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 4e-11 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 4e-11 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 4e-11 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 4e-11 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 4e-11 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 4e-11 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 4e-11 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 5e-11 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 5e-11 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 5e-11 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 5e-11 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 6e-11 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 6e-11 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 6e-11 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 6e-11 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 6e-11 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 6e-11 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 6e-11 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 7e-11 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 7e-11 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 8e-11 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 8e-11 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 8e-11 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 9e-11 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 9e-11 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-10 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-10 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 1e-10 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-10 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-10 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-10 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 1e-10 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-10 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 1e-10 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-10 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-10 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-10 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 1e-10 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-10 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-10 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-10 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-10 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 1e-10 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 1e-10 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-10 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-10 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-10 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-10 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-10 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-10 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-10 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 1e-10 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-10 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-10 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-10 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-10 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-10 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-10 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-10 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-10 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-10 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-10 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-10 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-10 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-10 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-10 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-10 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-10 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-10 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-10 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-10 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-10 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-10 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-10 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-10 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-10 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 3e-10 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-10 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 3e-10 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 3e-10 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-10 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 3e-10 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 3e-10 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-10 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 3e-10 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 3e-10 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-10 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 3e-10 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-10 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-10 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 3e-10 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 3e-10 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-10 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 4e-10 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 4e-10 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 4e-10 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 4e-10 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 4e-10 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 4e-10 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 4e-10 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 4e-10 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 4e-10 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 4e-10 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 4e-10 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 4e-10 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 4e-10 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 4e-10 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 4e-10 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 5e-10 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 5e-10 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 5e-10 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 5e-10 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 5e-10 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 5e-10 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 5e-10 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 6e-10 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 6e-10 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 6e-10 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-10 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 6e-10 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 6e-10 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 7e-10 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 7e-10 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 7e-10 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 8e-10 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 8e-10 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 8e-10 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 8e-10 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 8e-10 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 8e-10 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 8e-10 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 8e-10 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 9e-10 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 9e-10 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-10 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 9e-10 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 9e-10 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-09 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-09 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-09 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-09 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-09 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-09 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-09 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-09 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-09 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-09 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-09 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-09 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-09 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-09 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-09 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-09 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-09 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-09 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 2e-09 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-09 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-09 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-09 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-09 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-09 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-09 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-09 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-09 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-09 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-09 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-09 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 4e-09 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 4e-09 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 4e-09 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 4e-09 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 4e-09 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 4e-09 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 4e-09 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 4e-09 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 4e-09 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 5e-09 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 5e-09 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 5e-09 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 5e-09 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 6e-09 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 7e-09 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 7e-09 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 7e-09 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 7e-09 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 7e-09 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 7e-09 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 7e-09 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 7e-09 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 7e-09 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 8e-09 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 8e-09 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 8e-09 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-09 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 8e-09 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-09 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 8e-09 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-09 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 8e-09 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 8e-09 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 8e-09 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 8e-09 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 8e-09 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 8e-09 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 8e-09 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 8e-09 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 9e-09 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 9e-09 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 9e-09 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 9e-09 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 1e-08 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 1e-08 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 1e-08 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-08 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-08 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-08 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 1e-08 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-08 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 1e-08 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-08 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-08 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 1e-08 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-08 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 1e-08 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-08 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-08 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-08 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-08 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-08 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-08 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-08 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-08 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-08 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-08 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-08 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-08 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-08 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-08 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-08 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-08 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-08 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-08 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-08 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-08 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-08 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-08 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-08 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-08 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-08 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-08 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-08 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-08 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-08 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-08 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-08 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-08 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-08 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-08 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-08 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-08 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-08 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-08 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-08 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-08 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-08 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-08 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 2e-08 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-08 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-08 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-08 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 2e-08 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-08 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-08 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-08 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 3e-08 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-08 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-08 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 3e-08 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-08 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 3e-08 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 3e-08 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 3e-08 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-08 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-08 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 4e-08 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 4e-08 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 4e-08 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 4e-08 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 4e-08 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 4e-08 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-08 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 4e-08 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 4e-08 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 4e-08 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 5e-08 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-08 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 5e-08 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 5e-08 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 5e-08 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-08 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 5e-08 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 5e-08 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 5e-08 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 5e-08 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 5e-08 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 5e-08 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-08 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 6e-08 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 6e-08 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 6e-08 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 6e-08 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 6e-08 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 6e-08 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 6e-08 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 7e-08 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 7e-08 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 7e-08 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 7e-08 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 7e-08 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 7e-08 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 8e-08 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 8e-08 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 8e-08 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 8e-08 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 9e-08 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 9e-08 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 9e-08 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 9e-08 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 9e-08 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-07 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-07 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-07 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-07 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 1e-07 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-07 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 1e-07 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-07 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-07 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-07 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 1e-07 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-07 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 1e-07 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 1e-07 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-07 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-07 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-07 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-07 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-07 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-07 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-07 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-07 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-07 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-07 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 1e-07 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-07 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-07 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-07 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-07 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-07 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-07 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-07 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-07 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-07 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 2e-07 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-07 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 2e-07 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-07 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-07 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-07 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-07 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-07 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-07 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-07 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-07 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-07 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-07 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-07 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-07 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-07 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-07 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 2e-07 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 3e-07 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 3e-07 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 3e-07 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 3e-07 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 3e-07 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-07 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 3e-07 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-07 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-07 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 3e-07 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 3e-07 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-07 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 3e-07 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 3e-07 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-07 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-07 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-07 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 3e-07 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-07 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 3e-07 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 3e-07 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-07 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-07 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 4e-07 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 4e-07 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 4e-07 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 4e-07 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 4e-07 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 4e-07 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 4e-07 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 4e-07 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-07 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 4e-07 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 4e-07 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 4e-07 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 4e-07 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 4e-07 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 4e-07 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 4e-07 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 4e-07 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 4e-07 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 4e-07 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 5e-07 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 5e-07 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 5e-07 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 5e-07 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 5e-07 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-07 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 6e-07 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 6e-07 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 7e-07 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 7e-07 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 9e-07 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 9e-07 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 9e-07 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 9e-07 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 9e-07 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 1e-06 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-06 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-06 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 1e-06 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-06 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-06 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 2e-06 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-06 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 3e-06 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 3e-06 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 3e-06 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 3e-06 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 3e-06 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 4e-06 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 4e-06 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 4e-06 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 5e-06 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 5e-06 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 5e-06 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 5e-06 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 5e-06 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 6e-06 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 8e-06 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 9e-06 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 9e-06 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 1e-05 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 1e-05 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 1e-05 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-05 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-05 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 2e-05 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-05 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 2e-05 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 3e-05 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 512 bits (1322), Expect = 0.0
Identities = 128/312 (41%), Positives = 198/312 (63%), Gaps = 4/312 (1%)
Query: 159 VAAAITPEVSHLGWGHWYTLRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNL 218
V A PEV HLG ++LREL+V+++ F+++N++G GG+G VY G L D T VAVK L
Sbjct: 4 VPAEEDPEV-HLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRL 62
Query: 219 LNNRGQA-EKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDV 277
R Q E +F+ EVE I H+NL+RL G+C R+LVY Y+ NG++ L
Sbjct: 63 KEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERP 122
Query: 278 GPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK 337
PL W R I LG+A+GL YLH+ +PK++HRD+K++NILLD+++ + DFGLAK
Sbjct: 123 ESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 182
Query: 338 LLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPG 397
L+ + ++VTT V GT G++APEY STG +E++DV+ +G++++E+I+G+ D +R
Sbjct: 183 LMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLAN 242
Query: 398 E--VNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHV 455
+ V L++W+K ++ + E ++D LQ +++ + VAL C + +RPKM V
Sbjct: 243 DDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEV 302
Query: 456 IHMLEAEEFPFR 467
+ MLE + R
Sbjct: 303 VRMLEGDGLAER 314
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 489 bits (1261), Expect = e-173
Identities = 117/313 (37%), Positives = 184/313 (58%), Gaps = 4/313 (1%)
Query: 149 GSHHGSGDQTVAAAITPEVSHLGWGHWYTLRELEVSTNGFADENVIGEGGYGIVYHGVLE 208
GS + ++ A++ + L +LE +TN F + +IG G +G VY GVL
Sbjct: 2 GSKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLR 61
Query: 209 DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGN 268
D VA+K Q +EF+ E+E + RH +LV L+G+C E +L+Y+Y++NGN
Sbjct: 62 DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGN 121
Query: 269 LEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNP 328
L++ L+G P ++WE R+ I +G A+GL YLH ++HRD+KS NILLD+ + P
Sbjct: 122 LKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVP 178
Query: 329 KLSDFGLAKL-LGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGR 387
K++DFG++K ++++++T V GT GY+ PEY G L E+SDVYSFG+++ EV+ R
Sbjct: 179 KITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCAR 238
Query: 388 NPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAH 447
+ + S P VNL EW N E ++DP L +K +L++ A++C+ ++
Sbjct: 239 SAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSE 298
Query: 448 KRPKMGHVIHMLE 460
RP MG V+ LE
Sbjct: 299 DRPSMGDVLWKLE 311
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 405 bits (1042), Expect = e-140
Identities = 103/299 (34%), Positives = 171/299 (57%), Gaps = 21/299 (7%)
Query: 174 HWYTLRELEVSTNGFADE------NVIGEGGYGIVYHGVLEDNTNVAVKNLLNNR----G 223
H ++ EL+ TN F + N +GEGG+G+VY G + +NT VAVK L
Sbjct: 13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTE 71
Query: 224 QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPL 283
+ +++F E++ + + +H+NLV LLG+ ++G LVY Y+ NG+L L G PL
Sbjct: 72 ELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG-TPPL 130
Query: 284 TWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE- 342
+W +R I G A G+ +LH E +HRDIKS+NILLD+ + K+SDFGLA+
Sbjct: 131 SWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFA 187
Query: 343 RSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLV 402
++ +T+R++GT Y+APE G + +SD+YSFG++++E+I+G VD R L+
Sbjct: 188 QTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDEHRE--PQLLL 244
Query: 403 EWLKTMVTN-RNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 460
+ + + + E +D ++ + S +++ VA +C+ +KRP + V +L+
Sbjct: 245 DIKEEIEDEEKTIEDYIDKKMNDAD-STSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQ 302
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 280 bits (718), Expect = 4e-91
Identities = 74/308 (24%), Positives = 126/308 (40%), Gaps = 30/308 (9%)
Query: 177 TLRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAI 236
L + V G +G V+ L N VAVK + + + + + EV ++
Sbjct: 15 GTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVK-IFPIQDKQSWQNEYEVYSL 72
Query: 237 GRVRHKNLVRLLGYCAEGAH----RMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNII 292
++H+N+++ +G G L+ + + G+L +L + ++W +I
Sbjct: 73 PGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK-----ANVVSWNELCHIA 127
Query: 293 LGTAKGLTYLHE-------GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSY 345
A+GL YLHE G +P + HRDIKS N+LL ++DFGLA A +S
Sbjct: 128 ETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSA 187
Query: 346 V-TTRVMGTFGYVAPEYASTGMLNE-----RSDVYSFGILIMEVISGRNPVDYSRPPGEV 399
T +GT Y+APE + + R D+Y+ G+++ E+ S D +
Sbjct: 188 GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYML 247
Query: 400 NLVEWLKTMVTNRNAEGV-----LDPRLQEKPCSRALKRALL-VALRCVDPNAHKRPKMG 453
E + + + + V P L++ A L C D +A R G
Sbjct: 248 PFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAG 307
Query: 454 HVIHMLEA 461
V +
Sbjct: 308 CVGERITQ 315
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 212 bits (541), Expect = 9e-65
Identities = 69/322 (21%), Positives = 110/322 (34%), Gaps = 53/322 (16%)
Query: 180 ELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVE--AIG 237
E + + +IG G YG VY G L D VAVK + F E +
Sbjct: 7 EPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVF---SFANRQNFINEKNIYRVP 62
Query: 238 RVRHKNLVRLLGYCAEG-----AHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNII 292
+ H N+ R + +LV EY NG+L ++L W +
Sbjct: 63 LMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS-----LHTSDWVSSCRLA 117
Query: 293 LGTAKGLTYLHE------GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG------ 340
+GL YLH +P + HRD+ S N+L+ +SDFGL+ L
Sbjct: 118 HSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVR 177
Query: 341 -AERSYVTTRVMGTFGYVAPEYASTGM-------LNERSDVYSFGILIMEVISGRNPVDY 392
E +GT Y+APE + ++ D+Y+ G++ E+ +
Sbjct: 178 PGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFP 237
Query: 393 SRPPGEVNL-----------VEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVAL-- 439
E + E ++ +V+ P+ E +L L
Sbjct: 238 GESVPEYQMAFQTEVGNHPTFEDMQVLVSREK----QRPKFPEAWKENSLAVRSLKETIE 293
Query: 440 RCVDPNAHKRPKMGHVIHMLEA 461
C D +A R +
Sbjct: 294 DCWDQDAEARLTAQXAEERMAE 315
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 209 bits (534), Expect = 5e-64
Identities = 82/314 (26%), Positives = 145/314 (46%), Gaps = 24/314 (7%)
Query: 151 HHGSGDQTVAAAITPEVSHLGWGHWYTLRELEVSTNGFADENVIGEGGYGIVYHGVLEDN 210
HH ++ P +L + ++++ + IG G +G V+
Sbjct: 3 HHHH-HHPMSDYDIPTTENLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HG 60
Query: 211 TNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGN 268
++VAVK L+ + EF EV + R+RH N+V +G + + +V EY+ G+
Sbjct: 61 SDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGS 120
Query: 269 LEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNP 328
L + LH G L R+++ AKG+ YLH P +VHR++KS N+L+DK++
Sbjct: 121 LYRLLH-KSGAREQLDERRRLSMAYDVAKGMNYLH-NRNPPIVHRNLKSPNLLVDKKYTV 178
Query: 329 KLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRN 388
K+ DFGL++L A + GT ++APE NE+SDVYSFG+++ E+ + +
Sbjct: 179 KVCDFGLSRLK-ASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQ 237
Query: 389 PVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQ-EKPCSRALKRALLVALRCVDPNAH 447
P + +N + + V + RL+ + + + ++ C
Sbjct: 238 P--WG----NLNPAQVVA-AVGFKCK------RLEIPRNLNPQVAA-IIE--GCWTNEPW 281
Query: 448 KRPKMGHVIHMLEA 461
KRP ++ +L
Sbjct: 282 KRPSFATIMDLLRP 295
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 199 bits (508), Expect = 4e-60
Identities = 78/291 (26%), Positives = 126/291 (43%), Gaps = 29/291 (9%)
Query: 182 EVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRH 241
+ E V+G G +G+V +VA+K + + K F VE+ + RV H
Sbjct: 4 MIDYKEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIES--ESERKAFIVELRQLSRVNH 60
Query: 242 KNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTY 301
N+V+L G C LV EY + G+L LHG P T M+ L ++G+ Y
Sbjct: 61 PNIVKLYGACLN--PVCLVMEYAEGGSLYNVLHGA-EPLPYYTAAHAMSWCLQCSQGVAY 117
Query: 302 LHEGLEPKVVHRDIKSSNILLDKQWN-PKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPE 360
LH ++HRD+K N+LL K+ DFG A + T G+ ++APE
Sbjct: 118 LHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC----DIQTHMTNNKGSAAWMAPE 173
Query: 361 YASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDP 420
+E+ DV+S+GI++ EVI+ R P + E+ + +
Sbjct: 174 VFEGSNYSEKCDVFSWGIILWEVITRRKP--FD----EIGGPAFRIMWAVHNGT------ 221
Query: 421 RLQE-KPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA--EEFPFRD 468
R K + ++ L+ RC + +RP M ++ ++ FP D
Sbjct: 222 RPPLIKNLPKPIES-LMT--RCWSKDPSQRPSMEEIVKIMTHLMRYFPGAD 269
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 199 bits (508), Expect = 4e-60
Identities = 71/284 (25%), Positives = 121/284 (42%), Gaps = 34/284 (11%)
Query: 191 ENVIGEGGYGIVYHGVLEDNTN-VAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLG 249
V+G+G +G + + +K L+ + ++ F EV+ + + H N+++ +G
Sbjct: 15 GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIG 74
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK 309
+ + EYI G L + S W R++ A G+ YLH
Sbjct: 75 VLYKDKRLNFITEYIKGGTLRGIIK---SMDSQYPWSQRVSFAKDIASGMAYLH---SMN 128
Query: 310 VVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTR-------------VMGTFGY 356
++HRD+ S N L+ + N ++DFGLA+L+ E++ V+G +
Sbjct: 129 IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYW 188
Query: 357 VAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEG 416
+APE + +E+ DV+SFGI++ E+I N P +TM N G
Sbjct: 189 MAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLP----------RTMDFGLNVRG 238
Query: 417 VLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 460
LD C + + +RC D + KRP + H LE
Sbjct: 239 FLDRYCPPN-CPPSFFP---ITVRCCDLDPEKRPSFVKLEHWLE 278
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 198 bits (505), Expect = 6e-60
Identities = 73/300 (24%), Positives = 139/300 (46%), Gaps = 42/300 (14%)
Query: 179 RELEVSTNGFADENVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAE-------KEFK 230
R ++ N E IG+GG+G+V+ G ++D + VA+K+L+ + E +EF+
Sbjct: 12 RLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQ 71
Query: 231 VEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMN 290
EV + + H N+V+L G +V E++ G+L L P+ W +++
Sbjct: 72 REVFIMSNLNHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLD---KAHPIKWSVKLR 126
Query: 291 IILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQW-----NPKLSDFGLAKLLGAERSY 345
++L A G+ Y+ P +VHRD++S NI L K++DFGL++ + +
Sbjct: 127 LMLDIALGIEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ----QSVH 181
Query: 346 VTTRVMGTFGYVAPE--YASTGMLNERSDVYSFGILIMEVISGRNPVDYS-RPPGEVNLV 402
+ ++G F ++APE A E++D YSF +++ +++G P + G++ +
Sbjct: 182 SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGP--FDEYSYGKIKFI 239
Query: 403 EWLKTMVTNRNAEGVLDPRLQ-EKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461
M+ R + C L+ ++ C + KRP +++ L
Sbjct: 240 N----MIREEGL------RPTIPEDCPPRLRN-VIE--LCWSGDPKKRPHFSYIVKELSE 286
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 195 bits (497), Expect = 5e-59
Identities = 75/295 (25%), Positives = 130/295 (44%), Gaps = 40/295 (13%)
Query: 181 LEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLL----NNRGQAEKEFKVEVEAI 236
LE+ E +IG GG+G VY VAVK + Q + + E +
Sbjct: 2 LEIDFAELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLF 60
Query: 237 GRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTA 296
++H N++ L G C + + LV E+ G L + L G + +I +N + A
Sbjct: 61 AMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSG-----KRIPPDILVNWAVQIA 115
Query: 297 KGLTYLHEGLEPKVVHRDIKSSNILLDK--------QWNPKLSDFGLAKLLGAERSYVTT 348
+G+ YLH+ ++HRD+KSSNIL+ + K++DFGLA+ R+ +
Sbjct: 116 RGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREW--HRTTKMS 173
Query: 349 RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTM 408
G + ++APE M ++ SDV+S+G+L+ E+++G P + ++ +
Sbjct: 174 AA-GAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVP--FR----GIDGLAVAY-G 225
Query: 409 VTNRNAEGVLDPRLQEKP--CSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461
V L P C + + C +P+ H RP +++ L
Sbjct: 226 VAMNKL------AL-PIPSTCPEPFAK---LMEDCWNPDPHSRPSFTNILDQLTT 270
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 193 bits (494), Expect = 2e-58
Identities = 58/291 (19%), Positives = 115/291 (39%), Gaps = 34/291 (11%)
Query: 179 RELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNR--GQAEKEFKVEVEAI 236
+ + + E G ++ G ++ VK L + ++F E +
Sbjct: 3 KHSGIDFKQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRL 61
Query: 237 GRVRHKNLVRLLGYCAE--GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILG 294
H N++ +LG C H L+ ++ G+L LH G + + + L
Sbjct: 62 RIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHE--GTNFVVDQSQAVKFALD 119
Query: 295 TAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTF 354
A+G+ +LH LEP + + S ++++D+ ++S + S+ + M
Sbjct: 120 MARGMAFLH-TLEPLIPRHALNSRSVMIDEDMTARISMADVK------FSFQSPGRMYAP 172
Query: 355 GYVAPE---YASTGMLNERSDVYSFGILIMEVISGRNP-VDYSRPPGEVNLVEWLKTMVT 410
+VAPE +D++SF +L+ E+++ P D S E+ + V
Sbjct: 173 AWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLS--NMEIGM------KVA 224
Query: 411 NRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461
L P + S + + L+ C++ + KRPK ++ +LE
Sbjct: 225 LEG----LRPTIPPG-ISPHVSK-LMK--ICMNEDPAKRPKFDMIVPILEK 267
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 192 bits (490), Expect = 8e-58
Identities = 76/293 (25%), Positives = 131/293 (44%), Gaps = 30/293 (10%)
Query: 177 TLRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNR--GQAEKEFKVEVE 234
+ E+ IG G +G VY G + +VAVK L Q + FK EV
Sbjct: 15 AADDWEIPDGQITVGQRIGSGSFGTVYKGKW--HGDVAVKMLNVTAPTPQQLQAFKNEVG 72
Query: 235 AIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILG 294
+ + RH N++ +GY +V ++ + +L LH + + ++I
Sbjct: 73 VLRKTRHVNILLFMGYSTAP-QLAIVTQWCEGSSLYHHLH---ASETKFEMKKLIDIARQ 128
Query: 295 TAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA-ERSYVTTRVMGT 353
TA+G+ YLH ++HRD+KS+NI L + K+ DFGLA S+ ++ G+
Sbjct: 129 TARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGS 185
Query: 354 FGYVAPE---YASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVT 410
++APE + + +SDVY+FGI++ E+++G+ P ++ MV
Sbjct: 186 ILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI------IEMV- 238
Query: 411 NRNAEGVLDPRLQEKP--CSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461
G L P L + C + +KR + C+ +RP ++ +E
Sbjct: 239 ---GRGSLSPDLSKVRSNCPKRMKRLM---AECLKKKRDERPSFPRILAEIEE 285
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 191 bits (487), Expect = 6e-57
Identities = 66/301 (21%), Positives = 113/301 (37%), Gaps = 41/301 (13%)
Query: 177 TLRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNR--GQAEKEFKVEVE 234
L+E ++ +IG+G +G VYHG + VA++ + R K FK EV
Sbjct: 24 FLQEWDIPFEQLEIGELIGKGRFGQVYHGRW--HGEVAIRLIDIERDNEDQLKAFKREVM 81
Query: 235 AIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILG 294
A + RH+N+V +G C H ++ L + L I
Sbjct: 82 AYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVR---DAKIVLDVNKTRQIAQE 138
Query: 295 TAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVM--- 351
KG+ YLH ++H+D+KS N+ D ++DFGL + G ++ +
Sbjct: 139 IVKGMGYLH---AKGILHKDLKSKNVFYDN-GKVVITDFGLFSISGVLQAGRREDKLRIQ 194
Query: 352 -GTFGYVAPEYASTGML---------NERSDVYSFGILIMEVISGRNPVDYSR-PPGEVN 400
G ++APE ++ SDV++ G + E+ + P + P +
Sbjct: 195 NGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWP--FKTQPAEAI- 251
Query: 401 LVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 460
+ P L + + + L L C +RP ++ MLE
Sbjct: 252 ------IWQMGTG----MKPNLSQIGMGKEISDIL---LFCWAFEQEERPTFTKLMDMLE 298
Query: 461 A 461
Sbjct: 299 K 299
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 187 bits (478), Expect = 7e-56
Identities = 71/298 (23%), Positives = 116/298 (38%), Gaps = 40/298 (13%)
Query: 191 ENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVE--AIGRVRHKNLVRLL 248
+G+G YG V+ G NVAVK + EK + E E +RH+N++ +
Sbjct: 13 LECVGKGRYGEVWRGSW-QGENVAVKIF---SSRDEKSWFRETELYNTVMLRHENILGFI 68
Query: 249 GYCAEGAHR----MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 304
H L+ Y + G+L +L + L + I+L A GL +LH
Sbjct: 69 ASDMTSRHSSTQLWLITHYHEMGSLYDYLQ-----LTTLDTVSCLRIVLSIASGLAHLHI 123
Query: 305 GLE-----PKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL---GAERSYVTTRVMGTFGY 356
+ P + HRD+KS NIL+ K ++D GLA + + +GT Y
Sbjct: 124 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRY 183
Query: 357 VAPE------YASTGMLNERSDVYSFGILIMEVISGRNP---VDYSRPP-----GEVNLV 402
+APE +R D+++FG+++ EV V+ +PP
Sbjct: 184 MAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSF 243
Query: 403 EWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 460
E ++ +V + R P +L + L+ C N R + L
Sbjct: 244 EDMRKVVCVDQQRPNIPNRWFSDPTLTSLAK-LMK--ECWYQNPSARLTALRIKKTLT 298
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 185 bits (471), Expect = 2e-54
Identities = 66/296 (22%), Positives = 114/296 (38%), Gaps = 36/296 (12%)
Query: 191 ENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGY 250
IG+G YG V+ G VAVK + +A + E+ +RH+N++ +
Sbjct: 42 VKQIGKGRYGEVWMGKW-RGEKVAVK-VFFTTEEASWFRETEIYQTVLMRHENILGFIAA 99
Query: 251 CAEGAHR----MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE-- 304
+G L+ +Y +NG+L +L + L + + + + GL +LH
Sbjct: 100 DIKGTGSWTQLYLITDYHENGSLYDYLK-----STTLDAKSMLKLAYSSVSGLCHLHTEI 154
Query: 305 ---GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS---YVTTRVMGTFGYVA 358
+P + HRD+KS NIL+ K ++D GLA ++ + +GT Y+
Sbjct: 155 FSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMP 214
Query: 359 PE------YASTGMLNERSDVYSFGILIMEVISGRNPV----DYSRP----PGEVNLVEW 404
PE + +D+YSFG+++ EV +Y P E
Sbjct: 215 PEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYED 274
Query: 405 LKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 460
++ +V + R C R + + + C N R V L
Sbjct: 275 MREIVCIKKLRPSFPNRWSSDECLRQMGK---LMTECWAHNPASRLTALRVKKTLA 327
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 2e-52
Identities = 68/315 (21%), Positives = 119/315 (37%), Gaps = 47/315 (14%)
Query: 174 HWYTLRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEV 233
R + + + IG+G +G V+ G VAVK + E+ + E
Sbjct: 37 QRTIARTIVL-------QESIGKGRFGEVWRGKW-RGEEVAVKIF---SSREERSWFREA 85
Query: 234 E--AIGRVRHKNLVRLLGYC----AEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEI 287
E +RH+N++ + LV +Y ++G+L +L+ +T E
Sbjct: 86 EIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN-----RYTVTVEG 140
Query: 288 RMNIILGTAKGLTYLHEGLE-----PKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE 342
+ + L TA GL +LH + P + HRD+KS NIL+ K ++D GLA +
Sbjct: 141 MIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSA 200
Query: 343 RS---YVTTRVMGTFGYVAPE------YASTGMLNERSDVYSFGILIMEVISGRNPVD-- 391
+GT Y+APE +R+D+Y+ G++ E+ +
Sbjct: 201 TDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIH 260
Query: 392 ------YSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPN 445
Y VE ++ +V + + R Q R + + ++ C N
Sbjct: 261 EDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAK-IMR--ECWYAN 317
Query: 446 AHKRPKMGHVIHMLE 460
R + L
Sbjct: 318 GAARLTALRIKKTLS 332
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 5e-39
Identities = 74/278 (26%), Positives = 120/278 (43%), Gaps = 32/278 (11%)
Query: 191 ENVIGEGGYGIVYHGVL-EDNTNVAVKNL-LNNRGQAEKEFKVEVEAIGRVRHKNLVRLL 248
IG G +G V+ G L DNT VAVK+ + +F E + + H N+VRL+
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLI 178
Query: 249 GYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEP 308
G C + +V E + G+ +L + L + + ++ A G+ YL
Sbjct: 179 GVCTQKQPIYIVMELVQGGDFLTFLRTEGA---RLRVKTLLQMVGDAAAGMEYLE---SK 232
Query: 309 KVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGY--VAPEYASTGM 366
+HRD+ + N L+ ++ K+SDFG+++ A+ Y + + APE + G
Sbjct: 233 CCIHRDLAARNCLVTEKNVLKISDFGMSREE-ADGVYAASGGLRQVPVKWTAPEALNYGR 291
Query: 367 LNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEK 425
+ SDV+SFGIL+ E S G +P Y P N +G RL
Sbjct: 292 YSSESDVWSFGILLWETFSLGASP--Y---PNLSN------QQTREFVEKGG---RL-PC 336
Query: 426 P--CSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461
P C A+ R + +C +RP + L++
Sbjct: 337 PELCPDAVFR---LMEQCWAYEPGQRPSFSTIYQELQS 371
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 1e-37
Identities = 78/273 (28%), Positives = 128/273 (46%), Gaps = 28/273 (10%)
Query: 191 ENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGY 250
E +G+G +G V+ G T VA+K L + + F E + + ++RH+ LV+L
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 247
Query: 251 CAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKV 310
+E +V EY+ G+L +L G+ G + L +++ A G+ Y+
Sbjct: 248 VSE-EPIYIVTEYMSKGSLLDFLKGETGKY--LRLPQLVDMAAQIASGMAYVER---MNY 301
Query: 311 VHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNER 370
VHRD++++NIL+ + K++DFGLA+L+ + APE A G +
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 361
Query: 371 SDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKP--C 427
SDV+SFGIL+ E+ + GR P Y PG VN V ++ G R+ P C
Sbjct: 362 SDVWSFGILLTELTTKGRVP--Y---PGMVN------REVLDQVERGY---RM-PCPPEC 406
Query: 428 SRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 460
+L + +C +RP ++ LE
Sbjct: 407 PESLHD---LMCQCWRKEPEERPTFEYLQAFLE 436
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 2e-37
Identities = 70/302 (23%), Positives = 126/302 (41%), Gaps = 38/302 (12%)
Query: 164 TPEVSHLGWGHWYTLRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRG 223
P + LG+G W E+ +G G +G+V +G +VA+K +
Sbjct: 8 APSTAGLGYGSW------EIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMI-KEGS 60
Query: 224 QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPL 283
+E EF E + + + H+ LV+L G C + ++ EY+ NG L +L
Sbjct: 61 MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRH---RF 117
Query: 284 TWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER 343
+ + + + + YL + +HRD+ + N L++ Q K+SDFGL++ +
Sbjct: 118 QTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV--LD 172
Query: 344 SYVTTRVMGTFGY--VAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVN 400
T+ V F PE + +SD+++FG+L+ E+ S G+ P Y N
Sbjct: 173 DEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMP--Y---ERFTN 227
Query: 401 LVEWLKTMVTNRNAEGVLDPRLQEKP--CSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458
+ A+G+ RL +P S + + C A +RP ++
Sbjct: 228 ------SETAEHIAQGL---RL-YRPHLASEKVYT---IMYSCWHEKADERPTFKILLSN 274
Query: 459 LE 460
+
Sbjct: 275 IL 276
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 2e-37
Identities = 66/285 (23%), Positives = 121/285 (42%), Gaps = 26/285 (9%)
Query: 191 ENVIGEGGYGIVYHGVL-----EDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLV 245
+ +G+G +G V VAVK L ++ +++F+ E++ + + +V
Sbjct: 28 ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIV 87
Query: 246 RLLGYCAEGAHR--MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 303
+ G + LV EY+ +G L +L L + KG+ YL
Sbjct: 88 KYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRA---RLDASRLLLYSSQICKGMEYLG 144
Query: 304 EGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTF--GYVAPEY 361
+ VHRD+ + NIL++ + + K++DFGLAKLL ++ Y R G + APE
Sbjct: 145 ---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPES 201
Query: 362 ASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDP 420
S + + +SDV+SFG+++ E+ + S + ++ + + +L+
Sbjct: 202 LSDNIFSRQSDVWSFGVVLYELFTYCDKS--CSPSAEFLRMMGCERDVPALSRLLELLEE 259
Query: 421 --RLQEKP--CSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461
RL P C + + C P+ RP + L+
Sbjct: 260 GQRL-PAPPACPAEVHE---LMKLCWAPSPQDRPSFSALGPQLDM 300
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 3e-37
Identities = 65/202 (32%), Positives = 101/202 (50%), Gaps = 15/202 (7%)
Query: 194 IGEGGYGIVYHGVLED---NTNVAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKNLVRL 247
+G GG VY ED N VA+K + + + K F+ EV ++ H+N+V +
Sbjct: 19 LGGGGMSTVYLA--EDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSM 76
Query: 248 LGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLE 307
+ E LV EYI+ L +++ H PL+ + +N G+ + H+
Sbjct: 77 IDVDEEDDCYYLVMEYIEGPTLSEYIES----HGPLSVDTAINFTNQILDGIKHAHDM-- 130
Query: 308 PKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGML 367
++VHRDIK NIL+D K+ DFG+AK L T V+GT Y +PE A
Sbjct: 131 -RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEAT 189
Query: 368 NERSDVYSFGILIMEVISGRNP 389
+E +D+YS GI++ E++ G P
Sbjct: 190 DECTDIYSIGIVLYEMLVGEPP 211
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 4e-37
Identities = 71/303 (23%), Positives = 124/303 (40%), Gaps = 38/303 (12%)
Query: 164 TPEVSHLGWGHWYTLRELEVSTNGFADENVIGEGGYGIVYHGVLED-NTNVAVKNLLNNR 222
T + W E+ ++ +G G YG VY GV + + VAVK L
Sbjct: 204 TIYGVSPNYDKW------EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KED 256
Query: 223 GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSP 282
+EF E + ++H NLV+LLG C ++ E++ GNL +L
Sbjct: 257 TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR--QE 314
Query: 283 LTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE 342
++ + + + + + YL + +HR++ + N L+ + K++DFGL++L+
Sbjct: 315 VSAVVLLYMATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLM--T 369
Query: 343 RSYVTTRVMGTFGY--VAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEV 399
T F APE + + +SDV++FG+L+ E+ + G +P Y PG
Sbjct: 370 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP--Y---PGID 424
Query: 400 NLVEWLKTMVTNRNAEGVLDPRLQEKP--CSRALKRALLVALRCVDPNAHKRPKMGHVIH 457
+ V + R+ E+P C + + C N RP +
Sbjct: 425 L------SQVYELLEKDY---RM-ERPEGCPEKVYE---LMRACWQWNPSDRPSFAEIHQ 471
Query: 458 MLE 460
E
Sbjct: 472 AFE 474
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 5e-37
Identities = 73/296 (24%), Positives = 120/296 (40%), Gaps = 42/296 (14%)
Query: 173 GHWYTLRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVE 232
GH E+ +G G +G+V G + +VAVK + +E EF E
Sbjct: 1 GHM------ELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMI-KEGSMSEDEFFQE 53
Query: 233 VEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNII 292
+ + ++ H LV+ G C++ +V EYI NG L +L G + + M
Sbjct: 54 AQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSH-GKGLEPSQLLEM--C 110
Query: 293 LGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMG 352
+G+ +L + +HRD+ + N L+D+ K+SDFG+ + + + V
Sbjct: 111 YDVCEGMAFLE---SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYV--LDDQYVSSVGT 165
Query: 353 TFGY--VAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMV 409
F APE + +SDV++FGIL+ EV S G+ P Y
Sbjct: 166 KFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMP--Y---DL-----------Y 209
Query: 410 TNRNAEGVLDP--RLQEKP--CSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461
TN + RL +P S + + + C KRP ++ +E
Sbjct: 210 TNSEVVLKVSQGHRL-YRPHLASDTIYQ---IMYSCWHELPEKRPTFQQLLSSIEP 261
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 5e-37
Identities = 73/278 (26%), Positives = 119/278 (42%), Gaps = 36/278 (12%)
Query: 191 ENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGY 250
IG G +G+V+ G + VA+K + +E++F E E + ++ H LV+L G
Sbjct: 13 VQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 71
Query: 251 CAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKV 310
C E A LV E++++G L +L G E + + L +G+ YL E V
Sbjct: 72 CLEQAPICLVTEFMEHGCLSDYLRTQRG---LFAAETLLGMCLDVCEGMAYLE---EACV 125
Query: 311 VHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGY--VAPEYASTGMLN 368
+HRD+ + N L+ + K+SDFG+ + + T+ F +PE S +
Sbjct: 126 IHRDLAARNCLVGENQVIKVSDFGMTRFV--LDDQYTSSTGTKFPVKWASPEVFSFSRYS 183
Query: 369 ERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDP--RLQEK 425
+SDV+SFG+L+ EV S G+ P Y +N + RL K
Sbjct: 184 SKSDVWSFGVLMWEVFSEGKIP--Y---EN-----------RSNSEVVEDISTGFRL-YK 226
Query: 426 P--CSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461
P S + + + C RP ++ L
Sbjct: 227 PRLASTHVYQ---IMNHCWRERPEDRPAFSRLLRQLAE 261
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 1e-36
Identities = 78/273 (28%), Positives = 128/273 (46%), Gaps = 28/273 (10%)
Query: 191 ENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGY 250
E +G+G +G V+ G T VA+K L + + F E + + ++RH+ LV+L
Sbjct: 272 EVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 330
Query: 251 CAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKV 310
+E +V EY+ G+L +L G+ G + L +++ A G+ Y+
Sbjct: 331 VSE-EPIYIVTEYMSKGSLLDFLKGETGKY--LRLPQLVDMAAQIASGMAYVERM---NY 384
Query: 311 VHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNER 370
VHRD++++NIL+ + K++DFGLA+L+ + APE A G +
Sbjct: 385 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 444
Query: 371 SDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKP--C 427
SDV+SFGIL+ E+ + GR P Y PG VN V ++ G R+ P C
Sbjct: 445 SDVWSFGILLTELTTKGRVP--Y---PGMVN------REVLDQVERGY---RM-PCPPEC 489
Query: 428 SRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 460
+L + +C +RP ++ LE
Sbjct: 490 PESLHD---LMCQCWRKEPEERPTFEYLQAFLE 519
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 3e-36
Identities = 73/288 (25%), Positives = 130/288 (45%), Gaps = 36/288 (12%)
Query: 180 ELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV 239
E+ E +G G +G V+ +T VAVK + + + F E + +
Sbjct: 182 AWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTL 240
Query: 240 RHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGL 299
+H LV+L + ++ E++ G+L +L D G S ++ A+G+
Sbjct: 241 QHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEG--SKQPLPKLIDFSAQIAEGM 297
Query: 300 TYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGY--V 357
++ + +HRD++++NIL+ K++DFGLA+++ E + T R F
Sbjct: 298 AFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVI--EDNEYTAREGAKFPIKWT 352
Query: 358 APEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEG 416
APE + G +SDV+SFGIL+ME+++ GR P Y PG ++N
Sbjct: 353 APEAINFGSFTIKSDVWSFGILLMEIVTYGRIP--Y---PG-----------MSNPEVIR 396
Query: 417 VLDP--RLQEKP--CSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 460
L+ R+ +P C L + +RC +RP ++ +L+
Sbjct: 397 ALERGYRM-PRPENCPEELYN---IMMRCWKNRPEERPTFEYIQSVLD 440
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 3e-36
Identities = 67/266 (25%), Positives = 107/266 (40%), Gaps = 31/266 (11%)
Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVK--NLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLG 249
IG G + VY G+ E VA + FK E E + ++H N+VR
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 250 YCAEGAHRM----LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG 305
LV E + +G L+ +L + ++ + KGL +LH
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYLK----RFKVMKIKVLRSWCRQILKGLQFLHTR 148
Query: 306 LEPKVVHRDIKSSNILLD-KQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAST 364
P ++HRD+K NI + + K+ D GLA L A + V+GT ++APE
Sbjct: 149 -TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK---AVIGTPEFMAPEMYEE 204
Query: 365 GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQE 424
+E DVY+FG+ ++E+ + P YS E + VT+ P +
Sbjct: 205 K-YDESVDVYAFGMCMLEMATSEYP--YS----ECQNAAQIYRRVTSGVK-----PASFD 252
Query: 425 KPCSRALKRALLVALRCVDPNAHKRP 450
K +K + C+ N +R
Sbjct: 253 KVAIPEVKEII---EGCIRQNKDERY 275
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 4e-36
Identities = 72/288 (25%), Positives = 121/288 (42%), Gaps = 51/288 (17%)
Query: 191 ENVIGEGGYGIVYHGVLED-----NTNVAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNL 244
V+G G +G VY G+ VA+K L +A KE E + V + ++
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79
Query: 245 VRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 304
RLLG C + L+ + + G L ++ + + +N + AKG+ YL +
Sbjct: 80 CRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDN---IGSQYLLNWCVQIAKGMNYLED 135
Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRV-------MGTFGYV 357
++VHRD+ + N+L+ + K++DFGLAKLLGAE M
Sbjct: 136 ---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM------ 186
Query: 358 APEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEG 416
A E + +SDV+S+G+ + E+++ G P Y G +
Sbjct: 187 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKP--Y---DG-----------IPASEISS 230
Query: 417 VLDP--RLQEKP--CSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 460
+L+ RL +P C+ + + +C +A RPK +I
Sbjct: 231 ILEKGERL-PQPPICTIDVYM---IMRKCWMIDADSRPKFRELIIEFS 274
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 5e-36
Identities = 76/282 (26%), Positives = 120/282 (42%), Gaps = 38/282 (13%)
Query: 191 ENVIGEGGYGIVYHGVL---EDNTNVAVKNL-LNNRGQAEKEFKVEVEAIGRVRHKNLVR 246
+ +G G +G V GV + +VA+K L +E E + + ++ + +VR
Sbjct: 15 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 74
Query: 247 LLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGL 306
L+G C A MLV E G L ++L G + ++ + G+ YL E
Sbjct: 75 LIGVCQAEAL-MLVMEMAGGGPLHKFLVGKREE---IPVSNVAELLHQVSMGMKYLEE-- 128
Query: 307 EPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTF--GYVAPEYAST 364
VHRD+ + N+LL + K+SDFGL+K LGA+ SY T R G + + APE +
Sbjct: 129 -KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF 187
Query: 365 GMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDP--R 421
+ RSDV+S+G+ + E +S G+ P Y + ++ R
Sbjct: 188 RKFSSRSDVWSYGVTMWEALSYGQKP--Y---KK-----------MKGPEVMAFIEQGKR 231
Query: 422 LQEKP--CSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461
+ E P C L + C RP V + A
Sbjct: 232 M-ECPPECPPELYA---LMSDCWIYKWEDRPDFLTVEQRMRA 269
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 7e-36
Identities = 79/326 (24%), Positives = 122/326 (37%), Gaps = 48/326 (14%)
Query: 143 YPERAAGSHHGSGDQTVAAAITPEVSHLGWGHWYTLRELEVSTNGFADENVIGEGGYGIV 202
Y A G V W ++ IG+G +G V
Sbjct: 156 YTTDADGLCTRLIKPKVMEGTVAAQDEFYRSGW------ALNMKELKLLQTIGKGEFGDV 209
Query: 203 YHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHR-MLVY 261
G VAVK + + F E + ++RH NLV+LLG E +V
Sbjct: 210 MLGDYR-GNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 266
Query: 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNIL 321
EY+ G+L +L S L + + L + + YL VHRD+ + N+L
Sbjct: 267 EYMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVL 321
Query: 322 LDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGY--VAPEYASTGMLNERSDVYSFGIL 379
+ + K+SDFGL + +T+ G APE + +SDV+SFGIL
Sbjct: 322 VSEDNVAKVSDFGLT------KEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGIL 375
Query: 380 IMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDP--RLQEKP--CSRALKRA 434
+ E+ S GR P Y P + ++ ++ ++ + P C A+
Sbjct: 376 LWEIYSFGRVP--Y---PR-----------IPLKDVVPRVEKGYKM-DAPDGCPPAVYD- 417
Query: 435 LLVALRCVDPNAHKRPKMGHVIHMLE 460
V C +A RP + LE
Sbjct: 418 --VMKNCWHLDAATRPTFLQLREQLE 441
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 7e-36
Identities = 74/282 (26%), Positives = 122/282 (43%), Gaps = 40/282 (14%)
Query: 191 ENVIGEGGYGIVYHGVL---EDNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLV 245
+ +G G +G V G + VAVK L N + E E + ++ + +V
Sbjct: 22 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 81
Query: 246 RLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG 305
R++G C + MLV E + G L ++L + + + + ++ + G+ YL E
Sbjct: 82 RMIGICEAESW-MLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYL-E- 134
Query: 306 LEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTF--GYVAPEYAS 363
E VHRD+ + N+LL Q K+SDFGL+K L A+ +Y + G + + APE +
Sbjct: 135 -ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 193
Query: 364 TGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDP-- 420
+ +SDV+SFG+L+ E S G+ P Y G + +L+
Sbjct: 194 YYKFSSKSDVWSFGVLMWEAFSYGQKP--Y---RG-----------MKGSEVTAMLEKGE 237
Query: 421 RLQEKP--CSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 460
R+ P C R + + C + RP V L
Sbjct: 238 RM-GCPAGCPREMYD---LMNLCWTYDVENRPGFAAVELRLR 275
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 9e-36
Identities = 84/333 (25%), Positives = 139/333 (41%), Gaps = 49/333 (14%)
Query: 161 AAITPEVSHLGWGHWYTLRELEVSTNGFADENVIGEGGYGIVYHGVL------EDNTNVA 214
A++ PE Y E EV+ +G+G +G+VY GV E T VA
Sbjct: 2 ASVNPEYFSAA--DVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVA 59
Query: 215 VKNLLNNRGQAEK-EFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWL 273
+K + E+ EF E + ++VRLLG ++G +++ E + G+L+ +L
Sbjct: 60 IKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL 119
Query: 274 ------HGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWN 327
+ +P + + + A G+ YL+ K VHRD+ + N ++ + +
Sbjct: 120 RSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFT 176
Query: 328 PKLSDFGLAKLLGAERSYVTTRVMGTFGYV-----APEYASTGMLNERSDVYSFGILIME 382
K+ DFG+ + + Y G G + +PE G+ SDV+SFG+++ E
Sbjct: 177 VKIGDFGMTRDIYETDYY----RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWE 232
Query: 383 VIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKP--CSRALKRALLVAL 439
+ + P Y G N E + V L +KP C L +
Sbjct: 233 IATLAEQP--Y---QGLSN--EQVLRFVMEGG-------LL-DKPDNCPDMLFE---LMR 274
Query: 440 RCVDPNAHKRPKMGHVIHMLEAE-EFPFRDVSF 471
C N RP +I ++ E E FR+VSF
Sbjct: 275 MCWQYNPKMRPSFLEIISSIKEEMEPGFREVSF 307
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 1e-35
Identities = 81/281 (28%), Positives = 132/281 (46%), Gaps = 34/281 (12%)
Query: 191 ENVIGEGGYGIVYHGVL----EDNTNVAVKNLLNNRGQAEK-EFKVEVEAIGRVRHKNLV 245
E +IG G G V +G L + + VA+K L + ++ +F E +G+ H N++
Sbjct: 54 EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113
Query: 246 RLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG 305
RL G G M+V EY++NG+L+ +L G T + ++ G G+ YL +
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQ---FTIMQLVGMLRGVGAGMRYLSD- 169
Query: 306 LEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGY--VAPEYAS 363
VHRD+ + N+L+D K+SDFGL+++L + T G APE +
Sbjct: 170 --LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIA 227
Query: 364 TGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRL 422
+ SDV+SFG+++ EV++ G P Y N V + EG RL
Sbjct: 228 FRTFSSASDVWSFGVVMWEVLAYGERP--Y---WNMTN------RDVISSVEEGY---RL 273
Query: 423 QEKP--CSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461
P C AL + + L C + +RP+ ++ +L+A
Sbjct: 274 -PAPMGCPHALHQ---LMLDCWHKDRAQRPRFSQIVSVLDA 310
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 2e-35
Identities = 82/396 (20%), Positives = 141/396 (35%), Gaps = 38/396 (9%)
Query: 77 PTIPNISKEIQEIRIDPDSNSNSNCKPHSAPNPDPLPEPEPILVEDSPASGRNRIHIEIG 136
+ + ++ +++ D + + + P++ +
Sbjct: 227 TKFDTLWQLVEYLKLKADGLIYCLKEACPNSSASNASGAAAPTLPAHPSTLTHPQRRIDT 286
Query: 137 KDHRIAYPERAAGSHHGSGDQTVAAAITPEVSHLGWGHWYTLRELEVSTNGFADENVIGE 196
+ PE A + E + N + +G
Sbjct: 287 LNSDGYTPEPARITSPDKPRPMPMDTSVFESPFSDPEELKDKKLFLKRDNLLIADIELGC 346
Query: 197 GGYGIVYHGVLE---DNTNVAVKNL-LNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCA 252
G +G V GV +VA+K L +E E + + ++ + +VRL+G C
Sbjct: 347 GNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ 406
Query: 253 EGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVH 312
A MLV E G L ++L G + ++ + G+ YL E VH
Sbjct: 407 AEAL-MLVMEMAGGGPLHKFLVGKREE---IPVSNVAELLHQVSMGMKYLEE---KNFVH 459
Query: 313 RDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGY--VAPEYASTGMLNER 370
R++ + N+LL + K+SDFGL+K LGA+ SY T R G + APE + + R
Sbjct: 460 RNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSR 519
Query: 371 SDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDP--RLQEKP- 426
SDV+S+G+ + E +S G+ P Y + ++ R+ E P
Sbjct: 520 SDVWSYGVTMWEALSYGQKP--Y---KK-----------MKGPEVMAFIEQGKRM-ECPP 562
Query: 427 -CSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461
C L + C RP V + A
Sbjct: 563 ECPPELYA---LMSDCWIYKWEDRPDFLTVEQRMRA 595
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 3e-35
Identities = 79/281 (28%), Positives = 128/281 (45%), Gaps = 34/281 (12%)
Query: 191 ENVIGEGGYGIVYHGVL----EDNTNVAVKNLLNNRGQAEK-EFKVEVEAIGRVRHKNLV 245
+ V+G G +G V G L + +VA+K L + ++ +F E +G+ H N++
Sbjct: 50 DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 246 RLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG 305
RL G + M+V EY++NG+L+ +L T + ++ G A G+ YL
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA---QFTVIQLVGMLRGIASGMKYLS-- 164
Query: 306 LEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGY--VAPEYAS 363
+ VHRD+ + NIL++ K+SDFGL ++L + T G +PE +
Sbjct: 165 -DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIA 223
Query: 364 TGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRL 422
SDV+S+GI++ EV+S G P Y N V EG RL
Sbjct: 224 YRKFTSASDVWSYGIVLWEVMSYGERP--Y---WEMSN------QDVIKAVDEGY---RL 269
Query: 423 QEKP--CSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461
P C AL + + L C + + RPK ++ +L+
Sbjct: 270 -PPPMDCPAALYQ---LMLDCWQKDRNNRPKFEQIVSILDK 306
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 3e-35
Identities = 70/284 (24%), Positives = 123/284 (43%), Gaps = 43/284 (15%)
Query: 191 ENVIGEGGYGIVYHGVLED-----NTNVAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNL 244
V+G G +G V+ GV V +K + + G Q+ + + AIG + H ++
Sbjct: 18 LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI 77
Query: 245 VRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 304
VRLLG C G+ LV +Y+ G+L + G P +N + AKG+ YL E
Sbjct: 78 VRLLGLC-PGSSLQLVTQYLPLGSLLDHVRQHRGALGPQL---LLNWGVQIAKGMYYLEE 133
Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGT---FGYVAPEY 361
+VHR++ + N+LL +++DFG+A LL + + ++A E
Sbjct: 134 ---HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYS--EAKTPIKWMALES 188
Query: 362 ASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDP 420
G +SDV+S+G+ + E+++ G P Y G + +L+
Sbjct: 189 IHFGKYTHQSDVWSYGVTVWELMTFGAEP--Y---AG-----------LRLAEVPDLLEK 232
Query: 421 --RLQEKP--CSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 460
RL +P C+ + V ++C + + RP + +
Sbjct: 233 GERL-AQPQICTIDVYM---VMVKCWMIDENIRPTFKELANEFT 272
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 3e-35
Identities = 65/285 (22%), Positives = 111/285 (38%), Gaps = 42/285 (14%)
Query: 191 ENVIGEGGYGIVYHGVL----EDNTNVAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKN 243
+G+G +G+V G +VAVK L + ++ +A +F EV A+ + H+N
Sbjct: 23 LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 82
Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 303
L+RL G +V E G+L L G + A+G+ YL
Sbjct: 83 LIRLYGVV-LTPPMKMVTELAPLGSLLDRLRKHQGH---FLLGTLSRYAVQVAEGMGYLE 138
Query: 304 EGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGY--VAPEY 361
+ +HRD+ + N+LL + K+ DFGL + L + + + APE
Sbjct: 139 S---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPES 195
Query: 362 ASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDP 420
T + SD + FG+ + E+ + G+ P + G + +D
Sbjct: 196 LKTRTFSHASDTWMFGVTLWEMFTYGQEP--W---IG-----------LNGSQILHKIDK 239
Query: 421 ---RLQEKP--CSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 460
RL +P C + + V ++C RP + L
Sbjct: 240 EGERL-PRPEDCPQDIYN---VMVQCWAHKPEDRPTFVALRDFLL 280
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 4e-35
Identities = 74/278 (26%), Positives = 115/278 (41%), Gaps = 42/278 (15%)
Query: 191 ENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGY 250
IG+G +G V G VAVK + + F E + ++RH NLV+LLG
Sbjct: 26 LQTIGKGEFGDVMLGDYR-GNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGV 82
Query: 251 CAEGAHR-MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK 309
E +V EY+ G+L +L S L + + L + + YL
Sbjct: 83 IVEEKGGLYIVTEYMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEG---NN 137
Query: 310 VVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGY--VAPEYASTGML 367
VHRD+ + N+L+ + K+SDFGL + +T+ G APE
Sbjct: 138 FVHRDLAARNVLVSEDNVAKVSDFGLT------KEASSTQDTGKLPVKWTAPEALREKKF 191
Query: 368 NERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDP--RLQE 424
+ +SDV+SFGIL+ E+ S GR P Y P + ++ ++ ++ +
Sbjct: 192 STKSDVWSFGILLWEIYSFGRVP--Y---PR-----------IPLKDVVPRVEKGYKM-D 234
Query: 425 KP--CSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 460
P C A+ V C +A RP + LE
Sbjct: 235 APDGCPPAVYE---VMKNCWHLDAAMRPSFLQLREQLE 269
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 4e-35
Identities = 78/277 (28%), Positives = 131/277 (47%), Gaps = 36/277 (12%)
Query: 191 ENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGY 250
+G G +G V+ G +T VAVK+L + F E + +++H+ LVRL
Sbjct: 18 VERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYAV 76
Query: 251 CAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKV 310
+ ++ EY++NG+L +L G LT +++ A+G+ ++ E
Sbjct: 77 VTQE-PIYIITEYMENGSLVDFLKTPSGIK--LTINKLLDMAAQIAEGMAFIEER---NY 130
Query: 311 VHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGY--VAPEYASTGMLN 368
+HRD++++NIL+ + K++DFGLA+L+ + Y T R F APE + G
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARLI-EDNEY-TAREGAKFPIKWTAPEAINYGTFT 188
Query: 369 ERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDP--RLQEK 425
+SDV+SFGIL+ E+++ GR P Y PG +TN L+ R+ +
Sbjct: 189 IKSDVWSFGILLTEIVTHGRIP--Y---PG-----------MTNPEVIQNLERGYRM-VR 231
Query: 426 P--CSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 460
P C L + + C RP ++ +LE
Sbjct: 232 PDNCPEELYQ---LMRLCWKERPEDRPTFDYLRSVLE 265
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 4e-35
Identities = 66/292 (22%), Positives = 123/292 (42%), Gaps = 39/292 (13%)
Query: 191 ENVIGEGGYGIVYHGVLE-----DNTNVAVKNLLNNRGQAE-KEFKVEVEAIGRVRHKNL 244
+GEG +G V + VAVK+L G + K E+E + + H+N+
Sbjct: 26 IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 85
Query: 245 VRLLGYCAEGAHR--MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYL 302
V+ G C E L+ E++ +G+L+++L + + + ++ + KG+ YL
Sbjct: 86 VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK---INLKQQLKYAVQICKGMDYL 142
Query: 303 HEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTF--GYVAPE 360
+ VHRD+ + N+L++ + K+ DFGL K + ++ Y T + + APE
Sbjct: 143 GS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPE 199
Query: 361 YASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSR--------PPGEVNLVEWLKTMVTN 411
SDV+SFG+ + E+++ + G++ + + N
Sbjct: 200 CLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTR-----LVN 254
Query: 412 RNAEGVLDPRLQEKP--CSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461
EG RL P C + + + +C + R ++I EA
Sbjct: 255 TLKEGK---RL-PCPPNCPDEVYQ---LMRKCWEFQPSNRTSFQNLIEGFEA 299
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 6e-35
Identities = 69/278 (24%), Positives = 120/278 (43%), Gaps = 36/278 (12%)
Query: 191 ENVIGEGGYGIVYHGVLED-NTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLG 249
++ +G G YG VY GV + + VAVK L +EF E + ++H NLV+LLG
Sbjct: 18 KHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLG 76
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK 309
C ++ E++ GNL +L ++ + + + + + YL +
Sbjct: 77 VCTREPPFYIITEFMTYGNLLDYLRECNRQE--VSAVVLLYMATQISSAMEYLE---KKN 131
Query: 310 VVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGY--VAPEYASTGML 367
+HRD+ + N L+ + K++DFGL++L+ T F APE +
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLSRLM--TGDTYTAHAGAKFPIKWTAPESLAYNKF 189
Query: 368 NERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDP--RLQE 424
+ +SDV++FG+L+ E+ + G +P Y PG + +L+ R+ E
Sbjct: 190 SIKSDVWAFGVLLWEIATYGMSP--Y---PG-----------IDLSQVYELLEKDYRM-E 232
Query: 425 KP--CSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 460
+P C + + C N RP + E
Sbjct: 233 RPEGCPEKVYE---LMRACWQWNPSDRPSFAEIHQAFE 267
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 7e-35
Identities = 63/287 (21%), Positives = 122/287 (42%), Gaps = 29/287 (10%)
Query: 191 ENVIGEGGYGIVYHGVLE-----DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLV 245
+G+G +G V + VAVK L ++ + ++F+ E+E + ++H N+V
Sbjct: 15 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 74
Query: 246 RLLGYCAEGAHR--MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 303
+ G C R L+ EY+ G+L +L + + KG+ YL
Sbjct: 75 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYLG 131
Query: 304 EGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTF--GYVAPEY 361
+ +HRD+ + NIL++ + K+ DFGL K+L ++ + + G + APE
Sbjct: 132 T---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPES 188
Query: 362 ASTGMLNERSDVYSFGILIMEVIS-----GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEG 416
+ + SDV+SFG+++ E+ + P ++ R G + + +
Sbjct: 189 LTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNN 248
Query: 417 VLDPRLQEKP--CSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461
RL +P C + + C + N ++RP + ++
Sbjct: 249 G---RL-PRPDGCPDEIYM---IMTECWNNNVNQRPSFRDLALRVDQ 288
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 2e-34
Identities = 77/283 (27%), Positives = 132/283 (46%), Gaps = 39/283 (13%)
Query: 191 ENVIGEGGYGIVYHGVL-----EDNTNVAVKNLLNNRGQAEK-EFKVEVEAIGRVRHKNL 244
+ VIG G +G VY G+L + VA+K L + ++ +F E +G+ H N+
Sbjct: 49 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNI 108
Query: 245 VRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 304
+RL G ++ M++ EY++NG L+++L G + + ++ G A G+ YL
Sbjct: 109 IRLEGVISKYKPMMIITEYMENGALDKFLREKDG---EFSVLQLVGMLRGIAAGMKYLA- 164
Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGY--VAPEYA 362
VHRD+ + NIL++ K+SDFGL+++L + T G APE
Sbjct: 165 --NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAI 222
Query: 363 STGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDP- 420
S SDV+SFGI++ EV++ G P Y ++N ++
Sbjct: 223 SYRKFTSASDVWSFGIVMWEVMTYGERP--Y---WE-----------LSNHEVMKAINDG 266
Query: 421 -RLQEKP--CSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 460
RL P C A+ + + ++C +RPK ++ +L+
Sbjct: 267 FRL-PTPMDCPSAIYQ---LMMQCWQQERARRPKFADIVSILD 305
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 3e-34
Identities = 69/286 (24%), Positives = 118/286 (41%), Gaps = 29/286 (10%)
Query: 191 ENVIGEGGYGIVYHGVLED-----NTNVAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNL 244
+GEG +G V + VAVK L + G Q +K E++ + + H+++
Sbjct: 36 IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHI 95
Query: 245 VRLLGYCAEGAHR--MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYL 302
++ G C + LV EY+ G+L +L + L + +G+ YL
Sbjct: 96 IKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQL-----LLFAQQICEGMAYL 150
Query: 303 HEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTF--GYVAPE 360
H +HRD+ + N+LLD K+ DFGLAK + Y R G + APE
Sbjct: 151 HA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPE 207
Query: 361 YASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLD 419
SDV+SFG+ + E+++ + E+ + +T +L+
Sbjct: 208 CLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQ--GQMTVLRLTELLE 265
Query: 420 P--RLQEKP--CSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461
RL +P C + + C + A RP ++I +L+
Sbjct: 266 RGERL-PRPDKCPAEVYH---LMKNCWETEASFRPTFENLIPILKT 307
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 5e-34
Identities = 73/300 (24%), Positives = 119/300 (39%), Gaps = 35/300 (11%)
Query: 179 RELEVSTNGFADENVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIG 237
+ + + +GEGG+ V L D A+K +L + Q +E + E +
Sbjct: 22 HMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHR 81
Query: 238 RVRHKNLVRLLGYCAEGAHRM----LVYEYIDNGNLEQWLHGDVGPHSPLT-WEIRMNII 292
H N++RL+ YC L+ + G L + + LT +I + ++
Sbjct: 82 LFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQI-LWLL 140
Query: 293 LGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVM- 351
LG +GL +H HRD+K +NILL + P L D G +
Sbjct: 141 LGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTL 197
Query: 352 -------GTFGYVAPE---YASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNL 401
T Y APE S +++ER+DV+S G ++ ++ G P D G+
Sbjct: 198 QDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD--- 254
Query: 402 VEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461
+ PR S AL LL ++ VDP+ +RP + ++ LEA
Sbjct: 255 ---SVALAVQNQLSIPQSPRH-----SSAL-WQLLNSMMTVDPH--QRPHIPLLLSQLEA 303
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 6e-34
Identities = 51/207 (24%), Positives = 83/207 (40%), Gaps = 19/207 (9%)
Query: 191 ENVIGEGGYGIVYHGVLEDNT---NVAVKNLLNNRGQAEKE----FKVEVEAIGRVRHKN 243
++G GG G VY ED VA+K L++ ++ + E GR++ +
Sbjct: 39 RRLVGRGGMGDVYEA--EDTVRERIVALK-LMSETLSSDPVFRTRMQREARTAGRLQEPH 95
Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 303
+V + + + I+ +L L PL + I+ L H
Sbjct: 96 VVPIHDFGEIDGQLYVDMRLINGVDLAAMLRR----QGPLAPPRAVAIVRQIGSALDAAH 151
Query: 304 E-GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYA 362
G HRD+K NIL+ L DFG+A E+ +GT Y+APE
Sbjct: 152 AAGA----THRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERF 207
Query: 363 STGMLNERSDVYSFGILIMEVISGRNP 389
S R+D+Y+ ++ E ++G P
Sbjct: 208 SESHATYRADIYALTCVLYECLTGSPP 234
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 8e-34
Identities = 62/284 (21%), Positives = 120/284 (42%), Gaps = 23/284 (8%)
Query: 191 ENVIGEGGYGIVYHGVLE-----DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLV 245
+G+G +G V + VAVK L ++ + ++F+ E+E + ++H N+V
Sbjct: 46 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 105
Query: 246 RLLGYCAEGAHR--MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 303
+ G C R L+ EY+ G+L +L + + KG+ YL
Sbjct: 106 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYLG 162
Query: 304 EGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTF--GYVAPEY 361
+ +HRD+ + NIL++ + K+ DFGL K+L ++ Y + G + APE
Sbjct: 163 T---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPES 219
Query: 362 ASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDP- 420
+ + SDV+SFG+++ E+ + + + + + +L
Sbjct: 220 LTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNN 279
Query: 421 -RLQEKP--CSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461
RL +P C + + C + N ++RP + ++
Sbjct: 280 GRL-PRPDGCPDEIYM---IMTECWNNNVNQRPSFRDLALRVDQ 319
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 1e-33
Identities = 72/284 (25%), Positives = 124/284 (43%), Gaps = 43/284 (15%)
Query: 191 ENVIGEGGYGIVYHGVLED-----NTNVAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNL 244
V+G G +G VY G+ VA+K L +A KE E + V + ++
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79
Query: 245 VRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 304
RLLG C + L+ + + G L ++ + + +N + AKG+ YL +
Sbjct: 80 CRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDN---IGSQYLLNWCVQIAKGMNYLED 135
Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGT---FGYVAPEY 361
++VHRD+ + N+L+ + K++DFGLAKLLGAE G ++A E
Sbjct: 136 ---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE--GGKVPIKWMALES 190
Query: 362 ASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDP 420
+ +SDV+S+G+ + E+++ G P Y G + +L+
Sbjct: 191 ILHRIYTHQSDVWSYGVTVWELMTFGSKP--Y---DG-----------IPASEISSILEK 234
Query: 421 --RLQEKP--CSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 460
RL +P C+ + + ++C +A RPK +I
Sbjct: 235 GERL-PQPPICTIDVYM---IMVKCWMIDADSRPKFRELIIEFS 274
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 1e-33
Identities = 60/208 (28%), Positives = 97/208 (46%), Gaps = 21/208 (10%)
Query: 194 IGEGGYGIVYHGVLEDNT---NVAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKNLVRL 247
+G GG V+ D +VAVK L L F+ E + + H +V +
Sbjct: 20 LGFGGMSEVHLA--RDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV 77
Query: 248 LGY-CAEGAHRMLVY---EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 303
AE L Y EY+D L +H P+T + + +I + L + H
Sbjct: 78 YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSH 133
Query: 304 EGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTT--RVMGTFGYVAPEY 361
+ ++HRD+K +NI++ K+ DFG+A+ + + VT V+GT Y++PE
Sbjct: 134 QN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 190
Query: 362 ASTGMLNERSDVYSFGILIMEVISGRNP 389
A ++ RSDVYS G ++ EV++G P
Sbjct: 191 ARGDSVDARSDVYSLGCVLYEVLTGEPP 218
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 3e-33
Identities = 70/289 (24%), Positives = 119/289 (41%), Gaps = 40/289 (13%)
Query: 191 ENVIGEGGYGIVYHGVL------EDNTNVAVKNLLNNRGQAEK-EFKVEVEAIGRVRHKN 243
+G G +G VY G + VAVK L + ++ +F +E I + H+N
Sbjct: 35 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 94
Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLH---GDVGPHSPLTWEIRMNIILGTAKGLT 300
+VR +G + R ++ E + G+L+ +L S L +++ A G
Sbjct: 95 IVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 154
Query: 301 YLHEGLEPKVVHRDIKSSNILLDKQWNP---KLSDFGLAKLLGAERSYVTTRVMGTFG-- 355
YL E +HRDI + N LL K+ DFG+A+ + SY
Sbjct: 155 YLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI-YRASYYRKGGCAMLPVK 210
Query: 356 YVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNA 414
++ PE G+ ++D +SFG+L+ E+ S G P Y P + N + + VT+
Sbjct: 211 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP--Y---PSKSN--QEVLEFVTSGG- 262
Query: 415 EGVLDPRLQEKP--CSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461
R+ + P C + R + +C RP ++ +E
Sbjct: 263 ------RM-DPPKNCPGPVYR---IMTQCWQHQPEDRPNFAIILERIEY 301
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 5e-33
Identities = 80/343 (23%), Positives = 136/343 (39%), Gaps = 56/343 (16%)
Query: 150 SHHGSGDQTVAAAITPEVSHLGWGHWYTLRELEVSTNGFADENVIGEGGYGIVYHGVLED 209
SHH ++ + P S L ++ + N ++GEG +G V G L+
Sbjct: 4 SHHHHHH---SSGLVPRGSEE---LQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQ 57
Query: 210 ----NTNVAVKNL-LNNRGQAEK-EFKVEVEAIGRVRHKNLVRLLGYCAEG-----AHRM 258
+ VAVK + L+N Q E EF E + H N++RLLG C E M
Sbjct: 58 EDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPM 117
Query: 259 LVYEYIDNGNLEQWL--HGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIK 316
++ ++ G+L +L + + + ++ A G+ YL +HRD+
Sbjct: 118 VILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLA 174
Query: 317 SSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRV-------MGTFGYVAPEYASTGMLNE 369
+ N +L ++DFGL+K + + Y R+ + A E + +
Sbjct: 175 ARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI------AIESLADRVYTS 228
Query: 370 RSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKP-- 426
+SDV++FG+ + E+ + G P Y PG V E + + + RL ++P
Sbjct: 229 KSDVWAFGVTMWEIATRGMTP--Y---PG-VQNHEMYD-YLLHGH-------RL-KQPED 273
Query: 427 CSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEEFPFRDV 469
C L + C + RP + LE DV
Sbjct: 274 CLDELYE---IMYSCWRTDPLDRPTFSVLRLQLEKLLESLPDV 313
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 8e-33
Identities = 77/300 (25%), Positives = 125/300 (41%), Gaps = 56/300 (18%)
Query: 191 ENVIGEGGYGIVYHGVL------EDNTNVAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKN 243
+GE +G VY G L E VA+K L + G +EF+ E R++H N
Sbjct: 14 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPN 73
Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWL------------HGDVGPHSPLTWEIRMNI 291
+V LLG + +++ Y +G+L ++L D S L +++
Sbjct: 74 VVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 133
Query: 292 ILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTT--- 348
+ A G+ YL VVH+D+ + N+L+ + N K+SD GL + + A Y
Sbjct: 134 VAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNS 190
Query: 349 ----RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVE 403
R M APE G + SD++S+G+++ EV S G P Y G N +
Sbjct: 191 LLPIRWM------APEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP--Y---CGYSN--Q 237
Query: 404 WLKTMVTNRNAEGVLDPRLQEKP--CSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461
+ M+ NR L P C + + + C + +RP+ + L A
Sbjct: 238 DVVEMIRNRQ-------VL-PCPDDCPAWVYA---LMIECWNEFPSRRPRFKDIHSRLRA 286
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 9e-33
Identities = 69/296 (23%), Positives = 122/296 (41%), Gaps = 50/296 (16%)
Query: 191 ENVIGEGGYGIVYHGVL------EDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNL 244
+ +GEG +G V+ +D VAVK L A ++F+ E E + ++H+++
Sbjct: 46 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHI 105
Query: 245 VRLLGYCAEGAHRMLVYEYIDNGNLEQWL-----------HGDVGPHSPLTWEIRMNIIL 293
VR G C EG ++V+EY+ +G+L ++L G+ PL + +
Sbjct: 106 VRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 165
Query: 294 GTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGT 353
A G+ YL VHRD+ + N L+ + K+ DFG+++ + + Y +G
Sbjct: 166 QVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYY----RVGG 218
Query: 354 FGYV-----APEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKT 407
+ PE SDV+SFG+++ E+ + G+ P + N
Sbjct: 219 RTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP--W---YQLSN--TEAID 271
Query: 408 MVTNRNAEGVLDPRLQEKP--CSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461
+T L E+P C + + C +R + V L+A
Sbjct: 272 CITQGR-------EL-ERPRACPPEVYA---IMRGCWQREPQQRHSIKDVHARLQA 316
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 9e-33
Identities = 71/280 (25%), Positives = 116/280 (41%), Gaps = 37/280 (13%)
Query: 191 ENVIGEGGYGIVYHGVL----EDNTNVAVKNL-LNNRGQAEKEFKVEVEAIGRVRHKNLV 245
++GEG +G VY GV + NVAVK + +++F E + + H ++V
Sbjct: 17 NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76
Query: 246 RLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG 305
+L+G E ++ E G L +L + L + L K + YL
Sbjct: 77 KLIGIIEEEP-TWIIMELYPYGELGHYLERNKNS---LKVLTLVLYSLQICKAMAYLES- 131
Query: 306 LEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTG 365
VHRDI NIL+ KL DFGL++ + E Y + +++PE +
Sbjct: 132 --INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFR 189
Query: 366 MLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDP--RL 422
SDV+ F + + E++S G+ P + + N++ GVL+ RL
Sbjct: 190 RFTTASDVWMFAVCMWEILSFGKQP--F---FW-----------LENKDVIGVLEKGDRL 233
Query: 423 QEKP--CSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 460
KP C L + RC D + RP+ ++ L
Sbjct: 234 -PKPDLCPPVLYT---LMTRCWDYDPSDRPRFTELVCSLS 269
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 1e-32
Identities = 71/289 (24%), Positives = 115/289 (39%), Gaps = 56/289 (19%)
Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYC 251
V+G+G +G V D+ A+K + + + EV + + H+ +VR
Sbjct: 13 VLGQGAFGQVVKARNALDSRYYAIK-KIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAW 71
Query: 252 AEGAHRM-------------LVYEYIDNGNLEQWLHGDVGPHSP--LTWEIRMNIILGTA 296
E + + + EY +NG L +H + W + I+
Sbjct: 72 LERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIH-SENLNQQRDEYWRLFRQILEA-- 128
Query: 297 KGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYV---------- 346
L+Y+H ++HRD+K NI +D+ N K+ DFGLAK + +
Sbjct: 129 --LSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGS 183
Query: 347 ----TTRVMGTFGYVAPE-YASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNL 401
T+ + GT YVA E TG NE+ D+YS GI+ E+I +
Sbjct: 184 SDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP--------FSTGMER 234
Query: 402 VEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRP 450
V LK + R+ P + + K+ ++ L DPN KRP
Sbjct: 235 VNILKKL---RSVSIEFPPDF-DDNKMKVEKK-IIRLLIDHDPN--KRP 276
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-32
Identities = 72/287 (25%), Positives = 127/287 (44%), Gaps = 44/287 (15%)
Query: 191 ENVIGEGGYGIVYHGVLED----NTNVAVKNLLNNRGQAEK-EFKVEVEAIGRVRHKNLV 245
+ VIG+G +G+VYHG D A+K+L + F E + + H N++
Sbjct: 26 DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVL 85
Query: 246 RLLGYCAEGA-HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 304
L+G ++ Y+ +G+L Q++ P T + ++ L A+G+ YL E
Sbjct: 86 ALIGIMLPPEGLPHVLLPYMCHGDLLQFIRS---PQRNPTVKDLISFGLQVARGMEYLAE 142
Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYV-----AP 359
K VHRD+ + N +LD+ + K++DFGLA+ + +R Y + + + A
Sbjct: 143 ---QKFVHRDLAARNCMLDESFTVKVADFGLARDI-LDREYYSVQ-QHRHARLPVKWTAL 197
Query: 360 EYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVL 418
E T +SDV+SFG+L+ E+++ G P Y + + L
Sbjct: 198 ESLQTYRFTTKSDVWSFGVLLWELLTRGAPP--Y---RH-----------IDPFDLTHFL 241
Query: 419 DP--RLQEKP--CSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461
RL +P C +L + V +C + + RP ++ +E
Sbjct: 242 AQGRRL-PQPEYCPDSLYQ---VMQQCWEADPAVRPTFRVLVGEVEQ 284
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 1e-32
Identities = 58/290 (20%), Positives = 109/290 (37%), Gaps = 51/290 (17%)
Query: 191 ENVIGEGGYGIVYHGVL--------EDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHK 242
+G+G + ++ GV T V +K L + F + ++ HK
Sbjct: 13 NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72
Query: 243 NLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYL 302
+LV G C G +LV E++ G+L+ +L + + W++ + A + +L
Sbjct: 73 HLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKN-KNCINILWKLEV--AKQLAAAMHFL 129
Query: 303 HEGLEPKVVHRDIKSSNILLDKQWNP--------KLSDFGLAKLLGAERSYVTTRVMGTF 354
E ++H ++ + NILL ++ + KLSD G++ + + + R+
Sbjct: 130 E---ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITV-LPKDILQERIPWV- 184
Query: 355 GYVAPEYASTG-MLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNR 412
PE LN +D +SFG + E+ S G P + ++
Sbjct: 185 ---PPECIENPKNLNLATDKWSFGTTLWEICSGGDKP--L---SA-----------LDSQ 225
Query: 413 NAEGVLDP--RLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 460
+ +L P + L + C+D RP +I L
Sbjct: 226 RKLQFYEDRHQL-PAPKAAELAN---LINNCMDYEPDHRPSFRAIIRDLN 271
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 1e-32
Identities = 83/288 (28%), Positives = 127/288 (44%), Gaps = 46/288 (15%)
Query: 191 ENVIGEGGYGIVYHGVLEDN----TNVAVKNLLNNRGQAEK-EFKVEVEAIGRVRHKNLV 245
VIG G +G VYHG L DN + AVK+L E +F E + H N++
Sbjct: 30 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 89
Query: 246 RLLGYCAEGAH-RMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 304
LLG C ++V Y+ +G+L ++ + T + + L AKG+ YL
Sbjct: 90 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN---PTVKDLIGFGLQVAKGMKYLAS 146
Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFG------YVA 358
K VHRD+ + N +LD+++ K++DFGLA+ + + Y V G ++A
Sbjct: 147 ---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYY---SVHNKTGAKLPVKWMA 200
Query: 359 PEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGV 417
E T +SDV+SFG+L+ E+++ G P Y P V +
Sbjct: 201 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPP--Y---PD-----------VNTFDITVY 244
Query: 418 LDP--RLQEKP--CSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461
L RL +P C L V L+C P A RP ++ + A
Sbjct: 245 LLQGRRL-LQPEYCPDPLYE---VMLKCWHPKAEMRPSFSELVSRISA 288
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 3e-32
Identities = 69/289 (23%), Positives = 118/289 (40%), Gaps = 40/289 (13%)
Query: 191 ENVIGEGGYGIVYHGVL------EDNTNVAVKNLLNNRGQAEK-EFKVEVEAIGRVRHKN 243
+G G +G VY G + VAVK L + ++ +F +E I + H+N
Sbjct: 76 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 135
Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLH---GDVGPHSPLTWEIRMNIILGTAKGLT 300
+VR +G + R ++ E + G+L+ +L S L +++ A G
Sbjct: 136 IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 195
Query: 301 YLHEGLEPKVVHRDIKSSNILLDKQWNP---KLSDFGLAKLLGAERSYVTTRVMGTFG-- 355
YL E +HRDI + N LL K+ DFG+A+ + Y
Sbjct: 196 YLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI-YRAGYYRKGGCAMLPVK 251
Query: 356 YVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNA 414
++ PE G+ ++D +SFG+L+ E+ S G P Y P + N + + VT+
Sbjct: 252 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP--Y---PSKSN--QEVLEFVTSGG- 303
Query: 415 EGVLDPRLQEKP--CSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461
R+ + P C + R + +C RP ++ +E
Sbjct: 304 ------RM-DPPKNCPGPVYR---IMTQCWQHQPEDRPNFAIILERIEY 342
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 3e-32
Identities = 60/268 (22%), Positives = 112/268 (41%), Gaps = 33/268 (12%)
Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVK--NLLNNRGQAEKEFKV-EVEAIGRVRHKNLVRLL 248
IG G + VY L D VA+K + + + + E++ + ++ H N+++
Sbjct: 39 KIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYY 98
Query: 249 GYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEP 308
E +V E D G+L + + + + L ++H
Sbjct: 99 ASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS---R 155
Query: 309 KVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPE------YA 362
+V+HRDIK +N+ + KL D GL + ++ + + V GT Y++PE Y
Sbjct: 156 RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERIHENGY- 213
Query: 363 STGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRL 422
N +SD++S G L+ E+ + ++P ++NL L + + P L
Sbjct: 214 -----NFKSDIWSLGCLLYEMAALQSPFYGD----KMNLYS-LCKKIEQCDY-----PPL 258
Query: 423 QEKPCSRALKRALLVALRCVDPNAHKRP 450
S L++ + C++P+ KRP
Sbjct: 259 PSDHYSEELRQLV---NMCINPDPEKRP 283
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 3e-32
Identities = 50/200 (25%), Positives = 96/200 (48%), Gaps = 9/200 (4%)
Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVKNL-LNNRGQAEKEF-KVEVEAIGRVRHKNLVRLLG 249
IGEG +G ED +K + ++ E+E + EV + ++H N+V+
Sbjct: 31 KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK 309
E +V +Y + G+L + ++ G + ++ + L ++H+ K
Sbjct: 91 SFEENGSLYIVMDYCEGGDLFKRINAQKG--VLFQEDQILDWFVQICLALKHVHD---RK 145
Query: 310 VVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNE 369
++HRDIKS NI L K +L DFG+A++L + + GT Y++PE N
Sbjct: 146 ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI-GTPYYLSPEICENKPYNN 204
Query: 370 RSDVYSFGILIMEVISGRNP 389
+SD+++ G ++ E+ + ++
Sbjct: 205 KSDIWALGCVLYELCTLKHA 224
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 4e-32
Identities = 70/299 (23%), Positives = 124/299 (41%), Gaps = 55/299 (18%)
Query: 191 ENVIGEGGYGIVYHGVL------EDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNL 244
+ +GEG +G V+ +D VAVK L + A K+F+ E E + ++H+++
Sbjct: 20 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 79
Query: 245 VRLLGYCAEGAHRMLVYEYIDNGNLEQWL------------HGDVGPHSPLTWEIRMNII 292
V+ G C +G ++V+EY+ +G+L ++L L ++I
Sbjct: 80 VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 139
Query: 293 LGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTT---- 348
A G+ YL VHRD+ + N L+ K+ DFG+++ + + Y
Sbjct: 140 SQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTM 196
Query: 349 ---RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEW 404
R M PE SDV+SFG+++ E+ + G+ P + N E
Sbjct: 197 LPIRWM------PPESIMYRKFTTESDVWSFGVILWEIFTYGKQP--W---FQLSN-TEV 244
Query: 405 LKTMVTNRNAEGVLDPRLQEKP--CSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461
++ +T L E+P C + + V L C +R + + +L A
Sbjct: 245 IE-CITQGR-------VL-ERPRVCPKEVYD---VMLGCWQREPQQRLNIKEIYKILHA 291
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 5e-32
Identities = 62/204 (30%), Positives = 96/204 (47%), Gaps = 8/204 (3%)
Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVKNL-LNNRGQAEKEFKV-EVEAIGRVRHKNLVRLLG 249
IG G YG D + K L + +AEK+ V EV + ++H N+VR
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 250 YCAEGAHRML--VYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE--G 305
+ + L V EY + G+L + L E + ++ L H
Sbjct: 73 RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132
Query: 306 LEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTG 365
V+HRD+K +N+ LD + N KL DFGLA++L + S+ T V GT Y++PE +
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-GTPYYMSPEQMNRM 191
Query: 366 MLNERSDVYSFGILIMEVISGRNP 389
NE+SD++S G L+ E+ + P
Sbjct: 192 SYNEKSDIWSLGCLLYELCALMPP 215
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 8e-32
Identities = 61/307 (19%), Positives = 121/307 (39%), Gaps = 45/307 (14%)
Query: 176 YTLRELEVSTNGFADENVIGEGGYGIVYHGVLEDN----TNVAVKNL-LNNRGQAEKE-F 229
L ++ + F ++G+G +G V L+ VAVK L + ++ E F
Sbjct: 13 EKLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEF 72
Query: 230 KVEVEAIGRVRHKNLVRLLGYCAEG------AHRMLVYEYIDNGNLEQWL--HGDVGPHS 281
E + H ++ +L+G M++ ++ +G+L +L
Sbjct: 73 LREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPF 132
Query: 282 PLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA 341
L + + ++ A G+ YL +HRD+ + N +L + ++DFGL++ +
Sbjct: 133 NLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLSRKI-Y 188
Query: 342 ERSYVTTRVMGTF--GYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGE 398
Y ++A E + + SDV++FG+ + E+++ G+ P Y G
Sbjct: 189 SGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP--Y---AGI 243
Query: 399 VN--LVEWLKTMVTNRNAEGVLDPRLQEKP--CSRALKRALLVALRCVDPNAHKRPKMGH 454
N + +L G RL ++P C + + +C + +RP
Sbjct: 244 ENAEIYNYLI--------GGN---RL-KQPPECMEEVYD---LMYQCWSADPKQRPSFTC 288
Query: 455 VIHMLEA 461
+ LE
Sbjct: 289 LRMELEN 295
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 9e-32
Identities = 64/295 (21%), Positives = 111/295 (37%), Gaps = 37/295 (12%)
Query: 176 YTLRELEVSTNGFADENVIGEGGYGIVYHGVL----EDNTNVAVKNL-LNNRGQAEKEFK 230
+ R+ E+ IGEG +G V+ G+ VA+K ++F
Sbjct: 5 SSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFL 64
Query: 231 VEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMN 290
E + + H ++V+L+G ++ E G L +L L +
Sbjct: 65 QEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYS---LDLASLIL 120
Query: 291 IILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRV 350
+ L YL + VHRDI + N+L+ KL DFGL++ + Y ++
Sbjct: 121 YAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKG 177
Query: 351 MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMV 409
++APE + SDV+ FG+ + E++ G P + G V
Sbjct: 178 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP--F---QG-----------V 221
Query: 410 TNRNAEGVLDP--RLQEKP--CSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 460
N + G ++ RL P C L + +C + +RP+ + L
Sbjct: 222 KNNDVIGRIENGERL-PMPPNCPPTLYS---LMTKCWAYDPSRRPRFTELKAQLS 272
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-31
Identities = 80/287 (27%), Positives = 127/287 (44%), Gaps = 44/287 (15%)
Query: 191 ENVIGEGGYGIVYHGVLEDN----TNVAVKNLLNNRGQAEK-EFKVEVEAIGRVRHKNLV 245
VIG G +G VYHG L DN + AVK+L E +F E + H N++
Sbjct: 94 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 153
Query: 246 RLLGYCAEGAH-RMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 304
LLG C ++V Y+ +G+L ++ + T + + L AKG+ +L
Sbjct: 154 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN---PTVKDLIGFGLQVAKGMKFLAS 210
Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYV-----AP 359
K VHRD+ + N +LD+++ K++DFGLA+ + ++ + + T + A
Sbjct: 211 ---KKFVHRDLAARNCMLDEKFTVKVADFGLARDM-YDKEFDSVH-NKTGAKLPVKWMAL 265
Query: 360 EYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVL 418
E T +SDV+SFG+L+ E+++ G P Y P V + L
Sbjct: 266 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPP--Y---PD-----------VNTFDITVYL 309
Query: 419 DP--RLQEKP--CSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461
RL +P C L V L+C P A RP ++ + A
Sbjct: 310 LQGRRL-LQPEYCPDPLYE---VMLKCWHPKAEMRPSFSELVSRISA 352
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 1e-31
Identities = 63/280 (22%), Positives = 107/280 (38%), Gaps = 37/280 (13%)
Query: 191 ENVIGEGGYGIVYHGVL----EDNTNVAVKNL-LNNRGQAEKEFKVEVEAIGRVRHKNLV 245
IGEG +G V+ G+ VA+K ++F E + + H ++V
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 454
Query: 246 RLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG 305
+L+G E ++ E G L +L L + + L YL
Sbjct: 455 KLIGVITENP-VWIIMELCTLGELRSFLQVRKFS---LDLASLILYAYQLSTALAYLES- 509
Query: 306 LEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTG 365
+ VHRDI + N+L+ KL DFGL++ + Y ++ ++APE +
Sbjct: 510 --KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR 567
Query: 366 MLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDP--RL 422
SDV+ FG+ + E++ G P + G V N + G ++ RL
Sbjct: 568 RFTSASDVWMFGVCMWEILMHGVKP--F---QG-----------VKNNDVIGRIENGERL 611
Query: 423 QEKP--CSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 460
P C L + +C + +RP+ + L
Sbjct: 612 -PMPPNCPPTLYS---LMTKCWAYDPSRRPRFTELKAQLS 647
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-31
Identities = 45/207 (21%), Positives = 81/207 (39%), Gaps = 28/207 (13%)
Query: 193 VIGEGGYGIVYHG---VLEDNTNVAVKNLLNNRGQAEKE-FKVEVEAIGRVRHKNLVRLL 248
I GG G +Y + V +K L+++ + E + + V H ++V++
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRP-VVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIF 145
Query: 249 GYCAEGAHRM-----LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 303
+ +V EY+ +L++ L + +L L+YLH
Sbjct: 146 NFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ------KLPVAEAIAYLLEILPALSYLH 199
Query: 304 E-GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYA 362
GL V+ D+K NI+L ++ KL D G + + + GT G+ APE
Sbjct: 200 SIGL----VYNDLKPENIMLTEE-QLKLIDLGAVSRINS-----FGYLYGTPGFQAPEIV 249
Query: 363 STGMLNERSDVYSFGILIMEVISGRNP 389
TG +D+Y+ G + +
Sbjct: 250 RTGP-TVATDIYTVGRTLAALTLDLPT 275
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 3e-31
Identities = 72/262 (27%), Positives = 116/262 (44%), Gaps = 23/262 (8%)
Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYC 251
V+G+G YGIVY G L + +A+K + + + E+ ++HKN+V+ LG
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 252 AEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVV 311
+E + E + G+L L GP + +GL YLH+ ++V
Sbjct: 89 SENGFIKIFMEQVPGGSLSALLRSKWGP-LKDNEQTIGFYTKQILEGLKYLHDN---QIV 144
Query: 312 HRDIKSSNILLD-KQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPE--YASTGMLN 368
HRDIK N+L++ K+SDFG +K L T GT Y+APE
Sbjct: 145 HRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET-FTGTLQYMAPEIIDKGPRGYG 203
Query: 369 ERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCS 428
+ +D++S G I+E+ +G+ P + L E M + + P + E S
Sbjct: 204 KAADIWSLGCTIIEMATGKPP--FY------ELGEPQAAMF--KVGMFKVHPEIPES-MS 252
Query: 429 RALKRALLVALRCVDPNAHKRP 450
K + L+C +P+ KR
Sbjct: 253 AEAKAFI---LKCFEPDPDKRA 271
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 3e-31
Identities = 58/219 (26%), Positives = 98/219 (44%), Gaps = 28/219 (12%)
Query: 188 FADENVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVR 246
F + +IG GG+G V+ D +K + N +AE+E V+A+ ++ H N+V
Sbjct: 13 FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAERE----VKALAKLDHVNIVH 68
Query: 247 LLGYCAEGAHRM----------------LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMN 290
G + + E+ D G LEQW+ G L + +
Sbjct: 69 YNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG--EKLDKVLALE 126
Query: 291 IILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRV 350
+ KG+ Y+H K+++RD+K SNI L K+ DFGL L + TR
Sbjct: 127 LFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSL--KNDGKRTRS 181
Query: 351 MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNP 389
GT Y++PE S+ + D+Y+ G+++ E++ +
Sbjct: 182 KGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT 220
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 4e-31
Identities = 51/215 (23%), Positives = 91/215 (42%), Gaps = 29/215 (13%)
Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVKNL-LNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGY 250
+G GG+G+V+ D+ N A+K + L NR A ++ EV+A+ ++ H +VR
Sbjct: 12 CLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNA 71
Query: 251 CAEGAHRM------------LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKG 298
E + + NL+ W++G + ++I L A+
Sbjct: 72 WLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEER-ERSVCLHIFLQIAEA 130
Query: 299 LTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVM------- 351
+ +LH ++HRD+K SNI K+ DFGL + + T
Sbjct: 131 VEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARH 187
Query: 352 ----GTFGYVAPEYASTGMLNERSDVYSFGILIME 382
GT Y++PE + + D++S G+++ E
Sbjct: 188 TGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFE 222
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 6e-31
Identities = 77/340 (22%), Positives = 140/340 (41%), Gaps = 59/340 (17%)
Query: 153 GSGDQTVAAAITPEVSHLGWGHWYTLRELEVSTNGFADENVIGEGGYGIVYHGVL----- 207
GS + P ++ + + E + +GEG +G V
Sbjct: 2 GSSHHHHHHSQDPMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDK 61
Query: 208 ---EDNTNVAVKNLLNNRGQAEK-EFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYE 262
++ VAVK L ++ + + + E+E + + +HKN++ LLG C + ++ E
Sbjct: 62 DKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVE 121
Query: 263 YIDNGNLEQWL------------HGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKV 310
Y GNL ++L + P +T++ ++ A+G+ YL K
Sbjct: 122 YASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKC 178
Query: 311 VHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRV-------MGTFGYVAPEYAS 363
+HRD+ + N+L+ + K++DFGLA+ + Y T M APE
Sbjct: 179 IHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWM------APEALF 232
Query: 364 TGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRL 422
+ +SDV+SFG+L+ E+ + G +P Y PG E L ++ + R+
Sbjct: 233 DRVYTHQSDVWSFGVLMWEIFTLGGSP--Y---PGIPV--EELFKLLKEGH-------RM 278
Query: 423 QEKP--CSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 460
+KP C+ L + C +RP ++ L+
Sbjct: 279 -DKPANCTNELYM---MMRDCWHAVPSQRPTFKQLVEDLD 314
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 8e-31
Identities = 76/329 (23%), Positives = 136/329 (41%), Gaps = 59/329 (17%)
Query: 164 TPEVSHLGWGHWYTLRELEVSTNGFADENVIGEGGYGIVYHGVL--------EDNTNVAV 215
TP ++ + + E + +GEG +G V ++ VAV
Sbjct: 59 TPMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAV 118
Query: 216 KNLLNNRGQAEK-EFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYIDNGNL---- 269
K L ++ + + + E+E + + +HKN++ LLG C + ++ EY GNL
Sbjct: 119 KMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL 178
Query: 270 --------EQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNIL 321
E + P +T++ ++ A+G+ YL K +HRD+ + N+L
Sbjct: 179 RARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVL 235
Query: 322 LDKQWNPKLSDFGLAKLLGAERSYVTTRV-------MGTFGYVAPEYASTGMLNERSDVY 374
+ + K++DFGLA+ + Y T M APE + +SDV+
Sbjct: 236 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWM------APEALFDRVYTHQSDVW 289
Query: 375 SFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKP--CSRAL 431
SFG+L+ E+ + G +P Y PG E L ++ + R+ +KP C+ L
Sbjct: 290 SFGVLMWEIFTLGGSP--Y---PGIPV--EELFKLLKEGH-------RM-DKPANCTNEL 334
Query: 432 KRALLVALRCVDPNAHKRPKMGHVIHMLE 460
+ C +RP ++ L+
Sbjct: 335 YM---MMRDCWHAVPSQRPTFKQLVEDLD 360
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 1e-30
Identities = 72/294 (24%), Positives = 129/294 (43%), Gaps = 51/294 (17%)
Query: 191 ENVIGEGGYGIVYHGVL---EDNTNVAVKNLLNNRGQAEK-EFKVEVEAIGRV-RHKNLV 245
++VIGEG +G V + + A+K + + + +F E+E + ++ H N++
Sbjct: 30 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89
Query: 246 RLLGYCAEGAHRMLVYEYIDNGNLEQWL------------HGDVGPHSPLTWEIRMNIIL 293
LLG C + L EY +GNL +L S L+ + ++
Sbjct: 90 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149
Query: 294 GTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGT 353
A+G+ YL + + +HRD+ + NIL+ + + K++DFGL++ + + MG
Sbjct: 150 DVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVKKTMGR 202
Query: 354 F--GYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVN--LVEWLKTM 408
++A E + + SDV+S+G+L+ E++S G P Y G L E L
Sbjct: 203 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP--Y---CGMTCAELYEKLP-- 255
Query: 409 VTNRNAEGVLDPRLQEKP--CSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 460
+G RL EKP C + + +C ++RP ++ L
Sbjct: 256 ------QGY---RL-EKPLNCDDEVYD---LMRQCWREKPYERPSFAQILVSLN 296
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 4e-30
Identities = 77/316 (24%), Positives = 120/316 (37%), Gaps = 57/316 (18%)
Query: 176 YTLRELEVSTNGFADENVIGEGGYGIVYHGVL------EDNTNVAVKNLLNNRGQAEK-E 228
Y + E + +G G +G V VAVK L +E
Sbjct: 17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 76
Query: 229 FKVEVEAIGRV-RHKNLVRLLGYC-AEGAHRMLVYEYIDNGNLEQWL------------H 274
E++ + + H N+V LLG C G M++ E+ GNL +L
Sbjct: 77 LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVA 136
Query: 275 GDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFG 334
+ LT E + AKG+ +L K +HRD+ + NILL ++ K+ DFG
Sbjct: 137 PEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFG 193
Query: 335 LAKLLGAERSYVTT-------RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-G 386
LA+ + + YV + M APE + +SDV+SFG+L+ E+ S G
Sbjct: 194 LARDIYKDPDYVRKGDARLPLKWM------APETIFDRVYTIQSDVWSFGVLLWEIFSLG 247
Query: 387 RNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKP--CSRALKRALLVALRCVDP 444
+P Y + LK EG R+ P + + + L C
Sbjct: 248 ASP--YPGVKIDEEFCRRLK--------EGT---RM-RAPDYTTPEMYQ---TMLDCWHG 290
Query: 445 NAHKRPKMGHVIHMLE 460
+RP ++ L
Sbjct: 291 EPSQRPTFSELVEHLG 306
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 4e-30
Identities = 82/307 (26%), Positives = 130/307 (42%), Gaps = 64/307 (20%)
Query: 191 ENVIGEGGYGIVYHGVL------EDNTNVAVKNLLNNRGQAEK-EFKVEVEAIGRVRHKN 243
+GEG +G V T VAVK L N +E + E + +V H +
Sbjct: 28 GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPH 87
Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWL--------------------HGDVGPHSPL 283
+++L G C++ +L+ EY G+L +L D L
Sbjct: 88 VIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERAL 147
Query: 284 TWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER 343
T ++ ++G+ YL E K+VHRD+ + NIL+ + K+SDFGL++ + E
Sbjct: 148 TMGDLISFAWQISQGMQYLA---EMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEED 204
Query: 344 SYVTT-------RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRP 395
SYV + M A E + +SDV+SFG+L+ E+++ G NP Y
Sbjct: 205 SYVKRSQGRIPVKWM------AIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP--Y--- 253
Query: 396 PGEVNLVEWLKTMVTNRNAEGVLDPRLQEKP--CSRALKRALLVALRCVDPNAHKRPKMG 453
PG E L ++ + R+ E+P CS + R + L+C KRP
Sbjct: 254 PGIPP--ERLFNLLKTGH-------RM-ERPDNCSEEMYR---LMLQCWKQEPDKRPVFA 300
Query: 454 HVIHMLE 460
+ LE
Sbjct: 301 DISKDLE 307
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 1e-29
Identities = 72/302 (23%), Positives = 117/302 (38%), Gaps = 58/302 (19%)
Query: 191 ENVIGEGGYGIVYHGVL------EDNTNVAVKNLLNNRGQAEK-EFKVEVEAIGRV-RHK 242
+G G +G V + VAVK L + E+ E++ + + H
Sbjct: 28 GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHM 87
Query: 243 NLVRLLGYCAEGAHRMLVYEYIDNGNLEQWL--------------HGDVGPHSPLTWEIR 288
N+V LLG C G +++ EY G+L +L L E
Sbjct: 88 NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147
Query: 289 MNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTT 348
++ AKG+ +L +HRD+ + NILL K+ DFGLA+ + + +YV
Sbjct: 148 LSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVK 204
Query: 349 -------RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVN 400
+ M APE + SDV+S+GI + E+ S G +P Y PG
Sbjct: 205 GNARLPVKWM------APESIFNCVYTFESDVWSYGIFLWELFSLGSSP--Y---PGMPV 253
Query: 401 LVEWLKTMVTNRNAEGVLDPRLQEKP--CSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458
++ K M+ R+ P + + C D + KRP ++ +
Sbjct: 254 DSKFYK-MIKEGF-------RM-LSPEHAPAEMYD---IMKTCWDADPLKRPTFKQIVQL 301
Query: 459 LE 460
+E
Sbjct: 302 IE 303
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-29
Identities = 63/278 (22%), Positives = 112/278 (40%), Gaps = 26/278 (9%)
Query: 181 LEVSTNGFADENVIGEGGYGIVYHGV-LEDNTNVAVKNL-LNNRGQAEKEFKVEVEAIGR 238
+EV + +G G YG+V + +AVK + Q +K ++++ R
Sbjct: 2 MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMR 61
Query: 239 -VRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAK 297
V V G + E +D +L+++ + + +I I + K
Sbjct: 62 TVDCPFTVTFYGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVK 120
Query: 298 GLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYV 357
L +LH + V+HRD+K SN+L++ K+ DFG++ L G Y+
Sbjct: 121 ALEHLHS--KLSVIHRDVKPSNVLINALGQVKMCDFGISGYL--VDDVAKDIDAGCKPYM 176
Query: 358 APE----YASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRN 413
APE + + +SD++S GI ++E+ R P D P + LK +V
Sbjct: 177 APERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQ-----LKQVVEE-- 229
Query: 414 AEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPK 451
P+L S + +C+ N+ +RP
Sbjct: 230 ----PSPQLPADKFSAEFVD--FTS-QCLKKNSKERPT 260
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 3e-29
Identities = 58/204 (28%), Positives = 89/204 (43%), Gaps = 12/204 (5%)
Query: 188 FADENVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVR 246
IGEG GIV VAVK + + Q + EV + +H N+V
Sbjct: 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106
Query: 247 LLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIIL-GTAKGLTYLHEG 305
+ G ++ E++ G L D+ L E ++ + + L YLH
Sbjct: 107 MYKSYLVGEELWVLMEFLQGGALT-----DIVSQVRLN-EEQIATVCEAVLQALAYLHA- 159
Query: 306 LEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTG 365
V+HRDIKS +ILL KLSDFG + + + V GT ++APE S
Sbjct: 160 --QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAPEVISRS 216
Query: 366 MLNERSDVYSFGILIMEVISGRNP 389
+ D++S GI+++E++ G P
Sbjct: 217 LYATEVDIWSLGIMVIEMVDGEPP 240
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 4e-29
Identities = 68/298 (22%), Positives = 121/298 (40%), Gaps = 54/298 (18%)
Query: 191 ENVIGEGGYGIVYHGVL------EDNTNVAVKNLLNNRGQAEK-EFKVEVEAIGRV-RHK 242
+G G +G V + VAVK L + EK E++ + + +H+
Sbjct: 51 GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHE 110
Query: 243 NLVRLLGYCAEGAHRMLVYEYIDNGNLEQWL----------HGDVGPHSPLTWEIRMNII 292
N+V LLG C G +++ EY G+L +L +S + ++
Sbjct: 111 NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFS 170
Query: 293 LGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTT---- 348
A+G+ +L +HRD+ + N+LL K+ DFGLA+ + + +Y+
Sbjct: 171 SQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNAR 227
Query: 349 ---RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEW 404
+ M APE + +SDV+S+GIL+ E+ S G NP Y PG + ++
Sbjct: 228 LPVKWM------APESIFDCVYTVQSDVWSYGILLWEIFSLGLNP--Y---PGILVNSKF 276
Query: 405 LKTMVTNRNAEGVLDPRLQEKP--CSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 460
K +V + ++ +P + + + C RP + L+
Sbjct: 277 YK-LVKDGY-------QM-AQPAFAPKNIYS---IMQACWALEPTHRPTFQQICSFLQ 322
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 4e-29
Identities = 59/203 (29%), Positives = 91/203 (44%), Gaps = 16/203 (7%)
Query: 192 NVIGEGGYGIVYHGV-LEDNTNVAVKNL----LNNRGQAEKEFKVEVEAIGRVRHKNLVR 246
+G+G +G VY + +A+K L L G + + EVE +RH N++R
Sbjct: 15 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQ-LRREVEIQSHLRHPNILR 73
Query: 247 LLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGL 306
L GY + L+ EY G + + L S + I A L+Y H
Sbjct: 74 LYGYFHDATRVYLILEYAPLGTVYRELQ----KLSKFDEQRTATYITELANALSYCHS-- 127
Query: 307 EPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGM 366
+V+HRDIK N+LL K++DFG + + R GT Y+ PE M
Sbjct: 128 -KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT-DL--CGTLDYLPPEMIEGRM 183
Query: 367 LNERSDVYSFGILIMEVISGRNP 389
+E+ D++S G+L E + G+ P
Sbjct: 184 HDEKVDLWSLGVLCYEFLVGKPP 206
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 6e-29
Identities = 74/307 (24%), Positives = 128/307 (41%), Gaps = 63/307 (20%)
Query: 191 ENVIGEGGYGIVYHGVL------EDNTNVAVKNLLNNRGQAEK-EFKVEVEAIGRV-RHK 242
V+G G +G V + + VAVK L +E+ E++ + ++ H+
Sbjct: 50 GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHE 109
Query: 243 NLVRLLGYCAEGAHRMLVYEYIDNGNLEQWL-------------------HGDVGPHSPL 283
N+V LLG C L++EY G+L +L + + L
Sbjct: 110 NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 169
Query: 284 TWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER 343
T+E + AKG+ +L VHRD+ + N+L+ K+ DFGLA+ + ++
Sbjct: 170 TFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDS 226
Query: 344 SYVTT-------RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRP 395
+YV + M APE G+ +SDV+S+GIL+ E+ S G NP Y
Sbjct: 227 NYVVRGNARLPVKWM------APESLFEGIYTIKSDVWSYGILLWEIFSLGVNP--Y--- 275
Query: 396 PGEVNLVEWLKTMVTNRNAEGVLDPRLQEKP--CSRALKRALLVALRCVDPNAHKRPKMG 453
PG + K ++ N ++ ++P + + + C ++ KRP
Sbjct: 276 PGIPVDANFYK-LIQNGF-------KM-DQPFYATEEIYI---IMQSCWAFDSRKRPSFP 323
Query: 454 HVIHMLE 460
++ L
Sbjct: 324 NLTSFLG 330
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 6e-29
Identities = 57/204 (27%), Positives = 98/204 (48%), Gaps = 12/204 (5%)
Query: 188 FADENVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVR 246
+ IG+G G VY + + VA++ + + ++ E+ + ++ N+V
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 247 LLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIIL-GTAKGLTYLHEG 305
L G +V EY+ G+L DV + + E ++ + + L +LH
Sbjct: 82 YLDSYLVGDELWVVMEYLAGGSLT-----DVVTETCMD-EGQIAAVCRECLQALEFLHSN 135
Query: 306 LEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTG 365
+V+HRDIKS NILL + KL+DFG + E+S +T V GT ++APE +
Sbjct: 136 ---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRK 191
Query: 366 MLNERSDVYSFGILIMEVISGRNP 389
+ D++S GI+ +E+I G P
Sbjct: 192 AYGPKVDIWSLGIMAIEMIEGEPP 215
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 8e-29
Identities = 77/319 (24%), Positives = 121/319 (37%), Gaps = 60/319 (18%)
Query: 178 LRELEVSTNGFADENVIGEGGYGIVYHGVL------EDNTNVAVKNLLNNRGQAEK-EFK 230
L LE N IGEG +G V+ E T VAVK L + +F+
Sbjct: 39 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ 98
Query: 231 VEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWL----------------- 273
E + + N+V+LLG CA G L++EY+ G+L ++L
Sbjct: 99 REAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLS 158
Query: 274 ---HGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKL 330
PL+ ++ I A G+ YL E K VHRD+ + N L+ + K+
Sbjct: 159 TRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKI 215
Query: 331 SDFGLAKLLGAERSYVTTRVMGTFGYV-----APEYASTGMLNERSDVYSFGILIMEVIS 385
+DFGL++ + + Y + PE SDV+++G+++ E+ S
Sbjct: 216 ADFGLSRNIYSADYY----KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271
Query: 386 -GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKP--CSRALKRALLVALRCV 442
G P Y G + E + V + N L P C L + C
Sbjct: 272 YGLQP--Y---YGMAH--EEVIYYVRDGN-------IL-ACPENCPLELYN---LMRLCW 313
Query: 443 DPNAHKRPKMGHVIHMLEA 461
RP + +L+
Sbjct: 314 SKLPADRPSFCSIHRILQR 332
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 1e-28
Identities = 74/315 (23%), Positives = 133/315 (42%), Gaps = 61/315 (19%)
Query: 191 ENVIGEGGYGIVYHGVL--------EDNTNVAVKNLLNNRGQAEK-EFKVEVEAIGRV-R 240
+GEG +G V T VAVK L ++ + + + E+E + + +
Sbjct: 74 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133
Query: 241 HKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWL------------HGDVGPHSPLTWEIR 288
HKN++ LLG C + ++ EY GNL ++L + P L+ +
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193
Query: 289 MNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTT 348
++ A+G+ YL K +HRD+ + N+L+ + K++DFGLA+ + Y T
Sbjct: 194 VSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 250
Query: 349 -------RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVN 400
+ M APE + +SDV+SFG+L+ E+ + G +P Y PG
Sbjct: 251 TNGRLPVKWM------APEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP--Y---PGVPV 299
Query: 401 LVEWLKTMVTNRNAEGVLDPRLQEKP--CSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458
E L ++ + R+ +KP C+ L + C +RP ++
Sbjct: 300 --EELFKLLKEGH-------RM-DKPSNCTNELYM---MMRDCWHAVPSQRPTFKQLVED 346
Query: 459 LEA--EEFPFRDVSF 471
L+ +++ +
Sbjct: 347 LDRIVALTSNQEMGY 361
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 4e-28
Identities = 56/213 (26%), Positives = 100/213 (46%), Gaps = 11/213 (5%)
Query: 179 RELEVSTNGFADENVIGEGGYGIVYHGVL-EDNTNVAVKNL-LNNRGQAEKEFKVEVEAI 236
+ E+ + F + +G G G+V+ +A K + L + + E++ +
Sbjct: 26 KVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVL 85
Query: 237 GRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTA 296
+V G + E++D G+L+Q L + +I + +
Sbjct: 86 HECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK----KAGRIPEQILGKVSIAVI 141
Query: 297 KGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGY 356
KGLTYL E + K++HRD+K SNIL++ + KL DFG++ L S + V GT Y
Sbjct: 142 KGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMANSFV-GTRSY 196
Query: 357 VAPEYASTGMLNERSDVYSFGILIMEVISGRNP 389
++PE + +SD++S G+ ++E+ GR P
Sbjct: 197 MSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 229
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 5e-28
Identities = 35/293 (11%), Positives = 65/293 (22%), Gaps = 51/293 (17%)
Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVKNLL---NNRGQAEKEFKVEVEAIGRVRHKNLVRLL 248
+ G +V+ +E + A+K N + A R+ ++
Sbjct: 69 PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128
Query: 249 GYCAEGA--------------------------HRMLVYEYI--DNGNLEQWLHGDVGPH 280
+ +L+ D L L
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFR 188
Query: 281 SPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG 340
+ + L +VH N+ + L D +G
Sbjct: 189 GDEGILALHILTAQLIRLAANLQS---KGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVG 245
Query: 341 AERSYVTTRVMGTFGYVAPEY--ASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGE 398
Y E+ AST + + G+ I V P P +
Sbjct: 246 T----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIK 301
Query: 399 VNLVEWLKTMVTNRNAEGVLDPRLQEKPCS-RALKRALLVALRCVDPNAHKRP 450
W + + + + P + L L D +R
Sbjct: 302 ---GSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLN----FDRR--RRL 345
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 7e-28
Identities = 49/222 (22%), Positives = 91/222 (40%), Gaps = 30/222 (13%)
Query: 174 HWYTLRELEVSTNGFADENVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKVE 232
HW T + +G G +G V+ + AVK + + E E
Sbjct: 58 HWMTHQPR------------VGRGSFGEVHRMKDKQTGFQCAVKKV-----RLEVFRVEE 100
Query: 233 VEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNII 292
+ A + +V L G EG + E ++ G+L Q + L + + +
Sbjct: 101 LVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIK----QMGCLPEDRALYYL 156
Query: 293 LGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNP-KLSDFGLAKLLGAERSYVTTR-- 349
+GL YLH +++H D+K+ N+LL + L DFG A L + +
Sbjct: 157 GQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTG 213
Query: 350 --VMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNP 389
+ GT ++APE + + D++S +++ +++G +P
Sbjct: 214 DYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 255
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 8e-28
Identities = 58/287 (20%), Positives = 109/287 (37%), Gaps = 61/287 (21%)
Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVKNL-LNNRGQAEKEFKV-EVEAIGRV-RHKNLVRLL 248
IG G +G V+ V D A+K G +++ + EV A + +H ++VR
Sbjct: 18 KIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYF 77
Query: 249 GYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEP 308
AE H ++ EY + G+L + + S +++L +GL Y+H
Sbjct: 78 SAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH---SM 134
Query: 309 KVVHRDIKSSNILLDKQWNP-------------------KLSDFGLAKLLGAERSYVTTR 349
+VH DIK SNI + + P K+ D G + + +
Sbjct: 135 SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEE--- 191
Query: 350 VMGTFGYVAPEYASTGMLNER------SDVYSFGILIMEVISGRNPVDYSRPPGEVNLVE 403
G ++A E +L E +D+++ + ++ P + +
Sbjct: 192 --GDSRFLANE-----VLQENYTHLPKADIFALALTVVCAAGAE------PLPRNGD--Q 236
Query: 404 WLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRP 450
W + +G L PR+ + S+ L+ + + P+ +RP
Sbjct: 237 WHEIR------QGRL-PRIPQV-LSQEFTE--LLKV-MIHPDPERRP 272
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 9e-28
Identities = 56/204 (27%), Positives = 94/204 (46%), Gaps = 11/204 (5%)
Query: 188 FADENVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKE-FKVEVEAIGRVRHKNLV 245
F IG+G +G V+ G+ VA+K + + E E + E+ + + +
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 246 RLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG 305
+ G + ++ EY+ G+ D+ PL I+ KGL YLH
Sbjct: 84 KYYGSYLKDTKLWIIMEYLGGGSAL-----DLLEPGPLDETQIATILREILKGLDYLHSE 138
Query: 306 LEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTG 365
K +HRDIK++N+LL + KL+DFG+A L + T +GT ++APE
Sbjct: 139 ---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT-FVGTPFWMAPEVIKQS 194
Query: 366 MLNERSDVYSFGILIMEVISGRNP 389
+ ++D++S GI +E+ G P
Sbjct: 195 AYDSKADIWSLGITAIELARGEPP 218
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 1e-27
Identities = 76/283 (26%), Positives = 115/283 (40%), Gaps = 28/283 (9%)
Query: 179 RELEVSTNGFADENVIGEGGYGIVYHGV-LEDNTNVAVKNL-LNNRGQAEKEFKVEVEAI 236
+ + + D IG G YG V V +AVK + + +K+ ++++ +
Sbjct: 15 QHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVV 74
Query: 237 GR-VRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGT 295
R +V+ G + E + + + + + EI I L T
Sbjct: 75 MRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLAT 134
Query: 296 AKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFG 355
K L +L E K++HRDIK SNILLD+ N KL DFG++ L S TR G
Sbjct: 135 VKALNHLKE--NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQL--VDSIAKTRDAGCRP 190
Query: 356 YVAPE----YASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTN 411
Y+APE AS + RSDV+S GI + E+ +GR P + T V
Sbjct: 191 YMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD------QLTQVVK 244
Query: 412 RNAEGVLDPRLQEKPC---SRALKRALLVALRCVDPNAHKRPK 451
+ P+L S + V C+ + KRPK
Sbjct: 245 GDP-----PQLSNSEEREFSPSFIN--FVN-LCLTKDESKRPK 279
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-27
Identities = 50/214 (23%), Positives = 87/214 (40%), Gaps = 25/214 (11%)
Query: 192 NVIGEGGYGIVYHGVLEDNTNVAVK--NLLNNRGQAEKEFKVEVEAIGRVRHKNL--VRL 247
IG GG V+ + E A+K NL Q ++ E+ + +++ + +RL
Sbjct: 34 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93
Query: 248 LGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLE 307
Y + +V E N +L WL + R + + + +H+
Sbjct: 94 YDYEITDQYIYMVMEC-GNIDLNSWLK----KKKSIDPWERKSYWKNMLEAVHTIHQH-- 146
Query: 308 PKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA-ERSYVTTRVMGTFGYVAPE------ 360
+VH D+K +N L+ KL DFG+A + S V +GT Y+ PE
Sbjct: 147 -GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 204
Query: 361 -----YASTGMLNERSDVYSFGILIMEVISGRNP 389
S ++ +SDV+S G ++ + G+ P
Sbjct: 205 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 238
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 50/214 (23%), Positives = 87/214 (40%), Gaps = 25/214 (11%)
Query: 192 NVIGEGGYGIVYHGVLEDNTNVAVK--NLLNNRGQAEKEFKVEVEAIGRVRHKNL--VRL 247
IG GG V+ + E A+K NL Q ++ E+ + +++ + +RL
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 248 LGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLE 307
Y + +V E N +L WL + R + + + +H+
Sbjct: 75 YDYEITDQYIYMVMEC-GNIDLNSWLK----KKKSIDPWERKSYWKNMLEAVHTIHQH-- 127
Query: 308 PKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA-ERSYVTTRVMGTFGYVAPE------ 360
+VH D+K +N L+ KL DFG+A + S V +GT Y+ PE
Sbjct: 128 -GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 185
Query: 361 -----YASTGMLNERSDVYSFGILIMEVISGRNP 389
S ++ +SDV+S G ++ + G+ P
Sbjct: 186 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 219
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 2e-27
Identities = 60/203 (29%), Positives = 97/203 (47%), Gaps = 10/203 (4%)
Query: 188 FADENVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVR 246
F +GEG YG VY + E VA+K + +E E+ + + ++V+
Sbjct: 31 FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQV--PVESDLQEIIKEISIMQQCDSPHVVK 88
Query: 247 LLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGL 306
G + +V EY G++ + + LT + I+ T KGL YLH
Sbjct: 89 YYGSYFKNTDLWIVMEYCGAGSVSDIIRLR---NKTLTEDEIATILQSTLKGLEYLHFM- 144
Query: 307 EPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGM 366
+ +HRDIK+ NILL+ + + KL+DFG+A L + T + GT ++APE
Sbjct: 145 --RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI-GTPFWMAPEVIQEIG 201
Query: 367 LNERSDVYSFGILIMEVISGRNP 389
N +D++S GI +E+ G+ P
Sbjct: 202 YNCVADIWSLGITAIEMAEGKPP 224
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 3e-27
Identities = 36/236 (15%), Positives = 65/236 (27%), Gaps = 43/236 (18%)
Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVKNLL---NNRGQAEKEFKVEVEAIGRVR-------- 240
V+G+ E + V A K+ K EV + +R
Sbjct: 85 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144
Query: 241 -----------------HKNLVRLLGYCAEGAHRMLV----YEYIDNGNLEQWLHGDVGP 279
K ++R+ + + + L
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204
Query: 280 HSPLTWEIRMNIILGTAKGLTYLHE-GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL 338
H L R+ + L + L LH G +VH ++ +I+LD++ L+ F
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLHHYG----LVHTYLRPVDIVLDQRGGVFLTGFEHLVR 260
Query: 339 LGAERSYVTTRVMGTFGYVAPE-----YASTGMLNERSDVYSFGILIMEVISGRNP 389
GA R A ++ D ++ G+ I + P
Sbjct: 261 DGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP 316
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 109 bits (276), Expect = 4e-27
Identities = 51/204 (25%), Positives = 88/204 (43%), Gaps = 16/204 (7%)
Query: 194 IGEGGYGIVYHGV-LEDNTNVAVK----NLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLL 248
+G+GG+ + + A K +LL Q EK +E+ + H+++V
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK-MSMEISIHRSLAHQHVVGFH 81
Query: 249 GYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLT-WEIRMNIILGTAKGLTYLHEGLE 307
G+ + +V E +L + LT E R + G YLH
Sbjct: 82 GFFEDNDFVFVVLELCRRRSLLELHKR----RKALTEPEAR-YYLRQIVLGCQYLHRN-- 134
Query: 308 PKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGML 367
+V+HRD+K N+ L++ K+ DFGLA + + + GT Y+APE S
Sbjct: 135 -RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLSKKGH 192
Query: 368 NERSDVYSFGILIMEVISGRNPVD 391
+ DV+S G ++ ++ G+ P +
Sbjct: 193 SFEVDVWSIGCIMYTLLVGKPPFE 216
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 6e-27
Identities = 68/267 (25%), Positives = 98/267 (36%), Gaps = 42/267 (15%)
Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVKNL-LNNRGQAEKEFKV-EVEAIGRV-RHKNLVRLL 248
+G G YG V+ ED AVK RG ++ K+ EV + +V +H VRL
Sbjct: 64 RLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLE 123
Query: 249 GYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEP 308
EG L E +L+Q + L + T L +LH
Sbjct: 124 QAWEEGGILYLQTELCG-PSLQQHCEAW---GASLPEAQVWGYLRDTLLALAHLHS---Q 176
Query: 309 KVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPE-----YAS 363
+VH D+K +NI L + KL DFGL LG + G Y+APE Y
Sbjct: 177 GLVHLDVKPANIFLGPRGRCKLGDFGLLVELG-TAGAGEVQE-GDPRYMAPELLQGSY-- 232
Query: 364 TGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQ 423
+DV+S G+ I+EV W + +G L P
Sbjct: 233 ----GTAADVFSLGLTILEVACNMELPHGGEG--------WQQLR------QGYLPPEFT 274
Query: 424 EKPCSRALKRALLVALRCVDPNAHKRP 450
S L+ L + ++P+ R
Sbjct: 275 AG-LSSELRSVL---VMMLEPDPKLRA 297
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 9e-27
Identities = 57/202 (28%), Positives = 97/202 (48%), Gaps = 15/202 (7%)
Query: 194 IGEGGYGIVYHGV-LEDNTNVAVK----NLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLL 248
+G+G + VY + VA+K + G ++ + EV+ +++H +++ L
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQR-VQNEVKIHCQLKHPSILELY 77
Query: 249 GYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLT-WEIRMNIILGTAKGLTYLHEGLE 307
Y + + LV E NG + ++L V P + E R + + G+ YLH
Sbjct: 78 NYFEDSNYVYLVLEMCHNGEMNRYLKNRVKP---FSENEAR-HFMHQIITGMLYLHS--- 130
Query: 308 PKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGML 367
++HRD+ SN+LL + N K++DFGLA L T + GT Y++PE A+
Sbjct: 131 HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT-LCGTPNYISPEIATRSAH 189
Query: 368 NERSDVYSFGILIMEVISGRNP 389
SDV+S G + ++ GR P
Sbjct: 190 GLESDVWSLGCMFYTLLIGRPP 211
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 51/223 (22%), Positives = 92/223 (41%), Gaps = 27/223 (12%)
Query: 191 ENVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVR-HKNLVRLL 248
V+ EGG+ VY + A+K LL+N + + EV + ++ H N+V+
Sbjct: 33 RRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFC 92
Query: 249 GYCAEGAHRM-------LVYEYIDNGNLEQWLHGDVGPHSPLT-WEIRMNIILGTAKGLT 300
+ G L+ + G L ++L + PL+ + I T + +
Sbjct: 93 SAASIGKEESDTGQAEFLLLTELCKGQLVEFLK-KMESRGPLSCDTVL-KIFYQTCRAVQ 150
Query: 301 YLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVM--------- 351
++H +P ++HRD+K N+LL Q KL DFG A + Y +
Sbjct: 151 HMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEIT 209
Query: 352 --GTFGYVAPE---YASTGMLNERSDVYSFGILIMEVISGRNP 389
T Y PE S + E+ D+++ G ++ + ++P
Sbjct: 210 RNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP 252
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-26
Identities = 43/209 (20%), Positives = 95/209 (45%), Gaps = 15/209 (7%)
Query: 188 FADENVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVR 246
+ +G+G +G VY E A K + + +++ VE+E + H +V+
Sbjct: 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80
Query: 247 LLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIIL-GTAKGLTYLHEG 305
LLG ++ E+ G ++ + + E ++ ++ + L +LH
Sbjct: 81 LLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLT----EPQIQVVCRQMLEALNFLHSK 136
Query: 306 LEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTG 365
+++HRD+K+ N+L+ + + +L+DFG++ + +GT ++APE
Sbjct: 137 ---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS-FIGTPYWMAPEVVMCE 192
Query: 366 ML-----NERSDVYSFGILIMEVISGRNP 389
+ + ++D++S GI ++E+ P
Sbjct: 193 TMKDTPYDYKADIWSLGITLIEMAQIEPP 221
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-26
Identities = 55/202 (27%), Positives = 91/202 (45%), Gaps = 16/202 (7%)
Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVKNL----LNNRGQAEKEFKVEVEAIGRVRHKNLVRL 247
+G+G +G VY ++ +A+K L L G E + + E+E +RH N++R+
Sbjct: 21 PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGV-EHQLRREIEIQSHLRHPNILRM 79
Query: 248 LGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLE 307
Y + L+ E+ G L + L H + + A L Y HE
Sbjct: 80 YNYFHDRKRIYLMLEFAPRGELYKELQ----KHGRFDEQRSATFMEELADALHYCHE--- 132
Query: 308 PKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGML 367
KV+HRDIK N+L+ + K++DFG + + R + GT Y+ PE
Sbjct: 133 RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR---RRTMCGTLDYLPPEMIEGKTH 189
Query: 368 NERSDVYSFGILIMEVISGRNP 389
+E+ D++ G+L E + G P
Sbjct: 190 DEKVDLWCAGVLCYEFLVGMPP 211
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 51/202 (25%), Positives = 87/202 (43%), Gaps = 16/202 (7%)
Query: 194 IGEGGYGIVYHGV-LEDNTNVAVK----NLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLL 248
+G+GG+ + + A K +LL Q EK +E+ + H+++V
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK-MSMEISIHRSLAHQHVVGFH 107
Query: 249 GYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLT-WEIRMNIILGTAKGLTYLHEGLE 307
G+ + +V E +L + LT E R + G YLH
Sbjct: 108 GFFEDNDFVFVVLELCRRRSLLELHKR----RKALTEPEAR-YYLRQIVLGCQYLHR--- 159
Query: 308 PKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGML 367
+V+HRD+K N+ L++ K+ DFGLA + + + GT Y+APE S
Sbjct: 160 NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLSKKGH 218
Query: 368 NERSDVYSFGILIMEVISGRNP 389
+ DV+S G ++ ++ G+ P
Sbjct: 219 SFEVDVWSIGCIMYTLLVGKPP 240
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 4e-26
Identities = 58/290 (20%), Positives = 109/290 (37%), Gaps = 44/290 (15%)
Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVK--NLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLG 249
++G+G V+ G + A+K N ++ + + + E E + ++ HKN+V+L
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMR-EFEVLKKLNHKNIVKLFA 74
Query: 250 Y--CAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLE 307
H++L+ E+ G+L L + L + ++ G+ +L E
Sbjct: 75 IEEETTTRHKVLIMEFCPCGSLYTVLE-EPSNAYGLPESEFLIVLRDVVGGMNHLREN-- 131
Query: 308 PKVVHRDIKSSNILL----DKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAS 363
+VHR+IK NI+ D Q KL+DFG A+ L + + GT Y+ P+
Sbjct: 132 -GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-DDEQFVSLY-GTEEYLHPDMYE 188
Query: 364 TGML--------NERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAE 415
+L D++S G+ +G P P E + ++T + +
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGP--RRNKEVMYKIITGKPSG 246
Query: 416 GVLDPRLQEK----------------PCSRALKRALLVALRCVDPNAHKR 449
+ + E + L +L + D K
Sbjct: 247 AISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQE--KC 294
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 4e-26
Identities = 67/279 (24%), Positives = 112/279 (40%), Gaps = 34/279 (12%)
Query: 188 FADENVIGEGGYGIVYHGVLEDNTNVAVKNLL-NNRGQAEKEFKVEVEAIGRVRHKNLVR 246
F ++V+G G G + + + DN +VAVK +L A++E ++ E+ H N++R
Sbjct: 26 FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADREVQLLRESDE---HPNVIR 82
Query: 247 LLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGL 306
+ + + E L++++ + ++ T GL +LH
Sbjct: 83 YFCTEKDRQFQYIAIELCA-ATLQEYV---EQKDFAHLGLEPITLLQQTTSGLAHLHS-- 136
Query: 307 EPKVVHRDIKSSNILL-----DKQWNPKLSDFGLAKLLGAERSYVTTR--VMGTFGYVAP 359
+VHRD+K NIL+ + +SDFGL K L R + R V GT G++AP
Sbjct: 137 -LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAP 195
Query: 360 EY---ASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEG 416
E D++S G + VIS + P G+ +
Sbjct: 196 EMLSEDCKENPTYTVDIFSAGCVFYYVISEGSH-----PFGKSLQRQANI-----LLGAC 245
Query: 417 VLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHV 455
LD EK + L+ + + + KRP HV
Sbjct: 246 SLDCLHPEKHEDVIARE--LIE-KMIAMDPQKRPSAKHV 281
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 4e-26
Identities = 49/214 (22%), Positives = 86/214 (40%), Gaps = 25/214 (11%)
Query: 192 NVIGEGGYGIVYHGVLEDNTNVAVK--NLLNNRGQAEKEFKVEVEAIGRVRHKNL--VRL 247
IG GG V+ + E A+K NL Q ++ E+ + +++ + +RL
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 248 LGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLE 307
Y + +V E N +L WL + R + + + +H+
Sbjct: 122 YDYEITDQYIYMVMEC-GNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQH-- 174
Query: 308 PKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA-ERSYVTTRVMGTFGYVAPE------ 360
+VH D+K +N L+ KL DFG+A + S V +G Y+ PE
Sbjct: 175 -GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMS 232
Query: 361 -----YASTGMLNERSDVYSFGILIMEVISGRNP 389
S ++ +SDV+S G ++ + G+ P
Sbjct: 233 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 266
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 5e-26
Identities = 60/218 (27%), Positives = 93/218 (42%), Gaps = 23/218 (10%)
Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKE-FKVEVEAIGRVRHKNLVRLL-- 248
+G GG+G V + + VA+K +E + +E++ + ++ H N+V
Sbjct: 21 RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREV 80
Query: 249 ----GYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLT-WEIR--MNIILGTAKGLTY 301
A +L EY + G+L ++L+ L IR ++ I L Y
Sbjct: 81 PDGLQKLAPNDLPLLAMEYCEGGDLRKYLN-QFENCCGLKEGPIRTLLSDIS---SALRY 136
Query: 302 LHEGLEPKVVHRDIKSSNILLDKQWNP---KLSDFGLAKLLGAERSYVTTRVMGTFGYVA 358
LHE +++HRD+K NI+L K+ D G AK L + T V GT Y+A
Sbjct: 137 LHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD-QGELCTEFV-GTLQYLA 191
Query: 359 PEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPP 396
PE D +SFG L E I+G P + P
Sbjct: 192 PELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP 229
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 5e-26
Identities = 53/229 (23%), Positives = 95/229 (41%), Gaps = 16/229 (6%)
Query: 179 RELEVSTNGFADENVIGEGGYGIVYHGV-LEDNTNVAVKNL-LNNRGQAEKEFKVEVEAI 236
+ + N + +G G G V+ + +AVK + + + K ++++ +
Sbjct: 18 QRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVV 77
Query: 237 GR-VRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGT 295
+ +V+ G + E + + P+ I + +
Sbjct: 78 LKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKR----MQGPIPERILGKMTVAI 133
Query: 296 AKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFG 355
K L YL E + V+HRD+K SNILLD++ KL DFG++ L R G
Sbjct: 134 VKALYYLKE--KHGVIHRDVKPSNILLDERGQIKLCDFGISGRL--VDDKAKDRSAGCAA 189
Query: 356 YVAPE-----YASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEV 399
Y+APE + + R+DV+S GI ++E+ +G+ P + EV
Sbjct: 190 YMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEV 238
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 108 bits (270), Expect = 8e-26
Identities = 64/345 (18%), Positives = 118/345 (34%), Gaps = 51/345 (14%)
Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVK--NLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLG 249
++G+G V+ G + A+K N ++ + + + E E + ++ HKN+V+L
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMR-EFEVLKKLNHKNIVKLFA 74
Query: 250 YCAEGAHRM--LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLE 307
E R L+ E+ G+L L + L + ++ G+ +L E
Sbjct: 75 IEEETTTRHKVLIMEFCPCGSLYTVLE-EPSNAYGLPESEFLIVLRDVVGGMNHLREN-- 131
Query: 308 PKVVHRDIKSSNILL----DKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAS 363
+VHR+IK NI+ D Q KL+DFG A+ L + + GT Y+ P+
Sbjct: 132 -GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-DDEQFVSLY-GTEEYLHPDMYE 188
Query: 364 TGML--------NERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAE 415
+L D++S G+ +G P P E + ++T + +
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGP--RRNKEVMYKIITGKPSG 246
Query: 416 GVLDPRLQEK----------------PCSRALKRALLVALRCVDPNAHKRPKMGHVIHML 459
+ + E + L +L + D K
Sbjct: 247 AISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQE--KCWGFDQFFAET 304
Query: 460 EAEEFPFRDVSFGRVIGILFFLKALLYSTLVMQLYLLKNFLLHVS 504
D+ VI + + + + F V
Sbjct: 305 S-------DILHRMVIHVFSLQQMTAHKIYIHSYNTATIFHELVY 342
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 72/277 (25%), Positives = 122/277 (44%), Gaps = 37/277 (13%)
Query: 188 FADENVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV-RHKNLV 245
F ++G G YG VY G ++ A+K +++ G E+E K E+ + + H+N+
Sbjct: 26 FELVELVGNGTYGQVYKGRHVKTGQLAAIK-VMDVTGDEEEEIKQEINMLKKYSHHRNIA 84
Query: 246 RLLG-YCAEGAHRM-----LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGL 299
G + + M LV E+ G++ + G + L E I +GL
Sbjct: 85 TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG--NTLKEEWIAYICREILRGL 142
Query: 300 TYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAP 359
++LH+ KV+HRDIK N+LL + KL DFG++ L T +GT ++AP
Sbjct: 143 SHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT-FIGTPYWMAP 198
Query: 360 E-----YASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPP-GEVNLVEWLKTMVTNRN 413
E + +SD++S GI +E+ G PP +++ + L + N
Sbjct: 199 EVIACDENPDATYDFKSDLWSLGITAIEMAEG-------APPLCDMHPMRALFLIPRNP- 250
Query: 414 AEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRP 450
PRL+ K S+ + + L + +RP
Sbjct: 251 -----APRLKSKKWSKKFQSFIESCL-VKNH--SQRP 279
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 46/220 (20%), Positives = 89/220 (40%), Gaps = 29/220 (13%)
Query: 193 VIGEGGYGIVYHGVLEDNTNVAVK-----------------NLLNNRGQAEKEFKVEVEA 235
+ +G + + +DN A+K N + +FK E++
Sbjct: 38 TLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQI 96
Query: 236 IGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWL----HGDVGPHSPLTWEIRMNI 291
I ++++ + G ++YEY++N ++ ++ D + ++ I
Sbjct: 97 ITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCI 156
Query: 292 ILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVM 351
I +Y+H + HRD+K SNIL+DK KLSDFG ++ +
Sbjct: 157 IKSVLNSFSYIHNEK--NICHRDVKPSNILMDKNGRVKLSDFGESEY--MVDKKIKG-SR 211
Query: 352 GTFGYVAPEYAST--GMLNERSDVYSFGILIMEVISGRNP 389
GT+ ++ PE+ S + D++S GI + + P
Sbjct: 212 GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP 251
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 38/278 (13%), Positives = 81/278 (29%), Gaps = 39/278 (14%)
Query: 179 RELEVSTNGFADENVIGEGGYGIVYHGVLEDNTN------VAVKNLLNNRGQAEKEFKVE 232
E ++ + +++GEG + VY D + +K + EF +
Sbjct: 58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQ---KPANPWEFYIG 114
Query: 233 VEAIGRVR---HKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWL-HGDVGPHSPLTWEIR 288
+ + R++ ++ +LV E G L + P + +
Sbjct: 115 TQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLV 174
Query: 289 MNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNP-----------KLSDFGLAK 337
++ + + +H+ +++H DIK N +L + L D G +
Sbjct: 175 ISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSI 231
Query: 338 LLGAERSYVTTRVM-GTFGYVAPEYASTGMLNERS-----DVYSFGILIMEVISGRNPVD 391
+ T G+ E ML+ + D + + ++ G
Sbjct: 232 DMKLFPKGTIFTAKCETSGFQCVE-----MLSNKPWNYQIDYFGVAATVYCMLFGTYM-K 285
Query: 392 YSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSR 429
GE + + L C
Sbjct: 286 VKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHH 323
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 6e-25
Identities = 54/268 (20%), Positives = 91/268 (33%), Gaps = 80/268 (29%)
Query: 188 FADENVIGEGGYGIVYHGV-LEDNTNVAVKNL-LNNRGQAEKEFKVEVEAIGRVRHKNLV 245
F +G GG+G+V+ D+ N A+K + L NR A ++ EV+A+ ++ H +V
Sbjct: 8 FEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 67
Query: 246 RLLGYCAEGAHRMLVYE------------------------------------------- 262
R E E
Sbjct: 68 RYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQL 127
Query: 263 ---------YI-----DNGNLEQWLHGDVGPHSP---LTWEIRMNIILGTAKGLTYLHEG 305
YI NL+ W++ + I + I + +LH
Sbjct: 128 QPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAE----AVEFLH-- 181
Query: 306 LEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVT-----------TRVMGTF 354
++HRD+K SNI K+ DFGL + + T T +GT
Sbjct: 182 -SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240
Query: 355 GYVAPEYASTGMLNERSDVYSFGILIME 382
Y++PE + + D++S G+++ E
Sbjct: 241 LYMSPEQIHGNNYSHKVDIFSLGLILFE 268
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 6e-25
Identities = 37/241 (15%), Positives = 71/241 (29%), Gaps = 52/241 (21%)
Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVKNLL---NNRGQAEKEFKVEVEAIGRVR-------- 240
V+G+ E + V A K+ K EV + +R
Sbjct: 80 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139
Query: 241 -----------------HKNLVRLLGYCAEGAHRMLVYEY----IDNGNLEQWLHGDVGP 279
K ++R+ + + Y + + L
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199
Query: 280 HSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL 339
H L R+ + L + L LH +VH ++ +I+LD++ L+ F
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 256
Query: 340 GAERSYVTTRVMGTFGYVAPEYAST-----------GMLNERSDVYSFGILIMEVISGRN 388
GA + G+ PE + ++ D ++ G++I +
Sbjct: 257 GARVV-----SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADL 311
Query: 389 P 389
P
Sbjct: 312 P 312
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 6e-24
Identities = 68/286 (23%), Positives = 125/286 (43%), Gaps = 45/286 (15%)
Query: 188 FADENVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKE-FKVEVEAIGRVRHKNLV 245
+ + VIG G +V VA+K + + Q + E++A+ + H N+V
Sbjct: 17 YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIV 76
Query: 246 RLLGYCAEGAHRMLVYEYIDNGNL----EQWLHGDVGPHSPLTWEIRMNIIL-GTAKGLT 300
LV + + G++ + + L E + IL +GL
Sbjct: 77 SYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLD-ESTIATILREVLEGLE 135
Query: 301 YLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTF-G---Y 356
YLH+ +HRD+K+ NILL + + +++DFG++ L +V TF G +
Sbjct: 136 YLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCW 192
Query: 357 VAPE-------YASTGMLNERSDVYSFGILIMEVISGRNPVDYSR-PPGEVNLVEWLKTM 408
+APE Y + ++D++SFGI +E+ +G P Y + PP +V M
Sbjct: 193 MAPEVMEQVRGY------DFKADIWSFGITAIELATGAAP--YHKYPPMKV-------LM 237
Query: 409 VTNRNA----EGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRP 450
+T +N E + + K ++ ++ +++L C+ + KRP
Sbjct: 238 LTLQNDPPSLETGVQDKEMLKKYGKSFRK--MISL-CLQKDPEKRP 280
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 7e-24
Identities = 42/225 (18%), Positives = 72/225 (32%), Gaps = 18/225 (8%)
Query: 178 LRELEVSTNGFADENVIGEG--GYGIVYHGV-LEDNTNVAVK--NLLNNRGQAEKEFKVE 232
+ + VIG+G V V V+ NL + + E
Sbjct: 17 MSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGE 76
Query: 233 VEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNII 292
+ H N+V +V ++ G+ + + + I+
Sbjct: 77 LHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLIC--THFMDGMNELAIAYIL 134
Query: 293 LGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMG 352
G K L Y+H VHR +K+S+IL+ LS + +
Sbjct: 135 QGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDF 191
Query: 353 TFGYV------APEYASTGML--NERSDVYSFGILIMEVISGRNP 389
V +PE + + +SD+YS GI E+ +G P
Sbjct: 192 PKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVP 236
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 9e-24
Identities = 52/223 (23%), Positives = 86/223 (38%), Gaps = 34/223 (15%)
Query: 191 ENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV-RHKNLVRLLG 249
E ++G G G V VAVK +L + +E++ + H N++R
Sbjct: 20 EKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYC 76
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWL--HGDVGPHSPLTWEIRM-NIILGTAKGLTYLHEGL 306
+ E N NL+ + + L E +++ A G+ +LH
Sbjct: 77 SETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS-- 133
Query: 307 EPKVVHRDIKSSNILLDKQWNP-------------KLSDFGLAKLLGAERSYVTTRVM-- 351
K++HRD+K NIL+ +SDFGL K L + +S T +
Sbjct: 134 -LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNP 192
Query: 352 -GTFGYVAPE-------YASTGMLNERSDVYSFGILIMEVISG 386
GT G+ APE + L D++S G + ++S
Sbjct: 193 SGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 73/272 (26%), Positives = 116/272 (42%), Gaps = 38/272 (13%)
Query: 188 FADENVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAE---KEFKVEVEAIGRVRHKN 243
F+D IG G +G VY + ++ VA+K + + Q+ ++ EV + ++RH N
Sbjct: 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIIL-GTAKGLTYL 302
++ G LV EY G+ L P E+ + + G +GL YL
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQ----EVEIAAVTHGALQGLAYL 170
Query: 303 HEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPE-- 360
H ++HRD+K+ NILL + KL DFG A ++ S+V GT ++APE
Sbjct: 171 HSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV-----GTPYWMAPEVI 222
Query: 361 -YASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPP-GEVNLVEWLKTMVTNRNAEGVL 418
G + + DV+S GI +E+ +PP +N + L + N +
Sbjct: 223 LAMDEGQYDGKVDVWSLGITCIELAER-------KPPLFNMNAMSALYHIAQNES----- 270
Query: 419 DPRLQEKPCSRALKRALLVALRCVDPNAHKRP 450
P LQ S + + L P RP
Sbjct: 271 -PALQSGHWSEYFRNFVDSCL-QKIPQ--DRP 298
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 63/260 (24%), Positives = 106/260 (40%), Gaps = 42/260 (16%)
Query: 149 GSHHGSGDQTVAAAITPEVSHLGWG-----HWYTLRELEVSTNGFADENVIGEGGYGIVY 203
GS S + P T + E++ + + VIG G +G+V+
Sbjct: 1 GSFTMSNAPLNGVKLNPLDDPNKVIKVLASDGKTGEQREIA---YTNCKVIGNGSFGVVF 57
Query: 204 HGVLEDNTNVAVKNLLNNRGQAEKEFKV-EVEAIGRVRHKNLVRLLGYCAEGAHRM---- 258
L ++ VA+K +L +K FK E++ + V+H N+V L + +
Sbjct: 58 QAKLVESDEVAIKKVLQ-----DKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVF 112
Query: 259 --LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIK 316
LV EY+ + + + + + + L Y+H + HRDIK
Sbjct: 113 LNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIK 168
Query: 317 SSNILLDKQWNP-KLSDFGLAKLLGAER---SYVTTRVMGTFGYVAPEYASTGMLNERS- 371
N+LLD KL DFG AK+L A SY+ +R Y APE + +
Sbjct: 169 PQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRY-----YRAPEL----IFGATNY 219
Query: 372 ----DVYSFGILIMEVISGR 387
D++S G ++ E++ G+
Sbjct: 220 TTNIDIWSTGCVMAELMQGQ 239
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 1e-22
Identities = 59/217 (27%), Positives = 92/217 (42%), Gaps = 35/217 (16%)
Query: 188 FADENVIGEGGYGIVYHGVL-EDNTNVAVKNLLNNRGQAEKEFKV-EVEAIGRVRHKNLV 245
+ D VIG G +G+VY L + VA+K +L +K FK E++ + ++ H N+V
Sbjct: 56 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNIV 110
Query: 246 RLLGYCAEGAHRM------LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGL 299
RL + + LV +Y+ + + L + + L
Sbjct: 111 RLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 169
Query: 300 TYLHEGLEPKVVHRDIKSSNILLDKQWNP-KLSDFGLAKLLGAER---SYVTTRVMGTFG 355
Y+H + HRDIK N+LLD KL DFG AK L SY+ +R
Sbjct: 170 AYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY----- 221
Query: 356 YVAPEYASTGMLNERS-----DVYSFGILIMEVISGR 387
Y APE + DV+S G ++ E++ G+
Sbjct: 222 YRAPEL----IFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 3e-22
Identities = 56/216 (25%), Positives = 86/216 (39%), Gaps = 44/216 (20%)
Query: 192 NVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIG-------------R 238
IGEG YG+V+ +N + A K+F + +
Sbjct: 9 GKIGEGSYGVVFKC----------RNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQ 58
Query: 239 VRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKG 298
++H NLV LL LV+EY D+ + L D ++ +I T +
Sbjct: 59 LKHPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHEL--DRYQRGVPEHLVK-SITWQTLQA 114
Query: 299 LTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVA 358
+ + H+ +HRD+K NIL+ K KL DFG A+LL Y V T Y +
Sbjct: 115 VNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVA-TRWYRS 170
Query: 359 PE-------YASTGMLNERSDVYSFGILIMEVISGR 387
PE Y + DV++ G + E++SG
Sbjct: 171 PELLVGDTQY-GPPV-----DVWAIGCVFAELLSGV 200
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 3e-22
Identities = 50/220 (22%), Positives = 89/220 (40%), Gaps = 29/220 (13%)
Query: 185 TNGFADENVIGEGGYGIVYHGVL-EDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKN 243
+ F E + G+G +G V G +VA+K ++ + +E + ++ + + H N
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQ-IMQDLAVLHHPN 80
Query: 244 LVRLLGY-CAEGAHRM------LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTA 296
+V+L Y G +V EY+ + L + + +
Sbjct: 81 IVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLI 139
Query: 297 KGLTYLHEGLEPKVVHRDIKSSNILLDKQ-WNPKLSDFGLAKLLGAER---SYVTTRVMG 352
+ + LH V HRDIK N+L+++ KL DFG AK L +Y+ +R
Sbjct: 140 RSIGCLHLP-SVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRY-- 196
Query: 353 TFGYVAPEYASTGMLNERS-----DVYSFGILIMEVISGR 387
Y APE + + D++S G + E++ G
Sbjct: 197 ---YRAPEL----IFGNQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 93.0 bits (232), Expect = 3e-21
Identities = 60/212 (28%), Positives = 98/212 (46%), Gaps = 32/212 (15%)
Query: 192 NVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKE-FKV----EVEAIGRVRHKNLV 245
IGEG YG V+ E + VA+K + R + E E+ + ++HKN+V
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRV---RLDDDDEGVPSSALREICLLKELKHKNIV 64
Query: 246 RLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG 305
RL LV+E+ D +L+++ G P + + +L KGL + H
Sbjct: 65 RLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLL---KGLGFCHSR 120
Query: 306 LEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE-RSYVTTRVMGTFGYVAPE---- 360
V+HRD+K N+L+++ KL++FGLA+ G R Y + V+ T Y P+
Sbjct: 121 ---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY-SAEVV-TLWYRPPDVLFG 175
Query: 361 ---YASTGMLNERSDVYSFGILIMEVISGRNP 389
Y ST + D++S G + E+ + P
Sbjct: 176 AKLY-STSI-----DMWSAGCIFAELANAGRP 201
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 3e-21
Identities = 61/219 (27%), Positives = 101/219 (46%), Gaps = 46/219 (21%)
Query: 192 NVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVE------AIGR------- 238
+G G Y VY G N A KE K++ E AI R
Sbjct: 11 EKLGNGTYATVYKG----------LNKTTGVYVALKEVKLDSEEGTPSTAI-REISLMKE 59
Query: 239 VRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWL--HGDVGPHSPLTWEIRMNIILGTA 296
++H+N+VRL LV+E++DN +L++++ L +
Sbjct: 60 LKHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLL 118
Query: 297 KGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE-RSYVTTRVMGTFG 355
+GL + HE K++HRD+K N+L++K+ KL DFGLA+ G ++ ++ V+ T
Sbjct: 119 QGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTF-SSEVV-TLW 173
Query: 356 YVAPE-------YASTGMLNERSDVYSFGILIMEVISGR 387
Y AP+ Y ST + D++S G ++ E+I+G+
Sbjct: 174 YRAPDVLMGSRTY-STSI-----DIWSCGCILAEMITGK 206
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 3e-21
Identities = 50/182 (27%), Positives = 79/182 (43%), Gaps = 31/182 (17%)
Query: 192 NVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIG-------------R 238
++GEG YG+V +N R A K+F + +
Sbjct: 31 GLVGEGSYGMVMKC----------RNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQ 80
Query: 239 VRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKG 298
+RH+NLV LL C + LV+E++D+ + L ++ P+ L +++ + G
Sbjct: 81 LRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDL--ELFPN-GLDYQVVQKYLFQIING 136
Query: 299 LTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVA 358
+ + H ++HRDIK NIL+ + KL DFG A+ L A V T Y A
Sbjct: 137 IGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVA-TRWYRA 192
Query: 359 PE 360
PE
Sbjct: 193 PE 194
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 5e-21
Identities = 62/218 (28%), Positives = 100/218 (45%), Gaps = 40/218 (18%)
Query: 192 NVIGEGGYGIVYHGVLEDNTN--VAVKNLLNNRGQAEKEFKVEVEAI---------GRVR 240
IGEG YG V+ N VA+K + R Q +E + + I
Sbjct: 17 AEIGEGAYGKVFKARDLKNGGRFVALKRV---RVQTGEE-GMPLSTIREVAVLRHLETFE 72
Query: 241 HKNLVRLL----GYCAEGAHRM-LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGT 295
H N+VRL + ++ LV+E++D +L +L D P + E +++
Sbjct: 73 HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYL--DKVPEPGVPTETIKDMMFQL 129
Query: 296 AKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFG 355
+GL +LH +VVHRD+K NIL+ KL+DFGLA++ + + T+ V+ T
Sbjct: 130 LRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL-TSVVV-TLW 184
Query: 356 YVAPE------YASTGMLNERSDVYSFGILIMEVISGR 387
Y APE Y +T + D++S G + E+ +
Sbjct: 185 YRAPEVLLQSSY-ATPV-----DLWSVGCIFAEMFRRK 216
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 92.6 bits (231), Expect = 6e-21
Identities = 61/211 (28%), Positives = 105/211 (49%), Gaps = 35/211 (16%)
Query: 192 NVIGEGGYGIVYHGVLEDNTN--VAVKNLLNNRGQAEKE-FKV----EVEAIGRVRHKNL 244
+GEG YG+VY +D+ VA+K + R AE E E+ + + H N+
Sbjct: 27 EKVGEGTYGVVYKA--KDSQGRIVALKRI---RLDAEDEGIPSTAIREISLLKELHHPNI 81
Query: 245 VRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 304
V L+ LV+E+++ +L++ L + +I + +L +G+ + H+
Sbjct: 82 VSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLL---RGVAHCHQ 137
Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE-RSYVTTRVMGTFGYVAPE--- 360
+++HRD+K N+L++ KL+DFGLA+ G RSY T V+ T Y AP+
Sbjct: 138 H---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSY-THEVV-TLWYRAPDVLM 192
Query: 361 ----YASTGMLNERSDVYSFGILIMEVISGR 387
Y ST + D++S G + E+I+G+
Sbjct: 193 GSKKY-STSV-----DIWSIGCIFAEMITGK 217
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 91.8 bits (229), Expect = 6e-21
Identities = 60/211 (28%), Positives = 106/211 (50%), Gaps = 35/211 (16%)
Query: 192 NVIGEGGYGIVYHGVLEDNTN--VAVKNLLNNRGQAEKE-FKV----EVEAIGRVRHKNL 244
IGEG YG+VY ++N A+K + R + E E E+ + ++H N+
Sbjct: 8 EKIGEGTYGVVYKA--QNNYGETFALKKI---RLEKEDEGIPSTTIREISILKELKHSNI 62
Query: 245 VRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 304
V+L +LV+E++D +L++ L G +T + + +L G+ Y H+
Sbjct: 63 VKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLL---NGIAYCHD 118
Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE-RSYVTTRVMGTFGYVAPE--- 360
+V+HRD+K N+L++++ K++DFGLA+ G R Y T ++ T Y AP+
Sbjct: 119 R---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY-THEIV-TLWYRAPDVLM 173
Query: 361 ----YASTGMLNERSDVYSFGILIMEVISGR 387
Y ST + D++S G + E+++G
Sbjct: 174 GSKKY-STTI-----DIWSVGCIFAEMVNGT 198
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 6e-21
Identities = 58/214 (27%), Positives = 89/214 (41%), Gaps = 26/214 (12%)
Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVK----NLLNNRGQAEKEFKVEVEAIGRVRHKNLVRL 247
++GEG YG V + E AVK L E K E++ + R+RHKN+++L
Sbjct: 12 LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71
Query: 248 LG--YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLT-WEIR---MNIILGTAKGLTY 301
+ Y E +V EY G E D P + +I GL Y
Sbjct: 72 VDVLYNEEKQKMYMVMEYCVCGMQEML---DSVPEKRFPVCQAHGYFCQLID----GLEY 124
Query: 302 LHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER--SYVTTRVMGTFGYVAP 359
LH +VH+DIK N+LL K+S G+A+ L T G+ + P
Sbjct: 125 LH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRT-SQGSPAFQPP 180
Query: 360 EYASTGMLNE--RSDVYSFGILIMEVISGRNPVD 391
E A+ + D++S G+ + + +G P +
Sbjct: 181 EIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFE 214
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 7e-21
Identities = 52/205 (25%), Positives = 87/205 (42%), Gaps = 16/205 (7%)
Query: 191 ENVIGEGGYGIVYHGV-LEDNTNVAVK--NLLNNRGQAEKEFKVEVEAIGRVRHKNLVRL 247
+G G YG V + A+K + + + EV + + H N+++L
Sbjct: 42 VKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKL 101
Query: 248 LGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLE 307
+ + + LV E G L + II G+TYLH+
Sbjct: 102 YDFFEDKRNYYLVMECYKGGELFDEIIH----RMKFNEVDAAVIIKQVLSGVTYLHKH-- 155
Query: 308 PKVVHRDIKSSNILL---DKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAST 364
+VHRD+K N+LL +K K+ DFGL+ + E +GT Y+APE
Sbjct: 156 -NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVF--ENQKKMKERLGTAYYIAPE-VLR 211
Query: 365 GMLNERSDVYSFGILIMEVISGRNP 389
+E+ DV+S G+++ +++G P
Sbjct: 212 KKYDEKCDVWSIGVILFILLAGYPP 236
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 8e-21
Identities = 60/219 (27%), Positives = 93/219 (42%), Gaps = 40/219 (18%)
Query: 192 NVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKVEV-----------EAIGRV 239
IG G YG VY VA+K++ R + +
Sbjct: 15 AEIGVGAYGTVYKARDPHSGHFVALKSV---RVPNGGGGGGGLPISTVREVALLRRLEAF 71
Query: 240 RHKNLVRLLGYCAEGAHR-----MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILG 294
H N+VRL+ CA LV+E++D +L +L D P L E +++
Sbjct: 72 EHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYL--DKAPPPGLPAETIKDLMRQ 128
Query: 295 TAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTF 354
+GL +LH +VHRD+K NIL+ KL+DFGLA++ + + T V+ T
Sbjct: 129 FLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMAL-TPVVV-TL 183
Query: 355 GYVAPE------YASTGMLNERSDVYSFGILIMEVISGR 387
Y APE Y +T + D++S G + E+ +
Sbjct: 184 WYRAPEVLLQSTY-ATPV-----DMWSVGCIFAEMFRRK 216
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 2e-20
Identities = 61/210 (29%), Positives = 106/210 (50%), Gaps = 29/210 (13%)
Query: 192 NVIGEGGYGIVYHGV-LEDNTNVAVKNL-LNNRGQAEKEFKV----EVEAIGRVRHKNLV 245
+ +GEG + VY N VA+K + L +R +A+ E++ + + H N++
Sbjct: 16 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 75
Query: 246 RLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG 305
LL ++ LV+++++ +LE + LT +L T +GL YLH+
Sbjct: 76 GLLDAFGHKSNISLVFDFMET-DLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQH 131
Query: 306 LEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE-RSYVTTRVMGTFGYVAPE---- 360
++HRD+K +N+LLD+ KL+DFGLAK G+ R+Y T +V+ T Y APE
Sbjct: 132 ---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY-THQVV-TRWYRAPELLFG 186
Query: 361 ---YASTGMLNERSDVYSFGILIMEVISGR 387
Y G+ D+++ G ++ E++
Sbjct: 187 ARMY-GVGV-----DMWAVGCILAELLLRV 210
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 93.4 bits (232), Expect = 2e-20
Identities = 64/285 (22%), Positives = 115/285 (40%), Gaps = 26/285 (9%)
Query: 110 DPLPEPEPILV-EDSPASGRNRIHIEIGKDHRIAYPERAAGSHHGSGDQTVAAAITPEVS 168
P P+L+ D R E GK R + ++ E+
Sbjct: 92 KPCEPTAPVLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIK 151
Query: 169 HLGWGHWYTLRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTN--VAVKNLLNNRGQAE 226
H Y + E +G G +G+V+ E T A K ++ +
Sbjct: 152 HDHVLDHYDIHE------------ELGTGAFGVVHRVT-ERATGNNFAAKFVMTPHESDK 198
Query: 227 KEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWE 286
+ + E++ + +RH LV L + +++YE++ G L + + H+ ++ +
Sbjct: 199 ETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKV---ADEHNKMSED 255
Query: 287 IRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNP--KLSDFGLAKLLGAERS 344
+ + KGL ++HE VH D+K NI+ + + KL DFGL L ++S
Sbjct: 256 EAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS 312
Query: 345 YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNP 389
GT + APE A + +D++S G+L ++SG +P
Sbjct: 313 VKV--TTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP 355
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 2e-20
Identities = 56/207 (27%), Positives = 94/207 (45%), Gaps = 19/207 (9%)
Query: 191 ENVIGEGGYGIVYHGV-LEDNTNVAVK----NLLNNRGQAEKEFKVEVEAIGRVRHKNLV 245
+ V+G+G +G V AVK + + E EV+ + ++ H N++
Sbjct: 31 QRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKES-LLREVQLLKQLDHPNIM 89
Query: 246 RLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG 305
+L + + + LV E G L + + II G+TY+H+
Sbjct: 90 KLYEFFEDKGYFYLVGEVYTGGELFDEIIS----RKRFSEVDAARIIRQVLSGITYMHKN 145
Query: 306 LEPKVVHRDIKSSNILL---DKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYA 362
K+VHRD+K N+LL K N ++ DFGL+ A + +GT Y+APE
Sbjct: 146 ---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKD--KIGTAYYIAPE-V 199
Query: 363 STGMLNERSDVYSFGILIMEVISGRNP 389
G +E+ DV+S G+++ ++SG P
Sbjct: 200 LHGTYDEKCDVWSTGVILYILLSGCPP 226
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 3e-20
Identities = 55/216 (25%), Positives = 91/216 (42%), Gaps = 27/216 (12%)
Query: 191 ENVIGEGGYGIVYHGV-LEDNTNVAVK-------------NLLNNRGQAEKEFKVEVEAI 236
+G G YG V ++ A+K + N + +E E+ +
Sbjct: 41 VRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLL 100
Query: 237 GRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTA 296
+ H N+++L + + LV E+ + G L + + NI+
Sbjct: 101 KSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIIN----RHKFDECDAANIMKQIL 156
Query: 297 KGLTYLHEGLEPKVVHRDIKSSNILL---DKQWNPKLSDFGLAKLLGAERSYVTTRVMGT 353
G+ YLH+ +VHRDIK NILL + N K+ DFGL+ + Y +GT
Sbjct: 157 SGICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFF--SKDYKLRDRLGT 211
Query: 354 FGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNP 389
Y+APE NE+ DV+S G+++ ++ G P
Sbjct: 212 AYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGYPP 246
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 9e-20
Identities = 47/196 (23%), Positives = 85/196 (43%), Gaps = 13/196 (6%)
Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVK-----NLLNNRGQAEKEFKVEVEAIGRVRHKNLVR 246
VIG+G + +V + E AVK ++ G + ++ K E ++H ++V
Sbjct: 31 VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 247 LLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGL 306
LL + +V+E++D +L + + + + + + L Y H+
Sbjct: 91 LLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN- 149
Query: 307 EPKVVHRDIKSSNILLDKQWNP---KLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAS 363
++HRD+K +LL + N KL FG+A LG RV GT ++APE
Sbjct: 150 --NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV-GTPHFMAPEVVK 206
Query: 364 TGMLNERSDVYSFGIL 379
+ DV+ G++
Sbjct: 207 REPYGKPVDVWGCGVI 222
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 1e-19
Identities = 54/256 (21%), Positives = 98/256 (38%), Gaps = 20/256 (7%)
Query: 146 RAAGSHHGSGDQTVAAAITPEVSHLGWGHW-----YTLRELEVSTNGFAD----ENVIGE 196
R + HH G + P+++ + Y + +EV D +G
Sbjct: 2 RGSHHHHHHGSKVRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGS 61
Query: 197 GGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGA 255
G +G+V+ V K + + K E+ + ++ H L+ L +
Sbjct: 62 GAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKY 121
Query: 256 HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDI 315
+L+ E++ G L + + S M GL ++HE +VH DI
Sbjct: 122 EMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACE---GLKHMHEH---SIVHLDI 175
Query: 316 KSSNILLDKQWNP--KLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDV 373
K NI+ + + K+ DFGLA L + T + APE + +D+
Sbjct: 176 KPENIMCETKKASSVKIIDFGLATKLNPDEIVKV--TTATAEFAAPEIVDREPVGFYTDM 233
Query: 374 YSFGILIMEVISGRNP 389
++ G+L ++SG +P
Sbjct: 234 WAIGVLGYVLLSGLSP 249
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 1e-19
Identities = 49/222 (22%), Positives = 90/222 (40%), Gaps = 52/222 (23%)
Query: 192 NVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIG-------------R 238
+GEG YG VY + + N A K ++E E G
Sbjct: 40 TKLGEGTYGEVYKA----------IDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKE 89
Query: 239 VRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKG 298
++H+N++ L L++EY +N +L++++ + ++ + + + G
Sbjct: 90 LQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMD----KNPDVSMRVIKSFLYQLING 144
Query: 299 LTYLHEGLEPKVVHRDIKSSNILLDKQWNP-----KLSDFGLAKLLGAE-RSYVTTRVMG 352
+ + H + +HRD+K N+LL K+ DFGLA+ G R + T ++
Sbjct: 145 VNFCHS---RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQF-THEII- 199
Query: 353 TFGYVAPE-------YASTGMLNERSDVYSFGILIMEVISGR 387
T Y PE Y ST + D++S + E++
Sbjct: 200 TLWYRPPEILLGSRHY-STSV-----DIWSIACIWAEMLMKT 235
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 87.6 bits (218), Expect = 1e-19
Identities = 62/221 (28%), Positives = 93/221 (42%), Gaps = 49/221 (22%)
Query: 194 IGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKV--EVEAIGRVRHKNLVRLLGY 250
+GEG YG V V VAVK +++ + + + E+ + H+N+V+ G+
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 251 CAEGAHRMLVYEYIDNGNLEQWL--HGDVGPHSPLTWEIRMN----------IILGTAKG 298
EG + L EY G L + M ++ G
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRIEPDI------------GMPEPDAQRFFHQLMAGVV-- 119
Query: 299 LTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL--LGAERSYVTTRVMGTFGY 356
YLH + HRDIK N+LLD++ N K+SDFGLA + + GT Y
Sbjct: 120 --YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPY 173
Query: 357 VAPEYASTGMLNER------SDVYSFGILIMEVISGRNPVD 391
VAPE +L R DV+S GI++ +++G P D
Sbjct: 174 VAPE-----LLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 1e-19
Identities = 63/274 (22%), Positives = 111/274 (40%), Gaps = 57/274 (20%)
Query: 147 AAGSHHGSGDQTVAAAITPEVSHLGWGHWYTLRELEVSTNGFADENVIGEGGYGIVYHGV 206
HH SG + + P + L +E E + + ++G GG+G VY G+
Sbjct: 5 HHHHHHSSGLVPRGSHMAPC-NDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGI 63
Query: 207 -LEDNTNVAVK----NLLNNRGQAEKEFKV--EVEAIGRVRHK--NLVRLLGYCAEGAHR 257
+ DN VA+K + +++ G+ +V EV + +V ++RLL +
Sbjct: 64 RVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSF 123
Query: 258 MLVYEYIDN-GNLEQWL--HGDVGPHSPLTWEIRMN----------IILGTAKGLTYLHE 304
+L+ E + +L ++ G + ++ + + + H
Sbjct: 124 VLILERPEPVQDLFDFITERG------------ALQEELARSFFWQVL----EAVRHCHN 167
Query: 305 GLEPKVVHRDIKSSNILLD-KQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAS 363
V+HRDIK NIL+D + KL DFG LL + + T GT Y PE
Sbjct: 168 C---GVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDFD-GTRVYSPPE--- 218
Query: 364 TGMLNER------SDVYSFGILIMEVISGRNPVD 391
+ + V+S GIL+ +++ G P +
Sbjct: 219 --WIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 250
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 90.6 bits (225), Expect = 2e-19
Identities = 61/231 (26%), Positives = 102/231 (44%), Gaps = 32/231 (13%)
Query: 175 WYTLRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNV--AVKNLLNNRGQAEKEF--- 229
W L + + F D V+G GG+G V+ T A K L R + K +
Sbjct: 174 WKWLEAQPMGEDWFLDFRVLGRGGFGEVF-ACQMKATGKLYACKKLNKKRLKKRKGYQGA 232
Query: 230 KVEVEAIGRVRHKNLVRLLGYCAEGAHRM-LVYEYIDNGNLEQWLHGDVGPHSPLTWEIR 288
VE + + +V + +V L Y E + LV ++ G++ ++ + E R
Sbjct: 233 MVEKKILAKVHSRFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQ-EPR 290
Query: 289 MN-----IILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER 343
I+ G L +LH+ +++RD+K N+LLD N ++SD GLA L A +
Sbjct: 291 AIFYTAQIVSG----LEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ 343
Query: 344 SYVTTRVMGTFGYVAPEYASTGMLNERS-----DVYSFGILIMEVISGRNP 389
+ GT G++APE +L D ++ G+ + E+I+ R P
Sbjct: 344 TKTKGYA-GTPGFMAPE-----LLLGEEYDFSVDYFALGVTLYEMIAARGP 388
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 2e-19
Identities = 35/265 (13%), Positives = 70/265 (26%), Gaps = 57/265 (21%)
Query: 193 VIGEGGYGIVYHGVLEDNT---NVAVKNLLNNRGQAE---KEFKVEVEAIGRVRHKNLVR 246
G + + D VA+ + + +E + R+ + R
Sbjct: 38 FHGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 247 LLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE-G 305
+L A ++V E+I G+L++ P + + A H G
Sbjct: 96 VLDVVHTRAGGLVVAEWIRGGSLQEVADTSPSPVG------AIRAMQSLAAAADAAHRAG 149
Query: 306 LEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTG 365
V S + +S G L +
Sbjct: 150 ----VALSIDHPSRVR--------VSIDGDVVL-------------AYPATMPDA----- 179
Query: 366 MLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEK 425
N + D+ G + ++ R P+ + + A ++P ++
Sbjct: 180 --NPQDDIRGIGASLYALLVNRWPLPEAGVRSGL-------APAERDTAGQPIEPADIDR 230
Query: 426 PCSRALKRALLVALRCVDPNAHKRP 450
+ VA R V + R
Sbjct: 231 DIPFQISA---VAARSVQGDGGIRS 252
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 4e-19
Identities = 59/224 (26%), Positives = 86/224 (38%), Gaps = 46/224 (20%)
Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVK----NLLNNRGQAEKEFKV--EVEAIGRVR----H 241
++G+GG+G V+ G L D VA+K N + EV + +V H
Sbjct: 38 LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97
Query: 242 KNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGD----VGPHSPLT--------WEIRM 289
++RLL + MLV E D + PL ++
Sbjct: 98 PGVIRLLDWFETQEGFMLVLERPLPA-------QDLFDYITEKGPLGEGPSRCFFGQV-- 148
Query: 290 NIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNP-KLSDFGLAKLLGAERSYVTT 348
+ + H VVHRDIK NIL+D + KL DFG LL T
Sbjct: 149 ------VAAIQHCHSR---GVVHRDIKDENILIDLRRGCAKLIDFGSGALL--HDEPYTD 197
Query: 349 RVMGTFGYVAPEYASTGM-LNERSDVYSFGILIMEVISGRNPVD 391
GT Y PE+ S + V+S GIL+ +++ G P +
Sbjct: 198 FD-GTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFE 240
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 4e-19
Identities = 61/217 (28%), Positives = 98/217 (45%), Gaps = 47/217 (21%)
Query: 192 NVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVE------AIGR------- 238
+ +GEG Y VY G K+ L + A KE ++E E AI R
Sbjct: 8 DKLGEGTYATVYKG----------KSKLTDNLVALKEIRLEHEEGAPCTAI-REVSLLKD 56
Query: 239 VRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKG 298
++H N+V L LV+EY+D +L+Q+L + + + +G
Sbjct: 57 LKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDD---CGNIINMHNVKLFLFQLLRG 112
Query: 299 LTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE-RSYVTTRVMGTFGYV 357
L Y H KV+HRD+K N+L++++ KL+DFGLA+ ++Y V+ T Y
Sbjct: 113 LAYCHR---QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY-DNEVV-TLWYR 167
Query: 358 APE-------YASTGMLNERSDVYSFGILIMEVISGR 387
P+ Y ST + D++ G + E+ +GR
Sbjct: 168 PPDILLGSTDY-STQI-----DMWGVGCIFYEMATGR 198
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 87.9 bits (218), Expect = 4e-19
Identities = 54/256 (21%), Positives = 97/256 (37%), Gaps = 67/256 (26%)
Query: 181 LEVSTNGFADENVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKV-EVEAIGR 238
LE S+ ++ +G G +GIV +E A+K +L + +K E++ +
Sbjct: 2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQ-----DPRYKNRELDIMKV 56
Query: 239 VRHKNLVRLLGYCAEGAHRM--------------------------------------LV 260
+ H N+++L+ Y ++
Sbjct: 57 LDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVI 116
Query: 261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNI 320
EY+ + L + L + + + I + + ++H + HRDIK N+
Sbjct: 117 MEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL---GICHRDIKPQNL 172
Query: 321 LLDKQWNP-KLSDFGLAKLLGAER---SYVTTRVMGTFGYVAPEYASTGMLNERS----- 371
L++ + N KL DFG AK L +Y+ +R Y APE ML
Sbjct: 173 LVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRF-----YRAPEL----MLGATEYTPSI 223
Query: 372 DVYSFGILIMEVISGR 387
D++S G + E+I G+
Sbjct: 224 DLWSIGCVFGELILGK 239
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 6e-19
Identities = 54/210 (25%), Positives = 94/210 (44%), Gaps = 26/210 (12%)
Query: 191 ENVIGEGGYGIVYHGV-LEDNTNVAVK--NLLNNRGQAEKEFKVEVEAIGRVRHKNLVRL 247
++G+G +G V AVK N + + + EVE + ++ H N+++L
Sbjct: 27 VCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKL 86
Query: 248 LGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLE 307
+ + +V E G L + + II G+TY+H+
Sbjct: 87 FEILEDSSSFYIVGELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHKH-- 140
Query: 308 PKVVHRDIKSSNILL---DKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPE---- 360
+VHRD+K NILL +K + K+ DFGL+ +++ +GT Y+APE
Sbjct: 141 -NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF--QQNTKMKDRIGTAYYIAPEVLRG 197
Query: 361 -YASTGMLNERSDVYSFGILIMEVISGRNP 389
Y +E+ DV+S G+++ ++SG P
Sbjct: 198 TY------DEKCDVWSAGVILYILLSGTPP 221
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 7e-19
Identities = 63/222 (28%), Positives = 93/222 (41%), Gaps = 51/222 (22%)
Query: 194 IGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEK-EFKV--EVEAIGRVRHKNLVRLLG 249
+GEG YG V V VAVK + + +A + E+ + H+N+V+ G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIV--DMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWL--HGDVGPHSPLTWEIRMN----------IILGTAK 297
+ EG + L EY G L + M ++ G
Sbjct: 73 HRREGNIQYLFLEYCSGGELFDRIEPDI------------GMPEPDAQRFFHQLMAG--- 117
Query: 298 GLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL--LGAERSYVTTRVMGTFG 355
+ YLH + HRDIK N+LLD++ N K+SDFGLA + + GT
Sbjct: 118 -VVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLP 172
Query: 356 YVAPEYASTGMLNER------SDVYSFGILIMEVISGRNPVD 391
YVAPE +L R DV+S GI++ +++G P D
Sbjct: 173 YVAPE-----LLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 7e-19
Identities = 56/194 (28%), Positives = 86/194 (44%), Gaps = 26/194 (13%)
Query: 179 RELEVSTNGFADE----NVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKVEV 233
++L ++ F D IG G Y + + N AVK + ++ ++ E+
Sbjct: 11 QQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK----RDPTEEI 66
Query: 234 EAIGR-VRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRM--N 290
E + R +H N++ L +G + +V E + G L + S E R
Sbjct: 67 EILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKIL-RQKFFS----E-REASA 120
Query: 291 IILGTAKGLTYLHEGLEPKVVHRDIKSSNILL-DKQWNP---KLSDFGLAKLLGAERSYV 346
++ K + YLH VVHRD+K SNIL D+ NP ++ DFG AK L AE +
Sbjct: 121 VLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLL 177
Query: 347 TTRVMGTFGYVAPE 360
T T +VAPE
Sbjct: 178 MTPC-YTANFVAPE 190
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 1e-18
Identities = 45/201 (22%), Positives = 83/201 (41%), Gaps = 32/201 (15%)
Query: 191 ENVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLG 249
V+G G + V+ A+K + + + + E+ + +++H+N+V L
Sbjct: 14 MEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLED 73
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRM---------NIILGTAKGLT 300
H LV + + G L + + +I +
Sbjct: 74 IYESTTHYYLVMQLVSGGELFDRI-------------LERGVYTEKDASLVIQQVLSAVK 120
Query: 301 YLHEGLEPKVVHRDIKSSNILL---DKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYV 357
YLHE +VHRD+K N+L ++ ++DFGL+K+ + ++T GT GYV
Sbjct: 121 YLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKME--QNGIMSTAC-GTPGYV 174
Query: 358 APEYASTGMLNERSDVYSFGI 378
APE + ++ D +S G+
Sbjct: 175 APEVLAQKPYSKAVDCWSIGV 195
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 1e-18
Identities = 50/188 (26%), Positives = 86/188 (45%), Gaps = 31/188 (16%)
Query: 192 NVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKE-FKV----EVEAIGRVRHKNLV 245
IG+G +G V+ + VA+K + + EKE F + E++ + ++H+N+V
Sbjct: 23 AKIGQGTFGEVFKARHRKTGQKVALKKV---LMENEKEGFPITALREIKILQLLKHENVV 79
Query: 246 RLLGYCAEGAHRM--------LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAK 297
L+ C A LV+++ ++ +L L T ++
Sbjct: 80 NLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSN---VLVKFTLSEIKRVMQMLLN 135
Query: 298 GLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG-----AERSYVTTRVMG 352
GL Y+H K++HRD+K++N+L+ + KL+DFGLA+ Y T RV+
Sbjct: 136 GLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY-TNRVV- 190
Query: 353 TFGYVAPE 360
T Y PE
Sbjct: 191 TLWYRPPE 198
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 1e-18
Identities = 45/191 (23%), Positives = 80/191 (41%), Gaps = 11/191 (5%)
Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKE-FKVEVEAIGRVRHKNLVRLLGY 250
+G G +G V+ +K + +R Q E + E+E + + H N++++
Sbjct: 29 KLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEV 88
Query: 251 CAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKV 310
+ + +V E + G L + + L+ ++ L Y H V
Sbjct: 89 FEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HV 145
Query: 311 VHRDIKSSNILL---DKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGML 367
VH+D+K NIL K+ DFGLA+L ++ T GT Y+APE +
Sbjct: 146 VHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS-TNAA-GTALYMAPEVFK-RDV 202
Query: 368 NERSDVYSFGI 378
+ D++S G+
Sbjct: 203 TFKCDIWSAGV 213
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 2e-18
Identities = 45/181 (24%), Positives = 77/181 (42%), Gaps = 24/181 (13%)
Query: 193 VIGEGGYGIVYHGVLEDNTN--VAVK----NLLNNRGQAEKE----FKVEVEAIGRVRHK 242
+G G G V E T VA++ E + + E+E + ++ H
Sbjct: 142 TLGSGACGEVKLAF-ERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHP 200
Query: 243 NLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYL 302
++++ + + +V E ++ G L V + L + YL
Sbjct: 201 CIIKIKNFFDAEDY-YIVLELMEGGELFDK----VVGNKRLKEATCKLYFYQMLLAVQYL 255
Query: 303 HEGLEPKVVHRDIKSSNILL---DKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAP 359
HE ++HRD+K N+LL ++ K++DFG +K+LG E S + T GT Y+AP
Sbjct: 256 HEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG-ETSLMRTLC-GTPTYLAP 310
Query: 360 E 360
E
Sbjct: 311 E 311
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 2e-18
Identities = 41/200 (20%), Positives = 88/200 (44%), Gaps = 12/200 (6%)
Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYC 251
+G G +GIV+ V K + +G + K E+ + RH+N++ L
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAK-FVKVKGTDQVLVKKEISILNIARHRNILHLHESF 70
Query: 252 AEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVV 311
++++E+I ++ + ++ + ++ + + L +LH +
Sbjct: 71 ESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVC---EALQFLHSH---NIG 124
Query: 312 HRDIKSSNILLDKQWNP--KLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNE 369
H DI+ NI+ + + K+ +FG A+ L ++ + Y APE +++
Sbjct: 125 HFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL--LFTAPEYYAPEVHQHDVVST 182
Query: 370 RSDVYSFGILIMEVISGRNP 389
+D++S G L+ ++SG NP
Sbjct: 183 ATDMWSLGTLVYVLLSGINP 202
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 2e-18
Identities = 57/241 (23%), Positives = 97/241 (40%), Gaps = 63/241 (26%)
Query: 194 IGEGGYGIVYHGV-LEDNTNVAVK------------------------NLLNNRGQAEKE 228
IG+G YG+V DNT A+K
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 229 FKVEVE-AIGR-VRHKNLVRLLGY----CAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSP 282
+V E AI + + H N+V+L H +V+E ++ G + +V P
Sbjct: 81 EQVYQEIAILKKLDHPNVVKL--VEVLDDPNEDHLYMVFELVNQGPVM-----EVPTLKP 133
Query: 283 LT----WEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL 338
L+ ++I G + YLH K++HRDIK SN+L+ + + K++DFG++
Sbjct: 134 LSEDQARFYFQDLIKG----IEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNE 186
Query: 339 LGAERSYVTTRVMGTFGYVAPEYASTGMLNER--------SDVYSFGILIMEVISGRNPV 390
+ ++ V GT ++APE L+E DV++ G+ + + G+ P
Sbjct: 187 FKGSDALLSNTV-GTPAFMAPE-----SLSETRKIFSGKALDVWAMGVTLYCFVFGQCPF 240
Query: 391 D 391
Sbjct: 241 M 241
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 86.0 bits (213), Expect = 3e-18
Identities = 43/190 (22%), Positives = 79/190 (41%), Gaps = 36/190 (18%)
Query: 194 IGEGGYGIVYHGVLEDNTN---VAVKNLLNNRGQAEKEFKVEVEAIGRV------RHKNL 244
+G G YG VY +D + A+K + + + + A + +H N+
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQI--------EGTGISMSACREIALLRELKHPNV 80
Query: 245 VRLLGYCAEGAHR--MLVYEYIDNGNLEQWLH-----GDVGPHSPLTWEIRMNIILGTAK 297
+ L A R L+++Y ++ +L + L + +++
Sbjct: 81 ISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILD 139
Query: 298 GLTYLHEGLEPKVVHRDIKSSNILLDKQWNP----KLSDFGLAKLLGAE-RSY--VTTRV 350
G+ YLH V+HRD+K +NIL+ + K++D G A+L + + + V
Sbjct: 140 GIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV 196
Query: 351 MGTFGYVAPE 360
+ TF Y APE
Sbjct: 197 V-TFWYRAPE 205
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 5e-18
Identities = 62/317 (19%), Positives = 101/317 (31%), Gaps = 75/317 (23%)
Query: 68 SNYNSSSGNPTIP-NISKEIQEIRIDPDSNSNSNCKPHSAPNPDPLPEPEPILVEDSPAS 126
+++SS + + +EIR P+ N + DP +
Sbjct: 4 HHHHSSGVDNKFNKERRRARREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLND 63
Query: 127 GRNRIHIEIGKDHRIAYPERAAGSHHGSGDQTVAAAITPEVSHLGWGHWYTLRELEVSTN 186
+ + E G D+ A E Y ++
Sbjct: 64 AQPKG------------TENLYFQSMGPEDELPDWAAAKEFYQK-----YDPKD------ 100
Query: 187 GFADENVIGEGGYGIVYHGV-LEDNTNVAVK--------NLLNNRGQAEKEFKVEVEAIG 237
VIG G +V V AVK + + + E +
Sbjct: 101 ------VIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILR 154
Query: 238 RVR-HKNLVRLLGYCAEGAHRMLVYEYIDNGNL-----------EQWLHGDVGPHSPLTW 285
+V H +++ L+ + LV++ + G L E+
Sbjct: 155 QVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEK-------------- 200
Query: 286 EIR--MNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER 343
E R M +L + +++LH +VHRD+K NILLD +LSDFG + L
Sbjct: 201 ETRSIMRSLL---EAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGE 254
Query: 344 SYVTTRVMGTFGYVAPE 360
GT GY+APE
Sbjct: 255 KL-RELC-GTPGYLAPE 269
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 86.0 bits (213), Expect = 6e-18
Identities = 65/230 (28%), Positives = 103/230 (44%), Gaps = 33/230 (14%)
Query: 175 WYTLRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNV-AVKNLLNNRGQAEKEF---K 230
W L V+ N F V+G+GG+G V + + A K L R + K
Sbjct: 173 WKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMAL 232
Query: 231 VEVEAIGRVRHKNLVRLLGYCAEGAHRM-LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRM 289
E + + +V + +V L Y E + LV ++ G+L+ ++ P E R
Sbjct: 233 NEKQILEKVNSRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFP---EARA 288
Query: 290 -----NIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS 344
I G L LH ++V+RD+K NILLD + ++SD GLA + E
Sbjct: 289 VFYAAEICCG----LEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVP-EGQ 340
Query: 345 YVTTRVMGTFGYVAPEYASTGMLNERS-----DVYSFGILIMEVISGRNP 389
+ RV GT GY+APE ++ D ++ G L+ E+I+G++P
Sbjct: 341 TIKGRV-GTVGYMAPE-----VVKNERYTFSPDWWALGCLLYEMIAGQSP 384
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 6e-18
Identities = 51/198 (25%), Positives = 80/198 (40%), Gaps = 20/198 (10%)
Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVK-----NLLNNRGQAEKE-FKVEVEAIGRVRHKNLV 245
+G G + IV A K +R +E + EV + +V H N++
Sbjct: 19 ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78
Query: 246 RLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG 305
L +L+ E + G L +L S + IL G+ YLH
Sbjct: 79 TLHDVYENRTDVVLILELVSGGELFDFLA-QKESLSEEEATSFIKQILD---GVNYLHTK 134
Query: 306 LEPKVVHRDIKSSNILLDKQWNP----KLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEY 361
K+ H D+K NI+L + P KL DFGLA + + + GT +VAPE
Sbjct: 135 ---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN--IFGTPEFVAPEI 189
Query: 362 ASTGMLNERSDVYSFGIL 379
+ L +D++S G++
Sbjct: 190 VNYEPLGLEADMWSIGVI 207
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 7e-18
Identities = 52/224 (23%), Positives = 84/224 (37%), Gaps = 40/224 (17%)
Query: 188 FADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKE--FKVEVEA---------I 236
+ + I G YG V GV + VA+K + N +
Sbjct: 24 YTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLL 83
Query: 237 GRVRHKNLVRLLG-YCAEGAHRM----LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNI 291
H N++ L + M LV E + +L Q +H ++ +
Sbjct: 84 NHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHD---QRIVISPQHIQYF 139
Query: 292 ILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS---YVTT 348
+ GL LHE VVHRD+ NILL + + DF LA+ A+ + YVT
Sbjct: 140 MYHILLGLHVLHEA---GVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTH 196
Query: 349 RVMGTFGYVAPEYASTGMLNERS-----DVYSFGILIMEVISGR 387
R Y APE ++ + D++S G ++ E+ + +
Sbjct: 197 RW-----YRAPEL----VMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 85.7 bits (212), Expect = 7e-18
Identities = 58/225 (25%), Positives = 103/225 (45%), Gaps = 30/225 (13%)
Query: 179 RELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNV-AVKNLLNNRGQAEKEF---KVE-- 232
+ ++ N F+ +IG GG+G VY D + A+K L R + ++ E
Sbjct: 182 LNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERI 241
Query: 233 -VEAIGRVRHKNLVRLLGYCAEGAHRM-LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMN 290
+ + +V + Y ++ + + ++ G+L L + E M
Sbjct: 242 MLSLVSTGDCPFIVCM-SYAFHTPDKLSFILDLMNGGDLHYHLS-----QHGVFSEADMR 295
Query: 291 -----IILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSY 345
IILG L ++H VV+RD+K +NILLD+ + ++SD GLA ++ +
Sbjct: 296 FYAAEIILG----LEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH 348
Query: 346 VTTRVMGTFGYVAPEYASTGMLNERS-DVYSFGILIMEVISGRNP 389
V GT GY+APE G+ + S D +S G ++ +++ G +P
Sbjct: 349 --ASV-GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 9e-18
Identities = 50/199 (25%), Positives = 83/199 (41%), Gaps = 20/199 (10%)
Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVK-----NLLNNRGQAEKE-FKVEVEAIGRVRHKNLV 245
+G G + IV A K L ++R +E + EV + +RH N++
Sbjct: 12 ELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNII 71
Query: 246 RLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG 305
L +L+ E + G L +L + + IL G+ YLH
Sbjct: 72 TLHDIFENKTDVVLILELVSGGELFDFLAEK-ESLTEDEATQFLKQILD---GVHYLHSK 127
Query: 306 LEPKVVHRDIKSSNILLDKQWNP----KLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEY 361
++ H D+K NI+L + P KL DFG+A + A + + GT +VAPE
Sbjct: 128 ---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN--IFGTPEFVAPEI 182
Query: 362 ASTGMLNERSDVYSFGILI 380
+ L +D++S G++
Sbjct: 183 VNYEPLGLEADMWSIGVIT 201
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 1e-17
Identities = 53/219 (24%), Positives = 87/219 (39%), Gaps = 47/219 (21%)
Query: 194 IGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKV--EVEAIGRVRHKNLVRLLGY 250
IG+G + V + VA+K + + K+ EV + + H N+V+L
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 251 CAEGAHRMLVYEYIDNGNLEQWL--HGDVGPHSPLTWEIRMN----------IILGTAKG 298
L+ EY G + +L HG RM I+
Sbjct: 83 IETEKTLYLIMEYASGGEVFDYLVAHG------------RMKEKEARSKFRQIVSA---- 126
Query: 299 LTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVA 358
+ Y H+ ++VHRD+K+ N+LLD N K++DFG + + G Y A
Sbjct: 127 VQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEF-TVGGKLDAFC-GAPPYAA 181
Query: 359 PEYASTGMLNER------SDVYSFGILIMEVISGRNPVD 391
PE + + DV+S G+++ ++SG P D
Sbjct: 182 PE-----LFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 215
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 1e-17
Identities = 49/195 (25%), Positives = 70/195 (35%), Gaps = 24/195 (12%)
Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYC 251
IG G +G V V A K + + FK E+E + + H N++RL
Sbjct: 16 TIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETF 75
Query: 252 AEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVV 311
+ LV E G L + + I+ + Y H+ V
Sbjct: 76 EDNTDIYLVMELCTGGELFERVVH----KRVFRESDAARIMKDVLSAVAYCHKL---NVA 128
Query: 312 HRDIKSSNILL---DKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPE-----YAS 363
HRD+K N L KL DFGLA + T+V GT YV+P+ Y
Sbjct: 129 HRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM-RTKV-GTPYYVSPQVLEGLY-- 184
Query: 364 TGMLNERSDVYSFGI 378
D +S G+
Sbjct: 185 ----GPECDEWSAGV 195
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 1e-17
Identities = 50/193 (25%), Positives = 78/193 (40%), Gaps = 26/193 (13%)
Query: 184 STNGFADE----NVIGEGGYGIVYHGVLEDNTN--VAVK-------NLLNNRGQAEKEFK 230
ST+GF + ++G G +V + T AVK + E
Sbjct: 11 STHGFYENYEPKEILGRGVSSVVRRCI-HKPTCKEYAVKIIDVTGGGSFSAEEVQELREA 69
Query: 231 V--EVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEI 287
EV+ + +V H N+++L LV++ + G L +L L+ +
Sbjct: 70 TLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE----KVTLSEKE 125
Query: 288 RMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVT 347
I+ + + LH+ +VHRD+K NILLD N KL+DFG + L
Sbjct: 126 TRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL-R 181
Query: 348 TRVMGTFGYVAPE 360
GT Y+APE
Sbjct: 182 EVC-GTPSYLAPE 193
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 83.0 bits (205), Expect = 2e-17
Identities = 53/247 (21%), Positives = 85/247 (34%), Gaps = 54/247 (21%)
Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVK-----NLLNNRGQAEKEFKVEVEAIGRVRHKNLVR 246
IG+G YG+V + + A+K + + + K EV + ++ H N+ R
Sbjct: 33 AIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIAR 92
Query: 247 LLGYCAEGAHRMLVYEYIDNGNL--------------------EQWLHGDVGPHSPLTWE 286
L + + LV E G+L + + +
Sbjct: 93 LYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAING 152
Query: 287 IRMNIILGTAKGLT----------------YLHEGLEPKVVHRDIKSSNILL--DKQWNP 328
YLH + HRDIK N L +K +
Sbjct: 153 SIHGFRESLDFVQREKLISNIMRQIFSALHYLHN---QGICHRDIKPENFLFSTNKSFEI 209
Query: 329 KLSDFGLAKLLG----AERSYVTTRVMGTFGYVAPE--YASTGMLNERSDVYSFGILIME 382
KL DFGL+K E +TT+ GT +VAPE + + D +S G+L+
Sbjct: 210 KLVDFGLSKEFYKLNNGEYYGMTTKA-GTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHL 268
Query: 383 VISGRNP 389
++ G P
Sbjct: 269 LLMGAVP 275
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 2e-17
Identities = 52/217 (23%), Positives = 81/217 (37%), Gaps = 36/217 (16%)
Query: 194 IGEGGYGIVYHGV-LEDNTNVAVK--------NLLNNRGQAEKEFKVEVEAIGRVRHKNL 244
+G G +G V+ V E N V VK + +E+ + RV H N+
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 245 VRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDV----GPHSPLTWEIRMNIILGTAKGLT 300
+++L LV E +G D+ H L + I +
Sbjct: 92 IKVLDIFENQGFFQLVMEKHGSG-------LDLFAFIDRHPRLDEPLASYIFRQLVSAVG 144
Query: 301 YLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPE 360
YL ++HRDIK NI++ + + KL DFG A L T GT Y APE
Sbjct: 145 YLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYL-ERGKLFYTFC-GTIEYCAPE 199
Query: 361 YASTGMLNERS------DVYSFGILIMEVISGRNPVD 391
+L +++S G+ + ++ NP
Sbjct: 200 -----VLMGNPYRGPELEMWSLGVTLYTLVFEENPFC 231
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 2e-17
Identities = 51/198 (25%), Positives = 80/198 (40%), Gaps = 20/198 (10%)
Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVK-----NLLNNRGQAEKE-FKVEVEAIGRVRHKNLV 245
+G G + IV A K +R +E + EV + +V H N++
Sbjct: 19 ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNII 78
Query: 246 RLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG 305
L +L+ E + G L +L S + IL G+ YLH
Sbjct: 79 TLHDVYENRTDVVLILELVSGGELFDFLA-QKESLSEEEATSFIKQILD---GVNYLHTK 134
Query: 306 LEPKVVHRDIKSSNILLDKQWNP----KLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEY 361
K+ H D+K NI+L + P KL DFGLA + + + GT +VAPE
Sbjct: 135 ---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN--IFGTPEFVAPEI 189
Query: 362 ASTGMLNERSDVYSFGIL 379
+ L +D++S G++
Sbjct: 190 VNYEPLGLEADMWSIGVI 207
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 3e-17
Identities = 46/181 (25%), Positives = 78/181 (43%), Gaps = 24/181 (13%)
Query: 193 VIGEGGYGIVYHGVLEDNTN--VAVK----NLLNNRGQAEKE----FKVEVEAIGRVRHK 242
+G G G V E T VA+K E + + E+E + ++ H
Sbjct: 17 TLGSGACGEVKLAF-ERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHP 75
Query: 243 NLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYL 302
++++ + + +V E ++ G L + G + L + YL
Sbjct: 76 CIIKIKNFFDAEDY-YIVLELMEGGELFDKVVG----NKRLKEATCKLYFYQMLLAVQYL 130
Query: 303 HEGLEPKVVHRDIKSSNILL---DKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAP 359
HE ++HRD+K N+LL ++ K++DFG +K+LG E S + T GT Y+AP
Sbjct: 131 HEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG-ETSLMRTLC-GTPTYLAP 185
Query: 360 E 360
E
Sbjct: 186 E 186
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 3e-17
Identities = 61/290 (21%), Positives = 108/290 (37%), Gaps = 34/290 (11%)
Query: 97 SNSNCKPHSAPNPDPLPEPEPILVEDSPASGRNRIHIEIGKDHRIAYPERAAGSHHGSGD 156
N S N S + K R + + D
Sbjct: 15 GTENLYFQSMKNSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPAPPAPFD 74
Query: 157 QTVAAAITPEVSHLGWGHWYTLRELEVSTNGFADENVIGEGGYGIVYHGV-LEDNTNVAV 215
+ A V+ YT+ + E+ +G G +G V+ +A
Sbjct: 75 HRIVTAKQGAVNSF-----YTVSKTEI----------LGGGRFGQVHKCEETATGLKLAA 119
Query: 216 KNLLNNRGQAEKE-FKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLH 274
K ++ RG +KE K E+ + ++ H NL++L +LV EY+D G L +
Sbjct: 120 K-IIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRI- 177
Query: 275 GDVGPHSPLT-WEIR--MNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILL-DKQWNP-K 329
+ LT + M I G+ ++H+ ++H D+K NIL ++ K
Sbjct: 178 --IDESYNLTELDTILFMKQICE---GIRHMHQM---YILHLDLKPENILCVNRDAKQIK 229
Query: 330 LSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGIL 379
+ DFGLA+ GT ++APE + ++ +D++S G++
Sbjct: 230 IIDFGLARRYKPREKLKV--NFGTPEFLAPEVVNYDFVSFPTDMWSVGVI 277
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 4e-17
Identities = 56/217 (25%), Positives = 90/217 (41%), Gaps = 42/217 (19%)
Query: 191 ENVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVR-HKNLVRLL 248
+ +GEG + I V + N AVK + E + E+ A+ H N+V+L
Sbjct: 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM---EANTQKEITALKLCEGHPNIVKLH 72
Query: 249 GYCAEGAHRMLVYEYIDNGNL-----------EQWLHGDVGPHSPLTWEIRMNIILGTAK 297
+ H LV E ++ G L E E I+
Sbjct: 73 EVFHDQLHTFLVMELLNGGELFERIKKKKHFSET--------------EAS-YIMRKLVS 117
Query: 298 GLTYLHEGLEPKVVHRDIKSSNILL-DKQWNP--KLSDFGLAKLLGAERSYVTTRVMGTF 354
++++H+ VVHRD+K N+L D+ N K+ DFG A+L + + T T
Sbjct: 118 AVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC-FTL 173
Query: 355 GYVAPEYASTGMLNERSDVYSFGIL--IMEVISGRNP 389
Y APE + +E D++S G++ M +SG+ P
Sbjct: 174 HYAAPELLNQNGYDESCDLWSLGVILYTM--LSGQVP 208
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 4e-17
Identities = 49/204 (24%), Positives = 83/204 (40%), Gaps = 28/204 (13%)
Query: 191 ENVIGEGGYGIVYHGV-LEDNTNVAVK-----NLLNNRGQAEKE-FKVEVEAIGRVRHKN 243
+G G + +V A K ++R +E + EV + ++H N
Sbjct: 16 GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75
Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIR----MNIILGTAKGL 299
++ L +L+ E + G E L + LT E + IL G+
Sbjct: 76 VITLHEVYENKTDVILILELVAGG--E--LFDFLAEKESLT-EEEATEFLKQILN---GV 127
Query: 300 TYLHEGLEPKVVHRDIKSSNILLDKQWNP----KLSDFGLAKLLGAERSYVTTRVMGTFG 355
YLH ++ H D+K NI+L + P K+ DFGLA + + + GT
Sbjct: 128 YYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN--IFGTPE 182
Query: 356 YVAPEYASTGMLNERSDVYSFGIL 379
+VAPE + L +D++S G++
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVI 206
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 4e-17
Identities = 50/197 (25%), Positives = 83/197 (42%), Gaps = 26/197 (13%)
Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLG 249
++G+G +G V AVK + + EVE + ++ H N+++L
Sbjct: 29 MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK 309
+ + +V E G L + S + + G+TY+H+
Sbjct: 89 ILEDSSSFYIVGELYTGGELFDEII-KRKRFSEHDAARIIKQVFS---GITYMHKH---N 141
Query: 310 VVHRDIKSSNILL---DKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPE-----Y 361
+VHRD+K NILL +K + K+ DFGL+ R+ GT Y+APE Y
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM-KDRI-GTAYYIAPEVLRGTY 199
Query: 362 ASTGMLNERSDVYSFGI 378
+E+ DV+S G+
Sbjct: 200 ------DEKCDVWSAGV 210
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 5e-17
Identities = 51/212 (24%), Positives = 96/212 (45%), Gaps = 41/212 (19%)
Query: 194 IGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVR-HKNLVRLLGYC 251
+G G Y V+ + + +N V VK L + +K+ K E++ + +R N++ L
Sbjct: 44 LGRGKYSEVFEAINITNNEKVVVKIL---KPVKKKKIKREIKILENLRGGPNIITLADIV 100
Query: 252 AEGAHRMLVY--EYIDNGNLEQWLHGDVGPHSPLT-WEIR--MNIILGTAKGLTYLHEGL 306
+ R E+++N + +Q LT ++IR M IL K L Y H
Sbjct: 101 KDPVSRTPALVFEHVNNTDFKQLYQ-------TLTDYDIRFYMYEIL---KALDYCHSM- 149
Query: 307 EPKVVHRDIKSSNILLD-KQWNPKLSDFGLAKLLGAERSY---VTTRVMGTFGYVAPEYA 362
++HRD+K N+++D + +L D+GLA+ + Y V +R + PE
Sbjct: 150 --GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRY-----FKGPEL- 201
Query: 363 STGMLNERS-----DVYSFGILIMEVISGRNP 389
+++ + D++S G ++ +I + P
Sbjct: 202 ---LVDYQMYDYSLDMWSLGCMLASMIFRKEP 230
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 5e-17
Identities = 44/178 (24%), Positives = 77/178 (43%), Gaps = 22/178 (12%)
Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVKNLL--NNRGQAEKEFKVEVEAIGRVRHKNLVRLLG 249
+G+G + +V V + A + + ++ + E ++H N+VRL
Sbjct: 18 ELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHD 77
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIR----MNIILGTAKGLTYLHEG 305
+E H L+++ + G L + + +S E + IL + + H+
Sbjct: 78 SISEEGHHYLIFDLVTGGELFEDIV-AREYYS----EADASHCIQQILE---AVLHCHQM 129
Query: 306 LEPKVVHRDIKSSNILL---DKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPE 360
VVHR++K N+LL K KL+DFGLA + E+ GT GY++PE
Sbjct: 130 ---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA-GTPGYLSPE 183
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 6e-17
Identities = 49/215 (22%), Positives = 87/215 (40%), Gaps = 38/215 (17%)
Query: 193 VIGEGGYGIVYHGVLEDNTNV-AVKNLLNNRGQAEKEF---KVEVEAIGRVRHKNLVRLL 248
++GEG + V + A+K L E + E + + R+ H V+L
Sbjct: 37 ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY 96
Query: 249 GYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMN-------------IILGT 295
+ Y NG L +++ ++ I+
Sbjct: 97 FTFQDDEKLYFGLSYAKNGELLKYIR-------------KIGSFDETCTRFYTAEIVSA- 142
Query: 296 AKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVM-GTF 354
L YLH ++HRD+K NILL++ + +++DFG AK+L E GT
Sbjct: 143 ---LEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTA 196
Query: 355 GYVAPEYASTGMLNERSDVYSFGILIMEVISGRNP 389
YV+PE + + SD+++ G +I ++++G P
Sbjct: 197 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 7e-17
Identities = 53/220 (24%), Positives = 92/220 (41%), Gaps = 47/220 (21%)
Query: 191 ENVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVR-HKNLVRLL 248
E+V+GEG + V + L + AVK + G EVE + + + H+N++ L+
Sbjct: 18 EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELI 77
Query: 249 GYCAEGAHRMLVYEYIDNGNL-----------EQWLHGDVGPHSPLTWEIRMNIILGTAK 297
+ E LV+E + G++ E E ++ A
Sbjct: 78 EFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNEL--------------EAS-VVVQDVAS 122
Query: 298 GLTYLHEGLEPKVVHRDIKSSNILL---DKQWNPKLSDFGLAKLL--GAERSYVTTRVM- 351
L +LH + HRD+K NIL ++ K+ DF L + + S ++T +
Sbjct: 123 ALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELL 179
Query: 352 ---GTFGYVAPE-----YASTGMLNERSDVYSFG-IL-IM 381
G+ Y+APE + ++R D++S G IL I+
Sbjct: 180 TPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYIL 219
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 79.9 bits (198), Expect = 8e-17
Identities = 49/195 (25%), Positives = 86/195 (44%), Gaps = 18/195 (9%)
Query: 193 VIGEGGYGIVYHGVLEDNTN--VAVKNLLNNRGQAEKEFKV--EVEAIGRVRHKNLVRLL 248
+G+G + +V V T A K + + A K+ E +++H N+VRL
Sbjct: 13 ELGKGAFSVVRRCV-HKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLH 71
Query: 249 GYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEP 308
E + LV++ + G L + + +S + IL + + Y H
Sbjct: 72 DSIQEESFHYLVFDLVTGGELFEDIV-AREFYSEADASHCIQQIL---ESIAYCHSN--- 124
Query: 309 KVVHRDIKSSNILLDKQWNP---KLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTG 365
+VHR++K N+LL + KL+DFGLA + ++ GT GY++PE
Sbjct: 125 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW-HGFA-GTPGYLSPEVLKKD 182
Query: 366 MLNERSDVYSFG-IL 379
++ D+++ G IL
Sbjct: 183 PYSKPVDIWACGVIL 197
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 9e-17
Identities = 49/190 (25%), Positives = 79/190 (41%), Gaps = 15/190 (7%)
Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYC 251
+G G IVY A+K L + +K + E+ + R+ H N+++L
Sbjct: 60 ELGRGATSIVYRCKQKGTQKPYALKVL--KKTVDKKIVRTEIGVLLRLSHPNIIKLKEIF 117
Query: 252 AEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVV 311
LV E + G L + + + + + + YLHE +V
Sbjct: 118 ETPTEISLVLELVTGGELFDRIVE----KGYYSERDAADAVKQILEAVAYLHEN---GIV 170
Query: 312 HRDIKSSNILL-DKQWNP--KLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLN 368
HRD+K N+L + K++DFGL+K++ + T V GT GY APE
Sbjct: 171 HRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKT--VCGTPGYCAPEILRGCAYG 228
Query: 369 ERSDVYSFGI 378
D++S GI
Sbjct: 229 PEVDMWSVGI 238
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 1e-16
Identities = 55/221 (24%), Positives = 93/221 (42%), Gaps = 50/221 (22%)
Query: 194 IGEGGYGIVYHGV-LEDNTNVAVK----NLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLL 248
+G G +G V G VAVK + + K K E++ + RH ++++L
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGK-IKREIQNLKLFRHPHIIKLY 77
Query: 249 GYCAEGAHRMLVYEYIDNGNLEQWL--HGDVGPHSPLTWEIRMN----------IILGTA 296
+ +V EY+ G L ++ HG R+ I+
Sbjct: 78 QVISTPTDFFMVMEYVSGGELFDYICKHG------------RVEEMEARRLFQQIL---- 121
Query: 297 KGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGY 356
+ Y H VVHRD+K N+LLD N K++DFGL+ ++ T+ G+ Y
Sbjct: 122 SAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS--CGSPNY 176
Query: 357 VAPEYASTGMLNER------SDVYSFGILIMEVISGRNPVD 391
APE +++ R D++S G+++ ++ G P D
Sbjct: 177 AAPE-----VISGRLYAGPEVDIWSCGVILYALLCGTLPFD 212
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 1e-16
Identities = 58/221 (26%), Positives = 89/221 (40%), Gaps = 52/221 (23%)
Query: 194 IGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKV--EVEAIGRVRHKNLVRLLGY 250
IG G +G+ VAVK + RG A E V E+ +RH N+VR
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYI--ERGAAIDE-NVQREIINHRSLRHPNIVRFKEV 84
Query: 251 CAEGAHRMLVYEYIDNGNLEQWL--HGDVGPHSPLTWEIRMN----------IILGTAKG 298
H ++ EY G L + + G R + ++ G
Sbjct: 85 ILTPTHLAIIMEYASGGELYERICNAG------------RFSEDEARFFFQQLLS----G 128
Query: 299 LTYLHEGLEPKVVHRDIKSSNILLDKQWNP--KLSDFGLAKLLGAERSYVTTRVMGTFGY 356
++Y H ++ HRD+K N LLD P K+ DFG +K S + V GT Y
Sbjct: 129 VSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSS-VLHSQPKSTV-GTPAY 183
Query: 357 VAPEYASTGMLNER------SDVYSFGILIMEVISGRNPVD 391
+APE +L + +DV+S G+ + ++ G P +
Sbjct: 184 IAPE-----VLLRQEYDGKIADVWSCGVTLYVMLVGAYPFE 219
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 2e-16
Identities = 55/222 (24%), Positives = 102/222 (45%), Gaps = 37/222 (16%)
Query: 182 EVSTNGFADENVIGEGGYGIVYHGV-LEDNTNVAVKNLLN---NRGQAEKEFKVEVEAIG 237
E+ + +G G YG V + VA+K L + A++ ++ E+ +
Sbjct: 21 ELPKT-YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYR-ELLLLK 78
Query: 238 RVRHKNLVRLLG-YCAEGAHRM-----LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNI 291
++H+N++ LL + + R LV ++ +L++ + + E +
Sbjct: 79 HMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMG------LKFSEEKIQYL 131
Query: 292 ILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS-YVTTRV 350
+ KGL Y+H VVHRD+K N+ +++ K+ DFGLA+ AE + YV TR
Sbjct: 132 VYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRW 188
Query: 351 MGTFGYVAPEYASTGMLNERS-----DVYSFGILIMEVISGR 387
Y APE +L+ D++S G ++ E+++G+
Sbjct: 189 -----YRAPEV----ILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 2e-16
Identities = 60/213 (28%), Positives = 94/213 (44%), Gaps = 29/213 (13%)
Query: 188 FADENVIGEGGYGIVYHGV-LEDNTNVAVKNLLN---NRGQAEKEFKVEVEAIGRVRHKN 243
+ + IG G GIV NVA+K L N+ A++ ++ E+ + V HKN
Sbjct: 27 YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKN 85
Query: 244 LVRLLG-YCAEGAHRM-----LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAK 297
++ LL + + + +V E +D NL Q + L E ++
Sbjct: 86 IIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLC 138
Query: 298 GLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS---YVTTRVMGTF 354
G+ +LH ++HRD+K SNI++ K+ DFGLA+ G YV TR
Sbjct: 139 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY---- 191
Query: 355 GYVAPEYASTGMLNERSDVYSFGILIMEVISGR 387
Y APE E D++S G ++ E+I G
Sbjct: 192 -YRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 2e-16
Identities = 41/174 (23%), Positives = 76/174 (43%), Gaps = 15/174 (8%)
Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLG 249
+G+G + +V V A K + + + ++ + E +++H N+VRL
Sbjct: 36 ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD 95
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK 309
E + LV++ + G L + D+ + + I + + Y H
Sbjct: 96 SIQEESFHYLVFDLVTGGELFE----DIVAREFYSEADASHCIQQILESIAYCHSN---G 148
Query: 310 VVHRDIKSSNILLDKQWNP---KLSDFGLAKLLGAERSYVTTRVMGTFGYVAPE 360
+VHR++K N+LL + KL+DFGLA + ++ GT GY++PE
Sbjct: 149 IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW-HGFA-GTPGYLSPE 200
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 80.3 bits (198), Expect = 2e-16
Identities = 59/217 (27%), Positives = 95/217 (43%), Gaps = 37/217 (17%)
Query: 188 FADENVIGEGGYGIVYHGV-LEDNTNVAVKNLLN---NRGQAEKEFKVEVEAIGRVRHKN 243
+ + IG G GIV + NVA+K L N+ A++ ++ E+ + V HKN
Sbjct: 64 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKN 122
Query: 244 LVRLLG-YCAEGAHRM-----LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAK 297
++ LL + + LV E +D NL Q + L E ++
Sbjct: 123 IISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLC 175
Query: 298 GLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS---YVTTRVMGTF 354
G+ +LH ++HRD+K SNI++ K+ DFGLA+ G YV TR
Sbjct: 176 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY---- 228
Query: 355 GYVAPEYASTGMLNER----SDVYSFGILIMEVISGR 387
Y APE +L D++S G ++ E++ +
Sbjct: 229 -YRAPEV----ILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 7e-16
Identities = 55/241 (22%), Positives = 88/241 (36%), Gaps = 39/241 (16%)
Query: 169 HLGWGHWYTLRELEVSTNGFAD-----ENVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNR 222
H G + E D + V+G G G V A+K LL +
Sbjct: 7 HHSSGLEVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALK-LLYDS 65
Query: 223 GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM----LVYEYIDNGNL-----EQWL 273
+A +E +A G ++V +L H ++ E ++ G L E+
Sbjct: 66 PKARQEVDHHWQASG---GPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQER-- 120
Query: 274 HGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILL---DKQWNPKL 330
T I+ + +LH + HRD+K N+L +K KL
Sbjct: 121 -----GDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKL 172
Query: 331 SDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGIL--IMEVISGRN 388
+DFG AK + T T YVAPE ++ D++S G++ I+ + G
Sbjct: 173 TDFGFAKETTQNA--LQTPC-YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYIL--LCGFP 227
Query: 389 P 389
P
Sbjct: 228 P 228
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 78.7 bits (194), Expect = 9e-16
Identities = 55/214 (25%), Positives = 96/214 (44%), Gaps = 36/214 (16%)
Query: 194 IGEGGYGIVYHGV-LEDNTNVAVK----NLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLL 248
+G G +G V G VAVK + + K + E++ + RH ++++L
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGK-IRREIQNLKLFRHPHIIKLY 82
Query: 249 GYCAEGAHRMLVYEYIDNGNLEQWL--HGDVGPHSPLTWEIRM---NIILGTAKGLTYLH 303
+ + +V EY+ G L ++ +G + E R I+ G+ Y H
Sbjct: 83 QVISTPSDIFMVMEYVSGGELFDYICKNGRLDEK-----ESRRLFQQIL----SGVDYCH 133
Query: 304 EGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAS 363
VVHRD+K N+LLD N K++DFGL+ ++ T+ G+ Y APE
Sbjct: 134 RH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS--CGSPNYAAPE--- 185
Query: 364 TGMLNER------SDVYSFGILIMEVISGRNPVD 391
+++ R D++S G+++ ++ G P D
Sbjct: 186 --VISGRLYAGPEVDIWSSGVILYALLCGTLPFD 217
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 1e-15
Identities = 41/194 (21%), Positives = 82/194 (42%), Gaps = 14/194 (7%)
Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKV--EVEAIGRVRH-KNLVRLL 248
+G G + +V + A K L R + ++ E+ + + ++ L
Sbjct: 36 ELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLH 95
Query: 249 GYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEP 308
+ +L+ EY G + ++ ++ + +I +G+ YLH+
Sbjct: 96 EVYENTSEIILILEYAAGGEIFSLCLPELAEM--VSENDVIRLIKQILEGVYYLHQN--- 150
Query: 309 KVVHRDIKSSNILL-DKQWNP--KLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTG 365
+VH D+K NILL K+ DFG+++ +G +MGT Y+APE +
Sbjct: 151 NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELRE--IMGTPEYLAPEILNYD 208
Query: 366 MLNERSDVYSFGIL 379
+ +D+++ GI+
Sbjct: 209 PITTATDMWNIGII 222
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 1e-15
Identities = 55/216 (25%), Positives = 100/216 (46%), Gaps = 35/216 (16%)
Query: 188 FADENVIGEGGYGIVYHGV-LEDNTNVAVKNLLN---NRGQAEKEFKVEVEAIGRVRHKN 243
+ D +G G YG V V VA+K L + A++ ++ E+ + +RH+N
Sbjct: 27 YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYR-ELRLLKHMRHEN 85
Query: 244 LVRLLG-YCAEGAHRM-----LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAK 297
++ LL + + LV ++ +L + + + L + ++ K
Sbjct: 86 VIGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMKHE-----KLGEDRIQFLVYQMLK 139
Query: 298 GLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS-YVTTRVMGTFGY 356
GL Y+H ++HRD+K N+ +++ K+ DFGLA+ +E + YV TR Y
Sbjct: 140 GLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRW-----Y 191
Query: 357 VAPEYASTGMLNERS-----DVYSFGILIMEVISGR 387
APE +LN D++S G ++ E+I+G+
Sbjct: 192 RAPEV----ILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 2e-15
Identities = 50/229 (21%), Positives = 100/229 (43%), Gaps = 48/229 (20%)
Query: 188 FADENVIGEGGYGIVYHGV-LEDNTNVAVKNL-LNNRGQAEKEFKVEVEAIGRVRHKNLV 245
+ D +G GG G+V+ V + + VA+K + L + + + E++ I R+ H N+V
Sbjct: 13 YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALR-EIKIIRRLDHDNIV 71
Query: 246 RLL----------GYCAEGAHRM----LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNI 291
++ + +V EY++ +L L PL E
Sbjct: 72 KVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVLE-----QGPLLEEHARLF 125
Query: 292 ILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQW-NPKLSDFGLAKLLGAERS------ 344
+ +GL Y+H V+HRD+K +N+ ++ + K+ DFGLA+++ S
Sbjct: 126 MYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLS 182
Query: 345 -YVTTRVMGTFGYVAPEYASTGMLNERS-----DVYSFGILIMEVISGR 387
+ T+ Y +P +L+ + D+++ G + E+++G+
Sbjct: 183 EGLVTK-----WYRSPRL----LLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 6e-15
Identities = 58/226 (25%), Positives = 106/226 (46%), Gaps = 40/226 (17%)
Query: 182 EVSTNGFADENVIGEGGYGIVYHGV-LEDNTNVAVKNLLN--NRGQAEKEFKVEVEAIGR 238
+V + + + IGEG YG+V + VA+K + ++ ++ + E++ + R
Sbjct: 24 DVGPR-YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLR 81
Query: 239 VRHKNLVRLLG-YCAEGAHRM----LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIIL 293
RH+N++ + A +M +V + ++ +L + L L+ + +
Sbjct: 82 FRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKT-----QHLSNDHICYFLY 135
Query: 294 GTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS-------YV 346
+GL Y+H V+HRD+K SN+LL+ + K+ DFGLA++ + YV
Sbjct: 136 QILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 192
Query: 347 TTRVMGTFGYVAPEYASTGMLNERS-----DVYSFGILIMEVISGR 387
TR Y APE MLN + D++S G ++ E++S R
Sbjct: 193 ATR-----WYRAPEI----MLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 8e-15
Identities = 50/227 (22%), Positives = 94/227 (41%), Gaps = 46/227 (20%)
Query: 188 FADENVIGEGGYGIVYHGV-LEDNTNVAVK--NLLNNRGQAEKEFKVEVEAIGRVRHKNL 244
F ++++GEG YG+V VA+K + A + + E++ + +H+N+
Sbjct: 13 FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR-EIKILKHFKHENI 71
Query: 245 VRLLG-YCAEGAHRM----LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGL 299
+ + + ++ E + +L + + L+ + I T + +
Sbjct: 72 ITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVISTQ-----MLSDDHIQYFIYQTLRAV 125
Query: 300 TYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS--------------Y 345
LH V+HRD+K SN+L++ + K+ DFGLA+++ + +
Sbjct: 126 KVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEF 182
Query: 346 VTTRVMGTFGYVAPEYASTGMLNERS-----DVYSFGILIMEVISGR 387
V TR Y APE ML DV+S G ++ E+ R
Sbjct: 183 VATR-----WYRAPEV----MLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 8e-15
Identities = 57/214 (26%), Positives = 94/214 (43%), Gaps = 37/214 (17%)
Query: 194 IGEGGYGIVYHGV-LEDNTNVAVK----NLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLL 248
+GEG +G V + VA+K LL + + E+ + +RH ++++L
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMR-VEREISYLKLLRHPHIIKLY 75
Query: 249 GYCAEGAHRMLVYEYIDNGNLEQWL--HGDVGPHSPLTWEIRM---NIILGTAKGLTYLH 303
++V EY G L ++ + E R II + Y H
Sbjct: 76 DVITTPTDIVMVIEYA-GGELFDYIVEKKRMTED-----EGRRFFQQII----CAIEYCH 125
Query: 304 EGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAS 363
K+VHRD+K N+LLD N K++DFGL+ ++ T+ G+ Y APE
Sbjct: 126 RH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTS--CGSPNYAAPE--- 177
Query: 364 TGMLNER------SDVYSFGILIMEVISGRNPVD 391
++N + DV+S GI++ ++ GR P D
Sbjct: 178 --VINGKLYAGPEVDVWSCGIVLYVMLVGRLPFD 209
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 9e-15
Identities = 56/216 (25%), Positives = 99/216 (45%), Gaps = 35/216 (16%)
Query: 188 FADENVIGEGGYGIVYHGV-LEDNTNVAVKNLLN---NRGQAEKEFKVEVEAIGRVRHKN 243
+ + + +G G YG V + VAVK L + A++ ++ E+ + ++H+N
Sbjct: 31 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHEN 89
Query: 244 LVRLLG-YCAEGAHRM-----LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAK 297
++ LL + + LV + +L + LT + +I +
Sbjct: 90 VIGLLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIVK-----CQKLTDDHVQFLIYQILR 143
Query: 298 GLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS-YVTTRVMGTFGY 356
GL Y+H ++HRD+K SN+ +++ K+ DFGLA+ E + YV TR Y
Sbjct: 144 GLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATRW-----Y 195
Query: 357 VAPEYASTGMLNERS-----DVYSFGILIMEVISGR 387
APE MLN D++S G ++ E+++GR
Sbjct: 196 RAPEI----MLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 2e-14
Identities = 56/231 (24%), Positives = 95/231 (41%), Gaps = 33/231 (14%)
Query: 178 LRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNV-AVKNL----LNNRGQAEKEFKVE 232
L+E+ + + F VIG G + V ++ V A+K + + RG+ F+ E
Sbjct: 53 LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSC-FREE 111
Query: 233 VEAIGRVRHKNLVRLLGYCAEGAHRM-LVYEYIDNGNLEQWLHGDVGPHSPLTW------ 285
+ + + + +L + + + + LV EY G+L L G P
Sbjct: 112 RDVLVNGDRRWITQLH-FAFQDENYLYLVMEYYVGGDLLTLLS-KFGERIPAEMARFYLA 169
Query: 286 EIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSY 345
EI M + +H VHRDIK NILLD+ + +L+DFG L A+ +
Sbjct: 170 EIVM--------AIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTV 218
Query: 346 VTTRVMGTFGYVAPEYASTGMLNERSDVY-------SFGILIMEVISGRNP 389
+ +GT Y++PE + Y + G+ E+ G+ P
Sbjct: 219 RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 3e-14
Identities = 33/100 (33%), Positives = 50/100 (50%), Gaps = 18/100 (18%)
Query: 298 GLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYV 357
L YL +++HRD+K NILLD+ + ++DF +A +L E T + GT Y+
Sbjct: 127 ALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ--ITTMAGTKPYM 181
Query: 358 APEYASTGMLNERS--------DVYSFGILIMEVISGRNP 389
APE M + R D +S G+ E++ GR P
Sbjct: 182 APE-----MFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 5e-14
Identities = 55/221 (24%), Positives = 90/221 (40%), Gaps = 36/221 (16%)
Query: 181 LEVSTNGFADE-----NVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVE 234
L++ N D+ V+G G G V A+K +L + +A +E ++
Sbjct: 52 LQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWR 110
Query: 235 AIGRVRHKNLVRLLGYC----AEGAHRMLVYEYIDNGNL-----EQWLHGDVGPHSPLTW 285
A ++VR++ A ++V E +D G L ++ T
Sbjct: 111 ASQ---CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDR-------GDQAFTE 160
Query: 286 EIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILL-DKQWNP--KLSDFGLAKLLGAE 342
I+ + + YLH + HRD+K N+L K+ N KL+DFG AK +
Sbjct: 161 REASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH 217
Query: 343 RSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFG-IL-IM 381
S T T YVAPE ++ D++S G I+ I+
Sbjct: 218 NSLTT--PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYIL 256
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 72.9 bits (179), Expect = 5e-14
Identities = 47/255 (18%), Positives = 93/255 (36%), Gaps = 63/255 (24%)
Query: 188 FADENVIGEGGYGIVYHGV-LEDNTNVAVKNLLN---NRGQAEKEFKVEVEAIGRVRHKN 243
+ ++IG G YG V + VA+K +L + ++ + E+ + R+ H +
Sbjct: 55 YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILR-EIAILNRLNHDH 113
Query: 244 LVRLLG-YCAEGAHRM----LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKG 298
+V++L + + +V E + LT ++ G
Sbjct: 114 VVKVLDIVIPKDVEKFDELYVVLEI-----ADSDFKKLFRTPVYLTELHIKTLLYNLLVG 168
Query: 299 LTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS-------------- 344
+ Y+H ++HRD+K +N L+++ + K+ DFGLA+ + +
Sbjct: 169 VKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDM 225
Query: 345 -----------------YVTTRVMGTFGYVAPEYASTGMLNERS-----DVYSFGILIME 382
+V TR Y APE +L + + DV+S G + E
Sbjct: 226 NLVTFPHTKNLKRQLTGHVVTR-----WYRAPEL----ILLQENYTEAIDVWSIGCIFAE 276
Query: 383 VISGRNPVDYSRPPG 397
+++
Sbjct: 277 LLNMIKENVAYHADR 291
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 9e-14
Identities = 56/278 (20%), Positives = 107/278 (38%), Gaps = 64/278 (23%)
Query: 188 FADENVIGEGGYGIVYHGV-LEDNTNVAVKNLLN---NRGQAEKEFKVEVEAIGRVRHKN 243
+ +++IG G YG VY NVA+K + + ++ + E+ + R++
Sbjct: 28 YIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILR-EITILNRLKSDY 86
Query: 244 LVRLLG-YCAEGAHRM----LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKG 298
++RL + + +V E D+ +L++ + LT E I+ G
Sbjct: 87 IIRLYDLIIPDDLLKFDELYIVLEIADS-DLKKLFKTPI----FLTEEHIKTILYNLLLG 141
Query: 299 LTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS-------------- 344
++HE ++HRD+K +N LL++ + K+ DFGLA+ + +E+
Sbjct: 142 ENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPG 198
Query: 345 ------------YVTTRVMGTFGYVAPEYASTGMLNERS-----DVYSFGILIMEVISGR 387
+V TR Y APE +L + + D++S G + E+++
Sbjct: 199 PHNKNLKKQLTSHVVTR-----WYRAPEL----ILLQENYTKSIDIWSTGCIFAELLNML 249
Query: 388 NPVDYS----RP--PGEVNLVEWLKTMVTNRNAEGVLD 419
P PG + + D
Sbjct: 250 QSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRD 287
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 1e-13
Identities = 53/230 (23%), Positives = 90/230 (39%), Gaps = 36/230 (15%)
Query: 178 LRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNV-AVKNL----LNNRGQAEKEFKVE 232
+R+L + + VIG G +G V + V A+K L + R + F E
Sbjct: 61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAF-FWEE 119
Query: 233 VEAIGRVRHKNLVRLLGYCAEGAHRM-LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNI 291
+ + +V+L Y + + +V EY+ G+L + ++
Sbjct: 120 RDIMAFANSPWVVQLF-YAFQDDRYLYMVMEYMPGGDLVNLMS-------------NYDV 165
Query: 292 ILGTAK--------GLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER 343
A+ L +H +HRD+K N+LLDK + KL+DFG + E
Sbjct: 166 PEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG 222
Query: 344 SYVTTRVMGTFGYVAPE----YASTGMLNERSDVYSFGILIMEVISGRNP 389
+GT Y++PE G D +S G+ + E++ G P
Sbjct: 223 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 2e-13
Identities = 53/228 (23%), Positives = 93/228 (40%), Gaps = 29/228 (12%)
Query: 178 LRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNV-AVKNLLNNRGQAEKE---FKVEV 233
++++ + F VIG G +G V L++ V A+K L E F+ E
Sbjct: 66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREER 125
Query: 234 EAIGRVRHKNLVRLLGYCA--EGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIR--- 288
+ + K + L + A + + LV +Y G+L L E
Sbjct: 126 DVLVNGDSKWITTL--HYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLP----EEMARF 179
Query: 289 --MNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYV 346
+++ + +H+ VHRDIK NIL+D + +L+DFG L + +
Sbjct: 180 YLAEMVIA----IDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQ 232
Query: 347 TTRVMGTFGYVAPE-----YASTGMLNERSDVYSFGILIMEVISGRNP 389
++ +GT Y++PE G D +S G+ + E++ G P
Sbjct: 233 SSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 69.8 bits (171), Expect = 6e-13
Identities = 58/212 (27%), Positives = 88/212 (41%), Gaps = 33/212 (15%)
Query: 193 VIGEGGYGIVYHGVLEDNTNV-AVKNLLNNRGQAEKEF---KVEVEAIGRVRHKNLVRLL 248
++G+G +G V + A+K L A+ E E + RH L L
Sbjct: 155 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 214
Query: 249 GYCAEGAHRM-LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMN-----IILGTAKGLTYL 302
Y + R+ V EY + G L L + E R I+ L YL
Sbjct: 215 -YSFQTHDRLCFVMEYANGGELFFHLS-----RERVFSEDRARFYGAEIVSA----LDYL 264
Query: 303 HEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYA 362
H VV+RD+K N++LDK + K++DFGL K G + GT Y+APE
Sbjct: 265 HSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKTFCGTPEYLAPE-- 319
Query: 363 STGMLNERS-----DVYSFGILIMEVISGRNP 389
+L + D + G+++ E++ GR P
Sbjct: 320 ---VLEDNDYGRAVDWWGLGVVMYEMMCGRLP 348
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 1e-12
Identities = 58/243 (23%), Positives = 100/243 (41%), Gaps = 68/243 (27%)
Query: 188 FADENVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVR------ 240
+ +G+G YGIV+ + VAVK + + F+ +A R
Sbjct: 11 YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFD-------AFQNSTDAQRTFREIMILT 63
Query: 241 ----HKNLVRLLG-YCAEGAHRM-LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILG 294
H+N+V LL A+ + LV++Y++ +L + + L + ++
Sbjct: 64 ELSGHENIVNLLNVLRADNDRDVYLVFDYMET-DLHAVIRAN-----ILEPVHKQYVVYQ 117
Query: 295 TAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS---------- 344
K + YLH G ++HRD+K SNILL+ + + K++DFGL++ R
Sbjct: 118 LIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSIN 174
Query: 345 ---------------YVTTRVMGTFGYVAPEYASTGMLNERS-----DVYSFGILIMEVI 384
YV TR Y APE +L D++S G ++ E++
Sbjct: 175 ENTENFDDDQPILTDYVATR-----WYRAPEI----LLGSTKYTKGIDMWSLGCILGEIL 225
Query: 385 SGR 387
G+
Sbjct: 226 CGK 228
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 2e-12
Identities = 59/212 (27%), Positives = 87/212 (41%), Gaps = 34/212 (16%)
Query: 193 VIGEGGYGIVYHGVLEDNTNV-AVKNLLNNRGQAEKEF---KVEVEAIGRVRHKNLVRLL 248
++G+G +G V + A+K L A+ E E + RH L L
Sbjct: 12 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71
Query: 249 GYCAEGAHRM-LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMN-----IILGTAKGLTYL 302
Y + R+ V EY + G L L + E R I+ L YL
Sbjct: 72 -YAFQTHDRLCFVMEYANGGELFFHLS-----RERVFTEERARFYGAEIVSA----LEYL 121
Query: 303 HEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYA 362
H VV+RDIK N++LDK + K++DFGL K G GT Y+APE
Sbjct: 122 HSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPEYLAPE-- 175
Query: 363 STGMLNERS-----DVYSFGILIMEVISGRNP 389
+L + D + G+++ E++ GR P
Sbjct: 176 ---VLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 67.6 bits (165), Expect = 2e-12
Identities = 71/345 (20%), Positives = 111/345 (32%), Gaps = 95/345 (27%)
Query: 191 ENVIGEGGYGIVYHGVL------EDNTNVAVKNLLNNRGQAE-KEFKVE----------- 232
+G G +G V VAVK L +E + E
Sbjct: 27 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 86
Query: 233 --VEAIGRV--------------RHKNLVRLL--------GYCAEGAHRMLVYEYIDNGN 268
V +G + NL L Y +GA +Y+
Sbjct: 87 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIP 146
Query: 269 LEQWLHGDVGPHS-----------------------------PLTWEIRMNIILGTAKGL 299
++ D S LT E + AKG+
Sbjct: 147 VDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGM 206
Query: 300 TYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYV-TTRVMGTFGYVA 358
+L K +HRD+ + NILL ++ K+ DFGLA+ + + YV ++A
Sbjct: 207 EFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 263
Query: 359 PEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGV 417
PE + +SDV+SFG+L+ E+ S G +P Y + LK EG
Sbjct: 264 PETIFDRVYTIQSDVWSFGVLLWEIFSLGASP--YPGVKIDEEFCRRLK--------EGT 313
Query: 418 LDPRLQEKP--CSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 460
R+ P + + + L C +RP ++ L
Sbjct: 314 ---RM-RAPDYTTPEMYQ---TMLDCWHGEPSQRPTFSELVEHLG 351
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 66.8 bits (164), Expect = 2e-12
Identities = 34/97 (35%), Positives = 54/97 (55%), Gaps = 14/97 (14%)
Query: 298 GLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYV 357
L +LH +++RD+K NILLD++ + KL+DFGL+K + GT Y+
Sbjct: 138 ALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSK-ESIDHEKKAYSFCGTVEYM 193
Query: 358 APEYASTGMLNERS-----DVYSFGILIMEVISGRNP 389
APE ++N R D +SFG+L+ E+++G P
Sbjct: 194 APE-----VVNRRGHTQSADWWSFGVLMFEMLTGTLP 225
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 66.0 bits (162), Expect = 5e-12
Identities = 32/97 (32%), Positives = 50/97 (51%), Gaps = 14/97 (14%)
Query: 298 GLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYV 357
L +LH+ +++RD+K NI+L+ Q + KL+DFGL K VT GT Y+
Sbjct: 133 ALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCK-ESIHDGTVTHTFCGTIEYM 188
Query: 358 APEYASTGMLNERS-----DVYSFGILIMEVISGRNP 389
APE +L D +S G L+ ++++G P
Sbjct: 189 APE-----ILMRSGHNRAVDWWSLGALMYDMLTGAPP 220
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 5e-12
Identities = 32/97 (32%), Positives = 51/97 (52%), Gaps = 14/97 (14%)
Query: 298 GLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYV 357
L +LH+ +++RD+K N+LLD + + KL+DFG+ K G T GT Y+
Sbjct: 136 ALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCK-EGICNGVTTATFCGTPDYI 191
Query: 358 APEYASTGMLNERS-----DVYSFGILIMEVISGRNP 389
APE +L E D ++ G+L+ E++ G P
Sbjct: 192 APE-----ILQEMLYGPAVDWWAMGVLLYEMLCGHAP 223
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 5e-12
Identities = 34/97 (35%), Positives = 51/97 (52%), Gaps = 14/97 (14%)
Query: 298 GLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYV 357
L YLH +V+RD+K NILLD Q + L+DFGL K E + T+ GT Y+
Sbjct: 151 ALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCK-ENIEHNSTTSTFCGTPEYL 206
Query: 358 APEYASTGMLNERS-----DVYSFGILIMEVISGRNP 389
APE +L+++ D + G ++ E++ G P
Sbjct: 207 APE-----VLHKQPYDRTVDWWCLGAVLYEMLYGLPP 238
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 6e-12
Identities = 31/99 (31%), Positives = 52/99 (52%), Gaps = 15/99 (15%)
Query: 298 GLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYV 357
L +LH+ +++RDIK NILLD + L+DFGL+K A+ + GT Y+
Sbjct: 171 ALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYM 227
Query: 358 APEYASTGMLNERS-------DVYSFGILIMEVISGRNP 389
AP+ ++ D +S G+L+ E+++G +P
Sbjct: 228 APD-----IVRGGDSGHDKAVDWWSLGVLMYELLTGASP 261
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 9e-12
Identities = 53/211 (25%), Positives = 91/211 (43%), Gaps = 35/211 (16%)
Query: 193 VIGEGGYGIVYHGVLEDNTNV-AVKNLLNNRGQAEKEF---KVEVEAIGRVRHKNLVRLL 248
+G G +G V +++ N A+K L + K+ E + V LV+L
Sbjct: 48 TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 249 GYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMN----------IILGTAKG 298
+ ++ +V EY+ G E + H L R + I+L
Sbjct: 108 FSFKDNSNLYMVMEYVAGG--EMFSH--------LRRIGRFSEPHARFYAAQIVLT---- 153
Query: 299 LTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVA 358
YLH +++RD+K N+L+D+Q +++DFG AK + T + GT +A
Sbjct: 154 FEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWTLCGTPEALA 206
Query: 359 PEYASTGMLNERSDVYSFGILIMEVISGRNP 389
PE + N+ D ++ G+LI E+ +G P
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 64.9 bits (159), Expect = 1e-11
Identities = 33/97 (34%), Positives = 54/97 (55%), Gaps = 14/97 (14%)
Query: 298 GLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYV 357
L YLHE +++RD+K N+LLD + + KL+D+G+ K G T+ GT Y+
Sbjct: 122 ALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGDTTSTFCGTPNYI 177
Query: 358 APEYASTGMLNERS-----DVYSFGILIMEVISGRNP 389
APE +L D ++ G+L+ E+++GR+P
Sbjct: 178 APE-----ILRGEDYGFSVDWWALGVLMFEMMAGRSP 209
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 64.5 bits (158), Expect = 2e-11
Identities = 35/97 (36%), Positives = 53/97 (54%), Gaps = 14/97 (14%)
Query: 298 GLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYV 357
GL +LH +V+RD+K NILLDK + K++DFG+ K T GT Y+
Sbjct: 130 GLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCK-ENMLGDAKTNTFCGTPDYI 185
Query: 358 APEYASTGMLNERS-----DVYSFGILIMEVISGRNP 389
APE +L + D +SFG+L+ E++ G++P
Sbjct: 186 APE-----ILLGQKYNHSVDWWSFGVLLYEMLIGQSP 217
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 65.0 bits (158), Expect = 3e-11
Identities = 28/97 (28%), Positives = 52/97 (53%), Gaps = 14/97 (14%)
Query: 298 GLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYV 357
GL +L +++RD+K N++LD + + K++DFG+ K T GT Y+
Sbjct: 454 GLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK-ENIWDGVTTKTFCGTPDYI 509
Query: 358 APEYASTGMLNERS-----DVYSFGILIMEVISGRNP 389
APE ++ + D ++FG+L+ E+++G+ P
Sbjct: 510 APE-----IIAYQPYGKSVDWWAFGVLLYEMLAGQAP 541
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 3e-11
Identities = 33/97 (34%), Positives = 54/97 (55%), Gaps = 14/97 (14%)
Query: 298 GLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYV 357
L YLHE +++RD+K N+LLD + + KL+D+G+ K G T+ GT Y+
Sbjct: 165 ALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGDTTSTFCGTPNYI 220
Query: 358 APEYASTGMLNERS-----DVYSFGILIMEVISGRNP 389
APE +L D ++ G+L+ E+++GR+P
Sbjct: 221 APE-----ILRGEDYGFSVDWWALGVLMFEMMAGRSP 252
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 4e-11
Identities = 28/97 (28%), Positives = 52/97 (53%), Gaps = 14/97 (14%)
Query: 298 GLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYV 357
GL +L +++RD+K N++LD + + K++DFG+ K T GT Y+
Sbjct: 133 GLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK-ENIWDGVTTKTFCGTPDYI 188
Query: 358 APEYASTGMLNERS-----DVYSFGILIMEVISGRNP 389
APE ++ + D ++FG+L+ E+++G+ P
Sbjct: 189 APE-----IIAYQPYGKSVDWWAFGVLLYEMLAGQAP 220
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 62.5 bits (153), Expect = 6e-11
Identities = 37/97 (38%), Positives = 55/97 (56%), Gaps = 17/97 (17%)
Query: 298 GLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYV 357
L YLH +++RD+K NILLDK + K++DFG AK + VT + GT Y+
Sbjct: 118 ALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD----VTYTLCGTPDYI 170
Query: 358 APEYASTGMLNERS-----DVYSFGILIMEVISGRNP 389
APE +++ + D +SFGILI E+++G P
Sbjct: 171 APE-----VVSTKPYNKSIDWWSFGILIYEMLAGYTP 202
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 62.2 bits (150), Expect = 8e-11
Identities = 36/203 (17%), Positives = 61/203 (30%), Gaps = 57/203 (28%)
Query: 183 VSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVK--------NLLNNRGQAEKEFKVEVE 234
+ T IGEG +G V+ + D+T VA+K + + + +E E+
Sbjct: 17 LPTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEII 75
Query: 235 ---------AIGRVRHKNLVRLLG-YCAEGAH---------------------------- 256
R + + L +C +G++
Sbjct: 76 ISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDD 135
Query: 257 -RMLVYEYIDNGN-LEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRD 314
+V E+ G LEQ + +I+ L + HRD
Sbjct: 136 QLFIVLEFEFGGIDLEQM------RTKLSSLATAKSILHQLTASLAVAEA--SLRFEHRD 187
Query: 315 IKSSNILLDKQWNPKLSDFGLAK 337
+ N+LL K KL K
Sbjct: 188 LHWGNVLLKKTSLKKLHYTLNGK 210
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 2e-10
Identities = 50/225 (22%), Positives = 94/225 (41%), Gaps = 48/225 (21%)
Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVKNLLNN---RGQAEKEFKV-------EVEAIGRVRH 241
+G G + V+ + +NT+VA+K + + AE E K+ + +
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGA 85
Query: 242 KNLVRLLGY----CAEGAHRMLVYEYIDNGNLEQWL--HGDVGPHSPLTWEIRMNIILGT 295
++++LL + G H ++V+E + NL + + G +I ++LG
Sbjct: 86 NHILKLLDHFNHKGPNGVHVVMVFEVLGE-NLLALIKKYEHRGIPLIYVKQISKQLLLG- 143
Query: 296 AKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNP------KLSDFGLAKLLGAERS-YVTT 348
L Y+H ++H DIK N+L++ +P K++D G A + + T
Sbjct: 144 ---LDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQT 198
Query: 349 RVMGTFGYVAPE------YASTGMLNERSDVYSFGILIMEVISGR 387
R Y +PE + +D++S LI E+I+G
Sbjct: 199 RE-----YRSPEVLLGAPW------GCGADIWSTACLIFELITGD 232
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 1e-08
Identities = 54/232 (23%), Positives = 93/232 (40%), Gaps = 35/232 (15%)
Query: 173 GHWYTLRELEVSTNGFADENVIGEGGYGIVYHGV-LEDNTNVAVKNLLNN---RGQAEKE 228
Y ++ E + + +++IG+G +G V + VA+K + N QA+ E
Sbjct: 42 YD-YIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIE 100
Query: 229 FKV--EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWL--HGDVGPHSPLT 284
++ + +V L + H LV+E + NL L G LT
Sbjct: 101 VRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLT 159
Query: 285 WEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNP--KLSDFGLAKLLGAE 342
+ + L +L E ++H D+K NILL K+ DFG + LG
Sbjct: 160 RKFAQQMCTA----LLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR 214
Query: 343 R-SYVTTRVMGTFGYVAPE------YASTGMLNERSDVYSFGILIMEVISGR 387
Y+ +R F Y +PE Y + D++S G +++E+ +G
Sbjct: 215 IYQYIQSR----F-YRSPEVLLGMPY------DLAIDMWSLGCILVEMHTGE 255
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 3e-08
Identities = 41/176 (23%), Positives = 66/176 (37%), Gaps = 34/176 (19%)
Query: 181 LEVSTNGFADE-----NVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVE 234
L++ N D+ V+G G G V A+K L + + + EVE
Sbjct: 8 LQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVE 62
Query: 235 AIGRV-RHKNLVRLLGYC----AEGAHRMLVYEYIDNGNL-----EQWLHGDVGPHSPLT 284
R + ++VR++ A ++V E +D G L ++ T
Sbjct: 63 LHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDR-------GDQAFT 115
Query: 285 WEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILL---DKQWNPKLSDFGLAK 337
I+ + + YLH + HRD+K N+L KL+DFG AK
Sbjct: 116 EREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 3e-08
Identities = 33/155 (21%), Positives = 65/155 (41%), Gaps = 24/155 (15%)
Query: 194 IGEGGYGIVYHGV-LEDNTNVAVK--NLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGY 250
IG G +G + G L N VA+K + + Q E++ + + ++ +
Sbjct: 17 IGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGS---GDGIPQVYYF 73
Query: 251 CAEGAHRMLVYEYIDNG-NLEQWLHGDVGPHSPLTWEIRMNIILGT--AKGLTYLHEGLE 307
G + +V E + G +LE D+ T+ ++ +++ + Y+H
Sbjct: 74 GPCGKYNAMVLELL--GPSLE-----DLFDLCDRTFSLKTVLMIAIQLISRMEYVHS--- 123
Query: 308 PKVVHRDIKSSNILLDKQWNPK-----LSDFGLAK 337
+++RD+K N L+ + N + DF LAK
Sbjct: 124 KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 1e-07
Identities = 39/156 (25%), Positives = 66/156 (42%), Gaps = 26/156 (16%)
Query: 194 IGEGGYGIVYHGV-LEDNTNVAVKN--LLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGY 250
IGEG +G+++ G L +N VA+K ++ Q E++ G + + +
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCT---GIPNVYYF 74
Query: 251 CAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAK----GLTYLHEGL 306
EG H +LV + + +LE L S T + AK + +HE
Sbjct: 75 GQEGLHNVLVIDLLGP-SLEDLLDLCGRKFSVKT-------VAMAAKQMLARVQSIHE-- 124
Query: 307 EPKVVHRDIKSSNILLDKQWNPK-----LSDFGLAK 337
+V+RDIK N L+ + + + DFG+ K
Sbjct: 125 -KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 7e-07
Identities = 51/212 (24%), Positives = 93/212 (43%), Gaps = 36/212 (16%)
Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVKNLLNN---RGQAEKEFKV--EVEAIGRVRHKNLVR 246
VIG+G +G V + + +VA+K + N QA +E ++ + + N++
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIH 163
Query: 247 LLGYCAEGAHRMLVYEYIDNGNLEQWL--HGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 304
+L H + +E + NL + + + G PL + +I+ + L LH+
Sbjct: 164 MLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHSIL----QCLDALHK 218
Query: 305 GLEPKVVHRDIKSSNILLDKQWNP--KLSDFGLAKLLGAERS-YVTTRVMGTFGYVAPE- 360
+++H D+K NILL +Q K+ DFG + Y+ +R F Y APE
Sbjct: 219 ---NRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSR----F-YRAPEV 270
Query: 361 -----YASTGMLNERSDVYSFGILIMEVISGR 387
Y D++S G ++ E+++G
Sbjct: 271 ILGARY------GMPIDMWSLGCILAELLTGY 296
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 50.2 bits (120), Expect = 9e-07
Identities = 37/169 (21%), Positives = 72/169 (42%), Gaps = 34/169 (20%)
Query: 194 IGEGGYGIVYHGVLEDNTNV------AVKNLLNNRGQAEKEFKV-----EVEAIGRVRHK 242
IG+GG+G +Y + + +V VK ++ G E K + E I +
Sbjct: 43 IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102
Query: 243 NLVRLLG----------YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPL--TWEIRMN 290
++ LG ++R ++ + + +L++ ++ ++ +
Sbjct: 103 RKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGS-DLQK-IYEANAKRFSRKTVLQLSLR 160
Query: 291 IILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPK--LSDFGLAK 337
I+ L Y+HE + VH DIK+SN+LL+ + + L D+GLA
Sbjct: 161 IL----DILEYIHE---HEYVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 49.5 bits (118), Expect = 1e-06
Identities = 46/257 (17%), Positives = 89/257 (34%), Gaps = 74/257 (28%)
Query: 194 IGEGGYGIVYHGV-LEDNTNVAVK---NLLNNRGQAEKEFKVEVEAIGRVR-----HKNL 244
+G G + V+ ++ VA+K + + A E ++ +++ + +
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLL-KSVRNSDPNDPNREMV 103
Query: 245 VRLLGY----CAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLT 300
V+LL G H +V+E + + +L +W+ + L II +GL
Sbjct: 104 VQLLDDFKISGVNGTHICMVFEVLGH-HLLKWII--KSNYQGLPLPCVKKIIQQVLQGLD 160
Query: 301 YLHEGLEPKVVHRDIKSSNILL-------------------------------------- 322
YLH + +++H DIK NILL
Sbjct: 161 YLHT--KCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAG 218
Query: 323 -----------DKQWNPKLSDFGLAKLLGAERSY-VTTRVMGTFGYVAPEYASTGMLNER 370
++ K++D G A + + + TR Y + E N
Sbjct: 219 NFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQ-----YRSLEVLIGSGYNTP 273
Query: 371 SDVYSFGILIMEVISGR 387
+D++S + E+ +G
Sbjct: 274 ADIWSTACMAFELATGD 290
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 4e-06
Identities = 39/167 (23%), Positives = 69/167 (41%), Gaps = 33/167 (19%)
Query: 194 IGEGGYGIVYHGV-LEDNTNVA---VKNLLNNRGQAEKEFKVE-----VEAIGRVRHKNL 244
IG GG+G++Y A VK G E K + I + +
Sbjct: 45 IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQ 104
Query: 245 VRLLG-----YC-----AEGAHRMLVYEYIDNG-NLEQWLHGDVGPHSPLT-WEIRMNII 292
+ LG ++R +V E + G +L++ + G G T ++ + ++
Sbjct: 105 LDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQK-ISGQNGTFKKSTVLQLGIRML 161
Query: 293 LGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPK--LSDFGLAK 337
L Y+HE + VH DIK++N+LL + + L+D+GL+
Sbjct: 162 ----DVLEYIHE---NEYVHGDIKAANLLLGYKNPDQVYLADYGLSY 201
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 2e-05
Identities = 37/159 (23%), Positives = 63/159 (39%), Gaps = 34/159 (21%)
Query: 194 IGEGGYGIVYHGV-LEDNTNVAVK--NLLNNRGQAEKEFKVEVEAIGRVRHKNL------ 244
IG G +G +Y G + VA+K + Q E K+ +K +
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKI---------YKMMQGGVGI 67
Query: 245 VRLLGYCAEGAHRMLVYEYIDNG-NLEQWLHGDVGPHSPLTWEIRMNIILGT--AKGLTY 301
+ AEG + ++V E + G +LE D+ + ++ ++L + Y
Sbjct: 68 PTIRWCGAEGDYNVMVMELL--GPSLE-----DLFNFCSRKFSLKTVLLLADQMISRIEY 120
Query: 302 LHEGLEPKVVHRDIKSSNILLDKQWNPK---LSDFGLAK 337
+H +HRD+K N L+ + DFGLAK
Sbjct: 121 IHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 45.8 bits (108), Expect = 2e-05
Identities = 37/152 (24%), Positives = 63/152 (41%), Gaps = 20/152 (13%)
Query: 194 IGEGGYGIVYHGV-LEDNTNVAVK--NLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGY 250
IG G +G +Y G ++ N VA+K N+ Q E K+ G + + +
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQG---GTGIPNVRWF 71
Query: 251 CAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGT--AKGLTYLHEGLEP 308
EG + +LV + + +LE + S ++ ++L + ++H
Sbjct: 72 GVEGDYNVLVMDLLGP-SLEDLFNFCSRKLS-----LKTVLMLADQMINRVEFVHS---K 122
Query: 309 KVVHRDIKSSNILLDKQWNPK---LSDFGLAK 337
+HRDIK N L+ + DFGLAK
Sbjct: 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 3e-05
Identities = 27/170 (15%), Positives = 56/170 (32%), Gaps = 36/170 (21%)
Query: 194 IGEGGYGIVYHGV---------LEDNTNVAVKNLLNNRGQAEKEFKV--------EVEAI 236
GI+Y ++K L G+ E +V
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAKDGRLFNEQNFFQRAAKPLQVNKW 108
Query: 237 GRVRHKNLV---RLLGY-CAEGAHRMLVYEYIDNGNLEQWLHGDVGPHS---PLTWEIRM 289
++ L+ +G+ + +R LV + +L+ H ++
Sbjct: 109 KKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGR-SLQS-ALDVSPKHVLSERSVLQVAC 166
Query: 290 NIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPK--LSDFGLAK 337
++ L +LHE + VH ++ + NI +D + + L+ +G A
Sbjct: 167 RLL----DALEFLHE---NEYVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 41.4 bits (96), Expect = 8e-04
Identities = 65/515 (12%), Positives = 133/515 (25%), Gaps = 173/515 (33%)
Query: 35 VLVLFLISLWFTSKRNSNNSKRQLNAAKSSSLCSNYN----SSSGNPTIPNISKEIQEIR 90
L LF W + ++ + L NY P++ + +
Sbjct: 64 TLRLF----WTLLSKQEEMVQKFVE----EVLRINYKFLMSPIKTEQRQPSMMTRMYIEQ 115
Query: 91 IDPDSNSNSNCKPHSAPNPDPLPEPEPILVEDSPASGRNRIHIEIGKDHRIAYPERAAGS 150
D N N ++ P + L+E PA + I
Sbjct: 116 RDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKN-----VLI--------------- 155
Query: 151 HH---GSGDQTVAAAITPEVSHLGWGHWYTLRELEVSTNGFADENVIGEGGYGIVYHGVL 207
GSG VA V + + I + +
Sbjct: 156 -DGVLGSGKTWVALD--------------VCL----------SYKVQCKMDFKIFWLNLK 190
Query: 208 EDNTNVAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDN 266
N+ V +L Q + + + ++ + + R L
Sbjct: 191 NCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHS------IQAELRRL------- 237
Query: 267 GNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQW 326
L+ + + L ++L ++
Sbjct: 238 --LKSKPY----ENC-L-------LVL-------------------LNV----------Q 254
Query: 327 NPK-LSDFGL-AKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVY----SFGILI 380
N K + F L K+L +TTR +++ + L+ S +L+
Sbjct: 255 NAKAWNAFNLSCKIL------LTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLL 308
Query: 381 MEVISGRNPVDYSRPPGEVNLVEWLK-TMVTNRNAEGVLDPRLQEKPC---------SRA 430
+ + P EV + +++ AE +++
Sbjct: 309 -KYLD----CRPQDLPREVLTTNPRRLSII----AE-----SIRDGLATWDNWKHVNCDK 354
Query: 431 LKRALLVALRCVDPNAHKR--------PKMGHV-IHMLEA--EEFPFRDVSFGRVIGILF 479
L + +L ++P +++ P H+ +L + DV V+
Sbjct: 355 LTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDV---MVVVNKL 411
Query: 480 FLKALL------YSTLVMQLYLLKNFLLHVSLFLH 508
+L+ + + +YL L LH
Sbjct: 412 HKYSLVEKQPKESTISIPSIYLELKVKLENEYALH 446
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 508 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.95 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.91 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.82 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.71 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.38 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.27 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.09 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.04 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.75 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.56 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.53 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.45 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.29 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.29 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.06 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.04 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.02 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.85 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.57 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.54 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.41 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.34 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.33 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.32 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.22 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.16 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.13 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.01 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.84 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.84 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 96.82 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 96.77 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 96.53 | |
| 2k1k_A | 38 | Ephrin type-A receptor 1; EPHA1, receptor tyrosine | 96.45 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.89 | |
| 2l34_A | 33 | TYRO protein tyrosine kinase-binding protein; immu | 95.46 | |
| 2k9y_A | 41 | Ephrin type-A receptor 2; receptor tyrosine kinase | 95.1 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 93.3 | |
| 2l8s_A | 54 | Integrin alpha-1; transmembrane region, detergent | 93.24 | |
| 2knc_A | 54 | Integrin alpha-IIB; transmembrane signaling, prote | 92.55 | |
| 2k1a_A | 42 | Integrin alpha-IIB; single-PASS transmembrane segm | 91.15 | |
| 1iij_A | 35 | ERBB-2 receptor protein-tyrosine kinase; alpha-hel | 90.61 | |
| 1q55_A | 880 | EP-cadherin, C-cadherin; trans interaction, desmos | 86.12 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 84.61 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 84.44 | |
| 2knc_B | 79 | Integrin beta-3; transmembrane signaling, protein | 82.64 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 81.67 | |
| 2k9j_B | 43 | Integrin beta-3; transmembrane complex, cell adhes | 80.85 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-57 Score=446.33 Aligned_cols=261 Identities=25% Similarity=0.471 Sum_probs=214.4
Q ss_pred hcCCCCcccceEcccCcEEEEEEEEC------CCcEEEEEEeecCCchhHHHHHHHHHHHHccCCCCeeeEeeeeecCCe
Q 010513 183 VSTNGFADENVIGEGGYGIVYHGVLE------DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAH 256 (508)
Q Consensus 183 ~~~~~~~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 256 (508)
+..++|.+.+.||+|+||+||+|++. ++..||||++........++|.+|+++|++++|||||+++|+|.+++.
T Consensus 10 I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~ 89 (299)
T 4asz_A 10 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDP 89 (299)
T ss_dssp CCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred cCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCE
Confidence 45578999999999999999999864 367899999987766677889999999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHhccCC---------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCC
Q 010513 257 RMLVYEYIDNGNLEQWLHGDV---------GPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWN 327 (508)
Q Consensus 257 ~~lV~e~~~~g~L~~~l~~~~---------~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~ 327 (508)
.|+|||||++|+|.++|+... .....+++..++.++.|+++||+|||++ +|+||||||+|||++.++.
T Consensus 90 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~ 166 (299)
T 4asz_A 90 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLL 166 (299)
T ss_dssp EEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGC
T ss_pred EEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCc
Confidence 999999999999999997642 2345799999999999999999999999 9999999999999999999
Q ss_pred eEEeeeccceecCCCCcce-ecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHh-CCCCCCCCCCCCcchHHHHH
Q 010513 328 PKLSDFGLAKLLGAERSYV-TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWL 405 (508)
Q Consensus 328 ~kL~DFG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~ 405 (508)
+||+|||+|+......... ....+||+.|||||++.++.|+.++|||||||+||||+| |+.||..... .+.+
T Consensus 167 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~------~~~~ 240 (299)
T 4asz_A 167 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN------NEVI 240 (299)
T ss_dssp EEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH------HHHH
T ss_pred EEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH------HHHH
Confidence 9999999998765443333 234679999999999999999999999999999999999 9999975431 2222
Q ss_pred HHhhcccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010513 406 KTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (508)
Q Consensus 406 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~~ 462 (508)
........ +.. ...++.. +.+++.+||+.||++|||+.+|++.|++.
T Consensus 241 ~~i~~~~~------~~~-p~~~~~~---~~~li~~cl~~dP~~RPs~~~i~~~L~~~ 287 (299)
T 4asz_A 241 ECITQGRV------LQR-PRTCPQE---VYELMLGCWQREPHMRKNIKGIHTLLQNL 287 (299)
T ss_dssp HHHHHTCC------CCC-CTTCCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHcCCC------CCC-CccchHH---HHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 22222111 111 1224444 44588899999999999999999999864
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-56 Score=442.83 Aligned_cols=266 Identities=27% Similarity=0.459 Sum_probs=210.5
Q ss_pred HhhcCCCCcccceEcccCcEEEEEEEECCCcEEEEEEeecC--CchhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeE
Q 010513 181 LEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM 258 (508)
Q Consensus 181 ~~~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 258 (508)
+++..+++++.++||+|+||+||+|+++ ..||||.+... ..+..+.|.+|++++++++|||||++++++.+ +.+|
T Consensus 31 Wei~~~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~ 107 (307)
T 3omv_A 31 WEIEASEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLA 107 (307)
T ss_dssp CBCCTTSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCE
T ss_pred cEEcHHHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEE
Confidence 4678889999999999999999999875 35999988543 33455789999999999999999999999865 5689
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeecccee
Q 010513 259 LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL 338 (508)
Q Consensus 259 lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~ 338 (508)
||||||++|+|.++|+.. ...+++..+..++.|+++||+|||++ +||||||||+|||+++++.+||+|||+|+.
T Consensus 108 iVmEy~~gGsL~~~l~~~---~~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~ 181 (307)
T 3omv_A 108 IVTQWCEGSSLYKHLHVQ---ETKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATV 181 (307)
T ss_dssp EEEECCSSCBHHHHHHTS---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC
T ss_pred EEEEcCCCCCHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCcee
Confidence 999999999999999765 35799999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCC-cceecceecCCCCCChhhhhc---CCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhccccc
Q 010513 339 LGAER-SYVTTRVMGTFGYVAPEYAST---GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNA 414 (508)
Q Consensus 339 ~~~~~-~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 414 (508)
..... .......+||+.|||||++.+ +.|+.++|||||||+||||+||+.||...... ..+......+
T Consensus 182 ~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~------~~~~~~~~~~-- 253 (307)
T 3omv_A 182 KSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNR------DQIIFMVGRG-- 253 (307)
T ss_dssp ------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH------HHHHHHHHTT--
T ss_pred cccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChH------HHHHHHHhcC--
Confidence 64322 233455789999999999964 45899999999999999999999999754321 1122222221
Q ss_pred ccCCCccCC--CCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCCCCCC
Q 010513 415 EGVLDPRLQ--EKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEEFPFRD 468 (508)
Q Consensus 415 ~~~~~~~l~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~~~~~~~~ 468 (508)
...|.+. ...++..+ .+++.+||+.||++|||+.||+++|+....++++
T Consensus 254 --~~~p~~~~~~~~~~~~l---~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~lpk 304 (307)
T 3omv_A 254 --YASPDLSKLYKNCPKAM---KRLVADCVKKVKEERPLFPQILSSIELLQHSLPK 304 (307)
T ss_dssp --CCCCCSTTSCTTSCHHH---HHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTCCC
T ss_pred --CCCCCcccccccchHHH---HHHHHHHcCCCHhHCcCHHHHHHHHHHHhccCCC
Confidence 1122211 12244444 4478899999999999999999999877666654
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-56 Score=447.99 Aligned_cols=261 Identities=26% Similarity=0.460 Sum_probs=208.1
Q ss_pred hcCCCCcccceEcccCcEEEEEEEEC------CCcEEEEEEeecCCchhHHHHHHHHHHHHccCCCCeeeEeeeeecCCe
Q 010513 183 VSTNGFADENVIGEGGYGIVYHGVLE------DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAH 256 (508)
Q Consensus 183 ~~~~~~~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 256 (508)
+..++|.+.++||+|+||+||+|++. +++.||||++........++|.+|+++|++++|||||+++|+|.+++.
T Consensus 38 i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~ 117 (329)
T 4aoj_A 38 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRP 117 (329)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred cCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 45567888999999999999999864 467899999987766677889999999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHhccCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCC
Q 010513 257 RMLVYEYIDNGNLEQWLHGDVG-----------PHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQ 325 (508)
Q Consensus 257 ~~lV~e~~~~g~L~~~l~~~~~-----------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~ 325 (508)
.|||||||++|+|.++++.... ...++++..++.++.|+++||+|||++ +|+||||||+||||+++
T Consensus 118 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~ 194 (329)
T 4aoj_A 118 LLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQG 194 (329)
T ss_dssp EEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETT
T ss_pred EEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCC
Confidence 9999999999999999976431 235699999999999999999999999 99999999999999999
Q ss_pred CCeEEeeeccceecCCCCcc-eecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHh-CCCCCCCCCCCCcchHHH
Q 010513 326 WNPKLSDFGLAKLLGAERSY-VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVE 403 (508)
Q Consensus 326 ~~~kL~DFG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~ 403 (508)
+.+||+|||+++........ ..+..+||+.|||||++.+..|+.++|||||||+||||+| |+.||..... .+
T Consensus 195 ~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~------~~ 268 (329)
T 4aoj_A 195 LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN------TE 268 (329)
T ss_dssp TEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH------HH
T ss_pred CcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCH------HH
Confidence 99999999999876443322 3345689999999999999999999999999999999999 9999974431 22
Q ss_pred HHHHhhcccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010513 404 WLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (508)
Q Consensus 404 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~~ 462 (508)
.+.......+ +.. .+.++.. +.+++.+||+.||++|||+.||+++|+..
T Consensus 269 ~~~~i~~g~~------~~~-p~~~~~~---~~~li~~cl~~dP~~RPs~~ei~~~L~~l 317 (329)
T 4aoj_A 269 AIDCITQGRE------LER-PRACPPE---VYAIMRGCWQREPQQRHSIKDVHARLQAL 317 (329)
T ss_dssp HHHHHHHTCC------CCC-CTTCCHH---HHHHHHHHCCSSTTTSCCHHHHHHHHHHH
T ss_pred HHHHHHcCCC------CCC-cccccHH---HHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 2222222111 111 1224444 44588899999999999999999999874
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-56 Score=445.97 Aligned_cols=250 Identities=26% Similarity=0.352 Sum_probs=209.4
Q ss_pred CCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCchhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEEec
Q 010513 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYI 264 (508)
Q Consensus 186 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~ 264 (508)
+.|++.++||+|+||+||+|+++ +|+.||||++........+.+.+|+++|+.++|||||+++++|.+++.+|||||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 46999999999999999999976 68899999997665555677889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCCCc
Q 010513 265 DNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS 344 (508)
Q Consensus 265 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~ 344 (508)
+||+|.+++... .+++..+..++.||+.||+|||++ +|+||||||+|||++.+|++||+|||+|+.+....
T Consensus 154 ~gg~L~~~l~~~-----~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~- 224 (346)
T 4fih_A 154 EGGALTDIVTHT-----RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV- 224 (346)
T ss_dssp TTEEHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS-
T ss_pred CCCcHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCCC-
Confidence 999999999753 589999999999999999999999 99999999999999999999999999999775433
Q ss_pred ceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCCccCCC
Q 010513 345 YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQE 424 (508)
Q Consensus 345 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 424 (508)
...+..+||+.|||||++.+..|+.++|||||||++|||++|+.||.... ..+.+...... ..+.+..
T Consensus 225 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~------~~~~~~~i~~~------~~~~~~~ 292 (346)
T 4fih_A 225 PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP------PLKAMKMIRDN------LPPRLKN 292 (346)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC------HHHHHHHHHHS------SCCCCSC
T ss_pred CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC------HHHHHHHHHcC------CCCCCCc
Confidence 23455789999999999999999999999999999999999999997432 12222222111 1111111
Q ss_pred CchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 425 KPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 425 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
......++.+++.+||+.||++|||+.|++++
T Consensus 293 --~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 293 --LHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 324 (346)
T ss_dssp --GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred --cccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 11222345558889999999999999999874
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-56 Score=447.42 Aligned_cols=252 Identities=21% Similarity=0.362 Sum_probs=203.5
Q ss_pred CCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCC--chhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEE
Q 010513 185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY 261 (508)
Q Consensus 185 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 261 (508)
.++|++++.||+|+||+||+|++. +|+.||||++.... ....+.+.+|+++|++++|||||+++++|++++.+||||
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm 102 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM 102 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 368999999999999999999976 68899999996543 334567899999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCC
Q 010513 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA 341 (508)
Q Consensus 262 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 341 (508)
|||+||+|.++|.... ...+++..++.++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+|+.+..
T Consensus 103 Ey~~gg~L~~~i~~~~--~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 177 (350)
T 4b9d_A 103 DYCEGGDLFKRINAQK--GVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS 177 (350)
T ss_dssp ECCTTCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCH
T ss_pred eCCCCCcHHHHHHHcC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecC
Confidence 9999999999997642 35689999999999999999999999 999999999999999999999999999987643
Q ss_pred CCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCCcc
Q 010513 342 ERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPR 421 (508)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 421 (508)
. ....+..+||+.|||||++.+..|+.++|||||||+||||+||+.||...+ ..+.+....... . . .
T Consensus 178 ~-~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~------~~~~~~~i~~~~-~----~-~ 244 (350)
T 4b9d_A 178 T-VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGS------MKNLVLKIISGS-F----P-P 244 (350)
T ss_dssp H-HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS------HHHHHHHHHHTC-C----C-C
T ss_pred C-cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC------HHHHHHHHHcCC-C----C-C
Confidence 2 222345789999999999999999999999999999999999999997432 223333333221 1 1 1
Q ss_pred CCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 422 LQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 422 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
+.. ..+. ++.+++.+||+.||++|||+.|++++
T Consensus 245 ~~~-~~s~---~~~~li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 245 VSL-HYSY---DLRSLVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp CCT-TSCH---HHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CCc-cCCH---HHHHHHHHHccCChhHCcCHHHHhcC
Confidence 111 1233 34557889999999999999999864
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-56 Score=440.57 Aligned_cols=262 Identities=26% Similarity=0.416 Sum_probs=212.4
Q ss_pred hcCCCCcccceEcccCcEEEEEEEEC------CCcEEEEEEeecCC-chhHHHHHHHHHHHHccCCCCeeeEeeeeecCC
Q 010513 183 VSTNGFADENVIGEGGYGIVYHGVLE------DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGA 255 (508)
Q Consensus 183 ~~~~~~~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~ 255 (508)
+...++++.++||+|+||+||+|.+. +++.||||++.... ....++|.+|+.++++++|||||+++|+|.+++
T Consensus 23 i~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~ 102 (308)
T 4gt4_A 23 ISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQ 102 (308)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECC
Confidence 44556788899999999999999863 46789999986543 344578999999999999999999999999999
Q ss_pred eeEEEEEecCCCCHHHHhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEc
Q 010513 256 HRMLVYEYIDNGNLEQWLHGDVG------------PHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLD 323 (508)
Q Consensus 256 ~~~lV~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~ 323 (508)
..++|||||++|+|.++|..... ....+++..++.++.|+|+||+|||++ +||||||||+||||+
T Consensus 103 ~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~ 179 (308)
T 4gt4_A 103 PLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVY 179 (308)
T ss_dssp SCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEC
T ss_pred EEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEEC
Confidence 99999999999999999965421 124689999999999999999999999 999999999999999
Q ss_pred CCCCeEEeeeccceecCCCCc-ceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHh-CCCCCCCCCCCCcchH
Q 010513 324 KQWNPKLSDFGLAKLLGAERS-YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNL 401 (508)
Q Consensus 324 ~~~~~kL~DFG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~ 401 (508)
+++++||+|||+++....... ...+..+||+.|||||++.++.|+.++|||||||+||||+| |+.||.....
T Consensus 180 ~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~------ 253 (308)
T 4gt4_A 180 DKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN------ 253 (308)
T ss_dssp GGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH------
T ss_pred CCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH------
Confidence 999999999999987644332 23445689999999999999999999999999999999999 8999975432
Q ss_pred HHHHHHhhcccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 010513 402 VEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEE 463 (508)
Q Consensus 402 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~~~ 463 (508)
.+.+.. +..+.. .+ . .+.++.. +.+++.+||+.||++||++.||+++|++-.
T Consensus 254 ~~~~~~-i~~~~~----~~-~-p~~~~~~---~~~li~~C~~~dP~~RPs~~ei~~~L~a~~ 305 (308)
T 4gt4_A 254 QDVVEM-IRNRQV----LP-C-PDDCPAW---VYALMIECWNEFPSRRPRFKDIHSRLRAWG 305 (308)
T ss_dssp HHHHHH-HHTTCC----CC-C-CTTCCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred HHHHHH-HHcCCC----CC-C-cccchHH---HHHHHHHHcCCChhHCcCHHHHHHHHHhcc
Confidence 222222 222211 11 1 1224444 445888999999999999999999998753
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-55 Score=446.59 Aligned_cols=250 Identities=26% Similarity=0.347 Sum_probs=210.0
Q ss_pred CCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCchhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEEe
Q 010513 185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY 263 (508)
Q Consensus 185 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~ 263 (508)
.+.|++.++||+|+||+||+|+++ +|+.||||++........+.+.+|+++|+.++|||||+++++|.+++.+||||||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy 229 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 229 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence 457999999999999999999976 5889999999766666667789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCCC
Q 010513 264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER 343 (508)
Q Consensus 264 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 343 (508)
|+||+|.+++... .+++..+..++.||+.||+|||++ +||||||||+||||+.+|.+||+|||+|+.+....
T Consensus 230 ~~gG~L~~~i~~~-----~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~ 301 (423)
T 4fie_A 230 LEGGALTDIVTHT-----RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV 301 (423)
T ss_dssp CTTEEHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC
T ss_pred CCCCcHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCCCC
Confidence 9999999999753 589999999999999999999999 99999999999999999999999999999775433
Q ss_pred cceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCCccCC
Q 010513 344 SYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQ 423 (508)
Q Consensus 344 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 423 (508)
...+..+||+.|||||++.+..|+.++|||||||++|||++|+.||.... ..+.+....... .+.+.
T Consensus 302 -~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~------~~~~~~~i~~~~------~~~~~ 368 (423)
T 4fie_A 302 -PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP------PLKAMKMIRDNL------PPRLK 368 (423)
T ss_dssp -CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC------HHHHHHHHHHSC------CCCCS
T ss_pred -ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC------HHHHHHHHHcCC------CCCCc
Confidence 23456799999999999999999999999999999999999999997432 222222222111 11111
Q ss_pred C-CchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 424 E-KPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 424 ~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
. ...+. ++.+++.+||+.||++|||+.|++++
T Consensus 369 ~~~~~s~---~~~dli~~~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 369 NLHKVSP---SLKGFLDRLLVRDPAQRATAAELLKH 401 (423)
T ss_dssp CTTSSCH---HHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ccccCCH---HHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 1 11233 44557789999999999999999874
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-56 Score=436.55 Aligned_cols=247 Identities=22% Similarity=0.309 Sum_probs=207.2
Q ss_pred CCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCC---chhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEE
Q 010513 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY 261 (508)
Q Consensus 186 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 261 (508)
++|++.+.||+|+||+||+|++. +++.||||++.+.. ....+.+.+|+++|++++|||||+++++|++++.+|+||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 47999999999999999999976 68899999996542 234567899999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCC
Q 010513 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA 341 (508)
Q Consensus 262 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 341 (508)
|||+||+|.+++.+. +.+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.+..
T Consensus 112 Ey~~gG~L~~~i~~~----~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~ 184 (311)
T 4aw0_A 112 SYAKNGELLKYIRKI----GSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP 184 (311)
T ss_dssp CCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred ecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCC
Confidence 999999999999765 5799999999999999999999999 999999999999999999999999999998754
Q ss_pred CC-cceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCCc
Q 010513 342 ER-SYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDP 420 (508)
Q Consensus 342 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 420 (508)
.. .......+||+.|||||++.+..|+.++|||||||++|||+||+.||...+ ..+.+...... . .
T Consensus 185 ~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~------~~~~~~~i~~~-~------~ 251 (311)
T 4aw0_A 185 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN------EGLIFAKIIKL-E------Y 251 (311)
T ss_dssp TTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHT-C------C
T ss_pred CCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC------HHHHHHHHHcC-C------C
Confidence 33 233456799999999999999999999999999999999999999997432 22222222221 1 1
Q ss_pred cCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 010513 421 RLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVI 456 (508)
Q Consensus 421 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl 456 (508)
.+... .+. ++.+++.+||+.||++||++.|++
T Consensus 252 ~~p~~-~s~---~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 252 DFPEK-FFP---KARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp CCCTT-CCH---HHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred CCCcc-cCH---HHHHHHHHHccCCHhHCcChHHHc
Confidence 11111 223 345588899999999999999864
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-54 Score=433.57 Aligned_cols=251 Identities=19% Similarity=0.226 Sum_probs=203.0
Q ss_pred CCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCchhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEEe
Q 010513 185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY 263 (508)
Q Consensus 185 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~ 263 (508)
.+.|++.++||+|+||+||+|+++ +|+.||||++..... ..+|+++++.++|||||+++++|.+++.+||||||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 131 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL 131 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 456888999999999999999976 588999999965432 23599999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCC-CeEEeeeccceecCCC
Q 010513 264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQW-NPKLSDFGLAKLLGAE 342 (508)
Q Consensus 264 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~-~~kL~DFG~a~~~~~~ 342 (508)
|+||+|.+++++. +.+++..+..++.|++.||+|||++ +||||||||+||||+.+| ++||+|||+|+.+...
T Consensus 132 ~~gg~L~~~l~~~----~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~ 204 (336)
T 4g3f_A 132 LEGGSLGQLIKQM----GCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPD 204 (336)
T ss_dssp CTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC---
T ss_pred cCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCC
Confidence 9999999999865 5799999999999999999999999 999999999999999987 5999999999987543
Q ss_pred Ccc----eecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCC
Q 010513 343 RSY----VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVL 418 (508)
Q Consensus 343 ~~~----~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 418 (508)
... .....+||+.|||||++.+..|+.++|||||||++|||+||+.||......... .. ........
T Consensus 205 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~---~~---i~~~~~~~--- 275 (336)
T 4g3f_A 205 GLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLC---LK---IASEPPPI--- 275 (336)
T ss_dssp ---------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCH---HH---HHHSCCGG---
T ss_pred CcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHH---HH---HHcCCCCc---
Confidence 221 123468999999999999999999999999999999999999999765443221 11 11111000
Q ss_pred CccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 010513 419 DPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461 (508)
Q Consensus 419 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~ 461 (508)
..+. ..++.. +.+++.+||+.||++|||+.|++++|..
T Consensus 276 -~~~~-~~~s~~---~~~li~~~L~~dP~~R~sa~el~~~l~~ 313 (336)
T 4g3f_A 276 -REIP-PSCAPL---TAQAIQEGLRKEPVHRASAMELRRKVGK 313 (336)
T ss_dssp -GGSC-TTSCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -hhcC-ccCCHH---HHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence 0111 123333 4447779999999999999999988764
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-54 Score=424.80 Aligned_cols=246 Identities=24% Similarity=0.396 Sum_probs=197.5
Q ss_pred CcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCC--chhHHHHHHHHHHHHccCCCCeeeEeeeeec----CCeeEEE
Q 010513 188 FADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE----GAHRMLV 260 (508)
Q Consensus 188 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~----~~~~~lV 260 (508)
|++.++||+|+||+||+|.+. ++..||+|++.... ....+.|.+|++++++++|||||+++++|.+ +..+|||
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv 107 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence 366788999999999999976 58889999986542 3345679999999999999999999999865 3568999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eeeccCCCCCEEEcC-CCCeEEeeeccce
Q 010513 261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK--VVHRDIKSSNILLDK-QWNPKLSDFGLAK 337 (508)
Q Consensus 261 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~--iiHrDlkp~NIll~~-~~~~kL~DFG~a~ 337 (508)
||||++|+|.+++.+. ..+++..+..++.|++.||+|||++ + |+||||||+|||++. ++.+||+|||+|+
T Consensus 108 mEy~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~ylH~~---~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~ 180 (290)
T 3fpq_A 108 TELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp EECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCCCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred EeCCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCCEEecccChhheeEECCCCCEEEEeCcCCE
Confidence 9999999999999865 5799999999999999999999998 6 999999999999974 7899999999998
Q ss_pred ecCCCCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccC
Q 010513 338 LLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGV 417 (508)
Q Consensus 338 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 417 (508)
.... ......+||+.|||||++.+ .|+.++|||||||+||||+||+.||..... ...... .+....
T Consensus 181 ~~~~---~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~-----~~~~~~-~i~~~~---- 246 (290)
T 3fpq_A 181 LKRA---SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN-----AAQIYR-RVTSGV---- 246 (290)
T ss_dssp GCCT---TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS-----HHHHHH-HHTTTC----
T ss_pred eCCC---CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCc-----HHHHHH-HHHcCC----
Confidence 6432 23445789999999999865 699999999999999999999999964322 112222 222211
Q ss_pred CCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 418 LDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 418 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
..+.+... .+. ++.+++.+||+.||++|||+.|++++
T Consensus 247 ~~~~~~~~-~~~---~~~~li~~~L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 247 KPASFDKV-AIP---EVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp CCGGGGGC-CCH---HHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCCCCCcc-CCH---HHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11111111 222 34558889999999999999999864
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-54 Score=420.46 Aligned_cols=246 Identities=22% Similarity=0.345 Sum_probs=190.5
Q ss_pred CCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCC---chhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEE
Q 010513 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY 261 (508)
Q Consensus 186 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 261 (508)
++|++.+.||+|+||+||+|++. +|+.||+|++.+.. ....+.+.+|+++++.++|||||++++++.+++..|+||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 58999999999999999999965 68999999986542 233567899999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCC
Q 010513 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA 341 (508)
Q Consensus 262 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 341 (508)
||| +|+|.+++.+. +.+++..+..++.|++.||+|||++ +|+||||||+|||++.++++||+|||+|+....
T Consensus 93 Ey~-~g~L~~~l~~~----~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 164 (275)
T 3hyh_A 93 EYA-GNELFDYIVQR----DKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD 164 (275)
T ss_dssp ECC-CEEHHHHHHHS----CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC-----
T ss_pred eCC-CCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCC
Confidence 999 57999999765 5799999999999999999999999 999999999999999999999999999987543
Q ss_pred CCcceecceecCCCCCChhhhhcCCC-CCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCCc
Q 010513 342 ERSYVTTRVMGTFGYVAPEYASTGML-NERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDP 420 (508)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 420 (508)
. ......+||+.|||||++.+..| +.++|||||||++|||+||+.||.... ..+..+.... .. .
T Consensus 165 ~--~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~------~~~~~~~i~~-~~------~ 229 (275)
T 3hyh_A 165 G--NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES------IPVLFKNISN-GV------Y 229 (275)
T ss_dssp ------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHH-TC------C
T ss_pred C--CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCC------HHHHHHHHHc-CC------C
Confidence 2 23345789999999999988776 578999999999999999999996432 2222222222 11 1
Q ss_pred cCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 421 RLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 421 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
.+.. ..+. ++.+++.+||+.||++|||+.|++++
T Consensus 230 ~~p~-~~s~---~~~~li~~~L~~dP~~R~s~~eil~h 263 (275)
T 3hyh_A 230 TLPK-FLSP---GAAGLIKRMLIVNPLNRISIHEIMQD 263 (275)
T ss_dssp CCCT-TSCH---HHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred CCCC-CCCH---HHHHHHHHHccCChhHCcCHHHHHcC
Confidence 1111 1233 34457889999999999999999874
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-54 Score=434.89 Aligned_cols=268 Identities=25% Similarity=0.384 Sum_probs=217.1
Q ss_pred cchhhHhhcCCCCcccceEcccCcEEEEEEEECC------CcEEEEEEeecCCc-hhHHHHHHHHHHHHccCC-CCeeeE
Q 010513 176 YTLRELEVSTNGFADENVIGEGGYGIVYHGVLED------NTNVAVKNLLNNRG-QAEKEFKVEVEAIGRVRH-KNLVRL 247 (508)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h-pniv~l 247 (508)
|...+++++.++|++.+.||+|+||+||+|.+.. ++.||||.+..... ...+.|.+|+++|.+++| ||||++
T Consensus 54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l 133 (353)
T 4ase_A 54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 133 (353)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence 4456788999999999999999999999999653 25799999876543 345679999999999965 999999
Q ss_pred eeeeecC-CeeEEEEEecCCCCHHHHhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecc
Q 010513 248 LGYCAEG-AHRMLVYEYIDNGNLEQWLHGDVG------------PHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRD 314 (508)
Q Consensus 248 ~~~~~~~-~~~~lV~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrD 314 (508)
+|+|.+. +.+|+|||||++|+|.++|+.... ....+++..+..++.|+|+||+|||++ +|||||
T Consensus 134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRD 210 (353)
T 4ase_A 134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRD 210 (353)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCc
Confidence 9998764 568999999999999999975421 134689999999999999999999999 999999
Q ss_pred CCCCCEEEcCCCCeEEeeeccceecCCCCcc-eecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHh-CCCCCCC
Q 010513 315 IKSSNILLDKQWNPKLSDFGLAKLLGAERSY-VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDY 392 (508)
Q Consensus 315 lkp~NIll~~~~~~kL~DFG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~Pf~~ 392 (508)
|||+|||+++++.+||+|||+|+.+...... ..+..+||+.|||||++.++.|+.++|||||||+||||+| |+.||..
T Consensus 211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~ 290 (353)
T 4ase_A 211 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 290 (353)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred cCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999999977544433 3456789999999999999999999999999999999998 9999975
Q ss_pred CCCCCcchHHHHHHHhhcccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 010513 393 SRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461 (508)
Q Consensus 393 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~ 461 (508)
..... .+ ...+..+. .+... +.++. ++.+++.+||+.||++|||+.||+++|+.
T Consensus 291 ~~~~~--~~----~~~i~~g~-----~~~~p-~~~~~---~~~~li~~c~~~dP~~RPt~~eil~~L~~ 344 (353)
T 4ase_A 291 VKIDE--EF----CRRLKEGT-----RMRAP-DYTTP---EMYQTMLDCWHGEPSQRPTFSELVEHLGN 344 (353)
T ss_dssp CCCSH--HH----HHHHHHTC-----CCCCC-TTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCHHH--HH----HHHHHcCC-----CCCCC-ccCCH---HHHHHHHHHcCcChhHCcCHHHHHHHHHH
Confidence 43321 11 12222211 11111 22333 34558889999999999999999999875
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-54 Score=424.12 Aligned_cols=264 Identities=24% Similarity=0.350 Sum_probs=201.3
Q ss_pred CCcccceEcccCcEEEEEEEECCCcEEEEEEeecCCchhHHHHHHHHHHHHccCCCCeeeEeeeeecCC----eeEEEEE
Q 010513 187 GFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGA----HRMLVYE 262 (508)
Q Consensus 187 ~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~----~~~lV~e 262 (508)
+|.+.++||+|+||+||+|+++ |+.||||++.... .....+..|+..+.+++|||||++++++.+++ .+|||||
T Consensus 4 ~i~L~~~iG~G~fG~Vy~~~~~-g~~VAvK~l~~~~-~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~E 81 (303)
T 3hmm_A 4 TIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD 81 (303)
T ss_dssp GEEEEEEEEECSSSEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred EEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccc-hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEec
Confidence 5788899999999999999985 8899999985432 22223344666667889999999999998654 5799999
Q ss_pred ecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----CCCeeeccCCCCCEEEcCCCCeEEeeeccce
Q 010513 263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGL-----EPKVVHRDIKSSNILLDKQWNPKLSDFGLAK 337 (508)
Q Consensus 263 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~-----~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~ 337 (508)
||++|+|.++++.. .+++..+..++.|++.||+|||+++ +++|+||||||+|||++.++++||+|||+++
T Consensus 82 y~~~gsL~~~l~~~-----~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~ 156 (303)
T 3hmm_A 82 YHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp CCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred CCCCCcHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence 99999999999764 6899999999999999999999752 4589999999999999999999999999998
Q ss_pred ecCCCCcce---ecceecCCCCCChhhhhcC------CCCCCCCeeehHHHHHHHHhCCCCCCCCCCC---------Ccc
Q 010513 338 LLGAERSYV---TTRVMGTFGYVAPEYASTG------MLNERSDVYSFGILIMEVISGRNPVDYSRPP---------GEV 399 (508)
Q Consensus 338 ~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~---------~~~ 399 (508)
......... ....+||+.|||||++.+. .|+.++|||||||+||||+||..||...... ...
T Consensus 157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~ 236 (303)
T 3hmm_A 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred cccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccc
Confidence 775443322 2346899999999999764 3677999999999999999998877543221 111
Q ss_pred hHHHHHHHhhcccccccCCCccCCCCc-hHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010513 400 NLVEWLKTMVTNRNAEGVLDPRLQEKP-CSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (508)
Q Consensus 400 ~~~~~~~~~~~~~~~~~~~~~~l~~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~~ 462 (508)
.. +.+...... ..++|.+.... .......+.+++.+||+.||++|||+.||++.|+..
T Consensus 237 ~~-~~~~~~~~~----~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l 295 (303)
T 3hmm_A 237 SV-EEMRKVVCE----QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295 (303)
T ss_dssp CH-HHHHHHHTT----SCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred hH-HHHHHHHhc----ccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 12 222222222 22333333221 224455667789999999999999999999999753
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-54 Score=427.59 Aligned_cols=247 Identities=24% Similarity=0.282 Sum_probs=196.0
Q ss_pred CCCcccceEcccCcEEEEEEEEC----CCcEEEEEEeecCC--chhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEE
Q 010513 186 NGFADENVIGEGGYGIVYHGVLE----DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRML 259 (508)
Q Consensus 186 ~~~~~~~~LG~G~~g~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 259 (508)
++|++.+.||+|+||+||+|+.. +++.||||.+.+.. ......+.+|+++|++++|||||++++++++++.+|+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 57999999999999999999863 46789999986542 2223467889999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceec
Q 010513 260 VYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL 339 (508)
Q Consensus 260 V~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~ 339 (508)
|||||+||+|.+++.+. ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++++||+|||+|+..
T Consensus 104 vmEy~~gg~L~~~l~~~----~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~ 176 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKE----VMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKES 176 (304)
T ss_dssp EECCCTTCEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC-
T ss_pred EEEcCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceec
Confidence 99999999999999875 5799999999999999999999999 9999999999999999999999999999865
Q ss_pred CCCCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCC
Q 010513 340 GAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLD 419 (508)
Q Consensus 340 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 419 (508)
.... ......+||+.|||||++.+..|+.++|||||||++|||+||+.||...+ ..+.+.......
T Consensus 177 ~~~~-~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~------~~~~~~~i~~~~------- 242 (304)
T 3ubd_A 177 IDHE-KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKD------RKETMTMILKAK------- 242 (304)
T ss_dssp -----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHCC-------
T ss_pred cCCC-ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcC------HHHHHHHHHcCC-------
Confidence 3322 23345789999999999999999999999999999999999999997432 222222222211
Q ss_pred ccCCCCchHHHHHHHHHHHHHccCCCCCCCCCH-----HHHHH
Q 010513 420 PRLQEKPCSRALKRALLVALRCVDPNAHKRPKM-----GHVIH 457 (508)
Q Consensus 420 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~ 457 (508)
+.+.. ..+. ++.+++.+||+.||++||++ +|+++
T Consensus 243 ~~~p~-~~s~---~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 243 LGMPQ-FLSP---EAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp CCCCT-TSCH---HHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred CCCCC-cCCH---HHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 11111 1233 34557889999999999984 56664
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-53 Score=415.61 Aligned_cols=258 Identities=23% Similarity=0.430 Sum_probs=192.3
Q ss_pred CCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCc-hhHHHHHHHHHHHHccCCCCeeeEeeeeecCC---------
Q 010513 187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGA--------- 255 (508)
Q Consensus 187 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~--------- 255 (508)
+|++.+.||+|+||+||+|+++ +|+.||||++..... ...+.+.+|+++|++++|||||+++++|.+.+
T Consensus 6 dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~ 85 (299)
T 4g31_A 6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSS 85 (299)
T ss_dssp HEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC---------
T ss_pred hCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccC
Confidence 5899999999999999999976 688999999865433 34567899999999999999999999987544
Q ss_pred ---eeEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEee
Q 010513 256 ---HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSD 332 (508)
Q Consensus 256 ---~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~D 332 (508)
.+|+|||||++|+|.+++.... ......+..++.++.|+++||+|||++ +|+||||||+|||++.++.+||+|
T Consensus 86 ~~~~l~ivmE~~~gg~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 86 PKVYLYIQMQLCRKENLKDWMNGRC-TIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp -CEEEEEEEECCCSCCHHHHHHTCC-SGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC
T ss_pred CCcEEEEEEecCCCCcHHHHHHhcC-CCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEcc
Confidence 3689999999999999997652 223456777899999999999999999 999999999999999999999999
Q ss_pred eccceecCCCCcc-----------eecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchH
Q 010513 333 FGLAKLLGAERSY-----------VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNL 401 (508)
Q Consensus 333 FG~a~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~ 401 (508)
||+|+.+...... ..+..+||+.|||||++.+..|+.++|||||||++|||++ ||.. ....
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~-----~~~~ 233 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFST-----QMER 233 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSS-----HHHH
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCC-----ccHH
Confidence 9999876543221 1234689999999999999999999999999999999996 7742 1111
Q ss_pred HHHHHHhhcccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhcCCCCC
Q 010513 402 VEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIH--MLEAEEFPF 466 (508)
Q Consensus 402 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~Le~~~~~~ 466 (508)
...+.... ... +. .........+.+++.+||+.||++|||+.|+++ .+++.++|-
T Consensus 234 ~~~~~~~~-~~~--------~p-~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~~p~ 290 (299)
T 4g31_A 234 VRTLTDVR-NLK--------FP-PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPG 290 (299)
T ss_dssp HHHHHHHH-TTC--------CC-HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC----
T ss_pred HHHHHHHh-cCC--------CC-CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCCCCC
Confidence 12121111 110 00 112233344566888999999999999999998 455555443
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-50 Score=412.76 Aligned_cols=261 Identities=24% Similarity=0.361 Sum_probs=201.4
Q ss_pred CCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCC--chhHHHHHHHHHHHHccCCCCeeeEeeeeec------CCe
Q 010513 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE------GAH 256 (508)
Q Consensus 186 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~------~~~ 256 (508)
++|++++.||+|+||+||+|++. +|+.||||++.+.. ....+.+.+|+++|+.++|||||++++++.. .+.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 57999999999999999999976 68999999996543 2344678899999999999999999998753 367
Q ss_pred eEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccc
Q 010513 257 RMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLA 336 (508)
Q Consensus 257 ~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a 336 (508)
+|||||||+ |+|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|
T Consensus 134 ~~ivmE~~~-g~L~~~i~~~----~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGla 205 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHSS----QPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMA 205 (398)
T ss_dssp EEEEEECCS-EEHHHHHTSS----SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEeCCC-CCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeeccee
Confidence 899999996 5899999765 5799999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCC---cceecceecCCCCCChhhhhcC-CCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhccc
Q 010513 337 KLLGAER---SYVTTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNR 412 (508)
Q Consensus 337 ~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 412 (508)
+.+.... .......+||+.|+|||++.+. .|+.++||||+||++|||++|+.||...+.. .....+.......
T Consensus 206 ~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~---~~l~~I~~~~g~p 282 (398)
T 4b99_A 206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYV---HQLQLIMMVLGTP 282 (398)
T ss_dssp BCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHH---HHHHHHHHHHCCC
T ss_pred eecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHH---HHHHHHHHhcCCC
Confidence 8764321 2234557999999999998775 5799999999999999999999999754321 1111111111100
Q ss_pred ccc--------------cCCCccCCCCch----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 413 NAE--------------GVLDPRLQEKPC----SRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 413 ~~~--------------~~~~~~l~~~~~----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
... ..+.+. ..... +....++.+|+.+||..||++|||+.|++++
T Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 283 SPAVIQAVGAERVRAYIQSLPPR-QPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp CGGGTC-----CHHHHHHSSCCC-CCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred ChHHhhhhhhhhhhhhhhcCCCc-CCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 000 000000 00000 1112456678889999999999999999874
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-49 Score=397.35 Aligned_cols=283 Identities=40% Similarity=0.717 Sum_probs=248.0
Q ss_pred chhhHhhcCCCCcccceEcccCcEEEEEEEECCCcEEEEEEeecCCchhHHHHHHHHHHHHccCCCCeeeEeeeeecCCe
Q 010513 177 TLRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAH 256 (508)
Q Consensus 177 ~~~~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 256 (508)
++.+++...++|++.+.||+|+||+||+|.+++++.||+|++........+.+.+|+++++.++||||+++++++.+++.
T Consensus 30 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 109 (321)
T 2qkw_B 30 PLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNE 109 (321)
T ss_dssp CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTC
T ss_pred cHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCe
Confidence 34555667889999999999999999999988899999999877766667889999999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccc
Q 010513 257 RMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLA 336 (508)
Q Consensus 257 ~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a 336 (508)
.++||||+++|+|.+++.........+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~ 186 (321)
T 2qkw_B 110 MILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGIS 186 (321)
T ss_dssp CEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCCTTC
T ss_pred EEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeecccc
Confidence 9999999999999999977654455799999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCC-cceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccc
Q 010513 337 KLLGAER-SYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAE 415 (508)
Q Consensus 337 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (508)
+...... ........||+.|+|||++.+..++.++|||||||++|||++|+.||....+....+...|...........
T Consensus 187 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (321)
T 2qkw_B 187 KKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLE 266 (321)
T ss_dssp EECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCC
T ss_pred cccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHH
Confidence 8754322 222344579999999999999999999999999999999999999998877766667777766666666666
Q ss_pred cCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010513 416 GVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (508)
Q Consensus 416 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~~ 462 (508)
..+++.+.....+.....+.+++.+||+.||++||++.+++++|+..
T Consensus 267 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 313 (321)
T 2qkw_B 267 QIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYA 313 (321)
T ss_dssp SSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 77777777666777888888899999999999999999999999864
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-50 Score=400.73 Aligned_cols=293 Identities=40% Similarity=0.758 Sum_probs=254.5
Q ss_pred CcccchhhHhhcCCCCcccceEcccCcEEEEEEEECCCcEEEEEEeecCCc-hhHHHHHHHHHHHHccCCCCeeeEeeee
Q 010513 173 GHWYTLRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNLVRLLGYC 251 (508)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~ 251 (508)
...+++.++.+..++|++.+.||+|+||.||+|...+++.||+|++..... .....+.+|+++++.++||||+++++++
T Consensus 17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 96 (326)
T 3uim_A 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 96 (326)
T ss_dssp CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEE
Confidence 345778999999999999999999999999999988899999999865432 2233688999999999999999999999
Q ss_pred ecCCeeEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEe
Q 010513 252 AEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLS 331 (508)
Q Consensus 252 ~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~ 331 (508)
.+....++||||+++|+|.+++.........+++..+..++.|++.||+|||+++.++|+||||||+|||++.++.+||+
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~ 176 (326)
T 3uim_A 97 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG 176 (326)
T ss_dssp CCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEEC
T ss_pred ecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEec
Confidence 99999999999999999999998876556679999999999999999999999877789999999999999999999999
Q ss_pred eeccceecCCCCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCC--CCCCcchHHHHHHHhh
Q 010513 332 DFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS--RPPGEVNLVEWLKTMV 409 (508)
Q Consensus 332 DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~--~~~~~~~~~~~~~~~~ 409 (508)
|||+++..............||+.|+|||++.+..++.++|||||||++|||++|+.||+.. .........+++....
T Consensus 177 Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 256 (326)
T 3uim_A 177 DFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 256 (326)
T ss_dssp CCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTT
T ss_pred cCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHh
Confidence 99999987655555556677999999999999999999999999999999999999999643 2233445666776666
Q ss_pred cccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCCC
Q 010513 410 TNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEEFP 465 (508)
Q Consensus 410 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~~~~~ 465 (508)
.........+..+...........+.+++.+||+.||++||++.+++++|++....
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~~ 312 (326)
T 3uim_A 257 KEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLA 312 (326)
T ss_dssp SSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSCS
T ss_pred hchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcchh
Confidence 66677777787777777888888999999999999999999999999999986644
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-49 Score=401.43 Aligned_cols=199 Identities=25% Similarity=0.394 Sum_probs=171.1
Q ss_pred cCCCCcccceEcccCcEEEEEEEEC----CCcEEEEEEeecCCchhHHHHHHHHHHHHcc-CCCCeeeEeeeeecCCeeE
Q 010513 184 STNGFADENVIGEGGYGIVYHGVLE----DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRM 258 (508)
Q Consensus 184 ~~~~~~~~~~LG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~ 258 (508)
..++|++.+.||+|+||+||+|+.+ +++.||+|++.+.. ....+.+|+++|+.+ +|||||+++++|.+.+++|
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~ 96 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVV 96 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEE
T ss_pred ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEE
Confidence 3468999999999999999999864 36789999986543 345678899999998 6999999999999999999
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCC-CCeEEeeeccce
Q 010513 259 LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQ-WNPKLSDFGLAK 337 (508)
Q Consensus 259 lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~-~~~kL~DFG~a~ 337 (508)
+|||||++|+|.+++. .+++.++..++.|++.||+|||++ +|+||||||+|||++.+ +.+||+|||+|+
T Consensus 97 lvmE~~~g~~L~~~~~-------~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFGla~ 166 (361)
T 4f9c_A 97 IAMPYLEHESFLDILN-------SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFGLAQ 166 (361)
T ss_dssp EEEECCCCCCHHHHHT-------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEEeCCCcccHHHHHc-------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCCCCc
Confidence 9999999999999983 489999999999999999999999 99999999999999876 799999999998
Q ss_pred ecCCCCc---------------------------ceecceecCCCCCChhhhhcC-CCCCCCCeeehHHHHHHHHhCCCC
Q 010513 338 LLGAERS---------------------------YVTTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRNP 389 (508)
Q Consensus 338 ~~~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~P 389 (508)
....... ...+..+||+.|+|||++.+. .|+.++||||+||++|||++|+.|
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~P 246 (361)
T 4f9c_A 167 GTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYP 246 (361)
T ss_dssp ECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSS
T ss_pred ccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCC
Confidence 6543211 112345899999999998775 589999999999999999999999
Q ss_pred CCCCC
Q 010513 390 VDYSR 394 (508)
Q Consensus 390 f~~~~ 394 (508)
|....
T Consensus 247 f~~~~ 251 (361)
T 4f9c_A 247 FYKAS 251 (361)
T ss_dssp SSCCS
T ss_pred CCCCC
Confidence 96443
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-49 Score=423.80 Aligned_cols=253 Identities=21% Similarity=0.346 Sum_probs=210.7
Q ss_pred CCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCchhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEEe
Q 010513 185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY 263 (508)
Q Consensus 185 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~ 263 (508)
.++|++.+.||+|+||+||+|.++ +|+.||+|++........+.+.+|+++|+.++|||||+++++|.+++.+||||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 358999999999999999999976 6889999999877666677899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCC--CCeEEeeeccceecCC
Q 010513 264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQ--WNPKLSDFGLAKLLGA 341 (508)
Q Consensus 264 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~--~~~kL~DFG~a~~~~~ 341 (508)
|+||+|.++|... ...+++..+..++.||+.||+|||++ +|+||||||+|||++.+ +.+||+|||+++.+..
T Consensus 236 ~~gg~L~~~i~~~---~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~ 309 (573)
T 3uto_A 236 MSGGELFEKVADE---HNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 309 (573)
T ss_dssp CCCCBHHHHHTCT---TSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCT
T ss_pred cCCCcHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEccC
Confidence 9999999999754 35799999999999999999999999 99999999999999754 8899999999998754
Q ss_pred CCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCCcc
Q 010513 342 ERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPR 421 (508)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 421 (508)
.. .....+||+.|||||++.+..|+.++|||||||++|||++|+.||..... .+.+....... ..
T Consensus 310 ~~--~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~------~~~~~~i~~~~-------~~ 374 (573)
T 3uto_A 310 KQ--SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND------DETLRNVKSCD-------WN 374 (573)
T ss_dssp TS--EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH------HHHHHHHHTTC-------CC
T ss_pred CC--ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH------HHHHHHHHhCC-------CC
Confidence 33 33456899999999999999999999999999999999999999974422 22222222111 01
Q ss_pred CCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 422 LQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 422 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
+..........++.+|+.+||+.||++||++.|++++
T Consensus 375 ~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 375 MDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp CCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1111111223345568889999999999999999984
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-49 Score=421.52 Aligned_cols=252 Identities=22% Similarity=0.299 Sum_probs=201.7
Q ss_pred hcCCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCC---chhHHH---HHHHHHHHHccCCCCeeeEeeeeecCC
Q 010513 183 VSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKE---FKVEVEAIGRVRHKNLVRLLGYCAEGA 255 (508)
Q Consensus 183 ~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~---~~~E~~~l~~l~hpniv~l~~~~~~~~ 255 (508)
+..++|++.++||+|+||+||+|+.+ +|+.||||++.+.. ...... .+.++.+++.++|||||+++++|++.+
T Consensus 186 ~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~ 265 (689)
T 3v5w_A 186 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD 265 (689)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSS
T ss_pred CchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECC
Confidence 45578999999999999999999976 58899999996432 111222 334567778889999999999999999
Q ss_pred eeEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeecc
Q 010513 256 HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGL 335 (508)
Q Consensus 256 ~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~ 335 (508)
.+|+|||||+||+|.++|.+. +.+++..+..++.||+.||+|||++ +||||||||+||||+.+|++||+|||+
T Consensus 266 ~lylVmEy~~GGdL~~~l~~~----~~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGl 338 (689)
T 3v5w_A 266 KLSFILDLMNGGDLHYHLSQH----GVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGL 338 (689)
T ss_dssp EEEEEECCCCSCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred EEEEEEecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccce
Confidence 999999999999999999875 5799999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCcceecceecCCCCCChhhhhc-CCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhccccc
Q 010513 336 AKLLGAERSYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNA 414 (508)
Q Consensus 336 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 414 (508)
|+.+.... ....+||+.|||||++.+ ..|+.++|||||||+||||++|+.||........ .+.........
T Consensus 339 A~~~~~~~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~---~~i~~~i~~~~-- 410 (689)
T 3v5w_A 339 ACDFSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK---HEIDRMTLTMA-- 410 (689)
T ss_dssp CEECSSCC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCH---HHHHHHHHHCC--
T ss_pred eeecCCCC---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHhhcCCC--
Confidence 99764432 345789999999999964 5799999999999999999999999975433222 12122211111
Q ss_pred ccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 010513 415 EGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPK-----MGHVIHM 458 (508)
Q Consensus 415 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~ 458 (508)
..+.. ..+. ++.+++.+||+.||++|++ +.||+++
T Consensus 411 -----~~~p~-~~S~---~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H 450 (689)
T 3v5w_A 411 -----VELPD-SFSP---ELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 450 (689)
T ss_dssp -----CCCCT-TSCH---HHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred -----CCCCc-cCCH---HHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence 11111 1233 3455888999999999998 6787753
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-46 Score=367.13 Aligned_cols=252 Identities=25% Similarity=0.375 Sum_probs=208.2
Q ss_pred cCCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCchhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEE
Q 010513 184 STNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE 262 (508)
Q Consensus 184 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e 262 (508)
..++|++.+.||+|+||+||+|.+. +++.||+|++........+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 97 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEE
Confidence 3458999999999999999999964 688999999976666667788999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCC
Q 010513 263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE 342 (508)
Q Consensus 263 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 342 (508)
|+++|+|.+++... .+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++......
T Consensus 98 ~~~~~~L~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 169 (297)
T 3fxz_A 98 YLAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169 (297)
T ss_dssp CCTTCBHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCST
T ss_pred CCCCCCHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCCc
Confidence 99999999999764 589999999999999999999999 9999999999999999999999999999876543
Q ss_pred CcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCCccC
Q 010513 343 RSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRL 422 (508)
Q Consensus 343 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 422 (508)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.||....+ ............. . +
T Consensus 170 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~------~~~~~~~~~~~~~-~-----~ 236 (297)
T 3fxz_A 170 QS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP------LRALYLIATNGTP-E-----L 236 (297)
T ss_dssp TC-CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHHHCSC-C-----C
T ss_pred cc-ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhCCCC-C-----C
Confidence 32 23446799999999999999999999999999999999999999964322 1111111111110 0 0
Q ss_pred CCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 423 QEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 423 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
.. .......+.+++.+||+.||++||++.|++++
T Consensus 237 ~~--~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 237 QN--PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp SC--GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CC--ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 00 11122334557889999999999999999864
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-46 Score=371.34 Aligned_cols=257 Identities=26% Similarity=0.469 Sum_probs=212.2
Q ss_pred cCCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCchhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEE
Q 010513 184 STNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE 262 (508)
Q Consensus 184 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e 262 (508)
..++|.+.+.||+|+||+||+|.+. ++..||+|++........+.+.+|++++++++||||+++++++.++...++|||
T Consensus 8 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 87 (310)
T 3s95_A 8 RPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITE 87 (310)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEE
Confidence 4568999999999999999999976 588899999877666777889999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCC
Q 010513 263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE 342 (508)
Q Consensus 263 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 342 (508)
|+++|+|.+++... ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 88 ~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 161 (310)
T 3s95_A 88 YIKGGTLRGIIKSM---DSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDE 161 (310)
T ss_dssp CCTTCBHHHHHHHC---CTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC--
T ss_pred ecCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceecccc
Confidence 99999999999875 35799999999999999999999999 9999999999999999999999999999876433
Q ss_pred Ccce-------------ecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcc---hHHHHHH
Q 010513 343 RSYV-------------TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEV---NLVEWLK 406 (508)
Q Consensus 343 ~~~~-------------~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~---~~~~~~~ 406 (508)
.... .....||+.|+|||++.+..++.++|||||||++|||++|..||....+.... .......
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~ 241 (310)
T 3s95_A 162 KTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLD 241 (310)
T ss_dssp ------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHH
T ss_pred cccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccc
Confidence 2211 11457999999999999999999999999999999999999998764332211 1111111
Q ss_pred HhhcccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 010513 407 TMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEE 463 (508)
Q Consensus 407 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~~~ 463 (508)
.. ..+ .++. .+.+++.+||+.||++||++.++++.|+...
T Consensus 242 ~~---------~~~-----~~~~---~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~ 281 (310)
T 3s95_A 242 RY---------CPP-----NCPP---SFFPITVRCCDLDPEKRPSFVKLEHWLETLR 281 (310)
T ss_dssp HT---------CCT-----TCCT---THHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cc---------CCC-----CCCH---HHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 10 011 1222 3445888999999999999999999998654
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=366.28 Aligned_cols=265 Identities=27% Similarity=0.466 Sum_probs=203.7
Q ss_pred hhhHhhcCCCCcccceEcccCcEEEEEEEECCCcEEEEEEeecCC--chhHHHHHHHHHHHHccCCCCeeeEeeeeecCC
Q 010513 178 LRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGA 255 (508)
Q Consensus 178 ~~~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~ 255 (508)
...+++..++|++.+.||+|+||+||+|++. ++.||+|++.... ....+.+.+|++++++++||||+++++++.+..
T Consensus 29 ~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 107 (309)
T 3p86_A 29 GDDMDIPWCDLNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPP 107 (309)
T ss_dssp ---CBCCGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred cccccCChhHceeeeEeecCCCeEEEEEEEC-CCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC
Confidence 3455677789999999999999999999874 7889999986553 334467889999999999999999999999999
Q ss_pred eeEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eeeccCCCCCEEEcCCCCeEEeee
Q 010513 256 HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK--VVHRDIKSSNILLDKQWNPKLSDF 333 (508)
Q Consensus 256 ~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~--iiHrDlkp~NIll~~~~~~kL~DF 333 (508)
..++||||+++|+|.+++.... ....+++..++.++.|++.||+|||++ + |+||||||+|||++.++.+||+||
T Consensus 108 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Df 183 (309)
T 3p86_A 108 NLSIVTEYLSRGSLYRLLHKSG-AREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDF 183 (309)
T ss_dssp CCEEEEECCTTCBHHHHHHSTT-HHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCC
T ss_pred ceEEEEecCCCCcHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCC
Confidence 9999999999999999997652 112489999999999999999999998 8 999999999999999999999999
Q ss_pred ccceecCCCCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccc
Q 010513 334 GLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRN 413 (508)
Q Consensus 334 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 413 (508)
|+++..... ........||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+..........
T Consensus 184 g~a~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~------~~~~~~~~~~~~ 256 (309)
T 3p86_A 184 GLSRLKAST-FLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNP------AQVVAAVGFKCK 256 (309)
T ss_dssp C------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCH------HHHHHHHHHSCC
T ss_pred CCCcccccc-ccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhcCC
Confidence 999864332 2223446799999999999999999999999999999999999999974422 111111111110
Q ss_pred cccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 010513 414 AEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEE 463 (508)
Q Consensus 414 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~~~ 463 (508)
...+. ...+. ++.+++.+||+.||++||++.++++.|+..-
T Consensus 257 -----~~~~~-~~~~~---~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~ 297 (309)
T 3p86_A 257 -----RLEIP-RNLNP---QVAAIIEGCWTNEPWKRPSFATIMDLLRPLI 297 (309)
T ss_dssp -----CCCCC-TTSCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -----CCCCC-ccCCH---HHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 01111 11233 3445788999999999999999999998754
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=370.19 Aligned_cols=249 Identities=22% Similarity=0.328 Sum_probs=206.2
Q ss_pred cCCCCcccceEcccCcEEEEEEEE-CCCcEEEEEEeecC--CchhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEE
Q 010513 184 STNGFADENVIGEGGYGIVYHGVL-EDNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLV 260 (508)
Q Consensus 184 ~~~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 260 (508)
..++|++.+.||+|+||.||+|.+ .+|+.||+|++... .....+.+.+|+++++.++||||+++++++.+.+..|+|
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 92 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI 92 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence 346899999999999999999997 47899999998654 334456788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecC
Q 010513 261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG 340 (508)
Q Consensus 261 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 340 (508)
|||+++|+|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++++||+|||++....
T Consensus 93 ~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 165 (328)
T 3fe3_A 93 MEYASGGEVFDYLVAH----GRMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFT 165 (328)
T ss_dssp ECCCTTCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGS
T ss_pred EECCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecC
Confidence 9999999999999765 4689999999999999999999999 99999999999999999999999999998664
Q ss_pred CCCcceecceecCCCCCChhhhhcCCCC-CCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCC
Q 010513 341 AERSYVTTRVMGTFGYVAPEYASTGMLN-ERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLD 419 (508)
Q Consensus 341 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 419 (508)
... .....+||+.|+|||++.+..++ .++|||||||++|||++|+.||.... ..+......... .
T Consensus 166 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~------~~~~~~~i~~~~-~----- 231 (328)
T 3fe3_A 166 VGG--KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN------LKELRERVLRGK-Y----- 231 (328)
T ss_dssp SSC--GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHCC-C-----
T ss_pred CCC--ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCC------HHHHHHHHHhCC-C-----
Confidence 332 23456899999999999888775 78999999999999999999997432 222222222211 0
Q ss_pred ccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 420 PRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 420 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
.+. ...+ .++.+++.+||+.||++|||+.|++++
T Consensus 232 -~~p-~~~s---~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 232 -RIP-FYMS---TDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp -CCC-TTSC---HHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred -CCC-CCCC---HHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 011 1122 334558889999999999999999875
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=358.38 Aligned_cols=259 Identities=25% Similarity=0.407 Sum_probs=214.5
Q ss_pred hhcCCCCcccceEcccCcEEEEEEEECCCcEEEEEEeecCCchhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEE
Q 010513 182 EVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY 261 (508)
Q Consensus 182 ~~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 261 (508)
++..++|++.+.||+|+||+||+|.++++..||+|.+..... ..+.+.+|++++++++||||+++++++.++...++||
T Consensus 4 ~l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (268)
T 3sxs_A 4 ELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVT 82 (268)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEE
T ss_pred EechhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEE
Confidence 456678999999999999999999998888899999865543 3467889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCC
Q 010513 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA 341 (508)
Q Consensus 262 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 341 (508)
||+++++|.+++... ...+++..++.++.|++.||+|||++ +++||||||+||+++.++.+||+|||++.....
T Consensus 83 e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~ 156 (268)
T 3sxs_A 83 EYISNGCLLNYLRSH---GKGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLD 156 (268)
T ss_dssp ECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCT
T ss_pred EccCCCcHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecch
Confidence 999999999999765 24689999999999999999999999 999999999999999999999999999987755
Q ss_pred CCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHhhcccccccCCCc
Q 010513 342 ERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDP 420 (508)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 420 (508)
..........+|+.|+|||.+.+..++.++||||||+++|||++ |+.||..... .+......... ....
T Consensus 157 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~------~~~~~~~~~~~---~~~~- 226 (268)
T 3sxs_A 157 DQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTN------SEVVLKVSQGH---RLYR- 226 (268)
T ss_dssp TCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCH------HHHHHHHHTTC---CCCC-
T ss_pred hhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccCh------HHHHHHHHcCC---CCCC-
Confidence 54444444567788999999999999999999999999999999 9999964432 11111111111 1111
Q ss_pred cCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 010513 421 RLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEE 463 (508)
Q Consensus 421 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~~~ 463 (508)
....+. .+.+++.+||+.||++||++.+++++|+...
T Consensus 227 ---~~~~~~---~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~ 263 (268)
T 3sxs_A 227 ---PHLASD---TIYQIMYSCWHELPEKRPTFQQLLSSIEPLR 263 (268)
T ss_dssp ---CTTSCH---HHHHHHHHTTCSSGGGSCCHHHHHHHHGGGC
T ss_pred ---CCcChH---HHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 111233 3455788999999999999999999998764
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=362.56 Aligned_cols=263 Identities=26% Similarity=0.413 Sum_probs=206.9
Q ss_pred hcCCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCC---chhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeE
Q 010513 183 VSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM 258 (508)
Q Consensus 183 ~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 258 (508)
+..++|++.+.||+|+||.||+|.+. ++..||+|.+.... ....+.+.+|+.+++.++||||+++++++.+++..|
T Consensus 8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 87 (294)
T 4eqm_A 8 IINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYY 87 (294)
T ss_dssp CEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEE
T ss_pred HhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEE
Confidence 45578999999999999999999975 68899999985432 334567889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeecccee
Q 010513 259 LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL 338 (508)
Q Consensus 259 lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~ 338 (508)
+||||+++|+|.+++... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++..
T Consensus 88 lv~e~~~g~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~ 160 (294)
T 4eqm_A 88 LVMEYIEGPTLSEYIESH----GPLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKA 160 (294)
T ss_dssp EEEECCCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTT
T ss_pred EEEeCCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCccc
Confidence 999999999999999765 4799999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCC
Q 010513 339 LGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVL 418 (508)
Q Consensus 339 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 418 (508)
.............||+.|+|||.+.+..++.++|||||||++|||++|+.||..... .+........... . .
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~------~~~~~~~~~~~~~-~-~ 232 (294)
T 4eqm_A 161 LSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETA------VSIAIKHIQDSVP-N-V 232 (294)
T ss_dssp C-------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCH------HHHHHHHHSSCCC-C-H
T ss_pred cccccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHhhccCC-C-c
Confidence 654444444556799999999999999999999999999999999999999974321 1111222211100 0 0
Q ss_pred CccCCCCchHHHHHHHHHHHHHccCCCCCCCC-CHHHHHHHHhcCCC
Q 010513 419 DPRLQEKPCSRALKRALLVALRCVDPNAHKRP-KMGHVIHMLEAEEF 464 (508)
Q Consensus 419 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~Le~~~~ 464 (508)
..... ...+. .+.+++.+||+.||++|| ++.++.+.|+....
T Consensus 233 ~~~~~-~~~~~---~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~ 275 (294)
T 4eqm_A 233 TTDVR-KDIPQ---SLSNVILRATEKDKANRYKTIQEMKDDLSSVLH 275 (294)
T ss_dssp HHHSC-TTSCH---HHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred chhcc-cCCCH---HHHHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence 00011 11233 445578899999999998 89999999987643
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-46 Score=360.57 Aligned_cols=258 Identities=26% Similarity=0.445 Sum_probs=212.6
Q ss_pred hhcCCCCcccceEcccCcEEEEEEEECCCcEEEEEEeecCCchhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEE
Q 010513 182 EVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY 261 (508)
Q Consensus 182 ~~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 261 (508)
.+..++|++.+.||+|+||+||+|.+.+++.||+|++..... ..+.+.+|++++++++||||+++++++.++...++||
T Consensus 6 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (269)
T 4hcu_A 6 VIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVF 84 (269)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred EeChhhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEE
Confidence 455678999999999999999999998888999999875543 3467889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCC
Q 010513 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA 341 (508)
Q Consensus 262 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 341 (508)
||+++|+|.+++... ...+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++.....
T Consensus 85 e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 158 (269)
T 4hcu_A 85 EFMEHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 158 (269)
T ss_dssp ECCTTCBHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred EeCCCCcHHHHHHhc---CcccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEeccccccccccc
Confidence 999999999999765 35689999999999999999999999 999999999999999999999999999987644
Q ss_pred CCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHhhcccccccCCCc
Q 010513 342 ERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDP 420 (508)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 420 (508)
..........||+.|+|||.+.+..++.++||||||+++|+|++ |+.||..... .+......... .+
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~------~~~~~~~~~~~------~~ 226 (269)
T 4hcu_A 159 DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN------SEVVEDISTGF------RL 226 (269)
T ss_dssp HHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH------HHHHHHHHTTC------CC
T ss_pred cccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCH------HHHHHHHhcCc------cC
Confidence 33333344567788999999999999999999999999999999 9999974322 12222221110 01
Q ss_pred cCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010513 421 RLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (508)
Q Consensus 421 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~~ 462 (508)
. .....+. .+.+++.+||+.||++||++.+++++|++.
T Consensus 227 ~-~~~~~~~---~~~~li~~~l~~~p~~Rps~~~ll~~l~~l 264 (269)
T 4hcu_A 227 Y-KPRLAST---HVYQIMNHCWRERPEDRPAFSRLLRQLAEI 264 (269)
T ss_dssp C-CCTTSCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred C-CCCcCCH---HHHHHHHHHccCCcccCcCHHHHHHHHHHH
Confidence 1 1111233 345577899999999999999999999853
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=377.21 Aligned_cols=262 Identities=26% Similarity=0.443 Sum_probs=210.9
Q ss_pred hhcCCCCcccceEcccCcEEEEEEEEC--------CCcEEEEEEeecCCc-hhHHHHHHHHHHHHcc-CCCCeeeEeeee
Q 010513 182 EVSTNGFADENVIGEGGYGIVYHGVLE--------DNTNVAVKNLLNNRG-QAEKEFKVEVEAIGRV-RHKNLVRLLGYC 251 (508)
Q Consensus 182 ~~~~~~~~~~~~LG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpniv~l~~~~ 251 (508)
++..++|++.+.||+|+||+||+|.+. ++..||+|.+..... ...+.+.+|+++++.+ +||||+++++++
T Consensus 77 ~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~ 156 (370)
T 2psq_A 77 EFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 156 (370)
T ss_dssp BCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEE
T ss_pred cccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence 445678999999999999999999863 345699999876533 3456789999999999 899999999999
Q ss_pred ecCCeeEEEEEecCCCCHHHHhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCC
Q 010513 252 AEGAHRMLVYEYIDNGNLEQWLHGDVG------------PHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSN 319 (508)
Q Consensus 252 ~~~~~~~lV~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~N 319 (508)
.+.+..|+||||+++|+|.+++..... ....+++..++.++.|++.||+|||++ +|+||||||+|
T Consensus 157 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~N 233 (370)
T 2psq_A 157 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARN 233 (370)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGG
T ss_pred ccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---Ceeccccchhh
Confidence 999999999999999999999976532 124589999999999999999999999 99999999999
Q ss_pred EEEcCCCCeEEeeeccceecCCCCcc-eecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHh-CCCCCCCCCCCC
Q 010513 320 ILLDKQWNPKLSDFGLAKLLGAERSY-VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPG 397 (508)
Q Consensus 320 Ill~~~~~~kL~DFG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~Pf~~~~~~~ 397 (508)
||++.++.+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||++ |+.||......
T Consensus 234 Ill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~- 312 (370)
T 2psq_A 234 VLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE- 312 (370)
T ss_dssp EEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG-
T ss_pred EEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH-
Confidence 99999999999999999876543322 2233467889999999999999999999999999999999 99999754321
Q ss_pred cchHHHHHHHhhcccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010513 398 EVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (508)
Q Consensus 398 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~~ 462 (508)
.+...+ .... .+... ..++. ++.+++.+||+.||++||++.|+++.|+..
T Consensus 313 --~~~~~~----~~~~-----~~~~~-~~~~~---~l~~li~~~l~~dP~~Rpt~~ell~~L~~i 362 (370)
T 2psq_A 313 --ELFKLL----KEGH-----RMDKP-ANCTN---ELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 362 (370)
T ss_dssp --GHHHHH----HTTC-----CCCCC-TTSCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --HHHHHH----hcCC-----CCCCC-CCCCH---HHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 222211 1111 01111 11333 345577899999999999999999999853
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=360.94 Aligned_cols=258 Identities=22% Similarity=0.378 Sum_probs=209.5
Q ss_pred hhcCCCCcccceEcccCcEEEEEEEECCCcEEEEEEeecCCchhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEE
Q 010513 182 EVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY 261 (508)
Q Consensus 182 ~~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 261 (508)
++..++|++.+.||+|+||+||+|.+.++..||+|++..... ..+.+.+|+++++.++||||+++++++.+++..++||
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (283)
T 3gen_A 20 EIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIIT 98 (283)
T ss_dssp BCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred cCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEE
Confidence 567779999999999999999999999888999999875543 3467889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCC
Q 010513 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA 341 (508)
Q Consensus 262 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 341 (508)
||+++|+|.+++... ...+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++.....
T Consensus 99 e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 172 (283)
T 3gen_A 99 EYMANGCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD 172 (283)
T ss_dssp CCCTTCBHHHHHHCG---GGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCC
T ss_pred eccCCCcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEccccccccccc
Confidence 999999999999764 24699999999999999999999999 999999999999999999999999999987644
Q ss_pred CCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHhhcccccccCCCc
Q 010513 342 ERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDP 420 (508)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 420 (508)
..........+|+.|+|||.+.+..++.++||||||+++|||+| |+.||..... .+......... ..
T Consensus 173 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~------~~~~~~~~~~~------~~ 240 (283)
T 3gen_A 173 DEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN------SETAEHIAQGL------RL 240 (283)
T ss_dssp HHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCH------HHHHHHHHTTC------CC
T ss_pred cccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccCh------hHHHHHHhccc------CC
Confidence 33333334457788999999999999999999999999999998 9999974431 11112211110 01
Q ss_pred cCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010513 421 RLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (508)
Q Consensus 421 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~~ 462 (508)
. .....+. .+.+++.+||+.||++||++.+++++|++.
T Consensus 241 ~-~~~~~~~---~l~~li~~~l~~~p~~Rps~~~ll~~L~~~ 278 (283)
T 3gen_A 241 Y-RPHLASE---KVYTIMYSCWHEKADERPTFKILLSNILDV 278 (283)
T ss_dssp C-CCTTCCH---HHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred C-CCCcCCH---HHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 1 1111233 345588899999999999999999999753
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-45 Score=367.03 Aligned_cols=259 Identities=27% Similarity=0.467 Sum_probs=207.9
Q ss_pred hcCCCCcccceEcccCcEEEEEEEEC----CCcEEEEEEeecC-CchhHHHHHHHHHHHHccCCCCeeeEeeeeecCCee
Q 010513 183 VSTNGFADENVIGEGGYGIVYHGVLE----DNTNVAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHR 257 (508)
Q Consensus 183 ~~~~~~~~~~~LG~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 257 (508)
+..++|++.+.||+|+||+||+|.+. .+..||||.+... .....+.+.+|+++++.++||||+++++++.+++..
T Consensus 46 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 125 (325)
T 3kul_A 46 IEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLA 125 (325)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCC
T ss_pred cChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCcc
Confidence 45568999999999999999999975 3445999998765 334456789999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccce
Q 010513 258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK 337 (508)
Q Consensus 258 ~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~ 337 (508)
++||||+++|+|.+++... ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 126 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 199 (325)
T 3kul_A 126 MIVTEYMENGSLDTFLRTH---DGQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSR 199 (325)
T ss_dssp EEEEECCTTCBHHHHHHTT---TTCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCE
T ss_pred EEEeeCCCCCcHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCccc
Confidence 9999999999999999765 35799999999999999999999999 99999999999999999999999999999
Q ss_pred ecCCCCcc--eecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHhhccccc
Q 010513 338 LLGAERSY--VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNA 414 (508)
Q Consensus 338 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 414 (508)
........ ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||..... .+..........
T Consensus 200 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~------~~~~~~~~~~~~- 272 (325)
T 3kul_A 200 VLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN------RDVISSVEEGYR- 272 (325)
T ss_dssp ECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCH------HHHHHHHHTTCC-
T ss_pred ccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCH------HHHHHHHHcCCC-
Confidence 77543222 2233456788999999999999999999999999999999 9999964321 122222211110
Q ss_pred ccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 010513 415 EGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEE 463 (508)
Q Consensus 415 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~~~ 463 (508)
... ...++. .+.+++.+||+.||++||++.++++.|+...
T Consensus 273 -----~~~-~~~~~~---~l~~li~~~l~~dp~~Rps~~eil~~L~~l~ 312 (325)
T 3kul_A 273 -----LPA-PMGCPH---ALHQLMLDCWHKDRAQRPRFSQIVSVLDALI 312 (325)
T ss_dssp -----CCC-CTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -----CCC-CCCcCH---HHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 001 111333 4445788999999999999999999998753
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-45 Score=367.58 Aligned_cols=250 Identities=24% Similarity=0.278 Sum_probs=205.6
Q ss_pred cCCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecC---CchhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEE
Q 010513 184 STNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN---RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRML 259 (508)
Q Consensus 184 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 259 (508)
..++|++.+.||+|+||+||+|+.+ +++.||+|.+.+. .......+.+|+++++.++||||+++++++.+.+..|+
T Consensus 3 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l 82 (337)
T 1o6l_A 3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCF 82 (337)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEE
T ss_pred ChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEE
Confidence 3468999999999999999999976 5889999998654 22345678889999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceec
Q 010513 260 VYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL 339 (508)
Q Consensus 260 V~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~ 339 (508)
||||+++|+|.+++... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 83 v~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 155 (337)
T 1o6l_A 83 VMEYANGGELFFHLSRE----RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEG 155 (337)
T ss_dssp EEECCTTCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred EEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhc
Confidence 99999999999999765 4789999999999999999999999 9999999999999999999999999999864
Q ss_pred CCCCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCC
Q 010513 340 GAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLD 419 (508)
Q Consensus 340 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 419 (508)
... .......+||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+.........
T Consensus 156 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~------~~~~~~~i~~~~------- 221 (337)
T 1o6l_A 156 ISD-GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD------HERLFELILMEE------- 221 (337)
T ss_dssp CCT-TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHCC-------
T ss_pred ccC-CCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCC------HHHHHHHHHcCC-------
Confidence 322 223445789999999999999999999999999999999999999996432 112222222111
Q ss_pred ccCCCCchHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 010513 420 PRLQEKPCSRALKRALLVALRCVDPNAHKRP-----KMGHVIHM 458 (508)
Q Consensus 420 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 458 (508)
..+.. ..+. ++.+++.+||+.||++|| ++.+++++
T Consensus 222 ~~~p~-~~s~---~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 222 IRFPR-TLSP---EAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp CCCCT-TSCH---HHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred CCCCC-CCCH---HHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 01111 1233 344577799999999999 89999875
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=368.51 Aligned_cols=271 Identities=26% Similarity=0.375 Sum_probs=209.8
Q ss_pred hhcCCCCcccceEcccCcEEEEEEEECCCcEEEEEEeecCCchhHHHHHHHHHHHHccCCCCeeeEeeeeecCC----ee
Q 010513 182 EVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGA----HR 257 (508)
Q Consensus 182 ~~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~----~~ 257 (508)
.+..++|++.+.||+|+||+||+|++. ++.||||++.... .....+..|+.++++++||||+++++++.+.. ..
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 97 (322)
T 3soc_A 20 YFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDL 97 (322)
T ss_dssp EETTEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred ccchhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceE
Confidence 456678999999999999999999986 7899999986543 33345566899999999999999999998754 46
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-------CCCeeeccCCCCCEEEcCCCCeEE
Q 010513 258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGL-------EPKVVHRDIKSSNILLDKQWNPKL 330 (508)
Q Consensus 258 ~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~-------~~~iiHrDlkp~NIll~~~~~~kL 330 (508)
++||||+++|+|.+++... .+++..++.++.|++.||+|||+.+ +++|+||||||+|||++.++.+||
T Consensus 98 ~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL 172 (322)
T 3soc_A 98 WLITAFHEKGSLSDFLKAN-----VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACI 172 (322)
T ss_dssp EEEEECCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEE
T ss_pred EEEEecCCCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEE
Confidence 9999999999999999764 5899999999999999999999751 337999999999999999999999
Q ss_pred eeeccceecCCCCcc-eecceecCCCCCChhhhhcC-----CCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHH--
Q 010513 331 SDFGLAKLLGAERSY-VTTRVMGTFGYVAPEYASTG-----MLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLV-- 402 (508)
Q Consensus 331 ~DFG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-----~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~-- 402 (508)
+|||+++........ ......||+.|+|||++.+. .++.++|||||||++|||+||+.||............
T Consensus 173 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~ 252 (322)
T 3soc_A 173 ADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEE 252 (322)
T ss_dssp CCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHH
T ss_pred ccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhh
Confidence 999999876543332 23346799999999999763 4556889999999999999999999865433222111
Q ss_pred -------HHHHHhhcccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010513 403 -------EWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (508)
Q Consensus 403 -------~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~~ 462 (508)
..+............+....... ....++.+++.+||+.||++|||+.++++.|+..
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l 316 (322)
T 3soc_A 253 IGQHPSLEDMQEVVVHKKKRPVLRDYWQKH---AGMAMLCETIEECWDHDAEARLSAGCVGERITQM 316 (322)
T ss_dssp HCSSCCHHHHHHHHTTSCCCCCCCGGGGSS---HHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred hccCCchhhhhhhhhcccCCCCcccccccc---chHHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 11112222222222222222222 2344566688899999999999999999999853
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=368.31 Aligned_cols=252 Identities=23% Similarity=0.317 Sum_probs=205.7
Q ss_pred CCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCch------hHHHHHHHHHHHHccCCCCeeeEeeeeecCCee
Q 010513 185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQ------AEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHR 257 (508)
Q Consensus 185 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 257 (508)
.++|++.+.||+|+||+||+|..+ +|+.||+|.+...... ..+.+.+|+.+++.++||||+++++++.+....
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 357999999999999999999976 5889999998654322 356789999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCC----CeEEeee
Q 010513 258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQW----NPKLSDF 333 (508)
Q Consensus 258 ~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~----~~kL~DF 333 (508)
++||||+++|+|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++ .+||+||
T Consensus 91 ~lv~e~~~gg~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DF 163 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQK----ESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (361)
T ss_dssp EEEEECCCSCBHHHHHTTC----SCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEcCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEec
Confidence 9999999999999999764 5799999999999999999999999 999999999999998877 7999999
Q ss_pred ccceecCCCCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccc
Q 010513 334 GLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRN 413 (508)
Q Consensus 334 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 413 (508)
|++....... .....+||+.|+|||++.+..++.++|||||||++|+|++|..||..... .+.+...... .
T Consensus 164 G~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~------~~~~~~i~~~-~ 234 (361)
T 2yab_A 164 GLAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK------QETLANITAV-S 234 (361)
T ss_dssp SSCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH------HHHHHHHHTT-C
T ss_pred CCceEcCCCC--ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhc-C
Confidence 9998764432 23456799999999999999999999999999999999999999974321 1222222111 0
Q ss_pred cccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 414 AEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 414 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
. ..++. ........+.+++.+||..||++||++.|++++
T Consensus 235 ~--~~~~~----~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h 273 (361)
T 2yab_A 235 Y--DFDEE----FFSQTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (361)
T ss_dssp C--CCCHH----HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred C--CCCch----hccCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0 00110 011122345558889999999999999999864
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-45 Score=362.54 Aligned_cols=265 Identities=20% Similarity=0.303 Sum_probs=204.9
Q ss_pred hcCCCCcccceEcccCcEEEEEEEECCCcEEEEEEeecCCc--hhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEE
Q 010513 183 VSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRG--QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLV 260 (508)
Q Consensus 183 ~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 260 (508)
...++|++.+.||+|+||+||+|.+.+++.||+|++..... ...+.+.+|++++++++||||+++++++.++...++|
T Consensus 18 ~l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 97 (311)
T 3niz_A 18 GLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLV 97 (311)
T ss_dssp CSSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEE
T ss_pred chHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEE
Confidence 34568999999999999999999998899999999864422 2346788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecC
Q 010513 261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG 340 (508)
Q Consensus 261 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 340 (508)
|||+++ +|.+++... ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 98 ~e~~~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~ 170 (311)
T 3niz_A 98 FEFMEK-DLKKVLDEN---KTGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFG 170 (311)
T ss_dssp EECCSE-EHHHHHHTC---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETT
T ss_pred EcCCCC-CHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecC
Confidence 999986 888888765 35699999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCcceecceecCCCCCChhhhhc-CCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhccccc---cc
Q 010513 341 AERSYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNA---EG 416 (508)
Q Consensus 341 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~---~~ 416 (508)
... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......... ..+......... ..
T Consensus 171 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~---~~i~~~~~~~~~~~~~~ 246 (311)
T 3niz_A 171 IPV-RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQL---PKIFSILGTPNPREWPQ 246 (311)
T ss_dssp SCC-C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHH---HHHHHHHCCCCTTTSGG
T ss_pred CCc-ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHH---HHHHHHHCCCChHHhhh
Confidence 332 22344578999999999876 56899999999999999999999999765443221 111111111000 00
Q ss_pred C---------CCccCCCCch----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 417 V---------LDPRLQEKPC----SRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 417 ~---------~~~~l~~~~~----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
. .......... +....++.+++.+||+.||++|||+.|++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 301 (311)
T 3niz_A 247 VQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH 301 (311)
T ss_dssp GTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 0 0000011100 1112456678889999999999999999974
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-45 Score=370.19 Aligned_cols=250 Identities=20% Similarity=0.302 Sum_probs=199.1
Q ss_pred hcCCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecC---CchhHHHHHHHHHHHHcc-CCCCeeeEeeeeecCCee
Q 010513 183 VSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN---RGQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEGAHR 257 (508)
Q Consensus 183 ~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~ 257 (508)
+..++|++.+.||+|+||+||+|+++ +++.||+|++.+. .....+.+..|.+++..+ +||||+++++++.+.+..
T Consensus 20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~ 99 (353)
T 3txo_A 20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRL 99 (353)
T ss_dssp ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEE
Confidence 45678999999999999999999976 5889999998754 223445678899999988 799999999999999999
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccce
Q 010513 258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK 337 (508)
Q Consensus 258 ~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~ 337 (508)
|+||||+++|+|.+++... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 100 ~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~ 172 (353)
T 3txo_A 100 FFVMEFVNGGDLMFHIQKS----RRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCK 172 (353)
T ss_dssp EEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEcccccee
Confidence 9999999999999999765 4699999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccC
Q 010513 338 LLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGV 417 (508)
Q Consensus 338 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 417 (508)
.... ........+||+.|+|||++.+..|+.++|||||||++|||++|+.||..... .+......... .
T Consensus 173 ~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~------~~~~~~i~~~~----~ 241 (353)
T 3txo_A 173 EGIC-NGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENE------DDLFEAILNDE----V 241 (353)
T ss_dssp CSCC----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCC----C
T ss_pred eccc-CCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCH------HHHHHHHHcCC----C
Confidence 5422 22334457899999999999999999999999999999999999999974421 22222222211 0
Q ss_pred CCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCH------HHHHH
Q 010513 418 LDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKM------GHVIH 457 (508)
Q Consensus 418 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~------~evl~ 457 (508)
.+.. ..+. ++.+++.+||+.||++||++ .++++
T Consensus 242 ---~~p~-~~~~---~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 242 ---VYPT-WLHE---DATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp ---CCCT-TSCH---HHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred ---CCCC-CCCH---HHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 1111 1223 34557889999999999998 67765
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=357.29 Aligned_cols=261 Identities=25% Similarity=0.374 Sum_probs=202.2
Q ss_pred cCCCCcccceEcccCcEEEEEEEECCCcEEEEEEeecCCchhHHHHHHHHHHHHc--cCCCCeeeEeeeeec----CCee
Q 010513 184 STNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGR--VRHKNLVRLLGYCAE----GAHR 257 (508)
Q Consensus 184 ~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~hpniv~l~~~~~~----~~~~ 257 (508)
..++|++.+.||+|+||+||+|++ +++.||||++... ....+..|.+++.. ++||||+++++++.+ ....
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~ 81 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL 81 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence 456899999999999999999998 5889999998543 33455566676666 799999999998654 3467
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHH--------hcCCCCeeeccCCCCCEEEcCCCCeE
Q 010513 258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH--------EGLEPKVVHRDIKSSNILLDKQWNPK 329 (508)
Q Consensus 258 ~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH--------~~~~~~iiHrDlkp~NIll~~~~~~k 329 (508)
++||||+++|+|.++++. ..+++..++.++.|++.||+||| ++ +|+||||||+|||++.++.+|
T Consensus 82 ~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~k 153 (301)
T 3q4u_A 82 WLITHYHEMGSLYDYLQL-----TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQCC 153 (301)
T ss_dssp EEEECCCTTCBHHHHHTT-----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCEE
T ss_pred EEehhhccCCCHHHHHhh-----cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCEE
Confidence 899999999999999954 36899999999999999999999 77 999999999999999999999
Q ss_pred EeeeccceecCCCCcce---ecceecCCCCCChhhhhcC------CCCCCCCeeehHHHHHHHHhC----------CCCC
Q 010513 330 LSDFGLAKLLGAERSYV---TTRVMGTFGYVAPEYASTG------MLNERSDVYSFGILIMEVISG----------RNPV 390 (508)
Q Consensus 330 L~DFG~a~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~~~~sDvwSlGvvl~elltg----------~~Pf 390 (508)
|+|||+++......... .....||+.|+|||++.+. .++.++|||||||++|||+|| +.||
T Consensus 154 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf 233 (301)
T 3q4u_A 154 IADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPF 233 (301)
T ss_dssp ECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred EeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccc
Confidence 99999998764433322 2334799999999999876 345689999999999999999 8888
Q ss_pred CCCCCCCcchHHHHHHHhhcccccccCCCccCCCC-chHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010513 391 DYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEK-PCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (508)
Q Consensus 391 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~~ 462 (508)
....+.... . ........... ..+.+... .......++.+++.+||+.||++||++.++++.|+..
T Consensus 234 ~~~~~~~~~-~-~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 234 YDVVPNDPS-F-EDMRKVVCVDQ----QRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp TTTSCSSCC-H-HHHHHHHTTSC----CCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred cccCCCCcc-h-hhhhHHHhccC----CCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 654433221 1 11222221111 11111111 1233455667788899999999999999999999864
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=359.53 Aligned_cols=248 Identities=25% Similarity=0.360 Sum_probs=205.7
Q ss_pred CcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCchhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEEecCC
Q 010513 188 FADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDN 266 (508)
Q Consensus 188 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~ 266 (508)
|...+.||+|+||.||+|+.. +|+.||||++........+.+.+|+.+++.++||||+++++++..++..++||||+++
T Consensus 47 ~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 126 (321)
T 2c30_A 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQG 126 (321)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCS
T ss_pred hhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCC
Confidence 677889999999999999987 6899999999776666677889999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCCCcce
Q 010513 267 GNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYV 346 (508)
Q Consensus 267 g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~ 346 (508)
|+|.+++... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++........ .
T Consensus 127 ~~L~~~l~~~-----~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~-~ 197 (321)
T 2c30_A 127 GALTDIVSQV-----RLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-K 197 (321)
T ss_dssp CBHHHHHTTC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC-C
T ss_pred CCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCcEEEeeeeeeeecccCcc-c
Confidence 9999998643 689999999999999999999999 999999999999999999999999999987644322 2
Q ss_pred ecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCCccCCCCc
Q 010513 347 TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKP 426 (508)
Q Consensus 347 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 426 (508)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+........ ..+.+..
T Consensus 198 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~------~~~~~~~~~~------~~~~~~~-- 263 (321)
T 2c30_A 198 RKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP------VQAMKRLRDS------PPPKLKN-- 263 (321)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHHS------SCCCCTT--
T ss_pred cccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHhcC------CCCCcCc--
Confidence 3446799999999999999999999999999999999999999964321 1222221111 1111111
Q ss_pred hHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 427 CSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 427 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
.......+.+++.+||+.||++||++.+++++
T Consensus 264 ~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 264 SHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp GGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11122344557789999999999999999974
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=357.12 Aligned_cols=265 Identities=22% Similarity=0.396 Sum_probs=205.5
Q ss_pred hcCCCCcccceEcccCcEEEEEEEEC-----CCcEEEEEEeecCCchhHHHHHHHHHHHHccCCCCeeeEeeeeec--CC
Q 010513 183 VSTNGFADENVIGEGGYGIVYHGVLE-----DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE--GA 255 (508)
Q Consensus 183 ~~~~~~~~~~~LG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~--~~ 255 (508)
+..++|++.+.||+|+||+||+|++. +++.||+|++........+.+.+|++++++++||||+++++++.. ..
T Consensus 7 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 86 (295)
T 3ugc_A 7 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 86 (295)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHT
T ss_pred CCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence 45568999999999999999999852 578899999987766667789999999999999999999999864 35
Q ss_pred eeEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeecc
Q 010513 256 HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGL 335 (508)
Q Consensus 256 ~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~ 335 (508)
..++||||+++|+|.+++... ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 87 ~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~ 160 (295)
T 3ugc_A 87 NLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGL 160 (295)
T ss_dssp SCEEEEECCTTCBHHHHHHHC---GGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCS
T ss_pred ceEEEEEeCCCCCHHHHHHhc---ccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCcc
Confidence 689999999999999999775 24589999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCcc--eecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCC---------CCcchHHHH
Q 010513 336 AKLLGAERSY--VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRP---------PGEVNLVEW 404 (508)
Q Consensus 336 a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~---------~~~~~~~~~ 404 (508)
++........ ......|+..|+|||.+.+..++.++||||||+++|||+||..||..... .........
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (295)
T 3ugc_A 161 TKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 240 (295)
T ss_dssp CC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHH
T ss_pred cccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHH
Confidence 9876443222 12234567789999999999999999999999999999999999864210 001111111
Q ss_pred HHHhhcccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010513 405 LKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (508)
Q Consensus 405 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~~ 462 (508)
+......... ... ...++. ++.+++.+||+.||++||++.++++.|+..
T Consensus 241 ~~~~~~~~~~-----~~~-~~~~~~---~l~~li~~~l~~dp~~Rps~~el~~~L~~l 289 (295)
T 3ugc_A 241 LIELLKNNGR-----LPR-PDGCPD---EIYMIMTECWNNNVNQRPSFRDLALRVDQI 289 (295)
T ss_dssp HHHHHHTTCC-----CCC-CTTCCH---HHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHhccCc-----CCC-CcCcCH---HHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 1111111110 001 112333 445578899999999999999999999864
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=381.48 Aligned_cols=264 Identities=22% Similarity=0.283 Sum_probs=212.3
Q ss_pred chhhHhhcCCCCcccceEcccCcEEEEEEEECC-CcEEEEEEeecCCc---hhHHHHHHHHHHHHccCCCCeeeEeeeee
Q 010513 177 TLRELEVSTNGFADENVIGEGGYGIVYHGVLED-NTNVAVKNLLNNRG---QAEKEFKVEVEAIGRVRHKNLVRLLGYCA 252 (508)
Q Consensus 177 ~~~~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~ 252 (508)
.++++++..++|++.++||+|+||+||+|+++. ++.||+|++.+... .....+.+|+.++..++||||++++++|.
T Consensus 65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 144 (437)
T 4aw2_A 65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ 144 (437)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 356777888999999999999999999999874 77899999865321 22234788999999999999999999999
Q ss_pred cCCeeEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEee
Q 010513 253 EGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSD 332 (508)
Q Consensus 253 ~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~D 332 (508)
+++..|+||||+++|+|.+++... ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|
T Consensus 145 ~~~~~~lV~Ey~~gg~L~~~l~~~---~~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~D 218 (437)
T 4aw2_A 145 DDNNLYLVMDYYVGGDLLTLLSKF---EDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLAD 218 (437)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECC
T ss_pred eCCEEEEEEecCCCCcHHHHHHHc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcc
Confidence 999999999999999999999864 35799999999999999999999999 999999999999999999999999
Q ss_pred eccceecCCCCcceecceecCCCCCChhhhh-----cCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHH
Q 010513 333 FGLAKLLGAERSYVTTRVMGTFGYVAPEYAS-----TGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKT 407 (508)
Q Consensus 333 FG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~ 407 (508)
||+++.............+||+.|+|||++. ...|+.++|||||||++|||++|+.||..... .+....
T Consensus 219 FGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~------~~~~~~ 292 (437)
T 4aw2_A 219 FGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL------VETYGK 292 (437)
T ss_dssp CTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHH
T ss_pred hhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCCh------hHHHHh
Confidence 9999877655555555678999999999987 56789999999999999999999999974321 222222
Q ss_pred hhcccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHH
Q 010513 408 MVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHK--RPKMGHVIHM 458 (508)
Q Consensus 408 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~ 458 (508)
...... ...-|... ...+.. +.+++.+||..+|++ ||+++|++++
T Consensus 293 i~~~~~--~~~~p~~~-~~~s~~---~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 293 IMNHKE--RFQFPTQV-TDVSEN---AKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp HHTHHH--HCCCCSSC-CCSCHH---HHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred hhhccc--cccCCccc-ccCCHH---HHHHHHHHhcccccccCCCCHHHHhCC
Confidence 211100 00011110 112333 445777999888888 9999999875
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-44 Score=356.12 Aligned_cols=274 Identities=22% Similarity=0.267 Sum_probs=213.7
Q ss_pred cCCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCC-chhHHHHHHHHHHHHccCCCCeeeEeeeeecCC--eeEE
Q 010513 184 STNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGA--HRML 259 (508)
Q Consensus 184 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~--~~~l 259 (508)
..++|++.+.||+|+||+||+|.+. +++.||||++.... ....+.+.+|++++++++||||+++++++.+.. ..++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 86 (319)
T 4euu_A 7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL 86 (319)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred CCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEE
Confidence 3457999999999999999999986 48899999986543 234567789999999999999999999998665 7799
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEE----cCCCCeEEeeecc
Q 010513 260 VYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILL----DKQWNPKLSDFGL 335 (508)
Q Consensus 260 V~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll----~~~~~~kL~DFG~ 335 (508)
||||+++|+|.+++..... ...+++..++.++.|++.||+|||++ +|+||||||+|||+ +.++.+||+|||+
T Consensus 87 v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~ 162 (319)
T 4euu_A 87 IMEFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA 162 (319)
T ss_dssp EEECCTTCBHHHHHHSGGG-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTT
T ss_pred EEeCCCCCCHHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCC
Confidence 9999999999999976522 23499999999999999999999999 99999999999999 7788899999999
Q ss_pred ceecCCCCcceecceecCCCCCChhhhh--------cCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHH
Q 010513 336 AKLLGAERSYVTTRVMGTFGYVAPEYAS--------TGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKT 407 (508)
Q Consensus 336 a~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~ 407 (508)
++....... .....||+.|+|||++. +..++.++|||||||++|||++|+.||......... .+.+..
T Consensus 163 a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--~~~~~~ 238 (319)
T 4euu_A 163 ARELEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN--KEVMYK 238 (319)
T ss_dssp CEECCTTCC--BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGC--HHHHHH
T ss_pred ceecCCCCc--eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchh--HHHHHH
Confidence 987654332 23457999999999986 578899999999999999999999999754432221 122222
Q ss_pred hhcccc---cccC---C--------CccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCCC
Q 010513 408 MVTNRN---AEGV---L--------DPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEEFP 465 (508)
Q Consensus 408 ~~~~~~---~~~~---~--------~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~~~~~ 465 (508)
...... .... . +..............+.+++.+||+.||++||++.|++++..++..+
T Consensus 239 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~~ 310 (319)
T 4euu_A 239 IITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (319)
T ss_dssp HHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC-
T ss_pred HhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhhc
Confidence 221110 0000 0 00011122344555667788899999999999999999999877654
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=360.22 Aligned_cols=252 Identities=18% Similarity=0.281 Sum_probs=206.3
Q ss_pred CCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCchhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEEe
Q 010513 185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY 263 (508)
Q Consensus 185 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~ 263 (508)
.++|++.+.||+|+||+||+|.+. ++..||+|.+... ......+.+|+++++.++||||+++++++.+.+..++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 468999999999999999999976 5778999988644 34456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcC--CCCeEEeeeccceecCC
Q 010513 264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDK--QWNPKLSDFGLAKLLGA 341 (508)
Q Consensus 264 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~--~~~~kL~DFG~a~~~~~ 341 (508)
+++|+|.+++... ...+++..++.++.|++.||+|||++ +|+||||||+|||++. ++.+||+|||++.....
T Consensus 83 ~~g~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~ 156 (321)
T 1tki_A 83 ISGLDIFERINTS---AFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156 (321)
T ss_dssp CCCCBHHHHHTSS---SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred CCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCC
Confidence 9999999999765 35699999999999999999999999 9999999999999987 78999999999987644
Q ss_pred CCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCCcc
Q 010513 342 ERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPR 421 (508)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 421 (508)
.. ......||+.|+|||++.+..++.++|||||||++|+|++|..||..... .+.+........ .
T Consensus 157 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~------~~~~~~i~~~~~-------~ 221 (321)
T 1tki_A 157 GD--NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN------QQIIENIMNAEY-------T 221 (321)
T ss_dssp TC--EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHHTCC-------C
T ss_pred CC--ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCH------HHHHHHHHcCCC-------C
Confidence 32 23456799999999999988899999999999999999999999974321 122222221110 0
Q ss_pred CCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 422 LQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 422 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
+..........++.+++.+||+.||++||++.|++++
T Consensus 222 ~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 222 FDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 0000011123455668889999999999999999984
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=366.71 Aligned_cols=253 Identities=19% Similarity=0.297 Sum_probs=204.8
Q ss_pred cCCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCC--chhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEE
Q 010513 184 STNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLV 260 (508)
Q Consensus 184 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 260 (508)
..++|++.+.||+|+||.||+|.+. ++..||+|.+.... ....+.+.+|+++++.++||||+++++++.+++..|+|
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 3457999999999999999999976 58899999986543 23456788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCC---CeEEeeeccce
Q 010513 261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQW---NPKLSDFGLAK 337 (508)
Q Consensus 261 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~---~~kL~DFG~a~ 337 (508)
|||+++|+|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++ .+||+|||++.
T Consensus 107 ~e~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~ 179 (362)
T 2bdw_A 107 FDLVTGGELFEDIVAR----EFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAI 179 (362)
T ss_dssp ECCCCSCBHHHHHTTC----SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCB
T ss_pred EecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcce
Confidence 9999999999999764 5689999999999999999999999 999999999999997654 59999999998
Q ss_pred ecCCCCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccC
Q 010513 338 LLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGV 417 (508)
Q Consensus 338 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 417 (508)
...... .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||..... .+....... ... .
T Consensus 180 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~------~~~~~~i~~-~~~-~- 248 (362)
T 2bdw_A 180 EVNDSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ------HRLYAQIKA-GAY-D- 248 (362)
T ss_dssp CCTTCC--SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHH-TCC-C-
T ss_pred EecCCc--ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHHh-CCC-C-
Confidence 764332 23446899999999999999999999999999999999999999964321 111111111 110 0
Q ss_pred CCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 418 LDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 418 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
+..........++.+++.+||+.||++||++.+++++
T Consensus 249 ----~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 249 ----YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp ----CCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred ----CCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0111111222345558889999999999999999875
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=371.24 Aligned_cols=257 Identities=23% Similarity=0.330 Sum_probs=202.9
Q ss_pred hcCCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCC---chhHHHHHHHHHHHHcc-CCCCeeeEeeeeecCCee
Q 010513 183 VSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEGAHR 257 (508)
Q Consensus 183 ~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~ 257 (508)
+..++|++.++||+|+||+||+|+.+ +++.||+|++.+.. ....+.+..|..++.++ +||||++++++|.+....
T Consensus 49 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~ 128 (396)
T 4dc2_A 49 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL 128 (396)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEE
Confidence 34568999999999999999999976 47789999987542 22334577899999887 899999999999999999
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccce
Q 010513 258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK 337 (508)
Q Consensus 258 ~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~ 337 (508)
|+||||+++|+|.+++... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 129 ~lV~E~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~ 201 (396)
T 4dc2_A 129 FFVIEYVNGGDLMFHMQRQ----RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCK 201 (396)
T ss_dssp EEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEEEcCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceee
Confidence 9999999999999999765 4699999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCC--cchHHHHHHHhhcccccc
Q 010513 338 LLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPG--EVNLVEWLKTMVTNRNAE 415 (508)
Q Consensus 338 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~--~~~~~~~~~~~~~~~~~~ 415 (508)
.... ........+||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..+..+.+.........
T Consensus 202 ~~~~-~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~- 279 (396)
T 4dc2_A 202 EGLR-PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI- 279 (396)
T ss_dssp CCCC-TTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCC-
T ss_pred eccc-CCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcccc-
Confidence 5322 2233455789999999999999999999999999999999999999997543221 11122222222222111
Q ss_pred cCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCH------HHHHH
Q 010513 416 GVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKM------GHVIH 457 (508)
Q Consensus 416 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~------~evl~ 457 (508)
.+.. ..+ .++.+++.+||+.||++||++ .++++
T Consensus 280 -----~~p~-~~s---~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~ 318 (396)
T 4dc2_A 280 -----RIPR-SLS---VKAASVLKSFLNKDPKERLGCHPQTGFADIQG 318 (396)
T ss_dssp -----CCCT-TSC---HHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHH
T ss_pred -----CCCC-cCC---HHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhc
Confidence 1111 122 344558889999999999985 56654
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-45 Score=367.72 Aligned_cols=256 Identities=21% Similarity=0.336 Sum_probs=204.8
Q ss_pred CCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCC-----chhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeE
Q 010513 185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR-----GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM 258 (508)
Q Consensus 185 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 258 (508)
.++|++.+.||+|+||+||+|.+. +++.||+|++.... ....+.+.+|+++++.++||||+++++++.+++..|
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 357999999999999999999976 68899999985421 224577899999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCC---eEEeeecc
Q 010513 259 LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWN---PKLSDFGL 335 (508)
Q Consensus 259 lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~---~kL~DFG~ 335 (508)
+||||+++|+|.+++.........+++..++.++.|++.||+|||++ +|+||||||+|||++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 99999999999988865433345689999999999999999999999 9999999999999986655 99999999
Q ss_pred ceecCCCCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccc
Q 010513 336 AKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAE 415 (508)
Q Consensus 336 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (508)
+....... ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.... ... ....... ..
T Consensus 180 a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~----~~~---~~~i~~~-~~- 249 (351)
T 3c0i_A 180 AIQLGESG-LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK----ERL---FEGIIKG-KY- 249 (351)
T ss_dssp CEECCTTS-CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH----HHH---HHHHHHT-CC-
T ss_pred eeEecCCC-eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH----HHH---HHHHHcC-CC-
Confidence 98765432 22345679999999999999999999999999999999999999997431 111 1111111 10
Q ss_pred cCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 416 GVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 416 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
..++. .......++.+++.+||+.||++||++.+++++
T Consensus 250 -~~~~~----~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 287 (351)
T 3c0i_A 250 -KMNPR----QWSHISESAKDLVRRMLMLDPAERITVYEALNH 287 (351)
T ss_dssp -CCCHH----HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred -CCCcc----ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 00100 001122345568889999999999999999863
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=372.46 Aligned_cols=268 Identities=24% Similarity=0.369 Sum_probs=213.4
Q ss_pred chhhHhhcCCCCcccceEcccCcEEEEEEEEC------CCcEEEEEEeecCCc-hhHHHHHHHHHHHHcc-CCCCeeeEe
Q 010513 177 TLRELEVSTNGFADENVIGEGGYGIVYHGVLE------DNTNVAVKNLLNNRG-QAEKEFKVEVEAIGRV-RHKNLVRLL 248 (508)
Q Consensus 177 ~~~~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpniv~l~ 248 (508)
....+++..++|++.+.||+|+||.||+|.+. +++.||||++..... ...+.+.+|++++.++ +||||++++
T Consensus 13 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~ 92 (359)
T 3vhe_A 13 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 92 (359)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeee
Confidence 46677889999999999999999999999842 356899999976433 3446789999999999 799999999
Q ss_pred eeeecCC-eeEEEEEecCCCCHHHHhccCCCC------------------------------------------------
Q 010513 249 GYCAEGA-HRMLVYEYIDNGNLEQWLHGDVGP------------------------------------------------ 279 (508)
Q Consensus 249 ~~~~~~~-~~~lV~e~~~~g~L~~~l~~~~~~------------------------------------------------ 279 (508)
+++.+.+ ..++||||+++|+|.+++......
T Consensus 93 ~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (359)
T 3vhe_A 93 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKS 172 (359)
T ss_dssp EEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------
T ss_pred eeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccc
Confidence 9988755 488999999999999999765321
Q ss_pred --------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCCCc-
Q 010513 280 --------------HSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS- 344 (508)
Q Consensus 280 --------------~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~- 344 (508)
...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.......
T Consensus 173 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 249 (359)
T 3vhe_A 173 LSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 249 (359)
T ss_dssp -----------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTC
T ss_pred cchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeecccccc
Confidence 12289999999999999999999999 999999999999999999999999999987644332
Q ss_pred ceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHhhcccccccCCCccCC
Q 010513 345 YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQ 423 (508)
Q Consensus 345 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 423 (508)
.......||+.|+|||++.+..++.++|||||||++|||+| |+.||....... .... ....... ....
T Consensus 250 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~~~~----~~~~~~~-----~~~~ 318 (359)
T 3vhe_A 250 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--EFCR----RLKEGTR-----MRAP 318 (359)
T ss_dssp EEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH--HHHH----HHHHTCC-----CCCC
T ss_pred hhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH--HHHH----HHHcCCC-----CCCC
Confidence 23345678999999999999999999999999999999998 999997544321 1111 1111110 0111
Q ss_pred CCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010513 424 EKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (508)
Q Consensus 424 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~~ 462 (508)
...+. ++.+++.+||+.||++||++.+++++|++.
T Consensus 319 -~~~~~---~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 353 (359)
T 3vhe_A 319 -DYTTP---EMYQTMLDCWHGEPSQRPTFSELVEHLGNL 353 (359)
T ss_dssp -TTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -CCCCH---HHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence 11233 345578899999999999999999999853
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-44 Score=358.42 Aligned_cols=251 Identities=22% Similarity=0.318 Sum_probs=204.9
Q ss_pred CCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCch------hHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeE
Q 010513 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQ------AEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM 258 (508)
Q Consensus 186 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 258 (508)
++|.+.+.||+|+||.||+|... ++..||+|.+...... ..+.+.+|+++++.++||||+++++++.+....+
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 46899999999999999999976 5889999998654322 3577899999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCC----CeEEeeec
Q 010513 259 LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQW----NPKLSDFG 334 (508)
Q Consensus 259 lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~----~~kL~DFG 334 (508)
+||||+++|+|.+++... ..+++..++.++.|++.||.|||++ +|+||||||+|||++.++ .+||+|||
T Consensus 91 lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg 163 (326)
T 2y0a_A 91 LILELVAGGELFDFLAEK----ESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFG 163 (326)
T ss_dssp EEEECCCSCBHHHHHTTS----SCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEcCCCCCHHHHHHhc----CCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence 999999999999999764 5799999999999999999999999 999999999999998887 79999999
Q ss_pred cceecCCCCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhccccc
Q 010513 335 LAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNA 414 (508)
Q Consensus 335 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 414 (508)
+++...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||..... .+.+.......
T Consensus 164 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~------~~~~~~~~~~~-- 233 (326)
T 2y0a_A 164 LAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK------QETLANVSAVN-- 233 (326)
T ss_dssp TCEECCTTS--CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH------HHHHHHHHHTC--
T ss_pred CCeECCCCC--ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCH------HHHHHHHHhcC--
Confidence 998764332 23346799999999999999999999999999999999999999964321 11111111110
Q ss_pred ccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 415 EGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 415 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
..+...........+.+++.+||+.||++||++.+++++
T Consensus 234 -----~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 234 -----YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp -----CCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred -----CCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 001100011122345568889999999999999999975
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-45 Score=364.25 Aligned_cols=253 Identities=27% Similarity=0.409 Sum_probs=202.6
Q ss_pred CCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCc-hhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEE
Q 010513 185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE 262 (508)
Q Consensus 185 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e 262 (508)
.++|++.+.||+|+||+||+|.+. +++.||+|++..... ...+.+.+|+.+++.++||||+++++++.+++..|+|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 368999999999999999999976 688999999865432 334668899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCC
Q 010513 263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE 342 (508)
Q Consensus 263 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 342 (508)
|+++|+|.+++... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++..+...
T Consensus 86 ~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 158 (323)
T 3tki_A 86 YCSGGELFDRIEPD----IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (323)
T ss_dssp CCTTEEGGGGSBTT----TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred cCCCCcHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceeccC
Confidence 99999999999764 4699999999999999999999999 9999999999999999999999999999865432
Q ss_pred C-cceecceecCCCCCChhhhhcCCC-CCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCCc
Q 010513 343 R-SYVTTRVMGTFGYVAPEYASTGML-NERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDP 420 (508)
Q Consensus 343 ~-~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 420 (508)
. .......+||+.|+|||++.+..+ +.++|||||||++|||++|+.||........ ....+ .... ....
T Consensus 159 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~~~----~~~~---~~~~- 229 (323)
T 3tki_A 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDW----KEKK---TYLN- 229 (323)
T ss_dssp TEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH-HHHHH----HTTC---TTST-
T ss_pred CcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHH----hccc---ccCC-
Confidence 2 222345689999999999987765 7789999999999999999999975543211 11111 1110 0011
Q ss_pred cCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 421 RLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 421 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
........+.+++.+||+.||++||++.|++++
T Consensus 230 -----~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 230 -----PWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp -----TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred -----ccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 111222344558889999999999999999875
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=378.24 Aligned_cols=260 Identities=25% Similarity=0.405 Sum_probs=209.9
Q ss_pred HhhcCCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCc-hhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeE
Q 010513 181 LEVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM 258 (508)
Q Consensus 181 ~~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 258 (508)
+.+..++|++.+.||+|+||+||+|.+. +++.||||.+..... ...+.+.+|++++++++||||+++++++.++...+
T Consensus 109 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 188 (377)
T 3cbl_A 109 WVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIY 188 (377)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred cEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcE
Confidence 3566778999999999999999999986 688999999865432 33456888999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeecccee
Q 010513 259 LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL 338 (508)
Q Consensus 259 lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~ 338 (508)
+||||+++|+|.+++... ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 189 lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~ 262 (377)
T 3cbl_A 189 IVMELVQGGDFLTFLRTE---GARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSRE 262 (377)
T ss_dssp EEEECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred EEEEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCcee
Confidence 999999999999999764 24689999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCccee-cceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHhhccccccc
Q 010513 339 LGAERSYVT-TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEG 416 (508)
Q Consensus 339 ~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 416 (508)
......... ....+++.|+|||.+.++.++.++|||||||++|||+| |..||..... .+ ..........
T Consensus 263 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~------~~-~~~~~~~~~~-- 333 (377)
T 3cbl_A 263 EADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN------QQ-TREFVEKGGR-- 333 (377)
T ss_dssp CTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCH------HH-HHHHHHTTCC--
T ss_pred cCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH------HH-HHHHHHcCCC--
Confidence 533221111 12345778999999999999999999999999999998 9999975431 11 1111211110
Q ss_pred CCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010513 417 VLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (508)
Q Consensus 417 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~~ 462 (508)
... ...++.. +.+++.+||+.||++||++.++++.|++.
T Consensus 334 ---~~~-~~~~~~~---l~~li~~cl~~dP~~Rps~~~i~~~L~~i 372 (377)
T 3cbl_A 334 ---LPC-PELCPDA---VFRLMEQCWAYEPGQRPSFSTIYQELQSI 372 (377)
T ss_dssp ---CCC-CTTCCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---CCC-CCCCCHH---HHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 001 1123444 44577899999999999999999999864
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=352.49 Aligned_cols=278 Identities=36% Similarity=0.662 Sum_probs=220.8
Q ss_pred cchhhHhhcCCCCccc------ceEcccCcEEEEEEEECCCcEEEEEEeecC----CchhHHHHHHHHHHHHccCCCCee
Q 010513 176 YTLRELEVSTNGFADE------NVIGEGGYGIVYHGVLEDNTNVAVKNLLNN----RGQAEKEFKVEVEAIGRVRHKNLV 245 (508)
Q Consensus 176 ~~~~~~~~~~~~~~~~------~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~hpniv 245 (508)
+++.++...++.|... +.||+|+||.||+|.. +++.||+|++... .....+.+.+|+++++.++||||+
T Consensus 15 ~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~ 93 (307)
T 2nru_A 15 FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLV 93 (307)
T ss_dssp CCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBC
T ss_pred ccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeE
Confidence 4566666666666655 8999999999999987 4789999998643 233457789999999999999999
Q ss_pred eEeeeeecCCeeEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCC
Q 010513 246 RLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQ 325 (508)
Q Consensus 246 ~l~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~ 325 (508)
++++++.+.+..++||||+++|+|.+++.... ....+++..++.++.|++.||+|||++ +|+||||||+||+++.+
T Consensus 94 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nili~~~ 169 (307)
T 2nru_A 94 ELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD-GTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEA 169 (307)
T ss_dssp CEEEEECSSSSCEEEEECCTTCBHHHHHHTGG-GCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTT
T ss_pred EEEEEEecCCceEEEEEecCCCcHHHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEcCC
Confidence 99999999999999999999999999997542 135689999999999999999999999 99999999999999999
Q ss_pred CCeEEeeeccceecCCCCcc-eecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHH
Q 010513 326 WNPKLSDFGLAKLLGAERSY-VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEW 404 (508)
Q Consensus 326 ~~~kL~DFG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~ 404 (508)
+.+||+|||++......... ......||+.|+|||.+.+ .++.++||||||+++|+|++|+.||.......... .+
T Consensus 170 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~--~~ 246 (307)
T 2nru_A 170 FTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLL--DI 246 (307)
T ss_dssp CCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTT--HH
T ss_pred CcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHH--HH
Confidence 99999999999876543222 2334579999999998865 58899999999999999999999998665433221 11
Q ss_pred HHHhhc-ccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010513 405 LKTMVT-NRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (508)
Q Consensus 405 ~~~~~~-~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~~ 462 (508)
...... .......+++.+.. ........+.+++.+||+.||++||++.+++++|+..
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l 304 (307)
T 2nru_A 247 KEEIEDEEKTIEDYIDKKMND-ADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM 304 (307)
T ss_dssp HHHHHTTSCCHHHHSCSSCSC-CCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred HHHhhhhhhhhhhhccccccc-cchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 111111 11222333443332 2445566777899999999999999999999999864
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=371.48 Aligned_cols=251 Identities=20% Similarity=0.282 Sum_probs=190.4
Q ss_pred CCCccc-ceEcccCcEEEEEEEEC-CCcEEEEEEeecCCchhHHHHHHHHHHHH-ccCCCCeeeEeeeeec----CCeeE
Q 010513 186 NGFADE-NVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIG-RVRHKNLVRLLGYCAE----GAHRM 258 (508)
Q Consensus 186 ~~~~~~-~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~-~l~hpniv~l~~~~~~----~~~~~ 258 (508)
++|.+. +.||+|+||+||+|.+. +++.||||++... ..+.+|++++. ..+||||++++++|.. ....|
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~ 135 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 135 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence 356665 78999999999999976 5888999998532 45667888874 4589999999999875 56789
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcC---CCCeEEeeecc
Q 010513 259 LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDK---QWNPKLSDFGL 335 (508)
Q Consensus 259 lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~---~~~~kL~DFG~ 335 (508)
+||||+++|+|.+++.... ...+++..++.++.|++.||+|||++ +|+||||||+|||++. ++.+||+|||+
T Consensus 136 lv~E~~~gg~L~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG~ 210 (400)
T 1nxk_A 136 IVMECLDGGELFSRIQDRG--DQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGF 210 (400)
T ss_dssp EEEECCCSEEHHHHHHCC-----CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEEeCCCCcHHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEeccc
Confidence 9999999999999997652 24699999999999999999999999 9999999999999987 78899999999
Q ss_pred ceecCCCCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcc-hHHHHHHHhhccccc
Q 010513 336 AKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEV-NLVEWLKTMVTNRNA 414 (508)
Q Consensus 336 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~-~~~~~~~~~~~~~~~ 414 (508)
++...... .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||......... .....+. ....
T Consensus 211 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~----~~~~ 284 (400)
T 1nxk_A 211 AKETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR----MGQY 284 (400)
T ss_dssp CEECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHH----HTCC
T ss_pred ccccCCCC--ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHH----cCcc
Confidence 98754322 234568999999999999999999999999999999999999999765433211 1111111 1110
Q ss_pred ccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 415 EGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 415 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
....+.. ...+ .++.+++.+||+.||++||++.+++++
T Consensus 285 -~~~~~~~--~~~s---~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 285 -EFPNPEW--SEVS---EEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp -CCCTTTT--TTSC---HHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred -cCCCccc--ccCC---HHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0001111 1123 345558889999999999999999985
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=370.31 Aligned_cols=258 Identities=27% Similarity=0.478 Sum_probs=197.2
Q ss_pred hcCCCCcccceEcccCcEEEEEEEEC----CCcEEEEEEeecCC-chhHHHHHHHHHHHHccCCCCeeeEeeeeecCCee
Q 010513 183 VSTNGFADENVIGEGGYGIVYHGVLE----DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHR 257 (508)
Q Consensus 183 ~~~~~~~~~~~LG~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 257 (508)
+..++|++.+.||+|+||+||+|++. ++..||||.+.... ....+.+.+|++++++++||||+++++++.++...
T Consensus 42 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 121 (373)
T 2qol_A 42 LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPV 121 (373)
T ss_dssp CCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred cCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCce
Confidence 44568999999999999999999865 46679999986543 34456799999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccce
Q 010513 258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK 337 (508)
Q Consensus 258 ~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~ 337 (508)
++||||+++|+|.+++... ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 122 ~lv~e~~~~~sL~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 195 (373)
T 2qol_A 122 MIVTEYMENGSLDSFLRKH---DAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGR 195 (373)
T ss_dssp EEEEECCTTCBHHHHHHTT---TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC----
T ss_pred EEEEeCCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCcccc
Confidence 9999999999999999765 35799999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCcce--ecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHhhccccc
Q 010513 338 LLGAERSYV--TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNA 414 (508)
Q Consensus 338 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 414 (508)
......... .....+++.|+|||++.+..++.++|||||||++|||++ |+.||..... .+..........
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~------~~~~~~i~~~~~- 268 (373)
T 2qol_A 196 VLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN------QDVIKAVDEGYR- 268 (373)
T ss_dssp ------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH------HHHHHHHHTTEE-
T ss_pred ccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHHHcCCC-
Confidence 765432221 222346788999999999999999999999999999998 9999964421 121222111110
Q ss_pred ccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010513 415 EGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (508)
Q Consensus 415 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~~ 462 (508)
.+ ....++ ..+.+++.+||+.||++||++.+++++|+..
T Consensus 269 ----~~--~~~~~~---~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~ 307 (373)
T 2qol_A 269 ----LP--PPMDCP---AALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307 (373)
T ss_dssp ----CC--CCTTCB---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----CC--CCcccc---HHHHHHHHHHhCcChhhCcCHHHHHHHHHHH
Confidence 00 011123 3455588899999999999999999999864
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=358.37 Aligned_cols=246 Identities=25% Similarity=0.339 Sum_probs=204.2
Q ss_pred CCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCC---chhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEE
Q 010513 185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLV 260 (508)
Q Consensus 185 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 260 (508)
.++|++.+.||+|+||+||+|+.. +|+.||+|.+.+.. ....+.+.+|+.+++.++||||+++++++.+....|+|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 457999999999999999999976 68899999986542 23456778899999999999999999999999999999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecC
Q 010513 261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG 340 (508)
Q Consensus 261 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 340 (508)
|||+++|+|.+++... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 85 ~e~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~ 157 (318)
T 1fot_A 85 MDYIEGGELFSLLRKS----QRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVP 157 (318)
T ss_dssp ECCCCSCBHHHHHHHT----SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred EeCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecC
Confidence 9999999999999765 4689999999999999999999999 99999999999999999999999999998754
Q ss_pred CCCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCCc
Q 010513 341 AERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDP 420 (508)
Q Consensus 341 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 420 (508)
.. ....+||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+......... .
T Consensus 158 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~------~~~~~~~i~~~~-------~ 220 (318)
T 1fot_A 158 DV----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN------TMKTYEKILNAE-------L 220 (318)
T ss_dssp SC----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS------HHHHHHHHHHCC-------C
T ss_pred Cc----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC------HHHHHHHHHhCC-------C
Confidence 32 234689999999999999999999999999999999999999996432 122222222211 0
Q ss_pred cCCCCchHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 010513 421 RLQEKPCSRALKRALLVALRCVDPNAHKRP-----KMGHVIHM 458 (508)
Q Consensus 421 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 458 (508)
.+.. ..+. ++.+++.+||+.||++|| ++.+++++
T Consensus 221 ~~p~-~~~~---~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 221 RFPP-FFNE---DVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp CCCT-TSCH---HHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred CCCC-CCCH---HHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence 1111 1223 344577899999999999 88888854
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-45 Score=358.65 Aligned_cols=260 Identities=22% Similarity=0.374 Sum_probs=197.5
Q ss_pred hHhhcCCCCcccceEcccCcEEEEEEEECC----CcEEEEEEeecCC-chhHHHHHHHHHHHHccCCCCeeeEeeeeecC
Q 010513 180 ELEVSTNGFADENVIGEGGYGIVYHGVLED----NTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEG 254 (508)
Q Consensus 180 ~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~ 254 (508)
++++..++|++.+.||+|+||.||+|.+.. +..||+|.+.... ....+.+.+|+.++++++||||+++++++. +
T Consensus 9 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~ 87 (281)
T 1mp8_A 9 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E 87 (281)
T ss_dssp CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-S
T ss_pred ceEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-c
Confidence 345667799999999999999999999753 3468999886543 334567889999999999999999999985 4
Q ss_pred CeeEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeec
Q 010513 255 AHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFG 334 (508)
Q Consensus 255 ~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG 334 (508)
+..++||||+++|+|.+++... ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg 161 (281)
T 1mp8_A 88 NPVWIIMELCTLGELRSFLQVR---KYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFG 161 (281)
T ss_dssp SSCEEEEECCTTEEHHHHHHHT---TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC--
T ss_pred CccEEEEecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECccc
Confidence 6789999999999999999765 34689999999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHhhcccc
Q 010513 335 LAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRN 413 (508)
Q Consensus 335 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 413 (508)
+++..............+|+.|+|||++.+..++.++|||||||++|||++ |..||...... .....+ .....
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~---~~~~~i---~~~~~ 235 (281)
T 1mp8_A 162 LSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN---DVIGRI---ENGER 235 (281)
T ss_dssp -----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---GHHHHH---HTTCC
T ss_pred cccccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHH---HHHHHH---HcCCC
Confidence 998765444333444567889999999999999999999999999999997 99999754322 122211 11110
Q ss_pred cccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010513 414 AEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (508)
Q Consensus 414 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~~ 462 (508)
..+. ..++. .+.+++.+||+.||++||++.+++++|+..
T Consensus 236 ------~~~~-~~~~~---~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 274 (281)
T 1mp8_A 236 ------LPMP-PNCPP---TLYSLMTKCWAYDPSRRPRFTELKAQLSTI 274 (281)
T ss_dssp ------CCCC-TTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------CCCC-CCCCH---HHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 0111 11333 344578899999999999999999999753
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-44 Score=367.11 Aligned_cols=252 Identities=20% Similarity=0.285 Sum_probs=206.6
Q ss_pred CCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCchhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEEec
Q 010513 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYI 264 (508)
Q Consensus 186 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~ 264 (508)
++|++.+.||+|+||+||+|... +++.||+|.+..........+.+|+++++.++||||+++++++.+....++||||+
T Consensus 51 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~ 130 (387)
T 1kob_A 51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 130 (387)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcC
Confidence 57999999999999999999976 57889999987766556678899999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcC--CCCeEEeeeccceecCCC
Q 010513 265 DNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDK--QWNPKLSDFGLAKLLGAE 342 (508)
Q Consensus 265 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~--~~~~kL~DFG~a~~~~~~ 342 (508)
++|+|.+++... ...+++..++.++.|++.||+|||++ +|+||||||+|||++. ++.+||+|||+++.....
T Consensus 131 ~gg~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~ 204 (387)
T 1kob_A 131 SGGELFDRIAAE---DYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 204 (387)
T ss_dssp CCCBHHHHTTCT---TCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCCcHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence 999999999765 34689999999999999999999999 9999999999999974 577999999999976543
Q ss_pred CcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCCccC
Q 010513 343 RSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRL 422 (508)
Q Consensus 343 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 422 (508)
.. .....||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+.+....... . ..++..
T Consensus 205 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~------~~~~~~i~~~~-~--~~~~~~ 273 (387)
T 1kob_A 205 EI--VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD------LETLQNVKRCD-W--EFDEDA 273 (387)
T ss_dssp SC--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH------HHHHHHHHHCC-C--CCCSST
T ss_pred cc--eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCH------HHHHHHHHhCC-C--CCCccc
Confidence 22 3345799999999999999999999999999999999999999975321 12222221111 0 011111
Q ss_pred CCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 423 QEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 423 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
......++.+++.+||+.||++||++.+++++
T Consensus 274 ----~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 274 ----FSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp ----TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred ----cccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 11122345558889999999999999999975
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-45 Score=374.31 Aligned_cols=261 Identities=21% Similarity=0.283 Sum_probs=211.1
Q ss_pred chhhHhhcCCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCC---chhHHHHHHHHHHHHccCCCCeeeEeeeee
Q 010513 177 TLRELEVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCA 252 (508)
Q Consensus 177 ~~~~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~ 252 (508)
.++++++..++|++.+.||+|+||+||+|+++ +++.||+|++.+.. ....+.+.+|+.+++.++||||++++++|.
T Consensus 60 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~ 139 (410)
T 3v8s_A 60 KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQ 139 (410)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred HHHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 35667788899999999999999999999986 57889999986532 122345778999999999999999999999
Q ss_pred cCCeeEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEee
Q 010513 253 EGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSD 332 (508)
Q Consensus 253 ~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~D 332 (508)
++...|+||||+++|+|.+++... .+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|
T Consensus 140 ~~~~~~lV~E~~~gg~L~~~l~~~-----~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~D 211 (410)
T 3v8s_A 140 DDRYLYMVMEYMPGGDLVNLMSNY-----DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLAD 211 (410)
T ss_dssp CSSEEEEEECCCTTEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECC
T ss_pred ECCEEEEEEeCCCCCcHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEec
Confidence 999999999999999999999754 589999999999999999999999 999999999999999999999999
Q ss_pred eccceecCCCCcceecceecCCCCCChhhhhcCC----CCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHh
Q 010513 333 FGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGM----LNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTM 408 (508)
Q Consensus 333 FG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~ 408 (508)
||+++.............+||+.|+|||++.+.. |+.++|||||||++|||++|+.||..... .+.....
T Consensus 212 FG~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~------~~~~~~i 285 (410)
T 3v8s_A 212 FGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL------VGTYSKI 285 (410)
T ss_dssp CTTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHH
T ss_pred cceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCCh------hhHHHHH
Confidence 9999887655444455678999999999998765 78899999999999999999999974321 2222222
Q ss_pred hcccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHH
Q 010513 409 VTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHK--RPKMGHVIHM 458 (508)
Q Consensus 409 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~ 458 (508)
...... ..-|. ....+.. +.+++.+||+.+|++ ||++.|++++
T Consensus 286 ~~~~~~--~~~p~--~~~~s~~---~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 286 MNHKNS--LTFPD--DNDISKE---AKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp HTHHHH--CCCCT--TCCCCHH---HHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred Hhcccc--ccCCC--cccccHH---HHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 211100 00010 0112333 445777999999988 9999999976
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=351.30 Aligned_cols=258 Identities=26% Similarity=0.436 Sum_probs=211.5
Q ss_pred hhcCCCCcccceEcccCcEEEEEEEECCCcEEEEEEeecCCchhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEE
Q 010513 182 EVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY 261 (508)
Q Consensus 182 ~~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 261 (508)
.+..++|++.+.||+|+||.||+|.+.++..||+|.+..... ..+.+.+|+++++.++||||+++++++.+++..++||
T Consensus 4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (267)
T 3t9t_A 4 VIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVT 82 (267)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred EEchhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEE
Confidence 345678999999999999999999998888999999876543 3467889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCC
Q 010513 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA 341 (508)
Q Consensus 262 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 341 (508)
||+++++|.+++... ...+++..++.++.|++.||+|||++ +++||||||+||+++.++.+||+|||++.....
T Consensus 83 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 156 (267)
T 3t9t_A 83 EFMEHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 156 (267)
T ss_dssp CCCTTCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred eCCCCCcHHHHHhhC---cccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEccccccccccc
Confidence 999999999999765 35689999999999999999999999 999999999999999999999999999987643
Q ss_pred CCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHhhcccccccCCCc
Q 010513 342 ERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDP 420 (508)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 420 (508)
..........|++.|+|||++.+..++.++||||||+++|||++ |+.||..... .+.......... .
T Consensus 157 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~------~~~~~~i~~~~~------~ 224 (267)
T 3t9t_A 157 DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN------SEVVEDISTGFR------L 224 (267)
T ss_dssp HHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH------HHHHHHHHTTCC------C
T ss_pred ccccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCH------HHHHHHHhcCCc------C
Confidence 32222333467788999999999999999999999999999999 8999974321 122222211110 0
Q ss_pred cCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010513 421 RLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (508)
Q Consensus 421 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~~ 462 (508)
. .....+. .+.+++.+||+.||++||++.+++++|++.
T Consensus 225 ~-~~~~~~~---~l~~li~~~l~~~p~~Rps~~~ll~~L~~l 262 (267)
T 3t9t_A 225 Y-KPRLAST---HVYQIMNHCWRERPEDRPAFSRLLRQLAEI 262 (267)
T ss_dssp C-CCTTSCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred C-CCccCcH---HHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 0 1111233 344578899999999999999999999764
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-45 Score=380.91 Aligned_cols=264 Identities=23% Similarity=0.424 Sum_probs=214.5
Q ss_pred hhhHhhcCCCCcccceEcccCcEEEEEEEECCCcEEEEEEeecCCchhHHHHHHHHHHHHccCCCCeeeEeeeeecCCee
Q 010513 178 LRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHR 257 (508)
Q Consensus 178 ~~~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 257 (508)
...+++..++|.+.+.||+|+||+||+|.++++..||||++.... ...+.+.+|+++++.++||||+++++++. ....
T Consensus 180 ~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~ 257 (454)
T 1qcf_A 180 KDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPI 257 (454)
T ss_dssp TTCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSC
T ss_pred ccceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCcc
Confidence 345678888999999999999999999999888899999987544 34678999999999999999999999987 5678
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccce
Q 010513 258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK 337 (508)
Q Consensus 258 ~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~ 337 (508)
++||||+++|+|.+++.... ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 258 ~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~ 332 (454)
T 1qcf_A 258 YIITEFMAKGSLLDFLKSDE--GSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLAR 332 (454)
T ss_dssp EEEECCCTTCBHHHHHHSHH--HHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGG
T ss_pred EEEEeecCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCce
Confidence 99999999999999997542 23688999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHhhccccccc
Q 010513 338 LLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEG 416 (508)
Q Consensus 338 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 416 (508)
..............+++.|+|||++....++.++|||||||++|||+| |+.||..... .+..........
T Consensus 333 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~------~~~~~~i~~~~~--- 403 (454)
T 1qcf_A 333 VIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN------PEVIRALERGYR--- 403 (454)
T ss_dssp GBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH------HHHHHHHHHTCC---
T ss_pred EcCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCH------HHHHHHHHcCCC---
Confidence 764332222233456788999999999999999999999999999999 9999974431 121222111111
Q ss_pred CCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCC
Q 010513 417 VLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEEF 464 (508)
Q Consensus 417 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~~~~ 464 (508)
.+ ....++.. +.+++.+||+.||++||++.+|++.|++...
T Consensus 404 --~~--~~~~~~~~---l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~ 444 (454)
T 1qcf_A 404 --MP--RPENCPEE---LYNIMMRCWKNRPEERPTFEYIQSVLDDFYT 444 (454)
T ss_dssp --CC--CCTTSCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred --CC--CCCCCCHH---HHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence 00 11123344 4458889999999999999999999997643
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=363.82 Aligned_cols=267 Identities=26% Similarity=0.395 Sum_probs=214.2
Q ss_pred hhhHhhcCCCCcccceEcccCcEEEEEEEEC------CCcEEEEEEeecCC-chhHHHHHHHHHHHHccCCCCeeeEeee
Q 010513 178 LRELEVSTNGFADENVIGEGGYGIVYHGVLE------DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGY 250 (508)
Q Consensus 178 ~~~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~ 250 (508)
+..+++..++|++.+.||+|+||.||+|.+. +++.||+|.+.... ....+.+.+|+++++.++||||++++++
T Consensus 39 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 118 (343)
T 1luf_A 39 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGV 118 (343)
T ss_dssp HHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred cceeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence 4455677889999999999999999999975 24789999987653 3345678999999999999999999999
Q ss_pred eecCCeeEEEEEecCCCCHHHHhccCCCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 010513 251 CAEGAHRMLVYEYIDNGNLEQWLHGDVGP--------------------HSPLTWEIRMNIILGTAKGLTYLHEGLEPKV 310 (508)
Q Consensus 251 ~~~~~~~~lV~e~~~~g~L~~~l~~~~~~--------------------~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i 310 (508)
+.+++..++||||+++|+|.+++...... ...+++..++.++.|+++||+|||++ +|
T Consensus 119 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~i 195 (343)
T 1luf_A 119 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KF 195 (343)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TC
T ss_pred EccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence 99999999999999999999999764211 25799999999999999999999999 99
Q ss_pred eeccCCCCCEEEcCCCCeEEeeeccceecCCCCc-ceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHh-CCC
Q 010513 311 VHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS-YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRN 388 (508)
Q Consensus 311 iHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~ 388 (508)
+||||||+|||++.++.+||+|||+++....... .......||+.|+|||.+.+..++.++|||||||++|||++ |+.
T Consensus 196 vH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~ 275 (343)
T 1luf_A 196 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 275 (343)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred ecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCC
Confidence 9999999999999999999999999986643322 12234568899999999999999999999999999999999 999
Q ss_pred CCCCCCCCCcchHHHHHHHhhcccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 010513 389 PVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEE 463 (508)
Q Consensus 389 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~~~ 463 (508)
||..... .+..... ...... ... ..++. ++.+++.+||+.||++||++.+++++|+...
T Consensus 276 p~~~~~~------~~~~~~~-~~~~~~-----~~~-~~~~~---~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~ 334 (343)
T 1luf_A 276 PYYGMAH------EEVIYYV-RDGNIL-----ACP-ENCPL---ELYNLMRLCWSKLPADRPSFCSIHRILQRMC 334 (343)
T ss_dssp TTTTSCH------HHHHHHH-HTTCCC-----CCC-TTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred cCCCCCh------HHHHHHH-hCCCcC-----CCC-CCCCH---HHHHHHHHHcccCcccCCCHHHHHHHHHHHH
Confidence 9964321 1222221 111110 111 12333 4455788999999999999999999998765
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=368.19 Aligned_cols=264 Identities=25% Similarity=0.418 Sum_probs=213.0
Q ss_pred HhhcCCCCcccceEcccCcEEEEEEEEC--------CCcEEEEEEeecCCc-hhHHHHHHHHHHHHcc-CCCCeeeEeee
Q 010513 181 LEVSTNGFADENVIGEGGYGIVYHGVLE--------DNTNVAVKNLLNNRG-QAEKEFKVEVEAIGRV-RHKNLVRLLGY 250 (508)
Q Consensus 181 ~~~~~~~~~~~~~LG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpniv~l~~~ 250 (508)
+++..++|.+.+.||+|+||+||+|++. .+..||+|++..... ...+.+.+|+++++.+ +||||++++++
T Consensus 64 ~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~ 143 (382)
T 3tt0_A 64 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGA 143 (382)
T ss_dssp TBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheee
Confidence 3566789999999999999999999963 235799999876533 3456788999999999 99999999999
Q ss_pred eecCCeeEEEEEecCCCCHHHHhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCC
Q 010513 251 CAEGAHRMLVYEYIDNGNLEQWLHGDVG------------PHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSS 318 (508)
Q Consensus 251 ~~~~~~~~lV~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~ 318 (508)
+.+++..++||||+++|+|.+++..... ....+++..++.++.|++.||+|||++ +|+||||||+
T Consensus 144 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~ 220 (382)
T 3tt0_A 144 CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAAR 220 (382)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGG
T ss_pred eccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcc
Confidence 9999999999999999999999976532 124699999999999999999999999 9999999999
Q ss_pred CEEEcCCCCeEEeeeccceecCCCCc-ceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHh-CCCCCCCCCCC
Q 010513 319 NILLDKQWNPKLSDFGLAKLLGAERS-YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPP 396 (508)
Q Consensus 319 NIll~~~~~~kL~DFG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~Pf~~~~~~ 396 (508)
|||++.++.+||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||++ |..||....
T Consensus 221 NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~-- 298 (382)
T 3tt0_A 221 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP-- 298 (382)
T ss_dssp GEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC--
T ss_pred eEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC--
Confidence 99999999999999999987644332 22344567889999999999999999999999999999999 999996432
Q ss_pred CcchHHHHHHHhhcccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 010513 397 GEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEE 463 (508)
Q Consensus 397 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~~~ 463 (508)
..+.......... +... ..++. ++.+++.+||+.||++||++.+++++|+...
T Consensus 299 ----~~~~~~~~~~~~~------~~~~-~~~~~---~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 351 (382)
T 3tt0_A 299 ----VEELFKLLKEGHR------MDKP-SNCTN---ELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 351 (382)
T ss_dssp ----HHHHHHHHHTTCC------CCCC-SSCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----HHHHHHHHHcCCC------CCCC-ccCCH---HHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 1222222211111 1111 11333 3455788999999999999999999998653
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=365.08 Aligned_cols=254 Identities=22% Similarity=0.319 Sum_probs=190.5
Q ss_pred hhcCCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCchhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEE
Q 010513 182 EVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLV 260 (508)
Q Consensus 182 ~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 260 (508)
+...++|++.+.||+|+||+||+|.+. +++.||+|.+.... ..+.+.+|++++++++||||+++++++.+....++|
T Consensus 49 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 126 (349)
T 2w4o_A 49 DALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLV 126 (349)
T ss_dssp SCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEE
Confidence 445678999999999999999999987 47789999987543 345688899999999999999999999999999999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcC---CCCeEEeeeccce
Q 010513 261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDK---QWNPKLSDFGLAK 337 (508)
Q Consensus 261 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~---~~~~kL~DFG~a~ 337 (508)
|||+++|+|.+++... ..+++..++.++.|++.||+|||++ +|+||||||+|||++. ++.+||+|||+++
T Consensus 127 ~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~ 199 (349)
T 2w4o_A 127 LELVTGGELFDRIVEK----GYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSK 199 (349)
T ss_dssp ECCCCSCBHHHHHTTC----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC---
T ss_pred EEeCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCcccc
Confidence 9999999999999764 4689999999999999999999999 9999999999999975 8899999999998
Q ss_pred ecCCCCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccC
Q 010513 338 LLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGV 417 (508)
Q Consensus 338 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 417 (508)
..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... . ........ ... ..
T Consensus 200 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~---~~~~~i~~-~~~-~~ 270 (349)
T 2w4o_A 200 IVEHQ--VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGD--Q---FMFRRILN-CEY-YF 270 (349)
T ss_dssp ---------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCH--H---HHHHHHHT-TCC-CC
T ss_pred ccCcc--cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCccc--H---HHHHHHHh-CCC-cc
Confidence 65332 2234467999999999999999999999999999999999999999644321 1 11111111 111 01
Q ss_pred CCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 418 LDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 418 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
..+. ......++.+++.+||+.||++||++.+++++
T Consensus 271 ~~~~-----~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 271 ISPW-----WDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp CTTT-----TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CCch-----hhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1111 11122345558889999999999999999975
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-44 Score=373.58 Aligned_cols=253 Identities=20% Similarity=0.275 Sum_probs=203.7
Q ss_pred CCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCc--hhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEE
Q 010513 185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG--QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY 261 (508)
Q Consensus 185 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 261 (508)
.++|++.+.||+|+||+||+|... +++.||+|++..... ...+.+.+|+++++.++||||+++++++.+++..|+||
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF 89 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence 357999999999999999999975 688899999866542 34467889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEc---CCCCeEEeeecccee
Q 010513 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLD---KQWNPKLSDFGLAKL 338 (508)
Q Consensus 262 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~---~~~~~kL~DFG~a~~ 338 (508)
||+++|+|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+|||++ .++.+||+|||++..
T Consensus 90 E~~~gg~L~~~i~~~----~~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~ 162 (444)
T 3soa_A 90 DLVTGGELFEDIVAR----EYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIE 162 (444)
T ss_dssp CCCBCCBHHHHHHHC----SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCBC
T ss_pred EeCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeEE
Confidence 999999999999765 5699999999999999999999999 999999999999998 567899999999987
Q ss_pred cCCCCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCC
Q 010513 339 LGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVL 418 (508)
Q Consensus 339 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 418 (508)
..... ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||..... .+....... ... ...
T Consensus 163 ~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~------~~~~~~i~~-~~~-~~~ 233 (444)
T 3soa_A 163 VEGEQ-QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQ------HRLYQQIKA-GAY-DFP 233 (444)
T ss_dssp CCTTC-CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHH-TCC-CCC
T ss_pred ecCCC-ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccH------HHHHHHHHh-CCC-CCC
Confidence 64432 223446899999999999999999999999999999999999999964321 111222111 111 111
Q ss_pred CccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 419 DPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 419 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
.+.. ...+. ++.+++.+||+.||++||++.|++++
T Consensus 234 ~~~~--~~~s~---~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 234 SPEW--DTVTP---EAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp TTTT--TTSCH---HHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred cccc--ccCCH---HHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 1111 11233 44557889999999999999999975
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-44 Score=351.88 Aligned_cols=262 Identities=21% Similarity=0.329 Sum_probs=200.1
Q ss_pred CCCcccceEcccCcEEEEEEEECCCcEEEEEEeecCCc--hhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEEe
Q 010513 186 NGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRG--QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY 263 (508)
Q Consensus 186 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~ 263 (508)
++|++.+.||+|+||+||+|...+++.||+|++..... ...+.+.+|+++++.++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 57999999999999999999998899999999865432 2346788899999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCCC
Q 010513 264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER 343 (508)
Q Consensus 264 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 343 (508)
+++ +|.+++... ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 154 (288)
T 1ob3_A 82 LDQ-DLKKLLDVC---EGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154 (288)
T ss_dssp CSE-EHHHHHHTS---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred cCC-CHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCccc
Confidence 986 999998765 35789999999999999999999999 99999999999999999999999999998764322
Q ss_pred cceecceecCCCCCChhhhhc-CCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhccccc--------
Q 010513 344 SYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNA-------- 414 (508)
Q Consensus 344 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~-------- 414 (508)
.......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... ................
T Consensus 155 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 230 (288)
T 1ob3_A 155 -RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSE---ADQLMRIFRILGTPNSKNWPNVTE 230 (288)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred -cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHHCCCChhhchhhhc
Confidence 22334578999999999876 4589999999999999999999999975431 1111111111111000
Q ss_pred ccCCCccCCC-------CchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 415 EGVLDPRLQE-------KPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 415 ~~~~~~~l~~-------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
....++.+.. ........++.+++.+||+.||++||++.|++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp STTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0001111110 0001122345568889999999999999999864
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=351.89 Aligned_cols=253 Identities=28% Similarity=0.510 Sum_probs=195.5
Q ss_pred hhcCCCCcccceEcccCcEEEEEEEECCCcEEEEEEeecCCc----hhHHHHHHHHHHHHccCCCCeeeEeeeeecCCee
Q 010513 182 EVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRG----QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHR 257 (508)
Q Consensus 182 ~~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 257 (508)
++..++|++.+.||+|+||.||+|.+. ++.||+|.+..... ...+.+.+|+++++.++||||+++++++.+++..
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (271)
T 3dtc_A 3 EIDFAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNL 81 (271)
T ss_dssp BCCTTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--C
T ss_pred ccchhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCce
Confidence 345678999999999999999999986 88899998865432 2346788999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC---eeeccCCCCCEEEcC--------CC
Q 010513 258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK---VVHRDIKSSNILLDK--------QW 326 (508)
Q Consensus 258 ~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~---iiHrDlkp~NIll~~--------~~ 326 (508)
++||||+++++|.+++.. ..+++..++.++.|++.||+|||++ + |+||||||+|||++. ++
T Consensus 82 ~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~i~~~l~~~l~~lH~~---~~~~i~H~dikp~Nil~~~~~~~~~~~~~ 153 (271)
T 3dtc_A 82 CLVMEFARGGPLNRVLSG-----KRIPPDILVNWAVQIARGMNYLHDE---AIVPIIHRDLKSSNILILQKVENGDLSNK 153 (271)
T ss_dssp EEEEECCTTEEHHHHHTS-----SCCCHHHHHHHHHHHHHHHHHHHHS---SSSCCCCSCCSGGGEEESSCCSSSCCSSC
T ss_pred EEEEEcCCCCCHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CCCceeecCCchHHEEEecccccccccCc
Confidence 999999999999999864 3689999999999999999999998 7 999999999999986 67
Q ss_pred CeEEeeeccceecCCCCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHH
Q 010513 327 NPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLK 406 (508)
Q Consensus 327 ~~kL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~ 406 (508)
.+||+|||++....... .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||..... .....
T Consensus 154 ~~kl~Dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------~~~~~ 224 (271)
T 3dtc_A 154 ILKITDFGLAREWHRTT---KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDG------LAVAY 224 (271)
T ss_dssp CEEECCCCC----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCH------HHHHH
T ss_pred ceEEccCCccccccccc---ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHH
Confidence 89999999998654322 2245799999999999999999999999999999999999999974321 11111
Q ss_pred HhhcccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 010513 407 TMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461 (508)
Q Consensus 407 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~ 461 (508)
....... ..... ..++. .+.+++.+||+.||++||++.+++++|+.
T Consensus 225 ~~~~~~~-----~~~~~-~~~~~---~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 225 GVAMNKL-----ALPIP-STCPE---PFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp HHHTSCC-----CCCCC-TTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred hhhcCCC-----CCCCC-cccCH---HHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 1111110 11111 11333 34457889999999999999999999975
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-45 Score=366.43 Aligned_cols=272 Identities=25% Similarity=0.402 Sum_probs=211.9
Q ss_pred hHhhcCCCCcccceEcccCcEEEEEEEEC------CCcEEEEEEeecCC-chhHHHHHHHHHHHHcc-CCCCeeeEeeee
Q 010513 180 ELEVSTNGFADENVIGEGGYGIVYHGVLE------DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRV-RHKNLVRLLGYC 251 (508)
Q Consensus 180 ~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~l~~~~ 251 (508)
++++..++|++.+.||+|+||.||+|.+. ++..||+|.+.... ....+.+.+|+++++++ +||||+++++++
T Consensus 39 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 118 (344)
T 1rjb_A 39 KWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC 118 (344)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 35677789999999999999999999962 35579999986542 33456788999999999 899999999999
Q ss_pred ecCCeeEEEEEecCCCCHHHHhccCCCC-------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeee
Q 010513 252 AEGAHRMLVYEYIDNGNLEQWLHGDVGP-------------------HSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVH 312 (508)
Q Consensus 252 ~~~~~~~lV~e~~~~g~L~~~l~~~~~~-------------------~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH 312 (508)
.+.+..++||||+++|+|.+++...... ...+++..++.++.|++.||+|||++ +|+|
T Consensus 119 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH 195 (344)
T 1rjb_A 119 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVH 195 (344)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEE
T ss_pred eeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---Cccc
Confidence 9999999999999999999999765321 13489999999999999999999999 9999
Q ss_pred ccCCCCCEEEcCCCCeEEeeeccceecCCCCcc-eecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHh-CCCCC
Q 010513 313 RDIKSSNILLDKQWNPKLSDFGLAKLLGAERSY-VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPV 390 (508)
Q Consensus 313 rDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~Pf 390 (508)
|||||+|||++.++.+||+|||++......... ......||+.|+|||.+.+..++.++|||||||++|||+| |..||
T Consensus 196 ~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~ 275 (344)
T 1rjb_A 196 RDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY 275 (344)
T ss_dssp TTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred CCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCc
Confidence 999999999999999999999999876443332 3344678899999999999999999999999999999998 99999
Q ss_pred CCCCCCCcchHHHHHHHhhcccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCCCCCCC
Q 010513 391 DYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEEFPFRDV 469 (508)
Q Consensus 391 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~~~~~~~~~ 469 (508)
....... ... ....... .+... ...+. ++.+++.+||+.||++||++.+++++|+......++.
T Consensus 276 ~~~~~~~--~~~----~~~~~~~-----~~~~~-~~~~~---~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~ 339 (344)
T 1rjb_A 276 PGIPVDA--NFY----KLIQNGF-----KMDQP-FYATE---EIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAEEA 339 (344)
T ss_dssp TTCCCSH--HHH----HHHHTTC-----CCCCC-TTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC------
T ss_pred ccCCcHH--HHH----HHHhcCC-----CCCCC-CCCCH---HHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHHHH
Confidence 7554321 111 1111110 11111 11233 4455788999999999999999999999876554443
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=363.25 Aligned_cols=257 Identities=24% Similarity=0.324 Sum_probs=203.9
Q ss_pred cCCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCC---chhHHHHHHHHHHHHcc-CCCCeeeEeeeeecCCeeE
Q 010513 184 STNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRM 258 (508)
Q Consensus 184 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~ 258 (508)
..++|++.+.||+|+||.||+|+++ +++.||+|++.+.. ....+.+.+|..++.++ +||||+++++++.+....|
T Consensus 7 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 86 (345)
T 3a8x_A 7 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF 86 (345)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEE
Confidence 3457999999999999999999986 57889999997542 23445688899999988 8999999999999999999
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeecccee
Q 010513 259 LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL 338 (508)
Q Consensus 259 lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~ 338 (508)
+||||+++|+|.+++... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++++||+|||+++.
T Consensus 87 lv~e~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~ 159 (345)
T 3a8x_A 87 FVIEYVNGGDLMFHMQRQ----RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKE 159 (345)
T ss_dssp EEECCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBC
T ss_pred EEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEecccccc
Confidence 999999999999999764 4689999999999999999999999 999999999999999999999999999985
Q ss_pred cCCCCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcc--hHHHHHHHhhccccccc
Q 010513 339 LGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEV--NLVEWLKTMVTNRNAEG 416 (508)
Q Consensus 339 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~--~~~~~~~~~~~~~~~~~ 416 (508)
.... .......+||+.|+|||++.+..++.++|||||||++|||++|+.||......... .....+.........
T Consensus 160 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~-- 236 (345)
T 3a8x_A 160 GLRP-GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI-- 236 (345)
T ss_dssp SCCT-TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCC--
T ss_pred ccCC-CCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCC--
Confidence 4222 22344568999999999999999999999999999999999999999754222111 111222222222111
Q ss_pred CCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCH------HHHHHH
Q 010513 417 VLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKM------GHVIHM 458 (508)
Q Consensus 417 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~------~evl~~ 458 (508)
.+.. ..+. ++.+++.+||+.||++||++ .+++++
T Consensus 237 ----~~p~-~~s~---~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h 276 (345)
T 3a8x_A 237 ----RIPR-SLSV---KAASVLKSFLNKDPKERLGCHPQTGFADIQGH 276 (345)
T ss_dssp ----CCCT-TSCH---HHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred ----CCCC-CCCH---HHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence 1111 1223 34557889999999999995 566643
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=368.63 Aligned_cols=252 Identities=23% Similarity=0.342 Sum_probs=205.4
Q ss_pred hcCCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCC---chhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeE
Q 010513 183 VSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM 258 (508)
Q Consensus 183 ~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 258 (508)
+..++|++.+.||+|+||.||+|... +++.||+|.+.+.. ....+.+.+|+++++.++||||++++++|.+....|
T Consensus 12 v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 91 (384)
T 4fr4_A 12 VNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMF 91 (384)
T ss_dssp CCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 45568999999999999999999976 47889999986532 233567888999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeecccee
Q 010513 259 LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL 338 (508)
Q Consensus 259 lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~ 338 (508)
+||||+.+|+|.+++... ..+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++..
T Consensus 92 lv~e~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~ 164 (384)
T 4fr4_A 92 MVVDLLLGGDLRYHLQQN----VHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAM 164 (384)
T ss_dssp EEECCCTTEEHHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeee
Confidence 999999999999999764 5799999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCcceecceecCCCCCChhhhhc---CCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccc
Q 010513 339 LGAERSYVTTRVMGTFGYVAPEYAST---GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAE 415 (508)
Q Consensus 339 ~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (508)
.... ......+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||................ ...
T Consensus 165 ~~~~--~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~---~~~--- 236 (384)
T 4fr4_A 165 LPRE--TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFE---TTV--- 236 (384)
T ss_dssp CCTT--CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHH---HCC---
T ss_pred ccCC--CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHh---hcc---
Confidence 6433 23345689999999999864 458999999999999999999999997654433222222211 110
Q ss_pred cCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCC-HHHHHH
Q 010513 416 GVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPK-MGHVIH 457 (508)
Q Consensus 416 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~ 457 (508)
.... ...+ ..+.+++.+||+.||++||+ +.++++
T Consensus 237 ----~~~p-~~~s---~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 237 ----VTYP-SAWS---QEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp ----CCCC-TTSC---HHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred ----cCCC-CcCC---HHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 0011 1122 34555888999999999998 777765
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-45 Score=377.03 Aligned_cols=263 Identities=22% Similarity=0.261 Sum_probs=210.1
Q ss_pred chhhHhhcCCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCC---chhHHHHHHHHHHHHccCCCCeeeEeeeee
Q 010513 177 TLRELEVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCA 252 (508)
Q Consensus 177 ~~~~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~ 252 (508)
.+++.++..++|++.+.||+|+||+||+|+.+ +++.||+|++.+.. ....+.+.+|..++..++||||++++++|.
T Consensus 52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 131 (412)
T 2vd5_A 52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ 131 (412)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 45667788899999999999999999999986 68899999986532 122345788999999999999999999999
Q ss_pred cCCeeEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEee
Q 010513 253 EGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSD 332 (508)
Q Consensus 253 ~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~D 332 (508)
+.+..|+||||+++|+|.+++.+. ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++++||+|
T Consensus 132 ~~~~~~lVmE~~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~D 205 (412)
T 2vd5_A 132 DENYLYLVMEYYVGGDLLTLLSKF---GERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLAD 205 (412)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHH---SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECC
T ss_pred eCCEEEEEEcCCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEee
Confidence 999999999999999999999764 24789999999999999999999999 999999999999999999999999
Q ss_pred eccceecCCCCcceecceecCCCCCChhhhh-------cCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHH
Q 010513 333 FGLAKLLGAERSYVTTRVMGTFGYVAPEYAS-------TGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWL 405 (508)
Q Consensus 333 FG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~ 405 (508)
||+++.............+||+.|+|||++. ...|+.++|||||||++|||++|+.||..... .+..
T Consensus 206 FGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~------~~~~ 279 (412)
T 2vd5_A 206 FGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADST------AETY 279 (412)
T ss_dssp CTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSH------HHHH
T ss_pred chhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCH------HHHH
Confidence 9999887555444445578999999999987 35689999999999999999999999974321 1211
Q ss_pred HHhhcccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCC---CCHHHHHHH
Q 010513 406 KTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKR---PKMGHVIHM 458 (508)
Q Consensus 406 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~R---Ps~~evl~~ 458 (508)
........ ....|... ...+. ++.+++.+||. +|++| |+++|++++
T Consensus 280 ~~i~~~~~--~~~~p~~~-~~~s~---~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 280 GKIVHYKE--HLSLPLVD-EGVPE---EARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp HHHHTHHH--HCCCC-----CCCH---HHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred HHHHhccc--CcCCCccc-cCCCH---HHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 22111100 00011111 11233 44457779999 99998 689999865
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=359.58 Aligned_cols=264 Identities=28% Similarity=0.449 Sum_probs=212.7
Q ss_pred hHhhcCCCCcccceEcccCcEEEEEEEEC------CCcEEEEEEeecCC-chhHHHHHHHHHHHHccCCCCeeeEeeeee
Q 010513 180 ELEVSTNGFADENVIGEGGYGIVYHGVLE------DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCA 252 (508)
Q Consensus 180 ~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~ 252 (508)
.+++..++|.+.+.||+|+||.||+|.+. ++..||+|.+.... ....+.+.+|+++++.++||||+++++++.
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 96 (314)
T 2ivs_A 17 KWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACS 96 (314)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred ccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEe
Confidence 44667789999999999999999999862 34789999986543 344567889999999999999999999999
Q ss_pred cCCeeEEEEEecCCCCHHHHhccCCC--------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeee
Q 010513 253 EGAHRMLVYEYIDNGNLEQWLHGDVG--------------------PHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVH 312 (508)
Q Consensus 253 ~~~~~~lV~e~~~~g~L~~~l~~~~~--------------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH 312 (508)
+.+..++||||+++|+|.+++..... ....+++..++.++.|+++||+|||++ +|+|
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH 173 (314)
T 2ivs_A 97 QDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVH 173 (314)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEEC
T ss_pred cCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcc
Confidence 99999999999999999999976532 123489999999999999999999999 9999
Q ss_pred ccCCCCCEEEcCCCCeEEeeeccceecCCCCcce-ecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHh-CCCCC
Q 010513 313 RDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYV-TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPV 390 (508)
Q Consensus 313 rDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~Pf 390 (508)
|||||+||+++.++.+||+|||+++......... .....+|+.|+|||.+.+..++.++|||||||++|||++ |+.||
T Consensus 174 ~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~ 253 (314)
T 2ivs_A 174 RDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY 253 (314)
T ss_dssp CCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred cccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCC
Confidence 9999999999999999999999998765443322 233467889999999999999999999999999999999 99999
Q ss_pred CCCCCCCcchHHHHHHHhhcccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010513 391 DYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (508)
Q Consensus 391 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~~ 462 (508)
...... .....+. ... .+... ...+. .+.+++.+||+.||++||++.+++++|++.
T Consensus 254 ~~~~~~---~~~~~~~----~~~-----~~~~~-~~~~~---~~~~li~~~l~~dp~~Rps~~~l~~~l~~~ 309 (314)
T 2ivs_A 254 PGIPPE---RLFNLLK----TGH-----RMERP-DNCSE---EMYRLMLQCWKQEPDKRPVFADISKDLEKM 309 (314)
T ss_dssp TTCCGG---GHHHHHH----TTC-----CCCCC-TTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCHH---HHHHHhh----cCC-----cCCCC-ccCCH---HHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 755432 1222111 111 01111 11233 445588899999999999999999999864
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-44 Score=359.13 Aligned_cols=260 Identities=15% Similarity=0.172 Sum_probs=209.1
Q ss_pred cCCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCchhHHHHHHHHHHHHcc-CCCCeeeEeeeeecCCeeEEEE
Q 010513 184 STNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVY 261 (508)
Q Consensus 184 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lV~ 261 (508)
..++|++.+.||+|+||+||+|... +++.||||.+..... .+.+..|+++++.+ +||||+++++++.++...++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~ 84 (330)
T 2izr_A 7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVL 84 (330)
T ss_dssp ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEE
T ss_pred EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEE
Confidence 3468999999999999999999974 688899998865432 34578899999999 9999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCC-----eEEeeeccc
Q 010513 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWN-----PKLSDFGLA 336 (508)
Q Consensus 262 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~-----~kL~DFG~a 336 (508)
||+ +++|.+++... ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++. +||+|||++
T Consensus 85 e~~-~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a 157 (330)
T 2izr_A 85 ELL-GPSLEDLFDLC---DRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALA 157 (330)
T ss_dssp ECC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTC
T ss_pred EeC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEcccc
Confidence 999 88999999865 35799999999999999999999999 9999999999999998887 999999999
Q ss_pred eecCCCCcc------eecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhc
Q 010513 337 KLLGAERSY------VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVT 410 (508)
Q Consensus 337 ~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~ 410 (508)
+.+...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..............+.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~ 237 (330)
T 2izr_A 158 KEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKR 237 (330)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHH
T ss_pred eeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhc
Confidence 976443221 12456899999999999999999999999999999999999999987654333222222211111
Q ss_pred ccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010513 411 NRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (508)
Q Consensus 411 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~~ 462 (508)
.. .........+ ++.+++.+||+.||++||++.++++.|++.
T Consensus 238 ~~------~~~~~~~~~p----~~~~li~~~l~~~p~~RP~~~~l~~~l~~~ 279 (330)
T 2izr_A 238 AT------PIEVLCENFP----EMATYLRYVRRLDFFEKPDYDYLRKLFTDL 279 (330)
T ss_dssp HS------CHHHHTTTCH----HHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred cC------CHHHHhccCh----HHHHHHHHHHhCCCCCCCCHHHHHHHHHHH
Confidence 00 0000001122 556688899999999999999999999753
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-45 Score=386.73 Aligned_cols=263 Identities=24% Similarity=0.420 Sum_probs=216.2
Q ss_pred hhHhhcCCCCcccceEcccCcEEEEEEEECC-CcEEEEEEeecCCchhHHHHHHHHHHHHccCCCCeeeEeeeeecCCee
Q 010513 179 RELEVSTNGFADENVIGEGGYGIVYHGVLED-NTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHR 257 (508)
Q Consensus 179 ~~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 257 (508)
..+++..++|++.+.||+|+||.||+|.++. +..||||.+.... ...+.|.+|++++++++||||+++++++.+....
T Consensus 213 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 291 (495)
T 1opk_A 213 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF 291 (495)
T ss_dssp SCCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred cccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcE
Confidence 4456778889999999999999999999874 7889999986543 3467899999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccce
Q 010513 258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK 337 (508)
Q Consensus 258 ~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~ 337 (508)
++||||+++|+|.+++.... ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 292 ~lv~E~~~~g~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~ 366 (495)
T 1opk_A 292 YIITEFMTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSR 366 (495)
T ss_dssp EEEEECCTTCBHHHHHHHSC--TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEE
T ss_pred EEEEEccCCCCHHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccce
Confidence 99999999999999997642 35689999999999999999999999 99999999999999999999999999999
Q ss_pred ecCCCCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHhhccccccc
Q 010513 338 LLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEG 416 (508)
Q Consensus 338 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 416 (508)
..............+++.|+|||++.+..++.++|||||||++|||+| |+.||...... ...+.+ ....
T Consensus 367 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~---~~~~~~----~~~~--- 436 (495)
T 1opk_A 367 LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS---QVYELL----EKDY--- 436 (495)
T ss_dssp CCTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---GHHHHH----HTTC---
T ss_pred eccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH---HHHHHH----HcCC---
Confidence 765443333344556789999999999999999999999999999999 99999754322 122211 1110
Q ss_pred CCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 010513 417 VLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEE 463 (508)
Q Consensus 417 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~~~ 463 (508)
... ....++.. +.+++.+||+.||++||++.++++.|+...
T Consensus 437 --~~~-~~~~~~~~---l~~li~~cl~~dP~~RPs~~el~~~L~~~~ 477 (495)
T 1opk_A 437 --RME-RPEGCPEK---VYELMRACWQWNPSDRPSFAEIHQAFETMF 477 (495)
T ss_dssp --CCC-CCTTCCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred --CCC-CCCCCCHH---HHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 001 11123334 445788999999999999999999998753
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=364.93 Aligned_cols=251 Identities=23% Similarity=0.336 Sum_probs=203.0
Q ss_pred hhcCCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCC---chhHHHHHHHHHHHHcc-CCCCeeeEeeeeecCCe
Q 010513 182 EVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEGAH 256 (508)
Q Consensus 182 ~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~ 256 (508)
.+..++|++.+.||+|+||+||+|+++ +++.||+|.+.+.. ....+.+..|.+++..+ +||||+++++++.+.+.
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 456679999999999999999999986 57889999986542 23445677899999877 99999999999999999
Q ss_pred eEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccc
Q 010513 257 RMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLA 336 (508)
Q Consensus 257 ~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a 336 (508)
.|+||||+++|+|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 93 ~~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a 165 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQSC----HKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMC 165 (345)
T ss_dssp EEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhh
Confidence 99999999999999999764 4689999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhccccccc
Q 010513 337 KLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEG 416 (508)
Q Consensus 337 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 416 (508)
+..... .......+||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+.........
T Consensus 166 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~------~~~~~~i~~~~---- 234 (345)
T 1xjd_A 166 KENMLG-DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE------EELFHSIRMDN---- 234 (345)
T ss_dssp BCCCCT-TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCC----
T ss_pred hhcccC-CCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCH------HHHHHHHHhCC----
Confidence 854322 2234457899999999999999999999999999999999999999974321 12222221111
Q ss_pred CCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHH-HHHH
Q 010513 417 VLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMG-HVIH 457 (508)
Q Consensus 417 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl~ 457 (508)
+.+.. ..+. ++.+++.+||+.||++||++. ++++
T Consensus 235 ---~~~p~-~~s~---~~~~li~~lL~~dp~~R~~~~~~i~~ 269 (345)
T 1xjd_A 235 ---PFYPR-WLEK---EAKDLLVKLFVREPEKRLGVRGDIRQ 269 (345)
T ss_dssp ---CCCCT-TSCH---HHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred ---CCCCc-ccCH---HHHHHHHHHhcCCHhHcCCChHHHHc
Confidence 11111 1233 345578899999999999997 6653
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-45 Score=361.78 Aligned_cols=275 Identities=24% Similarity=0.333 Sum_probs=211.0
Q ss_pred hhcCCCCcccceEcccCcEEEEEEEE-CCCcEEEEEEeecCCchhHHHHHHHHHHHHccCCCCeeeEeeeee----cCCe
Q 010513 182 EVSTNGFADENVIGEGGYGIVYHGVL-EDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCA----EGAH 256 (508)
Q Consensus 182 ~~~~~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~----~~~~ 256 (508)
.+..++|++.+.||+|+||.||+|.. .+++.||+|++........+.+.+|+++++.++||||+++++++. ....
T Consensus 25 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (317)
T 2buj_A 25 IIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHE 104 (317)
T ss_dssp EETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEE
T ss_pred EECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCce
Confidence 34567899999999999999999997 468899999987766667788999999999999999999999987 3447
Q ss_pred eEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccc
Q 010513 257 RMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLA 336 (508)
Q Consensus 257 ~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a 336 (508)
.++||||+++|+|.+++.........+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 105 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~ 181 (317)
T 2buj_A 105 AWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSM 181 (317)
T ss_dssp EEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSC
T ss_pred eEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcc
Confidence 8899999999999999976433356799999999999999999999999 9999999999999999999999999998
Q ss_pred eecCCCCcc--------eecceecCCCCCChhhhhcCC---CCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHH
Q 010513 337 KLLGAERSY--------VTTRVMGTFGYVAPEYASTGM---LNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWL 405 (508)
Q Consensus 337 ~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~---~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~ 405 (508)
......... ......||+.|+|||++.+.. ++.++|||||||++|||++|+.||........ ....
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~~-- 258 (317)
T 2buj_A 182 NQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD-SVAL-- 258 (317)
T ss_dssp EESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS-CHHH--
T ss_pred hhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc-hhhH--
Confidence 765321111 012345799999999987554 68899999999999999999999953211111 1111
Q ss_pred HHhhcccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCc
Q 010513 406 KTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEEFPFRDVSFGR 473 (508)
Q Consensus 406 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~~~~~~~~~~~~~ 473 (508)
..... ...+. ....+ ..+.+++.+||+.||++||++.+++++|++...+.+......
T Consensus 259 --~~~~~----~~~~~--~~~~~---~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~~~~~~ 315 (317)
T 2buj_A 259 --AVQNQ----LSIPQ--SPRHS---SALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPGQHTTQ 315 (317)
T ss_dssp --HHHCC------CCC--CTTSC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCCC-----
T ss_pred --Hhhcc----CCCCc--cccCC---HHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCCCCCCCc
Confidence 11110 00000 11123 345558889999999999999999999999876666555443
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-44 Score=350.94 Aligned_cols=264 Identities=17% Similarity=0.203 Sum_probs=211.5
Q ss_pred hhcCCCCcccceEcccCcEEEEEEEE-CCCcEEEEEEeecCCchhHHHHHHHHHHHHcc-CCCCeeeEeeeeecCCeeEE
Q 010513 182 EVSTNGFADENVIGEGGYGIVYHGVL-EDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRML 259 (508)
Q Consensus 182 ~~~~~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~l 259 (508)
.+..++|++.+.||+|+||+||+|.. .+++.||+|.+.... ..+.+.+|+++++.+ +|+|++++++++.++...++
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~l 83 (298)
T 1csn_A 6 NVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVL 83 (298)
T ss_dssp CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEE
T ss_pred cccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEE
Confidence 34567899999999999999999996 468899999886443 234577899999999 89999999999999999999
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCC-----eEEeeec
Q 010513 260 VYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWN-----PKLSDFG 334 (508)
Q Consensus 260 V~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~-----~kL~DFG 334 (508)
||||+ +++|.+++... ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++. +||+|||
T Consensus 84 v~e~~-~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg 156 (298)
T 1csn_A 84 VIDLL-GPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFG 156 (298)
T ss_dssp EEECC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCT
T ss_pred EEEec-CCCHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECc
Confidence 99999 88999999865 34699999999999999999999999 9999999999999987776 9999999
Q ss_pred cceecCCCCcc------eecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHh
Q 010513 335 LAKLLGAERSY------VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTM 408 (508)
Q Consensus 335 ~a~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~ 408 (508)
+++........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||..............+...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 236 (298)
T 1csn_A 157 MVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEK 236 (298)
T ss_dssp TCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHH
T ss_pred cccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhh
Confidence 99876543221 234467999999999999999999999999999999999999999876544333332222211
Q ss_pred hcccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 010513 409 VTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEE 463 (508)
Q Consensus 409 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~~~ 463 (508)
...... +.+. ...+ .++.+++.+||+.||++||++.++++.|++..
T Consensus 237 ~~~~~~-----~~~~-~~~~---~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~ 282 (298)
T 1csn_A 237 KQSTPL-----RELC-AGFP---EEFYKYMHYARNLAFDATPDYDYLQGLFSKVL 282 (298)
T ss_dssp HHHSCH-----HHHT-TTSC---HHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred ccCccH-----HHHH-hhCc---HHHHHHHHHHhcCCcccCCCHHHHHHHHHHHH
Confidence 111000 0000 0122 34555888999999999999999999998653
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=362.53 Aligned_cols=246 Identities=23% Similarity=0.342 Sum_probs=201.3
Q ss_pred CCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCC---chhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEE
Q 010513 185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLV 260 (508)
Q Consensus 185 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 260 (508)
.++|.+.+.||+|+||+||+|.+. +++.||+|++.... ......+.+|+++++.++||||+++++++.+....++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 468999999999999999999974 68899999986532 22345788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecC
Q 010513 261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG 340 (508)
Q Consensus 261 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 340 (508)
|||+ +|+|.+++... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++....
T Consensus 88 ~E~~-~g~l~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~ 159 (336)
T 3h4j_B 88 IEYA-GGELFDYIVEK----KRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMT 159 (336)
T ss_dssp ECCC-CEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTT
T ss_pred EECC-CCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceecc
Confidence 9999 67999998765 4699999999999999999999999 99999999999999999999999999998664
Q ss_pred CCCcceecceecCCCCCChhhhhcCCC-CCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCC
Q 010513 341 AERSYVTTRVMGTFGYVAPEYASTGML-NERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLD 419 (508)
Q Consensus 341 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 419 (508)
... .....+||+.|+|||++.+..+ ++++|||||||++|+|++|+.||.......... .+..
T Consensus 160 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~---------------~i~~ 222 (336)
T 3h4j_B 160 DGN--FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFK---------------KVNS 222 (336)
T ss_dssp TSB--TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBC---------------CCCS
T ss_pred CCc--ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHH---------------HHHc
Confidence 332 2344579999999999988776 689999999999999999999997543321110 0000
Q ss_pred ccC-CCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 420 PRL-QEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 420 ~~l-~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
... ..+..+. .+.+++.+||+.||++|||+.|++++
T Consensus 223 ~~~~~p~~~s~---~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 223 CVYVMPDFLSP---GAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp SCCCCCTTSCH---HHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred CCCCCcccCCH---HHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 000 0111233 34457889999999999999999874
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=368.71 Aligned_cols=262 Identities=26% Similarity=0.407 Sum_probs=208.2
Q ss_pred hhcCCCCcccceEcccCcEEEEEEEEC------CCcEEEEEEeecC-CchhHHHHHHHHHHHHccCCCCeeeEeeeeecC
Q 010513 182 EVSTNGFADENVIGEGGYGIVYHGVLE------DNTNVAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEG 254 (508)
Q Consensus 182 ~~~~~~~~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~ 254 (508)
++..++|++.+.||+|+||+||+|.+. ++..||||++... .......+.+|+.++++++||||+++++++.+.
T Consensus 67 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 146 (367)
T 3l9p_A 67 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS 146 (367)
T ss_dssp BCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence 345678999999999999999999953 3567999998654 334456788999999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHhccCCC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCC---Ce
Q 010513 255 AHRMLVYEYIDNGNLEQWLHGDVG---PHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQW---NP 328 (508)
Q Consensus 255 ~~~~lV~e~~~~g~L~~~l~~~~~---~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~---~~ 328 (508)
...++||||+++|+|.+++..... ....+++..++.++.|++.||+|||++ +|+||||||+|||++.++ .+
T Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~ 223 (367)
T 3l9p_A 147 LPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVA 223 (367)
T ss_dssp SSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCE
T ss_pred CCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceE
Confidence 999999999999999999976431 224689999999999999999999999 999999999999999555 49
Q ss_pred EEeeeccceecCCCC-cceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHh-CCCCCCCCCCCCcchHHHHHH
Q 010513 329 KLSDFGLAKLLGAER-SYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLK 406 (508)
Q Consensus 329 kL~DFG~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~ 406 (508)
||+|||+++...... ........||+.|+|||++.+..++.++|||||||++|||++ |+.||..... .+...
T Consensus 224 kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~------~~~~~ 297 (367)
T 3l9p_A 224 KIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN------QEVLE 297 (367)
T ss_dssp EECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH------HHHHH
T ss_pred EECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH------HHHHH
Confidence 999999998553221 122234568999999999999999999999999999999998 9999974421 12222
Q ss_pred HhhcccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010513 407 TMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (508)
Q Consensus 407 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~~ 462 (508)
....... ... ...++. .+.+++.+||+.||++||++.+++++|+..
T Consensus 298 ~i~~~~~------~~~-~~~~~~---~l~~li~~~l~~dP~~Rps~~eil~~l~~~ 343 (367)
T 3l9p_A 298 FVTSGGR------MDP-PKNCPG---PVYRIMTQCWQHQPEDRPNFAIILERIEYC 343 (367)
T ss_dssp HHHTTCC------CCC-CTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHcCCC------CCC-CccCCH---HHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 2222111 001 112333 345588899999999999999999999854
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-44 Score=349.26 Aligned_cols=261 Identities=26% Similarity=0.438 Sum_probs=212.9
Q ss_pred hhHhhcCCCCcccceEcccCcEEEEEEEECCCcEEEEEEeecCCchhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeE
Q 010513 179 RELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM 258 (508)
Q Consensus 179 ~~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 258 (508)
+++++..++|++.+.||+|+||.||+|.+.++..||+|.+.... ...+.+.+|+++++.++||||+++++++.+ +..+
T Consensus 6 ~~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~ 83 (279)
T 1qpc_A 6 DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIY 83 (279)
T ss_dssp CTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred hhcccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcE
Confidence 45677888999999999999999999999888899999986543 345678999999999999999999999875 5689
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeecccee
Q 010513 259 LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL 338 (508)
Q Consensus 259 lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~ 338 (508)
+||||+++++|.+++.... ...+++..++.++.|++.||+|||++ +++||||||+||+++.++.+||+|||++..
T Consensus 84 ~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 158 (279)
T 1qpc_A 84 IITEYMENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARL 158 (279)
T ss_dssp EEEECCTTCBHHHHTTSHH--HHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEecCCCCCHHHHHhcCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCccccc
Confidence 9999999999999996531 12689999999999999999999999 999999999999999999999999999998
Q ss_pred cCCCCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHhhcccccccC
Q 010513 339 LGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGV 417 (508)
Q Consensus 339 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 417 (508)
.............+++.|+|||.+.+..++.++||||||+++|||++ |+.||..... .+.........
T Consensus 159 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~------~~~~~~~~~~~----- 227 (279)
T 1qpc_A 159 IEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN------PEVIQNLERGY----- 227 (279)
T ss_dssp CSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH------HHHHHHHHTTC-----
T ss_pred ccCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCH------HHHHHHHhccc-----
Confidence 75544333444567889999999998999999999999999999999 9999974321 12222211110
Q ss_pred CCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010513 418 LDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (508)
Q Consensus 418 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~~ 462 (508)
.... ....+. ++.+++.+||+.||++||++.++++.|++.
T Consensus 228 -~~~~-~~~~~~---~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 267 (279)
T 1qpc_A 228 -RMVR-PDNCPE---ELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267 (279)
T ss_dssp -CCCC-CTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -CCCC-cccccH---HHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence 0111 112333 445578899999999999999999999864
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-44 Score=362.08 Aligned_cols=276 Identities=18% Similarity=0.236 Sum_probs=207.0
Q ss_pred hcCCCCcccceEcccCcEEEEEEEEC----CCcEEEEEEeecCCchh-----------HHHHHHHHHHHHccCCCCeeeE
Q 010513 183 VSTNGFADENVIGEGGYGIVYHGVLE----DNTNVAVKNLLNNRGQA-----------EKEFKVEVEAIGRVRHKNLVRL 247 (508)
Q Consensus 183 ~~~~~~~~~~~LG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~hpniv~l 247 (508)
+..++|.+.+.||+|+||+||+|.+. ++..+|+|.+....... ...+.+|+..++.++||||+++
T Consensus 34 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~ 113 (345)
T 2v62_A 34 MEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLF 113 (345)
T ss_dssp TTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCE
T ss_pred ccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCccee
Confidence 44578999999999999999999976 46789999987654321 1235678889999999999999
Q ss_pred eeeeec----CCeeEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEc
Q 010513 248 LGYCAE----GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLD 323 (508)
Q Consensus 248 ~~~~~~----~~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~ 323 (508)
++++.+ ....|+||||+ +++|.+++... ..+++..++.++.|++.||+|||++ +|+||||||+|||++
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~ 185 (345)
T 2v62_A 114 YGSGLTEFKGRSYRFMVMERL-GIDLQKISGQN----GTFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLG 185 (345)
T ss_dssp EEEEEEESSSCEEEEEEEECE-EEEHHHHCBGG----GBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEE
T ss_pred ecccccccCCCcEEEEEEecc-CCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEc
Confidence 999987 67889999999 89999999765 3799999999999999999999999 999999999999998
Q ss_pred CCC--CeEEeeeccceecCCCCcc------eecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCC
Q 010513 324 KQW--NPKLSDFGLAKLLGAERSY------VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRP 395 (508)
Q Consensus 324 ~~~--~~kL~DFG~a~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~ 395 (508)
.++ .+||+|||+++.+...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 186 ~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~ 265 (345)
T 2v62_A 186 YKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLK 265 (345)
T ss_dssp SSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTT
T ss_pred cCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence 877 9999999999876432211 11345799999999999999999999999999999999999999964221
Q ss_pred CCcchHHHHHHHhhcccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCCCCCCCCCC
Q 010513 396 PGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEEFPFRDVSFG 472 (508)
Q Consensus 396 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~~~~~~~~~~~~ 472 (508)
. .............. ....+.........+. ++.+++.+||+.||++||++.++++.|+...+++......
T Consensus 266 ~--~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~---~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~d~~ 336 (345)
T 2v62_A 266 D--PVAVQTAKTNLLDE-LPQSVLKWAPSGSSCC---EIAQFLVCAHSLAYDEKPNYQALKKILNPHGIPLGPLDFS 336 (345)
T ss_dssp C--HHHHHHHHHHHHHT-TTHHHHHHSCTTSCCH---HHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCCCCCCCCCC
T ss_pred c--cHHHHHHHHhhccc-ccHHHHhhccccccHH---HHHHHHHHHhhcCcccCCCHHHHHHHHhccCCcccCCCcc
Confidence 1 11111111111110 0000000011111233 4555778999999999999999999999998877665544
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=357.95 Aligned_cols=265 Identities=25% Similarity=0.413 Sum_probs=213.5
Q ss_pred hHhhcCCCCcccceEcccCcEEEEEEEE------CCCcEEEEEEeecCCc-hhHHHHHHHHHHHHcc-CCCCeeeEeeee
Q 010513 180 ELEVSTNGFADENVIGEGGYGIVYHGVL------EDNTNVAVKNLLNNRG-QAEKEFKVEVEAIGRV-RHKNLVRLLGYC 251 (508)
Q Consensus 180 ~~~~~~~~~~~~~~LG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpniv~l~~~~ 251 (508)
.+++..++|++.+.||+|+||.||+|.+ .++..||+|.+..... ...+.+.+|+++++++ +||||+++++++
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 96 (313)
T 1t46_A 17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGAC 96 (313)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEE
Confidence 3466778999999999999999999985 2467899999875543 3456788999999999 999999999999
Q ss_pred ecCCeeEEEEEecCCCCHHHHhccCCC--------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCC
Q 010513 252 AEGAHRMLVYEYIDNGNLEQWLHGDVG--------------PHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKS 317 (508)
Q Consensus 252 ~~~~~~~lV~e~~~~g~L~~~l~~~~~--------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp 317 (508)
.+++..++||||+++|+|.+++..... ....+++..++.++.|++.||+|||++ +|+||||||
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp 173 (313)
T 1t46_A 97 TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAA 173 (313)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSG
T ss_pred ecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCcc
Confidence 999999999999999999999976532 123589999999999999999999999 999999999
Q ss_pred CCEEEcCCCCeEEeeeccceecCCCCcc-eecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHh-CCCCCCCCCC
Q 010513 318 SNILLDKQWNPKLSDFGLAKLLGAERSY-VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRP 395 (508)
Q Consensus 318 ~NIll~~~~~~kL~DFG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~Pf~~~~~ 395 (508)
+||+++.++.+||+|||++......... ......||+.|+|||.+.+..++.++|||||||++|||+| |+.||.....
T Consensus 174 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 253 (313)
T 1t46_A 174 RNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253 (313)
T ss_dssp GGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred ceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccc
Confidence 9999999999999999999876544332 2334567889999999999999999999999999999999 9999975432
Q ss_pred CCcchHHHHHHHhhcccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010513 396 PGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (508)
Q Consensus 396 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~~ 462 (508)
. ......+.... .+. .....+. .+.+++.+||+.||++||++.+++++|+..
T Consensus 254 ~--~~~~~~~~~~~---------~~~-~~~~~~~---~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 305 (313)
T 1t46_A 254 D--SKFYKMIKEGF---------RML-SPEHAPA---EMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305 (313)
T ss_dssp S--HHHHHHHHHTC---------CCC-CCTTSCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred h--hHHHHHhccCC---------CCC-CcccCCH---HHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 2 11122111111 011 1111233 445578899999999999999999999853
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=359.93 Aligned_cols=256 Identities=24% Similarity=0.270 Sum_probs=197.3
Q ss_pred ccchhhHhhcCCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCc--hhHHHHHHHHHHHHcc-CCCCeeeEeee
Q 010513 175 WYTLRELEVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG--QAEKEFKVEVEAIGRV-RHKNLVRLLGY 250 (508)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l-~hpniv~l~~~ 250 (508)
+++.+..++..++|++.++||+|+||+||+|.+. +++.||||++..... .....+..|+..+..+ +||||++++++
T Consensus 46 ~~p~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~ 125 (311)
T 3p1a_A 46 YDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQA 125 (311)
T ss_dssp CCTTSSSCHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CCCCCccchhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEE
Confidence 3344444455578999999999999999999987 688999998865432 2233444555555555 99999999999
Q ss_pred eecCCeeEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEE
Q 010513 251 CAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKL 330 (508)
Q Consensus 251 ~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL 330 (508)
+.++...++||||+ +++|.+++... ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||
T Consensus 126 ~~~~~~~~lv~e~~-~~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl 198 (311)
T 3p1a_A 126 WEEGGILYLQTELC-GPSLQQHCEAW---GASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKL 198 (311)
T ss_dssp EEETTEEEEEEECC-CCBHHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEE
T ss_pred EEeCCEEEEEEecc-CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEE
Confidence 99999999999999 56999998765 35699999999999999999999999 9999999999999999999999
Q ss_pred eeeccceecCCCCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhc
Q 010513 331 SDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVT 410 (508)
Q Consensus 331 ~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~ 410 (508)
+|||++....... ......||+.|+|||++.+ .++.++|||||||++|||++|..|+... ... .. +.
T Consensus 199 ~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~------~~~---~~-~~ 265 (311)
T 3p1a_A 199 GDFGLLVELGTAG--AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG------EGW---QQ-LR 265 (311)
T ss_dssp CCCTTCEECC--------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH------HHH---HH-HT
T ss_pred ccceeeeecccCC--CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc------cHH---HH-Hh
Confidence 9999998764332 2334579999999999875 7899999999999999999997766421 111 11 11
Q ss_pred ccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 411 NRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 411 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
.. ...+.+ ......++.+++.+||+.||++||++.|++++
T Consensus 266 ~~----~~~~~~----~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 266 QG----YLPPEF----TAGLSSELRSVLVMMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp TT----CCCHHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cc----CCCccc----ccCCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence 11 111111 11123445668889999999999999999964
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-44 Score=358.48 Aligned_cols=251 Identities=25% Similarity=0.341 Sum_probs=195.3
Q ss_pred hcCCCCcccceEcccCcEEEEEEEE----CCCcEEEEEEeecCC----chhHHHHHHHHHHHHccCCCCeeeEeeeeecC
Q 010513 183 VSTNGFADENVIGEGGYGIVYHGVL----EDNTNVAVKNLLNNR----GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEG 254 (508)
Q Consensus 183 ~~~~~~~~~~~LG~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~ 254 (508)
+..++|++.+.||+|+||.||+|+. .+++.||+|++.+.. ......+.+|+++++.++||||+++++++.++
T Consensus 14 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 93 (327)
T 3a62_A 14 IRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTG 93 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECS
T ss_pred CCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcC
Confidence 3456899999999999999999997 468899999986542 23345678899999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeec
Q 010513 255 AHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFG 334 (508)
Q Consensus 255 ~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG 334 (508)
+..|+||||+++|+|.+++... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg 166 (327)
T 3a62_A 94 GKLYLILEYLSGGELFMQLERE----GIFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFG 166 (327)
T ss_dssp SCEEEEEECCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCS
T ss_pred CEEEEEEeCCCCCcHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCC
Confidence 9999999999999999999765 4689999999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhccccc
Q 010513 335 LAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNA 414 (508)
Q Consensus 335 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 414 (508)
+++...... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+.........
T Consensus 167 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~~~i~~~~-- 237 (327)
T 3a62_A 167 LCKESIHDG-TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENR------KKTIDKILKCK-- 237 (327)
T ss_dssp CC-----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHTC--
T ss_pred cccccccCC-ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCH------HHHHHHHHhCC--
Confidence 998543222 223446799999999999999999999999999999999999999974321 12222222111
Q ss_pred ccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 010513 415 EGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRP-----KMGHVIHM 458 (508)
Q Consensus 415 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 458 (508)
..+.. ..+. ++.+++.+||+.||++|| ++.+++++
T Consensus 238 -----~~~p~-~~~~---~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 238 -----LNLPP-YLTQ---EARDLLKKLLKRNAASRLGAGPGDAGEVQAH 277 (327)
T ss_dssp -----CCCCT-TSCH---HHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred -----CCCCC-CCCH---HHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence 01111 1223 445577899999999999 77888764
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=360.48 Aligned_cols=251 Identities=21% Similarity=0.392 Sum_probs=199.6
Q ss_pred CCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCC-chhHHHHHHHHHHHHccCCCCeeeEeeeeecCC--------
Q 010513 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGA-------- 255 (508)
Q Consensus 186 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-------- 255 (508)
++|++.+.||+|+||.||+|++. +++.||||++.... ....+.+.+|++++++++||||++++++|.+..
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 85 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEM 85 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhh
Confidence 46899999999999999999986 78999999986543 345578999999999999999999999986543
Q ss_pred -------------------------------------------------eeEEEEEecCCCCHHHHhccCCCCCCCCCHH
Q 010513 256 -------------------------------------------------HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWE 286 (508)
Q Consensus 256 -------------------------------------------------~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~ 286 (508)
..++||||+++|+|.+++.... .....++.
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~ 164 (332)
T 3qd2_B 86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRC-SLEDREHG 164 (332)
T ss_dssp HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCC-SGGGSCHH
T ss_pred hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhccc-CccchhhH
Confidence 3789999999999999998753 23456777
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCCCc-----------ceecceecCCC
Q 010513 287 IRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS-----------YVTTRVMGTFG 355 (508)
Q Consensus 287 ~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~-----------~~~~~~~gt~~ 355 (508)
.++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++....... .......||+.
T Consensus 165 ~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 241 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred HHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence 8999999999999999999 999999999999999999999999999987754321 12234579999
Q ss_pred CCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCCccCCCCchHHHHHHHH
Q 010513 356 YVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRAL 435 (508)
Q Consensus 356 y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~ 435 (508)
|+|||++.+..++.++|||||||++|||++|..|+. .......... .. . ..........++.
T Consensus 242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~--------~~~~~~~~~~-~~--------~-~~~~~~~~~~~~~ 303 (332)
T 3qd2_B 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM--------ERVRIITDVR-NL--------K-FPLLFTQKYPQEH 303 (332)
T ss_dssp GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH--------HHHHHHHHHH-TT--------C-CCHHHHHHCHHHH
T ss_pred ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh--------HHHHHHHHhh-cc--------C-CCcccccCChhHH
Confidence 999999999999999999999999999999877652 1111111111 11 0 0111233344566
Q ss_pred HHHHHccCCCCCCCCCHHHHHHH
Q 010513 436 LVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 436 ~li~~cl~~dP~~RPs~~evl~~ 458 (508)
+++.+||+.||++||++.|++++
T Consensus 304 ~li~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 304 MMVQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp HHHHHHHCSSGGGSCCHHHHHHS
T ss_pred HHHHHHccCCCCcCCCHHHHhhc
Confidence 78889999999999999999974
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-44 Score=374.81 Aligned_cols=264 Identities=27% Similarity=0.414 Sum_probs=208.5
Q ss_pred hhHhhcCCCCcccceEcccCcEEEEEEEECCCcEEEEEEeecCCchhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeE
Q 010513 179 RELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM 258 (508)
Q Consensus 179 ~~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 258 (508)
..+++..++|++.+.||+|+||+||+|.++++..||||.+.... ...+.+.+|++++++++||||+++++++.+ +..+
T Consensus 177 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~ 254 (452)
T 1fmk_A 177 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY 254 (452)
T ss_dssp TCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred cccccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceE
Confidence 44567788999999999999999999999888889999987544 335678999999999999999999999976 6789
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeecccee
Q 010513 259 LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL 338 (508)
Q Consensus 259 lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~ 338 (508)
+||||+++|+|.+++.... ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 255 iv~e~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~ 329 (452)
T 1fmk_A 255 IVTEYMSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARL 329 (452)
T ss_dssp EEECCCTTCBHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC-
T ss_pred EEehhhcCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCcccee
Confidence 9999999999999997531 24589999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHhhcccccccC
Q 010513 339 LGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGV 417 (508)
Q Consensus 339 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 417 (508)
.............++..|+|||.+.++.++.++|||||||++|||++ |+.||..... .+.........+
T Consensus 330 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~------~~~~~~i~~~~~---- 399 (452)
T 1fmk_A 330 IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN------REVLDQVERGYR---- 399 (452)
T ss_dssp -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH------HHHHHHHHTTCC----
T ss_pred cCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCH------HHHHHHHHcCCC----
Confidence 65433223334467889999999999999999999999999999999 9999974321 122222211111
Q ss_pred CCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCCC
Q 010513 418 LDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEEFP 465 (508)
Q Consensus 418 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~~~~~ 465 (508)
... ...++.. +.+++.+||+.||++||++.++++.|++....
T Consensus 400 --~~~-~~~~~~~---l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~ 441 (452)
T 1fmk_A 400 --MPC-PPECPES---LHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 441 (452)
T ss_dssp --CCC-CTTSCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred --CCC-CCCCCHH---HHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence 001 1123333 44588899999999999999999999976433
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=359.27 Aligned_cols=266 Identities=20% Similarity=0.387 Sum_probs=195.7
Q ss_pred hhhHhhcCCCCcccceEcccCcEEEEEEEECCCc----EEEEEEeecC--CchhHHHHHHHHHHHHccCCCCeeeEeeee
Q 010513 178 LRELEVSTNGFADENVIGEGGYGIVYHGVLEDNT----NVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLLGYC 251 (508)
Q Consensus 178 ~~~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~----~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~ 251 (508)
++++.+..++|++.+.||+|+||+||+|.+..+. .||+|.+... .....+.+.+|+++++.++||||+++++++
T Consensus 15 ~~~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 94 (323)
T 3qup_A 15 LEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVS 94 (323)
T ss_dssp -CTTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEE
T ss_pred hhhcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhcee
Confidence 4555677889999999999999999999965332 7999998654 334567889999999999999999999999
Q ss_pred ecCCee------EEEEEecCCCCHHHHhccCC--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEc
Q 010513 252 AEGAHR------MLVYEYIDNGNLEQWLHGDV--GPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLD 323 (508)
Q Consensus 252 ~~~~~~------~lV~e~~~~g~L~~~l~~~~--~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~ 323 (508)
...... ++||||+++|+|.+++.... .....+++..++.++.|++.||+|||++ +|+||||||+|||++
T Consensus 95 ~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~ 171 (323)
T 3qup_A 95 LRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLA 171 (323)
T ss_dssp ECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEC
T ss_pred eccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEc
Confidence 877655 89999999999999986432 1123689999999999999999999999 999999999999999
Q ss_pred CCCCeEEeeeccceecCCCCcc-eecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHh-CCCCCCCCCCCCcchH
Q 010513 324 KQWNPKLSDFGLAKLLGAERSY-VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNL 401 (508)
Q Consensus 324 ~~~~~kL~DFG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~ 401 (508)
.++.+||+|||+++........ ......+++.|+|||.+.+..++.++|||||||++|||++ |+.||...... ..
T Consensus 172 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~---~~ 248 (323)
T 3qup_A 172 EDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENA---EI 248 (323)
T ss_dssp TTSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---GH
T ss_pred CCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChH---HH
Confidence 9999999999999876443322 2223456788999999999999999999999999999999 99999754332 11
Q ss_pred HHHHHHhhcccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010513 402 VEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (508)
Q Consensus 402 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~~ 462 (508)
.. ....... .... ...+ .++.+++.+||+.||++||++.++++.|++.
T Consensus 249 ~~---~~~~~~~------~~~~-~~~~---~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~ 296 (323)
T 3qup_A 249 YN---YLIGGNR------LKQP-PECM---EEVYDLMYQCWSADPKQRPSFTCLRMELENI 296 (323)
T ss_dssp HH---HHHTTCC------CCCC-TTCC---HHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred HH---HHhcCCC------CCCC-CccC---HHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 11 1111110 0011 1122 3455588899999999999999999999864
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-44 Score=360.92 Aligned_cols=251 Identities=22% Similarity=0.290 Sum_probs=203.4
Q ss_pred hcCCCCcccceEcccCcEEEEEEEECC-CcEEEEEEeecCC---chhHHHHHHHHHHHHcc-CCCCeeeEeeeeecCCee
Q 010513 183 VSTNGFADENVIGEGGYGIVYHGVLED-NTNVAVKNLLNNR---GQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEGAHR 257 (508)
Q Consensus 183 ~~~~~~~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~ 257 (508)
+..++|++.+.||+|+||+||+|+.+. ++.||+|++.+.. ....+.+..|..++..+ +||||+++++++.+.+..
T Consensus 17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~ 96 (353)
T 2i0e_A 17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 96 (353)
T ss_dssp --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEE
T ss_pred CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEE
Confidence 456789999999999999999999874 7789999986542 23456678899999988 899999999999999999
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccce
Q 010513 258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK 337 (508)
Q Consensus 258 ~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~ 337 (508)
|+||||+++|+|.+++... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 97 ~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~ 169 (353)
T 2i0e_A 97 YFVMEYVNGGDLMYHIQQV----GRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK 169 (353)
T ss_dssp EEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCccc
Confidence 9999999999999999764 4689999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccC
Q 010513 338 LLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGV 417 (508)
Q Consensus 338 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 417 (508)
..... .......+||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+.........
T Consensus 170 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~------~~~~~~~i~~~~----- 237 (353)
T 2i0e_A 170 ENIWD-GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED------EDELFQSIMEHN----- 237 (353)
T ss_dssp CCCCT-TCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHCC-----
T ss_pred ccccC-CcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCC------HHHHHHHHHhCC-----
Confidence 54222 223445689999999999999999999999999999999999999997432 122222222211
Q ss_pred CCccCCCCchHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 010513 418 LDPRLQEKPCSRALKRALLVALRCVDPNAHKRPK-----MGHVIHM 458 (508)
Q Consensus 418 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~ 458 (508)
..+.. ..+ .++.+++.+||+.||++||+ +.+++++
T Consensus 238 --~~~p~-~~s---~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 238 --VAYPK-SMS---KEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp --CCCCT-TSC---HHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred --CCCCC-CCC---HHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 01111 122 34455888999999999994 5777754
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-44 Score=352.18 Aligned_cols=263 Identities=21% Similarity=0.307 Sum_probs=201.1
Q ss_pred CCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCC--chhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEE
Q 010513 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE 262 (508)
Q Consensus 186 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e 262 (508)
++|++.+.||+|+||+||+|.+. +++.||+|++.... ....+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 57999999999999999999976 58889999986543 2334678889999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCC
Q 010513 263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE 342 (508)
Q Consensus 263 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 342 (508)
|+++ +|.+++... ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~~~-~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 154 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSC---NGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp CCSE-EHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSC
T ss_pred cCCC-CHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCc
Confidence 9986 666666554 35799999999999999999999999 9999999999999999999999999999876433
Q ss_pred CcceecceecCCCCCChhhhhcCC-CCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhccccccc-----
Q 010513 343 RSYVTTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEG----- 416 (508)
Q Consensus 343 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~----- 416 (508)
. .......||+.|+|||++.+.. ++.++|||||||++|||++|..||..... .......+...........
T Consensus 155 ~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~--~~~~~~~i~~~~~~~~~~~~~~~~ 231 (292)
T 3o0g_A 155 V-RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND--VDDQLKRIFRLLGTPTEEQWPSMT 231 (292)
T ss_dssp C-SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSS--HHHHHHHHHHHHCCCCTTTCTTGG
T ss_pred c-ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCC--HHHHHHHHHHHhCCCChhhhhhhc
Confidence 2 2234457899999999987765 89999999999999999999888643321 1111121111111100000
Q ss_pred -CCC---------ccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 417 -VLD---------PRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 417 -~~~---------~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
..+ ........+....++.+++.+||+.||++|||++|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 000 000000111223345568889999999999999999864
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-44 Score=360.39 Aligned_cols=246 Identities=21% Similarity=0.262 Sum_probs=204.4
Q ss_pred CCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCC---chhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEE
Q 010513 185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLV 260 (508)
Q Consensus 185 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 260 (508)
.++|++.+.||+|+||.||+|+.. +++.||+|.+.+.. ....+.+.+|+++++.++||||+++++++.+....|+|
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 119 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 457999999999999999999976 68899999986542 23456788899999999999999999999999999999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecC
Q 010513 261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG 340 (508)
Q Consensus 261 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 340 (508)
|||+++|+|.+++... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 120 ~e~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~ 192 (350)
T 1rdq_E 120 MEYVAGGEMFSHLRRI----GRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192 (350)
T ss_dssp EECCTTCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred EcCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceecc
Confidence 9999999999999765 4689999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCCc
Q 010513 341 AERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDP 420 (508)
Q Consensus 341 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 420 (508)
.. ....+||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+......... .
T Consensus 193 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~------~~~~~~~i~~~~-~------ 255 (350)
T 1rdq_E 193 GR----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ------PIQIYEKIVSGK-V------ 255 (350)
T ss_dssp SC----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHCC-C------
T ss_pred CC----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCC------HHHHHHHHHcCC-C------
Confidence 32 234689999999999999999999999999999999999999997432 122222222211 0
Q ss_pred cCCCCchHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 010513 421 RLQEKPCSRALKRALLVALRCVDPNAHKRPK-----MGHVIHM 458 (508)
Q Consensus 421 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~ 458 (508)
.+.. ..+. ++.+++.+||+.||++||+ +.+++++
T Consensus 256 ~~p~-~~~~---~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h 294 (350)
T 1rdq_E 256 RFPS-HFSS---DLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp CCCT-TCCH---HHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred CCCC-CCCH---HHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence 1111 1233 3445778999999999998 8888764
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-44 Score=352.66 Aligned_cols=251 Identities=24% Similarity=0.371 Sum_probs=195.8
Q ss_pred cCCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCch--------------------------hHHHHHHHHHHH
Q 010513 184 STNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQ--------------------------AEKEFKVEVEAI 236 (508)
Q Consensus 184 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--------------------------~~~~~~~E~~~l 236 (508)
..++|++.+.||+|+||.||+|... +++.||+|.+...... ..+.+.+|++++
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 90 (298)
T 2zv2_A 11 QLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAIL 90 (298)
T ss_dssp EETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHH
T ss_pred eecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHH
Confidence 4468999999999999999999975 5788999998654311 134688899999
Q ss_pred HccCCCCeeeEeeeeec--CCeeEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecc
Q 010513 237 GRVRHKNLVRLLGYCAE--GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRD 314 (508)
Q Consensus 237 ~~l~hpniv~l~~~~~~--~~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrD 314 (508)
+.++||||+++++++.+ +...++||||+++++|.+++.. ..+++..++.++.|++.||+|||++ +|+|||
T Consensus 91 ~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~D 162 (298)
T 2zv2_A 91 KKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL-----KPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRD 162 (298)
T ss_dssp HTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCC
T ss_pred HhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccC
Confidence 99999999999999986 5688999999999999886543 4799999999999999999999999 999999
Q ss_pred CCCCCEEEcCCCCeEEeeeccceecCCCCcceecceecCCCCCChhhhhcCC---CCCCCCeeehHHHHHHHHhCCCCCC
Q 010513 315 IKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGM---LNERSDVYSFGILIMEVISGRNPVD 391 (508)
Q Consensus 315 lkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~sDvwSlGvvl~elltg~~Pf~ 391 (508)
|||+|||++.++.+||+|||+++....... ......||+.|+|||.+.+.. ++.++|||||||++|||++|+.||.
T Consensus 163 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~ 241 (298)
T 2zv2_A 163 IKPSNLLVGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFM 241 (298)
T ss_dssp CCGGGEEECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CCHHHEEECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCC
Confidence 999999999999999999999987654322 234467999999999987655 3678999999999999999999996
Q ss_pred CCCCCCcchHHHHHHHhhcccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 392 YSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 392 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
... .......... .... .+. ....+. ++.+++.+||+.||++||++.|++++
T Consensus 242 ~~~------~~~~~~~~~~-~~~~---~~~--~~~~~~---~l~~li~~~l~~dp~~R~s~~e~l~h 293 (298)
T 2zv2_A 242 DER------IMCLHSKIKS-QALE---FPD--QPDIAE---DLKDLITRMLDKNPESRIVVPEIKLH 293 (298)
T ss_dssp CSS------HHHHHHHHHH-CCCC---CCS--SSCCCH---HHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred Ccc------HHHHHHHHhc-ccCC---CCC--ccccCH---HHHHHHHHHhhcChhhCCCHHHHhcC
Confidence 432 1121111111 1100 010 111233 34457889999999999999999753
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-44 Score=364.21 Aligned_cols=267 Identities=17% Similarity=0.226 Sum_probs=204.3
Q ss_pred hcCCCCcccceEcccCcEEEEEEEECC------CcEEEEEEeecCCchhH-----------HHHHHHHHHHHccCCCCee
Q 010513 183 VSTNGFADENVIGEGGYGIVYHGVLED------NTNVAVKNLLNNRGQAE-----------KEFKVEVEAIGRVRHKNLV 245 (508)
Q Consensus 183 ~~~~~~~~~~~LG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~hpniv 245 (508)
...++|++.+.||+|+||+||+|.+.. ++.||||.+........ ..+..|+..+..++||||+
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv 111 (364)
T 3op5_A 32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP 111 (364)
T ss_dssp TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence 456689999999999999999999764 36799999866543211 1233466677788999999
Q ss_pred eEeeeeecC----CeeEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEE
Q 010513 246 RLLGYCAEG----AHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNIL 321 (508)
Q Consensus 246 ~l~~~~~~~----~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIl 321 (508)
++++++... ...++||||+ +++|.+++... ...+++..++.++.|++.||+|||++ +|+||||||+|||
T Consensus 112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~---~~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nil 184 (364)
T 3op5_A 112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN---AKRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLL 184 (364)
T ss_dssp CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEE
T ss_pred eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEE
Confidence 999998764 4578999999 89999999775 35799999999999999999999999 9999999999999
Q ss_pred Ec--CCCCeEEeeeccceecCCCCcce------ecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCC
Q 010513 322 LD--KQWNPKLSDFGLAKLLGAERSYV------TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS 393 (508)
Q Consensus 322 l~--~~~~~kL~DFG~a~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~ 393 (508)
++ .++.+||+|||+++.+....... ....+||+.|+|||++.+..++.++|||||||++|||+||+.||...
T Consensus 185 l~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~ 264 (364)
T 3op5_A 185 LNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDN 264 (364)
T ss_dssp EESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred EecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence 98 88999999999998764332211 13356999999999999999999999999999999999999999753
Q ss_pred CCCCcchHHHHHHHhhcccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010513 394 RPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (508)
Q Consensus 394 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~~ 462 (508)
... ............ .....++++.+....++..+ .+++.+||+.||++||++.++++.|+..
T Consensus 265 ~~~--~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~---~~li~~cl~~~p~~RP~~~~l~~~l~~~ 327 (364)
T 3op5_A 265 LKD--PKYVRDSKIRYR-ENIASLMDKCFPAANAPGEI---AKYMETVKLLDYTEKPLYENLRDILLQG 327 (364)
T ss_dssp TTC--HHHHHHHHHHHH-HCHHHHHHHHSCTTCCCHHH---HHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred ccC--HHHHHHHHHHhh-hhHHHHHHHhcccccCHHHH---HHHHHHHhcCCCCCCCCHHHHHHHHHHH
Confidence 322 122222211111 11112222222222334444 4477799999999999999999998854
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-44 Score=350.01 Aligned_cols=263 Identities=27% Similarity=0.472 Sum_probs=197.1
Q ss_pred HhhcCCCCcccceEcccCcEEEEEEEECCCcEEEEEEeecCC--chhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeE
Q 010513 181 LEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM 258 (508)
Q Consensus 181 ~~~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 258 (508)
.++..++|++.+.||+|+||+||+|++. ..||+|.+.... ....+.+.+|+++++.++||||+++++++ .....+
T Consensus 19 ~ei~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~ 95 (289)
T 3og7_A 19 WEIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLA 95 (289)
T ss_dssp CBCCTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCE
T ss_pred CccCccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccE
Confidence 3677889999999999999999999864 359999986543 34456789999999999999999999966 456689
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeecccee
Q 010513 259 LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL 338 (508)
Q Consensus 259 lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~ 338 (508)
+||||+++++|.+++... ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++..
T Consensus 96 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~ 169 (289)
T 3og7_A 96 IVTQWCEGSSLYHHLHAS---ETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATE 169 (289)
T ss_dssp EEEECCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC----
T ss_pred EEEEecCCCcHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceeccc
Confidence 999999999999999765 35799999999999999999999999 999999999999999999999999999986
Q ss_pred cCCC-CcceecceecCCCCCChhhhh---cCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhccccc
Q 010513 339 LGAE-RSYVTTRVMGTFGYVAPEYAS---TGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNA 414 (508)
Q Consensus 339 ~~~~-~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 414 (508)
.... .........||+.|+|||++. +..++.++|||||||++|||++|+.||...... +.+.........
T Consensus 170 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~~~~~~~~~~ 243 (289)
T 3og7_A 170 KSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR------DQIIEMVGRGSL 243 (289)
T ss_dssp --------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCH------HHHHHHHHHTSC
T ss_pred cccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchH------HHHHHHhccccc
Confidence 5432 222234467999999999986 567888999999999999999999999754321 111122221111
Q ss_pred ccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 010513 415 EGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEE 463 (508)
Q Consensus 415 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~~~ 463 (508)
..... .+ ...++. ++.+++.+||+.||++||++.+++++|++..
T Consensus 244 ~~~~~-~~-~~~~~~---~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 244 SPDLS-KV-RSNCPK---RMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp CCCTT-SS-CTTSCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred Ccchh-hc-cccCCH---HHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 11111 01 112333 4455778999999999999999999998754
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-44 Score=363.08 Aligned_cols=254 Identities=20% Similarity=0.299 Sum_probs=194.8
Q ss_pred cCCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCchhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEE
Q 010513 184 STNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE 262 (508)
Q Consensus 184 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e 262 (508)
..++|++.+.||+|+||+||+|+.. +++.||+|++..... ..+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 96 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIME 96 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEE
Confidence 3468999999999999999999986 688999999865433 34568889999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCC--eEEeeeccceecC
Q 010513 263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWN--PKLSDFGLAKLLG 340 (508)
Q Consensus 263 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~--~kL~DFG~a~~~~ 340 (508)
|+++|+|.+++... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++. +||+|||+++...
T Consensus 97 ~~~~~~L~~~l~~~----~~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~ 169 (361)
T 3uc3_A 97 YASGGELYERICNA----GRFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 169 (361)
T ss_dssp CCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC----
T ss_pred eCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCcccccc
Confidence 99999999999764 4699999999999999999999999 9999999999999987765 9999999997432
Q ss_pred CCCcceecceecCCCCCChhhhhcCCCCCC-CCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCC
Q 010513 341 AERSYVTTRVMGTFGYVAPEYASTGMLNER-SDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLD 419 (508)
Q Consensus 341 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 419 (508)
.. ......+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||......... ...+........ ...
T Consensus 170 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~--~~~~~~~~~~~~---~~~ 242 (361)
T 3uc3_A 170 LH--SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDY--RKTIQRILSVKY---SIP 242 (361)
T ss_dssp -------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCH--HHHHHHHHTTCC---CCC
T ss_pred cc--CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHH--HHHHHHHhcCCC---CCC
Confidence 22 22334579999999999988887665 89999999999999999999765443222 222222221110 000
Q ss_pred ccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 420 PRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 420 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
. ....+ .++.+++.+||+.||++|||+.|++++
T Consensus 243 ~---~~~~s---~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 243 D---DIRIS---PECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp T---TSCCC---HHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred C---cCCCC---HHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 0 00122 344558889999999999999999975
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-44 Score=352.21 Aligned_cols=256 Identities=22% Similarity=0.343 Sum_probs=204.4
Q ss_pred hcCCCCcccceEcccCcEEEEEEEECC-C-------cEEEEEEeecCCchhHHHHHHHHHHHHccCCCCeeeEeeeeecC
Q 010513 183 VSTNGFADENVIGEGGYGIVYHGVLED-N-------TNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEG 254 (508)
Q Consensus 183 ~~~~~~~~~~~LG~G~~g~Vy~~~~~~-~-------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~ 254 (508)
+..++|.+.+.||+|+||+||+|.+.. + ..||+|.+........+.+.+|+++++.++||||+++++++.++
T Consensus 5 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 84 (289)
T 4fvq_A 5 IRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCG 84 (289)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCT
T ss_pred echhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeC
Confidence 455689999999999999999998653 3 46999998776666778899999999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCC-------
Q 010513 255 AHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWN------- 327 (508)
Q Consensus 255 ~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~------- 327 (508)
+..++||||+++|+|.+++... ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.
T Consensus 85 ~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~ 158 (289)
T 4fvq_A 85 DENILVQEFVKFGSLDTYLKKN---KNCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPP 158 (289)
T ss_dssp TCCEEEEECCTTCBHHHHHHHT---GGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCC
T ss_pred CCCEEEEECCCCCCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccc
Confidence 9999999999999999999875 24589999999999999999999999 9999999999999998887
Q ss_pred -eEEeeeccceecCCCCcceecceecCCCCCChhhhhc-CCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHH
Q 010513 328 -PKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWL 405 (508)
Q Consensus 328 -~kL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~ 405 (508)
+||+|||++...... ....||+.|+|||++.+ ..++.++|||||||++|||++|..|+..... .....
T Consensus 159 ~~kl~Dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~-----~~~~~ 228 (289)
T 4fvq_A 159 FIKLSDPGISITVLPK-----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALD-----SQRKL 228 (289)
T ss_dssp EEEECCCCSCTTTSCH-----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSC-----HHHHH
T ss_pred eeeeccCcccccccCc-----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccc-----hHHHH
Confidence 999999998754221 23468999999999987 6799999999999999999996544432211 11111
Q ss_pred HHhhcccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCCCC
Q 010513 406 KTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEEFPF 466 (508)
Q Consensus 406 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~~~~~~ 466 (508)
........ +.+. .+. ++.+++.+||+.||++||++.+++++|+....|-
T Consensus 229 ~~~~~~~~----~~~~-----~~~---~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~ 277 (289)
T 4fvq_A 229 QFYEDRHQ----LPAP-----KAA---ELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPD 277 (289)
T ss_dssp HHHHTTCC----CCCC-----SSC---TTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC---
T ss_pred HHhhccCC----CCCC-----CCH---HHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCC
Confidence 11111111 1111 111 2445888999999999999999999999776443
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=361.72 Aligned_cols=256 Identities=27% Similarity=0.464 Sum_probs=199.5
Q ss_pred cCCCCcccceEcccCcEEEEEEEEC-CCcE----EEEEEeecC-CchhHHHHHHHHHHHHccCCCCeeeEeeeeecCCee
Q 010513 184 STNGFADENVIGEGGYGIVYHGVLE-DNTN----VAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHR 257 (508)
Q Consensus 184 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~----vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 257 (508)
..++|++.+.||+|+||+||+|++. +++. ||+|.+... .....+.+.+|++++++++||||+++++++.++. .
T Consensus 13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~ 91 (327)
T 3poz_A 13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-V 91 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-E
T ss_pred CHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-e
Confidence 3457999999999999999999965 3443 577777543 2344578999999999999999999999998754 7
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccce
Q 010513 258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK 337 (508)
Q Consensus 258 ~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~ 337 (508)
++|+||+.+|+|.+++... ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 92 ~~v~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 165 (327)
T 3poz_A 92 QLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAK 165 (327)
T ss_dssp EEEEECCTTCBHHHHHHHS---TTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHH
T ss_pred EEEEEecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCccee
Confidence 8999999999999999875 35799999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCcc-eecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHhhcccccc
Q 010513 338 LLGAERSY-VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAE 415 (508)
Q Consensus 338 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (508)
........ ......||+.|+|||++.+..++.++|||||||++|||+| |+.||...... .....+. ...
T Consensus 166 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~~~~~~~----~~~-- 236 (327)
T 3poz_A 166 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS---EISSILE----KGE-- 236 (327)
T ss_dssp HHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---GHHHHHH----TTC--
T ss_pred EccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHH---HHHHHHH----cCC--
Confidence 76543322 2233467889999999999999999999999999999999 99999754322 1222111 111
Q ss_pred cCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010513 416 GVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (508)
Q Consensus 416 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~~ 462 (508)
... ....++ .++.+++.+||+.||++||++.+++++|+..
T Consensus 237 ---~~~-~~~~~~---~~~~~li~~~l~~~p~~Rps~~ell~~l~~~ 276 (327)
T 3poz_A 237 ---RLP-QPPICT---IDVYMIMVKCWMIDADSRPKFRELIIEFSKM 276 (327)
T ss_dssp ---CCC-CCTTBC---HHHHHHHHHHTCSCGGGSCCHHHHHHHHHHH
T ss_pred ---CCC-CCccCC---HHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 000 111122 3455588899999999999999999999764
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-44 Score=372.37 Aligned_cols=254 Identities=28% Similarity=0.415 Sum_probs=207.0
Q ss_pred hHhhcCCCCcccceEcccCcEEEEEEEECCCcEEEEEEeecCCchhHHHHHHHHHHHHccCCCCeeeEeeeeecCC-eeE
Q 010513 180 ELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGA-HRM 258 (508)
Q Consensus 180 ~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-~~~ 258 (508)
.+++..++|++.+.||+|+||.||+|.+. ++.||||.+.... ..+.+.+|++++++++||||+++++++.+.. ..+
T Consensus 187 ~~~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 263 (450)
T 1k9a_A 187 GWALNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY 263 (450)
T ss_dssp TCBCCGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEE
T ss_pred ccccChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceE
Confidence 34667788999999999999999999986 7799999986543 4577899999999999999999999987655 789
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeecccee
Q 010513 259 LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL 338 (508)
Q Consensus 259 lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~ 338 (508)
+||||+++|+|.+++.... ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 264 iv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~ 338 (450)
T 1k9a_A 264 IVTEYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKE 338 (450)
T ss_dssp EEEECCTTCBHHHHHHHHC--TTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEecCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCccc
Confidence 9999999999999998652 23479999999999999999999999 999999999999999999999999999985
Q ss_pred cCCCCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHhhcccccccC
Q 010513 339 LGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGV 417 (508)
Q Consensus 339 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 417 (508)
.... .....+++.|+|||.+.+..++.++|||||||++|||+| |+.||....... ....+ ..+.
T Consensus 339 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~---~~~~i----~~~~---- 403 (450)
T 1k9a_A 339 ASST----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPRV----EKGY---- 403 (450)
T ss_dssp CC----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT---HHHHH----HTTC----
T ss_pred cccc----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHH----HcCC----
Confidence 4322 222367889999999999999999999999999999998 999997654322 11111 1110
Q ss_pred CCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 010513 418 LDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461 (508)
Q Consensus 418 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~ 461 (508)
.... ...++.. +.+++.+||+.||++||++.++++.|+.
T Consensus 404 -~~~~-p~~~~~~---l~~li~~cl~~dp~~Rpt~~~l~~~L~~ 442 (450)
T 1k9a_A 404 -KMDA-PDGCPPA---VYDVMKNCWHLDAATRPTFLQLREQLEH 442 (450)
T ss_dssp -CCCC-CTTCCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -CCCC-CCcCCHH---HHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 0111 1223444 4447789999999999999999999975
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-44 Score=349.57 Aligned_cols=254 Identities=28% Similarity=0.565 Sum_probs=202.5
Q ss_pred hcCCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCchh-------HHHHHHHHHHHHccCCCCeeeEeeeeecC
Q 010513 183 VSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQA-------EKEFKVEVEAIGRVRHKNLVRLLGYCAEG 254 (508)
Q Consensus 183 ~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-------~~~~~~E~~~l~~l~hpniv~l~~~~~~~ 254 (508)
+..++|++.+.||+|+||+||+|.+. +++.||+|.+....... .+.+.+|++++++++||||+++++++.+.
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 95 (287)
T 4f0f_A 16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP 95 (287)
T ss_dssp CCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT
T ss_pred hhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC
Confidence 45578999999999999999999975 68899999985443221 16788999999999999999999999776
Q ss_pred CeeEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eeeccCCCCCEEEcCCCC-----
Q 010513 255 AHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK--VVHRDIKSSNILLDKQWN----- 327 (508)
Q Consensus 255 ~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~--iiHrDlkp~NIll~~~~~----- 327 (508)
. ++||||+++|+|.+++... ...+++..++.++.|++.||+|||++ + |+||||||+|||++.++.
T Consensus 96 ~--~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~ 167 (287)
T 4f0f_A 96 P--RMVMEFVPCGDLYHRLLDK---AHPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVC 167 (287)
T ss_dssp T--EEEEECCTTCBHHHHHHCT---TSCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCC
T ss_pred C--eEEEEecCCCCHHHHHhcc---cCCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCcee
Confidence 5 6999999999999998765 35799999999999999999999998 8 999999999999988776
Q ss_pred eEEeeeccceecCCCCcceecceecCCCCCChhhh--hcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHH
Q 010513 328 PKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYA--STGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWL 405 (508)
Q Consensus 328 ~kL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~ 405 (508)
+||+|||+++.... ......||+.|+|||++ ....++.++|||||||++|||++|+.||....... ....
T Consensus 168 ~kl~Dfg~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~----~~~~ 239 (287)
T 4f0f_A 168 AKVADFGLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK----IKFI 239 (287)
T ss_dssp EEECCCTTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCH----HHHH
T ss_pred EEeCCCCccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccH----HHHH
Confidence 99999999985432 23446799999999998 34567889999999999999999999997544321 1111
Q ss_pred HHhhcccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 010513 406 KTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461 (508)
Q Consensus 406 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~ 461 (508)
....... ..+.+.. .++. ++.+++.+||+.||++||++.++++.|++
T Consensus 240 ~~~~~~~-----~~~~~~~-~~~~---~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 240 NMIREEG-----LRPTIPE-DCPP---RLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp HHHHHSC-----CCCCCCT-TSCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred HHHhccC-----CCCCCCc-ccCH---HHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 1111111 1111111 1333 34457789999999999999999999975
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-44 Score=365.62 Aligned_cols=249 Identities=25% Similarity=0.291 Sum_probs=193.7
Q ss_pred hcCCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCc---hhHHHHHHHHHH-HHccCCCCeeeEeeeeecCCee
Q 010513 183 VSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG---QAEKEFKVEVEA-IGRVRHKNLVRLLGYCAEGAHR 257 (508)
Q Consensus 183 ~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~-l~~l~hpniv~l~~~~~~~~~~ 257 (508)
...++|++.+.||+|+||+||+|+.+ +++.||+|++.+... .....+..|..+ ++.++||||+++++++.+.+..
T Consensus 35 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~ 114 (373)
T 2r5t_A 35 AKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKL 114 (373)
T ss_dssp CCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEE
T ss_pred CChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEE
Confidence 34568999999999999999999986 477899999966432 223455666666 5678999999999999999999
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccce
Q 010513 258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK 337 (508)
Q Consensus 258 ~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~ 337 (508)
|+||||+++|+|.+++... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++++||+|||+++
T Consensus 115 ~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~ 187 (373)
T 2r5t_A 115 YFVLDYINGGELFYHLQRE----RCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCK 187 (373)
T ss_dssp EEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCG
T ss_pred EEEEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCcccc
Confidence 9999999999999999765 4689999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccC
Q 010513 338 LLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGV 417 (508)
Q Consensus 338 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 417 (508)
..... .......+||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+......... .
T Consensus 188 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~------~~~~~~~i~~~~-~--- 256 (373)
T 2r5t_A 188 ENIEH-NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN------TAEMYDNILNKP-L--- 256 (373)
T ss_dssp GGBCC-CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSB------HHHHHHHHHHSC-C---
T ss_pred ccccC-CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC------HHHHHHHHHhcc-c---
Confidence 64222 223445789999999999999999999999999999999999999996432 222222222211 0
Q ss_pred CCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 010513 418 LDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVI 456 (508)
Q Consensus 418 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl 456 (508)
.+.. ..+. .+.+++.+||+.||++||++.+.+
T Consensus 257 ---~~~~-~~~~---~~~~li~~lL~~dp~~R~~~~~~~ 288 (373)
T 2r5t_A 257 ---QLKP-NITN---SARHLLEGLLQKDRTKRLGAKDDF 288 (373)
T ss_dssp ---CCCS-SSCH---HHHHHHHHHTCSSGGGSTTTTTTH
T ss_pred ---CCCC-CCCH---HHHHHHHHHcccCHHhCCCCCCCH
Confidence 1111 1233 344577799999999999985433
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-44 Score=359.35 Aligned_cols=250 Identities=23% Similarity=0.344 Sum_probs=180.7
Q ss_pred cceEcccCcEEEEEEEEC-CCcEEEEEEeecCCchhHHHHHHHHHHHHccC-CCCeeeEeeeeecCCeeEEEEEecCCCC
Q 010513 191 ENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVR-HKNLVRLLGYCAEGAHRMLVYEYIDNGN 268 (508)
Q Consensus 191 ~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~lV~e~~~~g~ 268 (508)
.+.||+|+||+||+|.+. +++.||||++... ....+.+|+.+++.+. ||||+++++++.++...|+||||+++|+
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 378999999999999986 5889999998643 3456778999999997 9999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCC---CeEEeeeccceecCCCCcc
Q 010513 269 LEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQW---NPKLSDFGLAKLLGAERSY 345 (508)
Q Consensus 269 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~---~~kL~DFG~a~~~~~~~~~ 345 (508)
|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++ .+||+|||+++...... .
T Consensus 93 L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~-~ 164 (325)
T 3kn6_A 93 LFERIKKK----KHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN-Q 164 (325)
T ss_dssp HHHHHHHC----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC----
T ss_pred HHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCC-C
Confidence 99999875 5799999999999999999999999 999999999999997765 79999999998764332 2
Q ss_pred eecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcc-hHHHHHHHhhcccccccCCCccCCC
Q 010513 346 VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEV-NLVEWLKTMVTNRNAEGVLDPRLQE 424 (508)
Q Consensus 346 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~ 424 (508)
.....+||+.|+|||++.+..++.++|||||||++|||++|+.||......... ...+.+.. ...... .+..
T Consensus 165 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~-i~~~~~------~~~~ 237 (325)
T 3kn6_A 165 PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKK-IKKGDF------SFEG 237 (325)
T ss_dssp -------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHH-HTTTCC------CCCS
T ss_pred cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHH-HHcCCC------CCCc
Confidence 334567899999999999999999999999999999999999999865432221 22222222 221111 1111
Q ss_pred CchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 425 KPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 425 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
........++.+++.+||+.||++||++.+++++
T Consensus 238 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 238 EAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp HHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred ccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 1111223456668889999999999999998854
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=353.74 Aligned_cols=263 Identities=24% Similarity=0.434 Sum_probs=217.9
Q ss_pred hhhHhhcCCCCcccceEcccCcEEEEEEEECC-CcEEEEEEeecCCchhHHHHHHHHHHHHccCCCCeeeEeeeeecCCe
Q 010513 178 LRELEVSTNGFADENVIGEGGYGIVYHGVLED-NTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAH 256 (508)
Q Consensus 178 ~~~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 256 (508)
++.+++..++|++.+.||+|+||+||+|.+.. +..||+|.+.... ...+.+.+|+++++.++||||+++++++.++..
T Consensus 5 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 83 (288)
T 3kfa_A 5 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP 83 (288)
T ss_dssp CCTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 34567788899999999999999999999874 7789999986543 345778899999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccc
Q 010513 257 RMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLA 336 (508)
Q Consensus 257 ~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a 336 (508)
.++||||+++++|.+++.... ...+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 84 ~~~v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~ 158 (288)
T 3kfa_A 84 FYIITEFMTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLS 158 (288)
T ss_dssp EEEEEECCTTEEHHHHHHHCC--TTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGG
T ss_pred EEEEEEcCCCCcHHHHHHhcc--cCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccc
Confidence 999999999999999997642 35689999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHhhcccccc
Q 010513 337 KLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAE 415 (508)
Q Consensus 337 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (508)
...............+|+.|+|||.+.+..++.++||||||+++|+|++ |..||...... ...+.+.. .
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~---~~~~~~~~---~---- 228 (288)
T 3kfa_A 159 RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS---QVYELLEK---D---- 228 (288)
T ss_dssp GTSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---GHHHHHHT---T----
T ss_pred eeccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHhc---c----
Confidence 8776555555556678899999999999999999999999999999999 99999754322 12221111 1
Q ss_pred cCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010513 416 GVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (508)
Q Consensus 416 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~~ 462 (508)
...... ...+. ++.+++.+||+.||++||++.++++.|+..
T Consensus 229 --~~~~~~-~~~~~---~l~~li~~~l~~dp~~Rps~~~~~~~l~~~ 269 (288)
T 3kfa_A 229 --YRMERP-EGCPE---KVYELMRACWQWNPSDRPSFAEIHQAFETM 269 (288)
T ss_dssp --CCCCCC-TTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --CCCCCC-CCCCH---HHHHHHHHHhCCChhhCcCHHHHHHHHHHH
Confidence 011111 11233 445577899999999999999999998753
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=362.46 Aligned_cols=249 Identities=21% Similarity=0.297 Sum_probs=198.2
Q ss_pred cccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCchhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEEecCCC
Q 010513 189 ADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNG 267 (508)
Q Consensus 189 ~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~g 267 (508)
...+.||+|+||.||+|... ++..||+|++........+.+.+|++++++++||||+++++++.+.+..++||||+++|
T Consensus 92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~ 171 (373)
T 2x4f_A 92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGG 171 (373)
T ss_dssp EEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred ecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCC
Confidence 33678999999999999975 58899999998776666788999999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEE--cCCCCeEEeeeccceecCCCCcc
Q 010513 268 NLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILL--DKQWNPKLSDFGLAKLLGAERSY 345 (508)
Q Consensus 268 ~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll--~~~~~~kL~DFG~a~~~~~~~~~ 345 (508)
+|.+++... ...+++..++.++.|++.||+|||++ +|+||||||+|||+ +.++.+||+|||+++.......
T Consensus 172 ~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~- 244 (373)
T 2x4f_A 172 ELFDRIIDE---SYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK- 244 (373)
T ss_dssp EEHHHHHHT---GGGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB-
T ss_pred cHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc-
Confidence 999998754 34689999999999999999999999 99999999999999 5678899999999997654332
Q ss_pred eecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCCccCCCC
Q 010513 346 VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEK 425 (508)
Q Consensus 346 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 425 (508)
....+||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+.+........ .....
T Consensus 245 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~------~~~~~~i~~~~~--~~~~~----- 310 (373)
T 2x4f_A 245 -LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDND------AETLNNILACRW--DLEDE----- 310 (373)
T ss_dssp -CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHHTCC--CSCSG-----
T ss_pred -cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhccC--CCChh-----
Confidence 2345799999999999999999999999999999999999999974421 122222221110 00011
Q ss_pred chHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 426 PCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 426 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
.......++.+++.+||+.||++||++.|++++
T Consensus 311 ~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~h 343 (373)
T 2x4f_A 311 EFQDISEEAKEFISKLLIKEKSWRISASEALKH 343 (373)
T ss_dssp GGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred hhccCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 111122345558889999999999999999973
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-43 Score=348.93 Aligned_cols=266 Identities=21% Similarity=0.255 Sum_probs=198.9
Q ss_pred CCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCc---hhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEE
Q 010513 185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG---QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLV 260 (508)
Q Consensus 185 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 260 (508)
.++|++.+.||+|+||.||+|.+. +++.||+|.+..... ...+.+.+|+++++.++||||+++++++.+++..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 468999999999999999999976 688899999865432 2346788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecC
Q 010513 261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG 340 (508)
Q Consensus 261 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 340 (508)
|||+++++|.+++... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++....
T Consensus 113 ~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 185 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQ----GPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATT 185 (309)
T ss_dssp EECCCCEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC-----
T ss_pred EEecCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCcccc
Confidence 9999999999999765 4689999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCCc
Q 010513 341 AERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDP 420 (508)
Q Consensus 341 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 420 (508)
...........||+.|+|||.+.+..++.++||||||+++|||++|+.||..... ..+........ ..+
T Consensus 186 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-------~~~~~~~~~~~----~~~ 254 (309)
T 2h34_A 186 DEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQL-------SVMGAHINQAI----PRP 254 (309)
T ss_dssp -----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHH-------HHHHHHHHSCC----CCG
T ss_pred ccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchH-------HHHHHHhccCC----CCc
Confidence 4433334456799999999999999999999999999999999999999964321 11112221110 111
Q ss_pred cCCCCchHHHHHHHHHHHHHccCCCCCCCC-CHHHHHHHHhcCCCCCCCCCC
Q 010513 421 RLQEKPCSRALKRALLVALRCVDPNAHKRP-KMGHVIHMLEAEEFPFRDVSF 471 (508)
Q Consensus 421 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~Le~~~~~~~~~~~ 471 (508)
.......+.. +.+++.+||+.||++|| ++.++++.|+...........
T Consensus 255 ~~~~~~~~~~---l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~~~~~ 303 (309)
T 2h34_A 255 STVRPGIPVA---FDAVIARGMAKNPEDRYVTCGDLSAAAHAALATADQDRA 303 (309)
T ss_dssp GGTSTTCCTH---HHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC-------
T ss_pred cccCCCCCHH---HHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhcccch
Confidence 1111112333 44477899999999999 999999999976554444433
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-44 Score=358.97 Aligned_cols=254 Identities=20% Similarity=0.333 Sum_probs=198.3
Q ss_pred hhcCCCCcccceEcccCcEEEEEEEECCCcEEEEEEeecCC--chhHHHHHHHHHHHHccCC--CCeeeEeeeeecCCee
Q 010513 182 EVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRH--KNLVRLLGYCAEGAHR 257 (508)
Q Consensus 182 ~~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h--pniv~l~~~~~~~~~~ 257 (508)
.+..++|++.+.||+|+||.||+|...+++.||||++.... ....+.+.+|++++..++| |||+++++++.++...
T Consensus 5 ~~~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~ 84 (343)
T 3dbq_A 5 SVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI 84 (343)
T ss_dssp ESSSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred eeecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEE
Confidence 45567899999999999999999998889999999986543 3345678999999999976 9999999999999999
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccce
Q 010513 258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK 337 (508)
Q Consensus 258 ~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~ 337 (508)
++||| +.+|+|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+|||++ ++.+||+|||+++
T Consensus 85 ~lv~e-~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~ 155 (343)
T 3dbq_A 85 YMVME-CGNIDLNSWLKKK----KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIAN 155 (343)
T ss_dssp EEEEC-CCSEEHHHHHHHS----CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSC
T ss_pred EEEEe-CCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeeccccc
Confidence 99999 4577999999875 5789999999999999999999999 999999999999997 5789999999998
Q ss_pred ecCCCCcc-eecceecCCCCCChhhhhc-----------CCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHH
Q 010513 338 LLGAERSY-VTTRVMGTFGYVAPEYAST-----------GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWL 405 (508)
Q Consensus 338 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~ 405 (508)
........ .....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... ....+
T Consensus 156 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-----~~~~~ 230 (343)
T 3dbq_A 156 QMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-----QISKL 230 (343)
T ss_dssp CC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS-----HHHHH
T ss_pred ccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh-----HHHHH
Confidence 76443322 2345689999999999865 6788999999999999999999999964321 12222
Q ss_pred HHhhcccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 406 KTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 406 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
........ ...+. ...+. ++.+++.+||+.||++||++.+++++
T Consensus 231 ~~~~~~~~-----~~~~~-~~~~~---~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 231 HAIIDPNH-----EIEFP-DIPEK---DLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp HHHHCTTS-----CCCCC-CCSCH---HHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHhcCCc-----ccCCc-ccCCH---HHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 22221111 01111 11222 34558889999999999999999875
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=353.77 Aligned_cols=270 Identities=23% Similarity=0.420 Sum_probs=215.8
Q ss_pred cchhhHhhcCCCCcccceEcccCcEEEEEEEEC------CCcEEEEEEeecCCc-hhHHHHHHHHHHHHccCCCCeeeEe
Q 010513 176 YTLRELEVSTNGFADENVIGEGGYGIVYHGVLE------DNTNVAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNLVRLL 248 (508)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~ 248 (508)
+...++++..++|++.+.||+|+||.||+|.+. +++.||+|.+..... .....+.+|+++++.++||||++++
T Consensus 15 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 94 (322)
T 1p4o_A 15 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLL 94 (322)
T ss_dssp CCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred cChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeE
Confidence 445666788889999999999999999999864 367799999865433 3445788999999999999999999
Q ss_pred eeeecCCeeEEEEEecCCCCHHHHhccCC------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEE
Q 010513 249 GYCAEGAHRMLVYEYIDNGNLEQWLHGDV------GPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILL 322 (508)
Q Consensus 249 ~~~~~~~~~~lV~e~~~~g~L~~~l~~~~------~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll 322 (508)
+++.+++..++||||+++|+|.+++.... .....+++..++.++.|++.||+|||++ +|+||||||+||++
T Consensus 95 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli 171 (322)
T 1p4o_A 95 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMV 171 (322)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEE
T ss_pred EEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEE
Confidence 99999999999999999999999986531 1124679999999999999999999999 99999999999999
Q ss_pred cCCCCeEEeeeccceecCCCCcce-ecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHh-CCCCCCCCCCCCcch
Q 010513 323 DKQWNPKLSDFGLAKLLGAERSYV-TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVN 400 (508)
Q Consensus 323 ~~~~~~kL~DFG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~ 400 (508)
+.++.+||+|||+++......... .....||+.|+|||++.+..++.++|||||||++|||++ |+.||....
T Consensus 172 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~------ 245 (322)
T 1p4o_A 172 AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS------ 245 (322)
T ss_dssp CTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC------
T ss_pred cCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCC------
Confidence 999999999999998654332221 233467889999999999999999999999999999999 899996432
Q ss_pred HHHHHHHhhcccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCC
Q 010513 401 LVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEEF 464 (508)
Q Consensus 401 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~~~~ 464 (508)
..+......... .. .. ....+.. +.+++.+||+.||++||++.+++++|++...
T Consensus 246 ~~~~~~~~~~~~-~~-----~~-~~~~~~~---l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 246 NEQVLRFVMEGG-LL-----DK-PDNCPDM---LFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp HHHHHHHHHTTC-CC-----CC-CTTCCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HHHHHHHHHcCC-cC-----CC-CCCCCHH---HHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 112222222111 10 01 1113333 4457789999999999999999999998644
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-43 Score=350.42 Aligned_cols=270 Identities=25% Similarity=0.384 Sum_probs=204.4
Q ss_pred hhHhhcCCCCcccceEcccCcEEEEEEEECCCcEEEEEEeecCCchhHHHHHHHHHHHHcc--CCCCeeeEeeeeecC--
Q 010513 179 RELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV--RHKNLVRLLGYCAEG-- 254 (508)
Q Consensus 179 ~~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~hpniv~l~~~~~~~-- 254 (508)
.......++|++.+.||+|+||.||+|++. ++.||||++.... ...+..|.+++..+ +||||+++++++.+.
T Consensus 30 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~ 105 (337)
T 3mdy_A 30 LVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKGTG 105 (337)
T ss_dssp HHHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCG
T ss_pred ccccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCC
Confidence 333455578999999999999999999986 8899999985432 33444556666554 899999999999877
Q ss_pred --CeeEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----CCCeeeccCCCCCEEEcCCCC
Q 010513 255 --AHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGL-----EPKVVHRDIKSSNILLDKQWN 327 (508)
Q Consensus 255 --~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~-----~~~iiHrDlkp~NIll~~~~~ 327 (508)
...++||||+++|+|.++++.. .+++..++.++.|++.||+|||++. +++|+||||||+|||++.++.
T Consensus 106 ~~~~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~ 180 (337)
T 3mdy_A 106 SWTQLYLITDYHENGSLYDYLKST-----TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGT 180 (337)
T ss_dssp GGCEEEEEECCCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSC
T ss_pred CCCceEEEEeccCCCcHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCC
Confidence 6889999999999999999754 6899999999999999999999752 347999999999999999999
Q ss_pred eEEeeeccceecCCCCcce---ecceecCCCCCChhhhhcCCCCCC------CCeeehHHHHHHHHhC----------CC
Q 010513 328 PKLSDFGLAKLLGAERSYV---TTRVMGTFGYVAPEYASTGMLNER------SDVYSFGILIMEVISG----------RN 388 (508)
Q Consensus 328 ~kL~DFG~a~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~------sDvwSlGvvl~elltg----------~~ 388 (508)
+||+|||+++......... .....||+.|+|||++.+..++.. +|||||||++|||+|| +.
T Consensus 181 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~ 260 (337)
T 3mdy_A 181 CCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQL 260 (337)
T ss_dssp EEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCC
T ss_pred EEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccc
Confidence 9999999998764433221 224579999999999988777776 9999999999999999 66
Q ss_pred CCCCCCCCCcchHHHHHHHhhcccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010513 389 PVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (508)
Q Consensus 389 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~~ 462 (508)
||....+.... ....................... .....++.+++.+||+.||++||++.+++++|+..
T Consensus 261 p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l 329 (337)
T 3mdy_A 261 PYHDLVPSDPS--YEDMREIVCIKKLRPSFPNRWSS---DECLRQMGKLMTECWAHNPASRLTALRVKKTLAKM 329 (337)
T ss_dssp TTTTTSCSSCC--HHHHHHHHTTSCCCCCCCGGGGG---SHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred cHhhhcCCCCc--hhhhHHHHhhhccCccccccchh---hHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHH
Confidence 66544332211 12222222222111111111111 23455566688899999999999999999999864
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-44 Score=359.92 Aligned_cols=252 Identities=24% Similarity=0.343 Sum_probs=199.4
Q ss_pred CCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCchhHHHHHHHHHHHHcc-CCCCeeeEeeeeecCCeeEEEEE
Q 010513 185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYE 262 (508)
Q Consensus 185 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lV~e 262 (508)
.++|++.+.||+|+||+||+|..+ +++.||+|.+.+.... ..+|++++.++ +||||+++++++.++...|+|||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E 96 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTE 96 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEe
Confidence 347999999999999999999976 5888999999765433 34578888887 79999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCC----CCeEEeeecccee
Q 010513 263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQ----WNPKLSDFGLAKL 338 (508)
Q Consensus 263 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~----~~~kL~DFG~a~~ 338 (508)
|+++|+|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+|||+.++ +.+||+|||+++.
T Consensus 97 ~~~gg~L~~~i~~~----~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~ 169 (342)
T 2qr7_A 97 LMKGGELLDKILRQ----KFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQ 169 (342)
T ss_dssp CCCSCBHHHHHHTC----TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred CCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence 99999999999765 4699999999999999999999999 99999999999998443 3499999999987
Q ss_pred cCCCCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCC
Q 010513 339 LGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVL 418 (508)
Q Consensus 339 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 418 (508)
...... .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||........ .+.+..... ...
T Consensus 170 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~---~~~~~~i~~-~~~---- 240 (342)
T 2qr7_A 170 LRAENG-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTP---EEILARIGS-GKF---- 240 (342)
T ss_dssp CBCTTC-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCH---HHHHHHHHH-CCC----
T ss_pred CcCCCC-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCH---HHHHHHHcc-CCc----
Confidence 644332 23446899999999999888899999999999999999999999975432222 222222211 111
Q ss_pred CccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 419 DPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 419 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
.+..........++.+++.+||+.||++||++.+++++
T Consensus 241 --~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h 278 (342)
T 2qr7_A 241 --SLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH 278 (342)
T ss_dssp --CCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred --ccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 01111111122344557889999999999999999864
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-43 Score=348.63 Aligned_cols=262 Identities=23% Similarity=0.358 Sum_probs=198.1
Q ss_pred cCCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecC---CchhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEE
Q 010513 184 STNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN---RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRML 259 (508)
Q Consensus 184 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 259 (508)
..++|++.+.||+|+||.||+|... +++.||+|++... .....+.+.+|+++++.++||||+++++++.+.+..++
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 109 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI 109 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEE
Confidence 3457999999999999999999974 6889999998653 23445678899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceec
Q 010513 260 VYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL 339 (508)
Q Consensus 260 V~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~ 339 (508)
||||+++|+|.+++.........+++..++.++.|++.||.|||++ +++||||||+||+++.++.+||+|||++...
T Consensus 110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~ 186 (310)
T 2wqm_A 110 VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFF 186 (310)
T ss_dssp EEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC------
T ss_pred EEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeee
Confidence 9999999999999875322346789999999999999999999999 9999999999999999999999999999866
Q ss_pred CCCCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCC
Q 010513 340 GAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLD 419 (508)
Q Consensus 340 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 419 (508)
.... .......|++.|+|||.+.+..++.++||||||+++|+|++|+.||..... +......... ....
T Consensus 187 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~~-~~~~----- 255 (310)
T 2wqm_A 187 SSKT-TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLYSLCKKIE-QCDY----- 255 (310)
T ss_dssp -------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---C----CHHHHHHHHH-TTCS-----
T ss_pred cCCC-ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch----hHHHHHHHhh-cccC-----
Confidence 4332 223345789999999999999999999999999999999999999964322 1222222211 1111
Q ss_pred ccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010513 420 PRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (508)
Q Consensus 420 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~~ 462 (508)
+.......+.. +.+++.+||+.||++||++.+++++|+..
T Consensus 256 ~~~~~~~~~~~---l~~li~~~l~~dp~~Rps~~~il~~l~~l 295 (310)
T 2wqm_A 256 PPLPSDHYSEE---LRQLVNMCINPDPEKRPDVTYVYDVAKRM 295 (310)
T ss_dssp CCCCTTTSCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCcccccCHH---HHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 11111223333 44577799999999999999999999754
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-44 Score=354.98 Aligned_cols=258 Identities=25% Similarity=0.393 Sum_probs=195.4
Q ss_pred cCCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCc---hhHHHHHHHHHHHHccCCCCeeeEeeeeecCCe---
Q 010513 184 STNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG---QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAH--- 256 (508)
Q Consensus 184 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~--- 256 (508)
..++|++.+.||+|+||+||+|.+. +++.||+|++..... .....+.+|++++++++||||+++++++.....
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 89 (311)
T 3ork_A 10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 89 (311)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence 3568999999999999999999974 688899999866432 334578899999999999999999999876543
Q ss_pred -eEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeecc
Q 010513 257 -RMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGL 335 (508)
Q Consensus 257 -~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~ 335 (508)
.|+||||+++|+|.+++... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 90 ~~~lv~e~~~g~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~ 162 (311)
T 3ork_A 90 LPYIVMEYVDGVTLRDIVHTE----GPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGI 162 (311)
T ss_dssp EEEEEEECCCEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSC
T ss_pred ccEEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccC
Confidence 48999999999999999765 4689999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCcc--eecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccc
Q 010513 336 AKLLGAERSY--VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRN 413 (508)
Q Consensus 336 a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 413 (508)
++........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+..........
T Consensus 163 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~------~~~~~~~~~~~~ 236 (311)
T 3ork_A 163 ARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP------VSVAYQHVREDP 236 (311)
T ss_dssp C------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHCCC
T ss_pred cccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHhcCCC
Confidence 9876443222 22345799999999999999999999999999999999999999964322 222222222110
Q ss_pred cccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHH-HHHHHhc
Q 010513 414 AEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGH-VIHMLEA 461 (508)
Q Consensus 414 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e-vl~~Le~ 461 (508)
..+.......+ .++.+++.+||+.||++||++.+ +.+.|..
T Consensus 237 ----~~~~~~~~~~~---~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 278 (311)
T 3ork_A 237 ----IPPSARHEGLS---ADLDAVVLKALAKNPENRYQTAAEMRADLVR 278 (311)
T ss_dssp ----CCHHHHSTTCC---HHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred ----CCcccccCCCC---HHHHHHHHHHHhcCHhhChhhHHHHHHHHHH
Confidence 11111111122 34555888999999999996555 4455544
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=343.76 Aligned_cols=250 Identities=22% Similarity=0.291 Sum_probs=203.9
Q ss_pred CCCcccceEcccCcEEEEEEEECC-CcEEEEEEeecCCchhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEEec
Q 010513 186 NGFADENVIGEGGYGIVYHGVLED-NTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYI 264 (508)
Q Consensus 186 ~~~~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~ 264 (508)
++|++.+.||+|+||+||+|.+.. +..||+|++........+.+.+|++++++++||||+++++++.++...++||||+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 88 (277)
T 3f3z_A 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELC 88 (277)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEecc
Confidence 479999999999999999999764 6789999998766666788999999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEE---cCCCCeEEeeeccceecCC
Q 010513 265 DNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILL---DKQWNPKLSDFGLAKLLGA 341 (508)
Q Consensus 265 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll---~~~~~~kL~DFG~a~~~~~ 341 (508)
++++|.+++... ..+++..++.++.|++.||+|||++ +|+||||||+||++ +.++.+||+|||++.....
T Consensus 89 ~~~~L~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~ 161 (277)
T 3f3z_A 89 TGGELFERVVHK----RVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP 161 (277)
T ss_dssp CSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCT
T ss_pred CCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccceeccC
Confidence 999999998765 4689999999999999999999999 99999999999999 7888999999999987644
Q ss_pred CCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCCcc
Q 010513 342 ERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPR 421 (508)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 421 (508)
.. ......||+.|+|||.+.+. ++.++||||||+++|||++|+.||..... .+......... . .
T Consensus 162 ~~--~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~------~~~~~~~~~~~-~------~ 225 (277)
T 3f3z_A 162 GK--MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTD------SEVMLKIREGT-F------T 225 (277)
T ss_dssp TS--CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCC-C------C
T ss_pred cc--chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCH------HHHHHHHHhCC-C------C
Confidence 32 23345799999999998654 89999999999999999999999964321 11111111110 0 0
Q ss_pred CCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 422 LQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 422 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
............+.+++.+||+.||++||++.+++++
T Consensus 226 ~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h 262 (277)
T 3f3z_A 226 FPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEH 262 (277)
T ss_dssp CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred CCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000000122345568889999999999999999863
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-44 Score=362.75 Aligned_cols=207 Identities=24% Similarity=0.314 Sum_probs=181.7
Q ss_pred cchhhHhhcCCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCchhHHHHHHHHHHHHccC-----CCCeeeEee
Q 010513 176 YTLRELEVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVR-----HKNLVRLLG 249 (508)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----hpniv~l~~ 249 (508)
+.+++..+..++|++.+.||+|+||+||+|++. +++.||||++... ....+.+..|+++++.++ ||||+++++
T Consensus 25 ~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~ 103 (360)
T 3llt_A 25 FSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYHG 103 (360)
T ss_dssp CCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEE
T ss_pred eeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecccc
Confidence 345666778889999999999999999999975 6888999998643 344566778999999986 999999999
Q ss_pred eeecCCeeEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcC-----
Q 010513 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDK----- 324 (508)
Q Consensus 250 ~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~----- 324 (508)
++...+..++||||+ +++|.+++.... ...+++..++.++.|++.||+|||++ +|+||||||+|||++.
T Consensus 104 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~ 177 (360)
T 3llt_A 104 KFMYYDHMCLIFEPL-GPSLYEIITRNN--YNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFEK 177 (360)
T ss_dssp EEEETTEEEEEECCC-CCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTTCCE
T ss_pred eeeECCeeEEEEcCC-CCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEccccccc
Confidence 999999999999999 889999997653 24689999999999999999999999 9999999999999975
Q ss_pred --------------------CCCeEEeeeccceecCCCCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHH
Q 010513 325 --------------------QWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVI 384 (508)
Q Consensus 325 --------------------~~~~kL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ell 384 (508)
++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||+
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell 253 (360)
T 3llt_A 178 SLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELY 253 (360)
T ss_dssp EEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHH
T ss_pred cccchhcccccccccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHH
Confidence 788999999999865332 23457899999999999999999999999999999999
Q ss_pred hCCCCCCCC
Q 010513 385 SGRNPVDYS 393 (508)
Q Consensus 385 tg~~Pf~~~ 393 (508)
+|+.||...
T Consensus 254 ~g~~pf~~~ 262 (360)
T 3llt_A 254 TGSLLFRTH 262 (360)
T ss_dssp HSSCSCCCS
T ss_pred HCCCCCCCC
Confidence 999999754
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-44 Score=352.75 Aligned_cols=264 Identities=23% Similarity=0.404 Sum_probs=205.6
Q ss_pred hcCCCCcccceEcccCcEEEEEEEE-----CCCcEEEEEEeecCC-chhHHHHHHHHHHHHccCCCCeeeEeeeeecC--
Q 010513 183 VSTNGFADENVIGEGGYGIVYHGVL-----EDNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEG-- 254 (508)
Q Consensus 183 ~~~~~~~~~~~LG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-- 254 (508)
+..+.|++.+.||+|+||.||+|++ .+++.||+|++.... ....+.+.+|+++++.++||||+++++++.+.
T Consensus 18 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 97 (302)
T 4e5w_A 18 FEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGG 97 (302)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---
T ss_pred hhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCC
Confidence 3445689999999999999999984 357889999986443 33457789999999999999999999999876
Q ss_pred CeeEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeec
Q 010513 255 AHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFG 334 (508)
Q Consensus 255 ~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG 334 (508)
...++||||+++|+|.+++... ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||
T Consensus 98 ~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg 171 (302)
T 4e5w_A 98 NGIKLIMEFLPSGSLKEYLPKN---KNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFG 171 (302)
T ss_dssp CCEEEEEECCTTCBHHHHHHHH---TTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCT
T ss_pred ceEEEEEEeCCCCcHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECccc
Confidence 6689999999999999999665 35699999999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCcc--eecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCC--------CCCcchHHHH
Q 010513 335 LAKLLGAERSY--VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSR--------PPGEVNLVEW 404 (508)
Q Consensus 335 ~a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~--------~~~~~~~~~~ 404 (508)
++......... ......||..|+|||.+.+..++.++|||||||++|||++|..|+.... +.........
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 251 (302)
T 4e5w_A 172 LTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTR 251 (302)
T ss_dssp TCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHH
T ss_pred ccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHH
Confidence 99877544332 2234568888999999999999999999999999999999999864321 1111111111
Q ss_pred HHHhhcccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 010513 405 LKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461 (508)
Q Consensus 405 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~ 461 (508)
+........ ..... ...+ ..+.+++.+||+.||++||++.++++.|++
T Consensus 252 ~~~~~~~~~-----~~~~~-~~~~---~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 299 (302)
T 4e5w_A 252 LVNTLKEGK-----RLPCP-PNCP---DEVYQLMRKCWEFQPSNRTSFQNLIEGFEA 299 (302)
T ss_dssp HHHHHHTTC-----CCCCC-TTCC---HHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHhccC-----CCCCC-CCCC---HHHHHHHHHHcCCCCCCCCCHHHHHHHHHH
Confidence 111111111 00111 1123 345558889999999999999999999975
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=354.23 Aligned_cols=266 Identities=22% Similarity=0.365 Sum_probs=189.9
Q ss_pred CCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCc-hhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEE
Q 010513 185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE 262 (508)
Q Consensus 185 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e 262 (508)
.++|++.+.||+|+||+||+|... +++.||+|.+..... ...+.+.+|+++++.++||||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 457999999999999999999965 588999999865432 334678889999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCC--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecC
Q 010513 263 YIDNGNLEQWLHGDV--GPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG 340 (508)
Q Consensus 263 ~~~~g~L~~~l~~~~--~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 340 (508)
|++ |+|.+++.... .....+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 998 59999986532 1224589999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCcceecceecCCCCCChhhhhc-CCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccc---cc-
Q 010513 341 AERSYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRN---AE- 415 (508)
Q Consensus 341 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~---~~- 415 (508)
.... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... .....+........ ..
T Consensus 160 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~~i~~~~~~~~~~~~~~ 235 (317)
T 2pmi_A 160 IPVN-TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDE---EQLKLIFDIMGTPNESLWPS 235 (317)
T ss_dssp SCCC-CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCSCCTTTCGG
T ss_pred CCcc-cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhCCCChhHhhh
Confidence 3322 2334578999999999876 46899999999999999999999999754321 11111111111000 00
Q ss_pred ----cCCCccCCCC---ch---------HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 416 ----GVLDPRLQEK---PC---------SRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 416 ----~~~~~~l~~~---~~---------~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
....+.+... .. .....++.+++.+||+.||++||++.|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 236 VTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp GGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 0000000000 00 0112345668889999999999999999864
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=361.75 Aligned_cols=206 Identities=19% Similarity=0.231 Sum_probs=178.8
Q ss_pred cCCCCcccceEccc--CcEEEEEEEEC-CCcEEEEEEeecCC--chhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeE
Q 010513 184 STNGFADENVIGEG--GYGIVYHGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM 258 (508)
Q Consensus 184 ~~~~~~~~~~LG~G--~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 258 (508)
..++|++.+.||+| +||+||+|++. +++.||||++.... ....+.+.+|+++++.++||||+++++++.+++..|
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 102 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW 102 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEE
Confidence 34579999999999 99999999987 68899999996543 334567888999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeecccee
Q 010513 259 LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL 338 (508)
Q Consensus 259 lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~ 338 (508)
+||||+++|+|.+++.... ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||.+..
T Consensus 103 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~ 177 (389)
T 3gni_B 103 VVTSFMAYGSAKDLICTHF--MDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLS 177 (389)
T ss_dssp EEEECCTTCBHHHHHHHTC--TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred EEEEccCCCCHHHHHhhhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEccccccee
Confidence 9999999999999997652 35689999999999999999999999 999999999999999999999999999875
Q ss_pred cCCCCc------ceecceecCCCCCChhhhhc--CCCCCCCCeeehHHHHHHHHhCCCCCCCCC
Q 010513 339 LGAERS------YVTTRVMGTFGYVAPEYAST--GMLNERSDVYSFGILIMEVISGRNPVDYSR 394 (508)
Q Consensus 339 ~~~~~~------~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlGvvl~elltg~~Pf~~~~ 394 (508)
...... ......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 178 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 241 (389)
T 3gni_B 178 MISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMP 241 (389)
T ss_dssp CEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred eccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCC
Confidence 422111 11223478999999999987 579999999999999999999999997644
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=354.55 Aligned_cols=263 Identities=25% Similarity=0.446 Sum_probs=210.2
Q ss_pred HhhcCCCCcccceEcccCcEEEEEEEEC--------CCcEEEEEEeecCC-chhHHHHHHHHHHHHcc-CCCCeeeEeee
Q 010513 181 LEVSTNGFADENVIGEGGYGIVYHGVLE--------DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRV-RHKNLVRLLGY 250 (508)
Q Consensus 181 ~~~~~~~~~~~~~LG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~l~~~ 250 (508)
+++..++|++.+.||+|+||+||+|.+. ++..||+|.+.... ....+.+.+|+++++.+ +||||++++++
T Consensus 30 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 109 (334)
T 2pvf_A 30 WEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGA 109 (334)
T ss_dssp TBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEE
Confidence 3566789999999999999999999863 46679999987553 33456788999999999 89999999999
Q ss_pred eecCCeeEEEEEecCCCCHHHHhccCCCC------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCC
Q 010513 251 CAEGAHRMLVYEYIDNGNLEQWLHGDVGP------------HSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSS 318 (508)
Q Consensus 251 ~~~~~~~~lV~e~~~~g~L~~~l~~~~~~------------~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~ 318 (508)
+.+.+..++||||+++|+|.+++...... ...+++..++.++.|++.||+|||++ +|+||||||+
T Consensus 110 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~ 186 (334)
T 2pvf_A 110 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAAR 186 (334)
T ss_dssp ECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGG
T ss_pred EccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccc
Confidence 99999999999999999999999765321 23489999999999999999999999 9999999999
Q ss_pred CEEEcCCCCeEEeeeccceecCCCCcce-ecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHh-CCCCCCCCCCC
Q 010513 319 NILLDKQWNPKLSDFGLAKLLGAERSYV-TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPP 396 (508)
Q Consensus 319 NIll~~~~~~kL~DFG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~Pf~~~~~~ 396 (508)
|||++.++.+||+|||+++......... .....+|+.|+|||++.+..++.++|||||||++|||++ |+.||....
T Consensus 187 NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~-- 264 (334)
T 2pvf_A 187 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP-- 264 (334)
T ss_dssp GEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC--
T ss_pred eEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCC--
Confidence 9999999999999999998765433222 233467889999999999999999999999999999999 999996432
Q ss_pred CcchHHHHHHHhhcccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010513 397 GEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (508)
Q Consensus 397 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~~ 462 (508)
..+.......... +... ..++. ++.+++.+||+.||++||++.++++.|+..
T Consensus 265 ----~~~~~~~~~~~~~------~~~~-~~~~~---~l~~li~~~l~~dp~~Rps~~ell~~L~~l 316 (334)
T 2pvf_A 265 ----VEELFKLLKEGHR------MDKP-ANCTN---ELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316 (334)
T ss_dssp ----HHHHHHHHHHTCC------CCCC-TTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----HHHHHHHHhcCCC------CCCC-ccCCH---HHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 1121111111110 1111 11233 345578899999999999999999999864
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-44 Score=351.09 Aligned_cols=257 Identities=25% Similarity=0.423 Sum_probs=203.5
Q ss_pred hhcCCCCcccceEcccCcEEEEEEEECC----CcEEEEEEeecC-CchhHHHHHHHHHHHHccCCCCeeeEeeeeecCCe
Q 010513 182 EVSTNGFADENVIGEGGYGIVYHGVLED----NTNVAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAH 256 (508)
Q Consensus 182 ~~~~~~~~~~~~LG~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 256 (508)
.+..++|++.+.||+|+||+||+|.+.. +..||+|.+... .....+.+.+|+++++.++||||+++++++.+ +.
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~ 86 (281)
T 3cc6_A 8 GIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EP 86 (281)
T ss_dssp SCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SS
T ss_pred eecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CC
Confidence 3456789999999999999999998643 235999998765 33455778999999999999999999999876 45
Q ss_pred eEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccc
Q 010513 257 RMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLA 336 (508)
Q Consensus 257 ~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a 336 (508)
.++||||+++++|.+++... ...+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 87 ~~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 160 (281)
T 3cc6_A 87 TWIIMELYPYGELGHYLERN---KNSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLS 160 (281)
T ss_dssp CEEEEECCTTCBHHHHHHHH---TTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGG
T ss_pred CEEEEecCCCCCHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCC
Confidence 68999999999999999765 35689999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHhhcccccc
Q 010513 337 KLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAE 415 (508)
Q Consensus 337 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (508)
...............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...... .....+.. ...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~---~~~~~~~~---~~~-- 232 (281)
T 3cc6_A 161 RYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENK---DVIGVLEK---GDR-- 232 (281)
T ss_dssp GCC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGG---GHHHHHHH---TCC--
T ss_pred cccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChH---HHHHHHhc---CCC--
Confidence 8765444333444567889999999999999999999999999999998 99999754322 22222211 110
Q ss_pred cCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 010513 416 GVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461 (508)
Q Consensus 416 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~ 461 (508)
.. .....+.. +.+++.+||+.||++||++.+++++|+.
T Consensus 233 ----~~-~~~~~~~~---l~~li~~~l~~~p~~Rps~~ell~~L~~ 270 (281)
T 3cc6_A 233 ----LP-KPDLCPPV---LYTLMTRCWDYDPSDRPRFTELVCSLSD 270 (281)
T ss_dssp ----CC-CCTTCCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ----CC-CCCCCCHH---HHHHHHHHccCCchhCcCHHHHHHHHHH
Confidence 00 01113333 4457789999999999999999999975
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-44 Score=372.63 Aligned_cols=252 Identities=22% Similarity=0.271 Sum_probs=196.2
Q ss_pred hhcCCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecC---CchhHHHHHHHHHHHHccCCCCeeeEeeeeecCCee
Q 010513 182 EVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN---RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHR 257 (508)
Q Consensus 182 ~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 257 (508)
.+..++|++.+.||+|+||.||+|... +++.||+|++... .......+.+|+++++.++||||+++++++.+.+..
T Consensus 144 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~ 223 (446)
T 4ejn_A 144 RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRL 223 (446)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEE
T ss_pred CCChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEE
Confidence 345568999999999999999999975 5889999998653 223345677899999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeeccCCCCCEEEcCCCCeEEeeeccc
Q 010513 258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE-GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLA 336 (508)
Q Consensus 258 ~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a 336 (508)
|+||||+++|+|.+++... ..+++..+..++.|++.||+|||+ + +|+||||||+|||++.++.+||+|||++
T Consensus 224 ~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a 296 (446)
T 4ejn_A 224 CFVMEYANGGELFFHLSRE----RVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLC 296 (446)
T ss_dssp EEEECCCSSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCC
T ss_pred EEEEeeCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCc
Confidence 9999999999999999765 478999999999999999999998 7 9999999999999999999999999999
Q ss_pred eecCCCCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhccccccc
Q 010513 337 KLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEG 416 (508)
Q Consensus 337 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 416 (508)
+..... .......+||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+.........
T Consensus 297 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~------~~~~~~i~~~~---- 365 (446)
T 4ejn_A 297 KEGIKD-GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH------EKLFELILMEE---- 365 (446)
T ss_dssp CTTCC------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCC----
T ss_pred eeccCC-CcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH------HHHHHHHHhCC----
Confidence 854322 2233457899999999999999999999999999999999999999964321 12222222111
Q ss_pred CCCccCCCCchHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 010513 417 VLDPRLQEKPCSRALKRALLVALRCVDPNAHKRP-----KMGHVIHM 458 (508)
Q Consensus 417 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 458 (508)
..+.. ..+. ++.+++.+||+.||++|| ++.|++++
T Consensus 366 ---~~~p~-~~~~---~~~~li~~~L~~dP~~R~~~~~~t~~ell~h 405 (446)
T 4ejn_A 366 ---IRFPR-TLGP---EAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH 405 (446)
T ss_dssp ---CCCCT-TSCH---HHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred ---CCCCc-cCCH---HHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence 01111 1223 345578899999999999 99999863
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=352.63 Aligned_cols=262 Identities=24% Similarity=0.330 Sum_probs=199.3
Q ss_pred CCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCc--hhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEE
Q 010513 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG--QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE 262 (508)
Q Consensus 186 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e 262 (508)
++|++.+.||+|+||+||+|.+. +++.||+|++..... ...+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 57999999999999999999986 488999999865433 234668889999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCC
Q 010513 263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE 342 (508)
Q Consensus 263 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 342 (508)
|+++++|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++......
T Consensus 83 ~~~~~~l~~~~~~~----~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 155 (311)
T 4agu_A 83 YCDHTVLHELDRYQ----RGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGP 155 (311)
T ss_dssp CCSEEHHHHHHHTS----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred eCCCchHHHHHhhh----cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCc
Confidence 99999999988754 4689999999999999999999999 9999999999999999999999999999876433
Q ss_pred CcceecceecCCCCCChhhhhc-CCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhc-----------
Q 010513 343 RSYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVT----------- 410 (508)
Q Consensus 343 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~----------- 410 (508)
.. ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||........ ...+.....
T Consensus 156 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 231 (311)
T 4agu_A 156 SD-YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQ---LYLIRKTLGDLIPRHQQVFS 231 (311)
T ss_dssp -----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCSCCHHHHHHHH
T ss_pred cc-ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhcccccccccccc
Confidence 22 2344578999999999876 6789999999999999999999999975432211 111111110
Q ss_pred cc-ccc--cCCCccCCCCc---hHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 411 NR-NAE--GVLDPRLQEKP---CSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 411 ~~-~~~--~~~~~~l~~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
.. ... ...++...... .+.....+.+++.+||+.||++|||+.|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 232 TNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp TCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred cccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 00 000 01111100000 01123345668889999999999999999965
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-43 Score=341.44 Aligned_cols=254 Identities=19% Similarity=0.328 Sum_probs=205.1
Q ss_pred hcCCCCcccceEcccCcEEEEEEEECCCcEEEEEEeecCC--chhHHHHHHHHHHHHccCCCCeeeEeeeeecC--CeeE
Q 010513 183 VSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEG--AHRM 258 (508)
Q Consensus 183 ~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--~~~~ 258 (508)
+..++|++.+.||+|+||+||+|+++ ++.||+|.+.... ....+.+.+|++++++++||||+++++++.+. ...+
T Consensus 7 i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 85 (271)
T 3kmu_A 7 IDFKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPT 85 (271)
T ss_dssp CCGGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCE
T ss_pred CCHHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeE
Confidence 45568999999999999999999986 8889999986543 34456789999999999999999999999887 7789
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eeeccCCCCCEEEcCCCCeEEeeeccc
Q 010513 259 LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK--VVHRDIKSSNILLDKQWNPKLSDFGLA 336 (508)
Q Consensus 259 lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~--iiHrDlkp~NIll~~~~~~kL~DFG~a 336 (508)
+||||+++|+|.+++.... ...+++..++.++.|++.||+|||++ + ++||||||+||+++.++.++|+|||++
T Consensus 86 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~ 160 (271)
T 3kmu_A 86 LITHWMPYGSLYNVLHEGT--NFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVK 160 (271)
T ss_dssp EEEECCTTCBHHHHHHSCS--SCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSC
T ss_pred eeecccCCCcHHHHHhhcc--cCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEeccce
Confidence 9999999999999998652 23689999999999999999999998 8 999999999999999999999999887
Q ss_pred eecCCCCcceecceecCCCCCChhhhhcCCCCC---CCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccc
Q 010513 337 KLLGAERSYVTTRVMGTFGYVAPEYASTGMLNE---RSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRN 413 (508)
Q Consensus 337 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 413 (508)
.... .....||+.|+|||.+.+..++. ++|||||||++|||++|+.||.... ..+.........
T Consensus 161 ~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~------~~~~~~~~~~~~- 227 (271)
T 3kmu_A 161 FSFQ------SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLS------NMEIGMKVALEG- 227 (271)
T ss_dssp CTTS------CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSC------HHHHHHHHHHSC-
T ss_pred eeec------ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccC------hHHHHHHHHhcC-
Confidence 6432 22347899999999998766555 7999999999999999999997432 122222222211
Q ss_pred cccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 010513 414 AEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEE 463 (508)
Q Consensus 414 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~~~ 463 (508)
..+.+.. ..+.. +.+++.+||+.||++||++.++++.|+...
T Consensus 228 ----~~~~~~~-~~~~~---~~~li~~~l~~~p~~Rps~~~il~~L~~l~ 269 (271)
T 3kmu_A 228 ----LRPTIPP-GISPH---VSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269 (271)
T ss_dssp ----CCCCCCT-TCCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred ----CCCCCCC-CCCHH---HHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 1111111 13333 445777999999999999999999998643
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=351.76 Aligned_cols=260 Identities=21% Similarity=0.296 Sum_probs=199.1
Q ss_pred CCCccc-ceEcccCcEEEEEEEEC-CCcEEEEEEeecCCchhHHHHHHHHHHHHcc-CCCCeeeEeeeeecCCeeEEEEE
Q 010513 186 NGFADE-NVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYE 262 (508)
Q Consensus 186 ~~~~~~-~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lV~e 262 (508)
+.|.+. +.||+|+||+||+|... +++.||||++........+.+.+|++++.++ +||||+++++++.+++..++|||
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 91 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE 91 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence 467774 78999999999999965 6889999999776666677889999999985 79999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCC---eEEeeeccceec
Q 010513 263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWN---PKLSDFGLAKLL 339 (508)
Q Consensus 263 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~---~kL~DFG~a~~~ 339 (508)
|+++|+|.+++... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++. +||+|||++...
T Consensus 92 ~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~ 164 (316)
T 2ac3_A 92 KMRGGSILSHIHKR----RHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGI 164 (316)
T ss_dssp CCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred cCCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence 99999999999765 4689999999999999999999999 9999999999999988776 999999999865
Q ss_pred CCCCc------ceecceecCCCCCChhhhhc-----CCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcc--------h
Q 010513 340 GAERS------YVTTRVMGTFGYVAPEYAST-----GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEV--------N 400 (508)
Q Consensus 340 ~~~~~------~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~--------~ 400 (508)
..... ......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||......... .
T Consensus 165 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 244 (316)
T 2ac3_A 165 KLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPA 244 (316)
T ss_dssp -----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHH
T ss_pred ccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchh
Confidence 32211 11223569999999999875 56889999999999999999999999865432210 0
Q ss_pred HHHHHHHhhcccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 401 LVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 401 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
....+......... .+...........+.+++.+||+.||++||++.|++++
T Consensus 245 ~~~~~~~~i~~~~~------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 245 CQNMLFESIQEGKY------EFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp HHHHHHHHHHHCCC------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHHHHhccCc------ccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 01111111111110 00000001122345568889999999999999999975
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-44 Score=349.61 Aligned_cols=258 Identities=26% Similarity=0.448 Sum_probs=207.1
Q ss_pred hhcCCCCcccc-eEcccCcEEEEEEEEC---CCcEEEEEEeecCC-chhHHHHHHHHHHHHccCCCCeeeEeeeeecCCe
Q 010513 182 EVSTNGFADEN-VIGEGGYGIVYHGVLE---DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAH 256 (508)
Q Consensus 182 ~~~~~~~~~~~-~LG~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 256 (508)
.+..++|.+.+ .||+|+||.||+|.+. ++..||+|.+.... ....+.+.+|+++++.++||||+++++++. .+.
T Consensus 5 ~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~ 83 (287)
T 1u59_A 5 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-AEA 83 (287)
T ss_dssp BCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSS
T ss_pred cccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEec-CCC
Confidence 34556777776 9999999999999864 57789999987643 345677899999999999999999999994 566
Q ss_pred eEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccc
Q 010513 257 RMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLA 336 (508)
Q Consensus 257 ~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a 336 (508)
.++||||+++++|.+++... ...+++..++.++.|++.||.|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 84 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~ 157 (287)
T 1u59_A 84 LMLVMEMAGGGPLHKFLVGK---REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLS 157 (287)
T ss_dssp EEEEEECCTTEEHHHHHTTC---TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTC
T ss_pred cEEEEEeCCCCCHHHHHHhC---CccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccce
Confidence 89999999999999999754 35699999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCcce--ecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHhhcccc
Q 010513 337 KLLGAERSYV--TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRN 413 (508)
Q Consensus 337 ~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 413 (508)
.......... .....||+.|+|||++.+..++.++|||||||++|||++ |+.||...... ..... .....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~~~~~----i~~~~ 230 (287)
T 1u59_A 158 KALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---EVMAF----IEQGK 230 (287)
T ss_dssp EECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH---HHHHH----HHTTC
T ss_pred eeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH---HHHHH----HhcCC
Confidence 8775443322 223456889999999998899999999999999999998 99999754321 11111 11111
Q ss_pred cccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010513 414 AEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (508)
Q Consensus 414 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~~ 462 (508)
.+... ...+. ++.+++.+||+.||++||++.+++++|++.
T Consensus 231 -----~~~~~-~~~~~---~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 270 (287)
T 1u59_A 231 -----RMECP-PECPP---ELYALMSDCWIYKWEDRPDFLTVEQRMRAC 270 (287)
T ss_dssp -----CCCCC-TTCCH---HHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----cCCCC-CCcCH---HHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 01111 11333 444577899999999999999999999864
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=376.26 Aligned_cols=257 Identities=23% Similarity=0.297 Sum_probs=208.9
Q ss_pred hhcCCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCC---chhHHHHHHHHHHHHccCCCCeeeEeeeeecCCee
Q 010513 182 EVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHR 257 (508)
Q Consensus 182 ~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 257 (508)
.+..++|++.+.||+|+||.||+|... +|+.||+|++.+.. ......+.+|+++++.++||||+++++++.+.+..
T Consensus 180 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l 259 (576)
T 2acx_A 180 PVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDAL 259 (576)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred CccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEE
Confidence 466778999999999999999999976 68899999986532 23345678899999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccce
Q 010513 258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK 337 (508)
Q Consensus 258 ~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~ 337 (508)
|+||||++||+|.+++.... ...+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 260 ~lVmEy~~gg~L~~~l~~~~--~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~ 334 (576)
T 2acx_A 260 CLVLTLMNGGDLKFHIYHMG--QAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAV 334 (576)
T ss_dssp EEEECCCCSCBHHHHHHSSS--SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEEcCCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccce
Confidence 99999999999999997652 24589999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccC
Q 010513 338 LLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGV 417 (508)
Q Consensus 338 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 417 (508)
...... .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||.......... +.... ....
T Consensus 335 ~~~~~~--~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~--~i~~~-i~~~----- 404 (576)
T 2acx_A 335 HVPEGQ--TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKRE--EVERL-VKEV----- 404 (576)
T ss_dssp ECCTTC--CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHH--HHHHH-HHHC-----
T ss_pred ecccCc--cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHH--HHHHH-hhcc-----
Confidence 764332 2334589999999999999899999999999999999999999998654322211 11111 1111
Q ss_pred CCccCCCCchHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 010513 418 LDPRLQEKPCSRALKRALLVALRCVDPNAHKRP-----KMGHVIHM 458 (508)
Q Consensus 418 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 458 (508)
...+. ...+ .++.+++.+||+.||++|| ++.|++++
T Consensus 405 -~~~~p-~~~s---~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 405 -PEEYS-ERFS---PQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp -CCCCC-TTSC---HHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred -cccCC-ccCC---HHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 01111 1122 3445588899999999999 78998864
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=344.27 Aligned_cols=249 Identities=27% Similarity=0.418 Sum_probs=201.0
Q ss_pred hcCCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCC---chhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeE
Q 010513 183 VSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM 258 (508)
Q Consensus 183 ~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 258 (508)
...++|++.+.||+|+||+||+|.+. ++..||+|.+.... ......+.+|+++++.++||||+++++++.+....+
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 85 (279)
T 3fdn_A 6 WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVY 85 (279)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred eecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEE
Confidence 34568999999999999999999976 46789999986542 223467889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeecccee
Q 010513 259 LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL 338 (508)
Q Consensus 259 lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~ 338 (508)
+||||+++|+|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++..
T Consensus 86 lv~e~~~~~~l~~~l~~~----~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~ 158 (279)
T 3fdn_A 86 LILEYAPLGTVYRELQKL----SKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVH 158 (279)
T ss_dssp EEECCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESC
T ss_pred EEEecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEecccccc
Confidence 999999999999999765 4689999999999999999999998 999999999999999999999999999865
Q ss_pred cCCCCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCC
Q 010513 339 LGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVL 418 (508)
Q Consensus 339 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 418 (508)
.... ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||.... ..+.........
T Consensus 159 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~------~~~~~~~~~~~~------ 223 (279)
T 3fdn_A 159 APSS---RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT------YQETYKRISRVE------ 223 (279)
T ss_dssp C-----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS------HHHHHHHHHHTC------
T ss_pred CCcc---cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCc------HHHHHHHHHhCC------
Confidence 4322 2344579999999999999999999999999999999999999997432 112222211110
Q ss_pred CccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 419 DPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 419 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
..+. ...+. .+.+++.+||+.||++||++.|++++
T Consensus 224 -~~~~-~~~~~---~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 224 -FTFP-DFVTE---GARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp -CCCC-TTSCH---HHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred -CCCC-CcCCH---HHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0111 11233 34457789999999999999999975
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-44 Score=356.40 Aligned_cols=258 Identities=25% Similarity=0.437 Sum_probs=201.9
Q ss_pred hcCCCCcccceEcccCcEEEEEEEEC-CCcE----EEEEEeecCC-chhHHHHHHHHHHHHccCCCCeeeEeeeeecCCe
Q 010513 183 VSTNGFADENVIGEGGYGIVYHGVLE-DNTN----VAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAH 256 (508)
Q Consensus 183 ~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~----vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 256 (508)
+..++|++.+.||+|+||+||+|.+. +++. ||+|.+.... ......+.+|+.+++.++||||+++++++.+ ..
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~ 88 (325)
T 3kex_A 10 FKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG-SS 88 (325)
T ss_dssp CCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEECB-SS
T ss_pred cCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-Cc
Confidence 34568999999999999999999975 3443 7777764432 2333567789999999999999999999874 56
Q ss_pred eEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccc
Q 010513 257 RMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLA 336 (508)
Q Consensus 257 ~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a 336 (508)
.++||||+++|+|.+++... ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 89 ~~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a 162 (325)
T 3kex_A 89 LQLVTQYLPLGSLLDHVRQH---RGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVA 162 (325)
T ss_dssp EEEEEECCTTCBSHHHHHSS---GGGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGG
T ss_pred cEEEEEeCCCCCHHHHHHHc---cccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCcc
Confidence 88999999999999999765 35788999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCcc-eecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHhhccccc
Q 010513 337 KLLGAERSY-VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNA 414 (508)
Q Consensus 337 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 414 (508)
+........ ......||+.|+|||.+.+..++.++|||||||++|||++ |+.||...... ...+.+ ....
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~~~~----~~~~- 234 (325)
T 3kex_A 163 DLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLA---EVPDLL----EKGE- 234 (325)
T ss_dssp GGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTT---HHHHHH----HTTC-
T ss_pred cccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHH---HHHHHH----HcCC-
Confidence 876543322 2344578889999999999999999999999999999999 99999765432 111111 1111
Q ss_pred ccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 010513 415 EGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEE 463 (508)
Q Consensus 415 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~~~ 463 (508)
....+ ..++. ++.+++.+||+.||++||++.+++++|+...
T Consensus 235 -~~~~~----~~~~~---~~~~li~~~l~~dp~~Rps~~el~~~l~~~~ 275 (325)
T 3kex_A 235 -RLAQP----QICTI---DVYMVMVKCWMIDENIRPTFKELANEFTRMA 275 (325)
T ss_dssp -BCCCC----TTBCT---TTTHHHHHHTCSCTTTSCCHHHHHHHHHHHT
T ss_pred -CCCCC----CcCcH---HHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 00011 11122 2344888999999999999999999998653
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=349.89 Aligned_cols=256 Identities=29% Similarity=0.484 Sum_probs=197.4
Q ss_pred cCCCCcccceEcccCcEEEEEEEECCCcEEEEEEeecCCchhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEEe
Q 010513 184 STNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY 263 (508)
Q Consensus 184 ~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~ 263 (508)
..++|++.+.||+|+||+||+|.+. ++.||+|++... ...+.+.+|++++++++||||+++++++.+ ..++||||
T Consensus 6 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~ 80 (307)
T 2eva_A 6 DYKEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEY 80 (307)
T ss_dssp CGGGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEEC
T ss_pred CHhHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEc
Confidence 3457899999999999999999986 788999988543 345678899999999999999999999874 47899999
Q ss_pred cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCC-eEEeeeccceecCCC
Q 010513 264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWN-PKLSDFGLAKLLGAE 342 (508)
Q Consensus 264 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~-~kL~DFG~a~~~~~~ 342 (508)
+++|+|.+++.... ....+++..++.++.|+++||+|||+....+|+||||||+|||++.++. +||+|||++......
T Consensus 81 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~ 159 (307)
T 2eva_A 81 AEGGSLYNVLHGAE-PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH 159 (307)
T ss_dssp CTTCBHHHHHHCSS-SEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-------
T ss_pred CCCCCHHHHHhccC-CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc
Confidence 99999999997652 2235789999999999999999999921128999999999999998887 799999999765322
Q ss_pred CcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCCccC
Q 010513 343 RSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRL 422 (508)
Q Consensus 343 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 422 (508)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ............ .+..
T Consensus 160 ----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~----~~~~~~~~~~~~------~~~~ 225 (307)
T 2eva_A 160 ----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGP----AFRIMWAVHNGT------RPPL 225 (307)
T ss_dssp ---------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSS----HHHHHHHHHTTC------CCCC
T ss_pred ----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCcc----HHHHHHHHhcCC------CCCc
Confidence 23346999999999999999999999999999999999999999754322 111111111111 1111
Q ss_pred CCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 010513 423 QEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEE 463 (508)
Q Consensus 423 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~~~ 463 (508)
.. ..+. .+.+++.+||+.||++||++.+++++|+...
T Consensus 226 ~~-~~~~---~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 262 (307)
T 2eva_A 226 IK-NLPK---PIESLMTRCWSKDPSQRPSMEEIVKIMTHLM 262 (307)
T ss_dssp BT-TCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHG
T ss_pred cc-ccCH---HHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence 11 1233 3445788999999999999999999998654
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=356.26 Aligned_cols=259 Identities=24% Similarity=0.295 Sum_probs=199.2
Q ss_pred cCCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecC-----CchhHHHHHHHHHHHHccCCCCeeeEeeeeecCCee
Q 010513 184 STNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN-----RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHR 257 (508)
Q Consensus 184 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 257 (508)
..++|++.+.||+|+||+||+|... ++..||+|.+... .....+.+.+|+++++.++||||+++++++.+.+..
T Consensus 24 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 103 (345)
T 3hko_A 24 LQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYI 103 (345)
T ss_dssp HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeE
Confidence 3458999999999999999999975 5778999998643 234557889999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhccCCCC------------------------------------CCCCCHHHHHHHHHHHHHHHHH
Q 010513 258 MLVYEYIDNGNLEQWLHGDVGP------------------------------------HSPLTWEIRMNIILGTAKGLTY 301 (508)
Q Consensus 258 ~lV~e~~~~g~L~~~l~~~~~~------------------------------------~~~l~~~~~~~i~~qi~~al~~ 301 (508)
++||||+++|+|.+++...... ...+++..++.++.|++.||+|
T Consensus 104 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~ 183 (345)
T 3hko_A 104 CLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHY 183 (345)
T ss_dssp EEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHH
Confidence 9999999999999998531100 1224677888999999999999
Q ss_pred HHhcCCCCeeeccCCCCCEEEcCCC--CeEEeeeccceecCCCC---cceecceecCCCCCChhhhhc--CCCCCCCCee
Q 010513 302 LHEGLEPKVVHRDIKSSNILLDKQW--NPKLSDFGLAKLLGAER---SYVTTRVMGTFGYVAPEYAST--GMLNERSDVY 374 (508)
Q Consensus 302 LH~~~~~~iiHrDlkp~NIll~~~~--~~kL~DFG~a~~~~~~~---~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvw 374 (508)
||++ +|+||||||+|||++.++ .+||+|||+++.+.... ........||+.|+|||++.+ ..++.++|||
T Consensus 184 LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diw 260 (345)
T 3hko_A 184 LHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAW 260 (345)
T ss_dssp HHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHH
T ss_pred HHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHH
Confidence 9999 999999999999998776 89999999998764322 222345679999999999875 6789999999
Q ss_pred ehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHH
Q 010513 375 SFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGH 454 (508)
Q Consensus 375 SlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e 454 (508)
||||++|||++|+.||..... .+.......... ....+ ........+.+++.+||+.||++||++.+
T Consensus 261 slG~il~el~~g~~pf~~~~~------~~~~~~~~~~~~--~~~~~-----~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 327 (345)
T 3hko_A 261 SAGVLLHLLLMGAVPFPGVND------ADTISQVLNKKL--CFENP-----NYNVLSPLARDLLSNLLNRNVDERFDAMR 327 (345)
T ss_dssp HHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCCC--CTTSG-----GGGGSCHHHHHHHHHHSCSCTTTSCCHHH
T ss_pred HHHHHHHHHHHCCCCCCCCCh------HHHHHHHHhccc--ccCCc-----ccccCCHHHHHHHHHHcCCChhHCCCHHH
Confidence 999999999999999964431 222222222111 00011 11112234555888999999999999999
Q ss_pred HHHH
Q 010513 455 VIHM 458 (508)
Q Consensus 455 vl~~ 458 (508)
++++
T Consensus 328 ~l~h 331 (345)
T 3hko_A 328 ALQH 331 (345)
T ss_dssp HHHS
T ss_pred HhcC
Confidence 9874
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=351.78 Aligned_cols=265 Identities=25% Similarity=0.343 Sum_probs=198.0
Q ss_pred hcCCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCC-----chhHHHHHHHHHHHHcc---CCCCeeeEeeeeec
Q 010513 183 VSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR-----GQAEKEFKVEVEAIGRV---RHKNLVRLLGYCAE 253 (508)
Q Consensus 183 ~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l---~hpniv~l~~~~~~ 253 (508)
+..++|++.+.||+|+||+||+|++. +++.||+|++.... ......+.+|+++++.+ +||||+++++++..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~ 85 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 85 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence 45679999999999999999999964 68899999986432 11234566677777766 49999999999987
Q ss_pred CC-----eeEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCe
Q 010513 254 GA-----HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNP 328 (508)
Q Consensus 254 ~~-----~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~ 328 (508)
.. ..++||||+.+ +|.+++.... ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+
T Consensus 86 ~~~~~~~~~~lv~e~~~~-~L~~~~~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~ 159 (308)
T 3g33_A 86 SRTDREIKVTLVFEHVDQ-DLRTYLDKAP--PPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTV 159 (308)
T ss_dssp CCSSSEEEEEEEEECCCC-BHHHHHHTCC--TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCE
T ss_pred cCCCCceeEEEEehhhhc-CHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCE
Confidence 55 57899999974 9999997753 23499999999999999999999999 99999999999999999999
Q ss_pred EEeeeccceecCCCCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHh
Q 010513 329 KLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTM 408 (508)
Q Consensus 329 kL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~ 408 (508)
||+|||+++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+...
T Consensus 160 kl~Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---~~~~~i~~~ 234 (308)
T 3g33_A 160 KLADFGLARIYSYQ--MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA---DQLGKIFDL 234 (308)
T ss_dssp EECSCSCTTTSTTC--CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHH---HHHHHHHHH
T ss_pred EEeeCccccccCCC--cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHH
Confidence 99999999865432 2234568999999999999999999999999999999999999999754321 111111111
Q ss_pred hcccc---ccc-------CCCccCCCC---chHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 409 VTNRN---AEG-------VLDPRLQEK---PCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 409 ~~~~~---~~~-------~~~~~l~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
..... ... ...+..... ..+.....+.+++.+||+.||++|||+.|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 235 IGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp HCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 11000 000 000000000 001122455668889999999999999999864
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-43 Score=349.97 Aligned_cols=251 Identities=24% Similarity=0.323 Sum_probs=204.8
Q ss_pred CCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCch------hHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeE
Q 010513 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQ------AEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM 258 (508)
Q Consensus 186 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 258 (508)
++|++.+.||+|+||.||+|... +++.||+|.+...... ..+.+.+|+++++.++||||+++++++.+....+
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (321)
T 2a2a_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVV 91 (321)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 47999999999999999999976 5889999998654321 3577899999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCC----CeEEeeec
Q 010513 259 LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQW----NPKLSDFG 334 (508)
Q Consensus 259 lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~----~~kL~DFG 334 (508)
+||||+++++|.+++... ..+++..++.++.|++.||+|||++ +|+||||||+||+++.++ .+||+|||
T Consensus 92 lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg 164 (321)
T 2a2a_A 92 LILELVSGGELFDFLAQK----ESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (321)
T ss_dssp EEECCCCSCBHHHHHHTC----SCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred EEEEcCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccCc
Confidence 999999999999999764 5689999999999999999999999 999999999999999888 79999999
Q ss_pred cceecCCCCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhccccc
Q 010513 335 LAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNA 414 (508)
Q Consensus 335 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 414 (508)
++....... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||..... .+.+.......
T Consensus 165 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~~~i~~~~-- 234 (321)
T 2a2a_A 165 LAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK------QETLANITSVS-- 234 (321)
T ss_dssp TCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH------HHHHHHHHTTC--
T ss_pred cceecCccc--cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHHhcc--
Confidence 998764432 22345799999999999999999999999999999999999999964321 12222211110
Q ss_pred ccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 415 EGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 415 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
...++.. .......+.+++.+||+.||++||++.+++++
T Consensus 235 -~~~~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 235 -YDFDEEF----FSHTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp -CCCCHHH----HTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred -cccChhh----hcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0011110 01112345558889999999999999999975
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=368.68 Aligned_cols=250 Identities=23% Similarity=0.393 Sum_probs=205.8
Q ss_pred hcCCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCC---chhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeE
Q 010513 183 VSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM 258 (508)
Q Consensus 183 ~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 258 (508)
+..++|.+.+.||+|+||.||+|.+. +|+.||||++.... ....+.+.+|+++++.++||||+++++++.+.+..|
T Consensus 13 ~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~ 92 (476)
T 2y94_A 13 VKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIF 92 (476)
T ss_dssp CEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred ceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 34568999999999999999999976 68999999986542 223467889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeecccee
Q 010513 259 LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL 338 (508)
Q Consensus 259 lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~ 338 (508)
+||||+++|+|.+++... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++..
T Consensus 93 lv~E~~~gg~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~ 165 (476)
T 2y94_A 93 MVMEYVSGGELFDYICKN----GRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNM 165 (476)
T ss_dssp EEEECCSSEEHHHHTTSS----SSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred EEEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhh
Confidence 999999999999999764 5799999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCcceecceecCCCCCChhhhhcCCC-CCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccC
Q 010513 339 LGAERSYVTTRVMGTFGYVAPEYASTGML-NERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGV 417 (508)
Q Consensus 339 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 417 (508)
..... .....+||+.|+|||++.+..+ +.++|||||||++|||++|+.||..... .......... ..
T Consensus 166 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~------~~~~~~i~~~-~~--- 233 (476)
T 2y94_A 166 MSDGE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV------PTLFKKICDG-IF--- 233 (476)
T ss_dssp CCTTC--CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSS------HHHHHHHHTT-CC---
T ss_pred ccccc--cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCH------HHHHHHHhcC-Cc---
Confidence 64432 2344689999999999988765 6799999999999999999999975432 1112222211 10
Q ss_pred CCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 418 LDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 418 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
..+ ...+. ++.+++.+||+.||++||++.+++++
T Consensus 234 ~~p----~~~s~---~~~~Li~~~L~~dP~~Rpt~~eil~h 267 (476)
T 2y94_A 234 YTP----QYLNP---SVISLLKHMLQVDPMKRATIKDIREH 267 (476)
T ss_dssp CCC----TTCCH---HHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred CCC----ccCCH---HHHHHHHHHcCCCchhCcCHHHHHhC
Confidence 001 11222 34558889999999999999999973
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-43 Score=373.64 Aligned_cols=258 Identities=22% Similarity=0.286 Sum_probs=208.7
Q ss_pred hcCCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCc---hhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeE
Q 010513 183 VSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG---QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM 258 (508)
Q Consensus 183 ~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 258 (508)
+..++|.+.+.||+|+||+||+|+.+ +|+.||+|++.+... .....+..|+++++.++||||+++++++.+....|
T Consensus 182 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 261 (543)
T 3c4z_A 182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLC 261 (543)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEE
Confidence 45578999999999999999999986 588999999865422 23467888999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeecccee
Q 010513 259 LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL 338 (508)
Q Consensus 259 lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~ 338 (508)
+||||++||+|.+++.........+++..++.++.|++.||+|||++ +|+||||||+|||++.+|++||+|||+++.
T Consensus 262 lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~ 338 (543)
T 3c4z_A 262 LVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVE 338 (543)
T ss_dssp EEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeee
Confidence 99999999999999977544446799999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCC
Q 010513 339 LGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVL 418 (508)
Q Consensus 339 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 418 (508)
...... .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||........ ..+.........
T Consensus 339 ~~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~--~~~~~~~i~~~~------ 409 (543)
T 3c4z_A 339 LKAGQT-KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE--NKELKQRVLEQA------ 409 (543)
T ss_dssp CCTTCC-CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCC--HHHHHHHHHHCC------
T ss_pred ccCCCc-ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchh--HHHHHHHHhhcc------
Confidence 644322 23446899999999999999999999999999999999999999976543222 122222222111
Q ss_pred CccCCCCchHHHHHHHHHHHHHccCCCCCCCCCH-----HHHHH
Q 010513 419 DPRLQEKPCSRALKRALLVALRCVDPNAHKRPKM-----GHVIH 457 (508)
Q Consensus 419 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~ 457 (508)
..+. ...+. .+.+++.+||+.||++||++ .++++
T Consensus 410 -~~~p-~~~s~---~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 410 -VTYP-DKFSP---ASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp -CCCC-TTSCH---HHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred -cCCC-cccCH---HHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 0111 11233 34457779999999999964 66664
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=353.35 Aligned_cols=268 Identities=25% Similarity=0.380 Sum_probs=213.3
Q ss_pred chhhHhhcCCCCcccceEcccCcEEEEEEEE------CCCcEEEEEEeecCCc-hhHHHHHHHHHHHHcc-CCCCeeeEe
Q 010513 177 TLRELEVSTNGFADENVIGEGGYGIVYHGVL------EDNTNVAVKNLLNNRG-QAEKEFKVEVEAIGRV-RHKNLVRLL 248 (508)
Q Consensus 177 ~~~~~~~~~~~~~~~~~LG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpniv~l~ 248 (508)
....+++..++|++.+.||+|+||+||+|.+ .+++.||+|.+..... ...+.+.+|++++.++ +||||++++
T Consensus 18 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 97 (316)
T 2xir_A 18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 97 (316)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEE
Confidence 3556677888999999999999999999985 2457899999876533 3446788999999999 799999999
Q ss_pred eeeecCC-eeEEEEEecCCCCHHHHhccCCCC------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccC
Q 010513 249 GYCAEGA-HRMLVYEYIDNGNLEQWLHGDVGP------------HSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDI 315 (508)
Q Consensus 249 ~~~~~~~-~~~lV~e~~~~g~L~~~l~~~~~~------------~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDl 315 (508)
+++.+.+ ..++||||+++|+|.+++...... ...+++..++.++.|++.||.|||++ +|+||||
T Consensus 98 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~di 174 (316)
T 2xir_A 98 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDL 174 (316)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSCC
T ss_pred EEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---CcccccC
Confidence 9987654 589999999999999999775321 12388999999999999999999999 9999999
Q ss_pred CCCCEEEcCCCCeEEeeeccceecCCCCc-ceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHh-CCCCCCCC
Q 010513 316 KSSNILLDKQWNPKLSDFGLAKLLGAERS-YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYS 393 (508)
Q Consensus 316 kp~NIll~~~~~~kL~DFG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~Pf~~~ 393 (508)
||+||+++.++.+||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||+| |+.||...
T Consensus 175 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~ 254 (316)
T 2xir_A 175 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 254 (316)
T ss_dssp SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred ccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCccc
Confidence 99999999999999999999987644333 23345678999999999999999999999999999999998 99999754
Q ss_pred CCCCcchHHHHHHHhhcccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010513 394 RPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (508)
Q Consensus 394 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~~ 462 (508)
.... .....+. .... .... ...+. ++.+++.+||+.||++||++.+++++|++.
T Consensus 255 ~~~~--~~~~~~~----~~~~-----~~~~-~~~~~---~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 308 (316)
T 2xir_A 255 KIDE--EFCRRLK----EGTR-----MRAP-DYTTP---EMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308 (316)
T ss_dssp CCSH--HHHHHHH----HTCC-----CCCC-TTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred chhH--HHHHHhc----cCcc-----CCCC-CCCCH---HHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 3221 1111111 1110 0111 11223 345588899999999999999999999753
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=358.10 Aligned_cols=257 Identities=14% Similarity=0.179 Sum_probs=206.9
Q ss_pred hhHhhcCCCCcccceEcccCcEEEEEEE------ECCCcEEEEEEeecCCchhHHHHHHHHHHHHccC---CCCeeeEee
Q 010513 179 RELEVSTNGFADENVIGEGGYGIVYHGV------LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVR---HKNLVRLLG 249 (508)
Q Consensus 179 ~~~~~~~~~~~~~~~LG~G~~g~Vy~~~------~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---hpniv~l~~ 249 (508)
.++++..++|.+.+.||+|+||+||+|. ..+++.||+|++.... ..++..|++++..++ |+||+++++
T Consensus 58 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~ 134 (365)
T 3e7e_A 58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYS 134 (365)
T ss_dssp CEEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEE
T ss_pred eeEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhhe
Confidence 4456677899999999999999999994 4468889999986543 456777888888886 999999999
Q ss_pred eeecCCeeEEEEEecCCCCHHHHhccCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcC----
Q 010513 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVG-PHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDK---- 324 (508)
Q Consensus 250 ~~~~~~~~~lV~e~~~~g~L~~~l~~~~~-~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~---- 324 (508)
++..++..|+||||+++|+|.+++..... ....+++..++.++.|++.||+|||++ +|+||||||+|||++.
T Consensus 135 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~ 211 (365)
T 3e7e_A 135 AHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLE 211 (365)
T ss_dssp EEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTC
T ss_pred eeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccC
Confidence 99999999999999999999999975321 235799999999999999999999998 9999999999999988
Q ss_pred -------CCCeEEeeeccceecCC-CCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCC
Q 010513 325 -------QWNPKLSDFGLAKLLGA-ERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPP 396 (508)
Q Consensus 325 -------~~~~kL~DFG~a~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~ 396 (508)
++.+||+|||+++.+.. .........+||+.|+|||++.+..++.++|||||||++|||+||+.||......
T Consensus 212 ~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 291 (365)
T 3e7e_A 212 QDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGG 291 (365)
T ss_dssp C------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETT
T ss_pred ccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCC
Confidence 89999999999986532 2233445568999999999999999999999999999999999999999533221
Q ss_pred CcchHHHHHHHhhcccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCC-CCHHHHHHHHhcC
Q 010513 397 GEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKR-PKMGHVIHMLEAE 462 (508)
Q Consensus 397 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~R-Ps~~evl~~Le~~ 462 (508)
. ..+...+......+...+ ++..|++.+|.+| |++.++.+.|+..
T Consensus 292 ~------------------~~~~~~~~~~~~~~~~~~---~~~~~l~~~p~~r~~~~~~l~~~l~~~ 337 (365)
T 3e7e_A 292 E------------------CKPEGLFRRLPHLDMWNE---FFHVMLNIPDCHHLPSLDLLRQKLKKV 337 (365)
T ss_dssp E------------------EEECSCCTTCSSHHHHHH---HHHHHHCCCCTTCCCCHHHHHHHHHHH
T ss_pred c------------------eeechhccccCcHHHHHH---HHHHHcCCCCCCcchHHHHHHHHHHHH
Confidence 0 011122222234455555 6669999999999 5788888877653
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-43 Score=368.24 Aligned_cols=260 Identities=24% Similarity=0.284 Sum_probs=195.8
Q ss_pred CCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecC--CchhHHHHHHHHHHHHccCCCCeeeEeeeeecC------C
Q 010513 185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEG------A 255 (508)
Q Consensus 185 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~------~ 255 (508)
.++|++.+.||+|+||+||+|.+. +++.||||++... .....+.+.+|+++++.++||||+++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 468999999999999999999976 5888999999754 334456788999999999999999999999654 4
Q ss_pred eeEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeecc
Q 010513 256 HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGL 335 (508)
Q Consensus 256 ~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~ 335 (508)
..|+||||+++ +|.+.+.. .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 141 ~~~lv~E~~~~-~l~~~~~~------~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~ 210 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 210 (464)
T ss_dssp EEEEEEECCSE-EHHHHHTS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCC
T ss_pred eEEEEEeCCCC-CHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEe
Confidence 57999999987 57777643 489999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHH---------
Q 010513 336 AKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLK--------- 406 (508)
Q Consensus 336 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~--------- 406 (508)
++..... ...+..+||+.|+|||++.+..|+.++|||||||++|||++|+.||...+... .+...+.
T Consensus 211 a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~--~~~~i~~~lg~p~~~~ 286 (464)
T 3ttj_A 211 ARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID--QWNKVIEQLGTPCPEF 286 (464)
T ss_dssp C-----C--CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHHCSCCHHH
T ss_pred eeecCCC--cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHhcCCCCHHH
Confidence 9875432 23455789999999999999999999999999999999999999997543211 0000000
Q ss_pred ---------Hhhcccc-cc-----cCCCcc-CCCC--chHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 407 ---------TMVTNRN-AE-----GVLDPR-LQEK--PCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 407 ---------~~~~~~~-~~-----~~~~~~-l~~~--~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
....... .. ...... +..+ .......++.+++.+||+.||++|||+.|++++
T Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 287 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp HTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000000 00 000000 0000 011124567778999999999999999999975
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-44 Score=380.34 Aligned_cols=265 Identities=26% Similarity=0.410 Sum_probs=213.2
Q ss_pred hhHhhcCCCCcccceEcccCcEEEEEEEECCCcEEEEEEeecCCchhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeE
Q 010513 179 RELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM 258 (508)
Q Consensus 179 ~~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 258 (508)
..+++..++|++.+.||+|+||+||+|.++++..||||++.... ...+.|.+|+++|++++||||+++++++.+ ...|
T Consensus 260 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~ 337 (535)
T 2h8h_A 260 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY 337 (535)
T ss_dssp TCSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred cceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccce
Confidence 34566778899999999999999999999888889999987544 335678999999999999999999999976 6789
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeecccee
Q 010513 259 LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL 338 (508)
Q Consensus 259 lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~ 338 (508)
+||||+++|+|.+++.... ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 338 lv~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 412 (535)
T 2h8h_A 338 IVTEYMSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARL 412 (535)
T ss_dssp EEECCCTTEEHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTT
T ss_pred EeeehhcCCcHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEccccccee
Confidence 9999999999999997531 24589999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHhhcccccccC
Q 010513 339 LGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGV 417 (508)
Q Consensus 339 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 417 (508)
.............++..|+|||++.+..++.++|||||||+||||++ |+.||..... .+.+.......+
T Consensus 413 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~------~~~~~~i~~~~~---- 482 (535)
T 2h8h_A 413 IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN------REVLDQVERGYR---- 482 (535)
T ss_dssp CCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH------HHHHHHHHTTCC----
T ss_pred cCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHHHcCCC----
Confidence 64322222223456788999999999999999999999999999999 9999974321 122222211111
Q ss_pred CCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCCCC
Q 010513 418 LDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEEFPF 466 (508)
Q Consensus 418 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~~~~~~ 466 (508)
... ...++.. +.+++.+||+.||++||++.+|+++|+......
T Consensus 483 --~~~-~~~~~~~---l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~ 525 (535)
T 2h8h_A 483 --MPC-PPECPES---LHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 525 (535)
T ss_dssp --CCC-CTTCCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCC
T ss_pred --CCC-CCCCCHH---HHHHHHHHcCCChhHCcCHHHHHHHHHHHhhcc
Confidence 001 1123333 445888999999999999999999999765433
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=354.93 Aligned_cols=268 Identities=23% Similarity=0.354 Sum_probs=210.2
Q ss_pred cCCCCcccceEcccCcEEEEEEEE-----CCCcEEEEEEeecCCchhHHHHHHHHHHHHccCCCCeeeEeeeee--cCCe
Q 010513 184 STNGFADENVIGEGGYGIVYHGVL-----EDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCA--EGAH 256 (508)
Q Consensus 184 ~~~~~~~~~~LG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~--~~~~ 256 (508)
..++|++.+.||+|+||.||+|++ .++..||+|++........+.+.+|+++++.++||||+++++++. +...
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 100 (327)
T 3lxl_A 21 EERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQS 100 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCE
T ss_pred chhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCce
Confidence 446899999999999999999985 357889999998776666778999999999999999999999886 4567
Q ss_pred eEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccc
Q 010513 257 RMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLA 336 (508)
Q Consensus 257 ~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a 336 (508)
.++||||+++|+|.+++... ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~ 174 (327)
T 3lxl_A 101 LRLVMEYLPSGCLRDFLQRH---RARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLA 174 (327)
T ss_dssp EEEEEECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGC
T ss_pred EEEEEeecCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEcccccc
Confidence 88999999999999999764 24689999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCcc--eecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCC--------CcchHHHHHH
Q 010513 337 KLLGAERSY--VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPP--------GEVNLVEWLK 406 (508)
Q Consensus 337 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~--------~~~~~~~~~~ 406 (508)
......... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...... ........+.
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (327)
T 3lxl_A 175 KLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLL 254 (327)
T ss_dssp EECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHH
T ss_pred eecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHH
Confidence 977544332 223356888899999999999999999999999999999999998633110 0000111111
Q ss_pred HhhcccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCCCC
Q 010513 407 TMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEEFPF 466 (508)
Q Consensus 407 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~~~~~~ 466 (508)
....... .... ...++. .+.+++.+||+.||++||++.+++++|+......
T Consensus 255 ~~~~~~~-----~~~~-~~~~~~---~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 305 (327)
T 3lxl_A 255 ELLEEGQ-----RLPA-PPACPA---EVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS 305 (327)
T ss_dssp HHHHTTC-----CCCC-CTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----
T ss_pred HHhhccc-----CCCC-CCcccH---HHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 1111111 0111 112333 3455788999999999999999999999765433
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=359.64 Aligned_cols=256 Identities=23% Similarity=0.310 Sum_probs=204.7
Q ss_pred cCCCCcccceEcccCcEEEEEEEE----CCCcEEEEEEeecCC----chhHHHHHHHHHHHHcc-CCCCeeeEeeeeecC
Q 010513 184 STNGFADENVIGEGGYGIVYHGVL----EDNTNVAVKNLLNNR----GQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEG 254 (508)
Q Consensus 184 ~~~~~~~~~~LG~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~ 254 (508)
..++|++.+.||+|+||+||+|+. .+++.||||++.... ....+.+.+|+++++.+ +||||+++++++.++
T Consensus 52 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 131 (355)
T 1vzo_A 52 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE 131 (355)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET
T ss_pred cccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeC
Confidence 446899999999999999999997 368899999985432 23345567799999999 699999999999999
Q ss_pred CeeEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeec
Q 010513 255 AHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFG 334 (508)
Q Consensus 255 ~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG 334 (508)
...++||||+++|+|.+++... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||
T Consensus 132 ~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG 204 (355)
T 1vzo_A 132 TKLHLILDYINGGELFTHLSQR----ERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFG 204 (355)
T ss_dssp TEEEEEECCCCSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSS
T ss_pred ceEEEEeecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCC
Confidence 9999999999999999999765 4689999999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCcceecceecCCCCCChhhhhc--CCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhccc
Q 010513 335 LAKLLGAERSYVTTRVMGTFGYVAPEYAST--GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNR 412 (508)
Q Consensus 335 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 412 (508)
+++.+...........+||+.|+|||++.+ ..++.++|||||||++|||++|+.||......... ...........
T Consensus 205 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~--~~~~~~~~~~~ 282 (355)
T 1vzo_A 205 LSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ--AEISRRILKSE 282 (355)
T ss_dssp EEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH--HHHHHHHHHCC
T ss_pred CCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchH--HHHHHHHhccC
Confidence 998765444444455689999999999985 34788999999999999999999999755433221 22222222111
Q ss_pred ccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHH
Q 010513 413 NAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRP-----KMGHVIHML 459 (508)
Q Consensus 413 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~L 459 (508)
+.+.. ..+. .+.+++.+||+.||++|| ++.+++++.
T Consensus 283 -------~~~~~-~~~~---~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 283 -------PPYPQ-EMSA---LAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp -------CCCCT-TSCH---HHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred -------CCCCc-ccCH---HHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 11111 1223 344578899999999999 999998764
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-43 Score=344.62 Aligned_cols=253 Identities=21% Similarity=0.353 Sum_probs=197.6
Q ss_pred CCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCC-chhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEEe
Q 010513 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY 263 (508)
Q Consensus 186 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~ 263 (508)
++|.+.+.||+|+||+||+|... ++..+|+|++.... ....+.+.+|+++++.++||||+++++++.+....++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 47899999999999999999975 58899999986653 33457889999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEE---cCCCCeEEeeeccceecC
Q 010513 264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILL---DKQWNPKLSDFGLAKLLG 340 (508)
Q Consensus 264 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll---~~~~~~kL~DFG~a~~~~ 340 (508)
+++|+|.+++.........+++..++.++.|++.||+|||++ +|+||||||+||++ +.++.+||+|||++....
T Consensus 102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 999999999865422246799999999999999999999999 99999999999999 456789999999998654
Q ss_pred CCCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCCc
Q 010513 341 AERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDP 420 (508)
Q Consensus 341 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 420 (508)
... ......||+.|+|||++. +.++.++|||||||++|||++|+.||.... ..+.......... ..
T Consensus 179 ~~~--~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~------~~~~~~~~~~~~~-----~~ 244 (285)
T 3is5_A 179 SDE--HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTS------LEEVQQKATYKEP-----NY 244 (285)
T ss_dssp ----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHCCC-----CC
T ss_pred Ccc--cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCC------HHHHHhhhccCCc-----cc
Confidence 322 234457999999999885 568899999999999999999999997432 1111111111110 00
Q ss_pred cCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 421 RLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 421 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
.......+. ++.+++.+||+.||++||++.|++++
T Consensus 245 ~~~~~~~~~---~~~~li~~~L~~dP~~Rps~~e~l~h 279 (285)
T 3is5_A 245 AVECRPLTP---QAVDLLKQMLTKDPERRPSAAQVLHH 279 (285)
T ss_dssp CC--CCCCH---HHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred ccccCcCCH---HHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111111223 34457889999999999999999863
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-43 Score=351.29 Aligned_cols=259 Identities=28% Similarity=0.479 Sum_probs=201.9
Q ss_pred hhcCCCCcccceEcccCcEEEEEEEECC-----CcEEEEEEeecCC-chhHHHHHHHHHHHHccCCCCeeeEeeeeecCC
Q 010513 182 EVSTNGFADENVIGEGGYGIVYHGVLED-----NTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGA 255 (508)
Q Consensus 182 ~~~~~~~~~~~~LG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~ 255 (508)
++..++|++.+.||+|+||+||+|.+.. +..||+|.+.... ......+.+|+++++.++||||+++++++.+.+
T Consensus 40 ~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 119 (333)
T 1mqb_A 40 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYK 119 (333)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred cCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCC
Confidence 4556789999999999999999998653 2359999986543 334557889999999999999999999999999
Q ss_pred eeEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeecc
Q 010513 256 HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGL 335 (508)
Q Consensus 256 ~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~ 335 (508)
..++||||+++|+|.+++... ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 120 ~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 193 (333)
T 1mqb_A 120 PMMIITEYMENGALDKFLREK---DGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGL 193 (333)
T ss_dssp SEEEEEECCTTEEHHHHHHHT---TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred CcEEEEeCCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCc
Confidence 999999999999999999765 35799999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCcc--eecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHhhccc
Q 010513 336 AKLLGAERSY--VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNR 412 (508)
Q Consensus 336 a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~ 412 (508)
++........ ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||..... .+.........
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~------~~~~~~~~~~~ 267 (333)
T 1mqb_A 194 SRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN------HEVMKAINDGF 267 (333)
T ss_dssp -----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH------HHHHHHHHTTC
T ss_pred chhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH------HHHHHHHHCCC
Confidence 9876443221 1223456788999999999999999999999999999999 9999964321 12222221111
Q ss_pred ccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010513 413 NAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (508)
Q Consensus 413 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~~ 462 (508)
. ... ...++. .+.+++.+||+.||++||++.+++++|+..
T Consensus 268 ~------~~~-~~~~~~---~l~~li~~~l~~~p~~Rps~~~l~~~L~~~ 307 (333)
T 1mqb_A 268 R------LPT-PMDCPS---AIYQLMMQCWQQERARRPKFADIVSILDKL 307 (333)
T ss_dssp C------CCC-CTTCBH---HHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred c------CCC-cccCCH---HHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 1 001 111333 344578899999999999999999999864
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-43 Score=343.08 Aligned_cols=249 Identities=25% Similarity=0.395 Sum_probs=182.8
Q ss_pred CCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCc---hhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEE
Q 010513 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG---QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY 261 (508)
Q Consensus 186 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 261 (508)
++|++.+.||+|+||.||+|... +++.||+|.+..... ...+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL 90 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence 57999999999999999999974 688999999864321 23467889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCC
Q 010513 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA 341 (508)
Q Consensus 262 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 341 (508)
||+++++|.+++... ...+++..++.++.|+++||+|||++ +++||||||+||+++.++.+||+|||++.....
T Consensus 91 e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 164 (278)
T 3cok_A 91 EMCHNGEMNRYLKNR---VKPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKM 164 (278)
T ss_dssp ECCTTEEHHHHHHTC---SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred ecCCCCcHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence 999999999999765 35789999999999999999999999 999999999999999999999999999987643
Q ss_pred CCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCCcc
Q 010513 342 ERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPR 421 (508)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 421 (508)
... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||........ +..... .+..
T Consensus 165 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------~~~~~~-------~~~~ 230 (278)
T 3cok_A 165 PHE-KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT------LNKVVL-------ADYE 230 (278)
T ss_dssp ----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----------CCS-------SCCC
T ss_pred CCC-cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH------HHHHhh-------cccC
Confidence 222 22345789999999999998999999999999999999999999975432211 011000 0011
Q ss_pred CCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 422 LQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 422 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
.. ...+. ++.+++.+||+.||++||++.+++++
T Consensus 231 ~~-~~~~~---~~~~li~~~l~~dp~~Rps~~~~l~h 263 (278)
T 3cok_A 231 MP-SFLSI---EAKDLIHQLLRRNPADRLSLSSVLDH 263 (278)
T ss_dssp CC-TTSCH---HHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred Cc-cccCH---HHHHHHHHHcccCHhhCCCHHHHhcC
Confidence 11 11223 44558889999999999999999864
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-44 Score=359.12 Aligned_cols=265 Identities=24% Similarity=0.399 Sum_probs=211.7
Q ss_pred hHhhcCCCCcccceEcccCcEEEEEEEECC-C-----cEEEEEEeecCCc-hhHHHHHHHHHHHHcc-CCCCeeeEeeee
Q 010513 180 ELEVSTNGFADENVIGEGGYGIVYHGVLED-N-----TNVAVKNLLNNRG-QAEKEFKVEVEAIGRV-RHKNLVRLLGYC 251 (508)
Q Consensus 180 ~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~~-~-----~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpniv~l~~~~ 251 (508)
.+++..++|++.+.||+|+||+||+|.+.. + ..||+|.+..... ...+.+.+|+++++.+ +||||+++++++
T Consensus 40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 119 (333)
T 2i1m_A 40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC 119 (333)
T ss_dssp GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 456778899999999999999999999753 2 3799999865533 3456788999999999 899999999999
Q ss_pred ecCCeeEEEEEecCCCCHHHHhccCCC----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEE
Q 010513 252 AEGAHRMLVYEYIDNGNLEQWLHGDVG----------PHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNIL 321 (508)
Q Consensus 252 ~~~~~~~lV~e~~~~g~L~~~l~~~~~----------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIl 321 (508)
.+++..++||||+++|+|.+++..... ....+++..++.++.|++.||+|||++ +|+||||||+|||
T Consensus 120 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl 196 (333)
T 2i1m_A 120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVL 196 (333)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCE
T ss_pred ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEE
Confidence 999999999999999999999865311 134689999999999999999999999 9999999999999
Q ss_pred EcCCCCeEEeeeccceecCCCCcc-eecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHh-CCCCCCCCCCCCcc
Q 010513 322 LDKQWNPKLSDFGLAKLLGAERSY-VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEV 399 (508)
Q Consensus 322 l~~~~~~kL~DFG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~Pf~~~~~~~~~ 399 (508)
++.++.+||+|||++......... ......||+.|+|||.+.+..++.++|||||||++|||+| |..||.......
T Consensus 197 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-- 274 (333)
T 2i1m_A 197 LTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS-- 274 (333)
T ss_dssp EEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH--
T ss_pred ECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH--
Confidence 999999999999999866433322 2334567889999999999999999999999999999999 999997543221
Q ss_pred hHHHHHHHhhcccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010513 400 NLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (508)
Q Consensus 400 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~~ 462 (508)
.......... ... .....+. .+.+++.+||+.||++||++.+++++|++.
T Consensus 275 ~~~~~~~~~~---------~~~-~~~~~~~---~l~~li~~~l~~~p~~Rps~~~l~~~L~~~ 324 (333)
T 2i1m_A 275 KFYKLVKDGY---------QMA-QPAFAPK---NIYSIMQACWALEPTHRPTFQQICSFLQEQ 324 (333)
T ss_dssp HHHHHHHHTC---------CCC-CCTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHhcCC---------CCC-CCCCCCH---HHHHHHHHHhccChhhCcCHHHHHHHHHHH
Confidence 1111111110 000 1111233 445588899999999999999999999864
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=350.04 Aligned_cols=268 Identities=25% Similarity=0.373 Sum_probs=210.3
Q ss_pred chhhHhhcCCCCcccceEcccCcEEEEEEEECCCcEEEEEEeecCCchhHHHHHHHHHHHHc--cCCCCeeeEeeeeecC
Q 010513 177 TLRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGR--VRHKNLVRLLGYCAEG 254 (508)
Q Consensus 177 ~~~~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~hpniv~l~~~~~~~ 254 (508)
++...+...++|++.+.||+|+||.||+|.+. ++.||+|.+... ....+..|.+++.. ++||||+++++++...
T Consensus 33 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~ 108 (342)
T 1b6c_B 33 PLLVQRTIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKD 108 (342)
T ss_dssp CHHHHHHHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECC
T ss_pred ceeecccccccEEEEeeecCCCCcEEEEEEEc-CccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeeccc
Confidence 34444556678999999999999999999985 889999998543 34567778888887 7999999999999877
Q ss_pred C----eeEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHH--------hcCCCCeeeccCCCCCEEE
Q 010513 255 A----HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH--------EGLEPKVVHRDIKSSNILL 322 (508)
Q Consensus 255 ~----~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH--------~~~~~~iiHrDlkp~NIll 322 (508)
. ..++||||+++|+|.+++... .+++..++.++.|++.||+||| +. +|+||||||+|||+
T Consensus 109 ~~~~~~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIll 180 (342)
T 1b6c_B 109 NGTWTQLWLVSDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNILV 180 (342)
T ss_dssp CSSCCCEEEEECCCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEEE
T ss_pred CCccceeEEEEeecCCCcHHHHHhcc-----CccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEEE
Confidence 6 789999999999999999754 5899999999999999999999 77 99999999999999
Q ss_pred cCCCCeEEeeeccceecCCCCcc---eecceecCCCCCChhhhhcCC------CCCCCCeeehHHHHHHHHhC-------
Q 010513 323 DKQWNPKLSDFGLAKLLGAERSY---VTTRVMGTFGYVAPEYASTGM------LNERSDVYSFGILIMEVISG------- 386 (508)
Q Consensus 323 ~~~~~~kL~DFG~a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~~~~sDvwSlGvvl~elltg------- 386 (508)
+.++.+||+|||++......... ......||+.|+|||++.+.. ++.++|||||||++|||+||
T Consensus 181 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~ 260 (342)
T 1b6c_B 181 KKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIH 260 (342)
T ss_dssp CTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBC
T ss_pred CCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcc
Confidence 99999999999999876544322 224457999999999997653 33689999999999999999
Q ss_pred ---CCCCCCCCCCCcchHHHHHHHhhcccccccCCCccCCCC-chHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010513 387 ---RNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEK-PCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (508)
Q Consensus 387 ---~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~~ 462 (508)
+.||....+... ....+. ...... ...+.+... ........+.+++.+||+.||++||++.+++++|+..
T Consensus 261 ~~~~~p~~~~~~~~~-~~~~~~-~~~~~~----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i 334 (342)
T 1b6c_B 261 EDYQLPYYDLVPSDP-SVEEMR-KVVCEQ----KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 334 (342)
T ss_dssp CCCCCTTTTTSCSSC-CHHHHH-HHHTTS----CCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred cccccCccccCcCcc-cHHHHH-HHHHHH----HhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence 788875543221 222222 222221 122222211 1224455666788899999999999999999999864
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=364.07 Aligned_cols=201 Identities=26% Similarity=0.423 Sum_probs=164.0
Q ss_pred cCCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecC--CchhHHHHHHHHHHHHccC-CCCeeeEeeeeecCC--ee
Q 010513 184 STNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVR-HKNLVRLLGYCAEGA--HR 257 (508)
Q Consensus 184 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~--~~ 257 (508)
..++|++.+.||+|+||+||+|.+. +++.||||++... .......+.+|+.+++.+. ||||+++++++..++ ..
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 3468999999999999999999975 6889999998653 3344566788999999997 999999999997544 78
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccce
Q 010513 258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK 337 (508)
Q Consensus 258 ~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~ 337 (508)
|+||||+++ +|.+++... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 87 ~lv~e~~~~-~L~~~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~ 157 (388)
T 3oz6_A 87 YLVFDYMET-DLHAVIRAN-----ILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSR 157 (388)
T ss_dssp EEEEECCSE-EHHHHHHHT-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEecccCc-CHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCcccc
Confidence 999999985 999998753 689999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCC--------------------CcceecceecCCCCCChhhhhc-CCCCCCCCeeehHHHHHHHHhCCCCCCCC
Q 010513 338 LLGAE--------------------RSYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYS 393 (508)
Q Consensus 338 ~~~~~--------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~Pf~~~ 393 (508)
.+... .....+..+||+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 234 (388)
T 3oz6_A 158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGS 234 (388)
T ss_dssp ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Confidence 75321 1122344689999999999876 67899999999999999999999999754
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=340.54 Aligned_cols=260 Identities=19% Similarity=0.243 Sum_probs=205.7
Q ss_pred CCCCcccceEcccCcEEEEEEEE-CCCcEEEEEEeecCCchhHHHHHHHHHHHHccCCCCeeeEeeee-ecCCeeEEEEE
Q 010513 185 TNGFADENVIGEGGYGIVYHGVL-EDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYC-AEGAHRMLVYE 262 (508)
Q Consensus 185 ~~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~-~~~~~~~lV~e 262 (508)
.++|++.+.||+|+||+||+|++ .+++.||+|.+..... .+.+.+|+++++.++|++++..+.++ .++...++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 46899999999999999999997 4688999998865432 24588899999999988866666555 66778899999
Q ss_pred ecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEE---cCCCCeEEeeeccceec
Q 010513 263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILL---DKQWNPKLSDFGLAKLL 339 (508)
Q Consensus 263 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll---~~~~~~kL~DFG~a~~~ 339 (508)
|+ +++|.+++... ...+++..++.++.|++.||+|||++ +|+||||||+|||+ +.++.+||+|||++...
T Consensus 86 ~~-~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~ 158 (296)
T 3uzp_A 86 LL-GPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp CC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred ec-CCCHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccc
Confidence 99 88999999754 35799999999999999999999999 99999999999999 48889999999999876
Q ss_pred CCCCcc------eecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccc
Q 010513 340 GAERSY------VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRN 413 (508)
Q Consensus 340 ~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 413 (508)
...... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||..............+........
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (296)
T 3uzp_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 238 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred cccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc
Confidence 543321 12446799999999999999999999999999999999999999987654433333332222111000
Q ss_pred cccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010513 414 AEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (508)
Q Consensus 414 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~~ 462 (508)
. +.+. ...+ .++.+++.+||+.||++||++.++++.|+..
T Consensus 239 ~-----~~~~-~~~~---~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~ 278 (296)
T 3uzp_A 239 I-----EVLC-KGYP---SEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 278 (296)
T ss_dssp H-----HHHT-TTSC---HHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred h-----HHHH-hhCC---HHHHHHHHHHHhcCcCcCCCHHHHHHHHHHH
Confidence 0 0000 1122 3455588899999999999999999999864
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-43 Score=368.22 Aligned_cols=193 Identities=25% Similarity=0.373 Sum_probs=155.5
Q ss_pred CCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecC--CchhHHHHHHHHHHHHccCCCCeeeEeeeeec-----CCe
Q 010513 185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE-----GAH 256 (508)
Q Consensus 185 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-----~~~ 256 (508)
.++|++.+.||+|+||+||+|.+. +++.||||++... .....+.+.+|+++++.++||||+++++++.. ...
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 368999999999999999999976 6889999998654 23345678899999999999999999999843 357
Q ss_pred eEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccc
Q 010513 257 RMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLA 336 (508)
Q Consensus 257 ~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a 336 (508)
.|+||||+. |+|.+++... ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 132 ~~lv~e~~~-~~L~~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla 203 (458)
T 3rp9_A 132 LYVVLEIAD-SDFKKLFRTP----VYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLA 203 (458)
T ss_dssp EEEEECCCS-EEHHHHHHSS----CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEeccc-cchhhhcccC----CCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccc
Confidence 899999985 5999999764 5799999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCc--------------------------ceecceecCCCCCChhhh-hcCCCCCCCCeeehHHHHHHHHh
Q 010513 337 KLLGAERS--------------------------YVTTRVMGTFGYVAPEYA-STGMLNERSDVYSFGILIMEVIS 385 (508)
Q Consensus 337 ~~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~sDvwSlGvvl~ellt 385 (508)
+....... ...+..+||+.|+|||++ ....|+.++|||||||++|||++
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~ellt 279 (458)
T 3rp9_A 204 RTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLN 279 (458)
T ss_dssp BCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHT
T ss_pred hhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHH
Confidence 87643211 123456889999999976 56679999999999999999999
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=338.34 Aligned_cols=252 Identities=19% Similarity=0.314 Sum_probs=203.9
Q ss_pred CCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCC--chhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEE
Q 010513 185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY 261 (508)
Q Consensus 185 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 261 (508)
.++|++.+.||+|+||.||+|.+. +++.||+|++.... ....+.+.+|++++++++||||+++++++.++...++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 468999999999999999999976 58899999986543 334567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCC---eEEeeecccee
Q 010513 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWN---PKLSDFGLAKL 338 (508)
Q Consensus 262 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~---~kL~DFG~a~~ 338 (508)
||+++|+|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++. +||+|||++..
T Consensus 85 e~~~~~~l~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~ 157 (284)
T 3kk8_A 85 DLVTGGELFEDIVAR----EFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIE 157 (284)
T ss_dssp CCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred ecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEE
Confidence 999999999988765 4689999999999999999999999 9999999999999976655 99999999987
Q ss_pred cCCCCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCC
Q 010513 339 LGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVL 418 (508)
Q Consensus 339 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 418 (508)
...... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||..... .+......... . ...
T Consensus 158 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~------~~~~~~~~~~~-~-~~~ 227 (284)
T 3kk8_A 158 VNDSEA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ------HRLYAQIKAGA-Y-DYP 227 (284)
T ss_dssp CCSSCB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHTC-C-CCC
T ss_pred cccCcc--ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCch------hHHHHHHHhcc-c-cCC
Confidence 643322 2345799999999999999999999999999999999999999964321 11111111111 0 001
Q ss_pred CccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 419 DPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 419 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
.+. ....+. ++.+++.+||+.||++||++.|++++
T Consensus 228 ~~~--~~~~~~---~~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 228 SPE--WDTVTP---EAKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp TTT--TTTSCH---HHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred chh--hcccCH---HHHHHHHHHcccChhhCCCHHHHhcC
Confidence 111 111233 34557789999999999999999874
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=341.86 Aligned_cols=260 Identities=19% Similarity=0.243 Sum_probs=202.3
Q ss_pred CCCCcccceEcccCcEEEEEEEE-CCCcEEEEEEeecCCchhHHHHHHHHHHHHccCCCCeeeEeeee-ecCCeeEEEEE
Q 010513 185 TNGFADENVIGEGGYGIVYHGVL-EDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYC-AEGAHRMLVYE 262 (508)
Q Consensus 185 ~~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~-~~~~~~~lV~e 262 (508)
.++|++.+.||+|+||+||+|.+ .+++.||+|.+..... ...+..|+++++.++|++++..++.+ .++...++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 4hgt_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEE
Confidence 46899999999999999999997 4688899998654432 23577899999999988877666655 66778899999
Q ss_pred ecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEE---cCCCCeEEeeeccceec
Q 010513 263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILL---DKQWNPKLSDFGLAKLL 339 (508)
Q Consensus 263 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll---~~~~~~kL~DFG~a~~~ 339 (508)
|+ +++|.+++... ...+++..++.++.|++.||+|||++ +|+||||||+|||+ +.++.+||+|||+++..
T Consensus 86 ~~-~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~ 158 (296)
T 4hgt_A 86 LL-GPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp CC-CCBHHHHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred cc-CCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence 99 88999999754 34699999999999999999999999 99999999999999 78899999999999876
Q ss_pred CCCCcc------eecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccc
Q 010513 340 GAERSY------VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRN 413 (508)
Q Consensus 340 ~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 413 (508)
...... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.......................
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (296)
T 4hgt_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 238 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred cCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccch
Confidence 543321 22346799999999999999999999999999999999999999987655444333332221111100
Q ss_pred cccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010513 414 AEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (508)
Q Consensus 414 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~~ 462 (508)
. +.+. ...+ .++.+++.+||+.||++||++.++++.|++.
T Consensus 239 ~-----~~~~-~~~~---~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 278 (296)
T 4hgt_A 239 I-----EVLC-KGYP---SEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 278 (296)
T ss_dssp H-----HHHT-TTSC---HHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred h-----hhhh-ccCC---HHHHHHHHHHHhcCCCCCCCHHHHHHHHHHH
Confidence 0 0000 0122 3455588899999999999999999999863
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-43 Score=352.89 Aligned_cols=246 Identities=27% Similarity=0.414 Sum_probs=200.4
Q ss_pred CCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCc---hhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEE
Q 010513 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG---QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY 261 (508)
Q Consensus 186 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 261 (508)
+.|+..+.||+|+||+||+|... +++.||||++..... ...+.+.+|++++++++||||+++++++.+++..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 45889999999999999999974 688899999865432 33457889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCC
Q 010513 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA 341 (508)
Q Consensus 262 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 341 (508)
||+. |+|.+++... ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 134 e~~~-g~l~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 206 (348)
T 1u5q_A 134 EYCL-GSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 206 (348)
T ss_dssp ECCS-EEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred ecCC-CCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence 9998 5888888654 35789999999999999999999999 999999999999999999999999999986543
Q ss_pred CCcceecceecCCCCCChhhhh---cCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCC
Q 010513 342 ERSYVTTRVMGTFGYVAPEYAS---TGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVL 418 (508)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 418 (508)
. ....||+.|+|||++. .+.++.++|||||||++|||++|+.||.... ..+.+.......
T Consensus 207 ~-----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~------~~~~~~~~~~~~------ 269 (348)
T 1u5q_A 207 A-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN------AMSALYHIAQNE------ 269 (348)
T ss_dssp B-----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC------HHHHHHHHHHSC------
T ss_pred C-----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC------hHHHHHHHHhcC------
Confidence 2 2357999999999985 5678999999999999999999999996432 122222222211
Q ss_pred CccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 419 DPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 419 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
.+.......+..+. +++.+||+.||++||++.+++++
T Consensus 270 ~~~~~~~~~~~~l~---~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 270 SPALQSGHWSEYFR---NFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp CCCCCCTTSCHHHH---HHHHHHTCSSGGGSCCHHHHTTC
T ss_pred CCCCCCCCCCHHHH---HHHHHHcccChhhCcCHHHHhhC
Confidence 11222222344444 47779999999999999999865
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-43 Score=358.05 Aligned_cols=252 Identities=20% Similarity=0.330 Sum_probs=197.8
Q ss_pred cCCCCcccceEcccCcEEEEEEEECCCcEEEEEEeecCC--chhHHHHHHHHHHHHccC--CCCeeeEeeeeecCCeeEE
Q 010513 184 STNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVR--HKNLVRLLGYCAEGAHRML 259 (508)
Q Consensus 184 ~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~--hpniv~l~~~~~~~~~~~l 259 (508)
...+|++.+.||+|+||+||+|...+++.||||++.... ....+.+.+|+++++.++ ||||+++++++..++..|+
T Consensus 54 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~l 133 (390)
T 2zmd_A 54 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 133 (390)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred cCCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEE
Confidence 344699999999999999999998889999999986543 344577899999999996 5999999999999999999
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceec
Q 010513 260 VYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL 339 (508)
Q Consensus 260 V~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~ 339 (508)
||| +.+++|.+++... ..+++..++.++.|++.||+|||++ +|+||||||+|||++ ++.+||+|||+++.+
T Consensus 134 v~E-~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~ 204 (390)
T 2zmd_A 134 VME-CGNIDLNSWLKKK----KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQM 204 (390)
T ss_dssp EEE-CCSEEHHHHHHHC----SSCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC
T ss_pred EEe-cCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCccccc
Confidence 999 5678999999875 4789999999999999999999999 999999999999996 579999999999876
Q ss_pred CCCCcc-eecceecCCCCCChhhhhc-----------CCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHH
Q 010513 340 GAERSY-VTTRVMGTFGYVAPEYAST-----------GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKT 407 (508)
Q Consensus 340 ~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~ 407 (508)
...... .....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... ....+..
T Consensus 205 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~-----~~~~~~~ 279 (390)
T 2zmd_A 205 QPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-----QISKLHA 279 (390)
T ss_dssp ---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCC-----HHHHHHH
T ss_pred cCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhH-----HHHHHHH
Confidence 443222 2345689999999999875 4688899999999999999999999964321 1222222
Q ss_pred hhcccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 408 MVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 408 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
...... ...+.. ..+ .++.+++.+||+.||++||++.|++++
T Consensus 280 ~~~~~~-----~~~~~~-~~~---~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 280 IIDPNH-----EIEFPD-IPE---KDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp HHCTTS-----CCCCCC-CSC---HHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HhCccc-----cCCCCc-cch---HHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 222111 111111 122 344558889999999999999999875
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=354.40 Aligned_cols=275 Identities=25% Similarity=0.369 Sum_probs=201.2
Q ss_pred hcCCCCcccceEcccCcEEEEEEEECCCcEEEEEEeecCCchhHHHHHHHHHH--HHccCCCCeeeEeeeee-----cCC
Q 010513 183 VSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEA--IGRVRHKNLVRLLGYCA-----EGA 255 (508)
Q Consensus 183 ~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~--l~~l~hpniv~l~~~~~-----~~~ 255 (508)
+..++|++.+.||+|+||+||+|+. +++.||||++.... ...+..|.++ +..++||||+++++++. ...
T Consensus 10 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 85 (336)
T 3g2f_A 10 LDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRM 85 (336)
T ss_dssp CCTTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCE
T ss_pred cChHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCc
Confidence 4567899999999999999999987 48899999986433 2333444444 45589999999998543 334
Q ss_pred eeEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC------CCCeeeccCCCCCEEEcCCCCeE
Q 010513 256 HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGL------EPKVVHRDIKSSNILLDKQWNPK 329 (508)
Q Consensus 256 ~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~------~~~iiHrDlkp~NIll~~~~~~k 329 (508)
..++||||+++|+|.+++... ..++..++.++.|++.||+|||++. .++|+||||||+|||++.++.+|
T Consensus 86 ~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k 160 (336)
T 3g2f_A 86 EYLLVMEYYPNGSLXKYLSLH-----TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCV 160 (336)
T ss_dssp EEEEEECCCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEE
T ss_pred eEEEEEecCCCCcHHHHHhhc-----ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEE
Confidence 678999999999999999765 4588999999999999999999762 33899999999999999999999
Q ss_pred EeeeccceecCCCCc-------ceecceecCCCCCChhhhhc-------CCCCCCCCeeehHHHHHHHHhCCCCCCCCCC
Q 010513 330 LSDFGLAKLLGAERS-------YVTTRVMGTFGYVAPEYAST-------GMLNERSDVYSFGILIMEVISGRNPVDYSRP 395 (508)
Q Consensus 330 L~DFG~a~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~-------~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~ 395 (508)
|+|||+++.+..... ......+||+.|+|||++.+ ..++.++|||||||++|||++|..||.....
T Consensus 161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~ 240 (336)
T 3g2f_A 161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES 240 (336)
T ss_dssp ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSC
T ss_pred EeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccc
Confidence 999999987653221 12234579999999999976 3566789999999999999999877654332
Q ss_pred CCcc-h----------HHHHHHHhhcccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCC
Q 010513 396 PGEV-N----------LVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEEF 464 (508)
Q Consensus 396 ~~~~-~----------~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~~~~ 464 (508)
.... . ..+..............+...... ......++.+++.+||+.||++|||+.|+++.|++...
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~ 318 (336)
T 3g2f_A 241 VPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKE--NSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMM 318 (336)
T ss_dssp CCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCC--CSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCccccc--ccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHH
Confidence 1111 0 111111112211111111111111 22344556678889999999999999999999998665
Q ss_pred CCCC
Q 010513 465 PFRD 468 (508)
Q Consensus 465 ~~~~ 468 (508)
++..
T Consensus 319 ~~~~ 322 (336)
T 3g2f_A 319 IWER 322 (336)
T ss_dssp CCCC
T ss_pred HHHh
Confidence 5543
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-44 Score=356.59 Aligned_cols=259 Identities=25% Similarity=0.403 Sum_probs=203.9
Q ss_pred CcccceEcccCcEEEEEEEEC-----CCcEEEEEEeecCCc-hhHHHHHHHHHHHHccCCCCeeeEeeeeec--CCeeEE
Q 010513 188 FADENVIGEGGYGIVYHGVLE-----DNTNVAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNLVRLLGYCAE--GAHRML 259 (508)
Q Consensus 188 ~~~~~~LG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~--~~~~~l 259 (508)
|++.+.||+|+||+||++.+. +++.||||++..... ...+.+.+|+++++.++||||+++++++.+ ....++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 489999999999999998753 578899999976533 445678999999999999999999999987 467899
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceec
Q 010513 260 VYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL 339 (508)
Q Consensus 260 V~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~ 339 (508)
||||+++|+|.+++... .+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++...
T Consensus 113 v~e~~~~~~L~~~l~~~-----~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 184 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPRH-----SIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 184 (318)
T ss_dssp EECCCTTCBHHHHGGGS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEecccCCcHHHHHhhC-----CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCccccccc
Confidence 99999999999999765 489999999999999999999999 9999999999999999999999999999987
Q ss_pred CCCCcc--eecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCC--------CcchHHHHHHHhh
Q 010513 340 GAERSY--VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPP--------GEVNLVEWLKTMV 409 (508)
Q Consensus 340 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~--------~~~~~~~~~~~~~ 409 (508)
...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ........+....
T Consensus 185 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (318)
T 3lxp_A 185 PEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELL 264 (318)
T ss_dssp CTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHH
T ss_pred cccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHH
Confidence 544332 223456888899999999999999999999999999999999999643110 0000011111111
Q ss_pred cccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 010513 410 TNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEE 463 (508)
Q Consensus 410 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~~~ 463 (508)
.... .... ...++ .++.+++.+||+.||++||++.++++.|+...
T Consensus 265 ~~~~-----~~~~-~~~~~---~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~ 309 (318)
T 3lxp_A 265 ERGE-----RLPR-PDKCP---AEVYHLMKNCWETEASFRPTFENLIPILKTVH 309 (318)
T ss_dssp HTTC-----CCCC-CTTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hccc-----CCCC-Ccccc---HHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 1111 1111 11123 34555888999999999999999999998643
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=353.39 Aligned_cols=258 Identities=27% Similarity=0.469 Sum_probs=199.3
Q ss_pred hcCCCCcccceEcccCcEEEEEEEEC-CCcE----EEEEEeecC-CchhHHHHHHHHHHHHccCCCCeeeEeeeeecCCe
Q 010513 183 VSTNGFADENVIGEGGYGIVYHGVLE-DNTN----VAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAH 256 (508)
Q Consensus 183 ~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~----vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 256 (508)
+..++|++.+.||+|+||+||+|.+. +++. ||+|.+... .....+.+.+|+.+++.++||||+++++++.++.
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~- 90 (327)
T 3lzb_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST- 90 (327)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-
T ss_pred cCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-
Confidence 34568999999999999999999965 3443 577766443 3345678899999999999999999999998765
Q ss_pred eEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccc
Q 010513 257 RMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLA 336 (508)
Q Consensus 257 ~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a 336 (508)
.++|++|+.+|+|.+++... ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 91 ~~~v~~~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a 164 (327)
T 3lzb_A 91 VQLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLA 164 (327)
T ss_dssp EEEEECCCSSCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC-
T ss_pred ceEEEEecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcce
Confidence 78999999999999999875 35799999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCc-ceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHhhccccc
Q 010513 337 KLLGAERS-YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNA 414 (508)
Q Consensus 337 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 414 (508)
+....... .......||+.|+|||.+.+..++.++|||||||++|||++ |+.||...... .....+ ....
T Consensus 165 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~---~~~~~~----~~~~- 236 (327)
T 3lzb_A 165 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS---EISSIL----EKGE- 236 (327)
T ss_dssp ---------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---GHHHHH----HTTC-
T ss_pred eEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHH---HHHHHH----HcCC-
Confidence 87643322 22233457888999999999999999999999999999999 99999754332 122211 1111
Q ss_pred ccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 010513 415 EGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEE 463 (508)
Q Consensus 415 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~~~ 463 (508)
... ....++. ++.+++.+||+.||++||++.++++.|+...
T Consensus 237 ----~~~-~~~~~~~---~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 277 (327)
T 3lzb_A 237 ----RLP-QPPICTI---DVYMIMRKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp ----CCC-CCTTBCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----CCC-CCccCCH---HHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 000 1111333 3455888999999999999999999998654
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=355.22 Aligned_cols=260 Identities=22% Similarity=0.332 Sum_probs=191.0
Q ss_pred HhhcCCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCchhHHHHHHHHHHHHccC-CCCeeeEeeeee------
Q 010513 181 LEVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVR-HKNLVRLLGYCA------ 252 (508)
Q Consensus 181 ~~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~------ 252 (508)
+++...+|++.+.||+|+||.||+|.+. +++.||+|++........+.+.+|+.++.++. ||||+++++++.
T Consensus 23 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~ 102 (337)
T 3ll6_A 23 VELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEES 102 (337)
T ss_dssp EEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTS
T ss_pred eeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhcccccccccccc
Confidence 3556668999999999999999999975 68899999997776666778899999999996 999999999983
Q ss_pred --cCCeeEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eeeccCCCCCEEEcCCCCe
Q 010513 253 --EGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK--VVHRDIKSSNILLDKQWNP 328 (508)
Q Consensus 253 --~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~--iiHrDlkp~NIll~~~~~~ 328 (508)
.....++||||+. |+|.+++.... ....+++..++.++.|++.||+|||++ + |+||||||+|||++.++.+
T Consensus 103 ~~~~~~~~lv~e~~~-g~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~ 177 (337)
T 3ll6_A 103 DTGQAEFLLLTELCK-GQLVEFLKKME-SRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTI 177 (337)
T ss_dssp TTSSEEEEEEEECCS-EEHHHHHHHHH-TTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCE
T ss_pred ccCCceEEEEEEecC-CCHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCE
Confidence 3445789999996 59999886521 135699999999999999999999998 8 9999999999999999999
Q ss_pred EEeeeccceecCCCCcce-----------ecceecCCCCCChhhh---hcCCCCCCCCeeehHHHHHHHHhCCCCCCCCC
Q 010513 329 KLSDFGLAKLLGAERSYV-----------TTRVMGTFGYVAPEYA---STGMLNERSDVYSFGILIMEVISGRNPVDYSR 394 (508)
Q Consensus 329 kL~DFG~a~~~~~~~~~~-----------~~~~~gt~~y~aPE~~---~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~ 394 (508)
||+|||+++......... .....||+.|+|||++ .+..++.++|||||||++|||++|+.||....
T Consensus 178 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~ 257 (337)
T 3ll6_A 178 KLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGA 257 (337)
T ss_dssp EBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----
T ss_pred EEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchh
Confidence 999999998765432211 1135689999999998 56678899999999999999999999996432
Q ss_pred CCCcchHHHHHHHhhcccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCC
Q 010513 395 PPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEEF 464 (508)
Q Consensus 395 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~~~~ 464 (508)
.. ....... ... .....+.. +.+++.+||+.||++||++.+++++|+....
T Consensus 258 ~~------~~~~~~~---------~~~-~~~~~~~~---~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~ 308 (337)
T 3ll6_A 258 KL------RIVNGKY---------SIP-PHDTQYTV---FHSLIRAMLQVNPEERLSIAEVVHQLQEIAA 308 (337)
T ss_dssp --------------C---------CCC-TTCCSSGG---GHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HH------HhhcCcc---------cCC-cccccchH---HHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 21 1011000 000 01112222 4457889999999999999999999987643
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=361.12 Aligned_cols=199 Identities=26% Similarity=0.378 Sum_probs=168.8
Q ss_pred CCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecC--CchhHHHHHHHHHHHHccCCCCeeeEeeeeecC-----Ce
Q 010513 185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEG-----AH 256 (508)
Q Consensus 185 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-----~~ 256 (508)
.++|++.+.||+|+||+||+|.+. +++.||||++... .....+.+.+|+++++.++||||+++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 458999999999999999999976 5778999999654 233456788999999999999999999999766 57
Q ss_pred eEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccc
Q 010513 257 RMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLA 336 (508)
Q Consensus 257 ~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a 336 (508)
.|+||||+++ +|.+++... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 105 ~~lv~e~~~~-~L~~~~~~~----~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla 176 (432)
T 3n9x_A 105 LYIVLEIADS-DLKKLFKTP----IFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLA 176 (432)
T ss_dssp EEEEEECCSE-EHHHHHHSS----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEecCCc-CHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCc
Confidence 8999999975 999999764 5699999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCc---------------------ceecceecCCCCCChhhh-hcCCCCCCCCeeehHHHHHHHHhCCCCCC
Q 010513 337 KLLGAERS---------------------YVTTRVMGTFGYVAPEYA-STGMLNERSDVYSFGILIMEVISGRNPVD 391 (508)
Q Consensus 337 ~~~~~~~~---------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~sDvwSlGvvl~elltg~~Pf~ 391 (508)
+....... ...+..+||+.|+|||++ ....|+.++|||||||++|||++|..||.
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp EEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred ccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 97643321 123557899999999986 56679999999999999999998665554
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=340.73 Aligned_cols=256 Identities=30% Similarity=0.474 Sum_probs=200.5
Q ss_pred CCCcccceEcccCcEEEEEEEECCC----cEEEEEEeecCC-chhHHHHHHHHHHHHccCCCCeeeEeeee-ecCCeeEE
Q 010513 186 NGFADENVIGEGGYGIVYHGVLEDN----TNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYC-AEGAHRML 259 (508)
Q Consensus 186 ~~~~~~~~LG~G~~g~Vy~~~~~~~----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~-~~~~~~~l 259 (508)
.+|++.+.||+|+||+||+|.+.++ ..+|+|.+.... ....+.+.+|++++++++||||+++++++ ..++..++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 104 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence 4688999999999999999996432 257899886543 34456788999999999999999999985 45567899
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceec
Q 010513 260 VYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL 339 (508)
Q Consensus 260 V~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~ 339 (508)
||||+++|+|.+++... ...+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++..
T Consensus 105 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~ 178 (298)
T 3f66_A 105 VLPYMKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDM 178 (298)
T ss_dssp EEECCTTCBHHHHHHCT---TCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred EEeCCCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECcccccccc
Confidence 99999999999999765 35689999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCcc---eecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHhhcccccc
Q 010513 340 GAERSY---VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAE 415 (508)
Q Consensus 340 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (508)
...... ......||+.|+|||.+.+..++.++||||||+++|||++ |..||....... .... .....
T Consensus 179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~---~~~~---~~~~~--- 249 (298)
T 3f66_A 179 YDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---ITVY---LLQGR--- 249 (298)
T ss_dssp SCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT---HHHH---HHTTC---
T ss_pred cccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHH---HHHH---HhcCC---
Confidence 443221 2233567889999999999999999999999999999999 556665433221 1111 11111
Q ss_pred cCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 010513 416 GVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEE 463 (508)
Q Consensus 416 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~~~ 463 (508)
. .......+.. +.+++.+||+.||++||++.++++.|++.-
T Consensus 250 ~----~~~~~~~~~~---l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 290 (298)
T 3f66_A 250 R----LLQPEYCPDP---LYEVMLKCWHPKAEMRPSFSELVSRISAIF 290 (298)
T ss_dssp C----CCCCTTCCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred C----CCCCccCCHH---HHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 0 0111223333 445778999999999999999999998754
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-43 Score=349.89 Aligned_cols=267 Identities=22% Similarity=0.405 Sum_probs=200.3
Q ss_pred hhhHhhcCCCCcccceEcccCcEEEEEEEEC----CCcEEEEEEeecC--CchhHHHHHHHHHHHHccCCCCeeeEeeee
Q 010513 178 LRELEVSTNGFADENVIGEGGYGIVYHGVLE----DNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLLGYC 251 (508)
Q Consensus 178 ~~~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~----~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~ 251 (508)
+.++.+..++|.+.+.||+|+||.||+|.+. ++..||+|.+... .....+.+.+|++++++++||||+++++++
T Consensus 26 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 105 (313)
T 3brb_A 26 LEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVC 105 (313)
T ss_dssp TTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEE
T ss_pred HHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEE
Confidence 4555677789999999999999999999864 2347999998654 233456788999999999999999999999
Q ss_pred ecCCe-----eEEEEEecCCCCHHHHhccCC--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcC
Q 010513 252 AEGAH-----RMLVYEYIDNGNLEQWLHGDV--GPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDK 324 (508)
Q Consensus 252 ~~~~~-----~~lV~e~~~~g~L~~~l~~~~--~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~ 324 (508)
.+... .++||||+++|+|.+++.... .....+++..++.++.|++.||.|||++ +|+||||||+||+++.
T Consensus 106 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~ 182 (313)
T 3brb_A 106 IEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRD 182 (313)
T ss_dssp EC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECT
T ss_pred eeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcC
Confidence 87553 489999999999999985332 2245799999999999999999999999 9999999999999999
Q ss_pred CCCeEEeeeccceecCCCCcc-eecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHh-CCCCCCCCCCCCcchHH
Q 010513 325 QWNPKLSDFGLAKLLGAERSY-VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLV 402 (508)
Q Consensus 325 ~~~~kL~DFG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~ 402 (508)
++.+||+|||++......... ......+++.|+|||.+.+..++.++|||||||++|||++ |..||...... ...
T Consensus 183 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~ 259 (313)
T 3brb_A 183 DMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH---EMY 259 (313)
T ss_dssp TSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---GHH
T ss_pred CCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHH---HHH
Confidence 999999999999876433222 2233467889999999999999999999999999999999 99999754322 111
Q ss_pred HHHHHhhcccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 010513 403 EWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEE 463 (508)
Q Consensus 403 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~~~ 463 (508)
.. ..... .+... ...+ ..+.+++.+||+.||++||++.+++++|+...
T Consensus 260 ~~---~~~~~------~~~~~-~~~~---~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~ 307 (313)
T 3brb_A 260 DY---LLHGH------RLKQP-EDCL---DELYEIMYSCWRTDPLDRPTFSVLRLQLEKLL 307 (313)
T ss_dssp HH---HHTTC------CCCCB-TTCC---HHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HH---HHcCC------CCCCC-cccc---HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 11 11111 01111 1122 34555888999999999999999999998653
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=339.72 Aligned_cols=251 Identities=23% Similarity=0.339 Sum_probs=201.3
Q ss_pred CCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCc------hhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeE
Q 010513 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG------QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM 258 (508)
Q Consensus 186 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 258 (508)
++|++.+.||+|+||.||+|... +++.||+|.+..... ...+.+.+|+++++.++||||+++++++.+....+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 46899999999999999999987 588999999865422 23578899999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCC----CeEEeeec
Q 010513 259 LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQW----NPKLSDFG 334 (508)
Q Consensus 259 lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~----~~kL~DFG 334 (508)
+||||+++++|.+++... ..+++..++.++.|++.||+|||++ +++||||||+||+++.++ .+||+|||
T Consensus 85 lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg 157 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEK----ESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFG 157 (283)
T ss_dssp EEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEeecCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEecc
Confidence 999999999999999764 4689999999999999999999999 999999999999998877 79999999
Q ss_pred cceecCCCCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhccccc
Q 010513 335 LAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNA 414 (508)
Q Consensus 335 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 414 (508)
++....... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||..... .+.........
T Consensus 158 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~-- 227 (283)
T 3bhy_A 158 IAHKIEAGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETK------QETLTNISAVN-- 227 (283)
T ss_dssp TCEECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHTTC--
T ss_pred cceeccCCC--cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcch------HHHHHHhHhcc--
Confidence 998764332 22345789999999999999999999999999999999999999974321 11122211110
Q ss_pred ccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 415 EGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 415 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
..............+.+++.+||+.||++||++.+++++
T Consensus 228 -----~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 266 (283)
T 3bhy_A 228 -----YDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEH 266 (283)
T ss_dssp -----CCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHC
T ss_pred -----cCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhC
Confidence 000000011122345568889999999999999999973
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=356.02 Aligned_cols=242 Identities=21% Similarity=0.365 Sum_probs=200.3
Q ss_pred CCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCc--------hhHHHHHHHHHHHHccCCCCeeeEeeeeecCC
Q 010513 185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG--------QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGA 255 (508)
Q Consensus 185 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~ 255 (508)
.++|++.+.||+|+||+||+|.+. +++.||||.+..... ...+.+.+|+++++.++||||+++++++.+.+
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 102 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG 102 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence 357999999999999999999965 588899999865432 12345677999999999999999999999999
Q ss_pred eeEEEEEecCCC-CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeec
Q 010513 256 HRMLVYEYIDNG-NLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFG 334 (508)
Q Consensus 256 ~~~lV~e~~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG 334 (508)
..++||||+.+| +|.+++... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||
T Consensus 103 ~~~lv~e~~~~g~~l~~~~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg 175 (335)
T 3dls_A 103 FFQLVMEKHGSGLDLFAFIDRH----PRLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFG 175 (335)
T ss_dssp EEEEEEECCTTSCBHHHHHHTC----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCT
T ss_pred EEEEEEEeCCCCccHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeecc
Confidence 999999999777 999999765 4699999999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCcceecceecCCCCCChhhhhcCCC-CCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccc
Q 010513 335 LAKLLGAERSYVTTRVMGTFGYVAPEYASTGML-NERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRN 413 (508)
Q Consensus 335 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 413 (508)
++........ ....+||+.|+|||++.+..+ +.++|||||||++|||++|+.||...... ..
T Consensus 176 ~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------------~~--- 238 (335)
T 3dls_A 176 SAAYLERGKL--FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET------------VE--- 238 (335)
T ss_dssp TCEECCTTCC--BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG------------TT---
T ss_pred cceECCCCCc--eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH------------Hh---
Confidence 9987644332 334679999999999988776 78899999999999999999999632110 00
Q ss_pred cccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 414 AEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 414 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
.... .....+. ++.+++.+||+.||++||++.+++++
T Consensus 239 --~~~~---~~~~~~~---~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 239 --AAIH---PPYLVSK---ELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp --TCCC---CSSCCCH---HHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred --hccC---CCcccCH---HHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0011 1111233 34557789999999999999999986
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=342.81 Aligned_cols=258 Identities=28% Similarity=0.430 Sum_probs=204.4
Q ss_pred HhhcCCCCcccc-eEcccCcEEEEEEEEC---CCcEEEEEEeecCC--chhHHHHHHHHHHHHccCCCCeeeEeeeeecC
Q 010513 181 LEVSTNGFADEN-VIGEGGYGIVYHGVLE---DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEG 254 (508)
Q Consensus 181 ~~~~~~~~~~~~-~LG~G~~g~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~ 254 (508)
..+..++|.+.+ .||+|+||+||+|.+. +++.||+|.+.... ....+.+.+|+++++.++||||+++++++ +.
T Consensus 11 ~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~ 89 (291)
T 1xbb_A 11 VYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EA 89 (291)
T ss_dssp CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ES
T ss_pred eeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CC
Confidence 345556788888 9999999999999653 36789999986543 23356789999999999999999999999 55
Q ss_pred CeeEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeec
Q 010513 255 AHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFG 334 (508)
Q Consensus 255 ~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG 334 (508)
+..++||||+++++|.+++... ..+++..++.++.|++.||+|||++ +++||||||+||+++.++.+||+|||
T Consensus 90 ~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg 162 (291)
T 1xbb_A 90 ESWMLVMEMAELGPLNKYLQQN----RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFG 162 (291)
T ss_dssp SSEEEEEECCTTEEHHHHHHHC----TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCT
T ss_pred CCcEEEEEeCCCCCHHHHHHhC----cCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCC
Confidence 6789999999999999999775 4689999999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCccee--cceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHhhcc
Q 010513 335 LAKLLGAERSYVT--TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTN 411 (508)
Q Consensus 335 ~a~~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~ 411 (508)
++........... ....|++.|+|||.+.+..++.++||||||+++|||++ |+.||..... .+.. .....
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~------~~~~-~~~~~ 235 (291)
T 1xbb_A 163 LSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG------SEVT-AMLEK 235 (291)
T ss_dssp TCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH------HHHH-HHHHT
T ss_pred cceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCH------HHHH-HHHHc
Confidence 9987754443322 22356788999999999889999999999999999999 9999975432 1111 11111
Q ss_pred cccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010513 412 RNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (508)
Q Consensus 412 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~~ 462 (508)
.. .+... ...+. .+.+++.+||+.||++||++.++++.|++.
T Consensus 236 ~~-----~~~~~-~~~~~---~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 277 (291)
T 1xbb_A 236 GE-----RMGCP-AGCPR---EMYDLMNLCWTYDVENRPGFAAVELRLRNY 277 (291)
T ss_dssp TC-----CCCCC-TTCCH---HHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CC-----CCCCC-CCCCH---HHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 11 01111 11333 345578899999999999999999999753
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-43 Score=342.95 Aligned_cols=257 Identities=24% Similarity=0.342 Sum_probs=203.5
Q ss_pred CCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCC--chhHHHHHHHHHHHHccCCCCeeeEeeeee--cCCeeEE
Q 010513 185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCA--EGAHRML 259 (508)
Q Consensus 185 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~--~~~~~~l 259 (508)
.++|++.+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|++++++++||||+++++++. .....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 357999999999999999999976 68889999986543 334567889999999999999999999874 4568899
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-----eeeccCCCCCEEEcCCCCeEEeeec
Q 010513 260 VYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK-----VVHRDIKSSNILLDKQWNPKLSDFG 334 (508)
Q Consensus 260 V~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~-----iiHrDlkp~NIll~~~~~~kL~DFG 334 (508)
||||+++|+|.+++.........+++..++.++.|++.||+|||++ + ++||||||+||+++.++.+||+|||
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg 161 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDFG 161 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence 9999999999999976433345699999999999999999999998 7 9999999999999999999999999
Q ss_pred cceecCCCCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhccccc
Q 010513 335 LAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNA 414 (508)
Q Consensus 335 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 414 (508)
+++....... ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||..... ....+ . ......
T Consensus 162 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~---~-i~~~~~ 233 (279)
T 2w5a_A 162 LARILNHDTS-FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ---KELAG---K-IREGKF 233 (279)
T ss_dssp HHHHC---CH-HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHH---H-HHHTCC
T ss_pred hheeeccccc-cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH---HHHHH---H-Hhhccc
Confidence 9987643322 22345789999999999999999999999999999999999999975421 11111 1 111111
Q ss_pred ccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 010513 415 EGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461 (508)
Q Consensus 415 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~ 461 (508)
. .+.. ..+. ++.+++.+||+.||++||++.++++++..
T Consensus 234 ~-----~~~~-~~~~---~l~~li~~~l~~~p~~Rps~~~ll~~~~~ 271 (279)
T 2w5a_A 234 R-----RIPY-RYSD---ELNEIITRMLNLKDYHRPSVEEILENPLI 271 (279)
T ss_dssp C-----CCCT-TSCH---HHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred c-----cCCc-ccCH---HHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence 1 1111 1233 34457789999999999999999987653
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=352.30 Aligned_cols=263 Identities=20% Similarity=0.300 Sum_probs=193.5
Q ss_pred cCCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCc--hhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEE
Q 010513 184 STNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG--QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLV 260 (508)
Q Consensus 184 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 260 (508)
..++|++.+.||+|+||+||+|.+. +++.||+|++..... ...+.+.+|+++++.++||||+++++++.++...++|
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 111 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI 111 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence 3457999999999999999999965 688899999865432 2245677899999999999999999999999999999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEc-----CCCCeEEeeecc
Q 010513 261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLD-----KQWNPKLSDFGL 335 (508)
Q Consensus 261 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~-----~~~~~kL~DFG~ 335 (508)
|||+++ +|.+++... ..+++..++.++.|++.||+|||++ +|+||||||+|||++ .++.+||+|||+
T Consensus 112 ~e~~~~-~L~~~~~~~----~~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~ 183 (329)
T 3gbz_A 112 FEYAEN-DLKKYMDKN----PDVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGL 183 (329)
T ss_dssp EECCSE-EHHHHHHHC----TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTTH
T ss_pred EecCCC-CHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCCC
Confidence 999985 999999775 4689999999999999999999999 999999999999994 455699999999
Q ss_pred ceecCCCCcceecceecCCCCCChhhhhcC-CCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccc-
Q 010513 336 AKLLGAERSYVTTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRN- 413 (508)
Q Consensus 336 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~- 413 (508)
++...... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||...... ..............
T Consensus 184 a~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~~~~~~~~~~~~~~ 259 (329)
T 3gbz_A 184 ARAFGIPI-RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEI---DQLFKIFEVLGLPDD 259 (329)
T ss_dssp HHHHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHHHCCCCT
T ss_pred ccccCCcc-cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHH---HHHHHHHHHhCCCch
Confidence 98764332 223445789999999999774 5899999999999999999999999754321 11111111110000
Q ss_pred --cc--------cCCCccCCCCchHH-----HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 414 --AE--------GVLDPRLQEKPCSR-----ALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 414 --~~--------~~~~~~l~~~~~~~-----~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
.. ....+......... ...++.+++.+||+.||++||++.|++++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 319 (329)
T 3gbz_A 260 TTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH 319 (329)
T ss_dssp TTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred hhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence 00 00001111111111 12455678889999999999999999973
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=344.61 Aligned_cols=250 Identities=20% Similarity=0.327 Sum_probs=201.0
Q ss_pred CCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCchhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEEec
Q 010513 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYI 264 (508)
Q Consensus 186 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~ 264 (508)
++|.+.+.||+|+||+||+|... +++.||+|.+........+.+.+|+++++.++||||+++++++.+....++||||+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 88 (304)
T 2jam_A 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLV 88 (304)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcC
Confidence 47899999999999999999976 68899999997665555667889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEE---cCCCCeEEeeeccceecCC
Q 010513 265 DNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILL---DKQWNPKLSDFGLAKLLGA 341 (508)
Q Consensus 265 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll---~~~~~~kL~DFG~a~~~~~ 341 (508)
++++|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+||++ +.++.+||+|||++.....
T Consensus 89 ~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 161 (304)
T 2jam_A 89 SGGELFDRILER----GVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN 161 (304)
T ss_dssp CSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC
T ss_pred CCccHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcceecCC
Confidence 999999998764 4689999999999999999999999 99999999999999 7888999999999975432
Q ss_pred CCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCCcc
Q 010513 342 ERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPR 421 (508)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 421 (508)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+........ .. . ....
T Consensus 162 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~~~i~~~-~~-~-~~~~ 229 (304)
T 2jam_A 162 G---IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE------SKLFEKIKEG-YY-E-FESP 229 (304)
T ss_dssp B---TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHHC-CC-C-CCTT
T ss_pred C---ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHHcC-CC-C-CCcc
Confidence 2 22345799999999999999999999999999999999999999964321 1111111111 10 0 0111
Q ss_pred CCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 422 LQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 422 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
.. ...+ .++.+++.+||+.||++||++.+++++
T Consensus 230 ~~-~~~~---~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (304)
T 2jam_A 230 FW-DDIS---ESAKDFICHLLEKDPNERYTCEKALSH 262 (304)
T ss_dssp TT-TTSC---HHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred cc-ccCC---HHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 11 1122 345558889999999999999999973
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=357.12 Aligned_cols=271 Identities=21% Similarity=0.260 Sum_probs=210.9
Q ss_pred cCCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCC-chhHHHHHHHHHHHHccCCCCeeeEeeeeecCC--eeEE
Q 010513 184 STNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGA--HRML 259 (508)
Q Consensus 184 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~--~~~l 259 (508)
..++|.+.+.||+|+||+||+|.+. +++.||||++.... ....+.+.+|++++++++||||+++++++.+.. ..++
T Consensus 7 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 86 (396)
T 4eut_A 7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL 86 (396)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred CCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEE
Confidence 4568999999999999999999986 48899999986543 234567788999999999999999999998755 7799
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEE----cCCCCeEEeeecc
Q 010513 260 VYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILL----DKQWNPKLSDFGL 335 (508)
Q Consensus 260 V~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll----~~~~~~kL~DFG~ 335 (508)
||||+++|+|.+++..... ...+++..++.++.|++.||+|||++ +|+||||||+|||+ +.++.+||+|||+
T Consensus 87 v~e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~ 162 (396)
T 4eut_A 87 IMEFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA 162 (396)
T ss_dssp EECCCTTEEHHHHTTSGGG-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGG
T ss_pred EEecCCCCCHHHHHHhhhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCC
Confidence 9999999999999976521 23499999999999999999999999 99999999999999 7778899999999
Q ss_pred ceecCCCCcceecceecCCCCCChhhhhc--------CCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHH
Q 010513 336 AKLLGAERSYVTTRVMGTFGYVAPEYAST--------GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKT 407 (508)
Q Consensus 336 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~ 407 (508)
++...... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......... .+.+..
T Consensus 163 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~--~~~~~~ 238 (396)
T 4eut_A 163 ARELEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN--KEVMYK 238 (396)
T ss_dssp CEECCCGG--GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTC--HHHHHH
T ss_pred ceEccCCC--ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccch--HHHHHH
Confidence 98764432 2234579999999999865 56778999999999999999999999754432222 122222
Q ss_pred hhcccccc------cCC--------CccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010513 408 MVTNRNAE------GVL--------DPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (508)
Q Consensus 408 ~~~~~~~~------~~~--------~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~~ 462 (508)
........ ... +..............+.+++.+||+.||++||++.++++.++..
T Consensus 239 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~i 307 (396)
T 4eut_A 239 IITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (396)
T ss_dssp HHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred HhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHH
Confidence 22211100 000 00011122344555666788899999999999999999998764
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=353.95 Aligned_cols=261 Identities=22% Similarity=0.339 Sum_probs=194.3
Q ss_pred CCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCch-hHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEEe
Q 010513 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQ-AEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY 263 (508)
Q Consensus 186 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~ 263 (508)
++|++.+.||+|+||+||+|... +++.||+|++...... ....+.+|+++++.++||||+++++++.+++..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 57999999999999999999976 6889999998644322 112345699999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCCC
Q 010513 264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER 343 (508)
Q Consensus 264 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 343 (508)
+++ +|.+++... ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 154 (324)
T 3mtl_A 82 LDK-DLKQYLDDC---GNIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPT 154 (324)
T ss_dssp CSE-EHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC----
T ss_pred ccc-CHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCCc
Confidence 985 999998765 35689999999999999999999999 99999999999999999999999999998654322
Q ss_pred cceecceecCCCCCChhhhhc-CCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccc---cccC--
Q 010513 344 SYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRN---AEGV-- 417 (508)
Q Consensus 344 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~---~~~~-- 417 (508)
.......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... .....+........ ....
T Consensus 155 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---~~~~~i~~~~~~~~~~~~~~~~~ 230 (324)
T 3mtl_A 155 -KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVE---EQLHFIFRILGTPTEETWPGILS 230 (324)
T ss_dssp ---------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCCCCTTTSTTGGG
T ss_pred -cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhCCCChHhchhhhc
Confidence 22334578999999999876 56899999999999999999999999754321 11122221111100 0000
Q ss_pred -------CCccCCCCc----hHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 010513 418 -------LDPRLQEKP----CSRALKRALLVALRCVDPNAHKRPKMGHVIH 457 (508)
Q Consensus 418 -------~~~~l~~~~----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 457 (508)
..+...... .+....++.+++.+||+.||++|||+.|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 231 NEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp CHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred chhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 000000000 0011234566888999999999999999987
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-43 Score=356.17 Aligned_cols=261 Identities=29% Similarity=0.452 Sum_probs=196.4
Q ss_pred CCcccceEcccCcEEEEEEEEC--CC--cEEEEEEeecC-CchhHHHHHHHHHHHHccCCCCeeeEeeeee-cCCeeEEE
Q 010513 187 GFADENVIGEGGYGIVYHGVLE--DN--TNVAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCA-EGAHRMLV 260 (508)
Q Consensus 187 ~~~~~~~LG~G~~g~Vy~~~~~--~~--~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~~~~~lV 260 (508)
.|.+.+.||+|+||+||+|.+. ++ ..||+|.+... .....+.+.+|+.++++++||||+++++++. .++..++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 4778899999999999999864 22 35789988653 3345678999999999999999999999865 45678999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecC
Q 010513 261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG 340 (508)
Q Consensus 261 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 340 (508)
|||+++|+|.+++... ...+++..++.++.|+++||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 170 ~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 243 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMY 243 (373)
T ss_dssp EECCTTCBHHHHHHCT---TCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EECCCCCCHHHHHhhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeecccccccc
Confidence 9999999999999765 35688999999999999999999999 99999999999999999999999999998664
Q ss_pred CCCcc---eecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHhhccccccc
Q 010513 341 AERSY---VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEG 416 (508)
Q Consensus 341 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 416 (508)
..... ......+|+.|+|||.+.+..++.++|||||||++|||+| |..||....... ....+ .... .
T Consensus 244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~---~~~~~---~~~~---~ 314 (373)
T 3c1x_A 244 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---ITVYL---LQGR---R 314 (373)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC---HHHHH---HTTC---C
T ss_pred ccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH---HHHHH---HcCC---C
Confidence 33221 1233467889999999999999999999999999999999 777886543321 11111 1111 0
Q ss_pred CCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCCCCCCC
Q 010513 417 VLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEEFPFRDV 469 (508)
Q Consensus 417 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~~~~~~~~~ 469 (508)
.. ....++.. +.+++.+||+.||++||++.++++.|++....+...
T Consensus 315 ~~----~p~~~~~~---l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~~ 360 (373)
T 3c1x_A 315 LL----QPEYCPDP---LYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE 360 (373)
T ss_dssp CC----CCTTCCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSC
T ss_pred CC----CCCCCCHH---HHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcccc
Confidence 11 11223444 445778999999999999999999999765444433
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-43 Score=380.16 Aligned_cols=258 Identities=26% Similarity=0.439 Sum_probs=202.5
Q ss_pred hhcCCCCcccc-eEcccCcEEEEEEEEC---CCcEEEEEEeecCC-chhHHHHHHHHHHHHccCCCCeeeEeeeeecCCe
Q 010513 182 EVSTNGFADEN-VIGEGGYGIVYHGVLE---DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAH 256 (508)
Q Consensus 182 ~~~~~~~~~~~-~LG~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 256 (508)
.+..+++.+.+ .||+|+||.||+|.+. ++..||||++.... ....+.+.+|+++|+.++|||||++++++.+ +.
T Consensus 331 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~ 409 (613)
T 2ozo_A 331 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EA 409 (613)
T ss_dssp BCCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SS
T ss_pred eccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CC
Confidence 34455666666 8999999999999864 45679999987643 3456789999999999999999999999986 56
Q ss_pred eEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccc
Q 010513 257 RMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLA 336 (508)
Q Consensus 257 ~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a 336 (508)
.++||||+++|+|.+++... ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 410 ~~lv~E~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla 483 (613)
T 2ozo_A 410 LMLVMEMAGGGPLHKFLVGK---REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLS 483 (613)
T ss_dssp EEEEEECCTTCBHHHHHTTC---TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTT
T ss_pred eEEEEEeCCCCcHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCc
Confidence 89999999999999999765 35799999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCccee--cceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHhhcccc
Q 010513 337 KLLGAERSYVT--TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRN 413 (508)
Q Consensus 337 ~~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 413 (508)
+.......... ....+++.|+|||++.+..++.++|||||||++|||++ |+.||...... ...+ . +..+.
T Consensus 484 ~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~---~~~~---~-i~~~~ 556 (613)
T 2ozo_A 484 KALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---EVMA---F-IEQGK 556 (613)
T ss_dssp TTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH---HHHH---H-HHTTC
T ss_pred ccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH---HHHH---H-HHcCC
Confidence 87644332222 22346789999999999999999999999999999998 99999754322 1221 1 11111
Q ss_pred cccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010513 414 AEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (508)
Q Consensus 414 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~~ 462 (508)
. ... ...++.. +.+++.+||+.||++||++.++++.|+..
T Consensus 557 ~-----~~~-p~~~~~~---l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 596 (613)
T 2ozo_A 557 R-----MEC-PPECPPE---LYALMSDCWIYKWEDRPDFLTVEQRMRAC 596 (613)
T ss_dssp C-----CCC-CTTCCHH---HHHHHHHTTCSSTTTSCCHHHHHHHHHHH
T ss_pred C-----CCC-CCcCCHH---HHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 0 011 1123344 44588899999999999999999999864
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=340.55 Aligned_cols=250 Identities=20% Similarity=0.323 Sum_probs=204.8
Q ss_pred cCCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCC---chhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEE
Q 010513 184 STNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRML 259 (508)
Q Consensus 184 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 259 (508)
..++|.+.+.||+|+||.||+|.+. +++.||+|.+.... ....+.+.+|+++++.++||||+++++++.+++..++
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 92 (294)
T 2rku_A 13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 92 (294)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEE
Confidence 3457999999999999999999987 47789999886542 3345678899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceec
Q 010513 260 VYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL 339 (508)
Q Consensus 260 V~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~ 339 (508)
||||+++++|.+++... ..+++..++.++.|++.||+|||++ +++||||||+||+++.++.+||+|||++...
T Consensus 93 v~e~~~~~~L~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 165 (294)
T 2rku_A 93 VLELCRRRSLLELHKRR----KALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKV 165 (294)
T ss_dssp EEECCTTCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceec
Confidence 99999999999998764 4789999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCC
Q 010513 340 GAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLD 419 (508)
Q Consensus 340 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 419 (508)
..... ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||..... .+.........
T Consensus 166 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------~~~~~~~~~~~------- 231 (294)
T 2rku_A 166 EYDGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL------KETYLRIKKNE------- 231 (294)
T ss_dssp CSTTC-CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHTTC-------
T ss_pred ccCcc-ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHhhcc-------
Confidence 43222 23345799999999999998999999999999999999999999964321 11111111111
Q ss_pred ccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 420 PRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 420 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
..+.. ..+. .+.+++.+||+.||++||++.+++++
T Consensus 232 ~~~~~-~~~~---~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 232 YSIPK-HINP---VAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp CCCCT-TSCH---HHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred CCCcc-ccCH---HHHHHHHHHcccChhhCcCHHHHhhC
Confidence 01111 1223 34457789999999999999999974
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=348.37 Aligned_cols=249 Identities=20% Similarity=0.332 Sum_probs=204.6
Q ss_pred CCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecC---CchhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEE
Q 010513 185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN---RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLV 260 (508)
Q Consensus 185 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 260 (508)
.++|.+.+.||+|+||.||+|.+. +++.||+|.+... .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 457999999999999999999986 4778999988654 234456788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecC
Q 010513 261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG 340 (508)
Q Consensus 261 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 340 (508)
|||+++++|.+++... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++....
T Consensus 120 ~e~~~~~~L~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 192 (335)
T 2owb_A 120 LELCRRRSLLELHKRR----KALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 192 (335)
T ss_dssp ECCCTTCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EecCCCCCHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceecc
Confidence 9999999999998764 4689999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCCc
Q 010513 341 AERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDP 420 (508)
Q Consensus 341 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 420 (508)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+......... .
T Consensus 193 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~~~~~~~~~-------~ 258 (335)
T 2owb_A 193 YDG-ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC------LKETYLRIKKNE-------Y 258 (335)
T ss_dssp STT-CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS------HHHHHHHHHHTC-------C
T ss_pred cCc-ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCC------HHHHHHHHhcCC-------C
Confidence 332 22344679999999999999999999999999999999999999996432 112111111111 0
Q ss_pred cCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 421 RLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 421 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
.+.. ..+. .+.+++.+||+.||++||++.+++++
T Consensus 259 ~~~~-~~~~---~~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 259 SIPK-HINP---VAASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp CCCT-TSCH---HHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred CCCc-cCCH---HHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1111 1223 34457789999999999999999973
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-43 Score=340.02 Aligned_cols=252 Identities=27% Similarity=0.405 Sum_probs=203.3
Q ss_pred CCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCC-chhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEEe
Q 010513 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY 263 (508)
Q Consensus 186 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~ 263 (508)
++|++.+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+++++.++||||+++++++.+++..++||||
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEe
Confidence 47899999999999999999976 68899999986443 34457788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCCC
Q 010513 264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER 343 (508)
Q Consensus 264 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 343 (508)
+++++|.+++... ..+++..++.++.|++.||+|||++ +++||||||+||+++.++.+||+|||++.......
T Consensus 87 ~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 159 (276)
T 2yex_A 87 CSGGELFDRIEPD----IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (276)
T ss_dssp CTTEEGGGGSBTT----TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred cCCCcHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCCCc
Confidence 9999999998754 5689999999999999999999999 99999999999999999999999999998654322
Q ss_pred c-ceecceecCCCCCChhhhhcCCC-CCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCCcc
Q 010513 344 S-YVTTRVMGTFGYVAPEYASTGML-NERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPR 421 (508)
Q Consensus 344 ~-~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 421 (508)
. .......||+.|+|||.+.+..+ +.++||||||+++|||++|+.||........ ....+ .... ....
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~----~~~~---~~~~-- 229 (276)
T 2yex_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDW----KEKK---TYLN-- 229 (276)
T ss_dssp EECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH-HHHHH----HTTC---TTST--
T ss_pred chhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHh----hhcc---cccC--
Confidence 1 22344678999999999987665 6789999999999999999999976543211 11111 1110 0001
Q ss_pred CCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 422 LQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 422 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
........+.+++.+||+.||++||++.+++++
T Consensus 230 ----~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 230 ----PWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (276)
T ss_dssp ----TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ----chhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence 011122344558889999999999999999864
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=347.75 Aligned_cols=258 Identities=24% Similarity=0.420 Sum_probs=202.6
Q ss_pred cCCCCcccceEcccCcEEEEEEEEC-CCcEE--EEEEeecC-CchhHHHHHHHHHHHHcc-CCCCeeeEeeeeecCCeeE
Q 010513 184 STNGFADENVIGEGGYGIVYHGVLE-DNTNV--AVKNLLNN-RGQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRM 258 (508)
Q Consensus 184 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~v--avK~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~ 258 (508)
..++|++.+.||+|+||.||+|.+. ++..+ |+|.+... .....+.+.+|+++++++ +||||+++++++.+.+..+
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 102 (327)
T 1fvr_A 23 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY 102 (327)
T ss_dssp CGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEE
T ss_pred cHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceE
Confidence 3468999999999999999999965 45544 89988653 233445788999999999 9999999999999999999
Q ss_pred EEEEecCCCCHHHHhccCC------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCC
Q 010513 259 LVYEYIDNGNLEQWLHGDV------------GPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQW 326 (508)
Q Consensus 259 lV~e~~~~g~L~~~l~~~~------------~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~ 326 (508)
+||||+++|+|.+++.... .....+++..++.++.|++.||+|||++ +|+||||||+|||++.++
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~ 179 (327)
T 1fvr_A 103 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENY 179 (327)
T ss_dssp EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGG
T ss_pred EEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCC
Confidence 9999999999999997653 2235799999999999999999999999 999999999999999999
Q ss_pred CeEEeeeccceecCCCCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHh-CCCCCCCCCCCCcchHHHHH
Q 010513 327 NPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWL 405 (508)
Q Consensus 327 ~~kL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~ 405 (508)
.+||+|||+++.... ........+++.|+|||++.+..++.++|||||||++|||++ |+.||..... .+..
T Consensus 180 ~~kL~Dfg~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~------~~~~ 251 (327)
T 1fvr_A 180 VAKIADFGLSRGQEV--YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC------AELY 251 (327)
T ss_dssp CEEECCTTCEESSCE--ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH------HHHH
T ss_pred eEEEcccCcCccccc--cccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcH------HHHH
Confidence 999999999974321 112233467889999999999999999999999999999998 9999964421 2222
Q ss_pred HHhhcccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010513 406 KTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (508)
Q Consensus 406 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~~ 462 (508)
....... ..... ...+. ++.+++.+||+.||++||++.++++.|+..
T Consensus 252 ~~~~~~~------~~~~~-~~~~~---~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 298 (327)
T 1fvr_A 252 EKLPQGY------RLEKP-LNCDD---EVYDLMRQCWREKPYERPSFAQILVSLNRM 298 (327)
T ss_dssp HHGGGTC------CCCCC-TTBCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHhhcCC------CCCCC-CCCCH---HHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 2221111 11111 11233 345578899999999999999999998864
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=351.91 Aligned_cols=203 Identities=26% Similarity=0.410 Sum_probs=177.9
Q ss_pred hhcCCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCC-chhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEE
Q 010513 182 EVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRML 259 (508)
Q Consensus 182 ~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 259 (508)
++..++|++.+.||+|+||+||+|.+. ++..||+|.+.... ....+.+.+|+++++.++||||+++++++.+++..++
T Consensus 29 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 108 (360)
T 3eqc_A 29 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 108 (360)
T ss_dssp CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred ccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEE
Confidence 345678999999999999999999986 68889999987653 3445678899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceec
Q 010513 260 VYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL 339 (508)
Q Consensus 260 V~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~ 339 (508)
||||+++|+|.+++... ..+++..+..++.|++.||+|||++. +|+||||||+|||++.++.+||+|||++...
T Consensus 109 v~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 182 (360)
T 3eqc_A 109 CMEHMDGGSLDQVLKKA----GRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQL 182 (360)
T ss_dssp EECCCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHH
T ss_pred EEECCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEEECCCCccc
Confidence 99999999999999765 46899999999999999999999832 7999999999999999999999999998754
Q ss_pred CCCCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCC
Q 010513 340 GAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS 393 (508)
Q Consensus 340 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~ 393 (508)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 183 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 233 (360)
T 3eqc_A 183 ID---SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP 233 (360)
T ss_dssp HH---HC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCC
T ss_pred cc---ccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 22 1233457999999999999999999999999999999999999999754
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-43 Score=350.35 Aligned_cols=264 Identities=26% Similarity=0.417 Sum_probs=200.0
Q ss_pred CCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCc--hhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEE
Q 010513 185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG--QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY 261 (508)
Q Consensus 185 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 261 (508)
.++|++.+.||+|+||.||+|.+. +++.||+|++..... ...+.+.+|+++++.++||||+++++++.+....++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 458999999999999999999986 488999999865433 33456788999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCC
Q 010513 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA 341 (508)
Q Consensus 262 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 341 (508)
||+++++|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 104 e~~~~~~l~~~~~~~----~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 176 (331)
T 4aaa_A 104 EFVDHTILDDLELFP----NGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAA 176 (331)
T ss_dssp ECCSEEHHHHHHHST----TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred ecCCcchHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecC
Confidence 999999998887654 4699999999999999999999999 999999999999999999999999999986543
Q ss_pred CCcceecceecCCCCCChhhhhcC-CCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHH----------Hhh-
Q 010513 342 ERSYVTTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLK----------TMV- 409 (508)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~----------~~~- 409 (508)
.. .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||....... ....... ...
T Consensus 177 ~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 253 (331)
T 4aaa_A 177 PG-EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDID--QLYHIMMCLGNLIPRHQELFN 253 (331)
T ss_dssp --------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCSCCHHHHHHHH
T ss_pred Cc-cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHH--HHHHHHHHhCCCChhhhhHhh
Confidence 32 223345799999999998775 78999999999999999999999997543211 1111110 000
Q ss_pred cccccccCCCccCCCCch-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 410 TNRNAEGVLDPRLQEKPC-----SRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 410 ~~~~~~~~~~~~l~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
..........+.+..... +.....+.+++.+||+.||++||++.|++++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 254 KNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp HCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred hccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 001111111111111111 1123456668889999999999999999864
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-42 Score=352.30 Aligned_cols=275 Identities=19% Similarity=0.227 Sum_probs=209.8
Q ss_pred cccchhhHhhcCCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCchhHHHHHHHHHHHHccC--------CCCe
Q 010513 174 HWYTLRELEVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVR--------HKNL 244 (508)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------hpni 244 (508)
.++.++..++..++|++.+.||+|+||+||+|++. +++.||||++... ....+.+.+|+++++.++ |+||
T Consensus 25 ~~~~~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~i 103 (397)
T 1wak_A 25 GYHLVKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMV 103 (397)
T ss_dssp -CCSSCTTCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGB
T ss_pred CceEEehhhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCccee
Confidence 34455555666789999999999999999999975 5788999998643 344567888999999985 7889
Q ss_pred eeEeeeee----cCCeeEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCE
Q 010513 245 VRLLGYCA----EGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNI 320 (508)
Q Consensus 245 v~l~~~~~----~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NI 320 (508)
+++++++. ++...++||||+ +++|.+++.... ...+++..++.++.|++.||+|||+++ +|+||||||+||
T Consensus 104 v~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NI 178 (397)
T 1wak_A 104 VQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSN--YQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENI 178 (397)
T ss_dssp CCEEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGE
T ss_pred eeeecceeecCCCCceEEEEEecc-CccHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHe
Confidence 99999997 566889999999 557777665442 356999999999999999999999854 799999999999
Q ss_pred EEcCCC-------------------------------------------------CeEEeeeccceecCCCCcceeccee
Q 010513 321 LLDKQW-------------------------------------------------NPKLSDFGLAKLLGAERSYVTTRVM 351 (508)
Q Consensus 321 ll~~~~-------------------------------------------------~~kL~DFG~a~~~~~~~~~~~~~~~ 351 (508)
|++.++ .+||+|||++...... .....
T Consensus 179 ll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~ 254 (397)
T 1wak_A 179 LLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDI 254 (397)
T ss_dssp EECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCC
T ss_pred eEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCC
Confidence 998775 7999999999876432 23457
Q ss_pred cCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhc---c---------cccccCCC
Q 010513 352 GTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVT---N---------RNAEGVLD 419 (508)
Q Consensus 352 gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~---~---------~~~~~~~~ 419 (508)
||+.|+|||++.+..++.++|||||||++|||++|+.||............+.+..... . ........
T Consensus 255 gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~ 334 (397)
T 1wak_A 255 QTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFT 334 (397)
T ss_dssp SCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBC
T ss_pred CCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccC
Confidence 99999999999999999999999999999999999999986654433222222211111 0 00000000
Q ss_pred c--------cC-----------CCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 420 P--------RL-----------QEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 420 ~--------~l-----------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
. .. ...........+.+++.+||+.||++||++.|++++
T Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 335 KKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp TTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred CccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 0 00 001134455677889999999999999999999864
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-42 Score=364.73 Aligned_cols=252 Identities=23% Similarity=0.335 Sum_probs=201.1
Q ss_pred cCCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCc-------------hhHHHHHHHHHHHHccCCCCeeeEee
Q 010513 184 STNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG-------------QAEKEFKVEVEAIGRVRHKNLVRLLG 249 (508)
Q Consensus 184 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~hpniv~l~~ 249 (508)
..++|.+.+.||+|+||+||+|... +++.||+|.+..... ...+.+.+|+++++.++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 4568999999999999999999976 578899999865421 23467889999999999999999999
Q ss_pred eeecCCeeEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCC---
Q 010513 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQW--- 326 (508)
Q Consensus 250 ~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~--- 326 (508)
++.++...|+|||||++|+|.+++... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~ 186 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINR----HKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLL 186 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCS
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCc
Confidence 999999999999999999999998765 4699999999999999999999999 999999999999998776
Q ss_pred CeEEeeeccceecCCCCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHH
Q 010513 327 NPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLK 406 (508)
Q Consensus 327 ~~kL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~ 406 (508)
.+||+|||++....... .....+||+.|+|||++. +.++.++|||||||++|+|++|+.||..... .+.+.
T Consensus 187 ~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~------~~~~~ 257 (504)
T 3q5i_A 187 NIKIVDFGLSSFFSKDY--KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQND------QDIIK 257 (504)
T ss_dssp SEEECCCTTCEECCTTS--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHH
T ss_pred cEEEEECCCCEEcCCCC--ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCH------HHHHH
Confidence 69999999998764432 234467999999999986 5689999999999999999999999975422 22222
Q ss_pred HhhcccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 407 TMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 407 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
...... . . +..........++.+++.+||+.||++|||+.|++++
T Consensus 258 ~i~~~~-~----~--~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 258 KVEKGK-Y----Y--FDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp HHHHCC-C----C--CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHcCC-C----C--CCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 222111 0 0 0000011122345568889999999999999999864
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-43 Score=353.98 Aligned_cols=261 Identities=16% Similarity=0.185 Sum_probs=202.6
Q ss_pred CCCCcccceEcccCcEEEEEEEECC---------CcEEEEEEeecCCchhHHHHHHHHHHHHccCCCCeee---------
Q 010513 185 TNGFADENVIGEGGYGIVYHGVLED---------NTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVR--------- 246 (508)
Q Consensus 185 ~~~~~~~~~LG~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~--------- 246 (508)
.++|++.+.||+|+||.||+|.+.. ++.||+|.+... +.+.+|++++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 4689999999999999999999764 778999998654 35778999999999999988
Q ss_pred ------Eeeeeec-CCeeEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCC
Q 010513 247 ------LLGYCAE-GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSN 319 (508)
Q Consensus 247 ------l~~~~~~-~~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~N 319 (508)
+++++.. +...++||||+ +++|.+++.... ...+++..++.++.|++.||+|||++ +|+||||||+|
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~N 189 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP--KHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAEN 189 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGGG
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC--cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHH
Confidence 5666665 67889999999 899999997642 25799999999999999999999999 99999999999
Q ss_pred EEEcCCC--CeEEeeeccceecCCCCcc------eecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCC
Q 010513 320 ILLDKQW--NPKLSDFGLAKLLGAERSY------VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVD 391 (508)
Q Consensus 320 Ill~~~~--~~kL~DFG~a~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~ 391 (508)
||++.++ .+||+|||+++.+...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 190 Il~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 269 (352)
T 2jii_A 190 IFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWT 269 (352)
T ss_dssp EEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTG
T ss_pred EEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 9999998 8999999999876433221 1233579999999999999999999999999999999999999997
Q ss_pred CCCCCCcchHHHHHHHhhcccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010513 392 YSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (508)
Q Consensus 392 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~~ 462 (508)
...+.. ............. .....+........+. ++.+++.+||+.||++||++.++++.|++.
T Consensus 270 ~~~~~~-~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~---~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 334 (352)
T 2jii_A 270 NCLPNT-EDIMKQKQKFVDK--PGPFVGPCGHWIRPSE---TLQKYLKVVMALTYEEKPPYAMLRNNLEAL 334 (352)
T ss_dssp GGTTCH-HHHHHHHHHHHHS--CCCEECTTSCEECCCH---HHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred cCCcCH-HHHHHHHHhccCC--hhhhhhhccccCCCcH---HHHHHHHHHHhCChhhCCCHHHHHHHHHHH
Confidence 553221 1122211111111 1111111111111233 344577799999999999999999999865
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-43 Score=361.24 Aligned_cols=253 Identities=21% Similarity=0.349 Sum_probs=192.4
Q ss_pred cCCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCc--------hhHHHHHHHHHHHHccCCCCeeeEeeeeecC
Q 010513 184 STNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG--------QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEG 254 (508)
Q Consensus 184 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~ 254 (508)
..++|.+.+.||+|+||+||+|.+. +++.||+|++..... .....+.+|++++++++||||+++++++..
T Consensus 133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~- 211 (419)
T 3i6u_A 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA- 211 (419)
T ss_dssp HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-
T ss_pred hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-
Confidence 4578999999999999999999976 578999999865321 122347889999999999999999999865
Q ss_pred CeeEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCC---CeEEe
Q 010513 255 AHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQW---NPKLS 331 (508)
Q Consensus 255 ~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~---~~kL~ 331 (508)
...|+||||+++|+|.+++... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++ .+||+
T Consensus 212 ~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl~ 284 (419)
T 3i6u_A 212 EDYYIVLELMEGGELFDKVVGN----KRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKIT 284 (419)
T ss_dssp SEEEEEEECCTTCBGGGGTSSS----CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred CceEEEEEcCCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEEe
Confidence 5679999999999999998764 5799999999999999999999999 999999999999997544 59999
Q ss_pred eeccceecCCCCcceecceecCCCCCChhhhhc---CCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHh
Q 010513 332 DFGLAKLLGAERSYVTTRVMGTFGYVAPEYAST---GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTM 408 (508)
Q Consensus 332 DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~ 408 (508)
|||+++..... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||........ +.+.
T Consensus 285 DFG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~--~~~~---- 356 (419)
T 3i6u_A 285 DFGHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LKDQ---- 356 (419)
T ss_dssp CSSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC--HHHH----
T ss_pred ecccceecCCC--ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH--HHHH----
Confidence 99999876432 23345689999999999853 6688899999999999999999999975433222 2111
Q ss_pred hcccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 409 VTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 409 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
....... ..+. ........+.+++.+||+.||++||++.+++++
T Consensus 357 i~~~~~~--~~~~----~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 357 ITSGKYN--FIPE----VWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp HHTTCCC--CCHH----HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HhcCCCC--CCch----hhcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 1111100 0000 011123455668889999999999999999975
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-43 Score=350.32 Aligned_cols=265 Identities=22% Similarity=0.394 Sum_probs=208.7
Q ss_pred hcCCCCcccceEcccCcEEEEEEEE-----CCCcEEEEEEeecCCchhHHHHHHHHHHHHccCCCCeeeEeeeeecCC--
Q 010513 183 VSTNGFADENVIGEGGYGIVYHGVL-----EDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGA-- 255 (508)
Q Consensus 183 ~~~~~~~~~~~LG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-- 255 (508)
+..++|++.+.||+|+||.||+|++ .+++.||+|++........+.+.+|+++++.++||||+++++++...+
T Consensus 38 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 117 (326)
T 2w1i_A 38 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 117 (326)
T ss_dssp CCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----
T ss_pred cCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCC
Confidence 3455789999999999999999985 357889999998776666788999999999999999999999987654
Q ss_pred eeEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeecc
Q 010513 256 HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGL 335 (508)
Q Consensus 256 ~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~ 335 (508)
..++||||+++|+|.+++... ...+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 118 ~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~ 191 (326)
T 2w1i_A 118 NLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGL 191 (326)
T ss_dssp CCEEEECCCTTCBHHHHHHHS---TTSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTT
T ss_pred ceEEEEECCCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcc
Confidence 688999999999999999875 34689999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCcce--ecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCC---------CCCcchHHHH
Q 010513 336 AKLLGAERSYV--TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSR---------PPGEVNLVEW 404 (508)
Q Consensus 336 a~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~---------~~~~~~~~~~ 404 (508)
+.......... .....++..|+|||.+.+..++.++|||||||++|||+||..||.... ..........
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (326)
T 2w1i_A 192 TKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 271 (326)
T ss_dssp CEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHH
T ss_pred hhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHH
Confidence 98775443322 223457778999999999889999999999999999999999985321 0000111111
Q ss_pred HHHhhcccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010513 405 LKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (508)
Q Consensus 405 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~~ 462 (508)
+......... ... ...++. ++.+++.+||+.||++||++.++++.|+..
T Consensus 272 ~~~~~~~~~~-----~~~-~~~~~~---~l~~li~~cl~~dP~~Rps~~el~~~L~~l 320 (326)
T 2w1i_A 272 LIELLKNNGR-----LPR-PDGCPD---EIYMIMTECWNNNVNQRPSFRDLALRVDQI 320 (326)
T ss_dssp HHHHHHTTCC-----CCC-CTTCCH---HHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHhhcCCC-----CCC-CCcccH---HHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 1122211110 001 112333 445588899999999999999999999754
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=339.47 Aligned_cols=248 Identities=24% Similarity=0.386 Sum_probs=203.9
Q ss_pred hcCCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCC---chhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeE
Q 010513 183 VSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM 258 (508)
Q Consensus 183 ~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 258 (508)
...++|++.+.||+|+||.||+|... ++..||+|.+.... ....+.+.+|+++++.++||||+++++++.+++..+
T Consensus 11 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 90 (284)
T 2vgo_A 11 FTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIY 90 (284)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEE
Confidence 34468999999999999999999976 57789999986532 223467889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeecccee
Q 010513 259 LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL 338 (508)
Q Consensus 259 lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~ 338 (508)
+||||+++|+|.+++... ..+++..++.++.|++.||+|||++ +++||||||+||+++.++.+||+|||++..
T Consensus 91 lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~ 163 (284)
T 2vgo_A 91 LMLEFAPRGELYKELQKH----GRFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVH 163 (284)
T ss_dssp EEECCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEeCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEeccccccc
Confidence 999999999999999765 4689999999999999999999999 999999999999999999999999999976
Q ss_pred cCCCCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCC
Q 010513 339 LGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVL 418 (508)
Q Consensus 339 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 418 (508)
..... .....|++.|+|||++.+..++.++||||||+++|+|++|+.||..... .+........
T Consensus 164 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~~~~~~~------- 227 (284)
T 2vgo_A 164 APSLR---RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSH------TETHRRIVNV------- 227 (284)
T ss_dssp CSSSC---BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHTT-------
T ss_pred Ccccc---cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCH------hHHHHHHhcc-------
Confidence 54322 2345799999999999999999999999999999999999999964321 1112222111
Q ss_pred CccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 010513 419 DPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIH 457 (508)
Q Consensus 419 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 457 (508)
+..+.. ..+. .+.+++.+||+.||++||++.++++
T Consensus 228 ~~~~~~-~~~~---~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 228 DLKFPP-FLSD---GSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp CCCCCT-TSCH---HHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccCCCC-cCCH---HHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 111111 1223 3445788999999999999999986
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=356.69 Aligned_cols=266 Identities=22% Similarity=0.285 Sum_probs=196.3
Q ss_pred HhhcCCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCchhHHHHHHHHHHHHccCCCCeeeEeeeeec------
Q 010513 181 LEVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE------ 253 (508)
Q Consensus 181 ~~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~------ 253 (508)
++...++|++.+.||+|+||+||+|.+. +++.||+|++...... ..+|+++++.++||||++++++|..
T Consensus 2 l~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~ 77 (383)
T 3eb0_A 2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEP 77 (383)
T ss_dssp ----CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS----CCHHHHHHTTCCCTTBCCEEEEEEEC-----
T ss_pred CccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch----HHHHHHHHHHcCCCCccchhheeeecCcccc
Confidence 3456789999999999999999999974 6889999998655332 2369999999999999999999843
Q ss_pred --------------------------------CCeeEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHH
Q 010513 254 --------------------------------GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTY 301 (508)
Q Consensus 254 --------------------------------~~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~ 301 (508)
....++||||+++ +|.+.+.........+++..++.++.|++.||+|
T Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~ 156 (383)
T 3eb0_A 78 KPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGF 156 (383)
T ss_dssp --------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence 3347899999985 8888776432334679999999999999999999
Q ss_pred HHhcCCCCeeeccCCCCCEEEc-CCCCeEEeeeccceecCCCCcceecceecCCCCCChhhhhcC-CCCCCCCeeehHHH
Q 010513 302 LHEGLEPKVVHRDIKSSNILLD-KQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTG-MLNERSDVYSFGIL 379 (508)
Q Consensus 302 LH~~~~~~iiHrDlkp~NIll~-~~~~~kL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvv 379 (508)
||++ +|+||||||+|||++ .++.+||+|||+++....... .....||+.|+|||++.+. .++.++|||||||+
T Consensus 157 LH~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i 231 (383)
T 3eb0_A 157 IHSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP--SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV 231 (383)
T ss_dssp HHTT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC--CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred HHHC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC--CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence 9999 999999999999997 688999999999987643332 3345789999999988765 48999999999999
Q ss_pred HHHHHhCCCCCCCCCCCCcchHHHHHHHhh---------cccccccCCCccCCCCchH-----HHHHHHHHHHHHccCCC
Q 010513 380 IMEVISGRNPVDYSRPPGEVNLVEWLKTMV---------TNRNAEGVLDPRLQEKPCS-----RALKRALLVALRCVDPN 445 (508)
Q Consensus 380 l~elltg~~Pf~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~l~~~~~~-----~~~~~l~~li~~cl~~d 445 (508)
+|||++|+.||....... .+...++..- .+.......-+........ ....++.+++.+||+.|
T Consensus 232 l~ell~g~~pf~~~~~~~--~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 309 (383)
T 3eb0_A 232 FGELILGKPLFSGETSID--QLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYE 309 (383)
T ss_dssp HHHHHHSSCSSCCSSHHH--HHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSS
T ss_pred HHHHHhCCCCCCCCChHH--HHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCC
Confidence 999999999997543211 1111111000 0001111111111111111 12234566888999999
Q ss_pred CCCCCCHHHHHHH
Q 010513 446 AHKRPKMGHVIHM 458 (508)
Q Consensus 446 P~~RPs~~evl~~ 458 (508)
|++|||+.|++++
T Consensus 310 P~~R~t~~e~l~h 322 (383)
T 3eb0_A 310 PDLRINPYEAMAH 322 (383)
T ss_dssp GGGSCCHHHHHTS
T ss_pred hhhCCCHHHHhcC
Confidence 9999999999853
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=365.29 Aligned_cols=251 Identities=22% Similarity=0.351 Sum_probs=198.0
Q ss_pred CCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCC--chhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEE
Q 010513 185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY 261 (508)
Q Consensus 185 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 261 (508)
.++|++.+.||+|+||+||+|+.. ++..||+|++.... ......+.+|+++++.++||||+++++++.+....|+||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 347999999999999999999986 68889999986543 334567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCC---CCeEEeeecccee
Q 010513 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQ---WNPKLSDFGLAKL 338 (508)
Q Consensus 262 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~---~~~kL~DFG~a~~ 338 (508)
||+++|+|.+++... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.+ +.+||+|||++..
T Consensus 116 e~~~~g~L~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~ 188 (494)
T 3lij_A 116 ECYKGGELFDEIIHR----MKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAV 188 (494)
T ss_dssp ECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred ecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCeE
Confidence 999999999988765 4689999999999999999999999 99999999999999764 4599999999987
Q ss_pred cCCCCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCC
Q 010513 339 LGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVL 418 (508)
Q Consensus 339 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 418 (508)
..... .....+||+.|+|||++. +.|+.++|||||||++|+|++|+.||..... .+.+....... . ...
T Consensus 189 ~~~~~--~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~------~~~~~~i~~~~-~-~~~ 257 (494)
T 3lij_A 189 FENQK--KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTD------QEILRKVEKGK-Y-TFD 257 (494)
T ss_dssp CBTTB--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHTC-C-CCC
T ss_pred CCCCc--cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhCC-C-CCC
Confidence 64432 234467999999999986 5689999999999999999999999975432 22222222111 0 011
Q ss_pred CccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 419 DPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 419 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
.+... ..+ ..+.+++.+||+.||++|||+.+++++
T Consensus 258 ~~~~~--~~s---~~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 258 SPEWK--NVS---EGAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp SGGGT--TSC---HHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred chhcc--cCC---HHHHHHHHHHCCCChhhCccHHHHhcC
Confidence 11111 122 344558889999999999999998854
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=339.18 Aligned_cols=256 Identities=27% Similarity=0.405 Sum_probs=200.9
Q ss_pred CCcccceEcccCcEEEEEEEECC-Cc---EEEEEEeecCCc-hhHHHHHHHHHHHHccCCCCeeeEeeeeecCCee-EEE
Q 010513 187 GFADENVIGEGGYGIVYHGVLED-NT---NVAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHR-MLV 260 (508)
Q Consensus 187 ~~~~~~~LG~G~~g~Vy~~~~~~-~~---~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~-~lV 260 (508)
.|...+.||+|+||+||+|.+.+ +. .||+|.+..... ...+.+.+|+++++.++||||+++++++.+.+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 45667999999999999998642 22 689998865433 4456788999999999999999999999876665 899
Q ss_pred EEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecC
Q 010513 261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG 340 (508)
Q Consensus 261 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 340 (508)
|||+.+|+|.+++... ...+++..++.++.|++.||+|||++ +++||||||+|||++.++.+||+|||+++...
T Consensus 102 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 175 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSP---QRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDIL 175 (298)
T ss_dssp ECCCTTCBHHHHHHCT---TCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTT
T ss_pred EecccCCCHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCccccc
Confidence 9999999999999774 35789999999999999999999999 99999999999999999999999999998654
Q ss_pred CCCc---ceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccC
Q 010513 341 AERS---YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGV 417 (508)
Q Consensus 341 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 417 (508)
.... .......||+.|+|||.+.+..++.++|||||||++|+|++|..|+...... ........ ....
T Consensus 176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~--~~~~~~~~---~~~~---- 246 (298)
T 3pls_A 176 DREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP--FDLTHFLA---QGRR---- 246 (298)
T ss_dssp TGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCG--GGHHHHHH---TTCC----
T ss_pred CCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCH--HHHHHHhh---cCCC----
Confidence 3221 1223346788999999999999999999999999999999966554332221 12222111 1110
Q ss_pred CCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 010513 418 LDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEE 463 (508)
Q Consensus 418 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~~~ 463 (508)
.. .....+. .+.+++.+||+.||++||++.++++.|+...
T Consensus 247 --~~-~~~~~~~---~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 286 (298)
T 3pls_A 247 --LP-QPEYCPD---SLYQVMQQCWEADPAVRPTFRVLVGEVEQIV 286 (298)
T ss_dssp --CC-CCTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --CC-CCccchH---HHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 00 1111233 3455788999999999999999999998754
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=344.32 Aligned_cols=254 Identities=20% Similarity=0.308 Sum_probs=198.9
Q ss_pred cCCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCchhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEE
Q 010513 184 STNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE 262 (508)
Q Consensus 184 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e 262 (508)
..++|++.+.||+|+||.||+|.+. ++..||+|.+........+.+.+|+++++.++||||+++++++.+++..++|||
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 96 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE 96 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence 4568999999999999999999986 588899999876666667788999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCC
Q 010513 263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE 342 (508)
Q Consensus 263 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 342 (508)
|+++++|.+++... ...+++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||++......
T Consensus 97 ~~~~~~l~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 170 (302)
T 2j7t_A 97 FCPGGAVDAIMLEL---DRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT 170 (302)
T ss_dssp CCTTEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH
T ss_pred eCCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCcccccc
Confidence 99999999998764 25689999999999999999999999 9999999999999999999999999987643111
Q ss_pred CcceecceecCCCCCChhhhh-----cCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccC
Q 010513 343 RSYVTTRVMGTFGYVAPEYAS-----TGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGV 417 (508)
Q Consensus 343 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 417 (508)
........||+.|+|||++. +..++.++||||||+++|+|++|+.||..... .+.......... ..
T Consensus 171 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~~-~~- 241 (302)
T 2j7t_A 171 -LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP------MRVLLKIAKSDP-PT- 241 (302)
T ss_dssp -HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHHSCC-CC-
T ss_pred -ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCH------HHHHHHHhccCC-cc-
Confidence 11123357899999999883 66789999999999999999999999974421 122222221111 00
Q ss_pred CCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 418 LDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 418 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
.......+ ..+.+++.+||+.||++||++.+++++
T Consensus 242 ---~~~~~~~~---~~l~~li~~~l~~dp~~Rps~~~ll~h 276 (302)
T 2j7t_A 242 ---LLTPSKWS---VEFRDFLKIALDKNPETRPSAAQLLEH 276 (302)
T ss_dssp ---CSSGGGSC---HHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred ---cCCccccC---HHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 01111122 345557889999999999999999864
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=339.58 Aligned_cols=251 Identities=23% Similarity=0.419 Sum_probs=203.1
Q ss_pred CCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCchhHHHHHHHHHHHHccCCCCeeeEeeeeec----------
Q 010513 185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE---------- 253 (508)
Q Consensus 185 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~---------- 253 (508)
.++|++.+.||+|+||.||+|.+. +++.||+|.+.... +.+.+|+++++.++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 85 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSK 85 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC------
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccc
Confidence 347899999999999999999986 68899999986553 345679999999999999999998864
Q ss_pred ------CCeeEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCC
Q 010513 254 ------GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWN 327 (508)
Q Consensus 254 ------~~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~ 327 (508)
....++||||+++|+|.+++.... ...+++..++.++.|++.||.|||++ +|+||||||+||+++.++.
T Consensus 86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~ 160 (284)
T 2a19_B 86 NSSRSKTKCLFIQMEFCDKGTLEQWIEKRR--GEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQ 160 (284)
T ss_dssp ---CCEEEEEEEEECCCCSCBHHHHHHHGG--GSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTE
T ss_pred cccccCcceEEEEEeccCCCCHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCCCC
Confidence 445789999999999999997542 35789999999999999999999999 9999999999999999999
Q ss_pred eEEeeeccceecCCCCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHH
Q 010513 328 PKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKT 407 (508)
Q Consensus 328 ~kL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~ 407 (508)
+||+|||++....... ......||+.|+|||.+.+..++.++||||||+++|||++|..||.. .......
T Consensus 161 ~kl~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~--------~~~~~~~ 230 (284)
T 2a19_B 161 VKIGDFGLVTSLKNDG--KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE--------TSKFFTD 230 (284)
T ss_dssp EEECCCTTCEESSCCS--CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHH--------HHHHHHH
T ss_pred EEECcchhheeccccc--cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchh--------HHHHHHH
Confidence 9999999998764432 22345799999999999999999999999999999999999988731 1111111
Q ss_pred hhcccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCCCCC
Q 010513 408 MVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEEFPFR 467 (508)
Q Consensus 408 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~~~~~~~ 467 (508)
..... + . ...+.. +.+++.+||+.||++||++.+++++|+......+
T Consensus 231 -~~~~~----~----~-~~~~~~---~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~ 277 (284)
T 2a19_B 231 -LRDGI----I----S-DIFDKK---EKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPE 277 (284)
T ss_dssp -HHTTC----C----C-TTSCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC---
T ss_pred -hhccc----c----c-ccCCHH---HHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCC
Confidence 11111 1 1 112333 4457789999999999999999999987664443
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-42 Score=336.03 Aligned_cols=249 Identities=23% Similarity=0.381 Sum_probs=198.2
Q ss_pred CCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecC--CchhHHHHHHHHHHHHccCCCCeeeEeeeeec----CCee
Q 010513 185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE----GAHR 257 (508)
Q Consensus 185 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~----~~~~ 257 (508)
...|.+.+.||+|+||+||+|.+. ++..||+|.+... .....+.+.+|+++++.++||||+++++++.. ....
T Consensus 25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (290)
T 1t4h_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 104 (290)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceE
Confidence 345888999999999999999975 5778999988654 23445678899999999999999999998865 4568
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eeeccCCCCCEEEc-CCCCeEEeeec
Q 010513 258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK--VVHRDIKSSNILLD-KQWNPKLSDFG 334 (508)
Q Consensus 258 ~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~--iiHrDlkp~NIll~-~~~~~kL~DFG 334 (508)
++||||+++|+|.+++... ..+++..++.++.|++.||.|||++ + |+||||||+|||++ .++.+||+|||
T Consensus 105 ~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg 177 (290)
T 1t4h_A 105 VLVTELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLG 177 (290)
T ss_dssp EEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTT
T ss_pred EEEEEecCCCCHHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCC
Confidence 8999999999999999764 4689999999999999999999998 7 99999999999997 78999999999
Q ss_pred cceecCCCCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhccccc
Q 010513 335 LAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNA 414 (508)
Q Consensus 335 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 414 (508)
++...... ......||+.|+|||++. +.++.++|||||||++|+|++|+.||..... ............
T Consensus 178 ~~~~~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-----~~~~~~~~~~~~-- 246 (290)
T 1t4h_A 178 LATLKRAS---FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQN-----AAQIYRRVTSGV-- 246 (290)
T ss_dssp GGGGCCTT---SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSS-----HHHHHHHHTTTC--
T ss_pred Cccccccc---ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCc-----HHHHHHHHhccC--
Confidence 99754332 223457999999999886 4589999999999999999999999964322 122222221111
Q ss_pred ccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 415 EGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 415 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
....+.. ..+ .++.+++.+||+.||++||++.+++++
T Consensus 247 ---~~~~~~~-~~~---~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 247 ---KPASFDK-VAI---PEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp ---CCGGGGG-CCC---HHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ---CccccCC-CCC---HHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 0111111 112 345568889999999999999999964
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=366.98 Aligned_cols=252 Identities=23% Similarity=0.353 Sum_probs=204.7
Q ss_pred cCCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCC---chhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEE
Q 010513 184 STNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRML 259 (508)
Q Consensus 184 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 259 (508)
..++|++.+.||+|+||+||+|... +++.||||++.... ....+.+.+|++++++++||||+++++++.+....++
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 103 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 103 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 3457999999999999999999976 68899999986542 3446778999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEE---cCCCCeEEeeeccc
Q 010513 260 VYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILL---DKQWNPKLSDFGLA 336 (508)
Q Consensus 260 V~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll---~~~~~~kL~DFG~a 336 (508)
||||+.+|+|.+++... ..+++..++.++.|++.||+|||++ +|+||||||+|||+ +.++.+||+|||++
T Consensus 104 v~e~~~~~~L~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a 176 (484)
T 3nyv_A 104 VGEVYTGGELFDEIISR----KRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLS 176 (484)
T ss_dssp EECCCCSCBHHHHHHTC----SCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHH
T ss_pred EEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeee
Confidence 99999999999999765 5699999999999999999999999 99999999999999 56789999999999
Q ss_pred eecCCCCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhccccccc
Q 010513 337 KLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEG 416 (508)
Q Consensus 337 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 416 (508)
....... .....+||+.|+|||++.+ .++.++|||||||++|+|++|+.||..... .+.+....... .
T Consensus 177 ~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~------~~~~~~i~~~~-~-- 244 (484)
T 3nyv_A 177 THFEASK--KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANE------YDILKKVEKGK-Y-- 244 (484)
T ss_dssp HHBCCCC--SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCC-C--
T ss_pred EEccccc--ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHHcCC-C--
Confidence 8764332 2344579999999999876 689999999999999999999999975421 22222222211 1
Q ss_pred CCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 417 VLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 417 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
. +...........+.+++.+||+.||++|||+.+++++
T Consensus 245 --~--~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 245 --T--FELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp --C--CCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred --C--CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence 0 0001111223345558889999999999999999863
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-42 Score=340.03 Aligned_cols=249 Identities=25% Similarity=0.420 Sum_probs=204.9
Q ss_pred CCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCC-chhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEE
Q 010513 185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE 262 (508)
Q Consensus 185 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e 262 (508)
.+.|++.+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.+++.++||||+++++++.++...++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 346899999999999999999975 58899999986543 3446788999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCC
Q 010513 263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE 342 (508)
Q Consensus 263 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 342 (508)
|+++++|.+++.. ..+++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||++......
T Consensus 101 ~~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~ 172 (303)
T 3a7i_A 101 YLGGGSALDLLEP-----GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT 172 (303)
T ss_dssp CCTTEEHHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBTT
T ss_pred eCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCcc
Confidence 9999999999864 3689999999999999999999999 9999999999999999999999999999876433
Q ss_pred CcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCCccC
Q 010513 343 RSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRL 422 (508)
Q Consensus 343 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 422 (508)
. .......||+.|+|||++.+..++.++||||||+++|+|++|+.||..... .+......... .+.+
T Consensus 173 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~------~~~~ 239 (303)
T 3a7i_A 173 Q-IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHP------MKVLFLIPKNN------PPTL 239 (303)
T ss_dssp B-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHHSC------CCCC
T ss_pred c-cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCH------HHHHHHhhcCC------CCCC
Confidence 2 223445789999999999999999999999999999999999999964321 11111111111 1111
Q ss_pred CCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 423 QEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 423 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
.. ..+.. +.+++.+||+.||++||++.+++++
T Consensus 240 ~~-~~~~~---l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 240 EG-NYSKP---LKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp CS-SCCHH---HHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred cc-ccCHH---HHHHHHHHcCCChhhCcCHHHHhhC
Confidence 11 12333 4457789999999999999999875
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=362.87 Aligned_cols=245 Identities=16% Similarity=0.209 Sum_probs=189.3
Q ss_pred cCCCCcccceEcccCcEEEEEEEE-CCCcEEEEEEeecC---CchhHHHHHHHH---HHHHccCCCCeeeEe-------e
Q 010513 184 STNGFADENVIGEGGYGIVYHGVL-EDNTNVAVKNLLNN---RGQAEKEFKVEV---EAIGRVRHKNLVRLL-------G 249 (508)
Q Consensus 184 ~~~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~---~~l~~l~hpniv~l~-------~ 249 (508)
..++|++.+.||+|+||+||+|++ .+++.||||++... .....+.+.+|+ +.+++++||||++++ +
T Consensus 71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~ 150 (377)
T 3byv_A 71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 150 (377)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSE
T ss_pred CCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhh
Confidence 456899999999999999999995 46899999998643 334567888999 555666899999998 5
Q ss_pred eeecCC-----------------eeEEEEEecCCCCHHHHhccCCC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC
Q 010513 250 YCAEGA-----------------HRMLVYEYIDNGNLEQWLHGDVG---PHSPLTWEIRMNIILGTAKGLTYLHEGLEPK 309 (508)
Q Consensus 250 ~~~~~~-----------------~~~lV~e~~~~g~L~~~l~~~~~---~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ 309 (508)
++.+.+ ..|+||||+ +|+|.+++..... ....+++..++.++.|++.||+|||++ +
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ 226 (377)
T 3byv_A 151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---G 226 (377)
T ss_dssp EEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred hhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---C
Confidence 555443 278999999 5799999976411 012344588889999999999999999 9
Q ss_pred eeeccCCCCCEEEcCCCCeEEeeeccceecCCCCcceecceecCCCCCChhhhhcC-----------CCCCCCCeeehHH
Q 010513 310 VVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTG-----------MLNERSDVYSFGI 378 (508)
Q Consensus 310 iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~sDvwSlGv 378 (508)
|+||||||+|||++.++.+||+|||+++.... .....+| +.|+|||++.+. .++.++|||||||
T Consensus 227 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~ 301 (377)
T 3byv_A 227 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL 301 (377)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred eecCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence 99999999999999999999999999986422 3344578 999999999887 8999999999999
Q ss_pred HHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 379 LIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 379 vl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
++|||++|+.||.......... .... . ....+. ++.+++.+||+.||++||++.+++++
T Consensus 302 il~elltg~~Pf~~~~~~~~~~---------------~~~~-~--~~~~~~---~~~~li~~~L~~dp~~Rpt~~e~l~h 360 (377)
T 3byv_A 302 VIYWIWCADLPITKDAALGGSE---------------WIFR-S--CKNIPQ---PVRALLEGFLRYPKEDRLLPLQAMET 360 (377)
T ss_dssp HHHHHHHSSCCC------CCSG---------------GGGS-S--CCCCCH---HHHHHHHHHTCSSGGGCCCHHHHHTS
T ss_pred HHHHHHHCCCCCcccccccchh---------------hhhh-h--ccCCCH---HHHHHHHHHcCCCchhCCCHHHHhhC
Confidence 9999999999997543221110 0000 0 011233 34457789999999999999999863
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-43 Score=342.76 Aligned_cols=253 Identities=28% Similarity=0.421 Sum_probs=197.3
Q ss_pred hhcCCCCcccceEcccCcEEEEEEEECCCcEEEEEEeecCCchhHHHHHHHHHHHHccCCCCeeeEeeeeecC-CeeEEE
Q 010513 182 EVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEG-AHRMLV 260 (508)
Q Consensus 182 ~~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-~~~~lV 260 (508)
.+..++|++.+.||+|+||+||+|.+. ++.||+|.+.... ..+.+.+|+++++.++||||+++++++.+. ...++|
T Consensus 17 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv 93 (278)
T 1byg_A 17 ALNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV 93 (278)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEE
T ss_pred cCChhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEE
Confidence 455678999999999999999999886 7899999986543 456788999999999999999999997554 478999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecC
Q 010513 261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG 340 (508)
Q Consensus 261 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 340 (508)
|||+++|+|.+++.... ...+++..++.++.|++.||+|||++ +++||||||+||+++.++.+||+|||++....
T Consensus 94 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~ 168 (278)
T 1byg_A 94 TEYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 168 (278)
T ss_dssp ECCCTTEEHHHHHHHHH--HHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred EecCCCCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeecccccccc
Confidence 99999999999997641 12378999999999999999999999 99999999999999999999999999998653
Q ss_pred CCCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHhhcccccccCCC
Q 010513 341 AERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLD 419 (508)
Q Consensus 341 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 419 (508)
.. .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||...... .... . .... ..
T Consensus 169 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~---~~~~---~-~~~~-----~~ 232 (278)
T 1byg_A 169 ST----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVP---R-VEKG-----YK 232 (278)
T ss_dssp -----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG---GHHH---H-HTTT-----CC
T ss_pred cc----ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHH---HHHH---H-HhcC-----CC
Confidence 32 223467899999999999999999999999999999998 99999754321 1111 1 1111 01
Q ss_pred ccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010513 420 PRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (508)
Q Consensus 420 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~~ 462 (508)
+... ...+. .+.+++.+||+.||++||++.++++.|++.
T Consensus 233 ~~~~-~~~~~---~l~~li~~~l~~~p~~Rps~~~l~~~L~~i 271 (278)
T 1byg_A 233 MDAP-DGCPP---AVYEVMKNCWHLDAAMRPSFLQLREQLEHI 271 (278)
T ss_dssp CCCC-TTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCc-ccCCH---HHHHHHHHHhcCChhhCCCHHHHHHHHHHH
Confidence 1111 11233 444577899999999999999999999864
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=348.17 Aligned_cols=265 Identities=23% Similarity=0.311 Sum_probs=197.7
Q ss_pred cCCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCch-----hHHHHHHHHHHHHccCCCCeeeEeeeeecCCee
Q 010513 184 STNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQ-----AEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHR 257 (508)
Q Consensus 184 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 257 (508)
..++|++.+.||+|+||.||+|.+. +++.||+|++...... ..+.+.+|+++++.++||||+++++++.+....
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI 87 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence 3468999999999999999999975 5889999998643221 124677899999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccce
Q 010513 258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK 337 (508)
Q Consensus 258 ~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~ 337 (508)
++||||+++ +|.+++... ...+++..+..++.|+++||+|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 88 ~lv~e~~~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (346)
T 1ua2_A 88 SLVFDFMET-DLEVIIKDN---SLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAK 160 (346)
T ss_dssp EEEEECCSE-EHHHHHTTC---CSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred EEEEEcCCC-CHHHHHHhc---CcCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEecccce
Confidence 999999987 899998765 35688899999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCcceecceecCCCCCChhhhhcC-CCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhccccccc
Q 010513 338 LLGAERSYVTTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEG 416 (508)
Q Consensus 338 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 416 (508)
...... ......+||+.|+|||++.+. .++.++|||||||++|||++|..||..... ......+...........
T Consensus 161 ~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~---~~~~~~i~~~~~~~~~~~ 236 (346)
T 1ua2_A 161 SFGSPN-RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD---LDQLTRIFETLGTPTEEQ 236 (346)
T ss_dssp TTTSCC-CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHHHCCCCTTT
T ss_pred eccCCc-ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCH---HHHHHHHHHHcCCCChhh
Confidence 764332 223446799999999998654 588999999999999999999999975431 111111111111100000
Q ss_pred C---------CC-ccCCCCch----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 010513 417 V---------LD-PRLQEKPC----SRALKRALLVALRCVDPNAHKRPKMGHVIHML 459 (508)
Q Consensus 417 ~---------~~-~~l~~~~~----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 459 (508)
. .. ......+. .....++.+++.+||+.||++|||+.|++++-
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~ 293 (346)
T 1ua2_A 237 WPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMK 293 (346)
T ss_dssp SSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSG
T ss_pred hhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcCh
Confidence 0 00 00000000 11224566688899999999999999999863
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-42 Score=342.80 Aligned_cols=258 Identities=20% Similarity=0.290 Sum_probs=198.6
Q ss_pred CCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCchhHHHHHHHHHHHHccC-CCCeeeEeeeeec--CCeeEEE
Q 010513 185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVR-HKNLVRLLGYCAE--GAHRMLV 260 (508)
Q Consensus 185 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~--~~~~~lV 260 (508)
.++|++.+.||+|+||+||+|... +++.||+|.+... ..+.+.+|+++++.++ ||||+++++++.+ ....++|
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv 111 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 111 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence 367999999999999999999974 6889999998643 3467889999999997 9999999999987 6678999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCC-CeEEeeeccceec
Q 010513 261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQW-NPKLSDFGLAKLL 339 (508)
Q Consensus 261 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~-~~kL~DFG~a~~~ 339 (508)
|||+++++|.+++. .+++..+..++.|++.||+|||++ +|+||||||+|||++.++ .+||+|||+++..
T Consensus 112 ~e~~~~~~l~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~ 181 (330)
T 3nsz_A 112 FEHVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 181 (330)
T ss_dssp EECCCCCCHHHHGG-------GCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EeccCchhHHHHHH-------hCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEc
Confidence 99999999999984 378999999999999999999999 999999999999999776 8999999999876
Q ss_pred CCCCcceecceecCCCCCChhhhhc-CCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHH--------Hhhc
Q 010513 340 GAERSYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLK--------TMVT 410 (508)
Q Consensus 340 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~--------~~~~ 410 (508)
..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.......+ .+..... ....
T Consensus 182 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~-~l~~~~~~~~~~~~~~~~~ 258 (330)
T 3nsz_A 182 HPGQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD-QLVRIAKVLGTEDLYDYID 258 (330)
T ss_dssp CTTCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHH-HHHHHHHHHCHHHHHHHHH
T ss_pred CCCCc--cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHH-HHHHHHHhcCCchhhhHHH
Confidence 44332 334578999999999877 6789999999999999999999999964332111 1111000 0000
Q ss_pred ccc--------------cccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 411 NRN--------------AEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 411 ~~~--------------~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
... ...................++.+++.+||+.||++|||++|++++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 259 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp HTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 000 000000001111111123455668889999999999999999974
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=351.02 Aligned_cols=269 Identities=23% Similarity=0.282 Sum_probs=198.9
Q ss_pred hhhHhhcCCCCcccceEcccCcEEEEEEEECCCcEEEEEEeecCCc-----------hhHHHHHHHHHHHHccCCCCeee
Q 010513 178 LRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRG-----------QAEKEFKVEVEAIGRVRHKNLVR 246 (508)
Q Consensus 178 ~~~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-----------~~~~~~~~E~~~l~~l~hpniv~ 246 (508)
+.++....++|++.+.||+|+||.||+|...++..||||++..... ...+.+.+|++++++++||||++
T Consensus 14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 93 (362)
T 3pg1_A 14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILG 93 (362)
T ss_dssp HHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred HHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccc
Confidence 5677888899999999999999999999988899999999854322 12367889999999999999999
Q ss_pred Eeeeeec-----CCeeEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEE
Q 010513 247 LLGYCAE-----GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNIL 321 (508)
Q Consensus 247 l~~~~~~-----~~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIl 321 (508)
+++++.. ....|+||||++ |+|.+++... ...+++..++.++.|++.||.|||++ +|+||||||+|||
T Consensus 94 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl 166 (362)
T 3pg1_A 94 LRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ---RIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNIL 166 (362)
T ss_dssp CSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCT---TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEE
T ss_pred eeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHEE
Confidence 9999843 346899999998 5898888755 35799999999999999999999999 9999999999999
Q ss_pred EcCCCCeEEeeeccceecCCCCcceecceecCCCCCChhhhhc-CCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcch
Q 010513 322 LDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVN 400 (508)
Q Consensus 322 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~ 400 (508)
++.++.+||+|||++...... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...... .
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---~ 241 (362)
T 3pg1_A 167 LADNNDITICDFNLAREDTAD--ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFY---N 241 (362)
T ss_dssp ECTTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---H
T ss_pred EcCCCCEEEEecCcccccccc--cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHH---H
Confidence 999999999999999854332 22344578999999998876 67899999999999999999999999754321 1
Q ss_pred HHHHHHHhhcccc-----------cccCCCcc---CCCCc----hHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 401 LVEWLKTMVTNRN-----------AEGVLDPR---LQEKP----CSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 401 ~~~~~~~~~~~~~-----------~~~~~~~~---l~~~~----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
....+........ ....+... ..... .+.....+.+++.+||+.||++||++.+++++
T Consensus 242 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 242 QLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp HHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 1111111000000 00000000 00000 01112345668889999999999999999975
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=340.14 Aligned_cols=258 Identities=28% Similarity=0.451 Sum_probs=201.4
Q ss_pred hhcCCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCchhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEE
Q 010513 182 EVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLV 260 (508)
Q Consensus 182 ~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 260 (508)
....++|.....||+|+||.||+|.+. ++..||+|.+........+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 18 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 97 (295)
T 2clq_A 18 DYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIF 97 (295)
T ss_dssp EECBCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cccccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEE
Confidence 344556677779999999999999975 5788999999776666677899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcC-CCCeEEeeeccceec
Q 010513 261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDK-QWNPKLSDFGLAKLL 339 (508)
Q Consensus 261 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~-~~~~kL~DFG~a~~~ 339 (508)
|||+++++|.+++..... ...+++..+..++.|++.||+|||++ +++||||||+||+++. ++.+||+|||++...
T Consensus 98 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~ 173 (295)
T 2clq_A 98 MEQVPGGSLSALLRSKWG-PLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRL 173 (295)
T ss_dssp EECCSEEEHHHHHHHTTC-CCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEES
T ss_pred EEeCCCCCHHHHHHhhcc-CCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeeccccccc
Confidence 999999999999976522 24567899999999999999999999 9999999999999987 899999999999876
Q ss_pred CCCCcceecceecCCCCCChhhhhcCC--CCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccC
Q 010513 340 GAERSYVTTRVMGTFGYVAPEYASTGM--LNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGV 417 (508)
Q Consensus 340 ~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 417 (508)
..... ......||+.|+|||++.+.. ++.++||||||+++|+|++|+.||...... . ......... .
T Consensus 174 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~-~~~~~~~~~------~ 242 (295)
T 2clq_A 174 AGINP-CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEP---Q-AAMFKVGMF------K 242 (295)
T ss_dssp CC------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSH---H-HHHHHHHHH------C
T ss_pred CCCCC-cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCch---h-HHHHhhccc------c
Confidence 43222 233457899999999987654 888999999999999999999999643211 1 111111110 0
Q ss_pred CCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 418 LDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 418 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
..+.+.. ..+. ++.+++.+||+.||++||++.+++++
T Consensus 243 ~~~~~~~-~~~~---~~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 243 VHPEIPE-SMSA---EAKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp CCCCCCT-TSCH---HHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred ccccccc-cCCH---HHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1111211 1233 34457889999999999999999853
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=377.11 Aligned_cols=251 Identities=22% Similarity=0.298 Sum_probs=204.4
Q ss_pred hhcCCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecC---CchhHHHHHHHHHHHHcc-CCCCeeeEeeeeecCCe
Q 010513 182 EVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN---RGQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEGAH 256 (508)
Q Consensus 182 ~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~ 256 (508)
.+..++|++.+.||+|+||+||+|++. +++.||||++.+. .....+.+..|..++..+ +||||+++++++.+.+.
T Consensus 337 ~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~ 416 (674)
T 3pfq_A 337 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR 416 (674)
T ss_dssp ---CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSE
T ss_pred cccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCE
Confidence 345678999999999999999999976 5778999998653 223446677899999988 79999999999999999
Q ss_pred eEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccc
Q 010513 257 RMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLA 336 (508)
Q Consensus 257 ~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a 336 (508)
+|+||||+++|+|.+++... ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++++||+|||++
T Consensus 417 ~~lV~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla 489 (674)
T 3pfq_A 417 LYFVMEYVNGGDLMYHIQQV----GRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMC 489 (674)
T ss_dssp EEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTC
T ss_pred EEEEEeCcCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeeccee
Confidence 99999999999999999875 4699999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhccccccc
Q 010513 337 KLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEG 416 (508)
Q Consensus 337 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 416 (508)
+..... .......+||+.|+|||++.+..|+.++|||||||+||||++|+.||...+ ..+.........
T Consensus 490 ~~~~~~-~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~------~~~~~~~i~~~~---- 558 (674)
T 3pfq_A 490 KENIWD-GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED------EDELFQSIMEHN---- 558 (674)
T ss_dssp EECCCT-TCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHSSC----
T ss_pred eccccC-CcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCC------HHHHHHHHHhCC----
Confidence 864322 223455789999999999999999999999999999999999999997532 122222222211
Q ss_pred CCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCH-----HHHHH
Q 010513 417 VLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKM-----GHVIH 457 (508)
Q Consensus 417 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~ 457 (508)
..+.. ..+ .++.+++.+||+.||++||++ .+|++
T Consensus 559 ---~~~p~-~~s---~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 559 ---VAYPK-SMS---KEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp ---CCCCT-TSC---HHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred ---CCCCc-cCC---HHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 11111 122 345558889999999999997 67764
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=349.99 Aligned_cols=263 Identities=19% Similarity=0.295 Sum_probs=200.6
Q ss_pred CCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCc--hhHHHHHHHHHHHHccCCCCeeeEeeeeec--------C
Q 010513 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG--QAEKEFKVEVEAIGRVRHKNLVRLLGYCAE--------G 254 (508)
Q Consensus 186 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~--------~ 254 (508)
++|++.+.||+|+||+||+|++. +++.||+|++..... .....+.+|+++++.++||||+++++++.+ .
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 57999999999999999999984 688999999855432 234567889999999999999999999977 4
Q ss_pred CeeEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeec
Q 010513 255 AHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFG 334 (508)
Q Consensus 255 ~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG 334 (508)
+..++||||+++ +|.+.+... ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||
T Consensus 97 ~~~~lv~e~~~~-~l~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg 169 (351)
T 3mi9_A 97 GSIYLVFDFCEH-DLAGLLSNV---LVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFG 169 (351)
T ss_dssp CEEEEEEECCSE-EHHHHHHCT---TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred ceEEEEEeccCC-CHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccch
Confidence 468999999986 888887665 35699999999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCC---cceecceecCCCCCChhhhhc-CCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhc
Q 010513 335 LAKLLGAER---SYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVT 410 (508)
Q Consensus 335 ~a~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~ 410 (508)
+++.+.... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... .....+.....
T Consensus 170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~~~~i~~~~~ 246 (351)
T 3mi9_A 170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQ---HQLALISQLCG 246 (351)
T ss_dssp TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHC
T ss_pred hcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhC
Confidence 998764322 222344678999999998876 45899999999999999999999999754321 11111211111
Q ss_pred cccc---c--------cCCC-ccCCCCchHHH------HHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 411 NRNA---E--------GVLD-PRLQEKPCSRA------LKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 411 ~~~~---~--------~~~~-~~l~~~~~~~~------~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
.... . ..+. ........... ...+.+++.+||+.||++||++.|++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 247 SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp CCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 1000 0 0000 00000111111 1346678889999999999999999975
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=335.68 Aligned_cols=251 Identities=22% Similarity=0.374 Sum_probs=196.9
Q ss_pred hhcCCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCC---chhHHHHHHHHHHHHccCCCCeeeEeeeeecCCee
Q 010513 182 EVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHR 257 (508)
Q Consensus 182 ~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 257 (508)
.+..++|.+.+.||+|+||.||+|.+. +++.||+|.+.... ....+.+.+|+++++.++||||+++++++.+....
T Consensus 7 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 86 (276)
T 2h6d_A 7 RVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDF 86 (276)
T ss_dssp CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred cceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeE
Confidence 455678999999999999999999986 68899999986532 23346788999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccce
Q 010513 258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK 337 (508)
Q Consensus 258 ~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~ 337 (508)
++||||+++++|.+++... ..+++..++.++.|++.||+|||++ +++||||||+||+++.++.+||+|||++.
T Consensus 87 ~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~ 159 (276)
T 2h6d_A 87 FMVMEYVSGGELFDYICKH----GRVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSN 159 (276)
T ss_dssp EEEEECCCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGG
T ss_pred EEEEeccCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeeccccc
Confidence 9999999999999999765 4689999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCcceecceecCCCCCChhhhhcCCC-CCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhccccccc
Q 010513 338 LLGAERSYVTTRVMGTFGYVAPEYASTGML-NERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEG 416 (508)
Q Consensus 338 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 416 (508)
...... ......||+.|+|||.+.+..+ +.++||||||+++|+|++|+.||.... ..+....... ...
T Consensus 160 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~------~~~~~~~~~~-~~~-- 228 (276)
T 2h6d_A 160 MMSDGE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEH------VPTLFKKIRG-GVF-- 228 (276)
T ss_dssp CCCC---------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHH-CCC--
T ss_pred ccCCCc--ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCc------HHHHHHHhhc-Ccc--
Confidence 754322 2234578999999999987765 579999999999999999999996432 1111111111 100
Q ss_pred CCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 417 VLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 417 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
.+. ...+.. +.+++.+||+.||++||++.+++++
T Consensus 229 ----~~~-~~~~~~---l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 229 ----YIP-EYLNRS---VATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp ----CCC-TTSCHH---HHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred ----cCc-hhcCHH---HHHHHHHHccCChhhCCCHHHHHhC
Confidence 011 112333 4457789999999999999999975
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=346.07 Aligned_cols=256 Identities=25% Similarity=0.305 Sum_probs=192.5
Q ss_pred CCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecC--CchhHHHHHHHHHHHHccCCCCeeeEeeeeecCC------
Q 010513 185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGA------ 255 (508)
Q Consensus 185 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~------ 255 (508)
.++|++.+.||+|+||.||+|... +++.||||++... .....+.+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 468999999999999999999976 5888999998654 2334567889999999999999999999997654
Q ss_pred eeEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeecc
Q 010513 256 HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGL 335 (508)
Q Consensus 256 ~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~ 335 (508)
..|+||||+++ +|.+++.. .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 104 ~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 173 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 173 (371)
T ss_dssp EEEEEEECCSE-EHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred ceEEEEEcCCC-CHHHHHhh------ccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeec
Confidence 78999999986 88888853 488999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhc-----
Q 010513 336 AKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVT----- 410 (508)
Q Consensus 336 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~----- 410 (508)
++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...+.. +.+.....
T Consensus 174 a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~~~~i~~~~~~~ 245 (371)
T 2xrw_A 174 ARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHI------DQWNKVIEQLGTP 245 (371)
T ss_dssp ------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHC-CCCC
T ss_pred ccccccc--cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHHHhCCC
Confidence 9865332 2234468999999999999999999999999999999999999999754321 11111111
Q ss_pred -----------------cccc------ccCCCcc-CCCC--chHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 411 -----------------NRNA------EGVLDPR-LQEK--PCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 411 -----------------~~~~------~~~~~~~-l~~~--~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
+... ....... .... ........+.+++.+||+.||++|||+.|++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 246 CPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp CHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred CHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 0000 0000000 0000 011224567778999999999999999999975
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=339.63 Aligned_cols=257 Identities=23% Similarity=0.335 Sum_probs=189.6
Q ss_pred hhcCCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCc--hhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeE
Q 010513 182 EVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG--QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM 258 (508)
Q Consensus 182 ~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 258 (508)
++..++|++.+.||+|+||+||+|.+. +++.||+|++..... ...+.+.++...++.++||||+++++++.+++..+
T Consensus 3 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~ 82 (290)
T 3fme_A 3 EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVW 82 (290)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEE
T ss_pred cccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEE
Confidence 456678999999999999999999975 688899999865432 22234455556688889999999999999999999
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeecccee
Q 010513 259 LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL 338 (508)
Q Consensus 259 lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~ 338 (508)
+||||+++ +|.+++.........+++..++.++.|++.||+|||++. +|+||||||+||+++.++.+||+|||++..
T Consensus 83 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 159 (290)
T 3fme_A 83 ICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGY 159 (290)
T ss_dssp EEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCEEBCCC-----
T ss_pred EEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecCCccc
Confidence 99999985 888887653223467999999999999999999999853 899999999999999999999999999987
Q ss_pred cCCCCcceecceecCCCCCChhhh----hcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhccccc
Q 010513 339 LGAERSYVTTRVMGTFGYVAPEYA----STGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNA 414 (508)
Q Consensus 339 ~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 414 (508)
..... ......||+.|+|||++ .+..++.++|||||||++|||++|+.||..... ....+........
T Consensus 160 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~- 231 (290)
T 3fme_A 160 LVDDV--AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGT-----PFQQLKQVVEEPS- 231 (290)
T ss_dssp ------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSC-----HHHHHHHHHHSCC-
T ss_pred ccccc--cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCc-----hHHHHHHHhccCC-
Confidence 64332 22334799999999996 566788999999999999999999999974322 1122222222211
Q ss_pred ccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 010513 415 EGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIH 457 (508)
Q Consensus 415 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 457 (508)
+.......+. ++.+++.+||+.||++||++.++++
T Consensus 232 -----~~~~~~~~~~---~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 232 -----PQLPADKFSA---EFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp -----CCCCTTTSCH---HHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred -----CCcccccCCH---HHHHHHHHHhhcChhhCcCHHHHHh
Confidence 1111122333 3455788999999999999999987
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=353.74 Aligned_cols=257 Identities=22% Similarity=0.322 Sum_probs=193.8
Q ss_pred CCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecC--CchhHHHHHHHHHHHHccCCCCeeeEeeeeecCC------
Q 010513 185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGA------ 255 (508)
Q Consensus 185 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~------ 255 (508)
.++|++.+.||+|+||.||+|.+. +|+.||||++... .....+.+.+|+++++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 458999999999999999999975 6889999998553 2234567889999999999999999999997653
Q ss_pred eeEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeecc
Q 010513 256 HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGL 335 (508)
Q Consensus 256 ~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~ 335 (508)
..|+||||+ +++|.+++... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~~-----~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 174 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKHE-----KLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGL 174 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEecC-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeec
Confidence 469999999 77999999753 689999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCcceecceecCCCCCChhhhhc-CCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhccc--
Q 010513 336 AKLLGAERSYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNR-- 412 (508)
Q Consensus 336 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~-- 412 (508)
++..... .+..+||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... .....+.......
T Consensus 175 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~l~~i~~~~g~~~~ 247 (367)
T 1cm8_A 175 ARQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL---DQLKEIMKVTGTPPA 247 (367)
T ss_dssp CEECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHHHCCCCH
T ss_pred ccccccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHhcCCCCH
Confidence 9875432 344678999999999877 67999999999999999999999999754321 1111110000000
Q ss_pred ----------------ccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 413 ----------------NAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 413 ----------------~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
.........+.. ..+.....+.+++.+||+.||++|||+.+++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 248 EFVQRLQSDEAKNYMKGLPELEKKDFAS-ILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp HHHHTCSCHHHHHHHHHSCCCCCCCGGG-TCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHhhhHHHHHHHHhCCCCCCCCHHH-HCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 000000000000 011123345668889999999999999999984
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=346.07 Aligned_cols=262 Identities=26% Similarity=0.409 Sum_probs=203.8
Q ss_pred hhcCCCCcccceEcccCcEEEEEEEE------CCCcEEEEEEeecC-CchhHHHHHHHHHHHHccCCCCeeeEeeeeecC
Q 010513 182 EVSTNGFADENVIGEGGYGIVYHGVL------EDNTNVAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEG 254 (508)
Q Consensus 182 ~~~~~~~~~~~~LG~G~~g~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~ 254 (508)
++..++|++.+.||+|+||.||+|.+ .++..||+|.+... .......+.+|+.++++++||||+++++++.+.
T Consensus 26 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 105 (327)
T 2yfx_A 26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS 105 (327)
T ss_dssp BCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCC
Confidence 34567899999999999999999983 24678999998654 334456788999999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHhccCCC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcC---CCCe
Q 010513 255 AHRMLVYEYIDNGNLEQWLHGDVG---PHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDK---QWNP 328 (508)
Q Consensus 255 ~~~~lV~e~~~~g~L~~~l~~~~~---~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~---~~~~ 328 (508)
...++||||+++|+|.+++..... ....+++..++.++.|++.||.|||++ +|+||||||+|||++. +..+
T Consensus 106 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~ 182 (327)
T 2yfx_A 106 LPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVA 182 (327)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCE
T ss_pred CCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceE
Confidence 999999999999999999976532 124589999999999999999999999 9999999999999984 4469
Q ss_pred EEeeeccceecCCCCc-ceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHh-CCCCCCCCCCCCcchHHHHHH
Q 010513 329 KLSDFGLAKLLGAERS-YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLK 406 (508)
Q Consensus 329 kL~DFG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~ 406 (508)
||+|||++........ .......||+.|+|||++.+..++.++|||||||++|||+| |+.||..... .+...
T Consensus 183 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~------~~~~~ 256 (327)
T 2yfx_A 183 KIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN------QEVLE 256 (327)
T ss_dssp EECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH------HHHHH
T ss_pred EECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCH------HHHHH
Confidence 9999999975533222 12233567899999999999999999999999999999998 9999964321 12222
Q ss_pred HhhcccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010513 407 TMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (508)
Q Consensus 407 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~~ 462 (508)
....... +... ..++. .+.+++.+||+.||++||++.+++++|+..
T Consensus 257 ~~~~~~~------~~~~-~~~~~---~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 302 (327)
T 2yfx_A 257 FVTSGGR------MDPP-KNCPG---PVYRIMTQCWQHQPEDRPNFAIILERIEYC 302 (327)
T ss_dssp HHHTTCC------CCCC-TTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHhcCCC------CCCC-CCCCH---HHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 2111111 0111 11233 345578899999999999999999999854
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=363.86 Aligned_cols=250 Identities=23% Similarity=0.329 Sum_probs=201.1
Q ss_pred CCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecC--CchhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEE
Q 010513 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE 262 (508)
Q Consensus 186 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e 262 (508)
++|++.+.||+|+||+||+|... +++.||||++... .......+.+|++++++++||||+++++++.+....|+|||
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 101 (486)
T 3mwu_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE 101 (486)
T ss_dssp HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEE
Confidence 47999999999999999999976 6889999998543 22345678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEc---CCCCeEEeeeccceec
Q 010513 263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLD---KQWNPKLSDFGLAKLL 339 (508)
Q Consensus 263 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~---~~~~~kL~DFG~a~~~ 339 (508)
|+.+|+|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+|||++ .++.+||+|||+++..
T Consensus 102 ~~~~~~L~~~~~~~----~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 174 (486)
T 3mwu_A 102 LYTGGELFDEIIKR----KRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174 (486)
T ss_dssp CCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTB
T ss_pred cCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCeEC
Confidence 99999999998765 4689999999999999999999999 999999999999994 4567999999999865
Q ss_pred CCCCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCC
Q 010513 340 GAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLD 419 (508)
Q Consensus 340 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 419 (508)
.... .....+||+.|+|||++.+ .|+.++|||||||++|+|++|+.||.... ..+.+....... . .
T Consensus 175 ~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~------~~~~~~~i~~~~-~----~ 240 (486)
T 3mwu_A 175 QQNT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN------EYDILKRVETGK-Y----A 240 (486)
T ss_dssp CCC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHTC-C----C
T ss_pred CCCC--ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCC------HHHHHHHHHhCC-C----C
Confidence 4332 2344579999999999875 58999999999999999999999996432 122222222211 0 0
Q ss_pred ccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 420 PRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 420 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
...........++.+++.+||+.||++|||+.+++++
T Consensus 241 --~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 241 --FDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp --SCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred --CCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0001111223345568889999999999999999985
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-42 Score=348.69 Aligned_cols=255 Identities=21% Similarity=0.357 Sum_probs=203.8
Q ss_pred hhcCCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCc--------hhHHHHHHHHHHHHcc-CCCCeeeEeeee
Q 010513 182 EVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG--------QAEKEFKVEVEAIGRV-RHKNLVRLLGYC 251 (508)
Q Consensus 182 ~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l-~hpniv~l~~~~ 251 (508)
....++|.+.+.||+|+||.||+|.+. +|+.||||++..... ...+.+.+|+.+++.+ +||||+++++++
T Consensus 90 ~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 169 (365)
T 2y7j_A 90 KEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY 169 (365)
T ss_dssp HHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred hhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEE
Confidence 334567999999999999999999986 689999999865431 1235678899999999 899999999999
Q ss_pred ecCCeeEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEe
Q 010513 252 AEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLS 331 (508)
Q Consensus 252 ~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~ 331 (508)
......++||||+++++|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+
T Consensus 170 ~~~~~~~lv~e~~~g~~L~~~l~~~----~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~ikl~ 242 (365)
T 2y7j_A 170 ESSSFMFLVFDLMRKGELFDYLTEK----VALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLS 242 (365)
T ss_dssp EBSSEEEEEECCCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEEC
T ss_pred eeCCEEEEEEEeCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEE
Confidence 9999999999999999999999764 4689999999999999999999999 99999999999999999999999
Q ss_pred eeccceecCCCCcceecceecCCCCCChhhhhc------CCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHH
Q 010513 332 DFGLAKLLGAERSYVTTRVMGTFGYVAPEYAST------GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWL 405 (508)
Q Consensus 332 DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~ 405 (508)
|||++..+.... .....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.... ....+
T Consensus 243 DfG~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~------~~~~~ 314 (365)
T 2y7j_A 243 DFGFSCHLEPGE--KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRR------QILML 314 (365)
T ss_dssp CCTTCEECCTTC--CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSS------HHHHH
T ss_pred ecCcccccCCCc--ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCC------HHHHH
Confidence 999998765432 2344689999999999864 358889999999999999999999996432 11112
Q ss_pred HHhhcccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 406 KTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 406 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
...... .. ....+.. ......+.+++.+||+.||++||++.+++++
T Consensus 315 ~~i~~~-~~-~~~~~~~-----~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 315 RMIMEG-QY-QFSSPEW-----DDRSSTVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp HHHHHT-CC-CCCHHHH-----SSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHhC-CC-CCCCccc-----ccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 211111 00 0000000 0112345568889999999999999999974
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=345.21 Aligned_cols=261 Identities=20% Similarity=0.302 Sum_probs=204.0
Q ss_pred hhhHhhcCCCCccc-ceEcccCcEEEEEEEEC-CCcEEEEEEeecCC--chhHHHHHHHHHHHHcc-CCCCeeeEeeeee
Q 010513 178 LRELEVSTNGFADE-NVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRV-RHKNLVRLLGYCA 252 (508)
Q Consensus 178 ~~~~~~~~~~~~~~-~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~ 252 (508)
++..+...++|.+. +.||+|+||+||+|... +++.||+|++.... ......+.+|+.++..+ .||||+++++++.
T Consensus 20 ~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~ 99 (327)
T 3lm5_A 20 FQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYE 99 (327)
T ss_dssp SBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred HHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEE
Confidence 44445566678887 89999999999999976 58899999986542 33457788999999999 5699999999999
Q ss_pred cCCeeEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcC---CCCeE
Q 010513 253 EGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDK---QWNPK 329 (508)
Q Consensus 253 ~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~---~~~~k 329 (508)
+....++||||+++|+|.+++.... ...+++..++.++.|++.||+|||++ +|+||||||+|||++. ++.+|
T Consensus 100 ~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~~k 174 (327)
T 3lm5_A 100 NTSEIILILEYAAGGEIFSLCLPEL--AEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIK 174 (327)
T ss_dssp CSSEEEEEEECCTTEEGGGGGSSCC---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCCEE
T ss_pred eCCeEEEEEEecCCCcHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCcEE
Confidence 9999999999999999999986542 35799999999999999999999999 9999999999999987 78999
Q ss_pred EeeeccceecCCCCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhh
Q 010513 330 LSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMV 409 (508)
Q Consensus 330 L~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~ 409 (508)
|+|||+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+......
T Consensus 175 L~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~------~~~~~~i~ 246 (327)
T 3lm5_A 175 IVDFGMSRKIGHAC--ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDN------QETYLNIS 246 (327)
T ss_dssp ECCGGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHH
T ss_pred EeeCccccccCCcc--ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc------hHHHHHHH
Confidence 99999998764332 23346799999999999999999999999999999999999999964321 11111111
Q ss_pred cccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 410 TNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 410 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
... . . ............+.+++.+||+.||++||++.+++++
T Consensus 247 ~~~-~-~-----~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 247 QVN-V-D-----YSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp HTC-C-C-----CCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred hcc-c-c-----cCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 110 0 0 0111111122344557889999999999999999875
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=338.61 Aligned_cols=253 Identities=26% Similarity=0.370 Sum_probs=199.5
Q ss_pred hcCCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCchhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEE
Q 010513 183 VSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY 261 (508)
Q Consensus 183 ~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 261 (508)
...++|++.+.||+|+||.||+|.+. +++.||+|.+.... ..+.+.+|+++++.++||||+++++++.+....++||
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 103 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM 103 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEe
Confidence 34568999999999999999999976 58899999986543 3467888999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCC
Q 010513 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA 341 (508)
Q Consensus 262 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 341 (508)
||+++|+|.+++... ...+++..++.++.|++.||.|||++ +++||||||+||+++.++.+||+|||++.....
T Consensus 104 e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 177 (314)
T 3com_A 104 EYCGAGSVSDIIRLR---NKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTD 177 (314)
T ss_dssp ECCTTEEHHHHHHHH---TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECBT
T ss_pred ecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhhh
Confidence 999999999999743 35789999999999999999999999 999999999999999999999999999987643
Q ss_pred CCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCCcc
Q 010513 342 ERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPR 421 (508)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 421 (508)
.. .......||+.|+|||.+.+..++.++||||||+++|+|++|+.||..... ........... .+.
T Consensus 178 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~------~~~ 244 (314)
T 3com_A 178 TM-AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHP------MRAIFMIPTNP------PPT 244 (314)
T ss_dssp TB-SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHHSC------CCC
T ss_pred hc-cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHhcCC------Ccc
Confidence 32 223345789999999999999999999999999999999999999974321 11111111111 111
Q ss_pred CCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 422 LQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 422 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
+.. .......+.+++.+||+.||++||++.+++++
T Consensus 245 ~~~--~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (314)
T 3com_A 245 FRK--PELWSDNFTDFVKQCLVKSPEQRATATQLLQH 279 (314)
T ss_dssp CSS--GGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred cCC--cccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 110 11112345558889999999999999999863
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-43 Score=341.69 Aligned_cols=246 Identities=21% Similarity=0.310 Sum_probs=197.3
Q ss_pred CCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecC--CchhHHHHHHHHHHHHcc-CCCCeeeEeeeeecCCeeEEEE
Q 010513 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVY 261 (508)
Q Consensus 186 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lV~ 261 (508)
++|++.+.||+|+||+||+|.+. +++.||+|.+... .......+.+|+..+..+ +||||+++++++.+++..++||
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~ 90 (289)
T 1x8b_A 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQN 90 (289)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEE
T ss_pred chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57999999999999999999986 6889999998754 234456788899999999 9999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCC----------------
Q 010513 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQ---------------- 325 (508)
Q Consensus 262 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~---------------- 325 (508)
||+++|+|.+++.........+++..++.++.|++.||+|||++ +|+||||||+|||++.+
T Consensus 91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~ 167 (289)
T 1x8b_A 91 EYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWA 167 (289)
T ss_dssp ECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC------------------
T ss_pred EecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCccccccccccccc
Confidence 99999999999976432235689999999999999999999999 99999999999999844
Q ss_pred ---CCeEEeeeccceecCCCCcceecceecCCCCCChhhhhcC-CCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchH
Q 010513 326 ---WNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNL 401 (508)
Q Consensus 326 ---~~~kL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~ 401 (508)
..+||+|||++....... ...||+.|+|||++.+. .++.++|||||||++|+|++|..|+... ..
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~------~~ 236 (289)
T 1x8b_A 168 SNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG------DQ 236 (289)
T ss_dssp --CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS------HH
T ss_pred CCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch------hH
Confidence 479999999998764432 23589999999999766 5668999999999999999999876422 11
Q ss_pred HHHHHHhhcccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 402 VEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 402 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
... ...... +.+.. ..+.. +.+++.+||+.||++||++.+++++
T Consensus 237 ~~~----~~~~~~-----~~~~~-~~~~~---~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 237 WHE----IRQGRL-----PRIPQ-VLSQE---FTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp HHH----HHTTCC-----CCCSS-CCCHH---HHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred HHH----HHcCCC-----CCCCc-ccCHH---HHHHHHHHhCCCcccCCCHHHHhhC
Confidence 111 111111 11111 12333 4457779999999999999999865
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-43 Score=345.01 Aligned_cols=265 Identities=22% Similarity=0.372 Sum_probs=186.4
Q ss_pred HhhcCCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCC-chhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeE
Q 010513 181 LEVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM 258 (508)
Q Consensus 181 ~~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 258 (508)
+.+..++|++.+.||+|+||.||+|.+. +++.||+|.+.... ....+.+.+|+++++.++||||+++++++...+..+
T Consensus 10 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 89 (303)
T 2vwi_A 10 WSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELW 89 (303)
T ss_dssp ---CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEE
T ss_pred cccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcE
Confidence 3566789999999999999999999954 68899999885432 334567888999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhccC----CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeec
Q 010513 259 LVYEYIDNGNLEQWLHGD----VGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFG 334 (508)
Q Consensus 259 lV~e~~~~g~L~~~l~~~----~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG 334 (508)
+||||+++|+|.+++... ......+++..++.++.|++.||+|||++ +++||||||+||+++.++.+||+|||
T Consensus 90 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg 166 (303)
T 2vwi_A 90 LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFG 166 (303)
T ss_dssp EEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCH
T ss_pred EEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEecc
Confidence 999999999999998641 11235689999999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCc----ceecceecCCCCCChhhhhc-CCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhh
Q 010513 335 LAKLLGAERS----YVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMV 409 (508)
Q Consensus 335 ~a~~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~ 409 (508)
++........ .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... .. ....
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~---~~~~ 240 (303)
T 2vwi_A 167 VSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMK---VL---MLTL 240 (303)
T ss_dssp HHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGG---HH---HHHH
T ss_pred chheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhh---HH---HHHh
Confidence 9976543221 12234579999999999876 568999999999999999999999997543221 11 1111
Q ss_pred cccc--c-ccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 410 TNRN--A-EGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 410 ~~~~--~-~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
.... . ....++.... ..+. ++.+++.+||+.||++||++.+++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~-~~~~---~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 241 QNDPPSLETGVQDKEMLK-KYGK---SFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp TSSCCCTTC-----CCCC-CCCH---HHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred ccCCCccccccccchhhh-hhhH---HHHHHHHHHccCChhhCcCHHHHhhC
Confidence 1110 0 0011111111 1223 44557889999999999999999864
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-42 Score=354.27 Aligned_cols=261 Identities=25% Similarity=0.324 Sum_probs=195.4
Q ss_pred CCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCchhHHHHHHHHHHHHccCCCCeeeEeeeeecC------CeeE
Q 010513 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEG------AHRM 258 (508)
Q Consensus 186 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~------~~~~ 258 (508)
.+|++.+.||+|+||+||+|++. +++.||||++..... ...+|+++++.++||||++++++|... ...+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 36899999999999999999986 588999999865432 234699999999999999999988532 2367
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCC-CCeEEeeeccce
Q 010513 259 LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQ-WNPKLSDFGLAK 337 (508)
Q Consensus 259 lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~-~~~kL~DFG~a~ 337 (508)
+||||+++ +|.+.+.........+++..++.++.|+++||+|||++ +|+||||||+|||++.+ +.+||+|||+++
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 99999986 77776653222246799999999999999999999998 99999999999999965 568999999998
Q ss_pred ecCCCCcceecceecCCCCCChhhhhcC-CCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHh-------h
Q 010513 338 LLGAERSYVTTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTM-------V 409 (508)
Q Consensus 338 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~-------~ 409 (508)
....... .....||+.|+|||++.+. .|+.++|||||||++|||++|+.||..... ...+.+.++.. +
T Consensus 206 ~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~--~~~l~~i~~~lg~p~~~~~ 281 (420)
T 1j1b_A 206 QLVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG--VDQLVEIIKVLGTPTREQI 281 (420)
T ss_dssp ECCTTCC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHHHCSCCHHHH
T ss_pred hcccCCC--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHhCCCCHHHH
Confidence 7643322 2345789999999998764 799999999999999999999999975432 11122222110 0
Q ss_pred --cccccccCCCccCCCCchH-----HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 410 --TNRNAEGVLDPRLQEKPCS-----RALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 410 --~~~~~~~~~~~~l~~~~~~-----~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
..........+.+...... ....++.+++.+||+.||++||++.|++++
T Consensus 282 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h 337 (420)
T 1j1b_A 282 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 337 (420)
T ss_dssp HHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence 0111111112222221111 123456678889999999999999999864
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=334.88 Aligned_cols=252 Identities=21% Similarity=0.316 Sum_probs=202.4
Q ss_pred cCCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCC---------chhHHHHHHHHHHHHccC-CCCeeeEeeeee
Q 010513 184 STNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---------GQAEKEFKVEVEAIGRVR-HKNLVRLLGYCA 252 (508)
Q Consensus 184 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~ 252 (508)
..++|++.+.||+|+||.||+|.+. +++.||+|.+.... ....+.+.+|+++++++. ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 3468999999999999999999986 57889999986543 122356788999999995 999999999999
Q ss_pred cCCeeEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEee
Q 010513 253 EGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSD 332 (508)
Q Consensus 253 ~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~D 332 (508)
+....++||||+++++|.+++... ..+++..++.++.|++.||.|||++ +++||||||+||+++.++.+||+|
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~d 167 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTEK----VTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTD 167 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECC
T ss_pred cCCeEEEEEeccCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEec
Confidence 999999999999999999999764 4689999999999999999999999 999999999999999999999999
Q ss_pred eccceecCCCCcceecceecCCCCCChhhhh------cCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHH
Q 010513 333 FGLAKLLGAERSYVTTRVMGTFGYVAPEYAS------TGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLK 406 (508)
Q Consensus 333 FG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~ 406 (508)
||++....... ......||+.|+|||++. ...++.++||||||+++|||++|+.||.... ......
T Consensus 168 fg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~------~~~~~~ 239 (298)
T 1phk_A 168 FGFSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK------QMLMLR 239 (298)
T ss_dssp CTTCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHH
T ss_pred ccchhhcCCCc--ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCcc------HHHHHH
Confidence 99998764332 233457899999999885 4568889999999999999999999996432 111122
Q ss_pred HhhcccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 010513 407 TMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIH 457 (508)
Q Consensus 407 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 457 (508)
...... . . ............+.+++.+||+.||++||++.++++
T Consensus 240 ~~~~~~-~-~-----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 240 MIMSGN-Y-Q-----FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp HHHHTC-C-C-----CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHhcCC-c-c-----cCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 211111 0 0 011111122334555888999999999999999986
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-42 Score=343.06 Aligned_cols=259 Identities=27% Similarity=0.404 Sum_probs=199.2
Q ss_pred hhhHhhcCCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCchhHHHHHHHHHHHHcc-CCCCeeeEeeeeec--
Q 010513 178 LRELEVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAE-- 253 (508)
Q Consensus 178 ~~~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~-- 253 (508)
+..+....++|++.+.||+|+||.||+|.+. +++.||+|.+.... ...+.+.+|+.+++++ +||||+++++++..
T Consensus 16 ~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 94 (326)
T 2x7f_A 16 LSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKN 94 (326)
T ss_dssp CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC
T ss_pred chhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeecc
Confidence 3344556789999999999999999999975 68899999986543 3456788999999999 89999999999976
Q ss_pred ----CCeeEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeE
Q 010513 254 ----GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPK 329 (508)
Q Consensus 254 ----~~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~k 329 (508)
....++||||+++|+|.+++.... ...+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+|
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~k 169 (326)
T 2x7f_A 95 PPGMDDQLWLVMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVK 169 (326)
T ss_dssp --CCCCEEEEEEECCTTEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEE
T ss_pred CccccceEEEEEEcCCCCcHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEE
Confidence 467899999999999999997642 35689999999999999999999999 999999999999999999999
Q ss_pred EeeeccceecCCCCcceecceecCCCCCChhhhh-----cCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHH
Q 010513 330 LSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAS-----TGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEW 404 (508)
Q Consensus 330 L~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~ 404 (508)
|+|||++....... .......||+.|+|||++. +..++.++|||||||++|+|++|+.||..... ...
T Consensus 170 l~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~ 242 (326)
T 2x7f_A 170 LVDFGVSAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP------MRA 242 (326)
T ss_dssp ECCCTTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCH------HHH
T ss_pred EeeCcCceecCcCc-cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcH------HHH
Confidence 99999998654322 1223457999999999986 56789999999999999999999999964321 111
Q ss_pred HHHhhcccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 405 LKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 405 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
........ .+.......+.. +.+++.+||+.||++||++.+++++
T Consensus 243 ~~~~~~~~------~~~~~~~~~~~~---l~~li~~~l~~dp~~Rps~~~ll~h 287 (326)
T 2x7f_A 243 LFLIPRNP------APRLKSKKWSKK---FQSFIESCLVKNHSQRPATEQLMKH 287 (326)
T ss_dssp HHHHHHSC------CCCCSCSCSCHH---HHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HHHhhcCc------cccCCccccCHH---HHHHHHHHhccChhhCCCHHHHhhC
Confidence 11111111 111222223344 4447779999999999999999874
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=354.81 Aligned_cols=253 Identities=12% Similarity=0.045 Sum_probs=178.8
Q ss_pred CCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCc---hhHHHHHHHHHHHHcc--CCCCeeeEe-------eeee
Q 010513 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG---QAEKEFKVEVEAIGRV--RHKNLVRLL-------GYCA 252 (508)
Q Consensus 186 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l--~hpniv~l~-------~~~~ 252 (508)
..|.+.+.||+|+||+||+|.+. +++.||+|++..... ...+.+.+|+++++.+ +||||++++ +++.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 35889999999999999999976 688999999977543 3345677785444444 699988755 3433
Q ss_pred cC-----------------CeeEEEEEecCCCCHHHHhccCCCCCCCCCHHHH------HHHHHHHHHHHHHHHhcCCCC
Q 010513 253 EG-----------------AHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIR------MNIILGTAKGLTYLHEGLEPK 309 (508)
Q Consensus 253 ~~-----------------~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~------~~i~~qi~~al~~LH~~~~~~ 309 (508)
.. ...|+||||++ |+|.+++.... ..+.+..+ ..++.|++.||+|||++ +
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~---~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---~ 214 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD---FVYVFRGDEGILALHILTAQLIRLAANLQSK---G 214 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH---HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc---cccchhhhhhhhhHHHHHHHHHHHHHHHHHC---C
Confidence 22 34799999999 79999997641 23444445 67779999999999999 9
Q ss_pred eeeccCCCCCEEEcCCCCeEEeeeccceecCCCCcceecceecCCCCCChhhhhc--CCCCCCCCeeehHHHHHHHHhCC
Q 010513 310 VVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAST--GMLNERSDVYSFGILIMEVISGR 387 (508)
Q Consensus 310 iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlGvvl~elltg~ 387 (508)
|+||||||+|||++.++.+||+|||+++..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+
T Consensus 215 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~ 290 (371)
T 3q60_A 215 LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290 (371)
T ss_dssp EEETTCSGGGEEECTTSCEEECCGGGEEETTCE----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSS
T ss_pred CccCcCCHHHEEECCCCCEEEEecceeeecCCC----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCC
Confidence 999999999999999999999999999975322 213457799999999987 67999999999999999999999
Q ss_pred CCCCCCCCCCcchHHHHHHHhhcccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 010513 388 NPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIH 457 (508)
Q Consensus 388 ~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 457 (508)
.||....+..... ..................+......+.+++.+||+.||++||++.++++
T Consensus 291 ~Pf~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 291 LPFGLVTPGIKGS--------WKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp CSTTBCCTTCTTC--------CCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCCCCcCcccccc--------hhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 9998664321110 0000000000111111111122334555888999999999999999975
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=357.32 Aligned_cols=261 Identities=19% Similarity=0.240 Sum_probs=206.5
Q ss_pred cCCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCchhHHHHHHHHHHHHccCC-CCeeeEeeeeecCCeeEEEE
Q 010513 184 STNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRH-KNLVRLLGYCAEGAHRMLVY 261 (508)
Q Consensus 184 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~l~~~~~~~~~~~lV~ 261 (508)
..++|++.++||+|+||.||+|.+. +++.||||++..... ...+..|+++++.++| +++..+..++.+....++||
T Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvm 82 (483)
T 3sv0_A 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (483)
T ss_dssp ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEE
Confidence 3468999999999999999999974 688999998765432 2347789999999977 56666667777888899999
Q ss_pred EecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEE---cCCCCeEEeeecccee
Q 010513 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILL---DKQWNPKLSDFGLAKL 338 (508)
Q Consensus 262 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll---~~~~~~kL~DFG~a~~ 338 (508)
||+ +++|.+++... ...+++..++.++.||+.||+|||++ +|+||||||+|||+ +.++.+||+|||+++.
T Consensus 83 e~~-g~sL~~ll~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 155 (483)
T 3sv0_A 83 DLL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155 (483)
T ss_dssp ECC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred ECC-CCCHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCccee
Confidence 999 88999999754 35799999999999999999999999 99999999999999 6889999999999987
Q ss_pred cCCCCcc------eecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhccc
Q 010513 339 LGAERSY------VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNR 412 (508)
Q Consensus 339 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 412 (508)
+...... ......||+.|+|||++.+..++.++|||||||+||||++|+.||..............+.......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (483)
T 3sv0_A 156 YRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVAT 235 (483)
T ss_dssp CBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHS
T ss_pred ccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccc
Confidence 7543321 1235689999999999999999999999999999999999999998765544333333222211110
Q ss_pred ccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010513 413 NAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (508)
Q Consensus 413 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~~ 462 (508)
.... + +.....++.+++.+||+.||++||++.+|+++|+..
T Consensus 236 ~~~~-----l----~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l 276 (483)
T 3sv0_A 236 SIEA-----L----CRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDL 276 (483)
T ss_dssp CHHH-----H----HTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred cHHH-----H----hcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 0000 0 011123455688899999999999999999988864
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-42 Score=343.40 Aligned_cols=251 Identities=22% Similarity=0.362 Sum_probs=196.4
Q ss_pred CCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCc--------hhHHHHHHHHHHHHccCCCCeeeEeeeeecCCe
Q 010513 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG--------QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAH 256 (508)
Q Consensus 186 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 256 (508)
++|++.+.||+|+||.||+|.+. +++.||||.+..... .....+.+|+++++.++||||+++++++..+.
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 88 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED- 88 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-
T ss_pred hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-
Confidence 57999999999999999999976 578899999864321 12345788999999999999999999997755
Q ss_pred eEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCC---eEEeee
Q 010513 257 RMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWN---PKLSDF 333 (508)
Q Consensus 257 ~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~---~kL~DF 333 (508)
.|+||||+++|+|.+++... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++. +||+||
T Consensus 89 ~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Df 161 (322)
T 2ycf_A 89 YYIVLELMEGGELFDKVVGN----KRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDF 161 (322)
T ss_dssp EEEEEECCTTEETHHHHSTT----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEECCC
T ss_pred eEEEEecCCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEccC
Confidence 89999999999999998764 5789999999999999999999999 9999999999999987665 999999
Q ss_pred ccceecCCCCcceecceecCCCCCChhhhh---cCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhc
Q 010513 334 GLAKLLGAERSYVTTRVMGTFGYVAPEYAS---TGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVT 410 (508)
Q Consensus 334 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~ 410 (508)
|++...... .......||+.|+|||++. ...++.++|||||||++|+|++|+.||........ +...+..
T Consensus 162 g~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~~~~--- 234 (322)
T 2ycf_A 162 GHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LKDQITS--- 234 (322)
T ss_dssp TTCEECCCC--HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC--HHHHHHH---
T ss_pred ccceecccc--cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH--HHHHHHh---
Confidence 999876432 2233457999999999874 46788999999999999999999999975543322 2221111
Q ss_pred ccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 411 NRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 411 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
.... ..+.. ......++.+++.+||+.||++||++.+++++
T Consensus 235 -~~~~--~~~~~----~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h 275 (322)
T 2ycf_A 235 -GKYN--FIPEV----WAEVSEKALDLVKKLLVVDPKARFTTEEALRH 275 (322)
T ss_dssp -TCCC--CCHHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred -Cccc--cCchh----hhhcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence 1000 00100 11123455668889999999999999999863
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=355.19 Aligned_cols=262 Identities=24% Similarity=0.326 Sum_probs=195.1
Q ss_pred CCCCcccceEcccCcEEEEEEEECCCcEEEEEEeecCCchhHHHHHHHHHHHHccCCCCeeeEeeeeecCC------eeE
Q 010513 185 TNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGA------HRM 258 (508)
Q Consensus 185 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~------~~~ 258 (508)
..+|++.+.||+|+||+||+|++..+..+|+|++...... ..+|+++++.++||||+++++++.... ..+
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 114 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence 3479999999999999999999987778999998654332 235999999999999999999985433 378
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEc-CCCCeEEeeeccce
Q 010513 259 LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLD-KQWNPKLSDFGLAK 337 (508)
Q Consensus 259 lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~-~~~~~kL~DFG~a~ 337 (508)
+||||+++ ++.+.+.........+++..++.++.|++.||+|||++ +|+||||||+|||++ .++.+||+|||+++
T Consensus 115 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a~ 190 (394)
T 4e7w_A 115 LVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAK 190 (394)
T ss_dssp EEEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCcc
Confidence 99999987 44444332111235799999999999999999999999 999999999999999 79999999999998
Q ss_pred ecCCCCcceecceecCCCCCChhhhhcC-CCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHh--------
Q 010513 338 LLGAERSYVTTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTM-------- 408 (508)
Q Consensus 338 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~-------- 408 (508)
....... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||...... ..+....+..
T Consensus 191 ~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~--~~l~~i~~~~g~p~~~~~ 266 (394)
T 4e7w_A 191 ILIAGEP--NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGI--DQLVEIIKVLGTPSREQI 266 (394)
T ss_dssp ECCTTCC--CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHHHCCCCHHHH
T ss_pred cccCCCC--CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCCHHHH
Confidence 7643322 2345789999999998764 5899999999999999999999999754321 1111111100
Q ss_pred -hcccccccCCCccCCCCchHH-----HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 409 -VTNRNAEGVLDPRLQEKPCSR-----ALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 409 -~~~~~~~~~~~~~l~~~~~~~-----~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
..........-+......... ...++.+++.+||+.||++||++.|++++
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 267 KTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp HHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 000011111111111111111 23456678889999999999999999975
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-43 Score=347.20 Aligned_cols=265 Identities=25% Similarity=0.360 Sum_probs=205.0
Q ss_pred chhhHhhcCCCCcccceEcccCcEEEEEEEECCCcEEEEEEeecCC--chhHHHHHHHHHHHHccCCCCeeeEeeeeecC
Q 010513 177 TLRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEG 254 (508)
Q Consensus 177 ~~~~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~ 254 (508)
.+.++++..++|++.+.||+|+||.||+|.+.+ .+|+|.+.... ....+.+.+|+.+++.++||||+++++++.+.
T Consensus 24 ~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 101 (319)
T 2y4i_B 24 FLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSP 101 (319)
T ss_dssp CGGGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECS
T ss_pred ccccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecC
Confidence 466778889999999999999999999999863 48999886432 22335677899999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeec
Q 010513 255 AHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFG 334 (508)
Q Consensus 255 ~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG 334 (508)
...++||||+++++|.+++... ...+++..++.++.|++.||+|||++ +++||||||+||+++ ++.+||+|||
T Consensus 102 ~~~~iv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg 174 (319)
T 2y4i_B 102 PHLAIITSLCKGRTLYSVVRDA---KIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFG 174 (319)
T ss_dssp SCEEEECBCCCSEEHHHHTTSS---CCCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCS
T ss_pred CceEEEeecccCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecC
Confidence 9999999999999999999765 35689999999999999999999999 999999999999998 6799999999
Q ss_pred cceecCCCC----cceecceecCCCCCChhhhhc---------CCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchH
Q 010513 335 LAKLLGAER----SYVTTRVMGTFGYVAPEYAST---------GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNL 401 (508)
Q Consensus 335 ~a~~~~~~~----~~~~~~~~gt~~y~aPE~~~~---------~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~ 401 (508)
++....... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||.....
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~------ 248 (319)
T 2y4i_B 175 LFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPA------ 248 (319)
T ss_dssp CCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCH------
T ss_pred CccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------
Confidence 987653211 112233468999999999864 4578899999999999999999999964321
Q ss_pred HHHHHHhhcccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCCC
Q 010513 402 VEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEEFP 465 (508)
Q Consensus 402 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~~~~~ 465 (508)
......... .. .+.......+.. +.+++.+||+.||++||++.+++++|+.....
T Consensus 249 ~~~~~~~~~-~~-----~~~~~~~~~~~~---l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~ 303 (319)
T 2y4i_B 249 EAIIWQMGT-GM-----KPNLSQIGMGKE---ISDILLFCWAFEQEERPTFTKLMDMLEKLPKR 303 (319)
T ss_dssp HHHHHHHHT-TC-----CCCCCCSSCCTT---HHHHHHHHHCSSTTTSCCHHHHHHHHTTC---
T ss_pred HHHHHHhcc-CC-----CCCCCcCCCCHH---HHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence 122222211 11 111111112233 44578899999999999999999999976543
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-42 Score=373.19 Aligned_cols=247 Identities=28% Similarity=0.449 Sum_probs=195.6
Q ss_pred ceEcccCcEEEEEEEEC---CCcEEEEEEeecCCc--hhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEEecCC
Q 010513 192 NVIGEGGYGIVYHGVLE---DNTNVAVKNLLNNRG--QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDN 266 (508)
Q Consensus 192 ~~LG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~ 266 (508)
+.||+|+||+||+|.+. .++.||||++..... ...+++.+|++++++++|||||++++++.+ +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 47999999999999753 457899999865432 345789999999999999999999999975 458899999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCCCcc-
Q 010513 267 GNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSY- 345 (508)
Q Consensus 267 g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~- 345 (508)
|+|.+++... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.+......
T Consensus 454 g~L~~~l~~~----~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 526 (635)
T 4fl3_A 454 GPLNKYLQQN----RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 526 (635)
T ss_dssp EEHHHHHHHC----TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----
T ss_pred CCHHHHHhhC----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccc
Confidence 9999999764 5689999999999999999999999 9999999999999999999999999999876543322
Q ss_pred -eecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHhhcccccccCCCccCC
Q 010513 346 -VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQ 423 (508)
Q Consensus 346 -~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 423 (508)
......||+.|+|||++.+..++.++|||||||++|||++ |+.||...... +. ...+..... ...
T Consensus 527 ~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~------~~-~~~i~~~~~-----~~~- 593 (635)
T 4fl3_A 527 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS------EV-TAMLEKGER-----MGC- 593 (635)
T ss_dssp --------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH------HH-HHHHHTTCC-----CCC-
T ss_pred ccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH------HH-HHHHHcCCC-----CCC-
Confidence 2233457889999999999999999999999999999998 99999754321 11 112221111 111
Q ss_pred CCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010513 424 EKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (508)
Q Consensus 424 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~~ 462 (508)
...++. ++.+++.+||+.||++||++.+|++.|++.
T Consensus 594 p~~~~~---~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 629 (635)
T 4fl3_A 594 PAGCPR---EMYDLMNLCWTYDVENRPGFAAVELRLRNY 629 (635)
T ss_dssp CTTCCH---HHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCCCCH---HHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 112333 445588899999999999999999999853
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=344.29 Aligned_cols=262 Identities=23% Similarity=0.346 Sum_probs=200.5
Q ss_pred CCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCC-chhHHHHHHHHHHHHccCCCCeeeEeeeeecC-----Cee
Q 010513 185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEG-----AHR 257 (508)
Q Consensus 185 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-----~~~ 257 (508)
.++|++.+.||+|+||.||+|.+. ++..||+|++.... ....+.+.+|++++++++||||+++++++... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 358999999999999999999976 57789999986543 33446788999999999999999999999754 368
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccce
Q 010513 258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK 337 (508)
Q Consensus 258 ~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~ 337 (508)
|+||||+++ +|.+++... .+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 106 ~iv~e~~~~-~L~~~l~~~-----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~ 176 (364)
T 3qyz_A 106 YIVQDLMET-DLYKLLKTQ-----HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLAR 176 (364)
T ss_dssp EEEEECCSE-EHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEcccCc-CHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcceE
Confidence 999999985 999998754 589999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCcce--ecceecCCCCCChhhhhc-CCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhccccc
Q 010513 338 LLGAERSYV--TTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNA 414 (508)
Q Consensus 338 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 414 (508)
......... ....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ ...+.........
T Consensus 177 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~---~~~i~~~~~~~~~ 253 (364)
T 3qyz_A 177 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ---LNHILGILGSPSQ 253 (364)
T ss_dssp ECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGH---HHHHHHHHCSCCH
T ss_pred ecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHH---HHHHHHHhCCCCH
Confidence 765432221 244589999999998654 5589999999999999999999999976543221 1111111000000
Q ss_pred ---ccC----------CCccCCCCch----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 415 ---EGV----------LDPRLQEKPC----SRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 415 ---~~~----------~~~~l~~~~~----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
... ..+....... +....++.+++.+||+.||++||++.|++++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 254 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp HHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000 0000000000 1112345668889999999999999999974
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-42 Score=337.27 Aligned_cols=259 Identities=24% Similarity=0.383 Sum_probs=197.8
Q ss_pred hcCCCCcccceEcccCcEEEEEEEEC--CCc--EEEEEEeecC---CchhHHHHHHHHHHHHccCCCCeeeEeeeeecCC
Q 010513 183 VSTNGFADENVIGEGGYGIVYHGVLE--DNT--NVAVKNLLNN---RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGA 255 (508)
Q Consensus 183 ~~~~~~~~~~~LG~G~~g~Vy~~~~~--~~~--~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~ 255 (508)
+..++|++.+.||+|+||+||+|.+. +++ .||+|.+... .....+.+.+|+++++.++||||+++++++.++.
T Consensus 15 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 94 (291)
T 1u46_A 15 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP 94 (291)
T ss_dssp CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred cchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC
Confidence 34568999999999999999999864 233 5899988643 2345578889999999999999999999998765
Q ss_pred eeEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeecc
Q 010513 256 HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGL 335 (508)
Q Consensus 256 ~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~ 335 (508)
.++||||+++|+|.+++... ...+++..++.++.|++.||.|||++ +++||||||+||+++.++.+||+|||+
T Consensus 95 -~~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~ 167 (291)
T 1u46_A 95 -MKMVTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGL 167 (291)
T ss_dssp -CEEEEECCTTCBHHHHHHHH---GGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTT
T ss_pred -ceeeEecccCCCHHHHHHhc---cCCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEccccc
Confidence 88999999999999999764 24689999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCcce--ecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHhhccc
Q 010513 336 AKLLGAERSYV--TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNR 412 (508)
Q Consensus 336 a~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~ 412 (508)
+.......... .....+|+.|+|||++.+..++.++||||||+++|+|++ |+.||..... .+.........
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~------~~~~~~~~~~~ 241 (291)
T 1u46_A 168 MRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG------SQILHKIDKEG 241 (291)
T ss_dssp CEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH------HHHHHHHHTSC
T ss_pred cccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCH------HHHHHHHHccC
Confidence 98765433221 233467889999999999889999999999999999999 9999974421 22222222211
Q ss_pred ccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 010513 413 NAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEE 463 (508)
Q Consensus 413 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~~~ 463 (508)
.. .. .....+. ++.+++.+||+.||++||++.+++++|++..
T Consensus 242 ~~-----~~-~~~~~~~---~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 283 (291)
T 1u46_A 242 ER-----LP-RPEDCPQ---DIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 283 (291)
T ss_dssp CC-----CC-CCTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred CC-----CC-CCcCcCH---HHHHHHHHHccCCcccCcCHHHHHHHHHHhC
Confidence 10 00 1111333 4455888999999999999999999998654
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-42 Score=349.58 Aligned_cols=258 Identities=22% Similarity=0.322 Sum_probs=182.0
Q ss_pred CCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecC--CchhHHHHHHHHHHHHccCCCCeeeEeeeeecC------C
Q 010513 185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEG------A 255 (508)
Q Consensus 185 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~------~ 255 (508)
.++|++.+.||+|+||.||+|.+. +|+.||||++... .....+.+.+|+++++.++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 368999999999999999999965 5888999998653 233456788999999999999999999998654 5
Q ss_pred eeEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeecc
Q 010513 256 HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGL 335 (508)
Q Consensus 256 ~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~ 335 (508)
..|+||||+ +++|.+++.. ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~ 178 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGL 178 (367)
T ss_dssp CCEEEEECC-CEECC----------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC---
T ss_pred eEEEEeccc-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeeccc
Confidence 679999999 6799998864 3689999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCcceecceecCCCCCChhhhhc-CCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccc-
Q 010513 336 AKLLGAERSYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRN- 413 (508)
Q Consensus 336 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~- 413 (508)
++..... .+...||+.|+|||++.+ ..++.++|||||||++|||++|+.||...+.. .....+........
T Consensus 179 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~l~~i~~~~g~p~~ 251 (367)
T 2fst_X 179 ARHTADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI---DQLKLILRLVGTPGA 251 (367)
T ss_dssp ----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCSCCH
T ss_pred ccccccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhCCCCH
Confidence 9865322 344689999999999877 67999999999999999999999999754321 11111111110000
Q ss_pred --cccCCC----------ccCCCCchH----HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 414 --AEGVLD----------PRLQEKPCS----RALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 414 --~~~~~~----------~~l~~~~~~----~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
...+.. +........ .....+.+++.+||+.||++||++.+++++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 252 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp HHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 000000 000000000 112345668889999999999999999975
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-42 Score=344.65 Aligned_cols=262 Identities=21% Similarity=0.321 Sum_probs=205.3
Q ss_pred hhcCCCCcccceEcccCcEEEEEEEECCCcEEEEEEeecCCchh-----------------HHHHHHHHHHHHccCCCCe
Q 010513 182 EVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQA-----------------EKEFKVEVEAIGRVRHKNL 244 (508)
Q Consensus 182 ~~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-----------------~~~~~~E~~~l~~l~hpni 244 (508)
+...++|++.+.||+|+||.||+|.+ +++.||+|.+....... .+.+.+|+++++.++||||
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 105 (348)
T 2pml_X 27 DKYINDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYC 105 (348)
T ss_dssp CEEETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTB
T ss_pred ccccCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCc
Confidence 34457899999999999999999999 79999999986432211 1788999999999999999
Q ss_pred eeEeeeeecCCeeEEEEEecCCCCHHHH------hccCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeeccCCC
Q 010513 245 VRLLGYCAEGAHRMLVYEYIDNGNLEQW------LHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE-GLEPKVVHRDIKS 317 (508)
Q Consensus 245 v~l~~~~~~~~~~~lV~e~~~~g~L~~~------l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~~iiHrDlkp 317 (508)
+++++++.+.+..++||||+++|+|.++ +... ....+++..++.++.|++.||+|||+ + +++||||||
T Consensus 106 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p 180 (348)
T 2pml_X 106 LTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKN--YTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKP 180 (348)
T ss_dssp CCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSS--SCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCG
T ss_pred ceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhc--cccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCCh
Confidence 9999999999999999999999999998 5442 14679999999999999999999998 8 999999999
Q ss_pred CCEEEcCCCCeEEeeeccceecCCCCcceecceecCCCCCChhhhhcC-CCCC-CCCeeehHHHHHHHHhCCCCCCCCCC
Q 010513 318 SNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTG-MLNE-RSDVYSFGILIMEVISGRNPVDYSRP 395 (508)
Q Consensus 318 ~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~sDvwSlGvvl~elltg~~Pf~~~~~ 395 (508)
+||+++.++.+||+|||++...... ......||+.|+|||++.+. .++. ++|||||||++|||++|+.||.....
T Consensus 181 ~Nil~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 257 (348)
T 2pml_X 181 SNILMDKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKIS 257 (348)
T ss_dssp GGEEECTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSC
T ss_pred HhEEEcCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCc
Confidence 9999999999999999999876433 33456799999999999877 6666 89999999999999999999975443
Q ss_pred CCcchHHHHHHHhhccccccc------CCCccCCC---CchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 396 PGEVNLVEWLKTMVTNRNAEG------VLDPRLQE---KPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 396 ~~~~~~~~~~~~~~~~~~~~~------~~~~~l~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
. .+..... ....... ...+.... .........+.+++.+||+.||++||++.+++++
T Consensus 258 ~-----~~~~~~i-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h 323 (348)
T 2pml_X 258 L-----VELFNNI-RTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323 (348)
T ss_dssp S-----HHHHHHH-TSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred H-----HHHHHHH-hccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 2 1111111 1111100 00000000 0001122345568889999999999999999974
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-41 Score=349.33 Aligned_cols=201 Identities=20% Similarity=0.289 Sum_probs=174.3
Q ss_pred hcCCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCchhHHHHHHHHHHHHcc------CCCCeeeEeeeeecCC
Q 010513 183 VSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV------RHKNLVRLLGYCAEGA 255 (508)
Q Consensus 183 ~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~hpniv~l~~~~~~~~ 255 (508)
....+|++.+.||+|+||+||+|.+. +++.||||++... ......+.+|+++++.+ .|+||+++++++....
T Consensus 94 ~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~ 172 (429)
T 3kvw_A 94 HVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRN 172 (429)
T ss_dssp EETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETT
T ss_pred cccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCC
Confidence 44568999999999999999999976 4788999998654 23345677788888777 5779999999999999
Q ss_pred eeEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCC--eEEeee
Q 010513 256 HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWN--PKLSDF 333 (508)
Q Consensus 256 ~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~--~kL~DF 333 (508)
..++||||+. ++|.+++.... ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++. +||+||
T Consensus 173 ~~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DF 246 (429)
T 3kvw_A 173 HICMTFELLS-MNLYELIKKNK--FQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDF 246 (429)
T ss_dssp EEEEEECCCC-CBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCC
T ss_pred eEEEEEeccC-CCHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeec
Confidence 9999999996 59999987653 24589999999999999999999999 9999999999999999887 999999
Q ss_pred ccceecCCCCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCC
Q 010513 334 GLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSR 394 (508)
Q Consensus 334 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~ 394 (508)
|+++..... ....+||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 247 G~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~ 303 (429)
T 3kvw_A 247 GSSCYEHQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED 303 (429)
T ss_dssp TTCEETTCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccceecCCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 999865322 234579999999999999999999999999999999999999997553
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=341.14 Aligned_cols=264 Identities=19% Similarity=0.277 Sum_probs=204.7
Q ss_pred hhHhhcCCCCcccceEcccCcEEEEEEEE-C-CCcEEEEEEeecCCchhHHHHHHHHHHHHccCCCC------eeeEeee
Q 010513 179 RELEVSTNGFADENVIGEGGYGIVYHGVL-E-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKN------LVRLLGY 250 (508)
Q Consensus 179 ~~~~~~~~~~~~~~~LG~G~~g~Vy~~~~-~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn------iv~l~~~ 250 (508)
...++..++|++.+.||+|+||+||+|.+ . +++.||+|++... ....+.+.+|+++++.++|+| +++++++
T Consensus 7 ~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~ 85 (339)
T 1z57_A 7 QSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEW 85 (339)
T ss_dssp STTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEE
T ss_pred ecCCCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecc
Confidence 33455677999999999999999999997 3 5788999988643 344567888999999887654 9999999
Q ss_pred eecCCeeEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcC------
Q 010513 251 CAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDK------ 324 (508)
Q Consensus 251 ~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~------ 324 (508)
+.+.+..++||||+ +++|.+++.... ...+++..++.++.|++.||+|||++ +|+||||||+|||++.
T Consensus 86 ~~~~~~~~lv~e~~-~~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~ 159 (339)
T 1z57_A 86 FEHHGHICIVFELL-GLSTYDFIKENG--FLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEA 159 (339)
T ss_dssp EEETTEEEEEEECC-CCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEE
T ss_pred cccCCcEEEEEcCC-CCCHHHHHHhcC--CCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccc
Confidence 99999999999999 789999997652 24689999999999999999999999 9999999999999987
Q ss_pred -------------CCCeEEeeeccceecCCCCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCC
Q 010513 325 -------------QWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVD 391 (508)
Q Consensus 325 -------------~~~~kL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~ 391 (508)
++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 160 ~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 235 (339)
T 1z57_A 160 YNPKIKRDERTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFP 235 (339)
T ss_dssp EC----CEEEEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred cCCccccccccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCC
Confidence 668999999999865332 234578999999999999999999999999999999999999997
Q ss_pred CCCCCCcchHHHHHHHhhcc-----------cccc---------------------cCCCccCCCCchHHHHHHHHHHHH
Q 010513 392 YSRPPGEVNLVEWLKTMVTN-----------RNAE---------------------GVLDPRLQEKPCSRALKRALLVAL 439 (508)
Q Consensus 392 ~~~~~~~~~~~~~~~~~~~~-----------~~~~---------------------~~~~~~l~~~~~~~~~~~l~~li~ 439 (508)
...... ....+...... .... ..+.... ........++.+++.
T Consensus 236 ~~~~~~---~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~ 310 (339)
T 1z57_A 236 THDSKE---HLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFM--LSQDVEHERLFDLIQ 310 (339)
T ss_dssp CSCHHH---HHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGC--SCCSHHHHHHHHHHH
T ss_pred CCChHH---HHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhc--ccchhhHHHHHHHHH
Confidence 543211 11111111100 0000 0000000 011233455667888
Q ss_pred HccCCCCCCCCCHHHHHHH
Q 010513 440 RCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 440 ~cl~~dP~~RPs~~evl~~ 458 (508)
+||+.||++||++.|++++
T Consensus 311 ~~L~~dP~~Rpt~~ell~h 329 (339)
T 1z57_A 311 KMLEYDPAKRITLREALKH 329 (339)
T ss_dssp HHTCSSTTTSCCHHHHTTS
T ss_pred HHhCcCcccccCHHHHhcC
Confidence 9999999999999999864
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=370.77 Aligned_cols=261 Identities=22% Similarity=0.378 Sum_probs=205.9
Q ss_pred hhHhhcCCCCcccceEcccCcEEEEEEEECC----CcEEEEEEeecCC-chhHHHHHHHHHHHHccCCCCeeeEeeeeec
Q 010513 179 RELEVSTNGFADENVIGEGGYGIVYHGVLED----NTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE 253 (508)
Q Consensus 179 ~~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 253 (508)
..+++..++|++.+.||+|+||+||+|.+.. +..||+|.+.... ....+.+.+|+.++++++||||+++++++.+
T Consensus 383 ~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 462 (656)
T 2j0j_A 383 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE 462 (656)
T ss_dssp GGTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec
Confidence 4556677889999999999999999999753 4568999886543 3344678999999999999999999999854
Q ss_pred CCeeEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeee
Q 010513 254 GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDF 333 (508)
Q Consensus 254 ~~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DF 333 (508)
+..++||||+++|+|.+++... ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+||
T Consensus 463 -~~~~lv~E~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DF 535 (656)
T 2j0j_A 463 -NPVWIIMELCTLGELRSFLQVR---KFSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDF 535 (656)
T ss_dssp -SSCEEEEECCTTCBHHHHHHHT---TTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCC
T ss_pred -CceEEEEEcCCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEec
Confidence 5689999999999999999765 34689999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHhhccc
Q 010513 334 GLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNR 412 (508)
Q Consensus 334 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~ 412 (508)
|+++..............||+.|+|||++.+..++.++|||||||++|||++ |..||..... .+.........
T Consensus 536 G~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~------~~~~~~i~~~~ 609 (656)
T 2j0j_A 536 GLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN------NDVIGRIENGE 609 (656)
T ss_dssp CCCCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH------HHHHHHHHHTC
T ss_pred CCCeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCH------HHHHHHHHcCC
Confidence 9998775544444444567889999999999999999999999999999997 9999975432 12222221111
Q ss_pred ccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010513 413 NAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (508)
Q Consensus 413 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~~ 462 (508)
. +... ..++. .+.+++.+||+.||++||++.++++.|++.
T Consensus 610 ~------~~~~-~~~~~---~l~~li~~~l~~dP~~RPs~~el~~~L~~i 649 (656)
T 2j0j_A 610 R------LPMP-PNCPP---TLYSLMTKCWAYDPSRRPRFTELKAQLSTI 649 (656)
T ss_dssp C------CCCC-TTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred C------CCCC-ccccH---HHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 1 0111 11333 444588899999999999999999999753
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-41 Score=332.97 Aligned_cols=251 Identities=22% Similarity=0.314 Sum_probs=197.0
Q ss_pred CCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCC----chhHHHHHHHHHHHHccCCCCeeeEeeeee--cCCee
Q 010513 185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR----GQAEKEFKVEVEAIGRVRHKNLVRLLGYCA--EGAHR 257 (508)
Q Consensus 185 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~hpniv~l~~~~~--~~~~~ 257 (508)
.++|++.+.||+|+||.||+|... ++..||+|.+.... ....+.+.+|+++++.++||||+++++++. +....
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 358999999999999999999975 57899999986542 234567899999999999999999999984 45678
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccce
Q 010513 258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK 337 (508)
Q Consensus 258 ~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~ 337 (508)
++||||++++ |.+++.... ...+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++.
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~ 157 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVP--EKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAE 157 (305)
T ss_dssp EEEEECCSEE-HHHHHHHST--TCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEehhccCC-HHHHHHhCc--ccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeecccccc
Confidence 9999999986 777776542 35789999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCC-CcceecceecCCCCCChhhhhcCC--CCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhccccc
Q 010513 338 LLGAE-RSYVTTRVMGTFGYVAPEYASTGM--LNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNA 414 (508)
Q Consensus 338 ~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 414 (508)
..... .........||+.|+|||++.+.. ++.++||||||+++|||++|+.||.... ..+....... ...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~------~~~~~~~i~~-~~~ 230 (305)
T 2wtk_C 158 ALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN------IYKLFENIGK-GSY 230 (305)
T ss_dssp ECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSS------HHHHHHHHHH-CCC
T ss_pred ccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCch------HHHHHHHHhc-CCC
Confidence 76432 222334457999999999987644 3778999999999999999999997432 1222222111 110
Q ss_pred ccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 415 EGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 415 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
.+.. .++.. +.+++.+||+.||++||++.+++++
T Consensus 231 ------~~~~-~~~~~---l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 231 ------AIPG-DCGPP---LSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp ------CCCS-SSCHH---HHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred ------CCCC-ccCHH---HHHHHHHHccCChhhCCCHHHHhcC
Confidence 1111 13333 4457779999999999999999975
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=332.87 Aligned_cols=251 Identities=26% Similarity=0.409 Sum_probs=191.2
Q ss_pred CCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCchhHHHHHHHHHHHHccCCCCeeeEeeeeec-----------
Q 010513 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE----------- 253 (508)
Q Consensus 186 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~----------- 253 (508)
++|++.+.||+|+||.||+|... +++.||+|.+... ....+.+.+|+++++.++||||+++++++.+
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAV 84 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-----
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhccc
Confidence 47899999999999999999975 6889999998543 3445678899999999999999999998865
Q ss_pred --CCeeEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEe
Q 010513 254 --GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLS 331 (508)
Q Consensus 254 --~~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~ 331 (508)
....++||||+++|+|.+++... ...+++..++.++.|++.||+|||++ +++||||||+|||++.++.+||+
T Consensus 85 ~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~kl~ 158 (303)
T 1zy4_A 85 KKKSTLFIQMEYCENGTLYDLIHSE---NLNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIG 158 (303)
T ss_dssp -CEEEEEEEEECCCSCBHHHHHHHS---CGGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEEC
T ss_pred ccCCceEEEEecCCCCCHHHhhhcc---ccccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEEEe
Confidence 45678999999999999999765 34678899999999999999999999 99999999999999999999999
Q ss_pred eeccceecCCCC-------------cceecceecCCCCCChhhhhcC-CCCCCCCeeehHHHHHHHHhCCCCCCCCCCCC
Q 010513 332 DFGLAKLLGAER-------------SYVTTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRNPVDYSRPPG 397 (508)
Q Consensus 332 DFG~a~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~ 397 (508)
|||++....... ........||+.|+|||++.+. .++.++|||||||++|||++ ||...
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~---- 231 (303)
T 1zy4_A 159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTG---- 231 (303)
T ss_dssp CCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSH----
T ss_pred eCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCc----
Confidence 999998654221 1122345799999999999764 68999999999999999998 55311
Q ss_pred cchHHHHHHHhhcccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 398 EVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 398 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
....+....... .. ....+.+ .......+.+++.+||+.||++||++.+++++
T Consensus 232 -~~~~~~~~~~~~-~~--~~~~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 232 -MERVNILKKLRS-VS--IEFPPDF----DDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp -HHHHHHHHHHHS-TT--CCCCTTC----CTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred -hhHHHHHHhccc-cc--cccCccc----cccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 111222222111 10 1111112 12222334558889999999999999999975
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=336.57 Aligned_cols=269 Identities=21% Similarity=0.345 Sum_probs=196.0
Q ss_pred CCCCcccceEcccCcEEEEEEEECC-CcEEEEEEeecCCchhHHHHHHHHHHHHccCCCCeeeEeeeee-----------
Q 010513 185 TNGFADENVIGEGGYGIVYHGVLED-NTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCA----------- 252 (508)
Q Consensus 185 ~~~~~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~----------- 252 (508)
.++|++.+.||+|+||.||+|.+.. ++.||+|++........+.+.+|+++++.++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 4689999999999999999999874 8899999997776666788999999999999999999999873
Q ss_pred ---cCCeeEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEc-CCCCe
Q 010513 253 ---EGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLD-KQWNP 328 (508)
Q Consensus 253 ---~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~-~~~~~ 328 (508)
+....++||||++ |+|.+++.. ..+++..++.++.|++.||+|||++ +|+||||||+|||++ +++.+
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~ 160 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLEQ-----GPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVL 160 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTEE
T ss_pred cccccCceeEEeeccC-CCHHHHhhc-----CCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCeE
Confidence 4467899999998 599999864 4689999999999999999999999 999999999999997 56789
Q ss_pred EEeeeccceecCCCCc--ceecceecCCCCCChhhhhc-CCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHH
Q 010513 329 KLSDFGLAKLLGAERS--YVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWL 405 (508)
Q Consensus 329 kL~DFG~a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~ 405 (508)
||+|||+++....... .......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||...... .....+
T Consensus 161 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~---~~~~~~ 237 (320)
T 2i6l_A 161 KIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHEL---EQMQLI 237 (320)
T ss_dssp EECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHH
T ss_pred EEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHH---HHHHHH
Confidence 9999999987643211 12233567999999998865 67899999999999999999999999754321 111111
Q ss_pred HHhhccc----------cc-----ccCCCccCC-CCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--HhcCCCC
Q 010513 406 KTMVTNR----------NA-----EGVLDPRLQ-EKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM--LEAEEFP 465 (508)
Q Consensus 406 ~~~~~~~----------~~-----~~~~~~~l~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--Le~~~~~ 465 (508)
....... .. .....+... ....+....++.+++.+||+.||++||++.+++++ +....+|
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~p 315 (320)
T 2i6l_A 238 LESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSFP 315 (320)
T ss_dssp HHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC-
T ss_pred HHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccCc
Confidence 1000000 00 000000000 00001123445668889999999999999999873 4444333
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=349.99 Aligned_cols=202 Identities=22% Similarity=0.367 Sum_probs=155.5
Q ss_pred CCcc-cceEcccCcEEEEEEEEC---CCcEEEEEEeecCCchhHHHHHHHHHHHHccCCCCeeeEeeeee--cCCeeEEE
Q 010513 187 GFAD-ENVIGEGGYGIVYHGVLE---DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCA--EGAHRMLV 260 (508)
Q Consensus 187 ~~~~-~~~LG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~--~~~~~~lV 260 (508)
.|++ .++||+|+||+||+|++. ++..||+|++.... ....+.+|+++++.++||||+++++++. .+...++|
T Consensus 21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv 98 (405)
T 3rgf_A 21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLL 98 (405)
T ss_dssp HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEE
T ss_pred hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEE
Confidence 4555 458999999999999976 47789999986543 2346788999999999999999999994 46789999
Q ss_pred EEecCCCCHHHHhccCC-----CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEE----cCCCCeEEe
Q 010513 261 YEYIDNGNLEQWLHGDV-----GPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILL----DKQWNPKLS 331 (508)
Q Consensus 261 ~e~~~~g~L~~~l~~~~-----~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll----~~~~~~kL~ 331 (508)
|||+++ +|.+++.... .....+++..++.++.|++.||+|||++ +|+||||||+|||+ +.++.+||+
T Consensus 99 ~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~ 174 (405)
T 3rgf_A 99 FDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIA 174 (405)
T ss_dssp EECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCEEEC
T ss_pred EeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcEEEE
Confidence 999975 8888875321 1123589999999999999999999999 99999999999999 678899999
Q ss_pred eeccceecCCCCc--ceecceecCCCCCChhhhhc-CCCCCCCCeeehHHHHHHHHhCCCCCCCCC
Q 010513 332 DFGLAKLLGAERS--YVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSR 394 (508)
Q Consensus 332 DFG~a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~Pf~~~~ 394 (508)
|||+++....... ......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 175 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 240 (405)
T 3rgf_A 175 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 240 (405)
T ss_dssp CTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC
T ss_pred ECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcc
Confidence 9999987643221 22344689999999999877 458999999999999999999999997553
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-41 Score=343.23 Aligned_cols=208 Identities=23% Similarity=0.305 Sum_probs=176.1
Q ss_pred chhhHhhcCCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCchhHHHHHHHHHHHHccC-CC-----CeeeEee
Q 010513 177 TLRELEVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVR-HK-----NLVRLLG 249 (508)
Q Consensus 177 ~~~~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hp-----niv~l~~ 249 (508)
.+...+...++|++.+.||+|+||+||+|.+. +++.||||++... ......+..|+++++.++ |+ +|+++++
T Consensus 45 ~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~ 123 (382)
T 2vx3_A 45 IVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKR 123 (382)
T ss_dssp CCCTTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEE
T ss_pred EeecCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeee
Confidence 34555666789999999999999999999976 5778999998643 334566778888888884 55 4999999
Q ss_pred eeecCCeeEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEc--CCCC
Q 010513 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLD--KQWN 327 (508)
Q Consensus 250 ~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~--~~~~ 327 (508)
++...+..++||||+++ +|.+++.... ...+++..+..++.|++.||.|||++ +.+|+||||||+|||++ .++.
T Consensus 124 ~~~~~~~~~lv~e~~~~-~L~~~l~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~ 199 (382)
T 2vx3_A 124 HFMFRNHLCLVFEMLSY-NLYDLLRNTN--FRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSA 199 (382)
T ss_dssp EEEETTEEEEEEECCCC-BHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCC
T ss_pred eeccCCceEEEEecCCC-CHHHHHhhcC--cCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCc
Confidence 99999999999999965 9999997652 24689999999999999999999952 22899999999999994 5778
Q ss_pred eEEeeeccceecCCCCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCC
Q 010513 328 PKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS 393 (508)
Q Consensus 328 ~kL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~ 393 (508)
+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 200 ~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~ 261 (382)
T 2vx3_A 200 IKIVDFGSSCQLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA 261 (382)
T ss_dssp EEECCCTTCEETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred EEEEeccCceecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 999999999876432 23457899999999999999999999999999999999999999754
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=335.37 Aligned_cols=259 Identities=20% Similarity=0.332 Sum_probs=199.8
Q ss_pred chhhHhhcCCCCcccceEcccCcEEEEEEEECCCcEEEEEEeecC--CchhHHHHHHHHHHHHccC--CCCeeeEeeeee
Q 010513 177 TLRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVR--HKNLVRLLGYCA 252 (508)
Q Consensus 177 ~~~~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~--hpniv~l~~~~~ 252 (508)
.+..+.+..++|++.+.||+|+||.||+|...+++.||+|.+... .....+.+.+|++++.+++ ||||+++++++.
T Consensus 19 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~ 98 (313)
T 3cek_A 19 YFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI 98 (313)
T ss_dssp -CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEE
T ss_pred CeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEee
Confidence 345556777889999999999999999999888999999998654 2344577899999999997 599999999999
Q ss_pred cCCeeEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEee
Q 010513 253 EGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSD 332 (508)
Q Consensus 253 ~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~D 332 (508)
++...++||| +.+++|.+++... ..+++..++.++.|+++||.|||++ +|+||||||+|||+++ +.+||+|
T Consensus 99 ~~~~~~lv~e-~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~D 169 (313)
T 3cek_A 99 TDQYIYMVME-CGNIDLNSWLKKK----KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLID 169 (313)
T ss_dssp CSSEEEEEEC-CCSEEHHHHHHHC----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEECC
T ss_pred cCCEEEEEEe-cCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEee
Confidence 9999999999 5677999999865 4789999999999999999999999 9999999999999975 7999999
Q ss_pred eccceecCCCCcc-eecceecCCCCCChhhhhc-----------CCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcch
Q 010513 333 FGLAKLLGAERSY-VTTRVMGTFGYVAPEYAST-----------GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVN 400 (508)
Q Consensus 333 FG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~ 400 (508)
||++......... ......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||.....
T Consensus 170 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~----- 244 (313)
T 3cek_A 170 FGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN----- 244 (313)
T ss_dssp CSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCS-----
T ss_pred ccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHH-----
Confidence 9999876443222 2234579999999999875 4688899999999999999999999964321
Q ss_pred HHHHHHHhhcccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 401 LVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 401 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
....+........ ...+.. ..+. ++.+++.+||+.||++||++.+++++
T Consensus 245 ~~~~~~~~~~~~~-----~~~~~~-~~~~---~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 245 QISKLHAIIDPNH-----EIEFPD-IPEK---DLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp HHHHHHHHHCTTS-----CCCCCC-CSCH---HHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHHHhccc-----ccCCcc-cchH---HHHHHHHHHccCCcccCcCHHHHhcC
Confidence 1122222221111 111111 1233 44557789999999999999999964
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-41 Score=341.79 Aligned_cols=257 Identities=22% Similarity=0.318 Sum_probs=194.9
Q ss_pred CCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCC--chhHHHHHHHHHHHHccCCCCeeeEeeeeecCCee----
Q 010513 185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHR---- 257 (508)
Q Consensus 185 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~---- 257 (508)
.++|.+.+.||+|+||+||+|.+. +++.||+|++.... ....+.+.+|+.+++.++||||+++++++......
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 468999999999999999999976 58899999986543 23356788999999999999999999999877655
Q ss_pred --EEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeecc
Q 010513 258 --MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGL 335 (508)
Q Consensus 258 --~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~ 335 (508)
++||||+. ++|.+++. ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 121 ~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~ 190 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMG------MEFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGL 190 (371)
T ss_dssp CCEEEEECCC-EEHHHHTT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred eEEEEEcccc-ccHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCc
Confidence 99999998 48988873 3489999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCcceecceecCCCCCChhhhhc-CCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhccc--
Q 010513 336 AKLLGAERSYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNR-- 412 (508)
Q Consensus 336 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~-- 412 (508)
++..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...... .....+.......
T Consensus 191 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~~i~~~~~~~~~ 263 (371)
T 4exu_A 191 ARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL---DQLTQILKVTGVPGT 263 (371)
T ss_dssp C------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCCCCH
T ss_pred ccccccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhCCCcH
Confidence 9865332 334578999999999877 68999999999999999999999999754311 1111111000000
Q ss_pred cc-cc-----------CCCccCCCCc---hHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 413 NA-EG-----------VLDPRLQEKP---CSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 413 ~~-~~-----------~~~~~l~~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
.. .. .+........ .+.....+.+++.+||+.||++||++.|++++
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 264 EFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp HHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 00 00 0000000000 01113455668889999999999999999875
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-41 Score=335.15 Aligned_cols=264 Identities=25% Similarity=0.342 Sum_probs=197.8
Q ss_pred cCCCCcccceEcccCcEEEEEEEEC--CCcEEEEEEeecCCc--hhHHHHHHHHHHHHcc---CCCCeeeEeeeee----
Q 010513 184 STNGFADENVIGEGGYGIVYHGVLE--DNTNVAVKNLLNNRG--QAEKEFKVEVEAIGRV---RHKNLVRLLGYCA---- 252 (508)
Q Consensus 184 ~~~~~~~~~~LG~G~~g~Vy~~~~~--~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~hpniv~l~~~~~---- 252 (508)
..++|++.+.||+|+||.||+|.+. +++.||+|++..... .....+.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 3468999999999999999999983 578899998864322 1223455677776666 8999999999987
Q ss_pred -cCCeeEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEe
Q 010513 253 -EGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLS 331 (508)
Q Consensus 253 -~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~ 331 (508)
.....++||||++ |+|.+++.... ...+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~ 162 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLA 162 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSC--TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEEC
T ss_pred CCCceEEEEEecCC-CCHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEe
Confidence 5567899999998 59999997653 24589999999999999999999999 99999999999999999999999
Q ss_pred eeccceecCCCCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcc
Q 010513 332 DFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTN 411 (508)
Q Consensus 332 DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~ 411 (508)
|||++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+......
T Consensus 163 Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~~~~~~i~~~~~~ 237 (326)
T 1blx_A 163 DFGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD---VDQLGKILDVIGL 237 (326)
T ss_dssp SCCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHHCC
T ss_pred cCcccccccCCC--CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCH---HHHHHHHHHHcCC
Confidence 999998654322 23446789999999999999999999999999999999999999975432 1111111111110
Q ss_pred c---cccc-------CCCccC---CCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 412 R---NAEG-------VLDPRL---QEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 412 ~---~~~~-------~~~~~l---~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
. .... ...... ...........+.+++.+||+.||++||++.+++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 297 (326)
T 1blx_A 238 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297 (326)
T ss_dssp CCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0 0000 000000 000001122344558889999999999999999954
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=342.45 Aligned_cols=268 Identities=19% Similarity=0.240 Sum_probs=188.0
Q ss_pred HhhcCCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCchhHHHHHHHHHHHHccCCCCeeeEeeeeecCCe---
Q 010513 181 LEVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAH--- 256 (508)
Q Consensus 181 ~~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~--- 256 (508)
.....++|++.+.||+|+||+||+|.+. ++..||||++...... ...+.++++.++.++||||+++++++.....
T Consensus 18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~ 96 (360)
T 3e3p_A 18 SRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF-RNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDR 96 (360)
T ss_dssp HHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTC-CCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCT
T ss_pred chhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc-cHHHHHHHHHHHhcCCCCcccHHHhhhccccccc
Confidence 3456679999999999999999999985 5889999988654332 3345668888899999999999999865333
Q ss_pred ----eEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHH--hcCCCCeeeccCCCCCEEEcC-CCCeE
Q 010513 257 ----RMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH--EGLEPKVVHRDIKSSNILLDK-QWNPK 329 (508)
Q Consensus 257 ----~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH--~~~~~~iiHrDlkp~NIll~~-~~~~k 329 (508)
.++||||+++ +|.+.+.........+++..+..++.|++.||.||| ++ +|+||||||+|||++. ++.+|
T Consensus 97 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~~~k 172 (360)
T 3e3p_A 97 RDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADGTLK 172 (360)
T ss_dssp TCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTTTEEE
T ss_pred cceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCCCcEE
Confidence 7899999987 665554432223467899999999999999999999 87 9999999999999996 89999
Q ss_pred EeeeccceecCCCCcceecceecCCCCCChhhhhcC-CCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHh
Q 010513 330 LSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTM 408 (508)
Q Consensus 330 L~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~ 408 (508)
|+|||+++....... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||...... .....+...
T Consensus 173 l~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~---~~~~~~~~~ 247 (360)
T 3e3p_A 173 LCDFGSAKKLSPSEP--NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSA---GQLHEIVRV 247 (360)
T ss_dssp ECCCTTCBCCCTTSC--CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHH
T ss_pred EeeCCCceecCCCCC--cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChH---HHHHHHHHH
Confidence 999999987644332 2345789999999998655 4899999999999999999999999754321 111111110
Q ss_pred hcc------------cccccCCCcc------CCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 409 VTN------------RNAEGVLDPR------LQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 409 ~~~------------~~~~~~~~~~------l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
... .......+.. ...+.......++.+++.+||+.||++||++.|++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 248 LGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp HCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred cCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 000 0000000000 0000011123456678889999999999999999975
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-41 Score=328.69 Aligned_cols=252 Identities=23% Similarity=0.331 Sum_probs=201.0
Q ss_pred cCCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCC--chhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEE
Q 010513 184 STNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLV 260 (508)
Q Consensus 184 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 260 (508)
..++|++.+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|++++++++||||+++++++.+....++|
T Consensus 20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 99 (287)
T 2wei_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (287)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEE
Confidence 3458999999999999999999986 68899999986542 23457788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCC---CCeEEeeeccce
Q 010513 261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQ---WNPKLSDFGLAK 337 (508)
Q Consensus 261 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~---~~~kL~DFG~a~ 337 (508)
|||+++++|.+++... ..+++..++.++.|++.||+|||++ +++||||||+||+++.+ +.+||+|||++.
T Consensus 100 ~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~ 172 (287)
T 2wei_A 100 GELYTGGELFDEIIKR----KRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (287)
T ss_dssp ECCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTGGG
T ss_pred EEccCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCcce
Confidence 9999999999998764 4689999999999999999999999 99999999999999654 469999999998
Q ss_pred ecCCCCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccC
Q 010513 338 LLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGV 417 (508)
Q Consensus 338 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 417 (508)
....... .....||+.|+|||.+.+ .++.++||||||+++|+|++|+.||.... ..+......... .. .
T Consensus 173 ~~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~------~~~~~~~~~~~~-~~-~ 241 (287)
T 2wei_A 173 CFQQNTK--MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN------EYDILKRVETGK-YA-F 241 (287)
T ss_dssp TBCCCSS--CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHCC-CC-C
T ss_pred eecCCCc--cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCC------HHHHHHHHHcCC-CC-C
Confidence 6543322 233468999999998865 48999999999999999999999997432 122222222111 10 0
Q ss_pred CCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 418 LDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 418 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
..+.. ...+ .++.+++.+||+.||++||++.+++++
T Consensus 242 ~~~~~--~~~~---~~~~~li~~~l~~dp~~Rps~~ell~h 277 (287)
T 2wei_A 242 DLPQW--RTIS---DDAKDLIRKMLTFHPSLRITATQCLEH 277 (287)
T ss_dssp CSGGG--TTSC---HHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred Cchhh--hhcC---HHHHHHHHHHcccChhhCcCHHHHhcC
Confidence 00100 1122 345558889999999999999999973
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-41 Score=337.73 Aligned_cols=263 Identities=20% Similarity=0.306 Sum_probs=198.1
Q ss_pred cCCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCC-chhHHHHHHHHHHHHccCCCCeeeEeeeeecC-----Ce
Q 010513 184 STNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEG-----AH 256 (508)
Q Consensus 184 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-----~~ 256 (508)
..++|.+.+.||+|+||.||+|.+. +++.||||++.... ......+.+|+++++.++||||+++++++... ..
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 3468999999999999999999976 58889999986443 33456788899999999999999999988654 67
Q ss_pred eEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccc
Q 010513 257 RMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLA 336 (508)
Q Consensus 257 ~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a 336 (508)
.++||||+.+ +|.+++... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 89 ~~lv~e~~~~-~L~~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a 159 (353)
T 2b9h_A 89 VYIIQELMQT-DLHRVISTQ-----MLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLA 159 (353)
T ss_dssp EEEEECCCSE-EHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEeccCc-cHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEecccc
Confidence 8999999984 999998753 689999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCcc---------eecceecCCCCCChhhhhc-CCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHH
Q 010513 337 KLLGAERSY---------VTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLK 406 (508)
Q Consensus 337 ~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~ 406 (508)
......... .....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... .....+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~~~~ 236 (353)
T 2b9h_A 160 RIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYR---HQLLLIF 236 (353)
T ss_dssp EECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHH
T ss_pred cccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcH---HHHHHHH
Confidence 876432211 1223578999999998765 67899999999999999999999999754311 1111111
Q ss_pred HhhcccccccCCC--------------ccCCCCc----hHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 407 TMVTNRNAEGVLD--------------PRLQEKP----CSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 407 ~~~~~~~~~~~~~--------------~~l~~~~----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
............. +...... .+....++.+++.+||+.||++||++.+++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (353)
T 2b9h_A 237 GIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306 (353)
T ss_dssp HHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 1110000000000 0000000 01122345668889999999999999999974
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-41 Score=349.41 Aligned_cols=254 Identities=22% Similarity=0.289 Sum_probs=187.5
Q ss_pred CCCcccceEcccCcEEEEEEEECCCcEEEEEEeecCCchhHHHHHHHHHHHHcc-CCCCeeeEeeeeecCCeeEEEEEec
Q 010513 186 NGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYI 264 (508)
Q Consensus 186 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lV~e~~ 264 (508)
+.|...+.||+|+||+||.+...+|+.||||++... ..+.+.+|+++++.+ +||||+++++++.++...|+||||+
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~ 91 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC 91 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence 356667899999999998777778999999998653 235677899999876 8999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCC---CCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCC-------------CCe
Q 010513 265 DNGNLEQWLHGDVGPHSP---LTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQ-------------WNP 328 (508)
Q Consensus 265 ~~g~L~~~l~~~~~~~~~---l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~-------------~~~ 328 (508)
. |+|.+++......... .++..++.++.|++.||+|||++ +|+||||||+|||++.+ +.+
T Consensus 92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~ 167 (434)
T 2rio_A 92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRI 167 (434)
T ss_dssp S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceEE
Confidence 6 5999999765321111 13334678999999999999999 99999999999999754 479
Q ss_pred EEeeeccceecCCCCcc---eecceecCCCCCChhhhhc-------CCCCCCCCeeehHHHHHHHHh-CCCCCCCCCCCC
Q 010513 329 KLSDFGLAKLLGAERSY---VTTRVMGTFGYVAPEYAST-------GMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPG 397 (508)
Q Consensus 329 kL~DFG~a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-------~~~~~~sDvwSlGvvl~ellt-g~~Pf~~~~~~~ 397 (508)
||+|||+++........ .....+||+.|+|||++.+ ..++.++|||||||++|||+| |+.||......
T Consensus 168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~- 246 (434)
T 2rio_A 168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR- 246 (434)
T ss_dssp EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH-
T ss_pred EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh-
Confidence 99999999987543322 1234579999999999975 678999999999999999999 99999643221
Q ss_pred cchHHHHHHHhhcccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 398 EVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 398 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
....+.... . .+............++.+++.+||+.||++||++.+++++
T Consensus 247 ---~~~i~~~~~---~-----~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 296 (434)
T 2rio_A 247 ---ESNIIRGIF---S-----LDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH 296 (434)
T ss_dssp ---HHHHHHTCC---C-----CCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ---HHHHhcCCC---C-----cccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence 111111110 0 0111111123344566778889999999999999999863
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-41 Score=336.26 Aligned_cols=252 Identities=19% Similarity=0.257 Sum_probs=171.0
Q ss_pred CCCCcccc-eEcccCcEEEEEEEEC-CCcEEEEEEeecCCchhHHHHHHHHHHHHccCCCCeeeEeeeeec----CCeeE
Q 010513 185 TNGFADEN-VIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE----GAHRM 258 (508)
Q Consensus 185 ~~~~~~~~-~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~----~~~~~ 258 (508)
.++|.+.+ .||+|+||+||+|.+. +++.||+|++.... ....+....++.++||||+++++++.. +...+
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 102 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLL 102 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence 45788854 6999999999999987 68899999986532 122223344567799999999999876 45588
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcC---CCCeEEeeecc
Q 010513 259 LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDK---QWNPKLSDFGL 335 (508)
Q Consensus 259 lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~---~~~~kL~DFG~ 335 (508)
+||||+++|+|.+++.... ...+++..++.++.|++.||+|||++ +|+||||||+|||++. ++.+||+|||+
T Consensus 103 lv~e~~~gg~L~~~l~~~~--~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~ 177 (336)
T 3fhr_A 103 IIMECMEGGELFSRIQERG--DQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGF 177 (336)
T ss_dssp EEEECCTTEEHHHHHHTC---CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEeccCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEecccc
Confidence 9999999999999998652 24799999999999999999999999 9999999999999976 45599999999
Q ss_pred ceecCCCCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccc
Q 010513 336 AKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAE 415 (508)
Q Consensus 336 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (508)
++..... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||......... ............
T Consensus 178 ~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~---~~~~~~~~~~~~- 250 (336)
T 3fhr_A 178 AKETTQN---ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAIS---PGMKRRIRLGQY- 250 (336)
T ss_dssp CEEC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------------------------
T ss_pred ceecccc---ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhh---hhHHHhhhcccc-
Confidence 9865422 233457899999999998888999999999999999999999999754322110 000110100000
Q ss_pred cCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 010513 416 GVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIH 457 (508)
Q Consensus 416 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 457 (508)
....+. ....+ .++.+++.+||+.||++||++.++++
T Consensus 251 ~~~~~~--~~~~~---~~~~~li~~~L~~dP~~Rpt~~ell~ 287 (336)
T 3fhr_A 251 GFPNPE--WSEVS---EDAKQLIRLLLKTDPTERLTITQFMN 287 (336)
T ss_dssp CCCTTT--STTCC---HHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ccCchh--hccCC---HHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 000010 01123 34455888999999999999999998
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-41 Score=339.19 Aligned_cols=256 Identities=22% Similarity=0.316 Sum_probs=194.2
Q ss_pred CCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCC--chhHHHHHHHHHHHHccCCCCeeeEeeeeecCCe-----
Q 010513 185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAH----- 256 (508)
Q Consensus 185 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~----- 256 (508)
.++|.+.+.||+|+||.||+|.+. +|+.||||++.... ....+.+.+|+.+++.++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 358999999999999999999976 58899999986543 2335678899999999999999999999987654
Q ss_pred -eEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeecc
Q 010513 257 -RMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGL 335 (508)
Q Consensus 257 -~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~ 335 (508)
.|+||||+++ +|.+++. ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 103 ~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~ 172 (353)
T 3coi_A 103 DFYLVMPFMQT-DLQKIMG------LKFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGL 172 (353)
T ss_dssp CCEEEEECCSE-EGGGTTT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTC
T ss_pred eEEEEeccccC-CHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeeccc
Confidence 4999999984 8888773 3489999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCcceecceecCCCCCChhhhhc-CCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhccc--
Q 010513 336 AKLLGAERSYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNR-- 412 (508)
Q Consensus 336 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~-- 412 (508)
++..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... .....+.......
T Consensus 173 ~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~---~~~~~i~~~~~~~~~ 245 (353)
T 3coi_A 173 ARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL---DQLTQILKVTGVPGT 245 (353)
T ss_dssp TTC------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHH---HHHHHHHHHHCBCCH
T ss_pred ccCCCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhCCCCH
Confidence 9865322 234578999999999877 67899999999999999999999999754321 1111111100000
Q ss_pred ----------------ccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 413 ----------------NAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 413 ----------------~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
.......+.+. ...+....++.+++.+||+.||++||++.+++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 246 EFVQKLNDKAAKSYIQSLPQTPRKDFT-QLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp HHHTTCSCHHHHHHHHTSCBCSSCCTT-TTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHHHhhHHHHHHHHhCcCCCCccHH-HhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 00000000110 0111223445568889999999999999999875
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-41 Score=335.60 Aligned_cols=261 Identities=28% Similarity=0.372 Sum_probs=179.8
Q ss_pred HhhcCCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCc-hhHHHHHHHHH-HHHccCCCCeeeEeeeeecCCee
Q 010513 181 LEVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG-QAEKEFKVEVE-AIGRVRHKNLVRLLGYCAEGAHR 257 (508)
Q Consensus 181 ~~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~-~l~~l~hpniv~l~~~~~~~~~~ 257 (508)
+++..++|++.+.||+|+||.||+|... +++.||||++..... .....+..|+. +++.++||||+++++++.+++..
T Consensus 17 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~ 96 (327)
T 3aln_A 17 WDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDC 96 (327)
T ss_dssp ECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEE
T ss_pred cccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCce
Confidence 3566789999999999999999999986 688899999876532 33345555655 67778999999999999999999
Q ss_pred EEEEEecCCCCHHHHhccCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccc
Q 010513 258 MLVYEYIDNGNLEQWLHGDV-GPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLA 336 (508)
Q Consensus 258 ~lV~e~~~~g~L~~~l~~~~-~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a 336 (508)
++||||+++ +|.+++.... .....+++..+..++.|++.||.|||++. +|+||||||+|||++.++.+||+|||++
T Consensus 97 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~ivH~dlkp~NIll~~~~~~kl~Dfg~~ 173 (327)
T 3aln_A 97 WICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGIS 173 (327)
T ss_dssp EEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHH--SCCCSCCCGGGEEEETTTEEEECCCSSS
T ss_pred EEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccC--CEeECCCCHHHEEEcCCCCEEEccCCCc
Confidence 999999986 8888775310 11357899999999999999999999853 7999999999999999999999999999
Q ss_pred eecCCCCcceecceecCCCCCChhhh----hcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhccc
Q 010513 337 KLLGAERSYVTTRVMGTFGYVAPEYA----STGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNR 412 (508)
Q Consensus 337 ~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 412 (508)
+...... ......||+.|+|||++ .+..++.++|||||||++|||++|+.||....... +.+....
T Consensus 174 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-----~~~~~~~--- 243 (327)
T 3aln_A 174 GQLVDSI--AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF-----DQLTQVV--- 243 (327)
T ss_dssp CC--------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC------------CCCC---
T ss_pred eeccccc--ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH-----HHHHHHh---
Confidence 8664322 22334799999999998 45678999999999999999999999997532210 1010000
Q ss_pred ccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 010513 413 NAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIH 457 (508)
Q Consensus 413 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 457 (508)
....+.+...........+.+++.+||+.||++||++.++++
T Consensus 244 ---~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 244 ---KGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp ---CSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ---cCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 001111111111112234555888999999999999999976
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-42 Score=342.38 Aligned_cols=250 Identities=25% Similarity=0.398 Sum_probs=199.1
Q ss_pred cchhhHhhcCCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCch------hHHHHHHHHHHHHccC--CCCeee
Q 010513 176 YTLRELEVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQ------AEKEFKVEVEAIGRVR--HKNLVR 246 (508)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--hpniv~ 246 (508)
.+....+...++|++.+.||+|+||.||+|.+. +++.||||.+...... ..+.+..|+++++.++ ||||++
T Consensus 33 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~ 112 (320)
T 3a99_A 33 APGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIR 112 (320)
T ss_dssp -------CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCC
T ss_pred CcccccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceE
Confidence 445566777889999999999999999999975 6888999998654321 2245667999999996 599999
Q ss_pred EeeeeecCCeeEEEEEecCC-CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEc-C
Q 010513 247 LLGYCAEGAHRMLVYEYIDN-GNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLD-K 324 (508)
Q Consensus 247 l~~~~~~~~~~~lV~e~~~~-g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~-~ 324 (508)
+++++.+++..++|||++.+ ++|.+++... ..+++..++.++.|++.||+|||++ +|+||||||+|||++ +
T Consensus 113 ~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~----~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~ 185 (320)
T 3a99_A 113 LLDWFERPDSFVLILERPEPVQDLFDFITER----GALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLN 185 (320)
T ss_dssp EEEEEECSSEEEEEEECCSSEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETT
T ss_pred EEEEEecCCcEEEEEEcCCCCccHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCC
Confidence 99999999999999999986 8999999764 5789999999999999999999999 999999999999999 7
Q ss_pred CCCeEEeeeccceecCCCCcceecceecCCCCCChhhhhcCCC-CCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHH
Q 010513 325 QWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGML-NERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVE 403 (508)
Q Consensus 325 ~~~~kL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~ 403 (508)
++.+||+|||+++..... ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||.... +
T Consensus 186 ~~~~kL~Dfg~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~--------~ 254 (320)
T 3a99_A 186 RGELKLIDFGSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--------E 254 (320)
T ss_dssp TTEEEECCCTTCEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--------H
T ss_pred CCCEEEeeCccccccccc---cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh--------h
Confidence 889999999999876432 2234579999999999987765 678899999999999999999996321 1
Q ss_pred HHHHhhcccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 404 WLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 404 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
. .... .. +. ...+. ++.+++.+||+.||++||++.+++++
T Consensus 255 ~----~~~~---~~----~~-~~~~~---~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 255 I----IRGQ---VF----FR-QRVSS---ECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp H----HHCC---CC----CS-SCCCH---HHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred h----hccc---cc----cc-ccCCH---HHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1 1110 00 11 11233 34458889999999999999999874
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=338.80 Aligned_cols=265 Identities=20% Similarity=0.256 Sum_probs=199.4
Q ss_pred cCCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCchhHHHHHHHHHHHHccC-----------CCCeeeEeeee
Q 010513 184 STNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVR-----------HKNLVRLLGYC 251 (508)
Q Consensus 184 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------hpniv~l~~~~ 251 (508)
..++|++.+.||+|+||+||+|.+. +++.||||.+... ....+.+.+|++++++++ ||||+++++++
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~ 95 (373)
T 1q8y_A 17 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 95 (373)
T ss_dssp TTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred cCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHh
Confidence 4568999999999999999999975 6888999998643 234566788999998886 89999999999
Q ss_pred ecCC----eeEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEc----
Q 010513 252 AEGA----HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLD---- 323 (508)
Q Consensus 252 ~~~~----~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~---- 323 (508)
.... ..++||||+ +++|.+++.... ...+++..++.++.|++.||+|||+++ +|+||||||+|||++
T Consensus 96 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~~ 170 (373)
T 1q8y_A 96 NHKGPNGVHVVMVFEVL-GENLLALIKKYE--HRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDS 170 (373)
T ss_dssp EEEETTEEEEEEEECCC-CEEHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEET
T ss_pred hccCCCCceEEEEEecC-CCCHHHHHHHhh--ccCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccCC
Confidence 8654 788999999 789999997652 345899999999999999999999853 799999999999994
Q ss_pred --CCCCeEEeeeccceecCCCCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchH
Q 010513 324 --KQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNL 401 (508)
Q Consensus 324 --~~~~~kL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~ 401 (508)
..+.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...........
T Consensus 171 ~~~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~ 246 (373)
T 1q8y_A 171 PENLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 246 (373)
T ss_dssp TTTEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred CcCcceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCCh
Confidence 4447999999999876432 2345789999999999999999999999999999999999999986543221111
Q ss_pred HHHHHHhhc---c------------------c-ccccCCCccC---------CCCchHHHHHHHHHHHHHccCCCCCCCC
Q 010513 402 VEWLKTMVT---N------------------R-NAEGVLDPRL---------QEKPCSRALKRALLVALRCVDPNAHKRP 450 (508)
Q Consensus 402 ~~~~~~~~~---~------------------~-~~~~~~~~~l---------~~~~~~~~~~~l~~li~~cl~~dP~~RP 450 (508)
.+.+..... . . .......... ..........++.+++.+||+.||++||
T Consensus 247 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 326 (373)
T 1q8y_A 247 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA 326 (373)
T ss_dssp HHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred HHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccC
Confidence 111111110 0 0 0000000000 0112244556777899999999999999
Q ss_pred CHHHHHHH
Q 010513 451 KMGHVIHM 458 (508)
Q Consensus 451 s~~evl~~ 458 (508)
++.|++++
T Consensus 327 t~~ell~h 334 (373)
T 1q8y_A 327 DAGGLVNH 334 (373)
T ss_dssp CHHHHHTC
T ss_pred CHHHHhhC
Confidence 99999974
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=335.94 Aligned_cols=244 Identities=28% Similarity=0.421 Sum_probs=189.7
Q ss_pred hhcCCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCch------hHHHHHHHHHHHHcc----CCCCeeeEeee
Q 010513 182 EVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQ------AEKEFKVEVEAIGRV----RHKNLVRLLGY 250 (508)
Q Consensus 182 ~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l----~hpniv~l~~~ 250 (508)
+...++|++.+.||+|+||.||+|.+. +++.||+|.+...... ....+.+|+.++.++ +||||++++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 445678999999999999999999864 6889999998654321 223455688888888 89999999999
Q ss_pred eecCCeeEEEEEe-cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEc-CCCCe
Q 010513 251 CAEGAHRMLVYEY-IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLD-KQWNP 328 (508)
Q Consensus 251 ~~~~~~~~lV~e~-~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~-~~~~~ 328 (508)
+.+.+..++|||| +.+++|.+++... ..+++..++.++.|++.||+|||++ +|+||||||+||+++ .++.+
T Consensus 107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~ 179 (312)
T 2iwi_A 107 FETQEGFMLVLERPLPAQDLFDYITEK----GPLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCA 179 (312)
T ss_dssp C-----CEEEEECCSSEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTTEE
T ss_pred EecCCeEEEEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCCeE
Confidence 9999999999999 7899999999765 4689999999999999999999999 999999999999999 88999
Q ss_pred EEeeeccceecCCCCcceecceecCCCCCChhhhhcCCCC-CCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHH
Q 010513 329 KLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLN-ERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKT 407 (508)
Q Consensus 329 kL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~ 407 (508)
||+|||++....... .....||+.|+|||++.+..+. .++|||||||++|||++|+.||.... +..
T Consensus 180 kl~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--------~~~-- 246 (312)
T 2iwi_A 180 KLIDFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ--------EIL-- 246 (312)
T ss_dssp EECCCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--------HHH--
T ss_pred EEEEcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH--------HHh--
Confidence 999999998764432 3345799999999999877664 48999999999999999999996321 111
Q ss_pred hhcccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 408 MVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 408 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
... ..+.. ..+. ++.+++.+||+.||++||++.+++++
T Consensus 247 --~~~-------~~~~~-~~~~---~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 247 --EAE-------LHFPA-HVSP---DCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp --HTC-------CCCCT-TSCH---HHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred --hhc-------cCCcc-cCCH---HHHHHHHHHccCChhhCcCHHHHhcC
Confidence 100 01111 1223 34558889999999999999999974
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=334.22 Aligned_cols=267 Identities=18% Similarity=0.252 Sum_probs=202.9
Q ss_pred hhhHhhcCCCCcccceEcccCcEEEEEEEEC-CC-cEEEEEEeecCCchhHHHHHHHHHHHHccCCCC------eeeEee
Q 010513 178 LRELEVSTNGFADENVIGEGGYGIVYHGVLE-DN-TNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKN------LVRLLG 249 (508)
Q Consensus 178 ~~~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn------iv~l~~ 249 (508)
.+..+...++|++.+.||+|+||+||+|... ++ ..||+|.+... ....+.+.+|+++++.++|++ ++.+++
T Consensus 11 ~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~ 89 (355)
T 2eu9_A 11 CRIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSD 89 (355)
T ss_dssp CCTTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEE
T ss_pred cccCceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeee
Confidence 3444556789999999999999999999975 34 57999988643 344567888999999997765 999999
Q ss_pred eeecCCeeEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEE-------
Q 010513 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILL------- 322 (508)
Q Consensus 250 ~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll------- 322 (508)
++......++||||+ +++|.+++.... ...+++..++.++.|++.||+|||++ +|+||||||+|||+
T Consensus 90 ~~~~~~~~~lv~e~~-~~~l~~~l~~~~--~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~ 163 (355)
T 2eu9_A 90 WFNFHGHMCIAFELL-GKNTFEFLKENN--FQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFET 163 (355)
T ss_dssp EEEETTEEEEEEECC-CCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEE
T ss_pred eeeeCCeEEEEEecc-CCChHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecccccc
Confidence 999999999999999 567877776542 24689999999999999999999999 99999999999999
Q ss_pred ------------cCCCCeEEeeeccceecCCCCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCC
Q 010513 323 ------------DKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPV 390 (508)
Q Consensus 323 ------------~~~~~~kL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf 390 (508)
+.++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 164 ~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf 239 (355)
T 2eu9_A 164 LYNEHKSCEEKSVKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLF 239 (355)
T ss_dssp EECCC-CCCEEEESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred cccccccccccccCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCC
Confidence 56789999999999865332 23457999999999999999999999999999999999999999
Q ss_pred CCCCCCCcchHHHHHHHhhccc---------ccccCCCc--cCC-------------------CCchHHHHHHHHHHHHH
Q 010513 391 DYSRPPGEVNLVEWLKTMVTNR---------NAEGVLDP--RLQ-------------------EKPCSRALKRALLVALR 440 (508)
Q Consensus 391 ~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~--~l~-------------------~~~~~~~~~~l~~li~~ 440 (508)
...... .....+....... ........ ... ..........+.+++.+
T Consensus 240 ~~~~~~---~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 316 (355)
T 2eu9_A 240 QTHENR---EHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRR 316 (355)
T ss_dssp CCSSHH---HHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHH
T ss_pred CCCCHH---HHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHH
Confidence 754321 1111111111000 00000000 000 00112233466678889
Q ss_pred ccCCCCCCCCCHHHHHHH
Q 010513 441 CVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 441 cl~~dP~~RPs~~evl~~ 458 (508)
||+.||++||++.|++++
T Consensus 317 ~L~~dP~~Rpt~~e~l~h 334 (355)
T 2eu9_A 317 MLEFDPAQRITLAEALLH 334 (355)
T ss_dssp HTCSSTTTSCCHHHHTTS
T ss_pred HhcCChhhCcCHHHHhcC
Confidence 999999999999999853
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-40 Score=326.48 Aligned_cols=254 Identities=24% Similarity=0.362 Sum_probs=181.7
Q ss_pred hhcCCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCch-h-HHHHHHHHHHHHccCCCCeeeEeeeeecCCeeE
Q 010513 182 EVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQ-A-EKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM 258 (508)
Q Consensus 182 ~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~-~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 258 (508)
....++|++.+.||+|+||.||+|.+. +++.||||.+...... . .+.+.++..+++.++||||+++++++.+++..+
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~ 100 (318)
T 2dyl_A 21 QAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVF 100 (318)
T ss_dssp ECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred hhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEE
Confidence 445678999999999999999999986 6889999998765332 2 234445556788889999999999999999999
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeeccCCCCCEEEcCCCCeEEeeeccce
Q 010513 259 LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE-GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK 337 (508)
Q Consensus 259 lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~ 337 (508)
+||||+ ++.+..+.... ...+++..++.++.|++.||.|||+ . +++||||||+||+++.++.+||+|||++.
T Consensus 101 lv~e~~-~~~~~~l~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~ 173 (318)
T 2dyl_A 101 IAMELM-GTCAEKLKKRM---QGPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFGISG 173 (318)
T ss_dssp EEECCC-SEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCCTTC-
T ss_pred EEEecc-CCcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEECCCch
Confidence 999999 44666665443 3578999999999999999999998 5 89999999999999999999999999997
Q ss_pred ecCCCCcceecceecCCCCCChhhhh-----cCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhccc
Q 010513 338 LLGAERSYVTTRVMGTFGYVAPEYAS-----TGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNR 412 (508)
Q Consensus 338 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 412 (508)
...... ......||+.|+|||++. ...++.++|||||||++|||++|+.||..... ..+.+.......
T Consensus 174 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----~~~~~~~~~~~~ 246 (318)
T 2dyl_A 174 RLVDDK--AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKT-----DFEVLTKVLQEE 246 (318)
T ss_dssp ---------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCS-----HHHHHHHHHHSC
T ss_pred hccCCc--cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCc-----cHHHHHHHhccC
Confidence 654322 223457999999999984 56788999999999999999999999974322 112222222211
Q ss_pred ccccCCCccCCC-CchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 413 NAEGVLDPRLQE-KPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 413 ~~~~~~~~~l~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
. +.+.. ...+.. +.+++.+||+.||++||++.+++++
T Consensus 247 ~------~~~~~~~~~~~~---l~~li~~~l~~dp~~Rps~~~ll~h 284 (318)
T 2dyl_A 247 P------PLLPGHMGFSGD---FQSFVKDCLTKDHRKRPKYNKLLEH 284 (318)
T ss_dssp C------CCCCSSSCCCHH---HHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred C------CCCCccCCCCHH---HHHHHHHHccCChhHCcCHHHHhhC
Confidence 1 11111 112333 4457789999999999999998863
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=342.42 Aligned_cols=252 Identities=26% Similarity=0.330 Sum_probs=187.3
Q ss_pred hhcCCCCcccceEcccCcEEEEEEEECCCcEEEEEEeecCCchhHHHHHHHHHHHHcc-CCCCeeeEeeeeecCCeeEEE
Q 010513 182 EVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLV 260 (508)
Q Consensus 182 ~~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lV 260 (508)
.+...+|.+.+.||+|+||+||.....+++.||||++...... .+.+|+++++.+ +||||+++++++.+....|+|
T Consensus 20 ~i~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~---~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv 96 (432)
T 3p23_A 20 IVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS---FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIA 96 (432)
T ss_dssp EETTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE---ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEE
T ss_pred EEccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH---HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEE
Confidence 3455579999999999999977655667999999998654322 345799999999 899999999999999999999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcC-----CCCeEEeeecc
Q 010513 261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDK-----QWNPKLSDFGL 335 (508)
Q Consensus 261 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~-----~~~~kL~DFG~ 335 (508)
|||+.+ +|.+++.... ....+..++.++.|++.||+|||++ +|+||||||+|||++. ...+||+|||+
T Consensus 97 ~E~~~g-~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~ 169 (432)
T 3p23_A 97 IELCAA-TLQEYVEQKD---FAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGL 169 (432)
T ss_dssp EECCSE-EHHHHHHSSS---CCCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTE
T ss_pred EECCCC-CHHHHHHhcC---CCccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccc
Confidence 999975 9999997763 3344455678999999999999999 9999999999999943 33588999999
Q ss_pred ceecCCCCc--ceecceecCCCCCChhhhh---cCCCCCCCCeeehHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHhh
Q 010513 336 AKLLGAERS--YVTTRVMGTFGYVAPEYAS---TGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMV 409 (508)
Q Consensus 336 a~~~~~~~~--~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~ 409 (508)
++....... ......+||+.|+|||++. ...++.++|||||||++|||++ |..||...... ......
T Consensus 170 a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~-------~~~~~~ 242 (432)
T 3p23_A 170 CKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR-------QANILL 242 (432)
T ss_dssp EECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTH-------HHHHHT
T ss_pred eeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHH-------HHHHHh
Confidence 987643322 2234467999999999997 4567889999999999999999 99999533211 111111
Q ss_pred cccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 010513 410 TNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIH 457 (508)
Q Consensus 410 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 457 (508)
.... .+.... .......+.+++.+||+.||++||++.++++
T Consensus 243 ~~~~----~~~~~~---~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 243 GACS----LDCLHP---EKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp TCCC----CTTSCT---TCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccCC----ccccCc---cccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 1111 111111 1122333456888999999999999999985
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=316.78 Aligned_cols=232 Identities=13% Similarity=0.132 Sum_probs=182.7
Q ss_pred hcCCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCc---hhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeE
Q 010513 183 VSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG---QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM 258 (508)
Q Consensus 183 ~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 258 (508)
+..++|++.+.||+|+||.||+|.+. +++.||+|.+..... ...+.+.+|++.+.+++||||+++++++.+++..|
T Consensus 28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 107 (286)
T 3uqc_A 28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGL 107 (286)
T ss_dssp ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEE
Confidence 45578999999999999999999986 488999999865532 33467889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeecccee
Q 010513 259 LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL 338 (508)
Q Consensus 259 lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~ 338 (508)
+||||+++++|.+++... .....+..++.|++.||+|||++ +|+||||||+|||++.++.+||+++|
T Consensus 108 lv~e~~~g~~L~~~l~~~------~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~---- 174 (286)
T 3uqc_A 108 VVAEWIRGGSLQEVADTS------PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA---- 174 (286)
T ss_dssp EEEECCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC----
T ss_pred EEEEecCCCCHHHHHhcC------CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc----
Confidence 999999999999999542 35567888999999999999999 99999999999999999999997443
Q ss_pred cCCCCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhccccccc-C
Q 010513 339 LGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEG-V 417 (508)
Q Consensus 339 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 417 (508)
|++| ++.++|||||||++|||+||+.||.......... ........ .
T Consensus 175 -----------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~--------~~~~~~~~~~ 222 (286)
T 3uqc_A 175 -----------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLA--------PAERDTAGQP 222 (286)
T ss_dssp -----------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSE--------ECCBCTTSCB
T ss_pred -----------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhH--------HHHHHhccCC
Confidence 4443 6889999999999999999999998654322110 00000000 0
Q ss_pred CCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 010513 418 LDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEE 463 (508)
Q Consensus 418 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~~~ 463 (508)
..+.......+ .++.+++.+||+.||++| |+.++++.|+...
T Consensus 223 ~~~~~~~~~~~---~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~ 264 (286)
T 3uqc_A 223 IEPADIDRDIP---FQISAVAARSVQGDGGIR-SASTLLNLMQQAT 264 (286)
T ss_dssp CCHHHHCTTSC---HHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHH
T ss_pred CChhhcccCCC---HHHHHHHHHHcccCCccC-CHHHHHHHHHHHh
Confidence 00000001122 345558889999999999 9999999999754
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=354.78 Aligned_cols=241 Identities=21% Similarity=0.352 Sum_probs=194.2
Q ss_pred hhcCCCCcccceEcccCcEEEEEEEEC--CCcEEEEEEeecCC-chhHHHHHHHHHHHHccCCCCeeeEeeeeecCCe--
Q 010513 182 EVSTNGFADENVIGEGGYGIVYHGVLE--DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAH-- 256 (508)
Q Consensus 182 ~~~~~~~~~~~~LG~G~~g~Vy~~~~~--~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~-- 256 (508)
++..++|++.+.||+|+||+||+|.+. +++.||||.+.... ......+.+|++++++++||||+++++++.+.+.
T Consensus 76 ~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 155 (681)
T 2pzi_A 76 DIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHG 155 (681)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTS
T ss_pred CEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCC
Confidence 455679999999999999999999986 57889999886543 3445678899999999999999999999987655
Q ss_pred ---eEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeee
Q 010513 257 ---RMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDF 333 (508)
Q Consensus 257 ---~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DF 333 (508)
.|+||||+++++|.+++.. .+++..++.++.|++.||+|||++ +|+||||||+|||++.+ .+||+||
T Consensus 156 ~~~~~lv~E~~~g~~L~~~~~~------~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DF 225 (681)
T 2pzi_A 156 DPVGYIVMEYVGGQSLKRSKGQ------KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDL 225 (681)
T ss_dssp CEEEEEEEECCCCEECC----C------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCC
T ss_pred CceeEEEEEeCCCCcHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEec
Confidence 6999999999999987643 689999999999999999999999 99999999999999986 8999999
Q ss_pred ccceecCCCCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccc
Q 010513 334 GLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRN 413 (508)
Q Consensus 334 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 413 (508)
|+++..... ....||+.|+|||++.++. +.++|||||||++|+|++|..||.......
T Consensus 226 G~a~~~~~~-----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~---------------- 283 (681)
T 2pzi_A 226 GAVSRINSF-----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDG---------------- 283 (681)
T ss_dssp TTCEETTCC-----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSS----------------
T ss_pred ccchhcccC-----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccc----------------
Confidence 999876433 3457999999999987754 889999999999999999998886321110
Q ss_pred cccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCC-HHHHHHHHhc
Q 010513 414 AEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPK-MGHVIHMLEA 461 (508)
Q Consensus 414 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~~Le~ 461 (508)
. ............+.+++.+||+.||++||+ ++++.+.|.+
T Consensus 284 ---~----~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 284 ---L----PEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp ---C----CTTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred ---c----cccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 0 011112223345666888999999999995 6666666553
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=354.06 Aligned_cols=259 Identities=22% Similarity=0.338 Sum_probs=195.8
Q ss_pred CCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecC-CchhHHHHHHHHHHHHccCCCCeeeEeeeeec------CCe
Q 010513 185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE------GAH 256 (508)
Q Consensus 185 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~------~~~ 256 (508)
.++|++.+.||+|+||+||+|.+. +|+.||||++... .....+.+.+|+++++.++||||+++++++.. +..
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 368999999999999999999975 5888999988654 33445678899999999999999999999765 677
Q ss_pred eEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCC---eEEeee
Q 010513 257 RMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWN---PKLSDF 333 (508)
Q Consensus 257 ~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~---~kL~DF 333 (508)
.++||||+++|+|.+++.... ....+++..++.++.|++.||+|||++ +|+||||||+||+++.++. +||+||
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~-~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~DF 168 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFE-NCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDL 168 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSS-CTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECSC
T ss_pred EEEEEEeCCCCCHHHHHHhcc-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEccc
Confidence 899999999999999998752 234688999999999999999999999 9999999999999987765 899999
Q ss_pred ccceecCCCCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHh-----
Q 010513 334 GLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTM----- 408 (508)
Q Consensus 334 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~----- 408 (508)
|++....... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ...|....
T Consensus 169 G~a~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~-----~~~~~~~i~~~~~ 241 (676)
T 3qa8_A 169 GYAKELDQGE--LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ-----PVQWHGKVREKSN 241 (676)
T ss_dssp CCCCBTTSCC--CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCH-----HHHSSTTCC----
T ss_pred cccccccccc--ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccc-----hhhhhhhhhcccc
Confidence 9998764332 23446899999999999999999999999999999999999999964321 11110000
Q ss_pred ---hcccccccC--CCcc--CCCCchHHHHHHHHHHHHHccCCCCCCCCCHHH
Q 010513 409 ---VTNRNAEGV--LDPR--LQEKPCSRALKRALLVALRCVDPNAHKRPKMGH 454 (508)
Q Consensus 409 ---~~~~~~~~~--~~~~--l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e 454 (508)
......... .... ............+.+++.+||+.||++||++.+
T Consensus 242 ~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~e 294 (676)
T 3qa8_A 242 EHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQ 294 (676)
T ss_dssp --CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTT
T ss_pred hhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHH
Confidence 000000000 0000 011122234455666888999999999999976
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=325.13 Aligned_cols=245 Identities=15% Similarity=0.167 Sum_probs=184.5
Q ss_pred hcCCCCcccceEcccCcEEEEEEEECCCcEEEEEEeecCC--------chhHHHHHHHHHHHHccC---------CCCee
Q 010513 183 VSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNR--------GQAEKEFKVEVEAIGRVR---------HKNLV 245 (508)
Q Consensus 183 ~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~---------hpniv 245 (508)
+..++|++.+.||+|+||+||+|++ +++.||||++.... ....+.+.+|+++++.++ ||||+
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv 95 (336)
T 2vuw_A 17 LPTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFI 95 (336)
T ss_dssp SCHHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBC
T ss_pred cccccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchh
Confidence 3456789999999999999999998 58999999996542 223467888999998886 55555
Q ss_pred eE-----------------eeeeec-------------CCeeEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHH
Q 010513 246 RL-----------------LGYCAE-------------GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGT 295 (508)
Q Consensus 246 ~l-----------------~~~~~~-------------~~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi 295 (508)
++ ++++.+ ....|+||||+++|++.+.+.+ ..+++..++.++.|+
T Consensus 96 ~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-----~~~~~~~~~~i~~qi 170 (336)
T 2vuw_A 96 GLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-----KLSSLATAKSILHQL 170 (336)
T ss_dssp CEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-----TCCCHHHHHHHHHHH
T ss_pred hhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-----cCCCHHHHHHHHHHH
Confidence 55 444443 6789999999999977776643 358999999999999
Q ss_pred HHHHHHHH-hcCCCCeeeccCCCCCEEEcCCC--------------------CeEEeeeccceecCCCCcceecceecCC
Q 010513 296 AKGLTYLH-EGLEPKVVHRDIKSSNILLDKQW--------------------NPKLSDFGLAKLLGAERSYVTTRVMGTF 354 (508)
Q Consensus 296 ~~al~~LH-~~~~~~iiHrDlkp~NIll~~~~--------------------~~kL~DFG~a~~~~~~~~~~~~~~~gt~ 354 (508)
+.||+||| ++ +|+||||||+|||++.++ .+||+|||+++..... ..+||+
T Consensus 171 ~~aL~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~ 241 (336)
T 2vuw_A 171 TASLAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCD 241 (336)
T ss_dssp HHHHHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCC
T ss_pred HHHHHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEee
Confidence 99999999 88 999999999999999887 8999999999876432 348999
Q ss_pred CCCChhhhhcCCCCCCCCeeehHHH-HHHHHhCCCCCCCCCCCCcchHHHHHH-HhhcccccccCCCccCCCCchHHHHH
Q 010513 355 GYVAPEYASTGMLNERSDVYSFGIL-IMEVISGRNPVDYSRPPGEVNLVEWLK-TMVTNRNAEGVLDPRLQEKPCSRALK 432 (508)
Q Consensus 355 ~y~aPE~~~~~~~~~~sDvwSlGvv-l~elltg~~Pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~~~~~~~~~ 432 (508)
.|+|||++.+.. +.++||||||++ .+++++|..||.. ........ ....... ...............
T Consensus 242 ~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~------~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~s~ 310 (336)
T 2vuw_A 242 VSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSN------VLWLHYLTDKMLKQMT----FKTKCNTPAMKQIKR 310 (336)
T ss_dssp CTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHH------HHHHHHHHHHHHHTCC----CSSCCCSHHHHHHHH
T ss_pred cccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcc------hhhhhHHHHhhhhhhc----cCcccchhhhhhcCH
Confidence 999999998666 889999998777 7788889999831 10001111 1111111 111111122344566
Q ss_pred HHHHHHHHccCCCCCCCCCHHHHH-HH
Q 010513 433 RALLVALRCVDPNAHKRPKMGHVI-HM 458 (508)
Q Consensus 433 ~l~~li~~cl~~dP~~RPs~~evl-~~ 458 (508)
++.+++.+||+.| |+.|++ ++
T Consensus 311 ~~~dli~~~L~~d-----sa~e~l~~H 332 (336)
T 2vuw_A 311 KIQEFHRTMLNFS-----SATDLLCQH 332 (336)
T ss_dssp HHHHHHHHGGGSS-----SHHHHHHHC
T ss_pred HHHHHHHHHhccC-----CHHHHHhcC
Confidence 7788999999976 999988 53
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=311.31 Aligned_cols=229 Identities=19% Similarity=0.267 Sum_probs=176.3
Q ss_pred CCCccc-ceEcccCcEEEEEEEEC-CCcEEEEEEeecCCchhHHHHHHHHHHH-HccCCCCeeeEeeeeec----CCeeE
Q 010513 186 NGFADE-NVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAI-GRVRHKNLVRLLGYCAE----GAHRM 258 (508)
Q Consensus 186 ~~~~~~-~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~hpniv~l~~~~~~----~~~~~ 258 (508)
++|.+. +.||+|+||.||+|... +++.||+|.+... ..+.+|++++ +.++||||+++++++.+ ....+
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 91 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 91 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence 356666 78999999999999975 6889999998542 4566788887 55699999999999876 67789
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcC---CCCeEEeeecc
Q 010513 259 LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDK---QWNPKLSDFGL 335 (508)
Q Consensus 259 lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~---~~~~kL~DFG~ 335 (508)
+||||+++|+|.+++.... ...+++..++.++.|++.||+|||++ +|+||||||+|||++. ++.+||+|||+
T Consensus 92 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~ 166 (299)
T 3m2w_A 92 IVMECLDGGELFSRIQDRG--DQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGF 166 (299)
T ss_dssp EEECCCCSCBHHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEeecCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEecccc
Confidence 9999999999999998752 24699999999999999999999999 9999999999999988 78899999999
Q ss_pred ceecCCCCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccc
Q 010513 336 AKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAE 415 (508)
Q Consensus 336 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (508)
+.... +..++.++|||||||++|||++|+.||........ ......
T Consensus 167 a~~~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~-----------~~~~~~ 212 (299)
T 3m2w_A 167 AKETT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI-----------SPGMKT 212 (299)
T ss_dssp CEECT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC------------------CCSCC
T ss_pred ccccc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhh-----------hHHHHH
Confidence 87542 23467789999999999999999999965432110 000000
Q ss_pred cCCCccCCCCc--hHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 416 GVLDPRLQEKP--CSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 416 ~~~~~~l~~~~--~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
........... ......++.+++.+||+.||++||++.+++++
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 213 RIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 257 (299)
T ss_dssp SSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 11111111000 01123455568889999999999999999973
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-39 Score=331.47 Aligned_cols=244 Identities=17% Similarity=0.196 Sum_probs=179.2
Q ss_pred cCCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCc---hhHHHHHHHHHHHHccCC-CCeee------------
Q 010513 184 STNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG---QAEKEFKVEVEAIGRVRH-KNLVR------------ 246 (508)
Q Consensus 184 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h-pniv~------------ 246 (508)
....|...+.||+|+||+||+|.+. +|+.||||++..... ...+.+.+|+.+++.++| +|...
T Consensus 76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~ 155 (413)
T 3dzo_A 76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 155 (413)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence 3446888899999999999999965 688999998863322 235778999999999977 32111
Q ss_pred ---------Eeeeeec-----CCeeEEEEEecCCCCHHHHhccC---CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC
Q 010513 247 ---------LLGYCAE-----GAHRMLVYEYIDNGNLEQWLHGD---VGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK 309 (508)
Q Consensus 247 ---------l~~~~~~-----~~~~~lV~e~~~~g~L~~~l~~~---~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ 309 (508)
+..++.. ....+++|+++ +++|.+++... ......+++..++.++.|+++||+|||++ +
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ 231 (413)
T 3dzo_A 156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---G 231 (413)
T ss_dssp EEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred hcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---C
Confidence 1111111 12356777766 56999988411 11235678889999999999999999999 9
Q ss_pred eeeccCCCCCEEEcCCCCeEEeeeccceecCCCCcceecceecCCCCCChhhh----------hcCCCCCCCCeeehHHH
Q 010513 310 VVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYA----------STGMLNERSDVYSFGIL 379 (508)
Q Consensus 310 iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~sDvwSlGvv 379 (508)
|+||||||+|||++.++.+||+|||+++..+.. ....+| +.|+|||++ .+..++.++|||||||+
T Consensus 232 iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvi 306 (413)
T 3dzo_A 232 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLA 306 (413)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHH
T ss_pred cccCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHH
Confidence 999999999999999999999999999865332 445678 999999998 55568889999999999
Q ss_pred HHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 010513 380 IMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIH 457 (508)
Q Consensus 380 l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 457 (508)
+|||++|+.||.......... ..+.. ....+ ..+.+++.+||+.||++||++.++++
T Consensus 307 l~elltg~~Pf~~~~~~~~~~---------------~~~~~---~~~~~---~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 307 IYWIWCADLPNTDDAALGGSE---------------WIFRS---CKNIP---QPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp HHHHHHSSCCCCTTGGGSCSG---------------GGGSS---CCCCC---HHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHHCCCCCCCcchhhhHH---------------HHHhh---cccCC---HHHHHHHHHHccCChhhCcCHHHHHh
Confidence 999999999997543221110 01110 01123 34555888999999999999877654
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-32 Score=293.66 Aligned_cols=186 Identities=14% Similarity=0.068 Sum_probs=132.2
Q ss_pred eEcccCcEEEEEEE-ECCCcEEEEEEeecCC----------chhHHHHHHHHHHHHcc-CCCCeeeEeeeeecCCeeEEE
Q 010513 193 VIGEGGYGIVYHGV-LEDNTNVAVKNLLNNR----------GQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLV 260 (508)
Q Consensus 193 ~LG~G~~g~Vy~~~-~~~~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lV 260 (508)
.++.|++|.+..++ +-.|+.+++|.+.+.. ....++|.+|+++|+++ .|+||++++++++++...|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 46677777776655 3358889999986542 12345799999999999 799999999999999999999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecC
Q 010513 261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG 340 (508)
Q Consensus 261 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 340 (508)
|||++|++|.++|... ++++.. +|+.||+.||+|+|++ |||||||||+|||++.+|++||+|||+|+...
T Consensus 321 MEyv~G~~L~d~i~~~----~~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~ 390 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAG----EEIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTP 390 (569)
T ss_dssp EECCCSEEHHHHHHTT----CCCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC
T ss_pred EecCCCCcHHHHHHhC----CCCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCC
Confidence 9999999999999875 456654 5889999999999999 99999999999999999999999999998764
Q ss_pred CCCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCC
Q 010513 341 AERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPV 390 (508)
Q Consensus 341 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf 390 (508)
... ...+..+||+.|+|||++.+ .+..++|+||+|++++++.++..|+
T Consensus 391 ~~~-~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 391 QDC-SWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp ----CCSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred CCC-ccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccchh
Confidence 432 23455789999999999865 4677899999999988876655443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=9.2e-29 Score=263.56 Aligned_cols=185 Identities=17% Similarity=0.221 Sum_probs=146.9
Q ss_pred cccceEcccCcEEEEEEEECCCcEEEEEEeecCCc--------hhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEE
Q 010513 189 ADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRG--------QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLV 260 (508)
Q Consensus 189 ~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 260 (508)
...+.||+|+||+||+|.. .+..+++|+...... ...+.+.+|++++++++||||+++..++.+.+..|+|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 4467899999999999954 477899998744321 1134578999999999999999666666677788999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecC
Q 010513 261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG 340 (508)
Q Consensus 261 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 340 (508)
|||+++++|.+++.. +..++.|+++||+|||++ +|+||||||+|||++. ++||+|||+++...
T Consensus 418 mE~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~ 480 (540)
T 3en9_A 418 MSYINGKLAKDVIED------------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISN 480 (540)
T ss_dssp EECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECC
T ss_pred EECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECC
Confidence 999999999999865 457899999999999999 9999999999999999 99999999999875
Q ss_pred CCCcce------ecceecCCCCCChhhhhc--CCCCCCCCeeehHHHHHHHHhCCCCCC
Q 010513 341 AERSYV------TTRVMGTFGYVAPEYAST--GMLNERSDVYSFGILIMEVISGRNPVD 391 (508)
Q Consensus 341 ~~~~~~------~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlGvvl~elltg~~Pf~ 391 (508)
...... ....+||+.|+|||++.. ..|+..+|+||..+-..+.+.++-+|.
T Consensus 481 ~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 481 LDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp CHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred CccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 432221 235689999999999987 568888999999999999888887763
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=4.4e-25 Score=216.06 Aligned_cols=152 Identities=18% Similarity=0.101 Sum_probs=122.9
Q ss_pred hHhhcCCCCcccceEcccCcEEEEEEEECCCcEEEEEEeecCCc------------------hhHHHHHHHHHHHHccCC
Q 010513 180 ELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRG------------------QAEKEFKVEVEAIGRVRH 241 (508)
Q Consensus 180 ~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~h 241 (508)
.+......|.+.+.||+|+||.||+|.+.+|+.||+|.+..... .....+.+|+++++.++
T Consensus 84 ~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~- 162 (282)
T 1zar_A 84 RLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ- 162 (282)
T ss_dssp HHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc-
Confidence 33444566788899999999999999997789999999854321 13456889999999999
Q ss_pred CCeeeEeeeeecCCeeEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEE
Q 010513 242 KNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNIL 321 (508)
Q Consensus 242 pniv~l~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIl 321 (508)
| +++.+++.. +..|+||||++||+|.+ +.. .....++.|++.||.|||++ +|+||||||+|||
T Consensus 163 -~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~----------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NIL 225 (282)
T 1zar_A 163 -G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV----------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVL 225 (282)
T ss_dssp -T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC----------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEE
T ss_pred -C-CCcCeEEec-cceEEEEEecCCCcHHH-cch----------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHEE
Confidence 5 677776544 56699999999999998 421 12346899999999999999 9999999999999
Q ss_pred EcCCCCeEEeeeccceecCCCCcceecceecCCCCCChhhhhc
Q 010513 322 LDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAST 364 (508)
Q Consensus 322 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 364 (508)
++ ++.+||+|||+++. +..++|||++..
T Consensus 226 l~-~~~vkl~DFG~a~~--------------~~~~~a~e~l~r 253 (282)
T 1zar_A 226 VS-EEGIWIIDFPQSVE--------------VGEEGWREILER 253 (282)
T ss_dssp EE-TTEEEECCCTTCEE--------------TTSTTHHHHHHH
T ss_pred EE-CCcEEEEECCCCeE--------------CCCCCHHHHHHH
Confidence 99 99999999999973 445799998854
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.82 E-value=1.9e-20 Score=180.68 Aligned_cols=137 Identities=21% Similarity=0.168 Sum_probs=107.0
Q ss_pred CCcccceEcccCcEEEEEEEE-CCCcE--EEEEEeecCCch------------------------hHHHHHHHHHHHHcc
Q 010513 187 GFADENVIGEGGYGIVYHGVL-EDNTN--VAVKNLLNNRGQ------------------------AEKEFKVEVEAIGRV 239 (508)
Q Consensus 187 ~~~~~~~LG~G~~g~Vy~~~~-~~~~~--vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l 239 (508)
-|++.+.||+|+||.||+|.+ .+|+. ||||.+...... ....+.+|++.+..+
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 467889999999999999997 67888 999986433111 123678899999999
Q ss_pred CCCCe--eeEeeeeecCCeeEEEEEecCC-C----CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHH-hcCCCCee
Q 010513 240 RHKNL--VRLLGYCAEGAHRMLVYEYIDN-G----NLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH-EGLEPKVV 311 (508)
Q Consensus 240 ~hpni--v~l~~~~~~~~~~~lV~e~~~~-g----~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH-~~~~~~ii 311 (508)
.|+++ ..++++ ...++||||+.+ | +|.++... .++..+..++.|++.||.||| +. +|+
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~lH~~~---giv 193 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRLYQEA---ELV 193 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHHHHTS---CEE
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHHHHHC---CEE
Confidence 88764 333332 356899999942 4 77776532 124456789999999999999 88 999
Q ss_pred eccCCCCCEEEcCCCCeEEeeeccceec
Q 010513 312 HRDIKSSNILLDKQWNPKLSDFGLAKLL 339 (508)
Q Consensus 312 HrDlkp~NIll~~~~~~kL~DFG~a~~~ 339 (508)
||||||+|||++. .++|+|||++...
T Consensus 194 HrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 194 HADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp CSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred eCCCCHHHEEEcC--cEEEEECcccccC
Confidence 9999999999998 9999999999864
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.71 E-value=3.8e-18 Score=171.92 Aligned_cols=141 Identities=13% Similarity=0.080 Sum_probs=100.0
Q ss_pred cCCCCcccceEcccCcEEEEEEEECCCcEEEEEEeecCCc--------------hhHH--------HHHHHHHHHHccCC
Q 010513 184 STNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRG--------------QAEK--------EFKVEVEAIGRVRH 241 (508)
Q Consensus 184 ~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------------~~~~--------~~~~E~~~l~~l~h 241 (508)
...-|++.+.||+|+||.||+|...+|+.||||++..... .... ....|...|.++.+
T Consensus 93 rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~ 172 (397)
T 4gyi_A 93 RKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYE 172 (397)
T ss_dssp TTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred CCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHh
Confidence 3344999999999999999999998899999998743210 0011 12335556666644
Q ss_pred CCeeeEeeeeecCCeeEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEE
Q 010513 242 KNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNIL 321 (508)
Q Consensus 242 pniv~l~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIl 321 (508)
.++.-. ..+.. ...++||||++|++|.++... .....++.|++.+|.|||+. +||||||||.|||
T Consensus 173 ~gv~vp-~p~~~-~~~~LVME~i~G~~L~~l~~~----------~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NIL 237 (397)
T 4gyi_A 173 EGFPVP-EPIAQ-SRHTIVMSLVDALPMRQVSSV----------PDPASLYADLIALILRLAKH---GLIHGDFNEFNIL 237 (397)
T ss_dssp TTCSCC-CEEEE-ETTEEEEECCSCEEGGGCCCC----------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEE
T ss_pred cCCCCC-eeeec-cCceEEEEecCCccHhhhccc----------HHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEE
Confidence 333211 11111 223799999999888665321 12356788999999999998 9999999999999
Q ss_pred EcCCCC----------eEEeeeccceec
Q 010513 322 LDKQWN----------PKLSDFGLAKLL 339 (508)
Q Consensus 322 l~~~~~----------~kL~DFG~a~~~ 339 (508)
+++++. +.|+||+-+...
T Consensus 238 l~~dgd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 238 IREEKDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp EEEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred EeCCCCcccccccccceEEEEeCCcccC
Confidence 987763 899999977643
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.38 E-value=1.2e-12 Score=125.80 Aligned_cols=143 Identities=16% Similarity=0.068 Sum_probs=112.0
Q ss_pred CCCcccceEcccCcEEEEEEEECCCcEEEEEEeecCCchhHHHHHHHHHHHHccC-CCCeeeEeeeeecCCeeEEEEEec
Q 010513 186 NGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVR-HKNLVRLLGYCAEGAHRMLVYEYI 264 (508)
Q Consensus 186 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~lV~e~~ 264 (508)
..|++...++.|+.+.||++... ++.+++|............+.+|+++++.+. +..+.++++++.+....|+||||+
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i 92 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEA 92 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECC
T ss_pred ccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEec
Confidence 46888889999999999999755 6789999886432222345888999999884 677889999999888999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc---------------------------------------
Q 010513 265 DNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG--------------------------------------- 305 (508)
Q Consensus 265 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~--------------------------------------- 305 (508)
+|.+|.+.+.. ......++.+++++|..||+.
T Consensus 93 ~G~~l~~~~~~---------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (263)
T 3tm0_A 93 DGVLCSEEYED---------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP 163 (263)
T ss_dssp SSEEHHHHCCT---------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCS
T ss_pred CCeehhhccCC---------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccccc
Confidence 99999876321 112346788999999999981
Q ss_pred -----------------CCCCeeeccCCCCCEEEcCCCCeEEeeecccee
Q 010513 306 -----------------LEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL 338 (508)
Q Consensus 306 -----------------~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~ 338 (508)
..+.++|+|+++.|||++++..+.|+||+.+..
T Consensus 164 ~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp SSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred CCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 013589999999999998765567999997753
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.27 E-value=9.6e-12 Score=118.92 Aligned_cols=137 Identities=17% Similarity=0.135 Sum_probs=99.6
Q ss_pred CCcccceEcccCcEEEEEEEECCCcEEEEEEeecCCchhHHHHHHHHHHHHccCCCC--eeeEeeeeecCCeeEEEEEec
Q 010513 187 GFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKN--LVRLLGYCAEGAHRMLVYEYI 264 (508)
Q Consensus 187 ~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn--iv~l~~~~~~~~~~~lV~e~~ 264 (508)
.+.+....+.|..+.||++...+|..+++|..... ....+..|+++++.+.+.+ +.+++++..+++..++||||+
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i 97 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEV 97 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECC
T ss_pred CCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEec
Confidence 44444333456669999998777788999986543 2245778999998885444 556888888877889999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--------------------------------------
Q 010513 265 DNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGL-------------------------------------- 306 (508)
Q Consensus 265 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~-------------------------------------- 306 (508)
+|.+|. ... .. ...++.++++.|..||+..
T Consensus 98 ~G~~l~--~~~-------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (264)
T 1nd4_A 98 PGQDLL--SSH-------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGL 165 (264)
T ss_dssp SSEETT--TSC-------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTC
T ss_pred CCcccC--cCc-------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCc
Confidence 998874 211 11 1256677888888888641
Q ss_pred -----------------CCCeeeccCCCCCEEEcCCCCeEEeeecccee
Q 010513 307 -----------------EPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL 338 (508)
Q Consensus 307 -----------------~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~ 338 (508)
...++|+|++|.|||+++++.+.|+|||.+..
T Consensus 166 ~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 166 APAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp CHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 11299999999999998776667999998763
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.09 E-value=2e-10 Score=115.59 Aligned_cols=143 Identities=11% Similarity=0.160 Sum_probs=106.8
Q ss_pred cccceEcccCcEEEEEEEECCCcEEEEEEee--cCC-chhHHHHHHHHHHHHccC--CCCeeeEeeeeecC---CeeEEE
Q 010513 189 ADENVIGEGGYGIVYHGVLEDNTNVAVKNLL--NNR-GQAEKEFKVEVEAIGRVR--HKNLVRLLGYCAEG---AHRMLV 260 (508)
Q Consensus 189 ~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~--~~~-~~~~~~~~~E~~~l~~l~--hpniv~l~~~~~~~---~~~~lV 260 (508)
...+.|+.|.++.||+.... +..+++|+.. ... ......+.+|.++++.+. +..+.+++.++.+. ...|+|
T Consensus 41 ~~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~v 119 (359)
T 3dxp_A 41 LSVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYI 119 (359)
T ss_dssp CEEEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEE
T ss_pred ceEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEE
Confidence 34677899999999998876 4678888765 221 122456788999999986 45578888888776 347899
Q ss_pred EEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC----------------------------------
Q 010513 261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGL---------------------------------- 306 (508)
Q Consensus 261 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---------------------------------- 306 (508)
|||++|..+.+.. ...++......++.+++++|..||+..
T Consensus 120 me~v~G~~l~~~~------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (359)
T 3dxp_A 120 MEFVSGRVLWDQS------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETES 193 (359)
T ss_dssp EECCCCBCCCCTT------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSC
T ss_pred EEecCCeecCCCc------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcC
Confidence 9999997764321 234678888899999999999999720
Q ss_pred ---------------------CCCeeeccCCCCCEEEcCCCC--eEEeeecccee
Q 010513 307 ---------------------EPKVVHRDIKSSNILLDKQWN--PKLSDFGLAKL 338 (508)
Q Consensus 307 ---------------------~~~iiHrDlkp~NIll~~~~~--~kL~DFG~a~~ 338 (508)
.+.++|||+++.|||++.++. +.|+||+.+..
T Consensus 194 ~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 194 IPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp CHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred ChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 247999999999999987754 68999998875
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.04 E-value=1.1e-10 Score=114.79 Aligned_cols=183 Identities=19% Similarity=0.188 Sum_probs=122.3
Q ss_pred cceEcccCcEEEEEEEECCCcEEEEEEeecCCchhHHHHHHHHHHHHccC-CCC--eeeEeeeeecCC---eeEEEEEec
Q 010513 191 ENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVR-HKN--LVRLLGYCAEGA---HRMLVYEYI 264 (508)
Q Consensus 191 ~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpn--iv~l~~~~~~~~---~~~lV~e~~ 264 (508)
.+.++.|.+..||+.. ..+++|.... ......+.+|.++++.+. +.. +.+++.....+. ..|+||+++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~--~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKH--SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESS--HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCC--cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 4569999999999863 5688887532 234567888999998883 332 344554443333 347899999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc---------------------------------------
Q 010513 265 DNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG--------------------------------------- 305 (508)
Q Consensus 265 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~--------------------------------------- 305 (508)
+|.+|.+... ..++..+...++.++++.+..||+.
T Consensus 99 ~G~~l~~~~~------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (304)
T 3sg8_A 99 KGVPLTPLLL------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK 172 (304)
T ss_dssp CCEECCHHHH------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred CCeECCcccc------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence 9988765432 2467777888888899888888861
Q ss_pred ----------------CCCCeeeccCCCCCEEEcC--CCCeEEeeeccceecCCCCcceecceecCCCC---CChhhhhc
Q 010513 306 ----------------LEPKVVHRDIKSSNILLDK--QWNPKLSDFGLAKLLGAERSYVTTRVMGTFGY---VAPEYAST 364 (508)
Q Consensus 306 ----------------~~~~iiHrDlkp~NIll~~--~~~~kL~DFG~a~~~~~~~~~~~~~~~gt~~y---~aPE~~~~ 364 (508)
..+.++|+|+++.||++++ ...+.|+||+.+......... .....+ ..|+....
T Consensus 173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl-----~~~~~~~~~~~~~~~~~ 247 (304)
T 3sg8_A 173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDF-----ISLMEDDEEYGMEFVSK 247 (304)
T ss_dssp HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHH-----HTTCCTTTSCCHHHHHH
T ss_pred HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHH-----HHHHhhccccCHHHHHH
Confidence 1235899999999999988 455789999998754221111 011111 23332211
Q ss_pred -----CCC---------CCCCCeeehHHHHHHHHhCCCCC
Q 010513 365 -----GML---------NERSDVYSFGILIMEVISGRNPV 390 (508)
Q Consensus 365 -----~~~---------~~~sDvwSlGvvl~elltg~~Pf 390 (508)
+.. ....+.|++|.++|.+.+|..+|
T Consensus 248 ~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 248 ILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 111 11258899999999999998766
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.56 E-value=6.5e-07 Score=87.83 Aligned_cols=136 Identities=17% Similarity=0.166 Sum_probs=95.6
Q ss_pred cceEcccCcEEEEEEEECCCcEEEEEEeecCCchhHHHHHHHHHHHHccCCC---CeeeEeeeee-cCCeeEEEEEecCC
Q 010513 191 ENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHK---NLVRLLGYCA-EGAHRMLVYEYIDN 266 (508)
Q Consensus 191 ~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp---niv~l~~~~~-~~~~~~lV~e~~~~ 266 (508)
.+.++.|....||+. +..+++|.- ........+..|.++|+.+.+. .+.+.+.+.. ..+..++||||++|
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~--~~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFP--KSQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEE--SSHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE----CCEEEEEec--CCchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 456888999999988 567888874 2234456788999999999652 3556666664 34557899999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-----------------------------------------
Q 010513 267 GNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG----------------------------------------- 305 (508)
Q Consensus 267 g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~----------------------------------------- 305 (508)
..|.+... ..++......++.++++.|..||+.
T Consensus 98 ~~l~~~~~------~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~ 171 (306)
T 3tdw_A 98 QILGEDGM------AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY 171 (306)
T ss_dssp EECHHHHH------TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred eECchhhh------hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence 88766321 1234555555666666666666642
Q ss_pred ----------------CCCCeeeccCCCCCEEEcC---CCCe-EEeeecccee
Q 010513 306 ----------------LEPKVVHRDIKSSNILLDK---QWNP-KLSDFGLAKL 338 (508)
Q Consensus 306 ----------------~~~~iiHrDlkp~NIll~~---~~~~-kL~DFG~a~~ 338 (508)
..+.++|+|+++.|||++. ++.+ .|+||+.+..
T Consensus 172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 1235699999999999987 4554 8999998874
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.45 E-value=1e-06 Score=84.42 Aligned_cols=134 Identities=17% Similarity=0.112 Sum_probs=95.6
Q ss_pred EcccCcE-EEEEEEEC-CCcEEEEEEeecCCchhHHHHHHHHHHHHccC-CCCeeeEeeeeecCCeeEEEEEecCCCCHH
Q 010513 194 IGEGGYG-IVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVR-HKNLVRLLGYCAEGAHRMLVYEYIDNGNLE 270 (508)
Q Consensus 194 LG~G~~g-~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~lV~e~~~~g~L~ 270 (508)
+..|..| .||+.... ++..+++|.-.. .....+.+|...|+.+. +--+.++++++.+++..++|||+++|.++.
T Consensus 32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~ 108 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKPNAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAF 108 (272)
T ss_dssp EECSSSSCEEEEEECCTTCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHH
T ss_pred ccCCCcCCeEEEEEecCCCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcccc
Confidence 4445555 68987754 456788887532 23556888999998884 333677888888889999999999998887
Q ss_pred HHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--------------------------------------------
Q 010513 271 QWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGL-------------------------------------------- 306 (508)
Q Consensus 271 ~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~-------------------------------------------- 306 (508)
+..... ......+..++++.|.-||+.-
T Consensus 109 ~~~~~~--------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (272)
T 4gkh_A 109 QVLEEY--------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW 180 (272)
T ss_dssp HHHHHC--------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred ccccCC--------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence 764321 1223345666777777777421
Q ss_pred -----------CCCeeeccCCCCCEEEcCCCCeEEeeecccee
Q 010513 307 -----------EPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL 338 (508)
Q Consensus 307 -----------~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~ 338 (508)
.+.++|+|+.+.|||+++++.+-|+||+.+..
T Consensus 181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 12379999999999999877677999998864
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.29 E-value=9.9e-07 Score=88.30 Aligned_cols=80 Identities=10% Similarity=0.027 Sum_probs=54.0
Q ss_pred cceE-cccCcEEEEEEEEC-------CCcEEEEEEeecCC---chhHHHHHHHHHHHHccC-C--CCeeeEeeeeecC--
Q 010513 191 ENVI-GEGGYGIVYHGVLE-------DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVR-H--KNLVRLLGYCAEG-- 254 (508)
Q Consensus 191 ~~~L-G~G~~g~Vy~~~~~-------~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h--pniv~l~~~~~~~-- 254 (508)
.+.| +.|....+|+.... ++..+++|...... ......+..|..+++.+. + -.+.+++.++.+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 4667 88889999998754 25678888654322 101245677888888773 2 3466778777655
Q ss_pred -CeeEEEEEecCCCCHH
Q 010513 255 -AHRMLVYEYIDNGNLE 270 (508)
Q Consensus 255 -~~~~lV~e~~~~g~L~ 270 (508)
...++||||++|..+.
T Consensus 105 ~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp TSSCEEEEECCCCBCCC
T ss_pred cCCceEEEEecCCCChh
Confidence 3468999999986654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.06 E-value=2.5e-05 Score=77.17 Aligned_cols=143 Identities=20% Similarity=0.273 Sum_probs=79.8
Q ss_pred cceEcccCcEEEEEEEECCCcEEEEEEeecCCchhHHHHHHHHHHHHccCC--CCeeeEee------eeecCCeeEEEEE
Q 010513 191 ENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRH--KNLVRLLG------YCAEGAHRMLVYE 262 (508)
Q Consensus 191 ~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--pniv~l~~------~~~~~~~~~lV~e 262 (508)
.+.|+.|..+.||+....++ .+++|..... ...+..|.++++.+.. -.+.+++. +....+..+++|+
T Consensus 37 ~~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~ 111 (346)
T 2q83_A 37 IDVIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD 111 (346)
T ss_dssp EEECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred eeeccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence 34566677899999987654 5889987642 2333445555554421 12333332 1234567889999
Q ss_pred ecCCCCHH--------------HHhccC---CC-CC------CCCCHHHH------------------------------
Q 010513 263 YIDNGNLE--------------QWLHGD---VG-PH------SPLTWEIR------------------------------ 288 (508)
Q Consensus 263 ~~~~g~L~--------------~~l~~~---~~-~~------~~l~~~~~------------------------------ 288 (508)
|++|..+. ..++.. .. +. ....|...
T Consensus 112 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 191 (346)
T 2q83_A 112 WIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQE 191 (346)
T ss_dssp CCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHH
T ss_pred eecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHH
Confidence 99986432 112211 00 00 00122110
Q ss_pred -HHHHHHHHHHHHHHHh----------cCCCCeeeccCCCCCEEEcCCCCeEEeeecccee
Q 010513 289 -MNIILGTAKGLTYLHE----------GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL 338 (508)
Q Consensus 289 -~~i~~qi~~al~~LH~----------~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~ 338 (508)
..+..++..++++|++ .....++|+|+++.|||++.++.+.|+||+.+..
T Consensus 192 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 192 IDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 0111223445666653 1234899999999999998888899999997753
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=98.04 E-value=3.1e-05 Score=74.90 Aligned_cols=81 Identities=20% Similarity=0.257 Sum_probs=58.8
Q ss_pred cCCCCcccceEcccCcEEEEEEEECCCcEEEEEEeecCCchhHHHHHHHHHHHHccCCC---CeeeEeeeeecCCeeEEE
Q 010513 184 STNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHK---NLVRLLGYCAEGAHRMLV 260 (508)
Q Consensus 184 ~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp---niv~l~~~~~~~~~~~lV 260 (508)
......-.+.+|.|..+.||+....+|+.|++|+-..........|..|.+.|+.|.-. -+.+++++. .-++|
T Consensus 13 ~G~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv 88 (288)
T 3f7w_A 13 TGREVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLA 88 (288)
T ss_dssp HCCCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEE
T ss_pred cCCCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEE
Confidence 34456667889999999999999999999999976554444445678899988887421 244455442 23789
Q ss_pred EEecCCCC
Q 010513 261 YEYIDNGN 268 (508)
Q Consensus 261 ~e~~~~g~ 268 (508)
|||++++.
T Consensus 89 ~e~l~~~~ 96 (288)
T 3f7w_A 89 MEWVDERP 96 (288)
T ss_dssp EECCCCCC
T ss_pred EEeecccC
Confidence 99998764
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.02 E-value=1.6e-05 Score=80.82 Aligned_cols=75 Identities=16% Similarity=0.194 Sum_probs=48.8
Q ss_pred cceEcccCcEEEEEEEEC-CCcEEEEEEeecCCc-------hhHHHHHHHHHHHHccCC--CC-eeeEeeeeecCCeeEE
Q 010513 191 ENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG-------QAEKEFKVEVEAIGRVRH--KN-LVRLLGYCAEGAHRML 259 (508)
Q Consensus 191 ~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h--pn-iv~l~~~~~~~~~~~l 259 (508)
.+.||.|.++.||++... ++..+++|....... ...+.+..|.++++.+.. +. +.+++.+ +....++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 567999999999999754 467899997643211 123456778888887732 33 3455543 3445689
Q ss_pred EEEecCCC
Q 010513 260 VYEYIDNG 267 (508)
Q Consensus 260 V~e~~~~g 267 (508)
|||++++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999763
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.85 E-value=8.8e-05 Score=72.65 Aligned_cols=141 Identities=14% Similarity=0.129 Sum_probs=92.0
Q ss_pred cccceEcccCcEEEEEEEECCCcEEEEEEeecCCchhHHHHHHHHHHHHccC---CCCeeeEeeeeecCCeeEEEEEecC
Q 010513 189 ADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVR---HKNLVRLLGYCAEGAHRMLVYEYID 265 (508)
Q Consensus 189 ~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---hpniv~l~~~~~~~~~~~lV~e~~~ 265 (508)
.-.+.|+.|....+|+... ++..+++|..... ....+..|.+.|+.|. ...+.+++.+....+..++||||++
T Consensus 39 ~~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~ 114 (312)
T 3jr1_A 39 KHKEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALN 114 (312)
T ss_dssp CEEEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCC
T ss_pred eeeEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEecc
Confidence 3456799999999999875 4677888876432 3566888988888873 3568888888887788999999999
Q ss_pred CCCHH--------H---HhccCCC---CC-------C--------CCCHHHHH---HHH----------------HHHHH
Q 010513 266 NGNLE--------Q---WLHGDVG---PH-------S--------PLTWEIRM---NII----------------LGTAK 297 (508)
Q Consensus 266 ~g~L~--------~---~l~~~~~---~~-------~--------~l~~~~~~---~i~----------------~qi~~ 297 (508)
+..+. . .|+.... .+ + .-+|.... ++. ..+++
T Consensus 115 G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~ 194 (312)
T 3jr1_A 115 KSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQ 194 (312)
T ss_dssp CCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHH
T ss_pred CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHH
Confidence 87542 1 2333211 00 0 11343321 111 11111
Q ss_pred H-HHHHHh-cCCCCeeeccCCCCCEEEcCCCCeEEeeec
Q 010513 298 G-LTYLHE-GLEPKVVHRDIKSSNILLDKQWNPKLSDFG 334 (508)
Q Consensus 298 a-l~~LH~-~~~~~iiHrDlkp~NIll~~~~~~kL~DFG 334 (508)
. ...|.. ...+.++|+|+.+.|++++.++ +.|+||.
T Consensus 195 ~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 195 IVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 1 223321 2356899999999999999887 8899974
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.57 E-value=0.00033 Score=71.54 Aligned_cols=32 Identities=9% Similarity=0.253 Sum_probs=27.9
Q ss_pred CCCeeeccCCCCCEEEcCCCCeEEeeeccceec
Q 010513 307 EPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL 339 (508)
Q Consensus 307 ~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~ 339 (508)
.+.++|+|+++.|||++.++ ++++||+.+..-
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G 262 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYG 262 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEE
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccC
Confidence 34899999999999998876 999999988753
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.54 E-value=0.00026 Score=68.82 Aligned_cols=139 Identities=14% Similarity=0.092 Sum_probs=73.5
Q ss_pred cceEcccCcEEEEEEEECCCcEEEEEEeecCCchhHHHHHHHHHHHHccCCCCe-eeEeeeeecCCeeEEEEEec-CCCC
Q 010513 191 ENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNL-VRLLGYCAEGAHRMLVYEYI-DNGN 268 (508)
Q Consensus 191 ~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpni-v~l~~~~~~~~~~~lV~e~~-~~g~ 268 (508)
.+.|+.|....+|+. ..+++|........ ......|...++.+...++ .++++++ .+.-++++||+ +|.+
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCcc
Confidence 677999999999998 45888876543211 1122457777766632222 4555443 33457899999 5543
Q ss_pred HHH------------------HhccCCCC-CCCCCH-HHHHHHHH--------------HHHHHHH----HHHh-cCCCC
Q 010513 269 LEQ------------------WLHGDVGP-HSPLTW-EIRMNIIL--------------GTAKGLT----YLHE-GLEPK 309 (508)
Q Consensus 269 L~~------------------~l~~~~~~-~~~l~~-~~~~~i~~--------------qi~~al~----~LH~-~~~~~ 309 (508)
+.. .++..... ...... .....+.. .+.+.+. .+.. .....
T Consensus 95 l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~~ 174 (301)
T 3dxq_A 95 MSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPLA 174 (301)
T ss_dssp CCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCCE
T ss_pred CCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCce
Confidence 321 11221100 000111 11111100 0111111 1111 12335
Q ss_pred eeeccCCCCCEEEcCCCCeEEeeecccee
Q 010513 310 VVHRDIKSSNILLDKQWNPKLSDFGLAKL 338 (508)
Q Consensus 310 iiHrDlkp~NIll~~~~~~kL~DFG~a~~ 338 (508)
++|+|+.+.||+ ..++.+.++||..+..
T Consensus 175 l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 175 ACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp EECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred eeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 899999999999 5667889999998874
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.41 E-value=0.0011 Score=64.90 Aligned_cols=145 Identities=14% Similarity=0.133 Sum_probs=79.4
Q ss_pred cceEcccCcEEEEEEEECCCcEEEEEEeecCCchhHHHHHHHHHHHHccCCCC--eeeEeee------eecCCeeEEEEE
Q 010513 191 ENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKN--LVRLLGY------CAEGAHRMLVYE 262 (508)
Q Consensus 191 ~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn--iv~l~~~------~~~~~~~~lV~e 262 (508)
.+.|+.|....+|+....++ .+++|..... .....+..|..+++.+...+ +.+++.. ....+..+++|+
T Consensus 27 ~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~ 103 (322)
T 2ppq_A 27 YKGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALIS 103 (322)
T ss_dssp EEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEE
T ss_pred eeccCCCcccceEEEEeCCc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEE
Confidence 45678888899999987655 6888877542 12234556777777663212 2333321 122356789999
Q ss_pred ecCCCCHHH--------------HhccC---CC-CC-CCCC---HHHHHH------------HHHHHHHHHHHHHhc---
Q 010513 263 YIDNGNLEQ--------------WLHGD---VG-PH-SPLT---WEIRMN------------IILGTAKGLTYLHEG--- 305 (508)
Q Consensus 263 ~~~~g~L~~--------------~l~~~---~~-~~-~~l~---~~~~~~------------i~~qi~~al~~LH~~--- 305 (508)
|++|..+.. .++.. .. .. .... |..... +...+.+.++++.+.
T Consensus 104 ~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~ 183 (322)
T 2ppq_A 104 FLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPK 183 (322)
T ss_dssp CCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCC
T ss_pred eCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcc
Confidence 998854311 12211 00 00 0011 111000 001134455555532
Q ss_pred -CCCCeeeccCCCCCEEEcCCCCeEEeeecccee
Q 010513 306 -LEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL 338 (508)
Q Consensus 306 -~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~ 338 (508)
....++|+|+++.|||+++++.+.++||+.+..
T Consensus 184 ~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 184 DLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp SSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 134799999999999999875568999997763
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.34 E-value=0.0012 Score=64.89 Aligned_cols=142 Identities=14% Similarity=0.100 Sum_probs=71.1
Q ss_pred ceEcccCcEE-EEEEEECCCcEEEEEEeecCCchhHHHHHHHHHHHHccCC--CCeeeEeeeeecCCeeEEEEEecCCCC
Q 010513 192 NVIGEGGYGI-VYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRH--KNLVRLLGYCAEGAHRMLVYEYIDNGN 268 (508)
Q Consensus 192 ~~LG~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--pniv~l~~~~~~~~~~~lV~e~~~~g~ 268 (508)
+.|+.|+... +|+....++..+++|....... ..+..|+.+++.+.. -.+.+++.+..+.. +++||++.+..
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~ 98 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDAL 98 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCB
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcc
Confidence 4465555544 6676654466777775433211 223446666666532 23455665543332 78999997766
Q ss_pred HHHHhccC---------------------CCC-CCCCCHHHHH-------H-H------------HHHHHHHHHHHHh--
Q 010513 269 LEQWLHGD---------------------VGP-HSPLTWEIRM-------N-I------------ILGTAKGLTYLHE-- 304 (508)
Q Consensus 269 L~~~l~~~---------------------~~~-~~~l~~~~~~-------~-i------------~~qi~~al~~LH~-- 304 (508)
+.+++... ... ...+...... . + ...+...++.+.+
T Consensus 99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~ 178 (333)
T 3csv_A 99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ 178 (333)
T ss_dssp HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence 65443221 000 0112211100 0 0 0011122233311
Q ss_pred -cCCCCeeeccCCCCCEEEcCC----CCeEEeeecccee
Q 010513 305 -GLEPKVVHRDIKSSNILLDKQ----WNPKLSDFGLAKL 338 (508)
Q Consensus 305 -~~~~~iiHrDlkp~NIll~~~----~~~kL~DFG~a~~ 338 (508)
.....++|||+.+.|||++.+ +.+.|+||+.+..
T Consensus 179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 123479999999999999874 6799999998875
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.33 E-value=0.0018 Score=63.37 Aligned_cols=143 Identities=15% Similarity=0.155 Sum_probs=80.6
Q ss_pred ceEcccCcEEEEEEEECCCcEEEEEEeecCCchhHHHHHHHHHHHHccCCCC--eeeEeee-----eecCCeeEEEEEec
Q 010513 192 NVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKN--LVRLLGY-----CAEGAHRMLVYEYI 264 (508)
Q Consensus 192 ~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn--iv~l~~~-----~~~~~~~~lV~e~~ 264 (508)
..|+ |....||+....+|+.+++|...... .....+..|..+++.+...+ +.+++.. ...++..+++|+|+
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 4567 88889998877667779999875332 23455667888877774222 3444433 12244567899999
Q ss_pred CCCCHH-----HH---------hcc----CCC-CCCCCCHHHH----HHH---------------HHHHHHHHHHHHhc-
Q 010513 265 DNGNLE-----QW---------LHG----DVG-PHSPLTWEIR----MNI---------------ILGTAKGLTYLHEG- 305 (508)
Q Consensus 265 ~~g~L~-----~~---------l~~----~~~-~~~~l~~~~~----~~i---------------~~qi~~al~~LH~~- 305 (508)
+|..+. .+ ++. ... .....+.... ..+ ...+...++.+.+.
T Consensus 110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 189 (328)
T 1zyl_A 110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW 189 (328)
T ss_dssp CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence 874321 11 111 100 0111222111 000 01111223333221
Q ss_pred ---CCCCeeeccCCCCCEEEcCCCCeEEeeecccee
Q 010513 306 ---LEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL 338 (508)
Q Consensus 306 ---~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~ 338 (508)
....++|+|+++.|||++ + .+.++||+.+..
T Consensus 190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 234689999999999999 4 899999987764
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.32 E-value=0.00072 Score=69.27 Aligned_cols=71 Identities=18% Similarity=0.243 Sum_probs=48.3
Q ss_pred cceEcccCcEEEEEEEECC--------CcEEEEEEeecCCchhHHHHHHHHHHHHccCCCCe-eeEeeeeecCCeeEEEE
Q 010513 191 ENVIGEGGYGIVYHGVLED--------NTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNL-VRLLGYCAEGAHRMLVY 261 (508)
Q Consensus 191 ~~~LG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpni-v~l~~~~~~~~~~~lV~ 261 (508)
.+.|+.|....||++...+ +..+++|+..... ..+.+..|..+++.+...++ .++++.+.+ .+|+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~ 151 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 151 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence 4678888899999998753 4678888774321 12445578888888743333 566766543 3899
Q ss_pred EecCCC
Q 010513 262 EYIDNG 267 (508)
Q Consensus 262 e~~~~g 267 (508)
||++|.
T Consensus 152 e~l~G~ 157 (429)
T 1nw1_A 152 EYIPSR 157 (429)
T ss_dssp CCCCEE
T ss_pred EEeCCc
Confidence 999863
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.22 E-value=0.00085 Score=67.45 Aligned_cols=143 Identities=17% Similarity=0.118 Sum_probs=82.0
Q ss_pred cceEcccCcEEEEEEEEC--------CCcEEEEEEeecCCchhHHHHHHHHHHHHccC-CCCeeeEeeeeecCCeeEEEE
Q 010513 191 ENVIGEGGYGIVYHGVLE--------DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVR-HKNLVRLLGYCAEGAHRMLVY 261 (508)
Q Consensus 191 ~~~LG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~lV~ 261 (508)
.+.|..|-...+|++... ++..+++|+.... ......+.+|.++++.+. +.-..++++.+.+ .+||
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~ 129 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLE 129 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEE
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEE
Confidence 346777888899998864 2467888875332 223455668888888773 3223566766654 2999
Q ss_pred EecCCCCHHH--------------H---hccCCC-CCCCCC--HHHHHHHHHHHH-------------------HHHHHH
Q 010513 262 EYIDNGNLEQ--------------W---LHGDVG-PHSPLT--WEIRMNIILGTA-------------------KGLTYL 302 (508)
Q Consensus 262 e~~~~g~L~~--------------~---l~~~~~-~~~~l~--~~~~~~i~~qi~-------------------~al~~L 302 (508)
||++|.+|.. . |+.... ...... +....++..++. +.++.|
T Consensus 130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L 209 (379)
T 3feg_A 130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL 209 (379)
T ss_dssp ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence 9998754421 1 222211 111222 344444443332 123333
Q ss_pred Hhc-----CCCCeeeccCCCCCEEEcCC----CCeEEeeecccee
Q 010513 303 HEG-----LEPKVVHRDIKSSNILLDKQ----WNPKLSDFGLAKL 338 (508)
Q Consensus 303 H~~-----~~~~iiHrDlkp~NIll~~~----~~~kL~DFG~a~~ 338 (508)
.+. ....++|+|+.+.|||++.+ +.+.++||..+..
T Consensus 210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 221 13368999999999999876 7899999987763
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.16 E-value=0.0018 Score=66.71 Aligned_cols=74 Identities=12% Similarity=0.077 Sum_probs=47.1
Q ss_pred cceEcccCcEEEEEEEECC-CcEEEEEEeecCCchhHHHHHHHHHHHHccCCCCe-eeEeeeeecCCeeEEEEEecCCCC
Q 010513 191 ENVIGEGGYGIVYHGVLED-NTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNL-VRLLGYCAEGAHRMLVYEYIDNGN 268 (508)
Q Consensus 191 ~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpni-v~l~~~~~~~~~~~lV~e~~~~g~ 268 (508)
.+.|+.|-...+|++...+ +..+++|+......... ....|..+++.+...++ .++++.+.+ .+||||++|.+
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~i-dR~~E~~vl~~L~~~gl~P~ll~~~~~----G~v~e~I~G~~ 187 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEII-NREREKKISCILYNKNIAKKIYVFFTN----GRIEEFMDGYA 187 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCS-CHHHHHHHHHHHTTSSSBCCEEEEETT----EEEEECCCSEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhc-CHHHHHHHHHHHHhcCCCCCEEEEeCC----eEEEEeeCCcc
Confidence 4678888899999998865 46788887643321111 12468888888864444 567776632 35999998743
Q ss_pred H
Q 010513 269 L 269 (508)
Q Consensus 269 L 269 (508)
|
T Consensus 188 l 188 (458)
T 2qg7_A 188 L 188 (458)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.13 E-value=0.0009 Score=61.08 Aligned_cols=100 Identities=18% Similarity=0.110 Sum_probs=65.6
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCCCcce
Q 010513 267 GNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYV 346 (508)
Q Consensus 267 g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~ 346 (508)
-+|.++|... ..+++++++|.++.|.+.+|.-+-... .-..+=+.|..|++..+|.+.+.+ +.+.
T Consensus 33 vSL~eIL~~~---~~PlsEEqaWALc~Qc~~~L~~~~~~~--~~~~~i~~~~~i~l~~dG~V~f~~-~~s~--------- 97 (229)
T 2yle_A 33 LSLEEILRLY---NQPINEEQAWAVCYQCCGSLRAAARRR--QPRHRVRSAAQIRVWRDGAVTLAP-AADD--------- 97 (229)
T ss_dssp EEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCSGGGEEEETTSCEEECC-C------------
T ss_pred ccHHHHHHHc---CCCcCHHHHHHHHHHHHHHHHhhhhcc--cCCceecCCcceEEecCCceeccc-cccc---------
Confidence 3899999877 579999999999999999987762111 112333456899999999988764 1110
Q ss_pred ecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhC
Q 010513 347 TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISG 386 (508)
Q Consensus 347 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg 386 (508)
.....+.|||... ...+++.=|||||+++|..+-=
T Consensus 98 ----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDy 132 (229)
T 2yle_A 98 ----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDY 132 (229)
T ss_dssp -------------CCSS-SSSCHHHHHHHHHHHHHHHHTT
T ss_pred ----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhc
Confidence 1123467888653 3345677899999999998863
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.01 E-value=0.0012 Score=65.93 Aligned_cols=73 Identities=14% Similarity=0.044 Sum_probs=42.7
Q ss_pred cceEcccCcEEEEEEEECC---------CcEEEEEEeecCCchhHHHHHHHHHHHHccCCCC-eeeEeeeeecCCeeEEE
Q 010513 191 ENVIGEGGYGIVYHGVLED---------NTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKN-LVRLLGYCAEGAHRMLV 260 (508)
Q Consensus 191 ~~~LG~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn-iv~l~~~~~~~~~~~lV 260 (508)
.+.|+.|....+|+....+ +..+++|........ ......|.++++.+...+ ..++++.+. -++|
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~~----~~~v 112 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTFN----GGRI 112 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEET----TEEE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEecC----CcEE
Confidence 4567788888999998754 267888876443221 112356777787774333 345665442 2689
Q ss_pred EEecCCCC
Q 010513 261 YEYIDNGN 268 (508)
Q Consensus 261 ~e~~~~g~ 268 (508)
|||++|..
T Consensus 113 ~e~i~G~~ 120 (369)
T 3c5i_A 113 EEWLYGDP 120 (369)
T ss_dssp EECCCSEE
T ss_pred EEEecCCc
Confidence 99998743
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.84 E-value=0.0091 Score=58.92 Aligned_cols=31 Identities=23% Similarity=0.327 Sum_probs=27.7
Q ss_pred CCeeeccCCCCCEEEcCCCCeEEeeecccee
Q 010513 308 PKVVHRDIKSSNILLDKQWNPKLSDFGLAKL 338 (508)
Q Consensus 308 ~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~ 338 (508)
..++|+|+.+.||++++++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 4799999999999999888899999987764
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=96.82 E-value=0.0012 Score=43.31 Aligned_cols=20 Identities=30% Similarity=0.416 Sum_probs=11.9
Q ss_pred hHHHHHHHHHHHHHHHHHHH
Q 010513 22 LWVVLGICVGAGIVLVLFLI 41 (508)
Q Consensus 22 ~~~ii~I~~g~~~~~~l~~~ 41 (508)
.-.|+++++|+++++++.+.
T Consensus 11 ~~~Ia~~vVGvll~vi~~l~ 30 (44)
T 2jwa_A 11 LTSIISAVVGILLVVVLGVV 30 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHH
T ss_pred ccchHHHHHHHHHHHHHHHH
Confidence 45578888886544444333
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.77 E-value=0.0018 Score=42.57 Aligned_cols=33 Identities=12% Similarity=0.148 Sum_probs=16.3
Q ss_pred hhhHHHHHHHHH-HHHHHHHHHHHhhhhhccccC
Q 010513 20 LRLWVVLGICVG-AGIVLVLFLISLWFTSKRNSN 52 (508)
Q Consensus 20 ~~~~~ii~I~~g-~~~~~~l~~~~~~~~~rr~~~ 52 (508)
-+...|++.++| ++++++++++.++++|||+++
T Consensus 7 s~~~aIA~gVVgGv~~v~ii~~~~~~~~RRRr~~ 40 (44)
T 2l2t_A 7 ARTPLIAAGVIGGLFILVIVGLTFAVYVRRKSIK 40 (44)
T ss_dssp CSSHHHHHHHHHHHHHHHHHHHHHHHHHHTTCSS
T ss_pred CCcceEEEeehHHHHHHHHHHHHHHHHhhhhhhh
Confidence 344455555554 555554444444444444433
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.53 E-value=0.0017 Score=42.76 Aligned_cols=27 Identities=22% Similarity=0.178 Sum_probs=13.8
Q ss_pred HHHHHHHHHHHHHHHHHhhhhhccccC
Q 010513 26 LGICVGAGIVLVLFLISLWFTSKRNSN 52 (508)
Q Consensus 26 i~I~~g~~~~~~l~~~~~~~~~rr~~~ 52 (508)
.|++.|++++++++++.++++|||+++
T Consensus 15 ~gVVgGv~~~~ii~~~~~~~~RRr~~~ 41 (44)
T 2ks1_B 15 TGMVGALLLLLVVALGIGLFMRRRHIV 41 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHTTTCC
T ss_pred eehhHHHHHHHHHHHHHHHHhhhhHhh
Confidence 444445655555544545555555433
|
| >2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A | Back alignment and structure |
|---|
Probab=96.45 E-value=0.0034 Score=40.08 Aligned_cols=31 Identities=19% Similarity=0.265 Sum_probs=20.7
Q ss_pred chhhHHHHHHHHHHHHHHHHHH-HHhhhhhcc
Q 010513 19 GLRLWVVLGICVGAGIVLVLFL-ISLWFTSKR 49 (508)
Q Consensus 19 g~~~~~ii~I~~g~~~~~~l~~-~~~~~~~rr 49 (508)
|+.-..|.||++|+++.++++. +++|++|||
T Consensus 7 ~ls~GaIAGiVvG~v~gv~li~~l~~~~~rrr 38 (38)
T 2k1k_A 7 GLTGGEIVAVIFGLLLGAALLLGILVFRSRRA 38 (38)
T ss_dssp TCCHHHHHHHHHHHHHHHHHHHHHHHHHHCCC
T ss_pred CCCCCceeeeehHHHHHHHHHHHHHHHHeecC
Confidence 7788899999999876444434 445554443
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.89 E-value=0.021 Score=58.13 Aligned_cols=74 Identities=12% Similarity=0.075 Sum_probs=46.5
Q ss_pred cceEcccCcEEEEEEEECC--------CcEEEEEEeecCCchhHHHHHHHHHHHHccC-CCCeeeEeeeeecCCeeEEEE
Q 010513 191 ENVIGEGGYGIVYHGVLED--------NTNVAVKNLLNNRGQAEKEFKVEVEAIGRVR-HKNLVRLLGYCAEGAHRMLVY 261 (508)
Q Consensus 191 ~~~LG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~lV~ 261 (508)
.+.+..|-...+|+....+ +..+++|+..... ...-...+|..+++.+. +.-..++++.+. -++||
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~ 149 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADFP----EGRIE 149 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEE
Confidence 4567778888999998763 5778888754332 11112345777777773 222345555432 27899
Q ss_pred EecCCCCH
Q 010513 262 EYIDNGNL 269 (508)
Q Consensus 262 e~~~~g~L 269 (508)
||++|..|
T Consensus 150 efI~G~~l 157 (424)
T 3mes_A 150 EFIDGEPL 157 (424)
T ss_dssp ECCCSEEC
T ss_pred EEeCCccC
Confidence 99998653
|
| >2l34_A TYRO protein tyrosine kinase-binding protein; immunoreceptor, transmembrane assembly, DAP12, protein bindi; NMR {Homo sapiens} PDB: 2l35_B | Back alignment and structure |
|---|
Probab=95.46 E-value=0.016 Score=35.56 Aligned_cols=31 Identities=26% Similarity=0.439 Sum_probs=23.9
Q ss_pred cchhhHHHHHHHHHHHHHHHHHHHHhhhhhc
Q 010513 18 FGLRLWVVLGICVGAGIVLVLFLISLWFTSK 48 (508)
Q Consensus 18 ~g~~~~~ii~I~~g~~~~~~l~~~~~~~~~r 48 (508)
.+++.+.++||++|.++..+++.+.+|++.|
T Consensus 2 ~~L~~gaIaGIVvgdi~~t~~i~~~vy~~~r 32 (33)
T 2l34_A 2 STVSPGVLAGIVVGDLVLTVLIALAVYFLGR 32 (33)
T ss_dssp CCCCTHHHHHHHHHHHHHHHHHHHHHHHHCC
T ss_pred cccCcceEEeEeHHHHHHHHHHHHHHhheec
Confidence 4688899999999998877776666666543
|
| >2k9y_A Ephrin type-A receptor 2; receptor tyrosine kinase, membrane protein, dimeric transmembrane domain, ephrin receptor, ATP-binding, glycoprotein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=95.10 E-value=0.018 Score=37.51 Aligned_cols=28 Identities=32% Similarity=0.546 Sum_probs=13.0
Q ss_pred hHHHHHHHHHHHHHHHHHHHHhhhhhcc
Q 010513 22 LWVVLGICVGAGIVLVLFLISLWFTSKR 49 (508)
Q Consensus 22 ~~~ii~I~~g~~~~~~l~~~~~~~~~rr 49 (508)
.+++++.++|+++++++++++++++|||
T Consensus 13 ~~I~~~vv~Gv~ll~~iv~~~~~~~rRr 40 (41)
T 2k9y_A 13 LAVIGGVAVGVVLLLVLAGVGFFIHRRR 40 (41)
T ss_dssp THHHHHHHHHHHHHHHHHHHHHSSSSSC
T ss_pred EEEEeehhHHHHHHHHHHHHheeEeeec
Confidence 3445555556555442434444444433
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=93.30 E-value=0.33 Score=48.76 Aligned_cols=30 Identities=30% Similarity=0.424 Sum_probs=24.9
Q ss_pred CeeeccCCCCCEEE------cCCCCeEEeeecccee
Q 010513 309 KVVHRDIKSSNILL------DKQWNPKLSDFGLAKL 338 (508)
Q Consensus 309 ~iiHrDlkp~NIll------~~~~~~kL~DFG~a~~ 338 (508)
.++|+|+.+.|||+ +++..++++||-.|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 36799999999999 4456799999988763
|
| >2l8s_A Integrin alpha-1; transmembrane region, detergent micelle, CE adhesion; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=93.24 E-value=0.12 Score=35.45 Aligned_cols=26 Identities=31% Similarity=0.778 Sum_probs=18.0
Q ss_pred chhhHHHHHHHHHHHHHHHHHHHHhh
Q 010513 19 GLRLWVVLGICVGAGIVLVLFLISLW 44 (508)
Q Consensus 19 g~~~~~ii~I~~g~~~~~~l~~~~~~ 44 (508)
+..+|+|++-++|.++++.++.+++|
T Consensus 6 ~vp~WiIi~svl~GLLLL~Lii~~Lw 31 (54)
T 2l8s_A 6 RVPLWVILLSAFAGLLLLMLLILALW 31 (54)
T ss_dssp CCCTHHHHHHHHHHHHHHHHHHHHHH
T ss_pred cCchHHHHHHHHHHHHHHHHHHHHHH
Confidence 57889988877776666655555544
|
| >2knc_A Integrin alpha-IIB; transmembrane signaling, protein structure, cell A cleavage on PAIR of basic residues, disease mutation, disul bond, glycoprotein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=92.55 E-value=0.16 Score=34.91 Aligned_cols=26 Identities=23% Similarity=0.731 Sum_probs=18.1
Q ss_pred chhhHHHHHHHHHHHHHHHHHHHHhh
Q 010513 19 GLRLWVVLGICVGAGIVLVLFLISLW 44 (508)
Q Consensus 19 g~~~~~ii~I~~g~~~~~~l~~~~~~ 44 (508)
+..+|+|++-++|.++++.++.+++|
T Consensus 9 ~vp~wiIi~svl~GLllL~li~~~Lw 34 (54)
T 2knc_A 9 AIPIWWVLVGVLGGLLLLTILVLAMW 34 (54)
T ss_dssp TCCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred CcchHHHHHHHHHHHHHHHHHHHHHH
Confidence 67899988887776666655555544
|
| >2k1a_A Integrin alpha-IIB; single-PASS transmembrane segment, alternative splicing, calcium, cell adhesion, cleavage on PAIR of basic residues; NMR {Homo sapiens} PDB: 2k9j_A | Back alignment and structure |
|---|
Probab=91.15 E-value=0.31 Score=31.60 Aligned_cols=26 Identities=23% Similarity=0.731 Sum_probs=18.0
Q ss_pred chhhHHHHHHHHHHHHHHHHHHHHhh
Q 010513 19 GLRLWVVLGICVGAGIVLVLFLISLW 44 (508)
Q Consensus 19 g~~~~~ii~I~~g~~~~~~l~~~~~~ 44 (508)
+..+|+|++-++|.++++.++.+++|
T Consensus 7 ~vp~wiIi~s~l~GLllL~li~~~Lw 32 (42)
T 2k1a_A 7 AIPIWWVLVGVLGGLLLLTILVLAMW 32 (42)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred CcchHHHHHHHHHHHHHHHHHHHHHH
Confidence 67899988877766666655555544
|
| >1iij_A ERBB-2 receptor protein-tyrosine kinase; alpha-helix-PI-bulge-alpha-helix, signaling protein; NMR {Synthetic} SCOP: j.35.1.1 | Back alignment and structure |
|---|
Probab=90.61 E-value=0.14 Score=31.66 Aligned_cols=15 Identities=27% Similarity=0.569 Sum_probs=7.5
Q ss_pred HHHHHHHHHHHHHHH
Q 010513 24 VVLGICVGAGIVLVL 38 (508)
Q Consensus 24 ~ii~I~~g~~~~~~l 38 (508)
.|++.++|+++++++
T Consensus 9 sIaagVvglll~vii 23 (35)
T 1iij_A 9 FIIATVVGVLLFLIL 23 (35)
T ss_dssp HHHHHHHHHHHHHHH
T ss_pred EeHHHHHHHHHHHHH
Confidence 455556664444333
|
| >1q55_A EP-cadherin, C-cadherin; trans interaction, desmosome, junction, adhesion, structural protein; HET: NAG NDG; 30.00A {Mus musculus} SCOP: i.20.1.1 PDB: 1q5a_A* 1q5b_A* 1q5c_A* | Back alignment and structure |
|---|
Probab=86.12 E-value=0.14 Score=56.99 Aligned_cols=33 Identities=30% Similarity=0.462 Sum_probs=0.0
Q ss_pred ccchhhHHHHHHHHHHHHHHHHHHHHhhhhhcc
Q 010513 17 IFGLRLWVVLGICVGAGIVLVLFLISLWFTSKR 49 (508)
Q Consensus 17 ~~g~~~~~ii~I~~g~~~~~~l~~~~~~~~~rr 49 (508)
--||.+|.+|+|++|++++++++++++++++||
T Consensus 699 ~~~l~~~aii~il~~~~~ll~~~ll~~~~~~~~ 731 (880)
T 1q55_A 699 VGGFDLPIILVILGSVLALLILFLLLLLFLKRK 731 (880)
T ss_dssp ---------------------------------
T ss_pred ccCccHHHHHHHHHHHHHHHHHHHHHHhhhhhc
Confidence 458999999999999988877766666665444
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=84.61 E-value=1.2 Score=40.38 Aligned_cols=116 Identities=9% Similarity=0.070 Sum_probs=77.6
Q ss_pred CCCCeeeEeeeeecCCeeEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCC
Q 010513 240 RHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSN 319 (508)
Q Consensus 240 ~hpniv~l~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~N 319 (508)
.||+++.. .+-.+++.+.+.++.-+.+.=+..+ ...+...++.++.+++....+++. -+|--|.|+|
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~i-------k~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~N 109 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNI-------KSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPDE 109 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGG-------GGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGGG
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHHH-------HhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecce
Confidence 68988877 5666667666666654432222223 246788999999999888866653 4788899999
Q ss_pred EEEcCCCCeEEeeeccceecCCCCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCC
Q 010513 320 ILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVD 391 (508)
Q Consensus 320 Ill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~ 391 (508)
++++.++.+++.-.|+-..+. |.=+.+|-+ +-.+=|++..+++++..|+
T Consensus 110 L~f~~~~~p~i~~RGik~~l~-------------P~~~~ee~f----------L~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 110 LFFTRDGLPIAKTRGLQNVVD-------------PLPVSEAEF----------LTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp EEECTTSCEEESCCEETTTBS-------------CCCCCHHHH----------HHHHHHHHHHHHCTTCCHH
T ss_pred EEEcCCCCEEEEEccCccCCC-------------CCCCCHHHH----------HHHHHHHHHHHHcCCCCHH
Confidence 999999999998776543211 110122211 1245678888999988874
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=84.44 E-value=2.1 Score=38.86 Aligned_cols=84 Identities=7% Similarity=0.003 Sum_probs=60.7
Q ss_pred CCCCeeeEeeeeecCCeeEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHH-HHHhcCCCCeeeccCCCC
Q 010513 240 RHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLT-YLHEGLEPKVVHRDIKSS 318 (508)
Q Consensus 240 ~hpniv~l~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~-~LH~~~~~~iiHrDlkp~ 318 (508)
.||++ -..+-.+++.+.+.++.-+++.=...++ ..+...++.++.+++.... +++ .-+|--|+|+
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~-------~~~~~eKlrll~nl~~L~~~~~~-----~r~tf~l~P~ 113 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR-------KTTLLSRIRAAIHLVSKVKHHSA-----RRLIFIVCPE 113 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH-------TSCHHHHHHHHHHHHHHHSSCCS-----SSEECCCCGG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH-------hcCHHHHHHHHHHHHHHHHHhhh-----CceeEEEeCc
Confidence 68888 3444466777777777664543333443 4678889999888877766 555 4577789999
Q ss_pred CEEEcCCCCeEEeeeccce
Q 010513 319 NILLDKQWNPKLSDFGLAK 337 (508)
Q Consensus 319 NIll~~~~~~kL~DFG~a~ 337 (508)
||++|.++.+++.-.|+-.
T Consensus 114 NL~f~~~~~p~i~hRGi~~ 132 (219)
T 4ano_A 114 NLMFNRALEPFFLHVGVKE 132 (219)
T ss_dssp GEEECTTCCEEESCCEETT
T ss_pred eEEEeCCCcEEEEEcCCcc
Confidence 9999999999998777543
|
| >2knc_B Integrin beta-3; transmembrane signaling, protein structure, cell A cleavage on PAIR of basic residues, disease mutation, disul bond, glycoprotein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=82.64 E-value=1 Score=33.72 Aligned_cols=26 Identities=31% Similarity=0.502 Sum_probs=13.4
Q ss_pred chhhHHHHHHHHHHHHHHHHHHHHhh
Q 010513 19 GLRLWVVLGICVGAGIVLVLFLISLW 44 (508)
Q Consensus 19 g~~~~~ii~I~~g~~~~~~l~~~~~~ 44 (508)
..+.|.|++-++|++++++|+++++|
T Consensus 7 ~~n~~~Iv~gvi~gilliGllllliw 32 (79)
T 2knc_B 7 GPDILVVLLSVMGAILLIGLAALLIW 32 (79)
T ss_dssp SSCSHHHHHHHHHHHHHHHHHHHHHH
T ss_pred CCCchhhHHHHHHHHHHHHHHHHHHH
Confidence 34566666555554455554444433
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=81.67 E-value=0.15 Score=52.35 Aligned_cols=61 Identities=5% Similarity=-0.020 Sum_probs=18.7
Q ss_pred cccceEcccCcEEEEEEEECC-CcEEEE------EEeecCC--chhHHHHHHHHHHHHccCCCCeeeEeeeee
Q 010513 189 ADENVIGEGGYGIVYHGVLED-NTNVAV------KNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCA 252 (508)
Q Consensus 189 ~~~~~LG~G~~g~Vy~~~~~~-~~~vav------K~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~ 252 (508)
.+.+.|| ||+||+|.+.. ..+||+ |...... .+....+.+|..+++.++|||+++.+++..
T Consensus 145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~ 214 (463)
T 3cxl_A 145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV 214 (463)
T ss_dssp CSTTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred cccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence 4566776 99999999764 467888 6654322 222346777888899999999999988764
|
| >2k9j_B Integrin beta-3; transmembrane complex, cell adhesion, cleavage on basic residues, disease mutation, glycoprotein, pyrrolidone carboxylic acid; NMR {Homo sapiens} PDB: 2rmz_A 2rn0_A 2l91_A | Back alignment and structure |
|---|
Probab=80.85 E-value=1.9 Score=28.10 Aligned_cols=25 Identities=28% Similarity=0.434 Sum_probs=13.8
Q ss_pred hhhHHHHHHHHHHHHHHHHHHHHhh
Q 010513 20 LRLWVVLGICVGAGIVLVLFLISLW 44 (508)
Q Consensus 20 ~~~~~ii~I~~g~~~~~~l~~~~~~ 44 (508)
.+.+.+++-++|++++++++++.+|
T Consensus 7 ~n~~~Iv~gvi~~ivliGl~lLliw 31 (43)
T 2k9j_B 7 PDILVVLLSVMGAILLIGLAALLIW 31 (43)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred CCEeehHHHHHHHHHHHHHHHHHHH
Confidence 4666666555555555555555444
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 508 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 4e-71 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 3e-67 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 3e-64 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-63 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-62 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-62 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 3e-61 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-60 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 4e-60 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 7e-60 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-59 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-59 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 8e-59 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-58 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 5e-57 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 7e-57 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-56 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-56 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 7e-56 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-55 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-55 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 4e-54 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-53 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-53 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-53 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 4e-53 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 6e-53 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 3e-51 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 4e-51 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 4e-49 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 5e-49 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 7e-48 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 4e-46 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 5e-46 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 6e-46 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 6e-45 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 4e-44 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 9e-43 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 5e-42 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 8e-42 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 8e-42 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 8e-41 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 9e-41 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-40 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 4e-40 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-39 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 3e-39 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 5e-39 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 6e-39 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 8e-39 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-38 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-36 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-36 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 4e-35 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-34 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 4e-34 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 4e-33 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-30 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 8e-30 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-28 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 7e-27 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 3e-25 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 5e-21 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 226 bits (576), Expect = 4e-71
Identities = 75/287 (26%), Positives = 131/287 (45%), Gaps = 26/287 (9%)
Query: 180 ELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV 239
+ E+ IG G +G VY G + V + N+ Q + FK EV + +
Sbjct: 2 DWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT 61
Query: 240 RHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGL 299
RH N++ +GY +V ++ + +L LH + ++I TA+G+
Sbjct: 62 RHVNILLFMGYSTAP-QLAIVTQWCEGSSLYHHLH---IIETKFEMIKLIDIARQTAQGM 117
Query: 300 TYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG-AERSYVTTRVMGTFGYVA 358
YLH ++HRD+KS+NI L + K+ DFGLA + S+ ++ G+ ++A
Sbjct: 118 DYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMA 174
Query: 359 PEYAST---GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAE 415
PE + +SDVY+FGI++ E+++G+ P +N + + MV
Sbjct: 175 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS------NINNRDQIIFMV----GR 224
Query: 416 GVLDPRLQEKP--CSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 460
G L P L + C +A+KR + C+ +RP ++ +E
Sbjct: 225 GYLSPDLSKVRSNCPKAMKR---LMAECLKKKRDERPLFPQILASIE 268
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (549), Expect = 3e-67
Identities = 68/281 (24%), Positives = 122/281 (43%), Gaps = 22/281 (7%)
Query: 180 ELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV 239
E EV +G G +G V+ G +T VAVK L + F E + ++
Sbjct: 7 EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVK-SLKQGSMSPDAFLAEANLMKQL 65
Query: 240 RHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGL 299
+H+ LVRL + ++ EY++NG+L +L G LT +++ A+G+
Sbjct: 66 QHQRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGI--KLTINKLLDMAAQIAEGM 122
Query: 300 TYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAP 359
++ E +HRD++++NIL+ + K++DFGLA+L+ + AP
Sbjct: 123 AFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAP 179
Query: 360 EYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLD 419
E + G +SDV+SFGIL+ E+++ P + E ++ +
Sbjct: 180 EAINYGTFTIKSDVWSFGILLTEIVTHGRI-----PYPGMTNPEVIQNLERGY------- 227
Query: 420 PRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 460
++ C L + + C RP ++ +LE
Sbjct: 228 RMVRPDNCPEELYQ---LMRLCWKERPEDRPTFDYLRSVLE 265
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (531), Expect = 3e-64
Identities = 67/293 (22%), Positives = 122/293 (41%), Gaps = 30/293 (10%)
Query: 191 ENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGY 250
+ IG+G +G V+ G VAVK + ++R + + E+ +RH+N++ +
Sbjct: 8 QESIGKGRFGEVWRGKW-RGEEVAVK-IFSSREERSWFREAEIYQTVMLRHENILGFIAA 65
Query: 251 CAEG----AHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGL 306
+ LV +Y ++G+L +L+ +T E + + L TA GL +LH +
Sbjct: 66 DNKDNGTWTQLWLVSDYHEHGSLFDYLN-----RYTVTVEGMIKLALSTASGLAHLHMEI 120
Query: 307 -----EPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYV---TTRVMGTFGYVA 358
+P + HRD+KS NIL+ K ++D GLA + + +GT Y+A
Sbjct: 121 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 180
Query: 359 PEYASTGM------LNERSDVYSFGILIMEVISGRNP----VDYSRPPGEVNLVEWLKTM 408
PE + +R+D+Y+ G++ E+ + DY P ++ +
Sbjct: 181 PEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEE 240
Query: 409 VTNRNAEGVLDPRLQEKPCSRALKRALL-VALRCVDPNAHKRPKMGHVIHMLE 460
+ E L P + + S R + + C N R + L
Sbjct: 241 MRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (524), Expect = 1e-63
Identities = 71/269 (26%), Positives = 123/269 (45%), Gaps = 22/269 (8%)
Query: 192 NVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYC 251
IG G +G+V+ G + VA+K + +E++F E E + ++ H LV+L G C
Sbjct: 11 QEIGSGQFGLVHLGYWLNKDKVAIK-TIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 69
Query: 252 AEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVV 311
E A LV+E++++G L +L G + E + + L +G+ YL E V+
Sbjct: 70 LEQAPICLVFEFMEHGCLSDYLRTQRGLFA---AETLLGMCLDVCEGMAYLEE---ACVI 123
Query: 312 HRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERS 371
HRD+ + N L+ + K+SDFG+ + + ++ +T + +PE S + +S
Sbjct: 124 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKS 183
Query: 372 DVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRAL 431
DV+SFG+L+ EV S +R E +VE + + PRL S +
Sbjct: 184 DVWSFGVLMWEVFSEGKIPYENRSNSE--VVEDI------STGFRLYKPRL----ASTHV 231
Query: 432 KRALLVALRCVDPNAHKRPKMGHVIHMLE 460
+ + C RP ++ L
Sbjct: 232 YQ---IMNHCWKERPEDRPAFSRLLRQLA 257
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 204 bits (519), Expect = 2e-62
Identities = 76/303 (25%), Positives = 133/303 (43%), Gaps = 39/303 (12%)
Query: 176 YTLRELEVSTNGFADE---------NVIGEGGYGIVYHGVLEDNTN----VAVKNL-LNN 221
+T + + FA E VIG G +G V G L+ VA+K L
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 222 RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHS 281
+ ++F E +G+ H N++ L G + M++ E+++NG+L+ +L + G
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF- 125
Query: 282 PLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA 341
T + ++ G A G+ YL + VHRD+ + NIL++ K+SDFGL++ L
Sbjct: 126 --TVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180
Query: 342 ERSYVTTR----VMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPG 397
+ S T + APE SDV+S+GI++ EV+S P
Sbjct: 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGER-----PYW 235
Query: 398 EVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIH 457
++ + + + + +D C AL + + L C + + RPK G +++
Sbjct: 236 DMTNQDVINAIEQDYRLPPPMD-------CPSALHQ---LMLDCWQKDRNHRPKFGQIVN 285
Query: 458 MLE 460
L+
Sbjct: 286 TLD 288
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (514), Expect = 2e-62
Identities = 56/269 (20%), Positives = 109/269 (40%), Gaps = 22/269 (8%)
Query: 192 NVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYC 251
+G G +G+V +G +VA+K ++ +E EF E + + + H+ LV+L G C
Sbjct: 10 KELGTGQFGVVKYGKWRGQYDVAIK-MIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 68
Query: 252 AEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVV 311
+ ++ EY+ NG L +L + + + + + YL + +
Sbjct: 69 TKQRPIFIITEYMANGCLLNYLRE---MRHRFQTQQLLEMCKDVCEAMEYLES---KQFL 122
Query: 312 HRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERS 371
HRD+ + N L++ Q K+SDFGL++ + + + + PE + +S
Sbjct: 123 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKS 182
Query: 372 DVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRAL 431
D+++FG+L+ E+ S P E + + P L S +
Sbjct: 183 DIWAFGVLMWEIYSLGKM-----PYERFTNSETAEHIAQGLRLY---RPHL----ASEKV 230
Query: 432 KRALLVALRCVDPNAHKRPKMGHVIHMLE 460
+ C A +RP ++ +
Sbjct: 231 YT---IMYSCWHEKADERPTFKILLSNIL 256
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (510), Expect = 3e-61
Identities = 71/281 (25%), Positives = 121/281 (43%), Gaps = 22/281 (7%)
Query: 180 ELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV 239
E+ E +G+G +G V+ G T VA+K L + + F E + + ++
Sbjct: 11 AWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIK-TLKPGTMSPEAFLQEAQVMKKL 69
Query: 240 RHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGL 299
RH+ LV+L +E +V EY+ G+L +L G+ G + +++ A G+
Sbjct: 70 RHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLR--LPQLVDMAAQIASGM 126
Query: 300 TYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAP 359
Y+ VHRD++++NIL+ + K++DFGLA+L+ + AP
Sbjct: 127 AYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAP 183
Query: 360 EYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLD 419
E A G +SDV+SFGIL+ E+ + E V ++ G
Sbjct: 184 EAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE----------VLDQVERGYRM 233
Query: 420 PRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 460
P E C +L + +C +RP ++ LE
Sbjct: 234 PCPPE--CPESLHD---LMCQCWRKEPEERPTFEYLQAFLE 269
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (506), Expect = 2e-60
Identities = 54/213 (25%), Positives = 99/213 (46%), Gaps = 11/213 (5%)
Query: 181 LEVSTNGFADENVIGEGGYGIVYHGV-LEDNTNVAVKNL-LNNRGQAEKEFKVEVEAIGR 238
+E+ + F + +G G G+V+ +A K + L + + E++ +
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 239 VRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKG 298
+V G + E++D G+L+Q L + +I + + KG
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKG 116
Query: 299 LTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVA 358
LTYL E + K++HRD+K SNIL++ + KL DFG++ L +GT Y++
Sbjct: 117 LTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM---ANSFVGTRSYMS 171
Query: 359 PEYASTGMLNERSDVYSFGILIMEVISGRNPVD 391
PE + +SD++S G+ ++E+ GR P+
Sbjct: 172 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIP 204
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 197 bits (502), Expect = 4e-60
Identities = 61/282 (21%), Positives = 117/282 (41%), Gaps = 22/282 (7%)
Query: 180 ELEVSTNGFADENVIGEGGYGIVYHGVLED-NTNVAVKNLLNNRGQAEKEFKVEVEAIGR 238
+ E+ ++ +G G YG VY GV + + VAVK L + + E EF E +
Sbjct: 11 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKE 69
Query: 239 VRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKG 298
++H NLV+LLG C ++ E++ GNL +L ++ + + + +
Sbjct: 70 IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSA 127
Query: 299 LTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVA 358
+ YL + +HRD+ + N L+ + K++DFGL++L+ + + A
Sbjct: 128 MEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTA 184
Query: 359 PEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVL 418
PE + + +SDV++FG+L+ E+ + +V +L
Sbjct: 185 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV---------------YELL 229
Query: 419 DPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 460
+ + + ++ + C N RP + E
Sbjct: 230 EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 271
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 197 bits (501), Expect = 7e-60
Identities = 74/313 (23%), Positives = 117/313 (37%), Gaps = 50/313 (15%)
Query: 178 LRELEVSTNGFADENVIGEGGYGIVYHGVL------EDNTNVAVKNL-LNNRGQAEKEFK 230
L LE N IGEG +G V+ E T VAVK L + +F+
Sbjct: 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ 64
Query: 231 VEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHG--------------- 275
E + + N+V+LLG CA G L++EY+ G+L ++L
Sbjct: 65 REAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLS 124
Query: 276 -----DVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKL 330
PL+ ++ I A G+ YL E K VHRD+ + N L+ + K+
Sbjct: 125 TRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKI 181
Query: 331 SDFGLAKLL-GAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNP 389
+DFGL++ + A+ ++ PE SDV+++G+++ E+ S
Sbjct: 182 ADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241
Query: 390 VDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKP--CSRALKRALLVALRCVDPNAH 447
Y EV V D + P C L + C
Sbjct: 242 PYYGMAHEEV--------------IYYVRDGNILACPENCPLELYN---LMRLCWSKLPA 284
Query: 448 KRPKMGHVIHMLE 460
RP + +L+
Sbjct: 285 DRPSFCSIHRILQ 297
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (499), Expect = 1e-59
Identities = 76/294 (25%), Positives = 126/294 (42%), Gaps = 31/294 (10%)
Query: 179 RELEVSTNGFA-DENVIGEGGYGIVYHGVL---EDNTNVAVKNLLNNRGQAE-KEFKVEV 233
++L + + + +G G +G V GV + +VA+K L +A+ +E E
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60
Query: 234 EAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIIL 293
+ + ++ + +VRL+G C + MLV E G L ++L G + ++
Sbjct: 61 QIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLH 116
Query: 294 GTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTR--VM 351
+ G+ YL E VHRD+ + N+LL + K+SDFGL+K LGA+ SY T R
Sbjct: 117 QVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 173
Query: 352 GTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVT 410
+ APE + + RSDV+S+G+ + E +S G+ P + P + +E K M
Sbjct: 174 WPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMEC 233
Query: 411 NRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEEF 464
C L + C RP V + A +
Sbjct: 234 PPE-------------CPPELYA---LMSDCWIYKWEDRPDFLTVEQRMRACYY 271
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (496), Expect = 2e-59
Identities = 71/287 (24%), Positives = 130/287 (45%), Gaps = 29/287 (10%)
Query: 182 EVSTNGFADENVIGEGGYGIVYHGVLEDNTN-----VAVKNLLNNRGQAEK-EFKVEVEA 235
E+ + + VIG G +G VY G+L+ ++ VA+K L + ++ +F E
Sbjct: 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGI 62
Query: 236 IGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGT 295
+G+ H N++RL G ++ M++ EY++NG L+++L + + ++ G
Sbjct: 63 MGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGI 119
Query: 296 AKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL--GAERSYVTTRVMGT 353
A G+ YL VHRD+ + NIL++ K+SDFGL+++L E +Y T+
Sbjct: 120 AAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIP 176
Query: 354 FGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRN 413
+ APE S SDV+SFGI++ EV++ + EV
Sbjct: 177 IRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV-------------- 222
Query: 414 AEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 460
++ + + ++C +RPK ++ +L+
Sbjct: 223 -MKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILD 268
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (491), Expect = 8e-59
Identities = 70/280 (25%), Positives = 109/280 (38%), Gaps = 28/280 (10%)
Query: 182 EVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRH 241
++ IG+G +G V G VAVK + + F E + ++RH
Sbjct: 3 ALNMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCI--KNDATAQAFLAEASVMTQLRH 59
Query: 242 KNLVRLLGYCAEGAHRM-LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLT 300
NLV+LLG E + +V EY+ G+L +L S L + + L + +
Sbjct: 60 SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAME 117
Query: 301 YLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPE 360
YL VHRD+ + N+L+ + K+SDFGL K S + APE
Sbjct: 118 YLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA----SSTQDTGKLPVKWTAPE 170
Query: 361 YASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDP 420
+ +SDV+SFGIL+ E+ S P + L + + + +
Sbjct: 171 ALREKKFSTKSDVWSFGILLWEIYSFGRV-----PYPRIPLKDVVPRVEKGYKMD----- 220
Query: 421 RLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 460
C A+ V C +A RP + LE
Sbjct: 221 --APDGCPPAVYE---VMKNCWHLDAAMRPSFLQLREQLE 255
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (494), Expect = 1e-58
Identities = 78/280 (27%), Positives = 126/280 (45%), Gaps = 30/280 (10%)
Query: 191 ENVIGEGGYGIVYHGVLEDNTN----VAVKNLLNNRGQAE-KEFKVEVEAIGRVRHKNLV 245
VIG G +G VYHG L DN AVK+L E +F E + H N++
Sbjct: 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91
Query: 246 RLLGYCAEG-AHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 304
LLG C ++V Y+ +G+L ++ + T + + L AKG+ +L
Sbjct: 92 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKFLAS 148
Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL---GAERSYVTTRVMGTFGYVAPEY 361
K VHRD+ + N +LD+++ K++DFGLA+ + + + T ++A E
Sbjct: 149 ---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 205
Query: 362 ASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPR 421
T +SDV+SFG+L+ E+++ P P +VN + ++ R
Sbjct: 206 LQTQKFTTKSDVWSFGVLLWELMTRGAP-----PYPDVNTFDITVYLLQGR-------RL 253
Query: 422 LQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461
LQ + C L V L+C P A RP ++ + A
Sbjct: 254 LQPEYCPDPLYE---VMLKCWHPKAEMRPSFSELVSRISA 290
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 5e-57
Identities = 69/310 (22%), Positives = 123/310 (39%), Gaps = 47/310 (15%)
Query: 182 EVSTNGFADENVIGEGGYGIVYHGVLEDNTN------VAVKNLLNNRGQAEKE-FKVEVE 234
E V+G G +G V + + VAVK L +E+E E++
Sbjct: 33 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELK 92
Query: 235 AIGRV-RHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHS------------ 281
+ ++ H+N+V LLG C L++EY G+L +L S
Sbjct: 93 MMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRL 152
Query: 282 -------PLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFG 334
LT+E + AKG+ +L VHRD+ + N+L+ K+ DFG
Sbjct: 153 EEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFG 209
Query: 335 LAKLLGAERSYVT-TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS 393
LA+ + ++ +YV ++APE G+ +SDV+S+GIL+ E+ S
Sbjct: 210 LARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN---- 265
Query: 394 RPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKP-CSRALKRALLVALRCVDPNAHKRPKM 452
P + + ++ N ++ + + + + C ++ KRP
Sbjct: 266 -PYPGIPVDANFYKLIQN-------GFKMDQPFYATEEIYI---IMQSCWAFDSRKRPSF 314
Query: 453 GHVIHMLEAE 462
++ L +
Sbjct: 315 PNLTSFLGCQ 324
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (479), Expect = 7e-57
Identities = 72/289 (24%), Positives = 116/289 (40%), Gaps = 37/289 (12%)
Query: 190 DENVIGEGGYGIVYHGVLEDNTN---VAVKNLLN--NRGQAEKEFKVEVEAIGRVRHKNL 244
++ +G G +G V G + VAVK L N N + E E + ++ + +
Sbjct: 11 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 245 VRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 304
VR++G C E MLV E + G L ++L + + + + ++ + G+ YL E
Sbjct: 71 VRMIGIC-EAESWMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEE 125
Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTR--VMGTFGYVAPEYA 362
VHRD+ + N+LL Q K+SDFGL+K L A+ +Y + + APE
Sbjct: 126 ---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 182
Query: 363 STGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRL 422
+ + +SDV+SFG+L+ E S EV +
Sbjct: 183 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV--------------TAMLEKGER 228
Query: 423 QEKP--CSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEEFPFRDV 469
P C R + + C + RP V L + DV
Sbjct: 229 MGCPAGCPREMYD---LMNLCWTYDVENRPGFAAVELRLRN---YYYDV 271
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 189 bits (481), Expect = 1e-56
Identities = 66/272 (24%), Positives = 105/272 (38%), Gaps = 34/272 (12%)
Query: 188 FADENVIGEGGYGIVYHGV-LEDNTNVAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKN 243
F+D IG G +G VY + ++ VA+K + + ++ EV + ++RH N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 303
++ G LV EY + PL + G +GL YLH
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVH----KKPLQEVEIAAVTHGALQGLAYLH 132
Query: 304 EGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAS 363
++HRD+K+ NILL + KL DFG A ++ +GT ++APE
Sbjct: 133 S---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-----ANSFVGTPYWMAPEVIL 184
Query: 364 T---GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDP 420
G + + DV+S GI +E+ + P +N + L + N P
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIELAERK------PPLFNMNAMSALYHIAQNE------SP 232
Query: 421 RLQEKPCSRALKRALLVALRCVDPNAHKRPKM 452
LQ S + C+ RP
Sbjct: 233 ALQSGHWSEYFRN---FVDSCLQKIPQDRPTS 261
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 2e-56
Identities = 62/272 (22%), Positives = 108/272 (39%), Gaps = 24/272 (8%)
Query: 192 NVIGEGGYGIVYHGV-LEDNTNVAVK--NLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLL 248
IG G YG D + K + + ++ EV + ++H N+VR
Sbjct: 10 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 69
Query: 249 GYCAEGAHRML--VYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGL 306
+ + L V EY + G+L + L E + ++ L H
Sbjct: 70 DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 129
Query: 307 E--PKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAST 364
+ V+HRD+K +N+ LD + N KL DFGLA++L + S+ +GT Y++PE +
Sbjct: 130 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA-FVGTPYYMSPEQMNR 188
Query: 365 GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQE 424
NE+SD++S G L+ E+ + P + E + R
Sbjct: 189 MSYNEKSDIWSLGCLLYELCALMPPFT------AFSQKELAGKIREG-------KFRRIP 235
Query: 425 KPCSRALKRALLVALRCVDPNAHKRPKMGHVI 456
S L + R ++ + RP + ++
Sbjct: 236 YRYSDELNE---IITRMLNLKDYHRPSVEEIL 264
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 7e-56
Identities = 68/305 (22%), Positives = 114/305 (37%), Gaps = 40/305 (13%)
Query: 179 RELEVSTNGFADENVIGEGGYGIVYHGVL------EDNTNVAVKNLLNNRGQAEKE-FKV 231
+ E N + +G G +G V + VAVK L + E+E
Sbjct: 16 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMS 75
Query: 232 EVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHG--------------D 276
E++ + + H N+V LLG C G +++ EY G+L +L
Sbjct: 76 ELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIM 135
Query: 277 VGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLA 336
L E ++ AKG+ +L +HRD+ + NILL K+ DFGLA
Sbjct: 136 EDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLA 192
Query: 337 KLLGAERSY-VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRP 395
+ + + +Y V ++APE + SDV+S+GI + E+ S + P
Sbjct: 193 RDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP 252
Query: 396 PGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHV 455
M+ L + + + C D + KRP +
Sbjct: 253 V-----DSKFYKMIKEG------FRMLSPEHAPAEMYD---IMKTCWDADPLKRPTFKQI 298
Query: 456 IHMLE 460
+ ++E
Sbjct: 299 VQLIE 303
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (474), Expect = 1e-55
Identities = 63/296 (21%), Positives = 123/296 (41%), Gaps = 37/296 (12%)
Query: 182 EVSTNGFADENVIGEGGYGIVYHGVLEDN---TNVAVKNL-LNNRGQAEKEFKVEVEAIG 237
+ N ++VIGEG +G V ++ + + A+K + ++F E+E +
Sbjct: 6 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLC 65
Query: 238 RV-RHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHG------------DVGPHSPLT 284
++ H N++ LLG C + L EY +GNL +L S L+
Sbjct: 66 KLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 125
Query: 285 WEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS 344
+ ++ A+G+ YL + + +HRD+ + NIL+ + + K++DFGL++
Sbjct: 126 SQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK 182
Query: 345 YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEW 404
T ++A E + + SDV+S+G+L+ E++S P + E
Sbjct: 183 --KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT-----PYCGMTCAEL 235
Query: 405 LKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 460
+ + E L+ C + + +C ++RP ++ L
Sbjct: 236 YEKLPQGYRLEKPLN-------CDDEVYD---LMRQCWREKPYERPSFAQILVSLN 281
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (468), Expect = 2e-55
Identities = 64/275 (23%), Positives = 114/275 (41%), Gaps = 31/275 (11%)
Query: 191 ENVIGEGGYGIVYHGVL-EDNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRL 247
+ IG G + VY G+ E VA L + + + FK E E + ++H N+VR
Sbjct: 14 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73
Query: 248 LGYCAEGA----HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 303
+LV E + +G L+ +L + ++ + KGL +LH
Sbjct: 74 YDSWESTVKGKKCIVLVTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLH 129
Query: 304 EGLEPKVVHRDIKSSNILL-DKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYA 362
P ++HRD+K NI + + K+ D GLA L A V+GT ++APE
Sbjct: 130 T-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF---AKAVIGTPEFMAPEMY 185
Query: 363 STGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRL 422
+E DVY+FG+ ++E+ + P N + + + + + P
Sbjct: 186 E-EKYDESVDVYAFGMCMLEMATSEYP-----YSECQNAAQIYRRVTSG------VKPAS 233
Query: 423 QEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIH 457
+K +K + C+ N +R + +++
Sbjct: 234 FDKVAIPEVKE---IIEGCIRQNKDERYSIKDLLN 265
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (462), Expect = 4e-54
Identities = 74/313 (23%), Positives = 132/313 (42%), Gaps = 37/313 (11%)
Query: 176 YTLRELEVSTNGFADENVIGEGGYGIVYHGVL------EDNTNVAVKNL-LNNRGQAEKE 228
Y E EV+ +G+G +G+VY GV E T VA+K + + E
Sbjct: 10 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE 69
Query: 229 FKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLH------GDVGPHSP 282
F E + ++VRLLG ++G +++ E + G+L+ +L + +P
Sbjct: 70 FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAP 129
Query: 283 LTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE 342
+ + + A G+ YL+ K VHRD+ + N ++ + + K+ DFG+ + +
Sbjct: 130 PSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET 186
Query: 343 RSY-VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNL 401
Y + + +++PE G+ SDV+SFG+++ E+ + +V
Sbjct: 187 DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV-- 244
Query: 402 VEWLKTMVTNRNAEGVLDPRLQEKP--CSRALKRALLVALRCVDPNAHKRPKMGHVIHML 459
V++ L +KP C L + C N RP +I +
Sbjct: 245 ------------LRFVMEGGLLDKPDNCPDMLFE---LMRMCWQYNPKMRPSFLEIISSI 289
Query: 460 EAEEFP-FRDVSF 471
+ E P FR+VSF
Sbjct: 290 KEEMEPGFREVSF 302
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (457), Expect = 1e-53
Identities = 69/281 (24%), Positives = 117/281 (41%), Gaps = 31/281 (11%)
Query: 192 NVIGEGGYGIVYHGVLEDNTN----VAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKNL 244
+G+G +G+V G + + VAVK L + ++ +A +F EV A+ + H+NL
Sbjct: 14 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 245 VRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 304
+RL G +M V E G+L L G + A+G+ YL
Sbjct: 74 IRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGH---FLLGTLSRYAVQVAEGMGYLES 129
Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL--GAERSYVTTRVMGTFGYVAPEYA 362
+ +HRD+ + N+LL + K+ DFGL + L + + F + APE
Sbjct: 130 ---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL 186
Query: 363 STGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRL 422
T + SD + FG+ + E+ + P +N + L + EG PR
Sbjct: 187 KTRTFSHASDTWMFGVTLWEMFTYGQE-----PWIGLNGSQILHKIDK----EGERLPRP 237
Query: 423 QEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHML-EAE 462
++ C + + V ++C RP + L EA+
Sbjct: 238 ED--CPQDIYN---VMVQCWAHKPEDRPTFVALRDFLLEAQ 273
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (456), Expect = 1e-53
Identities = 67/285 (23%), Positives = 114/285 (40%), Gaps = 38/285 (13%)
Query: 176 YTLRELEVSTNGFADENVIGEGGYGIVYHGVL-EDNTNVAVKNLLN---NRGQAEKEFKV 231
+ L + E+ +G+G +G VY + +A+K L + E + +
Sbjct: 3 WALEDFEI-------GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 55
Query: 232 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNI 291
EVE +RH N++RL GY + L+ EY G + + L S +
Sbjct: 56 EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ----KLSKFDEQRTATY 111
Query: 292 ILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVM 351
I A L+Y H +V+HRDIK N+LL K++DFG + + R T +
Sbjct: 112 ITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTTLC 165
Query: 352 GTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTN 411
GT Y+ PE M +E+ D++S G+L E + G+ P + + +
Sbjct: 166 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI--------- 216
Query: 412 RNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVI 456
E + + + R + N +RP + V+
Sbjct: 217 SRVEFTFPDF-----VTEGARD---LISRLLKHNPSQRPMLREVL 253
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (457), Expect = 1e-53
Identities = 62/288 (21%), Positives = 109/288 (37%), Gaps = 29/288 (10%)
Query: 180 ELEVSTNGFADENVIGEGGYGIVYHGVLEDNTN----VAVKNLLNNRGQAEKE-FKVEVE 234
+ E+ IGEG +G V+ G+ N VA+K N + +E F E
Sbjct: 1 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL 60
Query: 235 AIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILG 294
+ + H ++V+L+G E ++ E G L +L L +
Sbjct: 61 TMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKYS---LDLASLILYAYQ 116
Query: 295 TAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTF 354
+ L YL + VHRDI + N+L+ KL DFGL++ + Y ++
Sbjct: 117 LSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPI 173
Query: 355 GYVAPEYASTGMLNERSDVYSFGILIMEVI-SGRNPVDYSRPPGEVNLVEWLKTMVTNRN 413
++APE + SDV+ FG+ + E++ G P + + +E + + N
Sbjct: 174 KWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPN 233
Query: 414 AEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461
C L + +C + +RP+ + L
Sbjct: 234 -------------CPPTLYS---LMTKCWAYDPSRRPRFTELKAQLST 265
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (455), Expect = 4e-53
Identities = 59/267 (22%), Positives = 107/267 (40%), Gaps = 27/267 (10%)
Query: 192 NVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGY 250
+G+G +G VY E + A K + + +++ VE++ + H N+V+LL
Sbjct: 18 GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 77
Query: 251 CAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKV 310
+ ++ E+ G ++ + PLT + T L YLH + K+
Sbjct: 78 FYYENNLWILIEFCAGGAVDAVML---ELERPLTESQIQVVCKQTLDALNYLH---DNKI 131
Query: 311 VHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGML--- 367
+HRD+K+ NIL + KL+DFG++ + + GT ++APE
Sbjct: 132 IHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPYWMAPEVVMCETSKDR 190
Query: 368 --NERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEK 425
+ ++DV+S GI ++E+ P P + + A+ Q
Sbjct: 191 PYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKI-----------AKSEPPTLAQPS 239
Query: 426 PCSRALKRALLVALRCVDPNAHKRPKM 452
S K L +C++ N R
Sbjct: 240 RWSSNFKDFL---KKCLEKNVDARWTT 263
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (455), Expect = 6e-53
Identities = 69/281 (24%), Positives = 122/281 (43%), Gaps = 31/281 (11%)
Query: 188 FADENVIGEGGYGIVYHGVLEDN-----TNVAVKNL-LNNRGQAEKEFKVEVEAIGRVRH 241
F V+G G +G VY G+ VA+K L +A KE E + V +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 242 KNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTY 301
++ RLLG C L+ + + G L ++ + +N + AKG+ Y
Sbjct: 71 PHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIG---SQYLLNWCVQIAKGMNY 126
Query: 302 LHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA-ERSYVTTRVMGTFGYVAPE 360
L + ++VHRD+ + N+L+ + K++DFGLAKLLGA E+ Y ++A E
Sbjct: 127 LED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 183
Query: 361 YASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDP 420
+ +SDV+S+G+ + E+++ P + + +++
Sbjct: 184 SILHRIYTHQSDVWSYGVTVWELMTFG------SKPYDGIPASEISSILEK-------GE 230
Query: 421 RLQEKP-CSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 460
RL + P C+ + + ++C +A RPK +I
Sbjct: 231 RLPQPPICTIDVYM---IMVKCWMIDADSRPKFRELIIEFS 268
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (440), Expect = 3e-51
Identities = 68/268 (25%), Positives = 105/268 (39%), Gaps = 25/268 (9%)
Query: 192 NVIGEGGYGIVYHGV-LEDNTNVAVKNL-LNNRGQAEKEFKVEVEAIGRVRHKNLVRLLG 249
+GEG YG V V VAVK + + + K E+ + H+N+V+ G
Sbjct: 11 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 70
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK 309
+ EG + L EY G L + P + G+ YLH
Sbjct: 71 HRREGNIQYLFLEYCSGGELFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLH---GIG 123
Query: 310 VVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA-ERSYVTTRVMGTFGYVAPEYASTGMLN 368
+ HRDIK N+LLD++ N K+SDFGLA + R + ++ GT YVAPE +
Sbjct: 124 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 183
Query: 369 -ERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPC 427
E DV+S GI++ +++G P D + + + K
Sbjct: 184 AEPVDVWSCGIVLTAMLAGELPWDQPSD-----------SCQEYSDWKEKKTYLNPWKKI 232
Query: 428 SRALKRALLVALRCVDPNAHKRPKMGHV 455
A L + + N R + +
Sbjct: 233 DSAPLALL---HKILVENPSARITIPDI 257
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (441), Expect = 4e-51
Identities = 68/263 (25%), Positives = 112/263 (42%), Gaps = 26/263 (9%)
Query: 192 NVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGY 250
IG+G G VY + + VA++ + + ++ E+ + ++ N+V L
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 251 CAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKV 310
G +V EY+ G+L + + + + + L +LH +V
Sbjct: 86 YLVGDELWVVMEYLAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALEFLHSN---QV 137
Query: 311 VHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNER 370
+HRDIKS NILL + KL+DFG + E+S +T V GT ++APE + +
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPK 196
Query: 371 SDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKP-CSR 429
D++S GI+ +E+I G P N + L + TN P LQ S
Sbjct: 197 VDIWSLGIMAIEMIEGEPPYL------NENPLRALYLIATNGT------PELQNPEKLSA 244
Query: 430 ALKRALLVALRCVDPNAHKRPKM 452
+ L RC+D + KR
Sbjct: 245 IFRDFL---NRCLDMDVEKRGSA 264
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (427), Expect = 4e-49
Identities = 68/302 (22%), Positives = 123/302 (40%), Gaps = 41/302 (13%)
Query: 182 EVSTNGFADENVIGEGGYGIVYHGVL--------EDNTNVAVKNLLNNRGQAE-KEFKVE 232
E+ + +GEG +G V T VAVK L ++ + + + E
Sbjct: 9 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISE 68
Query: 233 VEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLH------------GDVGP 279
+E + + +HKN++ LLG C + ++ EY GNL ++L P
Sbjct: 69 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNP 128
Query: 280 HSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL 339
L+ + ++ A+G+ YL K +HRD+ + N+L+ + K++DFGLA+ +
Sbjct: 129 EEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDI 185
Query: 340 GAERSYVTTRV-MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGE 398
Y T ++APE + +SDV+SFG+L+ E+ + P
Sbjct: 186 HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLG------GSPYP 239
Query: 399 VNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458
VE L ++ + + C+ L + C +RP ++
Sbjct: 240 GVPVEELFKLLKEGH------RMDKPSNCTNELYM---MMRDCWHAVPSQRPTFKQLVED 290
Query: 459 LE 460
L+
Sbjct: 291 LD 292
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 170 bits (431), Expect = 5e-49
Identities = 56/263 (21%), Positives = 113/263 (42%), Gaps = 24/263 (9%)
Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYC 251
+G G +G+V+ N A K ++ ++ + E++ + +RH LV L
Sbjct: 33 ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 92
Query: 252 AEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVV 311
+ +++YE++ G L + + + H+ ++ + + + KGL ++HE V
Sbjct: 93 EDDNEMVMIYEFMSGGELFEKVADE---HNKMSEDEAVEYMRQVCKGLCHMHEN---NYV 146
Query: 312 HRDIKSSNILLDKQWNP--KLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNE 369
H D+K NI+ + + KL DFGL L ++S T GT + APE A +
Sbjct: 147 HLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT--TGTAEFAAPEVAEGKPVGY 204
Query: 370 RSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSR 429
+D++S G+L ++SG +P +T+ ++ + +D S
Sbjct: 205 YTDMWSVGVLSYILLSGLSPFGGENDD---------ETLRNVKSCDWNMDDSAFSG-ISE 254
Query: 430 ALKRALLVALRCVDPNAHKRPKM 452
K + + + + + R +
Sbjct: 255 DGKDFI---RKLLLADPNTRMTI 274
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (419), Expect = 7e-48
Identities = 72/307 (23%), Positives = 116/307 (37%), Gaps = 39/307 (12%)
Query: 176 YTLRELEVSTNGFADENVIGEGGYGIVYHGV------LEDNTNVAVKNLLNNRGQAE-KE 228
Y + E + +G G +G V VAVK L +E +
Sbjct: 3 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 62
Query: 229 FKVEVEAIGR-VRHKNLVRLLGYCAE-GAHRMLVYEYIDNGNLEQWLHGDVGPHSP---- 282
E++ + H N+V LLG C + G M++ E+ GNL +L P
Sbjct: 63 LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVA 122
Query: 283 --------LTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFG 334
LT E + AKG+ +L K +HRD+ + NILL ++ K+ DFG
Sbjct: 123 PEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFG 179
Query: 335 LAKLLGAERSYV-TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS 393
LA+ + + YV ++APE + +SDV+SFG+L+ E+ S
Sbjct: 180 LARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS---- 235
Query: 394 RPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMG 453
P V + E + R + + + + L C +RP
Sbjct: 236 -PYPGVKIDEEFCRRLKEGT-----RMRAPDY-TTPEMYQ---TMLDCWHGEPSQRPTFS 285
Query: 454 HVIHMLE 460
++ L
Sbjct: 286 ELVEHLG 292
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 160 bits (405), Expect = 4e-46
Identities = 68/281 (24%), Positives = 117/281 (41%), Gaps = 31/281 (11%)
Query: 191 ENVIGEGGYGIVYHGV-LEDNTNVAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKNLVR 246
++G GG V+ L + +VAVK L L F+ E + + H +V
Sbjct: 12 GEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVA 71
Query: 247 LLGYCAE----GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYL 302
+ G +V EY+D L +H P+T + + +I + L +
Sbjct: 72 VYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH----TEGPMTPKRAIEVIADACQALNFS 127
Query: 303 HEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYV--TTRVMGTFGYVAPE 360
H+ ++HRD+K +NI++ K+ DFG+A+ + + V T V+GT Y++PE
Sbjct: 128 HQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 184
Query: 361 YASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDP 420
A ++ RSDVYS G ++ EV++G P + V V E + P
Sbjct: 185 QARGDSVDARSDVYSLGCVLYEVLTGEPPFT------GDSPVSVAYQHVR----EDPIPP 234
Query: 421 RLQEKPCSRALKRALLVALRCVDPNAHKRPK-MGHVIHMLE 460
+ + S L + L+ + N R + + L
Sbjct: 235 SARHEGLSADLDAVV---LKALAKNPENRYQTAAEMRADLV 272
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 5e-46
Identities = 56/290 (19%), Positives = 107/290 (36%), Gaps = 30/290 (10%)
Query: 191 ENVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAE---KEFKVEVEAIGRVRHKNLVR 246
++GEG + V L + A+K L E E + + R+ H V+
Sbjct: 13 GKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 72
Query: 247 LLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGL 306
L + Y NG L +++ L YLH
Sbjct: 73 LYFTFQDDEKLYFGLSYAKNGELLKYIR----KIGSFDETCTRFYTAEIVSALEYLHG-- 126
Query: 307 EPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE-RSYVTTRVMGTFGYVAPEYASTG 365
++HRD+K NILL++ + +++DFG AK+L E + +GT YV+PE +
Sbjct: 127 -KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 185
Query: 366 MLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEK 425
+ SD+++ G +I ++++G P ++ + + D +
Sbjct: 186 SACKSSDLWALGCIIYQLVAGLPPFRAGNEY-----------LIFQKIIKLEYDF---PE 231
Query: 426 PCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEEFP-FRDVSFGRV 474
+ + + + +A KR + + P F V++ +
Sbjct: 232 KFFPKARDLV---EKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL 278
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 161 bits (409), Expect = 6e-46
Identities = 53/263 (20%), Positives = 102/263 (38%), Gaps = 24/263 (9%)
Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYC 251
+G G +G+V+ V K + + K E+ + ++ H L+ L
Sbjct: 36 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95
Query: 252 AEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVV 311
+ +L+ E++ G L + ++ +N + +GL ++H E +V
Sbjct: 96 EDKYEMVLILEFLSGGELFDRIA---AEDYKMSEAEVINYMRQACEGLKHMH---EHSIV 149
Query: 312 HRDIKSSNILLDKQWNP--KLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNE 369
H DIK NI+ + + K+ DFGLA L + + T + APE +
Sbjct: 150 HLDIKPENIMCETKKASSVKIIDFGLATKLNPDE--IVKVTTATAEFAAPEIVDREPVGF 207
Query: 370 RSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSR 429
+D+++ G+L ++SG +P GE + L+T+ + + D S
Sbjct: 208 YTDMWAIGVLGYVLLSGLSPF-----AGE----DDLETLQNVKRCDWEFDEDAFSS-VSP 257
Query: 430 ALKRALLVALRCVDPNAHKRPKM 452
K + + KR +
Sbjct: 258 EAKDFI---KNLLQKEPRKRLTV 277
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 159 bits (403), Expect = 6e-45
Identities = 65/300 (21%), Positives = 114/300 (38%), Gaps = 34/300 (11%)
Query: 184 STNGFADENVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRV 239
+ N F+ +IG GG+G VY + A+K L R Q E E + V
Sbjct: 2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLV 61
Query: 240 R---HKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTA 296
+V + + + ++ G+L L H +
Sbjct: 62 STGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS----QHGVFSEADMRFYAAEII 117
Query: 297 KGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGY 356
GL ++H VV+RD+K +NILLD+ + ++SD GLA ++ +GT GY
Sbjct: 118 LGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PHASVGTHGY 171
Query: 357 VAPEYASTGM-LNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAE 415
+APE G+ + +D +S G ++ +++ G +P + + + TM
Sbjct: 172 MAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM------- 224
Query: 416 GVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEEFP-FRDVSFGRV 474
S L+ L + + ++R E +E P FR + + V
Sbjct: 225 ----AVELPDSFSPELRSLL---EGLLQRDVNRRLGCLGR-GAQEVKESPFFRSLDWQMV 276
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (394), Expect = 4e-44
Identities = 50/263 (19%), Positives = 99/263 (37%), Gaps = 25/263 (9%)
Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYC 251
+G G +GIV+ V K + +G + K E+ + RH+N++ L
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAK-FVKVKGTDQVLVKKEISILNIARHRNILHLHESF 70
Query: 252 AEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVV 311
++++E+I ++ + ++ L ++ + + L +LH +
Sbjct: 71 ESMEELVMIFEFISGLDIFERINTSAF---ELNEREIVSYVHQVCEALQFLH---SHNIG 124
Query: 312 HRDIKSSNILLDKQWNP--KLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNE 369
H DI+ NI+ + + K+ +FG A+ L ++ Y APE +++
Sbjct: 125 HFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL--FTAPEYYAPEVHQHDVVST 182
Query: 370 RSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSR 429
+D++S G L+ ++SG NP + + NAE D K S
Sbjct: 183 ATDMWSLGTLVYVLLSGINPFLAETNQQIIENI---------MNAEYTFDEEA-FKEISI 232
Query: 430 ALKRALLVALRCVDPNAHKRPKM 452
+ R + R
Sbjct: 233 EAMDFV---DRLLVKERKSRMTA 252
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 152 bits (384), Expect = 9e-43
Identities = 60/279 (21%), Positives = 107/279 (38%), Gaps = 27/279 (9%)
Query: 179 RELEVSTNGFADENVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQ-AEKEFKVEVEAI 236
++ E + + +V+G G + V VA+K + + E + E+ +
Sbjct: 2 KQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVL 61
Query: 237 GRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTA 296
+++H N+V L G H L+ + + G L + T +I
Sbjct: 62 HKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVE----KGFYTERDASRLIFQVL 117
Query: 297 KGLTYLHEGLEPKVVHRDIKSSNILL---DKQWNPKLSDFGLAKLLGAERSYVTTRVMGT 353
+ YLH + +VHRD+K N+L D+ +SDFGL+K+ + V + GT
Sbjct: 118 DAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME--DPGSVLSTACGT 172
Query: 354 FGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRN 413
GYVAPE + ++ D +S G++ ++ G P K
Sbjct: 173 PGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA---------KLFEQILK 223
Query: 414 AEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKM 452
AE D + S + K + ++ + KR
Sbjct: 224 AEYEFDSPYWDD-ISDSAKDFI---RHLMEKDPEKRFTC 258
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 149 bits (377), Expect = 5e-42
Identities = 57/279 (20%), Positives = 106/279 (37%), Gaps = 39/279 (13%)
Query: 191 ENVIGEGGYGIVYHGV-LEDNTNVAVKNL---------LNNRGQAEKEFKVEVEAIGRVR 240
+ ++G G +V + AVK + + + EV+ + +V
Sbjct: 8 KEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVS 67
Query: 241 -HKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGL 299
H N+++L LV++ + G L +L L+ + I+ + +
Sbjct: 68 GHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVI 123
Query: 300 TYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAP 359
LH+ +VHRD+K NILLD N KL+DFG + L + V GT Y+AP
Sbjct: 124 CALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQL--DPGEKLREVCGTPSYLAP 178
Query: 360 EYASTGMLNER------SDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRN 413
E M + D++S G+++ +++G P + + L+ +++
Sbjct: 179 EIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHR------KQMLMLRMIMSGN- 231
Query: 414 AEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKM 452
+ S +K + R + KR
Sbjct: 232 ---YQFGSPEWDDYSDTVKDLV---SRFLVVQPQKRYTA 264
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (378), Expect = 8e-42
Identities = 59/265 (22%), Positives = 101/265 (38%), Gaps = 30/265 (11%)
Query: 191 ENVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKE---FKVEVEAIGRV-RHKNLV 245
++G+G +G V+ + N A+K L + + + VE + H L
Sbjct: 7 HKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLT 66
Query: 246 RLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG 305
+ + V EY++ G+L + GL +LH
Sbjct: 67 HMFCTFQTKENLFFVMEYLNGGDLMYHIQ----SCHKFDLSRATFYAAEIILGLQFLHS- 121
Query: 306 LEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTG 365
+V+RD+K NILLDK + K++DFG+ K + T GT Y+APE
Sbjct: 122 --KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC-GTPDYIAPEILLGQ 178
Query: 366 MLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEK 425
N D +SFG+L+ E++ G++P G+ + E ++ + P
Sbjct: 179 KYNHSVDWWSFGVLLYEMLIGQSP-----FHGQ-DEEELFHSIRMDN-------PFYPRW 225
Query: 426 PCSRALKRALLVALRCVDPNAHKRP 450
+ K L ++ KR
Sbjct: 226 -LEKEAKDLL---VKLFVREPEKRL 246
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 148 bits (375), Expect = 8e-42
Identities = 51/275 (18%), Positives = 104/275 (37%), Gaps = 21/275 (7%)
Query: 192 NVIGEGGYGIVYHGVLEDNTNVAVK--NLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLG 249
IGEG YG+VY A+K L E+ + ++H N+V+L
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK 309
+LV+E++D + L + +L G+ Y H+ +
Sbjct: 68 VIHTKKRLVLVFEHLDQDLKKLLDV----CEGGLESVTAKSFLLQLLNGIAYCHD---RR 120
Query: 310 VVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNE 369
V+HRD+K N+L++++ K++DFGLA+ G T ++ + + +
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYST 180
Query: 370 RSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLD--------PR 421
D++S G + E+++G ++ + + ++N V +
Sbjct: 181 TIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTV 240
Query: 422 LQEKPCSRALKRALLVAL----RCVDPNAHKRPKM 452
+ P LK + + + + ++R
Sbjct: 241 YEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITA 275
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 147 bits (371), Expect = 8e-41
Identities = 67/279 (24%), Positives = 113/279 (40%), Gaps = 39/279 (13%)
Query: 176 YTLRELEVSTNGFADENVIGEGGYGIVYHGV-LEDNTNVAVKNL---LNNRGQAEKEFKV 231
Y+L++ ++ +G G +G V+ + A+K L + R + +
Sbjct: 1 YSLQDFQI-------LRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTND 53
Query: 232 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNI 291
E + V H ++R+ G + ++ +YI+ G L L +P+ +
Sbjct: 54 ERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV 113
Query: 292 ILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVM 351
L +++RD+K NILLDK + K++DFG AK + +
Sbjct: 114 -------CLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT----YTLC 162
Query: 352 GTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTN 411
GT Y+APE ST N+ D +SFGILI E+++G P S +KT
Sbjct: 163 GTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT---------MKTYEKI 213
Query: 412 RNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRP 450
NAE P + +K L R + + +R
Sbjct: 214 LNAELRFPPF-----FNEDVKDLL---SRLITRDLSQRL 244
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 146 bits (369), Expect = 9e-41
Identities = 47/281 (16%), Positives = 91/281 (32%), Gaps = 29/281 (10%)
Query: 191 ENVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLG 249
IG G +G +Y G + VA+K + +E + ++ + +
Sbjct: 12 GRKIGSGSFGDIYLGTDIAAGEEVAIKLE--CVKTKHPQLHIESKIYKMMQGGVGIPTIR 69
Query: 250 YC-AEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEP 308
+C AEG + ++V E + + + + + + + + Y+H
Sbjct: 70 WCGAEGDYNVMVMELLGPSLEDLFNF----CSRKFSLKTVLLLADQMISRIEYIHS---K 122
Query: 309 KVVHRDIKSSNIL---LDKQWNPKLSDFGLAKLLGAERSYV------TTRVMGTFGYVAP 359
+HRD+K N L K + DFGLAK R++ + GT Y +
Sbjct: 123 NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASI 182
Query: 360 EYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLD 419
+ R D+ S G ++M G P + + E + +
Sbjct: 183 NTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS------TP 236
Query: 420 PRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 460
+ K L C +P ++ +
Sbjct: 237 IEVLCKGYPSEFATYL---NFCRSLRFDDKPDYSYLRQLFR 274
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 2e-40
Identities = 59/285 (20%), Positives = 104/285 (36%), Gaps = 33/285 (11%)
Query: 181 LEVSTNGFAD-----ENVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVE 234
L++ N D V+G G G V A+K +L + +A +E ++
Sbjct: 2 LQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWR 60
Query: 235 AIGRVRHKNLVRLLGYC----AEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMN 290
A + ++VR++ A ++V E +D G L + T
Sbjct: 61 AS---QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDR--GDQAFTEREASE 115
Query: 291 IILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNP---KLSDFGLAKLLGAERSYVT 347
I+ + + YLH + HRD+K N+L + KL+DFG AK + S T
Sbjct: 116 IMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT 172
Query: 348 TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKT 407
T YVAPE ++ D++S G+++ ++ G P + +
Sbjct: 173 --PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG------LAISPG 224
Query: 408 MVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKM 452
M T P + S +K + + +R +
Sbjct: 225 MKTRIRMGQYEFPNPEWSEVSEEVKMLI---RNLLKTEPTQRMTI 266
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (368), Expect = 4e-40
Identities = 62/287 (21%), Positives = 120/287 (41%), Gaps = 23/287 (8%)
Query: 185 TNGFADENVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAE-KEFKVEVEAIGRVRHK 242
+ + + IGEG YG+V + VA+K + Q + E++ + R RH+
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 243 NLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYL 302
N++ + + Y+ + L+ + L+ + + +GL Y+
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLY-KLLKTQHLSNDHICYFLYQILRGLKYI 125
Query: 303 HEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVT--TRVMGTFGYVAPE 360
H V+HRD+K SN+LL+ + K+ DFGLA++ + + T + T Y APE
Sbjct: 126 HS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 182
Query: 361 YASTGMLNERS-DVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLD 419
+S D++S G ++ E++S R ++N + + + + +++
Sbjct: 183 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 242
Query: 420 ----------PRLQEKPCSRALKRALLVAL----RCVDPNAHKRPKM 452
P + P +R A AL + + N HKR ++
Sbjct: 243 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEV 289
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 1e-39
Identities = 65/280 (23%), Positives = 108/280 (38%), Gaps = 24/280 (8%)
Query: 192 NVIGEGGYGIVYHGVLEDNTN--VAVKNLLNNRGQAEKEFKVEVEA-----IGRVRHKNL 244
IGEG YG V+ N VA+K + G+ E + H N+
Sbjct: 13 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 72
Query: 245 VRLLGYCAEGAHRMLVYEYIDNGNLEQW--LHGDVGPHSPLTWEIRMNIILGTAKGLTYL 302
VRL C + +++Q + D P + E +++ +GL +L
Sbjct: 73 VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 132
Query: 303 HEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYA 362
H +VVHRD+K NIL+ KL+DFGLA++ + + T V+ T Y APE
Sbjct: 133 HS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL--TSVVVTLWYRAPEVL 187
Query: 363 STGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLV----------EWLKTMVTNR 412
D++S G + E+ + S ++ + +W + + R
Sbjct: 188 LQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPR 247
Query: 413 NAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKM 452
A + EK + + + L+C+ N KR
Sbjct: 248 QAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISA 287
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 3e-39
Identities = 55/271 (20%), Positives = 103/271 (38%), Gaps = 33/271 (12%)
Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVKNL------LNNRGQAEKEFKVEVEAIGRVRHKNLV 245
+G G + +V A K + + RG + ++ + EV + ++H N++
Sbjct: 17 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76
Query: 246 RLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG 305
L +L+ E + G L +L LT E + G+ YLH
Sbjct: 77 TLHEVYENKTDVILILELVAGGELFDFLA----EKESLTEEEATEFLKQILNGVYYLH-- 130
Query: 306 LEPKVVHRDIKSSNILLDKQWNP----KLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEY 361
++ H D+K NI+L + P K+ DFGLA + + + GT +VAPE
Sbjct: 131 -SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGTPEFVAPEI 187
Query: 362 ASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPR 421
+ L +D++S G++ ++SG +P + +
Sbjct: 188 VNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ-----------ETLANVSAVNYEFE 236
Query: 422 LQEKPCSRALKRALLVALRCVDPNAHKRPKM 452
+ + AL + + R + + KR +
Sbjct: 237 DEYFSNTSALAKDFI--RRLLVKDPKKRMTI 265
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 141 bits (356), Expect = 5e-39
Identities = 43/283 (15%), Positives = 87/283 (30%), Gaps = 31/283 (10%)
Query: 191 ENVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRH-KNLVRLL 248
IGEG +G+++ G L +N VA+K R + + E + + +
Sbjct: 10 GRRIGEGSFGVIFEGTNLLNNQQVAIKFE--PRRSDAPQLRDEYRTYKLLAGCTGIPNVY 67
Query: 249 GYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEP 308
+ EG H +LV + + + + + + +HE
Sbjct: 68 YFGQEGLHNVLVIDLLGPSLEDLLDL----CGRKFSVKTVAMAAKQMLARVQSIHE---K 120
Query: 309 KVVHRDIKSSNILLDKQWNP-----KLSDFGLAKLLGAERS------YVTTRVMGTFGYV 357
+V+RDIK N L+ + + + DFG+ K + + GT Y+
Sbjct: 121 SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYM 180
Query: 358 APEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGV 417
+ + R D+ + G + M + G P + E + +
Sbjct: 181 SINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS------ 234
Query: 418 LDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 460
R + + P ++ +
Sbjct: 235 TPLRELCAGFPEEFYK---YMHYARNLAFDATPDYDYLQGLFS 274
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 6e-39
Identities = 54/280 (19%), Positives = 101/280 (36%), Gaps = 21/280 (7%)
Query: 188 FADENVIGEGGYGIVYHGV-LEDNTNVAVK--NLLNNRGQAEKEFKVEVEAIGRVRHKNL 244
F IGEG YG+VY VA+K L E+ + + H N+
Sbjct: 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 245 VRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 304
V+LL LV+E++ + D + + + + + +GL + H
Sbjct: 64 VKLLDVIHTENKLYLVFEFLHQDLKKFM---DASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAST 364
+V+HRD+K N+L++ + KL+DFGLA+ G T V+ +
Sbjct: 121 ---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC 177
Query: 365 GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLD----- 419
+ D++S G + E+++ R ++ + GV
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 237
Query: 420 ---PRLQEKPCSRALKRALLVAL----RCVDPNAHKRPKM 452
P+ + S+ + + + + +KR
Sbjct: 238 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 277
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 8e-39
Identities = 58/283 (20%), Positives = 105/283 (37%), Gaps = 29/283 (10%)
Query: 188 FADENVIGEGGYGIVYHGVL-EDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVR 246
+ D VIG G +G+VY L + VA+K +L + ++ E++ + ++ H N+VR
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD----KRFKNRELQIMRKLDHCNIVR 77
Query: 247 LLGYCAEGAHRM------LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLT 300
L + + LV +Y+ H L + + L
Sbjct: 78 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQ-TLPVIYVKLYMYQLFRSLA 136
Query: 301 YLHEGLEPKVVHRDIKSSNILLD-KQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAP 359
Y+H + HRDIK N+LLD KL DFG AK L + + +
Sbjct: 137 YIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGEPNVSYICSRYYRAPE 192
Query: 360 EYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVT-------NR 412
DV+S G ++ E++ G+ ++ + + T N
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNP 252
Query: 413 NAEGVLDPRLQEKPCSRALKR-----ALLVALRCVDPNAHKRP 450
N P+++ P ++ + A+ + R ++ R
Sbjct: 253 NYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARL 295
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 1e-38
Identities = 58/279 (20%), Positives = 103/279 (36%), Gaps = 26/279 (9%)
Query: 192 NVIGEGGYGIVYHGV-LEDNTNVAVK-----NLLNNRGQAEKEFKVEVEAIGRVRHKNLV 245
+ +GEG + VY N VA+K + + + E++ + + H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 246 RLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG 305
LL ++ LV+++++ LT +L T +GL YLH+
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKDN----SLVLTPSHIKAYMLMTLQGLEYLHQ- 118
Query: 306 LEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTG 365
++HRD+K +N+LLD+ KL+DFGLAK G+ T +V T Y APE
Sbjct: 119 --HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV-VTRWYRAPELLFGA 175
Query: 366 ML-NERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLD----- 419
+ D+++ G ++ E++ + ++ + T +
Sbjct: 176 RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV 235
Query: 420 --PRLQEKPCSRALKRALLVAL----RCVDPNAHKRPKM 452
P A L N R
Sbjct: 236 TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITA 274
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (343), Expect = 1e-36
Identities = 67/298 (22%), Positives = 104/298 (34%), Gaps = 31/298 (10%)
Query: 183 VSTNGFADENVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKE---FKVEVEAIGR 238
V+ N F ++G+G +G V A+K L A+ E E +
Sbjct: 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 239 VRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKG 298
RH L L V EY + G L L T E
Sbjct: 62 TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLS----RERVFTEERARFYGAEIVSA 117
Query: 299 LTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVA 358
L YLH VV+RDIK N++LDK + K++DFGL K ++ + GT Y+A
Sbjct: 118 LEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT-MKTFCGTPEYLA 173
Query: 359 PEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVL 418
PE D + G+++ E++ GR P + + ++
Sbjct: 174 PEVLEDNDYGRAVDWWGLGVVMYEMMCGR------LPFYNQDHERLFELILME------- 220
Query: 419 DPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEEFP-FRDVSFGRVI 475
+ R S K L + + +R G E E F +++ V+
Sbjct: 221 EIRFPRT-LSPEAKSLL---AGLLKKDPKQRLGGGP-SDAKEVMEHRFFLSINWQDVV 273
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (338), Expect = 2e-36
Identities = 58/277 (20%), Positives = 103/277 (37%), Gaps = 23/277 (8%)
Query: 192 NVIGEGGYGIVYHGV-LEDNTNVAVK--NLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLL 248
IGEG YG V+ E + VA+K L ++ E+ + ++HKN+VRL
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 249 GYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEP 308
LV+E+ D + + + L EI + + KGL + H
Sbjct: 68 DVLHSDKKLTLVFEFCDQDLKKYFDS----CNGDLDPEIVKSFLFQLLKGLGFCHS---R 120
Query: 309 KVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLN 368
V+HRD+K N+L+++ KL++FGLA+ G + V+ + + +
Sbjct: 121 NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYS 180
Query: 369 ERSDVYSFGILIMEVISGRNPVDYSRPPGEV--NLVEWLKTMVTNRNAEGVLDPRLQEKP 426
D++S G + E+ + P+ + + L T + P + P
Sbjct: 181 TSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYP 240
Query: 427 CSRALKRALLVA-----------LRCVDPNAHKRPKM 452
A + V + N +R
Sbjct: 241 MYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISA 277
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (327), Expect = 4e-35
Identities = 63/271 (23%), Positives = 105/271 (38%), Gaps = 43/271 (15%)
Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKE------FKVEVEAIGRVR--HKN 243
++G GG+G VY G+ + DN VA+K++ +R E +EV + +V
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 303
++RLL + +L+ E + + L E+ + + + + H
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCH 127
Query: 304 EGLEPKVVHRDIKSSNILLD-KQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYA 362
V+HRDIK NIL+D + KL DFG LL + V T GT Y PE+
Sbjct: 128 ---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWI 181
Query: 363 STGMLNERS-DVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPR 421
+ RS V+S GIL+ +++ G P + + E +
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDIPFE--------------------HDEEIIRGQV 221
Query: 422 LQEKPCSRALKRALLVALRCVDPNAHKRPKM 452
+ S + + C+ RP
Sbjct: 222 FFRQRVSSECQHLI---RWCLALRPSDRPTF 249
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (329), Expect = 1e-34
Identities = 54/298 (18%), Positives = 109/298 (36%), Gaps = 27/298 (9%)
Query: 176 YTLRELEVSTNGFAD----ENVIGEGGYGIVYHGV-LEDNTNVAVK--NLLNNRGQAEKE 228
+ +E+ + +G G YG V V VA+K K
Sbjct: 4 FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63
Query: 229 FKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIR 288
E+ + +RH+N++ LL ++ G + H L +
Sbjct: 64 AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRI 123
Query: 289 MNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTT 348
++ KGL Y+H ++HRD+K N+ +++ K+ DFGLA+ +E T
Sbjct: 124 QFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEM---TG 177
Query: 349 RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTM 408
V+ + + + D++S G ++ E+I+G+ S ++ + +
Sbjct: 178 YVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGT 237
Query: 409 VTNRNAEGVLD----------PRLQEKPCSRALKRALLVAL----RCVDPNAHKRPKM 452
+ + P L++K + L A +A+ + + +A +R
Sbjct: 238 PPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTA 295
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (323), Expect = 4e-34
Identities = 56/291 (19%), Positives = 111/291 (38%), Gaps = 37/291 (12%)
Query: 192 NVIGEGGYGIVYHGV-LEDNTNVAVKNLL--NNRGQAEKEFKVEVEAIGRVRHKNLVRLL 248
IG+G +G V+ + VA+K +L N + E++ + ++H+N+V L+
Sbjct: 16 AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 75
Query: 249 GYCAEGAHRM--------LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLT 300
C A LV+++ ++ + T ++ GL
Sbjct: 76 EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN----VLVKFTLSEIKRVMQMLLNGLY 131
Query: 301 YLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS---YVTTRVMGTFGYV 357
Y+H K++HRD+K++N+L+ + KL+DFGLA+ ++ T + T Y
Sbjct: 132 YIHR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYR 188
Query: 358 APEYASTGML-NERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEG 416
PE D++ G ++ E+ + + + ++ L+ L +T
Sbjct: 189 PPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPN 248
Query: 417 VLDPRLQEK---------------PCSRALKRALLVALRCVDPNAHKRPKM 452
V + L EK AL + + + + +R
Sbjct: 249 VDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDS 299
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 126 bits (318), Expect = 4e-33
Identities = 56/247 (22%), Positives = 96/247 (38%), Gaps = 16/247 (6%)
Query: 147 AAGSHHGSGDQTVAAAITPEVSHLGWGHWYTLRELEVSTNGFADENVIGEGGYGIVYHGV 206
AA + GS ++V + W T + + F +G G +G V
Sbjct: 3 AAAAKKGSEQESVKEFLAKAKEDFL-KKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVK 61
Query: 207 -LEDNTNVAVKNLLNNRGQAEKE---FKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE 262
E + A+K L + K+ E + V LV+L + ++ +V E
Sbjct: 62 HKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVME 121
Query: 263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILL 322
Y+ G + L + YLH +++RD+K N+L+
Sbjct: 122 YVAGGEMFSHLR----RIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLI 174
Query: 323 DKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIME 382
D+Q +++DFG AK T + GT +APE + N+ D ++ G+LI E
Sbjct: 175 DQQGYIQVTDFGFAK----RVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYE 230
Query: 383 VISGRNP 389
+ +G P
Sbjct: 231 MAAGYPP 237
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (298), Expect = 1e-30
Identities = 63/283 (22%), Positives = 114/283 (40%), Gaps = 31/283 (10%)
Query: 183 VSTNGFADENVIGEGGYGIVYHGVL----EDNTNVAVKNL----LNNRGQAEKEFKVEVE 234
V F V+G G YG V+ + A+K L + + + + + E +
Sbjct: 21 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQ 80
Query: 235 AIGRVRHK-NLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIIL 293
+ +R LV L L+ +YI+ G L L T +
Sbjct: 81 VLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLS----QRERFTEHEVQIYVG 136
Query: 294 GTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGT 353
L +LH+ +++RDIK NILLD + L+DFGL+K A+ + GT
Sbjct: 137 EIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGT 193
Query: 354 FGYVAPEYASTGM--LNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTN 411
Y+AP+ G ++ D +S G+L+ E+++G +P ++ + + E + ++ +
Sbjct: 194 IEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP--FTVDGEKNSQAEISRRILKS 251
Query: 412 RNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGH 454
+P ++ S K + R + + KR G
Sbjct: 252 -------EPPYPQE-MSALAKDLI---QRLLMKDPKKRLGCGP 283
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 117 bits (293), Expect = 8e-30
Identities = 49/224 (21%), Positives = 94/224 (41%), Gaps = 24/224 (10%)
Query: 175 WYTLRELEVSTNGFAD---ENVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFK 230
++ V D +G G Y V+ + + +N V VK L + +K+ K
Sbjct: 21 YWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKIL---KPVKKKKIK 77
Query: 231 VEVEAIGRVR-HKNLVRLLGYCAEGAHRM--LVYEYIDNGNLEQWLHGDVGPHSPLTWEI 287
E++ + +R N++ L + R LV+E+++N + +Q LT
Sbjct: 78 REIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ-------TLTDYD 130
Query: 288 RMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLD-KQWNPKLSDFGLAKLLGAERSYV 346
+ K L Y H ++HRD+K N+++D + +L D+GLA+ + Y
Sbjct: 131 IRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY- 186
Query: 347 TTRVMGTFGYVAPE-YASTGMLNERSDVYSFGILIMEVISGRNP 389
+ + + PE M + D++S G ++ +I + P
Sbjct: 187 -NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP 229
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (282), Expect = 3e-28
Identities = 45/201 (22%), Positives = 83/201 (41%), Gaps = 9/201 (4%)
Query: 192 NVIGEGGYGIVYHGV-LEDNTNVAVK--NLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLL 248
+ +G G YG V + VAVK + K E+ + ++H+N++ LL
Sbjct: 24 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 83
Query: 249 GYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEP 308
+ +L ++ LT + +I +GL Y+H
Sbjct: 84 DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SA 140
Query: 309 KVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLN 368
++HRD+K SN+ +++ K+ DFGLA+ E T V + + N
Sbjct: 141 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---TGYVATRWYRAPEIMLNWMHYN 197
Query: 369 ERSDVYSFGILIMEVISGRNP 389
+ D++S G ++ E+++GR
Sbjct: 198 QTVDIWSVGCIMAELLTGRTL 218
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (272), Expect = 7e-27
Identities = 53/206 (25%), Positives = 83/206 (40%), Gaps = 21/206 (10%)
Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVK--NLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLG 249
IG G GIV + NVA+K + K E+ + V HKN++ LL
Sbjct: 24 PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83
Query: 250 YCA------EGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 303
E LV E +D + E ++ G+ +LH
Sbjct: 84 VFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL-------DHERMSYLLYQMLCGIKHLH 136
Query: 304 EGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAS 363
++HRD+K SNI++ K+ DFGLA+ G S++ T + T Y APE
Sbjct: 137 S---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTRYYRAPEVIL 191
Query: 364 TGMLNERSDVYSFGILIMEVISGRNP 389
E D++S G ++ E++ +
Sbjct: 192 GMGYKENVDIWSVGCIMGEMVRHKIL 217
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 104 bits (260), Expect = 3e-25
Identities = 42/234 (17%), Positives = 81/234 (34%), Gaps = 18/234 (7%)
Query: 191 ENVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLG 249
+G G + V+ + +NT+VA+K ++ + + E++ + RV + +
Sbjct: 18 VRKLGWGHFSTVWLAKDMVNNTHVAMK-IVRGDKVYTEAAEDEIKLLQRVNDADNTKEDS 76
Query: 250 YCAEGAHRMLVYEYIDNGNLEQW------------LHGDVGPHSPLTWEIRMNIILGTAK 297
A ++L + N H + I
Sbjct: 77 MGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLL 136
Query: 298 GLTYLHEGLEPKVVHRDIKSSNILLDKQ-WNPKLSDFGLAKLLGAERSYVT-TRVMGTFG 355
GL Y+H ++H DIK N+L++ L +A L A T + T
Sbjct: 137 GLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTRE 194
Query: 356 YVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMV 409
Y +PE +D++S LI E+I+G + + + ++
Sbjct: 195 YRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQII 248
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 88.7 bits (219), Expect = 5e-21
Identities = 27/163 (16%), Positives = 52/163 (31%), Gaps = 21/163 (12%)
Query: 192 NVIGEGGYGIVYHGVLEDNTNVAVK----------NLLNNRGQAEKEFKVEVEAIGRVRH 241
++GEG V++ E VK + R + F V R
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 242 KNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTY 301
+ L +L G VY + N L + + + ++ + +
Sbjct: 66 RALQKLQGLAV-----PKVYAWEGNAVLMELIDAKELYRVRVENPDE--VLDMILEEVAK 118
Query: 302 LHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS 344
+ +VH D+ N+L+ + + DF + +G E
Sbjct: 119 FY---HRGIVHGDLSQYNVLVSE-EGIWIIDFPQSVEVGEEGW 157
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 508 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.91 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.58 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.04 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.57 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.12 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.69 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.04 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-54 Score=422.98 Aligned_cols=262 Identities=28% Similarity=0.471 Sum_probs=205.9
Q ss_pred hHhhcCCCCcccceEcccCcEEEEEEEECCCcEEEEEEeecC--CchhHHHHHHHHHHHHccCCCCeeeEeeeeecCCee
Q 010513 180 ELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHR 257 (508)
Q Consensus 180 ~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 257 (508)
++++..++|++.+.||+|+||+||+|+++ ..||||++... .....+.|.+|++++++++|||||++++++.+ ...
T Consensus 2 dwei~~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~ 78 (276)
T d1uwha_ 2 DWEIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQL 78 (276)
T ss_dssp CCBCCTTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSC
T ss_pred CcccccccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEE
Confidence 34778899999999999999999999864 36999998643 34456789999999999999999999998765 568
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccce
Q 010513 258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK 337 (508)
Q Consensus 258 ~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~ 337 (508)
++|||||++|+|.+++... ...+++..+..++.|+++||+|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 79 ~lv~Ey~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~ 152 (276)
T d1uwha_ 79 AIVTQWCEGSSLYHHLHII---ETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLAT 152 (276)
T ss_dssp EEEEECCCEEEHHHHHHTS---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSC
T ss_pred EEEEecCCCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEcccccee
Confidence 9999999999999999765 35799999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCC-cceecceecCCCCCChhhhhc---CCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccc
Q 010513 338 LLGAER-SYVTTRVMGTFGYVAPEYAST---GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRN 413 (508)
Q Consensus 338 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 413 (508)
...... ....+...||+.|+|||++.+ ..|+.++|||||||+||||+||+.||....+. ..+......+
T Consensus 153 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~------~~~~~~~~~~- 225 (276)
T d1uwha_ 153 VKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR------DQIIFMVGRG- 225 (276)
T ss_dssp C------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH------HHHHHHHHHT-
T ss_pred eccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChH------HHHHHHHhcC-
Confidence 764432 233455689999999999864 35888999999999999999999999754321 1111112111
Q ss_pred cccCCCccC--CCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 010513 414 AEGVLDPRL--QEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEE 463 (508)
Q Consensus 414 ~~~~~~~~l--~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~~~ 463 (508)
...|.+ ....+++. +.+++.+||+.||++|||+.+|+++|+...
T Consensus 226 ---~~~p~~~~~~~~~~~~---l~~li~~cl~~dp~~RPt~~~il~~Le~l~ 271 (276)
T d1uwha_ 226 ---YLSPDLSKVRSNCPKA---MKRLMAECLKKKRDERPLFPQILASIELLA 271 (276)
T ss_dssp ---SCCCCGGGSCTTCCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---CCCCcchhccccchHH---HHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 111111 11123444 445778999999999999999999998643
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-54 Score=421.41 Aligned_cols=251 Identities=24% Similarity=0.361 Sum_probs=208.8
Q ss_pred CCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCchhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEEe
Q 010513 185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY 263 (508)
Q Consensus 185 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~ 263 (508)
.++|++.+.||+|+||+||+|.+. +|+.||||++........+.+.+|++++++++|||||++++++.+++..|+||||
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy 98 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEe
Confidence 357999999999999999999964 6899999999766555667899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCCC
Q 010513 264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER 343 (508)
Q Consensus 264 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 343 (508)
|++|+|.+++.+. .+++..++.++.|++.||+|||++ +|+||||||+|||++.++++||+|||+++.+....
T Consensus 99 ~~gg~L~~~~~~~-----~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~ 170 (293)
T d1yhwa1 99 LAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (293)
T ss_dssp CTTCBHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred cCCCcHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeecccc
Confidence 9999999988654 689999999999999999999999 99999999999999999999999999999875433
Q ss_pred cceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCCccCC
Q 010513 344 SYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQ 423 (508)
Q Consensus 344 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 423 (508)
......+||+.|+|||++.+..|+.++|||||||++|||+||+.||.... ..+.+......... .+.
T Consensus 171 -~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~------~~~~~~~~~~~~~~------~~~ 237 (293)
T d1yhwa1 171 -SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN------PLRALYLIATNGTP------ELQ 237 (293)
T ss_dssp -CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSC------HHHHHHHHHHHCSC------CCS
T ss_pred -ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCC------HHHHHHHHHhCCCC------CCC
Confidence 23445689999999999999999999999999999999999999996432 12222222222111 111
Q ss_pred CCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 424 EKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 424 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
. ......++.+++.+||+.||++|||+.|++++
T Consensus 238 ~--~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 238 N--PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp S--GGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred C--cccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 11122344557889999999999999999864
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-54 Score=417.18 Aligned_cols=254 Identities=26% Similarity=0.461 Sum_probs=199.0
Q ss_pred CCCCcccceEcccCcEEEEEEEECCCcEEEEEEeecCCchhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEEec
Q 010513 185 TNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYI 264 (508)
Q Consensus 185 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~ 264 (508)
.++|++.+.||+|+||+||+|.+.+++.||||++.... ...++|.+|++++++++|||||+++|++.+++..++||||+
T Consensus 4 p~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~ 82 (263)
T d1sm2a_ 4 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 82 (263)
T ss_dssp CSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred hHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEec
Confidence 45799999999999999999999888899999986543 34578999999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCCCc
Q 010513 265 DNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS 344 (508)
Q Consensus 265 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~ 344 (508)
++|+|.+++... ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.......
T Consensus 83 ~~g~L~~~l~~~---~~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~ 156 (263)
T d1sm2a_ 83 EHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 156 (263)
T ss_dssp TTCBHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC----------
T ss_pred CCCcHHHHhhcc---ccCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCCc
Confidence 999999998765 35789999999999999999999999 999999999999999999999999999987755544
Q ss_pred ceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhC-CCCCCCCCCCCcchHHHHHHHhhcccccccCCCccCC
Q 010513 345 YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISG-RNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQ 423 (508)
Q Consensus 345 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg-~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 423 (508)
.......||+.|+|||++.+..|+.++|||||||++|||+|+ +.||.... ..+.+....... ....|
T Consensus 157 ~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~------~~~~~~~i~~~~---~~~~p--- 224 (263)
T d1sm2a_ 157 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS------NSEVVEDISTGF---RLYKP--- 224 (263)
T ss_dssp --------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCC------HHHHHHHHHHTC---CCCCC---
T ss_pred eeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCC------HHHHHHHHHhcC---CCCCc---
Confidence 444556899999999999999999999999999999999995 55554221 122222221111 11111
Q ss_pred CCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 010513 424 EKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461 (508)
Q Consensus 424 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~ 461 (508)
..++. ++.+++.+||+.||++||++++|+++|+.
T Consensus 225 -~~~~~---~l~~li~~cl~~~p~~Rps~~~il~~L~~ 258 (263)
T d1sm2a_ 225 -RLAST---HVYQIMNHCWKERPEDRPAFSRLLRQLAE 258 (263)
T ss_dssp -TTSCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -cccCH---HHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence 22333 34558889999999999999999999985
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-54 Score=421.00 Aligned_cols=253 Identities=26% Similarity=0.367 Sum_probs=203.2
Q ss_pred CCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCC-chhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEE
Q 010513 185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE 262 (508)
Q Consensus 185 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e 262 (508)
.++|++.+.||+|+||+||+|+++ +|+.||||++.... .+..+.+.+|++++++++|||||++++++.+++..|+|||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 357999999999999999999986 68899999986543 2344678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCC
Q 010513 263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE 342 (508)
Q Consensus 263 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 342 (508)
||++|+|.+++... ..+++..++.++.|+++||+|||++ +|+||||||+|||++.++++||+|||+|+.....
T Consensus 84 y~~gg~L~~~l~~~----~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~ 156 (271)
T d1nvra_ 84 YCSGGELFDRIEPD----IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYN 156 (271)
T ss_dssp CCTTEEGGGGSBTT----TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEET
T ss_pred ccCCCcHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeeccC
Confidence 99999999999754 5799999999999999999999999 9999999999999999999999999999976433
Q ss_pred Cc-ceecceecCCCCCChhhhhcCCC-CCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCCc
Q 010513 343 RS-YVTTRVMGTFGYVAPEYASTGML-NERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDP 420 (508)
Q Consensus 343 ~~-~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 420 (508)
.. ...+..+||+.|+|||++.+..+ +.++|||||||++|||+||+.||........ .. ........ .
T Consensus 157 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~--~~---~~~~~~~~---~--- 225 (271)
T d1nvra_ 157 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ--EY---SDWKEKKT---Y--- 225 (271)
T ss_dssp TEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSH--HH---HHHHTTCT---T---
T ss_pred CccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHH--HH---HHHhcCCC---C---
Confidence 32 23445789999999999988776 5789999999999999999999975543211 11 11111110 0
Q ss_pred cCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 421 RLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 421 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
.........++.+++.+||+.||++|||++|++++
T Consensus 226 ---~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 260 (271)
T d1nvra_ 226 ---LNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 260 (271)
T ss_dssp ---STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ---CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 00111122344557889999999999999999763
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-54 Score=414.21 Aligned_cols=245 Identities=27% Similarity=0.433 Sum_probs=205.0
Q ss_pred CCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCC---chhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEE
Q 010513 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY 261 (508)
Q Consensus 186 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 261 (508)
++|++.+.||+|+||+||+|+++ +++.||+|++.+.. ....+.+.+|+++++.++|||||++++++.+++..|+||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 47999999999999999999986 58889999986432 234567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCC
Q 010513 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA 341 (508)
Q Consensus 262 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 341 (508)
|||++|+|.+++... ..+++..++.++.|+++||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 86 Ey~~~g~L~~~l~~~----~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~ 158 (263)
T d2j4za1 86 EYAPLGTVYRELQKL----SKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 158 (263)
T ss_dssp ECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC
T ss_pred eecCCCcHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCC
Confidence 999999999999765 5799999999999999999999999 999999999999999999999999999986543
Q ss_pred CCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCCcc
Q 010513 342 ERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPR 421 (508)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 421 (508)
. .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||.... ..+.+..... .. +.
T Consensus 159 ~---~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~------~~~~~~~i~~-~~------~~ 222 (263)
T d2j4za1 159 S---RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT------YQETYKRISR-VE------FT 222 (263)
T ss_dssp C---CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS------HHHHHHHHHT-TC------CC
T ss_pred C---cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCC------HHHHHHHHHc-CC------CC
Confidence 2 2334679999999999999999999999999999999999999996432 2222222221 11 11
Q ss_pred CCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 010513 422 LQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIH 457 (508)
Q Consensus 422 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 457 (508)
+. +..+.. +.+++.+||+.||++|||++|+++
T Consensus 223 ~p-~~~s~~---~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 223 FP-DFVTEG---ARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp CC-TTSCHH---HHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CC-ccCCHH---HHHHHHHHccCCHhHCcCHHHHHc
Confidence 11 113333 445777999999999999999986
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-54 Score=417.86 Aligned_cols=261 Identities=25% Similarity=0.413 Sum_probs=213.2
Q ss_pred hhHhhcCCCCcccceEcccCcEEEEEEEECCCcEEEEEEeecCCchhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeE
Q 010513 179 RELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM 258 (508)
Q Consensus 179 ~~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 258 (508)
+++++..++|++.+.||+|+||+||+|.+++++.||||++.... ...+.|.+|++++++++|||||++++++.+ +..+
T Consensus 6 ~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~ 83 (272)
T d1qpca_ 6 DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIY 83 (272)
T ss_dssp CTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred CCeecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeE
Confidence 45678888999999999999999999999988899999986543 345679999999999999999999998865 5679
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeecccee
Q 010513 259 LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL 338 (508)
Q Consensus 259 lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~ 338 (508)
+||||+++|+|.+++.... ...+++..++.++.|+++||+|||++ +|+||||||+|||+++++.+||+|||+++.
T Consensus 84 iv~Ey~~~g~L~~~~~~~~--~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~ 158 (272)
T d1qpca_ 84 IITEYMENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARL 158 (272)
T ss_dssp EEEECCTTCBHHHHTTSHH--HHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEeCCCCcHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEE
Confidence 9999999999999876542 23589999999999999999999999 999999999999999999999999999998
Q ss_pred cCCCCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCC
Q 010513 339 LGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVL 418 (508)
Q Consensus 339 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 418 (508)
.............||+.|+|||++.++.++.++|||||||++|||+||..|+..... ..+.+.... .. .
T Consensus 159 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~-----~~~~~~~i~-~~-----~ 227 (272)
T d1qpca_ 159 IEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT-----NPEVIQNLE-RG-----Y 227 (272)
T ss_dssp CSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC-----HHHHHHHHH-TT-----C
T ss_pred ccCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCC-----HHHHHHHHH-hc-----C
Confidence 866555555667899999999999999999999999999999999996555432211 112222221 11 1
Q ss_pred CccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 010513 419 DPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461 (508)
Q Consensus 419 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~ 461 (508)
.+.. .+.++.. +.+++.+||+.||++|||+.+|++.|+.
T Consensus 228 ~~~~-p~~~~~~---l~~li~~cl~~~P~~Rpt~~ei~~~L~~ 266 (272)
T d1qpca_ 228 RMVR-PDNCPEE---LYQLMRLCWKERPEDRPTFDYLRSVLED 266 (272)
T ss_dssp CCCC-CTTCCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCC-cccChHH---HHHHHHHHcCCCHhHCcCHHHHHHHhhh
Confidence 1111 1223344 4557889999999999999999999874
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.1e-54 Score=425.28 Aligned_cols=263 Identities=23% Similarity=0.398 Sum_probs=217.6
Q ss_pred hhHhhcCCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCchhHHHHHHHHHHHHccCCCCeeeEeeeeecCCee
Q 010513 179 RELEVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHR 257 (508)
Q Consensus 179 ~~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 257 (508)
+++++..++|++.+.||+|+||+||+|.+. +++.||||++.... ...++|.+|+++|++++|||||+++++|.+++..
T Consensus 10 ~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (287)
T d1opja_ 10 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF 88 (287)
T ss_dssp CTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred cccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCee
Confidence 445778889999999999999999999986 47889999986543 3456799999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccce
Q 010513 258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK 337 (508)
Q Consensus 258 ~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~ 337 (508)
++|||||++|+|.+++.... ...+++..+..++.|+++||+|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 89 ~iv~E~~~~g~l~~~l~~~~--~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~ 163 (287)
T d1opja_ 89 YIITEFMTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSR 163 (287)
T ss_dssp EEEEECCTTCBHHHHHHHSC--TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTT
T ss_pred EEEeecccCcchHHHhhhcc--ccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEcccccee
Confidence 99999999999999997642 35789999999999999999999999 99999999999999999999999999999
Q ss_pred ecCCCCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccC
Q 010513 338 LLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGV 417 (508)
Q Consensus 338 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 417 (508)
..............||+.|+|||++.++.|+.++|||||||++|||++|..||..... ..+ +...+..+.
T Consensus 164 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~-----~~~-~~~~i~~~~---- 233 (287)
T d1opja_ 164 LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-----LSQ-VYELLEKDY---- 233 (287)
T ss_dssp TCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC-----HHH-HHHHHHTTC----
T ss_pred ecCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcch-----HHH-HHHHHhcCC----
Confidence 8766555555667799999999999999999999999999999999997777643221 111 112222111
Q ss_pred CCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010513 418 LDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (508)
Q Consensus 418 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~~ 462 (508)
.+... +.++. ++.+++.+||+.||++|||+.++++.|+..
T Consensus 234 -~~~~~-~~~~~---~l~~li~~cl~~dP~~Rps~~ei~~~L~~~ 273 (287)
T d1opja_ 234 -RMERP-EGCPE---KVYELMRACWQWNPSDRPSFAEIHQAFETM 273 (287)
T ss_dssp -CCCCC-TTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred -CCCCC-ccchH---HHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 11111 12333 455588899999999999999999999764
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-53 Score=418.03 Aligned_cols=252 Identities=23% Similarity=0.343 Sum_probs=206.6
Q ss_pred CCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCchhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEEec
Q 010513 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYI 264 (508)
Q Consensus 186 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~ 264 (508)
+.|++.+.||+|+||+||+|++. ++..||||++........+.+.+|+++|++++|||||++++++.+++..|+|||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 46899999999999999999976 58889999997776666778999999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCCCc
Q 010513 265 DNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS 344 (508)
Q Consensus 265 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~ 344 (508)
++|+|.+++.+. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++++||+|||+++..... .
T Consensus 92 ~~g~L~~~~~~~---~~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~-~ 164 (288)
T d2jfla1 92 AGGAVDAVMLEL---ERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT-I 164 (288)
T ss_dssp TTEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHH-H
T ss_pred CCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCC-c
Confidence 999999998654 35799999999999999999999999 9999999999999999999999999999865322 1
Q ss_pred ceecceecCCCCCChhhhh-----cCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCC
Q 010513 345 YVTTRVMGTFGYVAPEYAS-----TGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLD 419 (508)
Q Consensus 345 ~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 419 (508)
......+||+.|+|||++. +..|+.++|||||||++|||+||+.||....+. . .+....... .
T Consensus 165 ~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~---~---~~~~i~~~~-~----- 232 (288)
T d2jfla1 165 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPM---R---VLLKIAKSE-P----- 232 (288)
T ss_dssp HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGG---G---HHHHHHHSC-C-----
T ss_pred ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHH---H---HHHHHHcCC-C-----
Confidence 2234568999999999984 456889999999999999999999999754322 1 112222111 0
Q ss_pred ccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 420 PRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 420 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
+.+.. ......++.+++.+||+.||++|||+.|++++
T Consensus 233 ~~~~~--~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 233 PTLAQ--PSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp CCCSS--GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred CCCCc--cccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11111 11222345557889999999999999999864
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-54 Score=416.71 Aligned_cols=256 Identities=23% Similarity=0.338 Sum_probs=193.7
Q ss_pred CCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCC--chhHHHHHHHHHHHHccCCCCeeeEeeeeec--CCeeEEE
Q 010513 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE--GAHRMLV 260 (508)
Q Consensus 186 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~--~~~~~lV 260 (508)
++|++.+.||+|+||+||+|+++ +|+.||+|.+.... ....+.+.+|++++++++|||||++++++.+ ++.+|+|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 57999999999999999999976 68899999986543 3344678899999999999999999999865 4568999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeeeccCCCCCEEEcCCCCeEEeeecccee
Q 010513 261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGL--EPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL 338 (508)
Q Consensus 261 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~ 338 (508)
||||++|+|.+++.+.......+++..++.++.|++.||+|||++. ..+|+||||||+|||++.++.+||+|||+++.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 9999999999998754333467999999999999999999999861 11399999999999999999999999999987
Q ss_pred cCCCCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCC
Q 010513 339 LGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVL 418 (508)
Q Consensus 339 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 418 (508)
+.... ......+||+.|+|||++.+..|+.++|||||||++|||+||+.||..... .+.... +......
T Consensus 164 ~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~------~~~~~~-i~~~~~~--- 232 (269)
T d2java1 164 LNHDT-SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ------KELAGK-IREGKFR--- 232 (269)
T ss_dssp C------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHH-HHHTCCC---
T ss_pred cccCC-CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCH------HHHHHH-HHcCCCC---
Confidence 64432 233457899999999999999999999999999999999999999964321 122222 1111111
Q ss_pred CccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 419 DPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 419 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
.+.. ..+. ++.+++.+||+.||++|||+.|++++
T Consensus 233 --~~~~-~~s~---~l~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 233 --RIPY-RYSD---ELNEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp --CCCT-TSCH---HHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred --CCCc-ccCH---HHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 1111 1333 34557789999999999999999864
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-53 Score=422.84 Aligned_cols=203 Identities=26% Similarity=0.412 Sum_probs=180.5
Q ss_pred hhcCCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCC-chhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEE
Q 010513 182 EVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRML 259 (508)
Q Consensus 182 ~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 259 (508)
++..++|++.+.||+|+||+||+|++. +|+.||+|++.... ....+.+.+|+++|++++|||||+++++|.++++.|+
T Consensus 2 el~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~i 81 (322)
T d1s9ja_ 2 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 81 (322)
T ss_dssp CCCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEE
T ss_pred CCCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 456788999999999999999999976 57889999986543 3445678999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeeccCCCCCEEEcCCCCeEEeeecccee
Q 010513 260 VYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE-GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL 338 (508)
Q Consensus 260 V~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~ 338 (508)
||||+++|+|.+++.+. ..+++..++.++.|++.||.|||+ + +|+||||||+|||++.++++||+|||+|+.
T Consensus 82 VmEy~~gg~L~~~l~~~----~~l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~ 154 (322)
T d1s9ja_ 82 CMEHMDGGSLDQVLKKA----GRIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQ 154 (322)
T ss_dssp EEECCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHH
T ss_pred EEEcCCCCcHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeECCCCCEEEeeCCCccc
Confidence 99999999999999765 469999999999999999999996 5 899999999999999999999999999986
Q ss_pred cCCCCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCC
Q 010513 339 LGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSR 394 (508)
Q Consensus 339 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~ 394 (508)
... ...+..+||+.|+|||++.+..|+.++|||||||++|||++|+.||...+
T Consensus 155 ~~~---~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~ 207 (322)
T d1s9ja_ 155 LID---SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD 207 (322)
T ss_dssp HHH---HTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCC
T ss_pred cCC---CccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 532 22345689999999999999999999999999999999999999997543
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-53 Score=405.97 Aligned_cols=254 Identities=22% Similarity=0.387 Sum_probs=213.7
Q ss_pred CCCCcccceEcccCcEEEEEEEECCCcEEEEEEeecCCchhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEEec
Q 010513 185 TNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYI 264 (508)
Q Consensus 185 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~ 264 (508)
.++|++.++||+|+||+||+|++++++.||||++.+... ..++|.+|++++++++||||++++|+|.+++..++||||+
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~ 81 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 81 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECC
T ss_pred hHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEcc
Confidence 368999999999999999999998888999999876543 4568999999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCCCc
Q 010513 265 DNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS 344 (508)
Q Consensus 265 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~ 344 (508)
++|+|.+++... ...+++..++.++.|+++||+|||++ +|+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~g~l~~~~~~~---~~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 155 (258)
T d1k2pa_ 82 ANGCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY 155 (258)
T ss_dssp TTEEHHHHHHSG---GGCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC
T ss_pred CCCcHHHhhhcc---ccCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCCc
Confidence 999999997665 35789999999999999999999999 999999999999999999999999999987765555
Q ss_pred ceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHhhcccccccCCCccCC
Q 010513 345 YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQ 423 (508)
Q Consensus 345 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 423 (508)
.......||+.|+|||++.+..++.++|||||||++|||+| |+.||..... .+.... +.... ....|
T Consensus 156 ~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~------~~~~~~-i~~~~--~~~~p--- 223 (258)
T d1k2pa_ 156 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN------SETAEH-IAQGL--RLYRP--- 223 (258)
T ss_dssp CCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCH------HHHHHH-HHTTC--CCCCC---
T ss_pred eeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCH------HHHHHH-HHhCC--CCCCc---
Confidence 45555779999999999999999999999999999999998 8999974432 222222 22211 11111
Q ss_pred CCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 010513 424 EKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461 (508)
Q Consensus 424 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~ 461 (508)
..++.. +.+++.+||+.||++|||+.+++++|.+
T Consensus 224 -~~~~~~---l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 224 -HLASEK---VYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp -TTCCHH---HHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred -ccccHH---HHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 223344 4457889999999999999999999864
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.7e-53 Score=416.11 Aligned_cols=258 Identities=27% Similarity=0.461 Sum_probs=198.2
Q ss_pred hcCCCCcccceEcccCcEEEEEEEECC-Cc---EEEEEEeecCC-chhHHHHHHHHHHHHccCCCCeeeEeeeeecCCee
Q 010513 183 VSTNGFADENVIGEGGYGIVYHGVLED-NT---NVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHR 257 (508)
Q Consensus 183 ~~~~~~~~~~~LG~G~~g~Vy~~~~~~-~~---~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 257 (508)
+..++|++.+.||+|+||+||+|+++. ++ .||||.+.... ....+.|.+|+++|++++|||||+++|++.+++..
T Consensus 23 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~ 102 (299)
T d1jpaa_ 23 IDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPV 102 (299)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEE
Confidence 344678999999999999999999753 22 48888876543 34456799999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccce
Q 010513 258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK 337 (508)
Q Consensus 258 ~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~ 337 (508)
++|||||++|+|.+++... ...+++..+..++.|+++||+|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 103 ~iv~Ey~~~g~L~~~~~~~---~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~ 176 (299)
T d1jpaa_ 103 MIITEFMENGSLDSFLRQN---DGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSR 176 (299)
T ss_dssp EEEEECCTTEEHHHHHHTT---TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC----
T ss_pred EEEEEecCCCcceeeeccc---cCCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCcccce
Confidence 9999999999999998765 35799999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCcce----ecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHhhccc
Q 010513 338 LLGAERSYV----TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNR 412 (508)
Q Consensus 338 ~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~ 412 (508)
.+....... .....||+.|+|||.+.++.++.++|||||||++|||+| |+.||..... .+.+.......
T Consensus 177 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~------~~~~~~i~~~~ 250 (299)
T d1jpaa_ 177 FLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN------QDVINAIEQDY 250 (299)
T ss_dssp -------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH------HHHHHHHHTTC
T ss_pred EccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCH------HHHHHHHHcCC
Confidence 765433221 122467999999999999999999999999999999998 8999974432 22222222211
Q ss_pred ccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010513 413 NAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (508)
Q Consensus 413 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~~ 462 (508)
+ +.. ...++.. +.+++.+||+.||++||++.||++.|+..
T Consensus 251 ~------~~~-~~~~~~~---l~~li~~cl~~~P~~RPs~~ei~~~L~~~ 290 (299)
T d1jpaa_ 251 R------LPP-PMDCPSA---LHQLMLDCWQKDRNHRPKFGQIVNTLDKM 290 (299)
T ss_dssp C------CCC-CTTCCHH---HHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred C------CCC-CccchHH---HHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 1 111 1123344 44588899999999999999999999753
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=3.3e-52 Score=418.34 Aligned_cols=257 Identities=21% Similarity=0.351 Sum_probs=212.1
Q ss_pred CCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCchhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEEec
Q 010513 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYI 264 (508)
Q Consensus 186 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~ 264 (508)
++|++.+.||+|+||+||+|++. +|+.||||++........+.+.+|+++|++++|||||++++++.+++..|+|||||
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 105 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 105 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 48999999999999999999975 68899999998776666778999999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEc--CCCCeEEeeeccceecCCC
Q 010513 265 DNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLD--KQWNPKLSDFGLAKLLGAE 342 (508)
Q Consensus 265 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~--~~~~~kL~DFG~a~~~~~~ 342 (508)
++|+|.+++... ...+++..++.++.||+.||+|||++ +|+||||||+|||++ .++.+||+|||+++.+...
T Consensus 106 ~gg~L~~~l~~~---~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~ 179 (350)
T d1koaa2 106 SGGELFEKVADE---HNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 179 (350)
T ss_dssp CSCBHHHHHTCT---TSCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred CCCCHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheecccc
Confidence 999999999654 35799999999999999999999999 999999999999995 4678999999999987543
Q ss_pred CcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCCccC
Q 010513 343 RSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRL 422 (508)
Q Consensus 343 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 422 (508)
.. ....+||+.|+|||++.+..|+.++|||||||++|||++|+.||...+ ..+.+....... . .+
T Consensus 180 ~~--~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~------~~~~~~~i~~~~-~------~~ 244 (350)
T d1koaa2 180 QS--VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN------DDETLRNVKSCD-W------NM 244 (350)
T ss_dssp SC--EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHTC-C------CS
T ss_pred cc--cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCC------HHHHHHHHHhCC-C------CC
Confidence 32 345689999999999999999999999999999999999999996432 222222222211 0 11
Q ss_pred CCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--HhcCC
Q 010513 423 QEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM--LEAEE 463 (508)
Q Consensus 423 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--Le~~~ 463 (508)
..........++.+++.+||+.||++|||++|++++ +....
T Consensus 245 ~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~ 287 (350)
T d1koaa2 245 DDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGN 287 (350)
T ss_dssp CCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTT
T ss_pred CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence 111112223345568889999999999999999986 54443
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-52 Score=404.34 Aligned_cols=246 Identities=24% Similarity=0.401 Sum_probs=196.6
Q ss_pred CcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCC--chhHHHHHHHHHHHHccCCCCeeeEeeeeec----CCeeEEE
Q 010513 188 FADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE----GAHRMLV 260 (508)
Q Consensus 188 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~----~~~~~lV 260 (508)
|++.++||+|+||+||+|.+. ++..||+|++.... ....+.+.+|+++|++++|||||++++++.+ +..+|+|
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 366788999999999999976 57889999986542 3345678999999999999999999999865 3567899
Q ss_pred EEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eeeccCCCCCEEEc-CCCCeEEeeeccce
Q 010513 261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK--VVHRDIKSSNILLD-KQWNPKLSDFGLAK 337 (508)
Q Consensus 261 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~--iiHrDlkp~NIll~-~~~~~kL~DFG~a~ 337 (508)
|||+++|+|.+++.+. ..+++..++.++.|+++||+|||++ + |+||||||+|||++ +++.+||+|||+++
T Consensus 91 mE~~~~g~L~~~l~~~----~~~~~~~~~~~~~qi~~gl~yLH~~---~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~ 163 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 163 (270)
T ss_dssp EECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred EeCCCCCcHHHHHhcc----ccccHHHHHHHHHHHHHHHHHHHHC---CCCEEeCCcChhhceeeCCCCCEEEeecCcce
Confidence 9999999999999765 5799999999999999999999998 6 99999999999996 57899999999998
Q ss_pred ecCCCCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccC
Q 010513 338 LLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGV 417 (508)
Q Consensus 338 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 417 (508)
..... .....+||+.|+|||++.+ .|+.++|||||||++|||++|+.||..... ..+..+. +....
T Consensus 164 ~~~~~---~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~-----~~~~~~~-i~~~~---- 229 (270)
T d1t4ha_ 164 LKRAS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN-----AAQIYRR-VTSGV---- 229 (270)
T ss_dssp GCCTT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS-----HHHHHHH-HTTTC----
T ss_pred eccCC---ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCccc-----HHHHHHH-HHcCC----
Confidence 64322 2345689999999999865 599999999999999999999999964322 1122222 22111
Q ss_pred CCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 418 LDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 418 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
..+.+... .+. ++.+++.+||+.||++|||+.|++++
T Consensus 230 ~~~~~~~~-~~~---~~~~li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 230 KPASFDKV-AIP---EVKEIIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp CCGGGGGC-CCH---HHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCcccCcc-CCH---HHHHHHHHHccCCHhHCcCHHHHhCC
Confidence 11111111 222 34557889999999999999999864
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-53 Score=413.22 Aligned_cols=248 Identities=22% Similarity=0.313 Sum_probs=202.9
Q ss_pred CCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCC---chhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEE
Q 010513 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY 261 (508)
Q Consensus 186 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 261 (508)
++|++++.||+|+||+||+|++. +++.||||++.+.. ....+.+.+|++++++++||||+++++++.+++..|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 57999999999999999999975 68899999986532 234467889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCC
Q 010513 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA 341 (508)
Q Consensus 262 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 341 (508)
|||++|+|.+++... +.+++..++.++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+|+.+..
T Consensus 88 Ey~~gg~L~~~~~~~----~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~ 160 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKI----GSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP 160 (288)
T ss_dssp CCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred EccCCCCHHHhhhcc----CCCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceeccc
Confidence 999999999998765 5799999999999999999999999 999999999999999999999999999998754
Q ss_pred CCc-ceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCCc
Q 010513 342 ERS-YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDP 420 (508)
Q Consensus 342 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 420 (508)
... ......+||+.|+|||++.+..|+.++|||||||++|||++|+.||...+ ..+....... .. .
T Consensus 161 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~~~~~~~i~~-~~------~ 227 (288)
T d1uu3a_ 161 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN------EYLIFQKIIK-LE------Y 227 (288)
T ss_dssp ---------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHT-TC------C
T ss_pred CCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcC------HHHHHHHHHc-CC------C
Confidence 332 23345689999999999999999999999999999999999999997432 2222222222 11 1
Q ss_pred cCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 010513 421 RLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIH 457 (508)
Q Consensus 421 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 457 (508)
.+... .+ .++.+++.+||+.||++|||++|+++
T Consensus 228 ~~p~~-~s---~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 228 DFPEK-FF---PKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp CCCTT-CC---HHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred CCCcc-CC---HHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 11111 22 34455888999999999999998754
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-53 Score=420.26 Aligned_cols=262 Identities=26% Similarity=0.421 Sum_probs=209.3
Q ss_pred HhhcCCCCcccceEcccCcEEEEEEEECC-C-----cEEEEEEeecC-CchhHHHHHHHHHHHHcc-CCCCeeeEeeeee
Q 010513 181 LEVSTNGFADENVIGEGGYGIVYHGVLED-N-----TNVAVKNLLNN-RGQAEKEFKVEVEAIGRV-RHKNLVRLLGYCA 252 (508)
Q Consensus 181 ~~~~~~~~~~~~~LG~G~~g~Vy~~~~~~-~-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~ 252 (508)
+++..++|++.+.||+|+||+||+|++.. + ..||+|.+... .......+.+|+.++.++ +|||||++++++.
T Consensus 32 wei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~ 111 (325)
T d1rjba_ 32 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT 111 (325)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEe
Confidence 46777899999999999999999999653 2 25899988654 333456788999999998 8999999999999
Q ss_pred cCCeeEEEEEecCCCCHHHHhccCCC-------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeec
Q 010513 253 EGAHRMLVYEYIDNGNLEQWLHGDVG-------------------PHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHR 313 (508)
Q Consensus 253 ~~~~~~lV~e~~~~g~L~~~l~~~~~-------------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHr 313 (508)
+.+..|+|||||++|+|.++|+.... ....+++..++.++.|+++||+|||++ +|+||
T Consensus 112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHR 188 (325)
T d1rjba_ 112 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHR 188 (325)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEET
T ss_pred eCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---Ceeec
Confidence 99999999999999999999976532 124589999999999999999999999 99999
Q ss_pred cCCCCCEEEcCCCCeEEeeeccceecCCCCcc-eecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHh-CCCCCC
Q 010513 314 DIKSSNILLDKQWNPKLSDFGLAKLLGAERSY-VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVD 391 (508)
Q Consensus 314 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~Pf~ 391 (508)
||||+|||++.++.+||+|||+|+........ ......||+.|+|||++.++.|+.++|||||||++|||+| |+.||.
T Consensus 189 DlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~ 268 (325)
T d1rjba_ 189 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 268 (325)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred cCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCC
Confidence 99999999999999999999999876544332 3345679999999999999999999999999999999998 899997
Q ss_pred CCCCCCcchHHHHHHHhhcccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 010513 392 YSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 460 (508)
Q Consensus 392 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le 460 (508)
..... ..+ ...+..+. .+... ..++. ++.+++.+||+.||++|||++||+++|.
T Consensus 269 ~~~~~--~~~----~~~~~~~~-----~~~~p-~~~~~---~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 269 GIPVD--ANF----YKLIQNGF-----KMDQP-FYATE---EIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp TCCCS--HHH----HHHHHTTC-----CCCCC-TTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCHH--HHH----HHHHhcCC-----CCCCC-CcCCH---HHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 54332 111 22222211 11111 12333 4455888999999999999999999985
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.2e-52 Score=414.36 Aligned_cols=252 Identities=21% Similarity=0.321 Sum_probs=190.0
Q ss_pred CCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCc-hhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEE
Q 010513 185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE 262 (508)
Q Consensus 185 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e 262 (508)
.+.|++.+.||+|+||+||+|+++ +++.||||.+.+... ...+.+.+|+++|++++|||||++++++.+++..|+|||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 467999999999999999999976 588899999865432 334567889999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEc---CCCCeEEeeeccceec
Q 010513 263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLD---KQWNPKLSDFGLAKLL 339 (508)
Q Consensus 263 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~---~~~~~kL~DFG~a~~~ 339 (508)
||+||+|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+|||+. +++.+||+|||+++..
T Consensus 88 ~~~gg~L~~~l~~~----~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~ 160 (307)
T d1a06a_ 88 LVSGGELFDRIVEK----GFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME 160 (307)
T ss_dssp CCCSCBHHHHHHTC----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred ccCCCcHHHhhhcc----cCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEEc
Confidence 99999999999764 5799999999999999999999999 999999999999994 5789999999999865
Q ss_pred CCCCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCC
Q 010513 340 GAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLD 419 (508)
Q Consensus 340 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 419 (508)
.... .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||.... ..+......... . ..+
T Consensus 161 ~~~~--~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~~~~~~~i~~~~-~--~~~ 229 (307)
T d1a06a_ 161 DPGS--VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEN------DAKLFEQILKAE-Y--EFD 229 (307)
T ss_dssp --------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS------HHHHHHHHHTTC-C--CCC
T ss_pred cCCC--eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCC------HHHHHHHHhccC-C--CCC
Confidence 4332 2345689999999999999999999999999999999999999996432 112222222111 1 011
Q ss_pred ccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 420 PRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 420 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
... .+....++.+++.+||+.||++|||+.|++++
T Consensus 230 ~~~----~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 230 SPY----WDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp TTT----TTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred Ccc----ccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 111 11122345558889999999999999999985
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-52 Score=408.01 Aligned_cols=262 Identities=26% Similarity=0.387 Sum_probs=205.8
Q ss_pred HhhcCCCCcccceEcccCcEEEEEEEECCCcEEEEEEeecCCchhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEE
Q 010513 181 LEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLV 260 (508)
Q Consensus 181 ~~~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 260 (508)
+++..++|++++.||+|+||+||+|+++++++||||++.... ...+.|.+|+.++++++|||||++++++.+ +..++|
T Consensus 12 ~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv 89 (285)
T d1fmka3 12 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV 89 (285)
T ss_dssp SBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred eEcCHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEE
Confidence 456778999999999999999999999988899999986543 445789999999999999999999999865 568899
Q ss_pred EEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecC
Q 010513 261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG 340 (508)
Q Consensus 261 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 340 (508)
|||+++|+|..++.... ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++++||+|||+++...
T Consensus 90 ~Ey~~~g~l~~~~~~~~--~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~ 164 (285)
T d1fmka3 90 TEYMSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIE 164 (285)
T ss_dssp ECCCTTCBHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC---
T ss_pred EEecCCCchhhhhhhcc--cccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhcc
Confidence 99999999999986542 24689999999999999999999999 99999999999999999999999999999775
Q ss_pred CCCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCCc
Q 010513 341 AERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDP 420 (508)
Q Consensus 341 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 420 (508)
...........||+.|+|||++.++.++.++|||||||++|||++|..||..... ..+.+....... .+
T Consensus 165 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~-----~~~~~~~i~~~~------~~ 233 (285)
T d1fmka3 165 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV-----NREVLDQVERGY------RM 233 (285)
T ss_dssp -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC-----HHHHHHHHHTTC------CC
T ss_pred CCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCC-----HHHHHHHHHhcC------CC
Confidence 5554455557899999999999999999999999999999999997666543221 122222222111 11
Q ss_pred cCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCC
Q 010513 421 RLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEEF 464 (508)
Q Consensus 421 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~~~~ 464 (508)
... ..++.. +.+++.+||+.||++||++.+|+++|+..-.
T Consensus 234 ~~~-~~~~~~---l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~ 273 (285)
T d1fmka3 234 PCP-PECPES---LHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 273 (285)
T ss_dssp CCC-TTSCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred CCC-cccCHH---HHHHHHHHcccCHhHCcCHHHHHHHHhhhhc
Confidence 111 123344 4457889999999999999999999987543
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-52 Score=407.59 Aligned_cols=257 Identities=26% Similarity=0.458 Sum_probs=207.6
Q ss_pred hcCCCCcccce-EcccCcEEEEEEEEC---CCcEEEEEEeecCC-chhHHHHHHHHHHHHccCCCCeeeEeeeeecCCee
Q 010513 183 VSTNGFADENV-IGEGGYGIVYHGVLE---DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHR 257 (508)
Q Consensus 183 ~~~~~~~~~~~-LG~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 257 (508)
+..++|.+.+. ||+|+||+||+|.++ ++..||||.+.... ....+.|.+|+++|++++|||||++++++.+ +..
T Consensus 5 l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~ 83 (285)
T d1u59a_ 5 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EAL 83 (285)
T ss_dssp CCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSE
T ss_pred ecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeE
Confidence 44567777774 999999999999864 34579999986543 3445789999999999999999999999975 468
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccce
Q 010513 258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK 337 (508)
Q Consensus 258 ~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~ 337 (508)
|+|||||++|+|.+++... ...+++..+..++.|+++||+|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 84 ~lvmE~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~ 157 (285)
T d1u59a_ 84 MLVMEMAGGGPLHKFLVGK---REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSK 157 (285)
T ss_dssp EEEEECCTTEEHHHHHTTC---TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEEeCCCCcHHHHhhcc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhh
Confidence 8999999999999998654 35799999999999999999999999 99999999999999999999999999999
Q ss_pred ecCCCCcce--ecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHhhccccc
Q 010513 338 LLGAERSYV--TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNA 414 (508)
Q Consensus 338 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 414 (508)
.+....... .....||+.|+|||++.++.++.++|||||||++|||+| |+.||...... .... .+..+.
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~---~~~~----~i~~~~- 229 (285)
T d1u59a_ 158 ALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---EVMA----FIEQGK- 229 (285)
T ss_dssp ECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH---HHHH----HHHTTC-
T ss_pred cccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH---HHHH----HHHcCC-
Confidence 875543322 234578999999999999999999999999999999998 99999754321 2222 122211
Q ss_pred ccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010513 415 EGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (508)
Q Consensus 415 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~~ 462 (508)
.+... ..++.. +.+++.+||+.||++||++.+|++.|+..
T Consensus 230 ----~~~~p-~~~~~~---l~~li~~cl~~~p~~RPs~~~i~~~L~~~ 269 (285)
T d1u59a_ 230 ----RMECP-PECPPE---LYALMSDCWIYKWEDRPDFLTVEQRMRAC 269 (285)
T ss_dssp ----CCCCC-TTCCHH---HHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----CCCCC-CcCCHH---HHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 11111 123344 44588899999999999999999998754
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=6.2e-52 Score=416.62 Aligned_cols=255 Identities=21% Similarity=0.302 Sum_probs=210.7
Q ss_pred CCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCchhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEEec
Q 010513 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYI 264 (508)
Q Consensus 186 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~ 264 (508)
++|++.+.||+|+||+||+|.+. +|+.||||++........+.+.+|+++|++++|||||+++++|.+++.+|+|||||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 108 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 108 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 47999999999999999999975 68899999997776666678889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEc--CCCCeEEeeeccceecCCC
Q 010513 265 DNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLD--KQWNPKLSDFGLAKLLGAE 342 (508)
Q Consensus 265 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~--~~~~~kL~DFG~a~~~~~~ 342 (508)
++|+|.+++... ...+++..++.++.||+.||+|||++ +|+||||||+|||++ .++.+||+|||+|+.+...
T Consensus 109 ~gg~L~~~~~~~---~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~ 182 (352)
T d1koba_ 109 SGGELFDRIAAE---DYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 182 (352)
T ss_dssp CCCBHHHHTTCT---TCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCChHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecCCC
Confidence 999999988665 35799999999999999999999999 999999999999997 6789999999999987543
Q ss_pred CcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCCccC
Q 010513 343 RSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRL 422 (508)
Q Consensus 343 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 422 (508)
. ......||+.|+|||++.+..|+.++|||||||++|||+||+.||.... ..+.+....... . .+
T Consensus 183 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~------~~~~~~~i~~~~-~------~~ 247 (352)
T d1koba_ 183 E--IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED------DLETLQNVKRCD-W------EF 247 (352)
T ss_dssp S--CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS------HHHHHHHHHHCC-C------CC
T ss_pred C--ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC------HHHHHHHHHhCC-C------CC
Confidence 3 2344689999999999999999999999999999999999999996432 122222222211 0 11
Q ss_pred CCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--Hhc
Q 010513 423 QEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM--LEA 461 (508)
Q Consensus 423 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--Le~ 461 (508)
.....+....++.+++.+||+.||++|||+.|++++ +++
T Consensus 248 ~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~ 288 (352)
T d1koba_ 248 DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKG 288 (352)
T ss_dssp CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSS
T ss_pred CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCC
Confidence 111111222345558889999999999999999985 544
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-51 Score=403.20 Aligned_cols=260 Identities=27% Similarity=0.483 Sum_probs=201.3
Q ss_pred hhcCCCCcccceEcccCcEEEEEEEECCC-----cEEEEEEeecCCc-hhHHHHHHHHHHHHccCCCCeeeEeeeeecCC
Q 010513 182 EVSTNGFADENVIGEGGYGIVYHGVLEDN-----TNVAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGA 255 (508)
Q Consensus 182 ~~~~~~~~~~~~LG~G~~g~Vy~~~~~~~-----~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~ 255 (508)
++..+.|+..++||+|+||+||+|.++++ ..||||++..... ....+|.+|++++++++|||||+++|++.+..
T Consensus 3 ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~ 82 (283)
T d1mqba_ 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYK 82 (283)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred cCCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCC
Confidence 34556789999999999999999997642 3699999865433 34457899999999999999999999999999
Q ss_pred eeEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeecc
Q 010513 256 HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGL 335 (508)
Q Consensus 256 ~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~ 335 (508)
..++||||+.+|++.+++... ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 83 ~~~~v~e~~~~~~l~~~~~~~---~~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGl 156 (283)
T d1mqba_ 83 PMMIITEYMENGALDKFLREK---DGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGL 156 (283)
T ss_dssp SEEEEEECCTTEEHHHHHHHT---TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred ceEEEEEecccCcchhhhhcc---cccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccch
Confidence 999999999999999988765 35799999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCc--ceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccc
Q 010513 336 AKLLGAERS--YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRN 413 (508)
Q Consensus 336 a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 413 (508)
++....... .......||+.|+|||++.++.++.++|||||||++|||++|..||..... ..+.+... ..+
T Consensus 157 a~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~-----~~~~~~~i-~~~- 229 (283)
T d1mqba_ 157 SRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS-----NHEVMKAI-NDG- 229 (283)
T ss_dssp -----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-----HHHHHHHH-HTT-
T ss_pred hhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCC-----HHHHHHHH-hcc-
Confidence 987644322 223345789999999999999999999999999999999997666543221 12222222 211
Q ss_pred cccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010513 414 AEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (508)
Q Consensus 414 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~~ 462 (508)
..+.... .++. ++.+++.+||+.||++||++.||+++|+..
T Consensus 230 ----~~~~~~~-~~~~---~l~~li~~cl~~~p~~RPt~~eil~~L~~l 270 (283)
T d1mqba_ 230 ----FRLPTPM-DCPS---AIYQLMMQCWQQERARRPKFADIVSILDKL 270 (283)
T ss_dssp ----CCCCCCT-TCBH---HHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred ----CCCCCch-hhHH---HHHHHHHHHCcCCHhHCcCHHHHHHHHHHH
Confidence 1111111 1333 345588899999999999999999999753
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1e-51 Score=407.88 Aligned_cols=245 Identities=27% Similarity=0.382 Sum_probs=201.4
Q ss_pred CCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCc---hhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEE
Q 010513 187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG---QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE 262 (508)
Q Consensus 187 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e 262 (508)
.|+..+.||+|+||+||+|++. +++.||||++..... ...+.+.+|+++|++++|||||++++++.+++..|+|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 5899999999999999999975 678899999865532 334578899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCC
Q 010513 263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE 342 (508)
Q Consensus 263 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 342 (508)
||.+|+|..++... ..+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 96 ~~~~g~l~~~~~~~----~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~ 168 (309)
T d1u5ra_ 96 YCLGSASDLLEVHK----KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (309)
T ss_dssp CCSEEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred ecCCCchHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCCC
Confidence 99999998776554 5799999999999999999999999 9999999999999999999999999999865332
Q ss_pred CcceecceecCCCCCChhhhhc---CCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCC
Q 010513 343 RSYVTTRVMGTFGYVAPEYAST---GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLD 419 (508)
Q Consensus 343 ~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 419 (508)
...+||+.|+|||++.+ +.|+.++|||||||++|||++|+.||.... ..+.+....... .
T Consensus 169 -----~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~------~~~~~~~i~~~~------~ 231 (309)
T d1u5ra_ 169 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN------AMSALYHIAQNE------S 231 (309)
T ss_dssp -----CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC------HHHHHHHHHHSC------C
T ss_pred -----CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCC------HHHHHHHHHhCC------C
Confidence 34579999999999864 468999999999999999999999996432 222222222221 1
Q ss_pred ccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 420 PRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 420 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
+.+.....+.. +.+++.+||+.||++|||+.|++++
T Consensus 232 ~~~~~~~~s~~---~~~li~~~L~~dP~~Rpt~~ell~H 267 (309)
T d1u5ra_ 232 PALQSGHWSEY---FRNFVDSCLQKIPQDRPTSEVLLKH 267 (309)
T ss_dssp CCCSCTTSCHH---HHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred CCCCCCCCCHH---HHHHHHHHCcCChhHCcCHHHHHhC
Confidence 12222223444 4457779999999999999999873
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-51 Score=403.14 Aligned_cols=252 Identities=22% Similarity=0.311 Sum_probs=206.4
Q ss_pred CCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCc------hhHHHHHHHHHHHHccCCCCeeeEeeeeecCCee
Q 010513 185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG------QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHR 257 (508)
Q Consensus 185 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 257 (508)
.++|++.+.||+|+||+||+|+++ +|+.||||++.+... ...+.+.+|+++|++++|||||+++++|.+.+..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 357999999999999999999975 688999999864322 2357899999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCC----CeEEeee
Q 010513 258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQW----NPKLSDF 333 (508)
Q Consensus 258 ~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~----~~kL~DF 333 (508)
|+|||||++|+|.+++... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++ .+||+||
T Consensus 89 ~iv~E~~~gg~L~~~i~~~----~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~Df 161 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEK----ESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDF 161 (293)
T ss_dssp EEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEEcCCCccccchhccc----cccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecch
Confidence 9999999999999999765 4799999999999999999999999 999999999999998776 4999999
Q ss_pred ccceecCCCCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccc
Q 010513 334 GLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRN 413 (508)
Q Consensus 334 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 413 (508)
|++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+ ..+.+.......
T Consensus 162 G~a~~~~~~~--~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~~~~~~~i~~~~- 232 (293)
T d1jksa_ 162 GLAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT------KQETLANVSAVN- 232 (293)
T ss_dssp TTCEECTTSC--BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHTTC-
T ss_pred hhhhhcCCCc--cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCC------HHHHHHHHHhcC-
Confidence 9998764432 2344679999999999999999999999999999999999999997432 122222222111
Q ss_pred cccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 414 AEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 414 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
..+.....+....++.+++.+||+.||++|||++|++++
T Consensus 233 ------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 233 ------YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp ------CCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ------CCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 011111111123345568889999999999999999874
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-51 Score=399.82 Aligned_cols=246 Identities=28% Similarity=0.447 Sum_probs=197.0
Q ss_pred ceEcccCcEEEEEEEECC---CcEEEEEEeecCC--chhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEEecCC
Q 010513 192 NVIGEGGYGIVYHGVLED---NTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDN 266 (508)
Q Consensus 192 ~~LG~G~~g~Vy~~~~~~---~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~ 266 (508)
++||+|+||+||+|.+.+ ++.||||++.... ....+.|.+|+++|++++|||||+++++|.+ +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 579999999999998643 4579999986532 3345679999999999999999999999965 457899999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCCCcce
Q 010513 267 GNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYV 346 (508)
Q Consensus 267 g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~ 346 (508)
|+|.+++... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.+.......
T Consensus 92 g~L~~~l~~~----~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 164 (277)
T d1xbba_ 92 GPLNKYLQQN----RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 164 (277)
T ss_dssp EEHHHHHHHC----TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred CcHHHHHhhc----cCCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhcccccccc
Confidence 9999999865 5799999999999999999999999 99999999999999999999999999999775443332
Q ss_pred --ecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHhhcccccccCCCccCC
Q 010513 347 --TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQ 423 (508)
Q Consensus 347 --~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 423 (508)
.....||+.|+|||.+.+..++.++|||||||++|||+| |+.||..... .+.. ..+..+. .+...
T Consensus 165 ~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~------~~~~-~~i~~~~-----~~~~p 232 (277)
T d1xbba_ 165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG------SEVT-AMLEKGE-----RMGCP 232 (277)
T ss_dssp EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH------HHHH-HHHHTTC-----CCCCC
T ss_pred ccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCH------HHHH-HHHHcCC-----CCCCC
Confidence 234578999999999999999999999999999999998 8999975421 1211 1222211 11111
Q ss_pred CCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 010513 424 EKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461 (508)
Q Consensus 424 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~ 461 (508)
..++.. +.+++.+||+.||++||++++|++.|+.
T Consensus 233 -~~~~~~---~~~li~~cl~~dp~~RPs~~~i~~~L~~ 266 (277)
T d1xbba_ 233 -AGCPRE---MYDLMNLCWTYDVENRPGFAAVELRLRN 266 (277)
T ss_dssp -TTCCHH---HHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred -cccCHH---HHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence 123444 4458889999999999999999998864
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-51 Score=409.02 Aligned_cols=250 Identities=24% Similarity=0.276 Sum_probs=207.6
Q ss_pred cCCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCC---chhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEE
Q 010513 184 STNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRML 259 (508)
Q Consensus 184 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 259 (508)
..++|++++.||+|+||+||+|+.+ +|+.||||++.+.. ....+.+.+|+++|+.++||||++++++|.+++.+|+
T Consensus 3 ~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~i 82 (337)
T d1o6la_ 3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCF 82 (337)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEE
T ss_pred chHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecccccccc
Confidence 3467999999999999999999975 68999999996542 2345678899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceec
Q 010513 260 VYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL 339 (508)
Q Consensus 260 V~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~ 339 (508)
|||||++|+|.+++... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.+|.+||+|||+|+..
T Consensus 83 v~ey~~gg~L~~~~~~~----~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~ 155 (337)
T d1o6la_ 83 VMEYANGGELFFHLSRE----RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEG 155 (337)
T ss_dssp EEECCTTCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred ceeccCCCchhhhhhcc----cCCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeeccccccc
Confidence 99999999999999875 5789999999999999999999999 9999999999999999999999999999865
Q ss_pred CCCCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCC
Q 010513 340 GAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLD 419 (508)
Q Consensus 340 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 419 (508)
... .......+||+.|+|||++.+..|+.++|||||||++|||++|+.||...+. .+........ .
T Consensus 156 ~~~-~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~------~~~~~~i~~~-~------ 221 (337)
T d1o6la_ 156 ISD-GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH------ERLFELILME-E------ 221 (337)
T ss_dssp CCT-TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHC-C------
T ss_pred ccC-CcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCH------HHHHHHHhcC-C------
Confidence 432 2334557899999999999999999999999999999999999999975432 2222222221 1
Q ss_pred ccCCCCchHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 010513 420 PRLQEKPCSRALKRALLVALRCVDPNAHKRPK-----MGHVIHM 458 (508)
Q Consensus 420 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~ 458 (508)
..+... .+. ++.+++.+||++||++||+ +.|++++
T Consensus 222 ~~~p~~-~s~---~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 222 IRFPRT-LSP---EAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp CCCCTT-SCH---HHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred CCCCcc-CCH---HHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence 111111 223 3455888999999999995 8888864
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-52 Score=405.22 Aligned_cols=258 Identities=22% Similarity=0.387 Sum_probs=198.1
Q ss_pred HhhcCCCCcccceEcccCcEEEEEEEECC----CcEEEEEEeecCCc-hhHHHHHHHHHHHHccCCCCeeeEeeeeecCC
Q 010513 181 LEVSTNGFADENVIGEGGYGIVYHGVLED----NTNVAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGA 255 (508)
Q Consensus 181 ~~~~~~~~~~~~~LG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~ 255 (508)
+++..++|++.+.||+|+||+||+|++.. +..||||.+..... ...+.+.+|++++++++|||||++++++.+ +
T Consensus 2 ~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~ 80 (273)
T d1mp8a_ 2 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-N 80 (273)
T ss_dssp CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-S
T ss_pred CCcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-C
Confidence 46777899999999999999999998753 34588888855433 345679999999999999999999999964 6
Q ss_pred eeEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeecc
Q 010513 256 HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGL 335 (508)
Q Consensus 256 ~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~ 335 (508)
..|+||||+++|+|.+++... ...+++..++.++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 81 ~~~iv~E~~~~g~l~~~~~~~---~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~ 154 (273)
T d1mp8a_ 81 PVWIIMELCTLGELRSFLQVR---KYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGL 154 (273)
T ss_dssp SCEEEEECCTTEEHHHHHHHT---TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC---
T ss_pred eEEEEEEeccCCcHHhhhhcc---CCCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchh
Confidence 789999999999999988765 35789999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHhhccccc
Q 010513 336 AKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNA 414 (508)
Q Consensus 336 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 414 (508)
++..........+...||+.|+|||++.+..|+.++|||||||++|||+| |..||...... .+.. ... ....
T Consensus 155 a~~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~---~~~~---~i~-~~~~ 227 (273)
T d1mp8a_ 155 SRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN---DVIG---RIE-NGER 227 (273)
T ss_dssp ----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---GHHH---HHH-TTCC
T ss_pred heeccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHH---HHHH---HHH-cCCC
Confidence 99776555555556788999999999999999999999999999999998 89999765432 2222 111 1111
Q ss_pred ccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 010513 415 EGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461 (508)
Q Consensus 415 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~ 461 (508)
+... ..++.. +.+++.+||+.||++|||+.||+++|+.
T Consensus 228 -----~~~~-~~~~~~---~~~li~~cl~~dp~~Rps~~ei~~~L~~ 265 (273)
T d1mp8a_ 228 -----LPMP-PNCPPT---LYSLMTKCWAYDPSRRPRFTELKAQLST 265 (273)
T ss_dssp -----CCCC-TTCCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -----CCCC-CCCCHH---HHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 1111 123333 4457889999999999999999999875
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.7e-50 Score=400.59 Aligned_cols=245 Identities=26% Similarity=0.352 Sum_probs=204.6
Q ss_pred CCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecC---CchhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEE
Q 010513 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN---RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY 261 (508)
Q Consensus 186 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 261 (508)
++|++.+.||+|+||+||+|+++ +|+.||||++.+. .....+.+.+|+.+++.++|||||++++++.+++..|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 46999999999999999999975 5889999998653 2234567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCC
Q 010513 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA 341 (508)
Q Consensus 262 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 341 (508)
|||+||+|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.+|.+||+|||+++....
T Consensus 84 E~~~gg~l~~~~~~~----~~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~ 156 (316)
T d1fota_ 84 DYIEGGELFSLLRKS----QRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD 156 (316)
T ss_dssp CCCCSCBHHHHHHHT----SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred eecCCcccccccccc----ccccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEecc
Confidence 999999999998775 5688999999999999999999999 999999999999999999999999999997643
Q ss_pred CCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCCcc
Q 010513 342 ERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPR 421 (508)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 421 (508)
. ....+||+.|+|||++.+..|+.++|||||||++|||+||+.||...+ ..+......... ..
T Consensus 157 ~----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~------~~~~~~~i~~~~-------~~ 219 (316)
T d1fota_ 157 V----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN------TMKTYEKILNAE-------LR 219 (316)
T ss_dssp C----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS------HHHHHHHHHHCC-------CC
T ss_pred c----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcC------HHHHHHHHHcCC-------CC
Confidence 2 234689999999999999999999999999999999999999997432 222222222211 01
Q ss_pred CCCCchHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 010513 422 LQEKPCSRALKRALLVALRCVDPNAHKRP-----KMGHVIHM 458 (508)
Q Consensus 422 l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 458 (508)
+.. ..+. ++.+++.+||+.||++|+ ++++++++
T Consensus 220 ~p~-~~s~---~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 220 FPP-FFNE---DVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp CCT-TSCH---HHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred CCC-CCCH---HHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 111 1223 344577799999999996 89999864
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=9.9e-51 Score=400.21 Aligned_cols=266 Identities=26% Similarity=0.400 Sum_probs=213.7
Q ss_pred hhhHhhcCCCCcccceEcccCcEEEEEEEEC------CCcEEEEEEeecCCc-hhHHHHHHHHHHHHccCCCCeeeEeee
Q 010513 178 LRELEVSTNGFADENVIGEGGYGIVYHGVLE------DNTNVAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNLVRLLGY 250 (508)
Q Consensus 178 ~~~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~ 250 (508)
+.+++++.++|++.+.||+|+||+||+|+++ +++.||||++..... +..++|.+|++++++++||||++++++
T Consensus 5 ~~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~ 84 (301)
T d1lufa_ 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGV 84 (301)
T ss_dssp HHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred hhhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceee
Confidence 5678889999999999999999999999964 346799999865443 345679999999999999999999999
Q ss_pred eecCCeeEEEEEecCCCCHHHHhccCC--------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 010513 251 CAEGAHRMLVYEYIDNGNLEQWLHGDV--------------------GPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKV 310 (508)
Q Consensus 251 ~~~~~~~~lV~e~~~~g~L~~~l~~~~--------------------~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i 310 (508)
+.+....++||||+++|+|.++++... .....+++..++.++.|++.||+|||++ +|
T Consensus 85 ~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~i 161 (301)
T d1lufa_ 85 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KF 161 (301)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TC
T ss_pred eccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---Ce
Confidence 999999999999999999999996532 1123589999999999999999999999 99
Q ss_pred eeccCCCCCEEEcCCCCeEEeeeccceecCCCCcc-eecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCC-C
Q 010513 311 VHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSY-VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGR-N 388 (508)
Q Consensus 311 iHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~-~ 388 (508)
+||||||+|||++.++.+||+|||+++........ ..+...||+.|+|||.+.+..|+.++|||||||++|||++|. .
T Consensus 162 vHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~ 241 (301)
T d1lufa_ 162 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241 (301)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred EeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCC
Confidence 99999999999999999999999999876443322 334567899999999999999999999999999999999986 5
Q ss_pred CCCCCCCCCcchHHHHHHHhhcccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010513 389 PVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (508)
Q Consensus 389 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~~ 462 (508)
||.... ..+.+... ..+.. +... +.++. ++.+++.+||+.||++||||.||+++|+..
T Consensus 242 p~~~~~------~~e~~~~v-~~~~~-----~~~p-~~~~~---~~~~li~~cl~~~P~~RPt~~ev~~~L~~i 299 (301)
T d1lufa_ 242 PYYGMA------HEEVIYYV-RDGNI-----LACP-ENCPL---ELYNLMRLCWSKLPADRPSFCSIHRILQRM 299 (301)
T ss_dssp TTTTSC------HHHHHHHH-HTTCC-----CCCC-TTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred CCCCCC------HHHHHHHH-HcCCC-----CCCC-ccchH---HHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 675332 22222222 22211 1111 11233 455688899999999999999999999864
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=5.8e-50 Score=390.11 Aligned_cols=257 Identities=25% Similarity=0.372 Sum_probs=200.9
Q ss_pred CCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCc---hhHHHHHHHHHHHHccCCCCeeeEeeeeecCC----e
Q 010513 185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG---QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGA----H 256 (508)
Q Consensus 185 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~----~ 256 (508)
.++|++.+.||+|+||+||+|++. +|+.||||++..... ...+.+.+|+++++.++|||||++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 468999999999999999999975 688999999965432 33457899999999999999999999987644 3
Q ss_pred eEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccc
Q 010513 257 RMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLA 336 (508)
Q Consensus 257 ~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a 336 (508)
.|+||||++||+|.+++... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++..+++|||.+
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~----~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~ 158 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTE----GPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIA 158 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTC
T ss_pred EEEEEECCCCCEehhhhccc----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhh
Confidence 78999999999999998765 5799999999999999999999999 9999999999999999999999999998
Q ss_pred eecCCCCc--ceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhccccc
Q 010513 337 KLLGAERS--YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNA 414 (508)
Q Consensus 337 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 414 (508)
........ ......+||+.|+|||++.+..++.++|||||||++|||+||+.||.... ..+.+........
T Consensus 159 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~------~~~~~~~~~~~~~- 231 (277)
T d1o6ya_ 159 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS------PVSVAYQHVREDP- 231 (277)
T ss_dssp EECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS------HHHHHHHHHHCCC-
T ss_pred hhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcC------HHHHHHHHHhcCC-
Confidence 76543222 23345689999999999999999999999999999999999999997432 2233333333221
Q ss_pred ccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCC-CHHHHHHHHhc
Q 010513 415 EGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRP-KMGHVIHMLEA 461 (508)
Q Consensus 415 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~Le~ 461 (508)
..+.......+.. +.+++.+||+.||++|| +++++++.|..
T Consensus 232 ---~~~~~~~~~~s~~---l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 232 ---IPPSARHEGLSAD---LDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp ---CCGGGTSSSCCHH---HHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred ---CCCchhccCCCHH---HHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence 1111111223344 44477799999999999 89999988864
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=5.8e-50 Score=389.31 Aligned_cols=252 Identities=22% Similarity=0.329 Sum_probs=204.7
Q ss_pred CCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCch---------hHHHHHHHHHHHHccC-CCCeeeEeeeeec
Q 010513 185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQ---------AEKEFKVEVEAIGRVR-HKNLVRLLGYCAE 253 (508)
Q Consensus 185 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---------~~~~~~~E~~~l~~l~-hpniv~l~~~~~~ 253 (508)
.++|++.+.||+|+||+||+|+.. +++.||||++.+.... ..+.+.+|+.++++++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 468999999999999999999975 6889999998654321 2245788999999997 9999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeee
Q 010513 254 GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDF 333 (508)
Q Consensus 254 ~~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DF 333 (508)
++..|+|||||++|+|.+++... ..+++..++.++.||++||+|||++ +|+||||||+|||++.++.+||+||
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~----~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DF 154 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEK----VTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDF 154 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCC
T ss_pred CcceEEEEEcCCCchHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccc
Confidence 99999999999999999999765 5799999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCcceecceecCCCCCChhhhhc------CCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHH
Q 010513 334 GLAKLLGAERSYVTTRVMGTFGYVAPEYAST------GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKT 407 (508)
Q Consensus 334 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~ 407 (508)
|+++...... ..+..+||+.|+|||.+.+ ..++.++||||+||++|||++|+.||....+ .+..+.
T Consensus 155 G~a~~~~~~~--~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~------~~~~~~ 226 (277)
T d1phka_ 155 GFSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ------MLMLRM 226 (277)
T ss_dssp TTCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHH
T ss_pred hheeEccCCC--ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCH------HHHHHH
Confidence 9999875432 2344689999999998863 3468899999999999999999999974421 122222
Q ss_pred hhcccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 408 MVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 408 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
..... .. ......+....++.+++.+||+.||++||++.|++++
T Consensus 227 i~~~~-~~------~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 227 IMSGN-YQ------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp HHHTC-CC------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred HHhCC-CC------CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 22211 10 1111122233455668889999999999999999764
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-51 Score=395.56 Aligned_cols=252 Identities=28% Similarity=0.425 Sum_probs=198.6
Q ss_pred hhcCCCCcccceEcccCcEEEEEEEECCCcEEEEEEeecCCchhHHHHHHHHHHHHccCCCCeeeEeeeeec-CCeeEEE
Q 010513 182 EVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE-GAHRMLV 260 (508)
Q Consensus 182 ~~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~~lV 260 (508)
++..++|++.+.||+|+||.||+|.++ |+.||||++.+. ...+.+.+|++++++++||||++++|++.+ .+.+|+|
T Consensus 3 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv 79 (262)
T d1byga_ 3 ALNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV 79 (262)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEE
T ss_pred ccCHHHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEE
Confidence 566778999999999999999999986 778999998654 345679999999999999999999999865 4568999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecC
Q 010513 261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG 340 (508)
Q Consensus 261 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 340 (508)
|||+++|+|.+++.... ...+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 80 ~ey~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~ 154 (262)
T d1byga_ 80 TEYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 154 (262)
T ss_dssp ECCCTTEEHHHHHHHHH--HHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred EeccCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecC
Confidence 99999999999996541 23589999999999999999999999 99999999999999999999999999998653
Q ss_pred CCCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHhhcccccccCCC
Q 010513 341 AERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLD 419 (508)
Q Consensus 341 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 419 (508)
.. .....+|+.|+|||++.++.+++++|||||||++|||+| |+.||...... .....+ .++ ..
T Consensus 155 ~~----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~---~~~~~i----~~~-----~~ 218 (262)
T d1byga_ 155 ST----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVPRV----EKG-----YK 218 (262)
T ss_dssp -----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG---GHHHHH----TTT-----CC
T ss_pred CC----CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH---HHHHHH----HcC-----CC
Confidence 32 233568999999999999999999999999999999998 78888654322 222222 111 11
Q ss_pred ccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 010513 420 PRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461 (508)
Q Consensus 420 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~ 461 (508)
+.+.. .++. ++.+++.+||+.||++|||+.+++++|+.
T Consensus 219 ~~~~~-~~~~---~~~~li~~cl~~dP~~Rps~~~l~~~L~~ 256 (262)
T d1byga_ 219 MDAPD-GCPP---AVYEVMKNCWHLDAAMRPSFLQLREQLEH 256 (262)
T ss_dssp CCCCT-TCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCCc-cCCH---HHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence 22221 1333 34457889999999999999999999975
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-50 Score=397.88 Aligned_cols=252 Identities=18% Similarity=0.269 Sum_probs=205.8
Q ss_pred CCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCchhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEEe
Q 010513 185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY 263 (508)
Q Consensus 185 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~ 263 (508)
.++|++.+.||+|+||+||+|.+. +++.||||.+.... .....+.+|+++|+.++|||||+++++|++++.+|+||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 468999999999999999999986 57889999986654 3345688999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcC--CCCeEEeeeccceecCC
Q 010513 264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDK--QWNPKLSDFGLAKLLGA 341 (508)
Q Consensus 264 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~--~~~~kL~DFG~a~~~~~ 341 (508)
|+||+|.+++... ...+++.+++.++.||+.||+|||++ +|+||||||+|||++. ...+||+|||+++....
T Consensus 83 ~~gg~L~~~i~~~---~~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~ 156 (321)
T d1tkia_ 83 ISGLDIFERINTS---AFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156 (321)
T ss_dssp CCCCBHHHHHTSS---SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred CCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhcccc
Confidence 9999999999765 34799999999999999999999999 9999999999999975 45799999999987643
Q ss_pred CCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCCcc
Q 010513 342 ERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPR 421 (508)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 421 (508)
.. ......||+.|+|||.+.+..|+.++|||||||++|+|++|+.||..... .+.+....... ..
T Consensus 157 ~~--~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~------~~~~~~i~~~~-------~~ 221 (321)
T d1tkia_ 157 GD--NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN------QQIIENIMNAE-------YT 221 (321)
T ss_dssp TC--EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHHTC-------CC
T ss_pred CC--cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhCC-------CC
Confidence 32 23446899999999999999999999999999999999999999975431 22222222211 00
Q ss_pred CCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 422 LQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 422 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
+.....+....++.+++.+||+.||++|||+.|++++
T Consensus 222 ~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 222 FDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1110011122345568889999999999999999983
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-50 Score=396.18 Aligned_cols=268 Identities=25% Similarity=0.378 Sum_probs=202.7
Q ss_pred cchhhHhhcCCCCcccceEcccCcEEEEEEEECC------CcEEEEEEeecCC-chhHHHHHHHHHHHHcc-CCCCeeeE
Q 010513 176 YTLRELEVSTNGFADENVIGEGGYGIVYHGVLED------NTNVAVKNLLNNR-GQAEKEFKVEVEAIGRV-RHKNLVRL 247 (508)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~l 247 (508)
|...++++..++|++.+.||+|+||+||+|.+.. ++.||||++.... ....+.+..|...+.++ +|+||+.+
T Consensus 3 ~~~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~ 82 (299)
T d1ywna1 3 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 82 (299)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCCccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEe
Confidence 3567788889999999999999999999999642 3579999986543 33456677888888777 68999999
Q ss_pred eeeeecC-CeeEEEEEecCCCCHHHHhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecc
Q 010513 248 LGYCAEG-AHRMLVYEYIDNGNLEQWLHGDVG------------PHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRD 314 (508)
Q Consensus 248 ~~~~~~~-~~~~lV~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrD 314 (508)
++++.+. ...++|||||++|+|.++++.... ....+++..+..++.|+++||+|||++ +|+|||
T Consensus 83 ~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrD 159 (299)
T d1ywna1 83 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRD 159 (299)
T ss_dssp EEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred eeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCc
Confidence 9987654 468899999999999999975421 134589999999999999999999999 999999
Q ss_pred CCCCCEEEcCCCCeEEeeeccceecCCCCcc-eecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhC-CCCCCC
Q 010513 315 IKSSNILLDKQWNPKLSDFGLAKLLGAERSY-VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISG-RNPVDY 392 (508)
Q Consensus 315 lkp~NIll~~~~~~kL~DFG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg-~~Pf~~ 392 (508)
|||+|||++.++.+||+|||+|+........ ..+...||+.|+|||++.++.++.++|||||||++|||+|| ..||..
T Consensus 160 lKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~ 239 (299)
T d1ywna1 160 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 239 (299)
T ss_dssp CCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999999876443332 33456899999999999999999999999999999999996 467764
Q ss_pred CCCCCcchHHHHHHHhhcccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 010513 393 SRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461 (508)
Q Consensus 393 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~ 461 (508)
.... ......+ ..+. .+... +.++. ++.+++.+||+.||++|||+.|++++|+.
T Consensus 240 ~~~~--~~~~~~~----~~~~-----~~~~~-~~~~~---~l~~li~~cl~~dP~~Rpt~~eil~~L~~ 293 (299)
T d1ywna1 240 VKID--EEFCRRL----KEGT-----RMRAP-DYTTP---EMYQTMLDCWHGEPSQRPTFSELVEHLGN 293 (299)
T ss_dssp CCCS--HHHHHHH----HHTC-----CCCCC-TTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCHH--HHHHHHH----hcCC-----CCCCC-ccCCH---HHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 4322 1122212 1111 11111 11333 45558889999999999999999999975
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=8.1e-50 Score=401.03 Aligned_cols=244 Identities=21% Similarity=0.265 Sum_probs=204.3
Q ss_pred CCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCC---chhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEE
Q 010513 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY 261 (508)
Q Consensus 186 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 261 (508)
++|++++.||+|+||+||+|+++ +|+.||||++.+.. ....+.+.+|+++|+.++|||||++++++.+....++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 57999999999999999999975 68999999986432 233467889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCC
Q 010513 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA 341 (508)
Q Consensus 262 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 341 (508)
||+.+|+|.+++... ..+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++.+..
T Consensus 121 e~~~~g~l~~~l~~~----~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~ 193 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRI----GRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp ECCTTCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred ccccccchhhhHhhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeeccc
Confidence 999999999999765 4799999999999999999999999 999999999999999999999999999997643
Q ss_pred CCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCCcc
Q 010513 342 ERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPR 421 (508)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 421 (508)
. ....+||+.|+|||++.+..|+.++|||||||++|||+||+.||...+ ..+......... +.
T Consensus 194 ~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~------~~~~~~~i~~~~-------~~ 256 (350)
T d1rdqe_ 194 R----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ------PIQIYEKIVSGK-------VR 256 (350)
T ss_dssp C----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHCC-------CC
T ss_pred c----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcC------HHHHHHHHhcCC-------CC
Confidence 2 234689999999999999999999999999999999999999996432 222222222211 01
Q ss_pred CCCCchHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 010513 422 LQEKPCSRALKRALLVALRCVDPNAHKRP-----KMGHVIH 457 (508)
Q Consensus 422 l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 457 (508)
... ..+. ++.+++.+||+.||++|+ +++++++
T Consensus 257 ~p~-~~s~---~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 257 FPS-HFSS---DLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp CCT-TCCH---HHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred CCc-cCCH---HHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 111 1223 345578899999999994 8999986
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2.1e-49 Score=400.12 Aligned_cols=250 Identities=22% Similarity=0.286 Sum_probs=199.6
Q ss_pred CCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCc---hhHHHHH---HHHHHHHccCCCCeeeEeeeeecCCee
Q 010513 185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG---QAEKEFK---VEVEAIGRVRHKNLVRLLGYCAEGAHR 257 (508)
Q Consensus 185 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~---~E~~~l~~l~hpniv~l~~~~~~~~~~ 257 (508)
.++|++.+.||+|+||+||+|++. +|+.||||++.+... .....+. .|+++++.++|||||+++++|.+++..
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 468999999999999999999976 588999999854321 1122233 357778888999999999999999999
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccce
Q 010513 258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK 337 (508)
Q Consensus 258 ~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~ 337 (508)
|+|||||++|+|.+++... ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+
T Consensus 83 ~ivmE~~~gg~L~~~l~~~----~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~ 155 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQH----GVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLAC 155 (364)
T ss_dssp EEEECCCCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCE
T ss_pred EEEEEecCCCcHHHHHHhc----ccccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceee
Confidence 9999999999999999765 5789999999999999999999999 99999999999999999999999999999
Q ss_pred ecCCCCcceecceecCCCCCChhhhhc-CCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhccccccc
Q 010513 338 LLGAERSYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEG 416 (508)
Q Consensus 338 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 416 (508)
.+.... ....+||+.|+|||++.. ..|+.++|||||||++|||+||+.||........ ....+.... .
T Consensus 156 ~~~~~~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~---~~~~~~~~~-~---- 224 (364)
T d1omwa3 156 DFSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK---HEIDRMTLT-M---- 224 (364)
T ss_dssp ECSSSC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCH---HHHHHHSSS-C----
T ss_pred ecCCCc---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHhccc-C----
Confidence 765432 344689999999999865 5689999999999999999999999976543221 111111111 0
Q ss_pred CCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 010513 417 VLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPK-----MGHVIHM 458 (508)
Q Consensus 417 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~ 458 (508)
.+.+. ...+. ++.+++.+||+.||++||+ ++|++++
T Consensus 225 --~~~~~-~~~s~---~~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 225 --AVELP-DSFSP---ELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp --CCCCC-SSSCH---HHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred --CCCCC-CCCCH---HHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence 11111 11233 3455788999999999999 6888763
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-50 Score=399.12 Aligned_cols=254 Identities=27% Similarity=0.457 Sum_probs=200.8
Q ss_pred CCCcccceEcccCcEEEEEEEEC-CCc----EEEEEEeecC-CchhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEE
Q 010513 186 NGFADENVIGEGGYGIVYHGVLE-DNT----NVAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRML 259 (508)
Q Consensus 186 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 259 (508)
++|+++++||+|+||+||+|.+. +|+ +||+|++... .....++|.+|++++++++|||||+++++|.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 47999999999999999999975 343 5888888643 334567899999999999999999999999875 5678
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceec
Q 010513 260 VYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL 339 (508)
Q Consensus 260 V~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~ 339 (508)
+|||+.+|+|.+++... ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 88 v~e~~~~~~l~~~~~~~---~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~ 161 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 161 (317)
T ss_dssp EEECCTTCBHHHHHHHT---SSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHT
T ss_pred EEEeccCCccccccccc---ccCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccceec
Confidence 89999999999988765 46799999999999999999999999 9999999999999999999999999999987
Q ss_pred CCCCcc-eecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHhhcccccccC
Q 010513 340 GAERSY-VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGV 417 (508)
Q Consensus 340 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 417 (508)
...... ......||+.|+|||++.++.|+.++|||||||++|||+| |..||+..... .+...+.. +.
T Consensus 162 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~---~~~~~i~~----~~---- 230 (317)
T d1xkka_ 162 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS---EISSILEK----GE---- 230 (317)
T ss_dssp TTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGG---GHHHHHHH----TC----
T ss_pred ccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHH---HHHHHHHc----CC----
Confidence 544333 2344578999999999999999999999999999999998 88998754322 22222221 11
Q ss_pred CCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010513 418 LDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (508)
Q Consensus 418 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~~ 462 (508)
.+.. ...++.. +.+++.+||+.||++|||+.+++++|+..
T Consensus 231 -~~~~-p~~~~~~---~~~li~~cl~~dP~~RPs~~eil~~l~~~ 270 (317)
T d1xkka_ 231 -RLPQ-PPICTID---VYMIMVKCWMIDADSRPKFRELIIEFSKM 270 (317)
T ss_dssp -CCCC-CTTBCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -CCCC-CcccCHH---HHHHHHHhCCCChhhCcCHHHHHHHHHHH
Confidence 0111 1123333 44588899999999999999999998753
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-50 Score=389.15 Aligned_cols=255 Identities=24% Similarity=0.378 Sum_probs=196.8
Q ss_pred CCCCcccceEcccCcEEEEEEEECC--C--cEEEEEEeecC---CchhHHHHHHHHHHHHccCCCCeeeEeeeeecCCee
Q 010513 185 TNGFADENVIGEGGYGIVYHGVLED--N--TNVAVKNLLNN---RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHR 257 (508)
Q Consensus 185 ~~~~~~~~~LG~G~~g~Vy~~~~~~--~--~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 257 (508)
.++|++.+.||+|+||+||+|++.. + ..||||++.+. ..+..+.|.+|++++++++|||||+++|++.+ ...
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~ 85 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPM 85 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cch
Confidence 4579999999999999999998642 2 36899988653 23445689999999999999999999999976 467
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccce
Q 010513 258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK 337 (508)
Q Consensus 258 ~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~ 337 (508)
++||||+++|+|.+++... ...+++..+..++.|+++||.|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 86 ~lv~e~~~~~~l~~~~~~~---~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~ 159 (273)
T d1u46a_ 86 KMVTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMR 159 (273)
T ss_dssp EEEEECCTTCBHHHHHHHH---GGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred heeeeeecCcchhhhhhcc---cCCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhh
Confidence 8999999999999988765 35699999999999999999999999 99999999999999999999999999999
Q ss_pred ecCCCCcce--ecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHhhccccc
Q 010513 338 LLGAERSYV--TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNA 414 (508)
Q Consensus 338 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 414 (508)
......... .....|+..|+|||++.+..++.++|||||||++|||+| |+.||... +..+.+.........
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~------~~~~~~~~i~~~~~~ 233 (273)
T d1u46a_ 160 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL------NGSQILHKIDKEGER 233 (273)
T ss_dssp ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTC------CHHHHHHHHHTSCCC
T ss_pred hcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCc------CHHHHHHHHHhCCCC
Confidence 875443322 234567889999999999999999999999999999998 89999643 222333333332211
Q ss_pred ccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 010513 415 EGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461 (508)
Q Consensus 415 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~ 461 (508)
+.. ....+.. +.+++.+||+.||++|||+.+|++.|++
T Consensus 234 -----~~~-~~~~~~~---l~~li~~cl~~dp~~RPt~~ei~~~L~~ 271 (273)
T d1u46a_ 234 -----LPR-PEDCPQD---IYNVMVQCWAHKPEDRPTFVALRDFLLE 271 (273)
T ss_dssp -----CCC-CTTCCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -----CCC-cccccHH---HHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 111 1123344 4457889999999999999999999875
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-50 Score=396.74 Aligned_cols=247 Identities=23% Similarity=0.339 Sum_probs=201.1
Q ss_pred CCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCC---chhHHHHHHHHHHHH-ccCCCCeeeEeeeeecCCeeEEE
Q 010513 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIG-RVRHKNLVRLLGYCAEGAHRMLV 260 (508)
Q Consensus 186 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~-~l~hpniv~l~~~~~~~~~~~lV 260 (508)
++|++++.||+|+||+||+|++. +++.||||++.+.. ....+.+..|..++. .++|||||++++++.+++..|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 57999999999999999999976 68889999996532 233445666766655 68999999999999999999999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecC
Q 010513 261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG 340 (508)
Q Consensus 261 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 340 (508)
|||+++|+|.+++... ..+++..++.++.|++.||+|||++ +|+||||||+|||+++++++||+|||+++...
T Consensus 82 mEy~~~g~L~~~i~~~----~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~ 154 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSC----HKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENM 154 (320)
T ss_dssp EECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EeecCCCcHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhcc
Confidence 9999999999999765 5689999999999999999999999 99999999999999999999999999998654
Q ss_pred CCCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCCc
Q 010513 341 AERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDP 420 (508)
Q Consensus 341 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 420 (508)
.. ....+..+||+.|+|||++.+..|+.++|||||||++|||+||+.||...+. .+........ .+
T Consensus 155 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~------~~~~~~i~~~-------~~ 220 (320)
T d1xjda_ 155 LG-DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE------EELFHSIRMD-------NP 220 (320)
T ss_dssp CT-TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHC-------CC
T ss_pred cc-cccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCH------HHHHHHHHcC-------CC
Confidence 33 2334456899999999999999999999999999999999999999974321 1222222111 11
Q ss_pred cCCCCchHHHHHHHHHHHHHccCCCCCCCCCHH-HHHH
Q 010513 421 RLQEKPCSRALKRALLVALRCVDPNAHKRPKMG-HVIH 457 (508)
Q Consensus 421 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl~ 457 (508)
.+.. ..+. ++.+++.+||+.||++||++. ++++
T Consensus 221 ~~p~-~~s~---~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 221 FYPR-WLEK---EAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp CCCT-TSCH---HHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred CCCc-cCCH---HHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 1111 1233 345578899999999999995 6754
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-50 Score=395.97 Aligned_cols=264 Identities=24% Similarity=0.374 Sum_probs=211.7
Q ss_pred hHhhcCCCCcccceEcccCcEEEEEEEEC------CCcEEEEEEeecCCc-hhHHHHHHHHHHHHcc-CCCCeeeEeeee
Q 010513 180 ELEVSTNGFADENVIGEGGYGIVYHGVLE------DNTNVAVKNLLNNRG-QAEKEFKVEVEAIGRV-RHKNLVRLLGYC 251 (508)
Q Consensus 180 ~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpniv~l~~~~ 251 (508)
.+++..++|++.+.||+|+||.||+|++. +++.||||++..... ....++.+|+.+++++ +|||||++++++
T Consensus 17 ~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~ 96 (311)
T d1t46a_ 17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGAC 96 (311)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence 35677889999999999999999999862 356799999875443 3455788999999999 699999999999
Q ss_pred ecCCeeEEEEEecCCCCHHHHhccCCC--------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCC
Q 010513 252 AEGAHRMLVYEYIDNGNLEQWLHGDVG--------------PHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKS 317 (508)
Q Consensus 252 ~~~~~~~lV~e~~~~g~L~~~l~~~~~--------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp 317 (508)
.+....++|||||++|+|.++++.... ....+++..+..++.|+++||+|||++ +++||||||
T Consensus 97 ~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp 173 (311)
T d1t46a_ 97 TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAA 173 (311)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSG
T ss_pred eeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeeccccc
Confidence 999999999999999999999976431 234689999999999999999999999 999999999
Q ss_pred CCEEEcCCCCeEEeeeccceecCCCCc-ceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhC-CCCCCCCCC
Q 010513 318 SNILLDKQWNPKLSDFGLAKLLGAERS-YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISG-RNPVDYSRP 395 (508)
Q Consensus 318 ~NIll~~~~~~kL~DFG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg-~~Pf~~~~~ 395 (508)
+|||++.++.+|++|||+++....... ...+..+||+.|+|||++.++.++.++|||||||++|||+|+ ..||.....
T Consensus 174 ~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~ 253 (311)
T d1t46a_ 174 RNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253 (311)
T ss_dssp GGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred ccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999997755433 334457899999999999999999999999999999999995 555543322
Q ss_pred CCcchHHHHHHHhhcccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 010513 396 PGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461 (508)
Q Consensus 396 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~ 461 (508)
. ..+...+ ..+. .+... ...+. ++.+|+.+||+.||++|||+.+|+++|+.
T Consensus 254 ~--~~~~~~i----~~~~-----~~~~~-~~~~~---~l~~Li~~cl~~dP~~RPs~~~il~~L~~ 304 (311)
T d1t46a_ 254 D--SKFYKMI----KEGF-----RMLSP-EHAPA---EMYDIMKTCWDADPLKRPTFKQIVQLIEK 304 (311)
T ss_dssp S--HHHHHHH----HHTC-----CCCCC-TTSCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred H--HHHHHHH----hcCC-----CCCCc-ccccH---HHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 1 1112222 1111 11111 11333 45558889999999999999999999974
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-49 Score=391.60 Aligned_cols=262 Identities=26% Similarity=0.436 Sum_probs=207.4
Q ss_pred HhhcCCCCcccceEcccCcEEEEEEEECC--------CcEEEEEEeecCCc-hhHHHHHHHHHHHHcc-CCCCeeeEeee
Q 010513 181 LEVSTNGFADENVIGEGGYGIVYHGVLED--------NTNVAVKNLLNNRG-QAEKEFKVEVEAIGRV-RHKNLVRLLGY 250 (508)
Q Consensus 181 ~~~~~~~~~~~~~LG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpniv~l~~~ 250 (508)
++++.++|++.+.||+|+||.||+|+... +..||||++..... ....++.+|...+.++ +|||||+++++
T Consensus 8 ~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~ 87 (299)
T d1fgka_ 8 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGA 87 (299)
T ss_dssp TBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccc
Confidence 46778899999999999999999998542 24699999876544 3456788899999888 89999999999
Q ss_pred eecCCeeEEEEEecCCCCHHHHhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCC
Q 010513 251 CAEGAHRMLVYEYIDNGNLEQWLHGDVG------------PHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSS 318 (508)
Q Consensus 251 ~~~~~~~~lV~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~ 318 (508)
|.++...++||||+++|+|.+++..... ....+++..++.++.|++.||+|||++ +|+||||||+
T Consensus 88 ~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~ 164 (299)
T d1fgka_ 88 CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAAR 164 (299)
T ss_dssp ECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGG
T ss_pred cccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeeccc
Confidence 9999999999999999999999976532 235689999999999999999999999 9999999999
Q ss_pred CEEEcCCCCeEEeeeccceecCCCCcc-eecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHh-CCCCCCCCCCC
Q 010513 319 NILLDKQWNPKLSDFGLAKLLGAERSY-VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPP 396 (508)
Q Consensus 319 NIll~~~~~~kL~DFG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~Pf~~~~~~ 396 (508)
|||++.++.+||+|||+++........ ......||+.|+|||.+.++.|+.++|||||||++|||++ |+.||.....
T Consensus 165 NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~- 243 (299)
T d1fgka_ 165 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV- 243 (299)
T ss_dssp GEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-
T ss_pred ceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH-
Confidence 999999999999999999977543332 2344678999999999999999999999999999999998 7888864332
Q ss_pred CcchHHHHHHHhhcccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 010513 397 GEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461 (508)
Q Consensus 397 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~ 461 (508)
.+ +...+..+. .+.... ..+. ++.+++.+||+.||++|||+.||++.|+.
T Consensus 244 -----~~-~~~~i~~~~-----~~~~p~-~~~~---~l~~li~~cl~~dP~~Rps~~eil~~L~~ 293 (299)
T d1fgka_ 244 -----EE-LFKLLKEGH-----RMDKPS-NCTN---ELYMMMRDCWHAVPSQRPTFKQLVEDLDR 293 (299)
T ss_dssp -----HH-HHHHHHTTC-----CCCCCS-SCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -----HH-HHHHHHcCC-----CCCCCc-cchH---HHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence 11 222222221 111111 1333 34558889999999999999999999975
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-49 Score=391.35 Aligned_cols=265 Identities=23% Similarity=0.272 Sum_probs=198.4
Q ss_pred ccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCch-----hHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEEe
Q 010513 190 DENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQ-----AEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY 263 (508)
Q Consensus 190 ~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~ 263 (508)
.+++||+|+||+||+|++. +|+.||||++...... ..+.+.+|++++++++|||||++++++.++++.|+||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 3678999999999999975 6889999998544222 134688899999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCCC
Q 010513 264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER 343 (508)
Q Consensus 264 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 343 (508)
+.++++..+.... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~~~~~~~~~----~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~ 154 (299)
T d1ua2a_ 82 METDLEVIIKDNS----LVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN 154 (299)
T ss_dssp CSEEHHHHHTTCC----SSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred hcchHHhhhhhcc----cCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCc
Confidence 9998777665443 5789999999999999999999999 99999999999999999999999999998764433
Q ss_pred cceecceecCCCCCChhhhhc-CCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccc---ccc---
Q 010513 344 SYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRN---AEG--- 416 (508)
Q Consensus 344 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~---~~~--- 416 (508)
. .....+||+.|+|||++.. ..|+.++|||||||++|||+||+.||..... ......+........ ...
T Consensus 155 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~---~~~l~~i~~~~~~~~~~~~~~~~~ 230 (299)
T d1ua2a_ 155 R-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD---LDQLTRIFETLGTPTEEQWPDMCS 230 (299)
T ss_dssp C-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHHHCCCCTTTSSSTTS
T ss_pred c-cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCH---HHHHHHHHHhcCCCChhhccchhc
Confidence 2 2334679999999998865 4689999999999999999999999964432 111111111111000 000
Q ss_pred ----CCCccCCCCch----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--HhcCCCC
Q 010513 417 ----VLDPRLQEKPC----SRALKRALLVALRCVDPNAHKRPKMGHVIHM--LEAEEFP 465 (508)
Q Consensus 417 ----~~~~~l~~~~~----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--Le~~~~~ 465 (508)
.........+. +....++.+++.+||+.||++|||++|++++ +.+.-.|
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~p 289 (299)
T d1ua2a_ 231 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGP 289 (299)
T ss_dssp STTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCC
T ss_pred cchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCCCC
Confidence 00000111111 1123456778889999999999999999974 6544333
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-49 Score=391.37 Aligned_cols=268 Identities=24% Similarity=0.419 Sum_probs=216.0
Q ss_pred hhhHhhcCCCCcccceEcccCcEEEEEEEEC------CCcEEEEEEeecCCc-hhHHHHHHHHHHHHccCCCCeeeEeee
Q 010513 178 LRELEVSTNGFADENVIGEGGYGIVYHGVLE------DNTNVAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNLVRLLGY 250 (508)
Q Consensus 178 ~~~~~~~~~~~~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~ 250 (508)
-+++++..++|++.+.||+|+||+||+|.+. +++.||||++..... .....|.+|++++++++|||||+++++
T Consensus 12 ~~~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~ 91 (308)
T d1p4oa_ 12 PDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGV 91 (308)
T ss_dssp CCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEE
T ss_pred ccceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeE
Confidence 3456788899999999999999999999864 256899999865433 344568899999999999999999999
Q ss_pred eecCCeeEEEEEecCCCCHHHHhccCC------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcC
Q 010513 251 CAEGAHRMLVYEYIDNGNLEQWLHGDV------GPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDK 324 (508)
Q Consensus 251 ~~~~~~~~lV~e~~~~g~L~~~l~~~~------~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~ 324 (508)
+..+...++||||+++|+|.+++.... .....+++..+..++.|+++||.|||++ +|+||||||+|||++.
T Consensus 92 ~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~ 168 (308)
T d1p4oa_ 92 VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAE 168 (308)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECT
T ss_pred EecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecC
Confidence 999999999999999999999985421 2235679999999999999999999999 9999999999999999
Q ss_pred CCCeEEeeeccceecCCCCcce-ecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCC-CCCCCCCCCCcchHH
Q 010513 325 QWNPKLSDFGLAKLLGAERSYV-TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGR-NPVDYSRPPGEVNLV 402 (508)
Q Consensus 325 ~~~~kL~DFG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~-~Pf~~~~~~~~~~~~ 402 (508)
++++||+|||+++......... .....||+.|+|||.+.++.++.++|||||||++|||+||. .||... +..
T Consensus 169 ~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~------~~~ 242 (308)
T d1p4oa_ 169 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL------SNE 242 (308)
T ss_dssp TCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS------CHH
T ss_pred CceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCC------CHH
Confidence 9999999999998764433322 34457999999999999999999999999999999999985 677532 223
Q ss_pred HHHHHhhcccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCC
Q 010513 403 EWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEEF 464 (508)
Q Consensus 403 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~~~~ 464 (508)
+.+........ .+ . ...++. .+.+++.+||+.||++|||+.+|+++|+...-
T Consensus 243 ~~~~~i~~~~~----~~--~-p~~~~~---~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 243 QVLRFVMEGGL----LD--K-PDNCPD---MLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp HHHHHHHTTCC----CC--C-CTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HHHHHHHhCCC----CC--C-cccchH---HHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 33333332211 11 1 112333 35558889999999999999999999987643
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-49 Score=396.28 Aligned_cols=252 Identities=21% Similarity=0.283 Sum_probs=198.8
Q ss_pred CCCcccc-eEcccCcEEEEEEEEC-CCcEEEEEEeecCCchhHHHHHHHHHHHHcc-CCCCeeeEeeeeec----CCeeE
Q 010513 186 NGFADEN-VIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAE----GAHRM 258 (508)
Q Consensus 186 ~~~~~~~-~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~----~~~~~ 258 (508)
++|.+.+ .||+|+||+||+|++. +++.||||++.+ ...+.+|++++.++ +|||||+++++|++ +..+|
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ 85 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 85 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence 4788765 6999999999999975 688999999854 24567799887655 89999999999875 46789
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcC---CCCeEEeeecc
Q 010513 259 LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDK---QWNPKLSDFGL 335 (508)
Q Consensus 259 lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~---~~~~kL~DFG~ 335 (508)
+|||||+||+|.+++.... ...+++.+++.++.|++.||+|||++ +|+||||||+|||++. ++.+||+|||+
T Consensus 86 ivmEy~~gg~L~~~i~~~~--~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~ 160 (335)
T d2ozaa1 86 IVMECLDGGELFSRIQDRG--DQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGF 160 (335)
T ss_dssp EEEECCCSEEHHHHHHSCS--CCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEECCCCCcHHHHHHhcC--CCCcCHHHHHHHHHHHHHHHHHHHHc---CCccccccccccccccccccccccccccce
Confidence 9999999999999997642 24799999999999999999999999 9999999999999975 55799999999
Q ss_pred ceecCCCCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccc
Q 010513 336 AKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAE 415 (508)
Q Consensus 336 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (508)
++....... ....+||+.|+|||++.+..|+.++|||||||++|+|+||+.||........ ...+.......
T Consensus 161 a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~---~~~~~~~i~~~--- 232 (335)
T d2ozaa1 161 AKETTSHNS--LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI---SPGMKTRIRMG--- 232 (335)
T ss_dssp CEECCCCCC--CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------CCCSC---
T ss_pred eeeccCCCc--cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHH---HHHHHHHHhcC---
Confidence 987654332 3456899999999999999999999999999999999999999975433211 11111111100
Q ss_pred cCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 416 GVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 416 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
...+..........++.+++.+||+.||++|||+.|++++
T Consensus 233 ---~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 233 ---QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp ---SSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ---CCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 1111222223344567778889999999999999999984
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-49 Score=388.67 Aligned_cols=272 Identities=22% Similarity=0.349 Sum_probs=204.8
Q ss_pred CCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCc--hhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEE
Q 010513 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG--QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE 262 (508)
Q Consensus 186 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e 262 (508)
++|++++.||+|+||+||+|++. +|+.||||++..... ...+.+.+|++++++++|||||++++++.++.+.|+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 58999999999999999999975 688999999854432 235678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCC
Q 010513 263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE 342 (508)
Q Consensus 263 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 342 (508)
|+.+ ++.+++.... ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~~~-~~~~~~~~~~--~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~ 155 (298)
T d1gz8a_ 82 FLHQ-DLKKFMDASA--LTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 155 (298)
T ss_dssp CCSE-EHHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC
T ss_pred ecCC-chhhhhhhhc--ccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCC
Confidence 9986 4555543321 35799999999999999999999999 9999999999999999999999999999876433
Q ss_pred CcceecceecCCCCCChhhhhcCC-CCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhccc---------
Q 010513 343 RSYVTTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNR--------- 412 (508)
Q Consensus 343 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~--------- 412 (508)
. .......||+.|+|||++.... ++.++|||||||++|+|++|+.||...+.. ..+...........
T Consensus 156 ~-~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~--~~~~~i~~~~~~~~~~~~~~~~~ 232 (298)
T d1gz8a_ 156 V-RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI--DQLFRIFRTLGTPDEVVWPGVTS 232 (298)
T ss_dssp S-BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHHHCCCCTTTSTTGGG
T ss_pred c-ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHH--HHHHHHHHhcCCCchhhcccccc
Confidence 2 2344468999999999877665 578999999999999999999999754311 11111111100000
Q ss_pred --ccccCCCccCCCCchH----HHHHHHHHHHHHccCCCCCCCCCHHHHHHH--HhcCCCCCC
Q 010513 413 --NAEGVLDPRLQEKPCS----RALKRALLVALRCVDPNAHKRPKMGHVIHM--LEAEEFPFR 467 (508)
Q Consensus 413 --~~~~~~~~~l~~~~~~----~~~~~l~~li~~cl~~dP~~RPs~~evl~~--Le~~~~~~~ 467 (508)
...... +........ ....++.+++.+||+.||++|||+.|++++ +++..-|.+
T Consensus 233 ~~~~~~~~-~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~p~p 294 (298)
T d1gz8a_ 233 MPDYKPSF-PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVP 294 (298)
T ss_dssp STTCCTTS-CCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCCCCC
T ss_pred cccccccc-ccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCCCCC
Confidence 000000 011111111 122456668889999999999999999986 666655544
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-49 Score=387.82 Aligned_cols=265 Identities=25% Similarity=0.342 Sum_probs=199.8
Q ss_pred CCCcccceEcccCcEEEEEEEECCCcEEEEEEeecCCchhHHHHHHHHHHHHccCCCCeeeEeeeeecCC----eeEEEE
Q 010513 186 NGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGA----HRMLVY 261 (508)
Q Consensus 186 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~----~~~lV~ 261 (508)
++|.+.+.||+|+||+||+|+++ |+.||||++.... ........|+..+..++|||||++++++.+.+ .+|+||
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~-g~~vAvK~~~~~~-~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~ 80 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccc-hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence 36788899999999999999975 8899999885432 21222334555556789999999999997653 578999
Q ss_pred EecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----CCCeeeccCCCCCEEEcCCCCeEEeeeccc
Q 010513 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGL-----EPKVVHRDIKSSNILLDKQWNPKLSDFGLA 336 (508)
Q Consensus 262 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~-----~~~iiHrDlkp~NIll~~~~~~kL~DFG~a 336 (508)
|||++|+|.+++++. .+++..++.++.|++.||+|||+.. +.+|+||||||+||||+.++.+||+|||++
T Consensus 81 Ey~~~g~L~~~l~~~-----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~ 155 (303)
T d1vjya_ 81 DYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp ECCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred ecccCCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcc
Confidence 999999999999764 6899999999999999999999631 238999999999999999999999999999
Q ss_pred eecCCCCcc---eecceecCCCCCChhhhhcCC------CCCCCCeeehHHHHHHHHhCCCCCCCCCCCCc--------c
Q 010513 337 KLLGAERSY---VTTRVMGTFGYVAPEYASTGM------LNERSDVYSFGILIMEVISGRNPVDYSRPPGE--------V 399 (508)
Q Consensus 337 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~--------~ 399 (508)
+........ .....+||+.|+|||++.+.. ++.++|||||||+||||+||..||........ .
T Consensus 156 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~ 235 (303)
T d1vjya_ 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235 (303)
T ss_dssp EEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred ccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccccc
Confidence 977543322 234568999999999987643 56789999999999999999988754321111 0
Q ss_pred hHHHHHHHhhcccccccCCCccCCCCc-hHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 010513 400 NLVEWLKTMVTNRNAEGVLDPRLQEKP-CSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461 (508)
Q Consensus 400 ~~~~~~~~~~~~~~~~~~~~~~l~~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~ 461 (508)
...+........ ..++|.+.... .......+.+++.+||+.||++|||+.||+++|++
T Consensus 236 ~~~~~~~~~~~~----~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~ 294 (303)
T d1vjya_ 236 PSVEEMRKVVCE----QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 294 (303)
T ss_dssp CCHHHHHHHHTT----SCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHH
T ss_pred chHHHHHHHHhc----cccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence 111222222222 22233332222 23455667779999999999999999999999975
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-49 Score=389.44 Aligned_cols=258 Identities=24% Similarity=0.400 Sum_probs=202.2
Q ss_pred cCCCCcccceEcccCcEEEEEEEECC-Cc--EEEEEEeecC-CchhHHHHHHHHHHHHcc-CCCCeeeEeeeeecCCeeE
Q 010513 184 STNGFADENVIGEGGYGIVYHGVLED-NT--NVAVKNLLNN-RGQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRM 258 (508)
Q Consensus 184 ~~~~~~~~~~LG~G~~g~Vy~~~~~~-~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~ 258 (508)
..++|++.++||+|+||+||+|.+++ +. .||||++... ..+..+.|.+|+++|.++ +|||||++++++.+++..+
T Consensus 8 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~ 87 (309)
T d1fvra_ 8 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY 87 (309)
T ss_dssp CGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEE
T ss_pred CHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeE
Confidence 34688999999999999999999763 44 4678887543 333456799999999999 7999999999999999999
Q ss_pred EEEEecCCCCHHHHhccCC------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCC
Q 010513 259 LVYEYIDNGNLEQWLHGDV------------GPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQW 326 (508)
Q Consensus 259 lV~e~~~~g~L~~~l~~~~------------~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~ 326 (508)
+||||+++|+|.++++... .....+++..+..++.|+++||.|||++ +|+||||||+|||++.++
T Consensus 88 iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~ 164 (309)
T d1fvra_ 88 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENY 164 (309)
T ss_dssp EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGG
T ss_pred EEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCC
Confidence 9999999999999997642 2346799999999999999999999999 999999999999999999
Q ss_pred CeEEeeeccceecCCCCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCC-CCCCCCCCCCcchHHHHH
Q 010513 327 NPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGR-NPVDYSRPPGEVNLVEWL 405 (508)
Q Consensus 327 ~~kL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~-~Pf~~~~~~~~~~~~~~~ 405 (508)
.+||+|||+++..... .......||..|+|||.+.++.|+.++|||||||++|||++|. .||...+ ..+..
T Consensus 165 ~~kl~DfG~a~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~------~~~~~ 236 (309)
T d1fvra_ 165 VAKIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT------CAELY 236 (309)
T ss_dssp CEEECCTTCEESSCEE--CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC------HHHHH
T ss_pred ceEEcccccccccccc--ccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCC------HHHHH
Confidence 9999999999864322 2223457899999999999999999999999999999999975 5665332 22222
Q ss_pred HHhhcccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010513 406 KTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (508)
Q Consensus 406 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~~ 462 (508)
....... .+.... .++.. +.+++.+||+.||++||++.||+++|+..
T Consensus 237 ~~i~~~~------~~~~~~-~~~~~---~~~li~~cl~~dP~~RPs~~eil~~L~~i 283 (309)
T d1fvra_ 237 EKLPQGY------RLEKPL-NCDDE---VYDLMRQCWREKPYERPSFAQILVSLNRM 283 (309)
T ss_dssp HHGGGTC------CCCCCT-TBCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHhcC------CCCCCc-cCCHH---HHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 2222211 111111 23344 44577899999999999999999998764
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-49 Score=387.61 Aligned_cols=255 Identities=29% Similarity=0.464 Sum_probs=202.3
Q ss_pred cceEcccCcEEEEEEEECCC----cEEEEEEeecC-CchhHHHHHHHHHHHHccCCCCeeeEeeeeec-CCeeEEEEEec
Q 010513 191 ENVIGEGGYGIVYHGVLEDN----TNVAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE-GAHRMLVYEYI 264 (508)
Q Consensus 191 ~~~LG~G~~g~Vy~~~~~~~----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~~lV~e~~ 264 (508)
.++||+|+||+||+|.+.++ ..||||++.+. .....++|.+|++++++++||||++++|++.+ +...++|||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 67899999999999997542 25899998643 44455789999999999999999999999865 56889999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCCCc
Q 010513 265 DNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS 344 (508)
Q Consensus 265 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~ 344 (508)
++|+|.+++... ...+++..++.++.|+++||.|||+. +|+||||||+|||+++++.+||+|||+++.......
T Consensus 112 ~~g~l~~~~~~~---~~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~ 185 (311)
T d1r0pa_ 112 KHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 185 (311)
T ss_dssp TTCBHHHHHHCT---TCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred ecCchhhhhccc---cccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhcccccc
Confidence 999999998866 45788899999999999999999999 999999999999999999999999999997654332
Q ss_pred c---eecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccccCCCcc
Q 010513 345 Y---VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPR 421 (508)
Q Consensus 345 ~---~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 421 (508)
. ......||+.|+|||.+.++.++.++||||||+++|||+||..||....... +.........+ ...|
T Consensus 186 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~-----~~~~~i~~g~~---~~~p- 256 (311)
T d1r0pa_ 186 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF-----DITVYLLQGRR---LLQP- 256 (311)
T ss_dssp CCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-----------CHHHHHTTCC---CCCC-
T ss_pred ccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH-----HHHHHHHcCCC---CCCc-
Confidence 2 2233578999999999999999999999999999999999888876432211 11122222111 1111
Q ss_pred CCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCCCC
Q 010513 422 LQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEEFPF 466 (508)
Q Consensus 422 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~~~~~~ 466 (508)
+.++.. +.+++.+||+.||++||++.||+++|+..-..+
T Consensus 257 ---~~~~~~---l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~ 295 (311)
T d1r0pa_ 257 ---EYCPDP---LYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 295 (311)
T ss_dssp ---TTCCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred ---ccCcHH---HHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhh
Confidence 223344 445788999999999999999999998764443
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2.4e-48 Score=380.38 Aligned_cols=262 Identities=20% Similarity=0.320 Sum_probs=199.8
Q ss_pred CCCcccceEcccCcEEEEEEEECCCcEEEEEEeecCCc--hhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEEe
Q 010513 186 NGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRG--QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY 263 (508)
Q Consensus 186 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~ 263 (508)
++|++.++||+|+||+||+|++++|+.||||++..... ...+.+.+|+.+|++++|||||++++++.+++..+++|||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 68999999999999999999999999999999865432 2356788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCCC
Q 010513 264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER 343 (508)
Q Consensus 264 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 343 (508)
+.++.+..+.... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||.+.......
T Consensus 82 ~~~~~~~~~~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~ 154 (286)
T d1ob3a_ 82 LDQDLKKLLDVCE----GGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154 (286)
T ss_dssp CSEEHHHHHHTST----TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred ehhhhHHHHHhhc----CCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccCc
Confidence 9987777666543 6799999999999999999999999 99999999999999999999999999998764332
Q ss_pred cceecceecCCCCCChhhhhcC-CCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccccc-------
Q 010513 344 SYVTTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAE------- 415 (508)
Q Consensus 344 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~------- 415 (508)
.......|++.|+|||.+.+. .++.++|||||||++|||++|+.||..... .................
T Consensus 155 -~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~---~~~~~~i~~~~~~~~~~~~~~~~~ 230 (286)
T d1ob3a_ 155 -RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSE---ADQLMRIFRILGTPNSKNWPNVTE 230 (286)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred -cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCH---HHHHHHHHHhhCCCChhhccchhh
Confidence 233445789999999988654 578999999999999999999999975432 11111111111000000
Q ss_pred -cCCCccCC-------CCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 416 -GVLDPRLQ-------EKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 416 -~~~~~~l~-------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
...+.... .........++.+++.+||+.||++|||+.|++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp STTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00000000 00011122455668889999999999999999854
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-49 Score=385.40 Aligned_cols=240 Identities=25% Similarity=0.419 Sum_probs=195.2
Q ss_pred CCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCch------hHHHHHHHHHHHHccC--CCCeeeEeeeeecCCe
Q 010513 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQ------AEKEFKVEVEAIGRVR--HKNLVRLLGYCAEGAH 256 (508)
Q Consensus 186 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--hpniv~l~~~~~~~~~ 256 (508)
++|++.+.||+|+||+||+|++. +|+.||||++.+.... ....+.+|+.++++++ |||||++++++.+++.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 57999999999999999999975 6889999998653211 1234667999999996 8999999999999999
Q ss_pred eEEEEEecCC-CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcC-CCCeEEeeec
Q 010513 257 RMLVYEYIDN-GNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDK-QWNPKLSDFG 334 (508)
Q Consensus 257 ~~lV~e~~~~-g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~-~~~~kL~DFG 334 (508)
.|+||||+.+ +++.+++... ..+++..++.++.|+++||+|||++ +|+||||||+|||++. ++.+||+|||
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~----~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG 156 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITER----GALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFG 156 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred EEEEEEeccCcchHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECccc
Confidence 9999999976 6888888764 5799999999999999999999999 9999999999999985 4789999999
Q ss_pred cceecCCCCcceecceecCCCCCChhhhhcCCC-CCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccc
Q 010513 335 LAKLLGAERSYVTTRVMGTFGYVAPEYASTGML-NERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRN 413 (508)
Q Consensus 335 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 413 (508)
+++..... ..+..+||+.|+|||++.+..+ +.++|||||||++|||+||+.||.... +. ....
T Consensus 157 ~a~~~~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~--------~i----~~~~- 220 (273)
T d1xwsa_ 157 SGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--------EI----IRGQ- 220 (273)
T ss_dssp TCEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--------HH----HHCC-
T ss_pred cceecccc---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch--------HH----hhcc-
Confidence 99875332 2345689999999999987765 567899999999999999999996321 11 1110
Q ss_pred cccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 414 AEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 414 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
.. +... .+. ++.+++.+||+.||++|||++|++++
T Consensus 221 --~~----~~~~-~s~---~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 221 --VF----FRQR-VSS---ECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp --CC----CSSC-CCH---HHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred --cC----CCCC-CCH---HHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 01 1111 233 34557889999999999999999874
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-47 Score=377.79 Aligned_cols=263 Identities=24% Similarity=0.313 Sum_probs=194.6
Q ss_pred CCCCcccceEcccCcEEEEEEEEC-C-CcEEEEEEeecCCc--hhHHHHHHHHHHHHcc---CCCCeeeEeeeeec----
Q 010513 185 TNGFADENVIGEGGYGIVYHGVLE-D-NTNVAVKNLLNNRG--QAEKEFKVEVEAIGRV---RHKNLVRLLGYCAE---- 253 (508)
Q Consensus 185 ~~~~~~~~~LG~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~hpniv~l~~~~~~---- 253 (508)
.++|++++.||+|+||+||+|++. + ++.||||++..... .....+.+|+.+++.+ +||||++++++|..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 368999999999999999999974 4 55689999854322 2223455677776665 89999999999853
Q ss_pred -CCeeEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEee
Q 010513 254 -GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSD 332 (508)
Q Consensus 254 -~~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~D 332 (508)
....+++|||++++++....... ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~---~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~d 159 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVP---EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLAD 159 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSC---TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECS
T ss_pred cCceEEEEEEeccCCchhhhhhcc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecc
Confidence 34678999999987776555443 35789999999999999999999999 999999999999999999999999
Q ss_pred eccceecCCCCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhccc
Q 010513 333 FGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNR 412 (508)
Q Consensus 333 FG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 412 (508)
||+++..... ......+||+.|+|||++.+..|+.++|||||||++|||++|+.||...++. .............
T Consensus 160 fg~~~~~~~~--~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~---~~~~~i~~~~~~~ 234 (305)
T d1blxa_ 160 FGLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV---DQLGKILDVIGLP 234 (305)
T ss_dssp CCSCCCCCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCCC
T ss_pred hhhhhhhccc--ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHH---HHHHHHHHhhCCC
Confidence 9999865332 2344568999999999999999999999999999999999999999754321 1111111111000
Q ss_pred ---ccc-------cCCCccCC---CCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 413 ---NAE-------GVLDPRLQ---EKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 413 ---~~~-------~~~~~~l~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
... ........ ..........+.+++.+||+.||++|||+.|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 235 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp CGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred chhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 000 00000000 00011112345557889999999999999999875
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-46 Score=373.84 Aligned_cols=263 Identities=19% Similarity=0.278 Sum_probs=196.0
Q ss_pred CCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecC--CchhHHHHHHHHHHHHccCCCCeeeEeeeeec--------C
Q 010513 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE--------G 254 (508)
Q Consensus 186 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~--------~ 254 (508)
++|++.+.||+|+||+||+|++. +|+.||||++... .....+.+.+|+++|++++||||+++++++.. .
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 58999999999999999999975 6899999998543 23345678899999999999999999998855 3
Q ss_pred CeeEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeec
Q 010513 255 AHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFG 334 (508)
Q Consensus 255 ~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG 334 (508)
.+.|+||||+.++++..+... ...+++..++.++.|+++||.|||++ +|+||||||+|||++.++.+||+|||
T Consensus 90 ~~~~iv~e~~~~~~~~~~~~~----~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~dfg 162 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLSNV----LVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFG 162 (318)
T ss_dssp -CEEEEEECCCEEHHHHHTCT----TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCT
T ss_pred ceEEEEEeccCCCccchhhhc----ccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeecc
Confidence 467899999988766655433 35789999999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCcc---eecceecCCCCCChhhhhcC-CCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhc
Q 010513 335 LAKLLGAERSY---VTTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVT 410 (508)
Q Consensus 335 ~a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~ 410 (508)
+++.+...... .....+||+.|+|||++.+. .|+.++|||||||++|||++|+.||....+ ............
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~---~~~~~~i~~~~~ 239 (318)
T d3blha1 163 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE---QHQLALISQLCG 239 (318)
T ss_dssp TCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHHC
T ss_pred eeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCH---HHHHHHHHHhcC
Confidence 99876533222 22335799999999998765 689999999999999999999999975432 111111111111
Q ss_pred ccc---cccC--------CC-ccCCCCchHHH------HHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 411 NRN---AEGV--------LD-PRLQEKPCSRA------LKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 411 ~~~---~~~~--------~~-~~l~~~~~~~~------~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
.-. .... .. ........... ...+++++.+||+.||++|||+.|++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 240 SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp CCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 100 0000 00 00001111111 2345678899999999999999999976
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-46 Score=377.39 Aligned_cols=258 Identities=25% Similarity=0.299 Sum_probs=191.4
Q ss_pred CCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCchhHHHHHHHHHHHHccCCCCeeeEeeeeec------CCeeEE
Q 010513 187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE------GAHRML 259 (508)
Q Consensus 187 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~------~~~~~l 259 (508)
+|+..++||+|+||+||+|++. +|+.||||++.+.... +.+|+++|++++||||++++++|.. ..++|+
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH----HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 6888999999999999999986 5889999999765432 2369999999999999999999853 335789
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCC-CeEEeeecccee
Q 010513 260 VYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQW-NPKLSDFGLAKL 338 (508)
Q Consensus 260 V~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~-~~kL~DFG~a~~ 338 (508)
|||||+++.+..+.. .......+++..++.++.|++.||+|||++ +|+||||||+|||++.++ .+||+|||+++.
T Consensus 97 v~Ey~~~~~~~~l~~-~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~ 172 (350)
T d1q5ka_ 97 VLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 172 (350)
T ss_dssp EEECCSEEHHHHHHH-HHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred EEeccCCccHHHHHh-hhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccchhh
Confidence 999998754333332 112246799999999999999999999999 999999999999999775 899999999987
Q ss_pred cCCCCcceecceecCCCCCChhhhhc-CCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHH-----------H
Q 010513 339 LGAERSYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWL-----------K 406 (508)
Q Consensus 339 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~-----------~ 406 (508)
...... ....+||+.|+|||.+.+ ..|+.++|||||||++|||++|+.||...... ..+.... .
T Consensus 173 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~--~~l~~i~~~~g~~~~~~~~ 248 (350)
T d1q5ka_ 173 LVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV--DQLVEIIKVLGTPTREQIR 248 (350)
T ss_dssp CCTTSC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHH--HHHHHHHHHHCCCCHHHHH
T ss_pred ccCCcc--cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHH--HHHHHHHHHhCCChHHhhh
Confidence 644332 334589999999998765 57899999999999999999999999754321 1111111 1
Q ss_pred HhhcccccccCCCccCCC-----CchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 407 TMVTNRNAEGVLDPRLQE-----KPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 407 ~~~~~~~~~~~~~~~l~~-----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
..... .....-+.... ...+....++.+++.+||+.||++|||+.|++++
T Consensus 249 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 303 (350)
T d1q5ka_ 249 EMNPN--YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303 (350)
T ss_dssp HHCC-----CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhccc--hhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11000 00000011100 0011123345668889999999999999999964
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-46 Score=373.04 Aligned_cols=261 Identities=22% Similarity=0.316 Sum_probs=194.4
Q ss_pred CCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecC--CchhHHHHHHHHHHHHccCCCCeeeEeeeeecCC------
Q 010513 185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGA------ 255 (508)
Q Consensus 185 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~------ 255 (508)
.++|++++.||+|+||+||+|.+. +|+.||||++... .....+.+.+|+++|+.++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 568999999999999999999975 5889999998654 2234567889999999999999999999997654
Q ss_pred eeEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeecc
Q 010513 256 HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGL 335 (508)
Q Consensus 256 ~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~ 335 (508)
++|+||||+ +++|..+++. ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~ 167 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGL 167 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEecc-cccHHHHHHh-----ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccccccc
Confidence 569999999 5588887754 3699999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCcceecceecCCCCCChhhhhc-CCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhccc--
Q 010513 336 AKLLGAERSYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNR-- 412 (508)
Q Consensus 336 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~-- 412 (508)
++..... .+...||+.|+|||++.+ ..++.++||||+||++|||++|+.||...+... ............
T Consensus 168 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~---~~~~~~~~~~~~~~ 240 (346)
T d1cm8a_ 168 ARQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD---QLKEIMKVTGTPPA 240 (346)
T ss_dssp CEECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHHHCCCCH
T ss_pred eeccCCc----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHH---HHHHHHhccCCCcH
Confidence 9876433 344679999999999876 457899999999999999999999997543211 100000000000
Q ss_pred ----------------ccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--HhcC
Q 010513 413 ----------------NAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM--LEAE 462 (508)
Q Consensus 413 ----------------~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--Le~~ 462 (508)
.........+.. ........+.+|+.+||+.||++|||+.|++++ +++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~ 307 (346)
T d1cm8a_ 241 EFVQRLQSDEAKNYMKGLPELEKKDFAS-ILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 307 (346)
T ss_dssp HHHHTCSCHHHHHHHHHSCCCCCCCGGG-TCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred HHHhhhcchhhhhhhccCCcccccchHH-hccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcC
Confidence 000000000000 001112345568889999999999999999986 6543
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-46 Score=372.73 Aligned_cols=253 Identities=24% Similarity=0.320 Sum_probs=203.2
Q ss_pred CCCCcccceEcccCcEEEEEEEEC----CCcEEEEEEeecCC----chhHHHHHHHHHHHHccCC-CCeeeEeeeeecCC
Q 010513 185 TNGFADENVIGEGGYGIVYHGVLE----DNTNVAVKNLLNNR----GQAEKEFKVEVEAIGRVRH-KNLVRLLGYCAEGA 255 (508)
Q Consensus 185 ~~~~~~~~~LG~G~~g~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h-pniv~l~~~~~~~~ 255 (508)
.++|++++.||+|+||+||+|+.. +|+.||||.+.+.. ....+.+.+|++++++++| |||+++++++.+..
T Consensus 23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~ 102 (322)
T d1vzoa_ 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 102 (322)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC
Confidence 357999999999999999999862 47889999885432 2334567889999999976 89999999999999
Q ss_pred eeEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeecc
Q 010513 256 HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGL 335 (508)
Q Consensus 256 ~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~ 335 (508)
..+++|||+.+|+|.+++... ..+.+..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 103 ~~~~v~e~~~~~~L~~~i~~~----~~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~ 175 (322)
T d1vzoa_ 103 KLHLILDYINGGELFTHLSQR----ERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGL 175 (322)
T ss_dssp EEEEEECCCCSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred ceeeeeecccccHHHHHHHhc----ccccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccc
Confidence 999999999999999999776 4678899999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCcceecceecCCCCCChhhhhcC--CCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccc
Q 010513 336 AKLLGAERSYVTTRVMGTFGYVAPEYASTG--MLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRN 413 (508)
Q Consensus 336 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 413 (508)
++.+............|++.|+|||.+.+. .++.++|||||||+||||++|+.||......... ..........
T Consensus 176 a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~--~~i~~~~~~~-- 251 (322)
T d1vzoa_ 176 SKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ--AEISRRILKS-- 251 (322)
T ss_dssp EEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH--HHHHHHHHHC--
T ss_pred hhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHHhcccC--
Confidence 998765555555567899999999998754 4788999999999999999999999766443322 1222222111
Q ss_pred cccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 010513 414 AEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRP-----KMGHVIH 457 (508)
Q Consensus 414 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 457 (508)
.+.+.. ..+ .++.+++.+||++||++|| +++|+++
T Consensus 252 -----~~~~~~-~~s---~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 252 -----EPPYPQ-EMS---ALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp -----CCCCCT-TSC---HHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred -----CCCCcc-cCC---HHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 011111 123 3445577799999999999 4788886
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-46 Score=375.79 Aligned_cols=262 Identities=22% Similarity=0.328 Sum_probs=195.6
Q ss_pred CCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCC-chhHHHHHHHHHHHHccCCCCeeeEeeeeecCC----eeEE
Q 010513 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGA----HRML 259 (508)
Q Consensus 186 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~----~~~l 259 (508)
++|++++.||+|+||+||+|++. +|+.||||++.+.. ....+.+.+|+++|++++||||+++++++.... ..++
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~ 87 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY 87 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEE
Confidence 47999999999999999999975 78999999996543 344567889999999999999999999987543 2345
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceec
Q 010513 260 VYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL 339 (508)
Q Consensus 260 V~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~ 339 (508)
+++|+.+|+|.+++... .+++..++.++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+++..
T Consensus 88 l~~~~~~g~L~~~l~~~-----~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~ 159 (345)
T d1pmea_ 88 LVTHLMGADLYKLLKTQ-----HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVA 159 (345)
T ss_dssp EEEECCCEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEeecCCchhhhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCceeec
Confidence 56667789999999753 689999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCcc--eecceecCCCCCChhhhh-cCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhccccc--
Q 010513 340 GAERSY--VTTRVMGTFGYVAPEYAS-TGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNA-- 414 (508)
Q Consensus 340 ~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~-- 414 (508)
...... .....+||+.|+|||++. ...++.++||||+||++|||++|+.||........ .............
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~ 236 (345)
T d1pmea_ 160 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ---LNHILGILGSPSQED 236 (345)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCSCCHHH
T ss_pred cCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHH---HHHHhhhccCCChhh
Confidence 443222 234467999999999884 45678899999999999999999999975432111 1100000000000
Q ss_pred -----------ccCCCccCCCCchH----HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 415 -----------EGVLDPRLQEKPCS----RALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 415 -----------~~~~~~~l~~~~~~----~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
.....+........ ....++.+++.+||+.||++|||+.|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 237 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00000000111111 112356678889999999999999999986
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.4e-45 Score=361.68 Aligned_cols=260 Identities=17% Similarity=0.203 Sum_probs=205.1
Q ss_pred cCCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCchhHHHHHHHHHHHHccCC-CCeeeEeeeeecCCeeEEEE
Q 010513 184 STNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRH-KNLVRLLGYCAEGAHRMLVY 261 (508)
Q Consensus 184 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~l~~~~~~~~~~~lV~ 261 (508)
-.++|++++.||+|+||+||+|++. +|+.||||.+.... ....+.+|++.++.++| +|++.+++++.++...++||
T Consensus 3 ig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vm 80 (293)
T d1csna_ 3 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI 80 (293)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred CCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEE
Confidence 3568999999999999999999976 58889999875432 23456778999999965 89999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcC-----CCCeEEeeeccc
Q 010513 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDK-----QWNPKLSDFGLA 336 (508)
Q Consensus 262 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~-----~~~~kL~DFG~a 336 (508)
||+ +++|.+++... ...++...+..++.|++.||+|||++ +|+||||||+|||++. ++.+||+|||++
T Consensus 81 e~~-~~~l~~~~~~~---~~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a 153 (293)
T d1csna_ 81 DLL-GPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 153 (293)
T ss_dssp ECC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred Eec-CCCHHHHHHhh---ccchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEccccee
Confidence 999 67999998765 35799999999999999999999999 9999999999999964 577999999999
Q ss_pred eecCCCCc------ceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhc
Q 010513 337 KLLGAERS------YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVT 410 (508)
Q Consensus 337 ~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~ 410 (508)
+.+..... ......+||+.|+|||.+.+..++.++|||||||++|||+||+.||..............+.....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~ 233 (293)
T d1csna_ 154 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ 233 (293)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH
T ss_pred EEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccC
Confidence 98643321 123346899999999999999999999999999999999999999986654433332222221111
Q ss_pred ccccccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 010513 411 NRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461 (508)
Q Consensus 411 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~ 461 (508)
.... +.+.. .+++ ++.+++..|++.+|++||+++.+.+.|+.
T Consensus 234 ~~~~-----~~l~~-~~p~---~l~~ii~~~~~~~~~~rP~y~~l~~~l~~ 275 (293)
T d1csna_ 234 STPL-----RELCA-GFPE---EFYKYMHYARNLAFDATPDYDYLQGLFSK 275 (293)
T ss_dssp HSCH-----HHHTT-TSCH---HHHHHHHHHHHCCTTCCCCHHHHHHHHHH
T ss_pred CCCh-----HHhcC-CCCH---HHHHHHHHHhcCCcccCcCHHHHHHHHHH
Confidence 1000 01111 1233 45557779999999999999988887764
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.3e-45 Score=361.41 Aligned_cols=258 Identities=19% Similarity=0.217 Sum_probs=195.5
Q ss_pred CCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCchhHHHHHHHHHHHHccCCCC-eeeEeeeeecCCeeEEEEEe
Q 010513 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKN-LVRLLGYCAEGAHRMLVYEY 263 (508)
Q Consensus 186 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn-iv~l~~~~~~~~~~~lV~e~ 263 (508)
++|++.+.||+|+||+||+|++. +|+.||||.+..... .+++..|+++++.++|+| |+.+.+++.++...++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 47999999999999999999975 588999998765432 245778999999998766 55556666788888999999
Q ss_pred cCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEc---CCCCeEEeeeccceecC
Q 010513 264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLD---KQWNPKLSDFGLAKLLG 340 (508)
Q Consensus 264 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~---~~~~~kL~DFG~a~~~~ 340 (508)
+. |+|.+.+... ...+++..+..++.|++.||+|||++ +|+||||||+|||++ .+..+||+|||+|+.+.
T Consensus 85 ~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~ 157 (299)
T d1ckia_ 85 LG-PSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 157 (299)
T ss_dssp CC-CBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECB
T ss_pred cC-Cchhhhhhhc---cCCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcceecc
Confidence 95 4777766554 35799999999999999999999999 999999999999985 45579999999999875
Q ss_pred CCCcc------eecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhccccc
Q 010513 341 AERSY------VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNA 414 (508)
Q Consensus 341 ~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 414 (508)
..... ......||+.|+|||.+.+..++.++|||||||++|||+||+.||.......................
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~- 236 (299)
T d1ckia_ 158 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP- 236 (299)
T ss_dssp CTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSC-
T ss_pred ccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCC-
Confidence 43321 23446899999999999999999999999999999999999999986544333222211111100000
Q ss_pred ccCCCccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 010513 415 EGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461 (508)
Q Consensus 415 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~Le~ 461 (508)
.+.+. ..++ .++.+++.+||+.||++||++.++.+.|+.
T Consensus 237 ----~~~~~-~~~p---~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 275 (299)
T d1ckia_ 237 ----IEVLC-KGYP---SEFATYLNFCRSLRFDDKPDYSYLRQLFRN 275 (299)
T ss_dssp ----HHHHT-TTSC---HHHHHHHHHHHHSCTTCCCCHHHHHHHHHH
T ss_pred ----hhHhc-cCCC---HHHHHHHHHHccCChhHCcCHHHHHHHHHH
Confidence 00000 1123 345557889999999999999998887764
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-45 Score=360.49 Aligned_cols=263 Identities=20% Similarity=0.271 Sum_probs=203.8
Q ss_pred CCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCC--chhHHHHHHHHHHHHccCCCCeeeEeeeeecCCeeEEEEE
Q 010513 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE 262 (508)
Q Consensus 186 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e 262 (508)
++|++++.||+|+||+||+|++. +++.||||++.... ....+.+.+|+.+++.++||||+++++++.+....++|++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 58999999999999999999975 68889999986543 3345788899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccceecCCC
Q 010513 263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE 342 (508)
Q Consensus 263 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 342 (508)
++.+++|..++... ..+++..+..++.|+++||+|||++ +|+||||||+|||++.++.+||+|||.++.....
T Consensus 82 ~~~~~~l~~~~~~~----~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~ 154 (292)
T d1unla_ 82 FCDQDLKKYFDSCN----GDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp CCSEEHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred eccccccccccccc----cccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCC
Confidence 99999998887654 5789999999999999999999999 9999999999999999999999999999976543
Q ss_pred CcceecceecCCCCCChhhhhcCC-CCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccc---c---c
Q 010513 343 RSYVTTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRN---A---E 415 (508)
Q Consensus 343 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~---~---~ 415 (508)
.. ......+++.|+|||++.... ++.++|||||||++|||++|+.||...... ......+........ . .
T Consensus 155 ~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 231 (292)
T d1unla_ 155 VR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV--DDQLKRIFRLLGTPTEEQWPSMT 231 (292)
T ss_dssp CS-CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSH--HHHHHHHHHHHCCCCTTTCTTGG
T ss_pred Cc-cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCH--HHHHHHHHhhcCCCChhhhhhhh
Confidence 32 233346788999999887665 689999999999999999999998543321 111111111111100 0 0
Q ss_pred cC--------CC-ccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 416 GV--------LD-PRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 416 ~~--------~~-~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
.. .. ..............+.+++.+||+.||++|||++|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00 00 000001111222345668889999999999999999874
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.1e-45 Score=366.43 Aligned_cols=258 Identities=19% Similarity=0.281 Sum_probs=196.1
Q ss_pred CCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCchhHHHHHHHHHHHHccC-CCCeeeEeeeeec--CCeeEEEE
Q 010513 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVR-HKNLVRLLGYCAE--GAHRMLVY 261 (508)
Q Consensus 186 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~--~~~~~lV~ 261 (508)
++|+++++||+|+||+||+|++. +|+.||||++... ..+.+.+|+++|+.++ ||||++++++|.. ....++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 57999999999999999999975 6888999998643 2467888999999995 9999999999974 35689999
Q ss_pred EecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCC-CeEEeeeccceecC
Q 010513 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQW-NPKLSDFGLAKLLG 340 (508)
Q Consensus 262 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~-~~kL~DFG~a~~~~ 340 (508)
|||.+|+|.++. ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||+++...
T Consensus 112 e~~~~~~L~~~~-------~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~ 181 (328)
T d3bqca1 112 EHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 181 (328)
T ss_dssp ECCCSCBGGGTT-------TSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEECC
T ss_pred eecCCCcHHHHh-------cCCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccceecc
Confidence 999999997763 3589999999999999999999999 999999999999998655 58999999998764
Q ss_pred CCCcceecceecCCCCCChhhhhcC-CCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcch--HH---------HHHHHh
Q 010513 341 AERSYVTTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVN--LV---------EWLKTM 408 (508)
Q Consensus 341 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~--~~---------~~~~~~ 408 (508)
.... ....+||+.|+|||.+.+. .++.++||||+||++|||++|+.||.......... .. .+....
T Consensus 182 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 259 (328)
T d3bqca1 182 PGQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY 259 (328)
T ss_dssp TTCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHT
T ss_pred CCCc--ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhc
Confidence 4322 3446799999999998765 57999999999999999999999997554321110 00 000000
Q ss_pred hcc--cccccCCC--------ccCCCCchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 409 VTN--RNAEGVLD--------PRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 409 ~~~--~~~~~~~~--------~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
... ........ .............++.+++.+||+.||++|||++|++++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H 319 (328)
T d3bqca1 260 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 319 (328)
T ss_dssp TCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000 00000000 001111112223456678889999999999999999863
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-44 Score=365.32 Aligned_cols=259 Identities=24% Similarity=0.277 Sum_probs=190.2
Q ss_pred CCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCC--chhHHHHHHHHHHHHccCCCCeeeEeeeeec------CCe
Q 010513 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE------GAH 256 (508)
Q Consensus 186 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~------~~~ 256 (508)
++|++.++||+|+||+||+|++. +|+.||||++.... ....+.+.+|+.++++++|||||+++++|.. ..+
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 68999999999999999999976 68999999997543 3344578899999999999999999999963 468
Q ss_pred eEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccc
Q 010513 257 RMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLA 336 (508)
Q Consensus 257 ~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a 336 (508)
.|+||||+.++ +.+.+. ..+++..++.++.|++.||+|||++ ||+||||||+|||++.++.+|++|||++
T Consensus 97 ~~iv~Ey~~~~-l~~~~~------~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~ 166 (355)
T d2b1pa1 97 VYLVMELMDAN-LCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_dssp EEEEEECCSEE-HHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred eEEEEeccchH-HHHhhh------cCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhhh
Confidence 89999999775 555553 3589999999999999999999999 9999999999999999999999999998
Q ss_pred eecCCCCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHH-----------
Q 010513 337 KLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWL----------- 405 (508)
Q Consensus 337 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~----------- 405 (508)
+..... ...+..+||+.|+|||++.+..+++++||||+||++|||++|+.||....... .....+
T Consensus 167 ~~~~~~--~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~--~~~~i~~~~~~~~~~~~ 242 (355)
T d2b1pa1 167 RTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID--QWNKVIEQLGTPCPEFM 242 (355)
T ss_dssp ----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHHCCCCHHHH
T ss_pred hccccc--cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHH--HHHHHHHhccCCCHHHH
Confidence 865432 23345689999999999999999999999999999999999999996443110 000000
Q ss_pred -------HHhhcccc-c-----ccCCCcc-CCC--CchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 406 -------KTMVTNRN-A-----EGVLDPR-LQE--KPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 406 -------~~~~~~~~-~-----~~~~~~~-l~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
........ . ....... ... ........++.+++.+||+.||++|||++|++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp TTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00000000 0 0000000 011 1122345677889999999999999999999966
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-44 Score=361.12 Aligned_cols=258 Identities=21% Similarity=0.292 Sum_probs=193.6
Q ss_pred CCCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCC--chhHHHHHHHHHHHHccCCCCeeeEeeeeecC-----Ce
Q 010513 185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEG-----AH 256 (508)
Q Consensus 185 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-----~~ 256 (508)
.++|++.+.||+|+||+||+|++. +|+.||||++.+.. ....+.+.+|+++|++++|||||++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 468999999999999999999975 68899999986543 23445788999999999999999999998633 34
Q ss_pred eEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeEEeeeccc
Q 010513 257 RMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLA 336 (508)
Q Consensus 257 ~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG~a 336 (508)
.+++|+|+.+|+|.+++.. ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+|++|||++
T Consensus 97 ~~~i~~~~~gg~L~~~~~~-----~~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a 168 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA 168 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC---
T ss_pred eEEEEEeecCCchhhhccc-----ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchh
Confidence 4677788889999999964 3699999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCcceecceecCCCCCChhhhhcC-CCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHhhcccc--
Q 010513 337 KLLGAERSYVTTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRN-- 413 (508)
Q Consensus 337 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~-- 413 (508)
..... ......||+.|+|||.+.+. .++.++|||||||++|+|++|+.||...+.. .....+........
T Consensus 169 ~~~~~----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~---~~~~~i~~~~~~~~~~ 241 (348)
T d2gfsa1 169 RHTDD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI---DQLKLILRLVGTPGAE 241 (348)
T ss_dssp -CCTG----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCCCCHH
T ss_pred cccCc----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHH---HHHHHHHHhcCCCChH
Confidence 75432 23446789999999987665 5688999999999999999999999754311 11111111100000
Q ss_pred ------------cccCCCccCCCCch----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010513 414 ------------AEGVLDPRLQEKPC----SRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (508)
Q Consensus 414 ------------~~~~~~~~l~~~~~----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 458 (508)
....+ +....... .....++.+++.+||+.||++|||+.|++++
T Consensus 242 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H 301 (348)
T d2gfsa1 242 LLKKISSESARNYIQSL-TQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301 (348)
T ss_dssp HHTTCCCHHHHHHHTTS-CCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred Hhhhccchhhhhhhhhc-ccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence 00000 00000000 0112345668889999999999999999983
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4.4e-40 Score=332.10 Aligned_cols=269 Identities=19% Similarity=0.188 Sum_probs=192.9
Q ss_pred HhhcC-CCCcccceEcccCcEEEEEEEEC-CCcEEEEEEeecCCchhHHHHHHHHHHHHccC-----------CCCeeeE
Q 010513 181 LEVST-NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVR-----------HKNLVRL 247 (508)
Q Consensus 181 ~~~~~-~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------hpniv~l 247 (508)
++... ++|+++++||+|+||+||+|+.. +|+.||||++.+.. ...+.+.+|+++++.++ |+||+++
T Consensus 7 g~~~~~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~ 85 (362)
T d1q8ya_ 7 GEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKL 85 (362)
T ss_dssp TCEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCC
T ss_pred CCCccCCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEE
Confidence 34433 46999999999999999999975 68899999986543 23456778998888775 5789999
Q ss_pred eeeeec--CCeeEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeeccCCCCCEEEcC
Q 010513 248 LGYCAE--GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE-GLEPKVVHRDIKSSNILLDK 324 (508)
Q Consensus 248 ~~~~~~--~~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~~iiHrDlkp~NIll~~ 324 (508)
++++.. ....+++|+++..+......... .....+++..++.++.|++.||+|||+ . +|+||||||+|||++.
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~ 161 (362)
T d1q8ya_ 86 LDHFNHKGPNGVHVVMVFEVLGENLLALIKK-YEHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEI 161 (362)
T ss_dssp CEEEEEEETTEEEEEEEECCCCEEHHHHHHH-TTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEE
T ss_pred EEEeeeccccceeeeeeeccccccccccccc-ccccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHeeeec
Confidence 998864 34566777777655433332221 124678999999999999999999997 6 8999999999999976
Q ss_pred CCC------eEEeeeccceecCCCCcceecceecCCCCCChhhhhcCCCCCCCCeeehHHHHHHHHhCCCCCCCCCCCCc
Q 010513 325 QWN------PKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGE 398 (508)
Q Consensus 325 ~~~------~kL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~Pf~~~~~~~~ 398 (508)
++. ++++|||.+...... ....+||+.|+|||++....++.++|+||+||++++|++|+.||........
T Consensus 162 ~~~~~~~~~~kl~dfg~s~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~ 237 (362)
T d1q8ya_ 162 VDSPENLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSY 237 (362)
T ss_dssp EETTTTEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred cCcccccceeeEeecccccccccc----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccc
Confidence 653 999999999865332 2446799999999999999999999999999999999999999975533222
Q ss_pred chHHHHHHHhhc---------------------ccccccCCCcc----------CCCCchHHHHHHHHHHHHHccCCCCC
Q 010513 399 VNLVEWLKTMVT---------------------NRNAEGVLDPR----------LQEKPCSRALKRALLVALRCVDPNAH 447 (508)
Q Consensus 399 ~~~~~~~~~~~~---------------------~~~~~~~~~~~----------l~~~~~~~~~~~l~~li~~cl~~dP~ 447 (508)
....+.+...+. ........... ...........++.+++.+||+.||+
T Consensus 238 ~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~ 317 (362)
T d1q8ya_ 238 TKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPR 317 (362)
T ss_dssp -CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTT
T ss_pred cchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChh
Confidence 221111111100 00000000000 01122345567788899999999999
Q ss_pred CCCCHHHHHHH
Q 010513 448 KRPKMGHVIHM 458 (508)
Q Consensus 448 ~RPs~~evl~~ 458 (508)
+|||++|++++
T Consensus 318 ~Rpta~e~L~H 328 (362)
T d1q8ya_ 318 KRADAGGLVNH 328 (362)
T ss_dssp TCBCHHHHHTC
T ss_pred HCcCHHHHhcC
Confidence 99999999985
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.91 E-value=1.2e-24 Score=198.34 Aligned_cols=164 Identities=18% Similarity=0.168 Sum_probs=120.9
Q ss_pred CcccceEcccCcEEEEEEEECCCcEEEEEEeecCCc------------------hhHHHHHHHHHHHHccCCCCeeeEee
Q 010513 188 FADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRG------------------QAEKEFKVEVEAIGRVRHKNLVRLLG 249 (508)
Q Consensus 188 ~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~hpniv~l~~ 249 (508)
+.+.++||+|+||+||+|.+.+|+.||||.+..... ........|...+.++.|.+++..++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 356899999999999999998899999998642210 01123456888999999999998886
Q ss_pred eeecCCeeEEEEEecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCEEEcCCCCeE
Q 010513 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPK 329 (508)
Q Consensus 250 ~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiHrDlkp~NIll~~~~~~k 329 (508)
+.. .+++|||+++..+.+ ++......++.|++++++|||++ +|+||||||+|||++++ .++
T Consensus 82 ~~~----~~lvme~~~~~~~~~-----------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~ 142 (191)
T d1zara2 82 WEG----NAVLMELIDAKELYR-----------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIW 142 (191)
T ss_dssp EET----TEEEEECCCCEEGGG-----------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEE
T ss_pred ecC----CEEEEEeeccccccc-----------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEE
Confidence 642 379999998865433 23344567899999999999999 99999999999999975 599
Q ss_pred EeeeccceecCCCCcceecceecCCCCCC------hhhhhcCCCCCCCCeeehHHHH
Q 010513 330 LSDFGLAKLLGAERSYVTTRVMGTFGYVA------PEYASTGMLNERSDVYSFGILI 380 (508)
Q Consensus 330 L~DFG~a~~~~~~~~~~~~~~~gt~~y~a------PE~~~~~~~~~~sDvwSlGvvl 380 (508)
|+|||.|.......... |.. .|.+ .+.|+.++|+||..--+
T Consensus 143 liDFG~a~~~~~~~~~~---------~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 143 IIDFPQSVEVGEEGWRE---------ILERDVRNIITYF-SRTYRTEKDINSAIDRI 189 (191)
T ss_dssp ECCCTTCEETTSTTHHH---------HHHHHHHHHHHHH-HHHHCCCCCHHHHHHHH
T ss_pred EEECCCcccCCCCCcHH---------HHHHHHHHHHHHH-cCCCCCcccHHHHHHHH
Confidence 99999998654322110 111 1111 35678899999976443
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.58 E-value=8.9e-08 Score=89.15 Aligned_cols=145 Identities=15% Similarity=0.072 Sum_probs=99.0
Q ss_pred cCCCCcccceEcccCcEEEEEEEECCCcEEEEEEeecCCchhHHHHHHHHHHHHccC-CCCeeeEeeeeecCCeeEEEEE
Q 010513 184 STNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVR-HKNLVRLLGYCAEGAHRMLVYE 262 (508)
Q Consensus 184 ~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~lV~e 262 (508)
..+.|++.+..+-++.+.||+... +++.+++|+...........+.+|...+..+. +--+.+++.+..+++..++||+
T Consensus 12 ~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~ 90 (263)
T d1j7la_ 12 LIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMS 90 (263)
T ss_dssp HHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEE
T ss_pred hhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEE
Confidence 335666666554444578998864 46678888876554444455677888887773 3336677888888888999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC------------------------------------
Q 010513 263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGL------------------------------------ 306 (508)
Q Consensus 263 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~------------------------------------ 306 (508)
+++|.++.+..... .. ...++.++++.++.||+..
T Consensus 91 ~l~G~~~~~~~~~~------~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (263)
T d1j7la_ 91 EADGVLCSEEYEDE------QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEED 161 (263)
T ss_dssp CCSSEEHHHHTTTC------SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTT
T ss_pred eccccccccccccc------cc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccccc
Confidence 99998876643221 11 2234455666666666421
Q ss_pred --------------------CCCeeeccCCCCCEEEcCCCCeEEeeecccee
Q 010513 307 --------------------EPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL 338 (508)
Q Consensus 307 --------------------~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~ 338 (508)
.+.++|+|+.|.|||+++++.+-|+||+.+..
T Consensus 162 ~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 162 TPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp CSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred ccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 12378999999999999876667999998763
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.04 E-value=1.1e-05 Score=73.96 Aligned_cols=130 Identities=17% Similarity=0.147 Sum_probs=83.3
Q ss_pred EcccCc-EEEEEEEECCCcEEEEEEeecCCchhHHHHHHHHHHHHccCC--CCeeeEeeeeecCCeeEEEEEecCCCCHH
Q 010513 194 IGEGGY-GIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRH--KNLVRLLGYCAEGAHRMLVYEYIDNGNLE 270 (508)
Q Consensus 194 LG~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--pniv~l~~~~~~~~~~~lV~e~~~~g~L~ 270 (508)
+..|.. +.||+....++..+++|...... ...+..|...++.+.. -.+.+++.+..+++..++||++++|.++.
T Consensus 18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~ 94 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL 94 (255)
T ss_dssp CSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred cCCcccCCeEEEEEeCCCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccccc
Confidence 344543 68999988777778888754332 2345667777776632 33566788888888889999999885543
Q ss_pred HHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHh----------------------------------------------
Q 010513 271 QWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE---------------------------------------------- 304 (508)
Q Consensus 271 ~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---------------------------------------------- 304 (508)
+. ..... .++.++++.|.-||+
T Consensus 95 ~~---------~~~~~---~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (255)
T d1nd4a_ 95 SS---------HLAPA---EKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF 162 (255)
T ss_dssp TS---------CCCHH---HHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred cc---------cccHH---HHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHH
Confidence 21 01111 112233333333332
Q ss_pred -----cC----CCCeeeccCCCCCEEEcCCCCeEEeeecccee
Q 010513 305 -----GL----EPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL 338 (508)
Q Consensus 305 -----~~----~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~~ 338 (508)
.. .+.++|+|+.|.|||++++..+-|+||+.+..
T Consensus 163 ~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 163 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 10 22379999999999999876678999997763
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.57 E-value=0.00012 Score=71.64 Aligned_cols=76 Identities=17% Similarity=0.216 Sum_probs=47.4
Q ss_pred cceEcccCcEEEEEEEECC-CcEEEEEEeecC-------CchhHHHHHHHHHHHHcc-CC--CCeeeEeeeeecCCeeEE
Q 010513 191 ENVIGEGGYGIVYHGVLED-NTNVAVKNLLNN-------RGQAEKEFKVEVEAIGRV-RH--KNLVRLLGYCAEGAHRML 259 (508)
Q Consensus 191 ~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~-------~~~~~~~~~~E~~~l~~l-~h--pniv~l~~~~~~~~~~~l 259 (508)
.+.||.|....||+....+ ++.+++|.-... .....+....|.+.|+.+ .+ ..+.+++.+ ++...++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 4568999999999998654 667889865321 111233455677777766 22 345555544 4455689
Q ss_pred EEEecCCCC
Q 010513 260 VYEYIDNGN 268 (508)
Q Consensus 260 V~e~~~~g~ 268 (508)
|||++.+..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999997643
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.12 E-value=0.00078 Score=63.90 Aligned_cols=136 Identities=15% Similarity=0.167 Sum_probs=76.6
Q ss_pred EEEEEEEECCCcEEEEEEeecCCchhHHHHHHHHHHHHccCCCCe-----eeEe--eeeecCCeeEEEEEecCCCCH---
Q 010513 200 GIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNL-----VRLL--GYCAEGAHRMLVYEYIDNGNL--- 269 (508)
Q Consensus 200 g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpni-----v~l~--~~~~~~~~~~lV~e~~~~g~L--- 269 (508)
-.||++..++|+.|++|..... ....+++..|...+..|...++ +..- ..+..+...+.++++++|..+
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~ 114 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD 114 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred ceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence 4899999989999999986543 2345667788888877742222 1111 123445667889999876321
Q ss_pred --HHH---------hc----cCCCC-CCCCCH-------------------HHHHHHHHHHHHHHHHHH----hcCCCCe
Q 010513 270 --EQW---------LH----GDVGP-HSPLTW-------------------EIRMNIILGTAKGLTYLH----EGLEPKV 310 (508)
Q Consensus 270 --~~~---------l~----~~~~~-~~~l~~-------------------~~~~~i~~qi~~al~~LH----~~~~~~i 310 (508)
..+ ++ ..... ....+. .....+...+...++.+. +....++
T Consensus 115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l 194 (325)
T d1zyla1 115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR 194 (325)
T ss_dssp CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence 111 11 11000 011111 111112222222333332 2224478
Q ss_pred eeccCCCCCEEEcCCCCeEEeeecccee
Q 010513 311 VHRDIKSSNILLDKQWNPKLSDFGLAKL 338 (508)
Q Consensus 311 iHrDlkp~NIll~~~~~~kL~DFG~a~~ 338 (508)
||+|+.+.|||++++ ..++||+-+..
T Consensus 195 iHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 195 LHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred ecCCCCcccEEEeCC--ceEEechhccc
Confidence 999999999999754 46899998764
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.69 E-value=0.0036 Score=60.76 Aligned_cols=72 Identities=17% Similarity=0.169 Sum_probs=47.8
Q ss_pred cceEcccCcEEEEEEEECCC--------cEEEEEEeecCCchhHHHHHHHHHHHHccC-CCCeeeEeeeeecCCeeEEEE
Q 010513 191 ENVIGEGGYGIVYHGVLEDN--------TNVAVKNLLNNRGQAEKEFKVEVEAIGRVR-HKNLVRLLGYCAEGAHRMLVY 261 (508)
Q Consensus 191 ~~~LG~G~~g~Vy~~~~~~~--------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~lV~ 261 (508)
++.|+.|-.=.+|++...++ ..|.+++... . .......+|..+++.+. +.-..++++++.+ .+||
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~-~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ 120 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-P-ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 120 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-C-CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-c-chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence 35688888899999986543 4566665542 2 22334567888888874 4334577777754 6899
Q ss_pred EecCCCC
Q 010513 262 EYIDNGN 268 (508)
Q Consensus 262 e~~~~g~ 268 (508)
||++|..
T Consensus 121 efi~g~~ 127 (395)
T d1nw1a_ 121 EYIPSRP 127 (395)
T ss_dssp CCCCEEE
T ss_pred EEecccc
Confidence 9998743
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.04 E-value=0.01 Score=55.40 Aligned_cols=31 Identities=26% Similarity=0.278 Sum_probs=27.2
Q ss_pred CCCeeeccCCCCCEEEcCCCCeEEeeeccce
Q 010513 307 EPKVVHRDIKSSNILLDKQWNPKLSDFGLAK 337 (508)
Q Consensus 307 ~~~iiHrDlkp~NIll~~~~~~kL~DFG~a~ 337 (508)
..++||+|+.++||+++++...-++||+.+.
T Consensus 182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 182 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccccccCCcchhhhhcccccceeEecccccc
Confidence 3479999999999999988777899999876
|